PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhou, X; Feng, Y; Zhan, ZB; Chen, JC				Zhou, Xiang; Feng, Yu; Zhan, Zhoubing; Chen, Jianchang			Hydrogen Sulfide Alleviates Diabetic Nephropathy in a Streptozotocin-induced Diabetic Rat Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENIN-ANGIOTENSIN SYSTEM; CHRONIC KIDNEY-DISEASE; NF-KAPPA-B; OXIDATIVE STRESS; MECHANISMS; PATHOGENESIS; INFLAMMATION; PROGRESSION	Accumulating evidence has demonstrated that hydrogen sulfide (H2S) plays critical roles in the pathogenesis of chronic kidney diseases. This study was designed to investigate whether H2S has protective effects against diabetic nephropathy. Diabetic rats were induced by intraperitoneal injection of streptozotocin and administrated with H2S donor NaHS for 12 weeks. Rat glomerular mesangial cells were pretreated with NaHS or MAPK inhibitors (U0126, SP600125, and SB203580) prior to high glucose exposure, and cell proliferation was determined. Our findings suggest that H2S can improve renal function and attenuate glomerular basement membrane thickening, mesangial matrix deposition, and renal interstitial fibrosis in diabetic rats. H2S was found to reduce high glucose-induced oxidative stress by activating the Nrf2 antioxidant pathway and to exert anti-inflammatory effects by inhibiting NF-kappa B signaling. In addition, H2S reduced high glucose-induced mesangial cell proliferation by blockade of MAPK signaling pathways. Moreover, H2S was also found to inhibit the renin-angiotensin system in diabetic kidney. In conclusion, our study demonstrates that H2S alleviates the development of diabetic nephropathy by attenuating oxidative stress and inflammation, reducing mesangial cell proliferation, and inhibiting renin-angiotensin system activity.	[Zhou, Xiang; Chen, Jianchang] Soochow Univ, Dept Cardiol, Affiliated Hosp 2, Suzhou 215004, Peoples R China; [Feng, Yu] Soochow Univ, Dept Endocrinol, Affiliated Hosp 2, Suzhou 215004, Peoples R China; [Zhan, Zhoubing] Soochow Univ, Dept Nephrol, Affiliated Hosp 2, Suzhou 215004, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Zhou, X (corresponding author), Soochow Univ, Dept Cardiol, Affiliated Hosp 2, 1055 Sanxiang Rd, Suzhou 215004, Peoples R China.	zhou-xiang@suda.edu.cn						Aminzadeh MA, 2012, NEPHROL DIAL TRANSPL, V27, P498, DOI 10.1093/ndt/gfr560; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Carey RM, 2003, TRENDS ENDOCRIN MET, V14, P274, DOI 10.1016/S1043-2760(03)00111-5; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Gurley SB, 2007, SEMIN NEPHROL, V27, P144, DOI 10.1016/j.semnephrol.2007.01.009; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kawano H, 2003, J AM SOC NEPHROL, V14, P584, DOI 10.1097/01.ASN.0000050415.97942.2F; Lim AKH, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/146154; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Remuzzi G, 2005, KIDNEY INT, V68, P57; Saito H, 2013, BIOCHEM PHARMACOL, V85, P865, DOI 10.1016/j.bcp.2013.01.006; Song K, 2014, KIDNEY INT, V85, P1318, DOI 10.1038/ki.2013.449; Stanton RC, 2011, CURR DIABETES REP, V11, P330, DOI 10.1007/s11892-011-0196-9; Sun YM, 2013, BIOCHEM BIOPH RES CO, V433, P359, DOI 10.1016/j.bbrc.2013.02.120; Wada J, 2013, CLIN SCI, V124, P139, DOI 10.1042/CS20120198; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x	20	115	123	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28827	28834		10.1074/jbc.M114.596593	http://dx.doi.org/10.1074/jbc.M114.596593			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25164822	Green Published, hybrid			2022-12-25	WOS:000344141000007
J	Teixeira, PC; Ducret, A; Ferber, P; Gaertner, H; Hartley, O; Pagano, S; Butterfield, M; Langen, H; Vuilleumier, N; Cutler, P				Teixeira, Priscila Camillo; Ducret, Axel; Ferber, Philippe; Gaertner, Hubert; Hartley, Oliver; Pagano, Sabrina; Butterfield, Michelle; Langen, Hanno; Vuilleumier, Nicolas; Cutler, Paul			Definition of Human Apolipoprotein A-I Epitopes Recognized by Autoantibodies Present in Patients with Cardiovascular Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; HIGH-DENSITY-LIPOPROTEIN; PERFORMANCE LIQUID-CHROMATOGRAPHY; PRIMARY ANTIPHOSPHOLIPID SYNDROME; RHEUMATOID-ARTHRITIS; A-1 AUTOANTIBODIES; OXIDIZED LDL; HUMAN-PLASMA; MYOCARDIAL-INFARCTION; REVERSIBLE BLOCKING	Autoantibodies to apolipoprotein A-I (anti-apoA-I IgG) have been shown to be both markers and mediators of cardiovascular disease, promoting atherogenesis and unstable atherosclerotic plaque. Previous studies have shown that high levels of anti-apoA-I IgGs are independently associated with major adverse cardiovascular events in patients with myocardial infarction. Autoantibody responses to apoA-I can be polyclonal and it is likely that more than one epitope may exist. To identify the specific immunoreactive peptides in apoA-I, we have developed a set of methodologies and procedures to isolate, purify, and identify novel apoA-I endogenous epitopes. First, we generated high purity apoA-I from human plasma, using thiophilic interaction chromatography followed by enzymatic digestion specifically at lysine or arginine residues. Immunoreactivity to the different peptides generated was tested by ELISA using serum obtained from patients with acute myocardial infarction and high titers of autoantibodies to native apoA-I. The immunoreactive peptides were further sequenced by mass spectrometry. Our approach successfully identified two novel immunoreactive peptides, recognized by autoantibodies from patients suffering from myocardial infarction, who contain a high titer of anti- apoA-I IgG. The discovery of these epitopes may open innovative prognostic and therapeutic opportunities potentially suitable to improve current cardiovascular risk stratification.	[Teixeira, Priscila Camillo; Ducret, Axel; Ferber, Philippe; Butterfield, Michelle; Langen, Hanno; Cutler, Paul] Roche Innovat Ctr, CH-4070 Basel, Switzerland; [Teixeira, Priscila Camillo; Pagano, Sabrina; Vuilleumier, Nicolas] 1205 Geneva Univ Hosp, Div Lab Med, Dept Genet & Lab Med, CH-1205 Geneva, Switzerland; [Gaertner, Hubert; Hartley, Oliver] Univ Geneva, Fac Med, Dept Immunopathol, CH-1205 Geneva, Switzerland	Roche Holding; University of Geneva; University of Geneva	Teixeira, PC (corresponding author), F Hoffmann La Roche, Roche Innovat Ctr Basel, Pharmaceut Sci Pharma Res & Early Dev, Grenzacherstr 124,Bldg 93,Rm 4-38, CH-4070 Basel, Switzerland.	priscila.teixeira@roche.com		, Nicolas/0000-0002-1122-438X; Camillo Teixeira, Priscila/0000-0002-9698-4563	Roche Postdoctoral Fellowship Program; Swiss National Science Foundation [31-0030_140736]	Roche Postdoctoral Fellowship Program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Roche Postdoctoral Fellowship Program and Swiss National Science Foundation Grant 31-0030_140736 (to N.V.).	Abe H, 2001, J RHEUMATOL, V28, P990; Alves JD, 2003, RHEUMATOLOGY, V42, P893, DOI 10.1093/rheumatology/keg248; Ames PRJ, 2010, LUPUS, V19, P711, DOI 10.1177/0961203309357765; Aranow C, 2000, LUPUS, V9, P166, DOI 10.1191/096120300678828208; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENDEL V, 1991, P NATL ACAD SCI USA, V88, P1536, DOI 10.1073/pnas.88.4.1536; Brouillette CG, 2001, BBA-MOL CELL BIOL L, V1531, P4, DOI 10.1016/S1388-1981(01)00081-6; BROUILLETTE CG, 1995, BBA-LIPID LIPID MET, V1256, P103, DOI 10.1016/0005-2760(95)00018-8; Brubaker G, 2006, BBA-MOL CELL BIOL L, V1761, P64, DOI 10.1016/j.bbalip.2006.01.007; BUTLER PJG, 1967, BIOCHEM J, V103, pP78; BUTLER PJG, 1969, BIOCHEM J, V112, P679, DOI 10.1042/bj1120679; Carbone F, 2013, THROMB HAEMOSTASIS, V109, P854, DOI 10.1160/TH12-10-0768; Contiero E, 1997, ELECTROPHORESIS, V18, P122, DOI 10.1002/elps.1150180123; DeMaria AN, 2002, AM J CARDIOL, V89, p33D; Deterding LJ, 2002, ELECTROPHORESIS, V23, P2296, DOI 10.1002/1522-2683(200207)23:14&lt;2296::AID-ELPS2296&gt;3.0.CO;2-I; DOHLMAN JG, 1993, BIOCHEM BIOPH RES CO, V195, P686, DOI 10.1006/bbrc.1993.2100; DUCCESCHI V, 1995, EUR HEART J, V16, P441, DOI 10.1093/oxfordjournals.eurheartj.a060934; EDELSTEIN C, 1986, METHOD ENZYMOL, V128, P339; FIDGE N, 1975, J LIPID RES, V16, P367; Foteinos G, 2005, CIRCULATION, V112, P1206, DOI 10.1161/CIRCULATIONAHA.105.547414; Frostegard J, 2008, LUPUS, V17, P364, DOI 10.1177/0961203308089988; GILL TJ, 1967, J BIOL CHEM, V242, P3308; Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10; Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028; HUGHES TA, 1988, J LIPID RES, V29, P363; Keller PF, 2012, J INTERN MED, V271, P451, DOI 10.1111/j.1365-2796.2011.02479.x; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Lyssenko NN, 2012, BBA-MOL CELL BIOL L, V1821, P456, DOI 10.1016/j.bbalip.2011.07.020; Mackay IR, 2004, AUTOIMMUN REV, V3, P487, DOI 10.1016/j.autrev.2004.07.011; Mahler M, 2010, ANN NY ACAD SCI, V1183, P267, DOI 10.1111/j.1749-6632.2009.05127.x; Montecucco F, 2011, EUR HEART J, V32, P412, DOI 10.1093/eurheartj/ehq521; Murphy TP, 2011, ATHEROSCLEROSIS, V216, P452, DOI 10.1016/j.atherosclerosis.2011.02.020; Naghavi Morteza, 2006, Crit Pathw Cardiol, V5, P187, DOI 10.1097/01.hpc.0000249784.29151.54; Nilsson J, 2004, CURR OPIN LIPIDOL, V15, P499, DOI 10.1097/00041433-200410000-00002; Nossent H, 2000, J RHEUMATOL, V27, P2282; OTT GS, 1982, J CHROMATOGR, V231, P1, DOI 10.1016/S0378-4347(00)80504-6; Pagano S, 2012, J INTERN MED, V272, P344, DOI 10.1111/j.1365-2796.2012.02530.x; Pawlak K, 2012, ATHEROSCLEROSIS, V224, P252, DOI 10.1016/j.atherosclerosis.2012.07.011; Plotz PH, 2003, NAT REV IMMUNOL, V3, P73, DOI 10.1038/nri976; PORATH J, 1985, FEBS LETT, V185, P306, DOI 10.1016/0014-5793(85)80928-5; Pruijm M, 2012, THER APHER DIAL, V16, P588, DOI 10.1111/j.1744-9987.2012.01102.x; Quercioli A, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/243158; Radwan MM, 2014, CLIN RHEUMATOL, V33, P493, DOI 10.1007/s10067-013-2399-8; Ravandi A, 2011, J LIPID RES, V52, P1829, DOI 10.1194/jlr.M015776; Rosales C, 2009, BIOCHEMISTRY-US, V48, P8070, DOI 10.1021/bi901087z; Rossier MF, 2012, ENDOCRINOLOGY, V153, P1269, DOI 10.1210/en.2011-1835; SANGER F, 1953, BIOCHEM J, V53, P366, DOI 10.1042/bj0530366; Sarzi-Puttini P, 2003, Minerva Med, V94, P63; SEGREST JP, 1992, J LIPID RES, V33, P141; Shoenfeld Y, 2007, ANN NY ACAD SCI, V1108, P227, DOI 10.1196/annals.1422.025; Sigalov AB, 2001, CHEM PHYS LIPIDS, V113, P133, DOI 10.1016/S0009-3084(01)00186-4; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; SPRECHER DL, 1984, CLIN CHEM, V30, P2084; Srivastava R, 2011, ARTHRITIS RHEUM-US, V63, P201, DOI 10.1002/art.27764; Svenungsson E, 2001, CIRCULATION, V104, P1887, DOI 10.1161/hc4101.097518; TADEY T, 1995, J CHROMATOGR B, V671, P237, DOI 10.1016/0378-4347(95)00051-J; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P10351, DOI 10.1021/bi060726t; Teixeira PC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/868251; Tricerri A, 1998, BBA-LIPID LIPID MET, V1391, P67, DOI 10.1016/S0005-2760(97)00187-2; Udi N, 2008, AUTOIMMUN REV, V7, P445, DOI 10.1016/j.autrev.2008.04.001; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; Vuilleumier N, 2004, J AUTOIMMUN, V23, P353, DOI 10.1016/j.jaut.2004.08.003; Vuilleumier N, 2010, SCAND J RHEUMATOL, V39, P447, DOI 10.3109/03009741003742755; Vuilleumier N, 2013, THROMB HAEMOSTASIS, V109, P706, DOI 10.1160/TH12-10-0714; Vuilleumier N, 2010, ARTHRITIS RHEUM-US, V62, P2640, DOI 10.1002/art.27546; Vuilleumier N, 2010, EUR HEART J, V31, P815, DOI 10.1093/eurheartj/ehq055; Wick G, 1999, EXP GERONTOL, V34, P559, DOI 10.1016/S0531-5565(99)00035-2; Wick PA, 2013, J PERIODONTAL RES, V48, P350, DOI 10.1111/jre.12014; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	70	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28249	28259		10.1074/jbc.M114.589002	http://dx.doi.org/10.1074/jbc.M114.589002			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25170076	hybrid, Green Published			2022-12-25	WOS:000343765400021
J	Ishida, S; Tanaka, R; Yamaguchi, N; Ogata, G; Mizutani, T; Kawabata, K; Haga, H				Ishida, Sumire; Tanaka, Ryosuke; Yamaguchi, Naoya; Ogata, Genki; Mizutani, Takeomi; Kawabata, Kazushige; Haga, Hisashi			Epithelial Sheet Folding Induces Lumen Formation by Madin-Darby Canine Kidney Cells in a Collagen Gel	PLOS ONE			English	Article							3-DIMENSIONAL CULTURE; TUBULE FORMATION; LEADER CELLS; WOUND-REPAIR; MYOSIN-II; MIGRATION; MORPHOGENESIS; POLARITY; BETA-1-INTEGRIN; PROLIFERATION	Lumen formation is important for morphogenesis; however, an unanswered question is whether it involves the collective migration of epithelial cells. Here, using a collagen gel overlay culture method, we show that Madin-Darby canine kidney cells migrated collectively and formed a luminal structure in a collagen gel. Immediately after the collagen gel overlay, an epithelial sheet folded from the periphery, migrated inwardly, and formed a luminal structure. The inhibition of integrin-beta 1 or Rac1 activity decreased the migration rate of the peripheral cells after the sheets folded. Moreover, lumen formation was perturbed by disruption of apical-basolateral polarity induced by transforming growth factor-beta 1. These results indicate that cell migration and cell polarity play an important role in folding. To further explore epithelial sheet folding, we developed a computer-simulated mechanical model based on the rigidity of the extracellular matrix. It indicated a soft substrate is required for the folding movement.	[Ishida, Sumire; Tanaka, Ryosuke; Yamaguchi, Naoya; Ogata, Genki; Mizutani, Takeomi; Kawabata, Kazushige; Haga, Hisashi] Hokkaido Univ, Fac Adv Life Sci, Transdisciplinary Life Sci Course, Sapporo, Hokkaido, Japan; [Haga, Hisashi] Hokkaido Univ, Grad Sch Med, Res Ctr Cooperat Projects, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Haga, H (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Transdisciplinary Life Sci Course, Sapporo, Hokkaido, Japan.	haga@sci.hokudai.ac.jp	Haga, Hisashi/E-6931-2010	Haga, Hisashi/0000-0001-9464-6723; Yamaguchi, Naoya/0000-0003-0573-695X	Ministry of Education, Culture, Sports, Science and Technology, Japan [24390285, 25127701, 23770167, 24106502, 25287106]; Special Expenditures for "Reverse Translational Research from Advanced Medical Technology to Advanced Life Science''; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [25287106] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Expenditures for "Reverse Translational Research from Advanced Medical Technology to Advanced Life Science''; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research (B) (24390285) and Scientific Research on Innovative Areas (25127701) to H.H., Young Scientists (B) (23770167) and Scientific Research on Innovative Areas (24106502) to T.M., and Scientific Research (B) (25287106) to K.K. from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This research was also partially supported by Special Expenditures for "Reverse Translational Research from Advanced Medical Technology to Advanced Life Science'' to H.H. funded by the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukhil I, 2000, PERIODONTOL 2000, V22, P44, DOI 10.1034/j.1600-0757.2000.2220104.x; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chen J, 2013, EXP CELL RES, V319, P1357, DOI 10.1016/j.yexcr.2013.03.021; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Eisen R, 2006, AM J PHYSIOL-CELL PH, V290, pC1297, DOI 10.1152/ajpcell.00287.2005; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Haga H, 2005, BIOPHYS J, V88, P2250, DOI 10.1529/biophysj.104.047654; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; HALL DE, 1990, J CELL BIOL, V110, P2175, DOI 10.1083/jcb.110.6.2175; HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hellman NE, 2008, J BIOL CHEM, V283, P4272, DOI 10.1074/jbc.M708027200; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Herard AL, 1996, AM J PHYSIOL-LUNG C, V271, pL726, DOI 10.1152/ajplung.1996.271.5.L726; HERGOTT GJ, 1993, INVEST OPHTH VIS SCI, V34, P2761; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishihara S, 2013, EXP CELL RES, V319, P2916, DOI 10.1016/j.yexcr.2013.09.018; Ishihara S, 2010, BIOCHEM BIOPH RES CO, V396, P651, DOI 10.1016/j.bbrc.2010.04.150; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Kadono Y, 1998, BIOCHEM BIOPH RES CO, V251, P681, DOI 10.1006/bbrc.1998.9531; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Kivela-Rajamaki M, 2003, J PERIODONTAL RES, V38, P583, DOI 10.1034/j.1600-0765.2003.00688.x; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Marsden M, 2001, DEVELOPMENT, V128, P3635; Mizutani T, 2006, JPN J APPL PHYS 1, V45, P2353, DOI 10.1143/JJAP.45.2353; Mizutani T, 2006, J CELL PHYSIOL, V209, P726, DOI 10.1002/jcp.20773; Nakayama M, 2005, GENES CELLS, V10, P107, DOI 10.1111/j.1365-2443.2005.00823.x; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Omelchenko T, 2003, P NATL ACAD SCI USA, V100, P10788, DOI 10.1073/pnas.1834401100; Reffay M, 2014, NAT CELL BIOL, V16, P217, DOI 10.1038/ncb2917; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SCHWIMMER R, 1995, J CELL SCI, V108, P2487; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yamao M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027950; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Yu W, 2008, EMBO REP, V9, P923, DOI 10.1038/embor.2008.135; Zahm JM, 1997, CELL MOTIL CYTOSKEL, V37, P33, DOI 10.1002/(SICI)1097-0169(1997)37:1<33::AID-CM4>3.0.CO;2-I; Zuk A, 1996, J CELL SCI, V109, P1875	46	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e99655	10.1371/journal.pone.0099655	http://dx.doi.org/10.1371/journal.pone.0099655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170757	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500003
J	Kenyon, CR; Vu, L; Menten, J; Maughan-Brown, B				Kenyon, Chris Richard; Lung Vu; Menten, Joris; Maughan-Brown, Brendan			Male Circumcision and Sexual Risk Behaviors May Contribute to Considerable Ethnic Disparities in HIV Prevalence in Kenya: An Ecological Analysis	PLOS ONE			English	Article							TRANSMITTED INFECTIONS; CONCURRENT PARTNERSHIPS; UNITED-STATES; AFRICA; SPREAD; ASSOCIATION; DISEASES	Background: HIV prevalence varies between 0.8 and 20.2% in Kenya's various ethnic groups. The reasons underlying these variations have not been evaluated before. Methods: We used data from seven national surveys spanning the period 1989 to 2008 to compare the prevalence of a range of risk factors in Kenya's ethnic groups. Spearman's and linear regression were used to assess the relationship between HIV prevalence and each variable by ethnic group. Results: The ethnic groups exhibited significant differences in a number of HIV related risk factors. Although the highest HIV prevalence group (the Luo) had the highest rates of HIV testing (Men 2008 survey: 56.8%, 95% CI 51.0-62.5%) and condom usage at last sex (Men 2008: 28.6%, 95% CI 19.6-37.6%), they had the lowest prevalence of circumcision (20.9%, 95% CI 15.9-26.0) the highest prevalence of sex with a non-married, non-cohabiting partner (Men: 40.2%, 95% CI 33.2-47.1%) and premarital sex (Men 2008: 73.9%, 95% CI 67.5-80.3%) and the youngest mean age of debut for women (1989 Survey: 15.7 years old, 95% CI 15.2-16.2). At a provincial level there was an association between the prevalence of HIV and male concurrency (Spearman's rho = 0.79, P = 0.04). Ethnic groups with higher HIV prevalence were more likely to report condom use (Men 2008 survey: R-2 = 0.62, P = 0.01) and having been for HIV testing (Men 2008 survey: R-2 = 0.47, P = 0.04). Conclusion: In addition to differences in male circumcision prevalence, variation in sexual behavior may contribute to the large variations in HIV prevalence in Kenya's ethnic groups. To complement the prevention benefits of the medical male circumcision roll-out in several parts of Kenya, interventions to reduce risky sexual behavior should continue to be promoted.	[Kenyon, Chris Richard; Menten, Joris] Inst Trop Med, HIV STI Unit, B-2000 Antwerp, Belgium; [Kenyon, Chris Richard] Univ Cape Town, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Lung Vu] Populat Council, Washington, DC USA; [Maughan-Brown, Brendan] Univ Cape Town, Southern Africa Labour & Dev Res Unit, ZA-7925 Cape Town, South Africa	Institute of Tropical Medicine (ITM); University of Cape Town; Population Council; University of Cape Town	Kenyon, CR (corresponding author), Inst Trop Med, HIV STI Unit, B-2000 Antwerp, Belgium.	ckenyon@itg.be	Maughan-Brown, Brendan/AAH-4254-2019	Maughan-Brown, Brendan/0000-0002-7606-8744				Baernighausen Till, 2009, HIV Therapy, V3, P435, DOI [10.2217/hiv.09.33, 10.2217/HIV.09.33]; Boerma JT, 2003, SEX TRANSM DIS, V30, P779, DOI 10.1097/01.OLQ.0000078820.62897.A6; Boily MC, 2012, AIDS BEHAV, V16, P304, DOI 10.1007/s10461-011-9887-0; Camlin CS, 2013, AIDS EDUC PREV, V25, P216, DOI 10.1521/aeap.2013.25.3.216; Central Bureau of Statistics (CBS) [Kenya] Ministry of Health (MOH) [Kenya] ORC Macro, 2004, ORC MACR KEN DEM HLT; De Walque D, 2006, WHO GETS AIDS DETERM; Department of Health, 2009, KEN AIDS IND SURV 20; Fenton KA, 2005, LANCET, V365, P1246, DOI 10.1016/S0140-6736(05)74813-3; Ferry B, 1995, SEXUAL BEHAV AIDS DE; Fox AM, 2014, AIDS BEHAV, V18, P791, DOI 10.1007/s10461-013-0684-9; Johnson K, 2006, JAIDS-J ACQ IMM DEF, V42, P627, DOI 10.1097/01.qai.0000225870.87456.ae; Kaul R, 2011, AM J REPROD IMMUNOL, V65, P317, DOI 10.1111/j.1600-0897.2010.00962.x; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kenyon C, 2013, INT J STD AIDS, V24, P211, DOI 10.1177/0956462412472455; Kenyon C, 2013, S AFR J HIV MED, V14, P25, DOI 10.7196/SAJHIVMED.884; Kenyon C, 2014, INT J STDS IN PRESS; Kenyon C, 2013, AJAR-AFR J AIDS RES, V12, P79, DOI 10.2989/16085906.2013.851717; Kenyon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064080; Kenyon C, 2009, AJAR-AFR J AIDS RES, V8, P243, DOI 10.2989/AJAR.2009.8.3.1.922; Kirungi WL, 2006, SEX TRANSM INFECT, V82, pI36, DOI 10.1136/sti.2005.017111; Kwena ZA, 2010, INT J STD AIDS, V21, P708, DOI 10.1258/ijsa.2010.010160; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Luginaah I, 2005, SOC SCI MED, V60, P1219, DOI 10.1016/j.socscimed.2004.07.010; McQuillan GM, 2004, AM J PUBLIC HEALTH, V94, P1952, DOI 10.2105/AJPH.94.11.1952; Mojola SA, 2011, SOC SCI MED, V72, P149, DOI 10.1016/j.socscimed.2010.11.006; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2013, AIDS BEHAV; Morris M, 2011, LANCET, V378, P1843, DOI 10.1016/S0140-6736(11)61803-5; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; National Council for Population and Development (NCPD) Central Bureau of Statistics (CBS) Macro International Inc (MI), 1994, KEN DEM HLTH SURV 19; NCPD (National Council for Population and Development) [Kenya] and IRD (Institute for Resource Development)/Macro Systems Inc, 1989, KEN DEM HLTH SURV 19; NCPD (National Council for Population and Development) Kenya CBS (Central Bureau of Statistics) Kenya and Macro International, 1999, KEN DEM HLTH SURV 19; Oluoch Tom, 2011, Open AIDS J, V5, P125, DOI 10.2174/1874613601105010125; Tequame M, 2012, JB NATIONALOKONOMIE, V232; *UNAIDS, 2008, 2008 REP GLOB AIDS E; *UNAIDS, 2008, UNAIDS REP GLOB AIDS; Wylie JL, 2010, SEX TRANSM INFECT, V86, P10, DOI 10.1136/sti.2010.044289	38	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106230	10.1371/journal.pone.0106230	http://dx.doi.org/10.1371/journal.pone.0106230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO2EE	25171060	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500130
J	Mukherjee, J; Dmitriev, I; Debatis, M; Tremblay, JM; Beamer, G; Kashentseva, EA; Curiel, DT; Shoemaker, CB				Mukherjee, Jean; Dmitriev, Igor; Debatis, Michelle; Tremblay, Jacqueline M.; Beamer, Gillian; Kashentseva, Elena A.; Curiel, David T.; Shoemaker, Charles B.			Prolonged Prophylactic Protection from Botulism with a Single Adenovirus Treatment Promoting Serum Expression of a VHH-Based Antitoxin Protein	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; THERAPEUTIC LEVELS; CELL LINE; DELIVERY; VECTORS; GENERATION; STRATEGIES; MICE; PHARMACOKINETICS; SEQUESTRATION	Current therapies for most acute toxin exposures are limited to administration of polyclonal antitoxin serum. We have shown that VHH-based neutralizing agents (VNAs) consisting of two or more linked, toxin-neutralizing heavy-chain-only V-H domains (VHHs), each binding distinct epitopes, can potently protect animals from lethality in several intoxication models including Botulinum neurotoxin serotype A1 (BoNT/A1). Appending a 14 amino acid albumin binding peptide (ABP) to an anti-BoNT/A1 heterodimeric VNA (H7/B5) substantially improved serum stability and resulted in an effective VNA serum half-life of 1 to 2 days. A recombinant, replication-incompetent, adenoviral vector (Ad/VNA-BoNTA) was engineered that induces secretion of biologically active VNA, H7/B5/ABP (VNA-BoNTA), from transduced cells. Mice administered a single dose of Ad/ VNA-BoNTA, or a different Ad/VNA, via different administration routes led to a wide range of VNA serum levels measured four days later; generally intravenous > intraperitoneal > intramuscular > subcutaneous. Ad/VNA-BoNTA treated mice were 100% protected from 10 LD50 of BoNT/A1 for more than six weeks and protection positively correlated with serum levels of VNA-BoNTA exceeding about 5 ng/ml. Some mice developed antibodies that inhibited VNA binding to target but these mice displayed no evidence of kidney damage due to deposition of immune complexes. Mice were also successfully protected from 10 LD50 BoNT/A1 when Ad/VNA-BoNTA was administered up to 1.5 hours post-intoxication, demonstrating rapid appearance of the protective VNA in serum following treatment. Genetic delivery of VNAs promises to be an effective method of providing prophylactic protection and/or acute treatments for many toxin-mediated diseases.	[Mukherjee, Jean; Debatis, Michelle; Tremblay, Jacqueline M.; Beamer, Gillian; Shoemaker, Charles B.] Tufts Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA; [Dmitriev, Igor; Kashentseva, Elena A.; Curiel, David T.] Washington Univ, Dept Radiat Oncol, St Louis, MO USA	Washington University (WUSTL)	Shoemaker, CB (corresponding author), Tufts Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA.	charles.shoemaker@tufts.edu			National Institutes of Health [U54-AI057159, R21/R33-AI101403]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R21AI101403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by in part by grants U54-AI057159 (CBS) and R21/R33-AI101403 (CBS/DTC) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health.	Annoni A, 2009, BLOOD, V114, P5152, DOI 10.1182/blood-2009-04-214569; Batra SK, 2002, CURR OPIN BIOTECH, V13, P603, DOI 10.1016/S0958-1669(02)00352-X; Beatty MS, 2012, ADV CANCER RES, V115, P39, DOI [10.1016/B978-0-12-3983,12-8.00002-1, 10.1016/B978-0-12-398342-8.00002-1]; Casadevall A, 2002, EMERG INFECT DIS, V8, P833, DOI 10.3201/eid0808.010516; Danthinne X, 2000, GENE THER, V7, P1707, DOI 10.1038/sj.gt.3301301; De BP, 2008, MOL THER, V16, P203, DOI 10.1038/sj.mt.6300344; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Fang JM, 2007, MOL THER, V15, P1153, DOI 10.1038/sj.mt.6300142; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Haisma HJ, 2011, MOL PHARMACEUT, V8, P50, DOI 10.1021/mp100310h; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Jiang MH, 2006, CLIN CANCER RES, V12, P6179, DOI 10.1158/1078-0432.CCR-06-0746; Kasala D, 2014, EXPERT OPIN DRUG DEL, V11, P379, DOI 10.1517/17425247.2014.874414; Kasuya K, 2005, MOL THER, V11, P237, DOI 10.1016/j.ymthe.2004.10.018; Koide Akiko, 2012, Methods Mol Biol, V911, P431, DOI 10.1007/978-1-61779-968-6_26; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; Lewis AD, 2002, J VIROL, V76, P8769, DOI 10.1128/JVI.76.17.8769-8775.2002; Liang MF, 1997, VIROLOGY, V235, P252, DOI 10.1006/viro.1997.8695; Lieber A, 1997, J VIROL, V71, P8798, DOI 10.1128/JVI.71.11.8798-8807.1997; Lopez-Requena A, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00159; Losman MJ, 1999, CLIN CANCER RES, V5, p3101S; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Matrai J, 2011, HEPATOLOGY, V53, P1696, DOI 10.1002/hep.24230; Meng Q, 2012, ANAL BIOCHEM, V430, P141, DOI 10.1016/j.ab.2012.08.005; Monegal A, 2009, PROTEIN ENG DES SEL, V22, P273, DOI 10.1093/protein/gzp002; Morimoto K, 2001, J IMMUNOL METHODS, V252, P199, DOI 10.1016/S0022-1759(01)00353-2; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nguyen A, 2006, PROTEIN ENG DES SEL, V19, P291, DOI 10.1093/protein/gzl011; Noel D, 2002, HUM GENE THER, V13, P1483, DOI 10.1089/10430340260185111; Parks RJ, 2000, CLIN GENET, V58, P1, DOI 10.1034/j.1399-0004.2000.580101.x; Patel K, 2014, EXPERT OPIN DRUG DIS, V9, P319, DOI 10.1517/17460441.2014.884066; Rainey GJA, 2004, NAT REV MICROBIOL, V2, P721, DOI 10.1038/nrmicro977; Sepulveda J, 2010, INFECT IMMUN, V78, P756, DOI 10.1128/IAI.01084-09; Shayakhmetov DM, 2004, J VIROL, V78, P5368, DOI 10.1128/JVI.78.10.5368-5381.2004; Skaricic D, 2008, VIROLOGY, V378, P79, DOI 10.1016/j.virol.2008.04.016; Smith JS, 2008, J VIROL METHODS, V147, P54, DOI 10.1016/j.jviromet.2007.08.009; Sofer-Podesta C, 2009, INFECT IMMUN, V77, P1561, DOI 10.1128/IAI.00856-08; Tao NJ, 2001, MOL THER, V3, P28, DOI 10.1006/mthe.2000.0227; Tremblay JM, 2013, INFECT IMMUN; Tutykhina IL, 2013, ANTIVIR RES, V97, P318, DOI 10.1016/j.antiviral.2012.12.021; Vance DJ, 2013, J BIOL CHEM; Verheesen P, 2006, BBA-PROTEINS PROTEOM, V1764, P1307, DOI 10.1016/j.bbapap.2006.05.011; Wang YB, 2000, DRUG DISCOV TODAY, V5, P10, DOI 10.1016/S1359-6446(99)01433-6; Wolff G, 1997, J VIROL, V71, P624, DOI 10.1128/JVI.71.1.624-629.1997; Worgall S, 1997, HUM GENE THER, V8, P37, DOI 10.1089/hum.1997.8.1-37; Zuber C, 2008, J GEN VIROL, V89, P2055, DOI 10.1099/vir.0.83670-0	50	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106422	10.1371/journal.pone.0106422	http://dx.doi.org/10.1371/journal.pone.0106422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170904	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500159
J	Rangel, M; dos Santos, JC; Ortiz, PHL; Hirata, M; Jasiulionis, MG; Araujo, RC; Ierardi, DF; Franco, MD				Rangel, Marina; dos Santos, Jessica Cassilla; Lima Ortiz, Paula Helena; Hirata, Mario; Jasiulionis, Miriam Galvonas; Araujo, Ronaldo C.; Ierardi, Daniela Filippini; Franco, Maria do Carmo			Modification of Epigenetic Patterns in Low Birth Weight Children: Importance of Hypomethylation of the ACE Gene Promoter	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; CARDIOVASCULAR-DISEASE; INSERTION/DELETION POLYMORPHISM; PROTEIN RESTRICTION; BLOOD-PRESSURE; FETAL ORIGINS; SYSTEM; RISK; HYPERTENSION; METHYLATION	There is a growing body of evidence that epigenetic alterations are involved in the pathological mechanisms of many chronic disorders linked to fetal programming. Angiotensin-converting enzyme (ACE) appears as one candidate gene that brings new insights into the epigenetic control and later development of diseases. In this view, we have postulated that epigenetic modifications in the ACE gene might show different interactions between birth weight (BW), blood pressure levels, plasma ACE activity and ACE I/D polymorphism. To explore this hypothesis, we performed a cross-sectional study to evaluate the DNA methylation of 3 CpG sites using pyrosequencing within the ACE gene promoter of peripheral blood leukocytes from 45 LBW children compared with 70 NBW children. Our results have revealed that LBW children have lower methylation levels (P<0.001) in parallel with a higher ACE activity (P=0.001). Adjusting for prematurity, gender, age, body mass index, and family history of cardiovascular disease did not alter these findings. We have also performed analyses of individual CpG sites. The frequency of DNA methylation was significantly different at two CpG sites (site 1: nucleotide position + 555; and site 3: nucleotide position + 563). In addition, we have found a significant inverse correlation between degree of DNA methylation and both ACE activity (P<0.001) and systolic blood pressure levels (P<0.001). We also observed that the methylation level was significantly lower in LBW children who are carriers of the DD genotype compared to NBW children with DD genotype (P<0.024). In conclusion, we are able to demonstrate that the hypomethylation in the 3 CpG sites of ACE gene promoter is associated with LBW in 6 to 12 year-old children. The magnitude of these epigenetic changes appears to be clinically important, which is supported by the observation that discrete changes in DNA methylation can affect systolic blood pressure and ACE protein activity levels.	[Rangel, Marina; Franco, Maria do Carmo] Univ Fed Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil; [dos Santos, Jessica Cassilla; Lima Ortiz, Paula Helena] Dante Pazzanese Inst Cardiol, Mol Biol Lab, Sao Paulo, Brazil; [Hirata, Mario] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil; [Jasiulionis, Miriam Galvonas] Univ Fed Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil; [Araujo, Ronaldo C.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Ierardi, Daniela Filippini] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	Universidade Federal de Sao Paulo (UNIFESP); Instituto Dante Pazzanese de Cardiologia; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); University of Chicago	Franco, MD (corresponding author), Univ Fed Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil.	mdcfranco@nefro.epm.br	Jasiulionis, Miriam/G-2207-2012; Hirata, Mario Hiroyuki/C-9718-2013; do Carmo P Franco, Maria/F-7771-2015; Araujo, Ronaldo Carvalho/O-7569-2019; Franco, Maria CP/F-9421-2012	Jasiulionis, Miriam/0000-0002-4135-0440; Hirata, Mario Hiroyuki/0000-0002-9521-7979; Araujo, Ronaldo Carvalho/0000-0003-0095-4608; Franco, Maria CP/0000-0003-0604-7689	FAPESP [2007/58044-2]; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by a project grant from the FAPESP (2007/58044-2) and Marina Rangel is supported by a Master's degree fellowship from the CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajala AR, 2012, AM J HYPERTENS, V25, P827, DOI 10.1038/ajh.2012.50; Barker DJP, 1999, ANN INTERN MED, V130, P322, DOI 10.7326/0003-4819-130-4-199902160-00019; Barker DJP, 1999, ANN MED, V31, P3, DOI 10.1080/07853890.1999.11904392; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; Carey RM, 2003, ENDOCR REV, V24, P261, DOI 10.1210/er.2003-0001; Cesari M, 2002, J HYPERTENS, V20, P793, DOI 10.1097/00004872-200205000-00002; Duygu Burcu, 2013, Frontiers in Genetics, V4, P219, DOI 10.3389/fgene.2013.00219; El Shamieh S, 2012, CLIN CHIM ACTA, V414, P259, DOI 10.1016/j.cca.2012.09.018; Fogo A, 1996, AM J PATHOL, V149, P1797; Forsyth JS, 2004, ARCH DIS CHILD-FETAL, V89, pF442, DOI 10.1136/adc.2003.027896; Franco MCP, 2008, CLIN SCI, V114, P375, DOI 10.1042/CS20070284; Franco MCP, 2006, HYPERTENSION, V48, P45, DOI 10.1161/01.HYP.0000223446.49596.3a; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Goossens GH, 2007, INT J OBESITY, V31, P382, DOI 10.1038/sj.ijo.0803388; Goyal R, 2010, REPROD SCI, V17, P227, DOI 10.1177/1933719109351935; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Higaki J, 2000, CIRCULATION, V101, P2060, DOI 10.1161/01.CIR.101.17.2060; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Jia YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063855; Lillycrop KA, 2011, INT J OBESITY, V35, P72, DOI 10.1038/ijo.2010.122; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Miyawaki M, 2006, ARCH DIS CHILD-FETAL, V91, P359, DOI 10.1136/adc.2005.089573; Muthumala A, 2007, HYPERTENSION, V50, P348, DOI 10.1161/HYPERTENSIONAHA.107.086843; Nafee TM, 2008, BJOG-INT J OBSTET GY, V115, P158, DOI 10.1111/j.1471-0528.2007.01528.x; Rakyan VK, 2001, BIOCHEM J, V356, P1, DOI 10.1042/0264-6021:3560001; Riviere G, 2011, EPIGENETICS-US, V6, P479, DOI 10.4161/epi.6.4.14961; SANTOS RAS, 1985, HYPERTENSION, V7, P244, DOI 10.1161/01.HYP.7.2.244; Schut AFC, 2004, EUR HEART J, V25, P2143, DOI 10.1016/j.ehj.2004.08.026; Slater-Jefferies JL, 2011, J DEV ORIG HLTH DIS, V2, P250, DOI 10.1017/S2040174410000425; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Ulrich C, 2006, NEPHROL DIAL TRANSPL, V21, P1596, DOI 10.1093/ndt/gfl008; Wehkalampi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067379; Zill P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040479	36	41	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106138	10.1371/journal.pone.0106138	http://dx.doi.org/10.1371/journal.pone.0106138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170764	gold, Green Submitted, Green Published			2022-12-25	WOS:000341127500113
J	Riley, BE; Gardai, SJ; Emig-Agius, D; Bessarabova, M; Ivliev, AE; Schule, B; Alexander, J; Wallace, W; Halliday, GM; Langston, JW; Braxton, S; Yednock, T; Shaler, T; Johnston, JA				Riley, Brigit E.; Gardai, Shyra J.; Emig-Agius, Dorothea; Bessarabova, Marina; Ivliev, Alexander E.; Schuele, Birgit; Alexander, Jeff; Wallace, William; Halliday, Glenda M.; Langston, J. William; Braxton, Scott; Yednock, Ted; Shaler, Thomas; Johnston, Jennifer A.			Systems-Based Analyses of Brain Regions Functionally Impacted in Parkinson's Disease Reveals Underlying Causal Mechanisms	PLOS ONE			English	Article							HUMAN SUBSTANTIA-NIGRA; GENE-EXPRESSION; OXIDATIVE-PHOSPHORYLATION; TRANSCRIPTIONAL ANALYSIS; PROTEOME ANALYSIS; ALPHA-SYNUCLEIN; QUANTIFICATION; IDENTIFICATION; PATHOGENESIS; ANNOTATION	Detailed analysis of disease-affected tissue provides insight into molecular mechanisms contributing to pathogenesis. Substantia nigra, striatum, and cortex are functionally connected with increasing degrees of alpha-synuclein pathology in Parkinson's disease. We undertook functional and causal pathway analysis of gene expression and proteomic alterations in these three regions, and the data revealed pathways that correlated with disease progression. In addition, microarray and RNAseq experiments revealed previously unidentified causal changes related to oligodendrocyte function and synaptic vesicle release, and these and other changes were reflected across all brain regions. Importantly, subsets of these changes were replicated in Parkinson's disease blood; suggesting peripheral tissue may provide important avenues for understanding and measuring disease status and progression. Proteomic assessment revealed alterations in mitochondria and vesicular transport proteins that preceded gene expression changes indicating defects in translation and/or protein turnover. Our combined approach of proteomics, RNAseq and microarray analyses provides a comprehensive view of the molecular changes that accompany functional loss and alpha-synuclein pathology in Parkinson's disease, and may be instrumental to understand, diagnose and follow Parkinson's disease progression.	[Riley, Brigit E.; Gardai, Shyra J.; Alexander, Jeff; Wallace, William; Yednock, Ted; Johnston, Jennifer A.] Elan Pharmaceut, San Francisco, CA 94080 USA; [Emig-Agius, Dorothea; Bessarabova, Marina; Ivliev, Alexander E.; Braxton, Scott] Thomson Reuters, Carlsbad, CA USA; [Schuele, Birgit; Langston, J. William] Parkinsons Inst, Sunnyvale, CA USA; [Halliday, Glenda M.] Neurosci Res Australia, Sydney, NSW, Australia; [Halliday, Glenda M.] Univ New S Wales, Sydney, NSW, Australia; [Shaler, Thomas] SRI Int, Menlo Pk, CA 94025 USA	Clarivate; Neuroscience Research Australia; University of New South Wales Sydney; SRI International	Riley, BE (corresponding author), Elan Pharmaceut, San Francisco, CA 94080 USA.	brigitriley@gmail.com; sgardai@gmail.com	Halliday, Glenda M/E-8555-2011	Halliday, Glenda M/0000-0003-0422-8398; Schuele, Birgitt/0000-0002-9952-5776; Johnston, Jennifer/0000-0002-4867-9230	National Health and Medical Research Council of Australia; Elan Pharmaceuticals	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Elan Pharmaceuticals	This work was supported by the National Health and Medical Research Council of Australia and Elan Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; Beach TG, 2010, ACTA NEUROPATHOL, V119, P689, DOI 10.1007/s00401-010-0664-3; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Bessarabova M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S13; Blandini F, 2003, ANN NY ACAD SCI, V1010, P675, DOI 10.1196/annals.1299.123; Bondarenko PV, 2002, ANAL CHEM, V74, P4741, DOI 10.1021/ac0256991; Bottomly D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017820; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bureeva S, 2009, METHODS MOL BIOL, V563, P75, DOI 10.1007/978-1-60761-175-2_5; Carbonetto P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003770; Caudle WM, 2010, EXPERT REV NEUROTHER, V10, P925, DOI [10.1586/ern.10.54, 10.1586/ERN.10.54]; Cesani M, 2014, ANN NEUROL, V75, P127, DOI 10.1002/ana.24053; Chartier-Harlin MC, 2011, AM J HUM GENET, V89, P398, DOI 10.1016/j.ajhg.2011.08.009; Del Tredici K, 2010, ACTA NEUROPATHOL, V119, P703, DOI 10.1007/s00401-010-0665-2; Devic I, 2011, BRAIN, V134, DOI 10.1093/brain/awr015; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Dubbelink KTEO, 2014, BRAIN, V137, P197, DOI 10.1093/brain/awt316; Dumitriu A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002794; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edwards YJK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016917; Fabelo N, 2011, MOL MED, V17, P1107, DOI 10.2119/molmed.2011.00119; Falick Arnold M, 2011, J Biomol Tech, V22, P21; Gardai SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071634; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Cersosimo MG, 2011, MOVEMENT DISORD, V26, P188, DOI 10.1002/mds.23344; Hattori T, 2012, HUM BRAIN MAPP, V33, P727, DOI 10.1002/hbm.21245; Hickey P, 2011, DRUG DES DEV THER, V5, P241, DOI 10.2147/DDDT.S11836; Hitzemann R, 2013, GENES BRAIN BEHAV, V12, P1, DOI 10.1111/gbb.12007; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaeger S, 2014, J BIOMOL SCREEN; Jin JH, 2007, MOL CELL PROTEOMICS, V6, P845, DOI 10.1074/mcp.M600182-MCP200; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Khan Z, 2009, P NATL ACAD SCI USA, V106, P15544, DOI 10.1073/pnas.0904100106; Kim YA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001095; Koppelkamm A, 2011, INT J LEGAL MED, V125, P573, DOI 10.1007/s00414-011-0578-1; Kthiri F, 2010, J BACTERIOL, V192, P6302, DOI 10.1128/JB.01077-10; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Lewis PA, 2012, BRAIN RES BULL, V88, P302, DOI 10.1016/j.brainresbull.2011.11.016; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Licker V, 2012, J PROTEOMICS, V75, P4656, DOI 10.1016/j.jprot.2012.02.032; Mooney M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061088; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Myhre O, 2013, OXIDATIVE MED CELLUL, V2013; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Pankratz N, 2012, ANN NEUROL, V71, P370, DOI 10.1002/ana.22687; Perier C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009332; Ponsen MM, 2013, NEUROIMAGE-CLIN, V2, P95, DOI 10.1016/j.nicl.2012.11.007; Rae CL, 2012, NEUROIMAGE, V62, P1675, DOI 10.1016/j.neuroimage.2012.06.012; Rochet JC, 2012, PROG MOL BIOL TRANSL, V107, P125, DOI 10.1016/B978-0-12-385883-2.00011-4; Schapira AH, 2011, MOVEMENT DISORD, V26, P1049, DOI 10.1002/mds.23732; Schwanhausser B, 2013, NATURE, V495, P126, DOI 10.1038/nature11848; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shachar T, 2011, MOVEMENT DISORD, V26, P1593, DOI 10.1002/mds.23774; Shadrina MI, 2010, INT REV CEL MOL BIO, V281, P229, DOI 10.1016/S1937-6448(10)81006-8; SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Su CW, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-6; Sutherland GT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004955; Taccioli C, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar007; Trinh J, 2013, NAT REV NEUROL, V9, P445, DOI 10.1038/nrneurol.2013.132; Vellaichamy A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010936; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang WX, 2003, ANAL CHEM, V75, P4818, DOI 10.1021/ac026468x; Werner CJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-8; Wong DJ, 2005, J INVEST DERMATOL, V125, P175, DOI 10.1111/j.0022-202X.2005.23827.x; Wu L, 2013, NATURE; Zhang JH, 2005, GENOMICS, V85, P297, DOI 10.1016/j.ygeno.2004.11.004; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195	73	47	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e102909	10.1371/journal.pone.0102909	http://dx.doi.org/10.1371/journal.pone.0102909			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170892	Green Published, gold			2022-12-25	WOS:000341127500006
J	Samikkannu, T; Rao, KVK; Ding, H; Agudelo, M; Raymond, AD; Yoo, C; Nair, MPN				Samikkannu, Thangavel; Rao, Kurapati V. K.; Ding, Hong; Agudelo, Marisela; Raymond, Andrea D.; Yoo, Changwon; Nair, Madhavan P. N.			Immunopathogenesis of HIV Infection in Cocaine Users: Role of Arachidonic Acid	PLOS ONE			English	Article							DENDRITIC CELLS; CYCLOPENTENONE PROSTAGLANDINS; DC-SIGN; RECEPTOR; 5-LIPOXYGENASE; EXPRESSION; ABUSE; CYCLOOXYGENASE; GP120; REPLICATION	Arachidonic acid (AA) is known to be increased in HIV infected patients and illicit drug users are linked with severity of viral replication, disease progression, and impaired immune functions. Studies have shown that cocaine accelerates HIV infection and disease progression mediated by immune cells. Dendritic cells (DC) are the first line of antigen presentation and defense against immune dysfunction. However, the role of cocaine use in HIV associated acceleration of AA secretion and its metabolites on immature dendritic cells (IDC) has not been elucidated yet. The aim of this study is to elucidate the mechanism of AA metabolites cyclooxygenase-2 (COX-2), prostaglandin E2 synthetase (PGE(2)), thromboxane A2 receptor (TBXA(2)R), cyclopentenone prostaglandins (CyPG), such as 15-deoxy-Delta 12,14-PGJ2 (15d-PGJ2), 14-3-3 zeta/delta and 5-lipoxygenase (5-LOX) mediated induction of IDC immune dysfunctions in cocaine using HIV positive patients. The plasma levels of AA, PGE(2), 15d-PGJ2, 14-3-3 zeta/delta and IDC intracellular COX-2 and 5-LOX expression were assessed in cocaine users, HIV positive patients, HIV positive cocaine users and normal subjects. Results showed that plasma concentration levels of AA, PGE(2) and COX-2, TBXA(2)R and 5-LOX in IDCs of HIV positive cocaine users were significantly higher whereas 15d-PGJ2 and 14-3-3 zeta/delta were significantly reduced compared to either HIV positive subjects or cocaine users alone. This report demonstrates that AA metabolites are capable of mediating the accelerative effects of cocaine on HIV infection and disease progression.	[Samikkannu, Thangavel; Rao, Kurapati V. K.; Ding, Hong; Agudelo, Marisela; Raymond, Andrea D.; Nair, Madhavan P. N.] Florida Int Univ, Herbert Wertheim Coll Med, Inst NeuroImmune Pharmacol, Dept Immunol, Miami, FL 33174 USA; [Yoo, Changwon] Florida Int Univ, Dept Biostat, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University	Nair, MPN (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Inst NeuroImmune Pharmacol, Dept Immunol, Modesto A Maidique Campus, Miami, FL 33174 USA.	nairm@fiu.edu		Yoo, Changwon/0000-0003-0969-7468	National Institutes Health [DA 025576, DA034547]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH080663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA025576, R01DA034547] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants from the National Institutes Health: DA 025576 and DA034547 to Prof. Madhavan Nair. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin GC, 1998, J NEUROIMMUNOL, V83, P133, DOI 10.1016/S0165-5728(97)00229-4; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Basselin M, 2011, J CEREBR BLOOD F MET, V31, P486, DOI 10.1038/jcbfm.2010.111; Basso MR, 2000, J PSYCHOPHARMACOL, V14, P228, DOI 10.1177/026988110001400306; Brock TG, 2008, NEUROCHEM RES, V33, P801, DOI 10.1007/s11064-007-9498-3; Calverley DC, 1998, BLOOD, V91, P1295, DOI 10.1182/blood.V91.4.1295; CAMERON PU, 1994, J LEUKOCYTE BIOL, V56, P257, DOI 10.1002/jlb.56.3.257; Corasaniti MT, 2000, BIOCHEM BIOPH RES CO, V274, P664, DOI 10.1006/bbrc.2000.3160; Crooks SW, 1998, INT J BIOCHEM CELL B, V30, P173, DOI 10.1016/S1357-2725(97)00123-4; Donaghy H, 2004, CURR OPIN INFECT DIS, V17, P1, DOI 10.1097/00001432-200402000-00002; Geijtenbeek TBH, 2003, CURR TOP MICROBIOL, V276, P31; GRIFFIN DE, 1994, ANN NEUROL, V35, P592, DOI 10.1002/ana.410350513; Gualde N, 2004, IMMUNOL CELL BIOL, V82, P353, DOI 10.1111/j.0818-9641.2004.01251.x; Hadley JS, 1998, BIOMED ENVIRON MASS, V15, P175; Harizi H, 2003, J LEUKOCYTE BIOL, V73, P756, DOI 10.1189/jlb.1002483; Harizi H, 2001, CELL IMMUNOL, V209, P19, DOI 10.1006/cimm.2001.1785; Harizi H, 2011, IMMUNOL CELL BIOL, V89, P275, DOI 10.1038/icb.2010.94; Hedi H, 2004, J BIOMED BIOTECHNOL, P99, DOI 10.1155/S1110724304310041; Janelle ME, 2002, J BIOL CHEM, V277, P30665, DOI 10.1074/jbc.M203041200; Kabashima K, 2003, NAT IMMUNOL, V4, P694, DOI 10.1038/ni943; Klegeris A, 2002, NEUROBIOL AGING, V23, P787, DOI 10.1016/S0197-4580(02)00021-0; KLEIN TW, 1993, INT J IMMUNOPHARMACO, V15, P77, DOI 10.1016/0192-0561(93)90033-U; Maccarrone M, 1998, BIOCHEM J, V333, P45, DOI 10.1042/bj3330045; Manev H, 2007, ARCH GEN PSYCHIAT, V64, P1333, DOI 10.1001/archpsyc.64.11.1333; Miyamoto K, 1996, AM J CHINESE MED, V24, P1, DOI 10.1142/S0192415X96000025; Nair MPN, 2012, CURR HIV RES, V10, P429, DOI 10.2174/157016212802138742; Nair MPN, 2000, CLIN DIAGN LAB IMMUN, V7, P96, DOI 10.1128/CDLI.7.1.96-100.2000; Nair MPN, 2005, J IMMUNOL, V174, P6617, DOI 10.4049/jimmunol.174.11.6617; Nath A, 2001, J NEUROVIROL, V7, P66; Porter KM, 2008, HIV 1 INDUCED 5 LIPO; RAMIS I, 1991, J CHROMATOGR, V557, P507, DOI 10.1016/S0021-9673(01)87159-4; Reynolds JL, 2009, IMMUNOL INVEST, V38, P526, DOI 10.1080/08820130902874110; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Roth MD, 2002, J INFECT DIS, V185, P701, DOI 10.1086/339012; Rozera C, 1996, J CLIN INVEST, V97, P1795, DOI 10.1172/JCI118609; Samikkannu T, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-113; Samikkannu T, 2011, J NEUROVIROL, V17, P230, DOI 10.1007/s13365-011-0026-5; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Spanbroek R, 2000, BLOOD, V96, P3857, DOI 10.1182/blood.V96.12.3857.h8003857_3857_3865; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Su KP, 2008, ASIA PAC J CLIN NUTR, V17, P151; Substance Abuse and Mental Health Services Administration, 2011, NSDUH SER H; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Tyor WR, 1999, J LEUKOCYTE BIOL, V65, P475, DOI 10.1002/jlb.65.4.475; UNAIDS/WHO, 2011, UNAIDS0936EJC2417E U; Uz Tolga, 2008, Open Neuropsychopharmacol J, V1, P1, DOI 10.2174/1876523800801010001; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727; Wang JH, 2007, J VIROL, V81, P8933, DOI 10.1128/JVI.00878-07; Xiong HG, 2000, J NEUROVIROL, V6, pS14; Yao HH, 2011, J NEUROSCI, V31, P5942, DOI 10.1523/JNEUROSCI.5618-10.2011	50	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106348	10.1371/journal.pone.0106348	http://dx.doi.org/10.1371/journal.pone.0106348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171226	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500154
J	Wang, Y; Qu, C; Luo, QL; Qu, LL; Li, XB				Wang, Yang; Qu, Chen; Luo, Qiuling; Qu, Lulu; Li, Xuebing			Like or Dislike? Affective Preference Modulates Neural Response to Others' Gains and Losses	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; MALE-WARRIOR HYPOTHESIS; SEX-DIFFERENCES; GENDER-DIFFERENCES; FACIAL EXPRESSIONS; COMPETITION; FEEDBACK; OUTCOMES; PERFORMANCE; NEGATIVITY	Previous studies have demonstrated that the brain responds differentially to others' gains and losses relative to one's own, moderated by social context factors such as competition and interpersonal relationships. In the current study, we tested the hypothesis that the neural response to others' outcomes could be modulated by a short-term induced affective preference. We engaged 17 men and 18 women in a social-exchange game, in which two confederates played fairly or unfairly. Both men and women rated the fair player as likable and the unfair players as unlikable. Afterwards, ERPs were recorded while participants observed each confederates playing a gambling game individually. This study examines feedback related negativity (FRN), an ERP component sensitive to negative feedback. ANOVA showed a significant interaction in which females but not males displayed stronger FRNs when observing likable players' outcomes compared to unlikable ones'. However, males did not respond differently under either circumstance. These findings suggest that, at least in females, the neural response is influenced by a short-term induced affective preference.	[Wang, Yang; Luo, Qiuling; Qu, Lulu] S China Normal Univ, Ctr Study Appl Psychol, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Wang, Yang; Qu, Chen] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Li, Xuebing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	South China Normal University; Chinese University of Hong Kong; Chinese Academy of Sciences; Institute of Psychology, CAS	Li, XB (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	lixb@psych.ac.cn			National Nature Science Foundation of China [31000504, 30930031, 30900441]; Humanities and Social Sciences project, Ministry of Education of China [09YJXLX008]; Guangdong Philosophy social science planning youth project [09SXLQ002]; Key Laboratory of Mental Health of Institute of Psychology of Chinese Academy of Sciences	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Humanities and Social Sciences project, Ministry of Education of China(Ministry of Education, China); Guangdong Philosophy social science planning youth project; Key Laboratory of Mental Health of Institute of Psychology of Chinese Academy of Sciences	This work was supported by: the National Nature Science Foundation of China (Grant No. 31000504, 30930031, 30900441: http://www.nsfc.gov.cn/publish/portal0/default.htm); Humanities and Social Sciences project, Ministry of Education of China (Grant No. 09YJXLX008); Humanities and Social Sciences project, Ministry of Education of China (Grant No. 09YJXLX008: http://xm.sinoss.net/indexAction!to_index.action); Guangdong Philosophy social science planning youth project (Grant No. 09SXLQ002: http://www.gdpplgopss.gov.cn/); and the Key Laboratory of Mental Health of Institute of Psychology of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Biele C, 2006, EXP BRAIN RES, V171, P1, DOI 10.1007/s00221-005-0254-0; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; Cohen MX, 2007, J NEUROSCI, V27, P371, DOI 10.1523/JNEUROSCI.4421-06.2007; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Frey SH, 2006, J NEUROSCI, V26, P13194, DOI 10.1523/JNEUROSCI.3914-06.2006; Fukushima H, 2006, SOC COGN AFFECT NEUR, V1, P149, DOI 10.1093/scan/nsl020; Fukushima H, 2009, SOC NEUROSCI-UK, V4, P261, DOI 10.1080/17470910802625009; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; Itagaki S, 2008, NEUROREPORT, V19, P383, DOI 10.1097/WNR.0b013e3282f556e8; Klein KJK, 2001, PERS SOC PSYCHOL B, V27, P720, DOI 10.1177/0146167201276007; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; LEBOEUF BJ, 1974, AM ZOOL, V14, P163; Leng Y, 2010, NEUROPSYCHOLOGIA, V48, P448, DOI 10.1016/j.neuropsychologia.2009.10.002; Lithari C, 2010, BRAIN TOPOGR, V23, P27, DOI 10.1007/s10548-009-0130-5; Ma QG, 2011, NEUROIMAGE, V54, P2472, DOI 10.1016/j.neuroimage.2010.10.045; Marco-Pallares J, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-86; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Nieuwenhuis S, 2004, CEREB CORTEX, V14, P741, DOI 10.1093/cercor/bhh034; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Proverbio AM, 2010, NEUROPSYCHOLOGIA, V48, P1454, DOI 10.1016/j.neuropsychologia.2010.01.015; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Van Vugt M, 2007, PSYCHOL SCI, V18, P19, DOI 10.1111/j.1467-9280.2007.01842.x; Van Vugt M, 2009, ANN NY ACAD SCI, V1167, P124, DOI 10.1111/j.1749-6632.2009.04539.x; Yu RJ, 2006, NEUROREPORT, V17, P1747, DOI 10.1097/01.wnr.0000239960.98813.50; Zhou ZH, 2010, NEUROPSYCHOLOGIA, V48, P3606, DOI 10.1016/j.neuropsychologia.2010.08.010	32	11	12	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105694	10.1371/journal.pone.0105694	http://dx.doi.org/10.1371/journal.pone.0105694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO2EE	25171075	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500065
J	Wijesundara, DK; Ranasinghe, C; Jackson, RJ; Lidbury, BA; Parish, CR; Quah, BJC				Wijesundara, Danushka K.; Ranasinghe, Charani; Jackson, Ronald J.; Lidbury, Brett A.; Parish, Christopher R.; Quah, Benjamin J. C.			Use of an In Vivo FTA Assay to Assess the Magnitude, Functional Avidity and Epitope Variant Cross-Reactivity of T Cell Responses Following HIV-1 Recombinant Poxvirus Vaccination	PLOS ONE			English	Article							PRIME-BOOST IMMUNIZATION; FLOW-CYTOMETRY; DNA PRIME; MUCOSAL; IMMUNITY; TRIAL; CTL; LYMPHOCYTES; VACCINES; VITRO	Qualitative characteristics of cytotoxic CD8(+) T cells (CTLs) are important in measuring the effectiveness of CTLs in controlling HIV-1 infections. Indeed, in recent studies patients who are naturally resistant to HIV-1 infections have been shown to possess CTLs that are of high functional avidity and have a high capacity to recognize HIV epitope variants, when compared to HIV-1 infection progressors. When developing efficacious vaccines, assays that can effectively measure CTL quality specifically in vivo are becoming increasingly important. Here we report the use of a recently developed high-throughput multi-parameter technique, known as the fluorescent target array (FTA) assay, to simultaneously measure CTL killing magnitude, functional avidity and epitope variant cross-reactivity in real time in vivo. In the current study we have applied the FTA assay as a screening tool to assess a large cohort of over 20 different HIV-1 poxvirus vaccination strategies in mice. This screen revealed that heterologous poxvirus prime-boost vaccination regimes (i.e., recombinant fowlpox (FPV)-HIV prime followed by a recombinant vaccinia virus (VV)-HIV booster) were the most effective in generating high quality CTL responses in vivo. In conclusion, we have demonstrated how the FTA assay can be utilized as a cost effective screening tool (by reducing the required number of animals by >100 fold), to evaluate a large range of HIV-1 vaccination strategies in terms of CTL avidity and variant cross-reactivity in an in vivo setting.	[Wijesundara, Danushka K.; Ranasinghe, Charani; Jackson, Ronald J.] Australian Natl Univ, John Curtin Sch Med Res, Mol Mucosal Vaccine Immunol Grp, Canberra, ACT 2601, Australia; [Parish, Christopher R.; Quah, Benjamin J. C.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Canc & Vasc Biol Grp, Canberra, ACT 2601, Australia; [Lidbury, Brett A.] Australian Natl Univ, John Curtin Sch Med Res, Dept Genome Biol, Alternat Anim Bioinformat Grp, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research	Quah, BJC (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Canc & Vasc Biol Grp, Canberra, ACT 2601, Australia.	ben.quah@anu.edu.au		Lidbury, Brett/0000-0003-2211-989X; Wijesundara, Danushka/0000-0002-0740-8362; Jackson, Ronald/0000-0002-6550-6251; Parish, Christopher/0000-0001-7740-0430; Quah, Ben/0000-0003-2938-5007	National Health and Medical Research Council of Australia [1010395, 525431, 455395]; Australian Centre for Hepatitis and HIV Virology EOI grant; Gordon and Gretel Bootes Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for Hepatitis and HIV Virology EOI grant; Gordon and Gretel Bootes Foundation	This work was supported by Project Grants # 1010395 (BQ and CP) and # 525431 (CR), and a Program Grant # 455395 (CP) from the National Health and Medical Research Council of Australia, an Australian Centre for Hepatitis and HIV Virology EOI 2012 grant (CR and RJJ) and a grant from the Gordon and Gretel Bootes Foundation (BQ and CR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; [Anonymous], [No title captured]; Barchet W, 2000, EUR J IMMUNOL, V30, P1356, DOI 10.1002/(SICI)1521-4141(200005)30:5<1356::AID-IMMU1356>3.0.CO;2-K; Belyakov IM, 2008, VIROLOGY, V381, P106, DOI 10.1016/j.virol.2008.08.019; Belyakov IM, 2007, J IMMUNOL, V178, P7211, DOI 10.4049/jimmunol.178.11.7211; Berger CT, 2011, J VIROL, V85, P9334, DOI 10.1128/JVI.00460-11; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Cohen J, 2013, SCIENCE, V340, P667, DOI 10.1126/science.340.6133.667; Coupar BEH, 2006, VACCINE, V24, P1378, DOI 10.1016/j.vaccine.2005.09.044; Earl PL, 2009, VACCINE, V27, P5885, DOI 10.1016/j.vaccine.2009.07.039; Estcourt MJ, 2002, INT IMMUNOL, V14, P31, DOI 10.1093/intimm/14.1.31; Hemachandra A, 2010, HUM VACCINES, V6, P835, DOI 10.4161/hv.6.10.12635; Kelleher AD, 2006, AIDS, V20, P294, DOI 10.1097/01.aids.0000199819.40079.e9; Mata M, 1999, J IMMUNOL, V163, P1449; Mothe B, 2012, PLOS ONE, V7; Oehen S, 1997, J IMMUNOL METHODS, V207, P33, DOI 10.1016/S0022-1759(97)00089-6; Quah B, 2004, INT IMMUNOL, V16, P567, DOI 10.1093/intimm/dxh060; Quah BJC, 2013, J IMMUNOL METHODS, V387, P181, DOI 10.1016/j.jim.2012.10.013; Quah BJC, 2012, CYTOM PART A, V81A, P679, DOI 10.1002/cyto.a.22084; Quah BJC, 2012, J IMMUNOL METHODS, V379, P1, DOI 10.1016/j.jim.2012.02.012; Ranasinghe C, 2013, MUCOSAL IMMUNOL, V6, P1068, DOI 10.1038/mi.2013.1; Ranasinghe C, 2007, J IMMUNOL, V178, P2370, DOI 10.4049/jimmunol.178.4.2370; Ranasinghe C, 2006, VACCINE, V24, P5881, DOI 10.1016/j.vaccine.2006.04.023; Ranasinghe C, 2011, VACCINE, V29, P3008, DOI 10.1016/j.vaccine.2011.01.106; Reece JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012774; Regoes RR, 2007, P NATL ACAD SCI USA, V104, P1599, DOI 10.1073/pnas.0508830104; TAKESHITA T, 1995, J IMMUNOL, V154, P1973; Wild J, 2009, VIRAL IMMUNOL, V22, P309, DOI 10.1089/vim.2009.0038; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009; Yates A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001301; Yerly D, 2008, J VIROL, V82, P3147, DOI 10.1128/JVI.02252-07	31	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105366	10.1371/journal.pone.0105366	http://dx.doi.org/10.1371/journal.pone.0105366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170620	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500046
J	Zhao, L; Wang, P; Hou, HL; Zhang, H; Wang, YP; Yan, SH; Huang, Y; Li, H; Tan, JJ; Hu, A; Gao, F; Zhang, Q; Li, YN; Zhou, H; Zhang, W; Li, LJ				Zhao, Lin; Wang, Pu; Hou, Haoli; Zhang, Hao; Wang, Yapei; Yan, Shihan; Huang, Yan; Li, Hui; Tan, Junjun; Hu, Ao; Gao, Fei; Zhang, Qi; Li, Yingnan; Zhou, Hong; Zhang, Wei; Li, Lijia			Transcriptional Regulation of Cell Cycle Genes in Response to Abiotic Stresses Correlates with Dynamic Changes in Histone Modifications in Maize	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; ARABIDOPSIS-THALIANA; PLANT DEVELOPMENT; H4 ACETYLATION; DROUGHT STRESS; SALT STRESS; EXPRESSION; METHYLATION; DEACETYLATION; PATTERNS	The histone modification level has been shown to be related with gene activation and repression in stress-responsive process, but there is little information on the relationship between histone modification and cell cycle gene expression responsive to environmental cues. In this study, the function of histone modifications in mediating the transcriptional regulation of cell cycle genes under various types of stress was investigated in maize (Zea mays L.). Abiotic stresses all inhibit the growth of maize seedlings, and induce total acetylation level increase compared with the control group in maize roots. The positive and negative regulation of the expression of some cell cycle genes leads to perturbation of cell cycle progression in response to abiotic stresses. Chromatin immunoprecipitation analysis reveals that dynamic histone acetylation change in the promoter region of cell cycle genes is involved in the control of gene expression in response to external stress and different cell cycle genes have their own characteristic patterns for histone acetylation. The data also showed that the combinations of hyperacetylation and hypoacetylation states of specific lysine sites on the H3 and H4 tails on the promoter regions of cell cycle genes regulate specific cell cycle gene expression under abiotic stress conditions, thus resulting in prolonged cell cycle duration and an inhibitory effect on growth and development in maize seedlings.	[Zhao, Lin; Wang, Pu; Hou, Haoli; Zhang, Hao; Wang, Yapei; Yan, Shihan; Huang, Yan; Li, Hui; Tan, Junjun; Hu, Ao; Gao, Fei; Zhang, Qi; Li, Yingnan; Zhou, Hong; Li, Lijia] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Zhang, Wei] Wuhan Univ, Renmin Hosp, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Zhang, W (corresponding author), Wuhan Univ, Renmin Hosp, Wuhan 430072, Peoples R China.	zw6676@163.com; ljli@whu.edu.cn		Yan, Shihan/0000-0001-9814-769X	National Natural Science Foundation of China (NSFC) [31171186]; Chinese Ministry of Education; Hubei Province Natural Science Fund	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Hubei Province Natural Science Fund	This work was supported by the National Natural Science Foundation of China [NSFC (No. 31171186)], Key Grant Project of Chinese Ministry of Education and Hubei Province Natural Science Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Venegas R, 2005, NUCLEIC ACIDS RES, V33, P5199, DOI 10.1093/nar/gki830; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Beemster GTS, 2005, PLANT PHYSIOL, V138, P734, DOI 10.1104/pp.104.053884; Burssens S, 2000, PLANTA, V211, P632, DOI 10.1007/s004250000334; Chen Rui, 2011, J Biomed Biotechnol, V2011, P679492, DOI 10.1155/2011/679492; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Engler JD, 2009, PLANT J, V59, P645, DOI 10.1111/j.1365-313X.2009.03893.x; Godinez-Palma SK, 2013, J EXP BOT, V64, P5661, DOI 10.1093/jxb/ert340; He YH, 2009, MOL PLANT, V2, P554, DOI 10.1093/mp/ssp005; Heimann L, 2013, PLANT PHYSIOL, V162, P456, DOI 10.1104/pp.113.216721; Hu Y, 2012, PLANT CELL ENVIRON, V35, P2130, DOI 10.1111/j.1365-3040.2012.02541.x; Huang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035139; Jasencakova Z, 2000, PLANT CELL, V12, P2087, DOI 10.1105/tpc.12.11.2087; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Kim JM, 2008, PLANT CELL PHYSIOL, V49, P1580, DOI 10.1093/pcp/pcn133; Kim JM, 2012, PLANT CELL PHYSIOL, V53, P847, DOI 10.1093/pcp/pcs053; Kim JM, 2010, PLANT CELL ENVIRON, V33, P604, DOI 10.1111/j.1365-3040.2009.02076.x; KNUDSON LL, 1977, PLANT PHYSIOL, V60, P606, DOI 10.1104/pp.60.4.606; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Leiva-Neto JT, 2004, PLANT CELL, V16, P1854, DOI 10.1105/tpc.022178; Li Y, 2005, PLANT J, V41, P346, DOI 10.1111/j.1365-313X.2004.02301.x; Menges M, 2005, PLANT J, V41, P546, DOI 10.1111/j.1365-313X.2004.02319.x; Miguel C, 2011, J EXP BOT, V62, P3713, DOI 10.1093/jxb/err155; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rossi V, 2007, PLANT CELL, V19, P1145, DOI 10.1105/tpc.106.042549; Rymen B, 2007, PLANT PHYSIOL, V143, P1429, DOI 10.1104/pp.106.093948; Schuppler U, 1998, PLANT PHYSIOL, V117, P667, DOI 10.1104/pp.117.2.667; Sharma S, 2004, PLANT CELL REPORTS, V23; Skirycz A, 2011, PLANT CELL, V23, P1876, DOI 10.1105/tpc.111.084160; Sridha S, 2006, PLANT J, V46, P124, DOI 10.1111/j.1365-313X.2006.02678.x; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Tian L, 2005, GENETICS, V169, P337, DOI 10.1534/genetics.104.033142; To TK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002055; Vandepoele K, 2002, PLANT CELL, V14, P903, DOI 10.1105/tpc.010445; Wang GF, 2004, PLANT PHYSIOL, V135, P1084, DOI 10.1104/pp.104.040436; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; West G, 2004, PLANT PHYSIOL, V135, P1050, DOI 10.1104/pp.104.040022; Yan SH, 2013, J HAZARD MATER, V246, P110, DOI 10.1016/j.jhazmat.2012.12.013; Yang F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-178; Zhang L, 2012, PLANT MOL BIOL, V79, P285, DOI 10.1007/s11103-012-9912-3; Zhang L, 2011, PHYSIOL PLANTARUM, V143, P287, DOI 10.1111/j.1399-3054.2011.01496.x; Zhao L, 2014, PHYSIOL PLANTARUM, V151, P459, DOI 10.1111/ppl.12136	43	53	56	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106070	10.1371/journal.pone.0106070	http://dx.doi.org/10.1371/journal.pone.0106070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171199	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500098
J	Herkt, D; Tumani, V; Gron, G; Kammer, T; Hofmann, A; Abler, B				Herkt, Deborah; Tumani, Visal; Groen, Georg; Kammer, Thomas; Hofmann, Arne; Abler, Birgit			Facilitating Access to Emotions: Neural Signature of EMDR Stimulation	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; EYE-MOVEMENT DESENSITIZATION; WORKING-MEMORY; BEHAVIOR-THERAPY; PAIN MODULATION; IMAGING PAIN; PTSD; METAANALYSIS; DISSOCIATION; EFFICACY	Background: Eye Movement Desensitisation and Reprocessing (EMDR) is a method in psychotherapy effective in treating symptoms of posttraumatic stress disorder. The client attends to alternating bilateral visual, auditory or sensory stimulation while confronted with emotionally disturbing material. It is thought that the bilateral stimulation as a specific element of EMDR facilitates accessing and processing of negative material while presumably creating new associative links. We hypothesized that the putatively facilitated access should be reflected in increased activation of the amygdala upon bilateral EMDR stimulation even in healthy subjects. Methods: We investigated 22 healthy female university students (mean 23.5 years) with fMRI. Subjects were scanned while confronted with blocks of disgusting and neutral picture stimuli. One third of the blocks was presented without any additional stimulation, one third with bilateral simultaneous auditory stimulation, and one third with bilateral alternating auditory stimulation as used in EMDR. Results: Contrasting disgusting vs. neutral picture stimuli confirmed the expected robust effect of amygdala activation for all auditory stimulation conditions. The interaction analysis with the type of auditory stimulation revealed a specific increase in activation of the right amygdala for the bilateral alternating auditory stimulation. Activation of the left dorsolateral prefrontal cortex showed the opposite effect with decreased activation. Conclusions: We demonstrate first time evidence for a putative neurobiological basis of the bilateral alternating stimulation as used in the EMDR method. The increase in limbic processing along with decreased frontal activation is in line with theoretical models of how bilateral alternating stimulation could help with therapeutic reintegration of information, and present findings may pave the way for future research on EMDR in the context of posttraumatic stress disorder.	[Herkt, Deborah; Tumani, Visal; Groen, Georg; Kammer, Thomas; Abler, Birgit] Univ Ulm, Dept Psychiat, D-89069 Ulm, Germany; [Hofmann, Arne] EMDR, Inst Deutschland, Bergisch Gladbach, Germany	Ulm University	Abler, B (corresponding author), Univ Ulm, Dept Psychiat, D-89069 Ulm, Germany.	birgit.abler@uni-ulm.de	Kammer, Thomas/K-2168-2012	Kammer, Thomas/0000-0002-2769-5645; Gron, Georg/0000-0002-0282-3575				Abler B, 2007, J PSYCHIATR RES, V41, P511, DOI 10.1016/j.jpsychires.2006.07.020; Abler B, 2010, PSYCHIAT RES-NEUROIM, V183, P105, DOI 10.1016/j.pscychresns.2010.05.010; Abler B, 2009, DIAGNOSTICA, V55, P144, DOI 10.1026/0012-1924.55.3.144; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Andrade J, 1997, BRIT J CLIN PSYCHOL, V36, P209, DOI 10.1111/j.2044-8260.1997.tb01408.x; [Anonymous], 1981, STAIT TRAIT ANGSTINV; Barrowcliff AL, 2004, J FORENSIC PSYCHI PS, V15, P325, DOI 10.1080/14789940410001673042; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; Bisson J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub3; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Cahill SP, 1999, J ANXIETY DISORD, V13, P5, DOI 10.1016/S0887-6185(98)00039-5; Clarke R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00228; Erk S, 2008, NEUROREPORT, V19, P447, DOI 10.1097/WNR.0b013e3282f5d92f; Erk S, 2006, EUR J NEUROSCI, V24, P1227, DOI 10.1111/j.1460-9568.2006.04976.x; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Ho MSK, 2012, EUR REV APPL PSYCHOL, V62, P253, DOI 10.1016/j.erap.2012.08.001; Holscher C, 1997, J NEUROSCI, V17, P6470; Hornsveld HK, 2011, J EMDR PRACT RES, V5, P146, DOI 10.1891/1933-3196.5.4.146; Korn DL, 2002, J CLIN PSYCHOL, V58, P1465, DOI 10.1002/jclp.10099; Lanius RA, 2006, J PSYCHIATR RES, V40, P709, DOI 10.1016/j.jpsychires.2005.07.007; Lanius RA, 2002, BIOL PSYCHIAT, V52, P305, DOI 10.1016/S0006-3223(02)01367-7; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; Lansing K, 2005, J NEUROPSYCH CLIN N, V17, P526, DOI 10.1176/appi.neuropsych.17.4.526; Lee CW, 2013, J BEHAV THER EXP PSY, V44, P231, DOI 10.1016/j.jbtep.2012.11.001; Lohr JM, 1998, BEHAV THER, V29, P123, DOI 10.1016/S0005-7894(98)80035-X; Lohr JM, 1999, J ANXIETY DISORD, V13, P185, DOI 10.1016/S0887-6185(98)00047-4; Maxfield L, 2008, J EMDR PRACT RES, V2, P234, DOI 10.1891/1933-3196.2.4.234; Moser DA, 2013, STRESS, V16, P493, DOI 10.3109/10253890.2013.816280; Nijenhuis ERS, 2011, J TRAUMA DISSOCIATIO, V12, P416, DOI 10.1080/15299732.2011.570592; Pagani M, 2007, NUCL MED COMMUN, V28, P757, DOI 10.1097/MNM.0b013e3282742035; Pagani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045753; Pagani M, 2011, J EMDR PRACT RES, V5, P42, DOI 10.1891/1933-3196.5.2.42; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Servan-Schreiber D, 2006, PSYCHOTHER PSYCHOSOM, V75, P290, DOI 10.1159/000093950; Shapiro F, 2002, J CLIN PSYCHOL, V58, P1, DOI 10.1002/jclp.1126; Shapiro F., 2018, EYE MOVEMENT DESENSI, V2; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Sprang G, 2001, RES SOCIAL WORK PRAC, V11, P300, DOI 10.1177/104973150101100302; Sprenger T, 2006, ANESTH ANALG, V103, P729, DOI 10.1213/01.ane.0000231635.14872.40; Staudinger MR, 2009, NEUROIMAGE, V47, P713, DOI 10.1016/j.neuroimage.2009.04.095; Tracey I, 2008, BRIT J ANAESTH, V101, P32, DOI 10.1093/bja/aen102; van den Hout MA, 2012, J EXP PSYCHOPATHOL, V3, P724; van den Hout MA, 2012, BEHAV RES THER, V50, P275, DOI 10.1016/j.brat.2012.02.001; van den Hout MA, 2011, BEHAV RES THER, V49, P92, DOI 10.1016/j.brat.2010.11.003; van den Hout MA, 2010, APPL COGNITIVE PSYCH, V24, P303, DOI 10.1002/acp.1677; van der Hart O, 2005, J TRAUMA STRESS, V18, P413, DOI 10.1002/jts.20049; van der Kolk B, 2000, Dialogues Clin Neurosci, V2, P7; Van Etten ML, 1998, CLIN PSYCHOL PSYCHOT, V5, P126, DOI 10.1002/(SICI)1099-0879(199809)5:3<126::AID-CPP153>3.3.CO;2-8; vanderKolk BA, 1996, AM J PSYCHIAT, V153, P83; Wagner KJ, 2007, ANESTHESIOLOGY, V106, P548, DOI 10.1097/00000542-200703000-00020; Watts BV, 2013, J CLIN PSYCHIAT, V74, pE541, DOI 10.4088/JCP.12r08225	56	29	29	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106350	10.1371/journal.pone.0106350	http://dx.doi.org/10.1371/journal.pone.0106350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JP	25165974	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303700088
J	Groenendijk, J; Hajek, F; Johnson, PJ; Macdonald, DW; Calvimontes, J; Staib, E; Schenck, C				Groenendijk, Jessica; Hajek, Frank; Johnson, Paul J.; Macdonald, David W.; Calvimontes, Jorge; Staib, Elke; Schenck, Christof			Demography of the Giant Otter (Pteronura brasiliensis) in Manu National Park, South-Eastern Peru: Implications for Conservation	PLOS ONE			English	Article							GROUP-SIZE; POPULATION; MUSTELIDAE; CARNIVORA; FISH	The giant otter (Pteronura brasiliensis) is an endangered semi-aquatic carnivore of South America. We present findings on the demography of a population inhabiting the floodplain of Manu National Park, south-eastern Peru, arising from 14 annual dry season censuses over a 16 year period. The breeding system of territorial groups, including only a single breeding female with non-reproductive adult 'helpers', resulted in a low intrinsic rate of increase (0.03) and a slow recovery from decades of hunting for the pelt trade. This is explained by a combination of factors: (1) physiological traits such as late age at first reproduction and long generation time, (2) a high degree of reproductive skew, (3) small litters produced only once a year, and (4) a 50% mortality between den emergence and age of dispersal, as well as high mortality amongst dispersers (especially males). Female and male giant otters show similar traits with respect to average reproductive life-spans (female 5.4 yrs., male 5.2 yrs.) and average cub productivity (female 6.9, male 6.7 cubs per lifetime); the longest reproductive life spans were 11 and 13 years respectively. Individual reproductive success varied substantially and depended mainly on the duration of dominance tenure in the territory. When breeding females died, the reproductive position in the group was usually occupied by sisters or daughters (n = 11), with immigrant male partners. Male philopatry was not observed. The vulnerability of the Manu giant otter population to anthropogenic disturbance emphasises the importance of effective protection of core lake habitats in particular. Riverine forests are the most endangered ecosystem in the Department of Madre de Dios due to the concentration of gold mining, logging and agricultural activities in floodplains, highlighting the need for a giant otter habitat conservation corridor along the Madre de Dios River.	[Groenendijk, Jessica] Dept Cusco, San Diego Zoo Global Peru, Cuzco, Peru; [Hajek, Frank] Dept Cusco, Nat Serv Peru, Cuzco, Peru; [Groenendijk, Jessica; Johnson, Paul J.; Macdonald, David W.] Univ Oxford, Wildlife Conservat Res Unit, Abingdon, Oxon, England; [Calvimontes, Jorge] Univ Estadual Campinas, Environm Studies & Res Ctr, Sao Paulo, Brazil; [Groenendijk, Jessica; Hajek, Frank; Calvimontes, Jorge; Staib, Elke; Schenck, Christof] Frankfurt Zool Soc, Frankfurt, Germany	University of Oxford; Universidade Estadual de Campinas	Groenendijk, J (corresponding author), Dept Cusco, San Diego Zoo Global Peru, Cuzco, Peru.	jessica.groenendijk@gmail.com	Bloom, Eric/AAY-3500-2020	Calvimontes, Jorge/0000-0001-6498-6903	Munich Wildlife Society; Gottlieb Daimler and Karl Benz Foundation; Frankfurt Zoological Society - Help for Threatened Wildlife; Whitley Wildlife Conservation Trust; John Ellerman Foundation	Munich Wildlife Society; Gottlieb Daimler and Karl Benz Foundation; Frankfurt Zoological Society - Help for Threatened Wildlife; Whitley Wildlife Conservation Trust; John Ellerman Foundation	ES and CS received support from the Munich Wildlife Society as well as two doctorate grants from the Gottlieb Daimler and Karl Benz Foundation. JG, FH, JC, ES, and CS received funding from the Frankfurt Zoological Society - Help for Threatened Wildlife (http://www.zgf.de/?id =148danguage= en). PJ received support from the Whitley Wildlife Conservation Trust (http://www.wwct.org.uk/) and the John Ellerman Foundation (http://ellerman.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo E, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-11; Autuori MP, 1997, ZOOL GART, V47, P1; Cabral MMM, 2010, ZOOLOGIA-CURITIBA, V27, P47, DOI 10.1590/S1984-46702010000100008; Carter SK, 1997, MAMMAL REV, V27, P1, DOI 10.1111/j.1365-2907.1997.tb00370.x; Chehebar C., 1990, OTTERS ACTION PLAN T; Corredor Londono G., 2006, International Zoo Yearbook, V40, P360, DOI 10.1111/j.1748-1090.2006.00360.x; CREEL S, 1995, ADV STUD BEHAV, V24, P203, DOI 10.1016/S0065-3454(08)60395-2; Creel S., 2002, AFRICAN WILD DOG BEH; Davenport L, 2008, OXBOW LAKES MANU BIO; de Oliveira GC, 2011, ANIM BIOL, V61, P175, DOI 10.1163/157075511X566506; DUPLAIX N, 1980, TERRE VIE-REV ECOL A, V34, P495; Duplaix N, 2008, IUCN 2012 IUCN RED L; Egg A Brack, 1978, OTTERS, P76; Franklin I.R., 1980, CONSERVATION BIOL EV; GOREMAD, 2013, PLAN ORD TERR MADR D; Groenendijk J, 2013, REPORTE MANU 2013 PA, P314; Groenendijk J, 2006, GIANTS MADRE DIOS; Groenendijk J., 2005, HABITAT, V16, P1; Groenendijk J, 1998, REV DISTRIBUTION CON; Gutleb AC, 1997, AMBIO, V26, P511; Hagenbeck Claus, 1992, International Zoo Yearbook, V31, P240, DOI 10.1111/j.1748-1090.1991.tb02392.x; Hajek F., 2005, HABITAT, V16; Henderson PA, 1997, J TROP ECOL, V13, P175, DOI 10.1017/S0266467400010403; INEI, 2011, EV POBR 2010; Kalpers J, 2003, ORYX, V37, P326, DOI 10.1017/S0030605303000589; Kelly MJ, 1998, J ZOOL, V244, P473, DOI 10.1017/S0952836998004014; Krebs CJ, 1989, ECOLOGICAL METHODOLO, Vxii; Kruuk H., 2006, OTTERS ECOLOGY BEHAV; Laidler PE, 1984, THESIS U CAMBRIDGE C; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NSP, 2013, BAS DIS MEC FIN DES; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; Uscamaita MR, 2010, ORYX, V44, P83, DOI 10.1017/S0030605309990196; Ribas Carolina, 2004, IUCN Otter Specialist Group Bulletin, V21, P89; ROOD JP, 1990, ANIM BEHAV, V39, P566, DOI 10.1016/S0003-3472(05)80423-3; Rosas FCW, 1999, BIOTROPICA, V31, P502, DOI 10.1111/j.1744-7429.1999.tb00393.x; Rosas-Ribeiro PF, 2012, BIOTROPICA, V44, P437, DOI 10.1111/j.1744-7429.2011.00828.x; Schenck C, 2003, LANDSCAPE ECOLOGY AND RESOURCE MANAGEMENT: LINKING THEORY WITH PRACTICE, P341; Schenck C, 1999, THESIS U MUNCHEN LIM; Spong GF, 2008, MOL ECOL, V17, P2287, DOI 10.1111/j.1365-294X.2008.03734.x; Staib E, 2005, ECO ETOLOGIA LOBO RI; Swenson JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018875; Sykes-Gatz S., 2005, INT GIANT OTTER STUD; Trebbau P., 1978, Zoologische Garten, V48, P187; Rosas FCW, 2009, SOCIOBIOLOGY, V54, P919	45	21	24	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106202	10.1371/journal.pone.0106202	http://dx.doi.org/10.1371/journal.pone.0106202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162684	Green Published, Green Submitted, gold			2022-12-25	WOS:000340880900096
J	Hirata, K; Kobayashi, K; Wong, KP; Manabe, O; Surmak, A; Tamaki, N; Huang, SC				Hirata, Kenji; Kobayashi, Kentaro; Wong, Koon-Pong; Manabe, Osamu; Surmak, Andrew; Tamaki, Nagara; Huang, Sung-Cheng			A Semi-Automated Technique Determining the Liver Standardized Uptake Value Reference for Tumor Delineation in FDG PET-CT	PLOS ONE			English	Article							TOTAL LESION GLYCOLYSIS; SQUAMOUS-CELL CARCINOMA; F-18-FDG PET/CT; RESPONSE EVALUATION; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC VALUE; SOLID TUMORS; LUNG-CANCER; PERCIST; VOLUME	Background: F-18-fluorodeoxyglucose (FDG) positron emission tomography (PET)-computed tomography (CT) has been an essential modality in oncology. We propose a semi-automated algorithm to objectively determine liver standardized uptake value (SUV), which is used as a threshold for tumor delineation. Methods: A large spherical volume of interest (VOI) was placed manually to roughly enclose the right lobe (RL) of the liver. For each voxel in this VOI, a coefficient of variation of voxel values (CVv) was calculated for neighboring voxels within a radius of d/2. The voxel with the minimum CVv was then selected, where a 30-mm spherical VOI was placed at that voxel in accordance with PERCIST criteria. Two nuclear medicine physicians independently defined 30-mm VOIs manually on 124 studies in 62 patients to generate the standard values, against which the results from the new method were compared. Results: The semi-automated method was successful in determining the liver SUV that was consistent between the two physicians in all the studies (d = 80 mm). The liver SUV threshold (mean +3 SD within 30-mm VOI) determined by the new semi-automated method (3.12 +/- 0.61) was not statistically different from those determined by the manual method (Physician-1: 3.14 +/- 0.58, Physician-2: 3.15 +/- 0.58). The semi-automated method produced tumor volumes that were not statistically different from those by experts' manual operation. Furthermore, the volume change in the two sequential studies had no statistical difference between semi-automated and manual methods. Conclusions: Our semi-automated method could define the liver SUV robustly as the threshold value used for tumor volume measurements according to PERCIST. The method could avoid possible subjective bias of manual liver VOI placement and is thus expected to improve clinical performance of volume-based parameters for prediction of cancer treatment response.	[Hirata, Kenji; Wong, Koon-Pong; Surmak, Andrew; Huang, Sung-Cheng] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Kobayashi, Kentaro; Manabe, Osamu; Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido, Japan	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Hokkaido University	Hirata, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	kenjihirata@ucla.edu	Wong, Koon-Pong/AAI-3780-2020	Manabe, Osamu/0000-0001-8518-8441; Wong, Koon-Pong/0000-0002-6095-4645	National Institutes of Health (NIH) [R01-AG033015, P50-CA086306, P01-N5058489]; SNMMI Wagner-Torizuka Fellowship; Hokkaido University HIROKO's Fund for Academic Exchange; NATIONAL CANCER INSTITUTE [P50CA086306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS058489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033015] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SNMMI Wagner-Torizuka Fellowship; Hokkaido University HIROKO's Fund for Academic Exchange; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the National Institutes of Health (NIH) grants R01-AG033015, P50-CA086306, P01-N5058489, by SNMMI Wagner-Torizuka Fellowship 2013/2015 (to Kenji Hirata), and by Hokkaido University HIROKO's Fund for Academic Exchange 2012 (to Kenji Hirata). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer C, 2012, MED PHYS, V39, P3112, DOI 10.1118/1.4711815; Bazan JG, 2013, J NUCL MED, V54, P27, DOI 10.2967/jnumed.112.109470; Ben-Haim S, 2009, J NUCL MED, V50, P88, DOI 10.2967/jnumed.108.054205; Bi L, 2012, IEEE ENG MED BIO, P5335, DOI 10.1109/EMBC.2012.6347199; Byun BH, 2013, J NUCL MED, V54, P1725, DOI 10.2967/jnumed.112.117697; Chen HHW, 2012, RADIOLOGY, V264, P559, DOI 10.1148/radiol.12111148; Davison AC, 1997, BOOTSTRAP METHODS TH; Falissard B, 2012, PSY VARIOUS PROCEDUR; Fencl P, 2012, NUCL MED COMMUN, V33, P1188, DOI 10.1097/MNM.0b013e3283573d0d; Gilbert J, 2012, CLIN CANCER RES, V18, P1735, DOI 10.1158/1078-0432.CCR-11-2544; HOLM S, 1979, SCAND J STAT, V6, P65; Israel O, 2007, J NUCL MED, V48, p28S; Jhanwar YS, 2006, J NUCL MED, V47, P1326; Kao CH, 2012, EUR J NUCL MED MOL I, V39, P1297, DOI 10.1007/s00259-012-2127-7; Kidd EA, 2013, INT J RADIAT ONCOL, V85, P116, DOI 10.1016/j.ijrobp.2012.02.056; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liao SS, 2013, CLIN NUCL MED, V38, P715, DOI 10.1097/RLU.0b013e31829f57fa; Liao SR, 2012, EUR J NUCL MED MOL I, V39, P27, DOI 10.1007/s00259-011-1934-6; Mhlanga JC, 2014, EUR J NUCL MED MOL I, V41, P596, DOI 10.1007/s00259-013-2671-9; Panin VY, 2006, IEEE T MED IMAGING, V25, P907, DOI 10.1109/TMI.2006.876171; Ryu IS, 2013, J NUCL MED, V54, P1032, DOI 10.2967/jnumed.112.116053; Skougaard K, 2013, J NUCL MED, V54, P1026, DOI 10.2967/jnumed.112.111757; Tateishi U, 2012, RADIOLOGY, V263, P53, DOI 10.1148/radiol.12111177; Thacker CA, 2012, CANCER MED-US, V1, P230, DOI 10.1002/cam4.33; Usmanij EA, 2013, J NUCL MED, V54, P1528, DOI 10.2967/jnumed.112.116921; Viner M, 2013, RADIOLOGY, V267, P596, DOI 10.1148/radiol.12121385; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Yanagawa M, 2012, J NUCL MED, V53, P872, DOI 10.2967/jnumed.111.098699	28	52	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105682	10.1371/journal.pone.0105682	http://dx.doi.org/10.1371/journal.pone.0105682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162396	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900043
J	Liao, M; Shi, JY; Huang, LR; Gao, Y; Tan, AH; Wu, CL; Lu, Z; Yang, XB; Zhang, SJ; Hu, YL; Qin, X; Li, JL; Chen, G; Xu, JF; Mo, ZN; Zhang, HY				Liao, Ming; Shi, Jianying; Huang, Lirong; Gao, Yong; Tan, Aihua; Wu, Chunlei; Lu, Zheng; Yang, Xiaobo; Zhang, Shijun; Hu, Yanlin; Qin, Xue; Li, Jianling; Chen, Gang; Xu, Jianfeng; Mo, Zengnan; Zhang, Haiying			Genome-Wide Association Study Identifies Variants in PMS1 Associated with Serum Ferritin in a Chinese Population	PLOS ONE			English	Article							TRANSFERRIN SATURATION; METABOLIC SYNDROME; COMMON VARIANTS; APLASTIC-ANEMIA; REPAIR GENES; IRON; HFE; TMPRSS6; HEMOCHROMATOSIS; POLYMORPHISMS	Only a small proportion of genetic variation in serum ferritin has been explained by variant genetic studies, and genome-wide association study (GWAS) for serum ferritin has not been investigated widely in Chinese population. We aimed at exploring the novel genetic susceptibility to serum ferritin, and performed this two stage GWAS in a healthy Chinese population of 3,495 men aged 20-69 y, including 1,999 unrelated subjects in the first stage and 1,496 independent individuals in the second stage. Serum ferritin was measured with electrochemiluminescence immunoassay, and DNA samples were collected for genotyping. A total of 1,940,243 SNPs were tested by using multivariate linear regression analysis. After adjusting for population stratification, age and BMI, the rs5742933 located in the 5'UTR region of PMS1 gene on chromosome 2 was the most significantly associated with ferritin concentrations (P-combined = 2.329x10(-10)) (beta = -0.11, 95% CI: -0.14, -0.07). Moreover, this marker was about 200kb away from the candidate gene SLC40A1 which is responsible for iron export. PMS1 gene was the novel genetic susceptibility to serum ferritin in Chinese males and its relation to SLC40A1 needs further study.	[Liao, Ming; Lu, Zheng; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi, Peoples R China; [Liao, Ming; Shi, Jianying; Huang, Lirong; Gao, Yong; Tan, Aihua; Wu, Chunlei; Lu, Zheng; Yang, Xiaobo; Zhang, Shijun; Hu, Yanlin; Qin, Xue; Li, Jianling; Chen, Gang; Mo, Zengnan; Zhang, Haiying] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi, Peoples R China; [Yang, Xiaobo] Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi, Peoples R China; [Zhang, Haiying] Guangxi Med Univ, Gen Practice Sch, Nanning, Guangxi, Peoples R China; [Zhang, Shijun] Guangxi Med Univ, Dept Pharmacol, Nanning, Guangxi, Peoples R China; [Hu, Yanlin] Guangxi Med Univ, Med Sci Res Ctr, Nanning, Guangxi, Peoples R China; [Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Li, Jianling] Guangxi Med Univ, Affiliated Hosp 1, Inst Cardiovasc Dis, Nanning, Guangxi, Peoples R China; [Chen, Gang] Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, Nanning, Guangxi, Peoples R China; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Xu, Jianfeng] Van Andel Res Inst, Ctr Genet Epidemiol, Grand Rapids, MI USA; [Wu, Chunlei] Xinxiang Med Coll, Affiliated Hosp 1, Dept Urol, Xinxiang, Henan Province, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Wake Forest University; Wake Forest Baptist Medical Center; Van Andel Institute; Xinxiang Medical University	Zhang, HY (corresponding author), Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi, Peoples R China.	billmamahyzhang@gmail.com	Yang, Xiaobo/G-3854-2016	mo, zengnan/0000-0002-3047-3138	National Natural Science Foundation of China [81260130, 81060234, 30945204, 30360124, 30260110]; Key Program and University Talents Highland Innovation Team of Guangxi [2012012D003, GJR201147-09]; Chairman Science and Technology Fund and Tackle Program of Guangxi [1116-03, GKG1298003-07-01]; Guangxi Science Fund for Distinguished Young Scholars [2012GXNSFFA060009]; Guangxi Natural Science Foundation [2012GXNSFDA053016]; Guangxi Graduate Education Innovation Program [2010105981002M175, 2011105981002M202]; Guangxi Provincial Department of Finance and Education [2009GJCJ150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program and University Talents Highland Innovation Team of Guangxi; Chairman Science and Technology Fund and Tackle Program of Guangxi; Guangxi Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Guangxi Graduate Education Innovation Program; Guangxi Provincial Department of Finance and Education	This study was supported by grants from the National Natural Science Foundation of China (81260130, 81060234, 30945204, 30360124, 30260110), Key Program and University Talents Highland Innovation Team of Guangxi (2012012D003, GJR201147-09), Chairman Science and Technology Fund and Tackle Program of Guangxi (1116-03, GKG1298003-07-01), Guangxi Science Fund for Distinguished Young Scholars (2012GXNSFFA060009), Guangxi Natural Science Foundation (2012GXNSFDA053016), Guangxi Graduate Education Innovation Program (2010105981002M175 and 2011105981002M202) and Guangxi Provincial Department of Finance and Education (2009GJCJ150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2012, HUM MOL GENET, V21, P2124, DOI 10.1093/hmg/dds028; Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456; Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; CASKEY JH, 1983, P NATL ACAD SCI-BIOL, V80, P482, DOI 10.1073/pnas.80.2.482; Cazzola M, 2002, BRIT J HAEMATOL, V119, P539, DOI 10.1046/j.1365-2141.2002.03946.x; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Constantine CC, 2009, BRIT J HAEMATOL, V147, P140, DOI 10.1111/j.1365-2141.2009.07843.x; del-Castillo-Rueda A, 2012, GENE, V508, P15, DOI 10.1016/j.gene.2012.07.069; Dong J, 2012, MOL CARCINOGEN, V51, P546, DOI 10.1002/mc.20819; Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5; Galli A, 2004, BRIT J HAEMATOL, V127, P598, DOI 10.1111/j.1365-2141.2004.05238.x; Gan W, 2012, AM J CLIN NUTR, V95, P626, DOI 10.3945/ajcn.111.025684; Greenfield TK, 2000, AM J PUBLIC HEALTH, V90, P47, DOI 10.2105/AJPH.90.1.47; Guo XJ, 2013, J K-THEORY, V12, P1, DOI 10.1017/is013010002jkt241; Hirano N, 2005, BRIT J HAEMATOL, V128, P221, DOI 10.1111/j.1365-2141.2004.05317.x; HORII A, 1994, BIOCHEM BIOPH RES CO, V204, P1257, DOI 10.1006/bbrc.1994.2598; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074168; Liu ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075908; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marroni F, 2008, HUM HERED, V65, P175, DOI 10.1159/000109734; Merryweather-Clarke AT, 1998, BRIT J HAEMATOL, V101, P369, DOI 10.1046/j.1365-2141.1998.00736.x; Milet J, 2007, AM J HUM GENET, V81, P799, DOI 10.1086/520001; Njajou OT, 2006, HUM HERED, V61, P222, DOI 10.1159/000094777; Pichler I, 2011, HUM MOL GENET, V20, P1232, DOI 10.1093/hmg/ddq552; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sun L, 2008, J CLIN ENDOCR METAB, V93, P4690, DOI 10.1210/jc.2008-1159; Tanaka T, 2010, BLOOD, V115, P94, DOI 10.1182/blood-2009-07-232496; Vari IS, 2007, DIABETES CARE, V30, P1795, DOI 10.2337/dc06-2312; Whitfield JB, 2000, AM J HUM GENET, V66, P1246, DOI 10.1086/302862; WORWOOD M, 1985, HUM GENET, V69, P371, DOI 10.1007/BF00291657; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yang XB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002916; Yoshida N, 2008, BRIT J HAEMATOL, V142, P427, DOI 10.1111/j.1365-2141.2008.07182.x	36	7	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105844	10.1371/journal.pone.0105844	http://dx.doi.org/10.1371/journal.pone.0105844			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162662	Green Published, Green Submitted, gold			2022-12-25	WOS:000340880900054
J	Witzenberger, KA; Hochkirch, A				Witzenberger, Kathrin A.; Hochkirch, Axel			The Genetic Integrity of the Ex Situ Population of the European Wildcat (Felis silvestris silvestris) Is Seriously Threatened by Introgression from Domestic Cats (Felis silvestris catus)	PLOS ONE			English	Article							INBREEDING DEPRESSION; MICROSATELLITE LOCI; COMPUTER-PROGRAM; LINKAGE MAP; CONSERVATION; HYBRIDIZATION; SOFTWARE; HYBRIDS; SIZE; DIFFERENTIATION	Studies on the genetic diversity and relatedness of zoo populations are crucial for implementing successful breeding programmes. The European wildcat, Felis s. silvestris, is subject to intensive conservation measures, including captive breeding and reintroduction. We here present the first systematic genetic analysis of the captive population of Felis s. silvestris in comparison with a natural wild population. We used microsatellites and mtDNA sequencing to assess genetic diversity, structure and integrity of the ex situ population. Our results show that the ex situ population of the European wildcat is highly structured and that it has a higher genetic diversity than the studied wild population. Some genetic clusters matched the breeding lines of certain zoos or groups of zoos that often exchanged individuals. Two mitochondrial haplotype groups were detected in the in situ populations, one of which was closely related to the most common haplotype found in domestic cats, suggesting past introgression in the wild. Although native haplotypes were also found in the captive population, the majority (68%) of captive individuals shared a common mtDNA haplotype with the domestic cat (Felis s. catus). Only six captive individuals (7.7%) were assigned as wildcats in the STRUCTURE analysis (at K = 2), two of which had domestic cat mtDNA haplotypes and only two captive individuals were assigned as purebred wildcats by NewHybrids. These results suggest that the high genetic diversity of the captive population has been caused by admixture with domestic cats. Therefore, the captive population cannot be recommended for further breeding and reintroduction.	[Witzenberger, Kathrin A.] Zoo Hoyerswerda, Hoyerswerda, Germany; [Witzenberger, Kathrin A.; Hochkirch, Axel] Univ Trier, Dept Biogeog, Trier, Germany	Universitat Trier	Hochkirch, A (corresponding author), Univ Trier, Dept Biogeog, Trier, Germany.	hochkirch@uni-trier.de	Hochkirch, Axel/A-4092-2008; Hochkirch, Axel/E-7891-2011	Hochkirch, Axel/0000-0002-4475-0394; 	Scholarship Programme of the German Federal Environmental Foundation	Scholarship Programme of the German Federal Environmental Foundation	This work is part of a PhD project that is financially supported by the Scholarship Programme of the German Federal Environmental Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Anderson EC, 2002, GENETICS, V160, P1217; Ballou Jonathan D., 1995, P76; Boakes E, 2005, GENET RES, V86, P139, DOI 10.1017/S001667230500772X; Boakes EH, 2007, HEREDITY, V98, P172, DOI 10.1038/sj.hdy.6800923; Bowling AT, 2003, CYTOGENET GENOME RES, V102, P226, DOI 10.1159/000075754; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Caballero A, 2000, GENET RES, V75, P331, DOI 10.1017/S0016672399004449; Campana MG, 2010, MOL ECOL RES; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 1996, GENETICS, V144, P2001; Cuaron AD, 2005, ZOO BIOL, V24, P115, DOI 10.1002/zoo.20040; Driscoll C, 2010, 2013 IUCN RED LIST T; Driscoll CA, 2007, SCIENCE, V317, P519, DOI 10.1126/science.1139518; Eckert I, 2010, MAMM BIOL, V75, P160, DOI 10.1016/j.mambio.2009.07.005; Ely JJ, 2005, AM J PRIMATOL, V67, P223, DOI 10.1002/ajp.20179; Estoup A, 1996, MOL MAR BIOL BIOTECH, V5, P295; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falconer D. S, 1996, INTRO QUANTITATIVE G; Falush D, 2003, GENETICS, V164, P1567; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Frankham R, 2008, MOL ECOL, V17, P325, DOI 10.1111/j.1365-294X.2007.03399.x; Frankham R, 2010, BIOL CONSERV, V143, P1919, DOI 10.1016/j.biocon.2010.05.011; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Germain E, 2008, J ZOOL, V276, P195, DOI 10.1111/j.1469-7998.2008.00479.x; Goncalves da Silva A, 2010, J HERED, V101, P581, DOI 10.1093/jhered/esq055; GOTTELLI D, 1994, MOL ECOL, V3, P301, DOI 10.1111/j.1365-294X.1994.tb00070.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grabe H, 2001, WILDKATZE ZURU CK LE; Hausdorf B, 2010, SYST BIOL, V59, P491, DOI 10.1093/sysbio/syq039; Hedrick PW, 1997, ZOO BIOL, V16, P47, DOI 10.1002/(SICI)1098-2361(1997)16:1<47::AID-ZOO7>3.0.CO;2-B; Henry P, 2009, MOL ECOL, V18, P3173, DOI 10.1111/j.1365-294X.2009.04266.x; Hertwig ST, 2009, J ZOOL SYST EVOL RES, V47, P283, DOI 10.1111/j.1439-0469.2009.00536.x; HUBBARD AL, 1992, BIOL CONSERV, V61, P203, DOI 10.1016/0006-3207(92)91117-B; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kraaijeveld-Smit FJL, 2006, J APPL ECOL, V43, P360, DOI 10.1111/j.1365-2664.2006.01137.x; Lau J, 2009, MOL ECOL RESOUR, V9, P1412, DOI 10.1111/j.1755-0998.2009.02683.x; Leberg PL, 2008, MOL ECOL, V17, P334, DOI 10.1111/j.1365-294X.2007.03433.x; Lecis R, 2006, MOL ECOL, V15, P119, DOI 10.1111/j.1365-294X.2005.02812.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lugon-Moulin N, 1999, MOL ECOL, V8, P419, DOI 10.1046/j.1365-294X.1999.00595.x; Luo SJ, 2008, CURR BIOL, V18, P592, DOI 10.1016/j.cub.2008.03.053; Macdonald David W., 2010, P471; Marshall TC, 2000, ANIM CONSERV, V3, P241, DOI 10.1111/j.1469-1795.2000.tb00109.x; Menotti-Raymond M, 2003, CYTOGENET GENOME RES, V102, P272, DOI 10.1159/000075762; Menotti-Raymond M, 2003, J HERED, V94, P95, DOI 10.1093/jhered/esg008; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Menotti-Raymond M, 2009, GENOMICS, V93, P305, DOI 10.1016/j.ygeno.2008.11.004; MENOTTIRAYMOND MA, 1995, J HERED, V86, P319, DOI 10.1093/oxfordjournals.jhered.a111594; O'Brien J, 2009, BIODIVERS CONSERV, V18, P2351, DOI 10.1007/s10531-009-9592-8; O'Brien SJ, 2006, EAZA NEWS, V57, P26; Oliveira R, 2008, PHILOS T R SOC B, V363, P2953, DOI 10.1098/rstb.2008.0052; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pierpaoli M, 2003, MOL ECOL, V12, P2585, DOI 10.1046/j.1365-294X.2003.01939.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramirez O, 2006, CONSERV GENET, V7, P861, DOI 10.1007/s10592-006-9123-z; Randi E, 2001, MOL BIOL EVOL, V18, P1679, DOI 10.1093/oxfordjournals.molbev.a003956; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Robert A, 2009, BIOL CONSERV, V142, P2915, DOI 10.1016/j.biocon.2009.07.016; Rodriguez-Ramilo ST, 2012, MOL ECOL RESOUR, V12, P873, DOI 10.1111/j.1755-0998.2012.03156.x; Roldan VA, 2010, ZOO BIOL, V29, P1; Saura M, 2008, CONSERV BIOL, V22, P1277, DOI 10.1111/j.1523-1739.2008.00992.x; Schulte U, 2012, MOL ECOL, V21, P4313, DOI 10.1111/j.1365-294X.2012.05693.x; SLATKIN M, 1995, GENETICS, V139, P457; Steyer K, 2013, EUR J WILDLIFE RES, V59, P39, DOI 10.1007/s10344-012-0644-0; Storfer A, 1999, BIOL CONSERV, V87, P173, DOI 10.1016/S0006-3207(98)00066-4; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; TEMPLETON AR, 1987, ZOO BIOL, V6, P305, DOI 10.1002/zoo.1430060405; Tzika AC, 2009, CONSERV GENET, V10, P69, DOI 10.1007/s10592-008-9519-z; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang J, 2007, GENET RES, V89, P135, DOI 10.1017/S0016672307008798; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Wang JL, 2002, GENETICS, V160, P1203; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WAZA (World Association of Zoos and Aquariums), 2005, BUILD FUT WILDL WORL; Williams SE, 2009, BIOL CONSERV, V142, P2388, DOI 10.1016/j.biocon.2009.05.034; Witzenberger KA, 2013, MAMM BIOL, V78, P379, DOI 10.1016/j.mambio.2013.03.001; Witzenberger KA, 2011, BIODIVERS CONSERV, V20, P1843, DOI 10.1007/s10531-011-0074-4	87	15	15	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106083	10.1371/journal.pone.0106083	http://dx.doi.org/10.1371/journal.pone.0106083			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162450	gold, Green Published			2022-12-25	WOS:000340880900086
J	Brown, KA; Fisman, DN; Moineddin, R; Daneman, N				Brown, Kevin A.; Fisman, David N.; Moineddin, Rahim; Daneman, Nick			The Magnitude and Duration of Clostridium difficile Infection Risk Associated with Antibiotic Therapy: A Hospital Cohort Study	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; DISEASE; ACQUISITION; INFLUENZA; PRESSURE; EXPOSURE; DIARRHEA; UPDATE; HEALTH; ONSET	Antibiotic therapy is the principal risk factor for Clostridium difficile infection (CDI), but little is known about how risks cumulate over the course of therapy and abate after cessation. We prospectively identified CDI cases among adults hospitalized at a tertiary hospital between June 2010 and May 2012. Poisson regression models included covariates for time since admission, age, hospitalization history, disease pressure, and intensive care unit stay. Impacts of antibiotic use through time were modeled using 4 measures: current antibiotic receipt, time since most recent receipt, time since first receipt during a hospitalization, and duration of receipt. Over the 24-month study period, we identified 127 patients with new onset nosocomial CDI (incidence rate per 10,000 patient days [IR] = 5.86). Of the 4 measures, time since most recent receipt was the strongest independent predictor of CDI incidence. Relative to patients with no prior receipt of antibiotics in the last 30 days (IR = 2.95), the incidence rate of CDI was 2.41 times higher (95% confidence interval [CI] 1.41, 4.13) during antibiotic receipt and 2.16 times higher when patients had receipt in the prior 1-5 days (CI 1.17, 4.00). The incidence rates of CDI following 1-3, 4-6 and 7-11 days of antibiotic exposure were 1.60 (CI 0.85, 3.03), 2.27 (CI 1.24, 4.16) and 2.10 (CI 1.12, 3.94) times higher compared to no prior receipt. These findings are consistent with studies showing higher risk associated with longer antibiotic use in hospitalized patients, but suggest that the duration of increased risk is shorter than previously thought.	[Brown, Kevin A.; Fisman, David N.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Moineddin, Rahim] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Daneman, Nick] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Div Infect Dis, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Brown, KA (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada.	kevin.brown@mail.utoronto.ca		Brown, Kevin Antoine/0000-0002-1483-2188	Frederick Banting and Charles Best Canada; Canadian Institutes of Health Research (CIHR); Clinician Scientist Salary Award from CIHR; Institute of Population and Public Health of the CIHR	Frederick Banting and Charles Best Canada(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Clinician Scientist Salary Award from CIHR(Canadian Institutes of Health Research (CIHR)); Institute of Population and Public Health of the CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a Frederick Banting and Charles Best Canada Graduate Scholarship awarded to K.A.B. from the Canadian Institutes of Health Research (CIHR, http://www.cihr.ca/). N.D. is supported by a Clinician Scientist Salary Award from CIHR. D.N.F. received a grant from the Institute of Population and Public Health of the CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamowicz M, 2012, STAT MED, V31, P1014, DOI 10.1002/sim.4343; Ajao AO, 2011, INFECT CONT HOSP EP, V32, P481, DOI 10.1086/659403; Baines SD, 2013, J ANTIMICROB CHEMOTH, V68, P1139, DOI 10.1093/jac/dks529; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Bignardi GE, 1998, J HOSP INFECT, V40, P1, DOI 10.1016/S0195-6701(98)90019-6; Bliss DZ, 1998, ANN INTERN MED, V129, P1012, DOI 10.7326/0003-4819-129-12-199812150-00004; Breslow N E, 1987, IARC Sci Publ, P1; Breslow N E, 1980, IARC Sci Publ, P5; Britton RA, 2012, TRENDS MICROBIOL, V20, P313, DOI 10.1016/j.tim.2012.04.001; Brown KA, 2013, AM J EPIDEMIOL, V178, P118, DOI 10.1093/aje/kws463; Brown KA, 2013, ANTIMICROB AGENTS CH, V57, P2326, DOI 10.1128/AAC.02176-12; Chang HT, 2007, INFECT CONT HOSP EP, V28, P926, DOI 10.1086/519178; Cherrie JW, 2006, ANN OCCUP HYG, V50, P693, DOI 10.1093/annhyg/me1035; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Delaney JAC, 2007, EMERG INFECT DIS, V13, P761, DOI 10.3201/eid1305.061124; Dial S, 2008, CAN MED ASSOC J, V179, P767, DOI 10.1503/cmaj.071812; Dubberke ER, 2007, ARCH INTERN MED, V167, P1092, DOI 10.1001/archinte.167.10.1092; Dubberke ER, 2009, INFECT CONT HOSP EP, V30, P332, DOI 10.1086/596604; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Gilca R, 2012, ANTIMICROB AGENTS CH, V56, P639, DOI 10.1128/AAC.05411-11; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; HALLORAN ME, 1991, EPIDEMIOLOGY, V2, P331, DOI 10.1097/00001648-199109000-00004; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hensgens MPM, 2012, J ANTIMICROB CHEMOTH, V67, P742, DOI 10.1093/jac/dkr508; Jump RLP, 2011, ANTIMICROB AGENTS CH, V55, P546, DOI 10.1128/AAC.00839-10; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kuntz JL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-194; Palmore TN, 2005, INFECT CONT HOSP EP, V26, P680, DOI 10.1086/502602; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Polgreen PM, 2010, INFECT CONT HOSP EP, V31, P382, DOI 10.1086/651095; Provincial Infectious Diseases Advisory Committee, 2007, BEST PRACT DOC MAN C; Schumacher M, 2013, INT J EPIDEMIOL, V42, P1502, DOI 10.1093/ije/dyt111; Slimings C, 2014, J ANTIMICROB CHEMOTH, V69, P881, DOI 10.1093/jac/dkt477; Stevens V, 2011, AM J EPIDEMIOL, V173, pS272; Stevens V, 2011, CLIN INFECT DIS, V53, P42, DOI 10.1093/cid/cir301; TANCREDE C, 1992, EUR J CLIN MICROBIOL, V11, P1012, DOI 10.1007/BF01967791; WHO Collaborating Centre for Drug Statistics Methodology, 2013, GUID ATC CLASS DDD A	38	51	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105454	10.1371/journal.pone.0105454	http://dx.doi.org/10.1371/journal.pone.0105454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157757	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303200032
J	Magnussen, S; Hadler-Olsen, E; Latysheva, N; Pirila, E; Steigen, SE; Hanes, R; Salo, T; Winberg, JO; Uhlin-Hansen, L; Svineng, G				Magnussen, Synnove; Hadler-Olsen, Elin; Latysheva, Nadezhda; Pirila, Emma; Steigen, Sonja E.; Hanes, Robert; Salo, Tuula; Winberg, Jan-Olof; Uhlin-Hansen, Lars; Svineng, Gunbjorg			Tumour Microenvironments Induce Expression of Urokinase Plasminogen Activator Receptor (uPAR) and Concomitant Activation of Gelatinolytic Enzymes	PLOS ONE			English	Article							CANCER-CELL-GROWTH; LIBERATED DOMAIN I; LIGAND-BINDING; CLEAVED FORM; METASTASIS; INVASION; PLASMA; GLYCOSYLATION; AFFINITY; SYSTEM	Background: The urokinase plasminogen activator receptor (uPAR) is associated with poor prognosis in oral squamous cell carcinoma (OSCC), and increased expression of uPAR is often found at the invasive tumour front. The aim of the current study was to elucidate the role of uPAR in invasion and metastasis of OSCC, and the effects of various tumour microenvironments in these processes. Furthermore, we wanted to study whether the cells' expression level of uPAR affected the activity of gelatinolytic enzymes. Methods: The Plaur gene was both overexpressed and knocked-down in the murine OSCC cell line AT84. Tongue and skin tumours were established in syngeneic mice, and cells were also studied in an ex vivo leiomyoma invasion model. Soluble factors derived from leiomyoma tissue, as well as purified extracellular matrix (ECM) proteins, were assessed for their ability to affect uPAR expression, glycosylation and cleavage. Activity of gelatinolytic enzymes in the tissues were assessed by in situ zymography. Results: We found that increased levels of uPAR did not induce tumour invasion or metastasis. However, cells expressing low endogenous levels of uPAR in vitro up-regulated uPAR expression both in tongue, skin and leiomyoma tissue. Various ECM proteins had no effect on uPAR expression, while soluble factors originating from the leiomyoma tissue increased both the expression and glycosylation of uPAR, and possibly also affected the proteolytic processing of uPAR. Tumours with high levels of uPAR, as well as cells invading leiomyoma tissue with up-regulated uPAR expression, all displayed enhanced activity of gelatinolytic enzymes. Conclusions: Although high levels of uPAR are not sufficient to induce invasion and metastasis, the activity of gelatinolytic enzymes was increased. Furthermore, several tumour microenvironments have the capacity to induce up-regulation of uPAR expression, and soluble factors in the tumour microenvironment may have an important role in the regulation of posttranslational modification of uPAR.	[Magnussen, Synnove; Hadler-Olsen, Elin; Latysheva, Nadezhda; Steigen, Sonja E.; Hanes, Robert; Winberg, Jan-Olof; Uhlin-Hansen, Lars; Svineng, Gunbjorg] Arctic Univ Norway, UiT, Fac Hlth Sci, Dept Med Biol, Tromso, Norway; [Pirila, Emma; Salo, Tuula] Univ Oulu, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland; [Pirila, Emma; Salo, Tuula] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland; [Salo, Tuula] Univ Helsinki, Inst Dent, Helsinki, Finland; [Steigen, Sonja E.; Uhlin-Hansen, Lars] Univ Hosp North Norway, Dept Clin Pathol, Diagnost Clin, Tromso, Norway	UiT The Arctic University of Tromso; University of Oulu; University of Oulu; University of Helsinki; UiT The Arctic University of Tromso; University Hospital of North Norway	Magnussen, S (corresponding author), Arctic Univ Norway, UiT, Fac Hlth Sci, Dept Med Biol, Tromso, Norway.	synnove.magnussen@uit.no	Magnussen, SynnÃve/AAG-4700-2021; Svineng, Gunbjorg/K-4738-2014; , tuula/ABG-2051-2021; Hadler-Olsen, Elin/AAL-7288-2020	Magnussen, SynnÃve/0000-0003-0762-1240; Salo, Tuula/0000-0001-6039-0088; Hadler-Olsen, Elin/0000-0001-8476-9439	North Norwegian Regional Health Authorities; Norwegian Cancer Society; Erna and Olav Aakre Foundation for Cancer Research; University of Tromso	North Norwegian Regional Health Authorities; Norwegian Cancer Society(Norwegian Cancer Society); Erna and Olav Aakre Foundation for Cancer Research; University of Tromso	This work was supported by grants from the North Norwegian Regional Health Authorities, The Norwegian Cancer Society, The Erna and Olav Aakre Foundation for Cancer Research, and The University of Tromso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasi CE, 2013, APMIS, V121, P189, DOI 10.1111/j.1600-0463.2012.02955.x; Almasi CE, 2011, PROSTATE, V71, P899, DOI 10.1002/pros.21306; Almasi CE, 2011, LUNG CANCER, V74, P510, DOI 10.1016/j.lungcan.2011.05.008; Andolfo A, 2002, THROMB HAEMOSTASIS, V88, P298; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Beaufort N, 2004, J IMMUNOL, V172, P540, DOI 10.4049/jimmunol.172.1.540; Behrendt N, 1996, J BIOL CHEM, V271, P22885, DOI 10.1074/jbc.271.37.22885; BEHRENDT N, 1990, J BIOL CHEM, V265, P6453; Bitu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070925; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Blasi F, 2010, FEBS LETT, V584, P1923, DOI 10.1016/j.febslet.2009.12.039; de Paulis A, 2004, J IMMUNOL, V173, P5739, DOI 10.4049/jimmunol.173.9.5739; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Engelholm LH, 2009, FRONT BIOSCI-LANDMRK, V14, P2103, DOI 10.2741/3365; Fazioli F, 1997, EMBO J, V16, P7279, DOI 10.1093/emboj/16.24.7279; Funk GF, 2002, HEAD NECK-J SCI SPEC, V24, P165, DOI 10.1002/hed.10004; Gonias SL, 2011, CURR PHARM DESIGN, V17, P1962; Hadler-Olsen E, 2010, J HISTOCHEM CYTOCHEM, V58, P29, DOI 10.1369/jhc.2009.954354; Henic E, 2006, GYNECOL ONCOL, V101, P28, DOI 10.1016/j.ygyno.2005.09.038; Hoyer-Hansen G, 2001, BIOCHEM J, V358, P673, DOI 10.1042/0264-6021:3580673; HoyerHansen G, 1997, EUR J BIOCHEM, V243, P21, DOI 10.1111/j.1432-1033.1997.0021a.x; HOYERHANSEN G, 1992, J BIOL CHEM, V267, P18224; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jo MJ, 2003, J BIOL CHEM, V278, P46692, DOI 10.1074/jbc.M308808200; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Laufs S, 2006, CELL CYCLE, V5, P1760; Leef G, 2013, ORAL ONCOL, V49, P381, DOI 10.1016/j.oraloncology.2012.12.014; Lin L, 2010, J BIOL CHEM, V285, P10982, DOI 10.1074/jbc.M109.093492; Lindberg P, 2006, INT J CANCER, V118, P2948, DOI 10.1002/ijc.21568; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou E, 2003, ORAL DIS, V9, P305, DOI 10.1034/j.1601-0825.2003.00968.x; LUND LR, 1992, FEBS LETT, V298, P177, DOI 10.1016/0014-5793(92)80050-Q; LUND LR, 1995, BIOCHEM J, V310, P345, DOI 10.1042/bj3100345; Magnussen S, 2014, PLOS ONE IN PRESS; MOLLER LB, 1993, J BIOL CHEM, V268, P11152; Montuori N, 1999, FEBS LETT, V460, P32, DOI 10.1016/S0014-5793(99)01314-9; Montuori N, 2005, THROMB HAEMOSTASIS, V93, P192, DOI 10.1160/TH04-09-0580; Montuori N, 2002, J BIOL CHEM, V277, P46932, DOI 10.1074/jbc.M207494200; Moserle L, 2013, J INTERN MED, V273, P128, DOI 10.1111/joim.12018; Nieves EC, 2010, J BIOL CHEM, V285, P12595, DOI 10.1074/jbc.M109.008581; Nurmenniemi S, 2009, AM J PATHOL, V175, P1281, DOI 10.2353/ajpath.2009.081110; Phronen T, 2006, CLIN CHEM, V52, P838, DOI 10.1373/clinchem.2005.064253; Piccolella M, 2008, INT J ONCOL, V32, P185; Ploug M, 1998, J BIOL CHEM, V273, P13933, DOI 10.1074/jbc.273.22.13933; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Ragno P, 1998, CANCER RES, V58, P1315; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Riisbro R, 2002, CLIN CANCER RES, V8, P1132; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; Schmidt M, 1999, ACTA OTO-LARYNGOL, V119, P949; SCHULTZHECTOR S, 1993, CANCER RES, V53, P1444; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sidenius N, 2000, FEBS LETT, V475, P52, DOI 10.1016/S0014-5793(00)01624-0; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siren V, 1999, OPHTHALMIC RES, V31, P184, DOI 10.1159/000055531; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Smith HA, 2013, J MOL MED, V91, P411, DOI 10.1007/s00109-013-1021-5; SOLBERG H, 1994, INT J CANCER, V58, P877, DOI 10.1002/ijc.2910580622; Stephens RW, 1997, CLIN CHEM, V43, P1868; Stephens RW, 1999, JNCI-J NATL CANCER I, V91, P869, DOI 10.1093/jnci/91.10.869; Svineng G, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P261; Taubert H, 2010, BRIT J CANCER, V102, P731, DOI 10.1038/sj.bjc.6605520; Teppo S, 2013, EXP CELL RES, V319, P376, DOI 10.1016/j.yexcr.2012.12.010; Thurison T, 2010, CLIN CHEM, V56, P1636, DOI 10.1373/clinchem.2010.144410; Wahlberg K, 1998, CANCER RES, V58, P3294; Wilhelm OG, 1999, J CELL PHYSIOL, V180, P225, DOI 10.1002/(SICI)1097-4652(199908)180:2<225::AID-JCP10>3.0.CO;2-2; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; Yoshida E, 1996, INFLAMMATION, V20, P319, DOI 10.1007/BF01488206; Zhang ZA, 2011, J ORAL PATHOL MED, V40, P127, DOI 10.1111/j.1600-0714.2010.00953.x	71	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105929	10.1371/journal.pone.0105929	http://dx.doi.org/10.1371/journal.pone.0105929			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157856	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200078
J	Russo, RIC; Beguelin, W; Flaque, MCD; Proietti, CJ; Venturutti, L; Galigniana, N; Tkach, M; Guzman, P; Roa, JC; O'Brien, NA; Charreau, EH; Schillaci, R; Elizalde, PV				Cordo Russo, R. I.; Beguelin, W.; Diaz Flaque, M. C.; Proietti, C. J.; Venturutti, L.; Galigniana, N.; Tkach, M.; Guzman, P.; Roa, J. C.; O'Brien, N. A.; Charreau, E. H.; Schillaci, R.; Elizalde, P. V.			Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; FACTOR RECEPTOR; PROGESTERONE-RECEPTOR; CYCLIN D1; CELL-PROLIFERATION; SIGNALING PATHWAYS; IN-VIVO; PI3K INHIBITOR; THERAPY; HER2	Membrane overexpression of ErbB-2/HER2 receptor tyrosine kinase (membrane ErbB-2 (MErbB-2)) has a critical role in breast cancer (BC). We and others have also shown the role of nuclear ErbB-2 (NErbB-2) in BC, whose presence we identified as a poor prognostic factor in MErbB-2-positive tumors. Current anti-ErbB-2 therapies, as with the antibody trastuzumab (Ttzm), target only MErbB-2. Here, we found that blockade of NErbB-2 action abrogates growth of BC cells, sensitive and resistant to Ttzm, in a scenario in which ErbB-2, ErbB-3 and Akt are phosphorylated, and ErbB-2/ErbB-3 dimers are formed. Also, inhibition of NErbB-2 presence suppresses growth of a preclinical BC model resistant to Ttzm. We showed that at the cyclin D1 promoter, ErbB-2 assembles a transcriptional complex with Stat3 (signal transducer and activator of transcription 3) and ErbB-3, another member of the ErbB family, which reveals the first nuclear function of ErbB-2/ErbB-3 dimer. We identified NErbB-2 as the major proliferation driver in Ttzm-resistant BC, and demonstrated that Ttzm inability to disrupt the Stat3/ErbB-2/ErbB-3 complex underlies its failure to inhibit growth. Furthermore, our results in the clinic revealed that nuclear interaction between ErbB-2 and Stat3 correlates with poor overall survival in primary breast tumors. Our findings challenge the paradigm of anti-ErbB-2 drug design and highlight NErbB-2 as a novel target to overcome Ttzm resistance.	[Cordo Russo, R. I.; Beguelin, W.; Diaz Flaque, M. C.; Proietti, C. J.; Venturutti, L.; Galigniana, N.; Tkach, M.; Charreau, E. H.; Schillaci, R.; Elizalde, P. V.] Consejo Nacl Invest Cient & Tecn, Lab Mol Mech Carcinogenesis, Inst Biol & Med Expt IBYME, RA-1428 Buenos Aires, DF, Argentina; [Guzman, P.; Roa, J. C.] Univ La Frontera, Dept Anat Patol BIOREN, Temuco, Chile; [O'Brien, N. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Universidad de La Frontera; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Elizalde, PV (corresponding author), Consejo Nacl Invest Cient & Tecn, Lab Mol Mech Carcinogenesis, Inst Biol & Med Expt IBYME, Obligado 2490, RA-1428 Buenos Aires, DF, Argentina.	patriciaelizalde@ibyme.conicet.gov.ar	Russo, Rosalia Cordo/O-9149-2017; Roa, Juan C./K-4749-2014	Russo, Rosalia Cordo/0000-0002-5984-9717; Roa, Juan C./0000-0001-8313-8774; Elizalde, Patricia V./0000-0002-5923-9898; Galigniana, Natalia/0000-0002-0712-719X; Schillaci, Roxana/0000-0002-7776-3378; Diaz Flaque, Maria Celeste/0000-0003-4167-6149	Susan G Komen for the Cure investigator-initiated research Grant [KG090250]; National Agency of Scientific Promotion of Argentina [IDB/PICT 2012-668, PID 2012-066, IDB/PICT 2012-382]; Henry Moore Institute of Argentina [CONICET 1819/03]	Susan G Komen for the Cure investigator-initiated research Grant; National Agency of Scientific Promotion of Argentina(ANPCyT); Henry Moore Institute of Argentina	We thank Mien-Chie Hung (MD Anderson Cancer Center, Houston, TX, USA) for his generous gift of the hErbB-2.NLS, which indeed made this work possible, and AA Molinolo (NIH, Bethesda, MD, USA) for his constant help and support. We also thank J Giudice (Baylor College of Medicine, Houston, TX, USA) for help with quantification of confocal images, and V Chiauzzi for her excellent technical assistance. This work was supported by the Susan G Komen for the Cure KG090250 investigator-initiated research Grant, IDB/PICT 2012-668 and PID 2012-066 from the National Agency of Scientific Promotion of Argentina (all of them awarded to PVE), IDB/PICT 2012-382 from the National Agency of Scientific Promotion of Argentina (awarded to RS) and Oncomed-Reno CONICET 1819/03, from the Henry Moore Institute of Argentina (awarded to PVE and RS).	Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; ALIMANDI M, 1995, ONCOGENE, V10, P1813; Andrique L, 2012, CELL SIGNAL, V24, P1074, DOI 10.1016/j.cellsig.2012.01.002; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Balana ME, 1999, ONCOGENE, V18, P6370, DOI 10.1038/sj.onc.1203028; Beguelin W, 2010, MOL CELL BIOL, V30, P5456, DOI 10.1128/MCB.00012-10; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Brand TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071518; Breuleux M, 2006, MOL CANCER RES, V4, P27, DOI 10.1158/1541-7786.MCR-05-0016; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Browne BC, 2009, CURR CANCER DRUG TAR, V9, P419, DOI 10.2174/156800909788166484; Chiu CG, 2010, ANN SURG, V251, P1107, DOI 10.1097/SLA.0b013e3181dbb77e; Daly JM, 1999, ONCOGENE, V18, P3440, DOI 10.1038/sj.onc.1202700; Flaque MCD, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3587; Diermeier S, 2005, EXP CELL RES, V304, P604, DOI 10.1016/j.yexcr.2004.12.008; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Esteva FJ, 2002, J CLIN ONCOL, V20, P1800, DOI 10.1200/JCO.2002.07.058; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Ghosh R, 2011, CANCER RES, V71, P1871, DOI 10.1158/0008-5472.CAN-10-1872; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Henderson IC, 1998, BREAST CANCER RES TR, V52, P261, DOI 10.1023/A:1006141703224; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kataoka Y, 2010, ANN ONCOL, V21, P255, DOI 10.1093/annonc/mdp304; Koninki K, 2010, CANCER LETT, V294, P211, DOI 10.1016/j.canlet.2010.02.002; Koumakpayi IH, 2006, CLIN CANCER RES, V12, P2730, DOI 10.1158/1078-0432.CCR-05-2242; Labriola L, 2003, MOL CELL BIOL, V23, P1095, DOI 10.1128/MCB.23.3.1095-1111.2003; Landgraf R, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1633; Lane HA, 2000, MOL CELL BIOL, V20, P3210, DOI 10.1128/MCB.20.9.3210-3223.2000; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Lenferink AEG, 2001, CANCER RES, V61, P6583; Leow CC, 2009, MOL CANCER THER, V8, P2131, DOI 10.1158/1535-7163.MCT-08-1038; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Li LY, 2011, CANCER RES, V71, P4269, DOI 10.1158/0008-5472.CAN-10-3504; Li WL, 1996, ONCOGENE, V12, P2473; Maegawa M, 2007, MOL CANCER RES, V5, P393, DOI 10.1158/1541-7786.MCR-06-0303; Marshall C, 2006, BREAST CANCER RES TR, V96, P163, DOI 10.1007/s10549-005-9073-z; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Neve RM, 2002, ONCOGENE, V21, P4567, DOI 10.1038/sj.onc.1205555; O'Brien NA, 2010, MOL CANCER THER, V9, P1489, DOI 10.1158/1535-7163.MCT-09-1171; Offterdinger M, 2002, J CELL BIOL, V157, P929, DOI 10.1083/jcb.200109033; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Proietti CJ, 2009, MOL CELL BIOL, V29, P1249, DOI 10.1128/MCB.00853-08; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Rivas MA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3187; Rivas MA, 2010, BREAST CANCER RES TR, V122, P111, DOI 10.1007/s10549-009-0546-3; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Salatino M, 2004, ONCOGENE, V23, P5161, DOI 10.1038/sj.onc.1207659; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Schillaci R, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-74; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Tanner M, 2004, MOL CANCER THER, V3, P1585; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wang YC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3067; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yakes FM, 2002, CANCER RES, V62, P4132; Yao E, 2009, CLIN CANCER RES, V15, P4147, DOI 10.1158/1078-0432.CCR-08-2814	67	39	40	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	26					3413	3428		10.1038/onc.2014.272	http://dx.doi.org/10.1038/onc.2014.272			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CL3SU	25174405	Green Published			2022-12-25	WOS:000356871700007
J	Jiang, S; Yan, C; Fang, QC; Shao, ML; Zhang, YL; Liu, Y; Deng, YP; Shan, B; Liu, JQ; Li, HT; Yang, L; Zhou, J; Dai, Z; Liu, Y; Jia, WP				Jiang, Shan; Yan, Cheng; Fang, Qi-chen; Shao, Meng-le; Zhang, Yong-liang; Liu, Yang; Deng, Yi-ping; Shan, Bo; Liu, Jing-qi; Li, Hua-ting; Yang, Liu; Zhou, Jian; Dai, Zhi; Liu, Yong; Jia, Wei-ping			Fibroblast Growth Factor 21 Is Regulated by the IRE1 alpha-XBP1 Branch of the Unfolded Protein Response and Counteracts Endoplasmic Reticulum Stress-induced Hepatic Steatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ER Stress; Fibroblast Growth Factor (FGF); Hepatocyte; Liver Metabolism; Unfolded Protein Response (UPR)	FATTY LIVER-DISEASE; ER STRESS; TRANSCRIPTION FACTOR; INSULIN SENSITIVITY; PPAR-ALPHA; METABOLIC REGULATOR; ENERGY-EXPENDITURE; MESSENGER-RNA; BETA-KLOTHO; FGF21	Background: Although both are involved in metabolic homeostasis, the interconnection between ER stress and FGF21 remains incompletely understood. Results: Directly up-regulated by the IRE1-XBP1 pathway, FGF21 could alleviate ER stress-induced liver steatosis. Conclusion: FGF21 acts as a metabolic effector of the UPR program, exerting feedback effects upon lipid metabolism. Significance: These findings reveal a regulatory mechanism linking FGF21 actions to metabolic ER stress. Endoplasmic reticulum (ER) stress activates the adaptive unfolded protein response (UPR) and represents a critical mechanism that underlies metabolic dysfunctions. Fibroblast growth factor 21 (FGF21), a hormone that is predominantly secreted by the liver, exerts a broad range of effects upon the metabolism of carbohydrates and lipids. Although increased circulating levels of FGF21 have been documented in animal models and human subjects with obesity and nonalcoholic fatty liver disease, the functional interconnections between metabolic ER stress and FGF21 are incompletely understood. Here, we report that increased ER stress along with the simultaneous elevation of FGF21 expression were associated with the occurrence of nonalcoholic fatty liver disease both in diet-induced obese mice and human patients. Intraperitoneal administration of the ER stressor tunicamycin in mice resulted in hepatic steatosis, accompanied by activation of the three canonical UPR branches and increased the expression of FGF21. Furthermore, the IRE1-XBP1 pathway of the UPR could directly activate the transcriptional expression of Fgf21. Administration of recombinant FGF21 in mice alleviated tunicamycin-induced liver steatosis, in parallel with reduced eIF2-ATF4-CHOP signaling. Taken together, these results suggest that FGF21 is an integral physiological component of the cellular UPR program, which exerts beneficial feedback effects upon lipid metabolism through counteracting ER stress.	[Jiang, Shan; Fang, Qi-chen; Li, Hua-ting; Jia, Wei-ping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst,Shanghai Clin Ctr Diabet, Shanghai Key Lab Diabet Mellitus,Dept Endocrinol, Shanghai 200233, Peoples R China; [Jiang, Shan; Fang, Qi-chen; Li, Hua-ting; Jia, Wei-ping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Clin Ctr Metab Dis, Shanghai 200233, Peoples R China; [Yan, Cheng; Shao, Meng-le; Zhang, Yong-liang; Liu, Yang; Deng, Yi-ping; Shan, Bo; Liu, Jing-qi; Yang, Liu; Liu, Yong] Univ Chinese Acad Sci, Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Zhou, Jian; Dai, Zhi] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg, Shanghai 200032, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Fudan University	Liu, Y (corresponding author), Chinese Acad Sci, Key Lab Nutr, 294 Tai Yuan Rd, Shanghai 200031, Peoples R China.	liuy@sibs.ac.cn; wpjia@sjtu.edu.cn	Shao, Mengle/D-9951-2014; SHAN, BO/AAC-5167-2021; Shao, Mengle/AAH-8392-2019	Shao, Mengle/0000-0002-5488-9904; SHAN, BO/0000-0002-1675-5809; Shao, Mengle/0000-0002-5488-9904	Ministry of Science and Technology 973 Programs [2011CB504001, 2012CB524900, 2011CB910900]; National Natural Science Foundation of China [81170379, 30988002, 31230036, 81021002, 91213306]; Young Scientists Fund from National Natural Science Foundation [81200292]; Shanghai Rising-Star Program [13QA1402900]	Ministry of Science and Technology 973 Programs(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Scientists Fund from National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	This work was supported by Ministry of Science and Technology 973 Programs 2011CB504001, 2012CB524900, and 2011CB910900, National Natural Science Foundation of China Grants 81170379, 30988002, 31230036, 81021002, and 91213306 (to W. J. and Y. L.), Young Scientists Fund from National Natural Science Foundation Grant 81200292, and Shanghai Rising-Star Program Grant 13QA1402900 (to H. L.).	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Chitturi S, 2007, J GASTROEN HEPATOL, V22, P778, DOI 10.1111/j.1440-1746.2007.05001.x; Christodoulides C, 2009, J CLIN ENDOCR METAB, V94, P3594, DOI 10.1210/jc.2009-0111; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Das SK, 2008, AM J PHYSIOL-ENDOC M, V295, pE393, DOI 10.1152/ajpendo.90355.2008; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Giannini C, 2013, J CLIN ENDOCR METAB, V98, P2993, DOI 10.1210/jc.2013-1250; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Li B, 2013, BIOCHEM J, V452, P139, DOI 10.1042/BJ20121671; Li HT, 2013, J HEPATOL, V58, P557, DOI 10.1016/j.jhep.2012.10.029; Li HT, 2010, J HEPATOL, V53, P934, DOI 10.1016/j.jhep.2010.05.018; Li HT, 2009, J CLIN ENDOCR METAB, V94, P2151, DOI 10.1210/jc.2008-2331; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; De Sousa-Coelho AL, 2012, BIOCHEM J, V443, P165, DOI 10.1042/BJ20111748; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Mao T, 2011, P NATL ACAD SCI USA, V108, P15852, DOI 10.1073/pnas.1107394108; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Rector RS, 2008, WORLD J GASTROENTERO, V14, P185, DOI 10.3748/wjg.14.185; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Shao ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4528; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Welihinda AA, 1996, J BIOL CHEM, V271, P18181, DOI 10.1074/jbc.271.30.18181; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yan HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024895; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	58	132	139	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29751	29765		10.1074/jbc.M114.565960	http://dx.doi.org/10.1074/jbc.M114.565960			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25170079	Green Published, hybrid			2022-12-25	WOS:000344370800023
J	Helgeson, LA; Prendergast, JG; Wagner, AR; Rodnick-Smith, M; Nolen, BJ				Helgeson, Luke A.; Prendergast, Julianna G.; Wagner, Andrew R.; Rodnick-Smith, Max; Nolen, Brad J.			Interactions with Actin Monomers, Actin Filaments, and Arp2/3 Complex Define the Roles of WASP Family Proteins and Cortactin in Coordinately Regulating Branched Actin Networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; N-WASP; EXTRACELLULAR-MATRIX; CAPPING PROTEIN; WASP/SCAR PROTEINS; ACTIVATION; NUCLEATION; BINDING; POLYMERIZATION; MECHANISM	Arp2/3 complex is an important actin filament nucleator that creates branched actin filament networks required for formation of lamellipodia and endocytic actin structures. Cellular assembly of branched actin networks frequently requires multiple Arp2/3 complex activators, called nucleation promoting factors (NPFs). We recently presented a mechanism by which cortactin, a weak NPF, can displace a more potent NPF, N-WASP, from nascent branch junctions to synergistically accelerate nucleation. The distinct roles of these NPFs in branching nucleation are surprising given their similarities. We biochemically dissected these two classes of NPFs to determine how their Arp2/3 complex and actin interacting segments modulate their influences on branched actin networks. We find that the Arp2/3 complex-interacting N-terminal acidic sequence (NtA) of cortactin has structural features distinct from WASP acidic regions (A) that are required for synergy between the two NPFs. Our mutational analysis shows that differences between NtA and A do not explain the weak intrinsic NPF activity of cortactin, but instead that cortactin is a weak NPF because it cannot recruit actin monomers to Arp2/3 complex. We use TIRF microscopy to show that cortactin bundles branched actin filaments using actin filament binding repeats within a single cortactin molecule, but that N-WASP antagonizes cortactin-mediated bundling. Finally, we demonstrate that multiple WASP family proteins synergistically activate Arp2/3 complex and determine the biochemical requirements in WASP proteins for synergy. Our data indicate that synergy between WASP proteins and cortactin may play a general role in assembling diverse actin-based structures, including lamellipodia, podosomes, and endocytic actin networks.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Nolen, BJ (corresponding author), 1229 Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA.	bnolen@uoregon.edu		Nolen, Brad/0000-0002-0224-9980	National Institutes of Health [R01-GM092917, GM007759]; American Heart Association [10SDG2610189]; NICHD Summer Research Program at University of Oregon through National Institutes of Health [R25HD070817]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD070817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092917, T32GM007759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NICHD Summer Research Program at University of Oregon through National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM092917 (to B. J. N.) and Predoctoral Training Grant GM007759 (to L. A. H.). This work was also supported by American Heart Association Grant 10SDG2610189 (to B. J. N.) and the NICHD Summer Research Program at the University of Oregon through National Institutes of Health Grant R25HD070817 (to J. G. P.).	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Basu R, 2011, CURR BIOL, V21, P905, DOI 10.1016/j.cub.2011.04.047; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Boczkowska M, 2008, STRUCTURE, V16, P695, DOI 10.1016/j.str.2008.02.013; Boczkowska M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4308; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Collins A, 2011, CURR BIOL, V21, P1167, DOI 10.1016/j.cub.2011.05.048; Cowieson NP, 2008, J BIOL CHEM, V283, P16187, DOI 10.1074/jbc.M708917200; Dang I, 2013, NATURE, V503, P281, DOI 10.1038/nature12611; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Edelstein A., 2010, CURR PROTOC MOL BIOL, V14, P20, DOI [10.1002/0471142727.mb1420s92, DOI 10.1002/0471142727.MB1420S92]; Galletta BJ, 2008, PLOS BIOL, V6, P72, DOI 10.1371/journal.pbio.0060001; Gohl C, 2010, J BIOL CHEM, V285, P40171, DOI 10.1074/jbc.M110.139337; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Helgeson LA, 2013, ELIFE, V2, DOI 10.7554/eLife.00884; Hetrick B, 2013, CHEM BIOL, V20, P701, DOI 10.1016/j.chembiol.2013.03.019; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Hufner K, 2001, J BIOL CHEM, V276, P35761, DOI 10.1074/jbc.M106520200; Kaksonen M, 2000, J CELL SCI, V113, P4421; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Katsube T, 2004, ARCH BIOCHEM BIOPHYS, V427, P79, DOI 10.1016/j.abb.2004.04.015; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Liu SL, 2013, J BIOL CHEM, V288, P487, DOI 10.1074/jbc.M112.406744; Liu SL, 2011, J BIOL CHEM, V286, P17039, DOI 10.1074/jbc.M111.219964; MacGrath SM, 2012, BIOCHEMISTRY-US, V51, P6644, DOI 10.1021/bi300722t; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Maritzen T, 2012, P NATL ACAD SCI USA, V109, P10382, DOI 10.1073/pnas.1206468109; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Mizutani K, 2002, CANCER RES, V62, P669; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Shvetsov A, 2009, CELL MOTIL CYTOSKEL, V66, P90, DOI 10.1002/cm.20328; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Siton O, 2011, CURR BIOL, V21, P2092, DOI 10.1016/j.cub.2011.11.010; Skau CT, 2011, J BIOL CHEM, V286, P26964, DOI 10.1074/jbc.M111.239004; Smith BA, 2013, ELIFE, V2, DOI 10.7554/eLife.01008; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Suetsugu S, 2013, SEMIN CELL DEV BIOL, V24, P267, DOI 10.1016/j.semcdb.2013.01.006; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tehrani S, 2006, MOL BIOL CELL, V17, P2882, DOI 10.1091/mbc.E06-03-0187; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Wagner AR, 2013, CURR BIOL, V23, P1990, DOI 10.1016/j.cub.2013.08.029; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Xu JY, 1999, CELL MOTIL CYTOSKEL, V42, P73, DOI 10.1002/(SICI)1097-0169(1999)42:1<73::AID-CM7>3.0.CO;2-Z; Xu XP, 2012, EMBO J, V31, P236, DOI 10.1038/emboj.2011.343; Yamada H, 2013, J NEUROSCI, V33, P4514, DOI 10.1523/JNEUROSCI.2762-12.2013; Yamaguchi H, 2000, P NATL ACAD SCI USA, V97, P12631, DOI 10.1073/pnas.190351397	76	38	38	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28856	28869		10.1074/jbc.M114.587527	http://dx.doi.org/10.1074/jbc.M114.587527			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25160634	Green Published, hybrid			2022-12-25	WOS:000344141000010
J	Ceglowski, M; Smoluch, M; Babij, M; Gotszalk, T; Silberring, J; Schroeder, G				Ceglowski, Michal; Smoluch, Marek; Babij, Michal; Gotszalk, Teodor; Silberring, Jerzy; Schroeder, Grzegorz			Dielectric Barrier Discharge Ionization in Characterization of Organic Compounds Separated on Thin-Layer Chromatography Plates	PLOS ONE			English	Article							DESORPTION/IONIZATION MASS-SPECTROMETRY; ASSISTED-LASER-DESORPTION/IONIZATION; ELECTROSPRAY-IONIZATION; DESORPTION IONIZATION; SURFACE; PROBE; TLC; MS	A new method for on-spot detection and characterization of organic compounds resolved on thin layer chromatography (TLC) plates has been proposed. This method combines TLC with dielectric barrier discharge ionization (DBDI), which produces stable low-temperature plasma. At first, the compounds were separated on TLC plates and then their mass spectra were directly obtained with no additional sample preparation. To obtain good quality spectra the center of a particular TLC spot was heated from the bottom to increase volatility of the compound. MS/MS analyses were also performed to additionally characterize all analytes. The detection limit of proposed method was estimated to be 100 ng/spot of compound.	[Ceglowski, Michal; Schroeder, Grzegorz] Adam Mickiewicz Univ, Fac Chem, Dept Supramol Chem, PL-60780 Poznan, Poland; [Smoluch, Marek; Silberring, Jerzy] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, Dept Biochem & Neurobiol, Krakow, Poland; [Babij, Michal; Gotszalk, Teodor] Wroclaw Univ Technol, Fac Microsyst Elect & Photon, PL-50370 Wroclaw, Poland; [Silberring, Jerzy] Polish Acad Sci, Ctr Polymer & Carbon Mat, Zabrze, Poland	Adam Mickiewicz University; AGH University of Science & Technology; Wroclaw University of Science & Technology; Polish Academy of Sciences; Centre of Polymer & Carbon Materials of the Polish Academy of Sciences	Ceglowski, M (corresponding author), Adam Mickiewicz Univ, Fac Chem, Dept Supramol Chem, Grunwaldzka 6, PL-60780 Poznan, Poland.	ceglowski.m@gmail.com	Silberring, Jerzy/AGA-5631-2022; Smoluch, Marek/AGA-6079-2022; Smoluch, Marek/AAN-8306-2021	Silberring, Jerzy/0000-0002-4362-8362; Smoluch, Marek/0000-0002-9481-988X; Schroeder, Grzegorz/0000-0002-6626-9542; Ceglowski, Michal/0000-0002-8257-642X	Polish National Science Center (NCN) [2011/03/B/ST5/01573]	Polish National Science Center (NCN)	This work was supported by the Polish National Science Center (NCN: www.ncn.gov.pl; grant no. 2011/03/B/ST5/01573). GS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babij M, 2013, MINIATURE PLASMA JET; BUSCH KL, 1995, J CHROMATOGR A, V692, P275, DOI 10.1016/0021-9673(94)00769-6; Chai WG, 2003, ANAL CHEM, V75, P118, DOI 10.1021/ac025833h; CHANG TT, 1984, ANAL CHEM, V56, P109, DOI 10.1021/ac00265a030; Chen YC, 1998, J CHROMATOGR A, V826, P77, DOI 10.1016/S0021-9673(98)00726-2; Cheng SC, 2011, J CHROMATOGR A, V1218, P2700, DOI 10.1016/j.chroma.2011.01.077; Cheng SC, 2009, ANAL CHEM, V81, P9274, DOI 10.1021/ac901514c; Fuchs B, 2009, CHROMATOGRAPHIA, V69, pS95, DOI 10.1365/s10337-008-0661-z; Ghosh P, 2004, ANAL CHIM ACTA, V508, P31, DOI 10.1016/j.aca.2003.11.058; Gilbert-Lopez B, 2013, ANAL CHEM, V85, P3174, DOI 10.1021/ac303452w; GUSEV AI, 1995, ANAL CHEM, V67, P1805, DOI 10.1021/ac00107a009; GUSEV AI, 1995, ANAL CHEM, V67, P4565, DOI 10.1021/ac00120a021; Harper JD, 2008, ANAL CHEM, V80, P9097, DOI 10.1021/ac801641a; Hayen H, 2009, ANAL CHEM, V81, P10239, DOI 10.1021/ac902176k; Hsu FL, 2003, ANAL CHEM, V75, P2493, DOI 10.1021/ac0203746; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; Kogelschatz U, 2002, IEEE T PLASMA SCI, V30, P1400, DOI 10.1109/TPS.2002.804201; KUBIS AJ, 1989, ANAL CHEM, V61, P2516, DOI 10.1021/ac00197a013; Lin SY, 2007, ANAL CHEM, V79, P8789, DOI 10.1021/ac070590k; Liu ZF, 2012, ANAL CHEM, V84, P10170, DOI 10.1021/ac3028504; Morlock G, 2006, ANAL BIOANAL CHEM, V385, P586, DOI 10.1007/s00216-006-0430-5; Morlock G, 2010, TRAC-TREND ANAL CHEM, V29, P1157, DOI 10.1016/j.trac.2010.07.010; Na N, 2007, J AM SOC MASS SPECTR, V18, P1859, DOI 10.1016/j.jasms.2007.07.027; Orinak A, 2004, SURF INTERFACE ANAL, V36, P1122, DOI 10.1002/sia.1855; Pasilis SP, 2010, J CHROMATOGR A, V1217, P3955, DOI 10.1016/j.chroma.2009.10.064; Peng S, 2004, RAPID COMMUN MASS SP, V18, P1803, DOI 10.1002/rcm.1556; Salo PK, 2007, ANAL CHEM, V79, P2101, DOI 10.1021/ac0620359; Salo PK, 2005, J AM SOC MASS SPECTR, V16, P906, DOI 10.1016/j.jasms.2005.02.025; Sherma J, 2002, ANAL CHEM, V74, P2653, DOI 10.1021/ac011764f; Smith NJ, 2008, ORG LETT, V10, P3493, DOI 10.1021/ol8012759; Tames F, 1999, J CHROMATOGR B, V729, P341, DOI 10.1016/S0378-4347(99)00120-6; Van Berkel GJ, 2005, ANAL CHEM, V77, P1207, DOI 10.1021/ac048217p; Van Berkel GJ, 2002, ANAL CHEM, V74, P6216, DOI 10.1021/ac020540+; Wilson ID, 1996, JPC-J PLANAR CHROMAT, V9, P84; Xu DM, 2014, J CHROMATOGR A, V1324, P49, DOI 10.1016/j.chroma.2013.11.017	35	18	19	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106088	10.1371/journal.pone.0106088	http://dx.doi.org/10.1371/journal.pone.0106088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170762	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500102
J	Labbe, MA; King, DI				Labbe, Michelle A.; King, David I.			The Effect of Local and Landscape-Level Characteristics on the Abundance of Forest Birds in Early-Successional Habitats during the Post-Fledging Season in Western Massachusetts	PLOS ONE			English	Article							FLEDGLING OVENBIRDS; REGENERATING CLEARCUTS; REPRODUCTIVE SUCCESS; COMMUNITY STRUCTURE; WOOD THRUSH; SURVIVAL; MOVEMENTS; SONGBIRDS; PREDATION; SELECTION	Many species of mature forest-nesting birds ("forest birds'') undergo a pronounced shift in habitat use during the post-fledging period and move from their forest nesting sites into areas of early-successional vegetation. Mortality is high during this period, thus understanding the resource requirements of post-fledging birds has implications for conservation. Efforts to identify predictors of abundance of forest birds in patches of early-successional habitats have so far been equivocal, yet these previous studies have primarily focused on contiguously forested landscapes and the potential for landscape-scale influences in more fragmented and modified landscapes is largely unknown. Landscape composition can have a strong influence on the abundance and productivity of forest birds during the nesting period, and could therefore affect the number of forest birds in the landscape available to colonize early-successional habitats during the post-fledging period. Therefore, the inclusion of landscape characteristics should increase the explanatory power of models of forest bird abundance in early-successional habitat patches during the post-fledging period. We examined forest bird abundance and body condition in relation to landscape and habitat characteristics of 15 early-successional sites during the post-fledging season in Massachusetts. The abundance of forest birds was influenced by within-patch habitat characteristics, however the explanatory power of these models was significantly increased by the inclusion of landscape fragmentation and the abundance of forest birds in adjacent forest during the nesting period for some species and age groups. Our findings show that including factors beyond the patch scale can explain additional variation in the abundance of forest birds in early-successional habitats during the post-fledging period. We conclude that landscape composition should be considered when siting early-successional habitat to maximize its benefit to forest birds during the post-fledging period, and should also be included in future investigations of post-fledging habitat use by forest birds.	[Labbe, Michelle A.; King, David I.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [King, David I.] Univ Massachusetts, US Forest Serv, No Res Stn, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; United States Department of Agriculture (USDA); United States Forest Service; University of Massachusetts System; University of Massachusetts Amherst	Labbe, MA (corresponding author), Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA.	labbemichelle@gmail.com			Massachusetts Division of Fisheries and Wildlife	Massachusetts Division of Fisheries and Wildlife	Funding for the project was provided by Massachusetts Division of Fisheries and Wildlife. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akresh ME, 2009, CONDOR, V111, P756, DOI 10.1525/cond.2009.080059; Anders AD, 1998, AUK, V115, P349, DOI 10.2307/4089193; Anders AD, 1997, CONSERV BIOL, V11, P698, DOI 10.1046/j.1523-1739.1997.95526.x; ASKINS RA, 1987, WILSON BULL, V99, P7; Bates D, 2012, LME4 LINEAR MIXED EF; Benoit LK, 1999, WETLANDS, V19, P194, DOI 10.1007/BF03161749; Berkeley LI, 2007, AUK, V124, P396, DOI 10.1642/0004-8038(2007)124[396:PSAMID]2.0.CO;2; Borgmann KL, 2005, RESTOR ECOL, V13, P334, DOI 10.1111/j.1526-100X.2005.00042.x; Borgmann KL, 2004, ECOL APPL, V14, P1757, DOI 10.1890/03-5129; BROTHERS TS, 1992, CONSERV BIOL, V6, P91, DOI 10.1046/j.1523-1739.1992.610091.x; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.2307/3802723, DOI 10.2307/3802723]; Chandler CC, 2012, FOREST ECOL MANAG, V264, P1, DOI 10.1016/j.foreco.2011.09.018; CHANDLER RB, 2006, EARLY SUCCESSIONAL B; Chandler RB, 2009, FOREST ECOL MANAG, V258, P1669, DOI 10.1016/j.foreco.2009.07.025; CONNER RN, 1975, J FOREST, V73, P781; DeGraaf R. M., 2000, NEW ENGLAND WILDLIFE; DICKSON JG, 1979, J WILDLIFE MANAGE, V43, P549, DOI 10.2307/3800371; Donovan TM, 1995, CONSERV BIOL, V9, P1396, DOI 10.1046/j.1523-1739.1995.09061396.x; Donovan TM, 1995, CONSERV BIOL, V9, P1380, DOI 10.1046/j.1523-1739.1995.09061380.x; Dunn EH, 2005, PARTNERS FLIGHT TECH; Fisher RJ, 2011, BIOL CONSERV, V144, P263, DOI 10.1016/j.biocon.2010.08.024; Flanders AA, 2006, AUK, V123, P171, DOI 10.1642/0004-8038(2006)123[0171:EOIEGO]2.0.CO;2; Freemark Kathryn E., 1995, P381; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Germaine SS, 1998, ECOL APPL, V8, P680, DOI 10.1890/1051-0761(1998)008[0680:RABBHA]2.0.CO;2; Halekoh U., 2012, PBKRTEST PARAMETRIC; Howell CA, 2000, LANDSCAPE ECOL, V15, P547, DOI 10.1023/A:1008190029786; HUNTER WC, 1988, CONDOR, V90, P113, DOI 10.2307/1368440; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Johnson VS, 2006, FOREST ECOL MANAG, V228, P124, DOI 10.1016/j.foreco.2006.02.033; JOHNSTON DW, 1956, ECOLOGY, V37, P50, DOI 10.2307/1929668; Keller JK, 2003, FOREST ECOL MANAG, V174, P541, DOI 10.1016/S0378-1127(02)00074-9; Kershner EL, 2004, AUK, V121, P1146, DOI 10.1642/0004-8038(2004)121[1146:PMASOJ]2.0.CO;2; King DI, 2006, J ZOOL, V269, P414, DOI 10.1111/j.1469-7998.2006.00158.x; King DI, 2009, FOREST ECOL MANAG, V257, P421, DOI 10.1016/j.foreco.2008.09.014; LEHNEN SE, 2008, THESIS OHIO STATE U; Marshall MR, 2003, FOREST ECOL MANAG, V183, P127, DOI 10.1016/S0378-1127(03)00101-4; Marzluff John M., 1999, P155; McDermott ME, 2010, WILSON J ORNITHOL, V122, P545, DOI 10.1676/09-050.1; MILLS GS, 1989, CONDOR, V91, P416, DOI 10.2307/1368320; Mitchell GW, 2010, AUK, V127, P354, DOI 10.1525/auk.2009.09060; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Ortega YK, 2006, OECOLOGIA, V149, P340, DOI 10.1007/s00442-006-0438-8; Pagen RW, 2000, CONDOR, V102, P738, DOI 10.1650/0010-5422(2000)102[0738:BAPBHU]2.0.CO;2; Poole A., 2005, BIRDS N AM ONLINE; Pyle P., 1997, IDENTIFICATION GUI 1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ralph CJ, 1997, PSWGTR149 USDA; Rivera JHV, 1998, CONDOR, V100, P69, DOI 10.2307/1369898; Rivera JHV, 1999, AUK, V116, P458; Rivera JHV, 1998, WILSON BULL, V110, P384; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Rodewald AD, 2001, ECOLOGY, V82, P3493, DOI 10.1890/0012-9658(2001)082[3493:IOLCOA]2.0.CO;2; Rodewald AD, 2001, AUK, V118, P1018, DOI 10.1642/0004-8038(2001)118[1018:ANSIFL]2.0.CO;2; Rottenborn SC, 1999, BIOL CONSERV, V88, P289, DOI 10.1016/S0006-3207(98)00128-1; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Rush SA, 2008, AUK, V125, P183, DOI 10.1525/auk.2008.125.1.183; Schlossberg S., 2007, ECOLOGY MANAGEMENT S; Schlossberg S, 2010, J WILDLIFE MANAGE, V74, P1513, DOI 10.2193/2008-601; Schmidt KA, 1999, CONSERV BIOL, V13, P1502, DOI 10.1046/j.1523-1739.1999.99050.x; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Streby HM, 2013, FOREST ECOL MANAG, V287, P9, DOI 10.1016/j.foreco.2012.08.046; Streby HM, 2011, J FIELD ORNITHOL, V82, P406, DOI 10.1111/j.1557-9263.2011.00343.x; Streby HM, 2011, CONDOR, V113, P817, DOI 10.1525/cond.2011.110012; SULLIVAN KA, 1989, J ANIM ECOL, V58, P275, DOI 10.2307/5000; Tallamy DW, 2004, CONSERV BIOL, V18, P1689, DOI 10.1111/j.1523-1739.2004.00512.x; Thompson FR, 2003, J WILDLIFE MANAGE, V67, P408, DOI 10.2307/3802781; Vitz AC, 2006, BIOL CONSERV, V127, P477, DOI 10.1016/j.biocon.2005.09.011; Vitz AC, 2007, AUK, V124, P494, DOI 10.1642/0004-8038(2007)124[494:VAFRAD]2.0.CO;2; Vitz AC, 2012, J FIELD ORNITHOL, V83, P73, DOI 10.1111/j.1557-9263.2011.00357.x; Vitz AC, 2011, CONDOR, V113, P400, DOI 10.1525/cond.2011.100023; Vitz AC, 2010, AUK, V127, P364, DOI 10.1525/auk.2010.09048; White JD, 2005, CONDOR, V107, P388, DOI 10.1650/7606; White JD, 2008, WILSON J ORNITHOL, V120, P62, DOI 10.1676/06-142.1; Yahner RH, 2003, WILSON BULL, V115, P292, DOI 10.1676/03-018; YAHNER RH, 1986, WILSON BULL, V98, P61	76	4	4	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106398	10.1371/journal.pone.0106398	http://dx.doi.org/10.1371/journal.pone.0106398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170610	gold, Green Published			2022-12-25	WOS:000341127500156
J	Olaru, ID; Heyckendorf, J; Grossmann, S; Lange, C				Olaru, Ioana D.; Heyckendorf, Jan; Grossmann, Susanne; Lange, Christoph			Time to Culture Positivity and Sputum Smear Microscopy during Tuberculosis Therapy	PLOS ONE			English	Article							ACID-FAST BACILLI; XPERT MTB/RIF ASSAY; PULMONARY TUBERCULOSIS; TREATMENT RESPONSE; DRUGS; PCR	Sputum smear microscopy is widely used for tuberculosis diagnosis and treatment monitoring. We evaluated the correlation between smear microscopy and time to liquid culture positivity during early tuberculosis treatment. The study included patients with smear-positive pulmonary tuberculosis hospitalized at a tuberculosis reference centre in Germany between 01/2012 and 05/2013. Patient records were reviewed and clinical, radiological and microbiological data were analysed. Sputum samples were collected before treatment initiation and weekly thereafter. A number of 310 sputum samples from 30 patients were analysed. Time to liquid culture positivity inversely correlated with smear grade (Spearman's rho -0.439, p<0.001). There was a better correlation within the first two months vs. after two months of therapy (-0.519 vs. -0.416) with a trend to a more rapid increase in time to positivity between baseline and week 2 in patients who culture-converted within the first two months (5.9 days vs. 9.4 days, p = 0.3). In conclusion, the numbers of acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis and time to culture positivity for M. tuberculosis cultures from sputum are correlated before and during tuberculosis treatment. A considerable proportion of patients with culture conversion after two months of therapy continued to have detectable acid-fast bacilli on sputum smears.	[Olaru, Ioana D.; Heyckendorf, Jan; Grossmann, Susanne; Lange, Christoph] Res Ctr Borstel, Div Clin Infect Dis, Borstel, Germany; [Olaru, Ioana D.; Heyckendorf, Jan; Lange, Christoph] German Ctr Infect Res DZIF, Res Ctr Borstel, Borstel, Germany; [Lange, Christoph] Univ Lubeck, Lubeck, Germany; [Lange, Christoph] Univ Namibia, Sch Med, Dept Med, Windhoek, Namibia	Forschungszentrum Borstel; Forschungszentrum Borstel; German Center for Infection Research; University of Lubeck; University of Namibia	Lange, C (corresponding author), Res Ctr Borstel, Div Clin Infect Dis, Borstel, Germany.	clange@fz-borstel.de	Lange, Christoph/J-6289-2012; Heyckendorf, Jan/AAA-8782-2021	Lange, Christoph/0000-0002-9691-4741; 	Research Center Bostel, Germany	Research Center Bostel, Germany	The study was funded by the Research Center Bostel, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Moamary MS, 1999, CHEST, V116, P726, DOI 10.1378/chest.116.3.726; [Anonymous], 2011, 5894332 DIN; Bark CM, 2011, TUBERCULOSIS, V91, P257, DOI 10.1016/j.tube.2011.01.004; Carroll NM, 2008, TUBERCULOSIS, V88, P624, DOI 10.1016/j.tube.2008.03.003; Friedrich SO, 2013, LANCET RESP MED, V1, P462, DOI 10.1016/S2213-2600(13)70119-X; JINDANI A, 1980, AM REV RESPIR DIS, V121, P939; Kent PT., 1985, PUBLIC HLTH MICROBIO; KIM TC, 1984, AM REV RESPIR DIS, V129, P264; Kim YJ, 2014, ANN LAB MED, V34, P203, DOI 10.3343/alm.2014.34.3.203; KVACH JT, 1982, INT J LEPROSY, V50, P183; Lange C, 2014, EUR RESPIR J, V44, P23, DOI 10.1183/09031936.00188313; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MITCHISON DA, 1990, EUR RESPIR J, V3, P385; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; Perrin FMR, 2007, LANCET INFECT DIS, V7, P481, DOI 10.1016/S1473-3099(07)70112-3; Pfyffer GE, 1997, J CLIN MICROBIOL, V35, P364, DOI 10.1128/JCM.35.2.364-368.1997; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; Thomsen VO, 1999, J CLIN MICROBIOL, V37, P3601; van der Kuyp F, 2012, INT J TUBERC LUNG D, V16, P1663, DOI 10.5588/ijtld.12.0238; Van Deun A, 2012, INT J TUBERC LUNG D, V16, P1174, DOI 10.5588/ijtld.11.0166; Vidal R, 1996, CHEST, V109, P1562, DOI 10.1378/chest.109.6.1562; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	23	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106075	10.1371/journal.pone.0106075	http://dx.doi.org/10.1371/journal.pone.0106075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171337	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000341127500099
J	Tannenbaum, SL; Hernandez, M; Zheng, DD; Sussman, DA; Lee, DJ				Tannenbaum, Stacey L.; Hernandez, Monique; Zheng, D. Dandan; Sussman, Daniel A.; Lee, David J.			Individual- and Neighborhood-Level Predictors of Mortality in Florida Colorectal Cancer Patients	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; RACIAL DISPARITIES; COLON-CANCER; ADJUVANT CHEMOTHERAPY; HEALTH-INSURANCE; MARITAL-STATUS; UNITED-STATES; SURVIVAL; COMORBIDITY; CARE	Purpose: We examined individual-level and neighborhood-level predictors of mortality in CRC patients diagnosed in Florida to identify high-risk groups for targeted interventions. Methods: Demographic and clinical data from the Florida Cancer Data System registry (2007-2011) were linked with Agency for Health Care Administration and US Census data (n = 47,872). Cox hazard regression models were fitted with candidate predictors of CRC survival and stratified by age group (18-49, 50-64, 65+). Results: Stratified by age group, higher mortality risk per comorbidity was found among youngest (21%), followed by middle (19%), and then oldest (14%) age groups. The two younger age groups had higher mortality risk with proximal compared to those with distal cancer. Compared with private insurance, those in the middle age group were at higher death risk if not insured (HR = 1.35), or received healthcare through Medicare (HR = 1.44), Medicaid (HR = 1.53), or the Veteran's Administration (HR = 1.26). Only Medicaid in the youngest (52% higher risk) and those not insured in the oldest group (24% lower risk) were significantly different from their privately insured counterparts. Among 18-49 and 50-64 age groups there was a higher mortality risk among the lowest SES (1.17- and 1.23-fold higher in the middle age and 1.12- and 1.17-fold higher in the older age group, respectively) compared to highest SES. Married patients were significantly better off than divorced/separated (HR = 1.22), single (HR = 1.29), or widowed (HR = 1.19) patients. Conclusion: Factors associated with increased risk for mortality among individuals with CRC included being older, uninsured, unmarried, more comorbidities, living in lower SES neighborhoods, and diagnosed at later disease stage. Higher risk among younger patients was attributed to proximal cancer site, Medicaid, and distant disease; however, lower SES and being unmarried were not risk factors in this age group. Targeted interventions to improve survivorship and greater social support while considering age classification may assist these high-risk groups.	[Tannenbaum, Stacey L.; Hernandez, Monique; Lee, David J.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Zheng, D. Dandan; Lee, David J.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Sussman, Daniel A.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Tannenbaum, SL (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.	STannenbaum@med.miami.edu			Bankhead-Coley Team Science Program [2BT02]	Bankhead-Coley Team Science Program	Funding for this study was provided by the Bankhead-Coley Team Science Program (2BT02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2013, HCUP COM SOFTW; Aizer AA, 2014, CANCER-AM CANCER SOC, V120, P1532, DOI 10.1002/cncr.28617; American Cancer Society, 2013, WHAT AR KEY STAT COL; American Society of Clinical Oncology (ASCO), 2014, COL CANC TREATM PLAN; [Anonymous], 2008, SCREEN COL CANC; Boland GM, 2013, CANCER-AM CANCER SOC, V119, P1593, DOI 10.1002/cncr.27935; Brenner H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2467; Cavalli-Bjorkman N, 2012, BRIT J CANCER, V107, P189, DOI 10.1038/bjc.2012.186; Centers for Disease Control and Prevention, 2010, CANC TYP GROUP STAT; Chien C, 2005, CANCER, V104, P629, DOI 10.1002/cncr.21204; Denberg TD, 2005, CANCER-AM CANCER SOC, V103, P1819, DOI 10.1002/cncr.20982; Du XL, 2007, CANCER, V110, P660, DOI 10.1002/cncr.22826; Faul LA, 2010, CANCER CONTROL, V17, P35, DOI 10.1177/107327481001700105; Feltner FJ, 2012, SOC WORK HEALTH CARE, V51, P430, DOI 10.1080/00981389.2012.657296; Fiscella K, 2012, CANCER EPIDEM BIOMAR, V21, P1673, DOI 10.1158/1055-9965.EPI-12-0506; Fritz A, 2000, INT CLASSIFICATION D; Gomez SL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-193; Gross CP, 2007, CANCER-AM CANCER SOC, V109, P2410, DOI 10.1002/cncr.22726; Haas JS, 2011, CANCER-AM CANCER SOC, V117, P4267, DOI 10.1002/cncr.26034; Hines RB, 2009, CANCER-AM CANCER SOC, V115, P5798, DOI 10.1002/cncr.24598; Hines RB, 2009, J CLIN ONCOL, V27, P4339, DOI 10.1200/JCO.2009.22.4758; Hu CY, 2011, MED ONCOL, V28, P1062, DOI 10.1007/s12032-010-9644-7; Institute of Medicine, 2013, DEL HIGH QUAL CANC C; Irby K, 2006, CANCER EPIDEM BIOMAR, V15, P792, DOI 10.1158/1055-9965.EPI-05-0879; Jackson GL, 2013, J NATL COMPR CANC NE, V11, P431, DOI 10.6004/jnccn.2013.0058; Jackson GL, 2010, J CLIN ONCOL, V28, P3176, DOI 10.1200/JCO.2009.26.7948; Kelz RR, 2004, CANCER-AM CANCER SOC, V101, P2187, DOI 10.1002/cncr.20624; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Landrum MB, 2012, J CLIN ONCOL, V30, P1072, DOI 10.1200/JCO.2011.35.6758; Le H, 2008, CANCER EPIDEM BIOMAR, V17, P1950, DOI 10.1158/1055-9965.EPI-07-2774; MacDermid E, 2009, COLORECTAL DIS, V11, P291, DOI 10.1111/j.1463-1318.2008.01580.x; Nash D, 2006, J URBAN HEALTH, V83, P231, DOI 10.1007/s11524-006-9029-6; Neugut AI, 2006, J CLIN ONCOL, V24, P2368, DOI 10.1200/JCO.2005.04.5005; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Niu XL, 2013, CANCER MED-US, V2, P403, DOI 10.1002/cam4.84; Pew Research Center, 2014, PEW RES HISP TREND P; Polednak AP, 2001, J HEALTH CARE POOR U, V12, P302; Polite BN, 2006, J CLIN ONCOL, V24, P2179, DOI 10.1200/JCO.2005.05.4775; Read WL, 2004, J CLIN ONCOL, V22, P3099, DOI 10.1200/JCO.2004.08.040; Rim SH, 2009, CANCER-AM CANCER SOC, V115, P1967, DOI 10.1002/cncr.24216; Robbins AS, 2009, J CLIN ONCOL, V27, P3627, DOI 10.1200/JCO.2008.20.8025; Roetzheim RG, 2000, AM J PUBLIC HEALTH, V90, P1746, DOI 10.2105/AJPH.90.11.1746; Safran DG, 2002, HEALTH AFFAIR, V21, pW253; Salz T, 2012, CA CANC J CLIN; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sogaard Mette, 2013, Clin Epidemiol, V5, P3, DOI 10.2147/CLEP.S47150; Surveillance Epidemiology and End Results (SEER) Program SEER*Stat Database, 2013, N AM ASS CENTR CANC; Tannenbaum SL, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-504; Tarlov E, 2012, CANCER EPIDEM BIOMAR, V21, P2231, DOI 10.1158/1055-9965.EPI-12-0548; Wang L, 2011, CANCER EPIDEMIOL, V35, P417, DOI 10.1016/j.canep.2011.02.004; Weiss JM, 2013, AM J GASTROENTEROL, V108, P1159, DOI 10.1038/ajg.2013.127; White A, 2010, CANCER-AM CANCER SOC, V116, P4622, DOI 10.1002/cncr.25395; Yancik R, 1998, CANCER, V82, P2123, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2123::AID-CNCR6>3.0.CO;2-W; Young JL, 2001, NIH PUB	55	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106322	10.1371/journal.pone.0106322	http://dx.doi.org/10.1371/journal.pone.0106322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO2EE	25170910	Green Submitted, Green Published, gold			2022-12-25	WOS:000341127500148
J	Valenza, G; Citi, L; Barbieri, R				Valenza, Gaetano; Citi, Luca; Barbieri, Riccardo			Estimation of Instantaneous Complex Dynamics through Lyapunov Exponents: A Study on Heartbeat Dynamics	PLOS ONE			English	Article							RATE-VARIABILITY; TIME-SERIES; APPROXIMATE ENTROPY; NONLINEAR DYNAMICS; CHAOS; IDENTIFICATION; ALGORITHM; DECREASE; HEALTH	Measures of nonlinearity and complexity, and in particular the study of Lyapunov exponents, have been increasingly used to characterize dynamical properties of a wide range of biological nonlinear systems, including cardiovascular control. In this work, we present a novel methodology able to effectively estimate the Lyapunov spectrum of a series of stochastic events in an instantaneous fashion. The paradigm relies on a novel point-process high-order nonlinear model of the event series dynamics. The long-term information is taken into account by expanding the linear, quadratic, and cubic Wiener-Volterra kernels with the orthonormal Laguerre basis functions. Applications to synthetic data such as the Henon map and Rossler attractor, as well as two experimental heartbeat interval datasets (i.e., healthy subjects undergoing postural changes and patients with severe cardiac heart failure), focus on estimation and tracking of the Instantaneous Dominant Lyapunov Exponent (IDLE). The novel cardiovascular assessment demonstrates that our method is able to effectively and instantaneously track the nonlinear autonomic control dynamics, allowing for complexity variability estimations.	[Valenza, Gaetano; Citi, Luca; Barbieri, Riccardo] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neurosci Stat Res Lab,Dept Anesthesia Crit Care &, Boston, MA 02163 USA; [Valenza, Gaetano; Citi, Luca; Barbieri, Riccardo] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Valenza, Gaetano] Univ Pisa, Res Ctr E Piaggio, Pisa, Italy; [Valenza, Gaetano] Univ Pisa, Dept Informat Engn, Pisa, Italy; [Citi, Luca] Univ Essex, Sch Comp Sci & Elect Engn, Colchester CO4 3SQ, Essex, England	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); University of Pisa; University of Pisa; University of Essex	Valenza, G (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neurosci Stat Res Lab,Dept Anesthesia Crit Care &, Boston, MA 02163 USA.	g.valenza@ieee.org	Citi, Luca/G-2270-2011; Barbieri, Riccardo/AAC-5310-2022; Citi, Luca/AAE-3192-2022	Citi, Luca/0000-0001-8702-5654; Barbieri, Riccardo/0000-0001-9381-3833; Citi, Luca/0000-0001-8702-5654; Valenza, Gaetano/0000-0001-6574-1879	Department of Anesthesia, Critical Care & Pain Medicine, Massachusetts General Hospital; Harvard Medical School, Boston, MA, USA; European Union Seventh Framework Programme FP7 [601165]	Department of Anesthesia, Critical Care & Pain Medicine, Massachusetts General Hospital; Harvard Medical School, Boston, MA, USA; European Union Seventh Framework Programme FP7	The research leading to these results has received partial funding from the Department of Anesthesia, Critical Care & Pain Medicine, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA, and European Union Seventh Framework Programme FP7/2007-2013 under Grant No. 601165 of the project "WEARHAP''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Akay M., 2000, NONLINEAR BIOMEDICAL, VII; [Anonymous], 2009, CHAOS, V19; [Anonymous], 1996, PHYS TODAY, DOI DOI 10.1063/1.881528; Armoundas AA, 2002, ANN BIOMED ENG, V30, P192, DOI 10.1114/1.1451074; Atyabi F, 2006, J BIOL PHYS, V32, P489, DOI 10.1007/s10867-006-9031-y; Bar KJ, 2007, CLIN NEUROPHYSIOL, V118, P2009, DOI 10.1016/j.clinph.2007.06.012; Baillie RT, 2009, CHAOS, V19, DOI 10.1063/1.3152006; Barbieri R, 2005, AM J PHYSIOL-HEART C, V288, pH424, DOI 10.1152/ajpheart.00482.2003; Barnett AG, 2005, IEEE T SIGNAL PROCES, V53, P26, DOI 10.1109/TSP.2004.838942; Chen Z, 2009, IEEE T BIO-MED ENG, V56, P1791, DOI 10.1109/TBME.2009.2016349; CHIALVO DR, 1990, NATURE, V343, P653, DOI 10.1038/343653a0; Chon KH, 2000, INT J BIFURCAT CHAOS, V10, P2745, DOI 10.1142/S021812740000178X; Citi L, 2012, REAL TIME AUTOMATED; Citi L, 2012, IEEE ENG MED BIO, P3124, DOI 10.1109/EMBC.2012.6346626; Citi L, 2012, IEEE ENG MED BIO, P13, DOI 10.1109/EMBC.2012.6345859; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Dieci L, 1997, SIAM J NUMER ANAL, V34, P402, DOI 10.1137/S0036142993247311; Gao J., 2007, MULTISCALE ANAL COMP; GEIST K, 1990, PROG THEOR PHYS, V83, P875, DOI 10.1143/PTP.83.875; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Granger C. W. J., 1980, Journal of Time Series Analysis, V1, P15, DOI 10.1111/j.1467-9892.1980.tb00297.x; Hagerman I, 1996, CARDIOVASC RES, V31, P410; Hernandez-Carrasco I, 2011, OCEAN MODEL, V36, P208, DOI 10.1016/j.ocemod.2010.12.006; HOLZFUSS J, 1991, LECT NOTES MATH, V1486, P263; Hu J, 2009, CHAOS, V19; Jelinek HF, 2011, COMPUT CARDIOL CONF, V38, P809; Kanters JK, 1996, CARDIOVASC RES, V31, P400; Keller J, 2010, AGU FALL M, V1, P1319; KORENBERG MJ, 1989, BIOL CYBERN, V60, P267, DOI 10.1007/BF00204124; KORENBERG MJ, 1991, ANN BIOMED ENG, V19, P429, DOI 10.1007/BF02584319; Lanata A, 2011, EXPERT SYST APPL, V38, P6798, DOI 10.1016/j.eswa.2010.12.066; Lindsay DH, 2011, J APPL BUSINESS RES, V12, P1; Lyapunov A. M., 1949, ANN FS TOULOUSE, V17, P203; Marmarelis V, 1993, ANN BIOMED ENG, V21; Orini M, 2012, PHYSIOL MEAS, V33, P315, DOI 10.1088/0967-3334/33/3/315; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Poon CS, 1997, NATURE, V389, P492, DOI 10.1038/39043; Porta A, 2007, J APPL PHYSIOL, V103, P1143, DOI 10.1152/japplphysiol.00293.2007; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; RUELLE D, 1994, PHYS TODAY, V47, P24, DOI 10.1063/1.881395; Schetzen M., 1980, VOLTERRA WIENER THEO; Schmitt DT, 2009, IEEE T BIO-MED ENG, V56, P1564, DOI 10.1109/TBME.2009.2014819; Schneider R, 2013, HEART RATE VARIABILITY (HRV) SIGNAL ANALYSIS: CLINICAL APPLICATIONS, P87; Schwartz PJ, 2011, HEART FAIL REV, V16, P101, DOI 10.1007/s10741-010-9179-1; SHIMADA I, 1979, PROG THEOR PHYS, V61, P1605, DOI 10.1143/PTP.61.1605; Sunagawa K, 1998, HEART VESSELS, V13, P157, DOI 10.1007/BF01745040; Tarvainen MP, 2012, ANN BIOMED ENG, V40, P1802, DOI 10.1007/s10439-012-0544-1; Thuraisingham RA, 2006, PHYSICA A, V366, P323, DOI 10.1016/j.physa.2005.10.008; Tulppo MP, 2001, CLIN PHYSIOL, V21, P515, DOI 10.1046/j.1365-2281.2001.00344.x; Valenza G, 2014, EPL-EUROPHYS LETT, V107, DOI 10.1209/0295-5075/107/18003; Valenza G., 2014, NATURE SCI REPORTS, V4; Valenza G., 2014, IEEE J BIOMEDICAL HL; Valenza G., 2012, FRONTIERS NEUROENGIN, V5; Valenza G, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052803; Valenza G, 2013, IEEE ENG MED BIO, P2579, DOI 10.1109/EMBC.2013.6610067; Valenza G, 2013, IEEE ENG MED BIO, P6131, DOI 10.1109/EMBC.2013.6610952; Valenza G, 2013, IEEE T SIGNAL PROCES, V61, P2914, DOI 10.1109/TSP.2013.2253775; Valenza G, 2013, PHYSIOL MEAS, V34, P449, DOI 10.1088/0967-3334/34/4/449; Valenza G, 2012, IEEE T INF TECHNOL B, V16, P683, DOI 10.1109/TITB.2012.2197632; WINFREE AT, 1994, SCIENCE, V266, P1003, DOI 10.1126/science.7973648; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Wu GQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004323; Zhai CX, 2011, LECT NOTES COMPUT SC, V6931, P1, DOI 10.1007/978-3-642-23318-0_1; Zong W., 2003, WQRS SINGLE CHANNEL	69	44	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105622	10.1371/journal.pone.0105622	http://dx.doi.org/10.1371/journal.pone.0105622			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170911	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000341127500062
J	Wilson, RP; Richards, R; Hartnell, A; King, AJ; Piasecka, J; Gaihre, YK; Butt, T				Wilson, Rory P.; Richards, Rebecca; Hartnell, Angharad; King, Andrew J.; Piasecka, Justyna; Gaihre, Yogendra K.; Butt, Tariq			A New Approach to Quantify Semiochemical Effects on Insects Based on Energy Landscapes	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL RESPONSES; BEHAVIORAL-RESPONSES; HYLOBIUS-ABIETIS; LYGUS-HESPERUS; HEALTH; VOLATILES; LOCOMOTION; ENERGETICS; PESTICIDES; PHEROMONE	Introduction: Our ability to document insect preference for semiochemicals is pivotal in pest control as these agents can improve monitoring and be deployed within integrated pest management programmes for more efficacious control of pest species. However, methods used to date have drawbacks that limit their utility. We present and test a new concept for determining insect motivation to move towards, or away from, semiochemicals by noting direction and speed of movement as animals work against a defined energy landscape (environmentally dependent variation in the cost of transport) requiring different powers to negotiate. We conducted trials with the pine weevils Hylobius abietis and peach-potato aphids Myzus persicae exposed to various attractants and repellents and placed so that they either moved up defined slopes against gravity or had to travel over variously rough surfaces. Results: Linear Mixed Models demonstrated clear reductions in travel speed by insects moving along increasingly energetically taxing energy landscapes but also that responses varied according to different semiochemicals, thus highlighting the value of energy landscapes as a new concept to help measure insect motivation to access or avoid different attractants or repellents across individuals. Conclusions: New sensitive, detailed indicators of insect motivation derived from this approach should prove important in pest control across the world.	[Wilson, Rory P.; Richards, Rebecca; Hartnell, Angharad; King, Andrew J.; Piasecka, Justyna; Gaihre, Yogendra K.; Butt, Tariq] Swansea Univ, Coll Sci, Swansea, W Glam, Wales	Swansea University	Butt, T (corresponding author), Swansea Univ, Coll Sci, Singleton Pk, Swansea, W Glam, Wales.	t.butt@swansea.ac.uk		Butt, Tariq/0000-0002-8789-9543	Welsh Government; NERC Postdoctoral Fellowship [NE.H016600.2]; NERC [NE/H016600/3, NE/H016600/2] Funding Source: UKRI; Natural Environment Research Council [NE/H016600/2, NE/H016600/3] Funding Source: researchfish	Welsh Government; NERC Postdoctoral Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	TB and JP thank the Welsh Government for an A4B CIRP grant. AJK was supported by a NERC Postdoctoral Fellowship (NE.H016600.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar EB, 2001, CAN ENTOMOL, V133, P389, DOI 10.4039/Ent133389-3; Alavanja MCR, 2004, ANNU REV PUBL HEALTH, V25, P155, DOI 10.1146/annurev.publhealth.25.101802.123020; Ansari MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016108; Ballhorn DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055602; Birkett MA, 2006, J CHEM ECOL, V32, P2475, DOI 10.1007/s10886-006-9165-1; Blackmer JL, 2004, J CHEM ECOL, V30, P1547, DOI 10.1023/B:JOEC.0000042067.27698.30; Boleij H, 2012, BEHAV BRAIN RES, V233, P45, DOI 10.1016/j.bbr.2012.04.039; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; DAWKINS MS, 1990, BEHAV BRAIN SCI, V13, P1, DOI 10.1017/S0140525X00077104; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; DUNCAN IJH, 1989, ANIM BEHAV, V37, P215, DOI 10.1016/0003-3472(89)90112-7; Egigu MC, 2011, ENTOMOL EXP APPL, V138, P162, DOI 10.1111/j.1570-7458.2010.01082.x; Fraser AM, 2003, J CHEM ECOL, V29, P1813, DOI 10.1023/A:1024898127549; FULL RJ, 1990, J EXP BIOL, V149, P307; Galhardo L, 2011, APPL ANIM BEHAV SCI, V130, P60, DOI 10.1016/j.applanim.2010.12.008; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Ho HY, 2002, ZOOL STUD, V41, P311; Jonsson M, 2005, ENTOMOL EXP APPL, V115, P363, DOI 10.1111/j.1570-7458.2005.00271.x; Kesavachandran CN, 2009, REV ENVIRON CONTAM T, V200, P33, DOI 10.1007/978-1-4419-0028-9_2; Khan Z, 2011, INT J AGR SUSTAIN, V9, P162, DOI 10.3763/ijas.2010.0558; Khan ZR, 2008, BIOL CONTROL, V45, P210, DOI 10.1016/j.biocontrol.2007.11.009; Koschier EH, 2000, J CHEM ECOL, V26, P2643, DOI 10.1023/A:1026470122171; Legaspi JC, 2011, SUBTROPICAL PLANT SC, V63, P36; Lipp A, 2005, J EXP BIOL, V208, P707, DOI 10.1242/jeb.01434; Margni M, 2002, AGR ECOSYST ENVIRON, V93, P379, DOI 10.1016/S0167-8809(01)00336-X; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Nauen R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/ps.1406; Nordlander G, 1987, SCAND J FOREST RES, V2, P199, DOI 10.1080/02827588709382458; Penuelas J, 2001, BIOL PLANTARUM, V44, P481, DOI 10.1023/A:1013797129428; Pickett JA, 1997, AGR ECOSYST ENVIRON, V64, P149, DOI 10.1016/S0167-8809(97)00033-9; Ragaert P, 2004, FOOD QUAL PREFER, V15, P259, DOI 10.1016/S0950-3293(03)00066-1; Reddy GVP, 2002, J CHEM ECOL, V28, P131, DOI 10.1023/A:1013519003944; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Rogowitz GL, 2000, J EXP BIOL, V203, P1131; Shepard ELC, 2013, AM NAT, V182, P298, DOI 10.1086/671257; Shepherd R, 1999, P NUTR SOC, V58, P807, DOI 10.1017/S0029665199001093; Sole J, 2010, PHYSIOL ENTOMOL, V35, P354, DOI 10.1111/j.1365-3032.2010.00750.x; TUCKER VA, 1970, COMP BIOCHEM PHYSIOL, V34, P841, DOI 10.1016/0010-406X(70)91006-6; Watson RR, 2011, P ROY SOC B-BIOL SCI, V278, P2040, DOI 10.1098/rspb.2010.2022; Weiner B., 1992, HUMAN MOTIVATION MET; Wilson RP, 2012, P ROY SOC B-BIOL SCI, V279, P975, DOI 10.1098/rspb.2011.1544	43	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106276	10.1371/journal.pone.0106276	http://dx.doi.org/10.1371/journal.pone.0106276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171062	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500139
J	Yiannakas, MC; Kakar, P; Hoy, LR; Miller, DH; Wheeler-Kingshott, CAM				Yiannakas, Marios C.; Kakar, Puneet; Hoy, Luke R.; Miller, David H.; Wheeler-Kingshott, Claudia A. M.			The Use of the Lumbosacral Enlargement as an Intrinsic Imaging Biomarker: Feasibility of Grey Matter and White Matter Cross-Sectional Area Measurements Using MRI at 3T	PLOS ONE			English	Article							SPINAL-CORD-INJURY; AMYOTROPHIC-LATERAL-SCLEROSIS; MULTIPLE SYSTEM ATROPHY; OF-THE-ART; CONUS MEDULLARIS; VERTEBRAL LEVEL; IMPACT; SEGMENTATION; TERMINATION; DYSFUNCTION	Histopathological studies have demonstrated the involvement of spinal cord grey matter (GM) and white matter (WM) in several diseases and recent research has suggested the use of magnetic resonance imaging (MRI) as a promising tool for in vivo assessment of the upper spinal cord. However, many neurological conditions would benefit from quantitative assessment of tissue integrity at different levels and relatively little work has been done, mainly due to technical challenges associated with imaging the lower spinal cord. In this study, the value of the lumbosacral enlargement (LSE) as an intrinsic imaging biomarker was determined by exploring the feasibility of obtaining within it reliable GM and WM cross-sectional area (CSA) measurements by means of a commercially available MRI system at 3 tesla (T). 10 healthy volunteers (mean age 27.5 years, 6 female) gave written informed consent and high resolution images of the LSE were acquired and analysed using an optimised MRI acquisition and analysis protocol. GM and WM mean CSA measurements were obtained from a 15 mm section at the level of the LSE and the reproducibility of the measurements was determined by means of scan-rescan, intra- and inter-observer assessments. Mean (+/- SD) LSE cross-sectional area (LSE-CSA) was 62.3 (+/- 4.1) mm 2 and mean (+/- SD) LSE grey matter cross-sectional area (LSE-GM-CSA) was 19.8 (+/- 3.3) mm(2). The mean scan-rescan, intra-and inter-observer % coefficient of variation (COV) for measuring the LSE-CSA were 2%, 2% and 2.5%, respectively and for measuring the LSE-GM-CSA were 7.8%, 8% and 8.6%, respectively. This study has shown that the LSE can be used reliably as an intrinsic imaging biomarker. The method presented here can be potentially extended to study the LSE in the diseased state and could provide a solid foundation for subsequent multi-parametric MRI investigations.	[Yiannakas, Marios C.; Kakar, Puneet; Hoy, Luke R.; Miller, David H.; Wheeler-Kingshott, Claudia A. M.] UCL Inst Neurol, Dept Neuroinflammat, NMR Res Unit, Queen Sq MS Ctr, London, England	University of London; University College London	Yiannakas, MC (corresponding author), UCL Inst Neurol, Dept Neuroinflammat, NMR Res Unit, Queen Sq MS Ctr, London, England.	m.yiannakas@ucl.ac.uk	Wheeler-Kingshott, Claudia A M Gandini/AAH-7480-2019	Wheeler-Kingshott, Claudia A M Gandini/0000-0002-4832-1300	UK Multiple Sclerosis Society; National Institute for Health Research University College London Hospitals Biomedical Research Centre; National Institute for Health Research [NF-SI-0508-10058] Funding Source: researchfish	UK Multiple Sclerosis Society; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); National Institute for Health Research(National Institute for Health Research (NIHR))	This study has received funding by the UK Multiple Sclerosis Society (http://www.mssociety.org.uk). This work was supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KD, 2007, SPINAL CORD, V45, P328, DOI 10.1038/sj.sc.3101977; BARSON AJ, 1970, J ANAT, V106, P489; Craggs MD, 2006, AUTON NEUROSCI-BASIC, V126, P355, DOI 10.1016/j.autneu.2006.03.010; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; DUBUISSON MP, 1994, INT C PATT RECOG, P566, DOI 10.1109/ICPR.1994.576361; Fernandez O, 2002, J NEUROL, V249, P1, DOI 10.1007/PL00007835; Freund P, 2013, NEUROSCIENTIST, V19, P116, DOI 10.1177/1073858412449192; Freund PAB, 2010, J MAGN RESON IMAGING, V32, P1242, DOI 10.1002/jmri.22340; Ge Y, 2006, AM J NEURORADIOL, V27, P1165; Gilmore CP, 2006, BRAIN PATHOL, V16, P202, DOI 10.1111/j.1750-3639.2006.00018.x; Held P, 2001, EUR J RADIOL, V38, P64, DOI 10.1016/S0720-048X(00)00253-9; Hess MJ, 2012, J SPINAL CORD MED, V35, P211, DOI 10.1179/2045772312Y.0000000025; Horsfield MA, 2010, NEUROIMAGE, V50, P446, DOI 10.1016/j.neuroimage.2009.12.121; Kim JT, 2003, ANESTHESIOLOGY, V99, P1359, DOI 10.1097/00000542-200312000-00018; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Koloski NA, 2012, J PSYCHOSOM RES, V73, P464, DOI 10.1016/j.jpsychores.2012.07.013; KONNO H, 1986, J NEUROL SCI, V73, P193, DOI 10.1016/0022-510X(86)90130-9; Losseff NA, 1996, BRAIN, V119, P701, DOI 10.1093/brain/119.3.701; Lundell H, 2011, SPINAL CORD, V49, P70, DOI 10.1038/sc.2010.87; Malas MA, 2000, SURG RADIOL ANAT, V22, P163, DOI 10.1007/s00276-000-0163-7; McCombe PA, 2009, EXPERT REV NEUROTHER, V9, P331, DOI 10.1586/14737175.9.3.331; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Nout YS, 2006, PROG BRAIN RES, V152, P359, DOI 10.1016/S0079-6123(05)52024-7; Reitz A, 2004, INT J IMPOT RES, V16, P167, DOI 10.1038/sj.ijir.3901193; Saifuddin A, 1998, SPINE, V23, P1452, DOI 10.1097/00007632-199807010-00005; Sakakibara R, 2000, J NEUROL NEUROSUR PS, V68, P65, DOI 10.1136/jnnp.68.1.65; SAKAKIBARA R, 1993, JPN J PSYCHIAT NEUR, V47, P591; Sathasivam S, 2010, SINGAP MED J, V51, P367; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Soleiman J, 2005, SPINE, V30, P1875, DOI 10.1097/01.brs.0000174116.74775.2e; Stroman PW, 2014, NEUROIMAGE, V84, P1070, DOI 10.1016/j.neuroimage.2013.04.124; TSUKAGOSHI H, 1979, J NEUROL SCI, V41, P287, DOI 10.1016/0022-510X(79)90089-3; Udupa JK, 1996, GRAPH MODEL IM PROC, V58, P246, DOI 10.1006/gmip.1996.0021; VETTIVEL S, 1991, J ANAT, V179, P149; Watanabe T, 1998, J UROLOGY, V159, P965, DOI 10.1016/S0022-5347(01)63786-8; Wheeler-Kingshott CA, 2014, NEUROIMAGE, V84, P1082, DOI 10.1016/j.neuroimage.2013.07.014; Yiannakas MC, 2012, NEUROIMAGE, V63, P1054, DOI 10.1016/j.neuroimage.2012.07.048	38	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105544	10.1371/journal.pone.0105544	http://dx.doi.org/10.1371/journal.pone.0105544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170763	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500058
J	Asnaghi, L; Lin, MH; Lim, KS; Lim, KJ; Tripathy, A; Wendeborn, M; Merbs, SL; Handa, JT; Sodhi, A; Bar, EE; Eberhart, CG				Asnaghi, Laura; Lin, Michael H.; Lim, Kah Suan; Lim, Kah Jing; Tripathy, Arushi; Wendeborn, Murilo; Merbs, Shannath L.; Handa, James T.; Sodhi, Akrit; Bar, Eli E.; Eberhart, Charles G.			Hypoxia Promotes Uveal Melanoma Invasion through Enhanced Notch and MAPK Activation	PLOS ONE			English	Article							LYSYL OXIDASE; CELL-MIGRATION; MAMMALIAN TARGET; MONOSOMY 3; VEGF-A; EXPRESSION; GROWTH; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; HIF-1-ALPHA; INCREASES	The transcriptional response promoted by hypoxia-inducible factors has been associated with metastatic spread of uveal melanoma. We found expression of hypoxia-inducible factor 1 alpha (HIF-1 alpha) protein in well-vascularized tumor regions as well as in four cell lines grown in normoxia, thus this pathway may be important even in well-oxygenated uveal melanoma cells. HIF-1 alpha protein accumulation in normoxia was inhibited by rapamycin. As expected, hypoxia (1% pO(2)) further induced HIF-1 alpha protein levels along with its target genes VEGF and LOX. Growth in hypoxia significantly increased cellular invasion of all 5 uveal melanoma lines tested, as did the introduction of an oxygen-insensitive HIF-1 alpha mutant into Mel285 cells with low HIF-1 alpha baseline levels. In contrast, HIF-1 alpha knockdown using shRNA significantly decreased growth in hypoxia, and reduced by more than 50% tumor invasion in four lines with high HIF-1 alpha baseline levels. Pharmacologic blockade of HIF-1 alpha protein expression using digoxin dramatically suppressed cellular invasion both in normoxia and in hypoxia. We found that Notch pathway components, including Jag1-2 ligands, Hes1-Hey1 targets and the intracellular domain of Notch1, were increased in hypoxia, as well as the phosphorylation levels of Erk1-2 and Akt. Pharmacologic and genetic inhibition of Notch largely blocked the hypoxic induction of invasion as did the pharmacologic suppression of Erk1-2 activity. In addition, the increase in Erk1-2 and Akt phosphorylation by hypoxia was partially reduced by inhibiting Notch signaling. Our findings support the functional importance of HIF-1 alpha signaling in promoting the invasive capacity of uveal melanoma cells in both hypoxia and normoxia, and suggest that pharmacologically targeting HIF-1 alpha pathway directly or through blockade of Notch or Erk1-2 pathways can slow tumor spread.	[Asnaghi, Laura; Lin, Michael H.; Lim, Kah Suan; Lim, Kah Jing; Tripathy, Arushi; Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Wendeborn, Murilo; Merbs, Shannath L.; Handa, James T.; Sodhi, Akrit; Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Merbs, Shannath L.; Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Bar, Eli E.] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Case Western Reserve University	Asnaghi, L (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	lasnagh1@jhmi.edu	Junior, Murilo Wendeborn Rodrigues/M-4125-2019; Rodrigues, Murilo/F-1684-2014	Rodrigues, Murilo/0000-0001-9734-8617	Research to Prevent Blindness; ABB Foundation; Moriarity fund; NATIONAL EYE INSTITUTE [K08EY021189] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ABB Foundation; Moriarity fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Research to Prevent Blindness, the ABB Foundation and the Moriarity fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourbih DA, 2010, MELANOMA RES, V20, P97, DOI 10.1097/CMR.0b013e328336edfe; Abraham RT, 2003, CURR TOP MICROBIOL, V279, P299; Asnaghi L, 2013, INVEST OPHTH VIS SCI, V54, P295, DOI 10.1167/iovs.12-10209; Asnaghi L, 2012, CLIN CANCER RES, V18, P654, DOI 10.1158/1078-0432.CCR-11-1406; Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; Bedogni B, 2005, CANCER CELL, V8, P443, DOI 10.1016/j.ccr.2005.11.005; Bhutto IA, 2004, INVEST OPHTH VIS SCI, V45, P1544, DOI 10.1167/iovs.03-0862; Chang SH, 2008, MELANOMA RES, V18, P191, DOI 10.1097/CMR.0b013e3283005270; Cheli Y, 2012, ONCOGENE, V31, P2461, DOI 10.1038/onc.2011.425; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; DEWAARDSIEBINGA I, 1995, INT J CANCER, V62, P155, DOI 10.1002/ijc.2910620208; el Filali M, 2012, DEV OPHTHALMOL, V49, P117, DOI 10.1159/000329591; el Filali M, 2010, INVEST OPHTH VIS SCI, V51, P2329, DOI 10.1167/iovs.09-4739; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Eskelin S, 2000, OPHTHALMOLOGY, V107, P1443, DOI 10.1016/S0161-6420(00)00182-2; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Griewank KG, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00971.x; Harbour JW, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00979.x; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Ingeson-Carlsson C, 2014, EXP CELL RES; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; KANMITCHELL J, 1989, INVEST OPHTH VIS SCI, V30, P829; Kirschmann DA, 2002, CANCER RES, V62, P4478; Kuphal S, 2010, EUR J CANCER, V46, P1159, DOI 10.1016/j.ejca.2010.01.031; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Lewis HD, 2007, CHEM BIOL, V14, P209, DOI 10.1016/j.chembiol.2006.12.010; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Luyten GPM, 1996, INT J CANCER, V66, P380, DOI 10.1002/(SICI)1097-0215(19960503)66:3<380::AID-IJC19>3.0.CO;2-F; MA D, 1995, IMMUNOLOGY, V86, P263; Maat W, 2009, BRIT J CANCER, V101, P312, DOI 10.1038/sj.bjc.6605172; Maat W, 2007, ARCH PATHOL LAB MED, V131, P91; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Mouriaux F, 2014, INVEST OPHTH VIS SCI, V55, P1277, DOI 10.1167/iovs.13-13345; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Onken MD, 2012, OPHTHALMOLOGY, V119, P1596, DOI 10.1016/j.ophtha.2012.02.017; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Pietras A, 2011, MOL CANCER RES, V9, P626, DOI 10.1158/1541-7786.MCR-10-0508; Prescher G, 1996, LANCET, V347, P1222; Rao W, 2014, CARCINOGENESIS, V35, P1573, DOI 10.1093/carcin/bgu070; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Schoenfield L, 2009, ARCH PATHOL LAB MED, V133, P1219, DOI 10.1043/1543-2165-133.8.1219; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shields CL, 2007, OPHTHALMOLOGY, V114, P1919, DOI 10.1016/j.ophtha.2007.04.054; Shields CL, 2009, ARCH OPHTHALMOL-CHIC, V127, P989, DOI 10.1001/archophthalmol.2009.208; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Tschentscher F, 2003, CANCER RES, V63, P2578; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Verbik DJ, 1997, INT J CANCER, V73, P470, DOI 10.1002/(SICI)1097-0215(19971114)73:4<470::AID-IJC3>3.0.CO;2-X; Victor N, 2006, CLIN EXP METASTAS, V23, P87, DOI 10.1007/s10585-006-9024-z; Widmer DS, 2013, J INVEST DERMATOL, V133, P2436, DOI 10.1038/jid.2013.115; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105	56	48	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105372	10.1371/journal.pone.0105372	http://dx.doi.org/10.1371/journal.pone.0105372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166211	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303700025
J	Li, K; Wang, G; Andersen, T; Zhou, PZ; Pu, WT				Li, Kai; Wang, Gang; Andersen, Troels; Zhou, Pingzhu; Pu, William T.			Optimization of Genome Engineering Approaches with the CRISPR/Cas9 System	PLOS ONE			English	Article							SPECIFICITY; MUTATIONS; CELLS; CAS9; PURIFICATION; NUCLEASES; GENES; MICE	Designer nucleases such as TALENS and Cas9 have opened new opportunities to scarlessly edit the mammalian genome. Here we explored several parameters that influence Cas9-mediated scarless genome editing efficiency in murine embryonic stem cells. Optimization of transfection conditions and enriching for transfected cells are critical for efficiently recovering modified clones. Paired gRNAs and wild-type Cas9 efficiently create programmed deletions, which facilitate identification of targeted clones, while paired gRNAs and the Cas9D10A nickase generated smaller targeted indels with lower chance of off-target mutagenesis. Genome editing is also useful for programmed introduction of exogenous DNA sequences at a target locus. Increasing the length of the homology arms of the homology-directed repair template strongly enhanced targeting efficiency, while increasing the length of the DNA insert reduced it. Together our data provide guidance on optimal design of scarless gene knockout, modification, or knock-in experiments using Cas9 nuclease.	[Li, Kai; Wang, Gang; Zhou, Pingzhu; Pu, William T.] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Andersen, Troels] Univ Copenhagen, Copenhagen, Denmark; [Pu, William T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; University of Copenhagen; Harvard University	Pu, WT (corresponding author), Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA.	wpu@pulab.org	Pu, William/AAJ-8301-2020	Pu, William/0000-0002-4551-8079	National Institutes of Health National Heart Lung Blood Institute [U01HL098188, U01HL098166]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098188, U01HL098166] Funding Source: NIH RePORTER	National Institutes of Health National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health National Heart Lung Blood Institute U01HL098188 and U01HL098166. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hendel A, 2014, CELL REP, V7, P293, DOI 10.1016/j.celrep.2014.02.040; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Mali P, 2013, SCIENCE; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shen B, 2014, NAT METHODS; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zhidkov I, 2011, NUCLEIC ACIDS RES, V39, pE47, DOI 10.1093/nar/gkq1354; Zhou PZ, 2013, P NATL ACAD SCI USA, V110, P15395, DOI 10.1073/pnas.1304124110	18	90	106	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105779	10.1371/journal.pone.0105779	http://dx.doi.org/10.1371/journal.pone.0105779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166277	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303700042
J	Chang, W; Wei, K; Ho, L; Berry, GJ; Jacobs, SS; Chang, CH; Rosen, GD				Chang, Wenteh; Wei, Ke; Ho, Lawrence; Berry, Gerald J.; Jacobs, Susan S.; Chang, Cheryl H.; Rosen, Glenn D.			A Critical Role for the mTORC2 Pathway in Lung Fibrosis	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; HYDROGEN-PEROXIDE; INHIBITORS; AKT; PHOSPHORYLATION; TRIPTOLIDE; APOPTOSIS; EFFICACY; COMPLEX; GROWTH	A characteristic of dysregulated wound healing in IPF is fibroblastic-mediated damage to lung epithelial cells within fibroblastic foci. In these foci, TGF-beta and other growth factors activate fibroblasts that secrete growth factors and matrix regulatory proteins, which activate a fibrotic cascade. Our studies and those of others have revealed that Akt is activated in IPF fibroblasts and it mediates the activation by TGF-beta of pro-fibrotic pathways. Recent studies show that mTORC2, a component of the mTOR pathway, mediates the activation of Akt. In this study we set out to determine if blocking mTORC2 with MLN0128, an active site dual mTOR inhibitor, which blocks both mTORC1 and mTORC2, inhibits lung fibrosis. We examined the effect of MLN0128 on TGF-beta-mediated induction of stromal proteins in IPF lung fibroblasts; also, we looked at its effect on TGF-beta-mediated epithelial injury using a Transwell co-culture system. Additionally, we assessed MLN0128 in the murine bleomycin lung model. We found that TGF-beta induces the Rictor component of mTORC2 in IPF lung fibroblasts, which led to Akt activation, and that MLN0128 exhibited potent anti-fibrotic activity in vitro and in vivo. Also, we observed that Rictor induction is Akt-mediated. MLN0128 displays multiple anti-fibrotic and lung epithelial-protective activities; it (1) inhibited the expression of pro-fibrotic matrix-regulatory proteins in TGF-beta-stimulated IPF fibroblasts; (2) inhibited fibrosis in a murine bleomycin lung model; and (3) protected lung epithelial cells from injury caused by TGF-beta-stimulated IPF fibroblasts. Our findings support a role for mTORC2 in the pathogenesis of lung fibrosis and for the potential of active site mTOR inhibitors in the treatment of IPF and other fibrotic lung diseases.	[Chang, Wenteh; Wei, Ke; Jacobs, Susan S.; Chang, Cheryl H.; Rosen, Glenn D.] Stanford Univ, Sch Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Ho, Lawrence] Univ Washington, Sch Med, Div Pulm & Crit Care Med, Seattle, WA USA; [Berry, Gerald J.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; University of Washington; University of Washington Seattle; Stanford University	Rosen, GD (corresponding author), Stanford Univ, Sch Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA.	grosen@stanford.edu		Berry, Gerald/0000-0002-6176-2629; CHANG, CHERYL/0000-0001-7810-0501	Takeda Corporation	Takeda Corporation	This work was supported by a grant from the Takeda Corporation. The funders had no role in data collection, and analysis or decision to publish. They did provide MLN-0128, made suggestions about its formulation for animal studies, and proofread the manuscript.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Ask Kjetil, 2006, Proc Am Thorac Soc, V3, P389, DOI 10.1513/pats.200602-021TK; Bhagwat SV, 2010, CURR OPIN INVEST DR, V11, P638; Chang W, 2010, J BIOL CHEM, V285, P8196, DOI 10.1074/jbc.M109.025684; Chang WT, 2001, J BIOL CHEM, V276, P2221, DOI 10.1074/jbc.M009713200; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Gan XQ, 2012, NAT CELL BIOL, V14, P686, DOI 10.1038/ncb2507; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Gokmen-Polar Y, 2012, BREAST CANCER RES TR, V136, P673, DOI 10.1007/s10549-012-2298-8; Goncharov D.A., 2013, CIRCULATION; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guo Y, 2013, MOL CANC RES MCR; Huang SK, 2009, FASEB J; Janes MR, 2013, LEUKEMIA, V27, P586, DOI 10.1038/leu.2012.276; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Krishna G, 2001, AM J PATHOL, V158, P997, DOI 10.1016/S0002-9440(10)64046-1; Lee HS, 2012, TRANSPL P, V44, P161, DOI 10.1016/j.transproceed.2011.11.059; Li Y., 2013, J BIOL CHEM; Malouf MA, 2011, RESPIROLOGY, V16, P776, DOI 10.1111/j.1440-1843.2011.01955.x; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Oneyama C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080300; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Peng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059348; Proud CG, 2009, BIOCHEM SOC T, V37, P227, DOI 10.1042/BST0370227; Richard DJ, 2010, CURR OPIN DRUG DISC, V13, P428; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Rodriguez-Pascual J, 2010, ANTI-CANCER DRUG, V21, P478, DOI 10.1097/CAD.0b013e32833760bf; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Serrano I, 2013, ONCOGENE, V32, P50, DOI 10.1038/onc.2012.30; Shibata S, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-6; Stumpf CR, 2013, MOL CELL, V52, P574, DOI 10.1016/j.molcel.2013.09.018; Syed F, 2012, AM J PATHOL, V181, P1642, DOI 10.1016/j.ajpath.2012.08.006; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Waghray M, 2005, FASEB J, V19, P854, DOI 10.1096/fj.04-2882fje; Wilson-Edell KA, 2014, BREAST CANCER RES TR, V144, P287, DOI 10.1007/s10549-014-2877-y; Xia H, 2010, AM J PATHOL, V176, P2626, DOI 10.2353/ajpath.2010.091117; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391; Zisman DA, 2005, METH MOLEC MED, V117, P3	42	39	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106155	10.1371/journal.pone.0106155	http://dx.doi.org/10.1371/journal.pone.0106155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162417	gold, Green Published, Green Submitted			2022-12-25	WOS:000340880900092
J	Lim, RS; Eyjolfsdottir, E; Shin, E; Perona, P; Anderson, DJ				Lim, Rod S.; Eyjolfsdottir, Eyrun; Shin, Euncheol; Perona, Pietro; Anderson, David J.			How Food Controls Aggression in Drosophila	PLOS ONE			English	Article							MALE COURTSHIP; RECEPTOR NEURONS; MELANOGASTER; BEHAVIOR; PHEROMONE; TERRITORIALITY; RECOGNITION; EXPERIENCE; EXPRESSION; DOMINANCE	How animals use sensory information to weigh the risks vs. benefits of behavioral decisions remains poorly understood. Inter-male aggression is triggered when animals perceive both the presence of an appetitive resource, such as food or females, and of competing conspecific males. How such signals are detected and integrated to control the decision to fight is not clear. For instance, it is unclear whether food increases aggression directly, or as a secondary consequence of increased social interactions caused by attraction to food. Here we use the vinegar fly, Drosophila melanogaster, to investigate the manner by which food influences aggression. We show that food promotes aggression in flies, and that it does so independently of any effect on frequency of contact between males, increase in locomotor activity or general enhancement of social interactions. Importantly, the level of aggression depends on the absolute amount of food, rather than on its surface area or concentration. When food resources exceed a certain level, aggression is diminished, suggestive of reduced competition. Finally, we show that detection of sugar via Gr5a(+) gustatory receptor neurons (GRNs) is necessary for food-promoted aggression. These data demonstrate that food exerts a specific effect to promote aggression in male flies, and that this effect is mediated, at least in part, by sweet-sensing GRNs.	[Lim, Rod S.; Anderson, David J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Lim, Rod S.; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Eyjolfsdottir, Eyrun; Perona, Pietro] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Shin, Euncheol] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; California Institute of Technology	Anderson, DJ (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	wuwei@caltech.edu	Shin, Euncheol/Q-7644-2018	Shin, Euncheol/0000-0002-6053-4050	National Institutes of Health (NIH) [NIH-NRSA5T32GM07616, T32 GM007616]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031389] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by funding from the National Institutes of Health (NIH), Code: NIH-NRSA5T32GM07616, Grant/Project #: T32 GM007616, Grant/Project Title: PREDOCTORAL TRAINING IN BIOLOGY AND CHEMISTRY. This study was supported by the funding from the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams E, 2001, ANN REV ECOLOGY SYST; [Anonymous], CORNM SUCR DEXTR YEA; [Anonymous], 2011, USDA NAT NUTR DAT ST; ANTONY C, 1982, J INSECT PHYSIOL, V28, P873, DOI 10.1016/0022-1910(82)90101-9; ARMSTRONG DP, 1991, BEHAV ECOL SOCIOBIOL, V29, P103, DOI 10.1007/BF00166484; Asahina K, 2014, CELL, V156, P221, DOI 10.1016/j.cell.2013.11.045; Billeter JC, 2013, CURR OPIN NEUROBIOL, V23, P17, DOI 10.1016/j.conb.2012.08.009; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Certel SJ, 2007, P NATL ACAD SCI USA, V104, P4706, DOI 10.1073/pnas.0700328104; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; COBB M, 1990, ANIM BEHAV, V39, P1058, DOI 10.1016/S0003-3472(05)80778-X; Cummins SF, 2011, CURR BIOL, V21, P322, DOI 10.1016/j.cub.2011.01.038; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Fernandez MD, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000541; Dethier V. G., 1976, HUNGRY FLY PHYSL STU; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; Fan P, 2013, CELL, V154, P89, DOI 10.1016/j.cell.2013.06.008; Fernandez MP, 2013, J COMP PHYSIOL A, V199, P1065, DOI 10.1007/s00359-013-0851-5; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Gray SJ, 2002, ANIM BEHAV, V63, P531, DOI 10.1006/anbe.2001.1932; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; Guerra PA, 2005, ETHOLOGY, V111, P626, DOI 10.1111/j.1439-0310.2005.01086.x; Harris TR, 2010, ANIM BEHAV, V79, P89, DOI 10.1016/j.anbehav.2009.10.007; Hixon MA, 1983, AM NAT; HOFFMANN AA, 1987, ANIM BEHAV, V35, P807, DOI 10.1016/S0003-3472(87)80117-3; HOFFMANN AA, 1990, ANIM BEHAV, V40, P526, DOI 10.1016/S0003-3472(05)80533-0; HOLLDOBLER B, 1980, SCIENCE, V210, P732, DOI 10.1126/science.210.4471.732; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Inagaki HK, 2014, NAT METHODS, V11, P325, DOI [10.1038/nmeth.2765, 10.1038/NMETH.2765]; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; JACOBS ME, 1960, ECOLOGY, V41, P182, DOI 10.2307/1931952; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Keene AC, 2012, NEUROSCIENCE, V222, P173, DOI 10.1016/j.neuroscience.2012.07.028; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Leopold LF, 2011, SPECTROSC-BIOMED APP, V26, P93, DOI 10.1155/2011/285890; Lewis EB, 1960, LEWIS NEW STANDARD F; Lone SR, 2012, J BIOL RHYTHM, V27, P107, DOI 10.1177/0748730411434384; Lu BK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002587; Manzo A, MOTOR NEURONS CONTRO; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Maynard Smith J., 1973, NATURE; Mundiyanapurath Sibu, 2007, J Vis Exp, P155, DOI 10.3791/155; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; Pikielny CW, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003555; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Rypstra AL, 2009, ANIM BEHAV, V77, P937, DOI 10.1016/j.anbehav.2008.12.026; Santangelo N, 2002, BEHAV ECOLOGY; Schwartz NU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037910; Simon JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008793; Skrzipek K, 1979, AGGRESSION BEI DROSO; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; Starostina E, 2012, J NEUROSCI, V32, P4665, DOI 10.1523/JNEUROSCI.6178-11.2012; Svetec N, 2005, CURR BIOL, V15, pR790, DOI 10.1016/j.cub.2005.09.034; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; Toda H, 2012, CELL REP; Toda H, 2012, CELL REP, V1, P599, DOI 10.1016/j.celrep.2012.05.007; Ueda A, 2002, PHYSIOL ENTOMOL, V27, P21, DOI 10.1046/j.1365-3032.2002.00262.x; van Swinderen B, 2003, BEHAV PROCESSES; Vijayan V, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004238; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wang LM, 2008, P NATL ACAD SCI USA, V105, P5657, DOI 10.1073/pnas.0801327105; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Watanabe K, 2011, BEHAV GENET, V41, P746, DOI 10.1007/s10519-011-9461-6; Yuan Q, 2014, NAT NEUROSCI, V17, P81, DOI 10.1038/nn.3581; Zhang YV, 2013, NAT NEUROSCI, V16, P1468, DOI 10.1038/nn.3513; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	76	34	34	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105626	10.1371/journal.pone.0105626	http://dx.doi.org/10.1371/journal.pone.0105626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162609	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000340880900039
J	Melo, GC; Monteiro, WM; Siqueira, AM; Silva, SR; Magalhaes, BML; Alencar, ACC; Kuehn, A; del Portillo, HA; Fernandez-Becerra, C; Lacerda, MVG				Melo, Gisely C.; Monteiro, Wuelton M.; Siqueira, Andre M.; Silva, Siuhelem R.; Magalhaes, Belisa M. L.; Alencar, Aline C. C.; Kuehn, Andrea; del Portillo, Hernando A.; Fernandez-Becerra, Carmen; Lacerda, Marcus V. G.			Expression Levels of pvcrt-o and pvmdr-1 Are Associated with Chloroquine Resistance and Severe Plasmodium vivax Malaria in Patients of the Brazilian Amazon	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PAPUA-NEW-GUINEA; FALCIPARUM; GENES; PARASITES; PFCRT; CHEMORESISTANCE; INDONESIA; EFFICACY; DISEASE	Molecular markers associated with the increase of chloroquine resistance and disease severity in Plasmodium vivax are needed. The objective of this study was to evaluate the expression levels of pvcrt-o and pvmdr-1 genes in a group of patients presenting CQRPv and patients who developed severe complications triggered exclusively by P. vivax infection. Two different sets of patients were included to this comprehensive study performed in the Brazilian Amazon: 1) patients with clinically characterized chloroquine-resistant P. vivax compared with patients with susceptible parasites from in vivo studies and 2) patients with severe vivax malaria compared with patients without severity. Quantitative real-time PCR was performed to compare the transcript levels of two main transporters genes, P. vivax chloroquine resistance transporter (pvcrt-o) and the P. vivax multidrug resistance transporter (pvmdr-1). Twelve chloroquine resistant cases and other 15 isolates from susceptible cases were included in the first set of patients. For the second set, seven patients with P. vivax-attributed severe and 10 mild manifestations were included. Parasites from patients with chloroquine resistance presented up to 6.1 (95% CI: 3.8-14.3) and 2.4 (95% CI: 0.53-9.1) fold increase in pvcrt-o and pvmdr-1 expression levels, respectively, compared to the susceptible group. Parasites from the severe vivax group had a 2.9 (95% CI: 1.1-8.3) and 4.9 (95% CI: 2.3-18.8) fold increase in pvcrt-o and pvmdr-1 expression levels as compared to the control group with mild disease. These findings suggest that chloroquine resistance and clinical severity in P. vivax infections are strongly associated with increased expression levels of the pvcrt-o and pvmdr-1 genes likely involved in chloroquine resistance.	[Melo, Gisely C.; Monteiro, Wuelton M.; Siqueira, Andre M.; Magalhaes, Belisa M. L.; Alencar, Aline C. C.; Lacerda, Marcus V. G.] Univ Estado Amazonas, Manaus, Amazonas, Brazil; [Monteiro, Wuelton M.; Kuehn, Andrea; Lacerda, Marcus V. G.] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Silva, Siuhelem R.] Univ Paulista, UNIP, Manaus, Amazonas, Brazil; [Kuehn, Andrea; del Portillo, Hernando A.; Fernandez-Becerra, Carmen] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, CRESIB, Barcelona, Spain; [del Portillo, Hernando A.] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain	Universidade do Estado do Amazonas; Universidade Paulista; ISGlobal; CRESIB; University of Barcelona; ICREA	Fernandez-Becerra, C (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, CRESIB, Barcelona, Spain.	carmen.fernandez@cresib.cat; marcuslacerda.br@gmail.com	Fernandez Becerra, Carmen/L-2069-2014; melo, gisely/GZK-5350-2022; Siqueira, Andre M/G-1340-2010; del Portillo Obando, Hernando A/L-2131-2014	Fernandez Becerra, Carmen/0000-0001-5154-0013; Siqueira, Andre M/0000-0003-2208-0294; del Portillo Obando, Hernando A/0000-0002-5278-3452	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [575788/2008-9]; Strategic Program for Science, Technology & Innovation of FAPEAM (PECTI-SAUDE); National Council for Scientific and Technological Development (CNPq); ICREA Funding Source: Custom	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Strategic Program for Science, Technology & Innovation of FAPEAM (PECTI-SAUDE); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ICREA(ICREA)	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (grant number 575788/2008-9). CFB received a visiting fellowship from the Strategic Program for Science, Technology & Innovation of FAPEAM (PECTI-SAUDE). MVGL has a Level 1 Productivity Fellowship from the National Council for Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alecrim MdG, 1999, REV SOC BRAS MED TRO, V32, P67; Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685; [Anonymous], 2012, MAN SEV MAL PRACT HD; Baird JK, 2011, ANTIMICROB AGENTS CH, V55, P1827, DOI 10.1128/AAC.01296-10; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; BAIRD JK, 1991, AM J TROP MED HYG, V44, P547, DOI 10.4269/ajtmh.1991.44.547; Barnadas C, 2008, ANTIMICROB AGENTS CH, V52, P4233, DOI 10.1128/AAC.00578-08; Brega S, 2005, J INFECT DIS, V191, P272, DOI 10.1086/426830; Lanca EFC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035406; Chotivanich K, 2000, J INFECT DIS, V181, P1206, DOI 10.1086/315353; Das S, 2013, AM J TROP MED HYG, V88, P828, DOI 10.4269/ajtmh.11-0795; Epidemiologica D d V, 2009, MANUAL DIAGNOSTICO L; Fernandez-Becerra C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-55; de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386; Gama BE, 2011, MEM I OSWALDO CRUZ, V106, P159, DOI 10.1590/S0074-02762011000900020; Gama BE, 2009, MEM I OSWALDO CRUZ, V104, P1009, DOI 10.1590/S0074-02762009000700012; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Lacerda MVG, 2012, CLIN INFECT DIS, V55, pE67, DOI 10.1093/cid/cis615; Lacerda MVG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marfurt J, 2007, AM J TROP MED HYG, V77, P947, DOI 10.4269/ajtmh.2007.77.947; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Naing C, 2010, T ROY SOC TROP MED H, V104, P695, DOI 10.1016/j.trstmh.2010.08.009; Ngo T, 2003, AM J TROP MED HYG, V68, P350, DOI 10.4269/ajtmh.2003.68.350; Nomura T, 2001, J INFECT DIS, V183, P1653, DOI 10.1086/320707; Orjuela-Sanchez P, 2009, ANTIMICROB AGENTS CH, V53, P3561, DOI 10.1128/AAC.00004-09; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Reilly HB, 2007, INT J PARASITOL, V37, P1599, DOI 10.1016/j.ijpara.2007.05.003; RIECKMANN KH, 1989, LANCET, V2, P1183, DOI 10.1016/S0140-6736(89)91792-3; Ruebush TK, 2003, AM J TROP MED HYG, V69, P548, DOI 10.4269/ajtmh.2003.69.548; Russell B, 2008, ANTIMICROB AGENTS CH, V52, P1040, DOI 10.1128/AAC.01334-07; Sa JM, 2006, MOL BIOCHEM PARASIT, V150, P219, DOI 10.1016/j.molbiopara.2006.08.006; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Soto J, 2001, AM J TROP MED HYG, V65, P90, DOI 10.4269/ajtmh.2001.65.90; Suwanarusk R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001089; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Vargas-Rodriguez R D, 2012, AM J TROP MED HYG; WHO, 2006, GUID TREATM MAL; WHO, 2010, MAL REP 2010	39	50	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105922	10.1371/journal.pone.0105922	http://dx.doi.org/10.1371/journal.pone.0105922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157811	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200077
J	Sanchez, C; Bueno-Orovio, A; Wettwer, E; Loose, S; Simon, J; Ravens, U; Pueyo, E; Rodriguez, B				Sanchez, Carlos; Bueno-Orovio, Alfonso; Wettwer, Erich; Loose, Simone; Simon, Jana; Ravens, Ursula; Pueyo, Esther; Rodriguez, Blanca			Inter-Subject Variability in Human Atrial Action Potential in Sinus Rhythm versus Chronic Atrial Fibrillation	PLOS ONE			English	Article							CELLULAR ELECTROPHYSIOLOGY; MATHEMATICAL-MODEL; CARDIAC REPOLARIZATION; SENSITIVITY-ANALYSIS; NA+/CA2+ EXCHANGER; OUTWARD CURRENTS; IONIC MECHANISMS; SYSTEMS BIOLOGY; I-KUR; ALTERNANS	Aims: Human atrial electrophysiology exhibits high inter-subject variability in both sinus rhythm (SR) and chronic atrial fibrillation (cAF) patients. Variability is however rarely investigated in experimental and theoretical electrophysiological studies, thus hampering the understanding of its underlying causes but also its implications in explaining differences in the response to disease and treatment. In our study, we aim at investigating the ability of populations of human atrial cell models to capture the inter-subject variability in action potential (AP) recorded in 363 patients both under SR and cAF conditions. Methods and Results: Human AP recordings in atrial trabeculae (n = 469) from SR and cAF patients were used to calibrate populations of computational SR and cAF atrial AP models. Three populations of over 2000 sampled models were generated, based on three different human atrial AP models. Experimental calibration selected populations of AP models yielding AP with morphology and duration in range with experimental recordings. Populations using the three original models can mimic variability in experimental AP in both SR and cAF, with median conductance values in SR for most ionic currents deviating less than 30% from their original peak values. All cAF populations show similar variations in G(K1), G(Kur) and G(to), consistent with AF-related remodeling as reported in experiments. In all SR and cAF model populations, inter-subject variability in I-K1 and I-NaK underlies variability in APD(90), variability in I-Kur, I-CaL and I-NaK modulates variability in APD(50) and combined variability in I-to and I-Kur determines variability in APD(20). The large variability in human atrial AP triangulation is mostly determined by I-K1 and either I-NaK or I-NaCa depending on the model. Conclusion: Experimentally-calibrated human atrial AP models populations mimic AP variability in SR and cAF patient recordings, and identify potential ionic determinants of inter-subject variability in human atrial AP duration and morphology in SR versus cAF.	[Sanchez, Carlos; Pueyo, Esther] Univ Zaragoza, Aragon Inst Engn Res I3A, Biosignal Interpretat & Computat Simulat BSICoS, Zaragoza, Spain; [Sanchez, Carlos; Pueyo, Esther] Univ Zaragoza, Aragon Hlth Res Inst IIS, Zaragoza, Spain; [Sanchez, Carlos; Pueyo, Esther] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Zaragoza, Spain; [Sanchez, Carlos; Bueno-Orovio, Alfonso; Rodriguez, Blanca] Univ Oxford, Dept Comp Sci, Oxford, England; [Wettwer, Erich; Loose, Simone; Simon, Jana; Ravens, Ursula] Tech Univ Dresden, Dept Pharmacol & Toxicol, Dresden, Germany	University of Zaragoza; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Oxford; Technische Universitat Dresden	Rodriguez, B (corresponding author), Univ Oxford, Dept Comp Sci, Oxford, England.	blanca.rodriguez@cs.ox.ac.uk	Sánchez, Carlos/C-8825-2012; Pueyo, Esther/C-6945-2009; Bueno-Orovio, Alfonso/K-7225-2013	Sánchez, Carlos/0000-0003-4273-5403; Pueyo, Esther/0000-0002-1960-407X; Bueno-Orovio, Alfonso/0000-0002-1634-3601; Rodriguez, Blanca/0000-0001-6361-3339	Ministerio de Economia y Competitividad, Spain [TEC2010-19410]; European Union 'EUTRAF' [FP7-HEALTH-261057]; Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences	Ministerio de Economia y Competitividad, Spain; European Union 'EUTRAF'; Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences(Wellcome Trust)	CS and EP: Grant TEC2010-19410 from Ministerio de Economia y Competitividad, Spain (http://www.mineco.es). EP: Ramon y Cajal program from Ministerio de Economia y Competitividad, Spain (http://www.mineco.es). EW, SL, JS and UR: European Union 'EUTRAF' Grant FP7-HEALTH-261057 (http://www.eutraf.eu). ABO and BR: BR's Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054635; Amos GJ, 1996, J PHYSIOL-LONDON, V491, P31, DOI 10.1113/jphysiol.1996.sp021194; Blaauw Y, 2004, CIRCULATION, V110, P1717, DOI 10.1161/01.CIR.0000143050.22291.2E; Britton OJ, 2013, P NATL ACAD SCI USA, V110, pE2098, DOI 10.1073/pnas.1304382110; Bueno-Orovio A, 2014, PFLUG ARCH EUR J PHY, V466, P183, DOI 10.1007/s00424-013-1293-1; Carusi A, 2012, AM J PHYSIOL-HEART C, V303, pH144, DOI 10.1152/ajpheart.01151.2011; Cherry EM, 2008, PROG BIOPHYS MOL BIO, V98, P24, DOI 10.1016/j.pbiomolbio.2008.05.002; Cherry EM, 2008, J THEOR BIOL, V254, P674, DOI 10.1016/j.jtbi.2008.06.030; Courtemanche M, 1999, CARDIOVASC RES, V42, P477, DOI 10.1016/S0008-6363(99)00034-6; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Davies MR, 2012, AM J PHYSIOL-HEART C, V302, pH1466, DOI 10.1152/ajpheart.00808.2011; Diaz ME, 2004, CIRC RES, V94, P650, DOI 10.1161/01.RES.0000119923.64774.72; Dobrev D, 2000, CIRCULATION, V102, P692, DOI 10.1161/01.CIR.102.6.692; Dossel O, 2012, MED BIOL ENG COMPUT, V50, P773, DOI 10.1007/s11517-012-0924-6; Feng JL, 1998, CIRC RES, V83, P541, DOI 10.1161/01.RES.83.5.541; FIREK L, 1995, CARDIOVASC RES, V30, P31, DOI 10.1016/0008-6363(95)00014-3; Forini F, 2004, THYROID, V14, P493, DOI 10.1089/1050725041517084; Franz MR, 2012, EUROPACE, V14, pV58, DOI 10.1093/europace/eus273; Gemmell P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090112; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; Gray DF, 1998, J PHARMACOL EXP THER, V284, P75; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Jost N, 2013, BRIT J PHARMACOL, V170, P768, DOI 10.1111/bph.12228; Kharche S, 2008, PROG BIOPHYS MOL BIO, V98, P186, DOI 10.1016/j.pbiomolbio.2008.10.010; Koller ML, 1998, AM J PHYSIOL-HEART C, V275, pH1635, DOI 10.1152/ajpheart.1998.275.5.H1635; Krueger MW, 2013, IEEE T MED IMAGING, V32, P73, DOI 10.1109/TMI.2012.2201948; Lindblad DS, 1996, AM J PHYSIOL-HEART C, V271, pH1666, DOI 10.1152/ajpheart.1996.271.4.H1666; Loose S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00026; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Maleckar MM, 2009, AM J PHYSIOL-HEART C, V297, pH1398, DOI 10.1152/ajpheart.00411.2009; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; Marder E, 2011, NAT NEUROSCI, V14, P133, DOI 10.1038/nn.2735; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Milberg P, 2012, HEART RHYTHM, V9, P570, DOI 10.1016/j.hrthm.2011.11.004; Nattel S, 2000, ANNU REV PHYSIOL, V62, P51, DOI 10.1146/annurev.physiol.62.1.51; Nygren A, 1998, CIRC RES, V82, P63; Office of Health Economics, 2009, EST DIR COSTS ATR FI; Pandit SV, 2005, BIOPHYS J, V88, P3806, DOI 10.1529/biophysj.105.060459; Piccini JP, 2009, J AM COLL CARDIOL, V54, P1089, DOI 10.1016/j.jacc.2009.04.085; Pruvot EJ, 2004, CIRC RES, V94, P1083, DOI 10.1161/01.RES.0000125629.72053.95; Pueyo E, 2011, BIOPHYS J, V101, P2892, DOI 10.1016/j.bpj.2011.09.060; Pueyo E, 2010, AM J PHYSIOL-HEART C, V298, pH1577, DOI 10.1152/ajpheart.00936.2009; Quinn TA, 2013, CARDIOVASC RES, V97, P601, DOI 10.1093/cvr/cvt003; Ramirez RJ, 2000, AM J PHYSIOL-HEART C, V279, pH1767, DOI 10.1152/ajpheart.2000.279.4.H1767; Ravens U, 2013, J PHYSIOL-LONDON, V591, P4087, DOI 10.1113/jphysiol.2013.256115; Romero L, 2011, PROG BIOPHYS MOL BIO, V107, P60, DOI 10.1016/j.pbiomolbio.2011.06.012; Romero L, 2009, AM J PHYSIOL-HEART C, V297, pH1436, DOI 10.1152/ajpheart.00263.2009; Sanchez C, 2012, AM J PHYSIOL-HEART C, V302, pH1146, DOI 10.1152/ajpheart.00668.2011; Sarkar AX, 2012, J PHYSIOL-LONDON, V590, P2555, DOI 10.1113/jphysiol.2011.223313; Sarkar AX, 2011, HEART RHYTHM, V8, P1749, DOI 10.1016/j.hrthm.2011.05.023; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Seemann G, 2006, PHILOS T R SOC A, V364, P1465, DOI 10.1098/rsta.2006.1781; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Sobie EA, 2011, IEEE ENG MED BIO, P4657, DOI 10.1109/IEMBS.2011.6091153; Syed Z, 2005, MED BIOL ENG COMPUT, V43, P561, DOI 10.1007/BF02351029; Tieleman RG, 1997, CIRCULATION, V95, P1945; Tobin AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006742; VanWagoner DR, 1997, CIRC RES, V80, P772; Walmsley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056359; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; Wettwer E, 2004, CIRCULATION, V110, P2299, DOI 10.1161/01.CIR.0000145155.60288.71; Wettwer E, 2013, CARDIOVASC RES, V98, P145, DOI 10.1093/cvr/cvt006; Wilhelms M, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00487; Xiao L, 2008, CIRCULATION, V118, P983, DOI 10.1161/CIRCULATIONAHA.107.758672; Yue LX, 1996, AM J PHYSIOL-HEART C, V270, pH2157, DOI 10.1152/ajpheart.1996.270.6.H2157	66	61	62	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105897	10.1371/journal.pone.0105897	http://dx.doi.org/10.1371/journal.pone.0105897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157495	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303200074
J	Santana, EA; Harrison, A; Zhang, XJ; Baker, BD; Kelly, BJ; White, P; Liu, YL; Munson, RS				Santana, Estevan A.; Harrison, Alistair; Zhang, Xinjun; Baker, Beth D.; Kelly, Benjamin J.; White, Peter; Liu, Yunlong; Munson, Robert S., Jr.			HrrF Is the Fur-Regulated Small RNA in Nontypeable Haemophilus influenzae	PLOS ONE			English	Article							GENERAL STRESS-RESPONSE; RYHB SMALL RNA; ESCHERICHIA-COLI; RIBONUCLEOTIDE REDUCTASE; NUCLEOTIDE-SEQUENCE; CHINCHILLA MODEL; OTITIS-MEDIA; IN-VIVO; IRON; EXPRESSION	Nontypeable Haemophilus influenzae (NTHi) are Gram-negative commensal bacteria that reside in the nasopharynx. NTHi can also cause multiple upper and lower respiratory tract diseases that include sinusitis, conjunctivitis, bronchitis, and otitis media. In numerous bacterial species the ferric uptake regulator (Fur) acts as a global regulator of iron homeostasis by negatively regulating the expression of iron uptake systems. However in NTHi strain 86-028NP and numerous other bacterial species there are multiple instances where Fur positively affects gene expression. It is known that many instances of positive regulation by Fur occur indirectly through a small RNA intermediate. However, no examples of small RNAs have been described in NTHi. Therefore we used RNA-Seq analysis to analyze the transcriptome of NTHi strain 86-028NPrpsL and an isogenic 86-028NPrpsL Delta fur strain to identify Fur-regulated intergenic transcripts. From this analysis we identified HrrF, the first small RNA described in any Haemophilus species. Orthologues of this small RNA exist only among other Pasteurellaceae. Our analysis showed that HrrF is maximally expressed when iron levels are low. Additionally, Fur was shown to bind upstream of the hrrF promoter. RNA-Seq analysis was used to identify targets of HrrF which include genes whose products are involved in molybdate uptake, deoxyribonucleotide synthesis, and amino acid biosynthesis. The stability of HrrF is not dependent on the RNA chaperone Hfq. This study is the first step in an effort to investigate the role small RNAs play in altering gene expression in response to iron limitation in NTHi.	[Santana, Estevan A.; Harrison, Alistair; Baker, Beth D.; Kelly, Benjamin J.; White, Peter; Munson, Robert S., Jr.] Res Inst Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Kelly, Benjamin J.; White, Peter] Res Inst Nationwide Childrens Hosp, Biomed Genom Core, Columbus, OH USA; [Santana, Estevan A.; Harrison, Alistair; Baker, Beth D.; Munson, Robert S., Jr.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Santana, Estevan A.; Munson, Robert S., Jr.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Zhang, Xinjun; Liu, Yunlong] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Indiana University System; Indiana University Bloomington	Munson, RS (corresponding author), Res Inst Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA.	robert.munson@nationwidechildrens.org	White, Peter/E-4301-2011	White, Peter/0000-0002-5218-5903	National Institute of Allergy and Infectious Diseases/National Institutes of Health [R01 A1077897]; The Ohio State University College of Medicine Systems in Integrative Biology Training Program; Dean's Graduate Enrichment Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026942] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); The Ohio State University College of Medicine Systems in Integrative Biology Training Program; Dean's Graduate Enrichment Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grant R01 A1077897 to RSM from the National Institute of Allergy and Infectious Diseases/National Institutes of Health. EAS was also supported by The Ohio State University College of Medicine Systems in Integrative Biology Training Program and the Dean's Graduate Enrichment Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe JJ, 2012, MOL ORAL MICROBIOL, V27, P327, DOI 10.1111/j.2041-1014.2012.00645.x; Andrews SC, 2011, MOL MICROBIOL, V80, P286, DOI 10.1111/j.1365-2958.2011.07594.x; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; BAGG A, 1987, BIOCHEMISTRY-US, V26, P5471, DOI 10.1021/bi00391a039; Bakaletz LO, 1997, VACCINE, V15, P955, DOI 10.1016/S0264-410X(96)00298-8; BAKALETZ LO, 1988, INFECT IMMUN, V56, P331, DOI 10.1128/IAI.56.2.331-335.1988; Boor KJ, 2006, PLOS BIOL, V4, P18, DOI 10.1371/journal.pbio.0040023; Breese MR, 2013, BIOINFORMATICS, V29, P494, DOI 10.1093/bioinformatics/bts731; Busch A, 2008, BIOINFORMATICS, V24, P2849, DOI 10.1093/bioinformatics/btn544; Carpenter BM, 2013, J BACTERIOL, V195, P5526, DOI 10.1128/JB.01026-13; Carruthers MD, 2012, J BACTERIOL, V194, P1927, DOI 10.1128/JB.06540-11; Coleman HN, 2003, J CLIN MICROBIOL, V41, P4408, DOI 10.1128/JCM.41.9.4408-4410.2003; Davis BM, 2005, J BACTERIOL, V187, P4005, DOI 10.1128/JB.187.12.4005-4014.2005; De Lay N, 2013, J BIOL CHEM, V288, P7996, DOI 10.1074/jbc.R112.441386; Delany I, 2004, MOL MICROBIOL, V52, P1081, DOI 10.1111/j.1365-2958.2004.04030.x; Deng ZL, 2012, RES MICROBIOL, V163, P413, DOI 10.1016/j.resmic.2012.05.006; DIXON LG, 1994, PLASMID, V32, P228, DOI 10.1006/plas.1994.1060; Ducey TF, 2009, MICROB PATHOGENESIS, V46, P166, DOI 10.1016/j.micpath.2008.12.003; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Harrison A, 2005, J BACTERIOL, V187, P4627, DOI 10.1128/JB.187.13.4627-4636.2005; Harrison A, 2013, INFECT IMMUN, V81, P1221, DOI 10.1128/IAI.01227-12; Hasan AA, 1997, FEMS MICROBIOL LETT, V150, P19, DOI 10.1016/S0378-1097(97)00089-X; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Hempel RJ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-134; Hengge-Aronis R, 2002, J MOL MICROB BIOTECH, V4, P341; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hoberman A, 2011, NEW ENGL J MED, V364, P105, DOI 10.1056/NEJMoa0912254; Huang SH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-148; HUMBERT R, 1980, J BACTERIOL, V142, P212, DOI 10.1128/JB.142.1.212-220.1980; Jacques JF, 2006, MOL MICROBIOL, V62, P1181, DOI 10.1111/j.1365-2958.2006.05439.x; Johnston JW, 2009, CURR PROTOC MICROBIO; Jung YS, 2008, CURR MICROBIOL, V57, P593, DOI 10.1007/s00284-008-9248-z; KOLLING R, 1985, J BACTERIOL, V164, P310; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Marles-Wright J, 2007, CURR OPIN STRUC BIOL, V17, P755, DOI 10.1016/j.sbi.2007.08.004; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; Mason KM, 2006, MOL MICROBIOL, V62, P1357, DOI 10.1111/j.1365-2958.2006.05460.x; Mason KM, 2005, INFECT IMMUN, V73, P599, DOI 10.1128/IAI.73.1.599-608.2005; Mason KM, 2003, INFECT IMMUN, V71, P3454, DOI 10.1128/IAI.71.6.3454-3462.2003; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Mellin JR, 2007, J BACTERIOL, V189, P3686, DOI 10.1128/JB.01890-06; Mellin JR, 2010, MICROBIOL-SGM, V156, P2316, DOI 10.1099/mic.0.039040-0; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; MORTON DJ, 1993, INFECT IMMUN, V61, P4033, DOI 10.1128/IAI.61.10.4033-4037.1993; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Murphy ER, 2007, INFECT IMMUN, V75, P3470, DOI 10.1128/IAI.00112-07; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; Nikolayeva O, 2014, METHODS MOL BIOL, V1150, P45, DOI 10.1007/978-1-4939-0512-6_3; Oglesby AG, 2005, MOL MICROBIOL, V58, P1354, DOI 10.1111/j.1365-2958.2005.04920.x; Oglesby-Sherrouse AG, 2013, METALLOMICS, V5, P276, DOI 10.1039/c3mt20224k; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Poje Grant, 2003, Methods Mol Med, V71, P57; Prevost K, 2007, MOL MICROBIOL, V64, P1260, DOI 10.1111/j.1365-2958.2007.05733.x; Raghavan R, 2011, GENOME RES, V21, P1487, DOI 10.1101/gr.119370.110; Read TD, 1997, MOL MICROBIOL, V23, P627, DOI 10.1046/j.1365-2958.1997.d01-1862.x; Read TD, 2000, INFECT IMMUN, V68, P6896, DOI 10.1128/IAI.68.12.6896-6902.2000; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Sauer E, 2013, RNA BIOL, V10, P610, DOI 10.4161/rna.24201; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Storz G, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P157; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tracy E, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-101; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101	70	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105644	10.1371/journal.pone.0105644	http://dx.doi.org/10.1371/journal.pone.0105644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157846	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303200042
J	Vorobieva, AA; Khan, MS; Soumillion, P				Vorobieva, Anastassia A.; Khan, Mohammad Shahneawz; Soumillion, Patrice			Escherichia coli D-Malate Dehydrogenase, a Generalist Enzyme Active in the Leucine Biosynthesis Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-MALIC ENZYME; ISOCITRATE DEHYDROGENASE; HOMOISOCITRATE DEHYDROGENASE; TARTRATE DEHYDROGENASE; THERMUS-THERMOPHILUS; 3-ISOPROPYLMALATE DEHYDROGENASE; SUBSTRATE-SPECIFICITY; ALKALINE-PHOSPHATASE; CRYSTAL-STRUCTURE; EVOLUTION	The enzymes of the beta-decarboxylating dehydrogenase superfamily catalyze the oxidative decarboxylation of D-malate-based substrates with various specificities. Here, we show that, in addition to its natural function affording bacterial growth on D-malate as a carbon source, the D-malate dehydrogenase of Escherichia coli (EcDmlA) naturally expressed from its chromosomal gene is capable of complementing leucine auxotrophy in a leuB(-) strain lacking the paralogous isopropylmalate dehydrogenase enzyme. To our knowledge, this is the first example of an enzyme that contributes with a physiologically relevant level of activity to two distinct pathways of the core metabolism while expressed from its chromosomal locus. EcDmlA features relatively high catalytic activity on at least three different substrates (L(+)-tartrate, D-malate, and 3-isopropylmalate). Because of these properties both in vivo and in vitro, EcDmlA may be defined as a generalist enzyme. Phylogenetic analysis highlights an ancient origin of DmlA, indicating that the enzyme has maintained its generalist character throughout evolution. We discuss the implication of these findings for protein evolution.	[Vorobieva, Anastassia A.; Soumillion, Patrice] Catholic Univ Louvain, Inst Sci Vie, Lab Biochim Biophys & Genet Microorganismes BBGM, B-1348 Louvain, Belgium; [Khan, Mohammad Shahneawz] Univ Dhaka, Dept Fisheries, Dhaka 1000, Bangladesh	Universite Catholique Louvain; University of Dhaka	Soumillion, P (corresponding author), UCLouvain, Inst Life Sci, Croix Sud 4-5,Box L7-07-06, B-1348 Louvain, Belgium.	patrice.soumillion@uclouvain.be		Vorobieva, Anastassia/0000-0001-5554-1398; Khan, Mohammad Shahneawz/0000-0002-0141-1827; Akter, Mosammat Salma/0000-0002-2704-7701	Belgian Fonds National de la Recherche Scientifique (FNRS); Belgian "Inter-university Attraction Poles" Program [P7/44 iPROS]	Belgian Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Belgian "Inter-university Attraction Poles" Program(Belgian Federal Science Policy Office)	This work was supported by a research assistant fellowship from the Belgian Fonds National de la Recherche Scientifique (FNRS) and by Belgian "Inter-university Attraction Poles" Program Project P7/44 iPROS.	Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Chen RD, 2000, PROTEIN SCI, V9, P2344, DOI 10.1110/ps.9.12.2344; Copley SD, 2012, J BIOL CHEM, V287, P3, DOI 10.1074/jbc.R111.254714; CROUZET P, 1995, J BACTERIOL, V177, P6518, DOI 10.1128/jb.177.22.6518-6526.1995; D'Ari R, 1998, BIOESSAYS, V20, P181, DOI 10.1002/(SICI)1521-1878(199802)20:2<181::AID-BIES10>3.3.CO;2-6; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dean AM, 1996, PROTEIN SCI, V5, P341; DEAN AM, 1989, J BIOL CHEM, V264, P20482; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Fedoy AE, 2007, J MOL BIOL, V372, P130, DOI 10.1016/j.jmb.2007.06.040; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GIFFHORN F, 1983, J BACTERIOL, V155, P281, DOI 10.1128/JB.155.1.281-290.1983; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; Goncalves S, 2012, BIOCHEMISTRY-US, V51, P7098, DOI 10.1021/bi300483w; Graczer E, 2011, MOL BIOSYST, V7, P1646, DOI 10.1039/c0mb00346h; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Huang RQ, 2012, P NATL ACAD SCI USA, V109, P2966, DOI 10.1073/pnas.1019605109; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jin JL, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-6; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; KNICHEL W, 1982, EUR J BIOCHEM, V123, P547; Lin Y, 2008, BIOCHEMISTRY-US, V47, P10809, DOI 10.1021/bi801370h; Lukas H, 2010, J BACTERIOL, V192, P2503, DOI 10.1128/JB.01665-09; Malik R, 2010, ACTA CRYSTALLOGR D, V66, P673, DOI 10.1107/S0907444910008851; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; McLoughlin SY, 2008, P NATL ACAD SCI USA, V105, P13497, DOI 10.1073/pnas.0804804105; Miller BG, 2005, BIOCHEMISTRY-US, V44, P10776, DOI 10.1021/bi0506268; Miller BG, 2004, BIOCHEMISTRY-US, V43, P6387, DOI 10.1021/bi049424m; Miyazaki J, 2005, J BACTERIOL, V187, P6779, DOI 10.1128/JB.187.19.6779-6788.2005; Miyazaki J, 2003, J BIOL CHEM, V278, P1864, DOI 10.1074/jbc.M205133200; Miyazaki K, 2005, BIOCHEM BIOPH RES CO, V336, P596, DOI 10.1016/j.bbrc.2005.08.139; Miyazaki K, 2005, BIOCHEM BIOPH RES CO, V331, P341, DOI 10.1016/j.bbrc.2005.03.169; MIYAZAKI K, 1993, FEBS LETT, V332, P35, DOI 10.1016/0014-5793(93)80477-C; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ohno S., 1970, EVOLUTION GENE DUPLI; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Senisterra GA, 2006, J BIOMOL SCREEN, V11, P940, DOI 10.1177/1087057106294699; SERFOZO P, 1995, BIOCHEMISTRY-US, V34, P7517, DOI 10.1021/bi00022a027; Soo VWC, 2011, P NATL ACAD SCI USA, V108, P1484, DOI 10.1073/pnas.1012108108; STERN JR, 1966, NATURE, V212, P1611, DOI 10.1038/2121611a0; Stokke R, 2007, ARCH MICROBIOL, V187, P361, DOI 10.1007/s00203-006-0200-y; Stokke R, 2007, EXTREMOPHILES, V11, P481, DOI 10.1007/s00792-006-0060-z; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; TIPTON PA, 1993, BIOCHEMISTRY-US, V32, P2822, DOI 10.1021/bi00062a013; TIPTON PA, 1994, ARCH BIOCHEM BIOPHYS, V313, P15, DOI 10.1006/abbi.1994.1352; TIPTON PA, 1990, BIOCHEMISTRY-US, V29, P1749, DOI 10.1021/bi00459a013; van Loo B, 2010, P NATL ACAD SCI USA, V107, P2740, DOI 10.1073/pnas.0903951107; Voordeckers K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001446; Wallon G, 1997, J MOL BIOL, V266, P1016, DOI 10.1006/jmbi.1996.0797; WESSLER SR, 1981, J MOL BIOL, V149, P579, DOI 10.1016/0022-2836(81)90348-X; Wright BE, 1997, MICROBIOL-UK, V143, P847, DOI 10.1099/00221287-143-3-847; Yang KC, 2004, P NATL ACAD SCI USA, V101, P7919, DOI 10.1073/pnas.0400664101; Yaoi T, 1997, J BIOCHEM-TOKYO, V121, P77; Yip SHC, 2013, MOL BIOL EVOL, V30, P2001, DOI 10.1093/molbev/mst105; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974	61	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29086	29096		10.1074/jbc.M114.595363	http://dx.doi.org/10.1074/jbc.M114.595363			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25160617	Green Published, hybrid			2022-12-25	WOS:000344141000026
J	Moreira, GC; Cipullo, JP; Ciorlia, LAS; Cesarino, CB; Vilela-Martin, JF				Moreira, Gisela Cipullo; Cipullo, Jose Paulo; Souza Ciorlia, Luiz Alberto; Cesarino, Claudia Bernardi; Vilela-Martin, Jose Fernando			Prevalence of Metabolic Syndrome: Association with Risk Factors and Cardiovascular Complications in an Urban Population	PLOS ONE			English	Article							SERUM URIC-ACID; INSULIN-RESISTANCE; SOCIODEMOGRAPHIC FACTORS; PHYSICAL-ACTIVITY; SOCIAL-CLASS; HEALTH; HYPERTENSION; ADULTS; ABNORMALITIES; ADIPOSITY	Introduction: Metabolic syndrome (MS) is a set of cardiovascular risk factors and type 2 diabetes, responsible for a 2.5-fold increased cardiovascular mortality and a 5-fold higher risk of developing diabetes. Objectives: 1-to evaluate the prevalence of MS in individuals over 18 years associated with age, gender, socioeconomic status, educational levels, body mass index (BMI), HOMA index and physical activity; moreover, to compare it to other studies; 2-to compare the prevalence of elevated blood pressure (BP), high triglycerides and plasma glucose levels, low HDL cholesterol and high waist circumference among individuals with MS also according to gender; 3-to determine the number of risk factors in subjects with MS and prevalence of complications in individuals with and without MS aged over 40 years. Methods: A cross-sectional study of 1369 Individuals, 667 males (48.7%) and 702 females (51.3%) was considered to evaluate the prevalence of MS and associated factors in the population. Results: The study showed that 22.7% (95% CI: 19.4% to 26.0%) of the population has MS, which increases with age, higher BMI and sedentary lifestyle. There was no significant difference between genders until age >= 70 years and social classes. Higher prevalence of MS was observed in lower educational levels and higher prevalence of HOMA positive among individuals with MS. The most prevalent risk factors were elevated blood pressure (85%), low HDL cholesterol (83.1%) and increased waist circumference (82.5%). The prevalence of elevated BP, low HDL cholesterol and plasma glucose levels did not show significant difference between genders. Individuals with MS had higher risk of cardiovascular complications over 40 years. Conclusion: The prevalence of MS found is similar to that in developed countries, being influenced by age, body mass index, educational levels, physical activity, and leading to a higher prevalence of cardiovascular complications after the 4th decade of life.	[Moreira, Gisela Cipullo; Cipullo, Jose Paulo; Souza Ciorlia, Luiz Alberto; Cesarino, Claudia Bernardi; Vilela-Martin, Jose Fernando] State Med Sch Sao Jose Rio Preto FAMERP, Hypertens Clin, Dept Internal Med, Sao Paulo, Brazil		Vilela-Martin, JF (corresponding author), State Med Sch Sao Jose Rio Preto FAMERP, Hypertens Clin, Dept Internal Med, Sao Paulo, Brazil.	vilelamartin@uol.com.br	VILELA-MARTIN, JOSE/I-8305-2014; CESARINO, CLAUDIA B/T-7645-2018	VILELA-MARTIN, JOSE/0000-0001-6960-2825; 				Afonso LC, 1997, CURR OPIN NEPHROL HY, V6, P219, DOI 10.1097/00041552-199705000-00004; Al-Daghri NM, 2013, NUTRIENTS, V5, P4587, DOI 10.3390/nu5114587; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Associacao Brasileira para o Estudo da Obesidade e da Sindrome Metabolica (Abeso), INF OB MET SYNDR BRA; Bahceci M, 2007, J ENDOCRINOL INVEST, V30, P210, DOI 10.1007/BF03347427; Balkau B, 2007, DIABETES METAB, V33, P405, DOI 10.1016/j.diabet.2007.08.001; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Brazilian Institute for Geography and Statistics (IBGE), INF POP CENS; Cesarino CB, 2008, ARQ BRAS CARDIOL, V91, P29, DOI 10.1590/S0066-782X2008001300005; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chow CK, 2008, ATHEROSCLEROSIS, V196, P943, DOI 10.1016/j.atherosclerosis.2007.02.027; Cipullo JP, 2010, ARQ BRAS CARDIOL, V94, P519, DOI 10.1590/S0066-782X2010005000014; Cuspidi Cesare, 2008, Expert Rev Cardiovasc Ther, V6, P731, DOI 10.1586/14779072.6.5.731; de Carvalho Vidigal Fernanda, 2013, BMC Public Health, V13, P1198, DOI 10.1186/1471-2458-13-1198; Deepa M, 2007, DIABETES-METAB RES, V23, P127, DOI 10.1002/dmrr.658; Del Brutto OH, 2013, DIABETES METAB SYND, V7, P218, DOI 10.1016/j.dsx.2013.10.006; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Esmailzadehha N, 2013, Endocr Regul, V47, P111; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Franklin Stanley S., 2006, Metabolic Syndrome and Related Disorders, V4, P287, DOI 10.1089/met.2006.4.287; Geloneze B, 2006, DIABETES RES CLIN PR, V72, P219, DOI 10.1016/j.diabres.2005.10.017; Gronner MF, 2011, BRAZ J MED BIOL RES, V44, P713, DOI 10.1590/S0100-879X2011007500087; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Gupta R, 2007, J Assoc Physicians India, V55, P705; International Diabetes Federation, INF IDF CONS WORLDW; Jaime PC, 2013, NOVA POLITICA NACL A; Jaipakdee J, 2013, SE ASIAN J TROP MED, V44, P512; Kim J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-489; Kim J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-624; Kokubo Y, 2008, HYPERTENS RES, V31, P2027, DOI 10.1291/hypres.31.2027; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Liu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066233; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; Marquez-Sandoval F, 2011, PUBLIC HEALTH NUTR, V14, P1702, DOI 10.1017/S1368980010003320; Mehta N. N., 2004, DRUG DISCOV TODAY, V1, P187, DOI DOI 10.1016/J.DDMEC; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Saad MAN, 2014, ARQ BRAS CARDIOL, V102, P263, DOI 10.5935/abc.20140013; Novak M, 2013, J HUM HYPERTENS, V27, P56, DOI 10.1038/jhh.2011.106; Onat A, 2013, TURK KARDIYOL DERN A, V41, P373, DOI 10.5543/tkda.2013.15853; Park H, 2012, ALCOHOL ALCOHOLISM, V47, P282, DOI 10.1093/alcalc/ags019; Franco GPP, 2009, ARQ BRAS CARDIOL, V92, P437, DOI 10.1590/S0066-782X2009000600010; Pierdomenico SD, 2007, AM J HYPERTENS, V20, P1291, DOI 10.1016/j.amjhyper.2007.06.011; Podang Jongkol, 2013, Journal of the Medical Association of Thailand, V96, pS33; Qiao Q, 2007, ANN CLIN BIOCHEM, V44, P232, DOI 10.1258/000456307780480963; Ramsay SE, 2008, DIABETES CARE, V31, P2380, DOI 10.2337/dc08-1158; Savage DB, 2005, HYPERTENSION, V45, P828, DOI 10.1161/01.HYP.0000163475.04421.e4; Scholze J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-529; Shahini N, 2013, J CLIN DIAGN RES, V7, P1849, DOI 10.7860/JCDR/2013/6035.3331; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stensvold D, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-109; Sy RG, 2014, J ATHEROSCLER THROMB, V21, pS9; Tamang H K, 2013, Nepal Med Coll J, V15, P50; Tibshirani R., 1993, INTRO BOOTSTRAP, DOI 10.1007/978-1-4899-4541-9; Vasques ACJ, 2008, ARQ BRAS ENDOCRINOL, V52, P32, DOI 10.1590/S0004-27302008000100006; VI Diretrizes Brasileiras de Hipertensao, 2010, INF BRAZ GUID HYP; Xavier HT, 2005, REV BRAS MED, V62, P197; Xi B, 2013, PREV MED, V57, P867, DOI 10.1016/j.ypmed.2013.09.023; Xu SY, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-104; You LL, 2014, J ATHEROSCLER THROMB, V21, P355, DOI 10.5551/jat.20529; Zhao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091578	62	81	85	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105056	10.1371/journal.pone.0105056	http://dx.doi.org/10.1371/journal.pone.0105056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180496	Green Published, Green Submitted, gold			2022-12-25	WOS:000341231500018
J	Elizer, SK; Marshall, AF; Moore, DJ				Elizer, Sydney K.; Marshall, Andrew F.; Moore, Daniel J.			Dysregulation of T Lymphocyte Proliferative Responses in Autoimmunity	PLOS ONE			English	Article							NONOBESE DIABETIC MICE; B-CELLS; NOD MICE; SYSTEMIC AUTOIMMUNITY; SJOGRENS-SYNDROME; IN-VIVO; CLONAL EXPANSION; MOUSE; ACTIVATION; DISEASE	T cells are critically dependent on cellular proliferation in order to carry out their effector functions. Autoimmune strains are commonly thought to have uncontrolled T cell proliferation; however, in the murine model of autoimmune diabetes, hypoproliferation of T cells leading to defective AICD was previously uncovered. We now determine whether lupus prone murine strains are similarly hyporesponsive. Upon extensive characterization of T lymphocyte activation, we have observed a common feature of CD4 T cell activation shared among three autoimmune strains-NOD, MRL, and NZBxNZW F1s. When stimulated with a polyclonal mitogen, CD4 T cells demonstrate arrested cell division and diminished dose responsiveness as compared to the non-autoimmune strain C57BL/6, a phenotype we further traced to a reliance on B cell mediated costimulation, which underscores the success of B cell directed immune therapies in preventing T cell mediated tissue injury. In turn, the diminished proliferative capacity of these CD4 T cells lead to a decreased, but activation appropriate, susceptibility to activation induced cell death. A similar decrement in stimulation response was observed in the CD8 compartment of NOD mice; NOD CD8 T cells were distinguished from lupus prone strains by a diminished dose-responsiveness to anti-CD3 mediated stimulation. This distinction may explain the differential pathogenetic pathways activated in diabetes and lupus prone murine strains.	[Elizer, Sydney K.; Marshall, Andrew F.; Moore, Daniel J.] Vanderbilt Univ, Sch Med, Dept Pediat, Ian Burr Div Endocrinol & Diabet, Nashville, TN 37212 USA; [Moore, Daniel J.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Moore, DJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, Ian Burr Div Endocrinol & Diabet, Nashville, TN 37212 USA.	daniel.moore@vanderbilt.edu	Moore, Daniel/V-6145-2019; Moore, Daniel J/A-4924-2008	Moore, Daniel/0000-0002-6889-9345; Moore, Daniel J/0000-0002-6889-9345	US Public Health Service NIH [KO8 DK090146]; Turner Hazinski Scholars Award; Price Family Discovery Award; Department of Pediatrics at Vanderbilt University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090146] Funding Source: NIH RePORTER	US Public Health Service NIH(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Turner Hazinski Scholars Award; Price Family Discovery Award; Department of Pediatrics at Vanderbilt University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the US Public Health Service NIH Grant KO8 DK090146 by the Turner Hazinski Scholars Award, the Price Family Discovery Award (DJM), and by funds from the Department of Pediatrics at Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN A, 1981, J EXP MED, V154, P791, DOI 10.1084/jem.154.3.791; BAKER D, 1995, J IMMUNOL, V155, P4046; BAXTER AG, 1994, SCAND J IMMUNOL, V39, P602, DOI 10.1111/j.1365-3083.1994.tb03419.x; BAXTER AG, 1991, EUR J IMMUNOL, V21, P2051, DOI 10.1002/eji.1830210912; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Bergerot I, 1997, RES IMMUNOL, V148, P348, DOI 10.1016/S0923-2494(97)87245-8; BERNARD NF, 1992, DIABETES, V41, P40, DOI 10.2337/diabetes.41.1.40; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Braley-Mullen H, 2000, J IMMUNOL, V165, P7262, DOI 10.4049/jimmunol.165.12.7262; Chan O, 1998, J IMMUNOL, V160, P51; Chan OTM, 1999, J IMMUNOL, V163, P3592; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; EYNON EE, 1992, J EXP MED, V175, P131, DOI 10.1084/jem.175.1.131; Gonzalez A, 1997, IMMUNITY, V7, P873, DOI 10.1016/S1074-7613(00)80405-7; Greeley SAW, 2001, J IMMUNOL, V167, P4351, DOI 10.4049/jimmunol.167.8.4351; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; HAGERTY DT, 1991, J IMMUNOL, V147, P3282; Hasbold J, 1999, IMMUNOL CELL BIOL, V77, P516, DOI 10.1046/j.1440-1711.1999.00874.x; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; HUMPHREYSBEHER MG, 1994, ADV EXP MED BIOL, V350, P631; JARAMILLO A, 1994, LIFE SCI, V55, P1163, DOI 10.1016/0024-3205(94)00655-5; Jordan MA, 2000, J IMMUNOL, V165, P1673, DOI 10.4049/jimmunol.165.3.1673; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Krause I, 1999, J AUTOIMMUN, V13, P49, DOI 10.1006/jaut.1999.0292; Lang J, 2002, SCAND J IMMUNOL, V55, P546, DOI 10.1046/j.1365-3083.2002.01086.x; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MANY MC, 1995, J ENDOCRINOL, V147, P311, DOI 10.1677/joe.0.1470311; MILICH DR, 1989, J IMMUNOL, V143, P3148; Noorchashm H, 2000, J IMMUNOL, V165, P4685, DOI 10.4049/jimmunol.165.8.4685; Noorchashm H, 1997, DIABETES, V46, P941, DOI 10.2337/diabetes.46.6.941; QUDDUS J, 1993, J CLIN INVEST, V92, P38, DOI 10.1172/JCI116576; Renno T, 1999, J IMMUNOL, V162, P6312; Robinson CP, 1998, ARTHRITIS RHEUM, V41, P150, DOI 10.1002/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T; Roth R, 1996, J IMMUNOL, V157, P2924; Salojin KV, 1998, IMMUNOL TODAY, V19, P468, DOI 10.1016/S0167-5699(98)01326-7; Silveira PA, 2001, AUTOIMMUNITY, V34, P53, DOI 10.3109/08916930108994126; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; TAX WJM, 1984, J IMMUNOL, V133, P1185; Valapour M, 2002, J ALLERGY CLIN IMMUN, V109, P238, DOI 10.1067/mai.2002.121145; van Blokland SCA, 2000, LAB INVEST, V80, P575, DOI 10.1038/labinvest.3780062; Watanabe R, 2010, J IMMUNOL, V184, P4801, DOI 10.4049/jimmunol.0902385; Webb S R, 1992, Semin Immunol, V4, P329; WEBB SR, 1993, IMMUNOL REV, V131, P169, DOI 10.1111/j.1600-065X.1993.tb01535.x; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106347	10.1371/journal.pone.0106347	http://dx.doi.org/10.1371/journal.pone.0106347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171173	Green Submitted, gold, Green Published			2022-12-25	WOS:000341127500153
J	Maragh, S; Miller, RA; Bessling, SL; Wang, GL; Hook, PW; McCallion, AS				Maragh, Samantha; Miller, Ronald A.; Bessling, Seneca L.; Wang, Guangliang; Hook, Paul W.; McCallion, Andrew S.			Rbm24a and Rbm24b Are Required for Normal Somitogenesis	PLOS ONE			English	Article							PRE-MESSENGER-RNA; ALAGILLE-SYNDROME; SEGMENTATION CLOCK; ZEBRAFISH SOMITOGENESIS; VERTEBRATE SEGMENTATION; SOMITE SEGMENTATION; SPLICING REGULATOR; ZYGOTIC TRANSITION; RECOGNITION MOTIF; GENE-EXPRESSION	We recently demonstrated that the gene encoding the RNA binding motif protein 24 (RBM24) is expressed during mouse cardiogenesis, and determined the developmental requirement for its zebrafish homologs Rbm24a and Rbm24b during cardiac development. We demonstrate here that both Rbm24a and Rbm24b are also required for normal somite and craniofacial development. Diminution of rbm24a or rbm24b gene products by morpholino knockdown resulted in significant disruption of somite formation. Detailed in situ hybridization-based analyses of a spectrum of somitogenesis-associated transcripts revealed reduced expression of the cyclic muscle pattering genes dlc and dld encoding Notch ligands, as well as their respective target genes her7, her1. By contrast expression of the Notch receptors notch1a and notch3 appears unchanged. Some RBM-family members have been implicated in pre-mRNA processing. Analysis of affected Notch-pathway mRNAs in rbm24a and rbm24b morpholino-injected embryos revealed aberrant transcript fragments of dlc and dld, but not her1 or her7, suggesting the reduction in transcription levels of Notch pathway components may result from aberrant processing of its ligands. These data imply a previously unknown requirement for Rbm24a and Rbm24b in somite and craniofacial development. Although we anticipate the influence of disrupting RBM24 homologs likely extends beyond the Notch pathway, our results suggest their perturbation may directly, or indirectly, compromise post-transcriptional processing, exemplified by imprecise processing of dlc and dld.	[Maragh, Samantha] NIST, Div Biochem Sci, Gaithersburg, MD 20899 USA; [Maragh, Samantha; Miller, Ronald A.; Bessling, Seneca L.; Wang, Guangliang; Hook, Paul W.; McCallion, Andrew S.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; [McCallion, Andrew S.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA	National Institute of Standards & Technology (NIST) - USA; Johns Hopkins University; Johns Hopkins University	McCallion, AS (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	amccall2@jhmi.edu		Hook, Paul/0000-0002-3912-1999	Leducq Foundation [114254]; NIH/NHLBI [R01HL111267]; NIH [DK080730, DK090816]; National Institute of Standards and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080730, RC4DK090816] Funding Source: NIH RePORTER	Leducq Foundation(Leducq Foundation); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the following grants: Leducq Foundation Award # 114254, NIH/NHLBI R01HL111267, NIH DK080730, and NIH DK090816. Author Samantha Maragh is supported by funds from National Institute of Standards and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Anyanful A, 2004, J CELL BIOL, V167, P639, DOI 10.1083/jcb.200407085; Baroux C, 2008, COLD SH Q B, V73, P89, DOI 10.1101/sqb.2008.73.053; Beres BJ, 2011, MECH DEVELOP, V128, P247, DOI 10.1016/j.mod.2011.02.002; Bigas A, 2010, INT J DEV BIOL, V54, P1175, DOI 10.1387/ijdb.093049ab; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Choorapoikayil S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039073; Cinquin O, 2007, MECH DEVELOP, V124, P501, DOI 10.1016/j.mod.2007.06.004; Gao G, 2011, CIRCULATION, V124, P1124, DOI 10.1161/CIRCULATIONAHA.111.044495; Giudicelli F, 2007, PLOS BIOL, V5, P1309, DOI 10.1371/journal.pbio.0050150; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; Gridley T, 2006, DEV DYNAM, V235, P2330, DOI 10.1002/dvdy.20850; Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693; HAMLETT KW, 1992, J PEDIATR PSYCHOL, V17, P33, DOI 10.1093/jpepsy/17.1.33; Henry CA, 2005, DEV BIOL, V287, P346, DOI 10.1016/j.ydbio.2005.08.049; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Holley SA, 2000, GENE DEV, V14, P1678; Jayasena CS, 2012, J CELL BIOL, V199, P453, DOI 10.1083/jcb.201204138; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jin DH, 2010, GENES CELLS, V15, P1158, DOI 10.1111/j.1365-2443.2010.01446.x; Jin WX, 2012, FEBS LETT, V586, P3852, DOI 10.1016/j.febslet.2012.09.006; Johnston JJ, 2010, AM J HUM GENET, V86, P743, DOI 10.1016/j.ajhg.2010.04.007; Julich D, 2005, DEV BIOL, V286, P391, DOI 10.1016/j.ydbio.2005.06.040; Kar A, 2006, J BIOL CHEM, V281, P24479, DOI 10.1074/jbc.M603971200; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kuroyanagi H, 2007, MOL CELL BIOL, V27, P8612, DOI 10.1128/MCB.01508-07; Li HY, 2010, MECH DEVELOP, V127, P281, DOI 10.1016/j.mod.2010.03.002; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Li SJ, 2013, NUCLEIC ACIDS RES, V41, P2659, DOI 10.1093/nar/gks1362; Lin JC, 2013, MOL CELL BIOL, V33, P319, DOI 10.1128/MCB.01266-12; Lin Jung-Chun, 2012, Front Biosci (Schol Ed), V4, P181; Lin JC, 2011, J CELL BIOL, V193, P509, DOI 10.1083/jcb.201007131; Mara A, 2008, DEV BIOL, V318, P126, DOI 10.1016/j.ydbio.2008.03.009; Maragh S, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-62; Marcelle C, 1997, DEVELOPMENT, V124, P3955; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Maroto M, 2012, DEVELOPMENT, V139, P2453, DOI 10.1242/dev.069310; McBride KL, 2008, HUM MOL GENET, V17, P2886, DOI 10.1093/hmg/ddn187; McCright B, 2002, DEVELOPMENT, V129, P1075; Miller RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002176; Miyamoto S, 2009, GENES CELLS, V14, P1241, DOI 10.1111/j.1365-2443.2009.01347.x; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Nakano H, 1992, Nihon Ronen Igakkai Zasshi, V29, P113; Niwa Y, 2011, GENE DEV, V25, P1115, DOI [10.1101/gad.2035311, 10.1101/gad.2035311.]; Nousbeck J, 2008, AM J HUM GENET, V82, P1114, DOI 10.1016/j.ajhg.2008.03.014; Oates AC, 2005, DEV BIOL, V280, P133, DOI 10.1016/j.ydbio.2005.01.010; Oates AC, 2002, DEVELOPMENT, V129, P2929; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Ohno G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002991; Parsons MJ, 2002, DEVELOPMENT, V129, P3505; Pedrotti S, 2012, NUCLEIC ACIDS RES, V40, P1021, DOI 10.1093/nar/gkr819; Penton AL, 2012, SEMIN CELL DEV BIOL, V23, P450, DOI 10.1016/j.semcdb.2012.01.010; Poon KL, 2012, CARDIOVASC RES, V94, P418, DOI 10.1093/cvr/cvs095; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Sawada A, 2001, DEVELOPMENT, V128, P4873; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Schroter C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001364; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Shifley Emily T., 2007, Birth Defects Research, V81, P121, DOI 10.1002/bdrc.20090; Sieger D, 2003, MECH DEVELOP, V120, P1083, DOI 10.1016/S0925-4773(03)00154-0; So J, 2008, AM J MED GENET A, V146A, P103, DOI 10.1002/ajmg.a.32055; Spinner NB, 2001, HUM MUTAT, V17, P18, DOI 10.1002/1098-1004(2001)17:1<18::AID-HUMU3>3.0.CO;2-T; Stickney HL, 2000, DEV DYNAM, V219, P287; Suvorova ES, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003305; Szeto DP, 2006, GENE DEV, V20, P1923, DOI 10.1101/gad.1435306; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tiedemann HB, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002586; Trofka A, 2012, DEVELOPMENT, V139, P940, DOI 10.1242/dev.073544; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Wang GL, 2012, DEV BIOL, V370, P52, DOI 10.1016/j.ydbio.2012.07.019; Whittock NV, 2004, CLIN GENET, V66, P67, DOI 10.1111/j.0009-9163.2004.00272.x; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yin CY, 2007, DEV DYNAM, V236, P2742, DOI 10.1002/dvdy.21295; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhou A, 2008, MOL CELL BIOL, V28, P5924, DOI 10.1128/MCB.00560-08	79	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105460	10.1371/journal.pone.0105460	http://dx.doi.org/10.1371/journal.pone.0105460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170925	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500050
J	Ramirez-Castrillon, M; Mendes, SDC; Inostroza-Ponta, M; Valente, P				Ramirez-Castrillon, Mauricio; Camargo Mendes, Sandra Denise; Inostroza-Ponta, Mario; Valente, Patricia			(GTG)(5) MSP-PCR Fingerprinting as a Technique for Discrimination of Wine Associated Yeasts?	PLOS ONE			English	Article							SP NOV.; SACCHAROMYCES-CEREVISIAE; SENSU-STRICTO; DNA; DIVERSITY; DIFFERENTIATION; IDENTIFICATION; STRAINS; REPRODUCIBILITY; FERMENTATIONS	In microbiology, identification of all isolates by sequencing is still unfeasible in small research laboratories. Therefore, many yeast diversity studies follow a screening procedure consisting of clustering the yeast isolates using MSP-PCR fingerprinting, followed by identification of one or a few selected representatives of each cluster by sequencing. Although this procedure has been widely applied in the literature, it has not been properly validated. We evaluated a standardized protocol using MSP-PCR fingerprinting with the primers (GTG)(5) and M13 for the discrimination of wine associated yeasts in South Brazil. Two datasets were used: yeasts isolated from bottled wines and vineyard environments. We compared the discriminatory power of both primers in a subset of 16 strains, choosing the primer (GTG)(5) for further evaluation. Afterwards, we applied this technique to 245 strains, and compared the results with the identification obtained by partial sequencing of the LSU rRNA gene, considered as the gold standard. An array matrix was constructed for each dataset and used as input for clustering with two methods (hierarchical dendrograms and QAPGrid layout). For both yeast datasets, unrelated species were clustered in the same group. The sensitivity score of (GTG)(5) MSP-PCR fingerprinting was high, but specificity was low. As a conclusion, the yeast diversity inferred in several previous studies may have been underestimated and some isolates were probably misidentified due to the compliance to this screening procedure.	[Ramirez-Castrillon, Mauricio; Camargo Mendes, Sandra Denise] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Ramirez-Castrillon, Mauricio; Camargo Mendes, Sandra Denise; Valente, Patricia] Univ Fed Rio Grande do Sul, ICBS, Dept Microbiol Imunol & Parasitol, Porto Alegre, RS, Brazil; [Camargo Mendes, Sandra Denise] Empresa Pesquisa Agr & Extensao Rural Santa Catar, Lab Anal Vinhos & Derivados, Estacao Expt Videira, Videira, Brazil; [Inostroza-Ponta, Mario] Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidad de Santiago de Chile	Valente, P (corresponding author), Univ Fed Rio Grande do Sul, ICBS, Dept Microbiol Imunol & Parasitol, Rua Sarmento Leite, Porto Alegre, RS, Brazil.	patricia.valente@ufrgs.br	Ramirez-Castrillon, Mauricio/G-6516-2012; Valente, Patricia/H-4773-2018; , sandra/M-4900-2017	Ramirez-Castrillon, Mauricio/0000-0001-8525-5341; Valente, Patricia/0000-0001-5374-0991; Inostroza-Ponta, Mario/0000-0003-1295-8972; , sandra/0000-0001-6812-0349	CNPq; CAPES; EMBRAPA; Cantina Santa Augusta; FONDECYT; COLCIENCIAS	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Cantina Santa Augusta; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was supported by CNPq, CAPES, EMBRAPA, Cantina Santa Augusta, FONDECYT "Iniciacion11121288'' and COLCIENCIAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MJ, 2006, INT J FOOD MICROBIOL, V107, P48, DOI 10.1016/j.ijfoodmicro.2005.08.011; Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Barquet M, 2012, APPL MICROBIOL BIOT, V93, P807, DOI 10.1007/s00253-011-3714-4; Basilio ACM, 2008, FOOD MICROBIOL, V27, P205; dos Santos SKB, 2007, WORLD J MICROB BIOT, V23, P1613, DOI 10.1007/s11274-007-9407-6; Capece A, 2003, INT J FOOD MICROBIOL, V84, P33, DOI 10.1016/S0168-1605(02)00392-6; Caruso M, 2002, LETT APPL MICROBIOL, V34, P323, DOI 10.1046/j.1472-765X.2002.01090.x; Chang CF, 2012, INT J FOOD MICROBIOL, V153, P10, DOI 10.1016/j.ijfoodmicro.2011.09.012; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Couto MMB, 1996, APPL ENVIRON MICROB, V62, P41, DOI 10.1128/AEM.62.1.41-46.1996; da Silva EA, 2005, ANTON LEEUW INT J G, V88, P13, DOI 10.1007/s10482-004-7283-8; Dellaglio F, 2003, ANN MICROBIOL, V53, P411; Fernandez NV, 2012, FEMS MICROBIOL ECOL, V80, P179, DOI 10.1111/j.1574-6941.2011.01287.x; Gadanho M, 2002, FEMS YEAST RES, V2, P47, DOI 10.1111/j.1567-1364.2002.tb00068.x; Garcia-Hernandez Y, 2012, RES VET SCI, V93, P798, DOI 10.1016/j.rvsc.2011.09.005; GAVIRIA V. JACKELINE, 2012, Rev.Bio.Agro, V10, P160; Greppi A, 2013, INT J FOOD MICROBIOL, V165, P200, DOI 10.1016/j.ijfoodmicro.2013.05.004; Greppi A, 2013, INT J FOOD MICROBIOL, V165, P84, DOI 10.1016/j.ijfoodmicro.2013.05.005; Guamán-Burneo Cristina, 2009, Univ. Sci., V14, P187; Hui FL, 2013, ANTON LEEUW INT J G, V103, P47, DOI 10.1007/s10482-012-9785-0; HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903, DOI 10.1128/JCM.28.9.1903-1905.1990; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Inostroza-Ponta M, 2007, LECT NOTES ARTIF INT, V4828, P156; Inostroza-Ponta M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014468; Kurtzman CP, 2014, INT J SYST EVOL MICR, V64, P325, DOI 10.1099/ijs.0.054197-0; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liberal ATD, 2007, J APPL MICROBIOL, V102, P538, DOI 10.1111/j.1365-2672.2006.03082.x; Libkind D., 2007, Rev. argent. microbiol., V39, P133; Libkind D, 2007, APPL ENVIRON MICROB, V73, P1120, DOI 10.1128/AEM.01432-06; LIECKFELDT E, 1993, J BASIC MICROB, V33, P413, DOI 10.1002/jobm.3620330609; Loureiro V, 2000, FOOD RES INT, V33, P247, DOI 10.1016/S0963-9969(00)00044-2; Magalhaes-Guedes K. T., 2013, African Journal of Microbiology Research, V7, P1121, DOI 10.5897/AJMR12.1974; Maqueda M, 2010, FOOD MICROBIOL, V27, P205, DOI 10.1016/j.fm.2009.10.004; Matsheka MI, 2006, LETT APPL MICROBIOL, V42, P600, DOI 10.1111/j.1472-765X.2006.01900.x; MEYER W, 1993, J CLIN MICROBIOL, V31, P2274, DOI 10.1128/JCM.31.9.2274-2280.1993; Miguel MGCP, 2013, BRAZ J MICROBIOL, V44, P113, DOI 10.1590/S1517-83822013005000005; Naumov GI, 2009, MICROBIOLOGY+, V78, P214, DOI 10.1134/S002626170902012X; Naumova ES, 2003, FEMS YEAST RES, V1531, P1; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Orlic S, 2010, WORLD J MICROB BIOT, V26, P1483, DOI 10.1007/s11274-010-0323-9; Osorio Cadavid Esteban, 2009, Rev. colomb. biotecnol, V11, P125; Papalexandratou Z, 2013, FOOD MICROBIOL, V35, P73, DOI 10.1016/j.fm.2013.02.015; Pedersen LL, 2012, INT J FOOD MICROBIOL, V159, P144, DOI 10.1016/j.ijfoodmicro.2012.08.016; Quan H, 1996, BIOMETRICS, V52, P1195, DOI 10.2307/2532835; Ramos JP, 2001, LETT APPL MICROBIOL, V33, P206, DOI 10.1046/j.1472-765X.2001.00981.x; Riveros C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014176; Rodrigues MG, 2003, INT J SYST EVOL MICR, V53, P607, DOI 10.1099/ijs.0.02437-0; Ryberg A, 2011, J MICROBIOL METH, V84, P183, DOI 10.1016/j.mimet.2010.11.019; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Solieri L, 2013, FEMS YEAST RES, V13, P245, DOI 10.1111/1567-1364.12027; Solieri L, 2013, INT J SYST EVOL MICR, V63, P364, DOI 10.1099/ijs.0.043323-0; Suh SO, 2013, INT J SYST EVOL MICR, V63, P1922, DOI 10.1099/ijs.0.048058-0; Taylor JD, 2010, J VET DIAGN INVEST, V22, P366, DOI 10.1177/104063871002200304; Torriani S, 1999, ANTON LEEUW INT J G, V75, P207, DOI 10.1023/A:1001773916407; Turchetti B, 2013, FEMS MICROBIOL ECOL, V86, P327, DOI 10.1111/1574-6941.12164; Urzi C, 1999, J MICROBIOL METH, V36, P95, DOI 10.1016/S0167-7012(99)00014-7; Valente P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046060; Weiss S, 2013, FEMS YEAST RES, V13, P117, DOI 10.1111/1567-1364.12017; White T., 1990, PCR PROTOCOLS GUIDE, P315; Yurkov AM, 2012, FUNGAL ECOL, V5, P24, DOI 10.1016/j.funeco.2011.07.004	61	28	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105870	10.1371/journal.pone.0105870	http://dx.doi.org/10.1371/journal.pone.0105870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171185	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500077
J	Yan, S; Wang, CC; Zheng, HX; Wang, W; Qin, ZD; Wei, LH; Wang, Y; Pan, XD; Fu, WQ; He, YG; Xiong, LJ; Jin, WF; Li, SL; An, Y; Li, H; Jin, L				Yan, Shi; Wang, Chuan-Chao; Zheng, Hong-Xiang; Wang, Wei; Qin, Zhen-Dong; Wei, Lan-Hai; Wang, Yi; Pan, Xue-Dong; Fu, Wen-Qing; He, Yun-Gang; Xiong, Li-Jun; Jin, Wen-Fei; Li, Shi-Lin; An, Yu; Li, Hui; Jin, Li			Y Chromosomes of 40% Chinese Descend from Three Neolithic Super-Grandfathers	PLOS ONE			English	Article							SHORT READ ALIGNMENT; DNA-SEQUENCING DATA; GENOME SEQUENCE; EAST-ASIA; HAPLOGROUP TREE; NORTHERN CHINA; MODERN HUMANS; MUTATION-RATE; POPULATION; ORIGINS	Demographic change of human populations is one of the central questions for delving into the past of human beings. To identify major population expansions related to male lineages, we sequenced 78 East Asian Y chromosomes at 3.9 Mbp of the non-recombining region, discovered >4,000 new SNPs, and identified many new clades. The relative divergence dates can be estimated much more precisely using a molecular clock. We found that all the Paleolithic divergences were binary; however, three strong star-like Neolithic expansions at similar to 6 kya (thousand years ago) (assuming a constant substitution rate of 1x10(-9)/bp/year) indicates that similar to 40% of modern Chinese are patrilineal descendants of only three super-grandfathers at that time. This observation suggests that the main patrilineal expansion in China occurred in the Neolithic Era and might be related to the development of agriculture.	[Yan, Shi; Wang, Chuan-Chao; Zheng, Hong-Xiang; Qin, Zhen-Dong; Wei, Lan-Hai; Wang, Yi; Pan, Xue-Dong; Fu, Wen-Qing; Li, Shi-Lin; An, Yu; Li, Hui; Jin, Li] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Yan, Shi; Wang, Chuan-Chao; Zheng, Hong-Xiang; Qin, Zhen-Dong; Wei, Lan-Hai; Wang, Yi; Pan, Xue-Dong; Fu, Wen-Qing; Li, Shi-Lin; An, Yu; Li, Hui; Jin, Li] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, Minist Educ,Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Yan, Shi; Wang, Wei; He, Yun-Gang; Jin, Wen-Fei; Jin, Li] Chinese Acad Sci, SIBS, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China; [Xiong, Li-Jun] Fudan Univ, Inst Biomed Sci, Epigenet Lab, Shanghai 200433, Peoples R China; [Fu, Wen-Qing] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Fudan University; University of Washington; University of Washington Seattle	Yan, S (corresponding author), Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	yanshi@fudan.edu.cn; lijin.fudan@gmail.com	Wei, Lan-Hai/R-6876-2018; Jin, Wenfei/H-5330-2011; Jin, Wenfei/V-9944-2019; Wang, Chuan-Chao/B-2975-2011; Wang, Chuan-Chao/AGY-2940-2022; Jin, Li/M-5063-2019; Yan, Shi/GYR-3441-2022; Jin, Li/C-1468-2009	Wei, Lan-Hai/0000-0003-3119-7400; Jin, Wenfei/0000-0002-0028-3739; Jin, Wenfei/0000-0002-0028-3739; Wang, Chuan-Chao/0000-0001-9628-0307; Wang, Chuan-Chao/0000-0003-4630-5232; Yan, Shi/0000-0001-8304-8445; Jin, Li/0000-0002-4546-2415	National Science Foundation of China [31271338, 31071096]; Ministry of Education [311016]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education	This research was supported by the grants from the National Science Foundation of China (31271338 and 31071096), and from Ministry of Education (311016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bettinger RL, 2010, EVOL ANTHROPOL, V19, P9, DOI 10.1002/evan.20236; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ellis N, 2002, GENOME RES, V12, P339; Fu Q, 2013, CURR BIOL, V23, P1; Fuller DQ, 2011, RICE, V4, P78, DOI 10.1007/s12284-011-9078-7; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; Gignoux CR, 2011, P NATL ACAD SCI USA, V108, P6044, DOI 10.1073/pnas.0914274108; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Hammer MF, 2002, ANNU REV ANTHROPOL, V31, P303, DOI 10.1146/annurev.anthro.31.040402.085413; Heyer E, 2001, AM J HUM GENET, V69, P1113, DOI 10.1086/324024; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; Jiao TL, 2001, GEND ARCHAEOL SERIES, V2, P51; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; JOBLING MA, 2003, HUMAN EVOLUTIONARY G; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafet TM, 2010, MOL BIOL EVOL, V27, P1833, DOI 10.1093/molbev/msq063; Ke YH, 2001, SCIENCE, V292, P1151, DOI 10.1126/science.1060011; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nylander J, 2004, MR MODELTEST V2 PROG; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Penny D, 2005, NATURE, V436, P183, DOI 10.1038/436183a; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; The Institute of Archaeology China Academy of Social Sciences, 2010, CHIN ARCH NEOL; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Yan S, 2011, EUR J HUM GENET, V19, P1013, DOI 10.1038/ejhg.2011.64; Yang XY, 2012, P NATL ACAD SCI USA, V109, P3726, DOI 10.1073/pnas.1115430109; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang Zhiheng, 2004, ZHONGGUO XINSHIQI SH; Zhao ZJ, 2010, ARCHAEOL ANTHROP SCI, V2, P99, DOI 10.1007/s12520-010-0028-x; Zheng HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025835; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	61	58	64	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105691	10.1371/journal.pone.0105691	http://dx.doi.org/10.1371/journal.pone.0105691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170956	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500064
J	Singh, H; Singh, S; Raghava, GPS				Singh, Harinder; Singh, Sandeep; Raghava, Gajendra P. S.			Evaluation of Protein Dihedral Angle Prediction Methods	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; REAL-VALUE PREDICTION; LOCAL-STRUCTURE; BETA-HAIRPINS; FOLD RECOGNITION; TURN TYPES; BACKBONE; ALIGNMENT; ACCURACY; MODEL	Tertiary structure prediction of a protein from its amino acid sequence is one of the major challenges in the field of bioinformatics. Hierarchical approach is one of the persuasive techniques used for predicting protein tertiary structure, especially in the absence of homologous protein structures. In hierarchical approach, intermediate states are predicted like secondary structure, dihedral angles, C-alpha - C-alpha distance bounds, etc. These intermediate states are used to restraint the protein backbone and assist its correct folding. In the recent years, several methods have been developed for predicting dihedral angles of a protein, but it is difficult to conclude which method is better than others. In this study, we benchmarked the performance of dihedral prediction methods ANGLOR and SPINE X on various datasets, including independent datasets. TANGLE dihedral prediction method was not benchmarked (due to unavailability of its standalone) and was compared with SPINE X and ANGLOR on only ANGLOR dataset on which TANGLE has reported its results. It was observed that SPINE X performed better than ANGLOR and TANGLE, especially in case of prediction of dihedral angles of glycine and proline residues. The analysis suggested that angle shifting was the foremost reason of better performance of SPINE X. We further evaluated the performance of the methods on independent ccPDB30 dataset and observed that SPINE X performed better than ANGLOR.	[Singh, Harinder; Singh, Sandeep; Raghava, Gajendra P. S.] Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Raghava, GPS (corresponding author), Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India.	raghava@imtech.res.in	Raghava, Gajendra/B-1717-2009; Singh, Harinder/V-7699-2019; Raghava, Gajendra P.S./AAA-2413-2022	Singh, Harinder/0000-0003-4897-9759; Raghava, Gajendra P.S./0000-0002-8902-2876; Singh, Sandeep/0000-0001-5361-4303	funding agency Council of Scientific and Industrial Research (project OSDD); funding agency Council of Scientific and Industrial Research (project GENESIS) [BSC0121]; funding agency Department of Biotechnology (project BTISNET), Govt. of India	funding agency Council of Scientific and Industrial Research (project OSDD); funding agency Council of Scientific and Industrial Research (project GENESIS); funding agency Department of Biotechnology (project BTISNET), Govt. of India	The authors are thankful to funding agencies Council of Scientific and Industrial Research (project OSDD and GENESIS BSC0121) and Department of Biotechnology (project BTISNET), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betancourt MR, 2004, J MOL BIOL, V342, P635, DOI 10.1016/j.jmb.2004.06.091; Branden C TJ, 1999, INTRO PROTEIN STRUCT; Bystroff C, 2000, J MOL BIOL, V301, P173, DOI 10.1006/jmbi.2000.3837; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; Dor O, 2007, PROTEINS, V68, P76, DOI 10.1002/prot.21408; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; Faraggi E, 2009, STRUCTURE, V17, P1515, DOI 10.1016/j.str.2009.09.006; Faraggi E, 2009, PROTEINS, V74, P847, DOI 10.1002/prot.22193; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hu XZ, 2008, PROTEIN J, V27, P115, DOI 10.1007/s10930-007-9114-z; Huang YM, 2006, BIOINFORMATICS, V22, P413, DOI 10.1093/bioinformatics/bti828; Jahandideh S, 2007, J THEOR BIOL, V249, P785, DOI 10.1016/j.jtbi.2007.09.002; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; KANG HS, 1993, J MOL BIOL, V229, P448, DOI 10.1006/jmbi.1993.1045; Karchin R, 2003, PROTEINS, V51, P504, DOI 10.1002/prot.10369; Kaur H, 2004, BIOINFORMATICS, V20, P2751, DOI 10.1093/bioinformatics/bth322; Kaur H, 2003, PROTEIN SCI, V12, P923, DOI 10.1110/ps.0241703; Kaur H, 2003, PROTEIN SCI, V12, P627, DOI 10.1110/ps.0228903; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Klepeis JL, 2003, BIOPHYS J, V85, P2119, DOI 10.1016/S0006-3495(03)74640-2; Kountouris P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-407; Kuang R, 2004, BIOINFORMATICS, V20, P1612, DOI 10.1093/bioinformatics/bth136; Kumar M, 2005, NUCLEIC ACIDS RES, V33, pW154, DOI 10.1093/nar/gki588; Kurgan L, 2011, CURR PROTEIN PEPT SC, V12, P470, DOI 10.2174/138920311796957711; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miao Xijiang, 2008, Journal of Bioinformatics and Computational Biology, V6, P163, DOI 10.1142/S0219720008003370; Mooney C, 2006, J COMPUT BIOL, V13, P1489, DOI 10.1089/cmb.2006.13.1489; Petersen B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015079; R Core Team R, 2022, R LANG ENV STAT COMP; Raghava GPS, 2000, COMBINATION METHOD P; ROOMAN MJ, 1991, J MOL BIOL, V221, P961, DOI 10.1016/0022-2836(91)80186-X; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Singh H, 2012, NUCLEIC ACIDS RES, V40, pD486, DOI 10.1093/nar/gkr1150; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030361; Wood MJ, 2005, PROTEINS, V59, P476, DOI 10.1002/prot.20435; Wu ST, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003400; Xia JF, 2010, PROTEIN PEPTIDE LETT, V17, P1123, DOI 10.2174/092986610791760333; Xue B, 2008, PROTEINS, V72, P427, DOI 10.1002/prot.21940; Zhang C, 2002, P NATL ACAD SCI USA, V99, P3581, DOI 10.1073/pnas.052003799; Zhang W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002325; Zheng C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-430; Zimmermann O, 2006, BIOINFORMATICS, V22, P3009, DOI 10.1093/bioinformatics/btl489	48	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105667	10.1371/journal.pone.0105667	http://dx.doi.org/10.1371/journal.pone.0105667			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166857	Green Submitted, gold, Green Published			2022-12-25	WOS:000341303700036
J	Fabi, JP; Broetto, SG; da Silva, SLGL; Zhong, SL; Lajolo, FM; do Nascimento, JRO				Fabi, Joao Paulo; Broetto, Sabrina Garcia; Garcia Leme da Silva, Sarah Ligia; Zhong, Silin; Lajolo, Franco Maria; Oliveira do Nascimento, Joao Roberto			Analysis of Papaya Cell Wall-Related Genes during Fruit Ripening Indicates a Central Role of Polygalacturonases during Pulp Softening	PLOS ONE			English	Article							DOWN-REGULATION; EXPRESSION; PROTEIN; ETHYLENE; REVEALS; CLONING; PLANTS	Papaya (Carica papaya L.) is a climacteric fleshy fruit that undergoes dramatic changes during ripening, most noticeably a severe pulp softening. However, little is known regarding the genetics of the cell wall metabolism in papayas. The present work describes the identification and characterization of genes related to pulp softening. We used gene expression profiling to analyze the correlations and co-expression networks of cell wall-related genes, and the results suggest that papaya pulp softening is accomplished by the interactions of multiple glycoside hydrolases. The polygalacturonase cpPG1 appeared to play a central role in the network and was further studied. The transient expression of cpPG1 in papaya results in pulp softening and leaf necrosis in the absence of ethylene action and confirms its role in papaya fruit ripening.	[Fabi, Joao Paulo; Broetto, Sabrina Garcia; Garcia Leme da Silva, Sarah Ligia; Lajolo, Franco Maria; Oliveira do Nascimento, Joao Roberto] Univ Sao Paulo, FCF, Dept Food Sci & Expt Nutr, Sao Paulo, Brazil; [Zhong, Silin] Chinese Univ Hong Kong, Sch Life Sci, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China; [Fabi, Joao Paulo; Lajolo, Franco Maria; Oliveira do Nascimento, Joao Roberto] Univ Sao Paulo, NAPAN Food & Nutr Res Ctr, Sao Paulo, Brazil	Universidade de Sao Paulo; Chinese University of Hong Kong; Universidade de Sao Paulo	Fabi, JP (corresponding author), Univ Sao Paulo, FCF, Dept Food Sci & Expt Nutr, Sao Paulo, Brazil.	jpfabi@usp.br	BROETTO, SABRINA/AAS-9616-2020; zhong, silin/O-7029-2015; Lajolo, Franco M/D-8173-2012; FABI, JOAO PAULO/J-2606-2012; Nascimento, João R.O/C-7260-2012; Fabi, João Paulo/ABB-3450-2021	zhong, silin/0000-0002-0198-7383; Lajolo, Franco M/0000-0003-3958-5934; FABI, JOAO PAULO/0000-0002-7430-7756; Fabi, João Paulo/0000-0002-7430-7756; Broetto, Sabrina/0000-0001-6422-7931; Nascimento, Joao/0000-0003-4475-4544	Sao Paulo Research Foundation (FAPESP) [2002/12452-9, 2008/54476-8, 2003/00932-9, 2007/56515-8, 2009/53329-4, 2008/58653-1]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was financially supported by grants #2002/12452-9 and #2008/54476-8, scholarships to JPF (#2003/00932-9 and #2007/56515-8), SGB (#2009/53329-4) and SLGLS (#2008/58653-1), Sao Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson RG, 2002, PLANT PHYSIOL, V129, P122, DOI 10.1104/pp.010986; Atkinson RG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-129; Bassel GW, 2008, PLANT PHYSIOL, V147, P143, DOI 10.1104/pp.107.110841; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boudart G, 2003, PLANT PHYSIOL, V131, P93, DOI 10.1104/pp.011585; Brummell DA, 2006, FUNCT PLANT BIOL, V33, P103, DOI 10.1071/FP05234; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cantu D, 2008, P NATL ACAD SCI USA, V105, P859, DOI 10.1073/pnas.0709813105; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Chen CC, 2012, PLANT CELL PHYSIOL, V53, P1457, DOI 10.1093/pcp/pcs090; Dalchau N, 2010, P NATL ACAD SCI USA, V107, P13171, DOI 10.1073/pnas.1001429107; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fabi JP, 2007, J AGR FOOD CHEM, V55, P6118, DOI 10.1021/jf070903c; Fabi JP, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-242; Fabi JP, 2010, PLANT SCI, V179, P225, DOI 10.1016/j.plantsci.2010.05.007; Fabi JP, 2009, PLANT PHYSIOL BIOCH, V47, P1075, DOI 10.1016/j.plaphy.2009.08.002; Fabi JP, 2009, SCI HORTIC-AMSTERDAM, V121, P159, DOI 10.1016/j.scienta.2009.01.036; Gapper NE, 2013, PLANT MOL BIOL, V82, P575, DOI 10.1007/s11103-013-0050-3; Hiwasa K, 2003, J EXP BOT, V54, P771, DOI 10.1093/jxb/erg073; Hyodo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078949; Jamet E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-505; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lazan H, 2004, PLANT PHYSIOL BIOCH, V42, P847, DOI 10.1016/j.plaphy.2004.10.007; Mandaokar A, 2006, PLANT J, V46, P984, DOI 10.1111/j.1365-313X.2006.02756.x; Manenoi A, 2007, PHYSIOL PLANTARUM, V131, P470, DOI 10.1111/j.1399-3054.2007.00967.x; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Morgutti S, 2006, NEW PHYTOL, V171, P315, DOI 10.1111/j.1469-8137.2006.01763.x; Nascimento JRO, 1997, J AGR FOOD CHEM, V45, P1103, DOI 10.1021/jf960407g; Ng S, 2013, J BIOL CHEM, V288, P3449, DOI 10.1074/jbc.M112.416727; Nogueira SB, 2012, J PROTEOMICS, V75, P1428, DOI 10.1016/j.jprot.2011.11.015; OTHMAN R, 1998, PLANT PHYSIOL, V118, P1102; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quesada MA, 2009, PLANT PHYSIOL, V150, P1022, DOI 10.1104/pp.109.138297; Santiago-Domenech N, 2008, J EXP BOT, V59, P2769, DOI 10.1093/jxb/ern142; Sanudo-Barajas JA, 2009, POSTHARVEST BIOL TEC, V51, P158, DOI 10.1016/j.postharvbio.2008.07.018; Sekine D, 2006, PHYSIOL PLANTARUM, V126, P163, DOI 10.1111/j.1399-3054.2006.00583.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi Q., 1990, GEL ELECTROPHORESIS; Shiga TM, 2009, J AGR FOOD CHEM, V57, P7064, DOI 10.1021/jf900073b; Soh CP, 2006, PHYTOCHEMISTRY, V67, P242, DOI 10.1016/j.phytochem.2005.09.032; Spolaore S, 2001, J EXP BOT, V52, P845, DOI 10.1093/jexbot/52.357.845; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhong SL, 2008, TRANSGENIC RES, V17, P985, DOI 10.1007/s11248-008-9199-y; Zuber H, 2010, PLANT PHYSIOL, V154, P913, DOI 10.1104/pp.110.162123	47	54	58	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105685	10.1371/journal.pone.0105685	http://dx.doi.org/10.1371/journal.pone.0105685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162506	Green Submitted, Green Published, gold			2022-12-25	WOS:000340880900044
J	Voigt, CC; Thalwitzer, S; Melzheimer, J; Blanc, AS; Jago, M; Wachter, B				Voigt, Christian C.; Thalwitzer, Susanne; Melzheimer, Joerg; Blanc, Anne-Sophie; Jago, Mark; Wachter, Bettina			The Conflict between Cheetahs and Humans on Namibian Farmland Elucidated by Stable Isotope Diet Analysis	PLOS ONE			English	Article							ACINONYX-JUBATUS; CARBON ISOTOPES; DISCRIMINATION FACTORS; AFRICAN SAVANNA; EXTINCTION RISK; PREY; NITROGEN; ECOLOGY; TISSUE; FRACTIONATION	Large areas of Namibia are covered by farmland, which is also used by game and predator species. Because it can cause conflicts with farmers when predators, such as cheetahs (Acinonyx jubatus), hunt livestock, we assessed whether livestock constitutes a significant part of the cheetah diet by analysing the stable isotope composition of blood and tissue samples of cheetahs and their potential prey species. According to isotopic similarities, we defined three isotopic categories of potential prey: members of a C4 food web with high delta N-15 values (gemsbok, cattle, springhare and guinea fowl) and those with low delta N-15 values (hartebeest, warthog), and members of a C3 food web, namely browsers (eland, kudu, springbok, steenbok and scrub hare). We quantified the trophic discrimination of heavy isotopes in cheetah muscle in 9 captive individuals and measured an enrichment for N-15 (3.2%) but not for C-13 in relation to food. We captured 53 free-ranging cheetahs of which 23 were members of groups. Cheetahs of the same group were isotopically distinct from members of other groups, indicating that group members shared their prey. Solitary males (n = 21) and males in a bachelor groups (n = 11) fed mostly on hartebeest and warthogs, followed by browsers in case of solitary males, and by grazers with high delta N-15 values in case of bachelor groups. Female cheetahs (n = 9) predominantly fed on browsers and used also hartebeest and warthogs. Mixing models suggested that the isotopic prey category that included cattle was only important, if at all, for males living in bachelor groups. Stable isotope analysis of fur, muscle, red blood cells and blood plasma in 9 free-ranging cheetahs identified most individuals as isotopic specialists, focussing on isotopically distinct prey categories as their food.	[Voigt, Christian C.; Thalwitzer, Susanne; Melzheimer, Joerg; Wachter, Bettina] Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Ecol, Berlin, Germany; [Blanc, Anne-Sophie] Univ Neuchatel, Inst Zool, CH-2007 Neuchatel, Switzerland; [Jago, Mark] AfriCat Fdn, Farm Okonjima, Otjiwarongo, Otjozondjupa, Namibia	Leibniz Institut fur Zoo und Wildtierforschung; University of Neuchatel	Voigt, CC (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Ecol, Berlin, Germany.	voigt@izw-berlin.de	Wachter, Bettina/AAJ-9663-2020	Wachter, Bettina/0000-0002-0414-2298	Messerli Foundation (Switzerland)	Messerli Foundation (Switzerland)	BW, ST, and JM were supported by the Messerli Foundation (Switzerland), grant #2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 1986, OECOLOGIA, V69, P395, DOI 10.1007/BF00377062; Barnes JI, 1996, S AFR J WILDL RES, V26, P37; Ben-David M, 2012, J MAMMAL, V93, P399, DOI 10.1644/11-MAMM-S-168.1; BENDER MM, 1971, PHYTOCHEMISTRY, V10, P1239, DOI 10.1016/S0031-9422(00)84324-1; Berger J, 2001, ECOL APPL, V11, P947, DOI 10.2307/3061004; Beschta RL, 2010, FOREST ECOL MANAG, V260, P915, DOI 10.1016/j.foreco.2010.06.012; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.2307/3072028; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Caro T., 1994, CHEETAHS SERENGETI P; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cerling TE, 2003, J MAMMAL, V84, P456, DOI 10.1644/1545-1542(2003)084&lt;0456:DOEABB&gt;2.0.CO;2; Cerling TE, 2009, P NATL ACAD SCI USA, V106, P8093, DOI 10.1073/pnas.0902192106; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Codron D, 2007, S AFR J WILDL RES, V37, P117, DOI 10.3957/0379-4369-37.2.117; Codron D, 2007, EUR J WILDLIFE RES, V53, P161, DOI 10.1007/s10344-006-0075-x; del Rio CM, 2009, OECOLOGIA, V161, P149, DOI 10.1007/s00442-009-1357-2; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Derbridge JJ, 2012, J WILDLIFE MANAGE, V76, P1277, DOI 10.1002/jwmg.359; Du Toit JT, 1999, BIODIVERS CONSERV, V8, P1643, DOI 10.1023/A:1008959721342; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Fry B, 2013, MAR ECOL PROG SER, V472, P1, DOI 10.3354/meps10168; Jackson P., 1996, BIOL CONSERVATION; Jenkins SG, 2001, OECOLOGIA, V129, P336, DOI 10.1007/s004420100755; Lehmann D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072190; Marker LL, 2003, BIOL CONSERV, V114, P401, DOI 10.1016/S0006-3207(03)00068-5; Marker LL, 2003, J MAMMAL, V84, P840, DOI 10.1644/BRB-036; Marker LL, 2003, S AFR J WILDL RES, V33, P43; Marker-Kraus L., 1996, CHEETAH SURVIVAL NAM; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; Mills M.G.L., 1984, Koedoe, V27, P281; Mills MGL, 2004, WILDLIFE BIOL, V10, P177, DOI 10.2981/wlb.2004.024; MILLS MGL, 1978, Z TIERPSYCHOL, V48, P113; Newsome SD, 2012, J MAMMAL, V93, P329, DOI 10.1644/11-MAMM-S-187.1; Parnell A., 2011, SIAR STABLE ISOTOPE; Parng E, 2014, J MAMMAL, V95, P151, DOI 10.1644/13-MAMM-A-014.1; Popa-Lisseanu AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030388; R Core Team, 2010, R LANG ENV STAT COMP; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Sponheimer M., 2003, Koedoe, V46, P101; Thalwitzer S, 2010, CLIN VACCINE IMMUNOL, V17, P232, DOI 10.1128/CVI.00345-09; TIESZEN LL, 1979, OECOLOGIA, V37, P337, DOI 10.1007/BF00347910; Urton EJM, 2005, OECOLOGIA, V145, P317, DOI 10.1007/s00442-005-0124-2; Voigt CC, 2006, FUNCT ECOL, V20, P656, DOI 10.1111/j.1365-2435.2006.01154.x; Voigt CC, 2008, OECOLOGIA, V157, P31, DOI 10.1007/s00442-008-1057-3; Voigt CC, 2013, WILDLIFE BIOL, V19, P311, DOI 10.2981/13-012; Wachter B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038066; Wachter B, 2011, CONSERV LETT, V4, P47, DOI 10.1111/j.1755-263X.2010.00142.x; Wachter Bettina, 2006, Cat News, V44, P8; West AG, 2004, FUNCT ECOL, V18, P616, DOI 10.1111/j.0269-8463.2004.00862.x	53	20	20	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e101917	10.1371/journal.pone.0101917	http://dx.doi.org/10.1371/journal.pone.0101917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162403	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900002
J	Miotto, EC; Balardin, JB; Vieira, G; Sato, JR; Martin, MDM; Scaff, M; Teixeira, MJ; Amaro, E				Miotto, Eliane C.; Balardin, Joana B.; Vieira, Gilson; Sato, Joao R.; Martin, Maria da Graca M.; Scaff, Milberto; Teixeira, Manoel J.; Amaro Junior, Edson			Right Inferior Frontal Gyrus Activation Is Associated with Memory Improvement in Patients with Left Frontal Low-Grade Glioma Resection	PLOS ONE			English	Article							PREFRONTAL CORTEX; BRAIN; PLASTICITY; STRATEGIES; LOBES	Patients with low-grade glioma (LGG) have been studied as a model of functional brain reorganization due to their slow-growing nature. However, there is no information regarding which brain areas are involved during verbal memory encoding after extensive left frontal LGG resection. In addition, it remains unknown whether these patients can improve their memory performance after instructions to apply efficient strategies. The neural correlates of verbal memory encoding were investigated in patients who had undergone extensive left frontal lobe (LFL) LGG resections and healthy controls using fMRI both before and after directed instructions were given for semantic organizational strategies. Participants were scanned during the encoding of word lists under three different conditions before and after a brief period of practice. The conditions included semantically unrelated (UR), related-non-structured (RNS), and related-structured words (RS), allowing for different levels of semantic organization. All participants improved on memory recall and semantic strategy application after the instructions for the RNS condition. Healthy subjects showed increased activation in the left inferior frontal gyrus (IFG) and middle frontal gyrus (MFG) during encoding for the RNS condition after the instructions. Patients with LFL excisions demonstrated increased activation in the right IFG for the RNS condition after instructions were given for the semantic strategies. Despite extensive damage in relevant areas that support verbal memory encoding and semantic strategy applications, patients that had undergone resections for LFL tumor could recruit the right-sided contralateral homologous areas after instructions were given and semantic strategies were practiced. These results provide insights into changes in brain activation areas typically implicated in verbal memory encoding and semantic processing.	[Miotto, Eliane C.; Balardin, Joana B.; Scaff, Milberto; Teixeira, Manoel J.] Univ Sao Paulo, Dept Neurol, Sao Paulo, Brazil; [Vieira, Gilson; Martin, Maria da Graca M.; Amaro Junior, Edson] Univ Sao Paulo, Dept Radiol, Sao Paulo, Brazil; [Sato, Joao R.] Univ Fed ABC, Ctr Math Computat & Cognit, Santo Andre, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do ABC (UFABC)	Miotto, EC (corresponding author), Univ Sao Paulo, Dept Neurol, Sao Paulo, Brazil.	ecmiotto@usp.br	amaro, edson/GLR-7735-2022; Amaro, Edson/B-6653-2009; Vieira, Gilson/H-9984-2015; Miotto, Eliane C/B-5380-2013; Balardin, Joana/I-5561-2016	amaro, edson/0000-0002-5889-1382; Amaro, Edson/0000-0002-5889-1382; Vieira, Gilson/0000-0001-5877-2810; Miotto, Eliane C/0000-0003-2711-1627; Sato, Joao Ricardo/0000-0002-7503-9781	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2000/11802-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This project was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP N. 2000/11802-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MP, 2009, J COGNITIVE NEUROSCI, V21, P1422, DOI 10.1162/jocn.2009.21094; Belleville S, 2011, BRAIN, V134, P1623, DOI 10.1093/brain/awr037; Champod AS, 2010, J NEUROSCI, V30, P3849, DOI 10.1523/JNEUROSCI.0097-10.2010; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Duffau H, 2003, J NEUROL NEUROSUR PS, V74, P901, DOI 10.1136/jnnp.74.7.901; Duffau H, 2012, CORTEX, V48, P120, DOI 10.1016/j.cortex.2011.04.029; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; Fridriksson J, 2012, NEUROIMAGE, V60, P854, DOI 10.1016/j.neuroimage.2011.12.057; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Kirchhoff BA, 2012, CEREB CORTEX, V22, P788, DOI 10.1093/cercor/bhr129; Klein M, 2012, J NEURO-ONCOL, V108, P309, DOI 10.1007/s11060-012-0811-x; Miotto EC, 1996, CORTEX, V32, P613, DOI 10.1016/S0010-9452(96)80034-7; Miotto EC, 2006, HUM BRAIN MAPP, V27, P288, DOI 10.1002/hbm.20184; Miotto EC, 2013, CLIN NEUROL NEUROSUR, V115, P309, DOI 10.1016/j.clineuro.2012.05.024; Miotto EC, 2011, ARQ NEURO-PSIQUIAT, V69, P596, DOI 10.1590/S0004-282X2011000500005; Nascimento E., 2004, WAIS III ESCALA INTE; Rey A., 1958, LEXAMEN CLINIQUE PSY; Richardson JD, 2011, BEHAV NEUROL, V24, P117, DOI [10.3233/BEN-2011-0283, 10.1155/2011/380810]; Savage CR, 2001, BRAIN, V124, P219, DOI 10.1093/brain/124.1.219; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Warrington EK., 1984, RECOGNITION MEMORY T	25	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105987	10.1371/journal.pone.0105987	http://dx.doi.org/10.1371/journal.pone.0105987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157573	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303200084
J	Wessels, S; Sharifi, RA; Luehmann, LM; Rueangsri, S; Krause, I; Pach, S; Hoerstgen-Schwark, G; Knorr, C				Wessels, Stephan; Sharifi, Reza Ahmad; Luehmann, Liane Magdalena; Rueangsri, Sawichaya; Krause, Ina; Pach, Sabrina; Hoerstgen-Schwark, Gabriele; Knorr, Christoph			Allelic Variant in the Anti-Mullerian Hormone Gene Leads to Autosomal and Temperature-Dependent Sex Reversal in a Selected Nile Tilapia Line	PLOS ONE			English	Article							OREOCHROMIS-NILOTICUS; DIMORPHIC EXPRESSION; LINKAGE MAP; AMH; GENOME; LOCI; DIFFERENTIATION; ASSOCIATION; DUPLICATION; SUBSTANCE	Owing to the demand for sustainable sex-control protocols in aquaculture, research in tilapia sex determination is gaining momentum. The mutual influence of environmental and genetic factors hampers disentangling the complex sex determination mechanism in Nile tilapia (Oreochromis niloticus). Previous linkage analyses have demonstrated quantitative trait loci for the phenotypic sex on linkage groups 1, 3, and 23. Quantitative trait loci for temperature-dependent sex reversal similarly reside on linkage group 23. The anti-Mullerian hormone gene (amh), located in this genomic region, is important for sexual fate in higher vertebrates, and shows sexually dimorphic expression in Nile tilapia. Therefore this study aimed at detecting allelic variants and marker-sex associations in the amh gene. Sequencing identified six allelic variants. A significant effect on the phenotypic sex for SNP ss831884014 (p < 0.0017) was found by stepwise logistic regression. The remaining variants were not significantly associated. Functional annotation of SNP ss831884014 revealed a non-synonymous amino acid substitution in the amh protein. Consequently, a fluorescence resonance energy transfer (FRET) based genotyping assay was developed and validated with a representative sample of fish. A logistic linear model confirmed a highly significant effect of the treatment and genotype on the phenotypic sex, but not for the interaction term (treatment: p<0.0001; genotype: p<0.0025). An additive genetic model proved a linear allele substitution effect of 12% in individuals from controls and groups treated at high temperature, respectively. Moreover, the effect of the genotype on the male proportion was significantly higher in groups treated at high temperature, giving 31% more males on average of the three genotypes. In addition, the groups treated at high temperature showed a positive dominance deviation (+11.4% males). In summary, marker-assisted selection for amh variant ss831884014 seems to be highly beneficial to increase the male proportion in Nile tilapia, especially when applying temperature-induced sex reversal.	[Wessels, Stephan; Luehmann, Liane Magdalena; Krause, Ina; Hoerstgen-Schwark, Gabriele] Goettingen Univ, Dept Anim Sci Aquaculture & Water Ecol, Gottingen, Germany; [Sharifi, Reza Ahmad] Goettingen Univ, Dept Anim Sci Anim Breeding & Genet, Gottingen, Germany; [Rueangsri, Sawichaya] Chiang Mai Univ, Fac Agr, Dept Anim & Aquat Sci, Chiang Mai 50000, Thailand; [Pach, Sabrina] Goettingen Univ, Dept Anim Sci Mol Biol & Mol Diagnost Livestock, Gottingen, Germany; [Knorr, Christoph] Goettingen Univ, Dept Anim Sci Livestock Biotechnol & Reprod, Gottingen, Germany	Chiang Mai University	Wessels, S (corresponding author), Goettingen Univ, Dept Anim Sci Aquaculture & Water Ecol, Gottingen, Germany.	swessel@gwdg.de			German Research Foundation DFG [DFG WE4434/2-1]	German Research Foundation DFG(German Research Foundation (DFG))	This work was funded by the German Research Foundation DFG (DFG WE4434/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; Baroiller JF, 2009, COMP BIOCHEM PHYS A, V153, P30, DOI 10.1016/j.cbpa.2008.11.018; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cnaani A, 2008, SEX DEV, V2, P43, DOI 10.1159/000117718; Cnaani A, 2007, SEX DEV, V1, P207, DOI 10.1159/000102109; Cnaani A, 2004, MOL GENET GENOMICS, V272, P162, DOI 10.1007/s00438-004-1045-1; Cnaani A, 2008, BIOL LETTERS, V4, P700, DOI 10.1098/rsbl.2008.0286; Cressey D, NATURE NEWS BLOG; Cressey D, 2009, NATURE, V458, P398, DOI 10.1038/458398a; Eshel O, 2012, G3-GENES GENOM GENET, V2, P35, DOI 10.1534/g3.111.001545; Eshel O, 2011, ANIM GENET, V42, P222, DOI 10.1111/j.1365-2052.2010.02128.x; Gandolfi G, 2011, MEAT SCI, V89, P478, DOI 10.1016/j.meatsci.2011.05.015; Gjedrem T, 2012, AQUACULTURE, V344, P12, DOI 10.1016/j.aquaculture.2012.03.003; GUERRERO RD, 1974, PROG FISH CULT, V36, P56, DOI 10.1577/1548-8659(1974)36[56:AASMFS]2.0.CO;2; Guyon R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-222; Halm S, 2007, GENE, V388, P148, DOI 10.1016/j.gene.2006.10.018; Hattori RS, 2012, P NATL ACAD SCI USA, V109, P2955, DOI 10.1073/pnas.1018392109; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Ijiri S, 2008, BIOL REPROD, V78, P333, DOI 10.1095/biolreprod.107.064246; Josso N, 2005, HUM REPROD UPDATE, V11, P351, DOI 10.1093/humupd/dmi014; Karayucel I, 2004, AQUACULTURE, V234, P51, DOI 10.1016/j.aquaculture.2003.12.016; Kluver N, 2007, DEV DYNAM, V236, P271, DOI 10.1002/dvdy.20997; Lee BY, 2007, ANIM GENET, V38, P85, DOI 10.1111/j.1365-2052.2007.01563.x; Lee BY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-278; Lee BY, 2005, GENETICS, V170, P237, DOI 10.1534/genetics.104.035022; Lee BY, 2004, HEREDITY, V92, P543, DOI 10.1038/sj.hdy.6800453; Lee BY, 2003, ANIM GENET, V34, P379, DOI 10.1046/j.1365-2052.2003.01035.x; LEWONTIN RC, 1964, GENETICS, V49, P49; Liping L, 2011, P 9 INT S TIL AQ; Liu F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-58; Luhmann LM, 2012, SEX DEV, V6, P247, DOI 10.1159/000339705; Miura T, 2002, DEVELOPMENT, V129, P2689; Palaiokostas C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068389; Poonlaphdecha S, 2011, SEX DEV, V5, P33, DOI 10.1159/000322579; Poonlaphdecha S, 2013, GEN COMP ENDOCRINOL; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Shirak A, 2002, J HERED, V93, P270, DOI 10.1093/jhered/93.4.270; Shirak A, 2006, GENETICS, V174, P1573, DOI 10.1534/genetics.106.059030; Shoemaker-Daly CM, 2010, DEV DYNAM, V239, P1061, DOI 10.1002/dvdy.22266; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; Soler L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-636; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wessels S, 2007, AQUACULTURE, V272, pS80, DOI 10.1016/j.aquaculture.2007.08.009; Wessels S, 2011, AQUACULTURE, V318, P79, DOI 10.1016/j.aquaculture.2011.04.039; Yoshinaga N, 2004, BIOCHEM BIOPH RES CO, V322, P508, DOI 10.1016/j.bbrc.2004.07.162	47	25	25	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104795	10.1371/journal.pone.0104795	http://dx.doi.org/10.1371/journal.pone.0104795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157978	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303200018
J	Warner, N; Burberry, A; Pliakas, M; McDonald, C; Nunez, G				Warner, Neil; Burberry, Aaron; Pliakas, Maria; McDonald, Christine; Nunez, Gabriel			A Genome-wide Small Interfering RNA (siRNA) Screen Reveals Nuclear Factor-kappa B (NF-kappa B)-independent Regulators of NOD2-induced Interleukin-8 (IL-8) Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERMANSKY-PUDLAK-SYNDROME; CROHNS-DISEASE; PROINFLAMMATORY CYTOKINES; CARD15 MUTATIONS; BINDING-PROTEIN; NOD2; INNATE; EXPRESSION; PATHWAY; HOST	NOD2 encodes an intracellular multidomain pattern recognition receptor that is the strongest known genetic risk factor in the pathogenesis of Crohn disease (CD), a chronic relapsing inflammatory disorder of the intestinal tract. NOD2 functions as a sensor for bacterial cell wall components and activates proinflammatory and antimicrobial signaling pathways. Here, using a genome-wide small interfering RNA (siRNA) screen, we identify numerous genes that regulate secretion of the proinflammatory cytokine IL-8 in response to NOD2 activation. Moreover, many of the identified IL-8 regulators are linked by protein-protein interactions, revealing subnetworks of highly connected IL-8 regulators implicated in processes such as vesicle formation, mRNA stability, and protein ubiquitination and trafficking. A TNF alpha counterscreen to induce IL-8 secretion in an NOD2-independent manner reveals that the majority of the identified regulators affect IL-8 secretion irrespective of the initiating stimuli. Using immortalized macrophages, we validate the ubiquitin protease, USP8, and the endosomal sorting protein, VPS28, as negative regulators of NOD2-induced cytokine secretion. Interestingly, several genes that affect NOD2-induced IL-8 secretion are present in loci associated with CD risk by genome-wide association studies, supporting a role for the NOD2/IL-8 pathway, and not just NOD2, in the pathogenesis of CD. Overall, this screen provides a valuable resource in the advancement of our understanding of the genes that regulate the secretion of IL-8.	[Warner, Neil; Burberry, Aaron; Nunez, Gabriel] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Pliakas, Maria; Nunez, Gabriel] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [McDonald, Christine] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cleveland Clinic Foundation	Nunez, G (corresponding author), Univ Michigan, Dept Pathol, Sch Med, 1500 E Med Ctr Dr,Rm 4215 CC, Ann Arbor, MI 48109 USA.	gabriel.nunez@umich.edu	Warner, Neil/ABE-7329-2020; Nuñez, Gabriel/A-7160-2014	Warner, Neil/0000-0002-9207-5979; McDonald, Christine/0000-0002-6745-9487	National Institutes of Health [R01DK082437, 2R01DK61707]; Crohn's and Colitis Foundation of America; Eli and Edythe L. Broad Foundation Medical Research Program for Inflammatory Bowel Disease; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061707, R01DK082437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Eli and Edythe L. Broad Foundation Medical Research Program for Inflammatory Bowel Disease; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK082437 (to C. M.) and 2R01DK61707 (to G. N.). This work was also supported by the Crohn's and Colitis Foundation of America and the Eli and Edythe L. Broad Foundation Medical Research Program for Inflammatory Bowel Disease.	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; ADAMI C, 1993, J LEUKOCYTE BIOL, V53, P475, DOI 10.1002/jlb.53.4.475; Adler J, 2011, AM J GASTROENTEROL, V106, P699, DOI 10.1038/ajg.2011.19; Balakathiresan NS, 2009, AM J PHYSIOL-LUNG C, V296, pL1012, DOI 10.1152/ajplung.90601.2008; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Beste MT, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007988; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Cao HP, 2004, BIOCHEMISTRY-US, V43, P13724, DOI 10.1021/bi049014y; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen JD, 2010, BIOCHEM SOC T, V38, P1082, DOI 10.1042/BST0381082; Chiang CY, 2012, CELL HOST MICROBE, V11, P306, DOI 10.1016/j.chom.2012.02.002; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Cleynen I, 2013, GUT, V62, P1556, DOI 10.1136/gutjnl-2011-300777; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Dauletbaev N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.205724; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Eliopoulos AG, 1999, J BIOL CHEM, V274, P16085, DOI 10.1074/jbc.274.23.16085; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gewurz BE, 2012, P NATL ACAD SCI USA, V109, P2467, DOI 10.1073/pnas.1120542109; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hedvat CV, 2004, J BIOL CHEM, V279, P6395, DOI 10.1074/jbc.M307524200; Hisatsune J, 2008, J IMMUNOL, V180, P5017, DOI 10.4049/jimmunol.180.7.5017; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kim YG, 2011, J IMMUNOL, V187, P2849, DOI 10.4049/jimmunol.1001854; Kjellerup RB, 2008, EXP DERMATOL, V17, P498, DOI 10.1111/j.1600-0625.2007.00672.x; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Lipinski S, 2012, P NATL ACAD SCI USA, V109, P21426, DOI 10.1073/pnas.1209673109; Loppalainen M, 2008, INFLAMM BOWEL DIS, V14, P176, DOI 10.1002/ibd.20287; Manetsch M, 2012, CELL SIGNAL, V24, P907, DOI 10.1016/j.cellsig.2011.12.013; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Richmond AL, 2012, GASTROENTEROLOGY, V142, P1483, DOI 10.1053/j.gastro.2012.02.040; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rowlett RM, 2008, AM J PHYSIOL-GASTR L, V294, pG452, DOI 10.1152/ajpgi.00077.2007; Seidelin JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007794; Seward SL, 2013, PEDIATRICS, V132, P153, DOI 10.1542/peds.2012-4003; Sharma D, 2013, INFECT IMMUN, V81, P3035, DOI 10.1128/IAI.00653-13; Simpson JC, 2012, NAT CELL BIOL, V14, P764, DOI 10.1038/ncb2510; Smibert CA, 1999, RNA, V5, P1535, DOI 10.1017/S1355838299991392; Tanghetti Emil A, 2013, J Clin Aesthet Dermatol, V6, P27; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Tigno-Aranjuez JT, 2012, BBA-MOL CELL RES, V1823, P2022, DOI 10.1016/j.bbamcr.2012.03.017; Till A, 2008, J CELL SCI, V121, P487, DOI 10.1242/jcs.016980; van Heel DA, 2006, INFLAMM BOWEL DIS, V12, P598, DOI 10.1097/01.ibd.0000225344.21979.89; Van Limbergen J, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.27; Warner N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003305; Watari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068351; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Wendler F, 2010, EMBO J, V29, P304, DOI 10.1038/emboj.2009.350; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; Yeretssian G, 2011, NATURE, V474, P96, DOI 10.1038/nature09982; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233	73	33	35	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28213	28224		10.1074/jbc.M114.574756	http://dx.doi.org/10.1074/jbc.M114.574756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25170077	Green Published, hybrid			2022-12-25	WOS:000343765400018
J	Han, P; Niu, CY; Desneux, N				Han, Peng; Niu, Chang-ying; Desneux, Nicolas			Identification of Top-Down Forces Regulating Cotton Aphid Population Growth in Transgenic Bt Cotton in Central China	PLOS ONE			English	Article							PROPYLAEA-JAPONICA COLEOPTERA; SOYBEAN APHID; NATURAL ENEMIES; GENERALIST PREDATORS; SPODOPTERA-LITURA; HYMENOPTERA-BRACONIDAE; BENEFICIAL ARTHROPODS; HELICOVERPA-ARMIGERA; GLYCINES HOMOPTERA; BIOLOGICAL-CONTROL	The cotton aphid Aphis gossypii Glover is the main aphid pest in cotton fields in the Yangtze River Valley Cotton-planting Zone (YRZ) in central China. Various natural enemies may attack the cotton aphid in Bt cotton fields but no studies have identified potential specific top-down forces that could help manage this pest in the YRZ in China. In order to identify possibilities for managing the cotton aphid, we monitored cotton aphid population dynamics and identified the effect of natural enemies on cotton aphid population growth using various exclusion cages in transgenic Cry1Ac (Bt)+CpTI (Cowpea trypsin inhibitor) cotton field in 2011. The aphid population growth in the open field (control) was significantly lower than those protected or restricted from exposure to natural enemies in the various exclusion cage types tested. The ladybird predator Propylaea japonica Thunberg represented 65% of Coccinellidae predators, and other predators consisted mainly of syrphids (2.1%) and spiders (1.5%). The aphid parasitoids Aphidiines represented 76.7% of the total count of the natural enemy guild (mainly Lysiphlebia japonica Ashmead and Binodoxys indicus Subba Rao & Sharma). Our results showed that P. japonica can effectively delay the establishment and subsequent population growth of aphids during the cotton growing season. Aphidiines could also reduce aphid density although their impact may be shadowed by the presence of coccinellids in the open field (likely both owing to resource competition and intraguild predation). The implications of these results are discussed in a framework of the compatibility of transgenic crops and top-down forces exerted by natural enemy guild.	[Han, Peng; Niu, Chang-ying] Huazhong Agr Univ, Plant Sci & Technol Coll, Hubei Key Lab Insect Resources Applicat & Sustain, Wuhan, Peoples R China; [Han, Peng; Desneux, Nicolas] INRA, French Natl Inst Agr Res, Sophia Antipolis, France	Huazhong Agricultural University; INRAE	Niu, CY (corresponding author), Huazhong Agr Univ, Plant Sci & Technol Coll, Hubei Key Lab Insect Resources Applicat & Sustain, Wuhan, Peoples R China.	niuchangying88@163.com; nicolas.desneux@sophia.inra.fr	Desneux, Nicolas/J-6262-2013; Han, Peng/Y-4457-2019	Han, Peng/0000-0002-5941-9362	National Natural Science Foundation of China [IBN-31071690, 31371945]; International Atomic Energy Agency [16015, 17153]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Atomic Energy Agency(International Atomic Energy Agency)	Funding: This study was financially supported by the National Natural Science Foundation of China (Grant IBN-31071690, 31371945), and International Atomic Energy Agency (via Research Contract No. 16015, 17153 to CYN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai TC, 2011, ECOL COMPLEX, V8, P9, DOI 10.1016/j.ecocom.2010.08.002; Amini B, 2012, J ENTOMOL RES SOC, V14, P15; Azzouz H, 2005, J INSECT PHYSIOL, V51, P941, DOI 10.1016/j.jinsphys.2005.04.009; Biondi A, 2012, PEST MANAG SCI, V68, P1523, DOI 10.1002/ps.3396; Bogran CE, 2002, ECOLOGY, V83, P653, DOI 10.1890/0012-9658(2002)083[0653:ICAIPF]2.0.CO;2; Bompard A, 2013, POPUL ECOL, V55, P433, DOI 10.1007/s10144-013-0371-8; Caballero-Lopez B, 2012, J PEST SCI, V85, P81, DOI 10.1007/s10340-011-0409-7; Carrero DA, 2013, J PEST SCI, V86, P437, DOI 10.1007/s10340-013-0487-9; Chacon JM, 2010, OECOLOGIA, V164, P213, DOI 10.1007/s00442-010-1611-7; Chailleux A, 2013, J PEST SCI, V86, P533, DOI 10.1007/s10340-013-0498-6; Chen LZ, 2011, J PEST SCI, V84, P9, DOI 10.1007/s10340-010-0319-0; Velasco-Hernandez MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080679; Costamagna AC, 2007, ECOL APPL, V17, P441, DOI 10.1890/06-0284; Costamagna AC, 2006, ECOL APPL, V16, P1619, DOI 10.1890/1051-0761(2006)016[1619:PETCOS]2.0.CO;2; Deng YX, 1998, FLA ENTOMOL, V81, P415, DOI 10.2307/3495931; Denno RF, 2002, ECOLOGY, V83, P1443, DOI 10.1890/0012-9658(2002)083[1443:BUFMNE]2.0.CO;2; Desneux N, 2006, J PEST SCI, V79, P95, DOI 10.1007/s10340-006-0121-1; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2006, ENVIRON ENTOMOL, V35, P1342, DOI 10.1603/0046-225X(2006)35[1342:SOPGOT]2.0.CO;2; Desneux N, 2012, ECOL LETT, V15, P453, DOI 10.1111/j.1461-0248.2012.01754.x; Desneux N, 2010, ECOTOXICOLOGY, V19, P1642, DOI 10.1007/s10646-010-0550-8; Desneux N, 2010, ECOTOXICOLOGY, V19, P1183, DOI 10.1007/s10646-010-0502-3; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Desneux N, 2009, ANN ENTOMOL SOC AM, V102, P925, DOI 10.1603/008.102.0603; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; Desneux N, 2009, J INSECT PHYSIOL, V55, P321, DOI 10.1016/j.jinsphys.2008.12.009; Elliott N, 1996, OECOLOGIA, V105, P537, DOI 10.1007/BF00330017; Fox TB, 2005, BIOCONTROL, V50, P545, DOI 10.1007/s10526-004-6592-1; Han P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04455; Han P, 2012, ECOTOXICOLOGY, V21, P2214, DOI 10.1007/s10646-012-0976-2; Han P, 2010, ECOTOXICOLOGY, V19, P1612, DOI 10.1007/s10646-010-0546-4; Han P, 2010, ECOTOXICOLOGY, V19, P1452, DOI 10.1007/s10646-010-0530-z; Harwood JD, 2007, MOL ECOL, V16, P4390, DOI 10.1111/j.1365-294X.2007.03482.x; Hawkins BA, 1997, OECOLOGIA, V112, P566, DOI 10.1007/s004420050346; Hejcman M, 2012, J PEST SCI, V85, P191, DOI 10.1007/s10340-012-0414-5; Hou ZY, 1997, J APPL ENTOMOL, V121, P9; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Juen A, 2012, J PEST SCI, V85, P89, DOI 10.1007/s10340-011-0406-x; Kuusk AK, 2012, J PEST SCI, V85, P253, DOI 10.1007/s10340-012-0431-4; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Liu J, 2004, ANN ENTOMOL SOC AM, V97, P235, DOI 10.1603/0013-8746(2004)097[0235:PDOAGH]2.0.CO;2; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lu ZZ, 2013, J PEST SCI, V86, P695, DOI 10.1007/s10340-013-0517-7; Lundgren JG, 2009, CROP PROT, V28, P1017, DOI 10.1016/j.cropro.2009.06.001; Lundgren JG, 2009, BIOCONTROL, V54, P135, DOI 10.1007/s10526-008-9165-x; Marcic D, 2012, J PEST SCI, V85, P395, DOI 10.1007/s10340-012-0442-1; Michaud JP, 2002, ANN ENTOMOL SOC AM, V95, P531, DOI 10.1603/0013-8746(2002)095[0531:CBCACR]2.0.CO;2; Naranjo SE, 2001, CROP PROT, V20, P835, DOI 10.1016/S0261-2194(01)00115-6; Norris R.F., 2003, CONCEPTS INTEGRATED; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Ramirez-Romero R, 2008, PESTIC BIOCHEM PHYS, V91, P110, DOI 10.1016/j.pestbp.2008.01.010; Romeis J, 2011, J APPL ENTOMOL, V135, P1, DOI 10.1111/j.1439-0418.2010.01546.x; Shad SA, 2012, J PEST SCI, V85, P153, DOI 10.1007/s10340-011-0404-z; Stary P., 1979, APHID PARASITES HYME; Stary P, 1967, REVISION FAR E ASIAN; Stary P, 1966, APHID PARASITES CZEC; Stiling P, 1997, ECOLOGY, V78, P1602, DOI 10.1890/0012-9658(1997)078[1602:EMOTDA]2.0.CO;2; Straub CS, 2013, J PEST SCI, V86, P235, DOI 10.1007/s10340-012-0465-7; Sun Chang-Gui, 2003, Acta Entomologica Sinica, V46, P705; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Takada H, 2011, ENTOMOL SCI, V14, P216, DOI 10.1111/j.1479-8298.2010.00422.x; Wan P, 2008, ENVIRON ENTOMOL, V37, P1043, DOI 10.1603/0046-225X(2008)37[1043:PDOSLL]2.0.CO;2; WEISENBURGER DD, 1993, HUM PATHOL, V24, P571, DOI 10.1016/0046-8177(93)90234-8; Wratten SD, 2012, AGR ECOSYST ENVIRON, V159, P112, DOI 10.1016/j.agee.2012.06.020; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Xu Y, 2012, J INTEGR AGR, V11, P1493, DOI 10.1016/S2095-3119(12)60149-X; Yi F, 2012, MOLECULES, V17, P7533, DOI 10.3390/molecules17067533; Yuan XH, 2012, J PEST SCI, V85, P497, DOI 10.1007/s10340-012-0456-8; Zappala L, 2013, J PEST SCI, V86, P635, DOI 10.1007/s10340-013-0531-9; Zhang GF, 2006, ENVIRON ENTOMOL, V35, P143, DOI 10.1603/0046-225X-35.1.143; Zhang GF, 2007, ENTOMOL EXP APPL, V123, P81, DOI 10.1111/j.1570-7458.2007.00528.x; Zhang GF, 2006, CROP PROT, V25, P527, DOI 10.1016/j.cropro.2005.08.008; Zhang SY, 2006, J APPL ENTOMOL, V130, P206, DOI 10.1111/j.1439-0418.2006.01049.x; Zhou Hong-Xu, 2004, Acta Entomologica Sinica, V47, P538; Zhu SR, 2006, ZOOL STUD, V45, P98	75	34	37	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e102980	10.1371/journal.pone.0102980	http://dx.doi.org/10.1371/journal.pone.0102980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170907	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500007
J	Peng, JJ; Ding, Y; Tu, SS; Shi, DB; Sun, L; Li, XX; Wu, HB; Cai, SJ				Peng, Junjie; Ding, Ying; Tu, Shanshan; Shi, Debing; Sun, Liang; Li, Xinxiang; Wu, Hongbin; Cai, Sanjun			Prognostic Nomograms for Predicting Survival and Distant Metastases in Locally Advanced Rectal Cancers	PLOS ONE			English	Article							LYMPH-NODE RATIO; POSTOPERATIVE CHEMORADIOTHERAPY; COLORECTAL-CANCER; PREOPERATIVE RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; STAGE; THERAPY; DYSFUNCTION; TUMOR; TRIAL	Aim: To develop prognostic nomograms for predicting outcomes in patients with locally advanced rectal cancers who do not receive preoperative treatment. Materials and Methods: A total of 883 patients with stage II-III rectal cancers were retrospectively collected from a single institution. Survival analyses were performed to assess each variable for overall survival (OS), local recurrence (LR) and distant metastases (DM). Cox models were performed to develop a predictive model for each endpoint. The performance of model prediction was validated by cross validation and on an independent group of patients. Results: The 5-year LR, DM and OS rates were 22.3%, 32.7% and 63.8%, respectively. Two prognostic nomograms were successfully developed to predict 5-year OS and DM-free survival rates, with c-index of 0.70 (95% CI = [0.66, 0.73]) and 0.68 (95% CI = [0.64, 0.72]) on the original dataset, and 0.76 (95% CI = [0.67, 0.86]) and 0.73 (95% CI = [0.63, 0.83]) on the validation dataset, respectively. Factors in our models included age, gender, carcinoembryonic antigen value, tumor location, T stage, N stage, metastatic lymph nodes ratio, adjuvant chemotherapy and chemoradiotherapy. Predicted by our nomogram, substantial variability in terms of 5-year OS and DM-free survival was observed within each TNM stage category. Conclusions: The prognostic nomograms integrated demographic and clinicopathological factors to account for tumor and patient heterogeneity, and thereby provided a more individualized outcome prognostication. Our individualized prediction nomograms could help patients with preoperatively under-staged rectal cancer about their postoperative treatment strategies and follow-up protocols.	[Peng, Junjie; Shi, Debing; Li, Xinxiang; Wu, Hongbin; Cai, Sanjun] Fudan Univ, Dept Colorectal Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Peng, Junjie; Shi, Debing; Li, Xinxiang; Wu, Hongbin; Cai, Sanjun] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Ding, Ying] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Tu, Shanshan] Univ Pittsburgh, Dept Stat, Pittsburgh, PA USA; [Sun, Liang] Georgia Gwinnett Coll, Sch Sci & Technol, Atlanta, GA USA	Fudan University; Fudan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; Georgia Gwinnett College	Cai, SJ (corresponding author), Fudan Univ, Dept Colorectal Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	caisanjun@gmail.com		Ding, Ying/0000-0003-1352-1000	Shanghai Municipal Commission of Health; Family Planning Program [KJ201204]	Shanghai Municipal Commission of Health; Family Planning Program	This work was supported by the grants from Shanghai Municipal Commission of Health and Family Planning Program KJ201204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Canadian Partnership Against Cancer, 2011, 2011 CANC SYST PERF; Capirci C, 2008, INT J RADIAT ONCOL, V72, P99, DOI 10.1016/j.ijrobp.2007.12.019; Cho MM, 2013, DIS COLON RECTUM, V56, P1357, DOI 10.1097/01.dcr.0000436362.81611.de; Edge SB, 2010, AJCC CANC STAGING MA; Ferri M, 2013, INT J SURG; FISHER B, 1988, JNCI-J NATL CANCER I, V80, P21, DOI 10.1093/jnci/80.1.21; Giordano A, 2013, CLIN CANCER RES, V19, P1596, DOI 10.1158/1078-0432.CCR-12-3137; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Greenberg R, 2011, TECH COLOPROCTOL, V15, P273, DOI 10.1007/s10151-011-0701-9; Greene FL, 2002, AJCC CANC STAGING MA; Gronchi A, 2013, J CLIN ONCOLOGY OFFI; Gunderson LL, 2010, J CLIN ONCOL, V28, P256, DOI 10.1200/JCO.2009.23.9194; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hyodo I, 2010, JPN J CLIN ONCOL, V40, pi38, DOI 10.1093/jjco/hyq125; KOLLMORGEN CF, 1994, ANN SURG, V220, P676, DOI 10.1097/00000658-199411000-00012; Lai LL, 2006, SEMIN ONCOL, V33, pS70, DOI 10.1053/j.seminoncol.2006.10.019; Lu YJ, 2013, WORLD J SURG, V37, P1927, DOI 10.1007/s00268-013-2051-4; Lundby L, 2005, DIS COLON RECTUM, V48, P1343, DOI 10.1007/s10350-005-0049-1; Meretoja TJ, 2012, ANN SURG ONCOL, V19, P567, DOI 10.1245/s10434-011-1882-1; Peeters KCMJ, 2005, J CLIN ONCOL, V23, P6199, DOI 10.1200/JCO.2005.14.779; Peng JJ, 2008, ANN SURG ONCOL, V15, P3118, DOI 10.1245/s10434-008-0123-8; Petersen SH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004078.pub2; Quah HM, 2008, CANCER-AM CANCER SOC, V113, P57, DOI 10.1002/cncr.23516; Rahal R, 2012, CURR ONCOL, V19, P175, DOI 10.3747/co.19.1065; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836; Sebag-Montefiore D, 2009, LANCET, V373, P811, DOI 10.1016/S0140-6736(09)60484-0; Tepper JE, 2002, J CLIN ONCOL, V20, P1744, DOI 10.1200/JCO.2002.07.132; Tveit KM, 1997, BRIT J SURG, V84, P1130, DOI 10.1046/j.1365-2168.1997.02863.x; Valentini V, 2011, J CLIN ONCOL, V29, P3163, DOI 10.1200/JCO.2010.33.1595; Wang YZ, 2013, J CLIN ONCOL, V31, P1188, DOI 10.1200/JCO.2012.41.5984	32	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106344	10.1371/journal.pone.0106344	http://dx.doi.org/10.1371/journal.pone.0106344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171093	gold, Green Published			2022-12-25	WOS:000341127500152
J	Huang, CC; Chung, MH; Weng, SF; Chien, CC; Lin, SJ; Lin, HJ; Guo, HR; Su, SB; Hsu, CC; Juan, CW				Huang, Chien-Cheng; Chung, Min-Hsien; Weng, Shih-Feng; Chien, Chih-Chiang; Lin, Shio-Jean; Lin, Hung-Jung; Guo, How-Ran; Su, Shih-Bin; Hsu, Chien-Chin; Juan, Chi-Wen			Long-Term Prognosis of Patients with Carbon Monoxide Poisoning: A Nationwide Cohort Study	PLOS ONE			English	Article							RISK-FACTORS; MORTALITY	Background: Carbon monoxide poisoning (COP) often produces severe complications and can be fatal. Because this topic has not been well delineated, we investigated long-term prognoses of patients with COP (COP[+]). Methods: In this retrospective nationwide cohort study, 441 COP[+] patients and 8820 COP[-] controls (120) from 1999 to 2010 were selected from Taiwan's National Health Insurance Research Database. Results: Thirty-seven (8.39%) COP[+] patients and 142 (1.61%) controls died (P<0.0001) during follow-up. Incidence rate ratios (IRR) of death were 5.24 times higher in COP[+] patients than in controls (P<0.0001). The risk of death was particularly high in the first month after COP (IRR: 308.78; 95% confidence interval [CI]: 40.79-2337.56), 1 to 6 months after (IRR: 18.92; 95% CI: 7.69-46.56), and 6-12 months after (IRR: 4.73; 95% CI: 1.02-21.90). After adjusting for age, gender, and selected comorbidities, the hazard ratio of death for COP[+] patients was still 4.097 times higher than for controls. Moreover, older age (>= 30 years old), male gender, diabetes mellitus, hypertension, and low income were also independent mortality predictors. Conclusions: COP significantly increases the risk for long-term mortality. Early follow-up and secondary prevention of death are needed for patients with COP.	[Huang, Chien-Cheng; Chung, Min-Hsien; Lin, Hung-Jung; Hsu, Chien-Chin] Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan; [Huang, Chien-Cheng] Southern Taiwan Univ Sci & Technol, Dept Child Care & Educ, Tainan, Taiwan; [Huang, Chien-Cheng; Guo, How-Ran] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Huang, Chien-Cheng] Kuo Gen Hosp, Dept Emergency Med, Tainan, Taiwan; [Weng, Shih-Feng; Su, Shih-Bin] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Chien, Chih-Chiang] Chi Mei Med Ctr, Dept Nephrol, Tainan, Taiwan; [Chien, Chih-Chiang] Chung Hwa Univ Med Technol, Dept Food Nutr, Tainan, Taiwan; [Lin, Shio-Jean] Chi Mei Med Ctr, Dept Pediat, Tainan, Taiwan; [Lin, Hung-Jung] Taipei Med Univ, Dept Emergency Med, Taipei, Taiwan; [Lin, Hung-Jung; Hsu, Chien-Chin] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Occupat Med, Tainan, Taiwan; [Su, Shih-Bin] Southern Taiwan Univ Sci & Technol, Dept Leisure Recreat & Tourism Management, Tainan, Taiwan; [Juan, Chi-Wen] Kuang Tien Gen Hosp, Dept Emergency Med, Taichung, Taiwan; [Juan, Chi-Wen] Hungkuang Univ, Dept Nursing, Taichung, Taiwan	Chi Mei Hospital; Southern Taiwan University of Science & Technology; National Cheng Kung University; Chi Mei Hospital; Chi Mei Hospital; Chung Hua University; Chi Mei Hospital; Taipei Medical University; Southern Taiwan University of Science & Technology; National Cheng Kung University; National Cheng Kung University Hospital; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Hungkuang University	Hsu, CC (corresponding author), Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan.	nych2525@gmail.com; juanchiwen@yahoo.com.tw	Guo, How-Ran/AAK-9063-2020	Guo, How-Ran/0000-0003-3343-3446; Weng, Shih-Feng/0000-0001-8684-3487	Chi-Mei Medical Center [CMFHR10252, CMFHR10334]	Chi-Mei Medical Center	This study was supported by grant CMFHR10252 and CMFHR10334 from the Chi-Mei Medical Center. It is based in part on data from the National Health Insurance Research Database provided by the National Health Insurance Administration, Ministry of Health and Welfare and managed by National Health Research Institutes (Registered number NHIRD-100-057). The interpretation and conclusions contained herein do not represent those of National Health Insurance Administration, Ministry of Health and Welfare or National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P1309; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171, DOI [10.1142/9789814261593_000710, 1142/9789814261593_0007, DOI 10.1142/9789814261593_0007]; Hampson NB, 2007, UNDERSEA HYPERBAR M, V34, P163; Hampson NB, 2012, AM J RESP CRIT CARE, V186, P1095, DOI 10.1164/rccm.201207-1284CI; Hampson NB, 2009, CRIT CARE MED, V37, P1941, DOI 10.1097/CCM.0b013e3181a0064f; Henry CR, 2006, JAMA-J AM MED ASSOC, V295, P398, DOI 10.1001/jama.295.4.398; Johnson-Arbor K, 2012, CLIN TOXICOL, V50, P384, DOI 10.3109/15563650.2012.683576; Kao LW, 2004, EMERG MED CLIN N AM, V22, P985, DOI 10.1016/j.emc.2004.05.003; Katirci Y, 2011, TOXICOL IND HEALTH, V27, P397, DOI 10.1177/0748233710387632; Mimura K, 1999, Seishin Shinkeigaku Zasshi, V101, P592; Paulozzi L., 2007, Morbidity and Mortality Weekly Report, V56, P93; Runyan CW, 2005, AM J PREV MED, V28, P102, DOI 10.1016/j.amepre.2004.09.014; Weaver LK, 2007, AM J RESP CRIT CARE, V176, P491, DOI 10.1164/rccm.200701-026OC	13	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105503	10.1371/journal.pone.0105503	http://dx.doi.org/10.1371/journal.pone.0105503			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25167083	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303700029
J	Diaz-Barrera, A; Martinez, F; Pezoa, FG; Acevedo, F				Diaz-Barrera, Alvaro; Martinez, Fabiola; Guevara Pezoa, Felipe; Acevedo, Fernando			Evaluation of Gene Expression and Alginate Production in Response to Oxygen Transfer in Continuous Culture of Azotobacter vinelandii	PLOS ONE			English	Article							DISSOLVED-OXYGEN; MOLECULAR-WEIGHT; GROWTH-RATE; ALG8; MASS	Alginates are polysaccharides used as food additives and encapsulation agents in biotechnology, and their functional properties depend on its molecular weight. In this study, different steady-states in continuous cultures of A. vinelandii were established to determine the effect of the dilution rate (D) and the agitation rate on alginate production and expression of genes involved in alginate polymerization and depolymerization. Both, the agitation and dilution rates, determined the partitioning of the carbon utilization from sucrose into alginate and CO2 under oxygen-limiting conditions. A low D (0.07 h(-1)) and 500 rpm resulted in the highest carbon utilization into alginate (25%). Quantitative real-time polymerase chain reaction was used to determine the transcription level of six genes involved in alginate polymerization and depolymerization. In chemostat cultures at 0.07 h(-1), the gene expression was affected by changes in the agitation rate. By increasing the agitation rate from 400 to 600 rpm, the algE7 gene expression decreased tenfold, whereas alyA1, algL and alyA2 gene expression increased between 1.5 and 2.8 times under similar conditions evaluated. Chemostat at 0.07 h(-1) showed a highest alginate molecular weight (580 kDa) at 500 rpm whereas similar molecular weights (480 kDa) were obtained at 400 and 600 rpm. The highest molecular weight was not explained by changes in the expression of alg8 and alg44 (genes involved in alginate polymerization). Nonetheless, a different expression pattern observed for lyases could explain the highest alginate molecular weight obtained. Overall, the results suggest that the control of alginate molecular weight in A. vinelandii cells growing in continuous mode is determined by a balance between the gene expression of intracellular and extracellular lyases in response to oxygen availability. These findings better our understanding of the biosynthesis of bacterial alginate and help us progress toward obtain tailor-made alginates.	[Diaz-Barrera, Alvaro; Martinez, Fabiola; Guevara Pezoa, Felipe; Acevedo, Fernando] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso	Diaz-Barrera, A (corresponding author), Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile.	alvaro.diaz@ucv.cl	Guevara, Felipe/AAE-9957-2019; Guevara, Felipe/D-4629-2016	Guevara, Felipe/0000-0003-4868-044X; Guevara, Felipe/0000-0003-4868-044X; Alvaro, Diaz-Barrera/0000-0002-0922-8648	FONDECYT [11110311]; DI-PUCV [203.784]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DI-PUCV	The authors acknowledge FONDECYT Grants 11110311 and DI-PUCV 203.784 for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Capone SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062032; Castillo T, 2013, J IND MICROBIOL BIOT, V40, P715, DOI 10.1007/s10295-013-1274-6; Diaz-Barrera A, 2007, APPL MICROBIOL BIOT, V76, P903, DOI 10.1007/s00253-007-1060-3; Diaz-Barrera A, 2010, AFR J BIOTECHNOL, V9, P5240; Diaz-Barrera A, 2012, J IND MICROBIOL BIOT, V39, P613, DOI 10.1007/s10295-011-1055-z; Diaz-Barrera A, 2011, PROCESS BIOCHEM, V46, P1879, DOI 10.1016/j.procbio.2011.06.022; Diaz-Barrera A, 2010, BIORESOURCE TECHNOL, V101, P9405, DOI 10.1016/j.biortech.2010.07.038; Flores C, 2013, ENZYME MICROB TECH, V53, P85, DOI 10.1016/j.enzmictec.2013.04.010; Galindo E, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-7; Garcia-Ochoa F, 2009, BIOTECHNOL ADV, V27, P153, DOI 10.1016/j.biotechadv.2008.10.006; Gimmestad M, 2009, J BACTERIOL, V191, P4845, DOI 10.1128/JB.00455-09; Hay ID, 2013, MICROB BIOTECHNOL, V6, P637, DOI 10.1111/1751-7915.12076; KARR DB, 1983, APPL ENVIRON MICROB, V46, P1339, DOI 10.1128/AEM.46.6.1339-1344.1983; Kayser A, 2005, MICROBIOL-SGM, V151, P693, DOI 10.1099/mic.0.27481-0; KUHLA J, 1988, ARCH MICROBIOL, V149, P509, DOI 10.1007/BF00446753; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Oglesby LL, 2008, MICROBIOL-SGM, V154, P1605, DOI 10.1099/mic.0.2007/015305-0; Priego-Jimenez R, 2005, BIOCHEM ENG J, V25, P187, DOI 10.1016/j.bej.2005.05.003; Remminghorst U, 2009, J BIOTECHNOL, V140, P176, DOI 10.1016/j.jbiotec.2009.02.006; Svanem BIG, 2001, J BIOL CHEM, V276, P31542, DOI 10.1074/jbc.M102562200	21	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105993	10.1371/journal.pone.0105993	http://dx.doi.org/10.1371/journal.pone.0105993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162704	Green Submitted, Green Published, gold			2022-12-25	WOS:000340880900069
J	Torregrossa, AM; Nikonova, L; Bales, MB; Leal, MV; Smith, JC; Contreras, RJ; Eckel, LA				Torregrossa, Ann-Marie; Nikonova, Larissa; Bales, Michelle B.; Leal, Maria Villalobos; Smith, James C.; Contreras, Robert J.; Eckel, Lisa A.			Induction of Salivary Proteins Modifies Measures of Both Orosensory and Postingestive Feedback during Exposure to a Tannic Acid Diet	PLOS ONE			English	Article							PROLINE-RICH PROTEINS; GENETIC TASTE SENSITIVITY; BITTER TASTE; ISOPROTERENOL TREATMENT; PAROTID-GLANDS; FOOD-INTAKE; CELLS; CYSTATIN; MAINTENANCE; POLYPHENOLS	There are hundreds of proteins in saliva. Although it has long been hypothesized that these proteins modulate taste by interacting with taste receptors or taste stimuli, the functional impact of these proteins on feeding remains relatively unexplored. We have developed a new technique for saliva collection that does not interfere with daily behavioral testing and allows us to explore the relationship between feeding behavior and salivary protein expression. First, we monitored the alterations in salivary protein expression while simultaneously monitoring the animals' feeding behavior and meal patterns on a custom control diet or on the same diet mixed with 3% tannic acid. We demonstrated that six protein bands increased in density with dietary tannic acid exposure. Several of these bands were significantly correlated with behaviors thought to represent both orosensory and postingestive signaling. In a follow-up experiment, unconditioned licking to 0.01-3% tannic acid solutions was measured during a brief-access taste test before and after exposure to the tannic acid diet. In this experiment, rats with salivary proteins upregulated found the tannin solution less aversive (i.e., licked more) than those in the control condition. These data suggest a role for salivary proteins in mediating changes in both orosensory and postingestive feedback.	[Torregrossa, Ann-Marie; Nikonova, Larissa; Bales, Michelle B.; Leal, Maria Villalobos; Smith, James C.; Contreras, Robert J.; Eckel, Lisa A.] Florida State Univ, Dept Psychol, Program Neurosci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Torregrossa, AM (corresponding author), Florida State Univ, Dept Psychol, Program Neurosci, Tallahassee, FL 32306 USA.	torregrossa@neuro.fsu.edu	Nikonova, Larissa/AAV-5151-2020		NIH [T32 DC 000044, DK 73936, DC 004785, DC R03 012632]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC012632, R01DC004785, T32DC000044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by NIH T32 DC 000044, DK 73936, DC 004785, and DC R03 012632. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Barratt-Fornell Anne, 2002, Nutr Today, V37, P144, DOI 10.1097/00017285-200207000-00003; BARTOSHUK LM, 1979, SCIENCE, V205, P934, DOI 10.1126/science.472717; Baxter NJ, 1997, BIOCHEMISTRY-US, V36, P5566, DOI 10.1021/bi9700328; BEDI GS, 1991, ARCH ORAL BIOL, V36, P611, DOI 10.1016/0003-9969(91)90112-8; BEELEY JA, 1991, ELECTROPHORESIS, V12, P1032, DOI 10.1002/elps.1150121207; Bennick A, 2002, CRIT REV ORAL BIOL M, V13, P184, DOI 10.1177/154411130201300208; Cabras T, 2010, MOL CELL PROTEOMICS, V9, P2099, DOI 10.1074/mcp.M110.001057; Cai KH, 2006, BIOCHEM PHARMACOL, V72, P974, DOI 10.1016/j.bcp.2006.06.026; Cai KH, 2006, BIOCHEM PHARMACOL, V71, P1570, DOI 10.1016/j.bcp.2006.02.013; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chen MC, 2006, AM J PHYSIOL-CELL PH, V291, pC726, DOI 10.1152/ajpcell.00003.2006; da Costa G, 2008, J CHEM ECOL, V34, P376, DOI 10.1007/s10886-007-9413-z; DAVIS JD, 1973, PHYSIOL BEHAV, V11, P39, DOI 10.1016/0031-9384(73)90120-0; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Dinnella C, 2009, CHEM SENSES, V34, P295, DOI 10.1093/chemse/bjp003; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Dsamou M, 2012, CHEM SENSES, V37, P87, DOI 10.1093/chemse/bjr070; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; GLENDINNING JI, 1992, CHEM SENSES, V17, P1, DOI 10.1093/chemse/17.1.1; Jeon TI, 2011, BIOCHEM J, V438, P33, DOI 10.1042/BJ20110009; JOHANSSON G, 1994, ARCH ORAL BIOL, V39, P283, DOI 10.1016/0003-9969(94)90118-X; JOHNSON DA, 1983, ARCH ORAL BIOL, V28, P549, DOI 10.1016/0003-9969(83)90189-9; Katsukawa H, 1999, J DENT RES, V78, P1609, DOI 10.1177/00220345990780100501; Keller KL, 2002, APPETITE, V38, P3, DOI 10.1006/appe.2001.0441; KOCK K, 1994, PHYSIOL BEHAV, V56, P1173, DOI 10.1016/0031-9384(94)90362-X; Lichtenstein G., 2001, Etologia, V9, P29; Lu Y, 1998, ARCH ORAL BIOL, V43, P717, DOI 10.1016/S0003-9969(98)00040-5; Matsuo R, 2000, CRIT REV ORAL BIOL M, V11, P216, DOI 10.1177/10454411000110020501; MEHANSHO H, 1983, P NATL ACAD SCI-BIOL, V80, P3948, DOI 10.1073/pnas.80.13.3948; MEHANSHO H, 1987, ANNU REV NUTR, V7, P423, DOI 10.1146/annurev.nu.07.070187.002231; MEHANSHO H, 1987, J BIOL CHEM, V262, P12344; Mirels L, 1998, BIOCHEM J, V330, P437, DOI 10.1042/bj3300437; MITARU BN, 1984, J NUTR, V114, P1787, DOI 10.1093/jn/114.10.1787; MUENZER J, 1979, J BIOL CHEM, V254, P5623; Nayak A, 2008, PHYSIOL BEHAV, V95, P290, DOI 10.1016/j.physbeh.2008.05.023; Oliver SJ, 2007, BRIT J NUTR, V97, P1109, DOI 10.1017/S0007114507682919; Quintana M, 2009, CHEMOSENS PERCEPT, V2, P133, DOI 10.1007/s12078-009-9048-2; Romero AC, 2012, ARCH ORAL BIOL, V57, P1189, DOI 10.1016/j.archoralbio.2012.02.016; Rozengurt N, 2006, AM J PHYSIOL-GASTR L, V291, pG792, DOI 10.1152/ajpgi.00074.2006; Sarni-Manchado P, 1999, J AGR FOOD CHEM, V47, P42, DOI 10.1021/jf9805146; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; SCOTT TR, 1987, BRAIN RES, V414, P197, DOI 10.1016/0006-8993(87)91347-3; Shaw PA, 2000, AUTON NEUROSCI-BASIC, V83, P49, DOI 10.1016/S1566-0702(00)00172-7; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Shimada T, 2006, J CHEM ECOL, V32, P1149, DOI 10.1007/s10886-006-9077-0; Silanikove N, 2001, ANIM FEED SCI TECH, V91, P69, DOI 10.1016/S0377-8401(01)00234-6; Skopec MM, 2004, J CHEM ECOL, V30, P1679, DOI 10.1023/B:JOEC.0000042395.31307.be; Smith JC, 2000, NEUROSCI BIOBEHAV R, V24, P199, DOI 10.1016/S0149-7634(99)00073-1; Soares S, 2013, J AGR FOOD CHEM, V61, P1525, DOI 10.1021/jf304198k; Sternini C, 2007, AM J PHYSIOL-GASTR L, V292, pG457, DOI 10.1152/ajpgi.00411.2006; STUCHELL RN, 1983, J DENT RES, V62, P552, DOI 10.1177/00220345830620050701; Tepper BJ, 2002, PHYSIOL BEHAV, V75, P305, DOI 10.1016/S0031-9384(01)00664-3; Torregrossa AM, 2009, FUNCT ECOL, V23, P48, DOI 10.1111/j.1365-2435.2008.01523.x; Vasanthi HR, 2009, MINI-REV MED CHEM, V9, P749, DOI 10.2174/138955709788452685; Walsh NP, 2004, MED SCI SPORT EXER, V36, P1535, DOI 10.1249/01.MSS.0000139797.26760.06; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378	58	25	25	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105232	10.1371/journal.pone.0105232	http://dx.doi.org/10.1371/journal.pone.0105232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162297	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900029
J	Zhou, T; Gao, CY; Du, LL; Feng, H; Wang, LJ; Lan, Y; Sun, F; Wei, LH; Fan, YJ; Shen, WB; Zhou, YJ				Zhou, Tong; Gao, Cunyi; Du, Linlin; Feng, Hui; Wang, Lijiao; Lan, Ying; Sun, Feng; Wei, Lihui; Fan, Yongjian; Shen, Wenbiao; Zhou, Yijun			Genetic Analysis and QTL Detection for Resistance to White Tip Disease in Rice	PLOS ONE			English	Article							NEMATODE GLOBODERA-ROSTOCHIENSIS; CYST-NEMATODE; APHELENCHOIDES-BESSEYI; CONFERRING RESISTANCE; YIELD COMPONENTS; QUANTITATIVE RESISTANCE; AGRONOMIC TRAITS; IDENTIFICATION; ENVIRONMENTS; TEMPERATURE	The inheritance of resistance to white tip disease (WTDR) in rice (Oryza sativa L.) was analyzed with an artificial inoculation test in a segregating population derived from the cross between Tetep, a highly resistant variety that was identified in a previous study, and a susceptible cultivar. Three resistance-associated traits, including the number of Aphelenchoides besseyi (A. besseyi) individuals in 100 grains (NA), the loss rate of panicle weight (LRPW) and the loss rate of the total grains per panicle (LRGPP) were analyzed for the detection of the quantitative trait locus (QTL) in the population after construction of a genetic map. Six QTLs distributed on chromosomes 3, 5 and 9 were mapped. qNA3 and qNA9, conferring reproduction number of A. besseyi in the panicle, accounted for 16.91% and 12.54% of the total phenotypic variance, respectively. qDRPW5a and qDRPW5b, associated with yield loss, were located at two adjacent marker intervals on chromosome 5 and explained 14.15% and 14.59% of the total phenotypic variation and possessed LOD values of 3.40 and 3.39, respectively. qDRPW9 was considered as a minor QTL and only explained 1.02% of the phenotypic variation. qLRGPP5 contributed to the loss in the number of grains and explained 10.91% of the phenotypic variation. This study provides useful information for the breeding of resistant cultivars against white tip disease in rice.	[Zhou, Tong; Gao, Cunyi; Du, Linlin; Feng, Hui; Wang, Lijiao; Lan, Ying; Sun, Feng; Wei, Lihui; Fan, Yongjian; Zhou, Yijun] Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China; [Gao, Cunyi; Shen, Wenbiao] Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Nanjing Agricultural University	Shen, WB (corresponding author), Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	wbshenh@njau.edu.cn; yjzhou@jaas.ac.cn	黎, 伟/GXM-4040-2022; wei, li/GSD-3630-2022		National Key Basic Research and Development Program (973 Program) of China [2013CBA01403]; Special Fund for Agro-Scientific Research in the Public Interest of China [201303021, 201003031]; Jiangsu Province Science and Technology Support Project [BE2012303]; Jiangsu Agricultural Science and Technology Independent Innovation Fund [cx[12]1003]	National Key Basic Research and Development Program (973 Program) of China(National Basic Research Program of China); Special Fund for Agro-Scientific Research in the Public Interest of China; Jiangsu Province Science and Technology Support Project; Jiangsu Agricultural Science and Technology Independent Innovation Fund	This research was financially supported by grants from the National Key Basic Research and Development Program (973 Program) of China (2013CBA01403), the Special Fund for Agro-Scientific Research in the Public Interest of China (201303021, 201003031), the Jiangsu Province Science and Technology Support Project (BE2012303) and the Jiangsu Agricultural Science and Technology Independent Innovation Fund (cx[12]1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridge John, 2005, P87, DOI 10.1079/9780851997278.0087; Cai DG, 1997, SCIENCE, V275, P832, DOI 10.1126/science.275.5301.832; Chen H, 2003, P NATL ACAD SCI USA, V100, P2544, DOI 10.1073/pnas.0437898100; Cho YC, 2003, TREAT CROP RES, V4, P19; CRALLEY EM, 1949, PHYTOPATHOLOGY, V39, P5; De Waele D., 2002, P141, DOI 10.1079/9780851994666.0141; Ernst K, 2002, PLANT J, V31, P127, DOI 10.1046/j.1365-313X.2002.01341.x; Feng H, 2014, J INTEGR AGR, V13, P2221, DOI 10.1016/S2095-3119(13)60608-5; Fortuner R., 1975, Helminthological Abstracts Series B Plant Nematology, V44, P1; GEBHARDT C, 1993, THEOR APPL GENET, V85, P541, DOI 10.1007/BF00220911; HAUGE BM, 2006, Patent No. 7154021; He CiXin, 2000, Scientia Agricultura Sinica, V33, P24; HUANG CS, 1975, NEMATOLOGICA, V21, P351, DOI 10.1163/187529275X00086; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Jacobs JME, 1996, MOL BREEDING, V2, P51, DOI 10.1007/BF00171351; Jamali S, 2012, J AGR SCI TECH-IRAN, V14, P195; Jamali S, 2006, J AGR TECHNOL, V2, P337; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li ZK, 1997, GENETICS, V145, P453; Lin HX, 1996, THEOR APPL GENET, V92, P920, DOI 10.1007/BF00224031; Lin M.S., 2004, RICE SCI, V12, P289; Lincoln SE, 1993, TECHNICAL REPORT; Liu W, 2007, ZHONGGUO NONG YE KE, V12, P14; Lorieux M, 2003, THEOR APPL GENET, V107, P691, DOI 10.1007/s00122-003-1285-1; Lu C, 1996, THEOR APPL GENET, V93, P1211, DOI 10.1007/BF00223452; Lu CF, 1997, THEOR APPL GENET, V94, P145, DOI 10.1007/s001220050393; MCGAWLEY EC, 1984, J NEMATOL, V16, P65; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; NISHIZAWA T., 1953, Bulletin of the Kyushu Agricultural Experiment Station, V1, P339; Paal J, 2004, PLANT J, V38, P285, DOI 10.1111/j.1365-313X.2004.02047.x; PINEDA O, 1993, GENOME, V36, P152, DOI 10.1139/g93-019; Ramalingam J, 2003, MOL PLANT MICROBE IN, V16, P14, DOI 10.1094/MPMI.2003.16.1.14; ROBERTS PA, 1982, J NEMATOL, V14, P24; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Septiningsih EM, 2012, THEOR APPL GENET, V124, P867, DOI 10.1007/s00122-011-1751-0; Sun MJ, 2009, RICE SCI, V16, P301, DOI 10.1016/S1672-6308(08)60094-3; Tan Z, 1996, ZUO WU XUE BAO, V23, P289; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; van der Vossen EAG, 2000, PLANT J, V23, P567, DOI 10.1046/j.1365-313x.2000.00814.x; Vos P, 1998, NAT BIOTECHNOL, V16, P1365, DOI 10.1038/4350; Wang S, 2005, WINDOWS QTL CARTOGRA; Wang ZhiYuan, 2006, Journal of Nanjing Agricultural University, V29, P54; WILLIAMS KJ, 1994, THEOR APPL GENET, V89, P927, DOI 10.1007/BF00224519; YAGHOOBI J, 1995, THEOR APPL GENET, V91, P457, DOI 10.1007/BF00222973; Yoshida K, 2009, J NEMATOL, V41, P17; YOSHII H., 1950, Journal of the Faculty of Agriculture, Kyushu University, V9, P309; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; Zhuang JY, 1997, THEOR APPL GENET, V95, P799, DOI 10.1007/s001220050628	48	3	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106099	10.1371/journal.pone.0106099	http://dx.doi.org/10.1371/journal.pone.0106099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162680	Green Submitted, Green Published, gold			2022-12-25	WOS:000340880900090
J	Al-Jumeily, D; Ghazali, R; Hussain, A				Al-Jumeily, Dhiya; Ghazali, Rozaida; Hussain, Abir			Predicting Physical Time Series Using Dynamic Ridge Polynomial Neural Networks	PLOS ONE			English	Article							CLASSIFICATION; COMBINATION; PARAMETERS; ALGORITHMS	Forecasting naturally occurring phenomena is a common problem in many domains of science, and this has been addressed and investigated by many scientists. The importance of time series prediction stems from the fact that it has wide range of applications, including control systems, engineering processes, environmental systems and economics. From the knowledge of some aspects of the previous behaviour of the system, the aim of the prediction process is to determine or predict its future behaviour. In this paper, we consider a novel application of a higher order polynomial neural network architecture called Dynamic Ridge Polynomial Neural Network that combines the properties of higher order and recurrent neural networks for the prediction of physical time series. In this study, four types of signals have been used, which are; The Lorenz attractor, mean value of the AE index, sunspot number, and heat wave temperature. The simulation results showed good improvements in terms of the signal to noise ratio in comparison to a number of higher order and feedforward neural networks in comparison to the benchmarked techniques.	[Al-Jumeily, Dhiya; Hussain, Abir] Liverpool John Moores Univ, Appl Comp Res Grp, Liverpool L3 5UX, Merseyside, England; [Ghazali, Rozaida] Univ Tun Hussein Onn Malaysia, Fac Comp Sci & Informat Technol, Parit Raja, Malaysia	Liverpool John Moores University; University of Tun Hussein Onn Malaysia	Al-Jumeily, D (corresponding author), Liverpool John Moores Univ, Appl Comp Res Grp, Liverpool L3 5UX, Merseyside, England.	D.Aljumeily@ljmu.ac.uk	Al-Jumeily, Dhiya/AAE-8272-2020; Ghazali, Rozaida/D-3985-2013	Al-Jumeily, Dhiya/0000-0002-9170-0568; Ghazali, Rozaida/0000-0003-0119-0873	Liverpool John Moores University	Liverpool John Moores University	This work was supported by Liverpool John Moores University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atiya AF, 2000, IEEE T NEURAL NETWOR, V11, P697, DOI 10.1109/72.846741; Beale R., 1990, NEURAL COMPUTING INT; BILLINGS SA, 1992, INT J CONTROL, V55, P193, DOI 10.1080/00207179208934232; Cao LJ, 2003, IEEE T NEURAL NETWOR, V14, P1506, DOI 10.1109/TNN.2003.820556; Cass R, 1996, CONTROL ENG PRACTICE, V4, P1579; Chen AS, 2004, COMPUT OPER RES, V31, P1049, DOI 10.1016/S0305-0548(03)00064-9; Conner J., 1991, IEEE INT JOINT C NEU, pI 301; Connor J., 1991, IJCNN-91-Seattle: International Joint Conference on Neural Networks (Cat. No.91CH3049-4), P301, DOI 10.1109/IJCNN.1991.155194; Draye JPS, 1996, IEEE T SYST MAN CY B, V26, P692, DOI 10.1109/3477.537312; Durbin R, 1989, NEURAL COMPUTATION, V1, P133; Ghazali R, 2009, NEUROCOMPUTING, V72, P2359, DOI 10.1016/j.neucom.2008.12.005; Ghosh J., 1993, International Journal of Neural Systems, V3, P323, DOI 10.1142/S0129065792000255; Giles C. L., 1998, ENCODING GEOMETRIC I, P310; Giles CL, APPL OPTICS, V26, P4972; Gou Fei, 1994, Proceedings of the SPIE - The International Society for Optical Engineering, V2243, P508; Huang CC, 2001, COMPUT-AIDED CIV INF, V16, P28, DOI 10.1111/0885-9507.00211; Kaita T, 2002, PATTERN RECOGN LETT, V23, P977, DOI 10.1016/S0167-8655(02)00028-4; Kuan C.M., 1989, THESIS U CALIFORNIA; Lee P, 1999, IEEE T SIGNAL PROCES, V47, P2503; Lorenz E. N., 1962, P INT S NUM WEATH PR, P629; MAKHOUL J, 1975, P IEEE, V63, P561, DOI 10.1109/PROC.1975.9792; Mirea L., 2002, 15 TRIENN WORLD C; Nanthagopal AP, 2013, J VISUAL-JAPAN, V16, P19, DOI 10.1007/s12650-012-0153-y; Pao Y.H., 1989, ADAPTIVE PATTERN REC; Plummer E, 2000, THESIS LARAMIE; Rao S. S., 1992, Neural Networks for Signal Processing II. Proceedings of the IEEE-SP Workshop (Cat. No.92TH0430-9), P531, DOI 10.1109/NNSP.1992.253659; Rape R., 1994, IEEE INSTR MEAS TECH, P145; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sermpinis G, 2012, DECIS SUPPORT SYST, V54, P316, DOI 10.1016/j.dss.2012.05.039; SHIN Y, 1995, IEEE T NEURAL NETWOR, V6, P610, DOI 10.1109/72.377967; Shin Y., 1992, COMPUTATIONALLY EFFI; Shin Y., 1991, P INT JOINT C NEUR N, V1, P13, DOI DOI 10.1109/IJCNN.1991.155142; Singh S., 1998, 6th European Congress on Intelligent Techniques and Soft Computing. EUFIT '98, P1901; Siniscalchi SM, 2013, NEUROCOMPUTING, V106, P148, DOI 10.1016/j.neucom.2012.11.008; Tang J., 2012, ACTA PHYS SINICA, V61; Tawfik H, 1997, P IWSSIP 97 C; Thimm G., 1995, OPTIMIZATION HIGH OR; Tokinaga S, 1999, ELECTRON COMM JPN 3, V82, P31, DOI 10.1002/(SICI)1520-6440(199903)82:3<31::AID-ECJC4>3.0.CO;2-H; Versace M, 2004, EXPERT SYST APPL, V27, P417, DOI 10.1016/j.eswa.2004.05.018; Wang JJ, 2012, OMEGA-INT J MANAGE S, V40, P758, DOI 10.1016/j.omega.2011.07.008; Williams RJ, 1989, NEURAL COMPUT, V1, P270, DOI 10.1162/neco.1989.1.2.270; YAO Y, 1991, NEURAL NETWORKS, V4, P103, DOI 10.1016/0893-6080(91)90036-5	42	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105766	10.1371/journal.pone.0105766	http://dx.doi.org/10.1371/journal.pone.0105766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157950	Green Published, gold			2022-12-25	WOS:000341303200062
J	Brownhill, S; Cohen, D; Burchill, S				Brownhill, Samantha; Cohen, Dena; Burchill, Sue			Proliferation Index: A Continuous Model to Predict Prognosis in Patients with Tumours of the Ewing's Sarcoma Family	PLOS ONE			English	Article							CASPASE-8 PROTEIN EXPRESSION; APOPTOTIC INDEX; CELL-PROLIFERATION; CLINICOPATHOLOGICAL SIGNIFICANCE; C-MYC; CARCINOMA; BONE; P53; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA	The prognostic value of proliferation index (PI) and apoptotic index (AI), caspase-8, -9 and -10 expression have been investigated in primary Ewing's sarcoma family of tumours (ESFT). Proliferating cells, detected by immunohistochemistry for Ki-67, were identified in 91% (91/100) of tumours with a median PI of 14 (range 0-87). Apoptotic cells, identified using the TUNEL assay, were detected in 96% (76/79) of ESFT; the median AI was 3 (range 0-33). Caspase-8 protein expression was negative (0) in 14% (11/79), low (1) in 33% (26/79), medium (2) in 38% (30/79) and high (3) in 15% (12/79) of tumours, caspase-9 expression was low (1) in 66% (39/59) and high (3) in 34% (20/59), and caspase-10 protein was low (1) in 37% (23/62) and negative (0) in 63% (39/62) of primary ESFT. There was no apparent relationship between caspase-8, -9 and -10 expression, PI and AI. PI was predictive of relapse-free survival (RFS; p = 0.011) and overall survival (OS; p = <0.001) in a continuous model, whereas AI did not predict outcome. Patients with tumours expressing low levels of caspase-9 protein had a trend towards a worse RFS than patients with tumours expressing higher levels of caspase-9 protein (p = 0.054, log rank test), although expression of caspases-8, -9 and/or -10 did not significantly predict RFS or OS. In a multivariate analysis model that included tumour site, tumour volume, the presence of metastatic disease at diagnosis, PI and AI, PI independently predicts OS (p = 0.003). Consistent with previous publications, patients with pelvic tumours had a significantly worse OS than patients with tumours at other sites (p = 0.028); patients with a pelvic tumour and a PI >= 20 had a 6 fold-increased risk of death. These studies advocate the evaluation of PI in a risk model of outcome for patients with ESFT.	[Brownhill, Samantha; Burchill, Sue] St James Univ Hosp, Leeds Inst Canc & Pathol, Childrens Canc Res Grp, Leeds, W Yorkshire, England; [Cohen, Dena] St James Univ Hosp, Leeds Inst Canc & Pathol, Clin Trials Res Unit, Leeds, W Yorkshire, England	Saint James's University Hospital; Saint James's University Hospital; University of Leeds	Brownhill, S (corresponding author), St James Univ Hosp, Leeds Inst Canc & Pathol, Childrens Canc Res Grp, Leeds, W Yorkshire, England.	s.c.brownhill@leeds.ac.uk		Howard, Dena/0000-0003-3333-9783	Cancer Research UK [CA1010/A2862]; Bone Cancer Research Trust (BCRT)	Cancer Research UK(Cancer Research UK); Bone Cancer Research Trust (BCRT)	This work was funded by Cancer Research UK (CA1010/A2862; http://www.cancerresearchuk.org) and the Bone Cancer Research Trust (BCRT; http://www.bcrt.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens S, 1999, MED PEDIATR ONCOL, V32, P186, DOI 10.1002/(SICI)1096-911X(199903)32:3<186::AID-MPO5>3.0.CO;2-D; Ali HR, 2012, J PATHOL, V226, P97, DOI 10.1002/path.2976; Amir G, 2002, HUM PATHOL, V33, P170, DOI 10.1053/hupa.2002.31475; Andressakis D, 2008, J LARYNGOL OTOL, V122, P1213, DOI 10.1017/S0022215108002636; Lopez-Guerrero JA, 2011, INT J CANCER, V128, P1139, DOI 10.1002/ijc.25424; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bacci G, 2000, J CLIN ONCOL, V18, P4, DOI 10.1200/JCO.2000.18.1.4; Bendardaf R, 2003, ONCOLOGY-BASEL, V64, P435, DOI 10.1159/000070304; Burchill SA, 2003, J CLIN PATHOL, V56, P96, DOI 10.1136/jcp.56.2.96; Craft AW, 1997, EUR J CANCER, V33, P1061, DOI 10.1016/S0959-8049(97)00043-9; Dalal S, 2005, CLIN CANCER RES, V11, P2364, DOI 10.1158/1078-0432.CCR-04-1201; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289; Fulda S, 2006, CANCER RES, V66, P10016, DOI 10.1158/0008-5472.CAN-05-4079; Gasinska A, 2002, NEOPLASMA, V49, P379; Harada K, 2002, CANCER RES, V62, P5897; Ibrahim T, 2013, ONCOLOGY-BASEL, V84, P150, DOI 10.1159/000345795; Jia YN, 2012, TUMOR BIOL, V33, P1151, DOI 10.1007/s13277-012-0357-8; Kaseta MKA, 2007, HYBRIDOMA, V26, P355, DOI 10.1089/hyb.2007.0519; Kobayashi T, 2007, CLIN CANCER RES, V13, P3868, DOI 10.1158/1078-0432.CCR-06-2730; Leung TW, 2004, GYNECOL ONCOL, V92, P866, DOI 10.1016/j.ygyno.2003.11.051; Lissat A, 2007, AM J PATHOL, V170, P1917, DOI 10.2353/ajpath.2007.060993; Liu LX, 2002, WORLD J GASTROENTERO, V8, P580, DOI 10.3748/wjg.v8.i4.580; Lopez-Beltran A, 2004, EUR UROL, V45, P606, DOI 10.1016/j.eururo.2003.11.011; Martinez R, 2007, CARCINOGENESIS, V28, P1264, DOI 10.1093/carcin/bgm014; Mejia C, 2003, ONCOL REP, V10, P243; NESBIT ME, 1990, J CLIN ONCOL, V8, P1664, DOI 10.1200/JCO.1990.8.10.1664; Oudejans JJ, 2005, MODERN PATHOL, V18, P877, DOI 10.1038/modpathol.3800398; Pingoud-Meier C, 2003, CLIN CANCER RES, V9, P6401; Rioux-Leclercq N, 2000, UROLOGY, V55, P501, DOI 10.1016/S0090-4295(99)00550-6; Rosito P, 1999, CANCER-AM CANCER SOC, V86, P421, DOI 10.1002/(SICI)1097-0142(19990801)86:3<421::AID-CNCR10>3.0.CO;2-O; Royston P, 2004, STAT MED, V23, P2509, DOI 10.1002/sim.1815; de Hooge ASK, 2007, CLIN CANCER RES, V13, P206, DOI 10.1158/1078-0432.CCR-06-1457; Santon A, 2011, HISTOPATHOLOGY, V58, P1072, DOI 10.1111/j.1365-2559.2011.03803.x; Shen XG, 2011, INT J COLORECTAL DIS, V26, P1519, DOI 10.1007/s00384-011-1239-z; Sinicrope FA, 1999, CLIN CANCER RES, V5, P1793; Sollazzo MR, 1999, TUMORI, V85, P167, DOI 10.1177/030089169908500304; Stammler G, 1997, APOPTOSIS, V2, P377, DOI 10.1023/A:1026405707823; Stearns V, 2003, CLIN CANCER RES, V9, P124; Strater J, 2010, INT J CANCER, V127, P873, DOI 10.1002/ijc.25111; Takita J, 2000, MED PEDIATR ONCOL, V35, P541, DOI 10.1002/1096-911X(20001201)35:6<541::AID-MPO9>3.0.CO;2-T; Tang LH, 2012, AM J SURG PATHOL, V36, P1761, DOI 10.1097/PAS.0b013e318263207c; Tannapfel A, 1997, ANTICANCER RES, V17, P1155; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Terrier P, 1996, SEMIN DIAGN PATHOL, V13, P250; van Diest PJ, 2004, J CLIN PATHOL, V57, P675, DOI 10.1136/jcp.2003.010777; Van Valen F, 2000, INT J CANCER, V88, P252, DOI 10.1002/1097-0215(20001015)88:2<252::AID-IJC17>3.0.CO;2-U; van Valen Frans, 2012, Sarcoma, V2012, P782970, DOI 10.1155/2012/782970; White DE, 2010, BR J CANC; Wu X, 2012, CANCER EPIDEMIOL, V36, P212, DOI 10.1016/j.canep.2011.08.002; Xu B, 2008, ONCOLOGY-BASEL, V74, P229, DOI 10.1159/000151392; Yamasaki F, 1997, GYNECOL ONCOL, V66, P439, DOI 10.1006/gyno.1997.4783; Yang QW, 2007, CLIN CANCER RES, V13, P3191, DOI 10.1158/1078-0432.CCR-06-2846	53	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104106	10.1371/journal.pone.0104106	http://dx.doi.org/10.1371/journal.pone.0104106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157404	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303200010
J	Chen, C; Li, P; Wang, RH; Schaal, BA; Fu, CX				Chen, Chuan; Li, Pan; Wang, Rui-Hong; Schaal, Barbara A.; Fu, Cheng-Xin			The Population Genetics of Cultivation: Domestication of a Traditional Chinese Medicine, Scrophularia ningpoensis Hemsl. (Scrophulariaceae)	PLOS ONE			English	Article							CINNAMIC ACID; WILD; DIVERSITY; PLANT; EVOLUTION; PHYLOGEOGRAPHY; CHLOROPLAST; INFERENCE; L.; HARPAGOSIDE	Background: Domestic cultivation of medicinal plants is an important strategy for protecting these species from over harvesting. Some species of medicinal plants have been brought into cultivation for more than hundreds years. Concerns about severe loss of genetic diversity and sustainable cultivation can potentially limit future use of these valuable plants. Genetic studies with comprehensive sampling of multiple medicinal species by molecular markers will allow for assessment and management of these species. Here we examine the population genetic consequences of cultivation and domestication in Scrophularia ningpoensis Hemsl. We used chloroplast DNA and genomic AFLP markers to clarify not only the effects of domestication on genetic diversity, but also determine the geographic origins of cultivars and their genetic divergence from native populations. These results will allow both better management of cultivated populations, but also provide insights for crop improvement. Results: Twenty-one cpDNA haplotypes of S. ningpoensis were identified. Wild populations contain all haplotypes, whereas only three haplotypes were found in cultivated populations with wild populations having twice the haplotype diversity of cultivated populations. Genetic differentiation between cultivated populations and wild populations was significant. Genomic AFLP markers revealed similar genetic diversity patterns. Furthermore, Structure analysis grouped all wild populations into two gene pools; two of which shared the same gene pool with cultivated S. ningpoensis. The result of Neighbor-Joining analysis was consistent with the structure analysis. In principal coordinate analysis, three cultivated populations from Zhejiang Province grouped together and were separated from other cultivated populations. Conclusions: These results suggest that cultivated S. ningpoensis has experienced dramatic loss of genetic diversity under anthropogenic influence. We postulate that strong artificial selection for medicinal quality has resulted in genetic differentiation between cultivated and wild populations. Furthermore, it appears that wild populations in Jiangxi-Hunan area were involved in the origin of cultivated S. ningpoensis.	[Chen, Chuan; Li, Pan; Wang, Rui-Hong; Fu, Cheng-Xin] Zhejiang Univ, Coll Life Sci, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Chuan] Hangzhou Bot Garden, Hangzhou, Zhejiang, Peoples R China; [Schaal, Barbara A.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Zhejiang University; Washington University (WUSTL)	Schaal, BA (corresponding author), Washington Univ, Dept Biol, St Louis, MO 63130 USA.	schaal@biology.wustl.edu; cxfu@zju.edu.cn			Key Breeding Project of Zhejiang Province [2012C12912]; National Natural Science Foundation of China [31070205]; Science and Technology Development Project of Hangzhou West Lake Scenic Area Management Committee [2012002]	Key Breeding Project of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Project of Hangzhou West Lake Scenic Area Management Committee	This research was supported by the Key Breeding Project of Zhejiang Province (2012C12912), the National Natural Science Foundation of China (31070205), and Science and Technology Development Project of Hangzhou West Lake Scenic Area Management Committee (2012002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MOL BIOL BIOTECHNOLO; [Anonymous], 1992, ILLUSTRATED CHINESE; [Anonymous], UTILIZATION CONSERVA; [Anonymous], 1991, CONSERVATION; Bagdonaite E, 2012, IND CROP PROD, V35, P302, DOI 10.1016/j.indcrop.2011.07.018; Bernath J, 1999, ACTA HORTIC, P31, DOI 10.17660/ActaHortic.1999.500.2; Canter PH, 2005, TRENDS BIOTECHNOL, V23, P180, DOI 10.1016/j.tibtech.2005.02.002; Cirak C, 2012, ACTA PHYSIOL PLANT, V34, P1313, DOI 10.1007/s11738-012-0928-8; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Diaz AM, 2004, LIFE SCI, V74, P2515, DOI 10.1016/j.lfs.2003.10.008; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; El-Domyati FM, 2011, J MED PLANTS RES, V5, P1918; Excoffier L, 1995, AMOVA ANAL MOL VARIA; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FELSENSTEIN J, 1973, SYST ZOOL, V22, P240, DOI 10.2307/2412304; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Fernie AR, 2007, PHYTOCHEMISTRY, V68, P2861, DOI 10.1016/j.phytochem.2007.07.010; Francisco-Ortega J, 2000, AM J BOT, V87, P909, DOI 10.2307/2656988; Frankel O.H., 1995, CONSERVATION PLANT B; FU YX, 1993, GENETICS, V133, P693; Galindez JD, 2002, PHARM BIOL, V40, P45; Gao Wenyuan, 2005, Plant Genetic Resources Characterization and Utilization, V3, P116, DOI 10.1079/PGR200577; Garcia D, 1996, FARMACO, V51, P443; Hartmann T, 2007, PHYTOCHEMISTRY, V68, P2831, DOI 10.1016/j.phytochem.2007.09.017; He JS, 2009, GENETICA, V135, P233, DOI 10.1007/s10709-008-9272-8; Hong D, 1994, FLORA CHINA; Huang S, 1982, SHEN NONG BEN CAO JI; KAJIMOTO T, 1989, PHYTOCHEMISTRY, V28, P2701, DOI 10.1016/S0031-9422(00)98071-3; Lambert J, 1997, MED PLANTS RESCUING, V355, P8; Li YM, 2004, VIB SPECTROSC, V36, P227, DOI 10.1016/j.vibspec.2003.12.009; Li YY, 2005, CONSERV BIOL, V19, P224, DOI 10.1111/j.1523-1739.2005.00025.x; LIU L, 1995, INT J CANCER, V62, P345, DOI 10.1002/ijc.2910620319; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; MILLIGAN BG, 1994, MOL ECOL, V3, P423, DOI 10.1111/j.1365-294X.1994.tb00082.x; Miyazawa M, 1998, J AGR FOOD CHEM, V46, P904, DOI 10.1021/jf9704221; National Pharmacopoeia Committee, 2010, CHIN PHARM 1; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M., 1987, MOL EVOLUTIONARY GEN; Nylander J, 2004, MR MODELTEST V2 PROG; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Olsen KM, 2007, MOL ECOL, V16, P2838, DOI 10.1111/j.1365-294X.2007.03359.x; Olsen KM, 1999, P NATL ACAD SCI USA, V96, P5586, DOI 10.1073/pnas.96.10.5586; Palevitch D., 1991, CONSERVATION MED PLA, P167; Pons O, 1996, GENETICS, V144, P1237; Pritchard JK, 2000, GENETICS, V155, P945; Qiu YX, 2009, PLANTA MED, V75, P94, DOI 10.1055/s-0028-1088365; Ran M., 1999, GUIDELINES MODERN CU; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sagare AP, 2001, BIOL PHARM BULL, V24, P1311, DOI 10.1248/bpb.24.1311; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Schippmann, 1997, TRADE SURVEY MED PLA; Schippmann U., 2002, BIODIVERSITY ECOSYST; Schonswetter P, 2005, TAXON, V54, P725, DOI 10.2307/25065429; Schwartz, 2010, P GAT COMP ENV WORKS; Shi W, 2008, PLANT BIOLOGY, V10, P485, DOI 10.1111/j.1438-8677.2008.00035.x; Singh SK, 2013, J ESSENT OIL RES, V25, P154, DOI 10.1080/10412905.2013.767757; SONNANTE G, 1994, THEOR APPL GENET, V89, P629, DOI 10.1007/BF00222458; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Su S, 1975, TU JING B CAO; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uniyal RC, 2000, CULTIVATION MED PLAN, P20; Verma RS, 2013, CHEM BIODIVERS, V10, P628, DOI 10.1002/cbdv.201200054; Vines G, 2004, SALISBURY PLANTLIFE, P1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang JK, 2007, HIST GENUINE CHARACT; WHO IUCN WWF, 1993, GUID CONS MED PLANTS, P21; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Woo YA, 1999, J PHARMACEUT BIOMED, V21, P407, DOI 10.1016/S0731-7085(99)00145-4; Xu CB, 2007, TEXTUAL RES COMMON C; Xu XW, 2008, THEOR APPL GENET, V116, P835, DOI 10.1007/s00122-008-0717-3; Yang ST, 2011, PLANTA MED, V77, P865, DOI 10.1055/s-0030-1250601; Yuan QJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-29; Zeder MA, 2006, EVOL ANTHROPOL, V15, P105, DOI 10.1002/evan.20101; Zhang DQ, 2010, BIOCHEM SYST ECOL, V38, P236, DOI 10.1016/j.bse.2009.12.029; Zhang Q, 2012, PLANT MOL BIOL REP, V30, P539, DOI 10.1007/s11105-011-0366-6; Zhang XG, 2009, CHROMATOGRAPHIA, V69, P51, DOI 10.1365/s10337-008-0851-8	88	9	9	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105064	10.1371/journal.pone.0105064	http://dx.doi.org/10.1371/journal.pone.0105064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157628	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303200022
J	Dehmel, S; Lowel, S				Dehmel, Susanne; Loewel, Siegrid			Cortico-Cortical Interactions Influence Binocularity of the Primary Visual Cortex of Adult Mice	PLOS ONE			English	Article							OCULAR DOMINANCE PLASTICITY; CALLOSAL CONNECTIONS; INTERHEMISPHERIC CONNECTIONS; CORTICOTHALAMIC PROJECTIONS; CONTRALATERAL THALAMUS; CORTICAL PROJECTIONS; RETICULAR NUCLEUS; PREFRONTAL CORTEX; INTRINSIC SIGNAL; LAYER 6	Electrophysiological studies have revealed that a large proportion of the mouse primary visual cortex ( V1) receives input also from the ipsilateral eye. This is surprising as most optic nerve fibers cross at the optic chiasm in mice. Inactivating V1 of one hemisphere has recently demonstrated a strong contribution of one hemisphere's activity on binocularity of single units and visually evoked potentials of V1 in the other hemisphere of young rats and of single units in young adult mice. Here we used intrinsic signal optical imaging to quantitatively study the influence of cortico-cortical connections on the magnitude of neuronal activation in the entire binocular zone of adult mouse V1. We simultaneously measured V1-activity of both hemispheres in adult C57BL/6J mice before and after blocking sensory-driven activity in one hemisphere with muscimol. In V1 contralateral to the inactivation, ipsilateral eye evoked activity was reduced by on average 18% while contralateral eye evoked activity did not change. Our results clearly show that cortico-cortical interactions exert a global amplification of ipsilateral eye evoked activity in adult mouse V1.	[Dehmel, Susanne; Loewel, Siegrid] Univ Gottingen, Johann Friedrich Blumbach Inst Zool & Anthropol, Dept Syst Neurosci Bernstein Fokus Neurotechn, D-37073 Gottingen, Germany; [Dehmel, Susanne; Loewel, Siegrid] Univ Gottingen, Sensory Collaborat Res Ctr 889, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Dehmel, S (corresponding author), Univ Gottingen, Johann Friedrich Blumbach Inst Zool & Anthropol, Dept Syst Neurosci Bernstein Fokus Neurotechn, D-37073 Gottingen, Germany.	sdehmel@gwdg.de	889, CRC/L-1607-2018	889, CRC/0000-0002-6678-3138	Federal Ministry of Education and Research (BMBF), Germany [01GQ0810]; Deutsche Forschungsgemeinschaft through the Collaborative Research Center [889]	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft through the Collaborative Research Center(German Research Foundation (DFG))	This study was supported by the Federal Ministry of Education and Research (BMBF), Germany, grant 01GQ0810 (to S. L.), and by a grant from the Deutsche Forschungsgemeinschaft through the Collaborative Research Center 889 "Cellular Mechanisms of Sensory Processing'' (to S. L., Project B5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitto HJ, 2003, CURR OPIN NEUROBIOL, V13, P440, DOI 10.1016/S0959-4388(03)00096-5; Alloway KD, 2008, J COMP NEUROL, V510, P100, DOI 10.1002/cne.21782; BATTAGLIA G, 1994, J COMP NEUROL, V347, P127, DOI 10.1002/cne.903470110; BECKSTEAD RM, 1979, J COMP NEUROL, V184, P43, DOI 10.1002/cne.901840104; Briggs F, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.003.2010; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; Cerri C, 2010, EUR J NEUROSCI, V32, P1163, DOI 10.1111/j.1460-9568.2010.07363.x; CHEN S, 1992, NEUROSCI LETT, V147, P85, DOI 10.1016/0304-3940(92)90780-B; CUSICK CG, 1981, BRAIN RES, V214, P239, DOI 10.1016/0006-8993(81)91192-6; DIAO YC, 1983, EXP BRAIN RES, V49, P410; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; Gordon JA, 1996, J NEUROSCI, V16, P3274; GRAFSTEIN B, 1971, SCIENCE, V172, P177, DOI 10.1126/science.172.3979.177; Greifzu F, 2011, P NATL ACAD SCI USA, V108, P15450, DOI 10.1073/pnas.1016458108; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Houzel JC, 2002, BRAZ J MED BIOL RES, V35, P1441, DOI 10.1590/S0100-879X2002001200005; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Khibnik LA, 2010, NEURON, V66, P493, DOI 10.1016/j.neuron.2010.04.012; LEONARD CM, 1969, BRAIN RES, V12, P321, DOI 10.1016/0006-8993(69)90003-1; LEWIS JW, 1995, J COMP NEUROL, V361, P119, DOI 10.1002/cne.903610110; Li L, 2006, EXP BRAIN RES, V172, P397, DOI 10.1007/s00221-005-0337-y; Ludvig N, 2012, BRAIN RES, V1441, P1, DOI 10.1016/j.brainres.2011.12.050; METIN C, 1988, EXP BRAIN RES, V69, P594; Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007; Mohajerani MH, 2011, P NATL ACAD SCI USA, V108, pE183, DOI 10.1073/pnas.1101914108; MOLINARI M, 1985, EXP BRAIN RES, V57, P305; OLAVARRIA J, 1983, BRAIN RES, V279, P233, DOI 10.1016/0006-8993(83)90182-8; OLAVARRIA J, 1984, J COMP NEUROL, V230, P249, DOI 10.1002/cne.902300209; OLAVARRIA J, 1985, J COMP NEUROL, V239, P1, DOI 10.1002/cne.902390102; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; PAYNE BR, 1984, EXP BRAIN RES, V53, P462; RAOS V, 1993, J COMP NEUROL, V332, P145, DOI 10.1002/cne.903320202; REITER HO, 1988, P NATL ACAD SCI USA, V85, P3623, DOI 10.1073/pnas.85.10.3623; Restani L, 2009, NEURON, V64, P707, DOI 10.1016/j.neuron.2009.10.019; RHOADES RW, 1984, EXP BRAIN RES, V56, P92; ROUILLER EM, 1991, NEUROSCI LETT, V125, P93, DOI 10.1016/0304-3940(91)90139-K; Rouiller EM, 2000, BRAIN RES BULL, V53, P727, DOI 10.1016/S0361-9230(00)00364-6; Schmidt KE, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/397176; Shibata H, 2005, BRAIN RES, V1059, P93, DOI 10.1016/j.brainres.2005.08.025; VALVERDE F., 1968, BRAIN RES, V9, P145, DOI 10.1016/0006-8993(68)90264-3; WAGOR E, 1980, J COMP NEUROL, V193, P187, DOI 10.1002/cne.901930113; Zhao XY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3088	43	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105745	10.1371/journal.pone.0105745	http://dx.doi.org/10.1371/journal.pone.0105745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157503	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303200056
J	Samanta, K; Bakowski, D; Parekh, AB				Samanta, Krishna; Bakowski, Daniel; Parekh, Anant B.			Key Role for Store-Operated Ca2+ Channels in Activating Gene Expression in Human Airway Bronchial Epithelial Cells	PLOS ONE			English	Article							CURRENT I-CRAC; BASOPHILIC LEUKEMIA-CELLS; EPIDERMAL-GROWTH-FACTOR; CALCIUM CURRENT; RBL-1 CELLS; MAST-CELLS; RELEASE; ASTHMA; INFLUX; SECRETION	Ca2+ entry into airway epithelia is important for activation of the NFAT family of transcription factors and expression of genes including epidermal growth factor that help orchestrate local inflammatory responses. However, the identity of epithelial Ca2+ channel that activates these transcriptional responses is unclear. In many other non-excitable cells, store-operated Ca2+ entry is a major route for Ca2+ influx and is mediated by STIM1 and Orai1 proteins. This study was performed to determine if store-operated Ca2+ channels were expressed in human bronchial epithelial cells and, if so, whether they coupled Ca2+ entry to gene expression. Cytoplasmic Ca2+ measurements, patch clamp recordings, RNAi knockdown and functional assays were used to identify and then investigate the role of these Ca2+ channels in activating the NFAT and c-fos pathways and EGF expression. STIM1 and Orai1 mRNA transcripts as well as proteins were robustly in epithelial cells and formed functional Ca2+ channels. Ca2+ entry through the channels activated expression of c-fos and EGF as well as an NFAT-dependent reporter gene. Store-operated Ca2+ entry was also important for epithelial cell migration in a scrape wound assay. These findings indicate that store-operated Ca2+ channels play an important role in stimulating airway epithelial cell gene expression and therefore comprise a novel potential therapeutic target for the treatment of chronic asthma and related airway disorders.	[Samanta, Krishna; Bakowski, Daniel; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	anant.parekh@dpag.ox.ac.uk			Medical Research Council [G0901791]; American Asthma Foundation; Medical Research Council [G1000813] Funding Source: researchfish; MRC [G1000813] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); American Asthma Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding provided by Medical Research Council G0901791 and American Asthma Foundation Senior Investigator Award to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amishima M, 1998, AM J RESP CRIT CARE, V157, P1907, DOI 10.1164/ajrccm.157.6.9609040; Bakowski D, 2000, J PHYSIOL-LONDON, V529, P295, DOI 10.1111/j.1469-7793.2000.00295.x; Bakowski D, 2001, J PHYSIOL-LONDON, V532, P55, DOI 10.1111/j.1469-7793.2001.0055g.x; Balghi H, 2011, FASEB J, V25, P4274, DOI 10.1096/fj.11-187682; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Chustz RT, 2011, AM J RESP CELL MOL, V45, P145, DOI 10.1165/rcmb.2010-0075OC; Dethlefsen SM, 1998, J CELL BIOCHEM, V69, P143, DOI 10.1002/(SICI)1097-4644(19980501)69:2<143::AID-JCB5>3.0.CO;2-S; Di Capite J, 2009, J ALLERGY CLIN IMMUN, V124, P1014, DOI 10.1016/j.jaci.2009.08.030; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; ELLIS EF, 1983, J ALLERGY CLIN IMMUN, V72, P526, DOI 10.1016/0091-6749(83)90479-7; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fierro L, 1999, J PHYSIOL-LONDON, V520, P407, DOI 10.1111/j.1469-7793.1999.00407.x; Fierro L, 1999, J MEMBRANE BIOL, V168, P9, DOI 10.1007/s002329900493; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Holgate ST, 1999, CLIN EXP ALLERGY, V29, P90, DOI 10.1046/j.1365-2222.1999.00016.x; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Kar P, 2012, CURR BIOL, V22, P242, DOI 10.1016/j.cub.2011.12.025; Kar P, 2011, J BIOL CHEM, V286, P14795, DOI 10.1074/jbc.M111.220582; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Li MC, 2011, J ALLERGY CLIN IMMUN, V128, P626, DOI 10.1016/j.jaci.2011.04.032; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; NOAH TL, 1991, AM J RESP CELL MOL, V5, P484, DOI 10.1165/ajrcmb/5.5.484; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Post S, 2013, ALLERGY, V68, P1117, DOI 10.1111/all.12202; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Ramadas RA, 2011, AM J RESP CELL MOL, V44, P134, DOI 10.1165/rcmb.2009-0315OC; ROBERTS ML, 1978, BIOCHIM BIOPHYS ACTA, V540, P246, DOI 10.1016/0304-4165(78)90137-X; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Seys SF, 2013, THORAX, V68, P906, DOI 10.1136/thoraxjnl-2013-203280; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Tourdot S, 2008, CLIN EXP ALLERGY, V38, P1016, DOI 10.1111/j.1365-2222.2008.02974.x; Trinh NTN, 2008, AM J PHYSIOL-LUNG C, V295, pL866, DOI 10.1152/ajplung.90224.2008; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Xiao B, 2011, NATURE; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	45	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105586	10.1371/journal.pone.0105586	http://dx.doi.org/10.1371/journal.pone.0105586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157492	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303200038
J	Yamamoto, KN; Hirota, K; Takeda, S; Haeno, H				Yamamoto, Kimiyo N.; Hirota, Kouji; Takeda, Shunichi; Haeno, Hiroshi			Evolution of Pre-Existing versus Acquired Resistance to Platinum Drugs and PARP Inhibitors in BRCA-Associated Cancers	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; EPITHELIAL OVARIAN-CANCER; SECONDARY MUTATIONS; MODEL; CARCINOMA; HETEROGENEITY; CHEMOTHERAPY; DYNAMICS; THERAPY; REPAIR	Platinum drugs and PARP inhibitors ("PARPis'') are considered to be effective in BRCA-associated cancers with impaired DNA repair. These agents cause stalled and collapsed replication forks and create double-strand breaks effectively in the absence of repair mechanisms, resulting in arrest of the cell cycle and induction of cell death. However, recent studies have shown failure of these chemotherapeutic agents due to emerging drug resistance. In this study, we developed a stochastic model of BRCA-associated cancer progression in which there are four cancer populations: those with (i) functional BRCA, (ii) dysfunctional BRCA, (iii) functional BRCA and a growth advantage, and (iv) dysfunctional BRCA and a growth advantage. These four cancer populations expand from one cancer cell with normal repair function until the total cell number reaches a detectable amount. We derived formulas for the probability and expected numbers of each population at the time of detection. Furthermore, we extended the model to consider the tumor dynamics during treatment. Results from the model were validated and showed good agreement with clinical and experimental evidence in BRCA-associated cancers. Based on the model, we investigated conditions in which drug resistance during the treatment course originated from either a preexisting drug-resistant population or a de novo population, due to secondary mutations. Finally, we found that platinum drugs and PARPis were effective if (i) BRCA inactivation is present, (ii) the cancer was diagnosed early, and (iii) tumor growth is rapid. Our results indicate that different types of cancers have a preferential way of acquiring resistance to platinum drugs and PARPis according to their growth and mutational characteristics.	[Yamamoto, Kimiyo N.] Nara Womens Univ, Dept Informat & Comp Sci, Nara 630, Japan; [Yamamoto, Kimiyo N.] Japan Soc Promot Sci, Tokyo, Japan; [Hirota, Kouji] Tokyo Metropolitan Univ, Dept Chem, Tokyo 158, Japan; [Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Kyoto, Japan; [Yamamoto, Kimiyo N.; Haeno, Hiroshi] Kyushu Univ, Dept Biol, Fukuoka, Japan	Nara Womens University; Japan Society for the Promotion of Science; Tokyo Metropolitan University; Kyoto University; Kyushu University	Haeno, H (corresponding author), Kyushu Univ, Dept Biol, Fukuoka, Japan.	haeno@kyushu-u.org		Takeda, Shunichi/0000-0002-7924-7991	Aihara Innovative Mathematical Modelling Project; Ministry of Education, Culture, Sports, Science and Technology of Japan [26115006]; JSPS KAKENHI [25891019, 26116518, 25281021]; JSPS Research Fellowship [6811]; JSPS	Aihara Innovative Mathematical Modelling Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Aihara Innovative Mathematical Modelling Project, the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program),'' initiated by the Council for Science and Technology Policy (CSTP) (HH), Grant in Aid for Scientific Research on Innovative Areas "Stem Cell Aging and Disease'' from Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 26115006) (HH), JSPS KAKENHI Grant Number 25891019 (HH), 26116518 (KH), and 25281021 (KH), and JSPS Research Fellowship for Young Scientists (PD) (No. 6811) (KNY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Barber LJ, 2013, J PATHOL, V229, P422, DOI 10.1002/path.4140; Bayani J, 2002, CANCER RES, V62, P3466; Bayraktar S, 2012, BREAST CANCER RES TR, V135, P355, DOI 10.1007/s10549-012-2158-6; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Buchholz TA, 2002, INT J CANCER, V97, P557, DOI 10.1002/ijc.10109; Cass I, 2003, CANCER, V97, P2187, DOI 10.1002/cncr.11310; Castro E, 2013, J CLIN ONCOL, V31, P1748, DOI 10.1200/JCO.2012.43.1882; Cooke SL, 2010, ONCOGENE, V29, P4905, DOI 10.1038/onc.2010.245; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Danesh K, 2012, J THEOR BIOL, V314, P10, DOI 10.1016/j.jtbi.2012.08.025; Dann RB, 2012, GYNECOL ONCOL, V125, P677, DOI 10.1016/j.ygyno.2012.03.006; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foo J, 2010, J THEOR BIOL, V263, P179, DOI 10.1016/j.jtbi.2009.11.022; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Greenup R, 2013, ANN SURG ONCOL, V20, P3254, DOI 10.1245/s10434-013-3205-1; Haeno H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065724; Iijima J, 2010, CANCER RES, V70, P8467, DOI 10.1158/0008-5472.CAN-10-0267; Iwasa Y, 2006, GENETICS, V172, P2557, DOI 10.1534/genetics.105.049791; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Jones R, 2003, GYNECOL ONCOL, V89, P112, DOI 10.1016/S0090-8258(03)00066-0; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Khalique L, 2007, J PATHOL, V211, P286, DOI 10.1002/path.2112; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; King TA, 2007, ANN SURG ONCOL, V14, P2510, DOI 10.1245/s10434-007-9372-1; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Komarova NL, 2007, THEOR POPUL BIOL, V72, P523, DOI 10.1016/j.tpb.2007.08.003; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Leder K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027682; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Lee JM, 2014, ANN ONCOL, V25, P32, DOI 10.1093/annonc/mdt384; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Liu GY, 2012, PHARMACOGENOMICS, V13, P1523, DOI [10.2217/PGS.12.137, 10.2217/pgs.12.137]; Liu M, 2013, ONCOL LETT, V5, P983, DOI 10.3892/ol.2012.1093; Lord CJ, 2013, NAT MED, V19, P1381, DOI 10.1038/nm.3369; Martin RW, 2007, CANCER RES, V67, P9658, DOI 10.1158/0008-5472.CAN-07-0290; Mullany LK, 2011, ONCOGENE, V30, P3522, DOI 10.1038/onc.2011.70; Noh JM, 2013, J BREAST CANCER, V16, P308, DOI 10.4048/jbc.2013.16.3.308; Norquist B, 2011, J CLIN ONCOL, V29, P3008, DOI 10.1200/JCO.2010.34.2980; OMURA GA, 1991, J CLIN ONCOL, V9, P1138, DOI 10.1200/JCO.1991.9.7.1138; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pennington KP, 2013, CANCER-AM CANCER SOC, V119, P332, DOI 10.1002/cncr.27720; Rennstam K, 2010, GENE CHROMOSOME CANC, V49, P78, DOI 10.1002/gcc.20723; Roditi LD, 2011, J THEOR BIOL, V273, P207, DOI 10.1016/j.jtbi.2010.12.033; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shen SX, 1998, ONCOGENE, V17, P3115, DOI 10.1038/sj.onc.1202243; Skoulidis F, 2010, CANCER CELL, V18, P499, DOI 10.1016/j.ccr.2010.10.015; Tan DSP, 2008, J CLIN ONCOL, V26, P5530, DOI 10.1200/JCO.2008.16.1703; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; van Leeuwen IMM, 2006, CELL PROLIFERAT, V39, P157, DOI 10.1111/j.1365-2184.2006.00378.x; Wu R, 2013, AM J PATHOL, V182, P1391, DOI 10.1016/j.ajpath.2012.12.031; Wysham WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030042; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108	66	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105724	10.1371/journal.pone.0105724	http://dx.doi.org/10.1371/journal.pone.0105724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25158060	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200054
J	Zheng, NB; Whalen, CC; Handel, A				Zheng, Nibiao; Whalen, Christopher C.; Handel, Andreas			Modeling the Potential Impact of Host Population Survival on the Evolution of M. tuberculosis Latency	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION DYNAMICS; EXOGENOUS REINFECTION; SENSITIVITY-ANALYSIS; ACTIVE TUBERCULOSIS; PERSISTENCE; INFECTION; RISK; EXTINCTION; PATHOGENS	Tuberculosis (TB) is an infectious disease with a peculiar feature: Upon infection with the causative agent, Mycobacterium Tuberculosis (MTB), most hosts enter a latent state during which no transmission of MTB to new hosts occurs. Only a fraction of latently infected hosts develop TB disease and can potentially infect new hosts. At first glance, this seems like a waste of transmission potential and therefore an evolutionary suboptimal strategy for MTB. It might be that the human immune response keeps MTB in check in most hosts, thereby preventing it from achieving its evolutionary optimum. Another possible explanation is that long latency and progression to disease in only a fraction of hosts are evolutionary beneficial to MTB by allowing it to persist better in small host populations. Given that MTB has co-evolved with human hosts for millenia or longer, it likely encountered small host populations for a large share of its evolutionary history and had to evolve strategies of persistence. Here, we use a mathematical model to show that indeed, MTB persistence is optimal for an intermediate duration of latency and level of activation. The predicted optimal level of activation is above the observed value, suggesting that human co-evolution has lead to host immunity, which keeps MTB below its evolutionary optimum.	[Zheng, Nibiao] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Whalen, Christopher C.; Handel, Andreas] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Handel, A (corresponding author), Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.	ahandel@uga.edu		Handel, Andreas/0000-0002-4622-1146	Fogarty International Center (ICOHRTA) [TW006900]; FOGARTY INTERNATIONAL CENTER [U2RTW006900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093856] Funding Source: NIH RePORTER	Fogarty International Center (ICOHRTA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CW was supported by the Fogarty International Center (ICOHRTA, TW006900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L.J.S., 2010, INTRO STOCHASTIC PRO; Allen LJS, 2000, MATH BIOSCI, V163, P1, DOI 10.1016/S0025-5564(99)00047-4; Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; ANTONUCCI G, 1995, JAMA-J AM MED ASSOC, V274, P143, DOI 10.1001/jama.274.2.143; Bacaer N, 2008, J MATH BIOL, V57, P557, DOI 10.1007/s00285-008-0177-z; Bahi-Jaber N, 2008, J R SOC INTERFACE, V5, P1031, DOI 10.1098/rsif.2007.1326; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Basu S, 2009, B MATH BIOL, V71, P1073, DOI 10.1007/s11538-009-9394-x; Bauer AL, 2008, MATH MODEL NAT PHENO, V3, P229, DOI 10.1051/mmnp:2008051; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Bonhoeffer S, 1996, P ROY SOC B-BIOL SCI, V263, P715, DOI 10.1098/rspb.1996.0107; Brites D, 2012, INFECT GENET EVOL, V12, P678, DOI 10.1016/j.meegid.2011.08.010; Cao Y, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2745299; Caraco T, 2008, J THEOR BIOL, V250, P569, DOI 10.1016/j.jtbi.2007.10.029; Castillo-Chavez C, 2004, MATH BIOSCI ENG, V1, P361, DOI 10.3934/mbe.2004.1.361; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chan J, 2004, CLIN IMMUNOL, V110, P2, DOI 10.1016/S1521-6616(03)00210-9; Chiang CY, 2005, LANCET INFECT DIS, V5, P629, DOI 10.1016/S1473-3099(05)70240-1; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; Comas I, 2011, TRENDS MICROBIOL, V19, P492, DOI 10.1016/j.tim.2011.07.002; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; Day T, 2007, ECOL LETT, V10, P876, DOI 10.1111/j.1461-0248.2007.01091.x; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Donoghue HD, 2004, LANCET INFECT DIS, V4, P584, DOI 10.1016/S1473-3099(04)01133-8; Dowdy DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070485; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Ernst JD, 2007, J CLIN INVEST, V117, P1738, DOI 10.1172/JCI31810; Flynn JL, 2005, TRENDS MICROBIOL, V13, P98, DOI 10.1016/j.tim.2005.01.005; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Guzzetta G, 2011, J THEOR BIOL, V289, P197, DOI 10.1016/j.jtbi.2011.08.032; Handel A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002989; Handel A, 2009, EPIDEMICS-NETH, V1, P185, DOI 10.1016/j.epidem.2009.09.001; Handel A, 2009, J THEOR BIOL, V256, P117, DOI 10.1016/j.jtbi.2008.09.021; Handel A, 2008, GENETICS, V180, P2193, DOI 10.1534/genetics.108.093013; Haraguchi Y, 2000, J THEOR BIOL, V203, P85, DOI 10.1006/jtbi.1999.1065; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hoare A, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-4; Holmes EC, 2009, ANNU REV ECOL EVOL S, V40, P353, DOI 10.1146/annurev.ecolsys.110308.120248; Hurtado AM, 2003, AM J PHYS ANTHROPOL, V121, P134, DOI 10.1002/ajpa.10228; Johnson P, 2013, ADAPTIVETAU TAU LEAP; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; Keeling M, 2000, P ROY SOC B-BIOL SCI, V267, P385, DOI 10.1098/rspb.2000.1013; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; Keeling MJ, 2002, P ROY SOC B-BIOL SCI, V269, P335, DOI 10.1098/rspb.2001.1898; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; King AA, 2009, AM NAT, V173, P446, DOI 10.1086/597217; Kirschner DE, 2010, CURR OPIN BIOTECH, V21, P524, DOI 10.1016/j.copbio.2010.06.002; LENSKI RE, 1994, J THEOR BIOL, V169, P253, DOI 10.1006/jtbi.1994.1146; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lion S, 2008, ECOL LETT, V11, P277, DOI 10.1111/j.1461-0248.2007.01132.x; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Messinger SM, 2009, AM NAT, V174, P441, DOI 10.1086/605375; Moller M, 2010, FEMS IMMUNOL MED MIC, V58, P3, DOI 10.1111/j.1574-695X.2009.00600.x; Nasell I, 2002, MATH BIOSCI, V179, P1, DOI 10.1016/S0025-5564(02)00098-6; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Parvinen K, 2013, J THEOR BIOL, V333, P1, DOI 10.1016/j.jtbi.2013.03.025; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Sanchez MA, 1997, AM J EPIDEMIOL, V145, P1127; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Smith NH, 2009, NAT REV MICROBIOL, V7, P537, DOI 10.1038/nrmicro2165; SUTHERLAND I, 1982, TUBERCLE, V63, P255, DOI 10.1016/S0041-3879(82)80013-5; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Van Leth F, 2008, B WORLD HEALTH ORGAN, V86, P20, DOI 10.2471/BLT.06.037804; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; Walther BA, 2004, BIOL REV, V79, P849, DOI 10.1017/S1464793104006475; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201; Whalen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016137; Wilbur AK, 2008, CURR ANTHROPOL, V49, P963, DOI 10.1086/592434; Young D, 2008, NAT REV MICROBIOL, V6, P520, DOI 10.1038/nrmicro1919	82	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105721	10.1371/journal.pone.0105721	http://dx.doi.org/10.1371/journal.pone.0105721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157958	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303200053
J	Ryzhikov, M; Gupta, R; Glickman, M; Korolev, S				Ryzhikov, Mikhail; Gupta, Richa; Glickman, Michael; Korolev, Sergey			RecO Protein Initiates DNA Recombination and Strand Annealing through Two Alternative DNA Binding Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; ESCHERICHIA-COLI; BREAK REPAIR; PRESYNAPTIC FILAMENT; REPLICATION FORKS; RECFOR PROTEINS; RAD52 PROTEIN; GENETIC-RECOMBINATION; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE	Recombination mediator proteins (RMPs) are important for genome stability in all organisms. Several RMPs support two alternative reactions: initiation of homologous recombination and DNA annealing. We examined mechanisms of RMPs in both reactions with Mycobacterium smegmatis RecO (MsRecO) and demonstrated that MsRecO interacts with ssDNA by two distinct mechanisms. Zinc stimulates MsRecO binding to ssDNA during annealing, whereas the recombination function is zinc-independent and is regulated by interaction with MsRecR. Thus, different structural motifs or conformations of MsRecO are responsible for interaction with ssDNA during annealing and recombination. Neither annealing nor recombinase loading depends on MsRecO interaction with the conserved C-terminal tail of single-stranded (ss) DNA-binding protein (SSB), which is known to bind Escherichia coli RecO. However, similarly to E. coli proteins, MsRecO and MsRecOR do not dismiss SSB from ssDNA, suggesting that RMPs form a complex with SSB-ssDNA even in the absence of binding to the major protein interaction motif. We propose that alternative conformations of such complexes define the mechanism by which RMPs initiate the repair of stalled replication and support two different functions during recombinational repair of DNA breaks.	[Ryzhikov, Mikhail; Korolev, Sergey] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Gupta, Richa; Glickman, Michael] Mem Sloan Kettering Canc Ctr, Div Infect Dis, New York, NY 10065 USA; [Gupta, Richa; Glickman, Michael] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA	Saint Louis University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Korolev, S (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, 1100 S Grand Blvd, St Louis, MO 63104 USA.	korolevs@slu.edu	Korolev, Sergey/ABA-7517-2020	Korolev, Sergey/0000-0001-9313-7126; Ryzhikov, Mikhail/0000-0003-0729-1368; Glickman, Michael S/0000-0001-7918-5164	National Institutes of Health [AI064693, GM073837]; Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI064693 (to M. G.) and GM073837 (to S. K.). This work was also supported by President's Research Fund, Saint Louis University (to S. K.).	ALONSO JC, 1991, MOL GEN GENET, V228, P393, DOI 10.1007/BF00260632; Antony E, 2012, J MOL BIOL, V420, P269, DOI 10.1016/j.jmb.2012.04.021; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; ASAI T, 1994, J BACTERIOL, V176, P7113, DOI 10.1128/JB.176.22.7113-7114.1994; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Buisson R, 2010, NAT STRUCT MOL BIOL, V17, P1247, DOI 10.1038/nsmb.1915; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Couch FJ, 2014, SCIENCE, V343, P1466, DOI 10.1126/science.1251827; Courcelle J, 2005, MUTAT RES-FUND MOL M, V577, P217, DOI 10.1016/j.mrfmmm.2005.03.019; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; COX MM, 1991, MOL MICROBIOL, V5, P1295, DOI 10.1111/j.1365-2958.1991.tb00775.x; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Ganesh N, 2003, BIOCHEMISTRY-US, V42, P7216, DOI 10.1021/bi0340548; Genois MM, 2012, NUCLEIC ACIDS RES, V40, P6570, DOI 10.1093/nar/gks306; George NP, 2012, J BIOL CHEM, V287, P22123, DOI 10.1074/jbc.M112.367573; Grimme JM, 2010, NUCLEIC ACIDS RES, V38, P2917, DOI 10.1093/nar/gkp1249; Gupta R, 2013, NUCLEIC ACIDS RES, V41, P2284, DOI 10.1093/nar/gks1298; Gupta R, 2011, MOL MICROBIOL, V79, P316, DOI 10.1111/j.1365-2958.2010.07463.x; Hanas JS, 2005, MOL B INT U, P39; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Holloman WK, 2008, FUNGAL GENET BIOL, V45, pS31, DOI 10.1016/j.fgb.2008.04.006; Inoue J, 2008, NUCLEIC ACIDS RES, V36, P94, DOI 10.1093/nar/gkm1004; Jackson D, 2002, J MOL BIOL, V321, P133, DOI 10.1016/S0022-2836(02)00541-7; JIANG H, 1993, J BIOL CHEM, V268, P7904; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Korolev S., 2011, DNA REPAIR, P1; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; Lao JP, 2008, MOL CELL, V29, P517, DOI 10.1016/j.molcel.2007.12.014; Leiros I, 2005, EMBO J, V24, P906, DOI 10.1038/sj.emboj.7600582; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Lia G, 2013, MOL CELL, V49, P547, DOI 10.1016/j.molcel.2012.11.018; Liu J, 2006, J BIOL CHEM, V281, P26308, DOI 10.1074/jbc.M604349200; Liu J, 2011, CRIT REV BIOCHEM MOL, V46, P240, DOI 10.3109/10409238.2011.576007; LOVETT ST, 1983, J BACTERIOL, V153, P1471, DOI 10.1128/JB.153.3.1471-1478.1983; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; MAHDI AA, 1989, MOL GEN GENET, V216, P503, DOI 10.1007/BF00334397; Makharashvili N, 2004, STRUCTURE, V12, P1881, DOI 10.1016/j.str.2004.08.006; Manfredi C, 2010, NUCLEIC ACIDS RES, V38, P6920, DOI 10.1093/nar/gkq533; Mazloum N, 2007, BIOCHEMISTRY-US, V46, P7163, DOI 10.1021/bi700399m; Mazloum N, 2009, MOL CELL, V33, P160, DOI 10.1016/j.molcel.2008.12.023; Mcllwraith MJ, 2008, MOL CELL, V29, P510, DOI 10.1016/j.molcel.2007.11.037; Michel B, 2001, P NATL ACAD SCI USA, V98, P8181, DOI 10.1073/pnas.111008798; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Morimatsu K, 2012, J BIOL CHEM, V287, P35621, DOI 10.1074/jbc.M112.397034; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nimonkar AV, 2009, P NATL ACAD SCI USA, V106, P3077, DOI 10.1073/pnas.0813247106; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Plate I, 2008, J BIOL CHEM, V283, P29077, DOI 10.1074/jbc.M804881200; Radzimanowski J, 2013, NUCLEIC ACIDS RES, V41, P7972, DOI 10.1093/nar/gkt572; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Robinson K, 2005, J INFECT DIS, V191, P579, DOI 10.1086/427657; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Ryzhikov Mikhail, 2012, Methods Mol Biol, V922, P123, DOI 10.1007/978-1-62703-032-8_7; Ryzhikov M, 2011, NUCLEIC ACIDS RES, V39, P6305, DOI 10.1093/nar/gkr199; Sakai A, 2009, J BIOL CHEM, V284, P3264, DOI 10.1074/jbc.M807220200; SANDLER SJ, 1994, J BACTERIOL, V176, P3661, DOI 10.1128/JB.176.12.3661-3672.1994; Satoh K, 2012, DNA REPAIR, V11, P410, DOI 10.1016/j.dnarep.2012.01.008; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Sechman EV, 2005, MOL MICROBIOL, V57, P468, DOI 10.1111/j.1365-2958.2005.04657.x; Seong C, 2008, J BIOL CHEM, V283, P12166, DOI 10.1074/jbc.M800763200; Serafini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078351; Shi I, 2009, J BIOL CHEM, V284, P33275, DOI 10.1074/jbc.M109.057752; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Southey MC, 2013, APPL CLIN GENET, V6, P43, DOI 10.2147/TACG.S34116; Stratton MR, 1996, CURR OPIN GENET DEV, V6, P93, DOI 10.1016/S0959-437X(96)90017-9; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sugiyama T, 2009, J MOL BIOL, V390, P45, DOI 10.1016/j.jmb.2009.05.009; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sweezy MA, 1997, J MOL BIOL, V266, P927, DOI 10.1006/jmbi.1996.0829; Sweezy MA, 1999, BIOCHEMISTRY-US, V38, P936, DOI 10.1021/bi9817055; Thompson LH, 1999, BIOCHIMIE, V81, P87, DOI 10.1016/S0300-9084(99)80042-X; Timmins J, 2007, EMBO J, V26, P3260, DOI 10.1038/sj.emboj.7601760; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; Venkitaraman AR, 2014, SCIENCE, V343, P1470, DOI 10.1126/science.1252230; Wang G, 2011, DNA REPAIR, V10, P373, DOI 10.1016/j.dnarep.2011.01.004; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3; Yadav T, 2012, NUCLEIC ACIDS RES, V40, P5546, DOI 10.1093/nar/gks173; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	89	10	10	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28846	28855		10.1074/jbc.M114.585117	http://dx.doi.org/10.1074/jbc.M114.585117			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25170075	Green Published, hybrid			2022-12-25	WOS:000344141000009
J	Wang, H; Yuan, YF; Zhang, Z; Yan, H; Feng, YQ; Li, W				Wang, Hao; Yuan, Yefeng; Zhang, Zhao; Yan, Hui; Feng, Yaqin; Li, Wei			Dysbindin-1C Is Required for the Survival of Hilar Mossy Cells and the Maturation of Adult Newborn Neurons in Dentate Gyrus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEWLY GENERATED NEURONS; SCHIZOPHRENIA-RELATED PROTEIN; HERMANSKY-PUDLAK-SYNDROME; SDY MUTANT MICE; HIPPOCAMPAL NEUROGENESIS; ORGANELLES COMPLEX-1; SUSCEPTIBILITY GENE; BLOC-1; BIOGENESIS; DTNBP1	DTNBP1 (dystrobrevin-binding protein 1), which encodes dysbindin-1, is one of the leading susceptibility genes for schizophrenia. Both dysbindin-1B and -1C isoforms are decreased, but the dysbindin-1A isoform is unchanged in schizophrenic hippocampal formation, suggesting dysbindin-1 isoforms may have distinct roles in schizophrenia. We found that mouse dysbindin-1C, but not dysbindin-1A, is localized in the hilar glutamatergic mossy cells of the dentate gyrus. The maturation rate of newborn neurons in sandy (sdy) mice, in which both dysbindin-1A and -1C are deleted, is significantly delayed when compared with that in wild-type mice or with that in muted (mu) mice in which dysbindin-1A is destabilized but dysbindin-1C is unaltered. Dysbindin-1C deficiency leads to a decrease in mossy cells, which causes the delayed maturation of newborn neurons. This suggests that dysbindin-1C, rather than dysbindin-1A, regulates adult hippocampal neurogenesis in a non-cell autonomous manner.	[Wang, Hao; Yuan, Yefeng; Zhang, Zhao; Yan, Hui; Feng, Yaqin; Li, Wei] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China; [Wang, Hao; Yuan, Yefeng; Zhang, Zhao] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Yan, Hui; Feng, Yaqin] Shanxi Med Univ, Dept Histol & Embryol, Taiyuan 030001, Peoples R China; [Li, Wei] Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Beijing 100053, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanxi Medical University	Li, W (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, 1 West Beichen Rd, Beijing 100101, Peoples R China.	wli@genetics.ac.cn	zhang, zhao/X-7967-2019	wang, hao/0000-0002-3267-5040; zhang, zhao/0000-0002-5086-5278	National Natural Science Foundation of China [91332116, 31230046, 30900777]; National Basic Research Program of China [2014CB942803]; Chinese Academy of Sciences [KJZD-EW-L08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by National Natural Science Foundation of China Grants 91332116, 31230046, and 30900777, by National Basic Research Program of China Grant 2014CB942803, and Chinese Academy of Sciences Grant KJZD-EW-L08.	Ayalew M, 2012, MOL PSYCHIATR, V17, P887, DOI 10.1038/mp.2012.37; Balu DT, 2011, NEUROSCI BIOBEHAV R, V35, P848, DOI 10.1016/j.neubiorev.2010.10.005; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Bhardwaj SK, 2009, BEHAV BRAIN RES, V197, P435, DOI 10.1016/j.bbr.2008.10.011; Chancey JH, 2014, J NEUROSCI, V34, P2349, DOI 10.1523/JNEUROSCI.3620-13.2014; Chen Q, 2012, EUR J NEUROSCI, V36, P2597, DOI 10.1111/j.1460-9568.2012.08180.x; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Fei EK, 2010, J BIOL CHEM, V285, P38630, DOI 10.1074/jbc.M110.107912; Feng YQ, 2008, SCHIZOPHR RES, V106, P218, DOI 10.1016/j.schres.2008.07.018; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gerrish A, 2009, SCHIZOPHR RES, V107, P110, DOI 10.1016/j.schres.2008.08.011; Glen WB, 2014, HIPPOCAMPUS, V24, P204, DOI 10.1002/hipo.22215; Hattori S, 2008, BIOCHEM BIOPH RES CO, V373, P298, DOI 10.1016/j.bbrc.2008.06.016; Hunsaker MR, 2009, BEHAV NEUROSCI, V123, P1315, DOI 10.1037/a0017616; Hyde TM, 2011, J NEUROSCI, V31, P11088, DOI 10.1523/JNEUROSCI.1234-11.2011; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Jeans A, 2011, NEUROPHARMACOLOGY, V61, P1345, DOI 10.1016/j.neuropharm.2011.08.007; Ji YY, 2009, P NATL ACAD SCI USA, V106, P19593, DOI 10.1073/pnas.0904289106; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Kim JY, 2012, CELL, V148, P1051, DOI 10.1016/j.cell.2011.12.037; Larimore J, 2014, J BIOL CHEM, V289, P14291, DOI 10.1074/jbc.M114.553750; Larimore J, 2011, MOL BIOL CELL, V22, P4854, DOI 10.1091/mbc.E11-07-0592; Li W, 2006, HUM MUTAT, V27, P402, DOI 10.1002/humu.20309; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Lutkenhoff E, 2012, NEUROIMAGE, V62, P120, DOI 10.1016/j.neuroimage.2012.05.008; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009325; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Morris DW, 2008, BIOL PSYCHIAT, V63, P24, DOI 10.1016/j.biopsych.2006.12.025; Mullin AP, 2011, MOL NEUROBIOL, V44, P53, DOI 10.1007/s12035-011-8183-3; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; Newell-Litwa K, 2010, J NEUROSCI, V30, P820, DOI 10.1523/JNEUROSCI.3400-09.2010; Newell-Litwa K, 2009, MOL BIOL CELL, V20, P1441, DOI 10.1091/mbc.E08-05-0456; Nihonmatsu-Kikuchi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015886; Orozco IJ, 2014, MOL CELL NEUROSCI, V58, P76, DOI 10.1016/j.mcn.2013.12.003; Oyama S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004199; Pieper AA, 2005, P NATL ACAD SCI USA, V102, P14052, DOI 10.1073/pnas.0506713102; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Talbot K, 2009, HANDBOOK OF NEUROCHEMISTRY AND MOLECULAR NEUROBIOLOGY: SCHIZOPHRENIA, THIRD EDITION, P107, DOI 10.1007/978-0-387-30410-6_2.2; Talbot K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016886; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wei AH, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12051; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Zhang Q, 2002, HUM MOL GENET, V11, P697, DOI 10.1093/hmg/11.6.697; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	58	23	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29060	29072		10.1074/jbc.M114.590927	http://dx.doi.org/10.1074/jbc.M114.590927			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25157109	Green Published, hybrid			2022-12-25	WOS:000344141000024
J	Fukuda, K; Bledzka, K; Yang, J; Perera, HD; Plow, EF; Qin, J				Fukuda, Koichi; Bledzka, Kamila; Yang, Jun; Perera, H. Dhanuja; Plow, Edward F.; Qin, Jun			Molecular Basis of Kindlin-2 Binding to Integrin-linked Kinase Pseudokinase for Regulating Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX ADHESION; ILK; PROTEIN; EXPRESSION; LOCALIZATION; CYTOSKELETON; ACTIVATION; COMPLEX; ADAPTER; SYSTEM	Integrin-linked kinase (ILK) is a distinct intracellular adaptor essential for integrin-mediated cell-extracellular matrix adhesion, cell spreading, and migration. Acting as a major docking platform in focal adhesions, ILK engages many proteins to dynamically link integrins with the cytoskeleton, but the underlying mechanism remains elusive. Here, we have characterized the interaction of ILK with kindlin-2, a key regulator for integrin bidirectional signaling. We show that human kindlin-2 binds to human ILK with high affinity. Using systematic mapping approaches, we have identified a major ILK binding site involving a 20-residue fragment (residues 339-358) in kindlin-2. NMR-based analysis reveals a helical conformation of this fragment that utilizes its leucine-rich surface to recognize the ILK pseudokinase domain in a mode that is distinct from another ILK pseudokinase domain binding protein, alpha-parvin. Structure-based mutational experiments further demonstrate that the kindlin-2 binding to ILK is crucial for the kindlin-2 localization to focal adhesions and cell spreading (integrin outside-in signaling) but dispensable for the kindlin-2-mediated integrin activation (integrin inside-out signaling). These data define a specific mode of the kindlin-2/ILK interaction with mechanistic implications as to how it spatiotemporally mediates integrin signaling and cell adhesion.	[Fukuda, Koichi; Bledzka, Kamila; Yang, Jun; Perera, H. Dhanuja; Plow, Edward F.; Qin, Jun] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Plow, EF (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Mail Code NB50,9500 Euclid Ave, Cleveland, OH 44195 USA.	plowe@ccf.org; qinj@ccf.org		Qin, Jun/0000-0002-2647-9270	National Institutes of Health [R01GM62823, R01HL58758, P01HL073311]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058758, P01HL073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM62823 and R01HL58758 (to J. Q.) and P01HL073311 (to E.F.P.).	Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; Bottcher RT, 2009, CURR OPIN CELL BIOL, V21, P670, DOI 10.1016/j.ceb.2009.05.008; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fukuda K, 2011, J BIOL CHEM, V286, P21886, DOI 10.1074/jbc.M111.240093; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Honda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085498; Honda S, 2009, BLOOD, V113, P5304, DOI 10.1182/blood-2008-07-169136; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jones CI, 2014, J THROMB HAEMOST, V12, P1342, DOI 10.1111/jth.12620; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Lossner D, 2009, J CELL PHYSIOL, V220, P367, DOI 10.1002/jcp.21774; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012; Plow EF, 2014, CURR OPIN HEMATOL, V21, P241, DOI 10.1097/MOH.0000000000000042; Plow EF, 2009, CURR OPIN HEMATOL, V16, P323, DOI 10.1097/MOH.0b013e32832ea389; Qadota H, 2012, J BIOL CHEM, V287, P28537, DOI 10.1074/jbc.M112.354852; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Qin J, 2012, CURR OPIN CELL BIOL, V24, P607, DOI 10.1016/j.ceb.2012.06.003; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Tucker KL, 2008, BLOOD, V112, P4523, DOI 10.1182/blood-2008-03-148502; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; WOODS VL, 1984, BLOOD, V63, P368; Yates LA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.415208; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007	40	45	46	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28363	28375		10.1074/jbc.M114.596692	http://dx.doi.org/10.1074/jbc.M114.596692			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25160619	hybrid, Green Published			2022-12-25	WOS:000343765400030
J	Pavlov, TS; Levchenko, V; Staruschenko, A				Pavlov, Tengis S.; Levchenko, Vladislav; Staruschenko, Alexander			Role of Rho GDP Dissociation Inhibitor alpha in Control of Epithelial Sodium Channel (ENaC)-mediated Sodium Reabsorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; SALT-SENSITIVE HYPERTENSION; CORTICAL COLLECTING DUCT; PHOSPHOINOSITIDE 3-OH KINASE; NA+ CHANNEL; ANGIOTENSIN-II; ENAC ACTIVITY; RAC1 GTPASE; PLASMA-MEMBRANE; ION CHANNELS	The epithelial sodium channel (ENaC) is expressed in the aldosterone-sensitive distal nephron where it performs sodium reabsorption from the lumen. We have recently shown that ENaC activity contributes to the development of salt-induced hypertension as a result of deficiency of EGF level. Previous studies revealed that Rho GDP-dissociation inhibitor alpha (RhoGDI alpha) is involved in the control of salt-sensitive hypertension and renal injury via Rac1, which is one of the small GTPases activating ENaC. Here we investigated the intracellular mechanism mediating the involvement of the RhoGDI alpha/Rac1 axis in the control of ENaC and the effect of EGF on ENaC in this pathway. We demonstrated that RhoGDI alpha is highly expressed in the cortical collecting ducts of mice and rats, and its expression is down-regulated in Dahl salt-sensitive rats fed a high salt diet. Knockdown of RhoGDI alpha in cultured cortical collecting duct principal cells increased ENaC subunits expression and ENaC-mediated sodium reabsorption. Furthermore, RhoGDI alpha deficiency causes enhanced response to EGF treatment. Patch clamp analysis reveals that RhoGDI alpha significantly decreases ENaC current density and prevents its up-regulation by RhoA and Rac1. Inhibition of Rho kinase with Y27632 had no effects on ENaC response to EGF either in control or RhoGDI alpha knocked down cells. However, EGF treatment increased levels of active Rac1, which was further enhanced in RhoGDI alpha-deficient cells. We conclude that changes in the RhoGDI alpha-dependent pathway have a permissive role in the Rac1-mediated enhancement of ENaC activity observed in salt-induced hypertension.	[Pavlov, Tengis S.; Levchenko, Vladislav; Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Pavlov, TS (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	tpavlov@mcw.edu; staruschenko@mcw.edu		Staruschenko, Alexander/0000-0002-5190-8356	National Institutes of Health [R01 HL108880, K99 HL116603]; National Kidney Foundation [IG1724]; Medical College of Wisconsin Research Affairs Committee; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL116603, R01HL108880, K99HL116603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation; Medical College of Wisconsin Research Affairs Committee; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL108880 (to A. S.) and K99 HL116603 (NHLBI). This work was also supported by National Kidney Foundation Grant IG1724 and a Medical College of Wisconsin Research Affairs Committee pilot grant (to T. S. P.).	Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Butterworth MB, 2012, J BIOL CHEM, V287, P32556, DOI 10.1074/jbc.M112.369520; Butterworth MB, 2012, AM J PHYSIOL-RENAL, V302, pF581, DOI 10.1152/ajprenal.00304.2011; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; CANTIELLO HF, 1991, AM J PHYSIOL, V261, pC882, DOI 10.1152/ajpcell.1991.261.5.C882; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cowley AW, 2008, HYPERTENSION, V52, P777, DOI 10.1161/HYPERTENSIONAHA.107.092858; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Cowley AW, 2013, HYPERTENSION, V62, P85, DOI 10.1161/HYPERTENSIONAHA.113.01194; COWLEY AW, 1992, PHYSIOL REV, V72, P231, DOI 10.1152/physrev.1992.72.1.231; De Miguel C, 2010, AM J PHYSIOL-REG I, V298, pR1136, DOI 10.1152/ajpregu.00298.2009; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Downs CA, 2013, J BIOL CHEM, V288, P8136, DOI 10.1074/jbc.M112.389536; Falin R, 2005, AM J PHYSIOL-CELL PH, V288, pC1003, DOI 10.1152/ajpcell.00213.2004; Falin RA, 2007, J GEN PHYSIOL, V130, P313, DOI 10.1085/jgp.200709775; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Gaeggeler HP, 2011, KIDNEY INT, V79, P843, DOI 10.1038/ki.2010.486; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gee HY, 2013, J CLIN INVEST, V123, P3243, DOI 10.1172/JCI69134; Gonzalez-Perrett S, 2002, J BIOL CHEM, V277, P24959, DOI 10.1074/jbc.M105084200; Gonzalez-Rodriguez E, 2007, KIDNEY INT, V71, P116, DOI 10.1038/sj.ki.5002018; Grossmann C, 2004, AM J PHYSIOL-RENAL, V286, pF1226, DOI 10.1152/ajprenal.00378.2003; Gupta IR, 2013, J MED GENET, V50, P330, DOI 10.1136/jmedgenet-2012-101442; Ilatovskaya DV, 2013, AM J PHYSIOL-CELL PH, V304, pC102, DOI 10.1152/ajpcell.00231.2012; Ilatovskaya DV, 2011, FASEB J, V25, P2688, DOI 10.1096/fj.10-167262; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Karpushev AV, 2011, HYPERTENSION, V57, P996, DOI 10.1161/HYPERTENSIONAHA.110.157784; Karpushev Alexey V, 2010, BMC Res Notes, V3, P210, DOI 10.1186/1756-0500-3-210; Karpushev AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008827; Karpushev AV, 2008, BIOCHEM BIOPH RES CO, V377, P521, DOI 10.1016/j.bbrc.2008.10.014; Kawarazaki W, 2012, J AM SOC NEPHROL, V23, P997, DOI 10.1681/ASN.2011070734; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Levchenko V, 2010, J CELL PHYSIOL, V223, P252, DOI 10.1002/jcp.22033; Liu L, 2009, AM J PHYSIOL-RENAL, V296, pF1417, DOI 10.1152/ajprenal.90337.2008; Ma HP, 2011, J BIOL CHEM, V286, P32444, DOI 10.1074/jbc.M111.254102; Mamenko M, 2012, J BIOL CHEM, V287, P660, DOI 10.1074/jbc.M111.298919; Mattson DL, 2008, AM J PHYSIOL-RENAL, V295, pF837, DOI 10.1152/ajprenal.90341.2008; Mazzochi C, 2006, AM J PHYSIOL-RENAL, V291, pF1113, DOI 10.1152/ajprenal.00195.2006; MUTO S, 1991, AM J PHYSIOL, V260, pF163, DOI 10.1152/ajprenal.1991.260.2.F163; Nagase M, 2013, CURR OPIN NEPHROL HY, V22, P148, DOI 10.1097/MNH.0b013e32835d0751; Nagase M, 2013, NAT REV NEPHROL, V9, P86, DOI 10.1038/nrneph.2012.282; Nofziger C, 2005, PFLUG ARCH EUR J PHY, V451, P445, DOI 10.1007/s00424-005-1477-4; Pavlov TS, 2013, J AM SOC NEPHROL, V24, P1053, DOI 10.1681/ASN.2012080839; Pavlov TS, 2011, AM J PHYSIOL-RENAL, V301, pF672, DOI 10.1152/ajprenal.00597.2010; Pavlov TS, 2010, J AM SOC NEPHROL, V21, P833, DOI 10.1681/ASN.2009080885; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Pochynyuk O, 2007, EXP BIOL MED, V232, P1258, DOI 10.3181/0703-MR-76; Pochynyuk O, 2007, J BIOL CHEM, V282, P14576, DOI 10.1074/jbc.M701348200; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; Sanders PW, 1996, AM J KIDNEY DIS, V28, P775, DOI 10.1016/S0272-6386(96)90265-6; Saxena SK, 2006, BIOCHEM BIOPH RES CO, V351, P582, DOI 10.1016/j.bbrc.2006.10.087; Shen JP, 2003, AM J PHYSIOL-RENAL, V284, pF57, DOI 10.1152/ajprenal.00028.2002; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Staruschenko A, 2005, BBA-BIOMEMBRANES, V1669, P108, DOI 10.1016/j.bbamem.2005.01.005; Staruschenko A, 2004, J BIOL CHEM, V279, P49989, DOI 10.1074/jbc.M409812200; Staruschenko A, 2004, J BIOL CHEM, V279, P37771, DOI 10.1074/jbc.M402176200; Staruschenko A, 2013, AM J PHYSIOL-RENAL, V305, pF12, DOI 10.1152/ajprenal.00112.2013; Staruschenko A, 2012, COMPR PHYSIOL, V2, P1541, DOI 10.1002/cphy.c110052; Staruschenko A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00154; Staruschenko Alexander, 2006, V337, P3; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; Sun P, 2012, AM J PHYSIOL-RENAL, V302, pF679, DOI 10.1152/ajprenal.00368.2011; Takemura Y, 2010, AM J PHYSIOL-LUNG C, V298, pL509, DOI 10.1152/ajplung.00230.2009; Togawa A, 1999, ONCOGENE, V18, P5373, DOI 10.1038/sj.onc.1202921; VEHASKARI VM, 1989, AM J PHYSIOL, V256, pF803, DOI 10.1152/ajprenal.1989.256.5.F803; VEHASKARI VM, 1991, AM J PHYSIOL, V261, pF896, DOI 10.1152/ajprenal.1991.261.5.F896; WARDEN DH, 1993, AM J PHYSIOL, V264, pF670, DOI 10.1152/ajprenal.1993.264.4.F670	70	8	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28651	28659		10.1074/jbc.M114.558262	http://dx.doi.org/10.1074/jbc.M114.558262			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25164814	hybrid, Green Published			2022-12-25	WOS:000343765400053
J	Zemp, I; Lingner, J				Zemp, Ivo; Lingner, Joachim			The Shelterin Component TPP1 Is a Binding Partner and Substrate for the Deubiquitinating Enzyme USP7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TELOMERE LENGTH REGULATOR; END-PROTECTION; PROTEIN TPP1; COMPLEX; POT1; RECRUITMENT; P53; PROCESSIVITY; RECOGNITION; MAINTENANCE	The telomeric shelterin component TPP1 has critical functions in telomeric protein complex assembly and telomerase recruitment and regulation. Here we identify USP7 as a novel interacting protein of the oligonucleotide/oligosaccharide-binding fold of TPP1, which was previously known to recruit telomerase to telomeres. We identify amino acids in TPP1 and USP7 that are critical for their interaction and multiple lysines within TPP1 that are oligo-ubiquitinated and deubiquitinated by USP7. Mutational analysis indicated that human TPP1 does not require ubiquitination for telomere association in contrast to previous observations reported for mouse Tpp1. Ubiquitination of human TPP1 also had no detectable effects on known protein interactions of TPP1 with TIN2, POT1, the CTC1-STN1-TEN1 complex, and telomerase. However, the close proximity of USP7 and telomerase binding sites on TPP1 suggest possible cross-talks. In addition, we found that TPP1 is degraded in a proteasome-dependent manner. Prevention of TPP1 ubiquitination prolonged TPP1 half-life similar to 2-fold from 45 to 90 min, and remarkably, proteasome inhibition prompted complete stability of TPP1. This indicates that the proteasome destabilizes TPP1 through both direct and indirect pathways possibly involving TPP1-interacting proteins. Altogether, our work identifies novel regulatory circuits that contribute to TPP1 stability and function.	[Zemp, Ivo; Lingner, Joachim] Ecole Polytech Fed Lausanne, Sch Life Sci SV, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Zemp, I (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, SV ISREC UPLIN, SV 1824 Batiment SV,Stn 19, CH-1015 Lausanne, Switzerland.	ivo.zemp@epfl.ch; joachim.lingner@epfl.ch		Zemp, Ivo/0000-0003-1549-9871; Lingner, Joachim/0000-0002-2853-5803	Swiss National Science Foundation; European Research Council [232812]; European Commission [316354]; Swiss Cancer League; Ecole Polytechnique Federale de Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss Cancer League; Ecole Polytechnique Federale de Lausanne	This work was supported by the Swiss National Science Foundation, a European Research Council advanced investigator grant (Grant Agreement 232812), an Initial Training Network grant (CodeAge) from the European Commission's Seventh Framework Programme (Grant Agreement 316354), the Swiss Cancer League, and Ecole Polytechnique Federale de Lausanne.	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Chen LY, 2012, NATURE, V488, P540, DOI 10.1038/nature11269; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Gietz RD, 2001, BIOTECHNIQUES, V30, P816, DOI 10.2144/01304rv02; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Grolimund L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3848; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Rai R, 2011, NAT STRUCT MOL BIOL, V18, P1400, DOI 10.1038/nsmb.2172; Sauerwald A, 2013, NAT STRUCT MOL BIOL, V20, P454, DOI 10.1038/nsmb.2530; Sexton AN, 2012, J BIOL CHEM, V287, P34455, DOI 10.1074/jbc.M112.394767; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Soudet J, 2014, MOL CELL, V53, P954, DOI 10.1016/j.molcel.2014.02.030; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048; Zhang Y, 2013, P NATL ACAD SCI USA, V110, P5457, DOI 10.1073/pnas.1217733110; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012	38	19	19	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28595	28606		10.1074/jbc.M114.596056	http://dx.doi.org/10.1074/jbc.M114.596056			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25172512	Green Published, hybrid			2022-12-25	WOS:000343765400048
J	Farahbakhshian, E; Verstegen, MM; Visser, TP; Kheradmandkia, S; Geerts, D; Arshad, S; Riaz, N; Grosveld, F; van Til, NP; Meijerink, JPP				Farahbakhshian, Elnaz; Verstegen, Monique M.; Visser, Trudi P.; Kheradmandkia, Sima; Geerts, Dirk; Arshad, Shazia; Riaz, Noveen; Grosveld, Frank; van Til, Niek P.; Meijerink, Jules P. P.			Angiopoietin-Like Protein 3 Promotes Preservation of Stemness during Ex Vivo Expansion of Murine Hematopoietic Stem Cells	PLOS ONE			English	Article							TERM REPOPULATING CELLS; SERUM-FREE CULTURES; GROWTH-FACTOR-I; SELF-RENEWAL; PROGENITOR CELLS; GENE-THERAPY; CD34(+)THY-1(+)LIN(-) CELLS; STIMULATES PROLIFERATION; LENTIVIRUS VECTOR; FLT3 LIGAND	Allogeneic hematopoietic stem cell (HSC) transplantations from umbilical cord blood or autologous HSCs for gene therapy purposes are hampered by limited number of stem cells. To test the ability to expand HSCs in vitro prior to transplantation, two growth factor cocktails containing stem cell factor, thrombopoietin, fms-related tyrosine kinase-3 ligand (STF) or stem cell factor, thrombopoietin, insulin-like growth factor-2, fibroblast growth factor-1 (STIF) either with or without the addition of angiopoietin-like protein-3 (Angptl3) were used. Culturing HSCs in STF and STIF media for 7 days expanded long-term repopulating stem cells content in vivo by similar to 6-fold and similar to 10-fold compared to freshly isolated stem cells. Addition of Angptl3 resulted in increased expansion of these populations by similar to 17-fold and similar to 32-fold, respectively, and was further supported by enforced expression of Angptl3 in HSCs through lentiviral transduction that also promoted HSC expansion. As expansion of highly purified lineage-negative, Sca-1(+), c-Kit(+) HSCs was less efficient than less pure lineage-negative HSCs, Angptl3 may have a direct effect on HCS but also an indirect effect on accessory cells that support HSC expansion. No evidence for leukemia or toxicity was found during long-term follow up of mice transplanted with ex vivo expanded HSCs or manipulated HSC populations that expressed Angptl3. We conclude that the cytokine combinations used in this study to expand HSCs ex vivo enhances the engraftment in vivo. This has important implications for allogeneic umbilical cord-blood derived HSC transplantations and autologous HSC applications including gene therapy.	[Farahbakhshian, Elnaz; Verstegen, Monique M.; Visser, Trudi P.; Arshad, Shazia; Riaz, Noveen; van Til, Niek P.] Erasmus MC, Dept Hematol, Rotterdam, Netherlands; [Farahbakhshian, Elnaz; Geerts, Dirk; Meijerink, Jules P. P.] Erasmus MC, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Verstegen, Monique M.] Erasmus MC, Dept Surg, Rotterdam, Netherlands; [Kheradmandkia, Sima; Grosveld, Frank] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Meijerink, JPP (corresponding author), Erasmus MC, Dept Pediat Oncol Hematol, Rotterdam, Netherlands.	j.meijerink@erasmusmc.nl	Meijerink, Jules P/D-4393-2017; Geerts, Dirk/K-8260-2015	Meijerink, Jules P/0000-0002-6860-798X; Geerts, Dirk/0000-0002-6386-8187; Verstegen, Monique/0000-0001-9908-6673; van Til, Niek/0000-0002-9515-4103	European 411 Community [QLK3-CT-2001-00 427-INHERINE, LSHB-CT-2004-005242-CONSERT 412, 222878-PERSIST]; Koningin 413 Wilhelmina Fonds (KWF) Foundation [2010-4691]; Kinderen Kankervrij (KiKa) 414 Foundation [2011-082]; Netherlands Organization for Health Research (ZonMW) [434-00-010]	European 411 Community; Koningin 413 Wilhelmina Fonds (KWF) Foundation; Kinderen Kankervrij (KiKa) 414 Foundation; Netherlands Organization for Health Research (ZonMW)(Netherlands Organization for Health Research and Development)	This work was supported by the 5th, 6th, and 7th Framework Programs of the European 411 Community (contracts QLK3-CT-2001-00 427-INHERINE, LSHB-CT-2004-005242-CONSERT 412 and grant agreement no. 222878-PERSIST). This work was also supported by the "Koningin 413 Wilhelmina Fonds" (KWF) Foundation 2010-4691 (EF), and "Kinderen Kankervrij" (KiKa) 414 Foundation 2011-082 (DG) and by The Netherlands Organization for Health Research (ZonMW; 415 grant 434-00-010). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Attar EC, 2004, LEUKEMIA, V18, P1760, DOI 10.1038/sj.leu.2403515; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Boyiadzis M, 2004, EXPERT OPIN PHARMACO, V5, P97, DOI 10.1517/14656566.5.1.97; BROUDY VC, 1995, BLOOD, V85, P1719, DOI 10.1182/blood.V85.7.1719.bloodjournal8571719; Broxmeyer HE, 2012, BLOOD CELL MOL DIS, V48, P25, DOI 10.1016/j.bcmd.2011.09.004; Bug G, 2005, CANCER RES, V65, P2537, DOI 10.1158/0008-5472.CAN-04-3011; Chou S, 2010, P NATL ACAD SCI USA, V107, P7799, DOI 10.1073/pnas.1003586107; de Haan G, 2003, DEV CELL, V4, P241, DOI 10.1016/S1534-5807(03)00018-2; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Goff JP, 1998, BLOOD, V92, P4098, DOI 10.1182/blood.V92.11.4098.423k28_4098_4107; Gratwohl A, 2005, BONE MARROW TRANSPL, V35, P869, DOI 10.1038/sj.bmt.1704892; GUILBERT LJ, 1976, NATURE, V263, P594, DOI 10.1038/263594a0; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Huynh HD, 2008, STEM CELLS, V26, P1628, DOI 10.1634/stemcells.2008-0064; Ikushima YM, 2013, BLOOD, V121, P1995, DOI 10.1182/blood-2012-06-437889; LI CL, 1994, BLOOD, V84, P408, DOI 10.1182/blood.V84.2.408.bloodjournal842408; LINNEKIN D, 1995, GROWTH FACTORS, V12, P57, DOI 10.3109/08977199509003214; Lisovsky M, 1996, BLOOD, V88, P3987, DOI 10.1182/blood.V88.10.3987.bloodjournal88103987; Luens KM, 1998, BLOOD, V91, P1206, DOI 10.1182/blood.V91.4.1206; Masuda S, 2013, CELL RES, V23, P458, DOI 10.1038/cr.2013.14; Matthews JM, 2013, NAT REV CANCER, V13, P111, DOI 10.1038/nrc3418; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207; MERCHAV S, 1984, INT J CELL CLONING, V2, P356, DOI 10.1002/stem.5530020604; Mouthon MA, 1999, INT J RADIAT ONCOL, V43, P867, DOI 10.1016/S0360-3016(98)00477-5; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Peled T, 2004, EXP HEMATOL, V32, P547, DOI 10.1016/j.exphem.2004.03.002; Pike-Overzet K, 2007, LEUKEMIA, V21, P754, DOI 10.1038/sj.leu.2404563; Purton LE, 2000, BLOOD, V95, P470, DOI 10.1182/blood.V95.2.470; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2003, RECENT PROG HORM RES, V58, P283, DOI 10.1210/rp.58.1.283; Samantha L, 2005, MJA, V182, P458; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; Shizuru JA, 2005, ANNU REV MED, V56, P509, DOI 10.1146/annurev.med.54.101601.152334; Sorrentino BP, 2004, NAT REV IMMUNOL, V4, P878, DOI 10.1038/nri1487; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; VANDENBOS C, 1992, CYTOMETRY, V13, P659, DOI 10.1002/cyto.990130616; Varnum-Finney B, 2003, BLOOD, V101, P1784, DOI 10.1182/blood-2002-06-1862; WAGEMAKER G, 1980, CELL TISSUE KINET, V13, P505, DOI 10.1111/j.1365-2184.1980.tb00491.x; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wognum AW, 2000, HUM GENE THER, V11, P2129, DOI 10.1089/104303400750001435; Yeoh JSG, 2006, STEM CELLS, V24, P1564, DOI 10.1634/stemcells.2005-0439; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095; Zheng JK, 2011, BLOOD, V117, P470, DOI 10.1182/blood-2010-06-291716; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	53	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105642	10.1371/journal.pone.0105642	http://dx.doi.org/10.1371/journal.pone.0105642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170927	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500063
J	Kahli, A; Guenancia, C; Zeller, M; Grosjean, S; Stamboul, K; Rochette, L; Girard, C; Vergely, C				Kahli, Abdelkader; Guenancia, Charles; Zeller, Marianne; Grosjean, Sandrine; Stamboul, Karim; Rochette, Luc; Girard, Claude; Vergely, Catherine			Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; CHRONIC HEART-FAILURE; FOLLISTATIN-LIKE 1; RISK STRATIFICATION; CIRCULATING CONCENTRATIONS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ELDERLY INDIVIDUALS; PREDICTS MORTALITY; URINARY BIOMARKER	Objective: Growth differentiation factor-15 (GDF-15) has been identified as a strong marker of cardiovascular disease; however, no data are available concerning the role of GDF-15 in the occurrence of organ dysfunction during coronary artery bypass grafting (CABG) associated with cardiopulmonary bypass (CPB). Methods: Five arterial blood samples were taken sequentially in 34 patients from anesthesia induction (IND) until 24 h after arrival at the intensive care unit (ICU). Plasma levels of GDF-15, follistatin-like 1 (FLST1), myeloperoxidases (MPO), hydroperoxides and plasma antioxidant status (PAS) were measured at each time-point. Markers of cardiac (cardiac-troponin I, cTnI) and renal dysfunction (neutrophil gelatinase-associated lipocalin, NGAL) and other classical biological factors and clinical data were measured. Results: Plasma GDF-15 levels increased gradually during and after surgery, reaching nearly three times the IND levels in the ICU (3,075 +/- 284 ng/L vs. 1,061 +/- 90 ng/L, p<0.001). Plasma MPO levels increased dramatically during surgery, attaining their highest level after unclamping (UNCLAMP) (49 +/- 11 ng/mL vs. 1,679 +/- 153 ng/mL, p<0.001) while PAS significantly decreased between IND and UNCLAMP (p<0.05), confirming the high oxidative status induced by this surgical procedure. ICU levels of GDF-15 correlated positively with cTnI and NGAL (p = 0.006 and p = 0.036, respectively), and also with hemoglobin and estimated glomerular filtration rate (eGFR). Among all the post-operative biomarkers available, only eGFR, NGAL and GDF-15 measured at ICU arrival were significantly associated with the onset of acute kidney injury (AKI). Patients with a EuroSCORE > 3 were shown to have higher GDF-15 levels. Conclusions: During cardiac surgery associated with CPB, GDF-15 levels increased substantially and were associated with markers of cardiac injury and renal dysfunction.	[Kahli, Abdelkader; Guenancia, Charles; Zeller, Marianne; Grosjean, Sandrine; Stamboul, Karim; Rochette, Luc; Girard, Claude; Vergely, Catherine] Univ Bourgogne, Lab Physiopathol & Pharmacol Cardiometab LPPCM, INSERM, Fac Sci Sante,U866, Dijon, France; [Kahli, Abdelkader; Grosjean, Sandrine; Girard, Claude] Ctr Hosp Reg Bocage Cent, Serv Anesthesie Reanimat, Dijon, France; [Guenancia, Charles; Stamboul, Karim] Ctr Hosp Reg Bocage Cent, Serv Cardiol, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne	Vergely, C (corresponding author), Univ Bourgogne, Lab Physiopathol & Pharmacol Cardiometab LPPCM, INSERM, Fac Sci Sante,U866, Dijon, France.	cvergely@u-bourgogne.fr	Vergely, Catherine/L-9534-2015; Guenancia, Charles/M-5558-2013	Vergely, Catherine/0000-0003-4009-776X; Guenancia, Charles/0000-0002-3554-7714; Rochette, Luc/0000-0001-9973-8803	French Ministry of Research; Institut National de la Sante et de la Recherche Medicale (INSERM); Regional Council of Burgundy	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Regional Council of Burgundy(Region Bourgogne-Franche-Comte)	This work was supported by grants from the French Ministry of Research, from the Institut National de la Sante et de la Recherche Medicale (INSERM) and from the Regional Council of Burgundy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2006, CIRC RES, V98, P294, DOI 10.1161/01.RES.0000207919.83894.9d; Breit SN, 2012, NEPHROL DIAL TRANSPL, V27, P70, DOI 10.1093/ndt/gfr575; Clermont G, 2002, ANESTHESIOLOGY, V96, P80, DOI 10.1097/00000542-200201000-00019; Doise JM, 2008, FUND CLIN PHARMACOL, V22, P203, DOI 10.1111/j.1472-8206.2008.00573.x; Eggers KM, 2013, CLIN CHEM, V59, P1091, DOI 10.1373/clinchem.2012.201210; Foley PWX, 2009, EUR HEART J, V30, P2749, DOI 10.1093/eurheartj/ehp300; Goudeau JJ, 2007, J CARDIOVASC PHARM, V49, P39, DOI 10.1097/FJC.0b013e31802c0cd0; Heringlake M, 2013, J AM COLL CARDIOL, V61, P672, DOI 10.1016/j.jacc.2012.09.059; Ho JE, 2013, CLIN CHEM, V59, P1613, DOI 10.1373/clinchem.2013.205716; Ho JE, 2012, CLIN CHEM, V58, P1582, DOI 10.1373/clinchem.2012.190322; Hochholzer W, 2010, AM HEART J, V160, P583, DOI 10.1016/j.ahj.2010.06.010; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kempf T, 2007, EUR HEART J, V28, P2858, DOI 10.1093/eurheartj/ehm465; Kempf T, 2007, J AM COLL CARDIOL, V50, P1054, DOI 10.1016/j.jacc.2007.04.091; Kempf T, 2007, CLIN CHEM, V53, P284, DOI 10.1373/clinchem.2006.076828; Kempf T, 2012, EUR J ENDOCRINOL, V167, P671, DOI 10.1530/EJE-12-0466; Khan SQ, 2009, EUR HEART J, V30, P1057, DOI 10.1093/eurheartj/ehn600; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lorgis L, 2010, ATHEROSCLEROSIS, V213, P616, DOI 10.1016/j.atherosclerosis.2010.09.018; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Rohatgi A, 2012, CLIN CHEM, V58, P172, DOI 10.1373/clinchem.2011.171926; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Simonson MS, 2012, AM J PHYSIOL-RENAL, V302, pF820, DOI 10.1152/ajprenal.00424.2011; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Theurl I, 2010, BRIT J HAEMATOL, V148, P449, DOI 10.1111/j.1365-2141.2009.07961.x; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; Wagener G, 2006, ANESTHESIOLOGY, V105, P485, DOI 10.1097/00000542-200609000-00011; Warren OJ, 2009, J CARDIOTHOR VASC AN, V23, P223, DOI 10.1053/j.jvca.2008.08.007; Widera C, 2012, CLIN CHEM, V58, P1233, DOI 10.1373/clinchem.2012.182816; Widera C, 2009, CLIN CHEM, V55, P1794, DOI 10.1373/clinchem.2009.129411; Wildhirt SM, 2001, SHOCK, V16, P55, DOI 10.1097/00024382-200116001-00011; Wollert KC, 2007, CIRCULATION, V116, P1540, DOI 10.1161/CIRCULATIONAHA.107.697714; Wollert KC, 2007, BASIC RES CARDIOL, V102, P412, DOI 10.1007/s00395-007-0662-3; Wollert KC, 2007, CIRCULATION, V115, P962, DOI 10.1161/CIRCULATIONAHA.106.650846; Xu XY, 2011, BIOMARKERS, V16, P466, DOI 10.3109/1354750X.2011.580006; Zhang M, 2012, INT HEART J, V53, P85, DOI 10.1536/ihj.53.85	38	49	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105759	10.1371/journal.pone.0105759	http://dx.doi.org/10.1371/journal.pone.0105759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171167	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500066
J	Maia, AR; Batista, TM; Victorio, JA; Clerici, SP; Delbin, MA; Carneiro, EM; Davel, AP				Maia, Aline R.; Batista, Thiago M.; Victorio, Jamaira A.; Clerici, Stefano P.; Delbin, Maria A.; Carneiro, Everardo M.; Davel, Ana P.			Taurine Supplementation Reduces Blood Pressure and Prevents Endothelial Dysfunction and Oxidative Stress in Post-Weaning Protein-Restricted Rats	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; NADPH OXIDASE; DIET; HYPERTENSION; EXPRESSION; HOMOCYSTEINE; INVOLVEMENT; BAROREFLEX; SECRETION; DECREASE	Introduction: Taurine is a sulfur-containing amino acid that exerts protective effects on vascular function and structure in several models of cardiovascular diseases through its antioxidant and anti-inflammatory properties. Early protein malnutrition reprograms the cardiovascular system and is linked to hypertension in adulthood. This study assessed the effects of taurine supplementation in vascular alterations induced by protein restriction in post-weaning rats. Methods and Results: Weaned male Wistar rats were fed normal- (12%, NP) or low-protein (6%, LP) diets for 90 days. Half of the NP and LP rats concomitantly received 2.5% taurine supplementation in the drinking water (NPT and LPT, respectively). LP rats showed elevated systolic, diastolic and mean arterial blood pressure versus NP rats; taurine supplementation partially prevented this increase. There was a reduced relaxation response to acetylcholine in isolated thoracic aortic rings from the LP group that was reversed by superoxide dismutase (SOD) or apocynin incubation. Protein expression of p47(phox) NADPH oxidase subunit was enhanced, whereas extracellular (EC)-SOD and endothelial nitric oxide synthase phosphorylation at Ser 1177 (p-eNOS) were reduced in aortas from LP rats. Furthermore, ROS production was enhanced while acetylcholine-induced NO release was reduced in aortas from the LP group. Taurine supplementation improved the relaxation response to acetylcholine and eNOS-derived NO production, increased EC-SOD and p-eNOS protein expression, as well as reduced ROS generation and p47(phox) expression in the aortas from LPT rats. LP rats showed an increased aortic wall/lumen ratio and taurine prevented this remodeling through a reduction in wall media thickness. Conclusion: Our data indicate a protective role of taurine supplementation on the high blood pressure, endothelial dysfunction and vascular remodeling induced by post-weaning protein restriction. The beneficial vascular effect of taurine was associated with restoration of vascular redox homeostasis and improvement of NO bioavailability.	[Maia, Aline R.; Batista, Thiago M.; Victorio, Jamaira A.; Clerici, Stefano P.; Delbin, Maria A.; Carneiro, Everardo M.; Davel, Ana P.] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Davel, AP (corresponding author), Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil.	anadavel@unicamp.br	Davel, Ana P/L-8801-2013; Batista, Thiago M/C-9816-2014; Carneiro, Everardo/D-4758-2012; Delbin, Maria A/F-4233-2012; Victorio, Jamaira A./R-7049-2018	Davel, Ana P/0000-0002-9862-4262; Batista, Thiago M/0000-0001-6971-1191; Victorio, Jamaira A./0000-0002-0686-5844; Delbin, Maria/0000-0002-3537-055X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work (data collection and analysis) was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). EMC is a research fellow from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkan J, 2002, BIOSCI BIOTECH BIOCH, V66, P1755, DOI 10.1271/bbb.66.1755; Batista TM, 2012, J NUTR BIOCHEM, V23, P306, DOI 10.1016/j.jnutbio.2010.12.012; Bauersachs J, 1999, CIRCULATION, V100, P292, DOI 10.1161/01.CIR.100.3.292; Brawley L, 2003, PEDIATR RES, V54, P83, DOI 10.1203/01.PDR.0000065731.00639.02; Dalaklioglu S, 2014, FUND CLIN PHARMACOL, V28, P394, DOI 10.1111/fcp.12041; Davel AP, 2012, J VASC RES, V49, P342, DOI 10.1159/000337486; de Belchior ACS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034876; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Delbin MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053318; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Dulloo AG, 2008, BEST PRACT RES CL EN, V22, P155, DOI 10.1016/j.beem.2007.08.001; Fennessy FM, 2003, CIRCULATION, V107, P410, DOI 10.1161/01.CIR.0000046447.72402.47; Franco MD, 2002, J CARDIOVASC PHARM, V40, P501, DOI 10.1097/00005344-200210000-00002; Franco MDP, 2003, CARDIOVASC RES, V59, P767, DOI 10.1016/S0008-6363(03)00461-9; FUJITA T, 1987, CIRCULATION, V75, P525, DOI 10.1161/01.CIR.75.3.525; Gomez-Roso M, 2009, BRIT J PHARMACOL, V158, P1911, DOI 10.1111/j.1476-5381.2009.00491.x; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; Hawkins P, 2000, REPROD FERT DEVELOP, V12, P443, DOI 10.1071/RD99071; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Ikubo N, 2011, BIOMED RES-TOKYO, V32, P187, DOI 10.2220/biomedres.32.187; Katama K, 1996, EUROPEAN J PHARM, V303, P47; KOHASHI N, 1983, JPN HEART J, V24, P91; Loss ID, 2007, LIFE SCI, V81, P944, DOI 10.1016/j.lfs.2007.08.005; MacMillan-Crow LA, 2001, FREE RADICAL RES, V34, P325, DOI 10.1080/10715760100300281; Martins CDD, 2011, CLIN EXP PHARMACOL P, V38, P89, DOI 10.1111/j.1440-1681.2010.05468.x; Niu LG, 2008, EUR J PHARMACOL, V580, P169, DOI 10.1016/j.ejphar.2007.10.039; Nonaka H, 2001, CIRCULATION, V104, P1165, DOI 10.1161/hc3601.093976; Oliveira EL, 2004, NUTR NEUROSCI, V7, P201, DOI 10.1080/10284150412331279827; Oliveira MWS, 2010, PHARMACOL REP, V62, P185, DOI 10.1016/S1734-1140(10)70256-5; Qin Z, 2008, TRANSL RES, V151, P68, DOI 10.1016/j.trsl.2007.10.003; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rodford JL, 2008, J PHYSIOL-LONDON, V586, P4709, DOI 10.1113/jphysiol.2008.156976; Scabora JE, 2013, J RENIN ANGIOTENSIN; Schuller-Levis GB, 2004, NEUROCHEM RES, V29, P117, DOI 10.1023/B:NERE.0000010440.37629.17; Sener G, 2005, FUND CLIN PHARMACOL, V19, P155, DOI 10.1111/j.1472-8206.2005.00322.x; Szabo C, 2009, BRIT J PHARMACOL, V156, P713, DOI 10.1111/j.1476-5381.2008.00086.x; Torrens C, 2006, HYPERTENSION, V47, P982, DOI 10.1161/01.HYP.0000215580.43711.d1; Torrens C, 2009, HYPERTENSION, V53, P661, DOI 10.1161/HYPERTENSIONAHA.108.122820; Tropia FC, 2001, NUTR NEUROSCI, V4, P99, DOI 10.1080/1028415X.2001.11747354; Wang LJ, 2008, EUR J PHARMACOL, V597, P75, DOI 10.1016/j.ejphar.2008.08.031; Yamori Y, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S6; Zulli A, 2009, HYPERTENSION, V53, P1017, DOI 10.1161/HYPERTENSIONAHA.109.129924	42	39	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105851	10.1371/journal.pone.0105851	http://dx.doi.org/10.1371/journal.pone.0105851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170895	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500072
J	Nordmann, D; Lickfeld, M; Warnsmann, V; Wiechert, J; Jendretzki, A; Schmitz, HP				Nordmann, Doris; Lickfeld, Manuela; Warnsmann, Verena; Wiechert, Johanna; Jendretzki, Arne; Schmitz, Hans-Peter			The Small GTP-Binding Proteins AgRho2 and AgRho5 Regulate Tip-Branching, Maintenance of the Growth Axis and Actin-Ring-Integrity in the Filamentous Fungus Ashbya gossypii	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL POLARITY; RHO GTPASES; NEUROSPORA-CRASSA; USTILAGO-MAYDIS; WALL INTEGRITY; HYPHAL GROWTH; BUDDING YEAST; TRANSFORMATION; HOMOLOG	GTPases of the Rho family are important molecular switches that regulate many basic cellular processes. The function of the Rho2 and Rho5 proteins from Saccharomyces cerevisiae and of their homologs in other species is poorly understood. Here, we report on the analysis of the AgRho2 and AgRho5 proteins of the filamentous fungus Ashbya gossypii. In contrast to S. cerevisiae mutants of both encoding genes displayed a strong morphological phenotype. The Agrho2 mutants showed defects in tip-branching, while Agrho5 mutants had a significantly decreased growth rate and failed to maintain their growth axis. In addition, the Agrho5 mutants had highly defective actin rings at septation sites. We also found that a deletion mutant of a putative GDP-GTP-exchange factor (GEF) that was homologous to a Rac-GEF from other species phenocopied the Agrho5 mutant, suggesting that both proteins act in the same pathway, but the AgRho5 protein has acquired functions that are fulfilled by Rac-proteins in other species.	[Nordmann, Doris; Lickfeld, Manuela; Warnsmann, Verena; Wiechert, Johanna; Jendretzki, Arne; Schmitz, Hans-Peter] Univ Osnabruck, Dept Genet, Osnabruck, Germany	University Osnabruck	Schmitz, HP (corresponding author), Univ Osnabruck, Dept Genet, Osnabruck, Germany.	hans-peter.schmitz@biologie.uni-osnabrueck.de		Warnsmann, Verena/0000-0001-7358-4180; Schmitz, Hans-Peter/0000-0001-5449-4593				AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826; Annan RB, 2008, EUKARYOT CELL, V7, P1441, DOI 10.1128/EC.00120-08; Arellano M, 1999, MICROSC RES TECHNIQ, V47, P51, DOI 10.1002/(SICI)1097-0029(19991001)47:1<51::AID-JEMT5>3.0.CO;2-3; ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Elias M, 2012, METHODS MOL BIOL, V827, P13, DOI 10.1007/978-1-61779-442-1_2; Gladfelter AS, 2002, J CELL BIOL, V156, P315, DOI 10.1083/jcb.200109062; Guest GM, 2004, FUNGAL GENET BIOL, V41, P13, DOI 10.1016/j.fgb.2003.08.006; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harris SD, 2011, MOL MICROBIOL, V79, P1123, DOI 10.1111/j.1365-2958.2010.07525.x; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hope H, 2008, MOL BIOL CELL, V19, P3638, DOI 10.1091/mbc.E07-12-1272; Kaufmann A, 2009, FUNGAL GENET BIOL, V46, P595, DOI 10.1016/j.fgb.2009.05.002; Kemper M, 2011, MOL MICROBIOL, V80, P1276, DOI 10.1111/j.1365-2958.2011.07644.x; Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167; Knechtle P, 2008, FUNGAL GENET BIOL, V45, P829, DOI 10.1016/j.fgb.2008.03.010; Koehli M, 2008, J CELL SCI, V121, P3878, DOI 10.1242/jcs.033852; Kohli M, 2008, J CELL SCI, V121, P1065, DOI 10.1242/jcs.015933; Kwon MJ, 2011, MOL MICROBIOL, V79, P1151, DOI 10.1111/j.1365-2958.2010.07524.x; Lichius A, 2014, J CELL SCI, V127, P1953, DOI 10.1242/jcs.141630; Lickfeld M, 2012, MOL MICROBIOL, V85, P574, DOI 10.1111/j.1365-2958.2012.08128.x; MADAULE P, 1987, P NATL ACAD SCI USA, V84, P779, DOI 10.1073/pnas.84.3.779; Mahlert M, 2006, MOL MICROBIOL, V59, P567, DOI 10.1111/j.1365-2958.2005.04952.x; Marcoux N, 2000, GENETICS, V156, P579; Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823; Pham CD, 2009, EUKARYOT CELL, V8, P977, DOI 10.1128/EC.00009-09; Richthammer C, 2012, MOL MICROBIOL, V85, P716, DOI 10.1111/j.1365-2958.2012.08133.x; Sambrook J, 2001, MOL CLONING LAB MANU; Schmitz HP, 2011, FUNGAL BIOL-UK, V115, P557, DOI 10.1016/j.funbio.2011.02.015; Schmitz HP, 2006, MOL BIOL CELL, V17, P130, DOI 10.1091/mbc.e05-06-0479; Schmitz HP, 2002, J CELL SCI, V115, P3139; Singh K, 2008, P NATL ACAD SCI USA, V105, P1522, DOI 10.1073/pnas.0707359105; Walther A, 2005, CURR GENET, V48, P247, DOI 10.1007/s00294-005-0017-2; Walther A, 2004, J CELL SCI, V117, P4947, DOI 10.1242/jcs.01377; Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0; Wendland J, 2001, GENETICS, V157, P601; Wendland J, 2000, J CELL SCI, V113, P1611; WRIGHT MC, 1991, GENE, V109, P99, DOI 10.1016/0378-1119(91)90593-Z	38	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106236	10.1371/journal.pone.0106236	http://dx.doi.org/10.1371/journal.pone.0106236			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171205	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500132
J	Pinto, EG; Santos, IO; Schmidt, TJ; Borborema, SET; Ferreira, VF; Rocha, DR; Tempone, AG				Pinto, Erika G.; Santos, Isabela O.; Schmidt, Thomas J.; Borborema, Samanta E. T.; Ferreira, Vitor F.; Rocha, David R.; Tempone, Andre G.			Potential of 2-Hydroxy-3-Phenylsulfanylmethyl-[1,4]-Naphthoquinones against Leishmania (L.) infantum: Biological Activity and Structure-Activity Relationships	PLOS ONE			English	Article							NAPHTHOQUINONES; APOPTOSIS; DONOVANI; DRUGS; HYDROXYNAPHTHOQUINONES; 1,4-NAPHTHOQUINONES; DERIVATIVES; CELLS; CRUZI	Naphtoquinones have been used as promising scaffolds for drug design studies against protozoan parasites. Considering the highly toxic and limited therapeutic arsenal, the global negligence with tropical diseases and the elevated prevalence of co-morbidities especially in developing countries, the parasitic diseases caused by various Leishmania species (leishmaniasis) became a significant public health threat in 98 countries. The aim of this work was the evaluation of antileishmanial in vitro potential of thirty-six 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinones obtained by a three component reaction of lawsone, the appropriate aldehyde and thiols adequately substituted, exploiting the in situ generation of o-quinonemethides (o-QM) via the Knoevenagel condensation. The antileishmanial activity of the naphthoquinone derivatives was evaluated against promastigotes and intracellular amastigotes of Leishmania (Leishmania) infantum and their cytotoxicity was verified in mammalian cells. Among the thirty-six compounds, twenty-seven were effective against promastigotes, with IC50 values ranging from 8 to 189 mu M; fourteen compounds eliminated the intracellular amastigotes, with IC50 values ranging from 12 to 65 mu M. The compounds containing the phenyl groups at R-1 and R-2 and with the fluorine substituent at the phenyl ring at R-2, rendered the most promising activity, demonstrating a selectivity index higher than 15 against amastigotes. A QSAR (quantitative structure activity relationship) analysis yielded insights into general structural requirements for activity of most compounds in the series. Considering the in vitro antileishmanial potential of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinones and their structure-activity relationships, novel lead candidates could be exploited in future drug design studies for leishmaniasis.	[Pinto, Erika G.; Borborema, Samanta E. T.; Tempone, Andre G.] Adolfo Lutz Inst, Ctr Parasitol & Mycol, Sao Paulo, Brazil; [Pinto, Erika G.] Univ Sao Paulo, Inst Med Trop Sao Paulo, Sao Paulo, Brazil; [Santos, Isabela O.; Ferreira, Vitor F.; Rocha, David R.] Univ Fed Fluminense, Inst Quim, Dept Quim Organ, Niteroi, RJ, Brazil; [Schmidt, Thomas J.] Univ Munster, Inst Pharmaceut Biol & Phytochem, D-48149 Munster, Germany	Instituto Adolfo Lutz; Universidade de Sao Paulo; Universidade Federal Fluminense; University of Munster	Tempone, AG (corresponding author), Adolfo Lutz Inst, Ctr Parasitol & Mycol, Sao Paulo, Brazil.	atempone@usp.br	Tempone, Andre/ABA-2231-2020; Tempone, Andre Gustavo/E-5932-2012; Schmidt, Thomas J/M-1678-2016; Pinto, Erika/Z-1585-2019; Borborema, Samanta Etel Treiger/I-8063-2012; da Rocha, David R/J-9912-2012; ferreira, Vitor francisco/Y-4031-2019; Tempone, Andre Gustavo/E-5932-2012	Tempone, Andre/0000-0003-2559-7344; Tempone, Andre Gustavo/0000-0003-2559-7344; Schmidt, Thomas J/0000-0003-2634-9705; Borborema, Samanta Etel Treiger/0000-0003-0696-9800; da Rocha, David R/0000-0002-7928-8646; ferreira, Vitor francisco/0000-0002-2166-766X; Tempone, Andre Gustavo/0000-0002-9900-1470	Sao Paulo Research Foundation (FAPESP) [2012/18756-1]; FAPESP [2011/23703-1]; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) scientific award; CNPq (Brazil); CAPES-FAPERJ; CNPq [471588/2009-1]; FAPERJ-PRONEX [110.574/2010]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) scientific award(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-FAPERJ(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ-PRONEX(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from Sao Paulo Research Foundation (FAPESP project 2012/18756-1). The authors are grateful to FAPESP scholarship awarded to EGP (2011/23703-1) and the Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) scientific award given to A.G.T. Fellowships granted to V.F.F., I.O.S. by CNPq (Brazil) and D.R.R. CAPES-FAPERJ are gratefully acknowledged. This work was partially supported by CNPq grant 471588/2009-1, FAPERJ-PRONEX grant number 110.574/2010. This publication is part of the activities of the Research Network Natural Products against Neglected Diseases (ResNetNPND) (http://www.uni-muenster.de/ResNetNPND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Camara CA, 2008, AN ACAD BRAS CIENC, V80, P329, DOI 10.1590/S0001-37652008000200011; Carneiro PF, 2012, BIOORGAN MED CHEM, V20, P4995, DOI 10.1016/j.bmc.2012.06.027; Chirac P, 2006, LANCET, V367, P1560, DOI 10.1016/S0140-6736(06)68672-8; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; CROFT SL, 1992, J ANTIMICROB CHEMOTH, V30, P827, DOI 10.1093/jac/30.6.827; Di Rosso ME, 2013, TOXICOL IN VITRO, V27, P2094, DOI 10.1016/j.tiv.2013.08.002; de Rezende LCD, 2013, BIOORG MED CHEM LETT, V23, P4583, DOI 10.1016/j.bmcl.2013.06.033; Ferreira SB, 2010, ARCH PHARM, V343, P81, DOI 10.1002/ardp.200900162; Kovacic P, 2014, J APPL TOXICOL, V34, P810, DOI 10.1002/jat.2980; Lezama-Davila CM, 2012, BIOL PHARM BULL, V35, P1761, DOI 10.1248/bpb.b12-00419; Lu SF, 2000, J MED CHEM, V43, P1611, DOI 10.1021/jm990599h; Mukherjee P, 2009, INT J ANTIMICROB AG, V34, P596, DOI 10.1016/j.ijantimicag.2009.08.007; Nixon GL, 2013, J ANTIMICROB CHEMOTH, V68, P977, DOI 10.1093/jac/dks504; Park BK, 2001, ANNU REV PHARMACOL, V41, P443, DOI 10.1146/annurev.pharmtox.41.1.443; Ray S, 1998, MOL PHARMACOL, V54, P994, DOI 10.1124/mol.54.6.994; Reimao JQ, 2012, EXP PARASITOL, V130, P195, DOI 10.1016/j.exppara.2012.01.010; Ribeiro GA, 2013, J ANTIMICROB CHEMOTH, V68, P789, DOI 10.1093/jac/dks498; Riffel A, 2002, BRAZ J MED BIOL RES, V35, P811, DOI 10.1590/S0100-879X2002000700008; Salas CO, 2011, CURR MED CHEM, V18, P144; Schmidt TJ, 2012, CURR MED CHEM, V19, P2128; Schmidt TJ, 2002, QUANT STRUCT-ACT REL, V21, P276, DOI 10.1002/1521-3838(200208)21:3<276::AID-QSAR276>3.0.CO;2-S; Schuck DC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-234; Sharma A, 2013, EUR J MED CHEM, V59, P48, DOI 10.1016/j.ejmech.2012.10.052; Su JC, 2010, CELL BIOCHEM FUNCT, V28, P695, DOI 10.1002/cbf.1710; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Tempone AG, 2011, PLANTA MED, V77, P572, DOI 10.1055/s-0030-1250663; Voak AA, 2014, ANTIMICROB AGENTS CH, V58, P370, DOI 10.1128/AAC.01459-13	28	43	43	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105127	10.1371/journal.pone.0105127	http://dx.doi.org/10.1371/journal.pone.0105127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171058	gold, Green Submitted, Green Published			2022-12-25	WOS:000341127500030
J	Schamberger, A; Orban, TI				Schamberger, Anita; Orban, Tamas I.			3 ' IsomiR Species and DNA Contamination Influence Reliable Quantification of MicroRNAs by Stem-Loop Quantitative PCR	PLOS ONE			English	Article							IN-SITU DETECTION; NUCLEIC-ACID PROBES; REAL-TIME PCR; TISSUE-SECTIONS; MAMMALIAN MICRORNAS; NORTHERN BLOT; EXPRESSION; MIRNA; RNAS; CELLS	MicroRNAs (miRNAs) are similar to 20-24 nucleotide-long regulatory RNAs that have been proven to play important roles in many cellular processes. Since their discovery, a number of different techniques have been developed to detect and accurately quantify them. For individual mature miRNA measurements, quantitative stem-loop real-time PCR represents a widely used method. Although there are some data on optimization of this technique, there are still many factors that have not been investigated yet. In this study, we have thoroughly optimized this technique and pointed out several important factors that influence reliable quantification. First, we found that total RNA input can affect the measurements. Second, our data showed that carryover DNA contamination could also mislead the detection in a sequence-specific manner. Additionally, we provided evidence that different 3' isomiR species of a particular miRNA can be reverse transcribed and cross-detected even by specifically targeted assays. Besides these, we have investigated the measurement of reaction efficiencies from total RNA samples and the accuracy of simultaneous reverse transcription reactions for increasing reliability and cost effectiveness without the loss of sensitivity and specificity. In summary, we provide a detailed, refined protocol for reliable detection of microRNA species by quantitative stem-loop PCR.	[Schamberger, Anita; Orban, Tamas I.] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary; [Orban, Tamas I.] Chem Technol Transfer Ltd, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Orban, TI (corresponding author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary.	orban.tamas@ttk.mta.hu	Orban, Tamas I/N-1160-2016	Orban, Tamas I/0000-0002-3424-3428	Jedlik Anyos predoc fellowship; European Union; State of Hungary; European Social Fund in the framework of 'National Excellence Program' [TAMOP 4.2.4. A/1-11-1-2012-0001]; Hungarian National Development Agency [KMR_12-2012-0112]; Chemical Technology Transfer Ltd.	Jedlik Anyos predoc fellowship; European Union(European Commission); State of Hungary; European Social Fund in the framework of 'National Excellence Program'; Hungarian National Development Agency; Chemical Technology Transfer Ltd.	Anita Schamberger is a recipient of the Jedlik Anyos predoc fellowship. This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4. A/1-11-1-2012-0001 'National Excellence Program' and also supported by the TransRat grant (KMR_12-2012-0112) from the Hungarian National Development Agency given to Tamas I. Orban. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Tamas I. Orban is employed by Chemical Technology Transfer Ltd. Chemical Technology Transfer Ltd provided support in the form of salary for author TIO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions'' section.	Ach RA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-69; Arora S, 2013, MOL GENET GENOMICS, V288, P77, DOI 10.1007/s00438-013-0734-z; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chugh P, 2012, WIRES RNA, V3, P601, DOI 10.1002/wrna.1120; de Planell-Saguer M, 2010, NAT PROTOC, V5, P1061, DOI 10.1038/nprot.2010.62; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Lao Kaiqin, 2007, Biotechnology Journal, V2, P33, DOI 10.1002/biot.200600119; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Li SC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S13; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Miyoshi K, 2010, MOL GENET GENOMICS, V284, P95, DOI 10.1007/s00438-010-0556-1; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Nuovo GJ, 2009, BIOTECHNIQUES, V46, P115, DOI 10.2144/000113068; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Redshaw N, 2013, BIOTECHNIQUES, V54, P155, DOI 10.2144/000114002; Schamberger A, 2012, RNA BIOL, V9, P1177, DOI 10.4161/rna.21359; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Sibley CR, 2012, NUCLEIC ACIDS RES, V40, P438, DOI 10.1093/nar/gkr722; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Varallyay E, 2008, NAT PROTOC, V3, P190, DOI 10.1038/nprot.2007.528; Wang WX, 2008, BBA-GENE REGUL MECH, V1779, P749, DOI 10.1016/j.bbagrm.2008.01.005; Westholm JO, 2012, RNA, V18, P177, DOI 10.1261/rna.030627.111; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024	35	35	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106315	10.1371/journal.pone.0106315	http://dx.doi.org/10.1371/journal.pone.0106315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170848	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500147
J	Szabo, A; Kovacs, A; Frecska, E; Rajnavolgyi, E				Szabo, Attila; Kovacs, Attila; Frecska, Ede; Rajnavolgyi, Eva			Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; ALZHEIMERS-DISEASE; IMMUNE CHALLENGE; BRAIN; DIMETHYLTRYPTAMINE; LIGAND; MICE; SEROTONIN; BINDING	The orphan receptor sigma-1 (sigmar-1) is a transmembrane chaperone protein expressed in both the central nervous system and in immune cells. It has been shown to regulate neuronal differentiation and cell survival, and mediates anti-inflammatory responses and immunosuppression in murine in vivo models. Since the details of these findings have not been elucidated so far, we studied the effects of the endogenous sigmar-1 ligands N,N-dimethyltryptamine (NN-DMT), its derivative 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and the synthetic high affinity sigmar-1 agonist PRE-084 hydrochloride on human primary monocyte-derived dendritic cell (moDCs) activation provoked by LPS, polyI: C or pathogen-derived stimuli to induce inflammatory responses. Co-treatment of moDC with these activators and sigma-1 receptor ligands inhibited the production of pro-inflammatory cytokines IL-1 beta, IL-6, TNF alpha and the chemokine IL-8, while increased the secretion of the anti-inflammatory cytokine IL-10. The T-cell activating capacity of moDCs was also inhibited, and dimethyltryptamines used in combination with E. coli or influenza virus as stimulators decreased the differentiation of moDC-induced Th1 and Th17 inflammatory effector T-cells in a sigmar-1 specific manner as confirmed by gene silencing. Here we demonstrate for the first time the immunomodulatory potential of NN-DMT and 5-MeO-DMT on human moDC functions via sigmar-1 that could be harnessed for the pharmacological treatment of autoimmune diseases and chronic inflammatory conditions of the CNS or peripheral tissues. Our findings also point out a new biological role for dimethyltryptamines, which may act as systemic endogenous regulators of inflammation and immune homeostasis through the sigma-1 receptor.	[Szabo, Attila; Rajnavolgyi, Eva] Univ Debrecen, Fac Med, Dept Immunol, Debrecen, Hungary; [Szabo, Attila; Rajnavolgyi, Eva] Univ Debrecen, Res Ctr Mol Med, Debrecen, Hungary; [Kovacs, Attila; Frecska, Ede] Univ Debrecen, Fac Med, Dept Psychiat, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen	Szabo, A (corresponding author), Univ Debrecen, Fac Med, Dept Immunol, Debrecen, Hungary.	szattila@med.unideb.hu		Szabo, Attila/0000-0001-7833-8894	European Union; State of Hungary; European Social Fund [TAMOP 4.2.4. A/2-11-1-2012-0001];  [OTKA-NK101538]	European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF)); 	This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4. A/2-11-1-2012-0001 "National Excellence Program" to AS, and OTKA-NK101538 to ER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD J, 1961, SCIENCE, V134, P343, DOI 10.1126/science.134.3475.343; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; BOURRIE B, 1995, EUR J IMMUNOL, V25, P2882, DOI 10.1002/eji.1830251026; CARAYON P, 1995, INT J IMMUNOPHARMACO, V17, P753, DOI 10.1016/0192-0561(95)00066-B; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; CHRISTIAN ST, 1977, BIOCHEM MED METAB B, V18, P164, DOI 10.1016/0006-2944(77)90088-6; dos Santos RG, 2011, J CLIN PSYCHOPHARM, V31, P717, DOI 10.1097/JCP.0b013e31823607f6; Fenizia C, 2014, J VIROL, V88, P393, DOI 10.1128/JVI.01788-13; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Frecska E, 2013, J NEURAL TRANSM, V120, P1295, DOI 10.1007/s00702-013-1024-y; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; HELLEWELL SB, 1994, EUR J PHARM-MOLEC PH, V268, P9, DOI 10.1016/0922-4106(94)90115-5; Jacob MS, 2005, MED HYPOTHESES, V64, P930, DOI 10.1016/j.mehy.2004.11.005; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Jurgens HA, 2012, J NEUROSCI, V32, P3958, DOI 10.1523/JNEUROSCI.6389-11.2012; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karkkainen J, 2005, SCAND J CLIN LAB INV, V65, P189, DOI 10.1080/00365510510013604; Katoh N, 2006, CLIN EXP IMMUNOL, V146, P354, DOI 10.1111/j.1365-2249.2006.03197.x; Krebs-Thomson K, 2006, PSYCHOPHARMACOLOGY, V189, P319, DOI 10.1007/s00213-006-0566-1; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2008, NEUROPSYCHOPHARMACOL, V33, P441, DOI 10.1038/sj.npp.1301413; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076941; Mothersill C, 2010, RADIAT RES, V174, P119, DOI 10.1667/RR2036.1; O'Connell PJ, 2006, BLOOD, V107, P1010, DOI 10.1182/blood-2005-07-2903; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Peviani M, 2014, NEUROBIOL DIS, V62, P218, DOI 10.1016/j.nbd.2013.10.010; Pierson E, 2012, IMMUNOL REV, V248, P205, DOI 10.1111/j.1600-065X.2012.01126.x; Ruscher K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045118; Shen HW, 2011, DRUG METAB DISPOS, V39, P1227, DOI 10.1124/dmd.111.039107; Shen HW, 2010, CURR DRUG METAB, V11, P659, DOI 10.2174/138920010794233495; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; STRASSMAN RJ, 1994, ARCH GEN PSYCHIAT, V51, P85; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; SU TP, 1982, J PHARMACOL EXP THER, V223, P284; Su TP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.261pe12; Szabo Attila, 2013, Current Immunology Reviews, V9, P241; Szabo A, 2013, AM J CLIN EXP IMMUNO, V2, P195; Szabo A, 2012, J LEUKOCYTE BIOL, V92, P159, DOI 10.1189/jlb.0711360; Theodorou V, 2002, GUT, V51, P522, DOI 10.1136/gut.51.4.522; Wallach JV, 2009, MED HYPOTHESES, V72, P91, DOI 10.1016/j.mehy.2008.07.052; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; WOLFE SA, 1988, J PHARMACOL EXP THER, V247, P1114; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zhu LX, 2003, J IMMUNOL, V170, P3585, DOI 10.4049/jimmunol.170.7.3585	48	62	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106533	10.1371/journal.pone.0106533	http://dx.doi.org/10.1371/journal.pone.0106533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171370	gold, Green Accepted, Green Published			2022-12-25	WOS:000341127500166
J	Tani, H; Onuma, Y; Ito, Y; Torimura, M				Tani, Hidenori; Onuma, Yasuko; Ito, Yuzuru; Torimura, Masaki			Long Non-Coding RNAs as Surrogate Indicators for Chemical Stress Responses in Human-Induced Pluripotent Stem Cells	PLOS ONE			English	Article							TRANSCRIPTION; EXPRESSION; REVEALS	In this study, we focused on two biological products as ideal tools for toxicological assessment: long non-coding RNAs (lncRNAs) and human-induced pluripotent stem cells (hiPSCs). lncRNAs are an important class of pervasive non-protein-coding transcripts involved in the molecular mechanisms associated with responses to cellular stresses. hiPSCs possess the capabilities of self-renewal and differentiation into multiple cell types, and they are free of the ethical issues associated with human embryonic stem cells. Here, we identified six novel lncRNAs (CDKN2B-AS1, MIR22HG, GABPB1-AS1, FLJ33630, LINC00152, and LINC0541471_v2) that respond to model chemical stresses (cycloheximide, hydrogen peroxide, cadmium, or arsenic) in hiPSCs. Our results indicated that the lncRNAs responded to general and specific chemical stresses. Compared with typical mRNAs such as p53-related mRNAs, the lncRNAs highly and rapidly responded to chemical stresses. We propose that these lncRNAs have the potential to be surrogate indicators of chemical stress responses in hiPSCs.	[Tani, Hidenori; Torimura, Masaki] Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, Tsukuba, Ibaraki, Japan; [Onuma, Yasuko; Ito, Yuzuru] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Tani, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, 16-1 Onogawa, Tsukuba, Ibaraki, Japan.	h.tani@aist.go.jp	Tani, Hidenori/A-7175-2017; Onuma, Yasuko/L-7083-2018; Torimura, Masaki/M-8401-2018; Tani, Hidenori/F-2042-2010; Ito, Yuzuru/M-1085-2018	Tani, Hidenori/0000-0001-6390-4136; Onuma, Yasuko/0000-0002-9330-194X; Tani, Hidenori/0000-0001-6390-4136; Ito, Yuzuru/0000-0001-7923-865X				Amaral PP, 2013, BRIEF FUNCT GENOMICS, V12, P254, DOI 10.1093/bfgp/elt016; Anson BD, 2011, CLIN PHARMACOL THER, V89, P754, DOI 10.1038/clpt.2011.9; Bergmann JH, 2014, CURR OPIN CELL BIOL, V26, P10, DOI 10.1016/j.ceb.2013.08.005; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hirose T, 2014, MOL BIOL CELL, V25, P169, DOI 10.1091/mbc.E13-09-0558; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Kuroda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037342; Lakhotia SC, 2012, WIRES RNA, V3, P779, DOI 10.1002/wrna.1135; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mizutani R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034949; Pang QQ, 2014, TUMOR BIOL, V35, P5441, DOI 10.1007/s13277-014-1709-3; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rotblat B, 2011, MED HYPOTHESES, V77, P962, DOI 10.1016/j.mehy.2011.08.020; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tani H, 2013, BIOCHEM BIOPH RES CO, V439, P547, DOI 10.1016/j.bbrc.2013.09.006; Tani H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055684; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	26	59	63	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106282	10.1371/journal.pone.0106282	http://dx.doi.org/10.1371/journal.pone.0106282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171338	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500142
J	Xiao, X; Sogge, H; Lagesen, K; Tooming-Klunderud, A; Jakobsen, KS; Rohrlack, T				Xiao, Xi; Sogge, Hanne; Lagesen, Karin; Tooming-Klunderud, Ave; Jakobsen, Kjetill S.; Rohrlack, Thomas			Use of High Throughput Sequencing and Light Microscopy Show Contrasting Results in a Study of Phytoplankton Occurrence in a Freshwater Environment	PLOS ONE			English	Article							COMMUNITY ECOLOGY; DIVERSITY; SEA; QUANTIFICATION; POPULATION; GENERATION; PLANKTON	Assessing phytoplankton diversity is of primary importance for both basic and applied ecological studies. Following the advances in molecular methods, phytoplankton studies are switching from using classical microscopy to high throughput sequencing approaches. However, methodological comparisons of these approaches have rarely been reported. In this study, we compared the two methods, using a unique dataset of multiple water samples taken from a natural freshwater environment. Environmental DNA was extracted from 300 water samples collected weekly during 20 years, followed by high throughput sequencing of amplicons from the 16S and 18S rRNA hypervariable regions. For each water sample, phytoplankton diversity was also estimated using light microscopy. Our study indicates that species compositions detected by light microscopy and 454 high throughput sequencing do not always match. High throughput sequencing detected more rare species and picoplankton than light microscopy, and thus gave a better assessment of phytoplankton diversity. However, when compared to light microscopy, high throughput sequencing of 16S and 18S rRNA amplicons did not adequately identify phytoplankton at the species level. In summary, our study recommends a combined strategy using both morphological and molecular techniques.	[Xiao, Xi; Sogge, Hanne; Lagesen, Karin; Tooming-Klunderud, Ave; Jakobsen, Kjetill S.] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Xiao, Xi] Zhejiang Univ, Ocean Coll, Hangzhou 310003, Zhejiang, Peoples R China; [Lagesen, Karin] Oslo Univ Hosp, Dept Med Genet, Norwegian Sequencing Ctr, Oslo, Norway; [Rohrlack, Thomas] Norwegian Univ Life Sci, Dept Plant & Environm Sci, As, Norway; [Rohrlack, Thomas] Norwegian Inst Water Res NIVA, Oslo, Norway	University of Oslo; Zhejiang University; University of Oslo; Norwegian University of Life Sciences; Norwegian Institute for Water Research (NIVA)	Rohrlack, T (corresponding author), Norwegian Univ Life Sci, Dept Plant & Environm Sci, As, Norway.	Thomas.Rohrlack@nmbu.no	xiao, xi/K-1027-2014; Xiao, Xi/M-4661-2019	xiao, xi/0000-0002-9753-6586; Xiao, Xi/0000-0002-9753-6586; Lagesen, Karin/0000-0003-1329-9032	Norwegian Research Council [183360/S30]; Government-Exchange Scholarship from the Research Council of Norway; China Scholarship Council	Norwegian Research Council(Research Council of NorwayEuropean Commission); Government-Exchange Scholarship from the Research Council of Norway; China Scholarship Council(China Scholarship Council)	This work was supported by Norwegian Research Council (grant 183360/S30 to TR), and Government-Exchange Scholarship from the Research Council of Norway and China Scholarship Council regarding KSJ and XX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BRABRAND A, 1993, OECOLOGIA, V95, P38, DOI 10.1007/BF00649504; Cao Y, 1998, LIMNOL OCEANOGR, V43, P1403, DOI 10.4319/lo.1998.43.7.1403; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caron DA, 2012, ANNU REV MAR SCI, V4, P467, DOI 10.1146/annurev-marine-120709-142802; Coupland P, 2012, BIOTECHNIQUES, V53, P365, DOI 10.2144/000113962; Ebenezer V, 2012, MAR BIOTECHNOL, V14, P129, DOI 10.1007/s10126-011-9427-y; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eiler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053516; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Ghiglione JF, 2012, ENVIRON MICROBIOL, V14, P617, DOI 10.1111/j.1462-2920.2011.02601.x; Gjolme N, 2009, HARMFUL ALGAE, V8, P726, DOI 10.1016/j.hal.2009.02.005; Gonzalez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029973; Hawkins CP, 2000, ECOL APPL, V10, P1456, DOI 10.1890/1051-0761(2000)010[1456:DAEOPM]2.0.CO;2; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Lauria V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047408; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Luo W, 2006, PROTIST, V157, P315, DOI 10.1016/j.protis.2006.05.006; Mcmanus GB, 2009, J PLANKTON RES, V31, P1119, DOI 10.1093/plankt/fbp061; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Monchy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039924; Ovaskainen O, 2010, FUNGAL ECOL, V3, P274, DOI 10.1016/j.funeco.2010.01.001; Palinska KA, 2008, HYDROBIOLOGIA, V607, P163, DOI 10.1007/s10750-008-9388-y; Peura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038552; Pfrender ME, 2010, Q REV BIOL, V85, P319, DOI 10.1086/655118; Pollard RT, 2009, NATURE, V457, P577, DOI 10.1038/nature07716; Preston DL, 2012, ECOLOGY, V93, P1254, DOI 10.1890/11-1821.1; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rohrlack T, 2008, LIMNOL OCEANOGR, V53, P1279, DOI 10.4319/lo.2008.53.4.1279; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sime Ngando T., 1991, Archiv fuer Protistenkunde, V140, P109; Soares MCS, 2011, METHODS MOL BIOL, V689, P215, DOI 10.1007/978-1-60761-950-5_13; Sogge H, 2014, COMMUNICATION; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sun F, 2012, ENVIRON TECHNOL, V33, P1773, DOI 10.1080/09593330.2011.644868; Taylor GT, 2012, P NATL ACAD SCI USA, V109, P19315, DOI 10.1073/pnas.1207514109; Utermohl H., 1931, Verhandlungen der Internationalen Vereinigung fuer Theoretische Limnologie Stuttgart, V5, P567; Veldhuis MJW, 2005, J SEA RES, V53, P7, DOI 10.1016/j.seares.2004.01.006	38	48	49	2	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106510	10.1371/journal.pone.0106510	http://dx.doi.org/10.1371/journal.pone.0106510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171164	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000341127500164
J	Yelenik, SG; Colman, BP; Levine, JM; HilleRisLambers, J				Yelenik, Stephanie G.; Colman, Benjamin P.; Levine, Jonathan M.; HilleRisLambers, Janneke			A Mechanistic Study of Plant and Microbial Controls over R* for Nitrogen in an Annual Grassland	PLOS ONE			English	Article							RESOURCE REDUCTION; N MINERALIZATION; SOIL; COMPETITION; AMMONIUM; NITRATE; TRAITS; CARBON; ROOTS; NITRIFICATION	Differences in species' abilities to capture resources can drive competitive hierarchies, successional dynamics, community diversity, and invasions. To investigate mechanisms of resource competition within a nitrogen (N) limited California grassland community, we established a manipulative experiment using an R* framework. R* theory holds that better competitors within a N limited community should better depress available N in monoculture plots and obtain higher abundance in mixture plots. We asked whether (1) plant uptake or (2) plant species influences on microbial dynamics were the primary drivers of available soil N levels in this system where N structures plant communities. To disentangle the relative roles of plant uptake and microbially-mediated processes in resource competition, we quantified soil N dynamics as well as N pools in plant and microbial biomass in monoculture plots of 11 native or exotic annual grassland plants over one growing season. We found a negative correlation between plant N content and soil dissolved inorganic nitrogen (DIN, our measure of R*), suggesting that plant uptake drives R*. In contrast, we found no relationship between microbial biomass N or potential net N mineralization and DIN. We conclude that while plant-microbial interactions may have altered the overall quantity of N that plants take up, the relationship between species' abundance and available N in monoculture was largely driven by plant N uptake in this first year of growth.	[Yelenik, Stephanie G.; Colman, Benjamin P.; Levine, Jonathan M.; HilleRisLambers, Janneke] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Colman, BP (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	colmanb@gmail.com	Levine, Jonathan/A-7167-2014; Colman, Benjamin P./AGJ-4864-2022; Yelenik, Stephanie/ABC-8265-2020	Colman, Benjamin P./0000-0001-6290-3705; Yelenik, Stephanie/0000-0002-9011-0769; Levine, Jonathan/0000-0003-2857-7904	David and Lucile Packard Foundation; National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service [2005-35320-16273]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This research was supported by a grant from the David and Lucile Packard Foundation (JML and JHRL), and from the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service, grant 2005-35320-16273 (SGY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELSER LW, 1980, APPL ENVIRON MICROB, V39, P505, DOI 10.1128/AEM.39.3.505-510.1980; Blagodatskaya EV, 2009, EUR J SOIL SCI, V60, P186, DOI 10.1111/j.1365-2389.2008.01103.x; Brzostek ER, 2013, BIOGEOCHEMISTRY, V115, P65, DOI 10.1007/s10533-012-9818-9; Cabrera ML, 2005, J ENVIRON QUAL, V34, P75, DOI 10.2134/jeq2005.0075; Colman BP, 2013, SOIL BIOL BIOCHEM, V60, P65, DOI 10.1016/j.soilbio.2013.01.003; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; DAVIDSON EA, 1990, ECOLOGY, V71, P1968, DOI 10.2307/1937605; Dukes JS, 2001, OECOLOGIA, V126, P563, DOI 10.1007/s004420000549; Eviner VT, 2004, ECOLOGY, V85, P2215, DOI 10.1890/03-0405; Fargione J, 2006, FUNCT ECOL, V20, P533, DOI 10.1111/j.1365-2435.2006.01116.x; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fierer N, 2002, SOIL BIOL BIOCHEM, V34, P777, DOI 10.1016/S0038-0717(02)00007-X; Fornara DA, 2009, J ECOL, V97, P48, DOI 10.1111/j.1365-2745.2008.01453.x; Fox JW, 2002, AM NAT, V159, P305, DOI 10.1086/338543; Frank DA, 2009, ECOLOGY, V90, P1512, DOI 10.1890/08-0789.1; Goldberg D. E., 1990, Perspectives on plant competition., P27; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; Harpole WS., 2007, CALIFORNIA GRASSLAND; Harrison S, 2007, SERPENTINE GRASSLAND, P145; HART SC, 1994, ECOLOGY, V75, P880, DOI 10.2307/1939413; Hawkes CV, 2005, ECOL LETT, V8, P976, DOI 10.1111/j.1461-0248.2005.00802.x; Herman DJ, 2006, SOIL SCI SOC AM J, V70, P1504, DOI 10.2136/sssaj2005.0113; HilleRisLambers J, 2010, J ECOL, V98, P1147, DOI 10.1111/j.1365-2745.2010.01706.x; Hodge A, 2013, FUNCT ECOL, V27, P865, DOI 10.1111/1365-2435.12002; JACKSON LE, 1989, SOIL BIOL BIOCHEM, V21, P409, DOI 10.1016/0038-0717(89)90152-1; Johnson DW, 2005, SOIL SCI SOC AM J, V69, P260, DOI 10.2136/sssaj2005.0260; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Kleber M, 2007, BIOGEOCHEMISTRY, V85, P9, DOI 10.1007/s10533-007-9103-5; Kuzyakov Y, 2013, NEW PHYTOL, V198, P656, DOI 10.1111/nph.12235; Miller TE, 2005, AM NAT, V165, P439, DOI 10.1086/428681; PACALA SW, 1994, AM NAT, V143, P222, DOI 10.1086/285602; Perakis SS, 2001, ECOLOGY, V82, P2245, DOI 10.1890/0012-9658(2001)082[2245:FAFONI]2.0.CO;2; Phillips RP, 2011, ECOL LETT, V14, P187, DOI 10.1111/j.1461-0248.2010.01570.x; QuickChemMethod10-107-04-1-A, 1995, QUICKCHEM AUTOMATED; R Core Team, 2022, R LANG ENV STAT COMP; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; SCHIMEL JP, 1989, SOIL BIOL BIOCHEM, V21, P1059, DOI 10.1016/0038-0717(89)90044-8; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schmidt SK, 2007, ECOLOGY, V88, P1379, DOI 10.1890/06-0164; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; SORENSEN P, 1991, ANAL CHIM ACTA, V252, P201, DOI 10.1016/0003-2670(91)87215-S; Suding KN, 2004, PLANT ECOL, V175, P47, DOI 10.1023/B:VEGE.0000048093.92118.27; TILMAN D, 1985, AM NAT, V125, P827, DOI 10.1086/284382; Tilman D., 1982, Monographs in Population Biology, pi; TILMAN D, 1991, ECOLOGY, V72, P685, DOI 10.2307/2937208; VERHAGEN FJM, 1995, PLANT SOIL, V170, P241, DOI 10.1007/BF00010477; WEDIN DA, 1990, OECOLOGIA, V84, P433, DOI 10.1007/BF00328157; Yelenik SG, 2010, ECOL APPL, V20, P716, DOI 10.1890/08-2365.1; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x	52	0	0	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106059	10.1371/journal.pone.0106059	http://dx.doi.org/10.1371/journal.pone.0106059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170943	gold, Green Submitted, Green Published			2022-12-25	WOS:000341127500095
J	Aprison, EZ; Ruvinsky, I				Aprison, Erin Z.; Ruvinsky, Ilya			Balanced Trade-Offs between Alternative Strategies Shape the Response of C-elegans Reproduction to Chronic Heat Stress	PLOS ONE			English	Article							SHOCK TRANSCRIPTIONAL RESPONSE; SEX-DETERMINATION GENE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; PHENOTYPIC DIVERSITY; REGULATES OVULATION; POPULATION-GROWTH; STEM-CELLS; TEMPERATURE; EXPRESSION	To ensure long-term reproductive success organisms have to cope with harsh environmental extremes. A reproductive strategy that simply maximizes offspring production is likely to be disadvantageous because it could lead to a catastrophic loss of fecundity under unfavorable conditions. To understand how an appropriate balance is achieved, we investigated reproductive performance of C. elegans under conditions of chronic heat stress. We found that following even prolonged exposure to temperatures at which none of the offspring survive, worms could recover and resume reproduction. The likelihood of producing viable offspring falls precipitously after exposure to temperatures greater than 28 degrees C primarily due to sperm damage. Surprisingly, we found that worms that experienced higher temperatures can recover considerably better, provided they did not initiate ovulation. Therefore mechanisms controlling this process must play a crucial role in determining the probability of recovery. We show, however, that suppressing ovulation is only beneficial under relatively long stresses, whereas it is a disadvantageous strategy under shorter stresses of the same intensity. This is because the benefit of shutting down egg laying, and thus protecting the reproductive system, is negated by the cost associated with implementing this strategy - it takes considerable time to recover and produce offspring. We interpret these balanced trade-offs as a dynamic response of the C. elegans reproductive system to stress and an adaptation to life in variable and unpredictable conditions.	[Aprison, Erin Z.; Ruvinsky, Ilya] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Aprison, Erin Z.; Ruvinsky, Ilya] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Ruvinsky, Ilya] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Ruvinsky, I (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	ruvinsky@uchicago.edu			National Institutes of Health [P50 GM081892]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was made possible by grant support from the National Institutes of Health (P50 GM081892) to IR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAVAYA K, 1991, GENE DEV, V5, P2117, DOI 10.1101/gad.5.11.2117; Ailion M, 2000, GENETICS, V156, P1047; Allman E, 2012, WIRES MEMBR TRANSP S, V1, P321, DOI [10.1002/wmts.25, DOI 10.1002/WMTS.25]; Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Andux S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000295; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; BARTON MK, 1987, GENETICS, V115, P107; Benedetti MG, 2008, EXP GERONTOL, V43, P882, DOI 10.1016/j.exger.2008.08.049; Bilgir C, 2013, G3-GENES GENOM GENET, V3, P585, DOI 10.1534/g3.112.005165; BRENNER S, 1974, GENETICS, V77, P71; Bui YK, 2002, MOL BIOL CELL, V13, P1641, DOI 10.1091/mbc.02-01-0008; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chen JJ, 2004, J NEMATOL, V36, P107; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Dolgin ES, 2008, HEREDITY, V100, P304, DOI 10.1038/sj.hdy.6801079; Eckmann CR, 2002, DEV CELL, V3, P697, DOI 10.1016/S1534-5807(02)00322-2; Ellis Ronald, 2007, WormBook, P1, DOI 10.1895/wormbook.1.82.2; Ellis RE, 2008, CURR TOP DEV BIOL, V83, P41, DOI 10.1016/S0070-2153(08)00402-X; EWERT MA, 1994, J EXP ZOOL, V270, P3, DOI 10.1002/jez.1402700103; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Feder ME, 1997, J THERM BIOL, V22, P1, DOI 10.1016/S0306-4565(96)00028-9; Felix MA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-10; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Freddolino PL, 2012, ANNU REV CELL DEV BI, V28, P363, DOI 10.1146/annurev-cellbio-092910-154129; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fruen BR, 1997, J BIOL CHEM, V272, P26965, DOI 10.1074/jbc.272.43.26965; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Golden TR, 2004, AGING CELL, V3, P111, DOI 10.1111/j.1474-9728.2004.00095.x; GREWAL PS, 1991, NEMATOLOGICA, V37, P72, DOI 10.1163/187529291X00079; Hall SE, 2010, CURR BIOL, V20, P149, DOI 10.1016/j.cub.2009.11.035; He ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022677; Hiatt SM, 2009, MOL BIOL CELL, V20, P3888, DOI 10.1091/mbc.E08-08-0833; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Huey R.B., 1990, Cold Spring Harbor Monograph Series, V19, P37; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Kariya K, 2004, DEV BIOL, V274, P201, DOI 10.1016/j.ydbio.2004.06.024; Kimata Tsubasa, 2012, Worm, V1, P31, DOI 10.4161/worm.19504; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Levy SF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001325; LHERNAULT SW, 1988, GENETICS, V120, P435; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; LITHGOW GJ, 1994, J GERONTOL, V49, pB270, DOI 10.1093/geronj/49.6.B270; Lucanic M, 2013, AGING-US, V5, P394, DOI 10.18632/aging.100564; Luo SJ, 2010, CELL, V143, P299, DOI 10.1016/j.cell.2010.09.013; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; McMullen PD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002338; Mendenhall AR, 2011, J GERONTOL A-BIOL, V66, P842, DOI 10.1093/gerona/glr089; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morran LT, 2009, EVOLUTION, V63, P1473, DOI 10.1111/j.1558-5646.2009.00652.x; Norman KR, 2005, CELL, V123, P119, DOI 10.1016/j.cell.2005.08.001; Casanueva MO, 2012, SCIENCE, V335, P82, DOI 10.1126/science.1213491; Park BJ, 2001, MOL BIOL CELL, V12, P2835, DOI 10.1091/mbc.12.9.2835; Pilipiuk J, 2009, DEV BIOL, V327, P34, DOI 10.1016/j.ydbio.2008.11.025; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Sanchez-Blanco A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002047; Satyal SH, 1998, GENE DEV, V12, P1962, DOI 10.1101/gad.12.13.1962; Schaedel ON, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001306; SCHEDL T, 1988, GENETICS, V119, P43; Schlichting CD, 2002, EVOL ECOL, V16, P189, DOI 10.1023/A:1019624425971; Simons AM, 2009, P ROY SOC B-BIOL SCI, V276, P1987, DOI 10.1098/rspb.2008.1920; SNUTCH TP, 1983, CAN J BIOCHEM CELL B, V61, P480, DOI 10.1139/o83-064; Stiernagle Theresa, 2006, WormBook, P1; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Sulston J., 1988, NEMATODE CAENORHABDI, P587; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SWANSON MM, 1981, DEV BIOL, V84, P27, DOI 10.1016/0012-1606(81)90367-5; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Thevenaz P, 2007, MICROSC RES TECHNIQ, V70, P135, DOI 10.1002/jemt.20393; Van Voorhies WA, 2006, EXP GERONTOL, V41, P1055, DOI 10.1016/j.exger.2006.05.006; Walker DS, 2002, MOL BIOL CELL, V13, P1329, DOI 10.1091/mbc.01-08-0422; WARD S, 1983, DEV BIOL, V98, P70, DOI 10.1016/0012-1606(83)90336-6; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; White A, 2012, BIOL OPEN, V1, P261, DOI 10.1242/bio.2012046; Xu XJ, 2005, FEBS LETT, V579, P549, DOI 10.1016/j.febslet.2004.12.026; Yamamoto I, 2006, DEV DYNAM, V235, P571, DOI 10.1002/dvdy.20662; Yin XY, 2004, MOL BIOL CELL, V15, P3938, DOI 10.1091/mbc.E04-03-0198	87	22	24	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105513	10.1371/journal.pone.0105513	http://dx.doi.org/10.1371/journal.pone.0105513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165831	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303700031
J	Bao, YH; Chen, ZG; Guo, YC; Feng, YS; Li, ZX; Han, WL; Wang, JG; Zhao, WX; Jiao, YJ; Li, K; Wang, Q; Wang, JQ; Zhang, HJ; Wang, L; Yang, WC				Bao, Yonghua; Chen, Zhiguo; Guo, Yongchen; Feng, Yansheng; Li, Zexin; Han, Wenliang; Wang, Jianguo; Zhao, Weixing; Jiao, Yunjuan; Li, Kai; Wang, Qian; Wang, Jiaqi; Zhang, Huijuan; Wang, Liang; Yang, Wancai			Tumor Suppressor MicroRNA-27a in Colorectal Carcinogenesis and Progression by Targeting SGPP1 and Smad2	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; COLITIS-ASSOCIATED CANCER; EPITHELIAL-CELLS; ONCOGENIC MICRORNA-27A; INFLAMMATION; STAT3; MICE; INHIBITION; COLON; MUC2	The aberrant expression of microRNAs (miRNAs) is associated with colorectal carcinogenesis, but the underlying mechanisms are not clear. This study showed that the miRNA-27a (miR-27a) was significantly reduced in colorectal cancer tissues and colorectal cancer cell lines, and that the reduced miR-27a was associated with distant metastasis and colorectal cancer clinical pathological stages-miR-27a was lower at stages III/IV than that at stage II. Bioinformatic and systemic biological analysis predicted several targets of miR-27a, among them SGPP1 and Smad2 were significantly affected. SGPP1 and Smad2 at mRNA and protein levels were negatively correlated with miR-27a in human colorectal cancer tissues and cancer cell lines. Increased miR-27a significantly repressed SGPP1 and Smad2 at transcriptional and translational levels. Functional studies showed that increasing miR-27a inhibited colon cancer cell proliferation, promoted apoptosis and attenuated cell migration, which were also linked to downregulation of p-STAT3 and upregulation of cleaved caspase 3. In vivo, miR-27a inhibited colon cancer cell growth in tumor-bearing mice. Taken together, this study has revealed miR-27a as a tumor suppressor and has identified SGPP1 and Smad2 as novel targets of miR-27a, linking to STAT3 for regulating cancer cell proliferation, apoptosis and migration in colorectal cancer. Therefore, miR-27a could be a useful biomarker for monitoring colorectal cancer development and progression, and also could have a therapeutic potential by targeting SGPP1, Smad2 and STAT3 for colorectal cancer therapy.	[Bao, Yonghua; Wang, Qian] Xinxiang Med Univ, Dept Immunol, Xinxiang, Peoples R China; [Chen, Zhiguo; Zhao, Weixing; Jiao, Yunjuan; Li, Kai; Wang, Jiaqi; Zhang, Huijuan; Wang, Liang; Yang, Wancai] Xinxiang Med Univ, Dept Pathol, Xinxiang, Peoples R China; [Guo, Yongchen] Xinxiang Med Univ, Dept Lab Med, Xinxiang, Peoples R China; [Feng, Yansheng] Xinxiang Med Univ, Dept Pathophysiol, Xinxiang, Peoples R China; [Li, Zexin; Wang, Jianguo] Xinxiang Med Univ, Affiliated Hosp 1, Dept Surg, Weihui, Peoples R China; [Han, Wenliang] Xinxiang Med Univ, Xinxiang Cent Hosp, Dept Gastroenterol, Xinxiang, Peoples R China; [Wang, Liang] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Yang, Wancai] Univ Illinois, Dept Pathol, Chicago, IL USA	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University; Medical College of Wisconsin; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yang, WC (corresponding author), Xinxiang Med Univ, Dept Immunol, Xinxiang, Peoples R China.	wyang06@uic.edu	Feng, Yansheng/AAH-1778-2019; Yang, Wancai/O-7655-2019; Feng, Yansheng/AAB-3079-2019; Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022	Feng, Yansheng/0000-0002-9788-8012; Yang, Wancai/0000-0001-7437-9197; 	National Natural Science Foundation of China [91229115, 81272251]; Innovative Team of Science and Technology from the Department of Education, Henan Province, China; Xinxiang Medical University, China [100820, 505011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Team of Science and Technology from the Department of Education, Henan Province, China; Xinxiang Medical University, China	This work was supported in part by the grant from the National Natural Science Foundation of China (grant #91229115 and 81272251), a grant for the Innovative Team of Science and Technology from the Department of Education, Henan Province, China and Doctor Research Fund (#100820 and 505011) and Startup Fund from Xinxiang Medical University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo M, 2013, P NATL ACAD SCI USA, V110, P8573, DOI 10.1073/pnas.1302107110; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Bao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099132; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Bi XL, 2012, CARCINOGENESIS, V33, P326, DOI 10.1093/carcin/bgr293; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chintharlapalli S, 2009, INT J CANCER, V125, P1965, DOI 10.1002/ijc.24530; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; Garofalo M, 2014, CURRENT PHARM DESIGN; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Johnson KR, 2003, J BIOL CHEM, V278, P34541, DOI 10.1074/jbc.M301741200; Lages E, 2012, FRONT BIOSCI-LANDMRK, V17, P2508, DOI 10.2741/4068; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Nguyen AV, 2013, NEOPLASIA, V15, P998, DOI 10.1593/neo.13952; Pathi SS, 2011, MOL CANCER RES, V9, P195, DOI 10.1158/1541-7786.MCR-10-0363; Petersson J, 2011, AM J PHYSIOL-GASTR L, V300, pG327, DOI 10.1152/ajpgi.00422.2010; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; Scheibner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050895; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Tang W, 2014, ONCOGENE, V33, P2629, DOI 10.1038/onc.2013.214; Tang W, 2012, PLOS ONE, V7; Tong C, 2007, AM J PATHOL, V171, P297, DOI 10.2353/ajpath.2007.061036; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Venkatesh T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054643; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; White NMA, 2011, NAT REV CLIN ONCOL, V8, P75, DOI 10.1038/nrclinonc.2010.173; Wu XL, 2013, ONCOTARGET, V4, P1388, DOI 10.18632/oncotarget.1239; Yang JY, 2009, CANCER RES, V69, P2185, DOI 10.1158/0008-5472.CAN-08-3961; Yang K, 2008, CANCER RES, V68, P7313, DOI 10.1158/0008-5472.CAN-08-0598; Yang WC, 2005, AM J PATHOL, V166, P1239, DOI 10.1016/S0002-9440(10)62342-5; Zanetti KA, 2012, CANCER RES, V72, P1467, DOI 10.1158/0008-5472.CAN-11-3073; Zhao BM, 2006, MOL BIOL CELL, V17, P3819, DOI 10.1091/mbc.e05-10-0990; Zhu LA, 2014, ONCOL REP, V31, P280, DOI 10.3892/or.2013.2807	45	72	77	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105991	10.1371/journal.pone.0105991	http://dx.doi.org/10.1371/journal.pone.0105991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166914	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303700060
J	Kageyama-Yahara, N; Yamamichi, N; Takahashi, Y; Nakayama, C; Shiogama, K; Inada, K; Konno-Shimizu, M; Kodashima, S; Fujishiro, M; Tsutsumi, Y; Ichinose, M; Koike, K				Kageyama-Yahara, Natsuko; Yamamichi, Nobutake; Takahashi, Yu; Nakayama, Chiemi; Shiogama, Kazuya; Inada, Ken-ichi; Konno-Shimizu, Maki; Kodashima, Shinya; Fujishiro, Mitsuhiro; Tsutsumi, Yutaka; Ichinose, Masao; Koike, Kazuhiko			Gli Regulates MUC5AC Transcription in Human Gastrointestinal Cells	PLOS ONE			English	Article							INTESTINAL METAPLASIA; GASTRIC-CANCER; MUCIN GENE; EXPRESSION; PROTEIN; ACTIVATION; DIFFERENTIATION; IDENTIFICATION; PROGNOSIS; PROMOTER	MUC5AC is a well-known gastric differentiation marker, which has been frequently used for the classification of stomach cancer. Immunohistochemistry revealed that expression of MUC5AC decreases accompanied with increased malignant property of gastric mucosa, which further suggests the importance of MUC5AC gene regulation. Alignment of the 5'-flanking regions of MUC5AC gene of 13 mammal species denoted high homology within 200 bp upstream of the coding region. Luciferase activities of the deletion constructs containing upstream 451 bp or shorter fragments demonstrated that 15 bp region between 2111 and 2125 bp plays a critical role on MUC5AC promoter activity in gastrointestinal cells. We found a putative Gli-binding site in this 15 bp sequence, and named this region a highly conserved region containing a Glibinding site (HCR-Gli). Overexpression of Gli homologs (Gli1, Gli2, and Gli3) clearly enhanced MUC5AC promoter activity. Exogenous modulation of Gli1 and Gli2 also affected the endogenous MUC5AC gene expression in gastrointestinal cells. Chromatin immunoprecipitation assays demonstrated that Gli1 directly binds to HCR-Gli: Gli regulates MUC5AC transcription via direct protein-DNA interaction. Conversely, in the 30 human cancer cell lines and various normal tissues, expression patterns of MUC5AC and Gli did not coincide wholly: MUC5AC showed cell line-specific or tissue-specific expression whereas Gli mostly revealed ubiquitous expression. Luciferase promoter assays suggested that the far distal MUC5AC promoter region containing upstream 4010 bp seems to have several enhancer elements for gene transcription. In addition, treatments with DNA demethylation reagent and/or histone deacetylase inhibitor induced MUC5AC expression in several cell lines that were deficient in MUC5AC expression. These results indicated that Gli is necessary but not sufficient for MUC5AC expression: namely, the multiple regulatory mechanisms should work in the distal promoter region of MUC5AC gene.	[Kageyama-Yahara, Natsuko; Yamamichi, Nobutake; Takahashi, Yu; Nakayama, Chiemi; Konno-Shimizu, Maki; Kodashima, Shinya; Fujishiro, Mitsuhiro; Koike, Kazuhiko] Univ Tokyo, Grad Sch Sci, Dept Gastroenterol, Bunkyo Ku, Tokyo 113, Japan; [Shiogama, Kazuya; Inada, Ken-ichi; Tsutsumi, Yutaka] Fujita Hlth Univ, Sch Med, Dept Pathol 1, Toyoake, Aichi 47011, Japan; [Ichinose, Masao] Wakayama Med Coll, Dept Internal Med 2, Wakayama 640, Japan	University of Tokyo; Fujita Health University; Wakayama Medical University	Yamamichi, N (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Gastroenterol, Bunkyo Ku, Tokyo 113, Japan.	nyamamic-tky@umin.ac.jp	Ichinose, Masao/HAB-1645-2022; 藤城, 光弘/AAN-3131-2020; Takahashi, Yu/I-4665-2015	Takahashi, Yu/0000-0002-3066-9501	Takeda Science Foundation; Tokyo Society of Medical Sciences; Japan Society for the Promotion of Science; Sato Memorial Foundation for Cancer Research; Nakayama Cancer Research Institute; Foundation for promotion of Cancer Research; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science [25460381]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23790355]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Tokyo Society of Medical Sciences; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sato Memorial Foundation for Cancer Research; Nakayama Cancer Research Institute; Foundation for promotion of Cancer Research; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from Takeda Science Foundation, in part by a research grant from the Tokyo Society of Medical Sciences, in part by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science, in part by Sato Memorial Foundation for Cancer Research, in part by a research grant from Nakayama Cancer Research Institute, in part by a research grant from Foundation for promotion of Cancer Research, and also in part by Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The URLs and grant numbers are as follows: A grant from Takeda Science Foundation, http://www.takeda-sci.or.jp/assist/, Grant number: N/A (Grant in 2012); a research grant from the Tokyo Society of Medical Sciences, http://square.umin.ac.jp/igakukai/02toppage/toppage.html, Grant number: N/A (Grant in 2012); Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science, http://www.jsps.go.jp/english/e-grants/index.html, Grant number: 25460381 (Grant in 2012-2014); Sato Memorial Foundation for Cancer Research, http://www.jca.gr.jp/researcher/reward/2010/sato.html, Grant number: N/A (Grant in 2011); a research grant from Nakayama Cancer Research Institute, http://ncri.or.jp/project/project.html, Grant number: N/A (Grant in 2010); a research grant from Foundation for promotion of Cancer Research, http://www.fpcr.or.jp/about/index.html, Grant number: N/A (Grant in 2010); Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), http://www.jsps.go.jp/english/e-grants/index.html, Grant number: 23790355 (Grant in 2010-2011).	Baldus SE, 2002, ANN SURG ONCOL, V9, P887, DOI 10.1007/BF02557526; Barros R, 2011, GUT, V60, P290, DOI 10.1136/gut.2010.222323; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bien-Willner GA, 2007, HUM MOL GENET, V16, P1143, DOI 10.1093/hmg/ddm061; Dallas PB, 1998, MOL CELL BIOL, V18, P3596, DOI 10.1128/MCB.18.6.3596; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Di YP, 2012, J BIOL CHEM, V287, P27948, DOI 10.1074/jbc.M111.334375; El-Zaatari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058935; FILIPE MI, 1994, INT J CANCER, V57, P324, DOI 10.1002/ijc.2910570306; Gonzalez CA, 2012, INT J CANCER, V130, P745, DOI 10.1002/ijc.26430; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Im H, 2005, P NATL ACAD SCI USA, V102, P17065, DOI 10.1073/pnas.0506164102; Inaguma S, 2011, ONCOGENE, V30, P714, DOI 10.1038/onc.2010.459; Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200; Jonckheere N, 2004, BIOCHEM J, V377, P797, DOI 10.1042/bj20030948; Jonckheere N, 2012, BBA-GENE REGUL MECH, V1819, P869, DOI 10.1016/j.bbagrm.2012.04.003; Kim SM, 2014, INT J CANCER, V134, P114, DOI 10.1002/ijc.28345; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Konno-Shimizu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056766; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HS, 2003, J PATHOL, V200, P39, DOI 10.1002/path.1288; Lee HJ, 2010, GASTROENTEROLOGY, V139, P213, DOI 10.1053/j.gastro.2010.04.008; Leung WK, 2002, ALIMENT PHARM THER, V16, P1209, DOI 10.1046/j.1365-2036.2002.01300.x; Li DZ, 1998, J BIOL CHEM, V273, P6812, DOI 10.1074/jbc.273.12.6812; Machado JC, 2000, J PATHOL, V190, P437; Mesquita P, 2003, J BIOL CHEM, V278, P51549, DOI 10.1074/jbc.M309019200; Mori Y, 2007, INT J CANCER, V121, P241, DOI 10.1002/ijc.22654; Park J, 2000, GASTROENTEROLOGY, V119, P89, DOI 10.1053/gast.2000.8520; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Reis CA, 1999, CANCER RES, V59, P1003; Reis CA, 1997, INT J CANCER, V74, P112, DOI 10.1002/(SICI)1097-0215(19970220)74:1<112::AID-IJC19>3.3.CO;2-Q; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; Tsukamoto Tetsuya, 2006, Gastric Cancer, V9, P156, DOI 10.1007/s10120-006-0375-6; Wakatsuki K, 2008, J SURG ONCOL, V98, P124, DOI 10.1002/jso.21093; Wang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018434; Xu Xuan-Fu, 2009, J Carcinog, V8, P13, DOI 10.4103/1477-3163.55429; Yamada N, 2010, J HEPATO-BIL-PAN SCI, V17, P844, DOI 10.1007/s00534-010-0278-0; Yamamichi N, 2005, ONCOGENE, V24, P5471, DOI 10.1038/sj.onc.1208716; Yamamichi N, 2009, EXP CELL RES, V315, P1779, DOI 10.1016/j.yexcr.2009.01.006; Yarnamichi N, 2007, CANCER RES, V67, P10727, DOI 10.1158/0008-5472.CAN-07-2601; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141; Zhu H, 2010, CURR GENOMICS, V11, P238, DOI 10.2174/138920210791233108	45	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106106	10.1371/journal.pone.0106106	http://dx.doi.org/10.1371/journal.pone.0106106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166306	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303700074
J	Sawoo, O; Dublineau, A; Batejat, C; Zhou, P; Manuguerra, JC; Leclercq, I				Sawoo, Olivier; Dublineau, Amelie; Batejat, Christophe; Zhou, Paul; Manuguerra, Jean-Claude; Leclercq, India			Cleavage of Hemagglutinin-Bearing Lentiviral Pseudotypes and Their Use in the Study of Influenza Virus Persistence	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AVIAN INFLUENZA; A VIRUSES; TRANSMISSION; WATER; PATHOGENICITY; INFECTIVITY; PARTICLES; DIAGNOSIS; PANDEMICS	Influenza A viruses (IAVs) are a major cause of infectious respiratory human diseases and their transmission is dependent upon the environment. However, the role of environmental factors on IAV survival outside the host still raises many questions. In this study, we used lentiviral pseudotypes to study the influence of the hemagglutinin protein in IAV survival. High-titered and cleaved influenza-based lentiviral pseudoparticles, through the use of a combination of two proteases (HAT and TMPRSS2) were produced. Pseudoparticles bearing hemagglutinin proteins derived from different H1N1, H3N2 and H5N1 IAV strains were subjected to various environmental parameters over time and tested for viability through single-cycle infectivity assays. We showed that pseudotypes with different HAs have different persistence profiles in water as previously shown with IAVs. Our results also showed that pseudotypes derived from H1N1 pandemic virus survived longer than those derived from seasonal H1N1 virus from 1999, at high temperature and salinity, as previously shown with their viral counterparts. Similarly, increasing temperature and salinity had a negative effect on the survival of the H3N2 and H5N1 pseudotypes. These results showed that pseudotypes with the same lentiviral core, but which differ in their surface glycoproteins, survived differently outside the host, suggesting a role for the HA in virus stability.	[Sawoo, Olivier; Dublineau, Amelie; Batejat, Christophe; Manuguerra, Jean-Claude; Leclercq, India] Inst Pasteur, Lab Urgent Response Biol Threats, Environm & Infect Risks Res & Expertise Unit, Paris, France; [Sawoo, Olivier; Leclercq, India] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Zhou, Paul] Chinese Acad Sci, Inst Pasteur Shanghai, Unit Antiviral Immun & Genet Therapy, Shanghai, Peoples R China	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Leclercq, I (corresponding author), Inst Pasteur, Lab Urgent Response Biol Threats, Environm & Infect Risks Res & Expertise Unit, Paris, France.	india.leclercq@pasteur.fr		Batejat, Christophe/0000-0002-2344-5710	European Union's Seventh Framework Programme for research, technological development and demonstration [278433-PREDEMICS]	European Union's Seventh Framework Programme for research, technological development and demonstration	The research leading to these results has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under Grant Agreement no 278433-PREDEMICS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini I, 2009, VACCINE, V27, P5998, DOI 10.1016/j.vaccine.2009.07.079; Bertram S, 2010, REV MED VIROL, V20, P298, DOI 10.1002/rmv.657; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Charneau P, 1998, USE TRIPLEX STRUCTUR; Domanska-Blicharz K, 2010, AVIAN DIS, V54, P734, DOI 10.1637/8786-040109-ResNote.1; DONALD HB, 1954, J GEN MICROBIOL, V10, P457, DOI 10.1099/00221287-10-3-457; Dublineau A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028043; Escors D, 2010, ARCH IMMUNOL THER EX, V58, P107, DOI 10.1007/s00005-010-0063-4; Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002; Garcia JM, 2011, EXPERT REV ANTI-INFE, V9, P443, DOI [10.1586/eri.11.25, 10.1586/ERI.11.25]; Garcia JM, 2010, J CLIN VIROL, V47, P29, DOI 10.1016/j.jcv.2009.10.009; Garoff H, 1998, MICROBIOL MOL BIOL R, V62, P1171, DOI 10.1128/MMBR.62.4.1171-1190.1998; Gilbert M, 2008, REV SCI TECH OIE, V27, P459, DOI 10.20506/rst.27.2.1821; HASAN MT, 1991, SOMAT CELL MOLEC GEN, V17, P513, DOI 10.1007/BF01233175; HINSHAW VS, 1979, INTERVIROLOGY, V11, P66, DOI 10.1159/000149014; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; LODGE R, 1994, J VIROL, V68, P4857, DOI 10.1128/JVI.68.8.4857-4861.1994; Nefkens I, 2007, J CLIN VIROL, V39, P27, DOI 10.1016/j.jcv.2007.02.005; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; OLSEN JC, 1995, HUM GENE THER, V6, P1195, DOI 10.1089/hum.1995.6.9-1195; Rachakonda PS, 2007, FASEB J, V21, P995, DOI 10.1096/fj.06-7052hyp; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Scalera NM, 2009, POSTGRAD MED, V121, P43, DOI 10.3810/pgm.2009.09.2051; Schrauwen EJA, 2011, J GEN VIROL, V92, P1410, DOI 10.1099/vir.0.030379-0; Scott Simon, 2012, J Mol Genet Med, V6, P304; Shigematsu S, 2014, INFLUENZA OTHER RESP, V8, P123, DOI 10.1111/irv.12179; Song GP, 2009, J MED CHEM, V52, P7368, DOI 10.1021/jm900275m; Stanley WM, 1944, J EXP MED, V79, P267, DOI 10.1084/jem.79.3.267; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Sun XJ, 2013, ADV EXP MED BIOL, V790, P72, DOI 10.1007/978-1-4614-7651-1_4; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Tsai CJ, 2009, J NANOPART RES, V11, P1, DOI 10.1007/s11051-008-9474-0; Wang W, 2008, J VIROL METHODS, V153, P111, DOI 10.1016/j.jviromet.2008.07.015; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Webster RG, 1997, FEMS IMMUNOL MED MIC, V18, P275, DOI 10.1016/S0928-8244(97)00058-8; Zambon MC, 2001, REV MED VIROL, V11, P227, DOI 10.1002/rmv.319; Zhang SL, 2008, J VIROL METHODS, V154, P99, DOI 10.1016/j.jviromet.2008.08.016	39	6	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106192	10.1371/journal.pone.0106192	http://dx.doi.org/10.1371/journal.pone.0106192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166303	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303700082
J	Sriram, P; Wang, CY; Yiannikas, C; Garrick, R; Barnett, M; Parratt, J; Graham, SL; Arvind, H; Klistorner, A				Sriram, Prema; Wang, Chenyu; Yiannikas, Con; Garrick, Raymond; Barnett, Michael; Parratt, John; Graham, Stuart L.; Arvind, Hemamalini; Klistorner, Alexander			Relationship between Optical Coherence Tomography and Electrophysiology of the Visual Pathway in Non-Optic Neuritis Eyes of Multiple Sclerosis Patients	PLOS ONE			English	Article							NERVE-FIBER LAYER; TRANSNEURONAL RETROGRADE DEGENERATION; RETINAL GANGLION-CELLS; STRIATE CORTEX; AXONAL LOSS; FIELD; REPRESENTATION; ABNORMALITIES; RADIATION; THICKNESS	Purpose: Loss of retinal ganglion cells in in non-optic neuritis eyes of Multiple Sclerosis patients (MS-NON) has recently been demonstrated. However, the pathological basis of this loss at present is not clear. Therefore, the aim of the current study was to investigate associations of clinical (high and low contrast visual acuity) and electrophysiological (electroretinogram and multifocal Visual Evoked Potentials) measures of the visual pathway with neuronal and axonal loss of RGC in order to better understand the nature of this loss. Methods: Sixty-two patients with relapsing remitting multiple sclerosis with no previous history of optic neuritis in at least one eye were enrolled. All patients underwent a detailed ophthalmological examination in addition to low contrast visual acuity, Optical Coherence Tomography, full field electroretinogram (ERG) and multifocal visual evoked potentials (mfVEP). Results: There was significant reduction of ganglion cell layer thickness, and total and temporal retinal nerve fibre layer (RNFL) thickness (p < 0.0001, 0.002 and 0.0002 respectively). Multifocal VEP also demonstrated significant amplitude reduction and latency delay (p < 0.0001 for both). Ganglion cell layer thickness, total and temporal RNFL thickness inversely correlated with mfVEP latency (r = -0.48, p < 0.0001 respectively; r = -0.53, p < 0.0001 and r = -0.59, p < 0.0001 respectively). Ganglion cell layer thickness, total and temporal RNFL thickness also inversely correlated with the photopic b-wave latency (r = -0.35, p = 0.01; r = -0.33, p = 0.025; r = -0.36, p = 0.008 respectively). Multivariate linear regression model demonstrated that while both factors were significantly associated with RGC axonal and neuronal loss, the estimated predictive power of the posterior visual pathway damage was considerably larger compare to retinal dysfunction. Conclusion: The results of our study demonstrated significant association of RGC axonal and neuronal loss in NON-eyes of MS patients with both retinal dysfunction and post-chiasmal damage of the visual pathway.	[Sriram, Prema; Graham, Stuart L.; Arvind, Hemamalini; Klistorner, Alexander] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Wang, Chenyu; Barnett, Michael] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Yiannikas, Con] Concord Hosp, Sydney, NSW, Australia; [Garrick, Raymond] St Vincents Hosp, Sydney, NSW 2010, Australia; [Parratt, John] Royal N Shore Hosp, Sydney, NSW, Australia; [Graham, Stuart L.; Arvind, Hemamalini; Klistorner, Alexander] Univ Sydney, Save Sight Inst, Dept Ophthalmol, Sydney, NSW 2006, Australia	Macquarie University; University of Sydney; Concord Repatriation General Hospital; St Vincents Hospital Sydney; Royal North Shore Hospital; University of Sydney; University of Sydney	Klistorner, A (corresponding author), Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia.	sasha@eye.usyd.edu.au		Klistorner, Alexander/0000-0003-0361-6399; Graham, Stuart/0000-0001-7519-969X	Sydney Medical Foundation; Glaucoma Australia; Novartis, Save Neuron Study	Sydney Medical Foundation; Glaucoma Australia; Novartis, Save Neuron Study	Funding was provided by Sydney Medical Foundation (AK), Glaucoma Australia (PS), and Novartis, Save Neuron Study (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcer LJ, 2010, NEUROLOGY, V74, pS16, DOI 10.1212/WNL.0b013e3181dbb664; Bridge H, 2011, INVEST OPHTH VIS SCI, V52, P382, DOI 10.1167/iovs.10-5708; Chaplin TA, 2013, J COMP NEUROL, V521, P1001, DOI 10.1002/cne.23215; Costello F, 2008, MULT SCLER J, V14, P893, DOI 10.1177/1352458508091367; Costello F, 2009, J NEUROL SCI, V281, P74, DOI 10.1016/j.jns.2009.02.354; Cowey A, 2011, BRAIN, V134, P2149, DOI 10.1093/brain/awr125; Dasenbrock HH, 2011, J NEUROIMAGING, V21, pe41, DOI 10.1111/j.1552-6569.2010.00468.x; Evangelou N, 2001, BRAIN, V124, P1813, DOI 10.1093/brain/124.9.1813; Forooghian F, 2006, DOC OPHTHALMOL, V113, P123, DOI 10.1007/s10633-006-9022-0; Frohman EM, 2009, J NEUROL SCI, V282, P96, DOI 10.1016/j.jns.2009.04.010; Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950; Gabilondo I, 2012, MULT SCLER J, V18, P36; Gelfand JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036847; Gordon GE, 1999, DOC OPHTHALMOL, V99, P1, DOI 10.1023/A:1002171011644; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Grazioli E, 2008, J NEUROL SCI, V268, P12, DOI 10.1016/j.jns.2007.10.020; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Gundogan FC, 2007, INVEST OPHTH VIS SCI, V48, P5773, DOI 10.1167/iovs.07-0834; Henderson APD, 2008, BRAIN, V131, P277, DOI 10.1093/brain/awm285; HOLLANDER H, 1984, EXP BRAIN RES, V55, P483; HORNABROOK RSL, 1992, NEUROLOGY, V42, P77, DOI 10.1212/WNL.42.1.77; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; Jindahra P, 2009, BRAIN, V132, P628, DOI 10.1093/brain/awp001; Johnson H, 2000, EXP BRAIN RES, V132, P269, DOI 10.1007/s002210000384; Klistorner A, 2013, NEUROLOGY, V80, P242, DOI 10.1212/WNL.0b013e31827deb39; Komaromy AM, 2003, J GLAUCOMA, V12, P307; LEHOCZKY T, 1954, Acta Morphol Acad Sci Hung, V4, P395; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Mehta JS, 2005, AM J OPHTHALMOL, V140, P727, DOI 10.1016/j.ajo.2005.03.059; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Pueyo V, 2008, MULT SCLER J, V14, P609, DOI 10.1177/1352458507087326; Pulicken M, 2007, NEUROLOGY, V69, P2085, DOI 10.1212/01.wnl.0000294876.49861.dc; Reich DS, 2009, ARCH NEUROL-CHICAGO, V66, P998, DOI 10.1001/archneurol.2009.107; Sepulcre J, 2007, NEUROLOGY, V68, P1488, DOI 10.1212/01.wnl.0000260612.51849.ed; Siger M, 2008, J NEUROL, V255, P1555, DOI 10.1007/s00415-008-0985-5; Sriram P, 2012, INVEST OPHTH VIS SCI, V53, P1271, DOI 10.1167/iovs.11-8732; WELLER RE, 1989, VISUAL NEUROSCI, V3, P327, DOI 10.1017/S0952523800005514	37	55	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e102546	10.1371/journal.pone.0102546	http://dx.doi.org/10.1371/journal.pone.0102546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166273	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303700001
J	Zhang, L; Jia, BG; Tan, XF; Thammina, CS; Long, HX; Liu, M; Wen, SN; Song, XL; Cao, HP				Zhang, Lin; Jia, Baoguang; Tan, Xiaofeng; Thammina, Chandra S.; Long, Hongxu; Liu, Min; Wen, Shanna; Song, Xianliang; Cao, Heping			Fatty Acid Profile and Unigene-Derived Simple Sequence Repeat Markers in Tung Tree (Vernicia fordii)	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; SSR-MARKERS; RNA-SEQ; MICROSATELLITES; OIL; EXPRESSION; CUCURBITA; EVOLUTION; PCR	Tung tree (Vernicia fordii) provides the sole source of tung oil widely used in industry. Lack of fatty acid composition and molecular markers hinders biochemical, genetic and breeding research. The objectives of this study were to determine fatty acid profiles and develop unigene-derived simple sequence repeat (SSR) markers in tung tree. Fatty acid profiles of 41 accessions showed that the ratio of alpha-eleostearic acid was increasing continuously with a parallel trend to the amount of tung oil accumulation while the ratios of other fatty acids were decreasing in different stages of the seeds and that alpha-eleostearic acid (18: 3) consisted of 77% of the total fatty acids in tung oil. Transcriptome sequencing identified 81,805 unigenes from tung cDNA library constructed using seed mRNA and discovered 6,366 SSRs in 5,404 unigenes. The di- and tri-nucleotide microsatellites accounted for 92% of the SSRs with AG/CT and AAG/CTT being the most abundant SSR motifs. Fifteen polymorphic genic-SSR markers were developed from 98 unigene loci tested in 41 cultivated tung accessions by agarose gel and capillary electrophoresis. Genbank database search identified 10 of them putatively coding for functional proteins. Quantitative PCR demonstrated that all 15 polymorphic SSR-associated unigenes were expressed in tung seeds and some of them were highly correlated with oil composition in the seeds. Dendrogram revealed that most of the 41 accessions were clustered according to the geographic region. These new polymorphic genic-SSR markers will facilitate future studies on genetic diversity, molecular fingerprinting, comparative genomics and genetic mapping in tung tree. The lipid profiles in the seeds of 41 tung accessions will be valuable for biochemical and breeding studies.	[Zhang, Lin; Jia, Baoguang; Tan, Xiaofeng; Long, Hongxu; Liu, Min; Wen, Shanna] Cent South Univ Forestry & Technol, Key Lab Cultivat & Protect Nonwood Forest Trees, Minist Educ, Changsha, Hunan, Peoples R China; [Zhang, Lin; Thammina, Chandra S.] Univ Connecticut, Dept Plant Sci & Landscape Architecture, Storrs, CT USA; [Song, Xianliang; Cao, Heping] USDA ARS, So Reg Res Ctr, New Orleans, LA USA	Central South University of Forestry & Technology; University of Connecticut; United States Department of Agriculture (USDA)	Tan, XF (corresponding author), Cent South Univ Forestry & Technol, Key Lab Cultivat & Protect Nonwood Forest Trees, Minist Educ, Changsha, Hunan, Peoples R China.	tanxiaofengcn@126.com; Heping.Cao@ars.usda.gov	Thammina, Chandra Sekhar/L-9586-2019; Cao, Heping/AAC-1666-2021; tan, xiao/GZL-0264-2022	Cao, Heping/0000-0002-0958-1468	"948 Project'' of China State Forestry Administration [2012-4-42]; National Forestry Public Welfare Industry Research Project of China [201204403]; Key Project of Chinese Ministry of Education [212126]; USDA-ARS Quality and Utilization of Agricultural Products Research Program 306 through CRIS [6435-41000-102-00D, 6435-41000-102-10N]	"948 Project'' of China State Forestry Administration; National Forestry Public Welfare Industry Research Project of China; Key Project of Chinese Ministry of Education(Ministry of Education, China); USDA-ARS Quality and Utilization of Agricultural Products Research Program 306 through CRIS	This work was supported by the "948 Project'' of China State Forestry Administration(2012-4-42), National Forestry Public Welfare Industry Research Project of China(201204403), the Key Project of Chinese Ministry of Education (212126), and USDA-ARS Quality and Utilization of Agricultural Products Research Program 306 through CRIS 6435-41000-102-00D and 6435-41000-102-10N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CE, 1929, J AGRIC RES, V38, P0679; [Anonymous], 1997, MOL BIOL BIOTECHNOLO; Aranguren MI, 2012, POLYM TEST, V31, P7, DOI 10.1016/j.polymertesting.2011.09.001; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Cao HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088409; Cao HP, 2013, IND CROP PROD, V50, P248, DOI 10.1016/j.indcrop.2013.07.030; Cao HP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076946, 10.1371/journal.pone.0052853]; Cao HP, 2012, J AGR FOOD CHEM, V60, P12296, DOI 10.1021/jf304690e; Cao HP, 2012, APPL MICROBIOL BIOT, V96, P711, DOI 10.1007/s00253-012-3869-7; Cao Heping, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-249; Cao HP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-73; Chen YC, 2012, SCI WORLD J, DOI 10.1100/2012/390672; Chen YH, 2010, BIORESOURCE TECHNOL, V101, P9521, DOI 10.1016/j.biortech.2010.06.117; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Dyer JM, 2004, J AM OIL CHEM SOC, V81, P647, DOI 10.1007/s11746-004-956-x; Dyer JM, 2002, PLANT PHYSIOL, V130, P2027, DOI 10.1104/pp.102.010835; Dyer JM, 2008, PLANT J, V54, P640, DOI 10.1111/j.1365-313X.2008.03430.x; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Gong L, 2008, THEOR APPL GENET, V117, P37, DOI 10.1007/s00122-008-0750-2; Gonzalez-Ibeas D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-306; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Gupta P. K., 2004, Functional & Integrative Genomics, V4, P139, DOI 10.1007/s10142-004-0107-0; Gupta SK, 2010, GENOME, V53, P508, DOI [10.1139/G10-028, 10.1139/g10-028]; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; KOPACZ BM, 1968, J AM OIL CHEM SOC, V45, P285, DOI 10.1007/BF02652428; Li P, 2008, AFR J BIOTECHNOL, V7, P1054; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Liu CG, 2013, IND CROP PROD, V43, P677, DOI 10.1016/j.indcrop.2012.07.072; [刘思峰 Liu Sifeng], 2013, [系统工程理论与实践, Systems Engineering-Theory & Practice], V33, P2041; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; [龙洪旭 Long Hongxu], 2010, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V30, P31; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MICHENER CD, 1957, EVOLUTION, V11, P130, DOI 10.2307/2406046; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Pan Y, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200004; Pastor S, 2013, PLANT SCI, V203, P79, DOI 10.1016/j.plantsci.2012.12.009; POTTER GF, 1968, J AM OIL CHEM SOC, V45, P281, DOI 10.1007/BF02652427; PRYDE EH, 1979, J AM OIL CHEM SOC, V56, pA719, DOI 10.1007/BF02667427; RAFALSKI JA, 1993, TRENDS GENET, V9, P275, DOI 10.1016/0168-9525(93)90013-8; ROHLF F, 2000, NTSYS NUMERICAL TAXO; Samadzadeh M, 2011, PROG ORG COAT, V70, P383, DOI 10.1016/j.porgcoat.2010.08.017; Schlotterer C, 1998, CURR BIOL, V8, pR132, DOI 10.1016/S0960-9822(98)70989-3; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Sonntag N.O.V., 1979, BAILEYS IND OIL FAT, V1, P289; Tan X, 2011, NONWOOD FOREST RES, V29, P1, DOI DOI 10.14067/j.cnki.1003-8981.2011.03.001; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tian CX, 2012, INT J MOL SCI, V13, P13203, DOI 10.3390/ijms131013203; Xu W, 2012, TREE GENET GENOMES, V8, P933, DOI 10.1007/s11295-012-0481-z; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90	55	25	26	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105298	10.1371/journal.pone.0105298	http://dx.doi.org/10.1371/journal.pone.0105298			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25167054	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303700021
J	Batista-Garcia, RA; Balcazar-Lopez, E; Miranda-Miranda, E; Sanchez-Reyes, A; Cuervo-Soto, L; Aceves-Zamudio, D; Atriztan-Hernandez, K; Morales-Herrera, C; Rodriguez-Hernandez, R; Folch-Mallol, J				Alberto Batista-Garcia, Ramon; Balcazar-Lopez, Edgar; Miranda-Miranda, Estefan; Sanchez-Reyes, Ayixon; Cuervo-Soto, Laura; Aceves-Zamudio, Denise; Atriztan-Hernandez, Karina; Morales-Herrera, Catalina; Rodriguez-Hernandez, Rocio; Folch-Mallol, Jorge			Characterization of Lignocellulolytic Activities from a Moderate Halophile Strain of Aspergillus caesiellus Isolated from a Sugarcane Bagasse Fermentation	PLOS ONE			English	Article							SP-NOV.; FILAMENTOUS FUNGI; MOLECULAR-IDENTIFICATION; THERMOSTABLE CELLULASE; BACTERIAL COMMUNITIES; HYPERSALINE WATERS; IONIC LIQUIDS; LARGE-SUBUNIT; SODA LAKES; GEN. NOV.	A moderate halophile and thermotolerant fungal strain was isolated from a sugarcane bagasse fermentation in the presence of 2 M NaCl that was set in the laboratory. This strain was identified by polyphasic criteria as Aspergillus caesiellus. The fungus showed an optimal growth rate in media containing 1 M NaCl at 28 degrees C and could grow in media added with up to 2 M NaCl. This strain was able to grow at 37 and 42 degrees C, with or without NaCl. A. caesiellus H1 produced cellulases, xylanases, manganese peroxidase (MnP) and esterases. No laccase activity was detected in the conditions we tested. The cellulase activity was thermostable, halostable, and no differential expression of cellulases was observed in media with different salt concentrations. However, differential band patterns for cellulase and xylanase activities were detected in zymograms when the fungus was grown in different lignocellulosic substrates such as wheat straw, maize stover, agave fibres, sugarcane bagasse and sawdust. Optimal temperature and pH were similar to other cellulases previously described. These results support the potential of this fungus to degrade lignocellulosic materials and its possible use in biotechnological applications.	[Alberto Batista-Garcia, Ramon; Balcazar-Lopez, Edgar; Sanchez-Reyes, Ayixon; Cuervo-Soto, Laura] Univ Autonoma Estado Morelos, Fac Ciencias, Cuernavaca, Morelos, Mexico; [Alberto Batista-Garcia, Ramon; Balcazar-Lopez, Edgar; Sanchez-Reyes, Ayixon; Cuervo-Soto, Laura; Aceves-Zamudio, Denise; Morales-Herrera, Catalina; Rodriguez-Hernandez, Rocio; Folch-Mallol, Jorge] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Cuernavaca, Morelos, Mexico; [Miranda-Miranda, Estefan] Inst Nacl Invest Forestales Agr & Pecuarias, Ctr Nacl Invest Disciplinaria Parasitol Vet, Cuernavaca, Morelos, Mexico; [Atriztan-Hernandez, Karina] Univ Autonoma Estado Morelos, Fac Ciencias Biol, Cuernavaca, Morelos, Mexico	Universidad Autonoma del Estado de Morelos; Universidad Autonoma del Estado de Morelos; Universidad Autonoma del Estado de Morelos	Folch-Mallol, J (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Cuernavaca, Morelos, Mexico.	jordi@uaem.mx	Sánchez-Reyes, Ayixon/AAI-5948-2020	Sánchez-Reyes, Ayixon/0000-0002-6749-5883; Folch-Mallol, Jorge/0000-0002-1860-8175; miranda-miranda, estefan/0000-0002-0464-3666; Batista-Garcia, Ramon Alberto/0000-0002-1032-0767; Balcazar, Edgar/0000-0003-0616-309X	National Council for Science and Technology (CONACyT) from the Mexican government [CB-153789-Q]	National Council for Science and Technology (CONACyT) from the Mexican government	The work was partially funded by grant CB-153789-Q from the National Council for Science and Technology (CONACyT) from the Mexican government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELHAFEZ SII, 1981, MYCOPATHOLOGIA, V75, P75, DOI 10.1007/BF00505781; Abrahao MC, 2008, ANN MICROBIOL, V58, P427, DOI 10.1007/BF03175538; Alam MZ, 2014, WORLD J MICROB BIOT, P1; Anton J, 2002, INT J SYST EVOL MICR, V52, P485, DOI 10.1099/00207713-52-2-485; Arahal DR, 1999, INT J SYST BACTERIOL, V49, P521, DOI 10.1099/00207713-49-2-521; Arakaki RL, 2013, BRAZ J MICROBIOL, V44, P1207, DOI 10.1590/S1517-83822014005000014; Babavalian H, 2013, MICROBIOLOGY+, V82, P466, DOI 10.1134/S0026261713040176; Barton RC, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/459405; Bhat MK, 1997, BIOTECHNOL ADV, V15, P583, DOI 10.1016/S0734-9750(97)00006-2; Bhattacharya A, 2014, ENZYME MICROB TECH, V55, P159, DOI 10.1016/j.enzmictec.2013.10.011; Bindiya P, 2012, J BIOTECHNOL TECHNOL, V3, pS203; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Bouchotroch S, 2001, INT J SYST EVOL MICR, V51, P1625, DOI 10.1099/00207713-51-5-1625; Bowman J, 2007, ANN OTO RHINOL LARYN, V116, P514, DOI 10.1177/000348940711600706; Butinar L, 2005, FEMS MICROBIOL ECOL, V51, P155, DOI 10.1016/j.femsec.2004.08.002; Butinar L, 2011, FEMS MICROBIOL ECOL, V77, P186, DOI 10.1111/j.1574-6941.2011.01108.x; Castillo G, 1997, MYCOL RES, V101, P341, DOI 10.1017/S0953756296002717; Challacombe JF, 2013, STAND GENOMIC SCI, V8, P206, DOI 10.4056/sigs.3677284; CHANG PK, 1995, APPL ENVIRON MICROB, V61, P40, DOI 10.1128/AEM.61.1.40-43.1995; Conte F, 2008, THESIS U NAPOLI FEDE; DasSarma S., 2012, HALOPHILES; Dave G, 2013, ACAD J BIOTECHNOLOGY, V1; De Paris LD, 2010, ESTUDOS TECNOLOGICOS, V6; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Dhanasekaran P, 2014, MALAYA J BIOSCIENCES, V1, P37; Diaz-Tena E, 2014, J CLEANER P IN PRESS, DOI 10.1016/j.jcle-pro.2014.01.061; Echigo Akinobu, 2005, Saline Syst, V1, P8, DOI 10.1186/1746-1448-1-8; Evans S, 2013, CRYPTOGAMIE MYCOL, V34, P329, DOI 10.7872/crym.v34.iss4.2013.329; Fisher RA, 1949, STAT TABLES BIOL AGR, V3, P112; Geiser DM, 1998, P NATL ACAD SCI USA, V95, P388, DOI 10.1073/pnas.95.1.388; Gomes J, 2004, FOOD TECHNOL BIOTECH, V42, P223; GONZALEZ C, 1978, CAN J MICROBIOL, V24, P710, DOI 10.1139/m78-119; Guarro J, 2012, ENFERM INFEC MICR CL, V30, P33, DOI 10.1016/j.eimc.2011.09.006; Gunde-Cimerman N, 2005, CELL ORIG LIFE EXTRE, V9, P397; Gunde-Cimerman N, 2000, FEMS MICROBIOL ECOL, V32, P235; Gunde-Cimerman N, 2009, MYCOL RES, V113, P1231, DOI 10.1016/j.mycres.2009.09.002; Gunny AAN, 2014, BIORESOURCE TECHNOL, V155, P177, DOI 10.1016/j.biortech.2013.12.101; Hamamura N, 2014, ENV MICROBIOL REP, V6, P476, DOI 10.1111/1758-2229.12144; HAO MV, 1984, J GEN APPL MICROBIOL, V30, P449, DOI 10.2323/jgam.30.449; Hinrikson HP, 2005, J CLIN MICROBIOL, V43, P2092, DOI 10.1128/JCM.43.5.2092-2103.2005; HOAGLIN DC, 1978, AM STAT, V32, P17, DOI 10.2307/2683469; Horikoshi K, 1999, MICROBIOL MOL BIOL R, V63, P735, DOI 10.1128/MMBR.63.4.735-750.1999; Iwen PC, 2002, MED MYCOL, V40, P87, DOI 10.1080/mmy.40.1.87.109; Jarvinen J, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-62; Jiang YJ, 2014, BIORESOURCE TECHNOL, V153, P278, DOI 10.1016/j.biortech.2013.12.001; Jurjevic Z, 2012, IMA FUNGUS, V3, P59, DOI 10.5598/imafungus.2012.03.01.07; Kanbe T, 2002, MICROBIOL IMMUNOL, V46, P841, DOI 10.1111/j.1348-0421.2002.tb02771.x; Kim MJ, 2014, ANN LAB MED, V34, P76, DOI 10.3343/alm.2014.34.1.76; Kivisto AT, 2011, J BIOTECHNOL, V152, P114, DOI 10.1016/j.jbiotec.2010.08.014; Klich M. A., 2002, IDENTIFICATION COMMO; Konte T, 2013, EXTREMOPHILES, V17, P623, DOI 10.1007/s00792-013-0546-4; Krimitzas A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/260395; Krishnamurthi S, 2014, STUDY PROKARYOTIC DI; Kuhad RC, 2004, FOLIA MICROBIOL, V49, P112, DOI 10.1007/BF02931383; Kumar M, 2014, ANN MICROBIOL, P1, DOI DOI 10.1007/978-81-322-2009-1_1; Kushner D.J., 1988, HALOPHILIC BACTERIA, V1, P109; Kutateladze NZ, 2009, B GEORGIAN NATL ACAD, V3; Kwiatkowski NP, 2012, J MOL DIAGN, V14, P393, DOI 10.1016/j.jmoldx.2012.02.004; Larsen H., 1962, BACTERIA, V4, P297; Leela A, 2013, THESIS BHARATHIDASSA; Li X, 2013, INT J BIOL MACROMOL, V62, P101, DOI 10.1016/j.ijbiomac.2013.08.047; Li X, 2012, BIOTECHNOL LETT, V34, P1531, DOI 10.1007/s10529-012-0938-z; Bonfa MRL, 2013, BIODEGRADATION, V24, P699, DOI 10.1007/s10532-012-9617-y; Liu DY, 2011, INT BIODETER BIODEGR, V65, P717, DOI 10.1016/j.ibiod.2011.04.005; Liu XS, 2014, EXTREMOPHILES, V18, P441, DOI 10.1007/s00792-014-0629-x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lugauskas A, 2004, INDOOR BUILT ENVIRON, V13, P101, DOI 10.1177/1420326X04040936; Madigan M. T., 2012, BROCK BIOL MICROORGA; Maller A, 2013, FOLIA MICROBIOL, V58, P615, DOI 10.1007/s12223-013-0249-3; Marcondes NR, 2008, MICROB ECOL, V56, P13, DOI 10.1007/s00248-007-9319-x; Margesin R, 2001, EXTREMOPHILES, V5, P73, DOI 10.1007/s007920100184; Marques E, 2013, REV ARVORE, V37, P41, DOI 10.1590/S0100-67622013000100005; Massire C, 2013, J CLIN MICROBIOL, V51, P959, DOI 10.1128/JCM.02621-12; Mesbah NM, 2007, INT J SYST EVOL MICR, V57, P2507, DOI 10.1099/ijs.0.65068-0; Mesbah NM, 2009, INT J SYST EVOL MICR, V59, P2042, DOI 10.1099/ijs.0.008151-0; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Molitoris HP, 2000, FUNGAL DIVERS, V5, P55; Moubasher A. H., 1990, Acta Mycologica, V26, P65, DOI 10.5586/am.1990.013; Muruga B, 2013, COLUMBIA INT PUBLISH, V2, P14, DOI DOI 10.7726/AJMCB.2013.1002; Narra M, 2014, INT BIODETER BIODEGR, V88, P150, DOI 10.1016/j.ibiod.2013.12.016; Nayak SS, 2012, INDIAN J GEO-MAR SCI, V41, P164; Nicolaus B, 1999, EXTREMOPHILES POLYSA; NIELSEN P, 1995, MICROBIOL-UK, V141, P1745, DOI 10.1099/13500872-141-7-1745; Novaki L, 2010, ENGEVISTA; Odero V, 2013, REV IBEROAMERICANA M; ONISHI H, 1980, AGR BIOL CHEM TOKYO, V44, P1253, DOI 10.1080/00021369.1980.10864132; Onsori H, 2005, AFR J BIOTECHNOL, V4, P26; Oren A, 2002, FEMS MICROBIOL ECOL, V39, P1, DOI 10.1111/j.1574-6941.2002.tb00900.x; Oren A, 2014, EXTREMOPHILES, V18, P75, DOI 10.1007/s00792-013-0594-9; Oren Aharon, 2012, Prog Mol Subcell Biol, V53, P115, DOI 10.1007/978-3-642-23342-5_6; Panchagnula B, 2013, INT J BIOL PHARM ALL, V2, P1488; Pang H, 2009, CURR MICROBIOL, V58, P404, DOI 10.1007/s00284-008-9346-y; Parawira W, 2012, CRIT REV BIOTECHNOL, V32, P172, DOI 10.3109/07388551.2011.595384; Passarini MRZ, 2013, ARCH MICROBIOL, V195, P99, DOI 10.1007/s00203-012-0854-6; PETERSON SW, 2000, INTEGRATION MODERN T, P323; Pinar G, 2001, APPL ENVIRON MICROB, V67, P4891, DOI 10.1128/AEM.67.10.4891-4895.2001; Pitt J., 1985, FUNGI FOOD SPOILAGE; Plemenitas A, 2008, STUD MYCOL, P67, DOI 10.3114/sim.2008.61.06; Quiroz-Castaneda RE, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue4-fulltext-3; Raddadi N, 2013, BIORESOURCE TECHNOL, V150, P121, DOI 10.1016/j.biortech.2013.09.089; Ren WZ, 2013, CELLULOSE, V20, P1947, DOI 10.1007/s10570-013-9953-z; Roldan-Carrillo T, 2013, J CHEM TECHNOL BIOT, V88, P1023, DOI 10.1002/jctb.3926; Saiz-Jimenez C, 2000, INT BIODETER BIODEGR, V46, P319, DOI 10.1016/S0964-8305(00)00104-9; Sambrook J, 2001, MOL CLONING LAB MANU; Santos DWCL, 2013, MYCOPATHOLOGIA, V175, P445, DOI 10.1007/s11046-012-9608-x; Shtarkman YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067221; Simmons CW, 2014, APPL SOIL ECOL, V73, P97, DOI 10.1016/j.apsoil.2013.08.014; Sorokin DY, 2014, EXTREMOPHILES, V18, P243, DOI 10.1007/s00792-013-0611-z; Spiess B, 2013, LAB PROTOCOLS FUNGAL, P315; Sugui JA, 2012, J CLIN MICROBIOL, V50, P3309, DOI 10.1128/JCM.01509-12; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Thom G, 1926, ASPERGILLI; Thom G, 1945, MANUAL ASPERGILLI; Trincone A, 2013, CURR ORG CHEM, V17, P1058, DOI 10.2174/1385272811317100008; Valderrama B, 2002, CHEM BIOL, V9, P555, DOI 10.1016/S1074-5521(02)00149-7; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wang L, 2001, INT J FOOD MICROBIOL, V71, P75, DOI 10.1016/S0168-1605(01)00597-9; WARIISHI H, 1992, J BIOL CHEM, V267, P23688; White TJ., 1990, PCR PROTOCOLS GUIDE, P315, DOI [10.1016/B978-0-12-372180-8.50042-1, DOI 10.1016/B978-0-12-372180-8.50042-1]; Xavier-Santos S, 2004, FOLIA MICROBIOL, V49, P46, DOI 10.1007/BF02931645; Xue DS, 2012, APPL BIOCHEM BIOTECH, V167, P1963, DOI 10.1007/s12010-012-9734-4; Yokoyama K, 2001, FEMS MICROBIOL LETT, V200, P241, DOI 10.1111/j.1574-6968.2001.tb10722.x; Yoon JH, 2003, INT J SYST EVOL MICR, V53, P687, DOI 10.1099/ijs.0.02421-0; Zalar P, 2007, STUD MYCOL, P157, DOI 10.3114/sim.2007.58.06; Zalar P, 2005, ANTON LEEUW INT J G, V87, P311, DOI 10.1007/s10482-004-6783-x; Zhang GM, 2012, EXTREMOPHILES, V16, P35, DOI 10.1007/s00792-011-0403-2; Zhang T, 2011, GREEN CHEM, V13, P2083, DOI 10.1039/c1gc15193b; Zvyagintseva IS, 1987, MIKROBIOLOGIYA, V56, P839	128	22	24	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105893	10.1371/journal.pone.0105893	http://dx.doi.org/10.1371/journal.pone.0105893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162614	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900059
J	Georgiades, P; Pudney, PDA; Rogers, S; Thornton, DJ; Waigh, TA				Georgiades, Pantelis; Pudney, Paul D. A.; Rogers, Sarah; Thornton, David J.; Waigh, Thomas A.			Tea Derived Galloylated Polyphenols Cross-Link Purified Gastrointestinal Mucins	PLOS ONE			English	Article							HUMAN WHOLE SALIVA; DILATIONAL RHEOLOGY; DIETARY POLYPHENOLS; PARTICLE TRACKING; MICRORHEOLOGY; DYNAMICS; MUCUS; SCATTERING; CATECHINS; BEHAVIOR	Polyphenols derived from tea are thought to be important for human health. We show using a combination of particle tracking microrheology and small-angle neutron scattering that polyphenols acts as cross-linkers for purified gastrointestinal mucin, derived from the stomach and the duodenum. Both naturally derived purified polyphenols, and green and black tea extracts are shown to act as cross-linkers. The main active cross-linking component is found to be the galloylated forms of catechins. The viscosity, elasticity and relaxation time of the mucin solutions experience an order of magnitude change in value upon addition of the polyphenol cross-linkers. Similarly small-angle neutron scattering experiments demonstrate a sol-gel transition with the addition of polyphenols, with a large increase in the scattering at low angles, which is attributed to the formation of large scale (>10 nm) heterogeneities during gelation. Cross-linking of mucins by polyphenols is thus expected to have an impact on the physicochemical environment of both the stomach and duodenum; polyphenols are expected to modulate the barrier properties of mucus, nutrient absorption through mucus and the viscoelastic microenvironments of intestinal bacteria.	[Georgiades, Pantelis; Waigh, Thomas A.] Univ Manchester, Dept Phys & Astron, Manchester, Lancs, England; [Georgiades, Pantelis; Rogers, Sarah] Rutherford Appleton Lab, Sci & Technol Facil Council, ISIS Facil, Didcot OX11 0QX, Oxon, England; [Thornton, David J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Pudney, Paul D. A.] Unilever, Unilever Discover, Strateg Sci Grp, Sharnbrook, Beds, England; [Waigh, Thomas A.] Univ Manchester, Photon Sci Inst, Manchester, Lancs, England	University of Manchester; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Manchester; Unilever; University of Manchester	Georgiades, P (corresponding author), Univ Manchester, Dept Phys & Astron, Manchester, Lancs, England.	pantelis.georgiades@manchester.ac.uk	Georgiades, Pantelis/AAJ-5588-2021; pudney, paul/R-6733-2019	Rogers, Sarah/0000-0003-2418-6965; Thornton, David/0000-0001-7148-1970	Unilever Discover; Wellcome Trust [088785/Z/09/Z]	Unilever Discover(Unilever); Wellcome Trust(Wellcome Trust)	The work was funded by Unilever Discover in its entirety. The company also provided polyphenol samples free of charge to perform the experiments presented. Facilities funded through the Wellcome Trust (grant number 088785/Z/09/Z) were used. The funders had no role in study design, data collection and analysis or preparation of the manuscript, for which they provided clearance to publish.	Alberts B, 2002, MOL BIOL CELL; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Auger C, 2008, J NUTR, V138, P1535; Axelsson MAB, 1998, J BIOL CHEM, V273, P18864, DOI 10.1074/jbc.273.30.18864; Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001; Beaucage G, 1996, J APPL CRYSTALLOGR, V29, P134, DOI 10.1107/S0021889895011605; Broedersz CP, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.238101; Cao XX, 1999, BIOPHYS J, V76, P1250, DOI 10.1016/S0006-3495(99)77288-7; Celli J, 2005, BIOMACROMOLECULES, V6, P1329, DOI 10.1021/bm0493990; Celli JP, 2007, BIOMACROMOLECULES, V8, P1580, DOI 10.1021/bm0609691; Celli JP, 2009, P NATL ACAD SCI USA, V106, P14321, DOI 10.1073/pnas.0903438106; D'Agostino EM, 2012, J AGR FOOD CHEM, V60, P3318, DOI 10.1021/jf205111k; De Luca E, 2005, POLYMER, V46, P7109, DOI 10.1016/j.polymer.2005.05.096; Di Cola E, 2008, BIOMACROMOLECULES, V9, P3216, DOI 10.1021/bm800799u; El Gharras H, 2009, INT J FOOD SCI TECH, V44, P2512, DOI 10.1111/j.1365-2621.2009.02077.x; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Georgiades P, 2014, BIOPOLYMERS IN PRESS; Georgiades P, 2014, BIOPOLYMERS, V101, P366, DOI 10.1002/bip.22372; Habauzit V, 2012, THER ADV CHRONIC DIS, V3, P87, DOI 10.1177/2040622311430006; Halliwell B, 2007, CARDIOVASC RES, V73, P341, DOI 10.1016/j.cardiores.2006.10.004; Heenan R. K., 2011, NEUTRON NEWS, V22, P19, DOI DOI 10.1080/10448632.2011.569531; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Higgins J.S., 1997, POLYM NEUTRON SCATTE; Jobstl E, 2004, BIOMACROMOLECULES, V5, P942, DOI 10.1021/bm0345110; Kenwright DA, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031910; Kishimoto Y, 2013, EUR J CLIN NUTR, V67, P532, DOI 10.1038/ejcn.2013.29; Lieleg O, 2011, NAT MATER, V10, P236, DOI [10.1038/nmat2939, 10.1038/NMAT2939]; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Papagiannopoulos A, 2008, FARADAY DISCUSS, V139, P337, DOI 10.1039/b714864j; Perron NR, 2009, CELL BIOCHEM BIOPHYS, V53, P75, DOI 10.1007/s12013-009-9043-x; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Rogers SS, 2007, PHYS BIOL, V4, P220, DOI 10.1088/1478-3975/4/3/008; Rossetti D, 2008, FOOD HYDROCOLLOID, V22, P1068, DOI 10.1016/j.foodhyd.2007.05.014; Rossetti D, 2013, COLLOID SURFACE B, V110, P474, DOI 10.1016/j.colsurfb.2013.03.004; Rossetti D, 2013, COLLOID SURFACE B, V110, P466, DOI 10.1016/j.colsurfb.2013.03.022; Rubinstein M., 2003, POLYM PHYS; Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Tsao R, 2010, NUTRIENTS, V2, P1231, DOI 10.3390/nu2121231; Vinson JA, 1999, J AGR FOOD CHEM, V47, P4821, DOI 10.1021/jf990312p; Vuong QV, 2011, FOOD REV INT, V27, P227, DOI 10.1080/87559129.2011.563397; Waigh TA, 2005, REP PROG PHYS, V68, P685, DOI 10.1088/0034-4885/68/3/R04; WIGNALL GD, 1987, J APPL CRYSTALLOGR, V20, P28, DOI 10.1107/S0021889887087181; Xu JY, 1998, MACROMOLECULES, V31, P6486, DOI 10.1021/ma9717754; Yakubov GE, 2007, BIOMACROMOLECULES, V8, P3791, DOI 10.1021/bm700721c; Zhao YY, 2012, J PHYS CHEM B, V116, P13010, DOI 10.1021/jp212059x	46	33	35	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105302	10.1371/journal.pone.0105302	http://dx.doi.org/10.1371/journal.pone.0105302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162539	Green Submitted, gold, Green Published			2022-12-25	WOS:000340880900031
J	Hohne, J; Holz, E; Staiger-Salzer, P; Muller, KR; Kubler, A; Tangermann, M				Hoehne, Johannes; Holz, Elisa; Staiger-Saelzer, Pit; Mueller, Klaus-Robert; Kuebler, Andrea; Tangermann, Michael			Motor Imagery for Severely Motor-Impaired Patients: Evidence for Brain-Computer Interfacing as Superior Control Solution	PLOS ONE			English	Article							SINGLE-TRIAL EEG; COMMUNICATION; STATE; CLASSIFICATION; MOVEMENT; DEVICE; ALS	Brain-Computer Interfaces (BCIs) strive to decode brain signals into control commands for severely handicapped people with no means of muscular control. These potential users of noninvasive BCIs display a large range of physical and mental conditions. Prior studies have shown the general applicability of BCI with patients, with the conflict of either using many training sessions or studying only moderately restricted patients. We present a BCI system designed to establish external control for severely motor-impaired patients within a very short time. Within only six experimental sessions, three out of four patients were able to gain significant control over the BCI, which was based on motor imagery or attempted execution. For the most affected patient, we found evidence that the BCI could outperform the best assistive technology (AT) of the patient in terms of control accuracy, reaction time and information transfer rate. We credit this success to the applied user-centered design approach and to a highly flexible technical setup. State-of-the art machine learning methods allowed the exploitation and combination of multiple relevant features contained in the EEG, which rapidly enabled the patients to gain substantial BCI control. Thus, we could show the feasibility of a flexible and tailorable BCI application in severely disabled users. This can be considered a significant success for two reasons: Firstly, the results were obtained within a short period of time, matching the tight clinical requirements. Secondly, the participating patients showed, compared to most other studies, very severe communication deficits. They were dependent on everyday use of AT and two patients were in a locked-in state. For the most affected patient a reliable communication was rarely possible with existing AT.	[Hoehne, Johannes] Berlin Inst Technol, Neurotechnol Grp, Berlin, Germany; [Holz, Elisa] Univ Wurzburg, Dept Psychol 1, D-97070 Wurzburg, Germany; [Staiger-Saelzer, Pit] Beratungsstelle Unterstutzte Kommunikat, Diakonie Bad Kreuznach, Bad Kreuznach, Germany; [Mueller, Klaus-Robert] Berlin Inst Technol, Machine Learning Lab, Berlin, Germany; [Mueller, Klaus-Robert] Bernstein Ctr Computat Neurosci, Berlin, Germany; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Tangermann, Michael] Univ Freiburg, BrainLinks BrainTools Excellence Cluster, D-79106 Freiburg, Germany	Technical University of Berlin; University of Wurzburg; Technical University of Berlin; Korea University; University of Freiburg	Hohne, J (corresponding author), Berlin Inst Technol, Neurotechnol Grp, Berlin, Germany.	j.hoehne@tu-berlin.de; klaus-robert.mueller@tu-berlin.de; Andrea.Kuebler@uni-wuerzburg.de; michael.tangermann@blbt.uni-freiburg.de	Tangermann, Michael/ABE-4178-2020; Mueller, Klaus-Robert/Y-3547-2019	Mueller, Klaus-Robert/0000-0002-3861-7685; Kubler, Andrea/0000-0003-4876-0415; Tangermann, Michael/0000-0001-6729-0290	European Information and Communication Technologies (ICT) Programme [FP7-224631, 216886]; Deutsche Forschungsgemeinschaft (DFG) [MU 987/3-2, EXC 1086]; Bundesministerium fur Bildung und Forschung (BMBF) [FKZ 01IB001A, 01GQ0850]; FP7-ICT Programme of the European Community under the PASCAL2 Network of Excellence [ICT-216886]; World Class University Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [R31-10008]; Albert Ludwigs University Freiburg	European Information and Communication Technologies (ICT) Programme; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); FP7-ICT Programme of the European Community under the PASCAL2 Network of Excellence; World Class University Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology(National Research Foundation of Korea); Albert Ludwigs University Freiburg	The authors are grateful for the financial support by several institutions: This work was partly supported by the European Information and Communication Technologies (ICT) Programme Project FP7-224631 and 216886, by the Deutsche Forschungsgemeinschaft (DFG) (grants MU 987/3-2, EXC 1086) and Bundesministerium fur Bildung und Forschung (BMBF) (FKZ 01IB001A, 01GQ0850) and by the FP7-ICT Programme of the European Community, under the PASCAL2 Network of Excellence, ICT-216886. This work was also supported by the World Class University Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology, under Grant R31-10008. This publication only reflects the authors' views. Funding agencies are not liable for any use that may be made of the information contained herein. The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2008, CLIN NEUROPHYSIOL, V119, P399, DOI 10.1016/j.clinph.2007.09.121; Bin GY, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025015; Birbaumer N, 2006, CLIN NEUROPHYSIOL, V117, P479, DOI 10.1016/j.clinph.2005.11.002; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Birbaumer N, 2000, IEEE T REHABIL ENG, V8, P190, DOI 10.1109/86.847812; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; Birbaumer N, 2008, CURR OPIN NEUROL, V21, P634, DOI 10.1097/WCO.0b013e328315ee2d; Blankertz B, 2002, ADV NEUR IN, V14, P157; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00198; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Brouwer AM, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00019; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; De Massari D, 2013, BRAIN, V136, P1989, DOI 10.1093/brain/awt102; Dornhege G, 2004, IEEE T BIO-MED ENG, V51, P993, DOI 10.1109/TBME.2004.827088; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; Grosse-Wentrup M, 2011, NEUROIMAGE, V56, P837, DOI 10.1016/j.neuroimage.2010.04.265; Halder S, 2011, NEUROIMAGE, V55, P1779, DOI 10.1016/j.neuroimage.2011.01.021; Hinterberger T, 2005, NEUROLOGY, V64, P1307, DOI 10.1212/01.WNL.0000156910.32995.F4; Hohne J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098322; Hohne J, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045003; Hohne J, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00099; Hohne J, 2014, P 2014 INT WORKSH PA, P1; Holz EM, 2013, ARTIF INTELL MED, V59, P111, DOI 10.1016/j.artmed.2013.08.001; Kaufmann T, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056016; Kaufmann T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00129; Kaufmann T, 2013, CLIN NEUROPHYSIOL, V124, P893, DOI 10.1016/j.clinph.2012.11.006; Kindermans PJ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035005; Kohlmorgen J., 2007, BRAIN COMPUTER INTER, P409; Kubler A, 2005, NEUROLOGY, V64, P1775, DOI 10.1212/01.WNL.0000158616.43002.6D; Kubler A, 2001, PSYCHOL BULL, V127, P358, DOI 10.1037//0033-2909.127.3.358; Kubler A, 2000, BRAIN COMPUTER COMMU; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; Kubler A, 2013, BRAIN, V136, DOI [10.1093/brain/awt156, 10.1093/brain/awt200]; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lotte F, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00568; Lule D, 2013, CLIN NEUROPHYSIOL, V124, P101, DOI 10.1016/j.clinph.2012.04.030; Lule D, 2008, DTSCH ARZTEBL INT, V105, P397, DOI 10.3238/arztebl.2008.0397; Mak Joseph N, 2009, IEEE Rev Biomed Eng, V2, P187, DOI 10.1109/RBME.2009.2035356; McFarland DJ, 2011, J NEUROSCI METH, V199, P103, DOI 10.1016/j.jneumeth.2011.04.037; Millan JDR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00161; Millan JD, 2009, IEEE ENG MED BIO, P3361, DOI 10.1109/IEMBS.2009.5332828; Muller KR, 2008, J NEUROSCI METH, V167, P82, DOI 10.1016/j.jneumeth.2007.09.022; Murguialday AR, 2011, CLIN NEUROPHYSIOL, V122, P925, DOI 10.1016/j.clinph.2010.08.019; Neumann N, 2003, IEEE T NEUR SYS REH, V11, P169, DOI 10.1109/TNSRE.2003.814431; Neuper C, 2003, CLIN NEUROPHYSIOL, V114, P399, DOI 10.1016/S1388-2457(02)00387-5; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Pfurtscheller G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnpro.2010.00003; Riccio A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045001; Samek Wojciech, 2014, IEEE Rev Biomed Eng, V7, P50, DOI 10.1109/RBME.2013.2290621; Schreuder M, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036025; Sellers EW, 2006, IEEE T NEUR SYS REH, V14, P221, DOI 10.1109/TNSRE.2006.875580; Sellers EW, 2013, CLIN NEUROPHYSIOL, V124, P2, DOI 10.1016/j.clinph.2012.07.012; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Tangermann M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00055; Tomioka R, 2010, NEUROIMAGE, V49, P415, DOI 10.1016/j.neuroimage.2009.07.045; Vidaurre C, 2011, IEEE T BIO-MED ENG, V58, P587, DOI 10.1109/TBME.2010.2093133; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, V3, P123, DOI [DOI 10.1093/ACPROF:OSO/9780195388855.001.0001, 10.1093/acprof:oso/9780195388855.003.0001]; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Zickler C, 2011, CLIN EEG NEUROSCI, V42, P236, DOI 10.1177/155005941104200409	64	53	56	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e104854	10.1371/journal.pone.0104854	http://dx.doi.org/10.1371/journal.pone.0104854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162231	gold, Green Published			2022-12-25	WOS:000340880900021
J	Norris, RD; Norris, JM; Lorenz, RD; Ray, J; Jackson, B				Norris, Richard D.; Norris, James M.; Lorenz, Ralph D.; Ray, Jib; Jackson, Brian			Sliding Rocks on Racetrack Playa, Death Valley National Park: First Observation of Rocks in Motion	PLOS ONE			English	Article							STONES; CALIFORNIA; MOVEMENT; BOULDERS	The engraved trails of rocks on the nearly flat, dry mud surface of Racetrack Playa, Death Valley National Park, have excited speculation about the movement mechanism since the 1940s. Rock movement has been variously attributed to high winds, liquid water, ice, or ice flotation, but has not been previously observed in action. We recorded the first direct scientific observation of rock movements using GPS-instrumented rocks and photography, in conjunction with a weather station and time-lapse cameras. The largest observed rock movement involved >60 rocks on December 20, 2013 and some instrumented rocks moved up to 224 m between December 2013 and January 2014 in multiple move events. In contrast with previous hypotheses of powerful winds or thick ice floating rocks off the playa surface, the process of rock movement that we have observed occurs when the thin, 3 to 6 mm, "windowpane" ice sheet covering the playa pool begins to melt in late morning sun and breaks up under light winds of similar to 4-5 m/s. Floating ice panels 10 s of meters in size push multiple rocks at low speeds of 2-5 m/min. along trajectories determined by the direction and velocity of the wind as well as that of the water flowing under the ice.	[Norris, Richard D.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Norris, James M.; Ray, Jib] Interwoof, Santa Barbara, CA USA; [Lorenz, Ralph D.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Jackson, Brian] Boise State Univ, Dept Phys, Boise, ID 83725 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Idaho; Boise State University	Norris, RD (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	RNorris@ucsd.edu	Lorenz, Ralph D/B-8759-2016; Jackson, Brian/N-8065-2013	Lorenz, Ralph D/0000-0001-8528-4644; Jackson, Brian/0000-0002-9495-9700	National Aeronautics and Space Administration [NNX07AL32G, NNX12AI04G]; Interwoof; Scripps Institution of Oceanography; Commercial Firm Interwoof	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Interwoof; Scripps Institution of Oceanography(University of California System); Commercial Firm Interwoof	This work was supported by National Aeronautics and Space Administration NNX07AL32G and NNX12AI04G (to RDL, BJ); Contributions from Interwoof (JMN, JR) and Scripps Institution of Oceanography (RDN) were self-funded. NASA provided support in the form of salaries for authors (RDL and BJ), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The Commercial Firm Interwoof likewise provided salary support to JMN and JR for the study, but did not otherwise play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon D, 1996, J GEOL, V104, P121, DOI 10.1086/629806; Dionne J.-C., 1988, GEOMORPHOL, V1, P297, DOI [10.1016/0169-555X(88)90002-5, DOI 10.1016/0169-555X(88)90002-5]; DRAKE JJ, 1982, CAN J EARTH SCI, V19, P748, DOI 10.1139/e82-063; Eriksson PG, 1996, J SEDIMENT RES, V66, P36; Kirks LG, 1952, J SEDIMENT PETROL, V22, P173; Kletetschka G, 2013, GEOMORPHOLOGY, V195, P110, DOI 10.1016/j.geomorph.2013.04.032; Lorenz RD, 2011, J APPL METEOROL CLIM, V50, P2361, DOI 10.1175/JAMC-D-11-075.1; Lorenz RD, 2011, AM J PHYS, V79, P37, DOI 10.1119/1.3490645; Lorenz RD, 2010, J ATMOS OCEAN TECH, V27, P246, DOI 10.1175/2009JTECHA1312.1; Lorenz RD, 2010, PLANET SPACE SCI, V58, P724, DOI 10.1016/j.pss.2009.05.012; MCALLISTER JF, 1948, GEOL SOC AM BULL, V59, P1377; Messina P, 2000, GEOMORPHOLOGY, V35, P253, DOI 10.1016/S0169-555X(00)00042-8; PHILIP AL, 1990, J COASTAL RES, V6, P661; PYOKARI M, 1981, CAN J EARTH SCI, V18, P1629, DOI 10.1139/e81-149; REID JB, 1995, GEOLOGY, V23, P819, DOI 10.1130/0091-7613(1995)023<0819:SRATRD>2.3.CO;2; Sanz-Montero ME, 2013, SEDIMENT GEOL, V298, P53, DOI 10.1016/j.sedgeo.2013.10.006; SHARP RP, 1976, GEOL SOC AM BULL, V87, P1704, DOI 10.1130/0016-7606(1976)87<1704:SSRPC>2.0.CO;2; Sharp WE, 1960, J GEOL, P567; SHELTON JS, 1953, SCIENCE, V117, P438, DOI 10.1126/science.117.3042.438-a; STANLEY GM, 1955, GEOL SOC AM BULL, V66, P1329, DOI 10.1130/0016-7606(1955)66[1329:OOPSTR]2.0.CO;2; Timco G, 2002, P 16 IAHR S IC, V2, P69; Weber JNE, 1958, J SEDIMENT PETROL, V28, P333	22	19	19	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105948	10.1371/journal.pone.0105948	http://dx.doi.org/10.1371/journal.pone.0105948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162535	gold, Green Published			2022-12-25	WOS:000340880900065
J	Polonelli, L; Beninati, C; Teti, G; Felici, F; Ciociola, T; Giovati, L; Sperinde, M; Lo Passo, C; Pernice, I; Domina, M; Arigo, M; Papasergi, S; Mancuso, G; Conti, S; Magliani, W				Polonelli, Luciano; Beninati, Concetta; Teti, Giuseppe; Felici, Franco; Ciociola, Tecla; Giovati, Laura; Sperinde, Martina; Lo Passo, Carla; Pernice, Ida; Domina, Maria; Arigo, Milena; Papasergi, Salvatore; Mancuso, Giuseppe; Conti, Stefania; Magliani, Walter			Yeast Killer Toxin-Like Candidacidal Ab6 Antibodies Elicited through the Manipulation of the Idiotypic Cascade	PLOS ONE			English	Article							ANTIIDIOTYPIC ANTIBODIES; INTERNAL IMAGE; NETWORK; MIMICRY; ANTIGEN; VACCINE; IMMUNIZATION; SPECIFICITY; PROTEIN; SERUM	A mouse anti-anti-anti-idiotypic (Id) IgM monoclonal antibody (mAb K20, Ab4), functionally mimicking a Wyckerhamomyces anomalus (Pichia anomala) killer toxin (KT) characterized by fungicidal activity against yeasts presenting specific cell wall receptors (KTR) mainly constituted by beta-1,3-glucan, was produced from animals presenting anti-KT Abs (Ab3) following immunization with a rat IgM anti-Id KT-like mAb (mAb K10, Ab2). MAb K10 was produced by immunization with a KT-neutralizing mAb (mAb KT4, Ab1) bearing the internal image of KTR. MAb K20, likewise mAb K10, proved to be fungicidal in vitro against KT-sensitive Candida albicans cells, an activity neutralized by mAb KT4, and was capable of binding to beta-1,3-glucan. MAb K20 and mAb K10 competed with each other and with KT for binding to C. albicans KTR. MAb K20 was used to identify peptide mimics of KTR by the selection of phage clones from random peptide phage display libraries. Using this strategy, four peptides (TK 1-4) were selected and used as immunogen in mice in the form of either keyhole limpet hemocyanin (KLH) conjugates or peptide-encoding minigenes. Peptide and DNA immunization could induce serum Abs characterized by candidacidal activity, which was inhibited by laminarin, a soluble beta-1,3-glucan, but not by pustulan, a beta-1,6glucan. These findings show that the idiotypic cascade can not only overcome the barrier of animal species but also the nature of immunogens and the type of technology adopted.	[Polonelli, Luciano; Ciociola, Tecla; Giovati, Laura; Sperinde, Martina; Conti, Stefania; Magliani, Walter] Univ Parma, Dipartimento Sci Biomed Biotecnol & Traslaz, Unita Microbiol & Virol, I-43100 Parma, Italy; [Beninati, Concetta; Teti, Giuseppe; Domina, Maria; Arigo, Milena; Papasergi, Salvatore; Mancuso, Giuseppe] Univ Messina, Metchnikoff Lab, Dipartimento Sci Pediat Ginecol Microbiol & Biome, Messina, Italy; [Felici, Franco] Univ Molise, Dipartimento Biosci & Terr DiBT, Pesche, IS, Italy; [Lo Passo, Carla; Pernice, Ida] Univ Messina, Dipartimento Sci Biol & Ambientali, Messina, Italy	University of Parma; University of Messina; University of Molise; University of Messina	Conti, S (corresponding author), Univ Parma, Dipartimento Sci Biomed Biotecnol & Traslaz, Unita Microbiol & Virol, I-43100 Parma, Italy.	stefania.conti@unipr.it	Domina, Maria/K-7883-2016; Conti, Stefania/N-3558-2015; Giovati, Laura/ABH-7376-2020; Felici, Franco/H-5693-2012; papasergi, salvatore/AAE-8818-2021; Ciociola, Tecla/AFN-5212-2022; Ciociola, Tecla/HCH-2453-2022	Conti, Stefania/0000-0001-9973-8352; Felici, Franco/0000-0003-2205-5195; Ciociola, Tecla/0000-0001-6499-2545; GIOVATI, LAURA/0000-0001-7514-1789; Domina, Maria/0000-0002-0445-8356; Mancuso, Giuseppe/0000-0001-5454-3228; BENINATI, Concetta/0000-0001-8305-1337; Lo Passo, Carla/0000-0001-5531-6748; Pernice, Ida/0000-0001-8328-2776				Beninati C, 2006, J EXP MED, V203, P111, DOI 10.1084/jem.20051540; Beninati C, 2009, PEPTIDES, V30, P1936, DOI 10.1016/j.peptides.2009.07.009; Bona CA, 1998, NAT MED, V4, P668, DOI 10.1038/nm0698-668; Bromuro C, 2010, VACCINE, V28, P2615, DOI 10.1016/j.vaccine.2010.01.012; Cassone A, 2010, J INFECT DIS, V202, P1930, DOI 10.1086/657417; CAZENAVE PA, 1983, ANN INST PASTEUR IMM, VD134, P7, DOI 10.1016/S0769-2625(83)80051-8; CAZENAVE PA, 1977, P NATL ACAD SCI USA, V74, P5122, DOI 10.1073/pnas.74.11.5122; Chung CC, 2005, J BIOL CHEM, V280, P41546, DOI 10.1074/jbc.M504562200; Conti S, 1996, MYCOPATHOLOGIA, V135, P1, DOI 10.1007/BF00436568; ERTL HCJ, 1988, VACCINE, V6, P80, DOI 10.1016/S0264-410X(88)80003-3; Falklind-Jerkerus S, 2005, MICROBES INFECT, V7, P1453, DOI 10.1016/j.micinf.2005.05.003; FELICI F, 1991, J MOL BIOL, V222, P301, DOI 10.1016/0022-2836(91)90213-P; GAULTON GN, 1986, ANNU REV IMMUNOL, V4, P253, DOI 10.1146/annurev.iy.04.040186.001345; GEHA RS, 1982, J IMMUNOL, V129, P139; HIERNAUX JR, 1988, INFECT IMMUN, V56, P1407, DOI 10.1128/IAI.56.6.1407-1413.1988; JERNE NK, 1982, EMBO J, V1, P243, DOI 10.1002/j.1460-2075.1982.tb01154.x; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; KUNKEL HG, 1963, SCIENCE, V140, P1218, DOI 10.1126/science.140.3572.1218; Lee G, 2010, CANCER IMMUNOL IMMUN, V59, P1347, DOI 10.1007/s00262-010-0864-7; Lim CSY, 2012, EUR J CLIN MICROBIOL, V31, P21, DOI 10.1007/s10096-011-1273-3; Lo Passo C, 2007, J IMMUNOL, V178, P4417, DOI 10.4049/jimmunol.178.7.4417; Luzzago A, 1998, METH MOL B, V87, P155; Magliani W, 1997, CLIN MICROBIOL REV, V10, P369, DOI 10.1128/CMR.10.3.369; Magliani W, 1997, NAT BIOTECHNOL, V15, P155, DOI 10.1038/nbt0297-155; Magliani W, 2008, FRONT BIOSCI-LANDMRK, V13, P6920, DOI 10.2741/3199; Hernandez AM, 2008, J IMMUNOL, V181, P6625, DOI 10.4049/jimmunol.181.9.6625; Mohanty K, 2007, BREAST CANCER RES TR, V104, P1, DOI 10.1007/s10549-006-9391-9; Moudgal V, 2010, EXPERT OPIN PHARMACO, V11, P2037, DOI 10.1517/14656566.2010.493875; Munoz P, 2010, INT J ANTIMICROB AG, V36, pS63, DOI 10.1016/j.ijantimicag.2010.11.007; NISONOFF A, 1981, CLIN IMMUNOL IMMUNOP, V21, P397, DOI 10.1016/0090-1229(81)90228-2; OUDIN J, 1963, CR HEBD ACAD SCI, V257, P805; Pal S, 2007, CANCER BIOL THER, V6, P1916, DOI 10.4161/cbt.6.12.4967; Pignatari GC, 2007, J BIOTECHNOL, V127, P615, DOI 10.1016/j.jbiotec.2006.08.007; POLONELLI L, 1993, SCAND J IMMUNOL, V37, P105, DOI 10.1111/j.1365-3083.1993.tb01671.x; Polonelli L, 1996, J IMMUNOL, V156, P1880; Polonelli L, 1997, CLIN DIAGN LAB IMMUN, V4, P142, DOI 10.1128/CDLI.4.2.142-146.1997; POLONELLI L, 1987, J CLIN MICROBIOL, V25, P460, DOI 10.1128/JCM.25.2.460-462.1987; Roilides E, 2011, EARLY HUM DEV, V87, pS75, DOI 10.1016/j.earlhumdev.2011.01.017; Shearer MH, 2000, AIDS RES HUM RETROV, V16, P77, DOI 10.1089/088922200309629; Silverstein AM, 1999, CELL IMMUNOL, V194, P213, DOI 10.1006/cimm.1999.1505; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; Vani J, 2007, VACCINE, V25, P4922, DOI 10.1016/j.vaccine.2007.04.005; Vyas NK, 2003, P NATL ACAD SCI USA, V100, P15023, DOI 10.1073/pnas.2431286100	43	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105727	10.1371/journal.pone.0105727	http://dx.doi.org/10.1371/journal.pone.0105727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162681	Green Published, Green Submitted, gold			2022-12-25	WOS:000340880900047
J	Telesca, L; Lovallo, M; Ramirez-Rojas, A; Flores-Marquez, L				Telesca, Luciano; Lovallo, Michele; Ramirez-Rojas, Alejandro; Flores-Marquez, Leticia			Relationship between the Frequency Magnitude Distribution and the Visibility Graph in the Synthetic Seismicity Generated by a Simple Stick-Slip System with Asperities	PLOS ONE			English	Article							TIME-SERIES; NETWORKS	By using the method of the visibility graph (VG) the synthetic seismicity generated by a simple stick-slip system with asperities is analysed. The stick-slip system mimics the interaction between tectonic plates, whose asperities are given by sandpapers of different granularity degrees. The VG properties of the seismic sequences have been put in relationship with the typical seismological parameter, the b-value of the Gutenberg-Richter law. Between the b-value of the synthetic seismicity and the slope of the least square line fitting the k-M plot (relationship between the magnitude M of each synthetic event and its connectivity degree k) a close linear relationship is found, also verified by real seismicity.	[Telesca, Luciano] CNR, Inst Methodol Environm Anal, Tito, Italy; [Lovallo, Michele] ARPAB, Potenza, Italy; [Ramirez-Rojas, Alejandro] Univ Autonoma Metropolitana Azcapotzalco, Dept Ciencias Basicas, Azcapotzalco, Mexico; [Flores-Marquez, Leticia] Univ Nacl Autonoma Mexico, Inst Geofis, Mexico City 04510, DF, Mexico	Consiglio Nazionale delle Ricerche (CNR); Istituto di Metodologie per l'Analisi Ambientale (IMAA-CNR); Universidad Autonoma Metropolitana - Mexico; Universidad Nacional Autonoma de Mexico	Telesca, L (corresponding author), CNR, Inst Methodol Environm Anal, Tito, Italy.	luciano.telesca@imaa.cnr.it	Telesca, Luciano/B-9779-2008	Telesca, Luciano/0000-0002-5978-6031	CNR-CONACyT	CNR-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The present study was supported by the CNR-CONACyT 2013-2015 project "Development of statistical entropic and informational methods for the investigation of complex dynamical systems" in the frame of the Bilateral Agreement for Scientific and Technological Cooperation between CNR and CONACyT.	Aki K., 1965, B EARTHQ RES I TOKYO, V43, P237; Bengoubou-Valerius M, 2013, NAT HAZARDS, V65, P443, DOI 10.1007/s11069-012-0376-1; BURRIDGE R, 1967, B SEISMOL SOC AM, V57, P341; Campanharo ASLO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023378; Donner RV, 2012, ACTA GEOPHYS, V60, P589, DOI 10.2478/s11600-012-0032-x; Flores-Marquez EL, 2014, PHYSICA A, V393, P508, DOI 10.1016/j.physa.2013.07.015; Gao ZK, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/50004; Gao ZK, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016210; IGLESIAS A, 2004, GEOFISICA INT, V43, P309; KOSTOGLODOV V, 1988, GEOPHYS J INT, V94, P65; Lacasa L, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-20809-8; Lacasa L, 2008, P NATL ACAD SCI USA, V105, P4972, DOI 10.1073/pnas.0709247105; PARSONS ID, 1988, B SEISMOL SOC AM, V78, P931; Renard F, 2012, J STRUCT GEOL, V45, P99, DOI 10.1016/j.jsg.2012.03.009; Telesca L, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/50002; Telesca L, 2013, PHYSICA A, V392, P6571, DOI 10.1016/j.physa.2013.08.078; Telesca L, 2010, TECTONOPHYSICS, V494, P155, DOI 10.1016/j.tecto.2010.09.012; Vallianatos F, 2010, PHYSICA A, V389, P4989, DOI 10.1016/j.physa.2010.06.056; Vargas CA, 2008, PHYSICA A, V387, P3137, DOI 10.1016/j.physa.2008.01.108; Vargas CA, 2012, REV MEX FIS, V58, P116; Xu XK, 2008, P NATL ACAD SCI USA, V105, P19601, DOI 10.1073/pnas.0806082105; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701	22	18	18	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106233	10.1371/journal.pone.0106233	http://dx.doi.org/10.1371/journal.pone.0106233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162728	gold, Green Published, Green Submitted			2022-12-25	WOS:000340880900097
J	Cope, LM; Fackler, MJ; Lopez-Bujanda, Z; Wolff, AC; Visvanathan, K; Gray, JW; Sukumar, S; Umbricht, CB				Cope, Leslie M.; Fackler, Mary Jo; Lopez-Bujanda, Zoila; Wolff, Antonio C.; Visvanathan, Kala; Gray, Joe W.; Sukumar, Saraswati; Umbricht, Christopher B.			Do Breast Cancer Cell Lines Provide a Relevant Model of the Patient Tumor Methylome?	PLOS ONE			English	Article							DNA METHYLATION; PROMOTER HYPERMETHYLATION; DRUG DISCOVERY; PREDICTION; CHEMOSENSITIVITY; EVOLUTION; PATTERNS; GENOME; GENES	It is well documented that tumor cells undergo dramatic genetic and epigenetic changes during initial establishment as cell lines and in subsequent serial passaging, and that the resultant cell lines may have evolved significantly from the primary tumors from which they were derived. This has potential implications due to their widespread use in drug response experiments and studies of genomic function. One approach to optimizing the design of such cell line studies is to identify and use the cell lines that faithfully recapitulate critical features of primary tumors. To evaluate the epigenetic fidelity of breast cancer cell lines in the context of primary tumors, we performed methylation profiling of 55 well-characterized breast cancer cell lines on the Illumina HumanMethylation27 BeadChip platform, and compared them to publicly available methylation profiles of primary breast tumors. We found that the DNA methylation profiles of breast cancer cell lines largely retain the features that characterize primary tumors, although there are crucial differences as well. We describe these similarities and differences between primary tumors and breast cancer cell lines in detail, and develop a quantitative measure of similarity that is used to score each cell line with respect to how faithfully its methylation profile mirrors that of primary tumors.	[Cope, Leslie M.; Fackler, Mary Jo; Lopez-Bujanda, Zoila; Wolff, Antonio C.; Visvanathan, Kala; Sukumar, Saraswati; Umbricht, Christopher B.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Umbricht, Christopher B.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Sukumar, Saraswati; Umbricht, Christopher B.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Visvanathan, Kala] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Gray, Joe W.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Oregon Health & Science University	Umbricht, CB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.	cumbrich@jhmi.edu	Wolff, Antonio C./T-8796-2019; Gray, Joe/AAX-9549-2020; Visvanathan, Kala/AAE-4396-2021	Wolff, Antonio C./0000-0003-3734-1063; Lopez Bujanda, Zoila/0000-0001-5729-7309	National Institutes of Health (SPORE Program in Breast Cancer) [P50 CA 88843]; Department of Defense [COE: W81XWH-04-1-0595]; National Institutes of Health [P50 CA 58207, P30 CA 82103, U54 CA 112970, U24 CA 126477, R01 CA 140311]; OHSU Knight Cancer Institute [5P30CA069533-16]; Susan G. Komen Foundation [SAC110012, IIR KG110094]; NATIONAL CANCER INSTITUTE [P50CA058207, R01CA140311, P30CA069533, U54CA112970, P30CA082103, P50CA088843, U24CA126477] Funding Source: NIH RePORTER	National Institutes of Health (SPORE Program in Breast Cancer); Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OHSU Knight Cancer Institute; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (SPORE Program in Breast Cancer, P50 CA 88843), and the Department of Defense (COE: W81XWH-04-1-0595) to SS; by National Institutes of Health grants (P50 CA 58207, P30 CA 82103, U54 CA 112970, U24 CA 126477), and by the OHSU Knight Cancer Institute (5P30CA069533-16), and by the Susan G. Komen Foundation (SAC110012) to JWG; and by the Susan G. Komen Foundation (IIR KG110094), and the National Institutes of Health (R01 CA 140311) to CBU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLIN SB, 2004, NOVART FDN SYMP, V259, P234; Baylin SB, 2004, NOVARTIS FDN S, V259, P285; Baylin Stephen B, 2004, Novartis Found Symp, V259, P226; Cheng F, 2011, J THEOR BIOL, V290, P27, DOI 10.1016/j.jtbi.2011.08.009; Dedeurwaerder S, 2011, EMBO MOL MED, V3, P726, DOI 10.1002/emmm.201100801; Edwards JR, 2010, GENOME RES, V20, P972, DOI 10.1101/gr.101535.109; Fackler MJ, 2011, CANCER RES, V71, P6195, DOI 10.1158/0008-5472.CAN-11-1630; Fackler MJ, 2004, CANCER RES, V64, P4442, DOI 10.1158/0008-5472.CAN-03-3341; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Ferriss JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030550; Hampton OA, 2009, GENOME RES, V19, P167, DOI 10.1101/gr.080259.108; Hastie T., 2009, UNSUPERVISED LEARNIN; Havaleshko DM, 2007, MOL CANCER THER, V6, P578, DOI 10.1158/1535-7163.MCT-06-0497; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee JS, 2007, CANC BIOL THER, V6; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Schmidt M, 2007, INT J ONCOL, V30, P565; Smith SC, 2010, CANCER RES, V70, P1753, DOI 10.1158/0008-5472.CAN-09-3562; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Taberlay PC, 2011, PROG DRUG RES, V67, P1, DOI 10.1007/978-3-7643-8989-5_1; VanderKraats ND, 2013, NUCLEIC ACIDS RES, V41, P6816, DOI 10.1093/nar/gkt482; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	28	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105545	10.1371/journal.pone.0105545	http://dx.doi.org/10.1371/journal.pone.0105545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157401	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303200037
J	Huang, N; Wang, L; Guo, YQ; Hao, PY; Niu, Z				Huang, Ni; Wang, Li; Guo, Yiqiang; Hao, Pengyu; Niu, Zheng			Modeling Spatial Patterns of Soil Respiration in Maize Fields from Vegetation and Soil Property Factors with the Use of Remote Sensing and Geographical Information System	PLOS ONE			English	Article							GROSS PRIMARY PRODUCTION; ORGANIC-CARBON; CHLOROPHYLL CONTENT; ECOSYSTEM RESPIRATION; ABIOTIC FACTORS; WATER-CONTENT; INDEXES; FOREST; PLANT; GIS	To examine the method for estimating the spatial patterns of soil respiration (R-s) in agricultural ecosystems using remote sensing and geographical information system (GIS), R-s rates were measured at 53 sites during the peak growing season of maize in three counties in North China. Through Pearson's correlation analysis, leaf area index (LAI), canopy chlorophyll content, aboveground biomass, soil organic carbon (SOC) content, and soil total nitrogen content were selected as the factors that affected spatial variability in R-s during the peak growing season of maize. The use of a structural equation modeling approach revealed that only LAI and SOC content directly affected R-s. Meanwhile, other factors indirectly affected R-s through LAI and SOC content. When three greenness vegetation indices were extracted from an optical image of an environmental and disaster mitigation satellite in China, enhanced vegetation index (EVI) showed the best correlation with LAI and was thus used as a proxy for LAI to estimate R-s at the regional scale. The spatial distribution of SOC content was obtained by extrapolating the SOC content at the plot scale based on the kriging interpolation method in GIS. When data were pooled for 38 plots, a first-order exponential analysis indicated that approximately 73% of the spatial variability in R-s during the peak growing season of maize can be explained by EVI and SOC content. Further test analysis based on independent data from 15 plots showed that the simple exponential model had acceptable accuracy in estimating the spatial patterns of R-s in maize fields on the basis of remotely sensed EVI and GIS-interpolated SOC content, with R-2 of 0.69 and root-mean-square error of 0.51 mu mol CO2 m(-2) s(-1). The conclusions from this study provide valuable information for estimates of R-s during the peak growing season of maize in three counties in North China.	[Huang, Ni; Wang, Li; Hao, Pengyu; Niu, Zheng] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Guo, Yiqiang] Land Consolidat & Rehabil Ctr, Beijing, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS	Wang, L (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.	wangli@radi.ac.cn	HAO, Pengyu/P-1175-2014; Wang, Li/P-9811-2018; niu, zheng/M-9923-2017	HAO, Pengyu/0000-0003-3711-6157; Wang, Li/0000-0002-2929-4255; 	National Natural Science Foundation of China [41301498]; Public Service Sectors (Ministry of Land and Resources) Special Fund Research [201311127]; State Laboratory of Remote Sensing Science [13RC-07]; Major State Basic Research Development Program of China [2013CB733405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Service Sectors (Ministry of Land and Resources) Special Fund Research; State Laboratory of Remote Sensing Science; Major State Basic Research Development Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (41301498), the Public Service Sectors (Ministry of Land and Resources) Special Fund Research (201311127), the Special Foundation for Young Scientists of the State Laboratory of Remote Sensing Science (13RC-07), and the Major State Basic Research Development Program of China (2013CB733405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro M, 2013, J SOIL SEDIMENT, V13, P641, DOI 10.1007/s11368-012-0643-5; Bian JH, 2013, J MT SCI-ENGL, V10, P754, DOI 10.1007/s11629-013-2545-4; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Broge NH, 2001, REMOTE SENS ENVIRON, V76, P156, DOI 10.1016/S0034-4257(00)00197-8; Buchmann N, 2000, SOIL BIOL BIOCHEM, V32, P1625, DOI 10.1016/S0038-0717(00)00077-8; Campbell JL, 2004, GLOBAL CHANGE BIOL, V10, P1857, DOI 10.1111/j.1365-2486.2004.00850.x; Ceccato P., 2005, Parassitologia (Rome), V47, P81; Chen ST, 2010, AGR FOREST METEOROL, V150, P590, DOI 10.1016/j.agrformet.2010.02.004; Chevallier F, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007375; Chevallier T, 2000, GEODERMA, V94, P43, DOI 10.1016/S0016-7061(99)00064-6; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P230, DOI 10.1111/j.1365-2486.2005.01062.x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Dewan AM, 2009, APPL GEOGR, V29, P390, DOI 10.1016/j.apgeog.2008.12.005; Epron D, 2006, J TROP ECOL, V22, P565, DOI 10.1017/S0266467406003415; FOLEY JA, 1995, TELLUS B, V47, P310, DOI 10.1034/j.1600-0889.47.issue3.3.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Franklin J, 1995, PROG PHYS GEOG, V19, P474, DOI 10.1177/030913339501900403; GALLAHER RN, 1976, SOIL SCI SOC AM J, V40, P887, DOI 10.2136/sssaj1976.03615995004000060026x; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; Gao YH, 2014, FIELD CROP RES, V156, P40, DOI 10.1016/j.fcr.2013.10.016; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P220, DOI 10.1016/j.agrformet.2006.08.003; Geng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034968; Gitelson AA, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006017; Gitelson AA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022688; Glenn EP, 2008, SENSORS-BASEL, V8, P2136, DOI 10.3390/s8042136; Haboudane D, 2002, REMOTE SENS ENVIRON, V81, P416, DOI 10.1016/S0034-4257(02)00018-4; Hansen PM, 2003, REMOTE SENS ENVIRON, V86, P542, DOI 10.1016/S0034-4257(03)00131-7; Hirose T, 1997, ECOLOGY, V78, P2339; Huang N, 2014, J GEOPHYS RES-ATMOS, V119, P6393, DOI 10.1002/2013JD020515; Huang N, 2013, PLANT SOIL, V367, P535, DOI 10.1007/s11104-012-1488-9; Huang N, 2013, ECOL INDIC, V26, P117, DOI 10.1016/j.ecolind.2012.10.027; Huang N, 2012, AGR FOREST METEOROL, V160, P80, DOI 10.1016/j.agrformet.2012.03.005; Hudak AT, 2002, REMOTE SENS ENVIRON, V82, P397, DOI 10.1016/S0034-4257(02)00056-1; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Iriondo JM, 2003, BIOL CONSERV, V113, P367, DOI 10.1016/S0006-3207(03)00129-0; Jonsson M, 2010, BIOL LETTERS, V6, P116, DOI 10.1098/rsbl.2009.0613; Keane RE, 2001, INT J WILDLAND FIRE, V10, P301, DOI 10.1071/WF01028; Kim G. S., 2010, AMOS 18 0 STRUCTURAL; Knorr W, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001119; Kou TJ, 2012, SOIL TILL RES, V118, P132, DOI 10.1016/j.still.2011.10.018; Krugh B., 1994, Maize Genetics Cooperation Newsletter, P25; Lal R., 1999, Progress in Environmental Science, V1, P307; Lin ML, 2011, INT J INNOV COMPUT I, V7, P657; Liu DW, 2006, AGR ECOSYST ENVIRON, V113, P73, DOI 10.1016/j.agee.2005.09.006; Liu YF, 2013, STAT INTERFACE, V6, P1; Longley PA., 2005, GEOGRAPHIC INFORM SY; Martin JG, 2009, AGR FOREST METEOROL, V149, P1722, DOI 10.1016/j.agrformet.2009.06.002; Matheron G., 1963, ECON GEOL, V58, P1246, DOI DOI 10.2113/GSECONGEO.58.8.1246; McGrath D, 2003, APPL GEOCHEM, V18, P1629, DOI 10.1016/S0883-2927(03)00045-3; Meng QM, 2009, ISPRS J PHOTOGRAMM, V64, P27, DOI 10.1016/j.isprsjprs.2008.06.006; National Bureau of statistics of China, 2006, CHIN SOC EC STAT YB; Peng Li, 2014, Remote Sensing, V6, P310, DOI 10.3390/rs6010310; Phillips SC, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2008JG000858; Pugesek BH, 2003, STRUCTURAL EQUATION; QI J, 1994, REMOTE SENS ENVIRON, V48, P119, DOI 10.1016/0034-4257(94)90134-1; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; Raup B, 2007, COMPUT GEOSCI-UK, V33, P104, DOI 10.1016/j.cageo.2006.05.015; Rayner PJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002254; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Rouse J.W., 1974, NASA GSFC TYPE 3 FIN, P1; Schaefer DA, 2009, SOIL BIOL BIOCHEM, V41, P1000, DOI 10.1016/j.soilbio.2008.11.015; Shalaby A, 2007, APPL GEOGR, V27, P28, DOI 10.1016/j.apgeog.2006.09.004; Suyker AE, 2005, AGR FOREST METEOROL, V131, P180, DOI 10.1016/j.agrformet.2005.05.007; Tsui OW, 2013, REMOTE SENS ENVIRON, V139, P340, DOI 10.1016/j.rse.2013.08.012; Vargas R, 2010, ECOL APPL, V20, P1569, DOI 10.1890/09-0693.1; Verstraeten WW, 2010, CLIMATIC CHANGE, V103, P117, DOI 10.1007/s10584-010-9920-8; Wang SD, 2012, PROCEDIA ENVIRON SCI, V13, P140, DOI 10.1016/j.proenv.2012.01.014; Wang SQ, 2003, TELLUS B, V55, P416, DOI 10.1034/j.1600-0889.2003.00039.x; Wang SQ, 2002, INT J REMOTE SENS, V23, P1565, DOI 10.1080/014311602753590887; Wang XD, 2008, J ARID ENVIRON, V72, P1929, DOI 10.1016/j.jaridenv.2008.06.005; Wardlow BD, 2007, REMOTE SENS ENVIRON, V108, P290, DOI 10.1016/j.rse.2006.11.021; Webster KL, 2009, SOIL SCI SOC AM J, V73, P1157, DOI 10.2136/sssaj2008.0310; Webster R., 2007, STAT PRACTICE; Weng QH, 2001, ENVIRON MANAGE, V28, P737, DOI 10.1007/s002670010258; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Wilhelm WW, 2007, AGRON J, V99, P1665, DOI 10.2134/agronj2007.0150; Wilson EH, 2002, REMOTE SENS ENVIRON, V80, P385, DOI 10.1016/S0034-4257(01)00318-2; Wu CY, 2008, AGR FOREST METEOROL, V148, P1230, DOI 10.1016/j.agrformet.2008.03.005; Wu CY, 2010, INT J REMOTE SENS, V31, P2159, DOI 10.1080/01431161003614382; Xiujuan Yu, 2010, Proceedings of the 2010 3rd International Congress on Image and Signal Processing (CISP 2010), P2125, DOI 10.1109/CISP.2010.5647381; Yuan WP, 2010, REMOTE SENS ENVIRON, V114, P1416, DOI 10.1016/j.rse.2010.01.022; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x; Zhong B, 2014, SCI CHINA EARTH SCI, V57, P1790, DOI 10.1007/s11430-014-4877-5	84	9	11	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105150	10.1371/journal.pone.0105150	http://dx.doi.org/10.1371/journal.pone.0105150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157827	Green Submitted, gold, Green Published			2022-12-25	WOS:000341303200024
J	Neuvonen, M; Manna, M; Mokkila, S; Javanainen, M; Rog, T; Liu, Z; Bittman, R; Vattulainen, I; Ikonen, E				Neuvonen, Maarit; Manna, Moutusi; Mokkila, Sini; Javanainen, Matti; Rog, Tomasz; Liu, Zheng; Bittman, Robert; Vattulainen, Ilpo; Ikonen, Elina			Enzymatic Oxidation of Cholesterol: Properties and Functional Effects of Cholestenone in Cell Membranes	PLOS ONE			English	Article							PLASMA-MEMBRANE; FLIP-FLOP; DYNAMICS; RAFTS; DOMAINS; CHOLESTANOL; TRAFFICKING	Bacterial cholesterol oxidase is commonly used as an experimental tool to reduce cellular cholesterol content. That the treatment also generates the poorly degradable metabolite 4-cholesten-3-one (cholestenone) has received less attention. Here, we investigated the membrane partitioning of cholestenone using simulations and cell biological experiments and assessed the functional effects of cholestenone in human cells. Atomistic simulations predicted that cholestenone reduces membrane order, undergoes faster flip-flop and desorbs more readily from membranes than cholesterol. In primary human fibroblasts, cholestenone was released from membranes to physiological extracellular acceptors more avidly than cholesterol, but without acceptors it remained in cells over a day. To address the functional effects of cholestenone, we studied fibroblast migration during wound healing. When cells were either cholesterol oxidase treated or part of cellular cholesterol was exchanged for cholestenone with cyclodextrin, cell migration during 22 h was markedly inhibited. Instead, when a similar fraction of cholesterol was removed using cyclodextrin, cells replenished their cholesterol content in 3 h and migrated similarly to control cells. Thus, cholesterol oxidation produces long-term functional effects in cells and these are in part due to the generated membrane active cholestenone.	[Neuvonen, Maarit; Ikonen, Elina] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Manna, Moutusi; Mokkila, Sini; Javanainen, Matti; Rog, Tomasz; Vattulainen, Ilpo] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland; [Liu, Zheng; Bittman, Robert] CUNY, Queens Coll, Dept Chem & Biochem, Flushing, NY 10021 USA; [Vattulainen, Ilpo] Univ Southern Denmark, Ctr Biomembrane Phys, MEMPHYS, Odense, Denmark; [Ikonen, Elina] Minerva Fdn, Helsinki, Finland	University of Helsinki; Tampere University; City University of New York (CUNY) System; Queens College NY (CUNY); University of Southern Denmark	Ikonen, E (corresponding author), Univ Helsinki, Inst Biomed, Helsinki, Finland.	elina.ikonen@helsinki.fi	Vattulainen, Ilpo T/G-4224-2014; Rog, Tomasz/ABE-3044-2020; Javanainen, Matti/GZA-9227-2022; Manna, Moutusi/GZL-7999-2022	Rog, Tomasz/0000-0001-6765-7013; Javanainen, Matti/0000-0003-4858-364X; Neuvonen, Maarit/0000-0002-7209-3029; Manna, Moutusi/0000-0001-9472-1594; Neuvonen, Mikko/0000-0002-7627-1638; Ikonen, Elina/0000-0001-8382-1135	Academy of Finland [257136, 218066, 131489, 135050]; Academy of Finland Center of Excellence program [272130]; European Research Council [CROWDED-PRO-LIPIDS]; National Institutes of Health [HL083187]; Sigrid Juselius Foundation; Finnish Medical Foundation; Emil Aaltonen Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL083187] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Academy of Finland Center of Excellence program(Academy of Finland); European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Medical Foundation; Emil Aaltonen Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was financially supported by the Academy of Finland project funds (257136 to M.N., 218066, 131489, 135050 to E.I.) and Academy of Finland Center of Excellence program (272130 to E.I. and I.V.), The European Research Council (Advanced Grant CROWDED-PRO-LIPIDS to I.V.), National Institutes of Health grant (HL083187 to R.B.), Sigrid Juselius Foundation grant (to E.I.), Finnish Medical Foundation grant (to E.I.), and Emil Aaltonen Foundation grant (to M.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MLS, 1996, J ORG CHEM, V61, P6587, DOI 10.1021/jo960361q; Anglin TC, 2009, BIOCHEMISTRY-US, V48, P10220, DOI 10.1021/bi901096j; Bennett WFD, 2009, J AM CHEM SOC, V131, P12714, DOI 10.1021/ja903529f; Bennett WFD, 2009, J AM CHEM SOC, V131, P1972, DOI 10.1021/ja808541r; Bjorkbom A, 2011, BBA-BIOMEMBRANES, V1808, P1179, DOI 10.1016/j.bbamem.2011.01.009; BJORKHEM I, 1974, BIOCHIM BIOPHYS ACTA, V337, P129, DOI 10.1016/0005-2760(74)90046-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bruckner RJ, 2009, BIOPHYS J, V97, P3113, DOI 10.1016/j.bpj.2009.09.025; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cahuzac N, 2006, BLOOD, V107, P2384, DOI 10.1182/blood-2005-07-2883; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; GRONBERG L, 1990, BIOCHEMISTRY-US, V29, P3173, DOI 10.1021/bi00465a003; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jansen M, 2011, TRAFFIC, V12, P218, DOI 10.1111/j.1600-0854.2010.01142.x; Jo S, 2010, J PHYS CHEM B, V114, P13342, DOI 10.1021/jp108166k; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanerva K, 2013, DEV CELL, V27, P249, DOI 10.1016/j.devcel.2013.09.016; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Le Lay S, 2009, J LIPID RES, V50, P1609, DOI 10.1194/jlr.M800601-JLR200; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Meszaros P, 2011, BIOCHEM J, V437, P483, DOI 10.1042/BJ20110427; Murzyn K, 2001, BIOPHYS J, V81, P170, DOI 10.1016/S0006-3495(01)75689-5; Orlowski A, 2011, J PHYS CHEM B, V115, P13541, DOI 10.1021/jp207177p; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Parisio G, 2012, J AM CHEM SOC, V134, P12198, DOI 10.1021/ja304007t; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Rhainds D, 2004, J CELL SCI, V117, P3095, DOI 10.1242/jcs.01182; Rog T, 2008, J PHYS CHEM B, V112, P1946, DOI 10.1021/jp075078h; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Sahl SJ, 2010, P NATL ACAD SCI USA, V107, P6829, DOI 10.1073/pnas.0912894107; SALEN G, 1994, J LIPID RES, V35, P1878; Samsonov AV, 2001, BIOPHYS J, V81, P1486, DOI 10.1016/S0006-3495(01)75803-1; Sapay N, 2009, SOFT MATTER, V5, P3295, DOI 10.1039/b902376c; SEELIG A, 1977, BIOCHEMISTRY-US, V16, P45, DOI 10.1021/bi00620a008; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Stepniewski M, 2012, J PHYS CHEM B, V116, P4889, DOI 10.1021/jp300899b; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Welf ES, 2012, J CELL BIOL, V197, P105, DOI 10.1083/jcb.201108152; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	50	44	45	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e103743	10.1371/journal.pone.0103743	http://dx.doi.org/10.1371/journal.pone.0103743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157633	Green Published, gold			2022-12-25	WOS:000341303200004
J	Shi, ZQ; Wang, B; Chihanga, T; Kennedy, MA; Weber, GF				Shi, Zhanquan; Wang, Bo; Chihanga, Tafadzwa; Kennedy, Michael A.; Weber, Georg F.			Energy Metabolism during Anchorage-Independence. Induction by Osteopontin-c	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; HYDROGEN-PEROXIDE GENERATION; BREAST-CANCER CELLS; ACYL-COA OXIDASE; EPITHELIAL-CELLS; METASTASIS; APOPTOSIS; GROWTH; TRANSFORMATION; PROLIFERATION	The detachment of epithelial cells, but not cancer cells, causes anoikis due to reduced energy production. Invasive tumor cells generate three splice variants of the metastasis gene osteopontin, the shortest of which (osteopontin-c) supports anchorage-independence. Osteopontin-c signaling upregulates three interdependent pathways of the energy metabolism. Glutathione, glutamine and glutamate support the hexose monophosphate shunt and glycolysis and can feed into the tricarboxylic acid cycle, leading to mitochondrial ATP production. Activation of the glycerol phosphate shuttle also supports the mitochondrial respiratory chain. Drawing substrates from glutamine and glycolysis, the elevated creatine may be synthesized from serine via glycine and supports the energy metabolism by increasing the formation of ATP. Metabolic probing with N-acetyl-L-cysteine, L-glutamate, or glycerol identified differential regulation of the pathway components, with mitochondrial activity being redox dependent and the creatine pathway depending on glutamine. The multiple skewed components in the cellular metabolism synergize in a flow toward two mechanisms of ATP generation, via creatine and the respiratory chain. It is consistent with a stimulation of the energy metabolism that supports anti-anoikis. Our findings imply a coalescence in cancer cells between osteopontin-a, which increases the cellular glucose levels, and osteopontin-c, which utilizes this glucose to generate energy.	[Shi, Zhanquan; Weber, Georg F.] Univ Cincinnati, Acad Hlth Ctr, Cincinnati, OH 45220 USA; [Wang, Bo; Chihanga, Tafadzwa; Kennedy, Michael A.] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA	University System of Ohio; University of Cincinnati; University System of Ohio; Miami University	Weber, GF (corresponding author), Univ Cincinnati, Acad Hlth Ctr, Cincinnati, OH 45220 USA.	georg.weber@uc.edu	Kennedy, Michael/ABE-6002-2021; Kennedy, Michael/M-2578-2019		Department of Defense [PR094070, BC095225]; National Institutes of Health/National Cancer Institute [1R15CA152985]; Ohio Board of Regents; NATIONAL CANCER INSTITUTE [R15CA152985] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ohio Board of Regents; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by Department of Defense grants PR094070 and BC095225 to GFW. MAK acknowledges support by a grant from the National Institutes of Health/National Cancer Institute (1R15CA152985). The instrumentation used in this work was obtained with the support of Miami University and the Ohio Board of Regents with funds used to establish the Ohio Eminent Scholar Laboratory where the work was performed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JX, 1999, J BIOL CHEM, V274, P26217, DOI 10.1074/jbc.274.37.26217; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Caneba CA, 2012, AM J PHYSIOL-ENDOC M, V303, pE1036, DOI 10.1152/ajpendo.00151.2012; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; CHU S, 1995, P NATL ACAD SCI USA, V92, P7080, DOI 10.1073/pnas.92.15.7080; Connor KM, 2007, CANCER RES, V67, P10260, DOI 10.1158/0008-5472.CAN-07-1204; Dadras SS, 1998, INT J ONCOL, V12, P37; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DENHARDT DT, 1995, ANN NY ACAD SCI, V760, P127, DOI 10.1111/j.1749-6632.1995.tb44625.x; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Giannoni E, 2008, CELL DEATH DIFFER, V15, P867, DOI 10.1038/cdd.2008.3; Glinsky GV, 1996, CANCER LETT, V101, P43, DOI 10.1016/0304-3835(96)04112-2; Goodpaster AM, 2011, CHEMOMETR INTELL LAB, V109, P162, DOI 10.1016/j.chemolab.2011.08.009; Goodpaster AM, 2010, ANAL BIOCHEM, V401, P134, DOI 10.1016/j.ab.2010.02.005; GREEN TR, 1991, BIOCHIM BIOPHYS ACTA, V1073, P91, DOI 10.1016/0304-4165(91)90187-L; Hansen SH, 2013, ADV EXP MED BIOL, V776, P3, DOI 10.1007/978-1-4614-6093-0_1; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harman D, 1987, MODERN BIOL THEORIES, P81; He B, 2006, ONCOGENE, V25, P2192, DOI 10.1038/sj.onc.1209248; HWANG S, 1994, J BIOL CHEM, V269, P711; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; McKnight SL, 2010, SCIENCE, V330, P1338, DOI 10.1126/science.1199908; Mirza M, 2008, INT J CANCER, V122, P889, DOI 10.1002/ijc.23204; Nelson KK, 2003, CLIN CANCER RES, V9, P424; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Pan James G, 2007, Sci STKE, V2007, ppe14; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; Shen H, 2014, MOL CARCINOGEN, V53, P480, DOI 10.1002/mc.21997; Shi ZQ, 2014, CANCER LETT, V344, P47, DOI 10.1016/j.canlet.2013.10.008; Sitte N, 1998, FREE RADICAL BIO MED, V24, P885, DOI 10.1016/S0891-5849(97)00363-8; Takaoka A, 1997, ONCOGENE, V14, P2971, DOI 10.1038/sj.onc.1201147; TIMBLIN CR, 1995, CANCER RES, V55, P2723; Valentinis B, 1999, ONCOGENE, V18, P1827, DOI 10.1038/sj.onc.1202471; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Watanabe M, 2012, CANCER LETT, V315, P18, DOI 10.1016/j.canlet.2011.10.005; Weber GF, 2008, CANCER LETT, V270, P181, DOI 10.1016/j.canlet.2008.04.030; Weber GF, 2011, ONCOL REP, V25, P433, DOI 10.3892/or.2010.1106; WEBER GF, 1995, IMMUNITY, V2, P363, DOI 10.1016/1074-7613(95)90144-2; WEBER GF, 1999, INFLAMMATORY CELLS M, P97; Wong CW, 2001, CANCER RES, V61, P333; Yeldandi AV, 2000, MUTAT RES-FUND MOL M, V448, P159, DOI 10.1016/S0027-5107(99)00234-1	45	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105675	10.1371/journal.pone.0105675	http://dx.doi.org/10.1371/journal.pone.0105675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157961	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303200044
J	Teng, Y; Zou, LY; Huang, M; Chen, YD				Teng, Yue; Zou, Luyi; Huang, Ming; Chen, Yadong			Molecular Interaction Mechanism between 2-Mercaptobenzimidazole and Copper-Zinc Superoxide Dismutase	PLOS ONE			English	Article							OXIDATIVE STRESS; FLUORESCENCE; THERMODYNAMICS; GLUTATHIONE; TOXICITY; PROTEINS; BINDING; OXYGEN; DAMAGE; ASSAY	2-Mercaptobenzimidazole (MBI) is widely utilized as a corrosion inhibitor, copper-plating brightener and rubber accelerator. The residue of MBI in the environment is potentially harmful. In the present work, the toxic interaction of MBI with the important antioxidant enzyme copper-zinc superoxide dismutase (Cu/ZnSOD) was investigated using spectroscopic and molecular docking methods. MBI can interact with Cu/ZnSOD to form an MBI-Cu/ZnSOD complex. The binding constant, number of binding sites and thermodynamic parameters were measured, which indicated that MBI could spontaneously bind with Cu/ZnSOD with one binding site through hydrogen bonds and van der Waals forces. MBI bound into the Cu/ZnSOD interface of two subdomains, which caused some microenvironmental and secondary structure changes of Cu/ZnSOD and further resulted in the inhibition of Cu/ZnSOD activity. This work provides direct evidence at a molecular level to show that exposure to MBI could induce changes in the structure and function of the enzyme Cu/ZnSOD. The estimated methods in this work may be applied to probe molecular interactions of biomacromolecules and other pollutants and drugs.	[Teng, Yue; Zou, Luyi; Huang, Ming] Jiangnan Univ, Sch Environm & Civil Engn, Wuxi, Jiangsu, Peoples R China; [Chen, Yadong] China Pharmaceut Univ, Sch Basic Sci, Lab Mol Design & Drug Discovery, Nanjing 210009, Jiangsu, Peoples R China	Jiangnan University; China Pharmaceutical University	Teng, Y (corresponding author), Jiangnan Univ, Sch Environm & Civil Engn, Wuxi, Jiangsu, Peoples R China.	tengyue@jiangnan.edu.cn			National Nature Science Foundation of China (NSFC) [21307043]; Independent Research Project of Jiangnan University [JUSRP1032]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Independent Research Project of Jiangnan University	The work is supported by National Nature Science Foundation of China (NSFC 21307043, Yue Teng received the funding. URL: http://www.nsfc.gov.cn/), Independent Research Project of Jiangnan University (JUSRP1032, Yue Teng received the funding. URL: http://www.sytu.edu.cn/) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaseth J, 2000, J TRACE ELEM EXP MED, V13, P105, DOI 10.1002/(SICI)1520-670X(2000)13:1<105::AID-JTRA12>3.0.CO;2-B; AIRAUDO C B, 1990, Journal of Biomaterials Science Polymer Edition, V1, P231; Amer J, 2006, BRIT J HAEMATOL, V132, P108, DOI 10.1111/j.1365-2141.2005.05834.x; Banaclocha MM, 1997, BRAIN RES, V762, P256, DOI 10.1016/S0006-8993(97)00493-9; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Cheng X L, 1999, Se Pu, V17, P602; Chi ZX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028361; DOERGE DR, 1986, BIOCHEMISTRY-US, V25, P4724, DOI 10.1021/bi00364a041; Finsgar M, 2013, CORROS SCI, V72, P90, DOI 10.1016/j.corsci.2013.03.010; Finsgar M, 2013, CORROS SCI, V72, P82, DOI 10.1016/j.corsci.2013.03.011; GAWORSKI CL, 1991, FUND APPL TOXICOL, V16, P161, DOI 10.1016/0272-0590(91)90144-S; Giustarini D, 2009, CRIT REV CL LAB SCI, V46, P241, DOI 10.3109/10408360903142326; Gokara M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008834; Hossain M, 2011, PLOS ONE, V6, P12, DOI DOI 10.1371/J0URNAL.P0NE.0018333; JUNGCLAUS GA, 1978, ENVIRON SCI TECHNOL, V12, P88, DOI 10.1021/es60137a015; Kawasaki Yasushi, 1998, Journal of Toxicological Sciences, V23, P53; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Khramov A, 2005, THIN SOLID FILMS, V483, P191, DOI 10.1016/j.tsf.2004.12.021; Kocer M, 2014, CANCER INVEST, V32, P37, DOI 10.3109/07357907.2013.861475; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4171, DOI 10.1021/bi00745a021; Ma LL, 2009, SPECTROCHIM ACTA A, V73, P330, DOI 10.1016/j.saa.2009.02.041; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Rastegarzadeh S, 2013, ENVIRON MONIT ASSESS, V185, P9037, DOI 10.1007/s10661-013-3233-0; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Sakemi K, 2002, ARCH TOXICOL, V76, P682, DOI 10.1007/s00204-002-0392-0; Shinomiya K, 2002, HYPERTENS RES, V25, P91, DOI 10.1291/hypres.25.91; SIES H, 1991, AM J MED, V91, pS31, DOI 10.1016/0002-9343(91)90281-2; SPIES RB, 1987, NATURE, V327, P697, DOI 10.1038/327697a0; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Strasser EM, 2005, BIOCHEM PHARMACOL, V70, P552, DOI 10.1016/j.bcp.2005.05.030; Subapriya R, 2002, CLIN BIOCHEM, V35, P489, DOI 10.1016/S0009-9120(02)00340-5; SUN Y, 1988, CLIN CHEM, V34, P497; Trpkovic A, 2012, ARCH TOXICOL, V86, P1809, DOI 10.1007/s00204-012-0859-6; Vilar S, 2008, CURR TOP MED CHEM, V8, P1555, DOI 10.2174/156802608786786624; WARE WR, 1962, J PHYS CHEM-US, V66, P455, DOI 10.1021/j100809a020; Wu TQ, 2007, BIOMACROMOLECULES, V8, P1899, DOI 10.1021/bm061189v; YAMANO T, 1995, FUND APPL TOXICOL, V25, P218, DOI 10.1006/faat.1995.1057; Zhang YZ, 2009, J HAZARD MATER, V163, P1345, DOI 10.1016/j.jhazmat.2008.07.132; Zhou YL, 2005, THERMOCHIM ACTA, V426, P173, DOI 10.1016/j.tca.2004.07.018; Zong WS, 2010, PROTEIN SCI, V19, P263, DOI 10.1002/pro.313	42	14	14	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e106003	10.1371/journal.pone.0106003	http://dx.doi.org/10.1371/journal.pone.0106003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157630	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303200085
J	Warnier, MJ; Rutten, FH; de Boer, A; Hoes, AW; De Bruin, ML				Warnier, Miriam J.; Rutten, Frans H.; de Boer, Anthonius; Hoes, Arno W.; De Bruin, Marie L.			Resting Heart Rate Is a Risk Factor for Mortality in Chronic Obstructive Pulmonary Disease, but Not for Exacerbations or Pneumonia	PLOS ONE			English	Article							BETA-BLOCKERS; ELDERLY-PATIENTS; RATE-VARIABILITY; RATE REDUCTION; FAILURE; DEATH; COPD; OUTCOMES; CARE	Background: Although it is known that patients with chronic obstructive pulmonary disease (COPD) generally do have an increased heart rate, the effects on both mortality and non-fatal pulmonary complications are unclear. We assessed whether heart rate is associated with all-cause mortality, and non-fatal pulmonary endpoints. Methods: A prospective cohort study of 405 elderly patients with COPD was performed. All patients underwent extensive investigations, including electrocardiography. Follow-up data on mortality were obtained by linking the cohort to the Dutch National Cause of Death Register and information on complications (exacerbation of COPD or pneumonia) by scrutinizing patient files of general practitioners. Multivariable cox regression analysis was performed. Results: During the follow-up 132 (33%) patients died. The overall mortality rate was 50/1000 py (42-59). The major causes of death were cardiovascular and respiratory. The relative risk of all-cause mortality increased with 21% for every 10 beats/minute increase in heart rate (adjusted HR: 1.21 [1.07-1.36], p = 0.002). The incidence of major non-fatal pulmonary events was 145/1000 py (120-168). The risk of a non-fatal pulmonary complication increased non-significantly with 7% for every 10 beats/minute increase in resting heart rate (adjusted HR: 1.07 [0.96-1.18], p = 0.208). Conclusions: Increased resting heart rate is a strong and independent risk factor for all-cause mortality in elderly patients with COPD. An increased resting heart rate did not result in an increased risk of exacerbations or pneumonia. This may indicate that the increased mortality risk of COPD is related to non-pulmonary causes. Future randomized controlled trials are needed to investigate whether heart-rate lowering agents are worthwhile for COPD patients.	[Warnier, Miriam J.; Rutten, Frans H.; Hoes, Arno W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Warnier, Miriam J.; de Boer, Anthonius; De Bruin, Marie L.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	De Bruin, ML (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.	m.l.debruin@uu.nl	De Bruin, Marie Louise/O-5349-2016	De Bruin, Marie Louise/0000-0001-9197-7068	Utrecht University; Netherlands Organisation for Scientific Research (NWO) [904-61-144]	Utrecht University; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Utrecht University. The funding source had no involvement in the study design and conduct of the study; in the collection, management analysis and interpretation data; and preparation, review, or approval of the manuscript; and in the decision to submit the paper for publication. The original UHFO-COPD cohort was funded by a research grant of the Netherlands Organisation for Scientific Research (NWO) [grant number 904-61-144]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badilini F, 2005, J ELECTROCARDIOL, V38, P310, DOI 10.1016/j.jelectrocard.2005.04.003; Boudestein LCM, 2009, EUR J HEART FAIL, V11, P1182, DOI 10.1093/eurjhf/hfp148; Burge S, 2003, EUR RESPIR J, V41, p46s, DOI DOI 10.1183/09031936.03.00078002; Burt L, 2013, AM J NURS, V113, P34, DOI 10.1097/01.NAJ.0000426688.96330.60; Engstrom G, 2001, CIRCULATION, V103, P3086, DOI 10.1161/01.CIR.103.25.3086; Flannery G, 2008, AM J CARDIOL, V101, P865, DOI 10.1016/j.amjcard.2007.11.023; Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X; Georgiopoulou VV, 2012, RESP CARE, V57, P2095, DOI 10.4187/respcare.01485; Gunduz H, 2009, CARDIOL J, V16, P553; Hawkins NM, 2010, EUR J HEART FAIL, V12, P557, DOI 10.1093/eurjhf/hfq040; Jensen HH, 2006, EUR RESPIR J, V28, P781, DOI 10.1183/09031936.06.00152205; Jensen MT, 2013, EUR RESPIR J, V42, P341, DOI 10.1183/09031936.00072212; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; MACKENBACH JP, 1987, J EPIDEMIOL COMMUN H, V41, P156, DOI 10.1136/jech.41.2.156; McAlister FA, 2009, ANN INTERN MED, V150, P784, DOI 10.7326/0003-4819-150-11-200906020-00006; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Rutten FH, 2005, BMJ-BRIT MED J, V331, P1379, DOI 10.1136/bmj.38664.661181.55; Rutten FH, 2005, EUR HEART J, V26, P1887, DOI 10.1093/eurheartj/ehi291; Rutten FH, 2010, ARCH INTERN MED, V170, P880, DOI 10.1001/archinternmed.2010.112; Salpeter S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003566.pub2; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; Sarapa N, 2008, J CLIN PHARMACOL, V48, P538, DOI 10.1177/0091270008316326; SHAPER AG, 1993, BRIT HEART J, V70, P49; Short PM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2549; Sidney S, 2005, CHEST, V128, P2068, DOI 10.1378/chest.128.4.2068; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; VOLTERRANI M, 1994, CHEST, V106, P1432, DOI 10.1378/chest.106.5.1432; Warnier MJ, 2013, COPD, V10, P62, DOI 10.3109/15412555.2012.727918; World Health Organization, 1992, INT STAT CLASS DIS R	30	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105152	10.1371/journal.pone.0105152	http://dx.doi.org/10.1371/journal.pone.0105152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157876	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200025
J	Davies, BA; Norgan, AP; Payne, JA; Schulz, ME; Nichols, MD; Tan, JA; Xu, ZH; Katzmann, DJ				Davies, Brian A.; Norgan, Andrew P.; Payne, Johanna A.; Schulz, Mary E.; Nichols, Micah D.; Tan, Jason A.; Xu, Zhaohui; Katzmann, David J.			Vps4 Stimulatory Element of the Cofactor Vta1 Contacts the ATPase Vps4 alpha 7 and alpha 9 to Stimulate ATP Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIVESICULAR BODY PATHWAY; ESCRT-III; STRUCTURAL BASIS; MEMBRANE SCISSION; ENDOSOMAL TRANSPORT; REGULATORY ROLE; MIT DOMAIN; PROTEIN; COMPLEX; RECOGNITION	The endosomal sorting complexes required for transport (ESCRTs) function in a variety of membrane remodeling processes including multivesicular body sorting, abscission during cytokinesis, budding of enveloped viruses, and repair of the plasma membrane. Vps4 ATPase activity modulates ESCRT function and is itself modulated by its cofactor Vta1 and its substrate ESCRT-III. The carboxyl-terminal Vta1/SBP-1/Lip5 (VSL) domain of Vta1 binds to the Vps4 alpha-domain to promote Vps4 oligomerization-dependent ATP hydrolysis. Additionally, the Vps4 stimulatory element (VSE) of Vta1 contributes to enhancing Vps4 oligomer ATP hydrolysis. The VSE is also required for Vta1-dependent stimulation of Vps4 by ESCRT-III subunits. However, the manner by which the Vta1 VSE contributes to Vps4 activation is unknown. Existing structural data were used to generate a model of the Vta1 VSE in complex with Vps4. This model implicated residues within the small ATPase associated with various activities (AAA) domain, specifically alpha-helices 7 and 9, as relevant contact sites. Rational generation of Vps4 mutants defective for VSE-mediated stimulation, as well as intergenic compensatory mutations, support the validity of this model. These findings have uncovered the Vps4 surface responsible for coordinating ESCRT-III-stimulated Vta1 input during ESCRT function and identified a novel mechanism of Vps4 stimulation.	[Davies, Brian A.; Norgan, Andrew P.; Payne, Johanna A.; Schulz, Mary E.; Nichols, Micah D.; Tan, Jason A.; Katzmann, David J.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Schulz, Mary E.] Lawrence Univ, Dept Biol, Appleton, WI 54911 USA; [Nichols, Micah D.] Byron High Sch, Byron, MN 55920 USA; [Xu, Zhaohui] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	Mayo Clinic; Lawrence University; University of Michigan System; University of Michigan	Katzmann, DJ (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	Katzmann.David@mayo.edu			National Institutes of Health [RO1 GM73024, 1F30DA26762, GM106693]; Mayo Graduate School; Fraternal Order of the Eagles Postdoctoral Fellowship; Lawrence University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095769, R01GM073024, F31GM106693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA026762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; Fraternal Order of the Eagles Postdoctoral Fellowship; Lawrence University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM73024 (to D. J. K.), F30 Predoctoral Fellowship 1F30DA26762 (to A. P. N.), and F31 Predoctoral Fellowship GM106693 (to J. A. T.). This work was also supported by funds from the Mayo Graduate School (to A. P. N. and J. A. T.), the Fraternal Order of the Eagles Postdoctoral Fellowship (to B. A. D.), and the Lawrence University LU-R1 Fellowship (to M. E. S.).	Adell MAY, 2014, J CELL BIOL, V205, P33, DOI 10.1083/jcb.201310114; Adell MAY, 2011, FEBS LETT, V585, P3191, DOI 10.1016/j.febslet.2011.09.001; Agromayor M, 2013, TRENDS CELL BIOL, V23, P433, DOI 10.1016/j.tcb.2013.04.006; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Babst M, 2011, TRAFFIC, V12, P1298, DOI 10.1111/j.1600-0854.2011.01230.x; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Buchkovich NJ, 2013, DEV CELL, V27, P201, DOI 10.1016/j.devcel.2013.09.009; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Davies BA, 2010, MOL BIOL CELL, V21, P3396, DOI 10.1091/mbc.E10-06-0512; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Hill CP, 2012, BBA-MOL CELL RES, V1823, P172, DOI 10.1016/j.bbamcr.2011.08.017; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Jouvenet N, 2012, CELL MOL LIFE SCI, V69, P4121, DOI 10.1007/s00018-012-1035-0; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kieffer CC, 2008, PSYCHOANAL INQ, V28, P1, DOI 10.1080/07351690701787077; Lottridge JM, 2006, P NATL ACAD SCI USA, V103, P6202, DOI 10.1073/pnas.0601712103; MacDonald C, 2012, EMBO REP, V13, P331, DOI 10.1038/embor.2012.18; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Monroe N, 2014, J MOL BIOL, V426, P510, DOI 10.1016/j.jmb.2013.09.043; Norgan AP, 2013, J BIOL CHEM, V288, P26147, DOI 10.1074/jbc.M113.494112; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shestakova A, 2013, J BIOL CHEM, V288, P26810, DOI 10.1074/jbc.M113.497032; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shields SB, 2011, TRAFFIC, V12, P1306, DOI 10.1111/j.1600-0854.2011.01242.x; Shiflett SL, 2004, J BIOL CHEM, V279, P10982, DOI 10.1074/jbc.M312669200; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Skalicky JJ, 2012, J BIOL CHEM, V287, P43910, DOI 10.1074/jbc.M112.417899; Stringer DK, 2011, J CELL BIOL, V192, P229, DOI 10.1083/jcb.201008121; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Takasu H, 2005, BIOCHEM BIOPH RES CO, V334, P460, DOI 10.1016/j.bbrc.2005.06.110; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Vajjhala PR, 2006, FEBS J, V273, P2357, DOI 10.1111/j.1742-4658.2006.05238.x; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Weissenhorn W, 2013, CURR OPIN VIROL, V3, P159, DOI 10.1016/j.coviro.2013.03.011; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xiao JY, 2008, DEV CELL, V14, P37, DOI 10.1016/j.devcel.2007.10.013; Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067; Xiao JY, 2009, MOL BIOL CELL, V20, P3514, DOI 10.1091/mbc.E09-05-0403; Yang D, 2010, STRUCTURE, V18, P976, DOI 10.1016/j.str.2010.04.014; Yang ZZ, 2012, J BIOL CHEM, V287, P43899, DOI 10.1074/jbc.M112.390724; Yeo SCL, 2003, J CELL SCI, V116, P3957, DOI 10.1242/jcs.00751	57	14	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28707	28718		10.1074/jbc.M114.580696	http://dx.doi.org/10.1074/jbc.M114.580696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25164817	Green Published, hybrid			2022-12-25	WOS:000343765400058
J	Kumari, A; Gupta, R				Kumari, Arti; Gupta, Rani			Novel Strategy of Using Methyl Esters as Slow Release Methanol Source during Lipase Expression by mut(+) Pichia pastoris X33	PLOS ONE			English	Article								One of the major issues with heterologous production of proteins in Pichia pastoris X33 under AOX1 promoter is repeated methanol induction. To obviate repeated methanol induction, methyl esters were used as a slow release source of methanol in lipase expressing mut(+) recombinant. Experimental design was based on the strategy that in presence of lipase, methyl esters can be hydrolysed to release their products as methanol and fatty acid. Hence, upon break down of methyl esters by lipase, first methanol will be used as a carbon source and inducer. Then P. pastoris can switch over to fatty acid as a carbon source for multiplication and biomass maintenance till further induction by methyl esters. We validated this strategy using recombinant P. pastoris expressing Lip A, Lip C from Trichosporon asahii and Lip11 from Yarrowia lipolytica. We found that the optimum lipase yield under repeated methanol induction after 120 h was 32866 U/L, 28271 U/L and 21978 U/L for Lip C, Lip A and Lip 11 respectively. In addition, we found that a single dose of methyl ester supported higher production than repeated methanol induction. Among various methyl esters tested, methyl oleate (0.5%) caused 1.2 fold higher yield for LipA and LipC and 1.4 fold for Lip11 after 120 h of induction. Sequential utilization of methanol and oleic acid by P. pastoris was observed and was supported by differential peroxisome proliferation studies by transmission electron microscopy. Our study identifies a novel strategy of using methyl esters as slow release methanol source during lipase expression.	[Kumari, Arti; Gupta, Rani] Univ Delhi, Dept Microbiol, New Delhi, India	University of Delhi	Gupta, R (corresponding author), Univ Delhi, Dept Microbiol, South Campus, New Delhi, India.	ranigupta15@rediffmail.com	Kumari, Arti Dr./L-5719-2017	Kumari, Arti Dr./0000-0001-7288-5993	Council of Scientific and Industrial Research (CSIR)	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	Arti Kumari acknowledges Council of Scientific and Industrial Research (CSIR) for providing senior research fellowship. Technology Based Incubator UDSC, New Delhi for providing gas chromatography facility and Transmission Electron Microscopy facility from All India Institute of Medical Sciences are duly acknowledged. We would like to thank Achievers League USA (Registration ID: 179977) for their editorial assistance.	Cereghino GPL, 2008, MOL CELL BIO, V26, P883; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Gupta N, 2002, ANAL BIOCHEM, V311, P98, DOI 10.1016/S0003-2697(02)00379-2; Krainer FW, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-22; Kumari A, 2012, WORLD J MICROB BIOT, V28, P3103, DOI 10.1007/s11274-012-1120-4; Kumari A, 2012, BIOTECHNOL LETT, V34, P1733, DOI 10.1007/s10529-012-0958-8; Liu DY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-25; NAKA Y, 1992, BIOSCI BIOTECH BIOCH, V56, P1066, DOI 10.1271/bbb.56.1066; Wang XF, 2012, APPL BIOCHEM BIOTECH, V166, P1355, DOI 10.1007/s12010-011-9524-4; Wriessnegger T, 2007, BBA-MOL CELL BIOL L, V1771, P455, DOI 10.1016/j.bbalip.2007.01.004; Yurimoto Hiroya, 2011, Int J Microbiol, V2011, P101298, DOI 10.1155/2011/101298	11	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e104272	10.1371/journal.pone.0104272	http://dx.doi.org/10.1371/journal.pone.0104272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170843	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500015
J	Sarker, MHR; Das, SK; Ahmed, S; Ferdous, F; Das, J; Farzana, FD; Shahid, ASMSB; Shahunja, KM; Afrad, MH; Malek, MA; Chisti, MJ; Bardhan, PK; Hossain, MI; Al Mamun, A; Faruque, ASG				Sarker, Mohammad Habibur Rahman; Das, Sumon Kumar; Ahmed, Shahnawaz; Ferdous, Farzana; Das, Jui; Farzana, Fahmida Dil; Shahid, Abu S. M. S. B.; Shahunja, K. M.; Afrad, Mokibul Hassan; Malek, Mohammad Abdul; Chisti, Mohammod Jobayer; Bardhan, Pradip Kumar; Hossain, Md Iqbal; Al Mamun, Abdullah; Faruque, Abu S. G.			Changing Characteristics of Rotavirus Diarrhea in Children Younger than Five Years in Urban Bangladesh	PLOS ONE			English	Article							CHILDHOOD DIARRHEA; PERSISTENT DIARRHEA; ZINC; PREVALENCE; MORTALITY; DISEASE; ASSOCIATION; POPULATION; VACCINE	Background: Childhood rotavirus diarrhea is still one of the major public health challenges. The present study aimed to determine changing characteristics of rotavirus diarrhea in under-5 children at two periods of time. Methods: We enrolled 5,357 under-5 children with rotavirus positive in two different time periods; i) 1993-1997 (n = 2,493), and ii) 2008-2012 (n = 2,864) considering beginning and ending of two decades. These children were enrolled in the urban Dhaka Hospital of icddr,b. Results: Overall, proportion of rotavirus was about 25% in 1993-97, which was 42% in 2008-12 (68% rise; p<0.001). Significant higher proportion of children were stunted [38% vs. 22%; aOR-1.33 (95% CI-1.09-1.62)], had vomiting [87% vs. 74%; aOR-2.58 (95% CI-2.02-3.28)], fever [10% vs. 8%; aOR-1.31 (95% CI-0.96-1.78)], family members >5 [38% vs. 35%; aOR-1.32 (95% CI-1.10-1.58)] required more intravenous fluid [9% vs. 3%; aOR-4.93 (95% CI-3.19-7.63)], had higher co-infection with Shigella [3% vs. 1%; aOR-3.36 (95% CI-1.61-7.03)], Vibrio cholerae [4% vs. 1%; aOR-3.70 (95% CI-2.12-6.46)]; and ETEC [13% vs. 7%; aOR-2.21 (95% CI-1.65-2.97)]; however, significantly lower proportion of them used sanitary toilets [54% vs. 78%; aOR-0.66 (95% CI-0.54-0.80)], boiled drinking water [16% vs. 38%; aOR-0.60 (95% CI-0.48-0.74)], used antimicrobial at home [63% vs. 82%; aOR-0.56 (95% CI-0.46-0.69)] and had some or severe dehydration [18% vs. 34%; aOR-0.15 (95% CI-0.120.20)] in 1st observation period compared to that of 2nd. Conclusion: Proportion of episodes of under-5 rotavirus diarrhea increased over the period. Concomitant changes in host, socio-demographic and clinical characteristics, and co-infections were also observed. Thus, vaccination campaign which is prevailing in private sector should also be introduced in public sector.	[Sarker, Mohammad Habibur Rahman; Das, Sumon Kumar; Ahmed, Shahnawaz; Ferdous, Farzana; Das, Jui; Farzana, Fahmida Dil; Shahid, Abu S. M. S. B.; Shahunja, K. M.; Afrad, Mokibul Hassan; Malek, Mohammad Abdul; Chisti, Mohammod Jobayer; Bardhan, Pradip Kumar; Hossain, Md Iqbal; Faruque, Abu S. G.] Int Ctr Diarrhoeal Dis Res Icddr B, Dhaka, Bangladesh; [Das, Sumon Kumar; Al Mamun, Abdullah] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); University of Queensland	Das, SK (corresponding author), Int Ctr Diarrhoeal Dis Res Icddr B, Dhaka, Bangladesh.	sumon@icddrb.org	Das, Sumon Kumar/AAD-1551-2019; Das, Sumon Kumar/T-6384-2019; Sarker, Mohammad Habibur Rahman/HHZ-8980-2022; Afrad, Mokibul/C-4149-2011; Shahunja, K M/AAR-6229-2020; Mamun, Abdullah A/A-4673-2011; Mamun, Abdullah/HHM-9898-2022; Chisti, Mohammod J/A-7216-2018; Afrad, Mokibul Hassan/H-6904-2012	Sarker, Mohammad Habibur Rahman/0000-0001-9614-0806; Afrad, Mokibul/0000-0002-9627-7877; Shahunja, K M/0000-0002-9345-206X; Mamun, Abdullah A/0000-0002-1535-8086; Afrad, Mokibul Hassan/0000-0002-9627-7877; Ahmed, Shahnawaz/0000-0001-8339-4137; FERDOUS, FARZANA/0000-0002-6373-3581	icddr,b; Government of the People's Republic of Bangladesh through IHP-HNPRP	icddr,b; Government of the People's Republic of Bangladesh through IHP-HNPRP	Hospital surveillance was funded by icddr,b and the Government of the People's Republic of Bangladesh through IHP-HNPRP. icddr,b acknowledges with gratitude the commitment of the Government of the People's Republic of Bangladesh to the Centre's research efforts. icddr,b also gratefully acknowledges the following donors which provide unrestricted support to the Centre's research efforts: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency (CIDA), Embassy of the Kingdom of the Netherlands (EKN), Swedish International Development Cooperation Agency (Sida), Swiss Agency for Development and Co-operation (SDC), and Department for International Development, UK (DFID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agustina R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-977; Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; Bhutta ZA, 2000, AM J CLIN NUTR, V72, P1516; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Cezard JP, 2007, ARCH PEDIATRIE, V14, pS169, DOI 10.1016/S0929-693X(07)80023-6; Das SK, 2014, TROP MED INT HEALTH, V19, P240, DOI 10.1111/tmi.12231; Das SK, 2012, ACTA PAEDIATR, V101, pE452, DOI 10.1111/j.1651-2227.2012.02761.x; Dewan N, 1998, ACTA PAEDIATR, V87, P627, DOI 10.1080/080352598750014012; Ellis AA, 2007, SOC SCI MED, V64, P701, DOI 10.1016/j.socscimed.2006.10.011; Jensen PK, 2004, TROP MED INT HEALTH, V9, P1210, DOI 10.1111/j.1365-3156.2004.01329.x; Joensuu J, 1997, LANCET, V350, P1205, DOI 10.1016/S0140-6736(97)05118-0; Larson CP, 2012, HEALTH POLICY PLANN, V27, P102, DOI 10.1093/heapol/czr015; Larson CP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000175; Lundgren O, 2001, MICROBES INFECT, V3, P1145, DOI 10.1016/S1286-4579(01)01475-7; NARAIN JP, 1989, INT J EPIDEMIOL, V18, P952, DOI 10.1093/ije/18.4.952; Parashar UD, 2003, B WORLD HEALTH ORGAN, V81, P236; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Patel MM, 2011, PEDIATR INFECT DIS J, V30, pS1, DOI 10.1097/INF.0b013e3181fefa1f; Qadri F, 2000, J CLIN MICROBIOL, V38, P27; Rahman M, 2007, EMERG INFECT DIS, V13, P18, DOI 10.3201/eid1301.060910; Rodriguez L, 2011, INT J ENV RES PUB HE, V8, P1174, DOI 10.3390/ijerph8041174; Santosham M, 1997, J PEDIATR-US, V131, P632, DOI 10.1016/S0022-3476(97)70076-3; STOLL BJ, 1982, BRIT MED J, V285, P1185, DOI 10.1136/bmj.285.6349.1185; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5	26	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105978	10.1371/journal.pone.0105978	http://dx.doi.org/10.1371/journal.pone.0105978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171098	gold, Green Submitted, Green Published			2022-12-25	WOS:000341127500087
J	Shikano, I; Cory, JS				Shikano, Ikkei; Cory, Jenny S.			Dietary Mechanism behind the Costs Associated with Resistance to Bacillus thuringiensis in the Cabbage Looper, Trichoplusia ni	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; SPODOPTERA-EXEMPTA WALKER; LIFE-HISTORY COSTS; FITNESS COSTS; HOST-PLANT; NUTRIENT REGULATION; DROSOPHILA-MELANOGASTER; SPECIALIST CATERPILLAR; INSECTICIDE RESISTANCE; PLUTELLA-XYLOSTELLA	Beneficial alleles that spread rapidly as an adaptation to a new environment are often associated with costs that reduce the fitness of the population in the original environment. Several species of insect pests have evolved resistance to Bacillus thuringiensis (Bt) toxins in the field, jeopardizing its future use. This has most commonly occurred through the alteration of insect midgut binding sites specific for Bt toxins. While fitness costs related to Bt resistance alleles have often been recorded, the mechanisms behind them have remained obscure. We asked whether evolved resistance to Bt alters dietary nutrient intake, and if reduced efficiency of converting ingested nutrients to body growth are associated with fitness costs and variation in susceptibility to Bt. We fed the cabbage looper Trichoplusia ni artificial diets differing in levels of dietary imbalance in two major macronutrients, protein and digestible carbohydrate. By comparing a Bt-resistant T. ni strain with a susceptible strain we found that the mechanism behind reduced pupal weights and growth rates associated with Bt-resistance in T. ni was reduced consumption rather than impaired conversion of ingested nutrients to growth. In fact, Bt-resistant T. ni showed more efficient conversion of nutrients than the susceptible strain under certain dietary conditions. Although increasing levels of dietary protein prior to Bt challenge had a positive effect on larval survival, the LC50 of the resistant strain decreased when fed high levels of excess protein, whereas the LC50 of the susceptible strain continued to rise. Our study demonstrates that examining the nutritional basis of fitness costs may help elucidate the mechanisms underpinning them.	[Shikano, Ikkei; Cory, Jenny S.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Shikano, I (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	ishikano@sfu.ca		Shikano, Ikkei/0000-0003-4857-1294	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant; NSERC Alexander Graham Bell Canada; Pacific Century Graduate Entrance Scholarship from the government of BC; Targeted Special Graduate Entrance Scholarship from SFU	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Alexander Graham Bell Canada; Pacific Century Graduate Entrance Scholarship from the government of BC; Targeted Special Graduate Entrance Scholarship from SFU	Financial support was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to J.S.C. and an NSERC Alexander Graham Bell Canada Graduate Scholarship-Doctoral, the Pacific Century Graduate Entrance Scholarship from the government of BC and a Targeted Special Graduate Entrance Scholarship from SFU to I.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2003, J ECON ENTOMOL, V96, P1290, DOI 10.1603/0022-0493-96.4.1290; Alyokhin AV, 1999, J ECON ENTOMOL, V92, P510, DOI 10.1093/jee/92.3.510; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Bird LJ, 2007, BIOL CONTROL, V40, P196, DOI 10.1016/j.biocontrol.2006.11.004; BOOTS M, 1993, FUNCT ECOL, V7, P528, DOI 10.2307/2390128; Bravo A, 2008, TRENDS BIOTECHNOL, V26, P573, DOI 10.1016/j.tibtech.2008.06.005; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Caccia S, 2012, APPL ENVIRON MICROB, V78, P5690, DOI 10.1128/AEM.00523-12; Carriere Y, 2005, J ECON ENTOMOL, V98, P947, DOI 10.1603/0022-0493-98.3.947; Carriere Y, 2004, J ECON ENTOMOL, V97, P1710, DOI 10.1603/0022-0493-97.5.1710; CARRIERE Y, 1994, P ROY SOC B-BIOL SCI, V258, P35, DOI 10.1098/rspb.1994.0138; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Cory JS, 2012, EVOL APPL, V5, P455, DOI 10.1111/j.1752-4571.2012.00269.x; Dubovskiy IM, 2008, J INVERTEBR PATHOL, V98, P360, DOI 10.1016/j.jip.2008.03.011; Duncan AB, 2011, EVOLUTION, V65, P3462, DOI 10.1111/j.1558-5646.2011.01388.x; Eberle KE, 2008, J INVERTEBR PATHOL, V98, P293, DOI 10.1016/j.jip.2008.03.003; Ericsson JD, 2009, J INVERTEBR PATHOL, V100, P61, DOI 10.1016/j.jip.2008.10.007; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; GOTTHARD K, 1994, OECOLOGIA, V99, P281, DOI 10.1007/BF00627740; GROETERS FR, 1994, EVOLUTION, V48, P197, DOI 10.2307/2410015; Gunning RV, 2005, APPL ENVIRON MICROB, V71, P2558, DOI 10.1128/AEM.71.5.2558-2563.2005; HARA T, 1982, SOIL SCI PLANT NUTR, V28, P109, DOI 10.1080/00380768.1982.10432376; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hernandez-Martinez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012795; Janmaat AF, 2007, J EVOLUTION BIOL, V20, P62, DOI 10.1111/j.1420-9101.2006.01232.x; Janmaat AF, 2006, ECOL ENTOMOL, V31, P172, DOI 10.1111/j.0307-6946.2006.00768.x; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Janmaat AF, 2005, P ROY SOC B-BIOL SCI, V272, P1031, DOI 10.1098/rspb.2004.3040; Janmaat AF, 2014, J INVERTEBR PATHOL, V119, P32, DOI 10.1016/j.jip.2014.04.001; Johnston PR, 2009, APPL ENVIRON MICROB, V75, P5094, DOI 10.1128/AEM.00966-09; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Lee KP, 2006, J EXP BIOL, V209, P2076, DOI 10.1242/jeb.02253; Lee KP, 2004, J INSECT PHYSIOL, V50, P1171, DOI 10.1016/j.jinsphys.2004.10.009; Lee KP, 2003, J INSECT PHYSIOL, V49, P1161, DOI 10.1016/j.jinsphys.2003.08.013; Lee KP, 2002, J INSECT PHYSIOL, V48, P655, DOI 10.1016/S0022-1910(02)00088-4; Ma G, 2005, INSECT BIOCHEM MOLEC, V35, P729, DOI 10.1016/j.ibmb.2005.02.011; Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889; McKenzie J., 1996, ECOLOGICAL EVOLUTION; Morehouse NI, 2010, OIKOS, V119, P636, DOI 10.1111/j.1600-0706.2009.17866.x; Oppert B, 2000, ENTOMOL EXP APPL, V96, P281, DOI 10.1023/A:1004061222318; Paris M, 2011, ECOTOXICOLOGY, V20, P1184, DOI 10.1007/s10646-011-0663-8; Povey S, 2014, J ANIM ECOL, V83, P245, DOI 10.1111/1365-2656.12127; Rahman MM, 2004, P NATL ACAD SCI USA, V101, P2696, DOI 10.1073/pnas.0306669101; Raubenheimer D, 1997, NUTR RES REV, V10, P151, DOI 10.1079/NRR19970009; Raubenheimer D, 2003, J EXP BIOL, V206, P1669, DOI 10.1242/jeb.00336; RAUBENHEIMER D, 1993, ANIM BEHAV, V45, P953, DOI 10.1006/anbe.1993.1114; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Raymond B, 2011, HEREDITY, V106, P281, DOI 10.1038/hdy.2010.65; Raymond B, 2007, BIOL LETT-UK, V3, P82, DOI 10.1098/rsbl.2006.0560; Raymond B, 2010, TRENDS MICROBIOL, V18, P189, DOI 10.1016/j.tim.2010.02.006; SCHROEDER LA, 1986, ENTOMOL EXP APPL, V41, P115, DOI 10.1007/BF00195566; Scriber J.M., 1984, P159; Shikano I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085709; Shirai Y, 1998, JPN J APPL ENTOMOL Z, V42, P59, DOI 10.1303/jjaez.42.59; SIMPSON SJ, 1993, PHILOS T R SOC B, V342, P381, DOI 10.1098/rstb.1993.0166; STOCKHOFF BA, 1991, OECOLOGIA, V88, P422, DOI 10.1007/BF00317588; Thompson SN, 2000, BBA-GEN SUBJECTS, V1523, P91, DOI 10.1016/S0304-4165(00)00102-1; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; Vijendravarma RK, 2009, EVOLUTION, V63, P104, DOI 10.1111/j.1558-5646.2008.00516.x; WALDBAUER GP, 1991, ANNU REV ENTOMOL, V36, P43, DOI 10.1146/annurev.en.36.010191.000355; Williams JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021863; ZANOTTO FP, 1993, PHYSIOL ENTOMOL, V18, P425, DOI 10.1111/j.1365-3032.1993.tb00617.x	65	19	19	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105864	10.1371/journal.pone.0105864	http://dx.doi.org/10.1371/journal.pone.0105864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171126	Green Submitted, Green Published, gold			2022-12-25	WOS:000341127500076
J	Zoltan, D; Oestreicher, J; Weaver, A; Santiago, S; Agoulnik, S; Chow, J; Oda, Y; Funahashi, Y				Zoltan Dezso; Oestreicher, Judith; Weaver, Amy; Santiago, Stephanie; Agoulnik, Sergei; Chow, Jesse; Oda, Yoshiya; Funahashi, Yasuhiro			Gene Expression Profiling Reveals Epithelial Mesenchymal Transition (EMT) Genes Can Selectively Differentiate Eribulin Sensitive Breast Cancer Cells	PLOS ONE			English	Article							OVARIAN-CANCER; BETA-TUBULIN; PACLITAXEL RESISTANCE; MICROTUBULE DYNAMICS; IN-VITRO; TAXOL; CARCINOMA; GROWTH; REGULARIZATION; SENSITIZATION	Objectives: Eribulin mesylate is a synthetic macrocyclic ketone analog of the marine sponge natural product halichondrin B. Eribulin is a mechanistically unique inhibitor of microtubule dynamics. In this study, we investigated whether selective signal pathways were associated with eribulin activity compared to paclitaxel, which stabilizes microtubules, based on gene expression profiling of cell line panels of breast, endometrial, and ovarian cancer in vitro. Results: We determined the sets of genes that were differentially altered between eribulin and paclitaxel treatment in breast, endometrial, and ovarian cancer cell line panels. Our unsupervised clustering analyses revealed that expression profiles of gene sets altered with treatments were correlated with the in vitro antiproliferative activities of the drugs. Several tubulin isotypes had significantly lower expression in cell lines treated with eribulin compared to paclitaxel. Pathway enrichment analyses of gene sets revealed that the common pathways altered between treatments in the 3 cancer panels were related to cytoskeleton remodeling and cell cycle regulation. The epithelial-mesenchymal transition (EMT) pathway was enriched in genes with significantly altered expression between the two drugs for breast and endometrial cancers, but not for ovarian cancer. Expression of genes from the EMT pathway correlated with eribulin sensitivity in breast cancer and with paclitaxel sensitivity in endometrial cancer. Alteration of expression profiles of EMT genes between sensitive and resistant cell lines allowed us to predict drug sensitivity for breast and endometrial cancers. Conclusion: Gene expression analysis showed that gene sets that were altered between eribulin and paclitaxel correlated with drug in vitro antiproliferative activities in breast and endometrial cancer cell line panels. Among the panels, breast cancer provided the strongest differentiation between eribulin and paclitaxel sensitivities based on gene expression. In addition, EMT genes were predictive of eribulin sensitivity in the breast and endometrial cancer panels.	[Zoltan Dezso; Oestreicher, Judith; Weaver, Amy; Santiago, Stephanie; Agoulnik, Sergei; Chow, Jesse; Oda, Yoshiya; Funahashi, Yasuhiro] Eisai Inc, Eisai Prod Creat Syst, Biomarkers & Personalized Med Core Funct Unit, Andover, MA 01810 USA	Eisai Co Ltd	Funahashi, Y (corresponding author), Eisai Inc, Eisai Prod Creat Syst, Biomarkers & Personalized Med Core Funct Unit, Andover, MA 01810 USA.	Yasuhiro_Funahashi@eisai.com			research and development budget of Eisai Inc.	research and development budget of Eisai Inc.	The funding for the work was from the research and development budget of Eisai Inc.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli E, 2002, CANCER RES, V62, P6864; [Anonymous], 2010, R LANG ENV STAT COMP; BACHURSKI CJ, 1994, MOL CELL BIOL, V14, P4076, DOI 10.1128/MCB.14.6.4076; Bani MR, 2004, MOL CANCER THER, V3, P111; Barlow SB, 2002, J CELL SCI, V115, P3469; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; Charles PC, 2007, INTERNET J GENOMICS, V3, P1, DOI [10.5580/1501, DOI 10.5580/1501]; Chien AJ, 2008, SEMIN ONCOL, V35, pS1, DOI 10.1053/j.seminoncol.2008.02.010; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; Hari M, 2006, MOL CANCER THER, V5, P270, DOI 10.1158/1535-7163.MCT-05-0190; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Helleman J, 2010, GYNECOL ONCOL, V117, P170, DOI 10.1016/j.ygyno.2010.01.010; Hendrix MJC, 1997, AM J PATHOL, V150, P483; Jain R, 2007, AM J RESP CELL MOL, V37, P38, DOI 10.1165/rcmb.2006-0353OC; Jordan MA, 2005, MOL CANCER THER, V4, P1086, DOI 10.1158/1535-7163.MCT-04-0345; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; L'Esperance S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-99; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; McConkey DJ, 2009, CANCER METAST REV, V28, P335, DOI 10.1007/s10555-009-9194-7; Mozzetti S, 2005, CLIN CANCER RES, V11, P298; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Scatena CD, 1998, J BIOL CHEM, V273, P30777, DOI 10.1074/jbc.273.46.30777; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Shiozaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038049; Smith JA, 2010, BIOCHEMISTRY-US, V49, P1331, DOI 10.1021/bi901810u; STARGELL LA, 1992, MOL CELL BIOL, V12, P1443, DOI 10.1128/MCB.12.4.1443; Suh Y, 2012, ONCOGENE, V1, P1; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Towle MJ, 2001, CANCER RES, V61, P1013; Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yoshida T, 2014, BRIT J CANCER, V110, P1497, DOI 10.1038/bjc.2014.80; Yu DH, 2001, SEMIN ONCOL, V28, P12; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang CC, 1998, ONCOGENE, V16, P1617, DOI 10.1038/sj.onc.1201658; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	42	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106131	10.1371/journal.pone.0106131	http://dx.doi.org/10.1371/journal.pone.0106131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171249	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500111
J	Peng, L; Ma, J; Cui, R; Chen, X; Wei, SY; Wei, QJ; Li, B				Peng, Lei; Ma, Jing; Cui, Rui; Chen, Xiao; Wei, Shi-Yao; Wei, Qiu-Ju; Li, Bing			The Calcineurin Inhibitor Tacrolimus Reduces Proteinuria in Membranous Nephropathy Accompanied by a Decrease in Angiopoietin-Like-4	PLOS ONE			English	Article							KIDNEY REPAIR; CYCLOSPORINE; TARGET; IMMUNOSUPPRESSION; CELLS	Tacrolimus is an anticalcineurinic agent with potent immunosuppressive activity that has recently been shown to have the added benefit of reducing proteinuria in membranous nephropathy (MN) patients. However, its potential mechanisms remain unknown. To reveal the mechanism, rat cohorts were administered tacrolimus or vehicle from days 7 to 28 after the induction of passive Heymann nephritis (PHN). PHN induction resulted in heavy proteinuria and increased expression of desmin, a marker of injured podocytes. We also showed that the glomerular expression of angiopoietin-like-4 (Angptl4) was markedly upregulated in PHN rats and human MN followed by an increase in urine Angptl4 excretion. In addition, increased Angptl4 expression may be related to podocyte injury and proteinuria. Furthermore, upregulated Angptl4 expression primarily colocalized with podocytes rather than endothelial or mesangial cells, indicating that podocytes may be the source of Angptl4, which then gradually migrated to the glomerular basement membrane over time. However, tacrolimus treatment markedly reduced glomerular and urinary Angptl4, accompanied by a reduction in the established proteinuria and the promotion of podocyte repair. Additionally, glomerular immune deposits and circulating IgG levels induced by PHN clearly decreased following tacrolimus treatment. In conclusion, this is the first demonstration that the calcineurin inhibitor tacrolimus can reduce Angptl4 in podocytes accompanied by a decrease in established proteinuria and promotion of podocyte repair in MN.	[Peng, Lei; Ma, Jing; Cui, Rui; Chen, Xiao; Wei, Shi-Yao; Wei, Qiu-Ju; Li, Bing] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Peoples R China; [Peng, Lei] Sichuan Acad Med Sci, Dept Nephrol, Chengdu, Peoples R China; [Peng, Lei] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China	Harbin Medical University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Li, B (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Peoples R China.	icecreamlee@hotmail.com			National Basic Research Program of China 973 Program [2012CB517602, 2012CB517803]; Research Fund for the Doctoral Program of Ministry of Education of China [20122307110018]; National Natural Science Foundation of China [81370812]; Heilongjiang Scientific research fund for postgraduates [YJSCX2012-237HLJ]	National Basic Research Program of China 973 Program(National Basic Research Program of China); Research Fund for the Doctoral Program of Ministry of Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Scientific research fund for postgraduates	This study was supported by research grants from the National Basic Research Program of China 973 Program (No. 2012CB517602), Research Fund for the Doctoral Program of Ministry of Education of China (20122307110018), the National Natural Science Foundation of China (No. 81370812), the National Basic Research Program of China 973 Program (No. 2012CB517803), and the Heilongjiang Scientific research fund for postgraduates (YJSCX2012-237HLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanger AJ, 2002, J MOL CELL CARDIOL, V34, P765, DOI 10.1006/jmcc.2002.2021; Chen M, 2010, AM J MED SCI, V339, P233, DOI 10.1097/MAJ.0b013e3181ca3a7d; Chen YZ, 2013, CLIN J AM SOC NEPHRO, V8, P787, DOI 10.2215/CJN.07570712; Chen ZH, 2010, KIDNEY INT, V77, P974, DOI 10.1038/ki.2010.41; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Hoorn EJ, 2011, NAT MED, V17, P1304, DOI 10.1038/nm.2497; Jefferson JA, 2011, AM J KIDNEY DIS, V58, P666, DOI 10.1053/j.ajkd.2011.05.032; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kitahara K, 2007, CURR OPIN RHEUMATOL, V19, P238, DOI 10.1097/BOR.0b013e328099af80; Li B, 2006, KIDNEY INT, V69, P323, DOI 10.1038/sj.ki.5000083; Li B, 2010, CIRCULATION, V121, P2211, DOI 10.1161/CIRCULATIONAHA.109.928796; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Li LS, 2004, KIDNEY INT, V66, P920, DOI 10.1111/j.1523-1755.2004.00837.x; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Massella L, 2010, PEDIATR NEPHROL, V25, P1269, DOI 10.1007/s00467-010-1484-3; Naumovic R, 2009, NEPHROL DIAL TRANSPL, V24, P877, DOI 10.1093/ndt/gfn564; Oike Y, 2005, TRENDS MOL MED, V11, P473, DOI 10.1016/j.molmed.2005.08.002; Ozbay LA, 2012, BRIT J CLIN PHARMACO, V73, P536, DOI 10.1111/j.1365-2125.2011.04118.x; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Penninga L, 2010, EUR J CLIN PHARMACOL, V66, P1177, DOI 10.1007/s00228-010-0902-6; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Praga M, 2007, KIDNEY INT, V71, P924, DOI 10.1038/sj.ki.5002215; Presser D, 2009, KIDNEY INT, V76, P557, DOI 10.1038/ki.2009.198; Ronco P, 2012, NAT REV NEPHROL, V8, P203, DOI 10.1038/nrneph.2012.35; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Waldman M, 2012, J AM SOC NEPHROL, V23, P1617, DOI 10.1681/ASN.2012010058; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Zhang QX, 2012, AM J NEPHROL, V35, P312, DOI 10.1159/000337175	32	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106164	10.1371/journal.pone.0106164	http://dx.doi.org/10.1371/journal.pone.0106164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165975	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303700080
J	Shambat, SM; Haggar, A; Vandenesch, F; Lina, G; van Wamel, WJB; Arakere, G; Svensson, M; Norrby-Teglund, A				Shambat, Srikanth Mairpady; Haggar, Axana; Vandenesch, Francois; Lina, Gerard; van Wamel, Willem J. B.; Arakere, Gayathri; Svensson, Mattias; Norrby-Teglund, Anna			Levels of Alpha-Toxin Correlate with Distinct Phenotypic Response Profiles of Blood Mononuclear Cells and with agr Background of Community-Associated Staphylococcus aureus Isolates	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; VIRULENCE FACTORS; CYTOLYTIC PEPTIDES; IMMUNOGLOBULIN-G; IN-VITRO; SUPERANTIGENS; ANTIBODIES; DISEASE; MRSA; POPULATION	Epidemiological studies of Staphylococcus aureus have shown a relation between certain clones and the presence of specific virulence genes, but how this translates into virulence-associated functional responses is not fully elucidated. Here we addressed this issue by analyses of community-acquired S. aureus strains characterized with respect to antibiotic resistance, ST types, agr types, and virulence gene profiles. Supernatants containing exotoxins were prepared from overnight bacterial cultures, and tested in proliferation assays using human peripheral blood mononuclear cells (PBMC). The strains displayed stable phenotypic response profiles, defined by either a proliferative or cytotoxic response. Although, virtually all strains elicited superantigen-mediated proliferative responses, the strains with a cytotoxic profile induced proliferation only in cultures with the most diluted supernatants. This indicated that the superantigen-response was masked by a cytotoxic effect which was also confirmed by flow cytometry analysis. The cytotoxic supernatants contained significantly higher levels of alpha-toxin than did the proliferative supernatants. Addition of alpha-toxin to supernatants characterized as proliferative switched the response into cytotoxic profiles. In contrast, no effect of Panton Valentine Leukocidin, delta-toxin or phenol soluble modulin alpha-3 was noted in the proliferative assay. Furthermore, a significant association between agr type and phenotypic profile was found, where agrII and agrIII strains had predominantly a proliferative profile whereas agrI and IV strains had a predominantly cytotoxic profile. The differential response profiles associated with specific S. aureus strains with varying toxin production could possibly have an impact on disease manifestations, and as such may reflect specific pathotypes.	[Shambat, Srikanth Mairpady; Haggar, Axana; Svensson, Mattias; Norrby-Teglund, Anna] Karolinska Inst, Ctr Infect Med, Stockholm, Sweden; [Vandenesch, Francois; Lina, Gerard] Univ Lyon 1, Hosp Civils Lyon,LabEx Ecofect, Ecole Normale Super Lyon,Int Ctr Infectiol Res,In, Ctr Natl Reference Staphylocoques,CIRI,CNRS UMR53, F-69365 Lyon, France; [van Wamel, Willem J. B.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Arakere, Gayathri] Indian Inst Sci Campus, Soc Innovat & Dev, Bangalore, Karnataka, India	Karolinska Institutet; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Erasmus University Rotterdam; Erasmus MC	Norrby-Teglund, A (corresponding author), Karolinska Inst, Ctr Infect Med, Stockholm, Sweden.	anna.norrby-teglund@ki.se	Lina, Gerard J/L-9352-2014; Vandenesch, Francois/C-7209-2014	Vandenesch, Francois/0000-0001-9412-7106; Mairpady Shambat, Srikanth/0000-0002-0527-3978; Lina, Gerard/0000-0002-9236-7998; van Wamel, Willem/0000-0001-9145-9121; Svensson, Mattias/0000-0003-1695-7934	Karolinska Institutet; Swedish Research Council [521-2011-2540, 521-2009-3900]; Swedish Research Links Programme [348-2009-6501]; Knut and Alice Wallenberg Foundation; European Union; NPP; Hospices Civils de Lyon; INSERM	Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Links Programme; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Union(European Commission); NPP; Hospices Civils de Lyon; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from Karolinska Institutet (ANT), Swedish Research Council (521-2011-2540, ANT; 521-2009-3900 MS), The Swedish Research Links Programme (348-2009-6501; ANT & GA), Knut and Alice Wallenberg Foundation, European Union FP7 INFECT-project, NPP grant New INDIGO ERA Net, Hospices Civils de Lyon (GL, FV) and INSERM (GL, FV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo F, 2013, NATURE, V493, P51, DOI 10.1038/nature11724; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Badiou C, 2008, CLIN MICROBIOL INFEC, V14, P1180, DOI 10.1111/j.1469-0691.2008.02105.x; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Brosnahan AJ, 2009, J IMMUNOL, V182, P2364, DOI 10.4049/jimmunol.0803283; Collery MM, 2008, J MED MICROBIOL, V57, P348, DOI 10.1099/jmm.0.47734-0; Croze M, 2009, CLIN MICROBIOL INFEC, V15, P144, DOI 10.1111/j.1469-0691.2008.02650.x; Darenberg J, 2004, CLIN INFECT DIS, V38, P836, DOI 10.1086/381979; Deghorain M, 2012, VIRUSES-BASEL, V4, P3316, DOI 10.3390/v4123316; DuMont AL, 2014, TRENDS MICROBIOL, V22, P21, DOI 10.1016/j.tim.2013.10.004; Farag N, 2013, EUR J CLIN MICROBIOL, V32, P1149, DOI 10.1007/s10096-013-1861-5; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Gauduchon V, 2004, J INFECT DIS, V189, P346, DOI 10.1086/380909; Geisinger E, 2012, J BACTERIOL, V194, P2854, DOI 10.1128/JB.06685-11; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Hansenova Manaskova S, 2013, J IMMUNOL METHODS; Ide F, 2004, PEDIATR INT, V46, P337, DOI 10.1111/j.1442-200x.2004.01880.x; Jacobsson G, 2010, EUR J CLIN MICROBIOL, V29, P715, DOI 10.1007/s10096-010-0919-x; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kanclerski K, 1996, J MED MICROBIOL, V44, P171, DOI 10.1099/00222615-44-3-171; Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004; Malachowa N, 2010, CELL MOL LIFE SCI, V67, P3057, DOI 10.1007/s00018-010-0389-4; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Nishi JI, 1997, J IMMUNOL, V158, P247; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Rasigade JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063176; Shambat S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-64; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Strandberg KL, 2010, J INFECT DIS, V202, P1690, DOI 10.1086/657156; Szkaradkiewicz A, 2012, EUR J CLIN MICROBIOL, V31, P2809, DOI 10.1007/s10096-012-1633-7; TAKEI S, 1993, J CLIN INVEST, V91, P602, DOI 10.1172/JCI116240; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Vandenesch F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00012; Verkaik NJ, 2010, CLIN INFECT DIS, V50, P61, DOI 10.1086/648673; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Xu SX, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00052; 1999, MORB MORTAL WKLY REP, V48, P707	43	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106107	10.1371/journal.pone.0106107	http://dx.doi.org/10.1371/journal.pone.0106107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166615	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000341303700075
J	Espinal-Enriquez, J; Darszon, A; Guerrero, A; Martinez-Mekler, G				Espinal-Enriquez, Jesus; Darszon, Alberto; Guerrero, Adan; Martinez-Mekler, Gustavo			In Silico Determination of the Effect of Multi-Target Drugs on Calcium Dynamics Signaling Network Underlying Sea Urchin Spermatozoa Motility	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TUNING SPERM CHEMOTAXIS; RABBIT PORTAL-VEIN; NIFLUMIC ACID; ACTIVATED CHLORIDE; NONSELECTIVE CATION; POTASSIUM CURRENTS; ACROSOME REACTION; CATSPER CHANNEL; XENOPUS OOCYTES	The motility of spermatozoa of both Lytechinus pictus and Strongylocentrotus purpuratus sea urchin species is modulated by the egg-derived decapeptide speract via an oscillatory [Ca2+]-dependent signaling pathway. Comprehension of this pathway is hence directly related to the understanding of regulated sperm swimming. Niflumic acid (NFA), a nonsteroidal anti-inflammatory drug alters several ion channels. Though unspecific, NFA profoundly affects how sea urchin sperm respond to speract, increasing the [Ca2+](i) oscillation period, amplitude, peak and average level values of the responses in immobilized and swimming cells. A previous logical network model we developed for the [Ca2+] dynamics of speract signaling cascade in sea urchin sperm allows integrated dissection of individual and multiple actions of NFA. Among the channels affected by NFA are: hyperpolarization-activated and cyclic nucleotide gated Na+ channels (HCN), [Ca2+]dependent Cl- channels (CaCC) and [Ca2+]-dependent K+ channels (CaKC), all present in the sea urchin genome. Here, using our model we investigated the effect of blocking in silico HCN and CaCC channels suggested by experiments. Regarding CaKC channels, arguments can be provided for either their blockage or activation by NFA. Our study yielded two scenarios compliant with experimental observations: i) under CaKC inhibition, this [Ca2+]-dependent K+ channel should be different from the Slo1 channel and ii) under activation of the CaKC channel, another [Ca2+] channel not considered previously in the network is required, such as the pH-dependent CatSper channel. Additionally, our findings predict cause-effect relations resulting from a selective inhibition of those channels. Knowledge of these relations may be of consequence for a variety of electrophysiological studies and have an impact on drug related investigations. Our study contributes to a better grasp of the network dynamics and suggests further experimental work.	[Espinal-Enriquez, Jesus; Martinez-Mekler, Gustavo] Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62191, Morelos, Mexico; [Espinal-Enriquez, Jesus; Martinez-Mekler, Gustavo] Ctr Ciencias Complejidad, Mexico City, DF, Mexico; [Espinal-Enriquez, Jesus] Inst Nacl Med Genom, Arenal Tepepan, Tlalpan, Mexico; [Darszon, Alberto] Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62191, Morelos, Mexico; [Guerrero, Adan] Univ Nacl Autonoma Mexico, Inst Biotechnol, Lab Nacl Microscopi Avanzada, Cuernavaca 62191, Morelos, Mexico; [Martinez-Mekler, Gustavo] Ctr Int Ciencias, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Martinez-Mekler, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62191, Morelos, Mexico.	mekler@fis.unam.mx	Guerrero, Adán/I-4892-2013; Cardenas, Adan Oswaldo Guerrero/AAQ-9036-2021	Guerrero, Adán/0000-0002-4389-5516; Cardenas, Adan Oswaldo Guerrero/0000-0002-4389-5516; Martinez-Mekler, Gustavo/0000-0002-1192-9769; Darszon, Alberto/0000-0002-2502-0505	CONACyT; PDCB of UNAM; CONACyT [129471, 49113, 128566]; DGAPA-UNAM [IN211907, IN109210, IN112407, IN112514]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PDCB of UNAM; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico)	JE thanks CONACyT for a PhD Scolarship, as well as the PDCB of UNAM. This work is part of his PhD Thesis. All authors thank the following grants: CONACyT (129471, 49113, 128566) and DGAPA-UNAM (IN211907, IN109210, IN112407, IN112514). GMM and AD thank DGAPA-UNAM and CONACyT for sabbatical leave support and the hospitality of the University of Florence (GMM) and the Program of Cell Biology at the SickKids Hospital in Toronto (AD), where part of this investigation took place. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera LU, 2012, BIOPHYS J, V102, P2481, DOI 10.1016/j.bpj.2012.03.075; AKBARALI HI, 1993, J PHYSIOL-LONDON, V460, P117, DOI 10.1113/jphysiol.1993.sp019462; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alvarez L, 2012, J CELL BIOL, V196, P653, DOI 10.1083/jcb.201106096; BENTLEY JK, 1986, J BIOL CHEM, V261, P4859; Bohmer M, 2005, EMBO J, V24, P2741, DOI 10.1038/sj.emboj.7600744; Brenker C, 2012, EMBO J, V31, P1654, DOI 10.1038/emboj.2012.30; BUSCH AE, 1994, MOL PHARMACOL, V46, P750; Cheng L, 2009, MOL PHARMACOL, V75, P1210, DOI 10.1124/mol.108.054437; Darszon A, 2008, INT J DEV BIOL, V52, P595, DOI 10.1387/ijdb.072550ad; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Espinal J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022619; Espinosa F, 1998, FEBS LETT, V426, P47, DOI 10.1016/S0014-5793(98)00305-6; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; FARRUGIA G, 1993, AM J PHYSIOL, V265, pG873, DOI 10.1152/ajpgi.1993.265.5.G873; Fernandez D, 2008, MOL PHARMACOL, V73, P1159, DOI 10.1124/mol.107.043505; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; GOGELEIN H, 1990, FEBS LETT, V268, P79, DOI 10.1016/0014-5793(90)80977-Q; GREENWOOD IA, 1995, BRIT J PHARMACOL, V116, P2939, DOI 10.1111/j.1476-5381.1995.tb15948.x; Gribkoff VK, 1996, MOL PHARMACOL, V50, P206; GROVER GJ, 1994, J PHARMACOL EXP THER, V269, P536; Guerrero A, 2013, J CELL SCI; Guerrero A, 2010, BIOCHEM SOC T, V38, P1270, DOI 10.1042/BST0381270; Guerrero A, 2010, DEV BIOL, V344, P52, DOI 10.1016/j.ydbio.2010.04.013; HANSBROUGH JR, 1981, J BIOL CHEM, V256, P1447; HOGG RC, 1994, BRIT J PHARMACOL, V112, P977, DOI 10.1111/j.1476-5381.1994.tb13177.x; Hu HZ, 2010, PFLUG ARCH EUR J PHY, V459, P579, DOI 10.1007/s00424-009-0749-9; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; JANSSEN LJ, 1992, J PHYSIOL-LONDON, V453, P197, DOI 10.1113/jphysiol.1992.sp019224; Kashikar ND, 2012, J CELL BIOL, V198, P1075, DOI 10.1083/jcb.201204024; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Kaupp UB, 2003, NAT CELL BIOL, V5, P109, DOI 10.1038/ncb915; LEE HC, 1986, J BIOL CHEM, V261, P6026; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; Ll Li, 2008, Shengli Xuebao, V60, P743; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Nishigaki T, 2004, DEV BIOL, V272, P376, DOI 10.1016/j.ydbio.2004.04.035; Nishigaki T, 2001, BIOCHEM BIOPH RES CO, V284, P531, DOI 10.1006/bbrc.2001.5000; Okamura Y, 2005, PHYSIOL GENOMICS, V22, P269, DOI 10.1152/physiolgenomics.00229.2004; OTTOLIA M, 1994, BIOPHYS J, V67, P2272, DOI 10.1016/S0006-3495(94)80712-X; PACAUD P, 1989, PFLUG ARCH EUR J PHY, V413, P629, DOI 10.1007/BF00581813; Peretz A, 2005, MOL PHARMACOL, V67, P1053, DOI 10.1124/mol.104.007112; Rodriguez E, 2003, J PHYSIOL-LONDON, V546, P89, DOI 10.1113/jphysiol.2002.030510; Satoh TO, 2001, NEUROSCI RES, V40, P375, DOI 10.1016/S0168-0102(01)00252-8; Shiba K, 2005, ZOOL SCI, V22, P293, DOI 10.2108/zsj.22.293; Strunker T, 2006, NAT CELL BIOL, V8, P1149, DOI 10.1038/ncb1473; WARD GE, 1985, J CELL BIOL, V101, P2324, DOI 10.1083/jcb.101.6.2324; WHITE MM, 1990, MOL PHARMACOL, V37, P720; Wiemuth D, 2011, MOL PHARMACOL, V80, P911, DOI 10.1124/mol.111.073726; Wood CD, 2005, J CELL BIOL, V169, P725, DOI 10.1083/jcb.200411001; Wood CD, 2003, J CELL BIOL, V161, P89, DOI 10.1083/jcb.200212053; Wood CD, 2007, DEV BIOL, V306, P525, DOI 10.1016/j.ydbio.2007.03.036; Yang DL, 2013, EUR J MED CHEM, V63, P907, DOI 10.1016/j.ejmech.2013.02.029; Yoshida M, 2002, P NATL ACAD SCI USA, V99, P14831, DOI 10.1073/pnas.242470599	56	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e104451	10.1371/journal.pone.0104451	http://dx.doi.org/10.1371/journal.pone.0104451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162222	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900014
J	Qi, L; Zhu, F; Li, SH; Si, LB; Hu, LK; Tian, H				Qi, Lei; Zhu, Feng; Li, Shu-hai; Si, Li-bo; Hu, Li-kuan; Tian, Hui			Retinoblastoma Binding Protein 2 (RBP2) Promotes HIF-1 alpha-VEGF-Induced Angiogenesis of Non-Small Cell Lung Cancer via the Akt Pathway	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; HISTONE DEMETHYLASE RBP2; DOWN-REGULATION; EXPRESSION; TRANSCRIPTION; ALPHA; HIF-1; INHIBITION; PROGNOSIS; APOPTOSIS	Background: Pathological angiogenesis plays an essential role in tumor aggressiveness and leads to unfavorable prognosis. The aim of this study is to detect the potential role of Retinoblastoma binding protein 2 (RBP2) in the tumor angiogenesis of non-small cell lung cancer (NSCLC). Methods: Immunohistochemical staining was used to detect the expression of RBP2, hypoxia-inducible factor-1 alpha (HIF-1 alpha), vascular endothelial growth factor (VEGF) and CD34. Two pairs of siRNA sequences and pcDNA3-HA-RBP2 were used to down-regulate and up-regulate RBP2 expression in H1975 and SK-MES-1 cells. An endothelial cell tube formation assay, VEGF enzyme-linked immunosorbent assay, real-time PCR and western blotting were performed to detect the potential mechanisms mediated by RBP2 in tumor angiogenesis. Results: Of the 102 stage I NSCLC specimens analyzed, high RBP2 protein expression is closely associated with tumor size (P = 0.030), high HIF-1 alpha expression (P = 0.028), high VEGF expression (P = 0.048), increased tumor angiogenesis (P = 0.033) and poor prognosis (P = 0.037); high MVD was associated with high HIF-1 alpha expression (P = 0.034), high VEGF expression (P = 0.001) and poor prognosis (P = 0.040). Multivariate analysis indicated that RBP2 had an independent influence on the survival of patients with stage I NSCLC (P = 0.044). By modulating the expression of RBP2, our findings suggested that RBP2 protein depletion decreased HUVECs tube formation by down-regulating VEGF in a conditioned medium. RBP2 stimulated the up-regulation of VEGF, which was dependent on HIF-1 alpha, and activated the HIF-1 alpha via phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway. Moreover, VEGF increased the activation of Akt regulated by RBP2. Conclusions: The RBP2 protein may stimulate HIF-1 alpha expression via the activation of the PI3K/Akt signaling pathway under normoxia and then stimulate VEGF expression. These findings indicate that RBP2 may play a critical role in tumor angiogenesis and serve as an attractive therapeutic target against tumor aggressiveness for early-stage NSCLC patients.	[Qi, Lei; Li, Shu-hai; Si, Li-bo; Hu, Li-kuan; Tian, Hui] Shandong Univ, Qi Lu Hosp, Dept Thorac Surg, Jinan 250100, Shandong, Peoples R China; [Zhu, Feng] Shan Dong Prov Chest Hosp, Dept Thorac Surg, Jinan, Shandong, Peoples R China	Shandong University	Tian, H (corresponding author), Shandong Univ, Qi Lu Hosp, Dept Thorac Surg, Jinan 250100, Shandong, Peoples R China.	tianhuiy@sohu.com		Qi, Lei/0000-0002-5787-3772	National Natural Science Foundation of China [30571844]; Science and Technology Development Foundation of Shandong Province [2009GG10002007]; National Natural Science Foundation of Shandong Province [ZR2009CM090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Foundation of Shandong Province; National Natural Science Foundation of Shandong Province	The project was supported by the National Natural Science Foundation of China (No. 30571844), the Science and Technology Development Foundation of Shandong Province (No. 2009GG10002007), and the National Natural Science Foundation of Shandong Province (No. ZR2009CM090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Bolas G, 2014, TOXICON, V79, P45, DOI 10.1016/j.toxicon.2013.12.006; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Charpidou A, 2011, CANCER LETT, V304, P144, DOI 10.1016/j.canlet.2011.02.018; Cheng JC, 2013, CANCER LETT, V329, P197, DOI 10.1016/j.canlet.2012.10.029; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Crabb SJ, 2009, J CLIN ONCOL, V27, P404, DOI 10.1200/JCO.2008.16.2545; Crociani O, 2013, SCI REP-UK, V3, DOI 10.1038/srep03308; D'Amico Thomas A, 2004, Semin Thorac Cardiovasc Surg, V16, P13; Dayan F, 2008, CANCER MICROENVIRON, V1, P53, DOI 10.1007/s12307-008-0006-3; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gabhann FM, 2008, MICROCIRCULATION, V15, P715, DOI 10.1080/10739680802095964; Grimshaw MJ, 2007, ENDOCR-RELAT CANCER, V14, P233, DOI 10.1677/ERC-07-0057; Ha GH, 2013, CANCER LETT, V332, P63, DOI 10.1016/j.canlet.2013.01.013; Igarashi M, 1998, CANCER, V82, P1225, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1225::AID-CNCR3>3.0.CO;2-E; Jahangiri A, 2014, CANCER RES, V74, P3, DOI 10.1158/0008-5472.CAN-13-1742; Jamison J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093968; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kalhori V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066189; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim CH, 2002, CIRC RES, V90, pE25, DOI 10.1161/hh0202.104923; Kim SM, 2014, PHYTOTHER RES, V28, P423, DOI 10.1002/ptr.5010; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Lee DY, 2010, J BIOL CHEM, V285, P30, DOI 10.1074/jbc.M109.010512; Lin JC, 2012, EMBO MOL MED, V4, P472, DOI 10.1002/emmm.201200222; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda A, 2013, ONCOL REP, V29, P39, DOI 10.3892/or.2012.2075; Malhotra R, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-9; Moreno-Layseca P, 2014, MATRIX BIOL, V34, P144, DOI 10.1016/j.matbio.2013.10.011; Nakamura M, 2009, VIROLOGY, V387, P442, DOI 10.1016/j.virol.2009.02.036; Park S, 2011, LUNG CANCER, V72, P100, DOI 10.1016/j.lungcan.2010.08.005; Pisters KMW, 2007, J CLIN ONCOL, V25, P5506, DOI 10.1200/JCO.2007.14.1226; Poettler M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-169; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Riddell JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050394; Rovina N, 2011, CYTOKINE, V54, P277, DOI 10.1016/j.cyto.2011.02.014; Saponaro C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053070; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shijubo N, 2003, MICROSC RES TECHNIQ, V60, P186, DOI 10.1002/jemt.10257; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Tanigawa N, 1996, CANCER RES, V56, P2671; Teng YC, 2013, CANCER RES, V73, P4711, DOI 10.1158/0008-5472.CAN-12-3165; Thamilselvan V, 2007, FASEB J, V21, P1730, DOI 10.1096/fj.06-6545com; Trisciuoglio D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011772; Vamesu S, 2008, ROM J MORPHOL EMBRYO, V49, P181; Vermeulen PB, 2002, EUR J CANCER, V38, P1564, DOI 10.1016/S0959-8049(02)00094-1; Vermeulen PB, 2010, CANCER-AM CANCER SOC, V116, P2748, DOI 10.1002/cncr.25169; Wang SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084735; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Zeng JP, 2010, GASTROENTEROLOGY, V138, P981, DOI 10.1053/j.gastro.2009.10.004	57	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106032	10.1371/journal.pone.0106032	http://dx.doi.org/10.1371/journal.pone.0106032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162518	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900079
J	Raabe, RC; Mathies, LD; Davies, AG; Bettinger, JC				Raabe, Richard C.; Mathies, Laura D.; Davies, Andrew G.; Bettinger, Jill C.			The Omega-3 Fatty Acid Eicosapentaenoic Acid Is Required for Normal Alcohol Response Behaviors in C. elegans	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; NATIONAL EPIDEMIOLOGIC SURVEY; MAJOR DEPRESSIVE DISORDER; VENTRAL TEGMENTAL AREA; CAENORHABDITIS-ELEGANS; SYNAPTIC-TRANSMISSION; DEPENDENT REGULATION; POTASSIUM CHANNELS; ETHANOL; PALMITOYLATION	Alcohol addiction is a widespread societal problem, for which there are few treatments. There are significant genetic and environmental influences on abuse liability, and understanding these factors will be important for the identification of susceptible individuals and the development of effective pharmacotherapies. In humans, the level of response to alcohol is strongly predictive of subsequent alcohol abuse. Level of response is a combination of counteracting responses to alcohol, the level of sensitivity to the drug and the degree to which tolerance develops during the drug exposure, called acute functional tolerance. We use the simple and well-characterized nervous system of Caenorhabditis elegans to model the acute behavioral effects of ethanol to identify genetic and environmental factors that influence level of response to ethanol. Given the strong molecular conservation between the neurobiological machinery of worms and humans, cellular-level effects of ethanol are likely to be conserved. Increasingly, variation in long-chain polyunsaturated fatty acid levels has been implicated in complex neurobiological phenotypes in humans, and we recently found that fatty acid levels modify ethanol responses in worms. Here, we report that 1) eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, is required for the development of acute functional tolerance, 2) dietary supplementation of eicosapentaenoic acid is sufficient for acute tolerance, and 3) dietary eicosapentaenoic acid can alter the wild-type response to ethanol. These results suggest that genetic variation influencing long-chain polyunsaturated fatty acid levels may be important abuse liability loci, and that dietary polyunsaturated fatty acids may be an important environmental modulator of the behavioral response to ethanol.	[Raabe, Richard C.; Mathies, Laura D.; Davies, Andrew G.; Bettinger, Jill C.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Davies, Andrew G.; Bettinger, Jill C.] Virginia Commonwealth Univ, VCU Alcohol Res Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Bettinger, JC (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	jcbettinger@vcu.edu	Davies, Andrew G/AAY-3567-2020		National Institutes of Health (NIH) [R01 AA016837, 5T32DA007027-38]; Direct For Biological Sciences [1314144] Funding Source: National Science Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007027] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (NIH) R01 AA016837 (JCB) and 5T32DA007027-38 (RCR). The content of this work is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaimo JT, 2012, ALCOHOL CLIN EXP RES, V36, P1840, DOI 10.1111/j.1530-0277.2012.01799.x; Barbadoro P, 2013, MOL NUTR FOOD RES, V57, P1110, DOI 10.1002/mnfr.201200676; Bettinger JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035192; Bhandari P, 2012, GENES BRAIN BEHAV, V11, P387, DOI 10.1111/j.1601-183X.2012.00765.x; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; Davies AG, 2004, NEURON, V42, P731, DOI 10.1016/j.neuron.2004.05.004; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Fan YY, 2003, J NUTR, V133, P1913, DOI 10.1093/jn/133.6.1913; GESSA GL, 1985, BRAIN RES, V348, P201, DOI 10.1016/0006-8993(85)90381-6; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Heath AC, 1999, PSYCHOL MED, V29, P1069, DOI 10.1017/S0033291799008909; Jeffries O, 2010, J BIOL CHEM, V285, P33307, DOI 10.1074/jbc.M110.153940; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; Kalu N, 2012, ALCOHOL CLIN EXP RES, V36, P522, DOI 10.1111/j.1530-0277.2011.01699.x; Kapfhamer D, 2008, GENES BRAIN BEHAV, V7, P669, DOI 10.1111/j.1601-183X.2008.00404.x; Kosel M, 2011, BIOCHEM J, V435, P689, DOI 10.1042/BJ20101942; Kulas J, 2008, ARCH BIOCHEM BIOPHYS, V472, P65, DOI 10.1016/j.abb.2008.02.002; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Lesa GM, 2003, J CELL SCI, V116, P4965, DOI 10.1242/jcs.00918; Lof E, 2007, PSYCHOPHARMACOLOGY, V195, P333, DOI 10.1007/s00213-007-0899-4; Ma DKK, 2013, SCIENCE, V341, P554, DOI 10.1126/science.1235753; Maes M, 1999, PSYCHIAT RES, V85, P275, DOI 10.1016/S0165-1781(99)00014-1; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; MARTINEZ M, 1992, BRAIN RES, V583, P171, DOI 10.1016/S0006-8993(10)80021-6; MARTINEZ M, 1988, J NEUROSCI RES, V20, P484, DOI 10.1002/jnr.490200412; Marza E, 2008, MOL BIOL CELL, V19, P833, DOI 10.1091/mbc.E07-07-0719; Molander A, 2007, ALCOHOL ALCOHOLISM, V42, P11, DOI 10.1093/alcalc/ag1085; NEWLIN DB, 1990, PSYCHOL BULL, V108, P383, DOI 10.1037/0033-2909.108.3.383; Parajuli SP, 2014, EUR J PHARMACOL, V738, P179, DOI 10.1016/j.ejphar.2014.05.042; Peet M, 1998, BIOL PSYCHIAT, V43, P315, DOI 10.1016/S0006-3223(97)00206-0; Ponomarev I, 2002, J PHARMACOL EXP THER, V302, P257, DOI 10.1124/jpet.302.1.257; Prescott CA, 1999, AM J PSYCHIAT, V156, P34, DOI 10.1176/ajp.156.1.34; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Schuckit MA, 1996, ARCH GEN PSYCHIAT, V53, P202; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; Spychalla JP, 1997, P NATL ACAD SCI USA, V94, P1142, DOI 10.1073/pnas.94.4.1142; Sublette ME, 2014, INT J NEUROPSYCHOPH, V17, P383, DOI 10.1017/S1461145713001399; Superko HR, 2013, CIRCULATION, V128, P2154, DOI 10.1161/CIRCULATIONAHA.113.002731; Thiele TE, 2003, PHYSIOL BEHAV, V79, P95, DOI 10.1016/S0031-9384(03)00109-4; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Treistman SN, 2009, TRENDS NEUROSCI, V32, P629, DOI 10.1016/j.tins.2009.08.001; Vasquez V, 2014, CELL REP, V6, P70, DOI 10.1016/j.celrep.2013.12.012; Volavka J, 1996, ARCH GEN PSYCHIAT, V53, P258; Vrablik TL, 2013, MOL REPROD DEV, V80, P244, DOI 10.1002/mrd.22167; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 1999, ARCH BIOCHEM BIOPHYS, V362, P175, DOI 10.1006/abbi.1998.1024; Watts JL, 2003, GENETICS, V163, P581; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Young-Wolff KC, 2011, CLIN PSYCHOL REV, V31, P800, DOI 10.1016/j.cpr.2011.03.005; Yuan C, 2008, J BIOL CHEM, V283, P5090, DOI 10.1074/jbc.M708214200; Yuan CB, 2007, J BIOL CHEM, V282, P7276, DOI 10.1074/jbc.M607593200; Yuan CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027572	58	24	24	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105999	10.1371/journal.pone.0105999	http://dx.doi.org/10.1371/journal.pone.0105999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162400	Green Submitted, Green Published, gold			2022-12-25	WOS:000340880900071
J	Boeer, U; Buettner, FFR; Klingenberg, M; Antonopoulos, GC; Meyer, H; Haverich, A; Wilhelmi, M				Boeer, Ulrike; Buettner, Falk F. R.; Klingenberg, Melanie; Antonopoulos, Georgios C.; Meyer, Heiko; Haverich, Axel; Wilhelmi, Mathias			Immunogenicity of Intensively Decellularized Equine Carotid Arteries Is Conferred by the Extracellular Matrix Protein Collagen Type VI	PLOS ONE			English	Article							XENOGENEIC SCAFFOLD GENERATION; PEDIATRIC-PATIENTS; INDUCED ARTHRITIS; ANTIGEN REMOVAL; IMMUNE-RESPONSE; EARLY FAILURE; COMPONENTS; TISSUES	The limited biocompatibility of decellularized scaffolds is an ongoing challenge in tissue engineering. Here, we demonstrate the residual immunogenicity of an extensively decellularized equine carotid artery (dEAC(intens)) and identify the involved immunogenic components. EAC were submitted to an elaborated intensified decellularization protocol with SDS/sodium desoxycholate for 72 h using increased processing volumes (dEAC(intens)), and compared to dEAC(ord) prepared by an ordinary protocol (40 h, normal volumes). Matrix integrity was checked via correlative volumetric visualization which revealed only minor structural changes in the arterial wall. In dEAC(intens), a substantial depletion of cellular components was obvious for smooth muscle actin (100%), MHC I complexes (97.8%), alphaGal epitops (98.4% and 91.3%) and for DNA (final concentration of 0.34 +/- 0.16 ng/mg tissue). However, dEAC(intens) still evoked antibody formation in mice after immunization with dEAC(intens) extracts, although to a lower extent than dEAC(ord). Mouse plasma antibodies recognized a 140 kDa band which was revealed to contain collagen VI alpha1 and alpha2 chains via mass spectrometry of both 2D electrophoretically separated and immunoprecipitated proteins. Thus, even the complete removal of cellular proteins did not yield non-immunogenic dEAC as the extracellular matrix still conferred immunogenicity by collagen VI. However, as lower antibody levels were achieved by the intensified decellularization protocol, this seems to be a promising basis for further development.	[Boeer, Ulrike; Klingenberg, Melanie; Haverich, Axel; Wilhelmi, Mathias] GMP Model Lab Tissue Engn, Hannover, Germany; [Boeer, Ulrike; Klingenberg, Melanie; Meyer, Heiko; Haverich, Axel; Wilhelmi, Mathias] Hannover Med Sch, Div Cardiac Thoracic Transplantat & Vasc Surg, Hannover, Germany; [Buettner, Falk F. R.] Hannover Med Sch, Dept Cellular Chem, Hannover, Germany; [Antonopoulos, Georgios C.; Meyer, Heiko] Laser Zentrum Hannover EV, Biomed Opt Dept, Hannover, Germany	Hannover Medical School; Hannover Medical School	Boeer, U (corresponding author), GMP Model Lab Tissue Engn, Hannover, Germany.	boeer.ulrike@mh-hannover.de	Haverich, Axel/AAC-7552-2022		"Else Kroener-Fresenius foundation'', Germany [2012-A58]; Federal Ministry of Education and Research [13N12605]	"Else Kroener-Fresenius foundation'', Germany; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The work was funded by the "Else Kroener-Fresenius foundation'', Germany (project number 2012-A58). SLOT was funded by the Federal Ministry of Education and Research (project number 13N12605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016; Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003; Boer U, 2013, TISSUE ENG PT A, V19, P1829, DOI [10.1089/ten.tea.2012.0558, 10.1089/ten.TEA.2012.0558]; Boer U, 2011, BIOMATERIALS, V32, P9730, DOI 10.1016/j.biomaterials.2011.09.015; Buettner FFR, 2009, PROTEOMICS, V9, P2383, DOI 10.1002/pmic.200800439; CHUNG E, 1976, BIOCHEM BIOPH RES CO, V71, P1167, DOI 10.1016/0006-291X(76)90776-2; Cicha I, 2011, CARDIOVASC PATHOL, V20, P222, DOI 10.1016/j.carpath.2010.04.006; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Dingemans KP, 2000, ANAT REC, V258, P1; ENGEL J, 1985, ANN NY ACAD SCI, V460, P25, DOI 10.1111/j.1749-6632.1985.tb51154.x; Fitzgerald J, 2013, CONNECT TISSUE RES, V54, P345, DOI 10.3109/03008207.2013.822865; GAY S, 1988, ARCH DERMATOL RES, V280, P333, DOI 10.1007/BF00426610; Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Koch C, 1996, APMIS, V104, P115, DOI 10.1111/j.1699-0463.1996.tb00696.x; Koenneker S, 2010, EUR J VASC ENDOVASC, V40, P810, DOI 10.1016/j.ejvs.2010.04.023; Lucchese Guglielmo, 2012, Front Biosci (Elite Ed), V4, P1843; Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Myers LK, 2004, AM J MED SCI, V327, P212, DOI 10.1097/00000441-200404000-00007; Myers LK, 2002, ARTHRITIS RHEUM-US, V46, P1086, DOI 10.1002/art.10163; Rabilloud T, 1999, METH MOL B, V112, P297; Ruffer A, 2010, EUR J CARDIO-THORAC, V38, P78, DOI 10.1016/j.ejcts.2010.01.044; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0; Takahashi H, 2013, ALLERGY; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Wong ML, 2014, ACTA BIOMATER, V10, P1806, DOI 10.1016/j.actbio.2014.01.028; Wong ML, 2013, ACTA BIOMATER, V9, P6492, DOI 10.1016/j.actbio.2012.12.034; Yang YG, 2007, NAT REV IMMUNOL, V7, P519, DOI 10.1038/nri2099	31	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105964	10.1371/journal.pone.0105964	http://dx.doi.org/10.1371/journal.pone.0105964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157402	Green Submitted, gold, Green Published			2022-12-25	WOS:000341303200082
J	Nakajima, A; Negishi, N; Tsurui, H; Kadowaki-Ohtsuji, N; Maeda, K; Nanno, M; Yamaguchi, Y; Shimizu, N; Yagita, H; Okumura, K; Habu, S				Nakajima, Akihito; Negishi, Naoko; Tsurui, Hiromichi; Kadowaki-Ohtsuji, Naomi; Maeda, Keiko; Nanno, Masanobu; Yamaguchi, Yoshitaka; Shimizu, Nobuyoshi; Yagita, Hideo; Okumura, Ko; Habu, Sonoko			Commensal Bacteria Regulate Thymic Aire Expression	PLOS ONE			English	Article							EPITHELIAL-CELLS; T-CELLS; RECOGNITION; NOD1; DIFFERENTIATION; PEPTIDOGLYCAN; ESTABLISHMENT; MICROBIOTA; RECEPTORS	Commensal bacteria in gastrointestinal tracts are reported to function as an environmental factor to regulate intestinal inflammation and immune responses. However, it remains largely unknown whether such bacterial function exerts any effect on other immune organs distant from the intestine. In this study, the influence of commensal bacteria in the thymus, where T cell lineages develop into mature type to form proper repertoires, was investigated using germ-free (GF) mice and Nod1-deficient mice lacking an intracellular recognition receptor for certain bacterial components, in which a commensal bacterial effect is predicted to be less. In both mice, there was no significant difference in the numbers and subset ratios of thymocytes. Interestingly, however, autoimmune regulator (Aire) expression in thymic epithelial cells (TECs), main components of the thymic microenvironment, was decreased in comparison to specific pathogen-free (SPF) mice and Nod1 wild-type (WT) mice, respectively. In vitro analysis using a fetal thymus organ culture (FTOC) system showed that Aire expression in TECs was increased in the presence of a bacterial component or a bacterial product. These results suggest that through their products, commensal bacteria have the potential to have some effect on epithelial cells of the thymus in tissues distant from the intestine where they are originally harbored.	[Nakajima, Akihito; Negishi, Naoko; Yagita, Hideo; Okumura, Ko; Habu, Sonoko] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 113, Japan; [Tsurui, Hiromichi; Kadowaki-Ohtsuji, Naomi] Juntendo Univ, Sch Med, Dept Pathol, Bunkyo Ku, Tokyo 113, Japan; [Maeda, Keiko; Okumura, Ko] Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, Tokyo 113, Japan; [Nanno, Masanobu] Yakult Cent Inst Microbiol Res, Kunitachi, Tokyo 186, Japan; [Yamaguchi, Yoshitaka; Shimizu, Nobuyoshi] Keio Univ, Adv Res Ctr Genome Super Power, Tsukuba, Ibaraki, Japan	Juntendo University; Juntendo University; Juntendo University; Yakult Honsha Company, Limited; Keio University	Habu, S (corresponding author), Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 113, Japan.	sonoko-h@juntendo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21390154, 23390260, 25860818]; Yakult -Bio-Science foundation; Grants-in-Aid for Scientific Research [25860818] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yakult -Bio-Science foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part a Grant-in-Aid for Scientific Research (B) (SH; 21390154), a Grant-in-Aid for Scientific Research (B) (KO; 23390260), and a Grant-in-Aid for Scientific Research Young Scientist (B) (AN; 25860818) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jsps.go.jp/english/e-grants/), and the Yakult -Bio-Science foundation (http://yakult-bioscience.or.jp/index.html) for AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hozumi K, 1998, EUR J IMMUNOL, V28, P1368, DOI 10.1002/(SICI)1521-4141(199804)28:04&lt;1368::AID-IMMU1368&gt;3.0.CO;2-B; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Ivanov II, 2011, CURR OPIN MICROBIOL, V14, P106, DOI 10.1016/j.mib.2010.12.003; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Villasenor J, 2008, P NATL ACAD SCI USA, V105, P15854, DOI 10.1073/pnas.0808069105; Yano M, 2008, J EXP MED, V205, P2827, DOI 10.1084/jem.20080046; Zhu MZ, 2006, J CLIN INVEST, V116, P2964, DOI 10.1172/JCI28326	21	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105904	10.1371/journal.pone.0105904	http://dx.doi.org/10.1371/journal.pone.0105904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157574	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200075
J	Perez, E; Das, G; Bergmann, A; Baehrecke, EH				Perez, E.; Das, G.; Bergmann, A.; Baehrecke, E. H.			Autophagy regulates tissue overgrowth in a context-dependent manner	ONCOGENE			English	Article							CELL-DEATH; GROWTH ARREST; DROSOPHILA; CANCER; RAS; EXPRESSION; TUMORS; NOTCH; PROLIFERATION; TUMORIGENESIS	Autophagy is a catabolic process that has been implicated both as a tumor suppressor and in tumor progression. Here, we investigate this dichotomy in cancer biology by studying the influence of altered autophagy in Drosophila models of tissue overgrowth. We find that the impact of altered autophagy depends on both genotype and cell type. As previously observed in mammals, decreased autophagy suppresses Ras-induced eye epithelial overgrowth. In contrast, autophagy restricts epithelial overgrowth in a Notch-dependent eye model. Even though decreased autophagy did not influence Hippo pathway-triggered overgrowth, activation of autophagy strongly suppresses this eye epithelial overgrowth. Surprisingly, activation of autophagy enhanced Hippo pathway-driven overgrowth in glia cells. These results indicate that autophagy has different influences on tissue growth in distinct contexts, and highlight the importance of understanding the influence of autophagy on growth to augment a rationale therapeutic strategy.	[Perez, E.; Das, G.; Bergmann, A.; Baehrecke, E. H.] Univ Massachusetts, Dept Canc Biol, Sch Med, Worcester, MA 01505 USA	University of Massachusetts System; University of Massachusetts Worcester	Baehrecke, EH (corresponding author), Univ Massachusetts, Dept Canc Biol, Sch Med, 364 Plantat St, Worcester, MA 01505 USA.	Andreas.Bergmann@umassmed.edu; Eric.Baehrecke@umassmed.edu		Bergmann, Andreas/0000-0002-9134-871X	NIH [GM068016, CA159314]; NATIONAL CANCER INSTITUTE [R01CA159314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068016] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T Chang, M Dominguez, M Freeman, G Halder, G Juhasz, M Kango-Singh, TP Neufeld, the Bloomington Stock Center, the VDRC for flies and antibodies, J Lindblad, C Nelson and T Fortier for technical support, and the Bergmann and Baehrecke labs for constructive comments. This work was supported by NIH grants GM068016 to AB and CA159314 to EHB. EHB is an Ellison Medical Foundation Scholar.	Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; BOS JL, 1989, CANCER RES, V49, P4682; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Chang TK, 2013, NAT CELL BIOL, V15, P1067, DOI 10.1038/ncb2804; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chen CL, 2012, P NATL ACAD SCI USA, V109, P484, DOI 10.1073/pnas.1113882109; Dutta S, 2008, CURR BIOL, V18, P1466, DOI 10.1016/j.cub.2008.08.052; Elsum I, 2012, ESSAYS BIOCHEM, V53, P141, DOI [10.1042/bse0530141, 10.1042/BSE0530141]; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Karim FD, 1998, DEVELOPMENT, V125, P1; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; McPhee CK, 2009, BBA-MOL CELL RES, V1793, P1452, DOI 10.1016/j.bbamcr.2009.02.009; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pircs K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044214; Rao S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4056; Reddy BVVG, 2011, DEVELOPMENT, V138, P5201, DOI 10.1242/dev.069385; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Rudrapatna VA, 2012, DEV DYNAM, V241, P107, DOI 10.1002/dvdy.22771; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shravage BV, 2013, DEVELOPMENT, V140, P1321, DOI 10.1242/dev.089490; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tipping M, 2014, J CELL PHYSIOL, V229, P27, DOI 10.1002/jcp.24427; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	41	29	30	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	26					3369	3376		10.1038/onc.2014.285	http://dx.doi.org/10.1038/onc.2014.285			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CL3SU	25174403	Bronze, Green Accepted			2022-12-25	WOS:000356871700003
J	Gonzalez-Chavarria, I; Cerro, RP; Parra, NP; Sandoval, FA; Zuniga, FA; Omazabal, VA; Lamperti, LI; Jimenez, SP; Fernandez, EA; Gutierrez, NA; Rodriguez, FS; Onate, SA; Sanchez, O; Vera, JC; Toledo, JR				Gonzalez-Chavarria, Ivan; Cerro, Rita P.; Parra, Natalie P.; Sandoval, Felipe A.; Zuniga, Felipe A.; Omazabal, Valeska A.; Lamperti, Liliana I.; Jimenez, Silvana P.; Fernandez, Edelmira A.; Gutierrez, Nicolas A.; Rodriguez, Federico S.; Onate, Sergio A.; Sanchez, Oliberto; Vera, Juan C.; Toledo, Jorge R.			Lectin-Like Oxidized LDL Receptor-1 Is an Enhancer of Tumor Angiogenesis in Human Prostate Cancer Cells	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ENDOTHELIAL GROWTH-FACTOR; CHORIOALLANTOIC MEMBRANE; EXPRESSION; OBESITY; LOX-1; MODEL; PROGRESSION; ACTIVATION	Altered expression and function of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) has been associated with several diseases such as endothelial dysfunction, atherosclerosis and obesity. In these pathologies, oxLDL/LOX-1 activates signaling pathways that promote cell proliferation, cell motility and angiogenesis. Recent studies have indicated that olr1 mRNA is over-expressed in stage III and IV of human prostatic adenocarcinomas. However, the function of LOX-1 in prostate cancer angiogenesis remains to be determined. Our aim was to analyze the contribution of oxLDL and LOX-1 to tumor angiogenesis using C4-2 prostate cancer cells. We analyzed the expression of pro-angiogenic molecules and angiogenesis on prostate cancer tumor xenografts, using prostate cancer cell models with overexpression or knockdown of LOX-1 receptor. Our results demonstrate that the activation of LOX-1 using oxLDL increases cell proliferation, and the expression of the pro-angiogenic molecules VEGF, MMP-2, and MMP-9 in a dose-dependent manner. Noticeably, these effects were prevented in the C4-2 prostate cancer model when LOX-1 expression was knocked down. The angiogenic effect of LOX-1 activated with oxLDL was further demonstrated using the aortic ring assay and the xenograft model of tumor growth on chorioallantoic membrane of chicken embryos. Consequently, we propose that LOX-1 activation by oxLDL is an important event that enhances tumor angiogenesis in human prostate cancer cells.	[Gonzalez-Chavarria, Ivan; Cerro, Rita P.; Parra, Natalie P.; Sandoval, Felipe A.; Jimenez, Silvana P.; Fernandez, Edelmira A.; Gutierrez, Nicolas A.; Rodriguez, Federico S.; Vera, Juan C.; Toledo, Jorge R.] Univ Concepcion, Biotechnol & Biopharmaceut Lab, Dept Pathophysiol, Sch Biol Sci, Concepcion, Chile; [Zuniga, Felipe A.; Lamperti, Liliana I.] Univ Concepcion, Sch Pharm, Dept Clin Biochem & Immunol, Concepcion, Chile; [Omazabal, Valeska A.] Univ Catolica Santisima Concepcion, Fac Med, Dept Basic Sci, Concepcion, Chile; [Onate, Sergio A.] Univ Concepcion, Sch Med, Translat Res Unit, Concepcion, Chile; [Sanchez, Oliberto] Univ Concepcion, Sch Biol Sci, Dept Pharmacol, Concepcion, Chile	Universidad de Concepcion; Universidad de Concepcion; Universidad Catolica de la Santisima Concepcion; Universidad de Concepcion; Universidad de Concepcion	Toledo, JR (corresponding author), Univ Concepcion, Biotechnol & Biopharmaceut Lab, Dept Pathophysiol, Sch Biol Sci, Concepcion, Chile.	jotoledo@udec.cl	Zuniga, Felipe/Q-8035-2019; Jiménez, Silvana/AAS-4242-2021; Zuniga, Felipe A/L-7885-2013	Jiménez, Silvana/0000-0002-7675-1666; Zuniga, Felipe A./0000-0003-0286-565X; Sanchez, Oliberto/0000-0002-9744-8674; Toledo, Jorge R./0000-0002-9879-7710	Fondecyt [1121159]; Conicyt, Chile	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This research was supported by Fondecyt Grant 1121159, Conicyt, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allijn IE, 2013, ACS NANO, V7, P9761, DOI 10.1021/nn403258w; [Anonymous], 2011, Harv Mens Health Watch, V15, P6; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen MJ, 2002, PHARMACOL THERAPEUT, V95, P89, DOI 10.1016/S0163-7258(02)00236-X; Chen XP, 2007, CHINESE MED J-PEKING, V120, P421, DOI 10.1097/00029330-200703010-00015; Chen YF, 2001, INT J CANCER, V91, P41, DOI 10.1002/1097-0215(20010101)91:1<41::AID-IJC1009>3.0.CO;2-2; Dandapat A, 2007, ARTERIOSCL THROM VAS, V27, P2435, DOI 10.1161/ATVBAHA.107.152272; DiPietro LA, 2013, CURR OPIN RHEUMATOL, V25, P87, DOI 10.1097/BOR.0b013e32835b13b6; Dunn S, 2008, BIOCHEM J, V409, P349, DOI 10.1042/BJ20071196; Durupt F, 2012, CANCER GENE THER, V19, P58, DOI 10.1038/cgt.2011.68; Fiaschi Tania, 2012, Int J Cell Biol, V2012, P762825, DOI 10.1155/2012/762825; Garbin U, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/367590; Golabek T, 2013, UROL INT; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hsu IR, 2007, AM J CLIN NUTR, V86, p867S, DOI 10.1093/ajcn/86.3.867S; Hu CP, 2008, J BIOL CHEM, V283, P10226, DOI 10.1074/jbc.M708820200; Hu CP, 2007, HYPERTENSION, V50, P952, DOI 10.1161/HYPERTENSIONAHA.107.096446; Inomata Y, 2009, INVEST OPHTH VIS SCI, V50, P3970, DOI 10.1167/iovs.07-1177; Kanata S, 2006, BIOCHEM BIOPH RES CO, V348, P1003, DOI 10.1016/j.bbrc.2006.07.133; Kapoor Prakhar, 2012, J Oral Maxillofac Pathol, V16, P330, DOI 10.4103/0973-029X.102478; Khaidakov M, 2012, PLOS ONE, V7; Khaidakov M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020277; LeRoith D, 2008, EXP CLIN ENDOCR DIAB, V116, pS4, DOI 10.1055/s-2008-1081488; Li DY, 2002, AM J PHYSIOL-HEART C, V283, pH1795, DOI 10.1152/ajpheart.00382.2002; Li H, 2013, CELL BIOCHEM BIOPHYS, V67, P635, DOI 10.1007/s12013-013-9552-5; Lissbrant IF, 1997, PROSTATE, V33, P38; Llaverias G, 2010, AM J PATHOL, V177, P3180, DOI 10.2353/ajpath.2010.100568; Moserle L, 2012, J INTERN MED; Norris AL, 2011, OBESITY, V19, P1415, DOI 10.1038/oby.2011.21; Park J, 2013, BJU INT; Pelton K, 2012, CURR OPIN PHARMACOL, V12, P751, DOI 10.1016/j.coph.2012.07.006; Pettersson A, 2013, JNCI-J NATL CANCER I, V105, P1881, DOI 10.1093/jnci/djt332; Pischon T, 2008, P NUTR SOC, V67, P128, DOI 10.1017/S0029665108006976; Ribatti D, 2008, ROM J MORPHOL EMBRYO, V49, P131; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Sugimoto K, 2009, CARDIOVASC RES, V84, P127, DOI 10.1093/cvr/cvp177; Tewari R, 2013, CYTOKINE, V63, P130, DOI 10.1016/j.cyto.2013.04.008; THALMANN GN, 1994, CANCER RES, V54, P2577; Tzeng HE, 2013, BIOCHEM PHARMACOL, V85, P531, DOI 10.1016/j.bcp.2012.11.021; WEIDNER N, 1993, AM J PATHOL, V143, P401; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Yamada Y, 1998, CELL MOL LIFE SCI, V54, P628, DOI 10.1007/s000180050191; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yoshida H, 1999, J LIPID RES, V40, P814; Yoshimoto R, 2011, CARDIOVASC DRUG THER, V25, P379, DOI 10.1007/s10557-011-6324-6; Zeman M, 2005, Cas Lek Cesk, V144, P737	49	34	34	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106219	10.1371/journal.pone.0106219	http://dx.doi.org/10.1371/journal.pone.0106219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170920	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500127
J	Jackson, C; Aabel, P; Eidet, JR; Messelt, EB; Lyberg, T; von Unge, M; Utheim, TP				Jackson, Catherine; Aabel, Peder; Eidet, Jon R.; Messelt, Edward B.; Lyberg, Torstein; von Unge, Magnus; Utheim, Tor P.			Effect of Storage Temperature on Cultured Epidermal Cell Sheets Stored in Xenobiotic-Free Medium	PLOS ONE			English	Article							LIMBAL EPITHELIAL-CELLS; HUMAN SKIN ALLOGRAFTS; SPLIT-THICKNESS SKIN; LONG-TERM VIABILITY; ADULT STEM-CELLS; HUMAN KERATINOCYTES; COLD-STORAGE; CRYOPRESERVATION; TRANSPLANTATION; GROWTH	Cultured epidermal cell sheets (CECS) are used in regenerative medicine in patients with burns, and have potential to treat limbal stem cell deficiency (LSCD), as demonstrated in animal models. Despite widespread use, short-term storage options for CECS are limited. Advantages of storage include: flexibility in scheduling surgery, reserve sheets for repeat operations, more opportunity for quality control, and improved transportation to allow wider distribution. Studies on storage of CECS have thus far focused on cryopreservation, whereas refrigeration is a convenient method commonly used for whole skin graft storage in burns clinics. It has been shown that preservation of viable cells using these methods is variable. This study evaluated the effect of different temperatures spanning 4 degrees C to 37 degrees C, on the cell viability, morphology, proliferation and metabolic status of CECS stored over a two week period in a xenobiotic-free system. Compared to non-stored control, best cell viability was obtained at 24 degrees C (95.2 +/- 9.9%); reduced cell viability, at approximately 60%, was demonstrated at several of the temperatures (12 degrees C, 28 degrees C, 32 degrees C and 37 degrees C). Metabolic activity was significantly higher between 24 degrees C and 37 degrees C, where glucose, lactate, lactate/glucose ratios, and oxygen tension indicated increased activation of the glycolytic pathway under aerobic conditions. Preservation of morphology as shown by phase contrast and scanning electron micrographs was best at 12 degrees C and 16 degrees C. PCNA immunocytochemistry indicated that only 12 degrees C and 20 degrees C allowed maintenance of proliferative function at a similar level to non-stored control. In conclusion, results indicate that 12 degrees C and 24 degrees C merit further investigation as the prospective optimum temperature for short-term storage of cultured epidermal cell sheets.	[Jackson, Catherine; Eidet, Jon R.; Lyberg, Torstein; Utheim, Tor P.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Jackson, Catherine] Univ Oslo, Oslo, Norway; [Aabel, Peder; von Unge, Magnus] Akershus Univ Hosp, Div Surg, Dept Ear Nose & Throat, Lorenskog, Norway; [Aabel, Peder; von Unge, Magnus] Univ Oslo, Inst Clin Med, Oslo, Norway; [Messelt, Edward B.; Utheim, Tor P.] Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway; [von Unge, Magnus] Uppsala Univ, LT Vastmanland, Clin Res Ctr, Uppsala, Sweden	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Uppsala University	Jackson, C (corresponding author), Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway.	catherinejoanjackson@gmail.com		Jackson, Catherine/0000-0001-9683-2343	South East Norway Regional Health Authority, Norway [2012074]; University of Oslo, Norway	South East Norway Regional Health Authority, Norway; University of Oslo, Norway	Funding was provided by (1) South East Norway Regional Health Authority, Norway, grant number 2012074 (http://www.helse-sorost.no/omoss_/english_/) to CJ, and (2) University of Oslo, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2010, J CELL PHYSIOL, V225, P15, DOI 10.1002/jcp.22251; Ang LPK, 2010, INVEST OPHTH VIS SCI, V51, P758, DOI 10.1167/iovs.09-3379; Atiyeh BS, 2007, BURNS, V33, P405, DOI 10.1016/j.burns.2006.11.002; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baris OR, 2011, STEM CELLS, V29, P1459, DOI 10.1002/stem.695; Barrandon Y, 2012, SEMIN CELL DEV BIOL, V23, P937, DOI 10.1016/j.semcdb.2012.09.011; Baylis O, 2013, J CELL PHYSIOL, V228, P1025, DOI 10.1002/jcp.24249; Baylis O, 2011, J CELL BIOCHEM, V112, P993, DOI 10.1002/jcb.23028; BELZER FO, 1988, TRANSPLANTATION, V45, P673, DOI 10.1097/00007890-198804000-00001; Brand KA, 1997, FASEB J, V11, P388, DOI 10.1096/fasebj.11.5.9141507; Bravo D, 2000, BURNS, V26, P367, DOI 10.1016/S0305-4179(99)00169-2; Chen FF, 2011, BIOMATERIALS, V32, P8426, DOI 10.1016/j.biomaterials.2011.07.008; Dragunova J, 2012, CELL TISSUE BANK, V13, P471, DOI 10.1007/s10561-011-9275-z; Eidet JR, 2012, EXP EYE RES, V94, P109, DOI 10.1016/j.exer.2011.11.015; Ge LP, 2010, BURNS, V36, P533, DOI 10.1016/j.burns.2009.08.001; Ghosh M. M., 1995, Journal of Burn Care and Rehabilitation, V16, P407, DOI 10.1097/00004630-199507000-00006; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; HALPRIN KM, 1966, J INVEST DERMATOL, V47, P222, DOI 10.1038/jid.1966.133; HENNINGS H, 1983, EXP CELL RES, V143, P127, DOI 10.1016/0014-4827(83)90115-5; Hibino Y, 1996, J CRANIO MAXILL SURG, V24, P346, DOI 10.1016/S1010-5182(96)80035-7; HORIKOSHI T, 1986, J INVEST DERMATOL, V86, P424, DOI 10.1111/1523-1747.ep12285695; Kino-oka M, 2005, J BIOSCI BIOENG, V100, P119, DOI 10.1263/jbb.100.119; Kito K, 2005, CORNEA, V24, P735, DOI 10.1097/01.ico.0000154405.68536.a4; Knapik A, 2013, J PLAST RECONSTR AES, V66, P827, DOI 10.1016/j.bjps.2013.02.003; KONSTANTINOW A, 1991, ANN PLAS SURG, V26, P89, DOI 10.1097/00000637-199101000-00014; Li JX, 2008, CELL RES, V18, P360, DOI 10.1038/cr.2007.103; Matylevitch NP, 1998, AM J PATHOL, V153, P567, DOI 10.1016/S0002-9440(10)65599-X; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Pasch J, 1999, CRYOBIOLOGY, V39, P158, DOI 10.1006/cryo.1999.2197; Pasovic L, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/216359; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Raeder S, 2007, ACTA OPHTHALMOL SCAN, V85, P377, DOI 10.1111/j.1600-0420.2006.00873.x; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Ronquist G, 2003, EXP DERMATOL, V12, P572, DOI 10.1034/j.1600-0625.2003.00018.x; ROOS G, 1993, LAB INVEST, V68, P204; Salahudeen AK, 2003, AM J TRANSPLANT, V3, P273, DOI 10.1034/j.1600-6143.2003.00042.x; Schiozer WA, 2013, ACTA CIR BRAS, V28, P824, DOI 10.1590/S0102-86502013001200004; Smith ADH, 2010, PHYSIOL MEAS, V31, P95, DOI 10.1088/0967-3334/31/1/007; Stoner ML, 1996, BURNS, V22, P197, DOI 10.1016/0305-4179(95)00126-3; Udoh Y, 2000, BURNS, V26, P535, DOI 10.1016/S0305-4179(00)00038-3; Utheim TP, 2009, BRIT J OPHTHALMOL, V93, P980, DOI 10.1136/bjo.2008.149591; Utheim TP, 2007, BRIT J OPHTHALMOL, V91, P797, DOI 10.1136/bjo.2006.103218; Utheim Tor Paaske, 2013, Methods Mol Biol, V1014, P3, DOI 10.1007/978-1-62703-432-6_1; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Yang XY, 2008, MOL VIS, V14, P1064; Yang XY, 2007, MOL REPROD DEV, V74, P386, DOI 10.1002/mrd.20598; Yeh HJ, 2008, CORNEA, V27, P327, DOI 10.1097/ICO.0b013e31815dcfaf; Zieger MAJ, 2006, CELL TRANSPLANT, V15, P499, DOI 10.3727/000000006783981756; Zito-Abbad E, 2006, CURR EYE RES, V31, P391, DOI 10.1080/02713680600681228	50	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105808	10.1371/journal.pone.0105808	http://dx.doi.org/10.1371/journal.pone.0105808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170754	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500069
J	Lam, HN; Chakravarthy, S; Wei, HL; BuiNguyen, H; Stodghill, PV; Collmer, A; Swingle, BM; Cartinhour, SW				Lam, Hanh N.; Chakravarthy, Suma; Wei, Hai-Lei; HoangChuong BuiNguyen; Stodghill, Paul V.; Collmer, Alan; Swingle, Bryan M.; Cartinhour, Samuel W.			Global Analysis of the HrpL Regulon in the Plant Pathogen Pseudomonas syringae pv. tomato DC3000 Reveals New Regulon Members with Diverse Functions	PLOS ONE			English	Article							SECRETION SYSTEM EFFECTORS; ALTERNATE SIGMA-FACTOR; III PROTEIN SECRETION; ESCHERICHIA-COLI; GENOMEWIDE IDENTIFICATION; CULTIVAR SPECIFICITY; AVIRULENCE GENE; PROMOTER; SEQUENCE; TRANSLOCATION	The type III secretion system (T3SS) is required for virulence in the gram-negative plant pathogen Pseudomonas syringae pv. tomato DC3000. The alternative sigma factor HrpL directly regulates expression of T3SS genes via a promoter sequence, often designated as the "hrp promoter." Although the HrpL regulon has been extensively investigated in DC3000, it is not known whether additional regulon members remain to be found. To systematically search for HrpL-regulated genes, we used chromatin immunoprecipitation coupled with high-throughput sequencing (ChIP-Seq) and bulk mRNA sequencing (RNA-Seq) to identify HrpL-binding sites and likely hrp promoters. The analysis recovered 73 sites of interest, including 20 sites that represent new hrp promoters. The new promoters lie upstream of a diverse set of genes encoding potential regulators, enzymes and hypothetical proteins. PSPTO_5633 is the only new HrpL regulon member that is potentially an effector and is now designated HopBM1. Deletions in several other new regulon members, including PSPTO_5633, PSPTO_0371, PSPTO_2130, PSPTO_2691, PSPTO_2696, PSPTO_3331, and PSPTO_5240, in either DC3000 or Delta hopQ1-1 backgrounds, do not affect the hypersensitive response or in planta growth of the resulting strains. Many new HrpL regulon members appear to be unrelated to the T3SS, and orthologs for some of these can be identified in numerous nonpathogenic bacteria. With the identification of 20 new hrp promoters, the list of HrpL regulon members is approaching saturation and most likely includes all DC3000 effectors.	[Lam, Hanh N.; Chakravarthy, Suma; Wei, Hai-Lei; HoangChuong BuiNguyen; Stodghill, Paul V.; Collmer, Alan; Swingle, Bryan M.; Cartinhour, Samuel W.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14850 USA; [Stodghill, Paul V.; Swingle, Bryan M.; Cartinhour, Samuel W.] USDA ARS, Ithaca, NY 14853 USA	Cornell University; United States Department of Agriculture (USDA)	Cartinhour, SW (corresponding author), Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14850 USA.	sam.cartinhour@ars.usda.gov	Lam, Hanh/AAV-9060-2020; Swingle, Bryan/AAX-6102-2021; Wei, Hailei/AAD-8664-2020	Lam, Hanh/0000-0002-6323-2146; Wei, Hailei/0000-0001-6554-009X; Bui Nguyen, Hoang/0000-0001-6975-3084; Chakravarthy, Suma/0000-0001-8245-998X	USDA-ARS (U.S. Department of Agriculture-Agricultural Research Service) CRIS; NSF [IOS-1025642]; Vietnam Education Foundation (VEF); ARS [ARS-0423000] Funding Source: Federal RePORTER	USDA-ARS (U.S. Department of Agriculture-Agricultural Research Service) CRIS; NSF(National Science Foundation (NSF)); Vietnam Education Foundation (VEF); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by USDA-ARS (U.S. Department of Agriculture-Agricultural Research Service) CRIS, by NSF funding IOS-1025642, and by a graduate research fellowship awarded to Cornell student H. Lam by the Vietnam Education Foundation (VEF). Three authors (P. Stodghill, B. Swingle and S. Cartinhour) are employees of the USDA-ARS. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. The USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Alfano JR, 1997, J BACTERIOL, V179, P5655, DOI 10.1128/jb.179.18.5655-5662.1997; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2005, FILA RPOF GENE PSEUD, P1; Badel JL, 2006, MOL PLANT MICROBE IN, V19, P99, DOI 10.1094/MPMI-19-0099; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bardoel BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002206; Bronstein PA, 2005, J BACTERIOL, V187, P8450, DOI 10.1128/JB.187.24.8450-8461.2005; Bronstein PA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-209; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Buell CR, 2003, PNAS, P1; Butcher BG, 2011, J BACTERIOL, V193, P4598, DOI 10.1128/JB.00340-11; CARPOUSIS AJ, 1982, J MOL BIOL, V157, P619, DOI 10.1016/0022-2836(82)90502-2; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Collmer A, 2002, TRENDS MICROBIOL, V10, P462, DOI 10.1016/S0966-842X(02)02451-4; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cunnac S, 2009, CURR OPIN MICROBIOL, V12, P53, DOI 10.1016/j.mib.2008.12.003; Cunnac S, 2011, P NATL ACAD SCI USA, V108, P2975, DOI 10.1073/pnas.1013031108; CUPPELS DA, 1995, APPL ENVIRON MICROB, V61, P3530, DOI 10.1128/AEM.61.10.3530-3536.1995; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Dong TG, 2012, NUCLEIC ACIDS RES, V40, P7766, DOI 10.1093/nar/gks567; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; ELLINGER T, 1994, J MOL BIOL, V239, P455, DOI 10.1006/jmbi.1994.1388; Enz S, 2003, J BACTERIOL, V185, P2387, DOI 10.1128/JB.185.7.2387-2391.2003; Feng F, 2012, CURR OPIN PLANT BIOL, V15, P469, DOI 10.1016/j.pbi.2012.03.004; Ferreira AO, 2006, MOL PLANT MICROBE IN, V19, P1167, DOI 10.1094/MPMI-19-1167; Filiatrault MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029335; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Fouts DE, 2002, P NATL ACAD SCI USA, V99, P2275, DOI 10.1073/pnas.032514099; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Hanahan D, 1985, TECHNIQUES TRANSFORM, P26; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jin QL, 2003, MICROBES INFECT, V5, P301, DOI 10.1016/S1286-4579(03)00032-7; Jovanovic M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1177; Kim JF, 2002, CURR TOP MICROBIOL, V264, P127; KING EO, 1954, J LAB CLIN MED, V44, P301; KOBAYASHI DY, 1989, P NATL ACAD SCI USA, V86, P157, DOI 10.1073/pnas.86.1.157; Kvitko B. H., 2009, PLOS PATHOG, V5, P1; Kvitko BH, 2007, J BACTERIOL, V189, P8059, DOI 10.1128/JB.01146-07; Lan L, 2006, MPMI, V19, P10; Lane WJ, 2006, PLOS BIOL, V4, P1491, DOI 10.1371/journal.pbio.0040269; LETOFFE S, 1990, EMBO J, V9, P1375, DOI 10.1002/j.1460-2075.1990.tb08252.x; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lindeberg M, 2005, MOL PLANT MICROBE IN, V18, P275, DOI 10.1094/MPMI-18-0275; Markel E, 2013, APPL ENVIRON MICROB, V79, P725, DOI 10.1128/AEM.02801-12; Markel E, 2011, J BACTERIOL, V193, P5775, DOI 10.1128/JB.05114-11; Mucyn TS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003807; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Oh HS, 2007, J BACTERIOL, V189, P8277, DOI 10.1128/JB.00998-07; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pel MJ, 2014, MOL PLANT MICROBE IN; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Preiter K, 2005, J BACTERIOL, V187, P7805, DOI 10.1128/JB.187.22.7805-7814.2005; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rhee HS, 2012, CURR PROTOC MOL BIOL; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schechter LM, 2006, MOL PLANT MICROBE IN, V19, P1180, DOI 10.1094/MPMI-19-1180; Schechter LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036038; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; SHEN H, 1993, J BACTERIOL, V175, P5916, DOI 10.1128/JB.175.18.5916-5924.1993; STASKAWICZ BJ, 1984, P NATL ACAD SCI-BIOL, V81, P6024, DOI 10.1073/pnas.81.19.6024; Swingle B, 2008, MOL MICROBIOL, V68, P871, DOI 10.1111/j.1365-2958.2008.06209.x; Vencato M, 2006, MOL PLANT MICROBE IN, V19, P1193, DOI 10.1094/MPMI-19-1193; Wagner R, 2000, TRANSCRIPTION REGULA, P380; Wei CF, 2007, PLANT J, V51, P32, DOI 10.1111/j.1365-313X.2007.03126.x; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; XIAO YX, 1994, J BACTERIOL, V176, P3089, DOI 10.1128/JB.176.10.3089-3091.1994; XIAO YX, 1994, J BACTERIOL, V176, P1025, DOI 10.1128/JB.176.4.1025-1036.1994; Yuan J, 1996, J BACTERIOL, V178, P6399, DOI 10.1128/jb.178.21.6399-6402.1996	80	34	34	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106115	10.1371/journal.pone.0106115	http://dx.doi.org/10.1371/journal.pone.0106115			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170934	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500107
J	Saha, P; Blumwald, E				Saha, Prasenjit; Blumwald, Eduardo			Assessing Reference Genes for Accurate Transcript Normalization Using Quantitative Real-Time PCR in Pearl Millet [Pennisetum glaucum (L.) R. Br.]	PLOS ONE			English	Article							RT-PCR; HOUSEKEEPING GENES; SETARIA-ITALICA; EXPRESSION; VALIDATION; IDENTIFICATION; PLANTS; STRESS; ARABIDOPSIS; RICE	Pearl millet [Pennisetum glaucum (L.) R. Br.], a close relative of Panicoideae food crops and bioenergy grasses, offers an ideal system to perform functional genomics studies related to C4 photosynthesis and abiotic stress tolerance. Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) provides a sensitive platform to conduct such gene expression analyses. However, the lack of suitable internal control reference genes for accurate transcript normalization during qRT-PCR analysis in pearl millet is the major limitation. Here, we conducted a comprehensive assessment of 18 reference genes on 234 samples which included an array of different developmental tissues, hormone treatments and abiotic stress conditions from three genotypes to determine appropriate reference genes for accurate normalization of qRT-PCR data. Analyses of Ct values using Stability Index, BestKeeper, Delta Ct, Normfinder, geNorm and RefFinder programs ranked PP2A, TIP41, UBC2, UBQ5 and ACT as the most reliable reference genes for accurate transcript normalization under different experimental conditions. Furthermore, we validated the specificity of these genes for precise quantification of relative gene expression and provided evidence that a combination of the best reference genes are required to obtain optimal expression patterns for both endogeneous genes as well as transgenes in pearl millet.	[Saha, Prasenjit; Blumwald, Eduardo] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Blumwald, E (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	eblumwald@ucdavis.edu	Blumwald, Eduardo/Y-2751-2019		United States Agency for International Development (USAID) [APS M/OAA/GRO/EGAS-11-002011]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This work is funded by The United States Agency for International Development (USAID) under the Grant No. APS M/OAA/GRO/EGAS-11-002011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Amil-Ruiz F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070603; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Borges A, 2012, PLANT CELL REP, V31, P827, DOI 10.1007/s00299-011-1204-x; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chao WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042839; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Cheng MC, 2013, PLANT PHYSIOL, V162, P1566, DOI [10.1104/pp.113.221911, 10.1104]; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; EJETA G, 1987, P NATL ACAD SCI USA, V84, P6016, DOI 10.1073/pnas.84.17.6016; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Gimenez MJ, 2011, PLANTA, V233, P163, DOI 10.1007/s00425-010-1290-y; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HILL GM, 1990, J ANIM SCI, V68, P2061; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; JEFFERSON RA, 1987, EMBO J, V6, P3901; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Kumar K, 2013, PLANT CELL TISS ORG, V115, P13, DOI 10.1007/s11240-013-0335-x; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Mishra RN, 2007, PLANT MOL BIOL, V64, P713, DOI 10.1007/s11103-007-9193-4; O'Kennedy MM, 2011, METHODS MOL BIOL, V710, P343, DOI 10.1007/978-1-61737-988-8_23; Ovesna J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041886; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Petit Cecile, 2012, BMC Res Notes, V5, P18, DOI 10.1186/1756-0500-5-18; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saha P, 2006, PLANTA, V223, P1329, DOI 10.1007/s00425-005-0182-z; Saha P, 2013, PLANT J, V75, P104, DOI 10.1111/tpj.12204; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Tenea Gabriela N, 2011, BMC Res Notes, V4, P373, DOI 10.1186/1756-0500-4-373; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Upadhyaya H. D., 2007, Journal of SAT Agricultural Research, V3, P1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yadav RS, 2011, J EXP BOT, V62, P397, DOI 10.1093/jxb/erq265; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]	53	34	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106308	10.1371/journal.pone.0106308	http://dx.doi.org/10.1371/journal.pone.0106308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170776	Green Submitted, Green Published, gold			2022-12-25	WOS:000341127500146
J	Yang, XY; Sun, B; Zhang, L; Li, N; Han, JL; Zhang, J; Sun, XS; He, QY				Yang, Xiao-Yan; Sun, Bin; Zhang, Liang; Li, Nan; Han, Junlong; Zhang, Jing; Sun, Xuesong; He, Qing-Yu			Chemical Interference with Iron Transport Systems to Suppress Bacterial Growth of Streptococcus pneumoniae	PLOS ONE			English	Article							ABC TRANSPORTER; RUTHENIUM(II) COMPLEXES; PATHOGENIC BACTERIA; ESCHERICHIA-COLI; METABOLISM; INFECTION; VIRULENCE; MANGANESE; PROTEINS; GALLIUM	Iron is an essential nutrient for the growth of most bacteria. To obtain iron, bacteria have developed specific iron-transport systems located on the membrane surface to uptake iron and iron complexes such as ferrichrome. Interference with the iron-acquisition systems should be therefore an efficient strategy to suppress bacterial growth and infection. Based on the chemical similarity of iron and ruthenium, we used a Ru(II) complex R-825 to compete with ferrichrome for the ferrichrome-transport pathway in Streptococcus pneumoniae. R-825 inhibited the bacterial growth of S. pneumoniae and stimulated the expression of PiuA, the iron-binding protein in the ferrichrome-uptake system on the cell surface. R-825 treatment decreased the cellular content of iron, accompanying with the increase of Ru(II) level in the bacterium. When the piuA gene (SPD_0915) was deleted in the bacterium, the mutant strain became resistant to R-825 treatment, with decreased content of Ru(II). Addition of ferrichrome can rescue the bacterial growth that was suppressed by R-825. Fluorescence spectral quenching showed that R-825 can bind with PiuA in a similar pattern to the ferrichrome-PiuA interaction in vitro. These observations demonstrated that Ru(II) complex R-825 can compete with ferrichrome for the ferrichrome-transport system to enter S. pneumoniae, reduce the cellular iron supply, and thus suppress the bacterial growth. This finding suggests a novel antimicrobial approach by interfering with iron-uptake pathways, which is different from the mechanisms used by current antibiotics.	[Yang, Xiao-Yan; Zhang, Liang; Li, Nan; Han, Junlong; Zhang, Jing; Sun, Xuesong; He, Qing-Yu] Jinan Univ, Coll Life Sci & Technol, Inst Life & Hlth Engn, Key Lab Funct Prot Res,Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China; [Sun, Bin] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China	Jinan University; Southern Medical University - China	Sun, XS (corresponding author), Jinan Univ, Coll Life Sci & Technol, Inst Life & Hlth Engn, Key Lab Funct Prot Res,Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China.	tsunxs@jnu.edu.cn; tqyhe@jnu.edu.cn	He, Qing-Yu/H-7078-2014	He, Qing-Yu/0000-0003-0503-9492	National Natural Science Foundation of China [21271086, 31000373]; Guangdong Natural Science Research [32213027, S2012010008685]; Fundamental Research Funds for the Central Universities [11610101, 21611201]; Pearl River Rising Star of Science and Technology of Guangzhou City [2011J2200003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Research; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Pearl River Rising Star of Science and Technology of Guangzhou City	This work was supported by the National Natural Science Foundation of China (21271086, to Q.-Y. H.; 31000373, to X. S.), Guangdong Natural Science Research Grant (32213027, to Q.-Y. H.; S2012010008685 to X. S.), the Fundamental Research Funds for the Central Universities (11610101 to Q.-Y. H.; 21611201, to X. S.), and the Pearl River Rising Star of Science and Technology of Guangzhou City (2011J2200003, to X. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banin E, 2008, P NATL ACAD SCI USA, V105, P16761, DOI 10.1073/pnas.0808608105; Biersack B, 2009, J INORG BIOCHEM, V103, P72, DOI 10.1016/j.jinorgbio.2008.09.005; Bolhuis A, 2011, EUR J PHARM SCI, V42, P313, DOI 10.1016/j.ejps.2010.12.004; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Cheng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071451; DWYER FP, 1952, NATURE, V170, P190, DOI 10.1038/170190a0; Ho J, 2010, CURR OPIN INFECT DIS, V23, P546, DOI 10.1097/QCO.0b013e32833f0d3e; Institute C.A.L.S., 2012, M100S22 CLSI I CALS; Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783; Kehres DG, 2000, MOL MICROBIOL, V36, P1085, DOI 10.1046/j.1365-2958.2000.01922.x; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Li CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021983; Li FF, 2012, J ANTIMICROB CHEMOTH, V67, P2686, DOI 10.1093/jac/dks291; Li FF, 2011, DALTON T, V40, P5032, DOI 10.1039/c1dt10250h; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Mitchell TJ, 2000, RES MICROBIOL, V151, P413, DOI 10.1016/S0923-2508(00)00175-3; Ong CLY, 2013, INFECT IMMUN, V81, P421, DOI 10.1128/IAI.00805-12; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Pramanik A, 2006, J BACTERIOL, V188, P3878, DOI 10.1128/JB.00205-06; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Stojiljkovic I, 1999, MOL MICROBIOL, V31, P429, DOI 10.1046/j.1365-2958.1999.01175.x; Sun B, 2008, J MOL STRUCT, V890, P203, DOI 10.1016/j.molstruc.2008.05.035; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wang Y, 2006, PROTEOMICS, V6, P2422, DOI 10.1002/pmic.200500595; Whalan RH, 2006, J BACTERIOL, V188, P1031, DOI 10.1128/JB.188.3.1031-1038.2006; Whitby PW, 1997, INFECT IMMUN, V65, P4696, DOI 10.1128/IAI.65.11.4696-4700.1997; Zheng TF, 2012, J AM CHEM SOC, V134, P18388, DOI 10.1021/ja3077268	31	11	12	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105953	10.1371/journal.pone.0105953	http://dx.doi.org/10.1371/journal.pone.0105953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170896	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500083
J	Zhang, H; Singh, KK				Zhang, Hengshan; Singh, Keshav K.			Global Genetic Determinants of Mitochondrial DNA Copy Number	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; SACCHAROMYCES-CEREVISIAE; THYMIDINE KINASE; LARGE SUBUNIT; EXPRESSION; MUTATIONS; DEPLETION; PROTEINS; BREAST; TRANSCRIPTION	Many human diseases including development of cancer is associated with depletion of mitochondrial DNA (mtDNA) content. These diseases are collectively described as mitochondrial DNA depletion syndrome (MDS). High similarity between yeast and human mitochondria allows genomic study of the budding yeast to be used to identify human disease genes. In this study, we systematically screened the pre-existing respiratory-deficient Saccharomyces cerevisiae yeast strains using fluorescent microscopy and identified 102 nuclear genes whose deletions result in a complete mtDNA loss, of which 52 are not reported previously. Strikingly, these genes mainly encode protein products involved in mitochondrial protein biosynthesis process (54.9%). The rest of these genes either encode protein products associated with nucleic acid metabolism (14.7%), oxidative phosphorylation (3.9%), or other protein products (13.7%) responsible for bud-site selection, mitochondrial intermembrane space protein import, assembly of cytochrome-c oxidase, vacuolar protein sorting, protein-nucleus import, calcium-mediated signaling, heme biosynthesis and iron homeostasis. Thirteen (12.7%) of the genes encode proteins of unknown function. We identified human orthologs of these genes, conducted the interaction between the gene products and linked them to human mitochondrial disorders and other pathologies. In addition, we screened for genes whose defects affect the nuclear genome integrity. Our data provide a systematic view of the nuclear genes involved in maintenance of mitochondrial DNA. Together, our studies i) provide a global view of the genes regulating mtDNA content; ii) provide compelling new evidence toward understanding novel mechanism involved in mitochondrial genome maintenance and iii) provide useful clues in understanding human diseases in which mitochondrial defect and in particular depletion of mitochondrial genome plays a critical role.	[Zhang, Hengshan] Fujian Med Univ, Affiliated Hosp 1, Dept Cent Lab, Fuzhou, Peoples R China; [Singh, Keshav K.] Univ Alabama Birmingham, Dept Genet, Ctr Free Radical Biol, Ctr Aging, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL USA; [Singh, Keshav K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA	Fujian Medical University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Singh, KK (corresponding author), Univ Alabama Birmingham, Dept Genet, Ctr Free Radical Biol, Ctr Aging, Birmingham, AL 35294 USA.	kksingh@uab.edu		Zhang, Hengshan/0000-0002-2226-4774	Veterans Administration [1I01BX001716]; National Institutes of Health (NIH) [R01CA121904]; NATIONAL CANCER INSTITUTE [R01CA121904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001716] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	Studies reported in this manuscript were supported in part by Veterans Administration grant 1I01BX001716 and National Institutes of Health (NIH) R01CA121904 (to KKS). Funding agencies has no role in design or data collection.	Ackeman SH, 1999, P NATL ACAD SCI USA, V87, P4986; Banfi S, 1999, GENOMICS, V59, P51, DOI 10.1006/geno.1999.5818; Barrientos A, 2003, IUBMB LIFE, V55, P83, DOI 10.1080/1521654031000098122; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Dahl HHM, 2001, AM J MED GENET, V106, P1, DOI 10.1002/ajmg.1427; de Bari L, 2013, FEBS LETT, V587, P467, DOI 10.1016/j.febslet.2013.01.011; de Clare M, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-24; De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047; Desouki MM, 2005, CANCER BIOL THER, V4, P1367, DOI 10.4161/cbt.4.12.2233; Endo T, 2011, BBA-BIOMEMBRANES, V1808, P955, DOI 10.1016/j.bbamem.2010.07.018; Graack HR, 1998, BIOCHEM J, V329, P433, DOI 10.1042/bj3290433; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Ismail S, 2014, GENE, V539, P279, DOI 10.1016/j.gene.2014.01.070; Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200; Kenmochi N, 2001, GENOMICS, V77, P65, DOI 10.1006/geno.2001.6622; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Kulawiec M, 2008, CANCER BIOL THER, V7, P1732, DOI 10.4161/cbt.7.11.6729; Lee JW, 2006, PATHOL RES PRACT, V202, P67, DOI 10.1016/j.prp.2005.11.001; Lipinski KA, 2010, BBA-BIOENERGETICS, V1797, P1086, DOI 10.1016/j.bbabio.2009.12.019; Lossi AM, 2002, J MED GENET, V39, P113, DOI 10.1136/jmg.39.2.113; Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A; Mears JA, 2006, J MOL BIOL, V358, P193, DOI 10.1016/j.jmb.2006.01.094; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Modica-Napolitano Josephine S, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004453; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Modica-Napolitano JS, 2004, MITOCHONDRION, V4, P755, DOI 10.1016/j.mito.2004.07.027; Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; O'Brien TW, 2005, GENE, V354, P147, DOI 10.1016/j.gene.2005.03.026; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Pickova A, 2003, FEBS LETT, V551, P42, DOI 10.1016/S0014-5793(03)00890-1; Rasmussen AK, 2003, NUCLEIC ACIDS RES, V31, P3909, DOI 10.1093/nar/gkg446; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Selvanayagam P, 1996, LAB INVEST, V74, P592; Simonnet H, 2002, CARCINOGENESIS, V23, P759, DOI 10.1093/carcin/23.5.759; Singh KK, 1999, ONCOGENE, V18, P6641, DOI 10.1038/sj.onc.1203056; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Tseng LH, 2006, TOXICOLOGY, V224, P33, DOI 10.1016/j.tox.2006.04.003; Vidoni S, 2013, ANTIOXID REDOX SIGN, V19, P379, DOI 10.1089/ars.2012.4800; Wang WF, 2013, WORLD J GASTROENTERO, V19, P4309, DOI 10.3748/wjg.v19.i27.4309; Wang ZG, 2001, J BIOL CHEM, V276, P30773, DOI 10.1074/jbc.M104133200; WILLIAMSON DH, 1971, MOL GEN GENET, V111, P209, DOI 10.1007/BF00433106; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Wu Kun, 2005, Wei Sheng Yan Jiu, V34, P58; Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838; Yis U, 2011, NEUROMUSCULAR DISORD, V21, P20, DOI 10.1016/j.nmd.2010.08.007; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955	51	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105242	10.1371/journal.pone.0105242	http://dx.doi.org/10.1371/journal.pone.0105242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170845	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500037
J	Houk, P; Benavente, D; Iguel, J; Johnson, S; Okano, R				Houk, Peter; Benavente, David; Iguel, John; Johnson, Steven; Okano, Ryan			Coral Reef Disturbance and Recovery Dynamics Differ across Gradients of Localized Stressors in the Mariana Islands	PLOS ONE			English	Article							BOTTOM-UP REGULATION; WATER-QUALITY; TOP-DOWN; POPULATION-STRUCTURE; PNEOPHYLLUM CONICUM; ACANTHASTER-PLANCI; FISH ASSEMBLAGES; RED ALGA; IMPACTS; COMMUNITIES	The individual contribution of natural disturbances, localized stressors, and environmental regimes upon longer-term reef dynamics remains poorly resolved for many locales despite its significance for management. This study examined coral reefs in the Commonwealth of the Northern Mariana Islands across a 12-year period that included elevated Crown-of-Thorns Starfish densities (COTS) and tropical storms that were drivers of spatially-inconsistent disturbance and recovery patterns. At the island scale, disturbance impacts were highest on Saipan with reduced fish sizes, grazing urchins, and water quality, despite having a more favorable geological foundation for coral growth compared with Rota. However, individual drivers of reef dynamics were better quantified through site-level investigations that built upon island generalizations. While COTS densities were the strongest predictors of coral decline as expected, interactive terms that included wave exposure and size of the overall fish assemblages improved models (R-2 and AIC values). Both wave exposure and fish size diminished disturbance impacts and had negative associations with COTS. However, contrasting findings emerged when examining net ecological change across the 12-year period. Wave exposure had a ubiquitous, positive influence upon the net change in favorable benthic substrates (i.e. corals and other heavily calcifying substrates, R-2 = 0.17 for all reeftypes grouped), yet including interactive terms for herbivore size and grazing urchin densities, as well as stratifying by major reeftypes, substantially improved models (R-2 = 0.21 to 0.89, lower AIC scores). Net changes in coral assemblages (i.e., coral ordination scores) were more sensitive to herbivore size or the water quality proxy acting independently (R-2 = 0.28 to 0.44). We conclude that COTS densities were the strongest drivers of coral decline, however, net ecological change was most influenced by localized stressors, especially herbivore sizes and grazing urchin densities. Interestingly, fish size, rather than biomass, was consistently a better predictor, supporting allometric, size-and-function relationships of fish assemblages. Management implications are discussed.	[Houk, Peter] Univ Guam, Marine Lab, UOG Stn, Mangilao, GU 96923 USA; [Houk, Peter] Pacific Marine Resources Inst, Saipan, CM USA; [Benavente, David; Iguel, John; Johnson, Steven; Okano, Ryan] CNMI Bur Environm & Coastal Qual, Saipan, CM USA	University of Guam	Houk, P (corresponding author), Univ Guam, Marine Lab, UOG Stn, Mangilao, GU 96923 USA.	houkp@uguam.uog.edu	Johnson, Steven Mana'oakamai/ABC-7915-2021	Johnson, Steven Mana'oakamai/0000-0001-6998-9759	National Oceanic and Atmospheric Administration (NOAA); NOAA domestic coral reef grant award [NA11-NOS4820015]; USEPA Region IX	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA domestic coral reef grant award; USEPA Region IX	This study was funded by the National Oceanic and Atmospheric Administration (NOAA) coral-reef monitoring grants administered to the CNMI Coastal Resources Management Office, and USEPA Region IX funding administered to the CNMI Division of Environmental Quality. Financial support for PH was provided through a NOAA domestic coral reef grant award (NA11-NOS4820015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TC, 2011, PLOS ONE, V5; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Antonius A, 1999, CORAL REEFS, V18, P301, DOI 10.1007/s003380050200; Antonius A, 2001, CORAL REEFS, V19, P418, DOI 10.1007/s003380000126; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Bak RPM, 1999, AM ZOOL, V39, P56; Bak RPM, 1998, MAR ECOL PROG SER, V162, P301, DOI 10.3354/meps162301; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Banse K, 2007, J BIOSCIENCES, V32, P791, DOI 10.1007/s12038-007-0080-6; Bearden C, 2012, COMMONWEALTH NO MARI; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Birkeland C, 2005, TRENDS ECOL EVOL, V20, P356, DOI 10.1016/j.tree.2005.03.015; Blackwood JC, 2011, ECOL APPL, V21, P2722, DOI 10.1890/10-2195.1; BOHNSACK J. A., 1986, 41 NMFS NAT OC ATM A; Brodie J, 2005, MAR POLLUT BULL, V51, P266, DOI 10.1016/j.marpolbul.2004.10.035; Brown BE, 2002, MAR BIOL, V141, P21, DOI 10.1007/s00227-002-0810-0; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Chollett I, 2012, LIMNOL OCEANOGR, V57, P1233, DOI 10.4319/lo.2012.57.4.1233; Cloud PE, 1959, 280K GEOL SURV; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Cooper TF, 2009, CORAL REEFS, V28, P589, DOI 10.1007/s00338-009-0512-x; Costa OS, 2000, HYDROBIOLOGIA, V440, P307, DOI 10.1023/A:1004104118208; Crossman DJ, 2001, LIMNOL OCEANOGR, V46, P1596, DOI 10.4319/lo.2001.46.7.1596; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; Done TJ, 1999, AM ZOOL, V39, P66; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Ekebom J, 2003, ESTUAR COAST SHELF S, V57, P887, DOI 10.1016/S0272-7714(02)00419-5; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Gardner TA, 2005, ECOLOGY, V86, P174, DOI 10.1890/04-0141; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Glynn PW, 2014, MAR ECOL PROG SER, V495, P233, DOI 10.3354/meps10594; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham T, 1994, 9402 CNMI DIV FISH W; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Houk P, 2006, PAC SCI, V60, P177, DOI 10.1353/psc.2006.0005; Houk P, 2012, CORAL REEFS, V31, P13, DOI 10.1007/s00338-011-0826-3; Houk P, 2013, MAR ECOL PROG SER, V488, P23, DOI 10.3354/meps10410; Houk P, 2012, BIODIVERS CONSERV, V21, P2045, DOI 10.1007/s10531-012-0296-0; Houk P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013913; Houk P, 2010, MAR ECOL-EVOL PERSP, V31, P318, DOI 10.1111/j.1439-0485.2009.00301.x; Houk P, 2007, J OCEANOGR, V63, P149, DOI 10.1007/s10872-007-0013-x; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Keats DW, 1997, BOT MAR, V40, P263, DOI 10.1515/botm.1997.40.1-6.263; Lapointe BE, 2004, J EXP MAR BIOL ECOL, V308, P23, DOI 10.1016/j.jembe.2004.01.019; Lokrantz J, 2008, CORAL REEFS, V27, P967, DOI 10.1007/s00338-008-0394-3; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Maynard J, 2012, CORAL REEF RES UNPUB; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McClanahan TR, 2005, CORAL REEFS, V24, P230, DOI 10.1007/s00338-004-0471-1; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Mork E, 2009, ESTUAR COAST SHELF S, V84, P331, DOI 10.1016/j.ecss.2009.03.033; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; O'Leary JK, 2012, CORAL REEFS, V31, P547, DOI 10.1007/s00338-012-0872-5; Perry CT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2409; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pratchett MS, 2011, CORAL REEFS, V30, P183, DOI 10.1007/s00338-010-0678-2; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; RDC, 2008, R LANG ENV STAT COMP; Sjoo GL, 2011, ESTUAR COAST SHELF S, V91, P511, DOI 10.1016/j.ecss.2010.12.003; Starmer J., 2008, MARINE WATER QUALITY; Trianni MS, 1998, SUMMARY FURTHE UNPUB; van Beukering P., 2006, EC VALUE CORAL REEFS; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Veron J.E.N., 2000, CORALS WORLD, V1-3; Walsh Sheila M., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/187248; Wilson SK, 2012, CONSERV BIOL, V26, P995, DOI 10.1111/j.1523-1739.2012.01926.x; Zar J. H., 1999, BIOSTATISTICS; Zuur Alain F., 2009, P1	73	25	25	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105731	10.1371/journal.pone.0105731	http://dx.doi.org/10.1371/journal.pone.0105731			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165893	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303700040
J	Kwon, SM; Lee, JH; Lee, SH; Jung, SY; Kim, DY; Kang, SH; Yoo, SY; Hong, JK; Park, JH; Kim, JH; Kim, SW; Kim, YJ; Lee, SJ; Kim, HG; Asahara, T				Kwon, Sang-Mo; Lee, Jun-Hee; Lee, Sang-Hun; Jung, Seok-Yun; Kim, Da-Yeon; Kang, Song-Hwa; Yoo, So-Young; Hong, Jong-Kyu; Park, Ji-Hye; Kim, Jung-Hee; Kim, Sung-Wook; Kim, Yeon-Ju; Lee, Sun-Jin; Kim, Hwi-Gon; Asahara, Takayuki			Cross Talk with Hematopoietic Cells Regulates the Endothelial Progenitor Cell Differentiation of CD34 Positive Cells	PLOS ONE			English	Article							BONE-MARROW; THERAPEUTIC ANGIOGENESIS; POSTNATAL VASCULOGENESIS; CLONOGENIC-ASSAY; CD31(+) CELLS; TRANSPLANTATION; NEOVASCULARIZATION; IMPLANTATION; STEM; IDENTIFICATION	Introduction: Despite the crucial role of endothelial progenitor cells (EPCs) in vascular regeneration, the specific interactions between EPCs and hematopoietic cells remain unclear. Methods: In EPC colony forming assays, we first demonstrated that the formation of EPC colonies was drastically increased in the coculture of CD34(+) and CD34(-) cells, and determined the optimal concentrations of CD34(+) cells and CD34(-) cells for spindle-shaped EPC differentiation. Results: Functionally, the coculture of CD34(+) and CD34(-) cells resulted in a significant enhancement of adhesion, tube formation, and migration capacity compared with culture of CD34(+) cells alone. Furthermore, blood flow recovery and capillary formation were remarkably increased by the coculture of CD34(+) and CD34(-) cells in a murine hind-limb ischemia model. To elucidate further the role of hematopoietic cells in EPC differentiation, we isolated different populations of hematopoietic cells. T lymphocytes (CD3(+)) markedly accelerated the early EPC status of CD34(+) cells, while macrophages (CD11b(+)) or megakaryocytes (CD41(+)) specifically promoted large EPC colonies. Conclusion: Our results suggest that specific populations of hematopoietic cells play a role in the EPC differentiation of CD34(+) cells, a finding that may aid in the development of a novel cell therapy strategy to overcome the quantitative and qualitative limitations of EPC therapy.	[Kwon, Sang-Mo; Lee, Jun-Hee; Jung, Seok-Yun; Kim, Da-Yeon; Kang, Song-Hwa; Yoo, So-Young; Hong, Jong-Kyu; Park, Ji-Hye; Kim, Jung-Hee; Kim, Sung-Wook; Kim, Yeon-Ju; Lee, Sun-Jin] Pusan Natl Univ, Sch Med, Med Res Inst, Dept Physiol,Lab Vasc Med & Stem Cell Biol, Yangsan, South Korea; [Lee, Sang-Hun] Soonchunhyang Univ, Seoul Hosp, Soonchunhyang Med Sci Res Inst, Seoul, South Korea; [Kim, Hwi-Gon] Pusan Natl Univ, Sch Med, Dept Obstet & Gynecol, Yangsan, South Korea; [Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa 25911, Japan	Pusan National University; Pusan National University Hospital; Soonchunhyang University; Pusan National University; Pusan National University Hospital; Tokai University	Kwon, SM (corresponding author), Pusan Natl Univ, Sch Med, Med Res Inst, Dept Physiol,Lab Vasc Med & Stem Cell Biol, Yangsan, South Korea.	smkwon323@hotmail.com; asa777@is.icc.u-tokai.ac.jp	lee, sang hun/Q-4650-2019; Kim, Yeon-Ju/AAE-5919-2019; Yoo, So Young/P-1386-2019	lee, sang hun/0000-0002-9005-5966; Yoo, So Young/0000-0001-8875-9289; Kim, Da Yeon/0000-0003-4696-0501	National Research Foundation - Korean government (MEST) [2010-0020260, 2012R1A2A01045085, 2012M3A0C6049720]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A120247]	National Research Foundation - Korean government (MEST); Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by grants from the National Research Foundation funded by the Korean government (MEST) (2010-0020260, 2012R1A2A01045085, 2012M3A0C6049720) and a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A120247). The authors have read and understood the regulations and have nothing to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Calzi SL, 2010, MICROVASC RES, V79, P207, DOI 10.1016/j.mvr.2010.02.011; Chung YC, 2011, CHINESE J PHYSIOL, V54, P169, DOI 10.4077/CJP.2011.AMM019; Ciraci E, 2011, BLOOD, V118, P2105, DOI 10.1182/blood-2010-10-316596; de Boer HC, 2011, ARTERIOSCL THROM VAS, V31, P408, DOI 10.1161/ATVBAHA.110.216879; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Friedrich EB, 2006, CIRC RES, V98, pE20, DOI 10.1161/01.RES.0000205765.28940.93; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Higashi Y, 2004, CIRCULATION, V109, P1215, DOI 10.1161/01.CIR.0000121427.53291.78; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Hur J, 2007, CIRCULATION, V116, P1671, DOI 10.1161/CIRCULATIONAHA.107.694778; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Kawamoto A, 2001, CIRCULATION, V103, P634; Kawamoto A, 2009, STEM CELLS, V27, P2857, DOI 10.1002/stem.207; Kawamura Akio, 2006, J Artif Organs, V9, P226, DOI 10.1007/s10047-006-0351-2; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Kim SW, 2010, J AM COLL CARDIOL, V56, P593, DOI 10.1016/j.jacc.2010.01.070; Lee JH, 2013, ARTERIOSCL THROM VAS, V33, P1622, DOI 10.1161/ATVBAHA.112.301052; Lenk K, 2005, EUR HEART J, V26, P1903, DOI 10.1093/eurheartj/ehi285; Madeddu P, 2004, FASEB J, V18, P1737, DOI 10.1096/fj.04-2192fje; Masuda H, 2013, TRENDS CARDIOVAS MED, V23, P99, DOI 10.1016/j.tcm.2012.09.007; Masuda H, 2011, CIRC RES, V109, P20, DOI 10.1161/CIRCRESAHA.110.231837; Matoba S, 2008, AM HEART J, V156, P1010, DOI 10.1016/j.ahj.2008.06.025; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; Naiyer AJ, 1999, BLOOD, V94, P4011, DOI 10.1182/blood.V94.12.4011.424k10_4011_4019; Nakamura Y, 1999, BLOOD, V94, P4053, DOI 10.1182/blood.V94.12.4053.424k41_4053_4059; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pai M, 2008, AM J GASTROENTEROL, V103, P1952, DOI 10.1111/j.1572-0241.2008.01993.x; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Saigawa T, 2004, CIRC J, V68, P1189, DOI 10.1253/circj.68.1189; Schatteman GC, 2000, J CLIN INVEST, V106, P571, DOI 10.1172/JCI9087; Seeger FH, 2009, ARTERIOSCL THROM VAS, V29, P1802, DOI 10.1161/ATVBAHA.109.194688; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Tsukada S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt168; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814	41	33	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106310	10.1371/journal.pone.0106310	http://dx.doi.org/10.1371/journal.pone.0106310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166961	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303700085
J	Perez-Montano, F; Jimenez-Guerrero, I; Del Cerro, P; Baena-Ropero, I; Lopez-Baena, FJ; Ollero, FJ; Bellogin, R; Lloret, J; Espuny, R				Perez-Montano, Francisco; Jimenez-Guerrero, Irene; Del Cerro, Pablo; Baena-Ropero, Irene; Javier Lopez-Baena, Francisco; Javier Ollero, Francisco; Bellogin, Ramon; Lloret, Javier; Espuny, Rosario			The Symbiotic Biofilm of Sinorhizobium fredii SMH12, Necessary for Successful Colonization and Symbiosis of Glycine max cv Osumi, Is Regulated by Quorum Sensing Systems and Inducing Flavonoids via NodD1	PLOS ONE			English	Article							SECRETION SYSTEM; GENE-EXPRESSION; NOPS SECRETION; FORM BIOFILMS; NODULATION; SIGNALS; EXOPOLYSACCHARIDE; RESISTANCE; DECREASES; VIRULENCE	Bacterial surface components, especially exopolysaccharides, in combination with bacterial Quorum Sensing signals are crucial for the formation of biofilms in most species studied so far. Biofilm formation allows soil bacteria to colonize their surrounding habitat and survive common environmental stresses such as desiccation and nutrient limitation. This mode of life is often essential for survival in bacteria of the genera Mesorhizobium, Sinorhizobium, Bradyrhizobium, and Rhizobium. The role of biofilm formation in symbiosis has been investigated in detail for Sinorhizobium meliloti and Bradyrhizobium japonicum. However, for S. fredii this process has not been studied. In this work we have demonstrated that biofilm formation is crucial for an optimal root colonization and symbiosis between S. fredii SMH12 and Glycine max cv Osumi. In this bacterium, nod-gene inducing flavonoids and the NodD1 protein are required for the transition of the biofilm structure from monolayer to microcolony. Quorum Sensing systems are also required for the full development of both types of biofilms. In fact, both the nodD1 mutant and the lactonase strain (the lactonase enzyme prevents AHL accumulation) are defective in soybean root colonization. The impairment of the lactonase strain in its colonization ability leads to a decrease in the symbiotic parameters. Interestingly, NodD1 together with flavonoids activates certain quorum sensing systems implicit in the development of the symbiotic biofilm. Thus, S. fredii SMH12 by means of a unique key molecule, the flavonoid, efficiently forms biofilm, colonizes the legume roots and activates the synthesis of Nod factors, required for successfully symbiosis.	[Perez-Montano, Francisco; Jimenez-Guerrero, Irene; Del Cerro, Pablo; Javier Lopez-Baena, Francisco; Javier Ollero, Francisco; Bellogin, Ramon; Espuny, Rosario] Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain; [Baena-Ropero, Irene; Lloret, Javier] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, E-28049 Madrid, Spain	University of Sevilla; Autonomous University of Madrid	Perez-Montano, F (corresponding author), Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain.	fperezm@us.es	Espuny, M. Rosario/N-1573-2014; Jiménez-Guerrero, Irene/G-7859-2015; Lopez-Baena, Francisco Javier/L-4670-2014; Lloret, Javier/P-5037-2015; del Cerro Sánhez, Pablo PdC/H-7198-2016; Pérez-Montaño, Francisco/K-8971-2014; del Cerro Sánchez, Pablo/ABG-1194-2020; Ollero Marquez, Francisco Javier/G-3271-2015	Espuny, M. Rosario/0000-0002-5641-6246; Jiménez-Guerrero, Irene/0000-0001-8661-5361; Lopez-Baena, Francisco Javier/0000-0001-7799-0338; Lloret, Javier/0000-0003-1284-4510; del Cerro Sánhez, Pablo PdC/0000-0002-8030-7226; Pérez-Montaño, Francisco/0000-0002-6272-2063; del Cerro Sánchez, Pablo/0000-0002-8030-7226; Ollero Marquez, Francisco Javier/0000-0002-3641-7946	Spanish Ministerio de Economia y Competitividad [AGL2012-38831]; Junta de Andalucia, Consejeria de Innovacion, Ciencia y Empresas [P10-AGR-5821, P11-CVI-7050]; FPU fellowship from the Spanish Ministerio de Ciencia y Tecnologia; University of Seville	Spanish Ministerio de Economia y Competitividad(Spanish Government); Junta de Andalucia, Consejeria de Innovacion, Ciencia y Empresas(Junta de Andalucia); FPU fellowship from the Spanish Ministerio de Ciencia y Tecnologia; University of Seville	This work was supported by the following grants: AGL2012-38831 from the Spanish Ministerio de Economia y Competitividad, http://www.idi.mineco.gob.es/portal/site/MICINN/ P10-AGR- 5821 and P11-CVI-7050 from the Junta de Andalucia, Consejeria de Innovacion, Ciencia y Empresas. http://www.juntadeandalucia.es/organismos/economiainnovacioncienciayempleo.html. Dr. Perez-Montano's work was supported by an FPU fellowship from the Spanish Ministerio de Ciencia y Tecnologia and a contract from the University of Seville. http://www.idi.mineco.gob.es/portal/site/MICINN/ http://www.us.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barahona E, 2010, ENVIRON MICROBIOL, V12, P3185, DOI 10.1111/j.1462-2920.2010.02291.x; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Cha C, 1998, MOL PLANT MICROBE IN, V11, P1119, DOI 10.1094/MPMI.1998.11.11.1119; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; de Lyra MDCP, 2006, INT MICROBIOL, V9, P125; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fujishige NA, 2006, FEMS MICROBIOL ECOL, V56, P195, DOI 10.1111/j.1574-6941.2005.00044.x; Fujishige NA, 2008, MOL MICROBIOL, V67, P504, DOI 10.1111/j.1365-2958.2007.06064.x; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gonzalez JE, 2003, MICROBIOL MOL BIOL R, V67, P574, DOI 10.1128/MMBR.67.4.574-592.2003; He XS, 2003, J BACTERIOL, V185, P809, DOI 10.1128/JB.185.3.809-822.2003; Lopez-Baena FJ, 2009, MOL PLANT MICROBE IN, V22, P1445, DOI 10.1094/MPMI-22-11-1445; Jitacksorn S, 2008, APPL ENVIRON MICROB, V74, P3749, DOI 10.1128/AEM.02939-07; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Krause A, 2002, MOL PLANT MICROBE IN, V15, P1228, DOI 10.1094/MPMI.2002.15.12.1228; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lamrabet Y, 1999, MOL PLANT MICROBE IN, V12, P207, DOI 10.1094/MPMI.1999.12.3.207; Loh JT, 2001, MOL MICROBIOL, V42, P37, DOI 10.1046/j.1365-2958.2001.02625.x; Lopez-Baena FJ, 2008, MICROBIOL-SGM, V154, P1825, DOI 10.1099/mic.0.2007/016337-0; Marketon MM, 2003, J BACTERIOL, V185, P325, DOI 10.1128/JB.185.1.325-331.2003; Maurhofer M, 1998, PHYTOPATHOLOGY, V88, P678, DOI 10.1094/PHYTO.1998.88.7.678; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Mueller K, 2011, J BACTERIOL, V193, P485, DOI 10.1128/JB.01129-10; Murray JD, 2011, MOL PLANT MICROBE IN, V24, P631, DOI 10.1094/MPMI-08-10-0181; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Ohtani K, 2002, MOL MICROBIOL, V44, P171, DOI 10.1046/j.1365-2958.2002.02863.x; Perez-Montano F, 2013, RES MICROBIOL, V164, P749, DOI 10.1016/j.resmic.2013.04.001; Perez-Montano F, 2011, RES MICROBIOL, V162, P715, DOI 10.1016/j.resmic.2011.05.002; Piper KR, 2000, J BACTERIOL, V182, P1080, DOI 10.1128/JB.182.4.1080-1088.2000; Quinones B, 2005, MOL PLANT MICROBE IN, V18, P682, DOI 10.1094/MPMI-18-0682; Reimmann C, 2002, MICROBIOL-SGM, V148, P923, DOI 10.1099/00221287-148-4-923; Rice SA, 2005, J BACTERIOL, V187, P3477, DOI 10.1128/JB.187.10.3477-3485.2005; Rinaudi L, 2006, RES MICROBIOL, V157, P867, DOI 10.1016/j.resmic.2006.06.002; Rinaudi LV, 2010, FEMS MICROBIOL LETT, V304, P1, DOI 10.1111/j.1574-6968.2009.01840.x; Rinaudi LV, 2009, J BACTERIOL, V191, P7216, DOI 10.1128/JB.01063-09; Rodriguez-Navarro DN, 2003, EUR J AGRON, V19, P299, DOI 10.1016/S1161-0301(02)00076-X; Russo DM, 2006, J BACTERIOL, V188, P4474, DOI 10.1128/JB.00246-06; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SIMON R, 1984, MOL GEN GENET, V196, P413, DOI 10.1007/BF00436188; Somers E, 2004, CRIT REV MICROBIOL, V30, P205, DOI 10.1080/10408410490468786; Stanley NR, 2004, MOL MICROBIOL, V52, P917, DOI 10.1111/j.1365-2958.2004.04036.x; Stuurman N, 2000, MOL PLANT MICROBE IN, V13, P1163, DOI 10.1094/MPMI.2000.13.11.1163; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Vinardell JM, 2004, MOL PLANT MICROBE IN, V17, P676, DOI 10.1094/MPMI.2004.17.6.676; Vincent JM, 1970, MANUAL PRACTICAL STU, P144; Wells DH, 2007, MOL MICROBIOL, V64, P647, DOI 10.1111/j.1365-2958.2007.05680.x	47	40	43	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105901	10.1371/journal.pone.0105901	http://dx.doi.org/10.1371/journal.pone.0105901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166872	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303700052
J	Seifi, A; Carr, K; Maltenfort, M; Moussouttas, M; Birnbaum, L; Parra, A; Adogwa, O; Bell, R; Rincon, F				Seifi, Ali; Carr, Kevin; Maltenfort, Mitchell; Moussouttas, Michael; Birnbaum, Lee; Parra, Augusto; Adogwa, Owoicho; Bell, Rodney; Rincon, Fred			The Incidence and Risk Factors of Associated Acute Myocardial Infarction (AMI) in Acute Cerebral Ischemic (ACI) Events in the United States	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; HEALTH-CARE PROFESSIONALS; THROMBOLYTIC THERAPY; UNIVERSAL DEFINITION; STROKE PATIENTS; MORTALITY; CARDIOLOGY; SURVIVAL; 1ST-EVER; COUNCIL	Objectives: To determine the association between myocardial infarction (AMI) and clinical outcome in patients with primary admissions diagnosis of acute cerebral ischemia (ACI) in the US. Methods: Data from Nationwide Inpatient Sample (NIS) was queried from 2002-2011 for inpatient admissions of patients with a primary diagnosis of ACI with and without AMI using International Classification of Diseases, Ninth Revision, Clinical Modification coding (ICD-9). A multivariate stepwise regression analysis was performed to assess the correlation between identifiable risk factors and clinical outcomes. Results: During 10 years the NIS recorded 886,094 ACI admissions with 17,526 diagnoses of AMI (1.98%). The overall cumulative mortality of cohort was 5.65%. In-hospital mortality was associated with AMI (aOR 3.68; 95% CI 3.49-3.88, p <= 0.0001), rTPA administration (aOR 2.39 CI, 2.11-2.71, p<0.0001), older age (aOR 1.03, 95% CI, 1.03-1.03, P<0.0001) and women (aOR 1.06, 95% CI 1.03-1.08, P<0.0001). Overall, mortality risk declined over the course of study; from 20.46% in 2002 to 11.8% in 2011 (OR 0.96, 95% CI 0.95-0.96, P<0.0001). Survival analysis demonstrated divergence between the AMI and non-AMI sub-groups over the course of study (log-rank p<0.0001). Conclusion: Our study demonstrates that although the prevalence of AMI in patients hospitalized with primary diagnosis of ACI is low, it negatively impacts survival. Considering the high clinical burden of AMI on mortality of ACI patients, a high quality monitoring in the event of cardiac events should be maintained in this patient cohort. Whether prompt diagnosis and treatment of associated cardiovascular diseases may improve outcome, deserves further study.	[Seifi, Ali; Carr, Kevin; Birnbaum, Lee; Parra, Augusto] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol Surg, San Antonio, TX 78229 USA; [Maltenfort, Mitchell] Thomas Jefferson Univ, Rothman Inst, Philadelphia, PA 19107 USA; [Moussouttas, Michael] Capital Inst Neurosci, Div Neuro Crit Care, Trenton, NJ USA; [Birnbaum, Lee; Parra, Augusto] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; [Adogwa, Owoicho] Duke Univ, Med Ctr, Dept Surg, Div Neurosurg, Durham, NC 27710 USA; [Bell, Rodney; Rincon, Fred] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA; [Bell, Rodney; Rincon, Fred] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA	University of Texas System; University of Texas Health San Antonio; Jefferson University; Rothman Institute; University of Texas System; University of Texas Health San Antonio; Duke University; Jefferson University; Jefferson University	Seifi, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol Surg, San Antonio, TX 78229 USA.	Seifi@uthscsa.edu	Seifi, Ali/AAR-6163-2020	Rincon, Fred/0000-0002-8510-118X; Maltenfort, Mitchell/0000-0002-0141-1720				Abtahian F, 2011, AM J CARDIOL, V107, P1441, DOI 10.1016/j.amjcard.2011.01.020; Adams HP, 1996, CIRCULATION, V94, P1167, DOI 10.1161/01.CIR.94.5.1167; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Adams RJ, 2003, STROKE, V34, P2310, DOI 10.1161/01.STR.0000090125.28466.E2; Adatia S, 2010, ANN INDIAN ACAD NEUR, V13, P64, DOI 10.4103/0972-2327.61282; Alberts MJ, 2005, STROKE, V36, P1597, DOI 10.1161/01.STR.0000170622.07210.b4; Alberts MJ, 2000, JAMA-J AM MED ASSOC, V283, P3102, DOI 10.1001/jama.283.23.3102; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Amarenco P, 2011, STROKE, V42, P22, DOI 10.1161/STROKEAHA.110.584086; [Anonymous], 1986, LANCET, V1, P397; Balami JS, 2013, CNS NEUROL DISORD-DR, V12, P155; Brott TG, 2011, J AM COLL CARDIOL, V57, P1002, DOI 10.1016/j.jacc.2010.11.005; Calvet D, 2010, CIRCULATION, V121, P1623, DOI 10.1161/CIRCULATIONAHA.109.906958; Chalela JA, 2004, NEUROCRIT CARE, V1, P343, DOI 10.1385/NCC:1:3:343; Dai XM, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000004; Derex L, 2001, NEUROLOGY, V57, P2122, DOI 10.1212/WNL.57.11.2122; Di Carlo A, 2009, AGE AGEING, V38, P4, DOI 10.1093/ageing/afn282; Franzosi MG, 1998, CIRCULATION, V98, P2659, DOI 10.1161/01.CIR.98.24.2659; GARRAWAY WM, 1987, JAMA-J AM MED ASSOC, V258, P214, DOI 10.1001/jama.258.2.214; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Govan L, 2007, STROKE, V38, P2536, DOI 10.1161/STROKEAHA.106.478842; Hankey GJ, 2000, STROKE, V31, P2080, DOI 10.1161/01.STR.31.9.2080; HERTZER NR, 1985, ARCH INTERN MED, V145, P849, DOI 10.1001/archinte.145.5.849; Heuschmann PU, 2004, JAMA-J AM MED ASSOC, V292, P1831, DOI 10.1001/jama.292.15.1831; Ingall Timothy, 2004, J Insur Med, V36, P143; James AH, 2006, CIRCULATION, V113, P1564, DOI 10.1161/CIRCULATIONAHA.105.576751; Jensen JK, 2007, AM J CARDIOL, V99, P867, DOI 10.1016/j.amjcard.2006.10.052; Khera S, 2013, INT J CARDIOL; Langer A, 1996, J AM COLL CARDIOL, V27, P1327, DOI 10.1016/0735-1097(96)00012-5; Liao J, 2009, EUR J NEUROL, V16, P1035, DOI 10.1111/j.1468-1331.2009.02647.x; Mehdiratta M, 2007, CAN J NEUROL SCI, V34, P417, DOI 10.1017/S0317167100007289; Micheli S, 2012, J NEUROL, V259, P106, DOI 10.1007/s00415-011-6136-4; Minino Arialdi M, 2011, Natl Vital Stat Rep, V59, P1; NORRIS JW, 1979, STROKE, V10, P548, DOI 10.1161/01.STR.10.5.548; Reed SD, 2001, STROKE, V32, P1832, DOI 10.1161/01.STR.32.8.1832; Rincon F, 2013, NEUROSURGERY, V73, P217, DOI 10.1227/01.neu.0000430290.93304.33; Sen S, 2004, J NEUROL NEUROSUR PS, V75, P1421, DOI 10.1136/jnnp.2004.038687; Soros P, 2012, LANCET NEUROL, V11, P179, DOI 10.1016/S1474-4422(11)70291-5; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Wardlaw JM, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000213; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; YASAKA M, 1994, ANGIOLOGY, V45, P481, DOI 10.1177/000331979404500611	46	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105785	10.1371/journal.pone.0105785	http://dx.doi.org/10.1371/journal.pone.0105785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166915	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303700045
J	Shepherd, DN; Dugdale, B; Martin, DP; Varsani, A; Lakay, FM; Bezuidenhout, ME; Monjane, AL; Thomson, JA; Dale, J; Rybicki, EP				Shepherd, Dionne N.; Dugdale, Benjamin; Martin, Darren P.; Varsani, Arvind; Lakay, Francisco M.; Bezuidenhout, Marion E.; Monjane, Aderito L.; Thomson, Jennifer A.; Dale, James; Rybicki, Edward P.			Inducible Resistance to Maize Streak Virus	PLOS ONE			English	Article							GEMINIVIRUS REPLICATION PROTEIN; WHEAT DWARF VIRUS; NEW-DELHI-VIRUS; CONSERVED NONANUCLEOTIDE MOTIF; NUCLEAR SHUTTLE PROTEIN; INITIATOR PROTEIN; PEPTIDE APTAMERS; DNA-REPLICATION; IN-VITRO; EXPRESSION	Maize streak virus (MSV), which causes maize streak disease (MSD), is the major viral pathogenic constraint on maize production in Africa. Type member of the Mastrevirus genus in the family Geminiviridae, MSV has a 2.7 kb, single-stranded circular DNA genome encoding a coat protein, movement protein, and the two replication-associated proteins Rep and RepA. While we have previously developed MSV-resistant transgenic maize lines constitutively expressing "dominant negative mutant'' versions of the MSV Rep, the only transgenes we could use were those that caused no developmental defects during the regeneration of plants in tissue culture. A better transgene expression system would be an inducible one, where resistance-conferring transgenes are expressed only in MSV-infected cells. However, most known inducible transgene expression systems are hampered by background or "leaky'' expression in the absence of the inducer. Here we describe an adaptation of the recently developed INPACT system to express MSV-derived resistance genes in cell culture. Split gene cassette constructs (SGCs) were developed containing three different transgenes in combination with three different promoter sequences. In each SGC, the transgene was split such that it would be translatable only in the presence of an infecting MSV's replication associated protein. We used a quantitative real-time PCR assay to show that one of these SGCs (pSPLITrep(III-Rb-)Ubi) inducibly inhibits MSV replication as efficiently as does a constitutively expressed transgene that has previously proven effective in protecting transgenic maize from MSV. In addition, in our cell-culture based assay pSPLITrep(III-Rb-)Ubi inhibited replication of diverse MSV strains, and even, albeit to a lesser extent, of a different mastrevirus species. The application of this new technology to MSV resistance in maize could allow a better, more acceptable product.	[Shepherd, Dionne N.; Lakay, Francisco M.; Bezuidenhout, Marion E.; Monjane, Aderito L.; Thomson, Jennifer A.; Rybicki, Edward P.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, South Africa; [Martin, Darren P.; Monjane, Aderito L.; Rybicki, Edward P.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Martin, Darren P.] Ctr High Performance Comp, Cape Town, South Africa; [Dugdale, Benjamin; Dale, James] Queensland Univ Technol, Ctr Trop Crops & Biocommod, Brisbane, Qld 4001, Australia; [Varsani, Arvind] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Varsani, Arvind] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand; [Varsani, Arvind] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Varsani, Arvind] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Varsani, Arvind] Univ Cape Town, Dept Clin Lab Sci, Div Med Biochem, Electron Microscope Unit, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; Queensland University of Technology (QUT); University of Canterbury; University of Canterbury; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Cape Town	Shepherd, DN (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, South Africa.	Dionne.shepherd@gmail.com	Martin, Darren/ABE-3614-2021; Martin, Darren P/C-4599-2008; Monjane, Adérito Luis/AAO-6997-2020; Rybicki, Edward/D-6138-2014	Rybicki, Edward/0000-0001-8024-9911; Dale, James/0000-0002-7910-5707; Varsani, Arvind/0000-0003-4111-2415	PANNAR (Pty) LTD	PANNAR (Pty) LTD	Funding was provided by PANNAR (Pty) LTD, http://www.pannar.com, to DNS, EPR and JAT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGUELLOASTORGA G, 1994, PLANT MOL BIOL, V26, P553, DOI 10.1007/BF00013742; ARGUELLOASTORGA GR, 1994, VIROLOGY, V203, P90, DOI 10.1006/viro.1994.1458; Bosque-Perez NA, 2000, VIRUS RES, V71, P107, DOI 10.1016/S0168-1702(00)00192-1; CALLIS J, 1987, GENE DEV, V1, P1183, DOI 10.1101/gad.1.10.1183; Chatterji A, 2001, J BIOL CHEM, V276, P25631, DOI 10.1074/jbc.M100030200; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; DONSON J, 1984, EMBO J, V3, P3069, DOI 10.1002/j.1460-2075.1984.tb02260.x; Dugdale B, 2014, NAT PROTOC IN PRESS; Dugdale B, 2013, PLANT CELL, V25, P2429, DOI 10.1105/tpc.113.113944; Dunder E., 1995, P127; FONTES EPB, 1992, PLANT CELL, V4, P597, DOI 10.1105/tpc.4.5.597; FONTES EPB, 1994, J BIOL CHEM, V269, P8459; Hartley RW, 1989, TRENDS BIOCH SCI; HAYES RJ, 1988, J GEN VIROL, V69, P1345, DOI 10.1099/0022-1317-69-6-1345; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HEYRAUD F, 1993, BIOCHIMIE, V75, P605, DOI 10.1016/0300-9084(93)90067-3; HEYRAUDNITSCHKE F, 1995, NUCLEIC ACIDS RES, V23, P910, DOI 10.1093/nar/23.6.910; Hong Y, 1996, VIROLOGY, V220, P119, DOI 10.1006/viro.1996.0292; Horvath GV, 1998, PLANT MOL BIOL, V38, P699, DOI 10.1023/A:1006076316887; Hussain M, 2005, J VIROL, V79, P4434, DOI 10.1128/JVI.79.7.4434-4439.2005; Hussain M, 2007, MOL PLANT MICROBE IN, V20, P1581, DOI 10.1094/MPMI-20-12-1581; KAMMANN M, 1991, VIROLOGY, V184, P786, DOI 10.1016/0042-6822(91)90453-I; Laufs J, 1995, BIOCHIMIE, V77, P765, DOI 10.1016/0300-9084(96)88194-6; LAUFS J, 1995, P NATL ACAD SCI USA, V92, P3879, DOI 10.1073/pnas.92.9.3879; LAZAROWITZ SG, 1989, EMBO J, V8, P1023, DOI 10.1002/j.1460-2075.1989.tb03469.x; Legg JP, 2004, PLANT MOL BIOL, V56, P585, DOI 10.1007/s11103-004-1651-7; Lopez-Ochoa L, 2006, J VIROL, V80, P5841, DOI 10.1128/JVI.02698-05; Martin DP, 2009, FOOD SECUR, V1, P305, DOI 10.1007/s12571-009-0023-1; Martin DP, 2001, VIROLOGY, V288, P247, DOI 10.1006/viro.2001.1075; Missich R, 2000, VIROLOGY, V273, P178, DOI 10.1006/viro.2000.0412; Moffat AS, 1999, SCIENCE, V286, P1835, DOI 10.1126/science.286.5446.1835; Muhire B, 2013, ARCH VIROL, V158, P1411, DOI 10.1007/s00705-012-1601-7; Orozco BM, 2000, J BIOL CHEM, V275, P6114, DOI 10.1074/jbc.275.9.6114; Owor BE, 2011, J GEN VIROL, V92, P2458, DOI 10.1099/vir.0.032862-0; Reyes MI, 2013, J VIROL, V87, P9691, DOI 10.1128/JVI.01095-13; Ruschhaupt M, 2013, VIROLOGY, V442, P173, DOI 10.1016/j.virol.2013.04.012; Schnippenkoetter WH, 2001, ARCH VIROL, V146, P1075, DOI 10.1007/s007050170107; Sera T, 2005, J VIROL, V79, P2614, DOI 10.1128/JVI.79.4.2614-2619.2005; Shepherd DN, 2007, PLANT BIOTECHNOL J, V5, P759, DOI 10.1111/j.1467-7652.2007.00279.x; Shepherd DN, 2007, J GEN VIROL, V88, P325, DOI 10.1099/vir.0.82338-0; Shepherd DN, 2010, MOL PLANT PATHOL, V11, P1, DOI [10.1111/j.1364-3703.2009.00568.x, 10.1111/j.1364-3703.2009.00568.X]; Shepherd DN, 2009, PLANT SCI, V176, P1, DOI 10.1016/j.plantsci.2008.08.011; Shepherd DN, 2005, J GEN VIROL, V86, P803, DOI 10.1099/vir.0.80694-0; Singh DK, 2008, VIROLOGY, V380, P75, DOI 10.1016/j.virol.2008.07.010; STANLEY J, 1995, VIROLOGY, V206, P707, DOI 10.1016/S0042-6822(95)80093-X; STANLEY J, 1986, NUCLEIC ACIDS RES, V14, P5981, DOI 10.1093/nar/14.15.5981; STENGER DC, 1991, P NATL ACAD SCI USA, V88, P8029, DOI 10.1073/pnas.88.18.8029; TOPFER R, 1990, PHYSIOL PLANTARUM, V79, P158, DOI 10.1111/j.1399-3054.1990.tb05879.x; Vanderschuren H, 2007, PLANT BIOTECHNOL J, V5, P207, DOI 10.1111/j.1467-7652.2006.00217.x; Varsani A, 2008, ARCH VIROL, V153, P601, DOI 10.1007/s00705-007-0020-7; Varsani A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-194; Wang T, 2004, BIOPHYS J, V87, P1618, DOI 10.1529/biophysj.104.040964; Willment JA, 2002, PHYTOPATHOLOGY, V92, P81, DOI 10.1094/PHYTO.2002.92.1.81; Willment JA, 2007, J GEN VIROL, V88, P1831, DOI 10.1099/vir.0.82513-0; Zhang P, 2003, PLANT BIOTECHNOLOGY 2002 AND BEYOND, P143	56	11	11	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105932	10.1371/journal.pone.0105932	http://dx.doi.org/10.1371/journal.pone.0105932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166274	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303700057
J	Vogel, LK; Saebo, M; Hoyer, H; Kopp, TI; Vogel, U; Godiksen, S; Frenzel, FB; Hamfjord, J; Bowitz-Lothe, IM; Johnson, E; Kure, EH; Andersen, V				Vogel, Lotte K.; Saebo, Mona; Hoyer, Helle; Kopp, Tine Iskov; Vogel, Ulla; Godiksen, Sine; Frenzel, Franz B.; Hamfjord, Julian; Bowitz-Lothe, Inger Marie; Johnson, Egil; Kure, Elin H.; Andersen, Vibeke			Intestinal PTGS2 mRNA Levels, PTGS2 Gene Polymorphisms, and Colorectal Carcinogenesis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CYCLOOXYGENASE-2 EXPRESSION; RISK-FACTORS; NSAID USE; CANCER; ADENOMAS; CARCINOMAS; COX-2; CHEMOPREVENTION; METAANALYSIS	Background & Aims: Inflammation is a major risk factor for development of colorectal cancer (CRC). Prostaglandin synthase cyclooxygenase-2 (COX-2) encoded by the PTGS2 gene is the rate limiting enzyme in prostaglandin synthesis and therefore plays a distinct role as regulator of inflammation. Methods: PTGS2 mRNA levels were determined in intestinal tissues from 85 intestinal adenoma cases, 115 CRC cases, and 17 healthy controls. The functional PTGS2 polymorphisms A-1195G (rs689466), G-765C (rs20417), T8473C (rs5275) were assessed in 200 CRC cases, 991 adenoma cases and 399 controls from the Norwegian KAM cohort. Results: PTGS2 mRNA levels were higher in mild/moderate adenoma tissue compared to morphologically normal tissue from the same individual (P<0.0001) and (P<0.035) and compared to mucosa from healthy individuals (P<0.0039) and (P< 0.0027), respectively. In CRC patients, PTGS2 mRNA levels were 8-9 times higher both in morphologically normal tissue and in cancer tissue, compared to healthy individuals (P<0.0001). PTGS2 A-1195G variant allele carriers were at reduced risk of CRC (odds ratio (OR) = 0.52, 95% confidence interval (95% CI): 0.28-0.99, P = 0.047). Homozygous carriers of the haplotype encompassing the A-1195G and G-765C wild type alleles and the T8473C variant allele (PTGS2 AGC) were at increased risk of CRC as compared to homozygous carriers of the PTGS2 AGT (A-1195G, G-765C, T8473C) haplotype (OR = 5.37, 95% CI: 1.40-20.5, P = 0.014). No association between the investigated polymorphisms and PTGS2 mRNA levels could be detected. Conclusion: High intestinal PTGS2 mRNA level is an early event in colorectal cancer development as it occurs already in mild/moderate dysplasia. PTGS2 polymorphisms that have been associated with altered PTGS2 mRNA levels/COX-2 activity in some studies, although not the present study, were associated with colorectal cancer risk. Thus, both PTGS2 polymorphisms and PTGS2 mRNA levels may provide information regarding CRC risk.	[Vogel, Lotte K.; Godiksen, Sine; Frenzel, Franz B.] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark; [Saebo, Mona; Hoyer, Helle; Kure, Elin H.] Telemark Univ Coll, Dept Environm & Hlth Studies, Telemark, Norway; [Hoyer, Helle] Telemark Hosp, Dept Lab Med, Skien, Norway; [Kopp, Tine Iskov] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Hamfjord, Julian; Bowitz-Lothe, Inger Marie; Kure, Elin H.] Oslo Univ Hosp, Dept Genet, Oslo, Norway; [Bowitz-Lothe, Inger Marie] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Johnson, Egil] Oslo Univ Hosp, Dept Gastrointestinal & Pediat Surg, Oslo, Norway; [Johnson, Egil] Univ Oslo, Inst Clin Med, Oslo, Norway; [Andersen, Vibeke] Hosp Southern Jutland, Organ Ctr, Aabenraa, Denmark; [Andersen, Vibeke] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Andersen, Vibeke] Reg Hosp Viborg, Dept Med, Viborg, Denmark	University of Copenhagen; University College of Southeast Norway; Telemark Hospital Trust; Technical University of Denmark; National Research Centre for the Working Environment; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Southern Denmark	Vogel, LK (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark.	vogel@sund.ku.dk; elin.kure@rr-research.no	Andersen, Vibeke/I-7932-2012; Vogel, Ulla B/I-5048-2012; Vogel, Ulla/ABC-2212-2020	Andersen, Vibeke/0000-0002-0127-2863; Vogel, Ulla B/0000-0001-6807-1524; Vogel, Ulla/0000-0001-6807-1524; Vogel, Lotte K./0000-0001-9920-0982; Hoyer, Helle/0000-0002-5445-0520; Kopp, Tine/0000-0003-3729-4420	Norwegian Cancer Society; "Familien Erichsens Mindefond'', Viborg Regional Hospital, Hospital of Southern Jutland; Norwegian Colorectal Cancer Prevention (NORCCAP) study; Department of Health and Social Affairs	Norwegian Cancer Society(Norwegian Cancer Society); "Familien Erichsens Mindefond'', Viborg Regional Hospital, Hospital of Southern Jutland; Norwegian Colorectal Cancer Prevention (NORCCAP) study; Department of Health and Social Affairs	"Familien Erichsens Mindefond'', Viborg Regional Hospital, Hospital of Southern Jutland and the Norwegian Colorectal Cancer Prevention (NORCCAP) study (Grants from the Norwegian Cancer Society and the Department of Health and Social Affairs) have supported the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen V, 2013, ALIMENT PHARM THER, V37, P383, DOI 10.1111/apt.12180; Andersen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078366; Andersen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072119; Andersen V, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-183; Andersen V, 2011, INFLAMM BOWEL DIS, V17, P937, DOI 10.1002/ibd.21440; Andersen V, 2011, EUR J GASTROEN HEPAT, V23, P282, DOI 10.1097/MEG.0b013e3283417f76; Andersen V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-484; Benamouzig R, 2010, GUT, V59, P622, DOI 10.1136/gut.2008.175406; Bornholdt J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-65; Brosens LAA, 2005, CLIN CANCER RES, V11, P4090, DOI 10.1158/1078-0432.CCR-04-2379; Cao H, 2010, TOHOKU J EXP MED, V222, P15, DOI 10.1620/tjem.222.15; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Dong J, 2010, J GASTROEN HEPATOL, V25, P1042, DOI 10.1111/j.1440-1746.2010.06293.x; Friis S, 2009, CANCER CAUSE CONTROL, V20, P731, DOI 10.1007/s10552-008-9286-7; Gondal G, 2005, EUR J CANCER PREV, V14, P373, DOI 10.1097/00008469-200508000-00010; Hansen R, 2005, CANCER LETT, V229, P85, DOI 10.1016/j.canlet.2005.04.019; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Karsa LV, 2010, BEST PRACT RES CL GA, V24, P381, DOI 10.1016/j.bpg.2010.06.004; Lorentzen A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-192; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moore AE, 2012, ONCOGENE, V31, P1592, DOI 10.1038/onc.2011.349; Ostergaard M, 2009, SCAND J GASTROENTERO, V44, P65, DOI 10.1080/00365520802400826; Papafili A, 2002, ARTERIOSCL THROM VAS, V22, P1631, DOI 10.1161/01.ATV.0000030340.80207.C5; Saebo M, 2008, ANTICANCER RES, V28, P2289; Saebo M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-208; Selzer-Plon J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-201; Skjelbred CF, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-175; Skjelbred CF, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-228; Skjelbred CF, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-67; Skovbjerg H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-136; Vinogradova Y, 2011, BRIT J CANCER, V105, P452, DOI 10.1038/bjc.2011.252; Vogel LK, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-176; Vogel U, 2008, MUTAT RES-FUND MOL M, V639, P89, DOI 10.1016/j.mrfmmm.2007.11.004; Vogel U, 2007, MUTAT RES-FUND MOL M, V617, P138, DOI 10.1016/j.mrfmmm.2007.01.005; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003	35	29	30	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105254	10.1371/journal.pone.0105254	http://dx.doi.org/10.1371/journal.pone.0105254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166592	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303700019
J	Baumann, MU; Schneider, H; Malek, A; Palta, V; Surbek, DV; Sager, R; Zamudio, S; Illsley, NP				Baumann, Marc U.; Schneider, Henning; Malek, Antoine; Palta, Vidya; Surbek, Daniel V.; Sager, Ruth; Zamudio, Stacy; Illsley, Nicholas P.			Regulation of Human Trophoblast GLUT1 Glucose Transporter by Insulin-Like Growth Factor I (IGF-I)	PLOS ONE			English	Article							MATERNAL NUTRIENT RESTRICTION; INTRAUTERINE GROWTH; HUMAN PLACENTA; AMINO-ACIDS; PROTEIN EXPRESSION; BINDING-PROTEINS; DOWN-REGULATION; FETAL-GROWTH; TERM; SYNCYTIOTROPHOBLAST	Glucose transport to the fetus across the placenta takes place via glucose transporters in the opposing faces of the barrier layer, the microvillous and basal membranes of the syncytiotrophoblast. While basal membrane content of the GLUT1 glucose transporter appears to be the rate-limiting step in transplacental transport, the factors regulating transporter expression and activity are largely unknown. In view of the many studies showing an association between IGF-I and fetal growth, we investigated the effects of IGF-I on placental glucose transport and GLUT1 transporter expression. Treatment of BeWo choriocarcinoma cells with IGF-I increased cellular GLUT1 protein. There was increased basolateral (but not microvillous) uptake of glucose and increased transepithelial transport of glucose across the BeWo monolayer. Primary syncytial cells treated with IGF-I also demonstrated an increase in GLUT1 protein. Term placental explants treated with IGF-I showed an increase in syncytial basal membrane GLUT1 but microvillous membrane GLUT1 was not affected. The placental dual perfusion model was used to assess the effects of fetally perfused IGF-I on transplacental glucose transport and syncytial GLUT1 content. In control perfusions there was a decrease in transplacental glucose transport over the course of the perfusion, whereas in tissues perfused with IGF-I through the fetal circulation there was no change. Syncytial basal membranes from IGF-I perfused tissues showed an increase in GLUT1 content. These results demonstrate that IGF-I, whether acting via microvillous or basal membrane receptors, increases the basal membrane content of GLUT1 and up-regulates basal membrane transport of glucose, leading to increased transepithelial glucose transport. These observations provide a partial explanation for the mechanism by which IGF-I controls nutrient supply in the regulation of fetal growth.	[Baumann, Marc U.; Schneider, Henning; Malek, Antoine; Surbek, Daniel V.; Sager, Ruth] Univ Bern, Inselspital, Dept Obstet & Gynecol, CH-3010 Bern, Switzerland; [Palta, Vidya] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Obstet, Newark, NJ 07103 USA; [Zamudio, Stacy; Illsley, Nicholas P.] Hackensack Univ, Med Ctr, Ctr Abnormal Placentat, Dept Obstet & Gynecol, Hackensack, NJ 07601 USA	University of Bern; University Hospital of Bern; Rutgers State University New Brunswick; Rutgers State University Medical Center; Hackensack University Medical Center	Illsley, NP (corresponding author), Hackensack Univ, Med Ctr, Ctr Abnormal Placentat, Dept Obstet & Gynecol, Hackensack, NJ 07601 USA.	NIllsley@hackensackUMC.org		Illsley, Nicholas/0000-0002-4336-2832; Surbek, Daniel/0000-0001-7705-1584	United States National Institutes of Health (NIH) [HD046982]; Swiss National Research Foundation [3200-061771.00]; Swiss National Science Foundation Grant (NCCR TransCure); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046982] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation Grant (NCCR TransCure); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding provided by United States National Institutes of Health (NIH HD046982; NI, SZ), Swiss National Research Foundation Grant (3200-061771.00; HS) and Swiss National Science Foundation Grant (NCCR TransCure; MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin R, 2005, TRAFFIC, V6, P1196, DOI 10.1111/j.1600-0854.2005.00354.x; Bajoria R, 2002, J CLIN ENDOCR METAB, V87, P308, DOI 10.1210/jc.87.1.308; BARROS LF, 1995, PLACENTA, V16, P623, DOI 10.1016/0143-4004(95)90031-4; Baumann MU, 2007, AM J PHYSIOL-CELL PH, V293, pC477, DOI 10.1152/ajpcell.00075.2007; Bibee KP, 2011, REPROD SCI, V18, P20, DOI 10.1177/1933719110380276; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown K, 2011, PLACENTA, V32, P1041, DOI 10.1016/j.placenta.2011.09.014; Chellakooty M, 2004, J CLIN ENDOCR METAB, V89, P384, DOI 10.1210/jc.2003-030282; Cohran V, 1996, PLACENTA, V17, P313, DOI 10.1016/S0143-4004(96)90055-7; Cowley EA, 2005, AM J PHYSIOL-CELL PH, V288, pC891, DOI 10.1152/ajpcell.00134.2004; Davidson S, 2006, CLIN ENDOCRINOL, V65, P586, DOI 10.1111/j.1365-2265.2006.02632.x; Di Santo S, 2003, PLACENTA, V24, P882, DOI 10.1016/S0143-4004(03)00142-5; Fladeby C, 2003, BBA-MOL CELL RES, V1593, P201, DOI 10.1016/S0167-4889(02)00390-7; Gaither K, 1999, J CLIN ENDOCR METAB, V84, P695, DOI 10.1210/jc.84.2.695; Gatford KL, 2008, AM J PHYSIOL-ENDOC M, V295, pE170, DOI 10.1152/ajpendo.00047.2008; GRULLON K, 1995, PLACENTA, V16, P589, DOI 10.1016/0143-4004(95)90028-4; Heasman L, 2000, REPROD FERT DEVELOP, V12, P345, DOI 10.1071/RD00115; Hiden U, 2009, J ANAT, V215, P60, DOI 10.1111/j.1469-7580.2008.01035.x; Jansson N, 2006, J PHYSIOL-LONDON, V576, P935, DOI 10.1113/jphysiol.2003.550004; JANSSON T, 1993, J CLIN ENDOCR METAB, V77, P1554, DOI 10.1210/jc.77.6.1554; Jansson T, 2001, AM J OBSTET GYNECOL, V184, P111, DOI 10.1067/mob.2001.108075; JANSSON T, 1990, PEDIATR RES, V28, P203, DOI 10.1203/00006450-199009000-00007; Jones HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074632; Kavitha JV, 2014, FASEB J, V28, P1294, DOI 10.1096/fj.13-242271; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; Li T, 2003, CIRC RES, V93, P1202, DOI 10.1161/01.RES.0000104085.76261.02; Luo ZC, 2012, J CLIN ENDOCR METAB, V97, P1720, DOI 10.1210/jc.2011-3296; Magnusson-Olsson AL, 2006, J LIPID RES, V47, P2551, DOI 10.1194/jlr.M600098-JLR200; Masuyama H, 1996, J PERINAT MED, V24, P213, DOI 10.1515/jpme.1996.24.3.213; Matthews JC, 1999, PLACENTA, V20, P639, DOI 10.1053/plac.1999.0421; Olausson H, 2010, BRIT J NUTR, V104, P842, DOI 10.1017/S0007114510001224; OWENS JA, 1994, J ENDOCRINOL, V140, P5, DOI 10.1677/joe.0.1400005; Palmer ME, 1997, HUM REPROD, V12, P379, DOI 10.1093/humrep/12.2.379; Rebourcet R, 1998, BIOL REPROD, V58, P37, DOI 10.1095/biolreprod58.1.37; Russo VC, 2004, BRAIN RES, V1009, P40, DOI 10.1016/j.brainres.2004.02.042; SCHNEIDE.H, 1972, AM J OBSTET GYNECOL, V114, P822, DOI 10.1016/0002-9378(72)90909-X; Schneider H, 2003, PLACENTA, V24, P27, DOI 10.1053/plac.2002.0869; Sferruzzi-Perri AN, 2011, J PHYSIOL-LONDON, V589, P7, DOI 10.1113/jphysiol.2010.198622; Sferruzzi-Perri AN, 2007, ENDOCRINOLOGY, V148, P4362, DOI 10.1210/en.2007-0411; Siman CM, 2001, AM J PHYSIOL-REG I, V280, pR1116, DOI 10.1152/ajpregu.2001.280.4.R1116; Vardhana PA, 2002, PLACENTA, V23, P653, DOI 10.1053/plac.2002.0857; Vatten LJ, 2002, PEDIATRICS, V109, P1131, DOI 10.1542/peds.109.6.1131; Verleysdonk S, 2004, NEUROCHEM RES, V29, P127, DOI 10.1023/B:NERE.0000010441.08234.ca; Wallborn T, 2010, J CLIN ENDOCR METAB, V95, P2316, DOI 10.1210/jc.2009-2404; WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7; Williams SF, 2012, PLACENTA, V33, P31, DOI 10.1016/j.placenta.2011.09.021; Zamudio S, 2006, PLACENTA, V27, P49, DOI 10.1016/j.placenta.2004.12.010; Zamudio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008551	48	53	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e106037	10.1371/journal.pone.0106037	http://dx.doi.org/10.1371/journal.pone.0106037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157747	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200086
J	Karkehabadi, S; Helmich, KE; Kaper, T; Hansson, H; Mikkelsen, NE; Gudmundsson, M; Piens, K; Fujdala, M; Banerjee, G; Scott-Craig, JS; Walton, JD; Phillips, GN; Sandgren, M				Karkehabadi, Saeid; Helmich, Kate E.; Kaper, Thijs; Hansson, Henrik; Mikkelsen, Nils-Egil; Gudmundsson, Mikael; Piens, Kathleen; Fujdala, Meredith; Banerjee, Goutami; Scott-Craig, John S.; Walton, Jonathan D.; Phillips, George N., Jr.; Sandgren, Mats			Biochemical Characterization and Crystal Structures of a Fungal Family 3 beta-Glucosidase, Cel3A from Hypocrea jecorina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING REGION; TRICHODERMA-REESEI; MACROMOLECULAR STRUCTURES; 3-DIMENSIONAL STRUCTURE; FUNCTIONAL EXPRESSION; STRUCTURE REFINEMENT; STRUCTURE VALIDATION; MAXIMUM-LIKELIHOOD; DIFFRACTION DATA; HYDROLASE	Cellulase mixtures from Hypocrea jecorina are commonly used for the saccharification of cellulose in biotechnical applications. The most abundant beta-glucosidase in the mesophilic fungus Hypocrea jecorina is HjCel3A, which hydrolyzes the beta-linkage between two adjacent molecules in dimers and short oligomers of glucose. It has been shown that enhanced levels of HjCel3A in H. jecorina cellulase mixtures benefit the conversion of cellulose to glucose. Biochemical characterization of HjCel3A shows that the enzyme efficiently hydrolyzes (1,4)-as well as (1,2)-, (1,3)-, and (1,6)-beta-D-linked disaccharides. For crystallization studies, HjCel3A was produced in both H. jecorina (HjCel3A) and Pichia pastoris (Pp-HjCel3A). Whereas the thermostabilities of HjCel3A and Pp-HjCel3A are the same, Pp-HjCel3A has a higher degree of N-linked glycosylation. Here, we present x-ray structures of HjCel3A with and without glucose bound in the active site. The structures have a three-domain architecture as observed previously for other glycoside hydrolase family 3 beta-glucosidases. Both production hosts resulted in HjCel3A structures that have N-linked glycosylations at Asn(208) and Asn(310). In H. jecorina-produced HjCel3A, a single N-acetylglucosamine is present at both sites, whereas in Pp-HjCel3A, the P. pastoris-produced HjCel3A enzyme, the glycan chains consist of 8 or 4 saccharides. The glycosylations are involved in intermolecular contacts in the structures derived from either host. Due to the different sizes of the glycosylations, the interactions result in different crystal forms for the two protein forms.	[Karkehabadi, Saeid; Hansson, Henrik; Mikkelsen, Nils-Egil; Gudmundsson, Mikael; Piens, Kathleen; Sandgren, Mats] Swedish Univ Agr Sci, Dept Chem & Biotechnol, SE-75007 Uppsala, Sweden; [Helmich, Kate E.; Phillips, George N., Jr.] Univ Wisconsin, Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Helmich, Kate E.; Phillips, George N., Jr.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Kaper, Thijs; Fujdala, Meredith] DuPont Ind Biosci, Palo Alto, CA 94304 USA; [Banerjee, Goutami; Scott-Craig, John S.; Walton, Jonathan D.] Michigan State Univ, Dept Energy, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Phillips, George N., Jr.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Phillips, George N., Jr.] Rice Univ, Dept Chem, Houston, TX 77251 USA	Swedish University of Agricultural Sciences; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Michigan State University; United States Department of Energy (DOE); Rice University; Rice University	Phillips, GN (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	georgep@rice.edu; mats.sandgren@slu.se		Sandgren, Mats/0000-0002-2358-4534; Hansson, Henrik/0000-0002-6003-2982; Gudmundsson, Mikael/0000-0002-8095-4423	Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences; United States Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Office of Science Biological and Environmental Research (BER) [DE-FC02-07ER64494]	Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences; United States Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Office of Science Biological and Environmental Research (BER)(United States Department of Energy (DOE))	This work was supported in part by the Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences through the research program "MicroDrivE." Work in the laboratories of J. D. W. and G. N. P. was supported by the United States Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Office of Science Biological and Environmental Research (BER) Grant DE-FC02-07ER64494).	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Banerjee G, 2010, BIOTECHNOL BIOENG, V106, P707, DOI 10.1002/bit.22741; BARNETT CC, 1991, BIO-TECHNOL, V9, P562, DOI 10.1038/nbt0691-562; BEGUIN P, 1994, FEMS MICROBIOL REV, V13, P25, DOI 10.1016/0168-6445(94)90099-X; Bezerra RMF, 2006, APPL BIOCHEM BIOTECH, V134, P27, DOI 10.1385/ABAB:134:1:27; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CALLEBAUT I, 1994, J COMPUT AID MOL DES, V8, P175, DOI 10.1007/BF00119866; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHIRICO WJ, 1987, EUR J BIOCHEM, V165, P343, DOI 10.1111/j.1432-1033.1987.tb11447.x; CHIRICO WJ, 1987, EUR J BIOCHEM, V165, P333, DOI 10.1111/j.1432-1033.1987.tb11446.x; Collaborative Comuptational Project 4, 2002, ACTA CRYSTALLOGR D, V58, P1897; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Foreman P., 2005, International Patent, Patent No. [WO/2005/001036, 2005001036]; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Fujdala M. K., 2010, United States Patent, Patent No. [US2010/0221784A1, 20100221784]; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Gritzali M., 1979, HYDROLYSIS CELLULOSE, V181, P237, DOI DOI 10.1021/BA-1979-0181.CH012; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Hong J, 2007, APPL MICROBIOL BIOT, V73, P1331, DOI 10.1007/s00253-006-0618-9; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Hrmova M, 2005, BIOCHEMISTRY-US, V44, P16529, DOI 10.1021/bi0514818; HRMOVA M, 1995, J BIOL CHEM, V270, P14556, DOI 10.1074/jbc.270.24.14556; Hrmova M, 2004, J BIOL CHEM, V279, P4970, DOI 10.1074/jbc.M307188200; Hrmova M, 2002, PLANT CELL, V14, P1033, DOI 10.1105/tpc.010442; Hrmova M, 1998, J BIOL CHEM, V273, P11134, DOI 10.1074/jbc.273.18.11134; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kleywegt GJ, 1997, J MOL BIOL, V273, P371, DOI 10.1006/jmbi.1997.1309; Korotkova OG, 2009, BIOCHEMISTRY-MOSCOW+, V74, P569, DOI 10.1134/S0006297909050137; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krogh KBR, 2004, APPL BIOCHEM BIOTECH, V113, P389; Kumar R, 2009, BIOTECHNOL BIOENG, V102, P1544, DOI 10.1002/bit.22203; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liu DY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-25; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; McAndrew RP, 2013, J BIOL CHEM, V288, P14985, DOI 10.1074/jbc.M113.458356; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Pozzo T, 2010, J MOL BIOL, V397, P724, DOI 10.1016/j.jmb.2010.01.072; Saloheimo M, 1997, EUR J BIOCHEM, V249, P584, DOI 10.1111/j.1432-1033.1997.00584.x; Salvi DA, 2010, APPL BIOCHEM BIOTECH, V161, P67, DOI 10.1007/s12010-010-8932-1; Schwarzinger S, 2002, BIOCHEMISTRY-US, V41, P12681, DOI 10.1021/bi020381o; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stubbs KA, 2007, J BIOL CHEM, V282, P21382, DOI 10.1074/jbc.M700084200; Suzuki K, 2013, BIOCHEM J, V452, P211, DOI 10.1042/BJ20130054; TEERI TT, 1987, GENE, V51, P43, DOI 10.1016/0378-1119(87)90472-0; Tengborg C, 2001, BIOTECHNOL PROGR, V17, P110, DOI 10.1021/bp000145+; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Vogel H.J., 1956, MICROB GENET B, V13, P42; WALSETH CS, 1952, TAPPI, V35, P228; Wildt S, 2005, NAT REV MICROBIOL, V3, P119, DOI 10.1038/nrmicro1087; WOOD TM, 1971, BIOCHEM J, V121, P353, DOI 10.1042/bj1210353; Yoshida E, 2010, BIOCHEM J, V431, P39, DOI 10.1042/BJ20100351; Zhang JW, 2010, BIORESOURCE TECHNOL, V101, P9815, DOI 10.1016/j.biortech.2010.07.078; Zverlov VV, 1997, MICROBIOL-SGM, V143, P3537, DOI 10.1099/00221287-143-11-3537	70	56	60	1	69	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31624	31637		10.1074/jbc.M114.587766	http://dx.doi.org/10.1074/jbc.M114.587766			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25164811	Green Published, hybrid			2022-12-25	WOS:000344549900062
J	Bajpai, P; Srinivasan, S; Ghosh, J; Nagy, LD; Wei, SZ; Guengerich, FP; Avadhani, NG				Bajpai, Prachi; Srinivasan, Satish; Ghosh, Jyotirmoy; Nagy, Leslie D.; Wei, Shouzou; Guengerich, F. Peter; Avadhani, Narayan G.			Targeting of Splice Variants of Human Cytochrome P450 2C8 (CYP2C8) to Mitochondria and Their Role in Arachidonic Acid Metabolism and Respiratory Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Arachidonic Acid (AA) (ARA); Cytochrome P450; Mitochondrial Respiratory Chain Complex; Mitochondrial Transport; Oxidative Stress; Splice Variant	ENDOPLASMIC-RETICULUM; MICROSOMAL CYTOCHROME-P450; EPOXYEICOSATRIENOIC ACIDS; MEDIATED PHOSPHORYLATION; LIVER-MICROSOMES; EXPRESSION; ACTIVATION; BINDING; PROTEIN; INHIBITORS	Background: Human CYP2C8 is involved in the metabolism of >20% of drugs on the market. Results: Both full-length (WT) CYP2C8 and splice variant 3 are bimodally targeted to mitochondria. Conclusion: Mitochondrial CYP2C8 metabolizes paclitaxel and arachidonic acid (-hydroxylation). Significance: Mitochondrial CYP2C8 is likely to play role in ischemic injury and oxidative stress. In this study, we found that the full-length CYP2C8 (WT CYP2C8) and N-terminal truncated splice variant 3 (approximate to 44-kDa mass) are localized in mitochondria in addition to the endoplasmic reticulum. Analysis of human livers showed that the mitochondrial levels of these two forms varied markedly. Molecular modeling based on the x-ray crystal structure coordinates of CYP2D6 and CYP2C8 showed that despite lacking the N-terminal 102 residues variant 3 possessed nearly complete substrate binding and heme binding pockets. Stable expression of cDNAs in HepG2 cells showed that the WT protein is mostly targeted to the endoplasmic reticulum and at low levels to mitochondria, whereas variant 3 is primarily targeted to mitochondria and at low levels to the endoplasmic reticulum. Enzyme reconstitution experiments showed that both microsomal and mitochondrial WT CYP2C8 efficiently catalyzed paclitaxel 6-hydroxylation. However, mitochondrial variant 3 was unable to catalyze this reaction possibly because of its inability to stabilize the large 854-Da substrate. Conversely, mitochondrial variant 3 catalyzed the metabolism of arachidonic acid into 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acids and 20-hydroxyeicosatetraenoic acid when reconstituted with adrenodoxin and adrenodoxin reductase. HepG2 cells stably expressing variant 3 generated higher levels of reactive oxygen species and showed a higher level of mitochondrial respiratory dysfunction. This study suggests that mitochondrially targeted variant 3 CYP2C8 may contribute to oxidative stress in various tissues.	[Bajpai, Prachi; Srinivasan, Satish; Ghosh, Jyotirmoy; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Bajpai, Prachi; Srinivasan, Satish; Ghosh, Jyotirmoy; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Nagy, Leslie D.; Wei, Shouzou; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Nagy, Leslie D.; Wei, Shouzou; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	University of Pennsylvania; University of Pennsylvania; Vanderbilt University; Vanderbilt University	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	Narayan@vet.upenn.edu			National Institutes of Health [R01 GM34883, R37 CA090426, P01 DK038226]; Harriet Ellison Woodward Endowment; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harriet Ellison Woodward Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM34883 (to N. G. A.) and R37 CA090426 and P01 DK038226 (to F. P. G.). This work was also supported by the Harriet Ellison Woodward Endowment (to N. G. A.).	Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Anandatheerthavarada HK, 1997, ARCH BIOCHEM BIOPHYS, V339, P136, DOI 10.1006/abbi.1996.9855; Avadhani NG, 2011, FEBS J, V278, P4218, DOI 10.1111/j.1742-4658.2011.08356.x; Bahadur N, 2002, BIOCHEM PHARMACOL, V64, P1579, DOI 10.1016/S0006-2952(02)01354-0; Bansal S, 2014, J BIOL CHEM, V289, P9936, DOI 10.1074/jbc.M113.525659; Bansal S, 2013, J BIOL CHEM, V288, P12627, DOI 10.1074/jbc.M113.452367; Bhagwat SV, 1999, J BIOL CHEM, V274, P24014, DOI 10.1074/jbc.274.34.24014; BHAT NK, 1985, BIOCHEMISTRY-US, V24, P8107, DOI 10.1021/bi00348a041; Boopathi E, 2000, J BIOL CHEM, V275, P34415, DOI 10.1074/jbc.M004431200; Chen P, 2005, AM J PATHOL, V166, P615, DOI 10.1016/S0002-9440(10)62282-1; CLARK BJ, 1991, J BIOL CHEM, V266, P5898; Daily EB, 2009, PHARMACOGENOMICS, V10, P1489, DOI 10.2217/PGS.09.82; Dasari VR, 2006, J BIOL CHEM, V281, P30834, DOI 10.1074/jbc.M510725200; DeLozier TC, 2007, DRUG METAB DISPOS, V35, P682, DOI 10.1124/dmd.106.012823; Edin ML, 2011, FASEB J, V25, P3436, DOI 10.1096/fj.11-188300; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447, DOI 10.1177/002215540405200403; GASSER SM, 1982, J BIOL CHEM, V257, P3034; Granville DJ, 2004, P NATL ACAD SCI USA, V101, P1321, DOI 10.1073/pnas.0308185100; Guengerich FP, 1982, PRINCIPLES METHODS T, P609; Ishizuka T, 2008, J PHARMACOL EXP THER, V324, P103, DOI 10.1124/jpet.107.130336; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim DH, 2013, J LIPID RES, V54, P786, DOI 10.1194/jlr.M033894; Klein K, 2007, DRUG METAB DISPOS, V35, P1247, DOI 10.1124/dmd.107.015149; Klose TS, 1999, J BIOCHEM MOL TOXIC, V13, P289, DOI 10.1002/(SICI)1099-0461(1999)13:6<289::AID-JBT1>3.0.CO;2-N; Knupfer H, 2004, BREAST, V13, P28, DOI 10.1016/j.breast.2003.07.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lin FM, 1995, AM J PHYSIOL-RENAL, V269, pF806, DOI 10.1152/ajprenal.1995.269.6.F806; Lundblad MS, 2005, BIOCHEM BIOPH RES CO, V327, P1052, DOI 10.1016/j.bbrc.2004.12.116; Muthalif MM, 1998, P NATL ACAD SCI USA, V95, P12701, DOI 10.1073/pnas.95.21.12701; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Neve EPA, 2008, ANAL BIOANAL CHEM, V392, P1075, DOI 10.1007/s00216-008-2200-z; NIRANJAN BG, 1984, J BIOL CHEM, V259, P2495; Nishimura M, 2003, YAKUGAKU ZASSHI, V123, P369; OMURA T, 1964, J BIOL CHEM, V239, P2370; Omura T, 2006, CHEM-BIOL INTERACT, V163, P86, DOI 10.1016/j.cbi.2006.06.008; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; RAHMAN A, 1994, CANCER RES, V54, P5543; Rendic S, 1997, DRUG METAB REV, V29, P413, DOI 10.3109/03602539709037591; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; Sangar MC, 2009, FEBS J, V276, P3440, DOI 10.1111/j.1742-4658.2009.07067.x; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Schoch GA, 2008, J BIOL CHEM, V283, P17227, DOI 10.1074/jbc.M802180200; Singh H, 2007, HYPERTENSION, V50, P123, DOI 10.1161/HYPERTENSIONAHA.107.089599; Tang ZM, 2009, ANAL CHEM, V81, P3071, DOI 10.1021/ac900021a; Thum T, 2000, LANCET, V355, P979, DOI 10.1016/S0140-6736(00)99016-0; Totah RA, 2005, CLIN PHARMACOL THER, V77, P341, DOI 10.1016/j.clpt.2004.12.267; VandenBrink BM, 2011, DRUG METAB DISPOS, V39, P1546, DOI 10.1124/dmd.111.039065; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Wu S, 1997, J BIOL CHEM, V272, P12551, DOI 10.1074/jbc.272.19.12551; Xu XZ, 2011, ADV DRUG DELIVER REV, V63, P597, DOI 10.1016/j.addr.2011.03.006; Yasar U, 2003, PHARMACOGENETICS, V13, P715, DOI [10.1097/00008571-200312000-00002, 10.1097/01.fpc.0000054141.14659.28]; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200	58	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29614	29630		10.1074/jbc.M114.583062	http://dx.doi.org/10.1074/jbc.M114.583062			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25160618	Green Published, hybrid			2022-12-25	WOS:000344370800012
J	Abbasi, FM; Hayat, T; Ahmad, B; Chen, GQ				Abbasi, Fahad Munir; Hayat, Tasawar; Ahmad, Bashir; Chen, Guo-Qian			Slip Effects on Mixed Convective Peristaltic Transport of Copper-Water Nanofluid in an Inclined Channel	PLOS ONE			English	Article							HEAT-TRANSFER; MHD FLUID; SORET; FLOW	Peristaltic transport of copper-water nanofluid in an inclined channel is reported in the presence of mixed convection. Both velocity and thermal slip conditions are considered. Mathematical modelling has been carried out using the long wavelength and low Reynolds number approximations. Resulting coupled system of equations is solved numerically. Quantities of interest are analyzed through graphs. Numerical values of heat transfer rate at the wall for different parameters are obtained and examined. Results showed that addition of copper nanoparticles reduces the pressure gradient, axial velocity at the center of channel, trapping and temperature. Velocity slip parameter has a decreasing effect on the velocity near the center of channel. Temperature of nanofluid increases with increase in the Grashoff number and channel inclination angle. It is further concluded that the heat transfer rate at the wall increases considerably in the presence of copper nanoparticles.	[Abbasi, Fahad Munir; Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Ahmad, Bashir; Chen, Guo-Qian] King Abdulaziz Univ, Fac Sci, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah, Saudi Arabia; [Chen, Guo-Qian] Peking Univ, Coll Engn, Beijing 100871, Peoples R China	Quaid I Azam University; King Abdulaziz University; Peking University	Abbasi, FM (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	abbasisarkar@gmail.com	Abbasi, Fahad/A-3471-2013; Hayat, Tasawar/E-9449-2015; Ahmad, Bashir/B-1977-2012; Hayat, Tasawar/Y-2524-2019; Hayat, Tasawar/A-3853-2013	Ahmad, Bashir/0000-0001-5350-2977; 	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [9-130/1434 HiCi]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This paper was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no. 9-130/1434 HiCi. The authors, therefore, acknowledge with thanks DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi FM, 2014, APPL MATH INFORM SCI, V8, P211; Abd Elmaboud Y, 2013, J HEAT TRANS-T ASME, V135, DOI 10.1115/1.4023127; Abd Elmaboud Y, 2011, APPL MATH MODEL, V35, P2695, DOI 10.1016/j.apm.2010.11.031; Ali N, 2008, PHYS LETT A, V372, P1477, DOI 10.1016/j.physleta.2007.09.061; BRINKMAN HC, 1952, J CHEM PHYS, V20, P571, DOI 10.1063/1.1700493; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Hayat T, 2014, HEAT TRANSF RES, V45, P589, DOI 10.1615/HeatTransRes.2014007299; Hayat T, 2014, ARAB J SCI ENG, V39, P4341, DOI 10.1007/s13369-014-1163-y; Hayat T, 2014, J MOL LIQ, V194, P93, DOI 10.1016/j.molliq.2014.01.021; Hayat T, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4004744; Hayat T, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/4/044701; Hayat T, 2014, Z NATURFORSCH A, V69, P43, DOI 10.5560/ZNA.2013-0074; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095070; Mekheimer KS, 2011, APPL BIONICS BIOMECH, V8, P295, DOI 10.1155/2011/424183; Munir AF, 2014, J CENT SOUTH UNIV, V21, P1411, DOI 10.1007/s11771-014-2079-0; Mustafa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061859; Rashidi MM, 2014, MECCANICA, V49, P469, DOI 10.1007/s11012-013-9805-9; Rashidi MM, 2012, INT J THERM ENV ENG, V4, P13, DOI DOI 10.5383/IJTEE.04.01.003; SHAPIRO AH, 1969, J FLUID MECH, V37, P799, DOI 10.1017/S0022112069000899; Sheikholeslami M, 2014, J MOL LIQ, V193, P174, DOI 10.1016/j.molliq.2013.12.023; Sheikholeslami M, 2013, POWDER TECHNOL, V246, P327, DOI 10.1016/j.powtec.2013.05.030; Tiwari RK, 2007, INT J HEAT MASS TRAN, V50, P2002, DOI 10.1016/j.ijheatmasstransfer.2006.09.034; Turkyilmazoglu M, 2014, J HEAT TRANS-T ASME, V136, DOI 10.1115/1.4025730; Turkyilmazoglu M, 2012, CHEM ENG SCI, V84, P182, DOI 10.1016/j.ces.2012.08.029; Xuan Y., 1999, REPORT NANJING U SCI; Xuan YM, 2003, J HEAT TRANS-T ASME, V125, P151, DOI 10.1115/1.1532008; Yildirim A, 2010, MATH COMPUT MODEL, V52, P618, DOI 10.1016/j.mcm.2010.04.007	27	44	44	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105440	10.1371/journal.pone.0105440	http://dx.doi.org/10.1371/journal.pone.0105440			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170908	Green Submitted, Green Published, gold			2022-12-25	WOS:000341127500049
J	Cao, Y; Roth, M; Piperdi, S; Montoya, K; Sowers, R; Rao, P; Geller, D; Houghton, P; Kolb, EA; Gill, J; Gorlick, R				Cao, Yu; Roth, Michael; Piperdi, Sajida; Montoya, Kristofer; Sowers, Rebecca; Rao, Pulivarthi; Geller, David; Houghton, Peter; Kolb, E. Anders; Gill, Jonathan; Gorlick, Richard			Insulin-Like Growth Factor 1 Receptor and Response to Anti-IGF1R Antibody Therapy in Osteosarcoma	PLOS ONE			English	Article							FACTOR-I RECEPTOR; IGF-BINDING PROTEIN-3; MONOCLONAL-ANTIBODY; BREAST-CANCER; PHASE-II; RISK; CHEMOTHERAPY; FIGITUMUMAB; PREDICTORS; IMATINIB	Background: Survival outcomes for patients with osteosarcoma (OS) have remained stagnant over the past three decades. Insulin-like growth factor 1 receptor (IGF1R) is over-expressed in a number of malignancies, and anti-IGF1R antibodies have and are currently being studied in clinical trials. Understanding the molecular aberrations which result in increased tumor response to anti-IGF1R therapy could allow for the selection of patients most likely to benefit from IGF1R targeted therapy. Methods: IGF1R mRNA expression was assessed by RT PCR in OS patient primary tumors, cell lines, and xenograft tumors. IGF1R copy number was assessed by 3 approaches: PCR, FISH, and dot blot analysis. Exons 1-20 of IGF1R were sequenced in xenograft tumors and 87 primary OS tumors, and surface expression of IGF1R was assessed by flow cytometry. Levels of mRNA and protein expression, copy number, and mutation status were compared with tumor response to anti-IGF1R antibody therapy in 4 OS xenograft models. Results: IGF1R mRNA is expressed in OS. Primary patient samples and xenograft samples had higher mRNA expression and copy number compared with corresponding cell lines. IGF1R mRNA expression, cell surface expression, copy number, and mutation status were not associated with tumor responsiveness to anti-IGF1R antibody therapy. Conclusions: IGF1R is expressed in OS, however, no clear molecular markers predict response to IGF1R antibody-mediated therapy. Additional pre-clinical studies assessing potential predictive biomarkers and investigating targetable molecular pathways critical to the proliferation of OS cells are needed.	[Cao, Yu; Roth, Michael; Piperdi, Sajida; Montoya, Kristofer; Sowers, Rebecca; Gill, Jonathan; Gorlick, Richard] Albert Einstein Coll Med, Div Pediat Hematol Oncol, Childrens Hosp Montefiore, Bronx, NY 10467 USA; [Rao, Pulivarthi] Baylor Coll Med, Texas Childrens Canc Ctr, Div Pediat Hematol Oncol, Houston, TX 77030 USA; [Geller, David] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Orthoped Surg, Bronx, NY 10467 USA; [Geller, David] Albert Einstein Coll Med, Childrens Hosp Montefiore, Bronx, NY 10467 USA; [Houghton, Peter] Nationwide Childrens Hosp, Ctr Childhood Canc & Blood Dis, Columbus, OH USA; [Kolb, E. Anders] Alfred I DuPont Hosp Children, Div Pediat Hematol Oncol, Wilmington, DE USA; [Gorlick, Richard] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Baylor College of Medicine; Texas Children's Cancer Center; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Nemours Alfred I. duPont Hospital for Children; Yeshiva University; Albert Einstein College of Medicine	Gorlick, R (corresponding author), Albert Einstein Coll Med, Div Pediat Hematol Oncol, Childrens Hosp Montefiore, Bronx, NY 10467 USA.	RGorlick@montefiore.org		GORLICK, RICHARD/0000-0001-8995-2929; Kolb, E. Anders/0000-0003-2854-9014	Foster Foundation; Swim Across America; National Cancer Institute [K12 CA-132783-04]; NATIONAL CANCER INSTITUTE [K12CA132783] Funding Source: NIH RePORTER	Foster Foundation; Swim Across America; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Foster Foundation, Swim Across America, and the Paul Calabresi Career Development Award for Clinical Oncology (MR) No. K12 CA-132783-04 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P SK, 2008, P 14 ANN M CONN TISS; Arcaro A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00030; Asmane I, 2012, EUR J CANCER, V48, P3027, DOI 10.1016/j.ejca.2012.05.009; Avnet S, 2009, CANCER RES, V69, P2443, DOI 10.1158/0008-5472.CAN-08-2645; Bagatell R, 2011, CLIN CANCER RES, V17, P611, DOI 10.1158/1078-0432.CCR-10-1731; Burrow S, 1998, J SURG ONCOL, V69, P21, DOI 10.1002/(SICI)1096-9098(199809)69:1<21::AID-JSO5>3.0.CO;2-M; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; Chan JM, 2002, J NATL CANCER I, V94, P1099; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Chou Alexander J, 2008, Paediatr Drugs, V10, P315, DOI 10.2165/00148581-200810050-00005; DAVIS AM, 1994, J CLIN ONCOL, V12, P423, DOI 10.1200/JCO.1994.12.2.423; Diorio C, 2005, CANCER EPIDEM BIOMAR, V14, P1065, DOI 10.1158/1055-9965.EPI-04-0706; Fleuren EDG, 2011, CLIN CANCER RES, V17, P7693, DOI 10.1158/1078-0432.CCR-11-1488; Gao J, 2012, CANCER RES, V72, P3, DOI 10.1158/0008-5472.CAN-11-0550; Giovannucci E, 2000, CANCER EPIDEM BIOMAR, V9, P345; Gooch JL, 1999, BREAST CANCER RES TR, V56, P1, DOI 10.1023/A:1006208721167; Hankinson Susan E, 2003, Breast Dis, V17, P27; Houghton PJ, 2010, PEDIATR BLOOD CANCER, V54, P921, DOI 10.1002/pbc.22367; Juergens H, 2011, J CLIN ONCOL, V29, P4534, DOI 10.1200/JCO.2010.33.0670; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Khandwala HM, 2000, ENDOCR REV, V21, P215, DOI 10.1210/er.21.3.215; Kindler HL, 2012, ANN ONCOL, V23, P2834, DOI 10.1093/annonc/mds142; Kolb EA, 2008, PEDIATR BLOOD CANCER, V50, P1190, DOI 10.1002/pbc.21450; Kolb EA, 2011, PEDIATR BLOOD CANCER, V56, P595, DOI 10.1002/pbc.22741; Kolb EA, 2009, CURR ONCOL REP, V11, P307, DOI 10.1007/s11912-009-0043-1; Kurmasheva RT, 2009, CANCER RES, V69, P7662, DOI 10.1158/0008-5472.CAN-09-1693; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; O'Day K, 2009, EXPERT REV ANTICANC, V9, P511, DOI [10.1586/era.09.7, 10.1586/ERA.09.7]; Olmos D, 2010, LANCET ONCOL, V11, P129, DOI 10.1016/S1470-2045(09)70354-7; Palmqvist R, 2002, GUT, V50, P642, DOI 10.1136/gut.50.5.642; Pandini G, 1999, CLIN CANCER RES, V5, P1935; Perez EA, 2008, CANCER INVEST, V26, P545, DOI 10.1080/07357900801971024; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pollak M, 2008, BEST PRACT RES CL EN, V22, P625, DOI 10.1016/j.beem.2008.08.004; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Quek R, 2011, CLIN CANCER RES, V17, P871, DOI 10.1158/1078-0432.CCR-10-2621; Reidy DL, 2010, J CLIN ONCOL, V28, P4240, DOI 10.1200/JCO.2010.30.4154; Schmitz S, 2012, ANN ONCOL, V23, P2153, DOI 10.1093/annonc/mdr574; Schwartz GK, 2013, LANCET ONCOLOGY; Tognon CE, 2012, EXPERT OPIN THER TAR, V16, P33, DOI 10.1517/14728222.2011.638626; Tolcher AW, 2009, J CLIN ONCOL, V27, P5800, DOI 10.1200/JCO.2009.23.6745; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Yuen JSP, 2008, EXPERT OPIN THER TAR, V12, P589, DOI 10.1517/14728222.12.5.589 ; Zha JP, 2010, CLIN CANCER RES, V16, P2512, DOI 10.1158/1078-0432.CCR-09-2232; Zha JP, 2009, MOL CANCER THER, V8, P2110, DOI 10.1158/1535-7163.MCT-09-0381	46	85	89	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106249	10.1371/journal.pone.0106249	http://dx.doi.org/10.1371/journal.pone.0106249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170759	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500135
J	Chang, HM; Lin, YY; Tsai, PC; Liang, CT; Yan, YT				Chang, Huang-Ming; Lin, Yu-Ying; Tsai, Pei-Chun; Liang, Chung-Tiang; Yan, Yu-Ting			The FYVE Domain of Smad Anchor for Receptor Activation (SARA) Is Required to Prevent Skin Carcinogenesis, but Not in Mouse Development	PLOS ONE			English	Article							BETA TGF-BETA; EARLY ENDOSOMES; DEPENDENT DEGRADATION; CELL-GROWTH; PROTEIN; INTERNALIZATION; TGF-BETA-1; TRANSITION; EXPRESSION; RESPONSES	Smad Anchor for Receptor Activation (SARA) has been reported as a critical role in TGF-beta signal transduction by recruiting non-activated Smad2/3 to the TGF-beta receptor and ensuring appropriate subcellular localization of the activated receptor-bound complex. However, controversies still exist in previous reports. In this study, we describe the expression of two SARA isoforms, SARA(1) and SARA(2), in mice and report the generation and characterization of SARA mutant mice with FYVE domain deletion. SARA mutant mice developed normally and showed no gross abnormalities. Further examination showed that the TGF-beta signaling pathway was indeed altered in SARA mutant mice, with the downregulation of Smad2 protein expression. The decreasing expression of Smad2 was caused by enhancing Smurf2-mediated proteasome degradation pathway. However, the internalization of TGF-beta receptors into the early endosome was not affected in SARA mutant mouse embryonic fibroblasts (MEFs). Moreover, the downregulation of Smad2 in SARA mutant MEFs was not sufficient to disrupt the diverse cellular biological functions of TGF-beta signaling, including growth inhibition, apoptosis, senescence, and the epithelial-to-mesenchymal transition. Our results indicate that SARA is not involved in the activation process of TGF-beta signal transduction. Using a two-stage skin chemical carcinogenesis assay, we found that the loss of SARA promoted skin tumor formation and malignant progression. Our data suggest a protective role of SARA in skin carcinogenesis.	[Chang, Huang-Ming; Yan, Yu-Ting] Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan; [Chang, Huang-Ming; Yan, Yu-Ting] Acad Sinica, Taipei 115, Taiwan; [Lin, Yu-Ying; Tsai, Pei-Chun; Yan, Yu-Ting] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chang, Huang-Ming; Yan, Yu-Ting] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Liang, Chung-Tiang] Natl Lab Anim Ctr, Natl Appl Res Labs, Taipei, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Applied Research Laboratories - Taiwan	Yan, YT (corresponding author), Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan.	yyan@ibms.sinica.edu.tw	CHANG, HUANG-MING/D-3880-2015; Yan, Yu-Ting/Q-3065-2018	CHANG, HUANG-MING/0000-0002-0255-5590; Yan, Yu-Ting/0000-0002-9559-706X	Academia Sinica; National Science Council in Taiwan [NSC-96-2311-B-001-027-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by Academia Sinica (http://www.ibms.sinica.edu.tw/index.php) and a grant (NSC-96-2311-B-001-027-MY3) from the National Science Council (http://web1.nsc.gov.tw/) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkebo M, 2012, FEBS LETT; Carvalho RLC, 2007, J CELL SCI, V120, P4269, DOI 10.1242/jcs.013169; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Glick AB, 2008, CARCINOGENESIS, V29, P9, DOI 10.1093/carcin/bgm215; Goto D, 2001, BIOCHEM BIOPH RES CO, V281, P1100, DOI 10.1006/bbrc.2001.4489; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Hoot KE, 2008, J CLIN INVEST, V118, P2722, DOI 10.1172/JCI33713; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Hu Y, 2002, J CELL SCI, V115, P4755, DOI 10.1242/jcs.00177; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Ito Y, 2001, DEV BIOL, V236, P181, DOI 10.1006/dbio.2001.0332; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; Morsut L, 2010, DEVELOPMENT, V137, P2571, DOI 10.1242/dev.053801; Moses HL, 1996, CURR OPIN GENET DEV, V6, P581, DOI 10.1016/S0959-437X(96)80087-6; Moustakas A, 2001, J CELL SCI, V114, P4359; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; REHMANN JA, 1994, INT IMMUNOL, V6, P315, DOI 10.1093/intimm/6.2.315; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Runyan CE, 2009, J BIOL CHEM, V284, P25181, DOI 10.1074/jbc.M109.032847; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; SMELAND EB, 1987, EXP CELL RES, V171, P213, DOI 10.1016/0014-4827(87)90264-3; Squire R. A., 1978, Pathology of laboratory animals, volume II, P1051; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; WAHL SM, 1992, J CLIN IMMUNOL, V12, P61, DOI 10.1007/BF00918135; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Wang XJ, 2001, MICROSC RES TECHNIQ, V52, P420, DOI 10.1002/1097-0029(20010215)52:4<420::AID-JEMT1027>3.3.CO;2-Z; Wilkinson D. G., 1999, SITU HYBRIDIZATION P; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Xu L, 2000, NAT CELL BIOL, V2, P559, DOI 10.1038/35019649; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974	51	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105299	10.1371/journal.pone.0105299	http://dx.doi.org/10.1371/journal.pone.0105299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170969	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500042
J	Vares, G; Wang, B; Ishii-Ohba, H; Nenoi, M; Nakajima, T				Vares, Guillaume; Wang, Bing; Ishii-Ohba, Hiroko; Nenoi, Mitsuru; Nakajima, Tetsuo			Diet-Induced Obesity Modulates Epigenetic Responses to Ionizing Radiation in Mice	PLOS ONE			English	Article							HIGH-FAT DIET; GENE-EXPRESSION PROFILES; INDUCED OXIDATIVE STRESS; INDUCED MICRONUCLEI; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; INSULIN-RESISTANCE; BONE-MARROW; LIVER CELLS; EARLY EVENT; DNA-DAMAGE	Both exposure to ionizing radiation and obesity have been associated with various pathologies including cancer. There is a crucial need in better understanding the interactions between ionizing radiation effects (especially at low doses) and other risk factors, such as obesity. In order to evaluate radiation responses in obese animals, C3H and C57BL/6J mice fed a control normal fat or a high fat (HF) diet were exposed to fractionated doses of X-rays (0.75 Gy x4). Bone marrow micronucleus assays did not suggest a modulation of radiation-induced genotoxicity by HF diet. Using MSP, we observed that the promoters of p16 and Dapk genes were methylated in the livers of C57BL/6J mice fed a HF diet (irradiated and non-irradiated); Mgmt promoter was methylated in irradiated and/or HF diet-fed mice. In addition, methylation PCR arrays identified Ep300 and Socs1 (whose promoters exhibited higher methylation levels in non-irradiated HF diet-fed mice) as potential targets for further studies. We then compared microRNA regulations after radiation exposure in the livers of C57BL/6J mice fed a normal or an HF diet, using microRNA arrays. Interestingly, radiation-triggered microRNA regulations observed in normal mice were not observed in obese mice. miR-466e was upregulated in non-irradiated obese mice. In vitro free fatty acid (palmitic acid, oleic acid) administration sensitized AML12 mouse liver cells to ionizing radiation, but the inhibition of miR-466e counteracted this radio-sensitization, suggesting that the modulation of radiation responses by diet-induced obesity might involve miR-466e expression. All together, our results suggested the existence of dietary effects on radiation responses (especially epigenetic regulations) in mice, possibly in relationship with obesity-induced chronic oxidative stress.	[Vares, Guillaume; Wang, Bing; Ishii-Ohba, Hiroko; Nenoi, Mitsuru; Nakajima, Tetsuo] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Inage Ku, Chiba 260, Japan	National Institutes for Quantum Science & Technology	Vares, G (corresponding author), Natl Inst Radiol Sci, Res Ctr Radiat Protect, Inage Ku, Chiba 260, Japan.	vares@nirs.go.jp; otetsu@nirs.go.jp	Vares, Guillaume/S-6530-2019; Vares, Guillaume/A-9257-2011	Vares, Guillaume/0000-0002-6191-9032; Vares, Guillaume/0000-0002-6191-9032; Nakajima, Tetsuo/0000-0001-6455-0122	Research Program of the Radiation Effect Mechanisms of the National Institute of Radiological Sciences	Research Program of the Radiation Effect Mechanisms of the National Institute of Radiological Sciences	This work was supported by grants for the Research Program of the Radiation Effect Mechanisms of the National Institute of Radiological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036197; Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Amundson SA, 2001, RADIAT RES, V156, P657, DOI 10.1667/0033-7587(2001)156[0657:IOGEAA]2.0.CO;2; An YS, 2013, EXP CELL RES, V319, P466, DOI 10.1016/j.yexcr.2012.12.008; Andreassi MG, 2011, MUTAGENESIS, V26, P77, DOI 10.1093/mutage/geq077; Baldeweg SE, 2000, EUR J CLIN INVEST, V30, P45; Barcellos-Hoff MH, 2005, SEMIN CANCER BIOL, V15, P138, DOI 10.1016/j.semcancer.2004.08.010; Bernal AJ, 2013, FASEB J, V27, P665, DOI 10.1096/fj.12-220350; Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brenner DJ, 1998, RADIAT RES, V150, P83, DOI 10.2307/3579648; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1066; Chang XX, 2010, J LIPID RES, V51, P2504, DOI 10.1194/jlr.M001958; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Choi EK, 2001, INT J RADIAT ONCOL, V49, P397, DOI 10.1016/S0360-3016(00)01485-1; Choi Jae Duk, 2013, Genomics & Informatics, V11, P164, DOI 10.5808/GI.2013.11.4.164; Christmann M, 2012, MUTAT RES-FUND MOL M, V736, P64, DOI 10.1016/j.mrfmmm.2011.06.004; Christmann M, 2011, BBA-REV CANCER, V1816, P179, DOI 10.1016/j.bbcan.2011.06.002; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; De Marchi E, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/564961; Deimling LI, 2009, MUTAT RES-GEN TOX EN, V672, P65, DOI 10.1016/j.mrgentox.2008.09.008; Demirbag R, 2006, INT J CLIN PRACT, V60, P1187, DOI 10.1111/j.1742-1241.2006.01042.x; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Dent P, 2003, RADIAT RES, V159, P283, DOI 10.1667/0033-7587(2003)159[0283:SARIAO]2.0.CO;2; Ding N, 2011, J RADIAT RES, V52, P425, DOI 10.1269/jrr.10158; Druz A, 2013, METAB ENG, V16, P87, DOI 10.1016/j.ymben.2012.12.004; Druz A, 2012, NUCLEIC ACIDS RES, V40, P7291, DOI 10.1093/nar/gks452; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; FRITZ G, 1991, MOL CELL BIOL, V11, P4660, DOI 10.1128/MCB.11.9.4660; Fujiki K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-38; Futscher BW, 2013, ADV EXP MED BIOL, V754, P179, DOI 10.1007/978-1-4419-9967-2_9; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; GROMBACHER T, 1995, BBA-MOL BASIS DIS, V1270, P63, DOI 10.1016/0925-4439(94)00073-Y; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; HAYASHI M, 1984, MUTAT RES, V127, P129, DOI 10.1016/0027-5107(84)90014-9; HEDDLE JA, 1977, MUTAT RES, V44, P63, DOI 10.1016/0027-5107(77)90115-4; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; Ilnytskyy Y, 2011, MUTAT RES-FUND MOL M, V714, P113, DOI 10.1016/j.mrfmmm.2011.06.014; Jagetia GC, 1999, MUTAT RES-FUND MOL M, V425, P87, DOI 10.1016/S0027-5107(99)00003-2; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katiyar SK, 2007, FREE RADICAL BIO MED, V42, P299, DOI 10.1016/j.freeradbiomed.2006.10.049; Kauppinen S, 2006, HANDB EXP PHARM, V173, P405; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Konner AC, 2012, CELL METAB, V16, P144, DOI 10.1016/j.cmet.2012.07.004; Kovalchuk O, 2004, MUTAT RES-FUND MOL M, V548, P75, DOI 10.1016/j.mrfmmm.2003.12.016; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumar MS, 2003, MUTAT RES-FUND MOL M, V527, P7, DOI 10.1016/S0027-5107(03)00052-6; Laws A, 1997, ARTERIOSCL THROM VAS, V17, P64, DOI 10.1161/01.ATV.17.1.64; Lee YJ, 2012, P NATL ACAD SCI USA, V109, P13656, DOI 10.1073/pnas.1203218109; Li XY, 2011, J EXP MED, V208, P663, DOI 10.1084/jem.20102384; Little JB, 2000, HOLLAND FREI CANC ME; Liu C, 2011, INT J BIOL SCI, V7, P347, DOI 10.7150/ijbs.7.347; Lu YC, 2013, GENOME MED, V5, DOI 10.1186/gm459; Luo Y, 2014, BBA-GENE REGUL MECH, V1839, P97, DOI 10.1016/j.bbagrm.2013.12.005; Marchesini G, 2008, J CLIN ENDOCR METAB, V93, pS74, DOI 10.1210/jc.2008-1399; Metheetrairut C, 2013, CURR OPIN GENET DEV, V23, P12, DOI 10.1016/j.gde.2013.01.002; Milagro FI, 2009, J PHYSIOL BIOCHEM, V65, P1, DOI 10.1007/BF03165964; Mittag F, 2006, CANCER LETT, V240, P69, DOI 10.1016/j.canlet.2005.08.034; Nakajima T, 2008, J RADIAT RES, V49, P1, DOI 10.1269/jrr.07053; Nishikawa S, 2007, EXP ANIM TOKYO, V56, P263, DOI 10.1538/expanim.56.263; Nuovo GJ, 1999, P NATL ACAD SCI USA, V96, P12754, DOI 10.1073/pnas.96.22.12754; Palanichamy JK, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00054; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Payne MWC, 2007, MED HYPOTHESES, V69, P778, DOI 10.1016/j.mehy.2007.01.077; Peslak SA, 2011, EXP HEMATOL, V39, P434, DOI 10.1016/j.exphem.2011.01.010; POLLICE AA, 1992, CYTOMETRY, V13, P432, DOI 10.1002/cyto.990130414; Raggi C, 2013, CLIN RES HEPATOL GAS, V37, P564, DOI 10.1016/j.clinre.2013.05.009; Ron-Harel N, 2008, REJUV RES, V11, P903, DOI 10.1089/rej.2008.0755; Roudkenar MH, 2008, J RADIAT RES, V49, P29, DOI 10.1269/jrr.07078; Runkle EA, 2012, EXP MOL PATHOL, V93, P324, DOI 10.1016/j.yexmp.2012.09.007; Sabido E, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.36; Schwenk RW, 2013, HORM METAB RES, V45, P786, DOI 10.1055/s-0033-1348263; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Shi Y, 2012, RADIAT RES, V177, P124, DOI 10.1667/RR2764.1; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; SINGH SP, 1990, INT J RADIAT BIOL, V58, P791, DOI 10.1080/09553009014552171; Su WX, 2012, INT J RADIAT BIOL, V88, P635, DOI 10.3109/09553002.2012.703362; Supic G, 2013, NUTR CANCER, V65, P781, DOI 10.1080/01635581.2013.805794; SUZUKI Y, 1989, MUTAGENESIS, V4, P420, DOI 10.1093/mutage/4.6.420; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uehara Y, 2010, RAD RES; Vares G, 2011, J RADIAT RES, V52, P249, DOI 10.1269/jrr.10110; Vincent HK, 2007, DIABETES OBES METAB, V9, P813, DOI 10.1111/j.1463-1326.2007.00692.x; Vincenti S, 2011, RADIAT RES, V175, P535, DOI 10.1667/RR2200.1; Wagner-Ecker M, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-25; Wakeford R., 2012, Annals of the ICRP, V41, P98, DOI 10.1016/j.icrp.2012.06.036; Wang SS, 2007, ARTERIOSCL THROM VAS, V27, P2671, DOI 10.1161/ATVBAHA.107.148106; WEITZMAN SA, 1994, P NATL ACAD SCI USA, V91, P1261, DOI 10.1073/pnas.91.4.1261; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wree A, 2011, DIGESTION, V83, P124, DOI 10.1159/000318741; Wright EG, 2010, MUTAT RES-FUND MOL M, V687, P28, DOI 10.1016/j.mrfmmm.2010.01.014; Xu WQ, 2012, J RADIAT RES, V53, P353, DOI 10.1269/jrr.11073; Yamada H, 2001, J BIOL CHEM, V276, P19052, DOI 10.1074/jbc.M100615200; Yoshida K, 1997, P NATL ACAD SCI USA, V94, P2615, DOI 10.1073/pnas.94.6.2615; Zang JJ, 2011, WORLD J GASTROENTERO, V17, P3043, DOI 10.3748/wjg.v17.i25.3043; Zheng GXY, 2011, P NATL ACAD SCI USA, V108, P15804, DOI 10.1073/pnas.1112772108	103	23	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106277	10.1371/journal.pone.0106277	http://dx.doi.org/10.1371/journal.pone.0106277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171162	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500140
J	Wang, ZQ; Luo, Y; Shao, QJ; Kinlock, BL; Wang, CL; Hildreth, JEK; Xie, H; Liu, BD				Wang, Ziqing; Luo, Yi; Shao, Qiujia; Kinlock, Ballington L.; Wang, Chenliang; Hildreth, James E. K.; Xie, Hua; Liu, Bindong			Heat-Stable Molecule Derived from Streptococcus cristatus Induces APOBEC3 Expression and Inhibits HIV-1 Replication	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIF PROTEIN; ANTIRETROVIRAL FACTOR; CYTIDINE DEAMINATION; ANTIVIRAL ACTIVITY; ORAL-TRANSMISSION; EPITHELIAL-CELLS; PLASMA-MEMBRANE; ENZYME APOBEC3G; DENDRITIC CELLS	Although most human immunodeficiency virus type 1 (HIV-1) cases worldwide are transmitted through mucosal surfaces, transmission through the oral mucosal surface is a rare event. More than 700 bacterial species have been detected in the oral cavity. Despite great efforts to discover oral inhibitors of HIV, little information is available concerning the anti-HIV activity of oral bacterial components. Here we show that a molecule from an oral commensal bacterium, Streptococcus cristatus CC5A can induce expression of APOBEC3G (A3G) and APOBEC3F (A3F) and inhibit HIV-1 replication in THP-1 cells. We show by qRT-PCR that expression levels of A3G and A3F increase in a dose-dependent manner in the presence of a CC5A extract, as does A3G protein levels by Western blot assay. In addition, when the human monocytic cell line THP-1 was treated with CC5A extract, the replication of HIV-1 IIIB was significantly suppressed compared with IIIB replication in untreated THP-1 cells. Knock down of A3G expression in THP-1 cells compromised the ability of CC5A to inhibit HIV-1 IIIB infectivity. Furthermore, SupT1 cells infected with virus produced from CC5A extract-treated THP-1 cells replicated virus with a higher G to A hypermutation rate (a known consequence of A3G activity) than virus used from untreated THP-1 cells. This suggests that S. cristatus CC5A contains a molecule that induces A3G/F expression and thereby inhibits HIV replication. These findings might lead to the discovery of a novel anti-HIV/AIDS therapeutic.	[Wang, Ziqing; Luo, Yi; Shao, Qiujia; Kinlock, Ballington L.; Wang, Chenliang; Hildreth, James E. K.; Liu, Bindong] Meharry Med Coll, Sch Med, Ctr AIDS Hlth Dispar Res, Nashville, TN 37208 USA; [Xie, Hua] Meharry Med Coll, Sch Dent, Dept Oral Biol & Res, Nashville, TN 37208 USA; [Wang, Chenliang] Sun Yat Sen Univ, Inst Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Chenliang] Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China	Meharry Medical College; Meharry Medical College; Sun Yat Sen University; Sun Yat Sen University	Xie, H (corresponding author), Meharry Med Coll, Sch Dent, Dept Oral Biol & Res, Nashville, TN 37208 USA.	hxie@mmc.edu; bliu@mmc.edu		wang, chenliang/0000-0003-4388-681X	NIH [SC1GM089269, U54RR019192, G12MD007586, P30AI054999, UL1TR000445, T32HL007737]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019192] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI054999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM089269] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586, U54MD007593] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH grants SC1GM089269, U54RR019192, G12MD007586, P30AI054999 and UL1TR000445 to BL and NIH grant U54RR019192 to HX. BLK is supported by NIH training grant T32HL007737. NIH website is www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2007, J CLIN PERIODONTOL, V34, P189, DOI 10.1111/j.1600-051X.2006.01034.x; Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Baron S, 2001, J DENT RES, V80, P1602, DOI 10.1177/00220345010800070201; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; Campo J, 2006, ORAL DIS, V12, P219, DOI 10.1111/j.1601-0825.2005.01187.x; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chen KY, 2006, J VIROL, V80, P7645, DOI 10.1128/JVI.00206-06; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; Edwards AM, 2006, INFECT IMMUN, V74, P654, DOI 10.1128/IAI.74.1.654-662.2006; FIGUEIREDO JFC, 1994, CLIN INFECT DIS, V19, P546, DOI 10.1093/clinids/19.3.546; FISHER AG, 1987, SCIENCE, V237, P888, DOI 10.1126/science.3497453; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Jones PH, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-50; Kim EY, 2010, J VIROL, V84, P10402, DOI 10.1128/JVI.01223-10; Kinlock BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096760; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu BD, 2004, J VIROL, V78, P2072, DOI 10.1128/JVI.78.4.2072-2081.2004; Liuzzi G, 1996, AIDS, V10, pF51, DOI 10.1097/00002030-199612000-00001; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Maticic M, 2000, J DENT RES, V79, P1496, DOI 10.1177/00220345000790071101; MBISA JL, 2007, J VIROL; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Mulder LCF, 2008, P NATL ACAD SCI USA, V105, P5501, DOI 10.1073/pnas.0710190105; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Okeoma CM, 2010, CELL HOST MICROBE, V8, P534, DOI 10.1016/j.chom.2010.11.003; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Pido-Lopez J, 2007, J IMMUNOL, V178, P1671, DOI 10.4049/jimmunol.178.3.1671; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Rose KM, 2005, AIDS RES HUM RETROV, V21, P611, DOI 10.1089/aid.2005.21.611; Rose KM, 2004, J BIOL CHEM, V279, P41744, DOI 10.1074/jbc.M406760200; Sarkis PTN, 2006, J IMMUNOL, V177, P4530, DOI 10.4049/jimmunol.177.7.4530; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shugars DC, 2001, J DENT RES, V80, P414, DOI 10.1177/00220345010800020301; Shugars DC, 1999, ARCH ORAL BIOL, V44, P445, DOI 10.1016/S0003-9969(99)00003-5; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; Sun LL, 2005, J VIROL, V79, P14318, DOI 10.1128/JVI.79.22.14318-14329.2005; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V341, P314, DOI 10.1016/j.bbrc.2005.12.192; Timmons CL, 2013, J INFECT DIS, V207, P1171, DOI 10.1093/infdis/jit001; Wahl S M, 1997, Oral Dis, V3 Suppl 1, pS64; Wang YD, 2011, J VIROL, V85, P4510, DOI 10.1128/JVI.01925-10; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xie H, 2006, ANTIMICROB AGENTS CH, V50, P3070, DOI 10.1128/AAC.01578-05; Yang Y, 2007, VIROLOGY; YASSI A, 1991, AM J INFECT CONTROL, V19, P129, DOI 10.1016/0196-6553(91)90018-8; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	66	31	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106078	10.1371/journal.pone.0106078	http://dx.doi.org/10.1371/journal.pone.0106078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165817	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303700070
J	Ferguson, D; Mattiuzzo, G; Ham, C; Stebbings, R; Li, B; Rose, NJ; Mee, ET; Smith, D; Page, M; Cranage, MP; Almond, N; Towers, GJ; Berry, NJ				Ferguson, Deborah; Mattiuzzo, Giada; Ham, Claire; Stebbings, Richard; Li, Bo; Rose, Nicola J.; Mee, Edward T.; Smith, Deborah; Page, Mark; Cranage, Martin P.; Almond, Neil; Towers, Greg J.; Berry, Neil J.			Early Biodistribution and Persistence of a Protective Live Attenuated SIV Vaccine Elicits Localised Innate Responses in Multiple Lymphoid Tissues	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CD4(+) T-CELLS; RESTRICTS HIV-1 INFECTION; YELLOW-FEVER VACCINE; DENDRITIC CELLS; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; WILD-TYPE; MACAQUES; REPLICATION	Vaccination of Mauritian cynomolgus macaques with the attenuated nef-truncated C8 variant of SIVmac251/32H (SIVmacC8) induces early, potent protection against pathogenic, heterologous challenge before the maturation of cognate immunity. To identify processes that contribute to early protection in this model the pathogenesis, anatomical distribution and viral vaccine kinetics were determined in relation to localised innate responses triggered by vaccination. The early biodistribution of SIVmacC8 was defined by rapid, widespread dissemination amongst multiple lymphoid tissues, detectable after 3 days. Cell-associated viral RNA dynamics identified mesenteric lymph nodes (MLN) and spleen, as well as the gut mucosae, as early major contributors of systemic virus burden. Rapid, localised infection was populated by discrete foci of persisting virus-infected cells. Localised productive infection triggered a broad innate response, with type-1 interferon sensitive IRF-7, STAT-1, TRIM5 alpha and ApoBEC3G genes all upregulated during the acute phase but induction did not prevent viral persistence. Profound changes in vaccine-induced cell-surface markers of immune activation were detected on macrophages, B-cells and dendritic cells (DC-SIGN, S-100, CD40, CD11c, CD123 and CD86). Notably, high DC-SIGN and S100 staining for follicular and interdigitating DCs respectively, in MLN and spleen were detected by 3 days, persisting 20 weeks post-vaccination. Although not formally evaluated, the early biodistribution of SIVmacC8 simultaneously targets multiple lymphoid tissues to induce strong innate immune responses coincident at the same sites critical for early protection from wild-type viruses. HIV vaccines which stimulate appropriate innate, as well as adaptive responses, akin to those generated by live attenuated SIV vaccines, may prove the most efficacious.	[Ferguson, Deborah; Mattiuzzo, Giada; Ham, Claire; Rose, Nicola J.; Mee, Edward T.; Smith, Deborah; Page, Mark; Almond, Neil; Berry, Neil J.] NIBSC, Div Virol, S Mimms, Herts, England; [Stebbings, Richard; Li, Bo] NIBSC, Div Biotherapeut, S Mimms, Herts, England; [Cranage, Martin P.] Univ London, Inst Infect & Immun, London, England; [Towers, Greg J.] UCL, MRC, Ctr Med Mol Biol, Div Infect & Immun, London, England	National Institute for Biological Standards & Control; National Institute for Biological Standards & Control; University of London; University of London; University College London	Towers, GJ (corresponding author), UCL, MRC, Ctr Med Mol Biol, Div Infect & Immun, London, England.	g.towers@ucl.ac.uk; neil.berry@nibsc.org	Rose, Nicola/E-9366-2013; Stebbings, Richard/E-2117-2013	Stebbings, Richard/0000-0001-9628-2708; Towers, Gregory/0000-0002-7707-0264; Almond, Neil/0000-0001-6105-0616	United Kingdom Medical Research Council [G9025730, G9419998, G0600007, G0801172]; Wellcome Trust; National Institute of Health Research UCL/UCLH Comprehensive Biomedical Research Centre; Sir Joseph Hotung Trust; MRC [G0601201, G9025730, G0600007, G0501446, G9721629, G0900950, G0801172] Funding Source: UKRI; Medical Research Council [G0501446, G0601201, G0600007, G0900950, G9025730, G0900950B, G0801172, G9721629B, G9721629] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health Research UCL/UCLH Comprehensive Biomedical Research Centre; Sir Joseph Hotung Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by United Kingdom Medical Research Council grants G9025730, G9419998, G0600007 and G0801172, a Wellcome Trust Fellowship to GJT and the National Institute of Health Research UCL/UCLH Comprehensive Biomedical Research Centre. MC was funded by the Sir Joseph Hotung Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2003, J VIROL, V77, P3099, DOI 10.1128/JVI.77.5.3099-3118.2003; Almond N, 1997, J GEN VIROL, V78, P1919, DOI 10.1099/0022-1317-78-8-1919; ALMOND N, 1995, LANCET, V345, P1342, DOI 10.1016/S0140-6736(95)92540-6; Berry N, 2008, J GEN VIROL, V89, P2240, DOI 10.1099/vir.0.2008/001693-0; Berry N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023092; Berry NJ, 2012, IMMUNOGENETICS, V64, P267, DOI 10.1007/s00251-011-0585-x; Borrow P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-84; Brenchley JM, 2012, BLOOD, V120, P4172, DOI 10.1182/blood-2012-06-437608; Canto-Nogues C, 2001, J GEN VIROL, V82, P2225, DOI 10.1099/0022-1317-82-9-2225; Clarke S, 2012, J NEUROVIROL, V18, P100, DOI 10.1007/s13365-012-0084-3; Connor RI, 1998, J VIROL, V72, P7501, DOI 10.1128/JVI.72.9.7501-7509.1998; Cranage MP, 1997, VIROLOGY, V229, P143, DOI 10.1006/viro.1996.8419; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Ferguson D, 2007, J MED PRIMATOL, V36, P131, DOI 10.1111/j.1600-0684.2007.00224.x; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Hong JJ, 2012, J IMMUNOL, V188, P3247, DOI 10.4049/jimmunol.1103138; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; KENT KA, 1991, AIDS, V5, P829, DOI 10.1097/00002030-199107000-00006; Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Lay MDH, 2009, J VIROL, V83, P7517, DOI 10.1128/JVI.00552-09; Li B, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-8; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Manoussaka MS, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-59; Mansfield K, 2008, J VIROL, V82, P4135, DOI 10.1128/JVI.00015-08; Martin-Serrano J, 2011, NAT REV MICROBIOL, V9, P519, DOI 10.1038/nrmicro2596; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mattiuzzo G, 2013, J GEN VIROL, V94, P606, DOI 10.1099/vir.0.047795-0; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mee ET, 2009, IMMUNOGENETICS, V61, P327, DOI 10.1007/s00251-009-0369-8; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Norley S, 1996, VIROLOGY, V219, P195, DOI 10.1006/viro.1996.0237; O'Connor SL, 2007, IMMUNOGENETICS, V59, P449, DOI 10.1007/s00251-007-0209-7; O'Connor SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000524; PAUL WE, 1995, CELL, V82, P177, DOI 10.1016/0092-8674(95)90304-6; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Petravic J, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-105; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; RUD EW, 1994, J GEN VIROL, V75, P529, DOI 10.1099/0022-1317-75-3-529; Sharpe SA, 1997, J GEN VIROL, V78, P1923, DOI 10.1099/0022-1317-78-8-1923; Sharpe SA, 2004, J GEN VIROL, V85, P2591, DOI 10.1099/vir.0.80050-0; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Singh R, 2011, J VIROL, V85, P208, DOI 10.1128/JVI.01810-10; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Stebbings R, 2005, J VIROL, V79, P12264, DOI 10.1128/JVI.79.19.12264-12272.2005; Stebbings R, 2004, VIROLOGY, V330, P249, DOI 10.1016/j.virol.2004.09.026; Stockwin LH, 2000, IMMUNOL CELL BIOL, V78, P91, DOI 10.1046/j.1440-1711.2000.00888.x; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Vanderford TH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002048; Whitney JB, 2004, CURR OPIN INFECT DIS, V17, P17, DOI 10.1097/00001432-200402000-00004; Wonderlich ER, 2011, IMMUNOL RES, V50, P228, DOI 10.1007/s12026-011-8220-3; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999; Yan N, 2011, CURR OPIN IMMUNOL, V23, P21, DOI 10.1016/j.coi.2010.11.004; Ylinen LMJ, 2005, J VIROL, V79, P11580, DOI 10.1128/JVI.79.18.11580-11587.2005	65	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e104390	10.1371/journal.pone.0104390	http://dx.doi.org/10.1371/journal.pone.0104390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162725	Green Published, gold			2022-12-25	WOS:000340880900013
J	Meloni, EG; Gillis, TE; Manoukian, J; Kaufman, MJ				Meloni, Edward G.; Gillis, Timothy E.; Manoukian, Jasmine; Kaufman, Marc J.			Xenon Impairs Reconsolidation of Fear Memories in a Rat Model of Post-Traumatic Stress Disorder (PTSD)	PLOS ONE			English	Article							METHYL-D-ASPARTATE; TISSUE-PLASMINOGEN ACTIVATOR; NITROUS-OXIDE; MOLECULAR-MECHANISMS; GLYCINE-SITE; EXTINCTION; RECEPTOR; DESTABILIZATION; INHIBITION; CHANNELS	Xenon (Xe) is a noble gas that has been developed for use in people as an inhalational anesthestic and a diagnostic imaging agent. Xe inhibits glutamatergic N-methyl-D-aspartate (NMDA) receptors involved in learning and memory and can affect synaptic plasticity in the amygdala and hippocampus, two brain areas known to play a role in fear conditioning models of post-traumatic stress disorder (PTSD). Because glutamate receptors also have been shown to play a role in fear memory reconsolidation - a state in which recalled memories become susceptible to modification - we examined whether Xe administered after fear memory reactivation could affect subsequent expression of fear-like behavior (freezing) in rats. Male Sprague-Dawley rats were trained for contextual and cued fear conditioning and the effects of inhaled Xe (25%, 1 hr) on fear memory reconsolidation were tested using conditioned freezing measured days or weeks after reactivation/Xe administration. Xe administration immediately after fear memory reactivation significantly reduced conditioned freezing when tested 48 h, 96 h or 18 d after reactivation/Xe administration. Xe did not affect freezing when treatment was delayed until 2 h after reactivation or when administered in the absence of fear memory reactivation. These data suggest that Xe substantially and persistently inhibits memory reconsolidation in a reactivation and time-dependent manner, that it could be used as a new research tool to characterize reconsolidation and other memory processes, and that it could be developed to treat people with PTSD and other disorders related to emotional memory.	[Meloni, Edward G.] Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02178 USA; McLean Hosp, Belmont, MA 02178 USA	Harvard University; Harvard University; McLean Hospital	Meloni, EG (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02178 USA.	emeloni@mclean.harvard.edu		Kaufman, Marc/0000-0002-4383-1264	National Institutes of Health [R03N5080073]; O'Keefe Family Junior Investigator Award; McLean Hospital (MJK, EGM); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS080073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); O'Keefe Family Junior Investigator Award; McLean Hospital (MJK, EGM); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the following: National Institutes of Health grant R03N5080073 (MJK); http://www.nih.govi; O'Keefe Family Junior Investigator Award (EGM); and McLean Hospital (MJK, EGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph O, 2010, NEUROIMAGE, V49, P720, DOI 10.1016/j.neuroimage.2009.08.034; Agren T, 2012, SCIENCE, V337, P1550, DOI 10.1126/science.1223006; Auber A, 2013, PSYCHOPHARMACOLOGY, V226, P631, DOI 10.1007/s00213-013-3004-1; Bantel C, 2010, ANESTHESIOLOGY, V112, P623, DOI 10.1097/ALN.0b013e3181cf894a; Barnes P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003248; Beardsley PM, 2002, BEHAV PHARMACOL, V13, P583, DOI 10.1097/00008877-200211000-00007; Bedi A, 2002, ANAESTHESIA, V57, P233, DOI 10.1046/j.0003-2409.2001.02455.x; Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; Betourne A, 2009, NEUROPHARMACOLOGY, V56, P615, DOI 10.1016/j.neuropharm.2008.11.001; Cain CK, 2012, EXPERT OPIN INV DRUG, V21, P1323, DOI 10.1517/13543784.2012.704020; Carlson AP, 2011, AM J NEURORADIOL, V32, P1315, DOI 10.3174/ajnr.A2522; Casse F, 2012, J NEUROSCI, V32, P5186, DOI 10.1523/JNEUROSCI.5296-11.2012; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Curzon P., 2009, METHODS BEHAV ANAL N, DOI DOI 10.1201/NOE1420052343.CH2; David HN, 2010, J CEREBR BLOOD F MET, V30, P718, DOI 10.1038/jcbfm.2009.275; de Kleine RA, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.21626; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Dunlop BW, 2012, CURR PHARM DESIGN, V18, P5645; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Ehlers A, 2004, MEMORY, V12, P403, DOI 10.1080/09658210444000025; Elzinga BM, 2002, J AFFECT DISORDERS, V70, P1, DOI 10.1016/S0165-0327(01)00351-2; Fernandez-Monreal M, 2004, J BIOL CHEM, V279, P50850, DOI 10.1074/jbc.M407069200; Fitzgerald PJ, 2014, BRAIN RES BULL, V105, P46, DOI 10.1016/j.brainresbull.2013.12.007; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Haseneder R, 2008, ANESTHESIOLOGY, V109, P998, DOI 10.1097/ALN.0b013e31818d6aee; Hong I, 2013, P NATL ACAD SCI USA, V110, P8218, DOI 10.1073/pnas.1305235110; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Kenney JW, 2012, HIPPOCAMPUS, V22, P1681, DOI 10.1002/hipo.22003; Kratzer S, 2012, ANESTHESIOLOGY, V116, P673, DOI 10.1097/ALN.0b013e3182475d66; Kroes MCW, 2014, NAT NEUROSCI, V17, P204, DOI 10.1038/nn.3609; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; Li Y, 2013, P NATL ACAD SCI USA, V110, P4798, DOI 10.1073/pnas.1217878110; Lochner JE, 2006, J NEUROBIOL, V66, P564, DOI 10.1002/neu.20250; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Merlo E, 2014, J NEUROSCI, V34, P2422, DOI 10.1523/JNEUROSCI.4001-13.2014; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Milton AL, 2013, J NEUROSCI, V33, P1109, DOI 10.1523/JNEUROSCI.3273-12.2013; Morrison FG, 2014, DEPRESS ANXIETY, V31, P279, DOI 10.1002/da.22214; Nader Karim, 2013, Dialogues Clin Neurosci, V15, P475; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Nagappan G, 2009, P NATL ACAD SCI USA, V106, P1267, DOI 10.1073/pnas.0807322106; Narayanan RT, 2007, NEUROREPORT, V18, P1107, DOI 10.1097/WNR.0b013e3282004992; Nicholson KL, 2009, PSYCHOPHARMACOLOGY, V203, P441, DOI 10.1007/s00213-009-1469-8; Obiang P, 2011, NEUROBIOL LEARN MEM, V96, P121, DOI 10.1016/j.nlm.2011.03.004; Parsons RG, 2013, NAT NEUROSCI, V16, P146, DOI 10.1038/nn.3296; Perouansky M, 2010, ANESTHESIOLOGY, V113, P1299, DOI 10.1097/ALN.0b013e3181f90ccc; Philips RG, 1997, BEH NEUROSCI, V106, P274; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Reichelt AC, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00118; Schiller D, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00024; Suzuki T, 2003, ANESTH ANALG, V96, P443, DOI 10.1097/00000539-200302000-00028; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Tronson NC, 2013, CURR OPIN NEUROBIOL, V23, P573, DOI 10.1016/j.conb.2013.01.022; VanElzakker MB, 2014, NEUROBIOL LEARN MEM, V113, P3, DOI 10.1016/j.nlm.2013.11.014; Yamakura T, 2000, ANESTHESIOLOGY, V93, P1095, DOI 10.1097/00000542-200010000-00034	57	27	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106189	10.1371/journal.pone.0106189	http://dx.doi.org/10.1371/journal.pone.0106189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162644	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900095
J	Seidel, N; Sauerbrei, A; Wutzler, P; Schmidtke, M				Seidel, Nora; Sauerbrei, Andreas; Wutzler, Peter; Schmidtke, Michaela			Hemagglutinin 222D/G Polymorphism Facilitates Fast Intra-Host Evolution of Pandemic (H1N1) 2009 Influenza A Viruses	PLOS ONE			English	Article							RECEPTOR-BINDING; INCREASED VIRULENCE; SEVERE DISEASE; UNITED-STATES; MICE; NEURAMINIDASE; SUBSTITUTION; D222G; SPECIFICITY; ADAPTATION	The amino acid substitution of aspartic acid to glycine in hemagglutinin (HA) in position 222 (HA-D222G) as well as HA222D/G polymorphism of pandemic (H1N1) 2009 influenza viruses (A(H1N1) pdm09) were frequently reported in severe influenza in humans and mice. Their impact on viral pathogenicity and the course of influenza has been discussed controversially and the underlying mechanism remained unclarified. In the present study, BALB/c mice, infected with the once mouse lung-and cell-passaged A(H1N1) pdm09 isolate A/Jena/5258/09 (mpJena/5258), developed severe pneumonia. From day 2 to 3 or 4 post infection (p. i.) symptoms (body weight loss and clinical score) continuously worsened. After a short disease stagnation or even recovery phase in most mice, severity of disease further increased on days 6 and 7 p. i. Thereafter, surviving mice recovered. A 45 times higher virus titer maximum in the lung than in the trachea on day 2 p. i. and significantly higher tracheal virus titers compared to lung on day 6 p. i. indicated changes in the organ tropism during infection. Sequence analysis revealed an HA-222D/G polymorphism. HA-D222 and HA-G222 variants co-circulated in lung and trachea. Whereas, HA-D222 variant predominated in the lung, HA-G222 became the major variant in the trachea after day 4 p. i. This was accompanied by lower neutralizing antibody titers and broader receptor recognition including terminal sialic acid alpha-2,3-linked galactose, which is abundant on mouse trachea epithelial cells. Plaque-purified HA-G222-mpJena/5258 virus induced severe influenza with maximum symptom on day 6 p. i. These results demonstrated for the first time that HA-222D/G quasispecies of A(H1N1) pdm09 caused severe biphasic influenza because of fast viral intra-host evolution, which enabled partial antibody escape and minor changes in receptor binding.	[Seidel, Nora; Sauerbrei, Andreas; Wutzler, Peter; Schmidtke, Michaela] Univ Jena, Jena Univ Hosp, Dept Virol & Antiviral Therapy, Jena, Germany	Friedrich Schiller University of Jena	Schmidtke, M (corresponding author), Univ Jena, Jena Univ Hosp, Dept Virol & Antiviral Therapy, Jena, Germany.	michaela.schmidtke@med.uni-jena.de			German Federal Ministry of Education and Research [01 K1 1006J]; Thuringia Ministry of Economy, Labour, and Technology; European Social Fund [2011 FGR 0137]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Thuringia Ministry of Economy, Labour, and Technology; European Social Fund(European Social Fund (ESF))	This study was supported by projects of the German Federal Ministry of Education and Research (01 K1 1006J) as well as by the Thuringia Ministry of Economy, Labour, and Technology and the European Social Fund (2011 FGR 0137) awarded to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2011, J INFECT DIS, V204, P1008, DOI 10.1093/infdis/jir483; Bauer K, 2012, MED MICROBIOL IMMUN, V201, P61, DOI 10.1007/s00430-011-0206-1; Bauer K, 2009, ANTIVIR RES, V82, P34, DOI 10.1016/j.antiviral.2009.01.006; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Corcioli F, 2014, VIRUS RES, V180, P39, DOI 10.1016/j.virusres.2013.12.010; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hamelin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001015; Hauge S, 2007, CLIN VACCINE IMMUNOL, V14, P978, DOI 10.1128/CVI.00033-07; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kilander A, 2010, EUROSURVEILLANCE, V15, P1, DOI DOI 10.1128/JVI.01136-10; Kirchmair J, 2011, FUTURE MED CHEM, V3, P437, DOI [10.4155/FMC.10.292, 10.4155/fmc.10.292]; Levine M, 2011, J CLIN MICROBIOL, V49, P1307, DOI 10.1128/JCM.02424-10; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Manchanda H, 2014, BIOSYSTEMS, V118, P51, DOI 10.1016/j.biosystems.2014.02.004; McKimm-Breschkin JL, 2013, J ANTIMICROB CHEMOTH, V68, P2210, DOI 10.1093/jac/dkt205; Medeiros R, 2001, VIROLOGY, V289, P74, DOI 10.1006/viro.2001.1121; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; MILLER RR, 2010, EURO SURVEILL, V15; Nguyen HT, 2012, ANTIVIR RES, V93, P381, DOI 10.1016/j.antiviral.2012.01.006; Ning ZY, 2009, VET RES COMMUN, V33, P895, DOI 10.1007/s11259-009-9307-3; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sakabe S, 2011, VIRUS RES, V158, P124, DOI 10.1016/j.virusres.2011.03.022; Selleri M, 2013, CLIN MICROBIOL INFEC, V19, P668, DOI 10.1111/j.1469-0691.2012.03984.x; Seyer R, 2012, J INFECT DIS, V205, P262, DOI 10.1093/infdis/jir716; Strengell M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025848; Takemae N, 2010, J GEN VIROL, V91, P938, DOI 10.1099/vir.0.016691-0; Uraki R, 2013, J VIROL, V87, P2226, DOI 10.1128/JVI.01565-12; Vazquez-Perez JA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-41; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Wang B, 2011, J CLIN VIROL, V52, P304, DOI 10.1016/j.jcv.2011.08.023; Wedde M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057059; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P21; WYDE PR, 1977, INFECT IMMUN, V15, P221, DOI 10.1128/IAI.15.1.221-229.1977; Xu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028901; Xu LL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-325; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145; Zheng BJ, 2010, EXP BIOL MED, V235, P981, DOI 10.1258/ebm.2010.010071	51	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e104233	10.1371/journal.pone.0104233	http://dx.doi.org/10.1371/journal.pone.0104233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162520	Green Published, Green Submitted, gold			2022-12-25	WOS:000340880900009
J	Jia, B; Xie, L; Zheng, Q; Yang, PF; Zhang, WJ; Ding, C; Qian, AR; Shang, P				Jia, Bin; Xie, Li; Zheng, Qi; Yang, Peng-fei; Zhang, Wei-ju; Ding, Chong; Qian, Ai-rong; Shang, Peng			A Hypomagnetic Field Aggravates Bone Loss Induced by Hindlimb Unloading in Rat Femurs	PLOS ONE			English	Article							STATIC MAGNETIC-FIELD; KAPPA-B LIGAND; OXIDATIVE STRESS; ZINC-DEFICIENCY; RECEPTOR ACTIVATOR; URINARY-EXCRETION; MINERAL DENSITY; IRON STATUS; IN-VITRO; MAGNESIUM	A hypomagnetic field is an extremely weak magnetic field-it is considerably weaker than the geomagnetic field. In deepspace exploration missions, such as those involving extended stays on the moon and interplanetary travel, astronauts will experience abnormal space environments involving hypomagnetic fields and microgravity. It is known that microgravity in space causes bone loss, which results in decreased bone mineral density. However, it is unclear whether hypomagnetic fields affect the skeletal system. In the present study, we aimed to investigate the complex effects of a hypomagnetic field and microgravity on bone loss. To study the effects of hypomagnetic fields on the femoral characteristics of rats in simulated weightlessness, we established a rat model of hindlimb unloading that was exposed to a hypomagnetic field. We used a geomagnetic field-shielding chamber to generate a hypomagnetic field of <300 nT. The results show that hypomagnetic fields can exacerbate bone mineral density loss and alter femoral biomechanical characteristics in hindlimb-unloaded rats. The underlying mechanism might involve changes in biological rhythms and the concentrations of trace elements due to the hypomagnetic field, which would result in the generation of oxidative stress responses in the rat. Excessive levels of reactive oxygen species would stimulate osteoblasts to secrete receptor activator of nuclear factor-kappa B ligand and promote the maturation and activation of osteoclasts and thus eventually cause bone resorption.	[Jia, Bin; Xie, Li; Zheng, Qi; Yang, Peng-fei; Zhang, Wei-ju; Ding, Chong; Qian, Ai-rong; Shang, Peng] Northwestern Polytech Univ, Sch Life Sci, Inst Special Environm Biophys, Key Lab Space Biosci & Biotechnol, Xian 710072, Peoples R China	Northwestern Polytechnical University	Shang, P (corresponding author), Northwestern Polytech Univ, Sch Life Sci, Inst Special Environm Biophys, Key Lab Space Biosci & Biotechnol, Xian 710072, Peoples R China.	shangpeng@nwpu.edu.cn			National Basic Research Program of China [2011CB710903]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (2011CB710903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaseth J, 2012, J TRACE ELEM MED BIO, V26, P149, DOI 10.1016/j.jtemb.2012.03.017; Almeida M, 2011, J BIOL CHEM, V286, P44326, DOI 10.1074/jbc.M111.283481; Altindag O, 2008, RHEUMATOL INT, V28, P317, DOI 10.1007/s00296-007-0452-0; Amblard D, 2003, J BONE MINER RES, V18, P561, DOI 10.1359/jbmr.2003.18.3.561; Arredondo Miguel, 2005, Molecular Aspects of Medicine, V26, P313, DOI 10.1016/j.mam.2005.07.010; ASASHIMA M, 1991, BIOELECTROMAGNETICS, V12, P215, DOI 10.1002/bem.2250120403; Aydin N, 2011, INT ORTHOP, V35, P135, DOI 10.1007/s00264-009-0932-9; Bai XC, 2005, J BIOL CHEM, V280, P17497, DOI 10.1074/jbc.M409332200; Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; Belyavskaya NA, 2004, ADV SPACE RES-SERIES, V34, P1566, DOI 10.1016/j.asr.2004.01.021; Bjelakovic G, 2007, J Basic Clin Physiol Pharmacol, V18, P115; Blaber EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061372; Blanco-Rojo R, 2013, EUR J NUTR, V52, P695, DOI 10.1007/s00394-012-0375-8; BLISS VL, 1976, NATURE, V261, P411, DOI 10.1038/261411a0; Castiglioni S, 2013, NUTRIENTS, V5, P3022, DOI 10.3390/nu5083022; COHEN L, 1981, ISRAEL J MED SCI, V17, P1123; DESPLANCHES D, 1987, J APPL PHYSIOL, V63, P558, DOI 10.1152/jappl.1987.63.2.558; Dubrov AP, 1989, GEOMAGNETIC FIELD LI; Eberle J, 1999, J TRACE ELEM MED BIO, V13, P21, DOI 10.1016/S0946-672X(99)80019-4; Eide DJ, 2011, METALLOMICS, V3, P1124, DOI 10.1039/c1mt00064k; Emkey RD, 2012, ENDOCRIN METAB CLIN, V41, P527, DOI 10.1016/j.ecl.2012.04.019; FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103; Feller DD, 1981, PHYSIOLOGIST S, V24, pS9; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FUSHIMI H, 1993, DIABETES RES CLIN PR, V20, P191, DOI 10.1016/0168-8227(93)90077-I; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Guggenbuhl P, 2008, METABOLISM, V57, P903, DOI 10.1016/j.metabol.2008.02.004; Hardeland R, 2003, CHRONOBIOL INT, V20, P921, DOI 10.1081/CBI-120025245; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hsu SH, 2010, CYTOTECHNOLOGY, V62, P143, DOI 10.1007/s10616-010-9271-3; [贾斌 Jia Bin], 2011, [航天医学与医学工程, Space Medicine & Medical Engineering], V24, P318; [贾斌 JIA Bin], 2009, [航天医学与医学工程, Space Medicine & Medical Engineering], V22, P308; Jia P, 2012, J ORTHOP RES, V30, P1843, DOI 10.1002/jor.22133; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; KOPANEV V I, 1979, Biology Bulletin of the Academy of Sciences of the USSR, V6, P289; Kotani H, 2002, J BONE MINER RES, V17, P1814, DOI 10.1359/jbmr.2002.17.10.1814; Langlais B, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002048; Leesungbok R, 2013, J ORAL IMPLANTOL, V39, P248, DOI 10.1563/AAID-JOI-D-11-00101; LEVINA RV, 1989, KOSM BIOL AVIAK MED+, V23, P45; Lumachi F, 2012, IN VIVO, V26, P1041; Maier JAM, 2012, CLIN SCI, V122, P397, DOI 10.1042/CS20110506; Mazur A, 2007, ARCH BIOCHEM BIOPHYS, V458, P48, DOI 10.1016/j.abb.2006.03.031; MCLAREN AM, 1992, ANN RHEUM DIS, V51, P648, DOI 10.1136/ard.51.5.648; Mo WC, 2012, PROG BIOCHEM BIOPHYS, V39, P835, DOI 10.3724/SP.J.1206.2011.00597; Mo WC, 2012, BIOELECTROMAGNETICS, V33, P238, DOI 10.1002/bem.20699; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; Morey-Holton ER, 1998, BONE, V22, p83S, DOI 10.1016/S8756-3282(98)00019-2; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; Orwoll ES, 2013, J BONE MINER RES, V28, P1243, DOI 10.1002/jbmr.1948; Puricelli Edela, 2006, Head Face Med, V2, P43, DOI 10.1186/1746-160X-2-43; Richardson IG, 2012, J SPACE WEATHER SPAC, V2, DOI 10.1051/swsc/2012003; Rico H, 2000, EUR J OBSTET GYN R B, V90, P97, DOI 10.1016/S0301-2115(99)00223-7; Rodionova NV, 2002, J GRAVITATIONAL PHYS, V9, P169; Rude RK, 2009, J AM COLL NUTR, V28, P131, DOI 10.1080/07315724.2009.10719764; Sakata T, 2004, J BONE MINER RES, V19, P436, DOI 10.1359/JBMR.0301241; Sanchez-Rodriguez MA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-124; Sato H, 2010, J CLIN BIOCHEM NUTR, V47, P224, DOI 10.3164/jcbn.10-58; Smietana MJ, 2010, BIOCHEM BIOPH RES CO, V403, P149, DOI 10.1016/j.bbrc.2010.11.006; Song Y, 2009, J NUTR, V139, P1626, DOI 10.3945/jn.109.106369; Steinhilber F, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014193; Suwanjang W, 2013, J STEROID BIOCHEM, V138, P116, DOI 10.1016/j.jsbmb.2013.04.008; Tombarkiewicz B, 2008, ENVIRON TOXICOL PHAR, V26, P75, DOI 10.1016/j.etap.2008.02.003; Toxqui L, 2014, EUR J NUTR, V53, P441, DOI 10.1007/s00394-013-0544-4; Tsunakawa H, 2010, SPACE SCI REV, V154, P219, DOI 10.1007/s11214-010-9652-0; UEBELHART D, 1990, BONE MINER, V8, P87, DOI 10.1016/0169-6009(91)90143-N; Wang ZJ, 2013, J BONE MINER METAB, V31, P285, DOI 10.1007/s00774-012-0417-6; Warburton Darren E R, 2007, Vasc Health Risk Manag, V3, P673; Weinberg Eugene D, 2008, Pediatr Endocrinol Rev, V6 Suppl 1, P81; Weinstein RS, 2012, ENDOCRIN METAB CLIN, V41, P595, DOI 10.1016/j.ecl.2012.04.004; Weydahl A, 2001, BIOMED PHARMACOTHER, V55, p57S; Wilking M, 2013, ANTIOXID REDOX SIGN, V19, P192, DOI 10.1089/ars.2012.4889; Xu SZ, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/620984; Yamamoto Y, 2003, J DENT RES, V82, P962, DOI 10.1177/154405910308201205; Yan QC, 1998, MED ENG PHYS, V20, P397, DOI 10.1016/S1350-4533(98)00051-4; Yang P, 2009, AVIAT SPACE ENVIR MD, V80, P88, DOI 10.3357/ASEM.2368.2009; Yang Yurun, 2011, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V25, P533; Zamoshchina T A, 2012, Aviakosm Ekolog Med, V46, P17; Zerath E, 1997, LIFE SCI, V61, P2397, DOI 10.1016/S0024-3205(97)00957-0; Zhang X, 2007, BIOELECTROMAGNETICS, V28, P155, DOI 10.1002/bem.20290; Zwart SR, 2013, AM J CLIN NUTR, V98, P217, DOI 10.3945/ajcn.112.056465	82	27	30	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105604	10.1371/journal.pone.0105604	http://dx.doi.org/10.1371/journal.pone.0105604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157571	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303200039
J	Kumar, SN; Sreekala, SR; Chandrasekaran, D; Nambisan, B; Anto, RJ				Kumar, Sasidharan Nishanth; Sreekala, Sreerag Ravikumar; Chandrasekaran, Dileep; Nambisan, Bala; Anto, Ruby John			Biocontrol of Aspergillus Species on Peanut Kernels by Antifungal Diketopiperazine Producing Bacillus cereus Associated with Entomopathogenic Nematode	PLOS ONE			English	Article							POSTHARVEST BIOLOGICAL-CONTROL; CYCLIC DIPEPTIDES; ESSENTIAL OILS; FLAVUS; GROWTH; ACID; METABOLITES; INHIBITION; BACTERIA; PURIFICATION	The rhabditid entomopathogenic nematode associated Bacillus cereus and the antifungal compounds produced by this bacterium were evaluated for their activity in reducing postharvest decay of peanut kernels caused by Aspergillus species in in vitro and in vivo tests. The results showed that B. cereus had a significant effect on biocontrol effectiveness in in vitro and in vivo conditions. The antifungal compounds produced by the B. cereus were purified using silica gel column chromatography and their structure was elucidated using extensive spectral analyses. The compounds were identified as diketopiperazines (DKPs) [cyclo-(L-Pro-Gly), cyclo(L-Tyr-L-Tyr), cyclo-(L-Phe-Gly) and cyclo(4-hydroxy-L-Pro-L-Trp)]. The antifungal activities of diketopiperazines were studied against five Aspergillus species and best MIC of 2 mu g/ml was recorded against A. flavus by cyclo(4-hydroxy-L-Pro-L-Trp). To investigate the potential application of cyclo(4-hydroxy-L-Pro-L-Trp) to eliminate fungal spoilage in food and feed, peanut kernels was used as a food model system. White mycelia and dark/pale green spores of Aspergillus species were observed in the control peanut kernels after 2 days incubation. However the fungal growth was not observed in peanut kernels treated with cyclo(4-hydroxy-L-Pro-L-Trp). The cyclo(4-hydroxy-L-Pro-L-Trp) was nontoxic to two normal cell lines [fore skin (FS) normal fibroblast and African green monkey kidney (VERO)] up to 200 mu g/ml in MTT assay. Thus the cyclo(4-hydroxy-L-Pro-L-Trp) identified in this study may be a promising alternative to chemical preservatives as a potential biopreservative agent which prevent fungal growth in food and feed. To the best of our knowledge, this is the first report demonstrating that the entomopathogenic nematode associated B. cereus and cyclo(4-hydroxy-L-Pro-L-Trp) could be used as a biocontrol agents against postharvest fungal disease caused by Aspergillus species.	[Kumar, Sasidharan Nishanth; Sreekala, Sreerag Ravikumar; Nambisan, Bala] Cent Tuber Crops Res Inst, Div Crop Protect, Div Crop Utilizat, Thiruvananthapuram, Kerala, India; [Chandrasekaran, Dileep] SD Coll, Dept Bot, Alappuzha, India; [Anto, Ruby John] Rajiv Gandhi Ctr Biotechnol, Div Canc Res, Integrated Canc Res Program, Thiruvananthapuram, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Tuber Crops Research Institute; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Nambisan, B (corresponding author), Cent Tuber Crops Res Inst, Div Crop Protect, Div Crop Utilizat, Thiruvananthapuram, Kerala, India.	balactcri@gmail.com			SRF	SRF	This was self financed work. The only funding received was the fellowship of SRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide-Molina M, 2009, J CHROMATOGR A, V1216, P1115, DOI 10.1016/j.chroma.2008.12.049; [Anonymous], 2011, SCI MICROBIAL PATHOG; Anto RJ, 2003, J BIOL CHEM, V278, P25490, DOI 10.1074/jbc.M301790200; Bouchra C, 2003, J ETHNOPHARMACOL, V89, P165, DOI 10.1016/S0378-8741(03)00275-7; Cho KM, 2009, FOOD CONTROL, V20, P402, DOI 10.1016/j.foodcont.2008.07.010; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V3rd; Clinical and Laboratory Standards Institute [CLSI], 2010, M51A CLSI; CLINICAL AND LABORATORY STANDARDS INSTITUTE (CLSI), 2012, REFERENCE METHOD BRO, V4th; CLSI, 2010, METHOD ANTIFUNGAL DI; Deepa I, 2010, J ROOT CROPS, V36, P227; Droby S, 2006, ACTA HORTIC, P45, DOI 10.17660/ActaHortic.2006.709.5; Duan JL, 2013, ANN MICROBIOL, V63, P1501, DOI 10.1007/s13213-013-0614-0; Dumdei EJ, 1997, AUST J CHEM, V50, P139, DOI 10.1071/C96111; Einholm AP, 2003, BIOCHEM J, V373, P723, DOI 10.1042/BJ20021880; Fan Q, 2001, POSTHARVEST BIOL TEC, V21, P341, DOI 10.1016/S0925-5214(00)00182-4; Fdhila F, 2003, J NAT PROD, V66, P1299, DOI 10.1021/np030233e; Gould M, 2008, BIOCONTROL SCI TECHN, V18, P1005, DOI 10.1080/09583150802478189; Hamdache A, 2011, J NAT PROD, V74, P893, DOI 10.1021/np100853e; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Holden MTG, 1999, MOL MICROBIOL, V33, P1254, DOI 10.1046/j.1365-2958.1999.01577.x; Holmes RA, 2008, APPL MICROBIOL BIOT, V78, P559, DOI 10.1007/s00253-008-1362-0; Horn BW, 2009, BIOCONTROL SCI TECHN, V19, P249, DOI 10.1080/09583150802696541; Huang HR, 2007, J NAT PROD, V70, P1696, DOI 10.1021/np0605891; Huang ZJ, 2010, CHEM NAT COMPD+, V46, P15, DOI 10.1007/s10600-010-9514-8; Jamali M, 2012, FOLIA MICROBIOL, V57, P27, DOI 10.1007/s12223-011-0090-5; JOHNSON JL, 1951, J AM CHEM SOC, V73, P2947, DOI 10.1021/ja01150a516; Kumar SN, 2013, MICROBIOL RES, V168, P278, DOI 10.1016/j.micres.2012.12.003; Kumar SN, 2012, J APPL MICROBIOL, V113, P914, DOI 10.1111/j.1365-2672.2012.05385.x; Li B, 2013, J ASIAN NAT PRODS RE, V12, P1146; Lin AQ, 2008, PHARMAZIE, V63, P323, DOI 10.1691/ph.2008.7700; Lopez-Malo A, 2007, FOOD CONTROL, V18, P1358, DOI 10.1016/j.foodcont.2006.04.010; Magnusson J, 2003, FEMS MICROBIOL LETT, V219, P129, DOI 10.1016/S0378-1097(02)01207-7; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Martins MB, 2007, TETRAHEDRON, V63, P9923, DOI 10.1016/j.tet.2007.04.105; Mohandas C, 2007, P NAT SEM ACH OPP PO, P195; Munoz R, 2010, BRAZ J MICROBIOL, V41, P1019, DOI 10.1590/S1517-838220100004000021; Nielsen PV, 2000, INT J FOOD MICROBIOL, V60, P219, DOI 10.1016/S0168-1605(00)00343-3; Nishanth Sasidharan Kumar, 2013, Archives of Phytopathology and Plant Protection, V46, P962, DOI 10.1080/03235408.2012.755800; Omidbeygi M, 2007, FOOD CONTROL, V18, P1518, DOI 10.1016/j.foodcont.2006.12.003; Pitt J. I., 1977, FUNGI FOOD SPOILAGE; PUSEY PL, 1984, PLANT DIS, V68, P753, DOI 10.1094/PD-69-753; Razzaghi-Abyaneh M, 2006, MYCOPATHOLOGIA, V161, P183, DOI 10.1007/s11046-005-0242-8; Shoda M, 2000, J BIOSCI BIOENG, V89, P515, DOI 10.1016/S1389-1723(00)80049-3; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Stierle AC, 1998, PNAS, V85, P8008; Stiles ME, 1996, ANTON LEEUW INT J G, V70, P331, DOI 10.1007/BF00395940; Strom K, 2002, APPL ENVIRON MICROB, V68, P4322, DOI 10.1128/AEM.68.9.4322-4327.2002; Ventura M, 2004, J CHROMATOGR A, V1048, P25, DOI 10.1016/j.chroma.2004.07.033; Wang YF, 2008, INT J FOOD MICROBIOL, V123, P234, DOI 10.1016/j.ijfoodmicro.2008.02.002; Yan PS, 2004, APPL ENVIRON MICROB, V70, P7466, DOI 10.1128/AEM.70.12.7466-7473.2004; Yang EJ, 2010, INT J FOOD MICROBIOL, V139, P56, DOI 10.1016/j.ijfoodmicro.2010.02.012; Zollner P, 2006, J CHROMATOGR A, V1136, P123, DOI 10.1016/j.chroma.2006.09.055	52	27	29	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e106041	10.1371/journal.pone.0106041	http://dx.doi.org/10.1371/journal.pone.0106041			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157831	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200087
J	Patro, CPK; Khan, AM; Tan, TW; Fu, XY				Patro, C. Pawan K.; Khan, Asif M.; Tan, Tin Wee; Fu, Xin-Yuan			STATdb: A Specialised Resource for the STATome	PLOS ONE			English	Article							COMMUNITY ANNOTATION; GENE FAMILY; DATABASE; PROTEIN; ROLES; JAKS	Signal transducers and activators of transcription (STAT) proteins are key signalling molecules in metazoans, implicated in various cellular processes. Increased research in the field has resulted in the accumulation of STAT sequence and structure data, which are scattered across various public databases, missing extensive functional annotations, and prone to effort redundancy because of the dearth of community sharing. Therefore, there is a need to integrate the existing sequence, structure and functional data into a central repository, one that is enriched with annotations and provides a platform for community contributions. Herein, we present STATdb (publicly available at http://statdb.bic.nus.edu.sg/), the first integrated resource for STAT sequences comprising 1540 records representing the known STATome, enriched with existing structural and functional information from various databases and literature and including manual annotations. STATdb provides advanced features for data visualization, analysis and prediction, and community contributions. A key feature is a meta-predictor to characterise STAT sequences based on a novel classification that integrates STAT domain architecture, lineage and function. A curation policy workflow has been devised for regulated and structured community contributions, with an update policy for the seamless integration of new data and annotations.	[Patro, C. Pawan K.; Tan, Tin Wee; Fu, Xin-Yuan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore; [Khan, Asif M.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD USA; [Khan, Asif M.] Perdana Univ, Grad Sch Med, Serdang, Selangor Darul, Malaysia; [Fu, Xin-Yuan] Natl Univ Singapore, Canc Sci Inst Singapore CSI, Singapore 117548, Singapore; [Fu, Xin-Yuan] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	National University of Singapore; Johns Hopkins University; Perdana University; National University of Singapore; Indiana University System; Indiana University-Purdue University Indianapolis	Tan, TW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore.	tinwee@bic.nus.edu.sg; bchfxy@nus.edu.sg	Khan, M. Asif/ABE-7839-2021; Khan, Mohammad Asif/F-4663-2010; Tan, Tin Wee/B-8963-2009	Khan, M. Asif/0000-0001-9202-279X; Khan, Mohammad Asif/0000-0001-9202-279X; Tan, Tin Wee/0000-0002-4062-2854	Office of the Deputy President (Research and Technology); Yong Loo Lin School of Medicine of the National University of Singapore (NUS); Ministry of Education of Singapore [MOE2010-T2-1-084]; NUS Research Scholarship	Office of the Deputy President (Research and Technology); Yong Loo Lin School of Medicine of the National University of Singapore (NUS)(National University of Singapore); Ministry of Education of Singapore(Ministry of Education, Singapore); NUS Research Scholarship(National University of Singapore)	XYF was supported by start-up funds from the Office of the Deputy President (Research and Technology) and the Yong Loo Lin School of Medicine of the National University of Singapore (NUS), and grants from Ministry of Education of Singapore (MOE2010-T2-1-084). CPKP was funded on an NUS Research Scholarship for part of this research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; COPELAND NG, 1995, GENOMICS, V29, P225, DOI 10.1006/geno.1995.1235; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Daub J, 2008, RNA, V14, P2462, DOI 10.1261/rna.1200508; Decker T., 2012, JAK STAT SIGNALING B; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; FU XY, 1992, CELL, V70, P323, DOI 10.1016/0092-8674(92)90106-M; Gaudet P, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq027; Hombria JCG, 2002, CURR BIOL, V12, pR569, DOI 10.1016/S0960-9822(02)01057-6; Huss JW, 2008, PLOS BIOL, V6, P1398, DOI 10.1371/journal.pbio.0060175; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Kay RR, 1997, CURR BIOL, V7, pR723, DOI 10.1016/S0960-9822(06)00366-6; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lewis RS, 2004, GENE, V338, P65, DOI 10.1016/j.gene.2004.05.012; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Mazumder R, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-12; McIntosh BK, 2012, NUCLEIC ACIDS RES, V40, pD1270, DOI 10.1093/nar/gkr880; Mons B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r89; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stehr H, 2010, DATABASE, V2010; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tan TW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S5-S13; Tan TW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S27; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Veeramani A, 2006, 2006 INTERNATIONAL CONFERENCE ON BIOMEDICAL AND PHARMACEUTICAL ENGINEERING, VOLS 1 AND 2, P324; Wang Y, 2006, FASEB J, V20, P1641, DOI 10.1096/fj.06-6051com; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482	38	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104597	10.1371/journal.pone.0104597	http://dx.doi.org/10.1371/journal.pone.0104597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157689	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200014
J	Qiao, GL; Le, Y; Li, J; Wang, LH; Shen, F				Qiao, Guoliang; Le, Yuan; Li, Jun; Wang, Lianghuan; Shen, Feng			Glycogen Synthase Kinase-3 beta Is Associated with the Prognosis of Hepatocellular Carcinoma and May Mediate the Influence of Type 2 Diabetes Mellitus on Hepatocellular Carcinoma	PLOS ONE			English	Article							CELL-SURVIVAL; INSULIN; CANCER; PHOSPHORYLATION; RISK; GLYCOGEN-SYNTHASE-KINASE-3-BETA; OVEREXPRESSION; PROLIFERATION; INACTIVATION; SUPPRESSION	Background: Although many studies have shown glycogen synthase kinase-3 beta(GSK-3 beta) was associated with type 2 diabetes mellitus(T2DM) and implicated with a wide range of cancers, the role of GSK-3 beta in hepatocellular carcinoma(HCC) and the correlation among GSK-3 beta, T2DM and HCC remains unclear. Our objectives were to identify the effect of p-Ser9-GSK-3 beta on the prognosis of patients with HCC and to learn more about the interaction among T2DM, GSK-3 beta and the prognosis of HCC. Methods: Firstly we used reverse transcriptase-PCR(RT-PCR) and western blotting to determine the expression levels of GSK-3 beta and p-Ser9-GSK-3 beta in human HCC samples. We then used immunohistochemical staining to evaluate the expression pattern of p-Ser9-GSK-3 beta in 178 patients with HCC after curative partial hepatectomy. Finally we statistically analyzed the association of p-Ser9-GSK-3 beta and T2DM with the prognosis of patients with HCC. Results: P-Ser9-GSK-3 beta was over-expressed in tumor tissues compared with their normal counterparts. Correlation and regression analysis indicated that the over-expression of p-Ser9-GSK-3 beta was significantly associated with T2DM, and the correlation coefficient was 0.259 (P = 0.001). Multivariate analysis showed that the over-expression of p-Ser9-GSK-3 beta(P<0.001) and T2DM(P = 0.008) were independently associated with poor prognosis of HCC, respectively. Further analysis demonstrated that these two variables are closely related with each other. Conclusion: The over-expression of p-Ser9-GSK-3 beta and T2DM are strongly correlated with worse surgical outcome of HCC. P-Ser9-GSK-3 beta may play a significant role in mediating the influence of T2DM on the prognosis of HCC.	[Qiao, Guoliang; Li, Jun; Shen, Feng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg, Shanghai, Peoples R China; [Le, Yuan; Wang, Lianghuan] Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Shen, F (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg, Shanghai, Peoples R China.	shenfdfgd@163.com	Shen, Feng/GSD-2508-2022					Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Ban KC, 2003, CANCER LETT, V199, P201, DOI 10.1016/S0304-3835(03)00421-X; Bannasch P, 1997, J BIOENERG BIOMEMBR, V29, P303, DOI 10.1023/A:1022438528634; Bilim V, 2009, BRIT J CANCER, V101, P2005, DOI 10.1038/sj.bjc.6605437; Boissan M, 2005, AM J PATHOL, V167, P869, DOI 10.1016/S0002-9440(10)62058-5; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Cao Q, 2006, CELL RES, V16, P671, DOI 10.1038/sj.cr.7310078; Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167; Desbois-Mouthon C, 2002, HEPATOLOGY, V36, P1528, DOI 10.1053/jhep.2002.37192; Duffy JP, 2008, CANCER J, V14, P100, DOI 10.1097/PPO.0b013e31816a5c1f; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Hassan MM, 2010, CANCER-AM CANCER SOC, V116, P1938, DOI 10.1002/cncr.24982; Henriksen EJ, 2006, CURR DRUG TARGETS, V7, P1435, DOI 10.2174/1389450110607011435; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huo TI, 2010, LIVER INT, V30, P198, DOI 10.1111/j.1478-3231.2009.02143.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kunnimalaiyaan M, 2007, MOL CANCER THER, V6, P1151, DOI 10.1158/1535-7163.MCT-06-0665; Lee JS, 2007, DIABETES RES CLIN PR, V77, pS49, DOI 10.1016/j.diabres.2007.01.033; Liao XB, 2003, MOL CANCER THER, V2, P1215; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; MACAULAY VM, 1992, BRIT J CANCER, V65, P311, DOI 10.1038/bjc.1992.65; Miyashita K, 2009, CLIN CANCER RES, V15, P887, DOI 10.1158/1078-0432.CCR-08-0760; Ougolkov AV, 2006, CLIN CANCER RES, V12, P5074, DOI 10.1158/1078-0432.CCR-06-0196; Patel S, 2004, BIOCHEM SOC T, V32, P803, DOI 10.1042/BST0320803; Poon RTP, 2002, AM J GASTROENTEROL, V97, P1480, DOI 10.1016/S0002-9270(02)04148-5; Scharf JG, 2003, HORM METAB RES, V35, P685; Schuppin GT, 1998, DIABETES, V47, P1074, DOI 10.2337/diabetes.47.7.1074; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Shakoori A, 2007, CANCER SCI, V98, P1388, DOI 10.1111/j.1349-7006.2007.00545.x; Shau WY, 2012, ONCOLOGIST, V17, P856, DOI 10.1634/theoncologist.2012-0065; Sun XJ, 2009, VITAM HORM, V80, P351, DOI 10.1016/S0083-6729(08)00613-4; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Tanaka S, 2002, SURGERY, V131, pS142, DOI 10.1067/msy.2002.119495; Wang K, 2010, HEPATOLOGY, V52, P164, DOI 10.1002/hep.23650; Wang P, 2012, DIABETES-METAB RES, V28, P109, DOI 10.1002/dmrr.1291; White MF, 2006, CAN J PHYSIOL PHARM, V84, P725, DOI 10.1139/Y06-008; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	41	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105624	10.1371/journal.pone.0105624	http://dx.doi.org/10.1371/journal.pone.0105624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157753	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303200041
J	Nakajima, T; Mezzarane, RA; Hundza, SR; Komiyama, T; Zehr, EP				Nakajima, Tsuyoshi; Mezzarane, Rinaldo A.; Hundza, Sandra R.; Komiyama, Tomoyoshi; Zehr, E. Paul			Convergence in Reflex Pathways from Multiple Cutaneous Nerves Innervating the Foot Depends upon the Number of Rhythmically Active Limbs during Locomotion	PLOS ONE			English	Article							SPINAL-CORD-INJURY; NEURAL-CONTROL; SIMULTANEOUS ARM; HUMAN WALKING; LEG MOVEMENT; MODULATION; INTERLIMB; SPECIFICITY; AFFERENTS; RESPONSES	Neural output from the locomotor system for each arm and leg influences the spinal motoneuronal pools directly and indirectly through interneuronal (IN) reflex networks. While well documented in other species, less is known about the functions and features of convergence in common IN reflex system from cutaneous afferents innervating different foot regions during remote arm and leg movement in humans. The purpose of the present study was to use spatial facilitation to examine possible convergence in common reflex pathways during rhythmic locomotor limb movements. Cutaneous reflexes were evoked in ipsilateral tibialis anterior muscle by stimulating (in random order) the sural nerve (SUR), the distal tibial nerve (TIB), and combined simultaneous stimulation of both nerves (TIB&SUR). Reflexes were evoked while participants performed rhythmic stepping and arm swinging movement with both arms and the leg contralateral to stimulation (ARM&LEG), with just arm movement (ARM) and with just contralateral leg movement (LEG). Stimulation intensities were just below threshold for evoking early latency (<80 ms to peak) reflexes. For each stimulus condition, rectified EMG signals were averaged while participants held static contractions in the stationary (stimulated) leg. During ARM&LEG movement, amplitudes of cutaneous reflexes evoked by combined TIB&SUR stimulation were significantly larger than simple mathematical summation of the amplitudes evoked by SUR or TIB alone. Interestingly, this extra facilitation seen during combined nerve stimulation was significantly reduced when performing ARM or LEG compared to ARM&LEG. We conclude that locomotor rhythmic limb movement induces excitation of common IN reflex pathways from cutaneous afferents innervating different foot regions. Importantly, activity in this pathway is most facilitated during ARM&LEG movement. These results suggest that transmission in IN reflex pathways is weighted according to the number of limbs directly engaged in human locomotor activity and underscores the importance of arm swing to support neuronal excitability in leg muscles.	[Nakajima, Tsuyoshi] Kyorin Univ, Dept Integrat Physiol, Sch Med, Tokyo, Japan; [Nakajima, Tsuyoshi; Mezzarane, Rinaldo A.; Zehr, E. Paul] Univ Victoria, Rehabil Neurosci Lab, Victoria, BC, Canada; [Mezzarane, Rinaldo A.] Univ Brasilia, Coll Phys Educ, Lab Signal Proc & Motor Control, Brasilia, DF, Brazil; [Hundza, Sandra R.] Univ Victoria, Mot & Mobil Rehabil Lab, Victoria, BC, Canada; [Hundza, Sandra R.; Zehr, E. Paul] Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Hundza, Sandra R.; Zehr, E. Paul] Univ Victoria, Ctr Biomed Res, Victoria, BC, Canada; [Komiyama, Tomoyoshi] Chiba Univ, Div Sports & Hlth Sci, Chiba, Japan; [Zehr, E. Paul] Univ Victoria, Div Med Sci, Victoria, BC, Canada	Kyorin University; University of Victoria; Universidade de Brasilia; University of Victoria; University of Victoria; Chiba University; University of Victoria	Zehr, EP (corresponding author), Univ Victoria, Rehabil Neurosci Lab, Victoria, BC, Canada.	pzehr@uvic.ca	MEZZARANE, Rinaldo A/I-2862-2013	Mezzarane, Rinaldo/0000-0001-9659-4015	Japan Society for the Promotion of Science (JSPS); Natural Sciences and Engineering Research Council (NSERC); Heart and Stroke Foundation of Canada (BC YUKON)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada (BC YUKON)(Heart & Stroke Foundation of Canada)	This work supported by grants from Japan Society for the Promotion of Science (JSPS) for young Scientists (TN), the Natural Sciences and Engineering Research Council (NSERC)(EPZ), the Heart and Stroke Foundation of Canada (BC & YUKON)(EPZ and RAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baken BCM, 2005, BRAIN RES, V1031, P268, DOI 10.1016/j.brainres.2004.10.058; Baldissera F., 1981, HDB PHYSL 1 1, V2, P509, DOI DOI 10.1002/CPHY.CP010212; Balter JE, 2007, J NEUROPHYSIOL, V97, P1809, DOI 10.1152/jn.01038.2006; BURKE D, 1991, J PHYSIOL-LONDON, V432, P445, DOI 10.1113/jphysiol.1991.sp018393; Burke RE, 1999, EXP BRAIN RES, V128, P263, DOI 10.1007/s002210050847; Carroll T, 2005, EXP BRAIN RES, V161, P133, DOI 10.1007/s00221-004-2050-7; CONWAY BA, 1987, EXP BRAIN RES, V68, P643; Dietz V, 2002, TRENDS NEUROSCI, V25, P462, DOI 10.1016/S0166-2236(02)02229-4; Dietz V, 2002, BRAIN, V125, P2626, DOI 10.1093/brain/awf273; DUYSENS J, 1993, BRAIN RES, V613, P230, DOI 10.1016/0006-8993(93)90903-Z; DUYSENS J, 1991, EXP BRAIN RES, V87, P193, DOI 10.1007/BF00228520; Hubli M, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-5; Hultborn H, 1998, ANN NY ACAD SCI, V860, P70, DOI 10.1111/j.1749-6632.1998.tb09039.x; Hultborn H, 2001, J PHYSIOL-LONDON, V533, P5, DOI 10.1111/j.1469-7793.2001.0005b.x; JANKOWSKA E, 1967, ACTA PHYSIOL SCAND, V70, P389, DOI 10.1111/j.1748-1716.1967.tb03637.x; Juvin L, 2005, J NEUROSCI, V25, P6025, DOI 10.1523/JNEUROSCI.0696-05.2005; Komiyama T, 2000, EXP BRAIN RES, V133, P267, DOI 10.1007/s002210000411; LABELLA LA, 1990, J NEUROPHYSIOL, V64, P403, DOI 10.1152/jn.1990.64.2.403; LUNDBERG A, 1975, BRAIN RES, V87, P81, DOI 10.1016/0006-8993(75)90783-0; Lundberg A, 1979, Prog Brain Res, V50, P11; Meyns P, 2014, CLIN NEUROP IN PRESS; Mezzarane RA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00136; Mezzarane RA, 2011, EXP BRAIN RES, V208, P157, DOI 10.1007/s00221-010-2467-0; Nakajima T, 2008, EUR J NEUROSCI, V27, P1566, DOI 10.1111/j.1460-9568.2008.06120.x; Nakajima T, 2006, EXP BRAIN RES, V175, P514, DOI 10.1007/s00221-006-0568-6; Nakajima T, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-28; Nakajima T, 2009, EXP BRAIN RES, V195, P403, DOI 10.1007/s00221-009-1802-9; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Sakamoto M, 2007, EXP BRAIN RES, V176, P188, DOI 10.1007/s00221-006-0742-x; Sakamoto M, 2006, CLIN NEUROPHYSIOL, V117, P1301, DOI 10.1016/j.clinph.2006.03.005; Sasada S, 2010, J NEUROPHYSIOL, V104, P210, DOI 10.1152/jn.00774.2009; Spaich EG, 2004, J NEUROPHYSIOL, V91, P258, DOI 10.1152/jn.00360.2003; Tsushima E, 2007, ANAL MED DATA SPSS; Van de Crommert HWAA, 1998, GAIT POSTURE, V7, P251, DOI 10.1016/S0966-6362(98)00010-1; VanWezel BMH, 1997, J NEUROSCI, V17, P3804; Zehr EP, 2007, J NEUROPHYSIOL, V98, P1810, DOI 10.1152/jn.00562.2007; Zehr EP, 2007, J PHYSIOL-LONDON, V582, P209, DOI 10.1113/jphysiol.2007.133843; Zehr EP, 2012, J NEUROPHYSIOL, V108, P891, DOI 10.1152/jn.01152.2011; Zehr EP, 2012, CLIN NEUROPHYSIOL, V123, P796, DOI 10.1016/j.clinph.2011.07.049; Zehr EP, 2009, EXERC SPORT SCI REV, V37, P102, DOI 10.1097/JES.0b013e31819c2ed6; Zehr EP, 1997, J NEUROPHYSIOL, V77, P3311, DOI 10.1152/jn.1997.77.6.3311; Zehr EP, 1999, PROG NEUROBIOL, V58, P185, DOI 10.1016/S0301-0082(98)00081-1; Zehr EP, 2005, EXERC SPORT SCI REV, V33, P54; Zehr EP, 1998, J PHYSIOL-LONDON, V507, P305, DOI 10.1111/j.1469-7793.1998.305bu.x; Zehr EP, 2004, NEUROSCIENTIST, V10, P347, DOI 10.1177/1073858404264680; Zehr EP, 2001, J PHYSIOL-LONDON, V537, P1033	48	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e104910	10.1371/journal.pone.0104910	http://dx.doi.org/10.1371/journal.pone.0104910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170606	gold, Green Submitted, Green Published			2022-12-25	WOS:000341127500024
J	Negoro, H; Urban-Maldonado, M; Liou, LS; Spray, DC; Thi, MM; Suadicani, SO				Negoro, Hiromitsu; Urban-Maldonado, Marcia; Liou, Louis S.; Spray, David C.; Thi, Mia M.; Suadicani, Sylvia O.			Pannexin 1 Channels Play Essential Roles in Urothelial Mechanotransduction and Intercellular Signaling	PLOS ONE			English	Article							ADENOSINE-TRIPHOSPHATE RELEASE; PIG SUBUROTHELIAL MYOFIBROBLASTS; BLADDER EPITHELIAL-CELLS; EVOKED CA2+ INFLUX; BOTULINUM-TOXIN-A; URINARY-BLADDER; ATP RELEASE; P2X(7) RECEPTOR; INTERSTITIAL CYSTITIS; MICE LACKING	Urothelial cells respond to bladder distension with ATP release, and ATP signaling within the bladder and from the bladder to the CNS is essential for proper bladder function. In other cell types, pannexin 1 (Panx1) channels provide a pathway for mechanically-induced ATP efflux and for ATP-induced ATP release through interaction with P2X(7) receptors (P2X(7)Rs). We report that Panx1 and P2X(7)R are functionally expressed in the bladder mucosa and in immortalized human urothelial cells (TRT-HU1), and participate in urothelial ATP release and signaling. ATP release from isolated rat bladders induced by distention was reduced by the Panx1 channel blocker mefloquine (MFQ) and was blunted in mice lacking Panx1 or P2X(7)R expression. Hypoosmotic shock induced YoPro dye uptake was inhibited by MFQ and the P2X(7)R blocker A438079 in TRT-HU1 cells, and was also blunted in primary urothelial cells derived from mice lacking Panx1 or P2X(7)R expression. Rinsing-induced mechanical stimulation of TRT-HU1 cells triggered ATP release, which was reduced by MFQ and potentiated in low divalent cation solution (LDPBS), a condition known to enhance P2X(7)R activation. ATP signaling evaluated as intercellular Ca2+ wave radius was significantly larger in LDPBS, reduced by MFQ and by apyrase (ATP scavenger). These findings indicate that Panx1 participates in urothelial mechanotransduction and signaling by providing a direct pathway for mechanically-induced ATP release and by functionally interacting with P2X(7)Rs.	[Negoro, Hiromitsu; Suadicani, Sylvia O.] Albert Einstein Coll Med, Dept Urol, Bronx, NY 10467 USA; [Urban-Maldonado, Marcia; Spray, David C.; Thi, Mia M.; Suadicani, Sylvia O.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Liou, Louis S.] Cambridge Hlth Alliance, Dept Urol, Cambridge, MA USA; [Thi, Mia M.] Albert Einstein Coll Med, Dept Orthopaed Surg, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Cambridge Health Alliance; Yeshiva University; Albert Einstein College of Medicine	Suadicani, SO (corresponding author), Albert Einstein Coll Med, Dept Urol, Bronx, NY 10467 USA.	sylvia.suadicani@einstein.yu.edu	Negoro, Hiromitsu/AAW-3261-2021; Thi, Mia Mia/K-8772-2019	Negoro, Hiromitsu/0000-0003-1144-2755; Spray, David/0000-0001-8368-5073	National Institute of Diabetes and Digestive and Kidney Disease [DK081435]; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [1P30HD071593-01]; National Institutes of Health [S10 RR020949]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091466, R01DK081435] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Disease (DK081435 to SOS). Use of the Image Core Facility of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (1P30HD071593-01), and equipment from a shared instrumentation grant from the National Institutes of Health (S10 RR020949). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto AVP, 2013, N-S ARCH PHARMACOL, V386, P775, DOI 10.1007/s00210-013-0868-x; Timoteo MA, 2014, BIOCHEM PHARMACOL, V87, P371, DOI 10.1016/j.bcp.2013.11.007; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Birder LA, 2003, AM J PHYSIOL-RENAL, V285, pF423, DOI 10.1152/ajprenal.00056.2003; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Birder LA, 2001, P NATL ACAD SCI USA, V98, P13396, DOI 10.1073/pnas.231243698; Birder L, 2007, J PHARMACOL EXP THER, V323, P227, DOI 10.1124/jpet.107.125435; Burnstock G, 2001, TRENDS PHARMACOL SCI, V22, P182, DOI 10.1016/S0165-6147(00)01643-6; Burnstock G, 2014, PURINERG SIGNAL, V10, P103, DOI 10.1007/s11302-013-9395-y; Burnstock G, 2011, BJU INT, V107, P192, DOI 10.1111/j.1464-410X.2010.09926.x; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chopra B, 2005, J PHYSIOL-LONDON, V562, P859, DOI 10.1113/jphysiol.2004.071159; Chopra B, 2008, AM J PHYSIOL-RENAL, V294, pF821, DOI 10.1152/ajprenal.00321.2006; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Dahl G, 2013, NEUROPHARMACOLOGY, V75, P583, DOI 10.1016/j.neuropharm.2013.02.019; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Du SQ, 2007, UROLOGY, V69, P590, DOI 10.1016/j.urology.2007.01.039; Dvoriantchikova G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031991; Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x; Ferguson DR, 1999, BJU INT, V84, P235; Fry CH, 2007, NEUROUROL URODYNAM, V26, P914, DOI 10.1002/nau.20483; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Girard BM, 2008, J MOL NEUROSCI, V36, P310, DOI 10.1007/s12031-008-9104-4; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Hanstein R, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00061; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Iglesias R, 2009, CELL COMMUN ADHES, V16, P131, DOI 10.3109/15419061003642618; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Khera M, 2004, NEUROCHEM INT, V45, P987, DOI 10.1016/j.neuint.2004.06.001; Kim J, 2011, IN VITRO CELL DEV-AN, V47, P2, DOI 10.1007/s11626-010-9350-y; Kullmann FA, 2008, AM J PHYSIOL-RENAL, V294, pF971, DOI 10.1152/ajprenal.00313.2007; Kumar V, 2007, J UROLOGY, V178, P1533, DOI 10.1016/j.juro.2007.05.116; Kumar V, 2010, EUR UROL, V57, P1087, DOI 10.1016/j.eururo.2009.11.042; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Lee HY, 2000, J UROLOGY, V163, P2002, DOI 10.1016/S0022-5347(05)67618-5; Lewis SA, 2000, AM J PHYSIOL-RENAL, V278, pF867; Leybaert L, 2012, PHYSIOL REV, V92, P1359, DOI 10.1152/physrev.00029.2011; Li MF, 2013, P NATL ACAD SCI USA, V110, pE3455, DOI 10.1073/pnas.1308088110; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Lutz SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066657; Martins JP, 2012, BRIT J PHARMACOL, V165, P183, DOI 10.1111/j.1476-5381.2011.01535.x; Miyamoto T, 2014, J BIOL CHEM, V289, P16565, DOI 10.1074/jbc.M113.528638; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Munoz A, 2011, NEUROCHEM INT, V58, P295, DOI 10.1016/j.neuint.2010.12.002; Namasivayam S, 1999, BJU INT, V84, P854; Negoro H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02152; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Olsen SM, 2011, ANN BIOMED ENG, V39, P688, DOI 10.1007/s10439-010-0203-3; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; Pandita RK, 2000, J UROLOGY, V164, P1385, DOI 10.1016/S0022-5347(05)67204-7; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; Sadananda P, 2009, BRIT J PHARMACOL, V158, P1655, DOI 10.1111/j.1476-5381.2009.00431.x; Salas NA, 2007, NEUROCHEM INT, V50, P345, DOI 10.1016/j.neuint.2006.09.002; Sanderson MJ, 1996, NEWS PHYSIOL SCI, V11, P262, DOI 10.1152/physiologyonline.1996.11.6.262; Sandilos JK, 2012, J PHYSIOL-LONDON, V590, P6257, DOI 10.1113/jphysiol.2012.240911; Santiago MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025178; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Scemes E, 2009, PFLUG ARCH EUR J PHY, V457, P1207, DOI 10.1007/s00424-008-0591-5; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Smith CP, 2005, NEUROCHEM INT, V47, P291, DOI 10.1016/j.neuint.2005.04.021; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Suadicani SO, 2006, J NEUROSCI; Suadicani SO, 2012, GLIA, V60, P1106, DOI 10.1002/glia.22338; Suadicani SO, 2009, ASN NEURO, V1, DOI 10.1042/AN20090001; Suadicani SO, 2009, BJU INT, V103, P1686, DOI 10.1111/j.1464-410X.2008.08337.x; Sui GP, 2004, J UROLOGY, V171, P938, DOI 10.1097/01.ju.0000108120.28291.eb; Sui GP, 2002, BJU INT, V90, P118, DOI 10.1046/j.1464-410X.2002.02834.x; Sui GP, 2006, BJU INT, V97, P1327, DOI 10.1111/j.1464-410X.2006.06200.x; Sun Y, 2006, AM J PHYSIOL-CELL PH, V290, pC27, DOI 10.1152/ajpcell.00552.2004; Sun Y, 2002, UROLOGY, V60, P351, DOI 10.1016/S0090-4295(02)01710-7; Sun Y, 2001, J UROLOGY, V166, P1951, DOI 10.1016/S0022-5347(05)65726-6; Thi MM, 2012, J MEMBRANE BIOL, V245, P401, DOI 10.1007/s00232-012-9462-2; Toft BR, 2006, CURR OPIN UROL, V16, P268, DOI 10.1097/01.mou.0000232048.81965.16; Vial C, 2000, BRIT J PHARMACOL, V131, P1489, DOI 10.1038/sj.bjp.0703720; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Vlaskovska M, 2001, J NEUROSCI, V21, P5670, DOI 10.1523/JNEUROSCI.21-15-05670.2001; Wang ECY, 2005, J CLIN INVEST, V115, P2412, DOI 10.1172/JCI24086; Wiseman OJ, 2003, BJU INT, V91, P89, DOI 10.1046/j.1464-410X.2003.03802.x; Wu C, 2004, J PHYSIOL-LONDON, V559, P231, DOI 10.1113/jphysiol.2004.067934	87	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106269	10.1371/journal.pone.0106269	http://dx.doi.org/10.1371/journal.pone.0106269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170954	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500138
J	Wang, ZS; Ren, S; Huang, N				Wang, Zhengshi; Ren, Shan; Huang, Ning			Saltation of Non-Spherical Sand Particles	PLOS ONE			English	Article							GRAINS; CLOUD; SHAPE; FLOW; DRAG; AIR	Saltation is an important geological process and the primary source of atmospheric mineral dust aerosols. Unfortunately, no studies to date have been able to precisely reproduce the saltation process because of the simplified theoretical models used. For example, sand particles in most of the existing wind sand movement models are considered to be spherical, the effects of the sand shape on the structure of the wind sand flow are rarely studied, and the effect of mid-air collision is usually neglected. In fact, sand grains are rarely round in natural environments. In this paper, we first analyzed the drag coefficients, drag forces, and starting friction wind speeds of sand grains with different shapes in the saltation process, then established a sand saltation model that considers the coupling effect between wind and the sand grains, the effect of the mid-air collision of sand grains, and the effect of the sand grain shape. Based on this model, the saltation process and sand transport rate of non-spherical sand particles were simulated. The results show that the sand shape has a significant impact on the saltation process; for the same wind speed, the sand transport rates varied for different shapes of sand grains by as much as several-fold. Therefore, sand shape is one of the important factors affecting wind-sand movement.	[Wang, Zhengshi; Huang, Ning] Lanzhou Univ, Key Lab Mech Disaster & Environm Western China, Minist Educ China, Lanzhou 730000, Peoples R China; [Wang, Zhengshi; Ren, Shan; Huang, Ning] Lanzhou Univ, Sch Civil Engn & Mech, Dept Mech, Lanzhou 730000, Peoples R China	Lanzhou University; Ministry of Education, China; Lanzhou University	Huang, N (corresponding author), Lanzhou Univ, Key Lab Mech Disaster & Environm Western China, Minist Educ China, Lanzhou 730000, Peoples R China.	huangn@lzu.edu.cn			National Key Basic Research and Development Program ("973'' Program) [2009CB421304]; Innovative Research Groups of the National Natural Science Foundation of China [11121202]; National Natural Science Foundation of China [11172118, 41371034, 91325203]; National Key Technologies R & D Program of China [2013BAC07B01]	National Key Basic Research and Development Program ("973'' Program)(National Basic Research Program of China); Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R & D Program of China(National Key Technology R&D Program)	This work is supported by the National Key Basic Research and Development Program ("973'' Program) (2009CB421304), the Innovative Research Groups of the National Natural Science Foundation of China (11121202), the National Natural Science Foundation of China (11172118, 41371034, 91325203), and the National Key Technologies R & D Program of China (2013BAC07B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MP, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.018001; Anderson R. S., 1991, WIND MODIFICATION BE, Vl, P21, DOI [DOI 10.1007/978-3-7091-6706-9_, DOI 10.1007/978-3-7091-6706-9_2]; Bagnold R., 1941, PHYS BLOWN SAND DESE; Barton ED, 1973, J AEROSOL SCI, V4, P139; Blott SJ, 2006, SEDIMENTOLOGY, V53, P671, DOI 10.1111/j.1365-3091.2006.00786.x; Carneiro MV, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.058001; [程旭 Cheng Xu], 2003, [工程热物理学报, Journal of Engineering Thermophysics], V24, P437; Clift R., 2005, BUBBLES DROPS PARTIC; Dong Q S, 1997, CHIN J RADIO SCI, V12, P15; Dong ZB, 2002, EARTH SURF PROC LAND, V27, P641, DOI 10.1002/esp.341; Dupont S, 2013, J GEOPHYS RES-ATMOS, V118, P7109, DOI 10.1002/jgrd.50528; Duran O, 2006, J STAT MECH-THEORY E, V2006, pP0711; Gao D, 1983, WORLD DESERT STUDY, V4, P47; Gavze E, 1997, INT J MULTIPHAS FLOW, V23, P155, DOI 10.1016/S0301-9322(96)00054-7; Huang N, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013593; Juan JKZ, 2009, B SOC GEOL MEX, V61, P1; Kok JF, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/106901; Kok JF, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011702; Liu XP, 2004, GEOMORPHOLOGY, V60, P371, DOI 10.1016/j.geomorph.2003.08.009; Loth E, 2008, POWDER TECHNOL, V182, P342, DOI 10.1016/j.powtec.2007.06.001; McTainsh G, 2013, TREATISE GEOMORPHOLO, P23; OWEN PR, 1964, J FLUID MECH, V20, P225, DOI 10.1017/S0022112064001173; Ren S, 2010, EUR PHYS J E, V33, P351, DOI 10.1140/epje/i2010-10681-4; SAGGA AMS, 1993, SEDIMENT GEOL, V87, P63, DOI 10.1016/0037-0738(93)90036-5; UNGAR JE, 1987, SEDIMENTOLOGY, V34, P289, DOI 10.1111/j.1365-3091.1987.tb00778.x; Wu Z., 1987, AEOLIAN GEOMORPHOLOG; Xu Weijiang, 2006, Journal of Xi'an Jiaotong University, V40, P298; Yin CG, 2003, CHEM ENG SCI, V58, P3489, DOI 10.1016/S0009-2509(03)00214-8; Zastawny M, 2012, INT J MULTIPHAS FLOW, V39, P227, DOI 10.1016/j.ijmultiphaseflow.2011.09.004; Zheng XJ, 2009, ENVIRON SCI-GER, P1, DOI 10.1007/978-3-540-88254-1_1; Zhou YH, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021305; 黄宁, 2008, [中国科学. G辑, 物理学，力学，天文学, Science in China. Series G, Physics, Mechanics & Astronomy], V38, P260	32	4	5	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105208	10.1371/journal.pone.0105208	http://dx.doi.org/10.1371/journal.pone.0105208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170614	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500035
J	Zong, SW; Wu, ZF; Xu, JW; Li, M; Gao, XF; He, HS; Du, HB; Wang, L				Zong, Shengwei; Wu, Zhengfang; Xu, Jiawei; Li, Ming; Gao, Xiaofeng; He, Hongshi; Du, Haibo; Wang, Lei			Current and Potential Tree Locations in Tree Line Ecotone of Changbai Mountains, Northeast China: The Controlling Effects of Topography	PLOS ONE			English	Article							CLIMATE-CHANGE; RESOLUTION IKONOS; INTERIOR ALASKA; TEMPERATURE; VEGETATION; IMAGERY; DISPERSAL; ELEVATION; DYNAMICS; GROWTH	Tree line ecotone in the Changbai Mountains has undergone large changes in the past decades. Tree locations show variations on the four sides of the mountains, especially on the northern and western sides, which has not been fully explained. Previous studies attributed such variations to the variations in temperature. However, in this study, we hypothesized that topographic controls were responsible for causing the variations in the tree locations in tree line ecotone of the Changbai Mountains. To test the hypothesis, we used IKONOS images and WorldView-1 image to identify the tree locations and developed a logistic regression model using topographical variables to identify the dominant controls of the tree locations. The results showed that aspect, wetness, and slope were dominant controls for tree locations on western side of the mountains, whereas altitude, SPI, and aspect were the dominant factors on northern side. The upmost altitude a tree can currently reach was 2140 m asl on the northern side and 2060 m asl on western side. The model predicted results showed that habitats above the current tree line on the both sides were available for trees. Tree recruitments under the current tree line may take advantage of the available habitats at higher elevations based on the current tree location. Our research confirmed the controlling effects of topography on the tree locations in the tree line ecotone of Changbai Mountains and suggested that it was essential to assess the tree response to topography in the research of tree line ecotone.	[Zong, Shengwei; Wu, Zhengfang; Xu, Jiawei; He, Hongshi; Du, Haibo; Wang, Lei] NE Normal Univ, Sch Geog Sci, Changchun, Peoples R China; [Li, Ming] Shanxi Normal Univ, Coll Urban & Environm Sci, Linfen, Shanxi, Peoples R China; [Gao, Xiaofeng] Beijing Normal Univ, Sch Geog, Beijing 100875, Peoples R China; [He, Hongshi] Univ Missouri, Sch Nat Resources, Columbia, MO USA	Northeast Normal University - China; Shanxi Normal University; Beijing Normal University; University of Missouri System; University of Missouri Columbia	Wu, ZF (corresponding author), NE Normal Univ, Sch Geog Sci, Changchun, Peoples R China.	wuzf@nenu.edu.cn	xu, jiawei/GWM-9710-2022	He, Hong S./0000-0002-3983-2512	Doctorial innovation fund of Northeast Normal University [10SSXT133]; National Natural Science Foundation of China [41171038, 41171072, 41101523]; Doctoral Fund of Ministry of Education of China [20120043110014]; Special Fund of National Seismological Bureau, China [201208005]	Doctorial innovation fund of Northeast Normal University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Special Fund of National Seismological Bureau, China	The study was supported by the Doctorial innovation fund of Northeast Normal University (No. 10SSXT133, http://www.nenu.edu.cn/), National Natural Science Foundation of China (No. 41171038, 41171072 and 41101523, http://www.nsfc.gov.cn/), Doctoral Fund of Ministry of Education of China (No. 20120043110014, http://www.moe.gov.cn/), and the Special Fund of National Seismological Bureau, China (No. 201208005, http://www.cea.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN DG, 1994, J VEG SCI, V5, P641, DOI 10.2307/3235880; Calef MP, 2005, J BIOGEOGR, V32, P863, DOI 10.1111/j.1365-2699.2004.01185.x; Chang HC, 2004, J GEOSPATIAL ENG, V6, P13; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dullinger S, 2004, J ECOL, V92, P241, DOI 10.1111/j.0022-0477.2004.00872.x; Elliott GP, 2004, J BIOGEOGR, V31, P733, DOI 10.1111/j.1365-2699.2004.01064.x; FISHER PF, 1993, INT J GEOGR INF SYST, V7, P331, DOI 10.1080/02693799308901965; Grace J, 2002, ANN BOT-LONDON, V90, P537, DOI 10.1093/aob/mcf222; Guo Li-ping, 2010, Yingyong Shengtai Xuebao, V21, P1381; Harsch MA, 2009, ECOL LETT, V12, P1040, DOI 10.1111/j.1461-0248.2009.01355.x; Holtmeier FK, 2007, LANDSCAPE ONLINE, V1, P1, DOI [DOI 10.3097/L0.200701, DOI 10.3097/LO.200701]; Huang Huaguo, 2011, 2011 Eighth International Conference on Fuzzy Systems and Knowledge Discovery (FSKD 2011), P2614, DOI 10.1109/FSKD.2011.6019949; HUTCHINSON MF, 1989, J HYDROL, V106, P211, DOI 10.1016/0022-1694(89)90073-5; [靳英华 Jin Yinghua], 2013, [地理科学, Scientia Geographica Sinica], V33, P203; Katoh M, 2004, J FOREST RES-JPN, V9, P7, DOI 10.1007/s10310-003-0045-z; Korner C, 2006, ARCT ANTARCT ALP RES, V38, P113, DOI 10.1657/1523-0430(2006)038[0113:ATOTTO]2.0.CO;2; Korner C, 1998, OECOLOGIA, V115, P445, DOI 10.1007/s004420050540; Korner C, 2004, J BIOGEOGR, V31, P713, DOI 10.1111/j.1365-2699.2003.01043.x; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Kullman L, 2007, J ECOL, V95, P41, DOI 10.1111/j.1365-2745.2006.01190.x; Li FQ, 2004, REMOTE SENS ENVIRON, V92, P521, DOI 10.1016/j.rse.2004.02.018; Liang EY, 2011, NEW PHYTOL, V190, P760, DOI 10.1111/j.1469-8137.2010.03623.x; [刘宏娟 LIU Hongjuan], 2009, [水科学进展, Advances in Water Science], V20, P105; Liu XG, 2009, JILIN METEOROLOGY, V3, P25; Lloyd AH, 2002, CLIMATIC CHANGE, V52, P481, DOI 10.1023/A:1014278819094; Malanson GP, 1997, PLANT ECOL, V131, P67, DOI 10.1023/A:1009770924942; Pierce KB, 2005, LANDSCAPE ECOL, V20, P137, DOI 10.1007/s10980-004-1296-6; Pu RL, 2012, REMOTE SENS ENVIRON, V124, P516, DOI 10.1016/j.rse.2012.06.011; Pussa K, 2005, FORESTSAT 2005 BOR, P79; Radoux J, 2007, REMOTE SENS ENVIRON, V110, P468, DOI 10.1016/j.rse.2007.02.031; Rees G, 2002, AMBIO, P56; Resler LM, 2005, PHYS GEOGR, V26, P112, DOI 10.2747/0272-3646.26.2.112; Rickebusch S, 2007, FOREST ECOL MANAG, V246, P251, DOI 10.1016/j.foreco.2007.04.030; Schmidt Frank, 2003, Precision Agriculture, V4, P179, DOI 10.1023/A:1024509322709; Shao GF, 1996, CAN J FOREST RES, V26, P206, DOI 10.1139/x26-024; Shi P., 2000, ACTA ECOL SIN, V20, P573; VanCleve K, 1996, ARCTIC ALPINE RES, V28, P388, DOI 10.2307/1552118; Wang Qing-wei, 2011, Yingyong Shengtai Xuebao, V22, P2227; [王晓东 Wang Xiaodong], 2012, [地理科学, Scientia Geographica Sinica], V32, P199; [王晓东 Wang Xiaodong], 2011, [地理科学进展, Progress in Geography], V30, P313; [王晓东 Wang Xiaodong], 2011, [地理研究, Geographical Research], V30, P531; Wulder MA, 2004, INT J REMOTE SENS, V25, P2225, DOI 10.1080/01431160310001659252; Yu DP, 2007, CHIN J APPL ECOL, V15, P1760; Zhang YJ, 2009, INT J REMOTE SENS, V30, P1327, DOI 10.1080/01431160802509009; Zheng DL, 1997, LANDSCAPE ECOL, V12, P241, DOI 10.1023/A:1007963324520; [宗盛伟 Zong Shengwei], 2013, [山地学报, Journal of Mountain Science], V31, P448	46	8	10	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106114	10.1371/journal.pone.0106114	http://dx.doi.org/10.1371/journal.pone.0106114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170918	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500106
J	Jiang, BJ; Nan, HY; Gao, YF; Tang, LL; Yue, YL; Lu, SJ; Ma, LM; Cao, D; Sun, S; Wang, JL; Wu, CX; Yuan, XH; Hou, WS; Kong, FJ; Han, TF; Liu, BH				Jiang, Bingjun; Nan, Haiyang; Gao, Youfei; Tang, Lili; Yue, Yanlei; Lu, Sijia; Ma, Liming; Cao, Dong; Sun, Shi; Wang, Jialin; Wu, Cunxiang; Yuan, Xiaohui; Hou, Wensheng; Kong, Fanjiang; Han, Tianfu; Liu, Baohui			Allelic Combinations of Soybean Maturity Loci E1, E2, E3 and E4 Result in Diversity of Maturity and Adaptation to Different Latitudes	PLOS ONE			English	Article							MAP-BASED CLONING; PHOTOPERIOD RESPONSE; GENETIC-VARIATION; TIME	Soybean cultivars are extremely diverse in time to flowering and maturation as a result of various photoperiod sensitivities. The underlying molecular genetic mechanism is not fully clear, however, four maturity loci E1, E2, E3 and E4 have been molecularly identified. In this report, cultivars were selected with various photoperiod sensitivities from different ecological zones, which covered almost all maturity groups (MG) from MG 000 to MG VIII and MG X adapted from latitude N 18 degrees to N 53 degrees. They were planted in the field under natural daylength condition (ND) in Beijing, China or in pots under different photoperiod treatments. Maturity-related traits were then investigated. The four E maturity loci were genotyped at the molecular level. Our results suggested that these four E genes have different impacts on maturity and their allelic variations and combinations determine the diversification of soybean maturity and adaptation to different latitudes. The genetic mechanisms underlying photoperiod sensitivity and adaptation in wild soybean seemed unique from those in cultivated soybean. The allelic combinations and functional molecular markers for the four E loci will significantly assist molecular breeding towards high productivity.	[Jiang, Bingjun; Gao, Youfei; Yue, Yanlei; Ma, Liming; Sun, Shi; Wu, Cunxiang; Hou, Wensheng; Han, Tianfu] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Jiang, Bingjun; Gao, Youfei; Yue, Yanlei; Ma, Liming; Sun, Shi; Wu, Cunxiang; Hou, Wensheng; Han, Tianfu] Chinese Acad Agr Sci, Inst Crop Sci, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China; [Nan, Haiyang; Tang, Lili; Lu, Sijia; Cao, Dong; Wang, Jialin; Yuan, Xiaohui; Kong, Fanjiang; Liu, Baohui] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Peoples R China; [Nan, Haiyang; Lu, Sijia] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Kong, FJ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Peoples R China.	kongfj@iga.ac.cn; hantianfu@caas.cn; liubh@iga.ac.cn	Jiang, Bingjun/GWQ-4354-2022; Kong, Fanjiang/AGQ-2334-2022	Kong, Fanjiang/0000-0001-7138-1478; Liu, Baohui/0000-0003-3491-8293	National Natural Science Foundation of China [31201232, 31071445, 31171579, 31201222, 31371643]; Open Foundation of Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences; "Hundred Talents" Program of Chinese Academy of Sciences; Strategic Action Plan for Science and Technology Innovation of Chinese Academy of Sciences [XDA08030100]; Heilongjiang Natural Science Foundation of China [ZD201001, JC201313]; China Agriculture Research System [CARS-04]; Chinese Academy of Agricultural Sciences (CAAS) Innovation Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences; "Hundred Talents" Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Strategic Action Plan for Science and Technology Innovation of Chinese Academy of Sciences; Heilongjiang Natural Science Foundation of China(Natural Science Foundation of Heilongjiang Province); China Agriculture Research System; Chinese Academy of Agricultural Sciences (CAAS) Innovation Project	This work was supported by the National Natural Science Foundation of China (31201232, 31071445, 31171579, 31201222 and 31371643); Open Foundation of Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences; "Hundred Talents" Program of Chinese Academy of Sciences; Strategic Action Plan for Science and Technology Innovation of Chinese Academy of Sciences (XDA08030100); Heilongjiang Natural Science Foundation of China (ZD201001, JC201313); China Agriculture Research System (CARS-04) and Chinese Academy of Agricultural Sciences (CAAS) Innovation Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 1996, CROP SCI, V36, P601, DOI 10.2135/cropsci1996.0011183X003600030013x; Cober ER, 1996, CROP SCI, V36, P606, DOI 10.2135/cropsci1996.0011183X003600030014x; Cober ER, 2001, CROP SCI, V41, P698, DOI 10.2135/cropsci2001.413698x; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Fei ZhiHong, 2009, Acta Agronomica Sinica, V35, P1525, DOI 10.3724/SP.J.1006.2009.01525; Hao G., 1992, Acta Agronomica Sinica, V18, P275; HARTWIG EE, 1970, TROP SCI, V12, P47; Jilin Academy of Agricultural Sciences, 1985, SOYB CULT CHIN; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; MCBLAIN BA, 1987, J HERED, V78, P160, DOI 10.1093/oxfordjournals.jhered.a110349; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; Soybean Institute Jilin Academy of Agricultural Sciences, 1993, SOYB CULT CHIN; Tsubokura Y, 2013, AGRONOMY-BASEL, V3, P117, DOI 10.3390/agronomy3010117; Wang G. X., 1981, Scientia Agricultura Sinica, P39; Wang Ying, 2008, Acta Agronomica Sinica, V34, P1160, DOI 10.3724/SP.J.1006.2008.01160; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; WD Li, 2006, HUANG HUAI HAI SUMME; Wu CX, 2006, PLANTA, V223, P725, DOI 10.1007/s00425-005-0130-y; Xia ZJ, 2012, PLANT SYST EVOL, V298, P1217, DOI 10.1007/s00606-012-0628-2; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Xu ML, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-91; Zhang L, 2007, CROP MANAGE	29	68	75	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106042	10.1371/journal.pone.0106042	http://dx.doi.org/10.1371/journal.pone.0106042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162675	gold, Green Published, Green Submitted			2022-12-25	WOS:000340880900082
J	Khalili, D; Sheikholeslami, FH; Bakhtiyari, M; Azizi, F; Momenan, AA; Hadaegh, F				Khalili, Davood; Sheikholeslami, Farhad Haj; Bakhtiyari, Mahmood; Azizi, Fereidoun; Momenan, Amir Abbas; Hadaegh, Farzad			The Incidence of Coronary Heart Disease and the Population Attributable Fraction of Its Risk Factors in Tehran: A 10-Year Population-Based Cohort Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; IRANIAN POPULATION; NONDIABETIC PEOPLE; UNITED-STATES; GLUCOSE; PREVALENCE; STROKE; WOMEN; MEN; COUNTRIES	Background: Data on incidence of coronary heart disease (CHD) is scarce in the Middle East and little is known about the contribution of known risk factors in this area. Methods: The incidence of CHD and the effect of modifiable risk factors were explored in 2889 men and 3803 women aged 30-74 years in the population based cohort of the Tehran Lipid and Glucose Study, during 1999-2010. Average population attributable fraction (aPAF) was calculated for any risk factor using direct method based on regression model. Results: The crude incidence rate in men was about twice that in women (11.9 vs. 6.5 per 1000 person-years). The aPAF of hypertension, diabetes, high total cholesterol and low-HDL cholesterol was 9.4%, 6.7%, 7.3% and 6.1% in men and 17%, 16.6%, 12% and 4.6% in women respectively. This index was 7.0% for smoking in men. High risk age contributed to 42% and 22% of risk in men and women respectively. Conclusions: The incidence in this population of Iran was comparable to those in the US in the seventies. Well known modifiable risk factors explained about 40% and 50% of CHD burden in men and women respectively. Aging, as a reflection of unmeasured or unknown risk factors, bears the most burden of CHD, especially in men; indicating more age-related health care is required.	[Khalili, Davood; Sheikholeslami, Farhad Haj; Bakhtiyari, Mahmood; Momenan, Amir Abbas; Hadaegh, Farzad] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran; [Khalili, Davood] Shahid Beheshti Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran; [Bakhtiyari, Mahmood] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences	Sheikholeslami, FH (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran.	fsheikholeslami@hotmail.com	hadaegh, farzad/K-2460-2017; Bakhtiyari, Mahmood/ABG-5363-2020; Khalili, Davood/T-2913-2017; Azizi, Fereidoun/ABD-4136-2021	Khalili, Davood/0000-0003-4956-1039; Azizi, Fereidoun/0000-0002-6470-2517; Hajsheikholeslami, Farhad/0000-0001-6016-1867; Hadaegh, Farzad/0000-0002-8935-2744; , Mahmood BAKHTIYARI/0000-0002-1216-7671; hadaegh, farzad/0000-0002-0352-8666	National Research Council of Iran [121]	National Research Council of Iran	This material is based upon work supported by the National Research Council of Iran under grant No. 121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Azizi F, 2002, SOZ PRAVENTIV MED, V47, P408, DOI 10.1007/s000380200008; Azizi F, 2010, ARCH IRAN MED, V13, P243; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Booth GL, 2006, LANCET, V368, P29, DOI 10.1016/S0140-6736(06)68967-8; Centers for Disease Control, 1992, MMWR-MORBID MORTAL W, V41, P526; EIDE GE, 1995, J CLIN EPIDEMIOL, V48, P645, DOI 10.1016/0895-4356(94)00161-I; Esteghamati A, 2008, AM J HYPERTENS, V21, P620, DOI 10.1038/ajh.2008.154; Forssas EH, 2008, J DIABETES COMPLICAT, V22, P10, DOI 10.1016/j.jdiacomp.2007.05.004; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guilbert J., 2003, WORLD HLTH REPORT 20; Hadaegh F, 2009, East Mediterr Health J, V15, P157; Hadaegh F, 2009, J ENDOCRINOL INVEST, V32, P724, DOI [10.3275/6399, 10.1007/BF03346527]; Hadaegh F, 2006, EUR J CARDIOV PREV R, V13, P571, DOI 10.1097/01.hjr.0000216552.81882.ca; Hosmer DW, 1997, STAT MED, V16, P965; Hozawa A, 2007, ARCH INTERN MED, V167, P573, DOI 10.1001/archinte.167.6.573; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Khalili D, 2012, AM J EPIDEMIOL, V176, P177, DOI 10.1093/aje/kws204; Khalili D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031427; Kiani S, 2010, ARCH IRAN MED, V13, P333, DOI 010134/AIM.0014; Kitamura A, 2008, J AM COLL CARDIOL, V52, P71, DOI 10.1016/j.jacc.2008.02.075; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Lakatta Edward G, 2002, Heart Fail Rev, V7, P29; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Menotti A, 2000, HEART, V84, P238, DOI 10.1136/heart.84.3.238; Moran A, 2011, INT J CARDIOL, V150, P332, DOI 10.1016/j.ijcard.2011.04.013; Motlagh B, 2009, EUR J CARDIOV PREV R, V16, P268, DOI 10.1097/HJR.0b013e328322ca1b; Odden MC, 2011, AM J MED, V124, P827, DOI 10.1016/j.amjmed.2011.04.010; Onat A, 2012, NUTR METAB CARDIOVAS, V22, P643, DOI 10.1016/j.numecd.2010.10.010; Onat A, 2010, CARDIOLOGY, V115, P297, DOI 10.1159/000312009; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; Sniderman AD, 2008, LANCET, V371, P1547, DOI [10.1016/S0140-6736(08)60313-X, 10.1016/s0140-6736(08)60313-x]; Statistical Center of Iran, 2006, POP AG SEX RES STAT; Sun Jia-yi, 2012, Zhonghua Xin Xue Guan Bing Za Zhi, V40, P194; Talaei M, 2013, ARCH IRAN MED, V16, P138, DOI 013163/AIM.004; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	37	51	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105804	10.1371/journal.pone.0105804	http://dx.doi.org/10.1371/journal.pone.0105804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162590	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900052
J	Ogai, K; Kuwana, A; Hisano, S; Nagashima, M; Koriyama, Y; Sugitani, K; Mawatari, K; Nakashima, H; Kato, S				Ogai, Kazuhiro; Kuwana, Ayaka; Hisano, Suguru; Nagashima, Mikiko; Koriyama, Yoshiki; Sugitani, Kayo; Mawatari, Kazuhiro; Nakashima, Hiroshi; Kato, Satoru			Upregulation of Leukemia Inhibitory Factor (LIF) during the Early Stage of Optic Nerve Regeneration in Zebrafish	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; CILIARY NEUROTROPHIC FACTOR; EMBRYONIC STEM-CELLS; AXON REGENERATION; ADULT ZEBRAFISH; INFLAMMATORY STIMULATION; SIGNALING PATHWAY; MESSENGER-RNA; DANIO-RERIO; IGF-I	Fish retinal ganglion cells (RGCs) can regenerate their axons after optic nerve injury, whereas mammalian RGCs normally fail to do so. Interleukin 6 (IL-6)-type cytokines are involved in cell differentiation, proliferation, survival, and axon regrowth; thus, they may play a role in the regeneration of zebrafish RGCs after injury. In this study, we assessed the expression of IL-6-type cytokines and found that one of them, leukemia inhibitory factor (LIF), is upregulated in zebrafish RGCs at 3 days post-injury (dpi). We then demonstrated the activation of signal transducer and activator of transcription 3 (STAT3), a downstream target of LIF, at 3-5 dpi. To determine the function of LIF, we performed a LIF knockdown experiment using LIF-specific antisense morpholino oligonucleotides (LIF MOs). LIF MOs, which were introduced into zebrafish RGCs via a severed optic nerve, reduced the expression of LIF and abrogated the activation of STAT3 in RGCs after injury. These results suggest that upregulated LIF drives Janus kinase (Jak)/STAT3 signaling in zebrafish RGCs after nerve injury. In addition, the LIF knockdown impaired axon sprouting in retinal explant culture in vitro; reduced the expression of a regeneration-associated molecule, growth-associated protein 43 (GAP-43); and delayed functional recovery after optic nerve injury in vivo. In this study, we comprehensively demonstrate the beneficial role of LIF in optic nerve regeneration and functional recovery in adult zebrafish.	[Ogai, Kazuhiro; Nagashima, Mikiko; Koriyama, Yoshiki; Kato, Satoru] Kanazawa Univ, Grad Sch Med Sci, Dept Mol Neurobiol, Kanazawa, Ishikawa, Japan; [Ogai, Kazuhiro] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Wellness Promot Sci Ctr, Kanazawa, Ishikawa, Japan; [Kuwana, Ayaka; Hisano, Suguru; Sugitani, Kayo; Mawatari, Kazuhiro; Nakashima, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Clin Lab Sci, Kanazawa, Ishikawa, Japan; [Koriyama, Yoshiki] Suzuka Univ Med Sci, Grad Sch, Suzuka, Mie, Japan; [Koriyama, Yoshiki] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie, Japan	Kanazawa University; Kanazawa University; Kanazawa University	Kato, S (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Mol Neurobiol, Kanazawa, Ishikawa, Japan.	satoru@med.kanazawa-u.ac.jp	Ogai, Kazuhiro/G-5462-2014; Koriyama, Yoshiki/AAA-1830-2022	Ogai, Kazuhiro/0000-0002-3462-9320; Koriyama, Yoshiki/0000-0001-8777-329X	Japan Society for the Promotion of Science KAKENHI [25890007, 23618006, 25462753, 23650163, 25640008]; Ministry of Education, Culture, Sports, Science and Technology/Japan Science and Technology Agency Tenure Track Promotion Program; Grants-in-Aid for Scientific Research [25890007] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology/Japan Science and Technology Agency Tenure Track Promotion Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Japan Society for the Promotion of Science KAKENHI Grant Numbers 25890007 (KO), 23618006 (KS), 25462753 (YK), 23650163 and 25640008 (SK). This study was also funded in part by the Ministry of Education, Culture, Sports, Science and Technology/Japan Science and Technology Agency Tenure Track Promotion Program (KO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Abe T, 2007, COMP BIOCHEM PHYS B, V147, P38, DOI 10.1016/j.cbpb.2006.12.019; ATTARDI DG, 1963, EXP NEUROL, V7, P46, DOI 10.1016/0014-4886(63)90093-1; Becker CG, 2007, J NEUROSCI RES, V85, P2793, DOI 10.1002/jnr.21121; Becker CG, 2004, J NEUROSCI, V24, P7837, DOI 10.1523/JNEUROSCI.2420-04.2004; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Cafferty WBJ, 2001, J NEUROSCI, V21, P7161, DOI 10.1523/JNEUROSCI.21-18-07161.2001; Elsaeidi F, 2014, J NEUROSCI, V34, P2632, DOI 10.1523/JNEUROSCI.3898-13.2014; Fang Y, 2013, P NATL ACAD SCI USA, V110, P13416, DOI 10.1073/pnas.1309810110; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Hanington PC, 2007, DEV COMP IMMUNOL, V31, P817, DOI 10.1016/j.dci.2006.12.001; Hanington PC, 2008, DEV BIOL, V314, P250, DOI 10.1016/j.ydbio.2007.10.012; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Homma K, 2007, NEUROCHEM INT, V50, P741, DOI 10.1016/j.neuint.2007.01.011; Horiuchi H, 2004, J BIOL CHEM, V279, P24514, DOI 10.1074/jbc.M313231200; IP NY, 1993, EUR J NEUROSCI, V5, P25, DOI 10.1111/j.1460-9568.1993.tb00201.x; Kaneda M, 2008, NEUROSCI RES, V61, P281, DOI 10.1016/j.neures.2008.03.008; Kassen SC, 2009, EXP EYE RES, V88, P1051, DOI 10.1016/j.exer.2009.01.007; Kato S, 2013, PROG RETIN EYE RES, V37, P13, DOI 10.1016/j.preteyeres.2013.07.004; Koriyama Y, 2007, NEUROCHEM INT, V50, P749, DOI 10.1016/j.neuint.2007.01.012; Lee N, 2004, J COMP NEUROL, V474, P535, DOI 10.1002/cne.20140; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.126; Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Lin JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052376; Liu Z, 2012, CELL MOL NEUROBIOL, V32, P191, DOI 10.1007/s10571-011-9746-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maxhimer JB, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000139; Muller A, 2007, BRAIN, V130, P3308, DOI 10.1093/brain/awm257; Munzel EJ, 2012, GLIA, V60, P253, DOI 10.1002/glia.21260; Nagashima M, 2009, BRAIN RES, V1302, P54, DOI 10.1016/j.brainres.2009.09.020; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Ogai K, 2012, NEUROCHEM INT, V61, P1202, DOI 10.1016/j.neuint.2012.08.015; Park K, 2004, J NEUROSCI, V24, P10806, DOI 10.1523/JNEUROSCI.3532-04.2004; Pernet V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.266; Pradervand S, 2004, EMBO J, V23, P4517, DOI 10.1038/sj.emboj.7600454; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; SCHADEN H, 1994, J NEUROBIOL, V25, P1570, DOI 10.1002/neu.480251209; SCHINDLER R, 1990, BLOOD, V75, P40; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; Stephanou A, 2000, CELL DEATH DIFFER, V7, P329, DOI 10.1038/sj.cdd.4400656; Sugitani K, 2006, NEUROSCIENCE, V142, P1081, DOI 10.1016/j.neuroscience.2006.07.042; Sugitani K, 2012, NEUROCHEM INT, V61, P423, DOI 10.1016/j.neuint.2012.06.004; Takahama Y, 1998, ONCOGENE, V16, P3189, DOI 10.1038/sj.onc.1201826; Varela M, 2012, DEV COMP IMMUNOL, V37, P97, DOI 10.1016/j.dci.2011.11.004; Veldman MB, 2007, DEV BIOL, V312, P596, DOI 10.1016/j.ydbio.2007.09.019; Wu YY, 1996, J BIOL CHEM, V271, P13023, DOI 10.1074/jbc.271.22.13023; Xue F, 2012, CELL REPROGRAM, V14, P364, DOI 10.1089/cell.2012.0001; Yamashita T, 2005, J NEUROCHEM, V94, P459, DOI 10.1111/j.1471-4159.2005.03227.x; Yang P, 2012, EXP NEUROL, V236, P19, DOI 10.1016/j.expneurol.2012.03.019; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Zigmond RE, 2012, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00062	58	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106010	10.1371/journal.pone.0106010	http://dx.doi.org/10.1371/journal.pone.0106010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162623	gold, Green Published, Green Submitted			2022-12-25	WOS:000340880900074
J	Riquelme, F; Hernandez-Patricio, M; Martinez-Davalos, A; Rodriguez-Villafuerte, M; Montejo-Cruz, M; Alvarado-Ortega, J; Ruvalcaba-Sil, JL; Zuniga-Mijangos, L				Riquelme, Francisco; Hernandez-Patricio, Miguel; Martinez-Davalos, Arnulfo; Rodriguez-Villafuerte, Mercedes; Montejo-Cruz, Maira; Alvarado-Ortega, Jesus; Ruvalcaba-Sil, Jose L.; Zuniga-Mijangos, Luis			Two Flat-Backed Polydesmidan Millipedes from the Miocene Chiapas-Amber Lagerstatte, Mexico	PLOS ONE			English	Article							DIPLOPODA; SIMOJOVEL	Two species of fossil polydesmidan millipedes (Diplopoda: Polydesmida) embedded in amber are described from Miocene strata near Simojovel, in the Chiapas Highlands, Mexico. Maatidesmus paachtun gen. et sp. nov., placed into Chelodesmidae Cook, 1895, and Anbarrhacus adamantis gen. et sp. nov., assigned in the family Platyrhacidae Pocock, 1895. Morphological data from fossil specimens have been recovered using 3D X-ray micro-computed tomography and regular to infrared-reflected microscopy. Both fossil species are recognizable as new primarily but not exclusively, by collum margin modification and remarkable paranotal and metatergite dorsal sculpture.	[Riquelme, Francisco] Univ Nacl Autonoma Mexico, Ciudad Univ, Mexico City 04510, DF, Mexico; [Riquelme, Francisco; Martinez-Davalos, Arnulfo; Rodriguez-Villafuerte, Mercedes; Ruvalcaba-Sil, Jose L.] Univ Nacl Autonoma Mexico, Inst Fis, Mexico City 04510, DF, Mexico; [Hernandez-Patricio, Miguel] Comis Nacl Conocimiento & Uso Biodiversidad, Subcoordinac Inventarios Biot, Tlalpan, DF, Mexico; [Montejo-Cruz, Maira] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico; [Alvarado-Ortega, Jesus] Univ Nacl Autonoma Mexico, Inst Geol, Mexico City 04510, DF, Mexico; [Zuniga-Mijangos, Luis] Museo Ambar Lilia Mijangos, San Cristobal de las Casa, Chiapas, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Riquelme, F (corresponding author), Univ Nacl Autonoma Mexico, Ciudad Univ, Mexico City 04510, DF, Mexico.	riquelme.fc@gmail.com	Martínez-Dávalos, Arnulfo/F-3498-2013; Riquelme, Francisco/P-8551-2014	Martínez-Dávalos, Arnulfo/0000-0002-9481-9548; Riquelme, Francisco/0000-0001-9893-7413; Alvarado-Ortega, Jesus/0000-0001-8458-7205; Ruvalcaba-Sil, Jose Luis/0000-0003-1431-3019	PAPIIT-UNAM [IN105913-2, IN402813]; CONACYT [131944]	PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Research has been partially founded by the following granting-projects: PAPIIT-UNAM IN105913-2, IN402813 and CONACYT 131944. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bueno-Villegas J, 2004, BIODIVERSIDAD TAXONO, P569; Chamberlin RV, 1941, B AM MUS NAT HIST, V48, P473; Cook OF., 1895, ANN NY ACAD SCI, V9, P1, DOI [10.1111/j.1749-6632.1896.tb55430.x, DOI 10.1111/J.1749-6632.1896.TB55430.X]; Perrilliat MD, 2010, J S AM EARTH SCI, V30, P111, DOI 10.1016/j.jsames.2010.04.005; DZIK J, 1975, Palaeontologia Polonica, V33, P17; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Ferrusquia-Villafranca I, 2006, J VERTEBR PALEONTOL, V26, P989, DOI 10.1671/0272-4634(2006)26[989:TFPMRO]2.0.CO;2; Frost S.H., 1974, REEF BIOFACIES TERTI; Graham A, 1999, AM J BOT, V86, P17, DOI 10.2307/2656951; Hoffman R, 2001, PAP AVULSOS ZOOL, V49, P557; HOFFMAN R L, 1975, Fieldiana Zoology, V65, P73; Hoffman R. L., 1953, Proceedings of the Entomological Society of Washington, V55, P251; Hoffman R. L., 1960, Proceedings of the United States National Museum, V111, P17; HOFFMAN R L, 1975, Proceedings of the Biological Society of Washington, V88, P211; Hoffman Richard L., 2011, Zootaxa, V3015, P52; Hoffman Richard L., 1999, Virginia Museum of Natural History Special Publication, V8, P1; Hopkin P.S., 1992, BIOL MILLIPEDES; Jeekel C.A.W., 2007, Myriapod Memoranda, V10, P49; KEILBACH R, 1982, DEUT ENTOMOL Z, V29, P301; LANGENHEIM JH, 1966, CIENC MEX, V24, P201; Langenheim JH, 2003, PLANT RESINS CHEM EV, P141; Martinez-Davalos A, 2010, AIP CONF PROC, V1310, P7, DOI 10.1063/1.3531613; Meneses-Rocha J.J., 2001, W GULF MEXICO BASIN, V75, P183; Mesibov Robert, 2006, Zootaxa, V1354, P31; Mullerried F. K. G., 1942, Anales del Instituto de Biologia Mexico, V13, P711; Poinar GO., 1992, LIFE AMBER; Rasband W. S., 2012, IMAGE J; Riquelme F., 2014, MAT RES SOC S P, V1618, P169, DOI DOI 10.1557/OPL.2014.466; Riquelme F, 2014, HIST BIOL, V26, P415, DOI 10.1080/08912963.2013.778843; Riquelme F, 2014, APPL PHYS A-MATER, V116, P97, DOI 10.1007/s00339-013-8185-2; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; SANTIAGOBLAY JA, 1992, ANN ENTOMOL SOC AM, V85, P363, DOI 10.1093/aesa/85.4.363; Shear WA, 2010, ARTHROPOD STRUCT DEV, V39, P174, DOI 10.1016/j.asd.2009.11.002; Shelley RM, 2013, ZOOTAXA, V3626, P477, DOI 10.11646/zootaxa.3626.4.4; Sierwald P, 2007, ANNU REV ENTOMOL, V52, P401, DOI 10.1146/annurev.ento.52.111805.090210; Spahr U, 1992, STUTTG BEITR NATUR B, V194, P1; Wilson HM, 2005, PALAEONTOLOGY, V48, P1097, DOI 10.1111/j.1475-4983.2005.00496.x; Wilson HM, 2004, J PALEONTOL, V78, P169, DOI 10.1666/0022-3360(2004)078<0169:MATOPM>2.0.CO;2; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	39	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105877	10.1371/journal.pone.0105877	http://dx.doi.org/10.1371/journal.pone.0105877			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162220	gold, Green Published, Green Submitted			2022-12-25	WOS:000340880900056
J	Chang, CH; Wang, CZ; Chang, JK; Hsu, CY; Ho, ML				Chang, Chih-Hsiang; Wang, Chau-Zen; Chang, Je-Ken; Hsu, Che-Yu; Ho, Mei-Ling			The Susceptive Alendronate-Treatment Timing and Dosage for Osteogenesis Enhancement in Human Bone Marrow-Derived Stem Cells	PLOS ONE			English	Article							MEVALONATE PATHWAY; IN-VITRO; STROMAL CELLS; INHIBITION; DIFFERENTIATION; BISPHOSPHONATES; PROLIFERATION; FARNESYL; APOPTOSIS; PRENYLATION	Recent studies indicated that alendronate enhanced osteogenesis in osteoblasts and human bone marrow-derived stem cells. However, the time-and dose-dependent effects of Aln on ostegenic differentiation and cytotoxicity of hBMSCs remain undefined. In present study, we investigated the effective dose range and timing of hBMSCs. hBMSCs were treated with various Aln doses (1, 5 and 10 mu M) according to the following groups: group A was treated with Aln during the first five days of bone medium, groups B, C and D were treated during the first, second, and final five days of osteo-induction medium and group E was treated throughout the entire experiment. The mineralization level and cytotoxicity were measured by quantified Alizarin Red S staining and MTT assay. In addition, the reversal effects of farnesyl pyrophosphate and geranylgeranyl pyrophosphate replenishment in group B were also investigated. The results showed that Aln treatment in groups A, B and E enhanced hBMSC mineralization in a dose-dependent manner, and the most pronounced effects were observed in groups B and E. The higher dose of Aln simultaneously enhanced mineralization and caused cytotoxicity in groups B, C and E. Replenishment of FPP or GGPP resulted in partial or complete reverse of the Aln-induced mineralization respectively. Furthermore, the addition of FPP or GGPP also eliminated the Aln-induced cytotoxicity. We demonstrated that hBMSCs are susceptible to 5 mu M Aln during the initiation stage of osteogenic differentiation and that a 10 mu M dose is cytotoxic.	[Chang, Chih-Hsiang; Wang, Chau-Zen; Chang, Je-Ken; Hsu, Che-Yu; Ho, Mei-Ling] Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Wang, Chau-Zen; Ho, Mei-Ling] Kaohsiung Med Univ, Dept Physiol, Kaohsiung, Taiwan; [Chang, Je-Ken] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Dept Orthopaed, Kaohsiung, Taiwan; [Chang, Je-Ken] Kaohsiung Municipal Tatung Hosp, Dept Orthopaed, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital	Ho, ML (corresponding author), Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan.	homelin@kmu.edu.tw		Ho, Mei-Ling/0000-0001-8064-8488	National Science Council [NSC 97-EC-17-A-17-S1-041, NSC 98-EC-17-A-17-S1-041, NSC 99-EC-17-A-17-S1-041, NSC 102-2325-B-037-003]	National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council: NSC 97-EC-17-A-17-S1-041, NSC 98-EC-17-A-17-S1-041, NSC 99-EC-17-A-17-S1-041, and NSC 102-2325-B-037-003. The funder's website is http://web1.most.gov.tw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom JD, 2000, ARCH BIOCHEM BIOPHYS, V373, P231, DOI 10.1006/abbi.1999.1502; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235; Duque G, 2011, BRIT J PHARMACOL, V162, P1109, DOI 10.1111/j.1476-5381.2010.01111.x; Ebert R, 2009, BONE, V44, P858, DOI 10.1016/j.bone.2009.01.009; Enjuanes A, 2010, ENDOCRINE, V37, P322, DOI 10.1007/s12020-009-9306-8; FERRARI M, 1990, J IMMUNOL METHODS, V131, P165, DOI 10.1016/0022-1759(90)90187-Z; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Idris AI, 2008, CALCIFIED TISSUE INT, V82, P191, DOI 10.1007/s00223-008-9104-y; Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024; Jeong JA, 2007, PROTEOMICS, V7, P4181, DOI 10.1002/pmic.200700502; Keller RK, 1999, BIOCHEM BIOPH RES CO, V266, P560, DOI 10.1006/bbrc.1999.1849; Kim HK, 2009, CLIN ORTHOP RELAT R, V467, P3121, DOI 10.1007/s11999-008-0409-y; Komatsu K, 2013, J ENDOCRINOL, V219, P145, DOI 10.1530/JOE-13-0040; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Moreau MF, 2007, BIOCHEM PHARMACOL, V73, P718, DOI 10.1016/j.bcp.2006.09.031; Moreira MS, 2005, DENT TRAUMATOL, V21, P329, DOI 10.1111/j.1600-9657.2005.00370.x; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Muller S, 2005, ANTICANCER RES, V25, P2655; Orriss IR, 2009, J CELL BIOCHEM, V106, P109, DOI 10.1002/jcb.21983; Correia VDP, 2006, DENT TRAUMATOL, V22, P312, DOI 10.1111/j.1600-9657.2005.00434.x; Suri S, 2001, BONE, V29, P336, DOI 10.1016/S8756-3282(01)00589-0; Susa M, 2009, ANTICANCER RES, V29, P1879; Thompson K, 2006, MOL PHARMACOL, V69, P1624, DOI 10.1124/mol.105.020776; Toyras A, 2003, EUR J PHARM SCI, V19, P223, DOI 10.1016/S0928-0987(03)00108-8; von Knoch F, 2005, BIOMATERIALS, V26, P6941, DOI 10.1016/j.biomaterials.2005.04.059; Wang CZ, 2010, BIOMATERIALS, V31, P8674, DOI 10.1016/j.biomaterials.2010.07.096; Weivoda MM, 2012, BONE, V50, P467, DOI 10.1016/j.bone.2011.09.056; Weivoda MM, 2011, ENDOCRINOLOGY, V152, P3113, DOI 10.1210/en.2011-0016; Weivoda MM, 2011, J CELL BIOCHEM, V112, P1506, DOI 10.1002/jcb.23087; Xiong Y, 2009, J INT MED RES, V37, P407, DOI 10.1177/147323000903700216; Yoshida T, 2006, FEBS LETT, V580, P5203, DOI 10.1016/j.febslet.2006.08.060	34	19	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105705	10.1371/journal.pone.0105705	http://dx.doi.org/10.1371/journal.pone.0105705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157615	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303200049
J	Han, ZY; Shen, FX; He, Y; Degos, V; Camus, M; Maze, M; Young, WL; Su, H				Han, Zhenying; Shen, Fanxia; He, Yue; Degos, Vincent; Camus, Marine; Maze, Mervyn; Young, William L.; Su, Hua			Activation of alpha-7 Nicotinic Acetylcholine Receptor Reduces Ischemic Stroke Injury through Reduction of Pro-Inflammatory Macrophages and Oxidative Stress	PLOS ONE			English	Article							GLUTAMATE NEUROTOXICITY; FOCAL ISCHEMIA; VAGUS NERVE; MOUSE; MICROGLIA; SENSORIMOTOR; INHIBITORS; RECOVERY; DISEASE; BRAIN	Activation of alpha-7 nicotinic acetylcholine receptor (alpha-7 nAchR) has a neuro-protective effect on ischemic and hemorrhagic stroke. However, the underlying mechanism is not completely understood. We hypothesized that alpha-7 nAchR agonist protects brain injury after ischemic stroke through reduction of pro-inflammatory macrophages (M1) and oxidative stress. C57BL/6 mice were treated with PHA568487 (PHA, alpha-7 nAchR agonist), methyllycaconitine (MLA, nAchR antagonist), or saline immediately and 24 hours after permanent occlusion of the distal middle cerebral artery (pMCAO). Behavior test, lesion volume, CD68(+), M1 (CD11b(+)/Iba1(+)) and M2 (CD206/Iba1(+)) microglia/macrophages, and phosphorylated p65 component of NF-kappa B in microglia/macrophages were quantified using histological stained sections. The expression of M1 and M2 marker genes, anti-oxidant genes and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase were quantified using real-time RT-PCR. Compared to the saline-treated mice, PHA mice had fewer behavior deficits 3 and 7 days after pMCAO, and smaller lesion volume, fewer CD68(+) and M1 macrophages, and more M2 macrophages 3 and 14 days after pMCAO, whereas MLA's effects were mostly the opposite in several analyses. PHA increased anti-oxidant genes and NADPH oxidase expression associated with decreased phosphorylation of NF-kappa B p65 in microglia/macrophages. Thus, reduction of inflammatory response and oxidative stress play roles in alpha-7 nAchR neuro-protective effect.	[Han, Zhenying; Shen, Fanxia; He, Yue; Degos, Vincent; Camus, Marine; Maze, Mervyn; Young, William L.; Su, Hua] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Ctr Cerebrovasc Res, San Francisco, CA 94143 USA; [Han, Zhenying] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China; [Degos, Vincent] Univ Paris 06, Hop La Pitie Salpetriere, Assistance Publi Hop Paris APHP, Paris, France; [Young, William L.] UMR INSERM 1141, Paris, France; [Young, William L.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Young, William L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of California System; University of California San Francisco; Tianjin Medical University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Su, H (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Ctr Cerebrovasc Res, San Francisco, CA 94143 USA.	hua.su@ucsf.edu			National Institutes of Health [R01NS027713, R21NS070153, P01NS044155, R01 GM104194]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027713, R21NS070153, P01NS044155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health to HS (R01NS027713, R21NS070153, and P01NS044155), and to MM (R01 GM104194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A, 2011, INTERN EMERG MED, V6, P119, DOI 10.1007/s11739-011-0675-7; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Chamorro A, 2006, STROKE, V37, P291, DOI 10.1161/01.STR.0000200561.69611.f8; Chen H, 2011, NEUROBIOL DIS, V42, P341, DOI 10.1016/j.nbd.2011.01.027; Cheyuo C, 2011, SHOCK, V35, P258, DOI 10.1097/SHK.0b013e3181f48a37; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Degos V, 2013, ANESTHESIOLOGY, V118, P1362, DOI 10.1097/ALN.0b013e31828c23f8; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Duris K, 2011, STROKE, V42, P3530, DOI 10.1161/STROKEAHA.111.619965; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Fosbol EL, 2010, CIRC-CARDIOVASC QUAL, V3, P395, DOI 10.1161/CIRCOUTCOMES.109.861104; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hayakawa K, 2010, ANN NY ACAD SCI, V1207, P50, DOI 10.1111/j.1749-6632.2010.05728.x; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Kahles T, 2012, CELL MOL LIFE SCI, V69, P2345, DOI 10.1007/s00018-012-1011-8; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Krafft PR, 2012, STROKE, V43, P844, DOI 10.1161/STROKEAHA.111.639989; Langdon KD, 2010, J CEREBR BLOOD F MET, V30, P1450, DOI 10.1038/jcbfm.2010.23; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; Lightfoot AP, 2008, PROGR MED CHEM, V46, P131, DOI 10.1016/S0079-6468(07)00003-3; Lo EH, 2009, NAT MED, V15, P844, DOI 10.1038/nm0809-844; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Pang L, 2001, STROKE, V32, P544, DOI 10.1161/01.STR.32.2.544; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Roumie CL, 2008, STROKE, V39, P2037, DOI 10.1161/STROKEAHA.107.508549; Roumie CL, 2009, PHARMACOEPIDEM DR S, V18, P1053, DOI 10.1002/pds.1820; Schilling M, 2005, EXP NEUROL, V196, P290, DOI 10.1016/j.expneurol.2005.08.004; Shimohama S, 1998, BRAIN RES, V779, P359, DOI 10.1016/S0006-8993(97)00194-7; Su X, 2007, AM J RESP CELL MOL, V37, P186, DOI 10.1165/rcmb.2006-0240OC; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Takada-Takatori Y, 2006, NEUROPHARMACOLOGY, V51, P474, DOI 10.1016/j.neuropharm.2006.04.007; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Wang ZY, 2013, FREE RADICAL BIO MED, V65, P942, DOI 10.1016/j.freeradbiomed.2013.08.166; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	38	75	79	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105711	10.1371/journal.pone.0105711	http://dx.doi.org/10.1371/journal.pone.0105711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157794	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303200050
J	Lettmann, S; Bloch, W; Maass, T; Niehoff, A; Schulz, JN; Eckes, B; Eming, SA; Bonaldo, P; Paulsson, M; Wagener, R				Lettmann, Sandra; Bloch, Wilhelm; Maass, Tobias; Niehoff, Anja; Schulz, Jan-Niklas; Eckes, Beate; Eming, Sabine A.; Bonaldo, Paolo; Paulsson, Mats; Wagener, Raimund			Col6a1 Null Mice as a Model to Study Skin Phenotypes in Patients with Collagen VI Related Myopathies: Expression of Classical and Novel Collagen VI Variants during Wound Healing	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; BETHLEM-MYOPATHY; ANIMAL-MODEL; FIBROSIS; CHAINS; MUTATIONS; MUSCLE; MOUSE; DEFICIENCY; DOMINANT	Patients suffering from collagen VI related myopathies caused by mutations in COL6A1, COL6A2 and COL6A3 often also display skin abnormalities, like formation of keloids or cigarette paper" scars, dry skin, striae rubrae and keratosis pilaris (follicular keratosis). Here we evaluated if Col6a1 null mice, an established animal model for the muscle changes in collagen VI related myopathies, are also suitable for the study of mechanisms leading to the skin pathology. We performed a comprehensive study of the expression of all six collagen VI chains in unwounded and challenged skin of wild type and Col6a1 null mice. Expression of collagen VI chains is regulated in both skin wounds and bleomycin-induced fibrosis and the collagen VI alpha 3 chain is proteolytically processed in both wild type and Col6a1 null mice. Interestingly, we detected a decreased tensile strength of the skin and an altered collagen fibril and basement membrane architecture in Col6a1 null mice, the latter being features that are also found in collagen VI myopathy patients. Although Col6a1 null mice do not display an overt wound healing defect, these mice are a relevant animal model to study the skin pathology in collagen VI related disease.	[Lettmann, Sandra; Maass, Tobias; Paulsson, Mats; Wagener, Raimund] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Bloch, Wilhelm] German Sport Univ Cologne, Inst Cardiovasc Res & Sport Med, Cologne, Germany; [Niehoff, Anja] German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Germany; [Niehoff, Anja] Univ Cologne, Fac Med, Cologne Ctr Musculoskeletal Biomech, D-50931 Cologne, Germany; [Schulz, Jan-Niklas; Eckes, Beate; Eming, Sabine A.] Univ Cologne, Dept Dermatol, D-50931 Cologne, Germany; [Eming, Sabine A.; Paulsson, Mats; Wagener, Raimund] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Eming, Sabine A.; Paulsson, Mats] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Bonaldo, Paolo] Univ Padua, Dept Mol Med, Padua, Italy	University of Cologne; German Sport University Cologne; German Sport University Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Padua	Wagener, R (corresponding author), Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany.	raimund.wagener@uni-koeln.de	Niehoff, Anja/K-6626-2015	Niehoff, Anja/0000-0002-4165-0929; Schulz, Jan-Niklas/0000-0001-9286-206X; Bonaldo, Paolo/0000-0002-9571-8140	Collaborative Research Centre "Molecular Mechanisms regulating Skin Homeostasis" [(SFB) 829]; Deutsche Forschungsgemeinschaft (DFG)	Collaborative Research Centre "Molecular Mechanisms regulating Skin Homeostasis"; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was funded to WB, BE, SAE, MP and RW by the Collaborative Research Centre (SFB) 829 "Molecular Mechanisms regulating Skin Homeostasis", an interdisciplinary research centre of excellence funded by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdam SY, 2012, BIOCHEM BIOPH RES CO, V421, P197, DOI 10.1016/j.bbrc.2012.03.134; Allamand Valerie, 2010, Neuromuscul Disord, V20, P346, DOI 10.1016/j.nmd.2010.02.012; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; Brinas L, 2010, ANN NEUROL, V68, P511, DOI 10.1002/ana.22087; BRUNS RR, 1984, J ULTRA MOL STRUCT R, V89, P136, DOI 10.1016/S0022-5320(84)80010-6; CHU ML, 1988, J BIOL CHEM, V263, P18601; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Gara SK, 2011, MATRIX BIOL, V30, P248, DOI 10.1016/j.matbio.2011.03.006; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Hermanns-Le T, 2014, ULTRASTRUCT PATHOL, V38, P164, DOI 10.3109/01913123.2013.829151; Izu Y, 2011, MATRIX BIOL, V30, P53, DOI 10.1016/j.matbio.2010.10.001; Jimenez-Mallebrera C, 2006, NEUROMUSCULAR DISORD, V16, P571, DOI 10.1016/j.nmd.2006.07.015; Jobsis GJ, 1996, NAT GENET, V14, P113, DOI 10.1038/ng0996-113; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Khorshid FA, 2005, MED SCI MONITOR, V11, pBR212; Knupp C, 2001, EMBO J, V20, P372, DOI 10.1093/emboj/20.3.372; Lampe AK, 2008, HUM MUTAT, V29, P809, DOI 10.1002/humu.20704; Leeming DJ, 2013, LIVER INT, V33, P439, DOI 10.1111/liv.12044; Leeming DJ, 2012, BIOMARK INSIGHTS, V7, P119, DOI 10.4137/BMI.S9415; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Merlini L, 2008, NEUROLOGY, V71, P1245, DOI 10.1212/01.wnl.0000327611.01687.5e; Minamitani T, 2004, EXP CELL RES, V298, P305, DOI 10.1016/j.yexcr.2004.04.030; Nadeau A, 2009, NEUROLOGY, V73, P25, DOI 10.1212/WNL.0b013e3181aae851; OONO T, 1993, J INVEST DERMATOL, V100, P329, DOI 10.1111/1523-1747.ep12470022; PABLOS JL, 1995, LAB INVEST, V72, P670; Pan TC, 2013, J BIOL CHEM, V288, P14320, DOI 10.1074/jbc.M112.433078; Park J, 2012, ONCOTARGET; Pasarica M, 2009, J CLIN ENDOCR METAB, V94, P5155, DOI 10.1210/jc.2009-0947; PEACOCK AC, 1968, BIOCHEMISTRY-US, V7, P668, DOI 10.1021/bi00842a023; Pepe Guglielmina, 2002, Neuromuscul Disord, V12, P296, DOI 10.1016/S0960-8966(01)00275-9; Sabatelli P, 2012, MATRIX BIOL, V31, P187, DOI 10.1016/j.matbio.2011.12.003; SPECKS U, 1995, AM J RESP CRIT CARE, V151, P1956, DOI 10.1164/ajrccm.151.6.7767545; Vanegas OC, 2002, MUSCLE NERVE, V25, P513, DOI 10.1002/mus.10100; VONDERMARK H, 1984, EUR J BIOCHEM, V142, P493; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x	40	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105686	10.1371/journal.pone.0105686	http://dx.doi.org/10.1371/journal.pone.0105686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25158062	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303200045
J	Markadieu, N; Rios, K; Spiller, BW; McDonald, WH; Welling, PA; Delpire, E				Markadieu, Nicolas; Rios, Kerri; Spiller, Benjamin W.; McDonald, W. Hayes; Welling, Paul A.; Delpire, Eric			Short Forms of Ste20-related Proline/Alanine-rich Kinase (SPAK) in the Kidney Are Created by Aspartyl Aminopeptidase (Dnpep)-mediated Proteolytic Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-2CL(-) COTRANSPORTER; SUBSTRATE-SPECIFICITY; CL-COTRANSPORTER; ACTIVATION; PROLINE; OSR1; IDENTIFICATION; INSIGHTS; DITHIOTHREITOL; INHIBITOR	The Ste20-related kinase SPAK regulates sodium, potassium, and chloride transport in a variety of tissues. Recently, SPAK fragments, which lack the catalytic domain and are inhibitory to Na+ transporters, have been detected in kidney. It has been hypothesized that the fragments originate from alternative translation start sites, but their precise origin is unknown. Here, we demonstrate that kidney lysate possesses proteolytic cleavage activity toward SPAK. Ion exchange and size exclusion chromatography combined with mass spectrometry identified the protease as aspartyl aminopeptidase. The presence of the protease was verified in the active fractions, and recombinant aspartyl aminopeptidase recapitulated the cleavage pattern observed with kidney lysate. Identification of the sites of cleavage by mass spectrometry allowed us to test the function of the smaller fragments and demonstrate their inhibitory action toward the Na+-K+-2Cl(-) cotransporter, NKCC2.	[Markadieu, Nicolas; Rios, Kerri; Delpire, Eric] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37232 USA; [Spiller, Benjamin W.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; [McDonald, W. Hayes] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA; [Welling, Paul A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University System of Maryland; University of Maryland Baltimore	Delpire, E (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, T-4202 Med Ctr North,1161 21st Ave, South Nashville, TN 37232 USA.	eric.delpire@vanderbilt.edu	McDonald, W. Hayes/B-4109-2016	McDonald, W. Hayes/0000-0002-3510-426X	National Institutes of Health [DK093501, GM081778]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063049, R01DK093501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK093501 (to E. D. and P. A. W.) and GM081778 (to B. W. S.).	[Anonymous], PHYSL REV, V92, P1577; Bylander JE, 2007, BIOL CHEM, V388, P1163, DOI 10.1515/BC.2007.156; Chen YY, 2012, J BIOL CHEM, V287, P13356, DOI 10.1074/jbc.M112.347518; Chow KM, 2009, BIOCHEMISTRY-US, V48, P2868, DOI 10.1021/bi8016125; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; Correa LM, 2000, DEV BIOL, V225, P124, DOI 10.1006/dbio.2000.9825; Cousins RJ, 2000, J NUTR, V130, p1384S, DOI 10.1093/jn/130.5.1384S; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; FRANK G, 1974, EUR J BIOCHEM, V44, P317; Franzetti B, 2002, EMBO J, V21, P2132, DOI 10.1093/emboj/21.9.2132; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KB, 2011, CELL PHYSIOL BIOCHEM, V28, P1219, DOI 10.1159/000335854; Geng Y, 2009, J BIOL CHEM, V284, P14020, DOI 10.1074/jbc.M900142200; Gondzik V, 2012, AM J PHYSIOL-CELL PH, V303, pC936, DOI 10.1152/ajpcell.00395.2011; Grimm PR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.402800; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Krezel A, 2001, J INORG BIOCHEM, V84, P77, DOI 10.1016/S0162-0134(00)00212-9; Lin SH, 2011, P NATL ACAD SCI USA, V108, P17538, DOI 10.1073/pnas.1107452108; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Martinez MN, 2012, J LIPID RES, V53, P379, DOI 10.1194/jlr.M019752; McCormick JA, 2011, CELL METAB, V14, P352, DOI 10.1016/j.cmet.2011.07.009; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Park HJ, 2013, AM J PHYSIOL-RENAL, V305, pF1687, DOI 10.1152/ajprenal.00211.2013; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Ranaldi G, 2002, AM J PHYSIOL-RENAL, V283, pF1365, DOI 10.1152/ajprenal.00094.2002; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; San-Cristobal P, 2009, P NATL ACAD SCI USA, V106, P4384, DOI 10.1073/pnas.0813238106; Schwacke JH, 2013, HYPERTENSION, V61, P690, DOI 10.1161/HYPERTENSIONAHA.111.00318; Tamura T, 2000, ARCH BIOCHEM BIOPHYS, V379, P261, DOI 10.1006/abbi.2000.1869; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Villa F, 2007, EMBO REP, V8, P839, DOI 10.1038/sj.embor.7401048; Wilk S, 1998, J BIOL CHEM, V273, P15961, DOI 10.1074/jbc.273.26.15961; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Wolf G, 1997, EXP NEPHROL, V5, P364; Yang SS, 2010, J AM SOC NEPHROL, V21, P1868, DOI 10.1681/ASN.2009121295; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Yokoyama R, 2006, FEBS J, V273, P192, DOI 10.1111/j.1742-4658.2005.05057.x	46	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29273	29284		10.1074/jbc.M114.604009	http://dx.doi.org/10.1074/jbc.M114.604009			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25164821	Green Published, hybrid			2022-12-25	WOS:000344141000041
J	Petkau, K; Parsons, BD; Duggal, A; Foley, E				Petkau, Kristina; Parsons, Brendon D.; Duggal, Aashna; Foley, Edan			A Deregulated Intestinal Cell Cycle Program Disrupts Tissue Homeostasis without Affecting Longevity in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT MIDGUT REGENERATION; STEM-CELLS; MULTIPLE PATHWAYS; HOST-DEFENSE; GUT IMMUNITY; DUAL OXIDASE; PROLIFERATION; MELANOGASTER; EGFR; MICROBIOTA	Recent studies illuminate a complex relationship between the control of stem cell division and intestinal tissue organization in the model system Drosophila melanogaster. Host and microbial signals drive intestinal proliferation to maintain an effective epithelial barrier. Although it is widely assumed that proliferation induces dysplasia and shortens the life span of the host, the phenotypic consequences of deregulated intestinal proliferation for an otherwise healthy host remain unexplored. To address this question, we genetically isolated and manipulated the cell cycle programs of adult stem cells and enterocytes. Our studies revealed that cell cycle alterations led to extensive cell death and morphological disruptions. Despite the extensive tissue damage, we did not observe an impact on longevity, suggesting a remarkable degree of plasticity in intestinal function.	[Petkau, Kristina; Parsons, Brendon D.; Duggal, Aashna; Foley, Edan] Univ Alberta, Dept Med Microbiol & Immunol, Inst Virol, Edmonton, AB T6G 2S2, Canada	University of Alberta	Foley, E (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada.	efoley@ualberta.ca			NICHD, National Institutes of Health; Canada Foundation for Innovation; Alberta Science and Research Investment Program	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Science and Research Investment Program	Transgenic flies were provided by Bruno Lemaitre, Bruce Edgar, Christian Lehner, and Pernille Rorth. The anti-Dl, anti-Prospero, and anti-Armadillo monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of NICHD, National Institutes of Health, and maintained by The University of Iowa Department of Biology (Iowa City, IA). Infrastructure funds were provided by the Canada Foundation for Innovation and the Alberta Science and Research Investment Program. We are grateful to Brittany Fraser for assistance with cell counting and to John Walsh, David Bond, and Andrew Simmonds for comments on the manuscript. We acknowledge the microscopy support from Dr. Stephen Ogg and the Faculty of Medicine and Dentistry Core Imaging Cell Imaging Centre of the University of Alberta.	Amcheslavsky A, 2011, J CELL BIOL, V193, P695, DOI 10.1083/jcb.201103018; Ayyaz A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00098; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Bond D, 2012, J BIOL CHEM, V287, P27359, DOI 10.1074/jbc.M112.378018; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Chatterjee M, 2009, J CELL PHYSIOL, V220, P664, DOI 10.1002/jcp.21808; Chen VL, 2014, GUT MICROBES, V5, P129, DOI 10.4161/gmic.27289; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cordero JB, 2012, DEVELOPMENT, V139, P4524, DOI 10.1242/dev.078261; Cordero JB, 2012, EMBO J, V31, P3901, DOI 10.1038/emboj.2012.248; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Ferrandon D, 2013, CURR OPIN IMMUNOL, V25, P59, DOI 10.1016/j.coi.2012.11.008; GARTNER LP, 1973, INT J RADIAT BIOL, V23, P23, DOI 10.1080/09553007314550031; Guntermann S, 2011, J BIOL CHEM, V286, P30284, DOI 10.1074/jbc.M111.220285; Guo Z, 2013, J CELL BIOL, V201, P945, DOI 10.1083/jcb.201302049; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Jiang HQ, 2011, EXP CELL RES, V317, P2780, DOI 10.1016/j.yexcr.2011.07.020; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Kannan K, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00288; Kapuria S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003045; Karpac J, 2009, AGING CELL, V8, P288, DOI 10.1111/j.1474-9726.2009.00476.x; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lee WJ, 2013, ANNU REV CELL DEV BI, V29, P571, DOI 10.1146/annurev-cellbio-101512-122333; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Li ZH, 2013, DEV CELL, V24, P133, DOI 10.1016/j.devcel.2012.12.010; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Liu W, 2010, J CELL BIOCHEM, V109, P992, DOI 10.1002/jcb.22482; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Montiel-Castro AJ, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00070; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Park JS, 2009, AGING-US, V1, P637, DOI 10.18632/aging.100054; Quan ZH, 2013, J CELL SCI, V126, P3884, DOI 10.1242/jcs.125294; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Stronach B, 2005, DEV DYNAM, V232, P575, DOI 10.1002/dvdy.20283; Takashima S, 2008, NATURE, V454, P651, DOI 10.1038/nature07156; Takashima S, 2012, STEM CELL REV REP, V8, P597, DOI 10.1007/s12015-012-9351-1; Takashima S, 2011, DEV BIOL, V353, P161, DOI 10.1016/j.ydbio.2011.01.039; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Xu N, 2011, DEV BIOL, V354, P31, DOI 10.1016/j.ydbio.2011.03.018	61	26	26	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28719	28729		10.1074/jbc.M114.578708	http://dx.doi.org/10.1074/jbc.M114.578708			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25170078	hybrid, Green Published			2022-12-25	WOS:000343765400059
J	De Nicola, S; Dongiovanni, P; Aghemo, A; Cheroni, C; D'Ambrosio, R; Pedrazzini, M; Marabita, F; Donnici, L; Maggioni, M; Fargion, S; Colombo, M; De Francesco, R; Valenti, L				De Nicola, Stella; Dongiovanni, Paola; Aghemo, Alessio; Cheroni, Cristina; D'Ambrosio, Roberta; Pedrazzini, Michele; Marabita, Francesco; Donnici, Lorena; Maggioni, Marco; Fargion, Silvia; Colombo, Massimo; De Francesco, Raffaele; Valenti, Luca			Interaction between PNPLA3 I148M Variant and Age at Infection in Determining Fibrosis Progression in Chronic Hepatitis C	PLOS ONE			English	Article							FATTY LIVER; NATURAL-HISTORY; DISEASE PROGRESSION; GENETIC-VARIATION; POLYMORPHISM; STEATOSIS; SEVERITY; GENOTYPE; SUSCEPTIBILITY; METAANALYSIS	Background and Aims: The PNPLA3 I148M sequence variant favors hepatic lipid accumulation and confers susceptibility to hepatic fibrosis and hepatocellular carcinoma. The aim of this study was to estimate the effect size of homozygosity for the PNPLA3 I148M variant (148M/M) on the fibrosis progression rate (FPR) and the interaction with age at infection in chronic hepatitis C (CHC). Methods: FPR was estimated in a prospective cohort of 247 CHC patients without alcohol intake and diabetes, with careful estimation of age at infection and determination of fibrosis stage by Ishak score. Results: Older age at infection was the strongest determinant of FPR (p<0.0001). PNPLA3 148M/M was associated with faster FPR in individuals infected at older age (above the median, 21 years; -0.64 +/- 0.2, n = 8 vs. -0.95 +/- 0.3, n = 166 log(10) FPR respectively; p = 0.001; confirmed for lower age thresholds, p<0.05), but not in those infected at younger age (p = ns). The negative impact of PNPLA3 148M/M on fibrosis progression was more marked in subjects at risk of altered hepatic lipid metabolism (those with grade 2-3 steatosis, genotype 3, and overweight; p<0.05). At multivariate analysis, PNPLA3 148M/M was associated with FPR (incremental effect 0.08 +/- 0.03 log(10) fibrosis unit per year; p = 0.022), independently of several confounders, and there was a significant interaction between 148M/M and older age at infection (p = 0.025). The association between 148M/M and FPR remained significant even after adjustment for steatosis severity (p = 0.032). Conclusions: We observed an interaction between homozygosity for the PNPLA3 I148M variant and age at infection in determining fibrosis progression in CHC patients.	[De Nicola, Stella; Aghemo, Alessio; D'Ambrosio, Roberta; Colombo, Massimo] Fdn IRCCS Ca Granda Osped Policlin Milano, Dept Gastroenterol, Milan, Italy; [Dongiovanni, Paola; Fargion, Silvia; Valenti, Luca] Fdn IRCCS Ca Granda Osped Policlin Milano, Dept Internal Med, Milan, Italy; [Cheroni, Cristina; Marabita, Francesco; Donnici, Lorena; De Francesco, Raffaele] INGM Ist Nazl Genet Mol Romeo & Enrica Invernizzi, Virol Program, Milan, Italy; [D'Ambrosio, Roberta; Pedrazzini, Michele; Fargion, Silvia; Colombo, Massimo; Valenti, Luca] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Maggioni, Marco] Fdn IRCCS Ca Granda Osped Policlin Milano, Dept Pathol, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	De Francesco, R (corresponding author), INGM Ist Nazl Genet Mol Romeo & Enrica Invernizzi, Virol Program, Milan, Italy.	defrancesco@ingm.it; luca.valenti@unimi.it	Maggioni, Marco/AAC-4617-2022; Aghemo, Alessio/ABE-5976-2021; Marabita, Francesco/AAD-6220-2019; Dongiovanni, Paola/AAC-9965-2019; Cheroni, Cristina/AAO-2316-2020; D'Ambrosio, Roberta/K-3078-2016; De Francesco, Raffaele/J-6003-2012; Valenti, Luca/B-3695-2009	Maggioni, Marco/0000-0001-8603-8998; Aghemo, Alessio/0000-0003-0941-3226; Marabita, Francesco/0000-0001-6180-0106; Dongiovanni, Paola/0000-0003-4343-7213; D'Ambrosio, Roberta/0000-0003-0019-1153; De Francesco, Raffaele/0000-0001-8754-5123; Valenti, Luca/0000-0001-8909-0345; Cheroni, Cristina/0000-0002-0832-2333	Ricerca Corrente Fondazione IRCCS Ca' Granda; Associazione Malattie Metaboliche del Fegato ONLUS	Ricerca Corrente Fondazione IRCCS Ca' Granda; Associazione Malattie Metaboliche del Fegato ONLUS	This manuscript was supported by Ricerca Corrente Fondazione IRCCS Ca' Granda (Institutional core funds; no grant number is available), and Associazione Malattie Metaboliche del Fegato ONLUS (non-profit organization for the study and the cure of metabolic liver diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Aghemo A, 2013, HEPATOLOGY, V58, P428, DOI 10.1002/hep.26371; Bassendine MF, 2011, J HEPATOL, V55, P1428, DOI 10.1016/j.jhep.2011.06.004; Burza MA, 2014, LIVER INT, V34, P514, DOI 10.1111/liv.12310; Cai T, 2011, J HEPATOL, V55, P529, DOI 10.1016/j.jhep.2010.12.020; Dongiovanni P, 2013, WORLD J GASTROENTERO, V19, P6969, DOI 10.3748/wjg.v19.i41.6969; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Hyysalo J, 2014, DIABETES, V63, P312, DOI 10.2337/db13-0774; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Knolle PA, 2014, GASTROENTEROLOGY; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Leandro G, 2006, GASTROENTEROLOGY, V130, P1636, DOI 10.1053/j.gastro.2006.03.014; Maasoumy B, 2012, BEST PRACT RES CL GA, V26, P401, DOI 10.1016/j.bpg.2012.09.009; Marabita F, 2011, HEPATOLOGY, V54, P1127, DOI 10.1002/hep.24503; Muller T, 2011, J HEPATOL, V55, P732, DOI 10.1016/j.jhep.2011.01.025; Pirazzi C, 2014, HUM MOL GENET; Pirazzi C, 2012, J HEPATOL, V57, P1276, DOI 10.1016/j.jhep.2012.07.030; Powell EE, 2000, HEPATOLOGY, V31, P828, DOI 10.1053/he.2000.6253; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rosselli M, 2013, GUT, V62, P1234, DOI 10.1136/gutjnl-2012-302826; Ruhanen H, 2014, J LIPID RES; Singal AG, 2014, AM J GASTROENTEROL, V109, P325, DOI 10.1038/ajg.2013.476; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Stickel F, 2011, HEPATOLOGY, V53, P86, DOI 10.1002/hep.24017; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trepo E, 2013, HEPATOLOGY; Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350; Trepo E, 2011, J HEPATOL, V55, P38, DOI 10.1016/j.jhep.2010.10.018; Valenti L, 2012, ALIMENT PHARM THER, V35, P1434, DOI 10.1111/j.1365-2036.2012.05109.x; Valenti L, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-111; Valenti L, 2012, J HEPATOL, V56, P1209, DOI 10.1016/j.jhep.2011.10.024; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Valenti L, 2010, HEPATOLOGY, V52, P1274, DOI 10.1002/hep.23823; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; Reggiardo MV, 2012, ANN HEPATOL, V11, P658	38	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106022	10.1371/journal.pone.0106022	http://dx.doi.org/10.1371/journal.pone.0106022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171251	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500089
J	Lee, JE; Kim, SK; Han, KH; Cho, MO; Yun, GY; Kim, KH; Choi, HY; Ryu, YH; Ha, SK; Park, HC				Lee, Jung Eun; Kim, Seung Kyu; Han, Kyung Hwa; Cho, Mi Ok; Yun, Gi Young; Kim, Ki Hyun; Choi, Hoon Young; Ryu, Young Hoon; Ha, Sung Kyu; Park, Hyeong Cheon			Risk Factors for Developing Hyponatremia in Thyroid Cancer Patients Undergoing Radioactive Iodine Therapy	PLOS ONE			English	Article							ANTIDIURETIC-HORMONE SECRETION; IMPAIRED WATER-EXCRETION; VASOPRESSIN; HYPOTHYROIDISM; ASSOCIATION; RELEASE; I-131	Background: Due to the alarming increase in the incidence of thyroid cancer worldwide, more patients are receiving postoperative radioactive iodine (RAI) therapy and these patients are given a low-iodine diet along with levothyroxine withdrawal to induce a hypothyroid state to maximize the uptake of RAI by thyroid tissues. Recently, the reported cases of patients suffering from life-threatening severe hyponatremia following postoperative RAI therapy have increased. This study aimed to systematically assess risk factors for developing hyponatremia following RAI therapy in post-thyroidectomy patients. Methods: We reviewed the medical records of all thyroid cancer patients who underwent thyroidectomy and postoperative RAI therapy from July 2009 to February 2012. Demographic and biochemical parameters including serum sodium and thyroid function tests were assessed along with medication history. Results: A total of 2229 patients (47.0 +/- 11.0 years, female 76.3%) were enrolled in the analysis. Three hundred seven patients (13.8%) of all patients developed hyponatremia; 44 patients (2.0%) developed moderate to severe hyponatremia (serum Na+<= 130 mEq/L) and another 263 (11.8%) patients showed mild hyponatremia (130 mEq/L<serum Na+<= 135 mEq/L). In univariate analysis, old age, female sex, presence of hypertension, presence of diabetes, use of thiazide diuretics, use of angiotensin receptor blocker or angiotensin-converting enzyme inhibitors, lung metastasis, and hyponatremia and lower estimated glomerular filtration rate at the start of RAI therapy were significantly associated with hyponatremia in patients undergoing RAI therapy after total thyroidectomy. Multivariate analysis showed that old age, female sex, use of thiazide diuretics, and hyponatremia at the initiation of RAI therapy were independent risk factors for the development of hyponatremia. Conclusion: Our data suggest that age greater than 60 years, female sex, use of thiazide, and hyponatremia at the initiation of RAI therapy are important risk factors for developing hyponatremia following RAI therapy in post-thyroidectomy patients.	[Lee, Jung Eun] Yonsei Univ, Coll Med, Yongin Severance Hosp, Dept Internal Med, Yongin, South Korea; [Kim, Seung Kyu; Cho, Mi Ok; Yun, Gi Young; Kim, Ki Hyun; Choi, Hoon Young; Ha, Sung Kyu; Park, Hyeong Cheon] Yonsei Univ, Coll Med, Dept Internal Med, Gangnam Severance Hosp, Seoul, South Korea; [Ryu, Young Hoon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Nucl Med, Seoul, South Korea; [Han, Kyung Hwa] Gangnam Med Res Ctr, Biostat Collaborat Unit, Seoul, South Korea; [Lee, Jung Eun; Choi, Hoon Young; Park, Hyeong Cheon] Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, HC (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Gangnam Severance Hosp, Seoul, South Korea.	amp97@yuhs.ac		Park, Hyeong-Cheon/0000-0002-1550-0812; LEE, JUNG EUN/0000-0003-0917-2872; Han, Kyunghwa/0000-0002-5687-7237; CHOI, HOON YOUNG/0000-0002-4245-0339; RYU, YOUNG HOON/0000-0002-9000-5563				Al Nozha OM, 2011, ENDOCR PRACT, V17, P113; ASHRAF N, 1981, AM J MED, V70, P1163, DOI 10.1016/0002-9343(81)90822-6; Baajafer FS, 1999, J ENDOCRINOL INVEST, V22, P35, DOI 10.1007/BF03345476; Berl T, 2010, RENAL ELECTROLYTE DI, P1; Chen YC, 2005, AM J PHYSIOL-RENAL, V289, pF672, DOI 10.1152/ajprenal.00384.2004; Cho BY, 2013, THYROID, V23, P797, DOI 10.1089/thy.2012.0329; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; EPSTEIN M, 1979, NEPHRON, V24, P121, DOI 10.1159/000181707; Hammami MM, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-27; Hirshberg B, 1997, AM J MED, V103, P270, DOI 10.1016/S0002-9343(97)00250-7; Kim SK, 2014, THYROID, V24, P773, DOI 10.1089/thy.2013.0110; Krishnamurthy VR, 2007, THYROID, V17, P889, DOI 10.1089/thy.2007.0094; Luckey AE, 2013, ARCH SURG-CHICAGO, V138, P1055; Nozu T, 2011, INTERNAL MED, V50, P2169, DOI 10.2169/internalmedicine.50.5740; Reiners C, 2008, BEST PRACT RES CL EN, V22, P989, DOI 10.1016/j.beem.2008.09.013; Scheinman S, 2000, WERNER INGBARS THYRO, P791; SCHRIER RW, 1981, J LAB CLIN MED, V98, P1; Shakir MKM, 2008, THYROID, V18, P787, DOI 10.1089/thy.2008.0050; SKOWSKY WR, 1978, AM J MED, V64, P613, DOI 10.1016/0002-9343(78)90581-8; Soh EY, 1996, ENDOCRIN METAB CLIN, V25, P115, DOI 10.1016/S0889-8529(05)70315-7; Spital A, 1999, AM J NEPHROL, V19, P447, DOI 10.1159/000013496; Sun GEC, 2012, ENDOCR PRACT, V18, P894, DOI 10.4158/EP12130.OR; SZATALOWICZ VL, 1982, CLIN SCI, V62, P235, DOI 10.1042/cs0620235; Turgutalp K, 2013, INT UROL NEPHROL, V45, P265, DOI 10.1007/s11255-012-0307-9; Verbalis JG, 2007, AM J MED, V120, pS1, DOI 10.1016/j.amjmed.2007.09.001; Yawar A, 2008, JCPSP-J COLL PHYSICI, V18, P467, DOI 08.2008/JCPSP.467471; ZOHAR Y, 1991, ANN OTO RHINOL LARYN, V100, P341, DOI 10.1177/000348949110000415	27	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106840	10.1371/journal.pone.0106840	http://dx.doi.org/10.1371/journal.pone.0106840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170831	Green Submitted, gold, Green Published			2022-12-25	WOS:000341127500169
J	Sierra, A; Navascues, J; Cuadros, MA; Calvente, R; Martin-Oliva, D; Ferrer-Martin, RM; Martin-Estebane, M; Carrasco, MC; Marin-Teva, JL				Sierra, Ana; Navascues, Julio; Cuadros, Miguel A.; Calvente, Ruth; Martin-Oliva, David; Ferrer-Martin, Rosa M.; Martin-Estebane, Maria; Carrasco, Maria-Carmen; Marin-Teva, Jose L.			Expression of Inducible Nitric Oxide Synthase (iNOS) in Microglia of the Developing Quail Retina	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL-CELL MIGRATION; PRO-INFLAMMATORY CYTOKINES; CHICK-EMBRYO RETINA; POSTNATAL-DEVELOPMENT; ACTIVATED MICROGLIA; AMEBOID MICROGLIA; GLUTAMATE RELEASE; CEREBRAL-CORTEX; NEURONAL DEATH	Inducible nitric oxide synthase (iNOS), which produce large amounts of nitric oxide (NO), is induced in macrophages and microglia in response to inflammatory mediators such as LPS and cytokines. Although iNOS is mainly expressed by microglia that become activated in different pathological and experimental situations, it was recently reported that undifferentiated amoeboid microglia can also express iNOS during normal development. The aim of this study was to investigate the pattern of iNOS expression in microglial cells during normal development and after their activation with LPS by using the quail retina as model. iNOS expression was analyzed by iNOS immunolabeling, western-blot, and RT-PCR. NO production was determined by using DAR-4M AM, a reliable fluorescent indicator of subcellular NO production by iNOS. Embryonic, postnatal, and adult in situ quail retinas were used to analyze the pattern of iNOS expression in microglial cells during normal development. iNOS expression and NO production in LPS-treated microglial cells were investigated by an in vitro approach based on organotypic cultures of E8 retinas, in which microglial cell behavior is similar to that of the in situ retina, as previously demonstrated in our laboratory. We show here that amoeboid microglia in the quail retina express iNOS during normal development. This expression is stronger in microglial cells migrating tangentially in the vitreal part of the retina and is downregulated, albeit maintained, when microglia differentiate and become ramified. LPS treatment of retina explants also induces changes in the morphology of amoeboid microglia compatible with their activation, increasing their lysosomal compartment and upregulating iNOS expression with a concomitant production of NO. Taken together, our findings demonstrate that immature microglial cells express iNOS during normal development, suggesting a certain degree of activation. Furthermore, LPS treatment induces overactivation of amoeboid microglia, resulting in a significant iNOS upregulation.	[Sierra, Ana; Navascues, Julio; Cuadros, Miguel A.; Calvente, Ruth; Martin-Oliva, David; Ferrer-Martin, Rosa M.; Martin-Estebane, Maria; Carrasco, Maria-Carmen; Marin-Teva, Jose L.] Univ Granada, Fac Ciencias, Dept Biol Celular, Granada, Spain	University of Granada	Marin-Teva, JL (corresponding author), Univ Granada, Fac Ciencias, Dept Biol Celular, Granada, Spain.	jlmarin@ugr.es	Navascues, Julio/P-1336-2014; MARTÍN, ANA SIERRA/Q-6241-2016; Cuadros, Miguel A/L-3954-2014; ESTEBANÉ, MARÍA MARTÍN/AAR-5385-2020; Martín-Oliva, David/L-8472-2014	MARTÍN, ANA SIERRA/0000-0002-9392-9374; Cuadros, Miguel A/0000-0003-4259-1649; ESTEBANÉ, MARÍA MARTÍN/0000-0002-9680-581X; Martín-Oliva, David/0000-0002-8095-5442; Navascues, Julio/0000-0003-2958-2705	Ministerio de Economia y Competitividad, Spain [BFU2010-19981]; Junta de Andalucia, Spain [P07-CVI-03008]	Ministerio de Economia y Competitividad, Spain; Junta de Andalucia, Spain(Junta de Andalucia)	This work was supported by grants from Ministerio de Economia y Competitividad, Spain (BFU2010-19981) and Junta de Andalucia, Spain (P07-CVI-03008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acarin L, 1996, J COMP NEUROL, V367, P361; Arias-Salvatierra D, 2011, CELL SIGNAL, V23, P425, DOI 10.1016/j.cellsig.2010.10.017; Arnhold S, 1997, NEUROSCI LETT, V229, P165, DOI 10.1016/S0304-3940(97)00457-6; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Bal-Price A, 2002, J NEUROCHEM, V80, P73, DOI 10.1046/j.0022-3042.2001.00675.x; Bechade C, 2014, GLIA, V62, P956, DOI 10.1002/glia.22652; Bertini G, 1996, NEUROSCIENCE, V70, P287, DOI 10.1016/0306-4522(95)00366-Q; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Carrasco MC, 2011, DEV NEUROBIOL, V71, P296, DOI 10.1002/dneu.20860; CHAO CC, 1992, J IMMUNOL, V149, P2736; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Cho S, 2005, J CEREBR BLOOD F MET, V25, P493, DOI 10.1038/sj.jcbfm.9600058; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Combs CK, 2001, J NEUROSCI, V21, P1179; Consonni A, 2011, MOL CELL NEUROSCI, V48, P151, DOI 10.1016/j.mcn.2011.07.006; Contestabile A, 2000, BRAIN RES REV, V32, P476, DOI 10.1016/S0165-0173(00)00018-7; Crain JM, 2013, J NEUROSCI RES, V91, P1143, DOI 10.1002/jnr.23242; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; CUADROS MA, 1992, NEUROSCI LETT, V148, P11, DOI 10.1016/0304-3940(92)90792-6; Cunningham CL, 2013, J NEUROSCI, V33, P4216, DOI 10.1523/JNEUROSCI.3441-12.2013; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; di Penta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054722; Estevez AG, 1998, J NEUROSCI, V18, P3708; Eyo UB, 2013, J NEUROIMMUNE PHARM, V8, P494, DOI 10.1007/s11481-013-9434-z; Fischer AJ, 1999, J COMP NEUROL, V405, P1, DOI 10.1002/(SICI)1096-9861(19990301)405:1<1::AID-CNE1>3.0.CO;2-U; Fiske BK, 2000, NEUROSCIENCE, V96, P807, DOI 10.1016/S0306-4522(99)00601-6; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fukui O, 2006, BRAIN RES, V1121, P35, DOI 10.1016/j.brainres.2006.08.121; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Gibbons HM, 2006, BRAIN RES, V1084, P1, DOI 10.1016/j.brainres.2006.02.032; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; Goings GE, 2006, GLIA, V54, P329, DOI 10.1002/glia.20381; Goureau O, 1997, J NEUROSCI RES, V50, P104; Govers R, 2004, HISTOL HISTOPATHOL, V19, P585, DOI 10.14670/HH-19.585; Graeber MB, 1998, BRAIN RES, V813, P241, DOI 10.1016/S0006-8993(98)00859-2; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hao AJ, 2001, J NEUROSCI RES, V64, P79, DOI 10.1002/jnr.1056; Haverkamp S, 1999, VISION RES, V39, P2299, DOI 10.1016/S0042-6989(99)00007-3; Hristova M, 2010, GLIA, V58, P11, DOI 10.1002/glia.20896; Ientile R, 1996, FEBS LETT, V379, P82, DOI 10.1016/0014-5793(95)01490-X; Ikeda H, 2006, EUR J NEUROSCI, V23, P1939, DOI 10.1111/j.1460-9568.2006.04713.x; Imura T, 2005, CEREB CORTEX, V15, P332, DOI 10.1093/cercor/bhh135; Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229; Kakita H, 2013, TOXICOL APPL PHARM, V268, P99, DOI 10.1016/j.taap.2013.01.024; Kang YC, 2004, IN VIVO, V18, P367; Kawasaki K, 2003, MOL CELL BIOL, V23, P5726, DOI 10.1128/MCB.23.16.5726-5737.2003; Kojima H, 2001, ANAL CHEM, V73, P1967, DOI 10.1021/ac001136i; Li YY, 2013, TOXICOLOGY, V312, P132, DOI 10.1016/j.tox.2013.08.008; Liu J, 2008, J PROTEOME RES, V7, P2033, DOI 10.1021/pr7007779; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Madore C, 2013, BRAIN BEHAV IMMUN, V34, P151, DOI 10.1016/j.bbi.2013.08.008; Mander P, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-20; Marin-Teva JL, 1999, ANAT EMBRYOL, V200, P289, DOI 10.1007/s004290050280; Marin-Teva JL, 1999, J COMP NEUROL, V412, P255; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Marin-Teva JL, 1998, GLIA, V22, P31, DOI 10.1002/(SICI)1098-1136(199801)22:1<31::AID-GLIA4>3.0.CO;2-B; Mejia-Garcia TA, 2007, J NEUROCHEM, V100, P382, DOI 10.1111/j.1471-4159.2006.04244.x; Miyake T, 2014, BIOCHEM BIOPH RES CO, V444, P212, DOI 10.1016/j.bbrc.2014.01.022; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Murohara T, 1999, ARTERIOSCL THROM VAS, V19, P1156, DOI 10.1161/01.ATV.19.5.1156; NAVASCUES J, 1994, J COMP NEUROL, V350, P171, DOI 10.1002/cne.903500203; Navascues J, 2000, AN ACAD BRAS CIENC, V72, P91, DOI 10.1590/S0001-37652000000100013; NAVASCUES J, 1995, J COMP NEUROL, V354, P209, DOI 10.1002/cne.903540205; Nikonenko I, 2008, J CELL BIOL, V183, P1115, DOI 10.1083/jcb.200805132; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; OGILVIE P, 1995, FASEB J, V9, P799, DOI 10.1096/fasebj.9.9.7541381; Ono K, 2010, NEUROSCI LETT, V473, P146, DOI 10.1016/j.neulet.2010.02.041; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pandit L, 2009, P NATL ACAD SCI USA, V106, P1211, DOI 10.1073/pnas.0810968106; PARDANAUD L, 1987, DEVELOPMENT, V100, P339; PARK CS, 1994, BIOCHEM BIOPH RES CO, V205, P85, DOI 10.1006/bbrc.1994.2633; Rigato C, 2011, GLIA, V59, P675, DOI 10.1002/glia.21140; Rios H, 2000, DEV BRAIN RES, V120, P17, DOI 10.1016/S0165-3806(99)00166-2; Saha RN, 2006, ANTIOXID REDOX SIGN, V8, P929, DOI 10.1089/ars.2006.8.929; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Sanchez-Lopez A, 2004, GLIA, V46, P261, DOI 10.1002/glia.20007; Sanchez-Lopez AM, 2005, J COMP NEUROL, V492, P20, DOI 10.1002/cne.20676; Sedel F, 2004, J NEUROSCI, V24, P2236, DOI 10.1523/JNEUROSCI.4464-03.2004; Shen YH, 1998, FEBS LETT, V433, P125, DOI 10.1016/S0014-5793(98)00844-8; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Shigemoto-Mogami Y, 2014, J NEUROSCI, V34, P2231, DOI 10.1523/JNEUROSCI.1619-13.2014; Siamwala JH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00679; Siamwala JH, 2010, PROTOPLASMA, V242, P3, DOI 10.1007/s00709-010-0114-z; Sivakumar V, 2011, J PATHOL, V224, P245, DOI 10.1002/path.2858; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Streit WJ, 2009, J NEUROIMMUNE PHARM, V4, P371, DOI 10.1007/s11481-009-9163-5; Strijbos PJLM, 1996, J NEUROSCI, V16, P5004; Swinnen N, 2013, GLIA, V61, P150, DOI 10.1002/glia.22421; Tambuyzer BR, 2009, J LEUKOCYTE BIOL, V85, P352, DOI 10.1189/jlb.0608385; Tekmen-Clark M, 2013, VISUAL NEUROSCI, V30, P91, DOI 10.1017/S0952523813000126; Tremblay S, 2013, INVEST OPHTH VIS SCI, V54, P8125, DOI 10.1167/iovs.13-12496; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Wang X, 2000, BRAIN RES, V878, P136, DOI 10.1016/S0006-8993(00)02727-X; Wen J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-38; Wilson M, 2011, VISUAL NEUROSCI, V28, P205, DOI 10.1017/S0952523811000083; Zhang LJ, 2012, NEUROCHEM INT, V61, P1220, DOI 10.1016/j.neuint.2012.09.002; Zhao J, 2006, GLIA, V53, P304, DOI 10.1002/glia.20283; Zusso M, 2012, J NEUROSCI, V32, P11285, DOI 10.1523/JNEUROSCI.6182-11.2012	105	48	50	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106048	10.1371/journal.pone.0106048	http://dx.doi.org/10.1371/journal.pone.0106048			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170849	Green Published, gold			2022-12-25	WOS:000341127500092
J	Wang, P; Lu, JH; Yu, XH				Wang, Pei; Lu, Jinhu; Yu, Xinghuo			Identification of Important Nodes in Directed Biological Networks: A Network Motif Approach	PLOS ONE			English	Article							RICH-CLUB ORGANIZATION; FEEDFORWARD LOOP; TRANSCRIPTIONAL REGULATION; INFLUENTIAL SPREADERS; MULTIAGENT SYSTEMS; SOCIAL NETWORKS; COMPLEX; CENTRALITY; ALGORITHM; CONSENSUS	Identification of important nodes in complex networks has attracted an increasing attention over the last decade. Various measures have been proposed to characterize the importance of nodes in complex networks, such as the degree, betweenness and PageRank. Different measures consider different aspects of complex networks. Although there are numerous results reported on undirected complex networks, few results have been reported on directed biological networks. Based on network motifs and principal component analysis (PCA), this paper aims at introducing a new measure to characterize node importance in directed biological networks. Investigations on five real-world biological networks indicate that the proposed method can robustly identify actually important nodes in different networks, such as finding command interneurons, global regulators and non-hub but evolutionary conserved actually important nodes in biological networks. Receiver Operating Characteristic (ROC) curves for the five networks indicate remarkable prediction accuracy of the proposed measure. The proposed index provides an alternative complex network metric. Potential implications of the related investigations include identifying network control and regulation targets, biological networks modeling and analysis, as well as networked medicine.	[Wang, Pei] Henan Univ, Sch Math & Informat Sci, Kaifeng, Peoples R China; [Lu, Jinhu] Chinese Acad Sci, Inst Syst Sci, Acad Math & Syst Sci, Beijing, Peoples R China; [Wang, Pei; Yu, Xinghuo] RMIT Univ, Sch Elect & Comp Engn, Melbourne, Vic 3001, Australia	Henan University; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Royal Melbourne Institute of Technology (RMIT)	Wang, P (corresponding author), Henan Univ, Sch Math & Informat Sci, Kaifeng, Peoples R China.	wp0307@126.com	LU, JINHU/B-6851-2013; Yu, Xinghuo/D-8423-2013; 王, 沛/W-4875-2019	LU, JINHU/0000-0003-0275-8387; Yu, Xinghuo/0000-0001-8093-9787; 王, 沛/0000-0002-8149-756X	National Science and Technology Major Project of China [2014ZX10004-001-014]; 973 Project [2014CB845302]; National Natural Science Foundation of China [61304151, 61025017]; Science Foundation of Henan University [2012YBZR007, 2013YBRW005]	National Science and Technology Major Project of China; 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Henan University	This work was supported by the National Science and Technology Major Project of China under Grant 2014ZX10004-001-014, the 973 Project under Grant 2014CB845302, the National Natural Science Foundation of China under Grants 61304151 and 61025017, the Science Foundation of Henan University under Grants 2012YBZR007 and 2013YBRW005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alon U, 2007, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Canali Claudia, 2012, International Journal of Social Network Mining, V1, P27, DOI 10.1504/IJSNM.2012.045104; Carmi S, 2007, P NATL ACAD SCI USA, V104, P11150, DOI 10.1073/pnas.0701175104; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chen DB, 2012, PHYSICA A, V391, P1777, DOI 10.1016/j.physa.2011.09.017; Chen Y, 2013, SIAM J CONTROL OPTIM, V51, P3274, DOI 10.1137/110850116; Chen Y, 2013, AUTOMATICA, V49, P1768, DOI 10.1016/j.automatica.2013.02.021; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; de Reus MA, 2013, J NEUROSCI, V33, P12929, DOI 10.1523/JNEUROSCI.1448-13.2013; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066732; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Goldenberg J, 2009, J MARKETING, V73, P1, DOI 10.1509/jmkg.73.2.1; Gross L, 2007, PLOS BIOL, V5, P2433, DOI [10.1371/journal.pbio.0050253, 10.1371/journal.pbio.0050249]; Hardle W., 2012, APPL MULTIVARIATE ST; Harriger L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046497; Huerta AM, 1998, NUCLEIC ACIDS RES, V26, P55, DOI 10.1093/nar/26.1.55; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Kim JR, 2008, BIOPHYS J, V94, P359, DOI 10.1529/biophysj.107.105106; Kintali S., 2008, 08091906 ARXIV; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Koschutzki D, 2007, J THEOR BIOL, V248, P471, DOI 10.1016/j.jtbi.2007.05.038; Koschutzki D, 2008, GENE REGUL SYST BIO, V2, P193, DOI 10.4137/GRSB.S702; Koyuturk M, 2004, BIOINFORMATICS, V20, P200, DOI 10.1093/bioinformatics/bth919; LALOUX I, 1990, MOL CELL BIOL, V10, P3541, DOI 10.1128/MCB.10.7.3541; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Opsahl T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168702; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Probst F, 2013, BUS INFORM SYST ENG+, V5, P179, DOI 10.1007/s12599-013-0263-7; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rutjes AWS., 2007, HEALTH TECHNOL ASSES, V11, P1; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Schreiber F, 2005, BIOINFORMATICS, V21, P3572, DOI 10.1093/bioinformatics/bti556; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Towlson EK, 2013, J NEUROSCI, V33, P6380, DOI 10.1523/JNEUROSCI.3784-12.2013; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wang E, 2007, CELL MOL LIFE SCI, V64, P1752, DOI 10.1007/s00018-007-7054-6; Wang P, 2015, IEEE T BIOMED CIRC S, V9, P312, DOI 10.1109/TBCAS.2014.2343620; Wang P, 2014, J SYST SCI COMPLEX, V27, P650, DOI 10.1007/s11424-014-2236-4; Wang P, 2013, IEEE INT SYMP CIRC S, P2103, DOI 10.1109/ISCAS.2013.6572289; Wang P, 2014, IEEE T BIOMED CIRC S, V8, P87, DOI 10.1109/TBCAS.2014.2303160; [王沛 Wang Pei], 2013, [自动化学报, Acta Automatica Sinica], V39, P1969; Wang P, 2012, CHIN CONTR CONF, P7376; Wang P, 2012, NEUROCOMPUTING, V78, P155, DOI 10.1016/j.neucom.2011.05.034; Wang XJ, 2011, BRIEF FUNCT GENOMICS, V10, P280, DOI 10.1093/bfgp/elr024; WEICKERT MJ, 1993, MOL MICROBIOL, V10, P245, DOI 10.1111/j.1365-2958.1993.tb01950.x; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Wuchty S, 2002, PROTEOMICS, V2, P1715, DOI 10.1002/1615-9861(200212)2:12<1715::AID-PROT1715>3.0.CO;2-O; Yan XF, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P721, DOI 10.1109/ICDM.2002.1184038; Zhou S, 2004, IEEE COMMUN LETT, V8, P180, DOI 10.1109/LCOMM.2004.823426	71	52	51	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106132	10.1371/journal.pone.0106132	http://dx.doi.org/10.1371/journal.pone.0106132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170616	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500112
J	Wen, JB; Zhu, FQ; Chen, WG; Jiang, LP; Chen, J; Hu, ZP; Huang, YJ; Zhou, ZW; Wang, GL; Lin, H; Zhou, SF				Wen, Jian-Bo; Zhu, Fang-Qing; Chen, Wei-Guo; Jiang, Li-Ping; Chen, Jie; Hu, Zhao-Peng; Huang, Yong-Jian; Zhou, Zhi-Wei; Wang, Gui-Liang; Lin, Hao; Zhou, Shu-Feng			Oxymatrine Improves Intestinal Epithelial Barrier Function Involving NF-kappa B-Mediated Signaling Pathway in CCl4-Induced Cirrhotic Rats	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FATTY LIVER-DISEASE; BACTERIAL TRANSLOCATION; HYPERTENSIVE-RATS; DENDRITIC CELLS; INDUCED COLITIS; INFLAMMATION; ALPHA; GUT; ACTIVATION	Accumulating evidence suggests that intestinal epithelial barrier dysfunction plays an important role in the pathogenesis of hepatic cirrhosis and its complications such as gastrointestinal injury and hepatic encephalopathy. To date, there is no cure for cirrhosis-associated intestinal mucosal lesion and ulcer. This study aimed to investigate the effect of oxymatrine on intestinal epithelial barrier function and the underlying mechanism in carbon tetrachloride (CCl4)-induced cirrhotic rats. Thirty CCl4-induced cirrhotic rats were randomly divided into treatment group, which received oxymatrine treatment (63 mg/kg), and non-treatment group, which received the same dose of 5% glucose solution (vehicle). The blank group (n = 10 healthy rats) received no treatment. Terminal ileal samples were collected for histopathological examination. The expression level of nuclear factor-kappa B (NF-kappa B) p65 in ileal tissue was evaluated by immunohistochemistry. The gene and protein expression levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin 6 (IL-6) in ileal tissues were analyzed by reverse-transcriptase polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. Additionally, plasma endotoxin level was determined. In comparison to the blank group, a significant alteration in the morphology of intestinal mucosal villi in the non-treatment group was observed. The intestinal mucosal villi were atrophic, shorter, and fractured, and inflammatory cells were infiltrated into the lamina propria and muscular layer. Besides, serious swell of villi and loose structure of mucous membrane were observed. Oxymatrine reversed the CCl4-induced histological changes and restored intestinal barrier integrity. Moreover, oxymatrine reduced the protein expression level of NF-kappa B p65, TNF-alpha, and IL-6, which were elevated in the vehicle-treated group. In addition, the serum endotoxin level was significantly decreased after oxymatrine treatment in CCl4-induced cirrhotic rats. The results indicate that oxymatrine improves intestinal barrier function via NF-kappa B-mediated signaling pathway and may be used as a new protecting agent for cirrhosis-associated intestinal mucosal damage.	[Wen, Jian-Bo; Zhu, Fang-Qing; Chen, Wei-Guo; Wang, Gui-Liang; Lin, Hao] Southern Med Univ, Affiliated Pingxiang Hosp, Dept Gastroenterol, Pingxiang, Jiangxi, Peoples R China; [Jiang, Li-Ping] Southern Med Univ, Affiliated Pingxiang Hosp, Anim Lab, Pingxiang, Jiangxi, Peoples R China; [Chen, Jie] Southern Med Univ, Affiliated Pingxiang Hosp, Dept Pharmacol, Pingxiang, Jiangxi, Peoples R China; [Hu, Zhao-Peng] Southern Med Univ, Affiliated Pingxiang Hosp, Dept Pathol, Pingxiang, Jiangxi, Peoples R China; [Huang, Yong-Jian] Southern Med Univ, Affiliated Pingxiang Hosp, Dept Clin Lab, Pingxiang, Jiangxi, Peoples R China; [Zhou, Zhi-Wei; Zhou, Shu-Feng] Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL USA	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; State University System of Florida; University of South Florida	Wen, JB (corresponding author), Southern Med Univ, Affiliated Pingxiang Hosp, Dept Gastroenterol, Pingxiang, Jiangxi, Peoples R China.	wenjbpx@126.com; szhou@health.usf.edu	Zhou, Shu-Feng/E-3166-2013; zhou, zhiwei/J-7878-2015	Zhou, Shu-Feng/0000-0002-5542-6119; zhou, zhiwei/0000-0002-8227-2573				Aller MA, 2005, MEDIAT INFLAMM, P101, DOI 10.1155/MI.2005.101; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bellot P, 2013, LIVER INT, V33, P31, DOI 10.1111/liv.12021; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chai NL, 2012, WORLD J GASTROENTERO, V18, P4199, DOI 10.3748/wjg.v18.i31.4199; Chen H, 2013, ONCOL REP, V30, P589, DOI 10.3892/or.2013.2529; Cirera I, 2001, J HEPATOL, V34, P32, DOI 10.1016/S0168-8278(00)00013-1; Dong XQ, 2011, INFLAMM RES, V60, P533, DOI 10.1007/s00011-010-0300-7; Fan H, 2008, J HUAZHONG U SCI-MED, V28, P415, DOI 10.1007/s11596-008-0409-x; Frances R, 2007, J HEPATOL, V46, P797, DOI 10.1016/j.jhep.2006.11.018; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Guzman JR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01629; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hosoyamada Y, 2005, ANAT EMBRYOL, V210, P1, DOI 10.1007/s00429-005-0011-y; Huang XY, 2013, PHYTOMEDICINE, V20, P202, DOI 10.1016/j.phymed.2012.10.012; Jiang HC, 2005, WORLD J SURG, V29, P1397, DOI 10.1007/s00268-005-7885-y; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Munoz L, 2012, HEPATOLOGY, V56, P1861, DOI 10.1002/hep.25854; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pijls KE, 2013, LIVER INT, V33, P1457, DOI 10.1111/liv.12271; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; RUNYON BA, 1994, J HEPATOL, V21, P792, DOI 10.1016/S0168-8278(94)80241-6; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Shi LJ, 2013, EUR J PHARMACOL, V714, P89, DOI 10.1016/j.ejphar.2013.06.013; Shi LJ, 2013, MOL MED REP, V8, P439, DOI 10.3892/mmr.2013.1512; Song HY, 2009, ROUTL ADV TOUR, V13, P70; TIEGS G, 1989, BIOCHEM PHARMACOL, V38, P627, DOI 10.1016/0006-2952(89)90208-6; Toda K, 2000, J GASTROENTEROL, V35, P214, DOI 10.1007/s005350050333; Ubeda M, 2013, GUT, V62, P330, DOI 10.1136/gutjnl-2012-302920; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Wiest R, 2013, J HEPATOL; Xu M, 2012, BRAIN RES, V1454, P48, DOI 10.1016/j.brainres.2012.03.020; Yang DH, 2011, WORLD J GASTROENTERO, V17, P1903, DOI 10.3748/wjg.v17.i14.1903; Yang RK, 2005, INTENS CARE MED, V31, P709, DOI 10.1007/s00134-005-2601-9; Zhao JP, 2008, SURG TODAY, V38, P931, DOI 10.1007/s00595-008-3785-8; Zheng P, 2005, WORLD J GASTROENTERO, V11, P4912, DOI 10.3748/wjg.v11.i31.4912	39	30	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106082	10.1371/journal.pone.0106082	http://dx.doi.org/10.1371/journal.pone.0106082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171482	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500100
J	Barennes, H; Guillet, S; Limsreng, S; Him, S; Nouhin, J; Hak, C; Srun, C; Viretto, G; Ouk, V; Delfraissy, JF; Segeral, O				Barennes, Hubert; Guillet, Stephanie; Limsreng, Setha; Him, Sovanvatey; Nouhin, Janin; Hak, Chanroeurn; Srun, Chanvatey; Viretto, Gerald; Ouk, Vara; Delfraissy, Jean Francois; Segeral, Olivier			Virological Failure and HIV-1 Drug Resistance Mutations among Naive and Antiretroviral Pre-Treated Patients Entering the ESTHER Program of Calmette Hospital in Cambodia	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; SUB-SAHARAN AFRICA; FOLLOW-UP; THERAPY; EMERGENCE; OUTCOMES; CHILDREN; IMPACT; HAART; RATES	Introduction: In resource limited settings, patients entering an antiretroviral therapy (ART) program comprise ART naive and ART pre-treated patients who may show differential virological outcomes. Methods: This retrospective study, conducted in 2010-2012 in the HIV clinic of Calmette Hospital located in Phnom Penh (Cambodia) assessed virological failure (VF) rates and patterns of drug resistance of naive and pre-treated patients. Naive and ART pre-treated patients were included when a Viral Load (VL) was performed during the first year of ART for naive subjects or at the first consultation for pre-treated individuals. Patients showing Virological failure (VF) (>1,000 copies/ml) underwent HIV DR genotyping testing. Interpretation of drug resistance mutations was done according to 2013 version 23 ANRS algorithms. Results: On a total of 209 patients, 164 (78.4%) were naive and 45 (21.5%) were ART pre-treated. Their median initial CD4 counts were 74 cells/mm(3) (IQR: 30-194) and 279 cells/mm(3) (IQR: 103-455) (p<0.001), respectively. Twenty seven patients (12.9%) exhibited VF (95% CI: 8.6-18.2%), including 10 naive (10/164, 6.0%) and 17 pre-treated (17/45, 37.8%) patients (p<0.001). Among these viremic patients, twenty-two (81.4%) were sequenced in reverse transcriptase and protease coding regions. Overall, 19 (86.3%) harbored >= 1 drug resistance mutations (DRMs) whereas 3 (all belonging to pre-treated patients) harbored wild-types viruses. The most frequent DRMs were M184V (86.3%), K103N (45.5%) and thymidine analog mutations (TAMs) (40.9%). Two (13.3%) pre-treated patients harbored viruses that showed a multi-nucleos(t)ide resistance including Q151M, K65R, E33A/D, E44A/D mutations. Conclusion: In Cambodia, VF rates were low for naive patients but the emergence of DRMs to NNRTI and 3TC occurred relatively quickly in this subgroup. In pre-treated patients, VF rates were much higher and TAMs were relatively common. HIV genotypic assays before ART initiation and for ART pre-treated patients infection should be considered as well.	[Barennes, Hubert; Guillet, Stephanie] Agence Natl Rech VIH & Hepatites ANRS, Phnom Penh, Cambodia; [Barennes, Hubert] Univ Bordeaux, Ctr INSERM, ISPED, Epidemiol Biostat U897, Bordeaux, France; [Barennes, Hubert] Inst Pasteur, Epidemiol Unit, Phnom Penh, Cambodia; [Guillet, Stephanie; Delfraissy, Jean Francois; Segeral, Olivier] Ctr Hosp Univ Bicetre, AP HP, Dept Med Interne & Immunol Clin, Le Kremlin Bicetre, France; [Limsreng, Setha; Him, Sovanvatey; Hak, Chanroeurn; Srun, Chanvatey; Ouk, Vara] Hosp Calmette, Phnom Penh, Cambodia; [Him, Sovanvatey; Hak, Chanroeurn; Viretto, Gerald; Ouk, Vara; Delfraissy, Jean Francois; Segeral, Olivier] ESTHER, Phnom Penh, Cambodia; [Nouhin, Janin] Inst Pasteur, HIV Hepatitis Unit, Phnom Penh, Cambodia; [Nouhin, Janin] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; UDICE-French Research Universities; Universite Paris Cite	Barennes, H (corresponding author), Agence Natl Rech VIH & Hepatites ANRS, Phnom Penh, Cambodia.	barenneshub@yahoo.fr	Nouhin, Janin/AAS-6946-2020; Nouhin, Janin/AAM-2322-2021	Nouhin, Janin/0000-0003-4985-8377; Nouhin, Janin/0000-0003-4985-8377	Esther French program; ANRS	Esther French program; ANRS(ANRSFrench National Research Agency (ANR))	Funds to allow the follow up of patients were granted by Esther French program. SG received a 6 months scholarship from ANRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghokeng AF, 2014, CLIN INFECT DIS, V58, P99, DOI 10.1093/cid/cit627; ANRS-AC 11 Resistance Group, 2007, ANRS AC 11 GEN INT N; Arnedo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047391; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Cambodia Ethical Comitee, 2011, CAMB ETH GUID HLTH R; Chetchotisakd Ploenchan, 2006, J Int Assoc Physicians AIDS Care (Chic), V5, P152, DOI 10.1177/1545109706294288; Coetzer M, 2013, AIDS RES HUM RETROV, V29, P985, DOI [10.1089/aid.2013.0025, 10.1089/AID.2013.0025]; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Ferradini L, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-14; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Isaakidis P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-11; Janin N, 2009, AIDS RES HUM RETROV, V25, P543, DOI 10.1089/aid.2008.0305; Janssens B, 2007, PEDIATRICS, V120, pE1134, DOI 10.1542/peds.2006-3503; NCHADS, 2013, NCHADS 3QUATERLY REP, P1; NCHADS, 2013, 4 Q REP 2012 NCHADS; NCHADS, 2012, CONC FRAM EL NEW HIV, P1; NCHADS, 2012, NAT GUID US ANT THER; NCHADS Chhea Chhorvann Saphonn Vonthanak, 2011, ESTIMATIONS PROJECTI, P1; Nerrienet E, 2012, J AIDS CLIN RES; Ngo-Giang-Huong N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027427; Nouhin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073744; Pujades-Rodriguez M, 2011, TROP MED INT HEALTH, V16, P205, DOI 10.1111/j.1365-3156.2010.02689.x; Ruel TD, 2011, JAIDS-J ACQ IMM DEF, V56, P44, DOI 10.1097/QAI.0b013e3181fbcbf7; Segeral O, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/142076; Segeral O, 2011, AIDS RES HUM RETROV, V27, P597, DOI [10.1089/AID.2010.0125, 10.1089/aid.2010.0125]; Stadeli KM, 2013, ANTIVIR THER, V18, P115, DOI 10.3851/IMP2437; Stricker SM, 2014, AIDS BEHAV, V18, pS465, DOI 10.1007/s10461-013-0598-6; Sungkanuparph S, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-12; van Oosterhout JJG, 2009, TROP MED INT HEALTH, V14, P856, DOI 10.1111/j.1365-3156.2009.02309.x; Westley BP, 2012, CLIN INFECT DIS, V55, P432, DOI 10.1093/cid/cis433; WHO, 2010, ANT THER HIV INF AD; WHO, 2010, ANT THER HIV INF CHI; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; World Health Organisation, 2021, CONSOLIDATED GUIDELI; World Health Organization, 2009, RAP ADV ANT THER HIV; Zolfo M, 2011, AIDS RES HUM RETROV, V27, P727, DOI [10.1089/aid.2010.0037, 10.1089/AID.2010.0037]	37	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105736	10.1371/journal.pone.0105736	http://dx.doi.org/10.1371/journal.pone.0105736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166019	Green Published, gold			2022-12-25	WOS:000341303700041
J	Gabanti, E; Bruno, F; Lilleri, D; Fornara, C; Zelini, P; Cane, I; Migotto, C; Sarchi, E; Furione, M; Gerna, G				Gabanti, Elisa; Bruno, Francesca; Lilleri, Daniele; Fornara, Chiara; Zelini, Paola; Cane, Ilaria; Migotto, Clara; Sarchi, Eleonora; Furione, Milena; Gerna, Giuseppe			Human Cytomegalovirus (HCMV)-Specific CD4(+) and CD8(+) T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-Organ Transplant Recipients	PLOS ONE			English	Article							LONG-TERM DEPLETION; PREEMPTIVE THERAPY; IMMUNE-RESPONSES; CMV INFECTION; HIGH-RISK; KIDNEY; HEART; LYMPHOCYTES; PERSISTENT; INFLATION	In solid-organ transplant recipients (SOTR) the protective role of human cytomegalovirus (HCMV)-specific CD4(+), CD8(+) and gamma delta T-cells vs. HCMV reactivation requires better definition. The aim of this study was to investigate the relevant role of HCMV-specific CD4(+), CD8(+) and gamma delta T-cells in different clinical presentations during the post-transplant period. Thirty-nine SOTR underwent virologic and immunologic follow-up for about 1 year after transplantation. Viral load was determined by real-time PCR, while immunologic monitoring was performed by measuring HCMV-specific CD4(+) and CD8(+) T cells (following stimulation with autologous HCMV-infected dendritic cells) and gamma delta T-cells by flow cytometry. Seven patients had no infection and 14 had a controlled infection, while both groups maintained CD4(+) T-cell numbers above the established cutoff (0.4 cell/mu L blood). Of the remaining patients, 9 controlled the infection temporarily in the presence of HCMV-specific CD8(+) only, until CD4(+) T-cell appearance; while 9 had to be treated preemptively due to a viral load greater than the established cut-off (3 x 10(5) DNA copies/mL blood) in the absence of specific CD4(+) T-cells. Polyfunctional CD8(+) T-cells as well as V delta 2(-) gamma delta T-cells were not associated with control of infection. In conclusion, in the absence of HCMV-specific CD4(+) T-cells, no long-term protection is conferred to SOTR by either HCMV-specific CD8(+) T-cells alone or V delta 2(-) gamma delta T-cell expansion.	[Gabanti, Elisa; Bruno, Francesca; Lilleri, Daniele; Fornara, Chiara; Zelini, Paola; Cane, Ilaria; Gerna, Giuseppe] Fdn IRCCS Policlin San Matteo, Lab Sperimentali Ric, Pavia, Italy; [Migotto, Clara] Fdn IRCCS Policlin San Matteo, Div Nefrol, Pavia, Italy; [Sarchi, Eleonora] Fdn IRCCS Policlin San Matteo, Div Cardiochirurg, Pavia, Italy; [Furione, Milena] Fdn IRCCS Policlin San Matteo, Pavia, Italy	IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo	Gerna, G (corresponding author), Fdn IRCCS Policlin San Matteo, Lab Sperimentali Ric, Pavia, Italy.	g.gerna@smatteo.pv.it	Lilleri, Daniele/K-7776-2016; Fornara, Chiara/Z-3464-2019; Gabanti, Elisa/Q-2729-2019; Zelini, Paola/Z-2975-2019; Furione, Milena/AAC-1945-2022	Lilleri, Daniele/0000-0001-7747-7622; Fornara, Chiara/0000-0002-8589-2647; Zelini, Paola/0000-0002-4913-0012; Gerna, Giuseppe/0000-0001-5956-2786; Milena, Furione/0000-0001-7328-1454; Gabanti, Elisa/0000-0003-4865-4006	Fondazione Carlo Denegri, Torino, Italy; Ricerca Finalizzata, Ministero della Salute, Rome, Italy [GR-2010-2311329]	Fondazione Carlo Denegri, Torino, Italy; Ricerca Finalizzata, Ministero della Salute, Rome, Italy	This work was supported by grants from the Fondazione Carlo Denegri, Torino, Italy, and Ricerca Finalizzata, Ministero della Salute, Rome, Italy (GR-2010-2311329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BenMarzouk-Hidalgo OJ, 2011, TRANSPLANTATION, V91, P927, DOI 10.1097/TP.0b013e3182115ba2; BORYSIEWICZ LK, 1983, EUR J IMMUNOL, V13, P804, DOI 10.1002/eji.1830131005; Bunde T, 2005, J EXP MED, V201, P1031, DOI 10.1084/jem.20042384; Calarota SA, 2012, TRANSPLANTATION, V93, P112, DOI 10.1097/TP.0b013e318239e90c; Dechanet J, 1999, J CLIN INVEST, V103, P1437, DOI 10.1172/JCI5409; Einsele H, 2002, BLOOD, V99, P3916, DOI 10.1182/blood.V99.11.3916; Fornara C, 2011, J CLIN IMMUNOL, V31, P1054, DOI 10.1007/s10875-011-9577-8; Furione M, 2012, J CLIN VIROL, V55, P317, DOI 10.1016/j.jcv.2012.08.017; Gamadia LE, 2003, BLOOD, V101, P2686, DOI 10.1182/blood-2002-08-2502; Genini E, 2011, J CLIN VIROL, V52, P113, DOI 10.1016/j.jcv.2011.06.018; Gerna G, 2006, AM J TRANSPLANT, V6, P2356, DOI 10.1111/j.1600-6143.2006.01488.x; Gerna G, 2011, AM J TRANSPLANT, V11, P2463, DOI 10.1111/j.1600-6143.2011.03636.x; Gerna G, 2006, J MED VIROL, V78, P408, DOI 10.1002/jmv.20555; Gerna G, 2008, J GEN VIROL, V89, P853, DOI 10.1099/vir.0.83523-0; Gerna G, 2007, ANTIVIR THER, V12, P63; Gerna G, 2012, NEW MICROBIOL, V35, P279; Halary F, 2005, J EXP MED, V201, P1567, DOI 10.1084/jem.20041851; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Hill JA, 2007, TRANSPLANTATION, V84, P1436, DOI 10.1097/01.tp.0000290686.68910.bd; Humphreys IR, 2007, J IMMUNOL, V179, P2195, DOI 10.4049/jimmunol.179.4.2195; JONJIC S, 1990, J VIROL, V64, P5457; JONJIC S, 1989, J EXP MED, V169, P1199, DOI 10.1084/jem.169.4.1199; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Kumar D, 2009, AM J TRANSPLANT, V9, P1214, DOI 10.1111/j.1600-6143.2009.02618.x; La Rosa C, 2007, J INFECT DIS, V195, P633, DOI 10.1086/511307; Lafarge X, 2001, J INFECT DIS, V184, P533, DOI 10.1086/322843; Lifferi D, 2009, CLIN IMMUNOL, V131, P395; Lilleri D, 2007, AM J TRANSPLANT, V7, P1997, DOI 10.1111/j.1600-6143.2007.01890.x; Lilleri D, 2004, J MED VIROL, V73, P412, DOI 10.1002/jmv.20107; Lilleri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059863; Lozza L, 2005, EUR J IMMUNOL, V35, P1795, DOI 10.1002/eji.200526023; Mattes FM, 2008, AM J TRANSPLANT, V8, P990, DOI 10.1111/j.1600-6143.2008.02191.x; MCLAUGHLINTAYLOR E, 1994, J MED VIROL, V43, P103, DOI 10.1002/jmv.1890430119; Pape L, 2010, AM J TRANSPLANT, V10, P2349, DOI 10.1111/j.1600-6143.2010.03266.x; Pitard V, 2008, BLOOD, V112, P1317, DOI 10.1182/blood-2008-01-136713; Sacre K, 2008, J VIROL, V82, P10143, DOI 10.1128/JVI.00688-08; Sester M, 2001, TRANSPLANTATION, V71, P1287, DOI 10.1097/00007890-200105150-00018; Sester U, 2005, AM J TRANSPLANT, V5, P1483, DOI 10.1111/j.1600-6143.2005.00871.x; Snyder CM, 2009, J IMMUNOL, V183, P3932, DOI 10.4049/jimmunol.0900227; Tu WW, 2004, J IMMUNOL, V172, P3260, DOI 10.4049/jimmunol.172.5.3260; Walker S, 2007, TRANSPL INFECT DIS, V9, P165, DOI 10.1111/j.1399-3062.2006.00199.x; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Walton SM, 2011, EUR J IMMUNOL, V41, P2248, DOI 10.1002/eji.201141575; Zelini P, 2010, CLIN IMMUNOL, V136, P269, DOI 10.1016/j.clim.2010.04.008	44	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106044	10.1371/journal.pone.0106044	http://dx.doi.org/10.1371/journal.pone.0106044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166270	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303700065
J	Stanley, D; Wu, SB; Rodgers, N; Swick, RA; Moore, RJ				Stanley, Dragana; Wu, Shu-Biao; Rodgers, Nicholas; Swick, Robert A.; Moore, Robert J.			Differential Responses of Cecal Microbiota to Fishmeal, Eimeria and Clostridium perfringens in a Necrotic Enteritis Challenge Model in Chickens	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; BUTYRIC-ACID; INFECTION	Clostridium perfringens causes enteric diseases in animals and humans. In poultry, avian-specific C. perfringens strains cause necrotic enteritis, an economically significant poultry disease that costs the global industry over $2 billion annually in losses and control measures. With removal of antibiotic growth promoters in some countries this disease appears to be on the rise. In experimental conditions used to study disease pathogenesis and potential control measures, reproduction of the disease relies on the use of predisposing factors such as Eimeria infection and the use of high protein diets, indicating complex mechanisms involved in the onset of necrotic enteritis. The mechanisms by which the predisposing factors contribute to disease progression are not well understood but it has been suggested that they may cause perturbations in the microbiota within the gastrointestinal tract. We inspected changes in cecal microbiota and short chain fatty acids (SCFA) induced by Eimeria and fishmeal, in birds challenged or not challenged with C. perfringens. C. perfringens challenge in the absence of predisposing factors did not cause significant changes in either the alpha or beta diversity of the microbiota nor in concentrations of SCFA. Moreover, there was no C. perfringens detected in the cecal microbiota 2 days post-challenge without the presence of predisposing factors. In contrast, both fishmeal and Eimeria caused significant changes in microbiota, seen in both alpha and beta diversity and also enabled C. perfringens to establish itself post challenge. Eimeria had its strongest influence on intestinal microbiota and SCFA when combined with fishmeal. Out of 6 SCFAs measured, including butyric acid, none were significantly influenced by C. perfringens, but their levels were strongly modified following the use of both predisposing factors. There was little overlap in the changes caused following Eimeria and fishmeal treatments, possibly indicating multiple routes for progressing towards clinical symptoms of necrotic enteritis.	[Stanley, Dragana] Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld 4702, Australia; [Stanley, Dragana; Moore, Robert J.] Australian Anim Hlth Lab, CSIRO Biosecur Flagship, Geelong, Vic, Australia; [Stanley, Dragana; Wu, Shu-Biao; Rodgers, Nicholas; Swick, Robert A.; Moore, Robert J.] Univ New England, Poultry Cooperat Res Ctr, Armidale, NSW, Australia; [Wu, Shu-Biao; Rodgers, Nicholas; Swick, Robert A.] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia	Central Queensland University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of New England; University of New England	Moore, RJ (corresponding author), Australian Anim Hlth Lab, CSIRO Biosecur Flagship, Geelong, Vic, Australia.	Rob.Moore@csiro.au	Moore, Robert J/D-8352-2011; Stanley, Dragana/AAC-2596-2020; Wu, Shu-Biao/R-5951-2019	Moore, Robert J/0000-0002-0776-5861; Stanley, Dragana/0000-0001-7019-4726; Wu, Shu-Biao/0000-0002-1790-6015; Swick, Robert/0000-0003-3376-1677	Australian Government's Cooperative Research Centres Program [2.1.5]	Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research was conducted within the Poultry CRC, established and supported under the Australian Government's Cooperative Research Centres Program, Contract 2.1.5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1986, BERGEYS MANUAL SYSTE; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chessel D., 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jerzsele A, 2012, POULTRY SCI, V91, P837, DOI 10.3382/ps.2011-01853; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Legendre L., 1987, DEV NUMERICAL ECOLOG, P139; Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Mishiro T, 2013, LAB INVEST, V93, P834, DOI 10.1038/labinvest.2013.70; PARISH WE, 1961, J COMP PATHOL THERAP, V71, P377, DOI 10.1016/S0368-1742(61)80043-X; PRESCOTT JF, 1979, AVIAN DIS, V23, P1072, DOI 10.2307/1589625; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Shojadoost B, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-74; Sluis W. van der, 2000, World Poultry, V16, P42; Snell-Castro R, 2005, FEMS MICROBIOL ECOL, V52, P229, DOI 10.1016/j.femsec.2004.11.016; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; Stanley D, 2012, VET MICROBIOL, V159, P155, DOI 10.1016/j.vetmic.2012.03.032; Talham GL, 1999, INFECT IMMUN, V67, P1992; Thompson CL, 2013, MUCOSAL IMMUNOL, V6, P200, DOI 10.1038/mi.2012.91; Timbermont L, 2010, AVIAN PATHOL, V39, P117, DOI 10.1080/03079451003610586; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; Van Immerseel F, 2009, TRENDS MICROBIOL, V17, P32, DOI 10.1016/j.tim.2008.09.005; Wang W, 2014, J CLIN MICROBIOL, V52, P398, DOI 10.1128/JCM.01500-13; Wu SB, 2014, VET MICROBIOL, V169, P188, DOI 10.1016/j.vetmic.2014.01.007; Wu SB, 2011, APPL ENVIRON MICROB, V77, P1135, DOI 10.1128/AEM.01803-10; Wu SB, 2010, AVIAN DIS, V54, P1058, DOI 10.1637/9338-032910-Reg.1	32	107	110	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e104739	10.1371/journal.pone.0104739	http://dx.doi.org/10.1371/journal.pone.0104739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25167074	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303700013
J	El Magraoui, F; Schrotter, A; Brinkmeier, R; Kunst, L; Mastalski, T; Muller, T; Marcus, K; Meyer, HE; Girzalsky, W; Erdmann, R; Platta, HW				El Magraoui, Fouzi; Schroetter, Andreas; Brinkmeier, Rebecca; Kunst, Lena; Mastalski, Thomas; Mueller, Thorsten; Marcus, Katrin; Meyer, Helmut E.; Girzalsky, Wolfgang; Erdmann, Ralf; Platta, Harald W.			The Cytosolic Domain of Pex22p Stimulates the Pex4p-Dependent Ubiquitination of the PTS1-Receptor	PLOS ONE			English	Article							PEROXISOMAL IMPORT RECEPTOR; MATRIX PROTEIN IMPORT; SIGNAL TYPE-1 RECEPTOR; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEINS; BIOGENESIS DISORDERS; CONJUGATING ENZYMES; MOLECULAR-BASIS; PEX5P; DEGRADATION	Peroxisomal biogenesis is an ubiquitin-dependent process because the receptors required for the import of peroxisomal matrix proteins are controlled via their ubiquitination status. A key step is the monoubiquitination of the import receptor Pex5p by the ubiquitin-conjugating enzyme (E2) Pex4p. This monoubiquitination is supposed to take place after Pex5p has released the cargo into the peroxisomal matrix and primes Pex5p for the extraction from the membrane by the mechano-enzymes Pex1p/Pex6p. These two AAA-type ATPases export Pex5p back to the cytosol for further rounds of matrix protein import. Recently, it has been reported that the soluble Pex4p requires the interaction to its peroxisomal membrane-anchor Pex22p to display full activity. Here we demonstrate that the soluble C-terminal domain of Pex22p harbours its biological activity and that this activity is independent from its function as membrane-anchor of Pex4p. We show that Pex4p can be functionally fused to the trans-membrane segment of the membrane protein Pex3p, which is not directly involved in Pex5-ubiquitination and matrix protein import. However, this Pex3(N)-Pex4p chimera can only complement the double-deletion strain pex4 Delta/pex22 Delta and ensure optimal Pex5p-ubiquitination when the C-terminal part of Pex22p is additionally expressed in the cell. Thus, while the membrane-bound portion Pex22(N) p is not required when Pex4p is fused to Pex3(N) p, the soluble Pex22(C) p is essential for peroxisomal biogenesis and efficient monoubiquitination of the import receptor Pex5p by the E3-ligase Pex12p in vivo and in vitro. The results merge into a picture of an ubiquitin-conjugating complex at the peroxisomal membrane consisting of three domains: the ubiquitin-conjugating domain (Pex4p), a membrane-anchor domain (Pex22(N) p) and an enhancing domain (Pex22(C) p), with the membrane-anchor domain being mutually exchangeable, while the Ubc- and enhancer-domains are essential.	[El Magraoui, Fouzi; Brinkmeier, Rebecca; Kunst, Lena; Girzalsky, Wolfgang; Erdmann, Ralf; Platta, Harald W.] Ruhr Univ Bochum, Bochum, Germany; [Schroetter, Andreas; Mastalski, Thomas] Med Proteom Ctr, AG Neuro Prote, Bochum, Germany; [Mueller, Thorsten; Marcus, Katrin] Med Proteom Ctr, Bochum, Germany; [El Magraoui, Fouzi; Schroetter, Andreas; Meyer, Helmut E.] Leibniz Inst Analyt Wissensch ISAS eV, Dortmund, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS)	Erdmann, R (corresponding author), Ruhr Univ Bochum, Univ Str 150, Bochum, Germany.	Ralf.Erdmann@rub.de; Harald.Platta@rub.de	Müller, Thorsten/AAX-1652-2021; Platta, Harald Wolfgang/G-7423-2014	Platta, Harald Wolfgang/0000-0001-8968-7280	DFG Forschergruppe [FOR1905]	DFG Forschergruppe(German Research Foundation (DFG))	This work was supported by DFG Forschergruppe FOR1905 "PerTrans" TP1 (RE) and TP4 (HWP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Bazirgan OA, 2008, J BIOL CHEM, V283, P12797, DOI 10.1074/jbc.M801122200; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Bolte K, 2011, BIOESSAYS, V33, P368, DOI 10.1002/bies.201100007; Brown AI, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003426; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; El Magraoui F, 2013, TRAFFIC, V14, P1290, DOI 10.1111/tra.12120; El Magraoui F, 2012, FEBS J, V279, P2060, DOI 10.1111/j.1742-4658.2012.08591.x; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Gabaldon T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-8; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; Girzalsky W, 2006, J BIOL CHEM, V281, P19417, DOI 10.1074/jbc.M603344200; Girzalsky W, 2009, BIOL CHEM, V390, P745, DOI 10.1515/BC.2009.104; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Halbach A, 2009, J BIOL CHEM, V284, P3906, DOI 10.1074/jbc.M806950200; Hasan S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00261; Hensel A, 2011, J BIOL CHEM, V286, P43495, DOI 10.1074/jbc.M111.286104; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Islinger M, 2012, HISTOCHEM CELL BIOL, V137, P547, DOI 10.1007/s00418-012-0941-4; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Knoblach B, 2013, EMBO J, V32, P2439, DOI 10.1038/emboj.2013.170; Koeliensperger G, 2007, BIOL CHEM, V388, P1209, DOI 10.1515/BC.2007.125; Koller A, 1999, J CELL BIOL, V146, P99, DOI 10.1083/jcb.146.1.99; Kostova Z, 2009, J CELL SCI, V122, P1374, DOI 10.1242/jcs.044255; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Liu XQ, 2013, J BIOL CHEM, V288, P7230, DOI 10.1074/jbc.M112.424911; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Metzger MB, 2013, MOL CELL, V50, P516, DOI 10.1016/j.molcel.2013.04.004; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Munck JM, 2009, J CELL BIOL, V187, P463, DOI 10.1083/jcb.200906161; Nagotu S, 2012, BBA-MOL BASIS DIS, V1822, P1326, DOI 10.1016/j.bbadis.2012.05.010; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2014, BIOCHIMIE, V98, P16, DOI 10.1016/j.biochi.2013.12.009; Platta HW, 2013, CELL MOL LIFE SCI, V70, P1393, DOI 10.1007/s00018-012-1136-9; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Platta HW, 2014, RECEPTOR CLIN INVEST, V1, P55; Poll-The BT, 2012, BBA-MOL BASIS DIS, V1822, P1421, DOI 10.1016/j.bbadis.2012.03.011; Ratzel SE, 2011, TRAFFIC, V12, P121, DOI 10.1111/j.1600-0854.2010.01136.x; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Schliebs W, 2010, NAT REV MOL CELL BIO, V11, P885, DOI 10.1038/nrm3008; Schluter A, 2010, NUCLEIC ACIDS RES, V38, pD800, DOI 10.1093/nar/gkp935; Schroetter A, 2012, MOL CELL PROTEOMICS, V11, P1274, DOI 10.1074/mcp.M112.019364; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Waterham HR, 2012, BBA-MOL BASIS DIS, V1822, P1430, DOI 10.1016/j.bbadis.2012.04.006; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Williams C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02212; Williams C, 2012, EMBO J, V31, P391, DOI 10.1038/emboj.2011.411; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691	60	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105894	10.1371/journal.pone.0105894	http://dx.doi.org/10.1371/journal.pone.0105894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162638	gold, Green Published, Green Submitted			2022-12-25	WOS:000340880900060
J	Gonzalez-Ortiz, V; Egea, LG; Jimenez-Ramos, R; Moreno-Marin, F; Perez-Llorens, JL; Bouma, TJ; Brun, FG				Gonzalez-Ortiz, Vanessa; Egea, Luis G.; Jimenez-Ramos, Rocio; Moreno-Marin, Francisco; Perez-Llorens, Jose L.; Bouma, Tjeed J.; Brun, Fernando G.			Interactions between Seagrass Complexity, Hydrodynamic Flow and Biomixing Alter Food Availability for Associated Filter-Feeding Organisms	PLOS ONE			English	Article							MYTILUS-EDULIS-L; COCKLES CERASTODERMA-EDULE; BENTHIC SUSPENSION-FEEDERS; JUVENILE BAY SCALLOPS; FILTRATION-RATE; WATER-FLOW; POSITIVE INTERACTIONS; POSIDONIA-OCEANICA; CANOPY STRUCTURE; CURRENT VELOCITY	Seagrass shoots interact with hydrodynamic forces and thereby a positively or negatively influence the survival of associated species. The modification of these forces indirectly alters the physical transport and flux of edible particles within seagrass meadows, which will influence the growth and survivorship of associated filter-feeding organisms. The present work contributes to gaining insight into the mechanisms controlling the availability of resources for filter feeders inhabiting seagrass canopies, both from physical (influenced by seagrass density and patchiness) and biological (regulated by filter feeder density) perspectives. A factorial experiment was conducted in a large racetrack flume, which combined changes in hydrodynamic conditions, chlorophyll a concentration in the water and food intake rate (FIR) in a model active filter-feeding organism (the cockle). Results showed that seagrass density and patchiness modified both hydrodynamic forces and availability of resources for filter feeders. Chlorophyll a water content decreased to 50% of the initial value when densities of both seagrass shoots and cockles were high. Also, filter feeder density controlled resource availability within seagrass patches, depending on its spatial position within the racetrack flume. Under high density of filter-feeding organisms, chlorophyll a levels were lower between patches. This suggests that the pumping activity of cockles (i. e. biomixing) is an emergent key factor affecting both resource availability and FIR for filter feeders in dense canopies. Applying our results to natural conditions, we suggest the existence of a direct correlation between habitat complexity (i. e. shoot density and degree of patchiness) and filter feeders density. Fragmented and low-density patches seem to offer both greater protection from hydrodynamic forces and higher resource availability. In denser patches, however, resources are allocated mostly within the canopy, which would benefit filter feeders if they occurred at low densities, but would be limiting when filter feeder were at high densities.	[Gonzalez-Ortiz, Vanessa; Egea, Luis G.; Jimenez-Ramos, Rocio; Moreno-Marin, Francisco; Perez-Llorens, Jose L.; Brun, Fernando G.] Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Cadiz, Spain; [Bouma, Tjeed J.] Netherlands Inst Sea Res, Dept Spatial Ecol, Yerseke, Netherlands	Universidad de Cadiz; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Brun, FG (corresponding author), Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Cadiz, Spain.	fernando.brun@uca.es	Egea, Luis G./AAT-7290-2020; Jiménez-Ramos, Rocío/AAT-8081-2020; Brun, Fernando G. G/L-1346-2014; Perez-Llorens, Jose Lucas/B-9361-2009; Perez-Llorens, Jose Lucas/AAD-7078-2020; Perez-Llorens, Jose Lucas/GQR-0711-2022	Egea, Luis G./0000-0002-2233-3426; Jiménez-Ramos, Rocío/0000-0003-1705-1149; Brun, Fernando G. G/0000-0002-6313-9531; Perez-Llorens, Jose Lucas/0000-0003-2813-1443; Perez-Llorens, Jose Lucas/0000-0003-2813-1443; Perez-Llorens, Jose Lucas/0000-0003-2813-1443; Bouma, Tjeerd/0000-0001-7824-7546	Junta de Andalucia Excellence Project PAMBIO [P08-RNM-03783]; Spanish Project Sea-Live from the Spanish Ministry of Science and Innovation [CTM2011-24482]; Junta de Andalucia	Junta de Andalucia Excellence Project PAMBIO(Junta de Andalucia); Spanish Project Sea-Live from the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Junta de Andalucia(Junta de Andalucia)	This work was supported by the Junta de Andalucia Excellence Project PAMBIO (P08-RNM-03783) and by the Spanish Project Sea-Live (CTM2011-24482) from the Spanish Ministry of Science and Innovation. Gonzalez-Ortiz V. holds a regional fellowship from the Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BJ, 2003, MAR ECOL PROG SER, V254, P57, DOI 10.3354/meps254057; ANDRE C, 1993, MAR ECOL PROG SER, V97, P183, DOI 10.3354/meps097183; Arkema KK, 2009, MAR ECOL PROG SER, V388, P207, DOI 10.3354/meps08140; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bouma TJ, 2005, ECOLOGY, V86, P2187, DOI 10.1890/04-1588; Bouma TJ, 2005, HYDROBIOLOGIA, V540, P259, DOI 10.1007/s10750-004-7149-0; Brun FG, 2009, HELGOLAND MAR RES, V63, P19, DOI 10.1007/s10152-008-0134-7; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; BUTMAN CA, 1994, LIMNOL OCEANOGR, V39, P1755, DOI 10.4319/lo.1994.39.7.1755; CAHALAN JA, 1989, J EXP MAR BIOL ECOL, V129, P45, DOI 10.1016/0022-0981(89)90062-2; Carroll JM, 2013, LANDSCAPE ECOL, V28, P1401, DOI 10.1007/s10980-013-9893-x; Christianen MJA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062413; Dang C, 2010, J SEA RES, V63, P108, DOI 10.1016/j.seares.2009.11.003; Danovaro R, 1997, ESTUAR COAST SHELF S, V44, P723, DOI 10.1006/ecss.1996.0135; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; Folkard AM, 2005, LIMNOL OCEANOGR, V50, P1592, DOI 10.4319/lo.2005.50.5.1592; FONSECA MS, 1986, MAR ECOL PROG SER, V29, P15, DOI 10.3354/meps029015; FONSECA MS, 1992, ESTUAR COAST SHELF S, V35, P565, DOI 10.1016/S0272-7714(05)80039-3; FOSTERSMITH RL, 1975, J EXP MAR BIOL ECOL, V17, P1, DOI 10.1016/0022-0981(75)90075-1; FRECHETTE M, 1989, LIMNOL OCEANOGR, V34, P19, DOI 10.4319/lo.1989.34.1.0019; FRECHETTE M, 1985, CAN J FISH AQUAT SCI, V42, P1166, DOI 10.1139/f85-144; GAMBI MC, 1990, MAR ECOL PROG SER, V61, P159, DOI 10.3354/meps061159; Gonzalez-Ortiz V, 2014, ESTUAR COAST SHELF S, V139, P20, DOI 10.1016/j.ecss.2013.12.015; GRIZZLE RE, 1992, J EXP MAR BIOL ECOL, V162, P213, DOI 10.1016/0022-0981(92)90202-L; Hendriks IE, 2008, MAR ECOL PROG SER, V356, P163, DOI 10.3354/meps07316; IGLESIAS JIP, 1992, J EXP MAR BIOL ECOL, V162, P177, DOI 10.1016/0022-0981(92)90200-T; Irlandi EA, 1996, J MAR RES, V54, P161, DOI 10.1357/0022240963213439; IRLANDI EA, 1991, OECOLOGIA, V87, P307, DOI 10.1007/BF00634584; Irlandi EA, 1999, J EXP MAR BIOL ECOL, V235, P21, DOI 10.1016/S0022-0981(98)00185-3; Jones CG, 2010, OIKOS, V119, P1862, DOI 10.1111/j.1600-0706.2010.18782.x; Jonsson PR, 2006, AQUAT ECOL, V40, P409, DOI 10.1007/s10452-006-9049-z; Jonsson PR, 2005, LIMNOL OCEANOGR, V50, P1989, DOI 10.4319/lo.2005.50.6.1989; Jorgensen C.B., 1990, BIVALVE FILTER FEEDI; Jorgensen CB, 1996, MAR ECOL PROG SER, V142, P287, DOI 10.3354/meps142287; JUDGE ML, 1993, MAR ECOL PROG SER, V92, P141, DOI 10.3354/meps092141; Kater BJ, 2006, MAR ECOL PROG SER, V318, P221, DOI 10.3354/meps318221; Koch EW, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P193; Lassen J, 2006, MAR ECOL PROG SER, V314, P77, DOI 10.3354/meps314077; Macreadie PI, 2010, ECOLOGY, V91, P2013, DOI 10.1890/08-1890.1; Macreadie PI, 2010, MAR FRESHWATER RES, V61, P214, DOI 10.1071/MF09072; Morris EP, 2008, LIMNOL OCEANOGR, V53, P1531, DOI 10.4319/lo.2008.53.4.1531; MUSCHENHEIM DK, 1987, J MAR RES, V45, P473, DOI 10.1357/002224087788401098; OLAFSSON EB, 1989, MAR ECOL PROG SER, V55, P171, DOI 10.3354/meps055171; Peralta G, 2008, MAR ECOL PROG SER, V368, P103, DOI 10.3354/meps07574; Peterson BJ, 2001, MAR ECOL PROG SER, V213, P143, DOI 10.3354/meps213143; Plew DR, 2009, AQUACULT ENG, V40, P55, DOI 10.1016/j.aquaeng.2008.12.003; Reusch TBH, 1999, OIKOS, V84, P398, DOI 10.2307/3546420; Ries L, 2004, ECOLOGY, V85, P2917, DOI 10.1890/03-8021; Riisgard HU, 2007, MAR ECOL PROG SER, V343, P141, DOI 10.3354/meps06930; Riisgard HU, 2003, J EXP MAR BIOL ECOL, V284, P105, DOI 10.1016/S0022-0981(02)00496-3; Riisgard HU, 1998, J ENVIRON MANAGE, V53, P195, DOI 10.1006/jema.1998.0205; Ritchie RJ, 2008, PHOTOSYNTHETICA, V46, P115, DOI 10.1007/s11099-008-0019-7; Sobral P, 2000, J EXP MAR BIOL ECOL, V245, P111, DOI 10.1016/S0022-0981(99)00154-9; Tsai CC, 2010, MAR BIOL, V157, P1929, DOI 10.1007/s00227-010-1462-0; van Duren LA, 2006, J SEA RES, V55, P3, DOI 10.1016/j.seares.2005.08.001; Widdows J, 2002, HELGOLAND MAR RES, V56, P3, DOI 10.1007/s10152-001-0100-0; Widdows J, 2002, J SEA RES, V48, P143, DOI 10.1016/S1385-1101(02)00148-X; Wildish D., 2005, BENTHIC SUSPENSION F; WILDISH DJ, 1990, J EXP MAR BIOL ECOL, V142, P213, DOI 10.1016/0022-0981(90)90092-Q; WILDISH DJ, 1993, J EXP MAR BIOL ECOL, V174, P65, DOI 10.1016/0022-0981(93)90251-I; Wilson DM, 1991, EFFECT SUBMERGED VEG	61	38	38	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e104949	10.1371/journal.pone.0104949	http://dx.doi.org/10.1371/journal.pone.0104949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162510	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900023
J	Van Leeuwen, P; Gustafson, KM; Cysarz, D; Geue, D; May, LE; Gronemeyer, D				Van Leeuwen, Peter; Gustafson, Kathleen M.; Cysarz, Dirk; Geue, Daniel; May, Linda E.; Groenemeyer, Dietrich			Aerobic Exercise during Pregnancy and Presence of Fetal-Maternal Heart Rate Synchronization	PLOS ONE			English	Article							HUMAN-FETUS; RESPONSES; INFANT; COORDINATION; PATTERNS; STRESS; STATES	It has been shown that short-term direct interaction between maternal and fetal heart rates may take place and that this interaction is affected by the rate of maternal respiration. The aim of this study was to determine the effect of maternal aerobic exercise during pregnancy on the occurrence of fetal-maternal heart rate synchronization. Methods: In 40 pregnant women at the 36th week of gestation, 21 of whom exercised regularly, we acquired 18 min. RR interval time series obtained simultaneously in the mothers and their fetuses from magnetocardiographic recordings. The time series of the two groups were examined with respect to their heart rate variability, the maternal respiratory rate and the presence of synchronization epochs as determined on the basis of synchrograms. Surrogate data were used to assess whether the occurrence of synchronization was due to chance. Results: In the original data, we found synchronization occurred less often in pregnancies in which the mothers had exercised regularly. These subjects also displayed higher combined fetal-maternal heart rate variability and lower maternal respiratory rates. Analysis of the surrogate data showed shorter epochs of synchronization and a lack of the phase coordination found between maternal and fetal beat timing in the original data. Conclusion: The results suggest that fetal-maternal heart rate coupling is present but generally weak. Maternal exercise has a damping effect on its occurrence, most likely due to an increase in beat-to-beat differences, higher vagal tone and slower breathing rates.	[Van Leeuwen, Peter; Groenemeyer, Dietrich] Univ Witten Herdecke, Gronemeyer Inst Microtherapy, Bochum, Germany; [Gustafson, Kathleen M.] Univ Kansas, Hoglund Brain Imaging Ctr, Kansas City, KS USA; [Gustafson, Kathleen M.] Univ Kansas, Dept Neurol, Kansas City, KS USA; [Cysarz, Dirk] Univ Witten Herdecke, Integrated Curriculum Anthroposoph Med, Herdecke, Germany; [Geue, Daniel] VISUS Technol Transfer GmbH, Res & Dev, Bochum, Germany; [May, Linda E.] E Carolina Univ, Dept Fdn Sci & Res, Greenville, NC USA	Witten Herdecke University; University of Kansas; University of Kansas; Witten Herdecke University; University of North Carolina; East Carolina University	Van Leeuwen, P (corresponding author), Univ Witten Herdecke, Gronemeyer Inst Microtherapy, Bochum, Germany.	petervl@microtherapy.de	Cysarz, Dirk/F-8845-2010; Gustafson, Kathleen/I-2725-2019	Cysarz, Dirk/0000-0001-8303-0261; Gustafson, Kathleen/0000-0003-3225-5086; Van Leeuwen, Peter/0000-0003-2394-412X	Hoglund Brain Imaging Center through a generous gift from Forrest and Sally Hoglund; Kansas City University of Medicine and Biosciences; Kansas Intellectual Development and Disabilities Research Center [P30 NICHD HD 002528]	Hoglund Brain Imaging Center through a generous gift from Forrest and Sally Hoglund; Kansas City University of Medicine and Biosciences; Kansas Intellectual Development and Disabilities Research Center	This study was supported in part (Kathleen M. Gustafson) by pilot funding from the Hoglund Brain Imaging Center through a generous gift from Forrest and Sally Hoglund, an intramural grant from the Kansas City University of Medicine and Biosciences (Linda E. May), and the Kansas Intellectual Development and Disabilities Research Center (P30 NICHD HD 002528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anishchenko VS, 2000, INT J BIFURCAT CHAOS, V10, P2339, DOI 10.1142/S0218127400001468; BEKEDAM DJ, 1991, EARLY HUM DEV, V27, P223, DOI 10.1016/0378-3782(91)90196-A; Bettermann Henrik, 2002, BMC Physiol, V2, P18, DOI 10.1186/1472-6793-2-18; Cramp AG, 2009, RES Q EXERCISE SPORT, V80, P403; Cysarz D, 2008, ANN BIOMED ENG, V36, P2085, DOI 10.1007/s10439-008-9580-2; DECASPER AJ, 1994, INFANT BEHAV DEV, V17, P159, DOI 10.1016/0163-6383(94)90051-5; DiPietro JA, 2003, EARLY HUM DEV, V74, P125, DOI 10.1016/j.earlhumdev.2003.07.001; DiPietro JA, 2008, BIOL PSYCHOL, V77, P11, DOI 10.1016/j.biopsycho.2007.08.008; DiPietro JA, 2010, INFANT CHILD DEV, V19, P27, DOI 10.1002/icd.651; Feldman R, 2006, DEV PSYCHOL, V42, P175, DOI 10.1037/0012-1649.42.1.175; FERRAZZI E, 1989, CLIN PHYS PHYSIOL M, V10, P57, DOI 10.1088/0143-0815/10/4B/009; FIELD T, 1989, INFANT BEHAV DEV, V12, P357, DOI 10.1016/0163-6383(89)90044-1; Gustafson KM, 2012, EARLY HUM DEV, V88, P539, DOI 10.1016/j.earlhumdev.2011.12.017; Hankins GDV, 1997, AM J PERINAT, V14, P217, DOI 10.1055/s-2007-994130; Harrist AW, 2002, DEV REV, V22, P555, DOI 10.1016/S0273-2297(02)00500-2; HILDEBRANDT G, 1979, KLIN WOCHENSCHR, V57, P87, DOI 10.1007/BF01491340; Kantz H, 1997, NONLINEAR TIME SERIE, V7; Lecanuet JP, 2000, DEV PSYCHOBIOL, V36, P29, DOI 10.1002/(SICI)1098-2302(200001)36:1<29::AID-DEV4>3.3.CO;2-A; May LE, 2010, EARLY HUM DEV, V86, P213, DOI 10.1016/j.earlhumdev.2010.03.002; Monk C, 2000, DEV PSYCHOBIOL, V36, P67, DOI 10.1002/(SICI)1098-2302(200001)36:1<67::AID-DEV7>3.3.CO;2-3; NIJHUIS JG, 1982, EARLY HUM DEV, V6, P177, DOI 10.1016/0378-3782(82)90106-2; PILLAI M, 1990, OBSTET GYNECOL, V76, P812, DOI 10.1097/00006250-199011000-00017; Porcaro C, 2006, BRAIN RES, V1101, P51, DOI 10.1016/j.brainres.2006.04.134; Riedl M, 2009, PHILOS T R SOC A, V367, P1407, DOI 10.1098/rsta.2008.0277; Thiel M, 2006, EUROPHYS LETT, V75, P535, DOI 10.1209/epl/i2006-10147-0; Toledo E, 2002, MED ENG PHYS, V24, P45, DOI 10.1016/S1350-4533(01)00114-X; Van Leeuwen P, 2009, P NATL ACAD SCI USA, V106, P13661, DOI 10.1073/pnas.0901049106; Van Leeuwen Peter, 2003, BMC Physiol, V3, P2, DOI 10.1186/1472-6793-3-2; Van Leeuwen P, 2009, IEEE ENG MED BIOL, V28, P49, DOI 10.1109/MEMB.2009.934625; VANGEIJN HP, 1980, AM J OBSTET GYNECOL, V136, P1061, DOI 10.1016/0002-9378(80)90638-9; Wang QQ, 2013, IEEE ENG MED BIO, P3821, DOI 10.1109/EMBC.2013.6610377; WEBB KA, 1994, J APPL PHYSIOL, V77, P2207, DOI 10.1152/jappl.1994.77.5.2207; Zuther, 1996, Blood Press Monit, V1, P347	33	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106036	10.1371/journal.pone.0106036	http://dx.doi.org/10.1371/journal.pone.0106036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162592	Green Published, gold			2022-12-25	WOS:000340880900080
J	Whetten, K; Ostermann, J; Pence, BW; Whetten, RA; Messer, LC; Ariely, S; O'Donnell, K; Wasonga, AI; Vann, V; Itemba, D; Eticha, M; Madan, I; Thielman, NM				Whetten, Kathryn; Ostermann, Jan; Pence, Brian W.; Whetten, Rachel A.; Messer, Lynne C.; Ariely, Sumedha; O'Donnell, Karen; Wasonga, Augustine I.; Vann, Vanroth; Itemba, Dafrosa; Eticha, Misganaw; Madan, Ira; Thielman, Nathan M.		Posit Outcomes Orphans POFO Res Te	Three-Year Change in the Wellbeing of Orphaned and Separated Children in Institutional and Family-Based Care Settings in Five Low-and Middle-Income Countries	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE SDQ; ABANDONED CHILDREN; STRENGTHS; INTERVENTION; MODELS	Background: With more than 2 million children living in group homes, or "institutions'', worldwide, the extent to which institution-based caregiving negatively affects development and wellbeing is a central question for international policymakers. Methods: A two-stage random sampling methodology identified community representative samples of 1,357 institutiond-welling orphaned and separated children (OSC) and 1,480 family-dwelling OSC aged 6-12 from 5 low and middle income countries. Data were collected from children and their primary caregivers. Survey-analytic techniques and linear mixed effects models describe child wellbeing collected at baseline and at 36 months, including physical and emotional health, growth, cognitive development and memory, and the variation in outcomes between children, care settings, and study sites. Findings: At 36-month follow-up, institution-dwelling OSC had statistically significantly higher height-for-age Z-scores and better caregiver-reported physical health; family-dwelling OSC had fewer caregiver-reported emotional difficulties. There were no statistically significant differences between the two groups on other measures. At both baseline and follow-up, the magnitude of the differences between the institution-and family-dwelling groups was small. Relatively little variation in outcomes was attributable to differences between sites (11-27% of total variation) or care settings within sites (8-14%), with most variation attributable to differences between children within settings (60-75%). The percent of variation in outcomes attributable to the care setting type, institution-versus family-based care, ranged from 0-4% at baseline, 0-3% at 36-month follow-up, and 0-4% for changes between baseline and 36 months. Interpretation: These findings contradict the hypothesis that group home placement universally adversely affects child wellbeing. Without substantial improvements in and support for family settings, the removal of institutions, broadly defined, would not significantly improve child wellbeing and could worsen outcomes of children who are moved from a setting where they are doing relatively well to a more deprived setting.	[Whetten, Kathryn; Ostermann, Jan; Pence, Brian W.; Whetten, Rachel A.; Messer, Lynne C.; Ariely, Sumedha; O'Donnell, Karen; Thielman, Nathan M.] Duke Univ, Duke Global Hlth Inst, Ctr Hlth Policy, Durham, NC 27708 USA; [Whetten, Kathryn] Duke Univ, Terry Sanford Inst Publ Policy, Durham, NC USA; [Pence, Brian W.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Messer, Lynne C.] Portland State Univ, Coll Urban & Publ Affairs, Sch Community Hlth, Portland, OR 97207 USA; [O'Donnell, Karen] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; [O'Donnell, Karen] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [O'Donnell, Karen] Duke Univ, Ctr Child & Family Hlth, Durham, NC USA; [Wasonga, Augustine I.] ACE Africa, Bungoma, Kenya; [Vann, Vanroth] Homeland, Battambang, Cambodia; [Itemba, Dafrosa] TAWREF, Moshi, Tanzania; [Eticha, Misganaw] Stand Vulnerable Org, Addis Ababa, Ethiopia; [Madan, Ira] Sahara House, Delhi, India; [Thielman, Nathan M.] Duke Univ, Dept Med, Div Infect Dis & Int Hlth, Durham, NC USA	Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Portland State University; Duke University; Duke University; Duke University; Duke University	Whetten, K (corresponding author), Duke Univ, Duke Global Hlth Inst, Ctr Hlth Policy, Durham, NC 27708 USA.	katewhetten@gmail.com	Ostermann, Jan/GQB-4743-2022; Thielman, Nathan/R-5142-2019	Thielman, Nathan/0000-0001-8152-2879; Ostermann, Jan/0000-0002-8236-9500; Agala, Chris B/0000-0001-7157-814X	National Institute of Child Health and Development (NICHD) [5R01HD046345]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046345] Funding Source: NIH RePORTER	National Institute of Child Health and Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the National Institute of Child Health and Development (NICHD) (grant 5R01HD046345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUD F, 1991, SOC SCI MED, V33, P1275, DOI 10.1016/0277-9536(91)90075-N; Braitstein P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070054; Cluver L, 2009, SOC SCI MED, V69, P1186, DOI 10.1016/j.socscimed.2009.07.033; Cluver LD, 2012, J CHILD PSYCHOL PSYC, V53, P363, DOI 10.1111/j.1469-7610.2011.02459.x; Delis DC., 2000, CALIFORNIA VERBAL LE; Embleton L, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-9; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Hong Y, 2011, HEALTH POLICY PLANN, V26, P115, DOI 10.1093/heapol/czq025; Johnson DE, 1999, INFANT YOUNG CHILD, V11, P34, DOI 10.1097/00001163-199904000-00008; Kaufman AS., 1983, KAUFMAN ASSESSMENT B; McCall RB, 2013, CHILD DEV, V84, P1734, DOI 10.1111/cdev.12098; McLaughlin KA, 2012, J CHILD PSYCHOL PSYC, V53, P46, DOI 10.1111/j.1469-7610.2011.02437.x; Merz EC, 2013, J CLIN CHILD ADOLESC, V42, P726, DOI 10.1080/15374416.2013.764826; Messer LC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-504; Moccia P, 2005, STATE WORLDS CHILDRE; Morantz G, 2013, CHILD ABUSE NEGLECT, V37, P778, DOI 10.1016/j.chiabu.2012.10.007; Morantz G, 2010, AIDS CARE, V22, P10, DOI 10.1080/09540120903012601; Muris P, 2004, CHILD PSYCHIAT HUM D, V34, P317; Nelson CA, 2007, SCIENCE, V318, P1937, DOI 10.1126/science.1143921; NGO Working Group, 2013, ID BAS CHAR FORM ALT; O'Donnell K, 2012, AIDS BEHAV, V16, P480, DOI 10.1007/s10461-011-9940-z; Otieno PA, 1999, E AFR MED J, V76, P430; Powell G., 2006, J SOCIAL DEV AFRICA, V21, P130; Rabe-Hesketh S, 2005, J ECONOMETRICS, V128, P301, DOI 10.1016/j.jeconom.2004.08.017; Richter J, 2011, J CHILD PSYCHOL PSYC, V52, P1002, DOI 10.1111/j.1469-7610.2011.02372.x; Skuy M, 2000, PSYCHOL REP, V86, P727, DOI 10.2466/PR0.86.3.727-737; StataCorp, 2013, STAT STAT SOFTW REL; Syed EU, 2009, JCPSP-J COLL PHYSICI, V19, P375, DOI 06.2009/JCPSP.375379; Thielman N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038109; UNICEF, 2009, PROGR CHILDR REP CAR; UNICEF, 2006, STAT WORLDS CHILDR 2; United Nations Children's Fund (UNICEF), 2008, ORPH; United States Government Action Plan on Children in Adversity, 2012, US GOV ACT PLAN CHIL; van Ijzendoorn MH, 2008, MERRILL PALMER QUART, V54, P341; Wanat S, 2010, HEALTH POLICY, V96, P45, DOI 10.1016/j.healthpol.2010.01.001; Ware JE, 2004, SF 36 PHYS MENTAL HL; Whetten K, 2011, J TRAUMA STRESS, V24, P174, DOI 10.1002/jts.20625; Whetten K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008169; WHO, 2006, WHO CHILD GROWTH STA; WOLFF PH, 1995, J CHILD PSYCHOL PSYC, V36, P633, DOI 10.1111/j.1469-7610.1995.tb02318.x; World Bank Group, 2013, WE CLASS COUNTR; Zeanah CH, 2003, DEV PSYCHOPATHOL, V15, P885, DOI 10.1017/S0954579403000452	44	35	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e104872	10.1371/journal.pone.0104872	http://dx.doi.org/10.1371/journal.pone.0104872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8UR	25162410	Green Submitted, Green Published, gold			2022-12-25	WOS:000340880900022
J	Chung, SD; Liu, SP; Sheu, JJ; Lin, CC; Lin, HC; Chen, CH				Chung, Shiu-Dong; Liu, Shih-Ping; Sheu, Jau-Jiuan; Lin, Ching-Chun; Lin, Herng-Ching; Chen, Chao-Hung			Increased Healthcare Service Utilizations for Patients with Dementia: A Population-Based Study	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; ALZHEIMERS-DISEASE; CLAIMS DATA; LONG-TERM; VASCULAR DEMENTIA; MANAGED CARE; COSTS; PREVALENCE; TAIWAN; ASSOCIATION	Background: The majority of previous studies investigating the health care utilization of people with dementia were conducted in Western societies. There is little information on the economic burden on the healthcare system attributable to dementia in Asian countries. This study thus investigated differences in utilization of healthcare services between subjects with and those without a diagnosis of dementia using Taiwan's National Health Insurance population-based database. Methods: This study comprised 5,666 subjects with a dementia diagnosis and 5,666 age- and gender-matched comparison subjects without a dementia diagnosis. We individually followed each subject for a 1-year period starting from their index date to evaluate their healthcare resource utilization. Healthcare resource utilization included the number of outpatient visits and inpatient days, and the mean costs of outpatient and inpatient treatments. In addition, we divided healthcare resource utilization into psychiatric and non-psychiatric services. Results: As for utilization of psychiatric services, subjects with a dementia diagnosis had significantly more outpatient visits (2.2 vs. 0.3, p<0.001) and significantly higher outpatient costs (US$124 vs. US$16, p<0.001) than comparison subjects. For non-psychiatric services, subjects with a dementia diagnosis also had significantly more outpatient visits (34.4 vs. 31.6, p< 0.001) and significantly higher outpatient costs (US$1754 vs. US$1322, p<0.001) than comparison subjects. For all healthcare services, subjects with a dementia diagnosis had significantly more outpatient visits (36.7 vs. 32.0, p<0.001) and significantly higher outpatient costs (US$1878 vs. US$1338, p<0.001) than comparison subjects. Furthermore, the total cost was about 2-fold greater for subjects with a dementia diagnosis than for comparison subjects (US$3997 vs. US$2409, p<0.001). Conclusions: We concluded that subjects who had received a clinical dementia diagnosis had significantly higher utilization of all healthcare services than comparison subjects.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, New Taipei City, Taiwan; [Chung, Shiu-Dong] Fu Jen Cathol Univ, Coll Med, Sch Med, Taipei, Taiwan; [Chung, Shiu-Dong; Liu, Shih-Ping; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Sheu, Jau-Jiuan] Taipei Med Univ Hosp, Dept Neurol, Taipei, Taiwan; [Sheu, Jau-Jiuan] Taipei Med Univ Hosp, Neurosci Res Ctr, Taipei, Taiwan; [Lin, Ching-Chun] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Chen, Chao-Hung] Mackay Mem Hosp, Dept Thorac Surg, Taiwa, Miyagi, Japan; [Chen, Chao-Hung] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan	Far Eastern Memorial Hospital; Fu Jen Catholic University; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Mackay Junior College of Medicine, Nursing & Management	Chen, CH (corresponding author), Mackay Mem Hosp, Dept Thorac Surg, Taiwa, Miyagi, Japan.	yichen@tmu.edu.tw		LIU, SHIH-PING/0000-0002-8015-0695				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; Arling G, 2013, MED CARE, V51, P575, DOI 10.1097/MLR.0b013e31828d4d4a; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bickel H, 2000, GESUNDHEITSWESEN, V62, P211, DOI 10.1055/s-2000-10858; Chen TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-54; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Dementia Guideline Development Group, 2007, DEM NICE SCIE GUID S; Fick DM, 2005, J GERONTOL A-BIOL, V60, P748, DOI 10.1093/gerona/60.6.748; Frytak JR, 2008, ALZHEIMERS DEMENT, V4, P361, DOI 10.1016/j.jalz.2008.02.007; Gustavsson A, 2010, J NUTR HEALTH AGING, V14, P648, DOI 10.1007/s12603-010-0311-7; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Jonsson L, 2005, EUR J NEUROL, V12, P50, DOI 10.1111/j.1468-1331.2005.01190.x; Kane RL, 2000, ALZ DIS ASSOC DIS, V14, P187, DOI 10.1097/00002093-200010000-00001; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Kunik ME, 2003, GERONTOLOGIST, V43, P86, DOI 10.1093/geront/43.1.86; Leicht H, 2011, ACTA PSYCHIAT SCAND, V124, P384, DOI 10.1111/j.1600-0447.2011.01741.x; Perkins P, 1997, NEUROLOGY, V49, P44, DOI 10.1212/WNL.49.1.44; Phelan EA, 2012, JAMA-J AM MED ASSOC, V307, P165, DOI 10.1001/jama.2011.1964; Schwarzkopf L, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-2; Schwarzkopf L, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-165; Shrestha S, 2011, AM J ALZHEIMERS DIS, V26, P115, DOI 10.1177/1533317510394156; Sicras A, 2005, DEMENT GERIATR COGN, V19, P305, DOI 10.1159/000084556; Wu CS, 2009, AM J GERIAT PSYCHIAT, V17, P614, DOI 10.1097/JGP.0b013e3181a65210; Zhao Y, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-108; Ziegler U, 2009, GESUNDHEITSWESEN, V71, P281, DOI 10.1055/s-0028-1119384	27	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105789	10.1371/journal.pone.0105789	http://dx.doi.org/10.1371/journal.pone.0105789			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JK	25157405	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303200064
J	MacQueen, KM; Chen, M; Ramirez, C; Nnko, SEA; Earp, KM				MacQueen, Kathleen M.; Chen, Mario; Ramirez, Catalina; Nnko, Soori E. A.; Earp, Kelly M.			Comparison of Closed-Ended, Open-Ended, and Perceived Informed Consent Comprehension Measures for a Mock HIV Prevention Trial among Women in Tanzania	PLOS ONE			English	Article							INJECTION-DRUG USERS; CLINICAL-TRIALS; VACCINE TRIAL; COUNTRIES; EDUCATION; THAILAND; QUALITY; BANGKOK; AFRICA	Verifying participant comprehension continues to be a difficult ethical and regulatory challenge for clinical research. An increasing number of articles assessing methods to improve comprehension have been published, but they use a wide range of outcome measures including open-ended, closed-ended, and self-perceived measures of comprehension. Systematic comparisons of different measures have rarely been reported. This study evaluated the likely direction of bias observed when using open-ended, closed-ended, and perceived ease of comprehension measures among women administered a mock informed consent process in Mwanza, Tanzania. Participants were randomized to either a closed-ended or an open-ended assessment of comprehension, administered the consent process for a hypothetical HIV prevention trial in Kiswahili, and then administered a comprehension assessment, per their randomization. They were then asked how easy or hard it was to understand each of the informed consent components measured in the comprehension assessment. Women in the closed-ended arm had significantly higher overall comprehension scores than in the open-ended arm. Perceived scores were significantly higher when compared to both open-ended and close-ended scores within arms but were similar between arms. Findings highlight the importance of comprehension assessments in complex clinical trials that go beyond asking participants if they understand or have any questions. They also indicate the need for continued exploration of objective measures of comprehension in international clinical research settings, so that points in need of clarification can be efficiently and effectively identified and addressed. Such measures would reduce burdens on both staff and participants that result from well-intentioned but potentially unnecessary time spent explaining in unwarranted detail things already understood.	[MacQueen, Kathleen M.; Chen, Mario; Ramirez, Catalina; Earp, Kelly M.] FHI 360, Global Hlth Populat & Nutr, Durham, NC 27701 USA; [Nnko, Soori E. A.] Natl Inst Med Res, Mwanza, Tanzania	FHI 360; National Institute of Medical Research	MacQueen, KM (corresponding author), FHI 360, Global Hlth Populat & Nutr, Durham, NC 27701 USA.	kmacqueen@fhi360.org			U.S. Agency for International Development (USAID) [GHO-A-00-09-00016-00]	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study was funded by the U.S. Agency for International Development (USAID) (GHO-A-00-09-00016-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of the paper are the responsibility of the authors and do not necessarily reflect the view of the funders or the U.S. government.	[Anonymous], 2011, TANZ DEM HLTH SURV 2; Buchbinder SP, 2004, JAIDS-J ACQ IMM DEF, V36, P604, DOI 10.1097/00126334-200405010-00009; Chaisson LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022696; Corneli AL, 2012, AIDS BEHAV, V16, P412, DOI 10.1007/s10461-011-9977-z; Elbourne D, 1997, BRIT MED J, V315, P248; Fitzgerald DW, 2002, LANCET, V360, P1301, DOI 10.1016/S0140-6736(02)11338-9; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Koh J, 2012, J MED ETHICS, V38, P102, DOI 10.1136/jme.2010.040972; Krosin MT, 2006, CLIN TRIALS, V3, P306, DOI 10.1191/1740774506cn150oa; Lindegger G, 2006, JAIDS-J ACQ IMM DEF, V43, P560; Mack N, 2010, J EMPIR RES HUM RES, V5, P3, DOI 10.1525/jer.2010.5.2.3; MacQueen Kathleen M, 2011, J Int AIDS Soc, V14 Suppl 2, pS3, DOI 10.1186/1758-2652-14-S2-S3; MacQueen KM, 1999, J ACQ IMMUN DEF SYND, V21, P243, DOI 10.1097/00126334-199907010-00010; Manafa Ogenna, 2007, Indian J Med Ethics, V4, P26; Mandava A, 2012, J MED ETHICS, V38, P356, DOI 10.1136/medethics-2011-100178; Marshall PA, 2006, J EMPIR RES HUM RES, V1, P25, DOI 10.1525/jer.2006.1.1.25; Molyneux CS, 2004, SOC SCI MED, V59, P2547, DOI 10.1016/j.socscimed.2004.03.037; Mystakidou K, 2009, SAHARA J-J SOC ASP H, V6, P46, DOI 10.1080/17290376.2009.9724930; Pace Christine, 2005, IRB, V27, P9, DOI 10.2307/3563866; Pucci E, 1999, BRIT MED J, V318, P875, DOI 10.1136/bmj.318.7187.875; Rennie S, 2010, J MED ETHICS, V36, P810, DOI 10.1136/jme.2010.035444; Sengupta S, 2011, AIDS CARE, V23, P1382, DOI 10.1080/09540121.2011.565031; The United Republic of Tanzania, 2013, 2012 POP HOUS CENS P; Vanichseni S, 2004, AIDS, V18, P311, DOI 10.1097/00002030-200401230-00022; Veronese F, 2011, AIDS RES HUM RETROV, V27, P81, DOI [10.1089/aid.2010.0226, 10.1089/AID.2010.0226]	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105720	10.1371/journal.pone.0105720	http://dx.doi.org/10.1371/journal.pone.0105720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JK	25157899	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200052
J	Mohebbi, K; Ibrahim, S; Zamani, M; Khezrian, M				Mohebbi, Keyvan; Ibrahim, Suhaimi; Zamani, Mazdak; Khezrian, Mojtaba			UltiMatch-NL: A Web Service Matchmaker Based on Multiple Semantic Filters	PLOS ONE			English	Article							ALGORITHM; SELECTION	In this paper, a Semantic Web service matchmaker called UltiMatch-NL is presented. UltiMatch-NL applies two filters namely Signature-based and Description-based on different abstraction levels of a service profile to achieve more accurate results. More specifically, the proposed filters rely on semantic knowledge to extract the similarity between a given pair of service descriptions. Thus it is a further step towards fully automated Web service discovery via making this process more semantic-aware. In addition, a new technique is proposed to weight and combine the results of different filters of UltiMatch-NL, automatically. Moreover, an innovative approach is introduced to predict the relevance of requests and Web services and eliminate the need for setting a threshold value of similarity. In order to evaluate UltiMatch-NL, the repository of OWLS-TC is used. The performance evaluation based on standard measures from the information retrieval field shows that semantic matching of OWL-S services can be significantly improved by incorporating designed matching filters.	[Mohebbi, Keyvan] Islamic Azad Univ, Dept Comp, Mobarakeh Branch, Esfahan, Iran; [Mohebbi, Keyvan; Khezrian, Mojtaba] UTM, Fac Comp, Johor Baharu, Malaysia; [Ibrahim, Suhaimi; Zamani, Mazdak] UTM, AIS, Kuala Lumpur, Malaysia	Islamic Azad University; Universiti Teknologi Malaysia; Universiti Teknologi Malaysia	Mohebbi, K (corresponding author), Islamic Azad Univ, Dept Comp, Mobarakeh Branch, Esfahan, Iran.	keyvanmohebbi@gmail.com	Zamani, Mazdak/A-1687-2013; Mohebbi, Keyvan/AAO-3666-2021	Zamani, Mazdak/0000-0002-6421-0053; Mohebbi, Keyvan/0000-0002-3545-2491	Research University grant of Universiti Teknologi Malaysia (UTM) [08H28]; Research Management Centre of UTM; Malaysian government	Research University grant of Universiti Teknologi Malaysia (UTM); Research Management Centre of UTM; Malaysian government	This research was funded by the Research University grant of Universiti Teknologi Malaysia (UTM) under the Vot no. 08H28. The authors would like to thank the Research Management Centre of UTM and the Malaysian government for their support and cooperation including students and other individuals who are either directly or indirectly involved in this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkarkhi AFM, 2008, J SUSTAINABLE DEV, V1; [Anonymous], 2015, EXTENSION CHAPTERS A, P589; Antonogeorgos G, 2009, INT J PEDIAT, V2009, DOI 10.1155/2009/952042; Austin D., 2004, WEB SERVICES ARCHITE; Batet M, 2010, DELIVERABLE D3 STATE; Bernstein A, 2006, IMPRECISE RDQL GENER, P1684; Bianchini D, 2008, WORLD WIDE WEB, V11, P227, DOI 10.1007/s11280-007-0040-y; BOURGEOIS F, 1971, COMMUN ACM, V14, P802, DOI 10.1145/362919.362945; Budanitsky A, 2006, COMPUT LINGUIST, V32, P13, DOI 10.1162/coli.2006.32.1.13; Burkard  R., 2009, ASSIGNMENT PROBLEMS; Burns R., 2008, BUSINESS RES METHODS, P568; Cramer D., 2003, ADV QUANTITATIVE DAT; DATTALO P, 1994, J SOC SERV RES, V19, P121; GRUBER TR, 1993, KNOWL ACQUIS, V5, P199, DOI 10.1006/knac.1993.1008; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jiang J.J., 1997, SEMANTIC SIMILARITY, P19; Khalid MA, 2008, OWLS TC OWL S SERVIC; Kiefer C, 2008, LECT NOTES COMPUT SC, V5021, P463; Klusch M., 2012, SEMANTIC WEB SERVICE; KLUSCH M, 2006, AAMAS 06, P915; Klusch M, 2012, MULTIAGENT GRID SYST, V8, P69, DOI 10.3233/MGS-2012-0184; Klusch M, 2010, LECT NOTES COMPUT SC, V6089, P30, DOI 10.1007/978-3-642-13489-0_3; Klusch M, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON WEB SERVICES, VOLS 1 AND 2, P335, DOI 10.1109/ICWS.2009.76; Klusch M, 2008, WHITESTEIN SER SOFTW, P59, DOI 10.1007/978-3-7643-8575-0_4; Klusch M, 2009, J WEB SEMANT, V7, P121, DOI 10.1016/j.websem.2008.10.001; Kluscha Matthias, 2009, Web Intelligence and Agent Systems, V7, P23, DOI 10.3233/WIA-2009-0153; Kuhn H.W., 1955, NAV RES LOGIST Q, V2, P83, DOI [10.1002/nav.3800020109, DOI 10.1002/NAV.3800020109]; Li HH, 2007, LECT NOTES ARTIF INT, V4798, P617; Li YH, 2006, IEEE T KNOWL DATA EN, V18, P1138, DOI 10.1109/TKDE.2006.130; Lin D., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P296; Liu CJ, 2002, IEEE T IMAGE PROCESS, V11, P467, DOI 10.1109/TIP.2002.999679; Liu M, 2009, EXPERT SYST APPL, V36, P12480, DOI 10.1016/j.eswa.2009.04.034; Maja P, 2004, METODOLOSKI ZVEZKI, V1, P143; Martin D., 2004, W3C MEMBER SUBMISSIO, V22; Martin D, 2007, IEEE INTELL SYST, V22, P8, DOI 10.1109/MIS.2007.118; Mohebbi Keyvan, 2013, Journal of Next Generation Information Technology, V4, P9; Mohebbi K, 2012, ADV INFORM SCI SERVI, V4, P330; Mohebbi K, 2012, INT J WEB SERVICE CO, V3, P65; Norusis M.J., 2010, PASW STAT 18 STAT PR; Oliva J, 2011, DATA KNOWL ENG, V70, P390, DOI 10.1016/j.datak.2011.01.002; Pirro G, 2009, DATA KNOWL ENG, V68, P1289, DOI 10.1016/j.datak.2009.06.008; Plebani P, 2009, IEEE T KNOWL DATA EN, V21, P1629, DOI 10.1109/TKDE.2009.35; Ramayah T, 2010, AFR J BUS MANAGE, V4, P1654; Spicer J, 2004, LOGISTIC REGRESSION, P256; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Sycara K, 2002, AUTON AGENT MULTI-AG, V5, P173, DOI 10.1023/A:1014897210525; TREC, 2012, TEXT RETRIEVAL C TRE; Tsatsaronis G, 2010, J ARTIF INTELL RES, V37, P1, DOI 10.1613/jair.2880; Wei DP, 2011, J WEB SEMANT, V9, P402, DOI 10.1016/j.websem.2011.08.001	50	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104735	10.1371/journal.pone.0104735	http://dx.doi.org/10.1371/journal.pone.0104735			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157872	Green Published, gold			2022-12-25	WOS:000341303200016
J	Krajewska, M; Fehrmann, RSN; Schoonen, PM; Labib, S; de Vries, EGE; Franke, L; van Vugt, MATM				Krajewska, M.; Fehrmann, R. S. N.; Schoonen, P. M.; Labib, S.; de Vries, E. G. E.; Franke, L.; van Vugt, M. A. T. M.			ATR inhibition preferentially targets homologous recombination-deficient tumor cells	ONCOGENE			English	Article							STRAND BREAK REPAIR; CANCER SUSCEPTIBILITY GENE; EMBRYONIC CELLULAR PROLIFERATION; INDUCED REPLICATIVE STRESS; RAD51 RECOMBINASE; MAMMALIAN-CELLS; BRCA2; TRANSFORMATION; MUTATIONS; MOUSE	Homologous recombination (HR) is required for faithful repair of double-strand DNA breaks. Defects in HR repair cause severe genomic instability and challenge cellular viability. Paradoxically, various cancers are HR defective and have apparently acquired characteristics to survive genomic instability. We aimed to identify these characteristics to uncover therapeutic targets for HR-deficient cancers. Cytogenetic analysis of 1143 ovarian cancers showed that the degree of genomic instability was correlated to amplification of replication checkpoint genes ataxia telangiectasia and Rad3-related kinase (ATR) and CHEK1. To test whether genomic instability leads to increased reliance on replication checkpoint signaling, we inactivated Rad51 to model HR-related genomic instability. Rad51 inactivation caused defective HR repair and induced aberrant replication dynamics. Notably, inhibition of Rad51 led to increased ATR/checkpoint kinase-1 (Chk1)-mediated replication stress signaling. Importantly, inhibition of ATR or Chk1 preferentially killed HR-deficient cancer cells. Combined, our data show that defective HR caused by Rad51 inhibition results in differential sensitivity for ATR and Chk1 inhibitors, implicating replication checkpoint kinases as potential drug targets for HR-defective cancers.	[Krajewska, M.; Fehrmann, R. S. N.; Schoonen, P. M.; Labib, S.; de Vries, E. G. E.; van Vugt, M. A. T. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, NL-9700 Groningen, Netherlands; [Franke, L.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Genet, NL-9700 Groningen, Netherlands	University of Groningen; University of Groningen	van Vugt, MATM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1, NL-9700 Groningen, Netherlands.	m.vugt@umcg.nl	Krajewska, Malgorzata/AAH-1158-2021; Franke, Lude/P-7036-2016; Fehrmann, Rudolf/E-2551-2011	Franke, Lude/0000-0002-5159-8802; Fehrmann, Rudolf/0000-0002-7516-315X; de Vries, Elisabeth/0000-0002-8949-7425; Krajewska, Malgorzata/0000-0002-2243-5924	NWO [917-3334]; Alpe d'HuZes/Dutch Cancer Society [RUG2013-5960]; Van der Meer-Boerema Foundation	NWO(Netherlands Organization for Scientific Research (NWO)); Alpe d'HuZes/Dutch Cancer Society; Van der Meer-Boerema Foundation	This work was financially supported by an NWO VIDI grant to MATMvV (917-3334), a Bas Mulder grant from the Alpe d'HuZes/Dutch Cancer Society (RUG2013-5960) to RSNF and funding from the Van der Meer-Boerema Foundation to MK. We thank Dr Maria Jasin for generously supplying materials.	Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; CLETONJANSEN AM, 1995, BRIT J CANCER, V72, P1241, DOI 10.1038/bjc.1995.493; Fang Y, 2004, EMBO J, V23, P3164, DOI 10.1038/sj.emboj.7600315; Frappart PO, 2009, P NATL ACAD SCI USA, V106, P1880, DOI 10.1073/pnas.0806882106; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Greenblatt MS, 2001, CANCER RES, V61, P4092; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Huang F, 2011, ACS CHEM BIOL, V6, P628, DOI 10.1021/cb100428c; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Karst AM, 2014, CANCER RES, V74, P1141, DOI 10.1158/0008-5472.CAN-13-2247; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Lee H, 1999, MOL CELL, V4, P1, DOI 10.1016/S1097-2765(00)80182-3; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Lopez-Contreras AJ, 2012, J EXP MED, V209, P455, DOI 10.1084/jem.20112147; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; Oza V, 2012, J MED CHEM, V55, P5130, DOI 10.1021/jm300025r; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Smith L, 1998, NAT GENET, V19, P39, DOI 10.1038/ng0598-39; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Suzuki A, 1997, GENE DEV, V11, P1242, DOI 10.1101/gad.11.10.1242; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	37	56	58	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	26					3474	3481		10.1038/onc.2014.276	http://dx.doi.org/10.1038/onc.2014.276			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CL3SU	25174396				2022-12-25	WOS:000356871700012
J	Podolski, M; Mahamdeh, M; Howard, J				Podolski, Marija; Mahamdeh, Mohammed; Howard, Jonathon			Stu2, the Budding Yeast XMAP215/Dis1 Homolog, Promotes Assembly of Yeast Microtubules by Increasing Growth Rate and Decreasing Catastrophe Frequency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TUBULIN-BINDING; PLUS-END; DYNAMICS; POLYMERASE; PROTEINS; PURIFICATION; MECHANISMS; REVEALS; COMPLEX	Stu2 is the budding yeast member of the XMAP215/Dis1 family of microtubule polymerases. It is essential in cell division, allowing proper spindle orientation and metaphase chromosome alignment, as well as spindle elongation during anaphase. Despite Stu2 having a phenotype that suggests it promotes microtubule growth, like the other members of the XMAP215/Dis1 family, previous studies with purified Stu2 indicate only that it antagonizes microtubule growth. One potential explanation for these contradictory findings is that the assays were performed with mammalian brain tubulin, which may not be the right substrate to test the activity of Stu2 given that yeast and brain tubulins are quite divergent in sequence and that the vertebrate tubulins are subject to many post-translational modifications. To test this possibility, we reconstituted the activity of Stu2 with purified budding yeast tubulin. We found that Stu2 accelerated microtubule growth in yeast tubulin by severalfold, similar to the acceleration reported for XMAP215 in porcine brain tubulin. Furthermore, Stu2 accelerated polymerization in yeast tubulin to a much greater extent than in porcine brain tubulin, and the concentration of Stu2 required to reach 50% maximum activity in yeast tubulin was nearly 2 orders of magnitude lower than that in porcine brain tubulin. We conclude that Stu2 is a microtubule polymerase, like its relatives, and that its activity is considerably higher in yeast tubulin compared with mammalian brain tubulin. The biochemical properties of Stu2 reported here account for many of the phenotypes of Stu2 observed in cells.	[Podolski, Marija; Mahamdeh, Mohammed; Howard, Jonathon] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA	Yale University	Howard, J (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06511 USA.	jonathon.howard@yale.edu	Mahamdeh, Mohammed/AAG-6530-2019; Howard, Jonathon/J-7492-2016; Howard, Jonathon/D-4229-2011	Howard, Jonathon/0000-0003-0086-1196; Howard, Jonathon/0000-0003-0086-1196	National Institutes of Health [R01 GM110386]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM110386 (to J. H.).	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Al-Bassam J, 2006, J CELL BIOL, V172, P1009, DOI 10.1083/jcb.200511010; Al-Bassam J, 2011, TRENDS CELL BIOL, V21, P604, DOI 10.1016/j.tcb.2011.06.007; Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Alper JB, 2013, BIOPHYS J, V104, P1989, DOI 10.1016/j.bpj.2013.03.041; Ayaz P, 2012, SCIENCE, V337, P857, DOI 10.1126/science.1221698; BARNES G, 1992, MOL BIOL CELL, V3, P29, DOI 10.1091/mbc.3.1.29; Bormuth V, 2007, J MICROSC-OXFORD, V226, P1, DOI 10.1111/j.1365-2818.2007.01756.x; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Cassimeris L, 2010, METHOD CELL BIOL, V97, P1; DAVIS A, 1993, BIOCHEMISTRY-US, V32, P8823, DOI 10.1021/bi00085a013; FIELD DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4041, DOI 10.1073/pnas.81.13.4041; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Gell C, 2011, METHODS MOL BIOL, V777, P15, DOI 10.1007/978-1-61779-252-6_2; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Howard J., 2001, MECH MOTOR PROTEINS; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kosco KA, 2001, MOL BIOL CELL, V12, P2870, DOI 10.1091/mbc.12.9.2870; Luduena RF, 1998, INT REV CYTOL, V178, P207; NEFF NF, 1983, CELL, V33, P211, DOI 10.1016/0092-8674(83)90350-1; SCHATZ PJ, 1986, MOL CELL BIOL, V6, P3711, DOI 10.1128/MCB.6.11.3711; Severin F, 2001, J CELL BIOL, V153, P435, DOI 10.1083/jcb.153.2.435; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Takeshita N, 2013, J CELL SCI, V126, P5400, DOI 10.1242/jcs.129841; van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097; van der Vaart B, 2009, BIOCHEM SOC T, V37, P1007, DOI 10.1042/BST0371007; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; Widlund PO, 2012, MOL BIOL CELL, V23, P4393, DOI 10.1091/mbc.E12-06-0444; Widlund PO, 2011, P NATL ACAD SCI USA, V108, P2741, DOI 10.1073/pnas.1016498108; Williams RC, 1999, ANAL BIOCHEM, V275, P265, DOI 10.1006/abio.1999.4326; Zanic M, 2013, NAT CELL BIOL, V15, P688, DOI 10.1038/ncb2744	36	41	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28087	28093		10.1074/jbc.M114.584300	http://dx.doi.org/10.1074/jbc.M114.584300			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25172511	hybrid, Green Published			2022-12-25	WOS:000343765400003
J	Qi, YY; Marlin, MC; Liang, ZM; Berry, WL; Janknecht, R; Zhou, J; Wang, ZH; Lu, GD; Li, GP				Qi, Yaoyao; Marlin, M. Caleb; Liang, Zhimin; Berry, William L.; Janknecht, Ralf; Zhou, Jie; Wang, Zonghua; Lu, Guodong; Li, Guangpu			Distinct Biochemical and Functional Properties of Two Rab5 Homologs from the Rice Blast Fungus Magnaporthe oryzae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL GTPASE RAB5; EARLY ENDOCYTIC PATHWAY; MEMBRANE-FUSION; ENDOSOME FUSION; RECYCLING ENDOSOMES; NEURITE OUTGROWTH; IN-VITRO; TRAFFICKING; EEA1; EFFECTOR	Rab5 is a key regulator of early endocytosis by promoting early endosomal fusion and motility. In this study, we have unexpectedly found distinct properties of the two Rab5 homologs (MoRab5A and MoRab5B) from Magnaporthe oryzae, a pathogenic fungus in plants whose infection causes rice blast disease. Like mammalian Rab5, MoRab5A and MoRab5B can bind to several Rab5 effectors in a GTP-dependent manner, including EEA1, Rabenosyn-5, and Rabaptin-5. However, MoRab5A shows distinct binding characteristics in the sense that both the wild-type and the GTP hydrolysis-defective constitutively active mutant bind the effectors equally well in GST pull-down assays, suggesting that MoRab5A is defective in GTP hydrolysis and mostly in the GTP-bound conformation in the cell. Indeed, GTP hydrolysis assays indicate that MoRab5A GTPase activity is dramatically lower than MoRab5B and human Rab5 and is insensitive to RabGAP5 stimulation. We have further identified a Pro residue in the switch I region largely responsible for the distinct MoRab5A properties by characterization of MoRab5A and MoRab5B chimeras and mutagenesis. The differences between MoRab5A and MoRab5B extend to their functions in the cell. Although they both target to early endosomes, only MoRab5B closely resembles human Rab5 in promoting early endosome fusion and stimulating fluid phase endocytosis. In contrast, MoRab5A correlates with another related early endosomal Rab, Rab22, in terms of the presence of the switch I Pro residue and the blocked GTPase activity. Our data thus identify MoRab5B as the Rab5 ortholog and suggest that MoRab5A specializes to perform a non-redundant function in endosomal sorting.	[Qi, Yaoyao; Zhou, Jie; Wang, Zonghua; Lu, Guodong] Fujian Agr & Forestry Univ, Key Lab Biopesticides & Chem Biol, Minist Educ, Fuzhou 350002, Fujian, Peoples R China; [Qi, Yaoyao; Marlin, M. Caleb; Liang, Zhimin; Li, Guangpu] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Berry, William L.; Janknecht, Ralf] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Janknecht, Ralf; Li, Guangpu] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73104 USA	Fujian Agriculture & Forestry University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lu, GD (corresponding author), Fujian Agr & Forestry Univ, Key Lab Biopesticides & Chem Biol, Minist Educ, Fuzhou 350002, Fujian, Peoples R China.	gdlufafu@163.com; guangpu-li@ouhsc.edu	Li, Guangpu/GRS-5397-2022	Marlin, M. Caleb/0000-0003-0453-5355; Berry, William/0000-0002-1661-5443; Janknecht, Ralf/0000-0003-1741-1562	National Institutes of Health [R01GM074692]; NSFC [31328002, 31070124]; China Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM074692, NSFC Grants 31328002 and 31070124, and a scholarship from the China Scholarship Council.	Atkinson HA, 2002, FUNGAL GENET BIOL, V37, P233, DOI 10.1016/S1087-1845(02)00535-2; Balaji K, 2012, J CELL SCI, V125, P5887, DOI 10.1242/jcs.113688; BARBIERI MA, 1994, J BIOL CHEM, V269, P18720; Berry WL, 2014, INT J ONCOL, V44, P1341, DOI 10.3892/ijo.2014.2279; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Diekmann Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002217; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Elias M, 2012, J CELL SCI, V125, P2500, DOI 10.1242/jcs.101378; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Kauppi M, 2002, J CELL SCI, V115, P899; Klopper TH, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-71; Kummel D, 2014, CURR OPIN CELL BIOL, V29, P61, DOI 10.1016/j.ceb.2014.04.007; Li G., 2012, YPT RAB GTPASES INTR, P3; LI GP, 1993, J BIOL CHEM, V268, P24475; LI GP, 1993, ARCH BIOCHEM BIOPHYS, V304, P471, DOI 10.1006/abbi.1993.1377; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Magadan JG, 2006, MOL CELL BIOL, V26, P2595, DOI 10.1128/MCB.26.7.2595-2614.2006; MARINO MP, 2003, LENTIVIRUS GENE ENG, P43; Mishra A, 2010, P NATL ACAD SCI USA, V107, P10866, DOI 10.1073/pnas.1000843107; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; STEINMAN RM, 1974, J CELL BIOL, V63, P949, DOI 10.1083/jcb.63.3.949; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Wang L, 2011, MOL BIOL CELL, V22, P3853, DOI 10.1091/mbc.E11-03-0277; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039; Zhu HP, 2009, MOL BIOL CELL, V20, P4720, DOI 10.1091/mbc.E09-06-0453	38	7	9	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28299	28309		10.1074/jbc.M114.591503	http://dx.doi.org/10.1074/jbc.M114.591503			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25164815	Green Published, hybrid			2022-12-25	WOS:000343765400025
J	Moreno, MB; Concha, L; Gonzalez-Santos, L; Ortiz, JJ; Barrios, FA				Beatriz Moreno, Martha; Concha, Luis; Gonzalez-Santos, Leopoldo; Ortiz, Juan Jose; Alejandro Barrios, Fernando			Correlation between Corpus Callosum Sub-Segmental Area and Cognitive Processes in School-Age Children	PLOS ONE			English	Article							SEX-DIFFERENCES; GENDER-DIFFERENCES; PREFRONTAL CORTEX; FIBER COMPOSITION; INTELLIGENCE; TRACTOGRAPHY; THICKNESS; MICROSTRUCTURE; ADOLESCENTS; DIMORPHISM	We assessed the relationship between structural characteristics (area) and microstructure (apparent diffusion coefficient; ADC) of the corpus callosum (CC) in 57 healthy children aged 7.0 to 9.1 years, with diverse cognitive and academic abilities as well as executive functions evaluated with a neuropsychological battery for children. The CC was manually delineated and sub-segmented into six regions, and their ADC and area were measured. There were no significant differences between genders in the callosal region area or in ADC. The CC area and ADC, mainly of anterior regions, correlated with different cognitive abilities for each gender. Our results suggest that the relationship between cognitive abilities and CC characteristics is different between girls and boys and between the anterior and posterior regions of the CC. Furthermore, these findings strenghten the idea that regardless of the different interhemispheric connectivity schemes per gender, the results of cognitive tasks are very similar for girls and boys throughout childhood.	[Beatriz Moreno, Martha; Concha, Luis; Gonzalez-Santos, Leopoldo; Ortiz, Juan Jose; Alejandro Barrios, Fernando] Univ Nacl Autonoma Mexico, Inst Neurobiol, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Barrios, FA (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Queretaro, Mexico.	fbarrios@unam.mx	Barrios, Fernando Alejandro/D-1591-2016; Concha, Luis/M-5720-2019; Concha, Luis/G-5161-2011	Barrios, Fernando Alejandro/0000-0002-5699-4222; Concha, Luis/0000-0002-7842-3869; MORENO-GARCIA, MARTHA BEATRIZ/0000-0002-5216-3915	"Programa de Doctorado en Ciencias Biomedicas'', Universidad Nacional Autonoma de Mexico (UNAM); Consejo Nacional de Ciencia y Tecnologia (the National Council of Science and Technology) (CONACYT) [29881]	"Programa de Doctorado en Ciencias Biomedicas'', Universidad Nacional Autonoma de Mexico (UNAM); Consejo Nacional de Ciencia y Tecnologia (the National Council of Science and Technology) (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	MBM is a doctoral student from "Programa de Doctorado en Ciencias Biomedicas'', Universidad Nacional Autonoma de Mexico (UNAM) and received the doctoral scholarship 29881 from The Consejo Nacional de Ciencia y Tecnologia (the National Council of Science and Technology) (CONACYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 1996, NEUROREPORT, V7, P1761, DOI 10.1097/00001756-199607290-00013; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Adisetiyo V, 2013, HUM BRAIN MAPP, DOI [10.1002/hbm.22317:1-15, DOI 10.1002/HBM.22317:1-15]; Allin M, 2007, ARCH PEDIAT ADOL MED, V161, P1183, DOI 10.1001/archpedi.161.12.1183; Ardila A, 2011, DEV PSYCHOL, V47, P984, DOI 10.1037/a0023819; Arnsten AFT, 2009, CNS DRUGS, V23, P33, DOI 10.2165/00023210-200923000-00005; Bell E, 2006, NEUROIMAGE, V30, P256; Bender L, 2007, TEST GUESTALTICO VIS; Burman DD, 2008, NEUROPSYCHOLOGIA, V46, P1349, DOI 10.1016/j.neuropsychologia.2007.12.021; Byars A.W., 2002, J CHILD NEUROL, V17, P885; Concha L., 2013, NEUROSCIENCE, DOI 10.1016; Frye RE, 2008, NEUROREPORT, V19, P1627, DOI 10.1097/WNR.0b013e328314b8ee; Ganjavi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019698; Giedd JN, 1996, DEV BRAIN RES, V91, P274; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Gur RC, 2000, BRAIN LANG, V74, P157, DOI 10.1006/brln.2000.2325; Heaton, 1981, WISCONSIN CARD SORTI; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hutchinson AD, 2009, EXP BRAIN RES, V192, P455, DOI 10.1007/s00221-008-1604-5; Ingalhalikar M, 2013, P NATL ACA SCI EARLY, P3; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johansen-Berg H, 2006, CURR OPIN NEUROL, V19, P379, DOI 10.1097/01.wco.0000236618.82086.01; Kanaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038272; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Keller K, 2009, NEUROIMAGE, V47, P342, DOI 10.1016/j.neuroimage.2009.04.042; Kim C, 2011, J NEUROSCI; Kimura Doreen, 1999, SEX COGNITION; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Liu F, 2010, BRAIN RES, V1343, P37, DOI 10.1016/j.brainres.2010.04.064; Luders E, 2007, NEUROIMAGE, V37, P1457, DOI 10.1016/j.neuroimage.2007.06.028; Luders E, 2011, NEUROIMAGE, V54, P1823, DOI 10.1016/j.neuroimage.2010.09.083; Luders E, 2010, J NEUROSCI, V30, P10985, DOI 10.1523/JNEUROSCI.5122-09.2010; Matute E., 2007, EVALUACION NEUROPSIC; Men WW, 2014, BRAIN, V137, DOI 10.1093/brain/awt252; Park HJ, 2008, HUM BRAIN MAPP, V29, P503, DOI 10.1002/hbm.20314; Piaget J., 2001, PSYCHOL INTELLIGENCE; Plessen KJ, 2006, J CHILD PSYCHOL PSYC, V47, P1013, DOI 10.1111/j.1469-7610.2006.01639.x; Porter JN, 2011, NEUROIMAGE, V55, P1865, DOI 10.1016/j.neuroimage.2011.01.018; Pruim R, 2010, PURE APPL UNDERGRADU, V13; Roca M, 2013, NEUROPSYCHOLOGIA, V51, P725, DOI 10.1016/j.neuropsychologia.2013.01.008; Saenz M, 2010, NEUROIMAGE, V52, P1224, DOI 10.1016/j.neuroimage.2010.05.060; Schmithorst VJ, 2008, HUM BRAIN MAPP, V29, P696, DOI 10.1002/hbm.20431; Sheehan D, 2000, MINIKID MINIINTERNAT; Spasojevic Goran, 2006, Vojnosanit Pregl, V63, P933, DOI 10.2298/VSP0611933S; Stoet G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057988; Tchanturia K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028331; Torres A, 2006, ACTAS ESP PSIQUIATRI, V34, P408; Unterrainer JM, 2005, NEUROIMAGE, V24, P586, DOI 10.1016/j.neuroimage.2004.09.020; Vandermosten M, 2012, BRAIN, V135, P935, DOI 10.1093/brain/awr363; Wechsler D., 1999, WECHSLER ABBREVIATED; Wechsler D., 1991, WISC 3 WECHSLER INTE; Westerhausen R, 2011, NEUROIMAGE, V56, P874, DOI 10.1016/j.neuroimage.2011.03.013	55	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e104549	10.1371/journal.pone.0104549	http://dx.doi.org/10.1371/journal.pone.0104549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170897	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500017
J	Pincus, M; LaViers, L; Prietula, MJ; Berns, G				Pincus, Melanie; LaViers, Lisa; Prietula, Michael J.; Berns, Gregory			The Conforming Brain and Deontological Resolve	PLOS ONE			English	Article							PREFRONTAL CORTEX; MORAL JUDGMENT; SACRED VALUES; RETRIEVAL; RULES	Our personal values are subject to forces of social influence. Deontological resolve captures how strongly one relies on absolute rules of right and wrong in the representation of one's personal values and may predict willingness to modify one's values in the presence of social influence. Using fMRI, we found that a neurobiological metric for deontological resolve based on relative activity in the ventrolateral prefrontal cortex (VLPFC) during the passive processing of sacred values predicted individual differences in conformity. Individuals with stronger deontological resolve, as measured by greater VLPFC activity, displayed lower levels of conformity. We also tested whether responsiveness to social reward, as measured by ventral striatal activity during social feedback, predicted variability in conformist behavior across individuals but found no significant relationship. From these results we conclude that unwillingness to conform to others' values is associated with a strong neurobiological representation of social rules.	[Pincus, Melanie; LaViers, Lisa; Prietula, Michael J.; Berns, Gregory] Emory Univ, Atlanta, GA 30322 USA	Emory University	Pincus, M (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	mpincu2@emory.edu	Prietula, Michael/E-5805-2011	Prietula, Michael/0000-0002-9157-1719	Office of Naval Research; Defense Advanced Research Projects Agency [D11AP00289]	Office of Naval Research(Office of Naval Research); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by the Office of Naval Research and Defense Advanced Research Projects Agency [D11AP00289]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atran S, 2010, ASIAN J SOC SCI, V38, P343, DOI 10.1163/156853110X499918; BABAD E, 1987, SOC BEHAV, V2, P185; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Baron J, 1997, ORGAN BEHAV HUM DEC, V70, P1, DOI 10.1006/obhd.1997.2690; Bartels DM, 2008, COGNITION, V108, P381, DOI 10.1016/j.cognition.2008.03.001; Bassili JN, 1996, J PERS SOC PSYCHOL, V71, P637, DOI 10.1037/0022-3514.71.4.637; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Berns GS, 2012, PHILOS T R SOC B, V367, P754, DOI 10.1098/rstb.2011.0262; Bhanji JP, 2010, NEUROIMAGE, V49, P1810, DOI 10.1016/j.neuroimage.2009.09.030; Brass M, 2003, NEUROIMAGE, V20, P1026, DOI 10.1016/S1053-8119(03)00357-4; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Bunge Silvia A., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P564; Donohue SE, 2005, NEUROIMAGE, V26, P1140, DOI 10.1016/j.neuroimage.2005.03.019; DRAKE RA, 1993, J RES PERS, V27, P184, DOI 10.1006/jrpe.1993.1013; Falk EB, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00168; Gazzaniga MS, 1998, SCI AM          0616; Ginges J, 2011, AM PSYCHOL, V66, P507, DOI 10.1037/a0024715; Izuma K, 2013, NEURON, V78, P563, DOI 10.1016/j.neuron.2013.03.023; Klucharev V, 2009, NEURON, V61, P140, DOI 10.1016/j.neuron.2008.11.027; Lombrozo T, 2009, COGNITIVE SCI, V33, P273, DOI 10.1111/j.1551-6709.2009.01013.x; RAMACHANDRAN VS, 1995, CONSCIOUS COGN, V4, P22, DOI 10.1006/ccog.1995.1002; Sharot T, 2012, P NATL ACAD SCI USA, V109, P17058, DOI 10.1073/pnas.1205828109; Souza MJ, 2009, NEUROIMAGE, V46, P299, DOI 10.1016/j.neuroimage.2009.01.046; Tetlock PE, 2003, TRENDS COGN SCI, V7, P320, DOI 10.1016/S1364-6613(03)00135-9; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Tormala ZL, 2002, J PERS SOC PSYCHOL, V83, P1298, DOI 10.1037//0022-3514.83.6.1298	27	7	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106061	10.1371/journal.pone.0106061	http://dx.doi.org/10.1371/journal.pone.0106061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO2EE	25170989	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500096
J	von Buttlar, H; Siegemund, S; Buttner, M; Alber, G				von Buttlar, Heiner; Siegemund, Sabine; Buettner, Mathias; Alber, Gottfried			Identification of Toll-Like Receptor 9 as Parapoxvirus Ovis-Sensing Receptor in Plasmacytoid Dendritic Cells	PLOS ONE			English	Article							DEPENDENT VIRAL RECOGNITION; ORF VIRUS RECOMBINANT; IFN-ALPHA PRODUCTION; IN-VIVO; INTERFERON; ACTIVATION; INFECTION; PATHWAYS; LAMBDA; INACTIVATION	Parapoxvirus ovis (PPVO) is known for its immunostimulatory capacities and has been successfully used to generate vector vaccines effective especially in non-permissive host species. Murine conventional and plasmacytoid dendritic cells (cDC and pDC) are able to recognize PPVO. The PPVO-sensing receptor on pDC is hitherto unknown. In this study we aimed to define the pattern recognition receptor responsible for the activation of murine pDC by inactivated and replication-competent PPVO. We show that PPVO-induced expression of type I and type III interferons, pro-inflammatory cytokines, and costimulatory CD86 by bone marrow-derived pDC but not cDC is blocked by chloroquine, an inhibitor of endosomal maturation. The activation of pDC is independent of viral replication and depends mainly on TLR9. Moreover, the use of phosphatidylinositol 3-kinase inhibitor wortmannin or C-Jun-N-terminal kinase inhibitor SP600125 results in significant reduction of PPVO-induced pDC activation. Taken together, our data identify endosomal TLR9 as PPVO-sensing receptor in pDC.	[von Buttlar, Heiner; Siegemund, Sabine; Alber, Gottfried] Univ Leipzig, Coll Vet Med, Inst Immunol, D-04109 Leipzig, Germany; [Buettner, Mathias] Bavarian Hlth & Food Safety Author, Oberschleissheim, Germany	Leipzig University; Bavarian Health & Food Safety Authority	Alber, G (corresponding author), Univ Leipzig, Coll Vet Med, Inst Immunol, D-04109 Leipzig, Germany.	alber@rz.uni-leipzig.de		von Buttlar, Heiner/0000-0003-4373-0823	University of Leipzig, Leipzig, Germany	University of Leipzig, Leipzig, Germany	This work was supported by the University of Leipzig, Leipzig, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R, 2013, J VIROL, V87, P1618, DOI 10.1128/JVI.02470-12; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Barrett JW, 2001, SEMIN IMMUNOL, V13, P73, DOI 10.1006/smim.2000.0298; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; BROWN A, 1974, J VIROL, V14, P840, DOI 10.1128/JVI.14.4.840-845.1974; BUTTNER M, 1995, VET IMMUNOL IMMUNOP, V46, P237, DOI 10.1016/0165-2427(94)05357-X; Cao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036823; Carter GC, 2005, J GEN VIROL, V86, P1279, DOI 10.1099/vir.0.80831-0; Delhon G, 2004, J VIROL, V78, P168, DOI 10.1128/JVI.78.1.168-177.2004; Fejer G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000208; Fischer T, 2003, J VIROL, V77, P9312, DOI 10.1128/JVI.77.17.9312-9323.2003; Friebe A, 2011, J GEN VIROL, V92, P1571, DOI 10.1099/vir.0.028894-0; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; HARPER JMM, 1978, J VIROL, V26, P646, DOI 10.1128/JVI.26.3.646-659.1978; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henkel M, 2005, J VIROL, V79, P314, DOI 10.1128/JVI.79.1.314-325.2005; Hillyer P, 2012, IMMUNOL CELL BIOL, V90, P774, DOI 10.1038/icb.2011.109; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kumagai Y, 2009, J IMMUNOL, V182, P3960, DOI 10.4049/jimmunol.0804315; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Manuse MJ, 2010, VIROLOGY, V405, P383, DOI 10.1016/j.virol.2010.06.023; McInnes CJ, 1998, VIRUS GENES, V17, P107, DOI 10.1023/A:1026431704679; Morris S, 2011, J IMMUNOL, V187, P3953, DOI 10.4049/jimmunol.1100524; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Paulsen D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074605; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Rziha HJ, 1999, J BIOTECHNOL, V73, P235, DOI 10.1016/S0168-1656(99)00141-8; Samuelsson C, 2008, J CLIN INVEST, V118, P1776, DOI 10.1172/JCI33940; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Schutze N, 2010, VET MICROBIOL, V140, P81, DOI 10.1016/j.vetmic.2009.07.027; Schutze N, 2009, VET MICROBIOL, V137, P260, DOI 10.1016/j.vetmic.2009.01.035; Siegemund S, 2009, J VIROL, V83, P9411, DOI 10.1128/JVI.02362-08; Sutherland DB, 2011, IMMUNOL CELL BIOL, V89, P706, DOI 10.1038/icb.2010.157; Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06; Vijaysri S, 2003, VIROLOGY, V314, P305, DOI 10.1016/S0042-6822(03)00433-1; Voigt H, 2007, VACCINE, V25, P5915, DOI 10.1016/j.vaccine.2007.05.035; Waibler Z, 2007, J VIROL, V81, P12102, DOI 10.1128/JVI.01190-07; WITTEK R, 1979, J GEN VIROL, V43, P231, DOI 10.1099/0022-1317-43-1-231; Zhang J, 2013, INT ENDOD J, V46, P666, DOI 10.1111/iej.12043	43	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106188	10.1371/journal.pone.0106188	http://dx.doi.org/10.1371/journal.pone.0106188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171368	Green Published, gold			2022-12-25	WOS:000341127500122
J	Barjesteh, N; Behboudi, S; Brisbin, JT; Villanueva, AI; Nagy, E; Sharif, S				Barjesteh, Neda; Behboudi, Shahriar; Brisbin, Jennifer T.; Villanueva, Alexander Ian; Nagy, Eva; Sharif, Shayan			TLR Ligands Induce Antiviral Responses in Chicken Macrophages	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; NITRIC-OXIDE PRODUCTION; TOLL-LIKE RECEPTORS; CELL-LINE; A VIRUS; CPG OLIGODEOXYNUCLEOTIDE; ALVEOLAR MACROPHAGES; IMMUNE-RESPONSES; INTERFERON-GAMMA; IN-VIVO	Chicken macrophages express several receptors for recognition of pathogens, including Toll-like receptors (TLRs). TLRs bind to pathogen-associated molecular patterns (PAMPs) derived from bacterial or viral pathogens leading to the activation of macrophages. Macrophages play a critical role in immunity against viruses, including influenza viruses. The present study was designed to test the hypothesis that treatment of chicken macrophages with TLR ligands reduces avian influenza replication. Furthermore, we sought to study the expression of some of the key mediators involved in the TLR-mediated antiviral responses of macrophages. Chicken macrophages were treated with the TLR2, 3, 4, 7 and 21 ligands, Pam3CSK4, poly(I:C), LPS, R848 and CpG ODN, respectively, at different doses and time points pre-and post-H4N6 avian influenza virus (AIV) infection. The results revealed that pre-treatment of macrophages with Pam3CSK4, LPS and CpG ODN reduced the replication of AIV in chicken macrophages. In addition, the relative expression of genes involved in inflammatory and antiviral responses were quantified at 3, 8 and 18 hours post-treatment with the TLR2, 4 and 21 ligands. Pam3CSK4, LPS and CpG ODN increased the expression of interleukin (IL)-1 beta, interferon (IFN)-gamma, IFN-beta and interferon regulatory factor (IFR) 7. The expression of these genes correlated with the reduction of viral replication in macrophages. These results shed light on the process of immunity to AIV in chickens.	[Barjesteh, Neda; Brisbin, Jennifer T.; Villanueva, Alexander Ian; Nagy, Eva; Sharif, Shayan] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Behboudi, Shahriar] Pirbright Inst, Compton Lab, Newbury, Berks, England	University of Guelph; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Sharif, S (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.	shayan@uoguelph.ca		behboudi, shahriar/0000-0001-6455-4086	Canadian Poultry Research Council - Agriculture and Agri-Food Canada; Poultry Industry Council; Ontario Ministry of Agriculture and Food; BBSRC [BBS/E/I/00001825] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001825] Funding Source: researchfish	Canadian Poultry Research Council - Agriculture and Agri-Food Canada; Poultry Industry Council; Ontario Ministry of Agriculture and Food; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the Canadian Poultry Research Council - Agriculture and Agri-Food Canada, Poultry Industry Council, and Ontario Ministry of Agriculture and Food. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Careem MF, 2011, ANTIVIR RES, V92, P346, DOI 10.1016/j.antiviral.2011.09.004; Abdul-Careem MF, 2007, VACCINE, V25, P424, DOI 10.1016/j.vaccine.2006.08.006; Arsenault RJ, 2013, CELL SIGNAL, V25, P2246, DOI 10.1016/j.cellsig.2013.07.014; Barjesteh N, 2013, VET MICROBIOL, V164, P122, DOI 10.1016/j.vetmic.2013.02.002; Brisbin JT, 2010, CLIN VACCINE IMMUNOL, V17, P1337, DOI 10.1128/CVI.00143-10; Ciraci C, 2011, DEV COMP IMMUNOL, V35, P392, DOI 10.1016/j.dci.2010.11.012; Coleman JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-9; Crippen TL, 2006, VET IMMUNOL IMMUNOP, V109, P127, DOI 10.1016/j.vetimm.2005.08.024; Fitzgerald KA, 2011, J INTERF CYTOK RES, V31, P131, DOI 10.1089/jir.2010.0127; FUJISAWA H, 1987, J GEN VIROL, V68, P425, DOI 10.1099/0022-1317-68-2-425; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Guillermo LVC, 2004, POULTRY SCI, V83, P776, DOI 10.1093/ps/83.5.776; Gursel M, 2002, J LEUKOCYTE BIOL, V71, P813; Haddadi S, 2013, VET IMMUNOL IMMUNOP, V155, P270, DOI 10.1016/j.vetimm.2013.08.005; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; He HQ, 2007, MOL IMMUNOL, V44, P3234, DOI 10.1016/j.molimm.2007.01.034; He HQ, 2006, MOL IMMUNOL, V43, P783, DOI 10.1016/j.molimm.2005.07.002; Hsu ACY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032947; Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927; Kaufmann A, 2001, IMMUNOBIOLOGY, V204, P603, DOI 10.1078/0171-2985-00099; Keestra AM, 2008, J IMMUNOL, V181, P4354, DOI 10.4049/jimmunol.181.6.4354; Kogut MH, 2005, DEV COMP IMMUNOL, V29, P791, DOI 10.1016/j.dci.2005.02.002; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Le Tortorec A, 2011, VIRUSES-BASEL, V3, P520, DOI 10.3390/v3050520; Liang SL, 2006, IUBMB LIFE, V58, P508, DOI 10.1080/15216540600838232; Lillehoj HS, 2004, AVIAN DIS, V48, P244, DOI 10.1637/7054; Liniger M, 2012, J VIROL, V86, P705, DOI 10.1128/JVI.00742-11; LYON JA, 1991, J GEN VIROL, V72, P2011, DOI 10.1099/0022-1317-72-8-2011; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mosser D. M., 2008, ACTIVATION MURINE MA; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Paul MS, 2012, VACCINE, V30, P4524, DOI 10.1016/j.vaccine.2012.04.033; Peroval MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051243; Qiu LQ, 2009, BLOOD, V113, P3520, DOI 10.1182/blood-2008-07-171942; QURESHI MA, 1990, VET IMMUNOL IMMUNOP, V26, P237, DOI 10.1016/0165-2427(90)90094-9; Qureshi MA, 2000, DEV COMP IMMUNOL, V24, P103, DOI 10.1016/S0145-305X(99)00067-1; Shinya K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-97; St Paul M, 2013, RES VET SCI, V4, P1; St Paul M, 2013, RES VET SCI, V95, P87, DOI 10.1016/j.rvsc.2013.01.024; St Paul M, 2013, VET IMMUNOL IMMUNOP, V152, P191, DOI 10.1016/j.vetimm.2012.10.013; St Paul Michael, 2012, BMC Res Notes, V5, P616, DOI 10.1186/1756-0500-5-616; St Paul M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043381; St Paul M, 2011, VET IMMUNOL IMMUNOP, V144, P228, DOI 10.1016/j.vetimm.2011.09.004; Stewart CR, 2012, J INTERF CYTOK RES, V32, P46, DOI 10.1089/jir.2011.0036; Suarez DL, 2000, DEV COMP IMMUNOL, V24, P269, DOI 10.1016/S0145-305X(99)00078-6; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Tacken PJ, 2011, BLOOD, V118, P6836, DOI 10.1182/blood-2011-07-367615; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Tuvim MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030596; van de Sandt CE, 2012, VIRUSES-BASEL, V4, P1438, DOI 10.3390/v4091438; Van Reeth K, 2000, VET MICROBIOL, V74, P109, DOI 10.1016/S0378-1135(00)00171-1; Vanrompay D, 2001, IMMUNOLOGY, V103, P106, DOI 10.1046/j.1365-2567.2001.01215.x; Villanueva AI, 2011, DEV COMP IMMUNOL, V35, P28, DOI 10.1016/j.dci.2010.08.001; WELSH MD, 1995, VET IMMUNOL IMMUNOP, V46, P195, DOI 10.1016/0165-2427(94)05366-Z; Wong JP, 2009, VACCINE, V27, P3481, DOI 10.1016/j.vaccine.2009.01.048; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xie H, 2003, DEV COMP IMMUNOL, V27, P823, DOI 10.1016/S0145-305X(03)00079-X; Xing Z, 2008, J GEN VIROL, V89, P1288, DOI 10.1099/vir.0.83362-0; Xing Z, 2010, J GEN VIROL, V91, P343, DOI 10.1099/vir.0.015578-0; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229	64	53	57	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105713	10.1371/journal.pone.0105713	http://dx.doi.org/10.1371/journal.pone.0105713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165812	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303700038
J	Hutt, DM; Roth, DM; Vignaud, H; Cullin, C; Bouchecareilh, M				Hutt, Darren M.; Roth, Daniela Martino; Vignaud, Helene; Cullin, Christophe; Bouchecareilh, Marion			The Histone Deacetylase Inhibitor, Vorinostat, Represses Hypoxia Inducible Factor 1 Alpha Expression through Translational Inhibition	PLOS ONE			English	Article							INITIATION-FACTOR 3; HEPATOCELLULAR-CARCINOMA; RISK-FACTORS; EUKARYOTIC TRANSLATION; TUMOR ANGIOGENESIS; CANCER-TREATMENT; HIF-1; HIF-1-ALPHA; SORAFENIB; CELLS	Hypoxia inducible factor 1 alpha (HIF-1 alpha) is a master regulator of tumor angiogenesis being one of the major targets for cancer therapy. Previous studies have shown that Histone Deacetylase Inhibitors (HDACi) block tumor angiogenesis through the inhibition of HIF-1 alpha expression. As such, Vorinostat (Suberoylanilide Hydroxamic Acid/SAHA) and Romidepsin, two HDACis, were recently approved by the Food and Drug Administration (FDA) for the treatment of cutaneous T cell lymphoma. Although HDACis have been shown to affect HIF-1 alpha expression by modulating its interactions with the Hsp70/Hsp90 chaperone axis or its acetylation status, the molecular mechanisms by which HDACis inhibit HIF-1 alpha expression need to be further characterized. Here, we report that the FDA-approved HDACi Vorinostat/SAHA inhibits HIF-1 alpha expression in liver cancer-derived cell lines, by a new mechanism independent of p53, prolyl-hydroxylases, autophagy and proteasome degradation. We found that SAHA or silencing of HDAC9 mechanism of action is due to inhibition of HIF-1 alpha translation, which in turn, is mediated by the eukaryotic translation initiation factor - eIF3G. We also highlighted that HIF-1 alpha translation is dramatically inhibited when SAHA is combined with eIF3H silencing. Taken together, we show that HDAC activity regulates HIF-1 alpha translation, with HDACis such as SAHA representing a potential novel approach for the treatment of hepatocellular carcinoma.	[Hutt, Darren M.; Roth, Daniela Martino] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Vignaud, Helene; Cullin, Christophe; Bouchecareilh, Marion] Univ Bordeaux, Inst Biochim & Genet Cellulaires, CNRS, UMR 5095, Bordeaux, France	Scripps Research Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Bouchecareilh, M (corresponding author), Univ Bordeaux, Inst Biochim & Genet Cellulaires, CNRS, UMR 5095, Bordeaux, France.	mbouchecareilh@gmail.com	cullin, christophe/AAM-2179-2020	cullin, christophe/0000-0003-4110-4677	Foundation pour la Recherche Medicale (FRM) [SPF20130526734]	Foundation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	MB was supported by a fellowship from the Foundation pour la Recherche Medicale (FRM), SPF20130526734. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Bouchecareilh M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404707; Bouchecareilh M, 2011, FASEB J, V25, P3115, DOI 10.1096/fj.11-182931; Boumber Y, 2011, ONCOLOGY-NY, V25, P220; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Dasari A, 2013, INVEST NEW DRUG, V31, P115, DOI 10.1007/s10637-012-9812-z; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Ellis L, 2009, CANCER LETT, V280, P145, DOI 10.1016/j.canlet.2008.11.012; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Geng H, 2011, J BIOL CHEM, V286, P38095, DOI 10.1074/jbc.M111.257055; Gottschald OR, 2010, J MOL CELL BIOL, V2, P345, DOI 10.1093/jmcb/mjq032; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kumar M, 2007, J GASTROEN HEPATOL, V22, P1104, DOI 10.1111/j.1440-1746.2007.04908.x; Lachenmayer A, 2012, J HEPATOL, V56, P1343, DOI 10.1016/j.jhep.2012.01.009; Liang DM, 2006, CELL CYCLE, V5, P2430, DOI 10.4161/cc.5.21.3409; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Marks PA, 2005, EXPERT OPIN INV DRUG, V14, P1497, DOI 10.1517/13543784.14.12.1497; Martineau Y, 2008, MOL CELL BIOL, V28, P6658, DOI 10.1128/MCB.00738-08; Martineau Y, 2014, MOL CELL BIOL, V34, P1046, DOI 10.1128/MCB.01079-13; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Moeini A, 2012, LIVER CANCER, V1, P83, DOI 10.1159/000342405; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; Nupponen NN, 1999, AM J PATHOL, V154, P1777, DOI 10.1016/S0002-9440(10)65433-8; Okamoto H, 2003, HEPATOLOGY, V38, P1242, DOI 10.1053/jhep.2003.50457; Powis G, 2004, MOL CANCER THER, V3, P647; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Ravi R, 2000, GENE DEV, V14, P34; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Sarfstein R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024468; Schlaeger C, 2008, HEPATOLOGY, V47, P511, DOI 10.1002/hep.22033; Schmid T, 2004, J CELL MOL MED, V8, P423, DOI 10.1111/j.1582-4934.2004.tb00467.x; Schult C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-560; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Sesen J, 2014, INT J MOL SCI, V15, P2172, DOI 10.3390/ijms15022172; Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194; Siegel D, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-31; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Thornton RD, 2000, BIOCHEM J, V350, P307, DOI 10.1042/0264-6021:3500307; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Yan W, 2013, ONCOGENE, V32, P599, DOI 10.1038/onc.2012.81; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013910; Zhu KY, 2009, CANCER RES, V69, P1836, DOI 10.1158/0008-5472.CAN-08-4103; Zundel W, 2000, GENE DEV, V14, P391	59	69	75	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106224	10.1371/journal.pone.0106224	http://dx.doi.org/10.1371/journal.pone.0106224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166596	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303700083
J	Maarouf, CL; Kokjohn, TA; Walker, DG; Whiteside, CM; Kalback, WM; Whetzel, A; Sue, LI; Serrano, G; Jacobson, SA; Sabbagh, MN; Reiman, EM; Beach, TG; Roher, AE				Maarouf, Chera L.; Kokjohn, Tyler A.; Walker, Douglas G.; Whiteside, Charisse M.; Kalback, Walter M.; Whetzel, Alexis; Sue, Lucia I.; Serrano, Geidy; Jacobson, Sandra A.; Sabbagh, Marwan N.; Reiman, Eric M.; Beach, Thomas G.; Roher, Alex E.			Biochemical Assessment of Precuneus and Posterior Cingulate Gyrus in the Context of Brain Aging and Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; AMYLOID PRECURSOR PROTEIN; CEREBRAL-BLOOD-FLOW; C-TERMINAL FRAGMENT; APOLIPOPROTEIN-E; NEURODEGENERATIVE DISEASES; EPSILON-4 ALLELE; A-BETA; ALPHA-SYNUCLEIN; THERAPEUTIC TARGET	Defining the biochemical alterations that occur in the brain during "normal'' aging is an important part of understanding the pathophysiology of neurodegenerative diseases and of distinguishing pathological conditions from aging-associated changes. Three groups were selected based on age and on having no evidence of neurological or significant neurodegenerative disease: 1) young adult individuals, average age 26 years (n = 9); 2) middle-aged subjects, average age 59 years (n = 5); 3) oldest-old individuals, average age 93 years (n = 6). Using ELISA and Western blotting methods, we quantified and compared the levels of several key molecules associated with neurodegenerative disease in the precuneus and posterior cingulate gyrus, two brain regions known to exhibit early imaging alterations during the course of Alzheimer's disease. Our experiments revealed that the bioindicators of emerging brain pathology remained steady or decreased with advancing age. One exception was S100B, which significantly increased with age. Along the process of aging, neurofibrillary tangle deposition increased, even in the absence of amyloid deposition, suggesting the presence of amyloid plaques is not obligatory for their development and that limited tangle density is a part of normal aging. Our study complements a previous assessment of neuropathology in oldest-old subjects, and within the limitations of the small number of individuals involved in the present investigation, it adds valuable information to the molecular and structural heterogeneity observed along the course of aging and dementia. This work underscores the need to examine through direct observation how the processes of amyloid deposition unfold or change prior to the earliest phases of dementia emergence.	[Maarouf, Chera L.; Whiteside, Charisse M.; Kalback, Walter M.; Roher, Alex E.] Banner Sun Hlth Res Inst, Longtine Ctr Neurodegenerat Biochem, Sun City, AZ 85351 USA; [Kokjohn, Tyler A.] Midwestern Univ, Dept Microbiol, Glendale, AZ USA; [Walker, Douglas G.; Whetzel, Alexis] Banner Sun Hlth Res Inst, Lab Neuroinflammat, Sun City, AZ USA; [Sue, Lucia I.; Serrano, Geidy; Beach, Thomas G.] Banner Sun Hlth Res Inst, Civin Lab Neuropathol, Sun City, AZ USA; [Jacobson, Sandra A.; Sabbagh, Marwan N.] Banner Sun Hlth Res Inst, Cleo Roberts Ctr Clin Res, Sun City, AZ USA; [Reiman, Eric M.] Banner Alzheimers Inst, Phoenix, AZ USA	Banner Research; Banner Health; Banner Sun Health Research Institute; Midwestern University; Banner Research; Banner Health; Banner Sun Health Research Institute; Banner Research; Banner Health; Banner Sun Health Research Institute; Banner Research; Banner Health; Banner Sun Health Research Institute; Banner Research; Banner Health; Banner Alzheimer's Institute	Roher, AE (corresponding author), Banner Sun Hlth Res Inst, Longtine Ctr Neurodegenerat Biochem, Sun City, AZ 85351 USA.	alex.roher@bannerhealth.com			National Institute on Aging [R01 AG019795, R21 AG035078, R21 AG034409, R01AG031581, P30 AG19610]; Arizona Alzheimer's Disease Core Center [P30AG0119610]; National Institute of Neurological Disorders and Stroke (National Brain and Tissue Resource for Parkinson's Disease and Related Disorders) [U24 NS072026]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS072026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019795, R21AG035078, R01AG031581, R21AG034409, P30AG019610] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Alzheimer's Disease Core Center; National Institute of Neurological Disorders and Stroke (National Brain and Tissue Resource for Parkinson's Disease and Related Disorders); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute on Aging grants R01 AG019795, R21 AG035078 (AER), R21 AG034409 (DGW) and R01AG031581 (EMR). In addition EMR receives funding from the Arizona Alzheimer's Disease Core Center (P30AG0119610). The Brain Donation Program at Banner Sun Health Research Institute (TGB) is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection, analysis or interpretation of data, decision to publish or preparation of the manuscript.	Ahlgren S, 1996, ACTA NEUROPATHOL, V92, P49, DOI 10.1007/s004010050488; Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Apostolova LG, 2010, MOL IMAGING BIOL, V12, P218, DOI 10.1007/s11307-009-0247-7; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; Asllani I, 2008, J CEREBR BLOOD F MET, V28, P725, DOI 10.1038/sj.jcbfm.9600570; Austin BP, 2011, J ALZHEIMERS DIS, V26, P123, DOI 10.3233/JAD-2011-0010; Aydin D, 2012, EXP BRAIN RES, V217, P423, DOI 10.1007/s00221-011-2861-2; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Baumkotter F, 2012, EXP BRAIN RES, V217, P389, DOI 10.1007/s00221-011-2878-6; Beach T. G., 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P57, DOI 10.2174/1568013033358635; BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; Beach TG, 2008, ACTA NEUROPATHOL, V116, P277, DOI 10.1007/s00401-008-0409-8; Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7; Benzinger TLS, 2013, P NATL ACAD SCI USA, V110, pE4502, DOI 10.1073/pnas.1317918110; Binnewijzend MAA, 2013, RADIOLOGY, V267, P221, DOI 10.1148/radiol.12120928; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Castellani RJ, 2009, J ALZHEIMERS DIS, V18, P447, DOI 10.3233/JAD-2009-1151; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cevenini E, 2010, CURR PHARM DESIGN, V16, P609, DOI 10.2174/138161210790883840; Chhatwal JP, 2013, NEUROLOGY, V81, P736, DOI 10.1212/WNL.0b013e3182a1aafe; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CRYSTAL H, 1988, NEUROLOGY, V38, P1682, DOI 10.1212/WNL.38.11.1682; Dai WY, 2009, RADIOLOGY, V250, P856, DOI 10.1148/radiol.2503080751; Daly J, 1998, LIFE SCI, V63, P2121, DOI 10.1016/S0024-3205(99)80009-5; David JP, 1997, NEUROSCI LETT, V235, P53, DOI 10.1016/S0304-3940(97)00708-8; Davis DG, 1999, J NEUROPATH EXP NEUR, V58, P376, DOI 10.1097/00005072-199904000-00008; Desikan RS, 2014, JAMA NEUROL, V71, P180, DOI 10.1001/jamaneurol.2013.4560; Devi L, 2012, NEUROBIOL DIS, V45, P417, DOI 10.1016/j.nbd.2011.09.001; DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Driscoll I, 2011, CURR ALZHEIMER RES, V8, P330, DOI 10.2174/156720511795745348; Driscoll I, 2009, NEUROLOGY, V72, P1906, DOI 10.1212/WNL.0b013e3181a82634; Dugger BN, 2014, J NEUROPATH EXP NEUR, V73, P244, DOI 10.1097/NEN.0000000000000046; Esiri MM, 2007, J PATHOL, V211, P181, DOI 10.1002/path.2089; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Esposito R, 2013, PEERJ, V1, DOI 10.7717/peerj.135; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Finch CE, 2003, NEUROBIOL AGING, V24, pS123, DOI 10.1016/S0197-4580(03)00051-4; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; Fleisher AS, 2012, LANCET NEUROL, V11, P1057, DOI 10.1016/S1474-4422(12)70227-2; Freeman SH, 2008, J NEUROPATH EXP NEUR, V67, P1205, DOI 10.1097/NEN.0b013e31818fc72f; Frisoni GB, 2002, J NEUROL NEUROSUR PS, V73, P657, DOI 10.1136/jnnp.73.6.657; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Gersbacher MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069363; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Golde TE, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt5; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Grammas P, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-26; GRAY EG, 1987, NEUROPATH APPL NEURO, V13, P91, DOI 10.1111/j.1365-2990.1987.tb00174.x; Grinberg LT, 2010, ACTA NEUROPATHOL, V119, P277, DOI 10.1007/s00401-010-0652-7; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Heininger K, 2000, REV NEUROSCIENCE, V11, P213; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Hirono N, 2004, J NEUROPSYCH CLIN N, V16, P488, DOI 10.1176/appi.neuropsych.16.4.488; HIXSON JE, 1990, J LIPID RES, V31, P545; Hof PR, 1996, HISTOL HISTOPATHOL, V11, P1075; Holland D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047739; Hunter JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036893; Jack CR, 2013, NEUROLOGY, V81, P1732, DOI 10.1212/01.wnl.0000435556.21319.e4; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jana NR, 2012, NEUROCHEM INT, V60, P443, DOI 10.1016/j.neuint.2012.02.009; Jellinger KA, 2011, THESCIENTIFICWORLDJO, V11, P1893, DOI 10.1100/2011/371893; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kalback W, 2004, NEUROL RES, V26, P525, DOI 10.1179/016164104225017668; Kandalepas PC, 2012, J NEUROCHEM, V120, P55, DOI 10.1111/j.1471-4159.2011.07512.x; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kim SM, 2013, NEURORADIOLOGY, V55, P25, DOI 10.1007/s00234-012-1077-x; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klunk WE, 2013, NEUROLOGY, V81, P1728, DOI 10.1212/01.wnl.0000435568.38352.2e; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087; Kurnellas MP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005681; Langbaum JBS, 2010, ARCH NEUROL-CHICAGO, V67, P462, DOI 10.1001/archneurol.2010.30; Lee HG, 2005, TRENDS MOL MED, V11, P164, DOI 10.1016/j.molmed.2005.02.008; Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Lehmann M, 2014, J NEUROL NEUROSUR PS, V85, P266, DOI 10.1136/jnnp-2013-305858; Lindner AB, 2009, BBA-GEN SUBJECTS, V1790, P980, DOI 10.1016/j.bbagen.2009.06.005; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Lue LF, 2010, MOL NEUROBIOL, V41, P115, DOI 10.1007/s12035-010-8106-8; Maarouf CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027291; Mahley RW, 2007, CURR ALZHEIMER RES, V4, P537, DOI 10.2174/156720507783018334; Mahley RW, 2009, ANN NEUROL, V65, P623, DOI 10.1002/ana.21736; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Matsuda H, 2001, ANN NUCL MED, V15, P85, DOI 10.1007/BF02988596; McPhie DL, 1997, J BIOL CHEM, V272, P24743, DOI 10.1074/jbc.272.40.24743; Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357; Mirra SS, 1997, NEUROBIOL AGING, V18, pS91, DOI 10.1016/S0197-4580(97)00058-4; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Morbelli S, 2010, EUR J NUCL MED MOL I, V37, P36, DOI 10.1007/s00259-009-1218-6; Mori T., 2010, CARDIOVASC PSYCHIAT; Mosconi L, 2004, J NEUROL NEUROSUR PS, V75, P370, DOI 10.1136/jnnp.2003.014993; Mrak RE, 1997, J NEUROPATH EXP NEUR, V56, P1269, DOI 10.1097/00005072-199712000-00001; Munch C, 2012, J MOL BIOL, V421, P491, DOI 10.1016/j.jmb.2011.12.061; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nelson PT, 2009, NEUROSCI LETT, V450, P336, DOI 10.1016/j.neulet.2008.11.006; NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P; O'Brien RJ, 2009, J ALZHEIMERS DIS, V18, P665, DOI 10.3233/JAD-2009-1179; O'Callaghan P, 2014, AMYLOID; Pakkenberg B, 2003, EXP GERONTOL, V38, P95, DOI 10.1016/S0531-5565(02)00151-1; Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; Pizza V, 2011, REV RECENT CLIN TRIA, V6, P189, DOI 10.2174/157488711796575577; Popescu BO, 2009, J NEUROL SCI, V283, P99, DOI 10.1016/j.jns.2009.02.321; Porchet R, 2003, PROTEOMICS, V3, P1476, DOI 10.1002/pmic.200300456; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Prior R, 2000, ANN NY ACAD SCI, V903, P180, DOI 10.1111/j.1749-6632.2000.tb06367.x; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Radanovic M, 2013, EXPERT REV NEUROTHER, V13, P483, DOI [10.1586/ERN.13.45, 10.1586/ern.13.45]; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reddy PH, 2011, CURR ALZHEIMER RES, V8, P393; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Resnick SM, 2003, J NEUROSCI, V23, P3295; Robinson SR, 2002, NEUROBIOL AGING, V23, P1051, DOI 10.1016/S0197-4580(01)00342-6; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Roher AE, 2011, ALZHEIMERS DEMENT, V7, P445, DOI 10.1016/j.jalz.2010.09.002; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Sadigh-Eteghad S, 2012, NEUROSCIENCES, V17, P321; Sakamoto S, 2002, J NEUROL SCI, V200, P27, DOI 10.1016/S0022-510X(02)00114-4; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Scarmeas N, 2004, AM J GERIAT PSYCHIAT, V12, P596, DOI 10.1176/appi.ajgp.12.6.596; Schettini G, 2010, J NEUROCHEM, V115, P1299, DOI 10.1111/j.1471-4159.2010.07044.x; Serbinek D, 2010, CARDIOVASC PSYCHIAT; Shariati SAM, 2013, FEBS LETT, V587, P2036, DOI 10.1016/j.febslet.2013.05.026; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Sonnen JA, 2011, ARCH NEUROL-CHICAGO, V68, P1049, DOI 10.1001/archneurol.2011.157; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Stroick M, 2006, CURR MED CHEM, V13, P3053, DOI 10.2174/092986706778521751; Swerdlow RH, 2011, BBA-MOL BASIS DIS, V1812, P1630, DOI 10.1016/j.bbadis.2011.08.012; Takahashi Tohru, 2006, Legal Medicine, V8, P161, DOI 10.1016/j.legalmed.2006.01.002; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; TERRY RD, 1987, ANN NEUROL, V21, P530, DOI 10.1002/ana.410210603; Terry RD, 2006, J GERIATR PSYCH NEUR, V19, P125, DOI 10.1177/0891988706291079; Toledo JB, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-65; Townsend KP, 2002, ANN NY ACAD SCI, V977, P65, DOI 10.1111/j.1749-6632.2002.tb04799.x; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Valla J, 2010, J ALZHEIMERS DIS, V22, P307, DOI 10.3233/JAD-2010-100129; Waddington MM, 1974, ATLAS CEREBRAL ANGIO; Walker DG, 2009, EXP NEUROL, V215, P5, DOI 10.1016/j.expneurol.2008.09.003; Waragai M, 2007, J NEUROL SCI, V260, P57, DOI 10.1016/j.jns.2007.03.027; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wirth M, 2013, JAMA NEUROL, V70, P1512, DOI 10.1001/jamaneurol.2013.4013; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yasha TC, 1997, INDIAN J MED RES, V105, P141; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; ZLOKOVIC BV, 1994, BIOCHEM BIOPH RES CO, V205, P1431, DOI 10.1006/bbrc.1994.2825	161	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105784	10.1371/journal.pone.0105784	http://dx.doi.org/10.1371/journal.pone.0105784			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166759	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303700044
J	Kang, OE; Huffer, KE; Wheatley, TP				Kang, Olivia E.; Huffer, Katherine E.; Wheatley, Thalia P.			Pupil Dilation Dynamics Track Attention to High-Level Information	PLOS ONE			English	Article							NITROGEN; MARS; SURFACE; CARBONATES; FIXATION; ELEMENTS; WATER; PH	It has long been thought that the eyes index the inner workings of the mind. Consistent with this intuition, empirical research has demonstrated that pupils dilate as a consequence of attentional effort. Recently, Smallwood et al. (2011) demonstrated that pupil dilations not only provide an index of overall attentional effort, but are time-locked to stimulus changes during attention (but not during mind-wandering). This finding suggests that pupil dilations afford a dynamic readout of conscious information processing. However, because stimulus onsets in their study involved shifts in luminance as well as information, they could not determine whether this coupling of stimulus and pupillary dynamics reflected attention to low-level (luminance) or high-level (information) changes. Here, we replicated the methodology and findings of Smallwood et al. (2011) while controlling for luminance changes. When presented with isoluminant digit sequences, participants' pupillary dilations were synchronized with stimulus onsets when attending, but not when mind-wandering. This replicates Smallwood et al. (2011) and clarifies their finding by demonstrating that stimulus-pupil coupling reflects online cognitive processing beyond sensory gain.	[Kang, Olivia E.; Huffer, Katherine E.; Wheatley, Thalia P.] Dartmouth Coll, Hanover, NH 03755 USA	Dartmouth College	Wheatley, TP (corresponding author), Dartmouth Coll, Hanover, NH 03755 USA.	thalia.p.wheatley@dartmouth.edu		Huffer, Katherine/0000-0001-5003-3140				BAUR PS, 1974, PHYTON-INT J EXP BOT, V32, P133; Brack A, 1998, EXTREMOPHILES, V2, P313, DOI 10.1007/s007920050074; Bullock MA, 2004, ICARUS, V170, P404, DOI 10.1016/j.icarus.2004.03.016; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Carlton CA., 2014, JSC MARS 1 MARTIAN R; Chevrier V, 2007, PLANET SPACE SCI, V55, P289, DOI 10.1016/j.pss.2006.05.039; CLARK BC, 1981, ICARUS, V45, P370, DOI 10.1016/0019-1035(81)90041-5; CLARK BC, 1993, GEOCHIM COSMOCHIM AC, V57, P4575, DOI 10.1016/0016-7037(93)90183-W; Ferl RJ, 2010, ASTROBIOLOGY, V10, P261, DOI 10.1089/ast.2009.0417; Foley C.N., 2003, J GEOPHYS RES, V108; Foy C. D., 1984, Soil acidity and liming, P57; FOY CD, 1978, ANNU REV PLANT PHYS, V29, P511, DOI 10.1146/annurev.pp.29.060178.002455; Garg N, 2007, AGRON SUSTAIN DEV, V27, P59, DOI 10.1051/agro:2006030; GIBSON EK, 1977, PHYS CHEM EARTH, V10, P57, DOI 10.1016/0079-1946(77)90006-4; Golubyatnikov LL, 2013, IZV ATMOS OCEAN PHY+, V49, P229, DOI 10.1134/S0001433813030079; Houlton BZ, 2008, NATURE, V454, P327, DOI 10.1038/nature07028; Hui HJ, 2013, NAT GEOSCI, V6, P177, DOI 10.1038/ngeo1735; Kozyrovska NO, 2006, ADV SPACE RES-SERIES, V37, P93, DOI 10.1016/j.asr.2005.03.005; Kral TA, 2004, ORIGINS LIFE EVOL B, V34, P615, DOI 10.1023/B:ORIG.0000043129.68196.5f; Leshin LA, 2013, SCIENCE, V341, DOI 10.1126/science.1238937; Mancinelli RL, 1996, ADV SPACE RES-SERIES, V18, P241, DOI 10.1016/0273-1177(96)00113-5; Mancinelli RL., 2003, INT J ASTROBIOL, V2, P217, DOI DOI 10.1017/S1473550403001599; McCullagh P, 1989, GEN LINEAR MODELS; Mohlmann DTF, 2004, ICARUS, V168, P318, DOI 10.1016/j.icarus.2003.11.008; Muller O, 1974, P 5 LUN SCI C, P1907; MYLONA P, 1995, PLANT CELL, V7, P869, DOI 10.1105/tpc.7.7.869; Palomba E, 2009, ICARUS, V203, P58, DOI 10.1016/j.icarus.2009.04.013; Parnell J, 2005, P GEOLOGIST ASSOC, V116, P281, DOI 10.1016/S0016-7878(05)80046-X; Rickman D, 2007, CHARACTERIZATION SUM; Stevens CJ, 2011, ENVIRON POLLUT, V159, P665, DOI 10.1016/j.envpol.2010.12.008; Vitousek PM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0119; Wamelink GWW, 2011, J VEG SCI, V22, P741, DOI 10.1111/j.1654-1103.2011.01286.x; Wamelink G.W.W., 2012, BIODIVERSITY ECOLOGY, V2012, P125; Wamelink GWW, 2005, J VEG SCI, V16, P461, DOI 10.1111/j.1654-1103.2005.tb02386.x; Wu SC, 2005, GEODERMA, V125, P155, DOI 10.1016/j.geoderma.2004.07.003; Zaets I, 2011, ADV SPACE RES, V47, P1071, DOI 10.1016/j.asr.2010.11.014	36	72	72	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e102463	10.1371/journal.pone.0102463	http://dx.doi.org/10.1371/journal.pone.0102463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162597	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900004
J	Lecky, DM; Hawking, MKD; Verlander, NQ; McNulty, CAM				Lecky, Donna M.; Hawking, Meredith K. D.; Verlander, Neville Q.; McNulty, Cliodna A. M.			Using Interactive Family Science Shows to Improve Public Knowledge on Antibiotic Resistance: Does It Work?	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; PRIMARY-CARE; E-BUG; CAMPAIGNS; AWARENESS; INFECTIONS; ATTITUDES; HYGIENE	The public plays an important role in controlling the emergence and spread of antibiotic resistance. A large British survey showed that there is still public misunderstanding about microbes and antibiotics. e-Bug, a European DG Sanco sponsored project, aims to disseminate a school antibiotic and hygiene educational pack and website across Europe. Interactive science shows based on the e-Bug educational packs were developed to take the key health and hygiene messages from the e-Bug school resources to families. The science show was evaluated to assess public knowledge and understanding of antibiotics and antibiotic resistance pre and post intervention. An interactive stall comprised of a 362 m backing stand with background information, an interactive activity and discussions with a trained demonstrator was on display at a family holiday resort. Pre-piloted knowledge questionnaires were completed by parents and children pre and post intervention. Adult (>= 19 years) baseline knowledge regarding antibiotics and antibiotic resistance was high although significant knowledge improvement was observed where baseline knowledge was low. Children's (5-11 years) knowledge around antibiotics and antibiotic resistance was significantly improved for all questions. The science show can be viewed as a success in improving parents' and children's knowledge of antibiotic use thereby highlighting the importance of educating the public through interaction.	[Lecky, Donna M.; Hawking, Meredith K. D.; McNulty, Cliodna A. M.] Gloucester Royal Hosp, Dept Microbiol, Publ Hlth England Primary Care Unit, Gloucester, England; [Verlander, Neville Q.] Publ Hlth England Ctr Infect, Stat Modelling & Econ Dept, London, England	Public Health England	Lecky, DM (corresponding author), Gloucester Royal Hosp, Dept Microbiol, Publ Hlth England Primary Care Unit, Gloucester, England.	donna.lecky@phe.gov.uk	Lecky, Donna Marie/AAB-6849-2019; Hawking, Meredith KD/E-7692-2015	Lecky, Donna Marie/0000-0002-1223-9356; Hawking, Meredith KD/0000-0003-1519-2458	Public Health England; British Society for Antimicrobial Chemotherapy	Public Health England; British Society for Antimicrobial Chemotherapy	This work was supported by internal funding from Public Health England and the British Society for Antimicrobial Chemotherapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush P J, 1985, NIDA Res Monogr, V56, P45; BUSH PJ, 1990, SOC SCI MED, V31, P1043, DOI 10.1016/0277-9536(90)90117-B; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Davey P, 2002, CLIN MICROBIOL INFEC, V8, P43, DOI 10.1046/j.1469-0691.8.s.2.6.x; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; Del Mar C, 2001, BMJ-BRIT MED J, V335, P407; Earnshaw S, 2009, EUROSURVEILLANCE, V14, P23; Emslie Margaret J, 2003, Eur J Gen Pract, V9, P84; European Centre of Disease Prevention and Control (ECDC), 2011, ANN REPORT EUROPEAN; European commission, 2010, SPEC EUR 338 ANT RES; European commission, 2013, SPEC EUR 407 ANT RES; Francis NA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2885; Freimuth V, 2000, EMERG INFECT DIS, V6, P337, DOI 10.3201/eid0604.000403; Goossens H, 2006, EUR J CLIN PHARMACOL, V62, P373, DOI 10.1007/s00228-005-0094-7; Grigoryan L, 2007, J ANTIMICROB CHEMOTH, V59, P152, DOI 10.1093/jac/dkl457; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Lecky DM, 2010, J ANTIMICROB CHEMOTH, V65, P2674, DOI 10.1093/jac/dkq356; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; McNulty CAM, 2007, HLTH ED, V1, P10; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V60, pI63, DOI 10.1093/jac/dkm161; McNulty CAM, 2013, BRIT J GEN PRACT, V63, pE429, DOI 10.3399/bjgp13X669149; McNulty CAM, 2011, J ANTIMICROB CHEMOTH, V66, pV3, DOI 10.1093/jac/dkr119; McNulty CAM, 2010, J ANTIMICROB CHEMOTH, V65, P1526, DOI 10.1093/jac/dkq126; Moore M, 2009, BRIT J GEN PRACT, V59, P728, DOI 10.3399/bjgp09X472601; RCGP and members of Antimicrobial Stewardship in Primary Care Group, 2012, TARGET ANT; Rogers EM, 1983, DIFFUSION INNOVATION; Simoens S, 2010, PHARMACEUTICALS-BASE, V3, P1348, DOI 10.3390/ph3051348; Trepka MJ, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e6; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1	29	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e104556	10.1371/journal.pone.0104556	http://dx.doi.org/10.1371/journal.pone.0104556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162505	gold, Green Published, Green Submitted			2022-12-25	WOS:000340880900016
J	Barbosa, EJL; Glad, CAM; Nilsson, AG; Bosaeus, N; Nystrom, HF; Svensson, PA; Bengtsson, BA; Nilsson, S; Bosaeus, I; Boguszewski, CL; Johannsson, G				Barbosa, Edna J. L.; Glad, Camilla A. M.; Nilsson, Anna G.; Bosaeus, Niklas; Nystrom, Helena Filipsson; Svensson, Per-Arne; Bengtsson, Bengt-Ake; Nilsson, Staffan; Bosaeus, Ingvar; Boguszewski, Cesar Luiz; Johannsson, Gudmundur			Extracellular Water and Blood Pressure in Adults with Growth Hormone (GH) Deficiency: A Genotype-Phenotype Association Study	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; CARDIOVASCULAR RISK-FACTORS; CHANNEL GAMMA-SUBUNIT; CL-COTRANSPORTER GENE; BIOIMPEDANCE SPECTROSCOPY; DOUBLE-BLIND; ENDOTHELIAL FUNCTION; GITELMANS-SYNDROME; BODY-COMPOSITION; RECEPTOR GENE	Objectives: Growth hormone deficiency (GHD) in adults is associated with decreased extracellular water volume (ECW). In response to GH replacement therapy (GHRT), ECW increases and blood pressure (BP) reduces or remains unchanged. Our primary aim was to study the association between polymorphisms in genes related to renal tubular function with ECW and BP before and 1 year after GHRT. The ECW measures using bioimpedance analysis (BIA) and bioimpedance spectroscopy (BIS) were validated against a reference method, the sodium bromide dilution method (Br-). Design and Methods: Using a candidate gene approach, fifteen single-nucleotide polymorphisms (SNPs) in nine genes with known impact on renal tubular function (AGT, SCNN1A, SCNN1G, SLC12A1, SLC12A3, KCNJ1, STK39, WNK1 and CASR) were genotyped and analyzed for associations with ECW and BP at baseline and with their changes after 1 year of GHRT in 311 adult GHD patients. ECW was measured with the Br-, BIA, and BIS. Results: Both BIA and BIS measurements demonstrated similar ECW results as the reference method. At baseline, after adjustment for sex and BMI, SNP rs2291340 in the SLC12A1 gene was associated with ECW volume in GHD patients (p = 0.039). None of the SNPs influenced the ECW response to GHRT. One SNP in the SLC12A3 gene (rs11643718; p = 0.024) and three SNPs in the SCNN1G gene [rs5723 (p = 0.02), rs5729 (p = 0.016) and rs13331086 (p = 0.035)] were associated with the inter-individual differences in BP levels at baseline. A polymorphism in the calcium-sensing receptor (CASR) gene (rs1965357) was associated with changes in systolic BP after GHRT (p = 0.036). None of these associations remained statistically significant when corrected for multiple testing. Conclusion: The BIA and BIS are as accurate as Br- to measure ECW in GHD adults before and during GHRT. Our study provides the first evidence that individual polymorphisms may have clinically relevant effects on ECW and BP in GHD adults.	[Barbosa, Edna J. L.; Glad, Camilla A. M.; Nilsson, Anna G.; Nystrom, Helena Filipsson; Bengtsson, Bengt-Ake; Johannsson, Gudmundur] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Endocrinol, Gothenburg, Sweden; [Barbosa, Edna J. L.; Boguszewski, Cesar Luiz] Univ Fed Parana, Hosp Clin, SEMPR, Serv Endocrinol & Metabol, BR-80060000 Curitiba, Parana, Brazil; [Glad, Camilla A. M.; Svensson, Per-Arne] Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Ctr Cardiovasc & Metab Res, Inst Med,Dept Mol & Clin Med, Gothenburg, Sweden; [Nilsson, Staffan] Chalmers Univ Technol, Inst Math Sci, Dept Math Stat, S-41296 Gothenburg, Sweden; [Bosaeus, Niklas; Bosaeus, Ingvar] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Clin Nutr Unit, Gothenburg, Sweden	University of Gothenburg; Universidade Federal do Parana; University of Gothenburg; Chalmers University of Technology; Sahlgrenska University Hospital; University of Gothenburg	Johannsson, G (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Endocrinol, Gothenburg, Sweden.	gudmundur.johannsson@medic.gu.se	BOGUSZEWSKI, CESAR LUIZ/D-4603-2013; Boguszewski, Cesar Luiz/V-5661-2019; Svensson, Per-Arne/R-4626-2019; Nyström, Helena Filipsson/ABI-5659-2020	Boguszewski, Cesar Luiz/0000-0001-7285-7941; Nilsson, Staffan/0000-0003-4748-0446; Johannsson, Gudmundur/0000-0003-3484-8440; Svensson, Per-Arne/0000-0002-6731-806X	Swedish federal government under the LUA/ALF; NovoNordisk; Pfizer	Swedish federal government under the LUA/ALF; NovoNordisk(Novo Nordisk); Pfizer(Pfizer)	This project has received financial support from the Swedish federal government under the LUA/ALF agreement, NovoNordisk and Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boger RH, 1996, J CLIN INVEST, V98, P2706, DOI 10.1172/JCI119095; Busst CJ, 2011, HYPERTENSION, V58, P1073, DOI 10.1161/HYPERTENSIONAHA.111.176370; Busst CJ, 2007, HYPERTENSION, V50, P672, DOI 10.1161/HYPERTENSIONAHA.107.089128; Capaldo B, 2001, CIRCULATION, V103, P520, DOI 10.1161/01.CIR.103.4.520; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; CHIN E, 1992, ENDOCRINOLOGY, V131, P3061, DOI 10.1210/en.131.6.3061; DeLorenzo A, 1997, J APPL PHYSIOL, V82, P1542, DOI 10.1152/jappl.1997.82.5.1542; Dimke H, 2007, GROWTH HORM IGF RES, V17, P353, DOI 10.1016/j.ghir.2007.04.008; Dimke H, 2007, AM J PHYSIOL-RENAL, V292, pF723, DOI 10.1152/ajprenal.00276.2006; Evans LM, 2000, EUR J ENDOCRINOL, V142, P254, DOI 10.1530/eje.0.1420254; Hanisch Dorin, 2004, Anthropol Anz, V62, P51; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Iwai N, 2004, J HYPERTENS, V22, P1119, DOI 10.1097/00004872-200406000-00012; Jaffrin MY, 2009, MED BIOL ENG COMPUT, V47, P77, DOI 10.1007/s11517-008-0394-z; Jaffrin MY, 2008, MED ENG PHYS, V30, P1257, DOI 10.1016/j.medengphy.2008.06.009; Johannsson G, 2005, J CLIN ENDOCR METAB, V90, P3989, DOI 10.1210/jc.2005-0553; Johannsson G, 2002, J CLIN ENDOCR METAB, V87, P1743, DOI 10.1210/jc.87.4.1743; Jung JS, 2009, J CLIN ENDOCR METAB, V94, P1042, DOI 10.1210/jc.2008-1861; Koranyi J, 2006, EUR J ENDOCRINOL, V154, P545, DOI 10.1530/eje.1.02118; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; LANDINWILHELMSEN K, 1994, CLIN ENDOCRINOL, V41, P351, DOI 10.1111/j.1365-2265.1994.tb02556.x; Lin JL, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-9; Longobardi S, 2000, GROWTH HORM IGF RES, V10, P242, DOI 10.1054/ghir.2000.0160; Maison P, 2004, J CLIN ENDOCR METAB, V89, P2192, DOI 10.1210/jc.2003-030840; Matayoshi T, 2004, HYPERTENS RES, V27, P821, DOI 10.1291/hypres.27.821; Matsuo A, 2004, J HYPERTENS, V22, P2123, DOI 10.1097/00004872-200411000-00014; Matthie JR, 2005, J APPL PHYSIOL, V99, P780, DOI 10.1152/japplphysiol.00145.2005; Melander O, 2000, HYPERTENSION, V36, P389, DOI 10.1161/01.HYP.36.3.389; MILLER ME, 1989, AM J CLIN NUTR, V50, P168, DOI 10.1093/ajcn/50.1.168; Moller J, 1999, EUR J ENDOCRINOL, V140, P11, DOI 10.1530/eje.0.1400011; Pfeifer M, 1999, J CLIN ENDOCR METAB, V84, P453, DOI 10.1210/jc.84.2.453; Plank LD, 1998, APPL RADIAT ISOTOPES, V49, P481, DOI 10.1016/S0969-8043(97)00060-2; ROSEN T, 1993, CLIN ENDOCRINOL, V38, P63, DOI 10.1111/j.1365-2265.1993.tb00974.x; ROSEN T, 1993, ACTA ENDOCRINOL-COP, V129, P195, DOI 10.1530/acta.0.1290195; Rossoni G, 1999, J CARDIOVASC PHARM, V34, P454, DOI 10.1097/00005344-199909000-00021; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Silva AM, 2008, AM J CLIN NUTR, V88, P315, DOI 10.1093/ajcn/88.2.315; Silva AM, 2007, PHYSIOL MEAS, V28, P489, DOI 10.1088/0967-3334/28/5/004; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Smith JC, 2002, CLIN ENDOCRINOL, V56, P493, DOI 10.1046/j.1365-2265.2002.01514.x; SNEL YEM, 1995, ANN NUTR METAB, V39, P242, DOI 10.1159/000177869; Svensson J, 1997, CLIN ENDOCRINOL, V46, P579, DOI 10.1046/j.1365-2265.1997.1851001.x; Tanaka N, 2003, DIABETES, V52, P2848, DOI 10.2337/diabetes.52.11.2848; Tengvall M, 2010, PHYSIOL MEAS, V31, P59, DOI 10.1088/0967-3334/31/1/005; Tobin MD, 2008, HYPERTENSION, V51, P1658, DOI 10.1161/HYPERTENSIONAHA.108.112664; Tobin MD, 2005, CIRCULATION, V112, P3423, DOI 10.1161/CIRCULATIONAHA.105.555474; Tong QS, 2006, AM J PHYSIOL-RENAL, V290, pF821, DOI 10.1152/ajprenal.00312.2005; Turner ST, 2005, HYPERTENSION, V46, P758, DOI 10.1161/01.HYP.0000186240.81996.57; Vormfelde SV, 2007, CLIN PHARMACOL THER, V82, P300, DOI 10.1038/sj.clpt.6100131; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106	51	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105754	10.1371/journal.pone.0105754	http://dx.doi.org/10.1371/journal.pone.0105754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157616	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303200058
J	Zhou, F; Zhang, L; Gao, L; Hao, YB; Zhao, XL; Liu, JM; Lu, J; Li, XW; Yang, Y; Chen, JG; Deng, Y				Zhou, Feng; Zhang, Li; Gao, Lei; Hao, Yibin; Zhao, Xianli; Liu, Jianmin; Lu, Jie; Li, Xiangwei; Yang, Yu; Chen, Junguo; Deng, Ying			Latent Tuberculosis Infection and Occupational Protection among Health Care Workers in Two Types of Public Hospitals in China	PLOS ONE			English	Article							RISK; DISEASE; ASSAY	Objective: To determine the impact factors of latent tuberculosis infection (LTBI) and the knowledge of TB prevention and treatment policy among health care workers (HCWs) in different types of hospitals and explore the strategies for improving TB prevention and control in medical institutions in China. Methods: A cross-sectional study was carried out to evaluate the risk of TB infection and personnel occupational protection among HCWs who directly engage in medical duties in one of two public hospitals. Each potential participant completed a structured questionnaire and performed a tuberculin skin test (TST). Factors associated with LTBI were identified by logistic regression analysis. Results: Seven hundred twelve HCWs completed questionnaires and 74.3% (n = 529) took the TST or had previous positive results. The TST-positive prevalence was 58.0% (n = 127) in the infectious disease hospital and 33.9% (n = 105) in the non-TB hospital. The duration of employment in the healthcare profession (6-10 years vs. <= 5 years [OR = 1.89; 95% CI = 1.10, 3.25] and >10 vs. <= 5[OR = 1.80; 95% CI = 1.20, 2.68]), type of hospital (OR = 2.40; 95% CI = 1.59, 3.62), and ever-employment in a HIV clinic or ward (OR = 1.87; 95% CI = 1.08, 3.26) were significantly associated with LTBI. The main reasons for an unwillingness to accept TST were previous positive TST results (70.2%) and concerns about skin reaction (31.9%). Conclusion: A high prevalence of TB infections was observed among HCWs working in high-risk settings and with long professional experiences in Henan Province in China. Comprehensive guidelines should be developed for different types of medical institutions to reduce TB transmission and ensure the health of HCWs.	[Zhou, Feng; Chen, Junguo] Third Mil Med Univ, Chongqing, Peoples R China; [Zhou, Feng; Zhang, Li; Deng, Ying] Beijing Res Ctr Prevent Med, Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China; [Gao, Lei; Li, Xiangwei; Yang, Yu] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Gao, Lei; Li, Xiangwei; Yang, Yu] Peking Union Med Coll, Beijing 100021, Peoples R China; [Hao, Yibin] Zhengzhou Cent Hosp, Zhengzhou, Peoples R China; [Zhao, Xianli; Liu, Jianmin] Henan Prov Infect Dis Hosp, Zhengzhou, Peoples R China; [Lu, Jie] Zhengzhou Univ, Sch Publ Hlth, Zhengzhou 450052, Peoples R China	Army Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Zhengzhou University; Zhengzhou University	Chen, JG (corresponding author), Third Mil Med Univ, Chongqing, Peoples R China.	cqchenjunguo@sina.com; ydeng2014@sina.com		Yang, Yu/0000-0002-5611-8951	Institute of Pathogen Biology, Chinese Academy of Medical Science [IPB2011IPB104]	Institute of Pathogen Biology, Chinese Academy of Medical Science	This work was supported by the grants from the Institute of Pathogen Biology, Chinese Academy of Medical Science (IPB2011IPB104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CDC Ministry of Health of the People' Republic of China, 2008, GUID IMPL CHIN TUB C; Chai SJ, 2013, HEALTH POLICY PLANN, V28, P100, DOI 10.1093/heapol/czs029; Chinese Ministry of Health, 2013, ADM MEAS PREV CONTR; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Fennelly KP, 1999, INT J TUBERC LUNG D, V3, P363; Franco C, 2006, INT J TUBERC LUNG D, V10, P384; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010736; Harries AD, 1997, B WORLD HEALTH ORGAN, V75, P477; He GX, 2012, INT J TUBERC LUNG D, V16, P1485, DOI 10.5588/ijtld.12.0193; He GX, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-313; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kassim S, 2000, INT J TUBERC LUNG D, V4, P321; Kayanja HK, 2005, INT J TUBERC LUNG D, V9, P686; Li JM, 2006, CHINESE J PUBLIC HLT, V22, P488; Lien Luu Thi, 2009, PLoS One, V4, pe6798, DOI 10.1371/journal.pone.0006798; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; National Technical Steering Group of the Epidemiological Sampling Survey for Tuberculosis, 2002, CHIN J TUBERC RESP D, V25, P5; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Sepkowitz KA, 1996, TUBERCLE LUNG DIS, V77, P81, DOI 10.1016/S0962-8479(96)90081-7; Wang Guo-jie, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P980; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2010, WHOHTMTB20107; Wrighton-Smith P, 2012, J OCCUP ENVIRON MED, V54, P806, DOI 10.1097/JOM.0b013e318254620f; Zahnow K, 1998, INFECT CONT HOSP EP, V19, P829; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066412; Zhou F, 2013, ZHONGGUO YU FANG YI, V14, P905	26	15	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104673	10.1371/journal.pone.0104673	http://dx.doi.org/10.1371/journal.pone.0104673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157814	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303200015
J	Truesdell, P; Ahn, J; Chander, H; Meens, J; Watt, K; Yang, X; Craig, AWB				Truesdell, P.; Ahn, J.; Chander, H.; Meens, J.; Watt, K.; Yang, X.; Craig, A. W. B.			CIP4 promotes lung adenocarcinoma metastasis and is associated with poor prognosis	ONCOGENE			English	Article							CDC42-INTERACTING PROTEIN 4; GROWTH-FACTOR RECEPTOR; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER-CELL INVASION; ACTIN CYTOSKELETON; MEMBRANE INVAGINATION; TUMOR PROGRESSION; DOWN-REGULATION; KINASE DOMAIN; BAR PROTEINS	Aberrant epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer (NSCLC) is linked to tumor progression, metastasis and poor survival rates. Here we report the role of Cdc42-interacting protein 4 (CIP4) in the regulation of NSCLC cell invasiveness and tumor metastasis. CIP4 was highly expressed in a panel of NSCLC cell lines and normal lung epithelial cell lines. Stable knockdown (KD) of CIP4 in lung adenocarcinoma H1299 cells, expressing wild-type EGFR, led to increased EGFR levels on the cell surface and defects in sustained activation of Erk kinase in H1299 cells treated with EGF. CIP4 localized to leading edge projections in NSCLC cells, and CIP4 KD cells displayed defects in EGF-induced cell motility and invasion through extracellular matrix. This correlated with reduced expression and activity of matrix metalloproteinase-2 (MMP-2) in CIP4 KD cells compared with control. In xenograft assays, CIP4 silencing had no effect on tumor growth but resulted in significant defects in spontaneous metastases to the lungs from these subcutaneous tumors. This correlated with reduced expression of the Erk target gene Zeb1 and the Zeb1 target gene MMP-2 in CIP4 KD tumors compared with control. CIP4 also enhanced rates of metastasis to the liver and lungs in an intrasplenic experimental metastasis model. In human NSCLC tumor sections, CIP4 expression was elevated greater than or equal to twofold in 43% of adenocarcinomas and 32% of squamous carcinomas compared with adjacent normal lung tissues. Analysis of microarray data for NSCLC patients also revealed that high CIP4 transcript levels correlated with reduced overall survival. Together, these results identify CIP4 as a positive regulator of NSCLC metastasis and a potential poor prognostic biomarker in lung adenocarcinoma.	[Truesdell, P.; Ahn, J.; Chander, H.; Meens, J.; Watt, K.; Craig, A. W. B.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Truesdell, P.; Ahn, J.; Chander, H.; Meens, J.; Watt, K.; Craig, A. W. B.] Queens Canc Res Inst, Canc Biol & Genet, Kingston, ON, Canada; [Yang, X.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada	Queens University - Canada; McMaster University; Queens University - Canada	Craig, AWB (corresponding author), Queens Univ, Dept Biomed & Mol Sci & Canc Biol & Genet, 18 Stuart St, Kingston, ON K7L 3N6, Canada.	andrew.craig@queensu.ca	Craig, Andrew/AAC-6923-2019; Craig, Andrew/G-2312-2017	Craig, Andrew/0000-0002-2039-2393; Craig, Andrew/0000-0002-2039-2393; Watt, Kathleen/0000-0001-6642-9756	Canadian Cancer Society Research Institute; Canadian Institutes for Health Research [MOP119562]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	We thank Stephanie Everingham for technical assistance, Jeff Mewburn for help with time-lapse confocal microscopy and Lee Boudreau (Queen's Laboratory for Molecular Pathology) for help in optimizing IHC staining. Thanks also to Lois Mulligan, Peter Greer and Chris Nicol for sharing reagents and equipment. This research was supported by operating grants from Canadian Cancer Society Research Institute and Canadian Institutes for Health Research to AWBC (MOP119562).	Ahn J, 2013, MOL CANCER RES, V11, P952, DOI 10.1158/1541-7786.MCR-13-0003-T; Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; Aspenstrom P, 2006, TRENDS BIOCHEM SCI, V31, P670, DOI 10.1016/j.tibs.2006.10.001; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Bae GY, 2013, ONCOTARGET, V4, P2512, DOI 10.18632/oncotarget.1463; Bai SJ, 2012, INT J BIOL SCI, V8, P859, DOI 10.7150/ijbs.3490; Dong QZ, 2013, AM J PATHOL, V182, P954, DOI 10.1016/j.ajpath.2012.11.019; Downward J, 2008, NAT MED, V14, P1315, DOI 10.1038/nm1208-1315; Feng YM, 2010, J BIOL CHEM, V285, P4348, DOI 10.1074/jbc.M109.041038; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hirsch FR, 2008, J CLIN ONCOL, V26, P3351, DOI 10.1200/JCO.2007.14.0111; Hsu CC, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-12; Hu JH, 2011, J CELL SCI, V124, P1739, DOI 10.1242/jcs.078014; Hu JH, 2009, CELL SIGNAL, V21, P1686, DOI 10.1016/j.cellsig.2009.07.007; Huang MS, 2002, CLIN EXP METASTAS, V19, P359, DOI 10.1023/A:1015562532564; Ishikawa D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062104; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kao SJ, 2012, TOXICOL APPL PHARM, V261, P105, DOI 10.1016/j.taap.2012.03.020; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Koduru S, 2010, P NATL ACAD SCI USA, V107, P16252, DOI 10.1073/pnas.1002747107; Koshkina NV, 2013, CURR CANCER DRUG TAR, V13, P48; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Li ZX, 2012, MOL CARCINOGEN, V51, P522, DOI 10.1002/mc.20815; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Malet-Engra G, 2013, CANCER RES, V73, P3412, DOI 10.1158/0008-5472.CAN-12-3564; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Pichot CS, 2010, CANCER RES, V70, P8347, DOI 10.1158/0008-5472.CAN-09-4149; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Rosell R, 2010, CLIN TRANSL ONCOL, V12, P75, DOI 10.1007/S12094-010-0473-0; Rusch V, 1997, CLIN CANCER RES, V3, P515; Saengsawang W, 2013, J CELL SCI, V126, P2411, DOI 10.1242/jcs.117473; Saengsawang W, 2012, CURR BIOL, V22, P494, DOI 10.1016/j.cub.2012.01.038; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tian L, 2000, J BIOL CHEM, V275, P7854, DOI 10.1074/jbc.275.11.7854; Tsuji E, 2006, BIOCHEM BIOPH RES CO, V339, P1083, DOI 10.1016/j.bbrc.2005.11.117; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Yang MM, 2013, INT J CANCER, V132, pE74, DOI 10.1002/ijc.27813; Zhang J, 2013, RENAL FAILURE, V35, P989, DOI 10.3109/0886022X.2013.808957; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	44	20	20	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	27					3527	3535		10.1038/onc.2014.280	http://dx.doi.org/10.1038/onc.2014.280			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM1IQ	25174397	Green Accepted, Bronze			2022-12-25	WOS:000357434900005
J	Lai, RPJ; Hock, M; Radzimanowski, J; Tonks, P; Hulsik, DL; Effantin, G; Seilly, DJ; Dreja, H; Kliche, A; Wagner, R; Barnett, SW; Tumba, N; Morris, L; LaBranche, CC; Montefiori, DC; Seaman, MS; Heeney, JL; Weissenhorn, W				Lai, Rachel P. J.; Hock, Miriam; Radzimanowski, Jens; Tonks, Paul; Hulsik, David Lutje; Effantin, Gregory; Seilly, David J.; Dreja, Hanna; Kliche, Alexander; Wagner, Ralf; Barnett, Susan W.; Tumba, Nancy; Morris, Lynn; LaBranche, Celia C.; Montefiori, David C.; Seaman, Michael S.; Heeney, Jonathan L.; Weissenhorn, Winfried			A Fusion Intermediate gp41 Immunogen Elicits Neutralizing Antibodies to HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						AIDS; Membrane Fusion; Protein Conformation; Vaccine Development; X-ray Scattering; HIV-1; HIV-1 gp41	HUMAN-IMMUNODEFICIENCY-VIRUS; PROXIMAL EXTERNAL REGION; HUMAN MONOCLONAL-ANTIBODIES; SCATTERING DATA-ANALYSIS; B-CELL RESPONSES; ENVELOPE GLYCOPROTEIN; TYPE-1 HIV-1; BROAD NEUTRALIZATION; RATIONAL DESIGN; MEDIATED FUSION	Background: HIV-1 gp41 MPER is a target for inducing broadly neutralizing antibodies. Results: Gp41(int) folds into a compact elongated structure that induces neutralizing antibodies upon immunization. Conclusion: Presentation of gp41(int) in a lipid environment is beneficial to induce neutralizing antibodies. Significance: Membrane-anchored gp41(int) is a promising antigen to improve breadth and potency of anti-gp41 antibody responses. The membrane-proximal external region (MPER) of the human immunodeficiency virus, type 1 (HIV-1) envelope glycoprotein subunit gp41 is targeted by potent broadly neutralizing antibodies 2F5, 4E10, and 10E8. These antibodies recognize linear epitopes and have been suggested to target the fusion intermediate conformation of gp41 that bridges viral and cellular membranes. Anti-MPER antibodies exert different degrees of membrane interaction, which is considered to be the limiting factor for the generation of such antibodies by immunization. Here we characterize a fusion intermediate conformation of gp41 (gp41(int)-Cys) and show that it folds into an elongated approximate to 12-nm-long extended structure based on small angle x-ray scattering data. Gp41(int)-Cys was covalently linked to liposomes via its C-terminal cysteine and used as immunogen. The gp41(int)-Cys proteoliposomes were administered alone or in prime-boost regimen with trimeric envelope gp140(CA018) in guinea pigs and elicited high anti-gp41 IgG titers. The sera interacted with a peptide spanning the MPER region, demonstrated competition with broadly neutralizing antibodies 2F5 and 4E10, and exerted modest lipid binding, indicating the presence of MPER-specific antibodies. Although the neutralization potency generated solely by gp140(CA018) was higher than that induced by gp41(int)-Cys, the majority of animals immunized with gp41(int)-Cys proteoliposomes induced modest breadth and potency in neutralizing tier 1 pseudoviruses and replication-competent simian/human immunodeficiency viruses in the TZM-bl assay as well as responses against tier 2 HIV-1 in the A3R5 neutralization assay. Our data thus demonstrate that liposomal gp41 MPER formulation can induce neutralization activity, and the strategy serves to improve breadth and potency of such antibodies by improved vaccination protocols.	[Lai, Rachel P. J.; Tonks, Paul; Seilly, David J.; Dreja, Hanna; Heeney, Jonathan L.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Hock, Miriam; Radzimanowski, Jens; Hulsik, David Lutje; Effantin, Gregory; Weissenhorn, Winfried] Univ Grenoble Alpes, UVHCI, F-38000 Grenoble, France; [Hock, Miriam; Radzimanowski, Jens; Hulsik, David Lutje; Effantin, Gregory; Weissenhorn, Winfried] CNRS, UVHCI, F-38000 Grenoble, France; [Kliche, Alexander; Wagner, Ralf] Univ Regensburg, Inst Med Microbiol & Hyg, D-93053 Regensburg, Germany; [Barnett, Susan W.] Novartis Vaccines & Diagnost Inc, Cambridge, MA 02139 USA; [Tumba, Nancy; Morris, Lynn] Natl Inst Communicable Dis, Ctr HIV & Sexually Transmitted Infect, ZA-2131 Johannesburg, South Africa; [LaBranche, Celia C.; Montefiori, David C.] Duke Univ, Dept Surg, Med Ctr, Durham, NC 27710 USA; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02115 USA	University of Cambridge; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); University of Regensburg; Novartis; National Institute for Communicable Diseases (NICD); Duke University; Harvard University; Beth Israel Deaconess Medical Center	Heeney, JL (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.	jlh66@cam.ac.uk; weissenhorn@embl.fr	Morris, Lynn/V-3941-2018	Morris, Lynn/0000-0003-3961-7828; Lai, Rachel/0000-0003-3418-850X; Heeney, Jonathan/0000-0003-2702-1621	Bill and Melinda Gates Foundation [38637]; Comprehensive Antibody-Vaccine Immune Monitoring Consortium [38619]; Sidaction; Labex Grenoble Alliance for Integrated Structural Cell Biology (GRAL) [ANR-10-LABX-49-01]; Agence nationale de recherche sur le sida et les hepatites virales	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Comprehensive Antibody-Vaccine Immune Monitoring Consortium; Sidaction; Labex Grenoble Alliance for Integrated Structural Cell Biology (GRAL); Agence nationale de recherche sur le sida et les hepatites virales(ANRSFrench National Research Agency (ANR))	This work was supported in part by the Bill and Melinda Gates Foundation-funded Consortium of AIDS Vaccine Discovery (Grant 38637), the Comprehensive Antibody-Vaccine Immune Monitoring Consortium (Grant 38619), and Sidaction (to W. W.).; Supported by Labex Grenoble Alliance for Integrated Structural Cell Biology (GRAL) Grant ANR-10-LABX-49-01.; Supported by a postdoctoral fellowship from the Agence nationale de recherche sur le sida et les hepatites virales.	Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Bar KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002721; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Behrendt R, 2012, INTERVIROLOGY, V55, P252, DOI 10.1159/000324483; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Bonsignori M, 2009, J IMMUNOL, V183, P2708, DOI 10.4049/jimmunol.0901068; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; BUITING AMJ, 1992, RES IMMUNOL, V143, P541, DOI 10.1016/0923-2494(92)80066-T; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Caffrey M, 1997, J MOL BIOL, V271, P819, DOI 10.1006/jmbi.1997.1217; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13; Chen Y, 2013, J IMMUNOL, V191, P1260, DOI 10.4049/jimmunol.1300770; Choudhry V, 2006, BIOCHEM BIOPH RES CO, V348, P1107, DOI 10.1016/j.bbrc.2006.07.163; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; Cole KS, 1997, J VIROL, V71, P5069, DOI 10.1128/JVI.71.7.5069-5079.1997; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dawood R, 2013, AIDS, V27, P717, DOI 10.1097/QAD.0b013e32835cfca5; Decroix N, 2001, SCAND J IMMUNOL, V53, P401, DOI 10.1046/j.1365-3083.2001.00894.x; Dennison SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027824; Dey AK, 2012, VACCINE, V30, P2749, DOI 10.1016/j.vaccine.2012.02.027; Dimitrov AS, 2007, BIOCHEMISTRY-US, V46, P1398, DOI 10.1021/bi062245f; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Eckhart L, 1996, J GEN VIROL, V77, P2001, DOI 10.1099/0022-1317-77-9-2001; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; FORTIN A, 1993, IMMUNOBIOLOGY, V188, P316, DOI 10.1016/S0171-2985(11)80239-1; FREUDENBERG MA, 1989, INFECTION, V17, P322, DOI 10.1007/BF01650719; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Frey G, 2010, NAT STRUCT MOL BIOL, V17, P1486, DOI 10.1038/nsmb.1950; Guenaga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016074; Haynes BF, 2010, NAT STRUCT MOL BIOL, V17, P543, DOI 10.1038/nsmb0510-543; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hinz A, 2009, VIROLOGY, V390, P221, DOI 10.1016/j.virol.2009.05.015; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Hulsik DL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003202; Jain S, 2010, VACCINE, V28, P7070, DOI 10.1016/j.vaccine.2010.08.009; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kim M, 2007, VACCINE, V25, P5102, DOI 10.1016/j.vaccine.2006.09.071; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kusov YY, 2007, ANTIVIR RES, V73, P101, DOI 10.1016/j.antiviral.2006.08.003; Lai RPJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035083; Law M, 2007, J VIROL, V81, P4272, DOI 10.1128/JVI.02536-06; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liang XP, 1999, VACCINE, V17, P2862, DOI 10.1016/S0264-410X(99)00125-5; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liao MF, 2000, PEPTIDES, V21, P463, DOI 10.1016/S0196-9781(00)00179-0; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Luo M, 2006, VACCINE, V24, P435, DOI 10.1016/j.vaccine.2005.08.006; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mantis NJ, 2001, VACCINE, V19, P3990, DOI 10.1016/S0264-410X(01)00115-3; Marusic C, 2001, J VIROL, V75, P8434, DOI 10.1128/JVI.75.18.8434-8439.2001; Matoba N, 2006, VACCINE, V24, P5047, DOI 10.1016/j.vaccine.2006.03.045; McGaughey GB, 2003, BIOCHEMISTRY-US, V42, P3214, DOI 10.1021/bi026952u; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Merk A, 2013, CURR OPIN STRUC BIOL, V23, P268, DOI 10.1016/j.sbi.2013.03.007; Meyerson JR, 2013, P NATL ACAD SCI USA, V110, P513, DOI 10.1073/pnas.1214810110; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Munoz-Barroso I, 1999, J VIROL, V73, P6089; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1995, J VIROL, V69, P6678, DOI 10.1128/JVI.69.11.6678-6686.1995; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Ni JH, 2004, BIOORGAN MED CHEM, V12, P3141, DOI 10.1016/j.bmc.2004.04.008; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; Oster AM, 2011, AIDS, V25, P2157, DOI 10.1097/QAD.0b013e32834bfde9; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pastori C, 2012, VIROLOGY, V431, P1, DOI 10.1016/j.virol.2012.05.005; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Pietzsch J, 2010, J VIROL, V84, P5032, DOI 10.1128/JVI.00154-10; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Reardon PN, 2014, P NATL ACAD SCI USA, V111, P1391, DOI 10.1073/pnas.1309842111; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Samygina VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067145; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Scherer EM, 2007, AIDS, V21, P2131, DOI 10.1097/QAD.0b013e3282a4a632; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Singh H, 2011, AIDS, V25, P1247, DOI 10.1097/QAD.0b013e32834785cf; Srivastava IK, 2002, J VIROL, V76, P2835, DOI 10.1128/JVI.76.6.2835-2847.2002; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Strasz N, 2014, AIDS RES HUM RETROV, V30, P498, DOI [10.1089/aid.2013.0191, 10.1089/AID.2013.0191]; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Toukam DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038068; Verkoczy L, 2010, P NATL ACAD SCI USA, V107, P181, DOI 10.1073/pnas.0912914107; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018233; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 1996, EMBO J, V15, P1507, DOI 10.1002/j.1460-2075.1996.tb00494.x; Weissenhorn W, 1997, P NATL ACAD SCI USA, V94, P6065, DOI 10.1073/pnas.94.12.6065; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Ye L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014813; Yi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072205; Zhang HT, 2004, J VIROL, V78, P8342, DOI 10.1128/jvi.78.15.8342-8348.2004; Zhou MK, 2012, VACCINE, V30, P1911, DOI 10.1016/j.vaccine.2012.01.026; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	117	26	30	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29912	29926		10.1074/jbc.M114.569566	http://dx.doi.org/10.1074/jbc.M114.569566			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25160627	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000344370800034
J	Da-Re, C; von Stockum, S; Biscontin, A; Millino, C; Cisotto, P; Zordan, MA; Zeviani, M; Bernardi, P; De Pitta, C; Costa, R				Da-Re, Caterina; von Stockum, Sophia; Biscontin, Alberto; Millino, Caterina; Cisotto, Paola; Zordan, Mauro A.; Zeviani, Massimo; Bernardi, Paolo; De Pitta, Cristiano; Costa, Rodolfo			Leigh Syndrome in Drosophila melanogaster MORPHOLOGICAL AND BIOCHEMICAL CHARACTERIZATION OF Surf1 POST-TRANSCRIPTIONAL SILENCING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; DROSOPHILA-MELANOGASTER HOMOLOG; COMPLEX-I; FUNCTIONAL-CHARACTERIZATION; TRANSLATIONAL REGULATION; BINDING PROTEIN; GENE-EXPRESSION; SURF1 GENE; MUTATIONS; DEFECTS	Leigh Syndrome (LS) is the most common early-onset, progressive mitochondrial encephalopathy usually leading to early death. The single most prevalent cause of LS is occurrence of mutations in the SURF1 gene, and LSSurf1 patients show a ubiquitous and specific decrease in the activity of mitochondrial respiratory chain complex IV (cytochrome c oxidase, COX). SURF1 encodes an inner membrane mitochondrial protein involved in COX assembly. We established a Drosophila melanogaster model of LS based on the post-transcriptional silencing of CG9943, the Drosophila homolog of SURF1. Knockdown of Surf1 was induced ubiquitously in larvae and adults, which led to lethality; in the mesodermal derivatives, which led to pupal lethality; or in the central nervous system, which allowed survival. A biochemical characterization was carried out in knockdown individuals, which revealed that larvae unexpectedly displayed defects in all complexes of the mitochondrial respiratory chain and in the F-ATP synthase, while adults had a COX-selective impairment. Silencing of Surf1 expression in Drosophila S2R(+) cells led to selective loss of COX activity associated with decreased oxygen consumption and respiratory reserve. We conclude that Surf1 is essential for COX activity and mitochondrial function in D. melanogaster, thus providing a new tool that may help clarify the pathogenic mechanisms of LS.	[Da-Re, Caterina; Biscontin, Alberto; Cisotto, Paola; Zordan, Mauro A.; De Pitta, Cristiano; Costa, Rodolfo] Univ Padua, Dept Biol, I-35121 Padua, Italy; [von Stockum, Sophia; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Millino, Caterina] Univ Padua, CRIBI Biotechnol Ctr, I-35121 Padua, Italy; [Zeviani, Massimo] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England	University of Padua; University of Padua; University of Padua; University of Cambridge	De Pitta, C (corresponding author), Univ Padua, Dept Biol, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	cristiano.depitta@unipd.it; rodolfo.costa@unipd.it	Zeviani, Massimo/AAU-2632-2021; Bernardi, Paolo/C-3656-2008; De Pitta, Cristiano/AAY-7302-2020	Zeviani, Massimo/0000-0002-9067-5508; Bernardi, Paolo/0000-0001-9187-3736; De Pitta, Cristiano/0000-0001-8013-8162; Biscontin, Alberto/0000-0003-1492-7715	University of Padova (Progetto Strategico di Ateneo: "Models of Mitochondrial Diseases"); Fondazione CARIPLO: Scientific Research in Biomedicine ("MITGEN: Definition and Characterization of Disease Genes in Mitochondrial Disorders"); Telethon Project ("MitMed: a Multicenter Consortium for the Identification and Characterization of Nuclear Genes Responsible for Human Mitochondrial Disorders") [GGP11011]; Medical Research Council [MC_UP_1002/1] Funding Source: researchfish; MRC [MC_UP_1002/1] Funding Source: UKRI	University of Padova (Progetto Strategico di Ateneo: "Models of Mitochondrial Diseases"); Fondazione CARIPLO: Scientific Research in Biomedicine ("MITGEN: Definition and Characterization of Disease Genes in Mitochondrial Disorders"); Telethon Project ("MitMed: a Multicenter Consortium for the Identification and Characterization of Nuclear Genes Responsible for Human Mitochondrial Disorders")(Fondazione Telethon); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by grants from the University of Padova (Progetto Strategico di Ateneo: 2008: "Models of Mitochondrial Diseases") (to P. B. and R. C.); Fondazione CARIPLO: Scientific Research in Biomedicine 2011 ("MITGEN: Definition and Characterization of Disease Genes in Mitochondrial Disorders") (to M. Z. and R. C.); Telethon Project N. GGP11011 ("MitMed: a Multicenter Consortium for the Identification and Characterization of Nuclear Genes Responsible for Human Mitochondrial Disorders") (to M. Z. and R. C.).	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Baumbach J, 2014, CELL METAB, V19, P331, DOI 10.1016/j.cmet.2013.12.004; Bestwick M, 2010, MOL CELL BIOL, V30, P4480, DOI 10.1128/MCB.00228-10; Boistau B. M., 2005, BIOINFORMATICS, V19, P185; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bruno C, 2002, J CHILD NEUROL, V17, P233, DOI 10.1177/088307380201700318; Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309; Chen JQ, 2009, BBA-MOL CELL RES, V1793, P1540, DOI 10.1016/j.bbamcr.2009.06.001; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Da-Re C, 2014, EMBO REP, V15, P586, DOI 10.1002/embr.201337972; Da-Re C, 2014, J BIOL CHEM, V289, P7448, DOI 10.1074/jbc.M113.543926; Deepa SS, 2013, FASEB J, V27, P1371, DOI 10.1096/fj.12-221879; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Dieteren CEJ, 2008, J BIOL CHEM, V283, P34753, DOI 10.1074/jbc.M807323200; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; DIMAURO S, 1988, J BIOENERG BIOMEMBR, V20, P353, DOI 10.1007/BF00769637; Farina L, 2002, AM J NEURORADIOL, V23, P1095; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Flockhart IT, 2012, NUCLEIC ACIDS RES, V40, pD715, DOI 10.1093/nar/gkr953; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4; Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761; Giuliani G, 2014, NUCLEIC ACIDS RES, V42, P1970, DOI 10.1093/nar/gkt1118; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Lazarou M, 2009, FEBS J, V276, P6701, DOI 10.1111/j.1742-4658.2009.07384.x; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; Lin AL, 2013, J CEREBR BLOOD F MET, V33, P1605, DOI 10.1038/jcbfm.2013.116; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Nijtmans LGJ, 2001, FEBS LETT, V498, P46, DOI 10.1016/S0014-5793(01)02447-4; Oliveira MT, 2011, J BIOL CHEM, V286, P40649, DOI 10.1074/jbc.M111.289983; Pequignot MO, 2001, HUM MUTAT, V17, P374, DOI 10.1002/humu.1112.abs; Poyau A, 1999, FEBS LETT, V462, P416, DOI 10.1016/S0014-5793(99)01571-9; Reinhold R, 2011, HUM MOL GENET, V20, P2379, DOI 10.1093/hmg/ddr145; Rinaldi T, 2010, FEMS YEAST RES, V10, P1006, DOI 10.1111/j.1567-1364.2010.00685.x; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sales G, 2013, NUCLEIC ACIDS RES, V41, pW89, DOI 10.1093/nar/gkt386; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Suthammarak W, 2010, J BIOL CHEM, V285, P40724, DOI 10.1074/jbc.M110.159608; Taanman JW, 1997, J BIOENERG BIOMEMBR, V29, P151, DOI 10.1023/A:1022638013825; Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541; YAO KM, 1994, J NEUROCHEM, V63, P41; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zara V, 2009, FEBS J, V276, P1900, DOI 10.1111/j.1742-4658.2009.06916.x; Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259; Zeviani M, 1999, ITAL J NEUROL SCI, V20, P401; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804; Zordan MA, 2006, GENETICS, V172, P229, DOI 10.1534/genetics.105.049072	64	15	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29235	29246		10.1074/jbc.M114.602938	http://dx.doi.org/10.1074/jbc.M114.602938			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25164807	Green Published, hybrid			2022-12-25	WOS:000344141000038
J	Bird, GA; Polsky, A; Estes, P; Hanlon, T; Hamilton, H; Morton, JJ; Gutman, J; Jimeno, A; Turner, BC; Refaeli, Y				Bird, Gregory A.; Polsky, Avital; Estes, Patricia; Hanlon, Teri; Hamilton, Haley; Morton, John J.; Gutman, Jonathan; Jimeno, Antonio; Turner, Brian C.; Refaeli, Yosef			Expansion of Human and Murine Hematopoietic Stem and Progenitor Cells Ex Vivo without Genetic Modification Using MYC and Bcl-2 Fusion Proteins	PLOS ONE			English	Article							5-FLUOROURACIL; RECEPTOR; PURIFICATION; PROGRESS; GENESIS	The long-term repopulating hematopoietic stem cell (HSC) population can self-renew in vivo, support hematopoiesis for the lifetime of the individual, and is of critical importance in the context of bone marrow stem cell transplantation. The mechanisms that regulate the expansion of HSCs in vivo and in vitro remain unclear to date. Since the current set of surface markers only allow for the identification of a population of cells that is highly enriched for HSC activity, we will refer to the population of cells we expand as Hematopoietic Stem and Progenitor cells (HSPCs). We describe here a novel approach to expand a cytokine-dependent Hematopoietic Stem and Progenitor Cell (HSPC) population ex vivo by culturing primary adult human or murine HSPCs with fusion proteins including the protein transduction domain of the HIV-1 transactivation protein (Tat) and either MYC or Bcl-2. HSPCs obtained from either mouse bone marrow, human cord blood, human G-CSF mobilized peripheral blood, or human bone marrow were expanded an average of 87 fold, 16.6 fold, 13.6 fold, or 10 fold, respectively. The expanded cell populations were able to give rise to different types of colonies in methylcellulose assays in vitro, as well as mature hematopoietic populations in vivo upon transplantation into irradiated mice. Importantly, for both the human and murine case, the ex vivo expanded cells also gave rise to a self-renewing cell population in vivo, following initial transplantation, that was able to support hematopoiesis upon serial transplantation. Our results show that a self-renewing cell population, capable of reconstituting the hematopoietic compartment, expanded ex vivo in the presence of Tat-MYC and Tat-Bcl-2 suggesting that this may be an attractive approach to expand human HSPCs ex vivo for clinical use.	[Bird, Gregory A.; Estes, Patricia; Turner, Brian C.; Refaeli, Yosef] Taiga Biotechnol Inc, Aurora, CO 80045 USA; [Polsky, Avital; Hanlon, Teri; Hamilton, Haley; Turner, Brian C.; Refaeli, Yosef] Univ Colorado, Sch Med, Charles C Gates Ctr Regenerat Med & Stem Cell Bio, Aurora, CO USA; [Polsky, Avital; Hanlon, Teri; Hamilton, Haley; Turner, Brian C.; Refaeli, Yosef] Univ Colorado, Sch Med, Dept Dermatol, Aurora, CO USA; [Morton, John J.; Gutman, Jonathan; Jimeno, Antonio] Univ Colorado, Sch Med, Dept Med, Div Med Oncol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Refaeli, Y (corresponding author), Taiga Biotechnol Inc, Aurora, CO 80045 USA.	Yosef.Refaeli@UCDenver.edu		Polsky, Avital Luba/0000-0002-5105-9198	United States Public Health Service, National Institutes of Heath [RO1 CA117802-06, P30 AR057212-02, PO1 AI022295-24]; Leukemia and Lymphoma Society;  [2R44HL091740-02A1];  [1R43HL014760-01];  [W81XWN-10-1-0798];  [P30-CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA117802] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL091740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057212] Funding Source: NIH RePORTER	United States Public Health Service, National Institutes of Heath; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by United States Public Health Service, National Institutes of Heath grants RO1 CA117802-06, P30 AR057212-02, PO1 AI022295-24, and a Translational Research Award from the Leukemia and Lymphoma Society (Y.R.), and grants 2R44HL091740-02A1 and 1R43HL014760-01 (B.T. and Y.R.), and grants W81XWN-10-1-0798 (A.J.) and P30-CA046934 (A.J. and Y.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 1999, PROTEIN EXPRES PURIF, V15, P162, DOI 10.1006/prep.1998.0996; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Bernstein ID, 2012, CELL STEM CELL, V10, P113, DOI 10.1016/j.stem.2012.01.012; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Chou S, 2010, CELL STEM CELL, V7, P427, DOI 10.1016/j.stem.2010.09.001; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; Domashenko AD, 2010, BLOOD, V116, P2676, DOI 10.1182/blood-2010-03-273441; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; LERNER C, 1990, EXP HEMATOL, V18, P114; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Refaeli Y, 2005, P NATL ACAD SCI USA, V102, P4097, DOI 10.1073/pnas.0409832102; Refaeli Y, 2008, PLOS BIOL, V6, P1208, DOI 10.1371/journal.pbio.0060152; Sideri A, 2011, HAEMATOL-HEMATOL J, V96, P1213, DOI 10.3324/haematol.2010.038836; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Suzuki T, 2006, STEM CELLS, V24, P2456, DOI 10.1634/stemcells.2006-0258; Turner BC, 2008, DNA CELL BIOL, V27, P133, DOI 10.1089/dna.2007.0675; VETVICKA V, 1986, J IMMUNOL, V137, P2405; Walasek MA, 2012, ANN NY ACAD SCI, V1266, P138, DOI 10.1111/j.1749-6632.2012.06549.x; Yang JC, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-38; YEAGER AM, 1983, EXP HEMATOL, V11, P944; Young RM, 2008, FUTURE ONCOL, V4, P591, DOI 10.2217/14796694.4.5.591	23	15	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105525	10.1371/journal.pone.0105525	http://dx.doi.org/10.1371/journal.pone.0105525			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170611	Green Submitted, Green Published, gold			2022-12-25	WOS:000341127500057
J	Handa, K; Inukai, K; Onuma, H; Kudo, A; Nakagawa, F; Tsugawa, K; Kitahara, A; Moriya, R; Takahashi, K; Sumitani, Y; Hosaka, T; Kawakami, H; Oyadomari, S; Ishida, H				Handa, Keiko; Inukai, Kouichi; Onuma, Hirohisa; Kudo, Akihiko; Nakagawa, Fumiyuki; Tsugawa, Kazue; Kitahara, Atsuko; Moriya, Rie; Takahashi, Kazuto; Sumitani, Yoshikazu; Hosaka, Toshio; Kawakami, Hayato; Oyadomari, Seiichi; Ishida, Hitoshi			Long-Term Low Carbohydrate Diet Leads to Deleterious Metabolic Manifestations in Diabetic Mice	PLOS ONE			English	Article							IMPROVES INSULIN SENSITIVITY; ENERGY-EXPENDITURE; HEPATIC STEATOSIS; GENE-EXPRESSION; FATTY-ACIDS; WEIGHT-LOSS; RESISTANCE; MACRONUTRIENTS; STRESS; GROWTH	We investigated long-term effects of low carbohydrate diets on wild type mice, streptozotocin-injected and KKAy obese diabetic mice. These mice were pair-fed three different types of diets, standard chow (SC, C:P:F = 63:15:22), a low carbohydrate (LC, C:P:F = 38:25:37) diet and a severely carbohydrate restricted (SR, C:P:F = 18:45:37) diet for 16 weeks. Despite comparable body weights and serum lipid profiles, wild type and diabetic mice fed the low carbohydrate diets exhibited lower insulin sensitivity and this reduction was dependent on the amount of carbohydrate in the diet. When serum fatty acid compositions were investigated, monounsaturation capacity, i.e. C16:1/C16:0 and C18:1/C18:0, was impaired in all murine models fed the low carbohydrate diets, consistent with the decreased expression of hepatic stearoyl-CoA desaturase-1 (SCD1). Interestingly, both the hepatic expressions and serum levels of fibroblast growth factor 21 (FGF21), which might be related to longevity, were markedly decreased in both wild type and KKAy mice fed the SR diet. Taking into consideration that fat compositions did not differ between the LC and SR diets, we conclude that low carbohydrate diets have deleterious metabolic effects in both wild type and diabetic mice, which may explain the association between diets relatively low in carbohydrate and the elevated risk of cardiovascular events observed in clinical studies.	[Handa, Keiko; Inukai, Kouichi; Onuma, Hirohisa; Kitahara, Atsuko; Moriya, Rie; Takahashi, Kazuto; Sumitani, Yoshikazu; Hosaka, Toshio; Ishida, Hitoshi] Kyorin Univ, Sch Med, Div Diabet Endocrinol & Metab, Dept Internal Med 3, Mitaka, Tokyo 181, Japan; [Kudo, Akihiko; Kawakami, Hayato] Kyorin Univ, Sch Med, Dept Anat, Mitaka, Tokyo 181, Japan; [Nakagawa, Fumiyuki] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan; [Tsugawa, Kazue; Oyadomari, Seiichi] Univ Tokushima, Inst Genome Res, Div Mol Biol, Kuramoto, Tokushima, Japan	Kyorin University; Kyorin University; Shiga University of Medical Science; Tokushima University	Inukai, K (corresponding author), Kyorin Univ, Sch Med, Div Diabet Endocrinol & Metab, Dept Internal Med 3, Mitaka, Tokyo 181, Japan.	kinukai@ks.kyorin-u.ac.jp	Oyadomari, Seiichi/GZA-7072-2022; Kudo, Akihiko/ACZ-3340-2022; Oyadomari, Seiichi/GZA-7157-2022	Kudo, Akihiko/0000-0002-2630-5991; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [25350898]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grant-in-Aid for Scientific Research no. 25350898 (to KI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. URL:http://www.jsps.go.jp/j-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shudiefat AAR, 2013, MOL CELL BIOCHEM, V372, P75, DOI 10.1007/s11010-012-1447-z; Anderson JW, 2004, J AM COLL NUTR, V23, P5, DOI 10.1080/07315724.2004.10719338; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bowen CL, 2010, J CHROMATOGR B, V878, P3125, DOI 10.1016/j.jchromb.2010.09.020; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P3099, DOI 10.1210/en.2013-1191; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Dyson PA, 2008, J HUM NUTR DIET, V21, P530, DOI 10.1111/j.1365-277X.2008.00896.x; Gianotti TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076912; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Garbow JR, 2011, AM J PHYSIOL-GASTR L, V300, pG956, DOI 10.1152/ajpgi.00539.2010; Geng T, 2013, DIABETOLOGIA, V56, P2078, DOI 10.1007/s00125-013-2973-2; Gillingham LG, 2011, LIPIDS, V46, P209, DOI 10.1007/s11745-010-3524-y; Hoevenaar-Blom MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045458; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Ikegami Y, 2009, DIABETES, V58, P61, DOI 10.2337/db07-0690; Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010; Kim KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063517; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Lagiou P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4026; Murata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069330; Nakashima Y, 2008, METABOLISM, V57, P1350, DOI 10.1016/j.metabol.2008.05.001; NTAMBI JM, 1992, J BIOL CHEM, V267, P10925; Robert AE, 2014, METABOLISM, V63, P283; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Sjogren P, 2010, AM J CLIN NUTR, V92, P967, DOI 10.3945/ajcn.2010.29345; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Stefan N, 2008, DIABETOLOGIA, V51, P648, DOI 10.1007/s00125-008-0938-7; TAKETOMI S, 1973, HORM METAB RES, V5, P333, DOI 10.1055/s-0028-1093938; Westman EC, 2007, AM J CLIN NUTR, V86, P276, DOI 10.1093/ajcn/86.2.276; Wheeler ML, 2012, DIABETES CARE, V35, P434, DOI 10.2337/dc11-2216; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yamashita S, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106443; Yong R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073428; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]	39	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e104948	10.1371/journal.pone.0104948	http://dx.doi.org/10.1371/journal.pone.0104948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170869	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500027
J	Li, YF; Lee, KG; Ou, XJ; Lam, KP				Li, Yan-Feng; Lee, Koon-Guan; Ou, Xijun; Lam, Kong-Peng			Bruton's Tyrosine Kinase and Protein Kinase C mu Are Required for TLR7/9-Induced IKK alpha and IRF-1 Activation and Interferon-beta Production in Conventional Dendritic Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; DEPENDENT TRANSCRIPTION; CYTOKINE PRODUCTION; SIGNALING PATHWAY; IMMUNE-RESPONSES; RECEPTOR; BTK; RECOGNITION; PKC; LIPOPOLYSACCHARIDE	Stimulation of TLR7/9 by their respective ligands leads to the activation of I kappa B kinase alpha (IKK alpha) and Interferon Regulatory Factor 1 (IRF-1) and results in interferon (IFN)-beta production in conventional dendritic cells (cDC). However, which other signaling molecules are involved in IKKa and IRF-1 activation during TLR7/9 signaling pathway are not known. We and others have shown that Bruton's Tyrosine Kinase (BTK) played a part in TLR9-mediated cytokine production in B cells and macrophages. However, it is unclear if BTK participates in TLR7/9-induced IFN-beta production in cDC. In this study, we show that BTK is required for IFN-beta synthesis in cDC upon TLR7/9 stimulation and that stimulated BTK-deficient cDC are defective in the induction of IKK alpha/beta phosphorylation and IRF-1 activation. In addition, we demonstrate that Protein Kinase C m (PKC mu) is also required for TLR7/9-induced IRF-1 activation and IFN-beta upregulation in cDC and acts downstream of BTK. Taken together, we have uncovered two new molecules, BTK and PKCm, that are involved in TLR7/9-triggered IFN-beta production in cDC.	[Li, Yan-Feng; Lee, Koon-Guan; Ou, Xijun; Lam, Kong-Peng] Agcy Sci Technol & Res, Immunol Grp, Bioproc Technol Inst, Singapore, Singapore; [Lam, Kong-Peng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Lam, Kong-Peng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Lam, Kong-Peng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore; National University of Singapore; National University of Singapore	Lam, KP (corresponding author), Agcy Sci Technol & Res, Immunol Grp, Bioproc Technol Inst, Singapore, Singapore.	lam_kong_peng@bti.a-star.edu.sg	li, yan/GTI-4638-2022	Ou, Xijun/0000-0002-4525-5205; Lam, Kong-Peng/0000-0002-1316-4333	Biomedical Research Council of the Singapore Agency for Science Technology and Research	Biomedical Research Council of the Singapore Agency for Science Technology and Research(Agency for Science Technology & Research (A*STAR))	Biomedical Research Council of the Singapore Agency for Science Technology and Research (http://www.a-star.edu.sg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bajpai UD, 2000, J EXP MED, V191, P1735, DOI 10.1084/jem.191.10.1735; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doyle SL, 2007, J BIOL CHEM, V282, P36953, DOI 10.1074/jbc.M707682200; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Gschwendt M, 1998, FEBS LETT, V421, P165, DOI 10.1016/S0014-5793(97)01530-5; Hasan M, 2008, IMMUNOLOGY, V123, P239, DOI 10.1111/j.1365-2567.2007.02693.x; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Holden NS, 2008, CELL SIGNAL, V20, P1338, DOI 10.1016/j.cellsig.2008.03.001; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Hoshino K, 2010, J IMMUNOL, V184, P3341, DOI 10.4049/jimmunol.0901648; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jefferies CA, 2004, IMMUNOL LETT, V92, P15, DOI 10.1016/j.imlet.2003.11.017; Johannes FJ, 1999, FEBS LETT, V461, P68, DOI 10.1016/S0014-5793(99)01424-6; Johnson J, 2007, J BIOL CHEM, V282, P15022, DOI 10.1074/jbc.M700421200; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawakami Y, 2006, P NATL ACAD SCI USA, V103, P153, DOI 10.1073/pnas.0509784103; Langlet C, 2010, EUR J IMMUNOL, V40, P505, DOI 10.1002/eji.200939391; Lee KG, 2008, J BIOL CHEM, V283, P11189, DOI 10.1074/jbc.M708516200; Lee KG, 2012, P NATL ACAD SCI USA, V109, P5791, DOI 10.1073/pnas.1119238109; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Martin P, 2002, EMBO J, V21, P4049, DOI 10.1093/emboj/cdf407; MATSUDA T, 1995, BLOOD, V85, P627, DOI 10.1182/blood.V85.3.627.bloodjournal853627; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mochly-Rosen D, 1998, FASEB J, V12, P35; Mohamed AJ, 1999, SCAND J IMMUNOL, V49, P113; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Park JE, 2008, J IMMUNOL, V181, P2044, DOI 10.4049/jimmunol.181.3.2044; Park JE, 2009, J IMMUNOL, V182, P6316, DOI 10.4049/jimmunol.0804239; Petro JB, 2000, J EXP MED, V191, P1745, DOI 10.1084/jem.191.10.1745; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408; SATO S, 1994, J EXP MED, V180, P2101, DOI 10.1084/jem.180.6.2101; Satterthwaite AB, 2000, IMMUNOL REV, V175, P120, DOI 10.1034/j.1600-065X.2000.017504.x; Schmidt NW, 2006, J IMMUNOL, V177, P7203, DOI 10.4049/jimmunol.177.10.7203; Schmitz F, 2007, EUR J IMMUNOL, V37, P315, DOI 10.1002/eji.200636767; Taneichi H, 2008, CLIN IMMUNOL, V126, P148, DOI 10.1016/j.clim.2007.10.005; Wagner H, 2004, TRENDS IMMUNOL, V25, P381, DOI 10.1016/j.it.2004.04.011; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	50	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105420	10.1371/journal.pone.0105420	http://dx.doi.org/10.1371/journal.pone.0105420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170774	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500047
J	Liu, K; Wang, F; Ye, XY; Wang, LL; Yang, J; Zhang, JZ; Liu, L				Liu, Kai; Wang, Fang; Ye, Xiaoying; Wang, Lingling; Yang, Jiao; Zhang, Jingzhuo; Liu, Lin			KSR-Based Medium Improves the Generation of High-Quality Mouse iPS Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; SOMATIC-CELLS; GROUND-STATE; INDUCTION; FGF; EXPRESSION; EFFICIENT; OCT4; MICE	Induced pluripotent stem (iPS) cells from somatic cells have great potential for regenerative medicine. The efficiency in generation of iPS cells has been significantly improved in recent years. However, the generation of high-quality iPS cells remains of high interest. Consistently, we demonstrate that knockout serum replacement (KSR)-based medium accelerates iPS cell induction and improves the quality of iPS cells, as confirmed by generation of chimeras and all iPS cell-derived offspring with germline transmission competency. Both alkaline phosphatase (AP) activity assay and expression of Nanog have been used to evaluate the efficiency of iPS cell induction and formation of ES/iPS cell colonies; however, appropriate expression of Nanog frequently indicates the quality of ES/iPS cells. Interestingly, whereas foetal bovine serum (FBS)-based media increase iPS cell colony formation, as revealed by AP activity, KSR-based media increase the frequency of iPS cell colony formation with Nanog expression. Furthermore, inhibition of MAPK/ERK by a specific inhibitor, PD0325901, in KSR-but not in FBS-based media significantly increases Nanog-GFP(+) iPS cells. In contrast, addition of bFGF in KSR-based media decreases proportion of Nanog-GFP(+) iPS cells. Remarkably, PD can rescue Nanog-GFP(+) deficiency caused by bFGF. These data suggest that MAPK/ERK pathway influences high quality mouse iPS cells and that KSR- and PD-based media could enrich homogeneous authentic pluripotent stem cells.	[Liu, Kai; Wang, Fang; Ye, Xiaoying; Wang, Lingling; Yang, Jiao; Zhang, Jingzhuo; Liu, Lin] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University	Liu, L (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	liulin@nankai.edu.cn			China MOST National Major Basic Research Program [2012CB911202, 2011CBA01002]; National Natural Science Foundation of China [31271587]; Natural Science Foundation of Tianjin [12JCZDJC24800]	China MOST National Major Basic Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by China MOST National Major Basic Research Program (2012CB911202, 2011CBA01002), National Natural Science Foundation of China (31271587), and Natural Science Foundation of Tianjin (12JCZDJC24800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Binetruy B, 2007, STEM CELLS, V25, P1090, DOI 10.1634/stemcells.2006-0612; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chen JK, 2010, J BIOL CHEM, V285, P31066, DOI 10.1074/jbc.M110.139436; Cheng J, 2004, GENESIS, V39, P100, DOI 10.1002/gene.20031; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Di Stefano B, 2011, PLOS ONE, V5; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Gafni O, 2013, NATURE; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hao J, 2013, J PROTEOMICS, V86, P70, DOI 10.1016/j.jprot.2013.04.018; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Huang JJ, 2008, STEM CELLS, V26, P1883, DOI 10.1634/stemcells.2008-0164; Huang JJ, 2011, CELL RES, V21, P779, DOI 10.1038/cr.2011.16; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Jiao J, 2013, STEM CELLS, V31, P729, DOI 10.1002/stem.1318; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Li CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006724; Liang GY, 2010, J BIOL CHEM, V285, P25516, DOI 10.1074/jbc.M110.142059; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Liu K, 2012, CELL REPROGRAM, V14, P505, DOI 10.1089/cell.2012.0047; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Okada M, 2010, BBA-GEN SUBJECTS, V1800, P956, DOI 10.1016/j.bbagen.2010.04.004; Polo JM, 2010, CELL STEM CELL, V7, P5, DOI 10.1016/j.stem.2010.05.018; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Wang F, 2012, CELL RES, V22, P757, DOI 10.1038/cr.2011.201; Yao K, 2014, STEM CELL RES, V12, P139, DOI 10.1016/j.scr.2013.10.005; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026592; Zhao XY, 2010, CELL RES, V20, P383, DOI 10.1038/cr.2010.26; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	46	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105309	10.1371/journal.pone.0105309	http://dx.doi.org/10.1371/journal.pone.0105309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171101	gold, Green Submitted, Green Published			2022-12-25	WOS:000341127500043
J	Martin, GJO; Hill, DRA; Olmstead, ILD; Bergamin, A; Shears, MJ; Dias, DA; Kentish, SE; Scales, PJ; Botte, CY; Callahan, DL				Martin, Gregory J. O.; Hill, David R. A.; Olmstead, Ian L. D.; Bergamin, Amanda; Shears, Melanie J.; Dias, Daniel A.; Kentish, Sandra E.; Scales, Peter J.; Botte, Cyrille Y.; Callahan, Damien L.			Lipid Profile Remodeling in Response to Nitrogen Deprivation in the Microalgae Chlorella sp (Trebouxiophyceae) and Nannochloropsis sp (Eustigmatophyceae)	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; TRIACYLGLYCEROL ACCUMULATION; PHAEODACTYLUM-TRICORNUTUM; OLEAGINOUS MICROALGAE; BIODIESEL PRODUCTION; MASS-SPECTROMETRY; PLANT-CELLS; CHLAMYDOMONAS; STARVATION; CULTURE	Many species of microalgae produce greatly enhanced amounts of triacylglycerides (TAGs), the key product for biodiesel production, in response to specific environmental stresses. Improvement of TAG production by microalgae through optimization of growth regimes is of great interest. This relies on understanding microalgal lipid metabolism in relation to stress response in particular the deprivation of nutrients that can induce enhanced TAG synthesis. In this study, a detailed investigation of changes in lipid composition in Chlorella sp. and Nannochloropsis sp. in response to nitrogen deprivation (N-deprivation) was performed to provide novel mechanistic insights into the lipidome during stress. As expected, an increase in TAGs and an overall decrease in polar lipids were observed. However, while most membrane lipid classes (phosphoglycerolipids and glycolipids) were found to decrease, the non-nitrogen containing phosphatidylglycerol levels increased considerably in both algae from initially low levels. Of particular significance, it was observed that the acyl composition of TAGs in Nannochloropsis sp. remain relatively constant, whereas Chlorella sp. showed greater variability following N-deprivation. In both algae the overall fatty acid profiles of the polar lipid classes were largely unaffected by N-deprivation, suggesting a specific FA profile for each compartment is maintained to enable continued function despite considerable reductions in the amount of these lipids. The changes observed in the overall fatty acid profile were due primarily to the decrease in proportion of polar lipids to TAGs. This study provides the most detailed lipidomic information on two different microalgae with utility in biodiesel production and nutraceutical industries and proposes the mechanisms for this rearrangement. This research also highlights the usefulness of the latest MS-based approaches for microalgae lipid research.	[Martin, Gregory J. O.; Hill, David R. A.; Olmstead, Ian L. D.; Bergamin, Amanda; Kentish, Sandra E.; Scales, Peter J.] Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3052, Australia; [Shears, Melanie J.; Dias, Daniel A.; Callahan, Damien L.] Univ Melbourne, Metabol Australia, Parkville, Vic 3052, Australia; [Shears, Melanie J.; Botte, Cyrille Y.] Univ Grenoble 1, CNRS, Lab Adapt & Pathogenie Microorganismes UMR5163, Apicolipid Grp, La Tronche, France; [Callahan, Damien L.] Deakin Univ, Sch Life & Environm Sci, Ctr Chem & Biotechnol, Burwood, Vic, Australia	University of Melbourne; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Deakin University	Botte, CY (corresponding author), Univ Grenoble 1, CNRS, Lab Adapt & Pathogenie Microorganismes UMR5163, Apicolipid Grp, La Tronche, France.	cyrille.botte@ujf-grenoble.fr	Martin, Gregory/C-9415-2009; Botte, Cyrille/G-1972-2014; Scales, Peter j/I-8103-2013; Kentish, Sandra E/C-7658-2011	Martin, Gregory/0000-0002-7099-7913; Botte, Cyrille/0000-0002-2245-536X; Scales, Peter j/0000-0002-8033-3686; Kentish, Sandra E/0000-0002-4250-7489; Callahan, Damien/0000-0002-6384-8717; Dias, Daniel/0000-0003-0129-3178; Shears, Melanie/0000-0002-8226-4354	The University of Melbourne: Interdisciplinary Seed Funding; Victorian Node of Metabolomics Australia (Bioplatforms Australia Ltd, Federal Government grants); Australian Commonwealth Government (Second Generation Biofuels Research and Development Grant Program); Bio Fuels Ltd (Victoria Australia); Agence Nationale pour la Recherche (ApicoLipid Project); Atip-Avenir-Finovi (ApicoLipid project)	The University of Melbourne: Interdisciplinary Seed Funding; Victorian Node of Metabolomics Australia (Bioplatforms Australia Ltd, Federal Government grants); Australian Commonwealth Government (Second Generation Biofuels Research and Development Grant Program); Bio Fuels Ltd (Victoria Australia); Agence Nationale pour la Recherche (ApicoLipid Project)(French National Research Agency (ANR)); Atip-Avenir-Finovi (ApicoLipid project)	The study was funded by The University of Melbourne: Interdisciplinary Seed Funding, Victorian Node of Metabolomics Australia (Bioplatforms Australia Ltd, Federal Government grants), Australian Commonwealth Government (Second Generation Biofuels Research and Development Grant Program), Bio Fuels Ltd (Victoria Australia), Agence Nationale pour la Recherche (ApicoLipid Project), and Atip-Avenir-Finovi (ApicoLipid project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisz SA, 2000, PHYTOCHEMISTRY, V53, P265, DOI 10.1016/S0031-9422(99)00505-1; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Botte CY, 2011, J BIOL CHEM, V286, P29893, DOI 10.1074/jbc.M111.254979; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Breuer G, 2012, BIORESOURCE TECHNOL, V124, P217, DOI 10.1016/j.biortech.2012.08.003; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Converti A, 2009, CHEM ENG PROCESS, V48, P1146, DOI 10.1016/j.cep.2009.03.006; Cui Z, 2009, J CHROMATOGR B, V877, P2709, DOI 10.1016/j.jchromb.2009.06.034; DUNSTAN GA, 1993, J APPL PHYCOL, V5, P71, DOI 10.1007/BF02182424; Fan JL, 2011, FEBS LETT, V585, P1985, DOI 10.1016/j.febslet.2011.05.018; Gong YM, 2013, J BASIC MICROB, V53, P29, DOI 10.1002/jobm.201100487; Gouveia L, 2009, J IND MICROBIOL BIOT, V36, P269, DOI 10.1007/s10295-008-0495-6; Gray CG, 2009, EUR J PHYCOL, V44, P191, DOI 10.1080/09670260802419481; Guiheneuf F, 2009, J EXP MAR BIOL ECOL, V369, P136, DOI 10.1016/j.jembe.2008.11.009; Hartel H, 1998, BBA-BIOMEMBRANES, V1415, P205, DOI 10.1016/S0005-2736(98)00197-7; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Jouhet J, 2007, PROG LIPID RES, V46, P37, DOI 10.1016/j.plipres.2006.06.002; Joyard J, 2010, PROG LIPID RES, V49, P128, DOI 10.1016/j.plipres.2009.10.003; Keusgen M, 1997, LIPIDS, V32, P1101, DOI 10.1007/s11745-997-0142-9; Kobayashi K, 2013, PLANT J, V73, P250, DOI 10.1111/tpj.12028; Li XB, 2012, PLANT CELL, V24, P4670, DOI 10.1105/tpc.112.105106; MacDougall KM, 2011, ANAL BIOANAL CHEM, V401, P2609, DOI 10.1007/s00216-011-5376-6; Olmstead ILD, 2013, BIORESOURCE TECHNOL, V148, P615, DOI 10.1016/j.biortech.2013.09.022; Olmstead ILD, 2013, BIOTECHNOL BIOENG, V110, P2096, DOI 10.1002/bit.24844; Pal D, 2011, APPL MICROBIOL BIOT, V90, P1429, DOI 10.1007/s00253-011-3170-1; Recht L, 2012, APPL MICROBIOL BIOT, V94, P1495, DOI 10.1007/s00253-012-3940-4; Roche SA, 2010, PHYCOL RES, V58, P298, DOI 10.1111/j.1440-1835.2010.00590.x; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Roleda MY, 2013, BIORESOURCE TECHNOL, V129, P439, DOI 10.1016/j.biortech.2012.11.043; Roncarati A, 2004, J WORLD AQUACULT SOC, V35, P401, DOI 10.1111/j.1749-7345.2004.tb00104.x; Samarakoon T., 2012, HIGH THROUGHPUT PHEN, P179; Sanjaya, 2013, PLANT CELL, V25, P677, DOI 10.1105/tpc.112.104752; Sharma KK, 2012, ENERGIES, V5, P1532, DOI 10.3390/en5051532; Shiva Sunitha, 2013, Methods Mol Biol, V1009, P79, DOI 10.1007/978-1-62703-401-2_9; SICKOGOAD L, 1988, J PHYCOL, V24, P1; Simionato D, 2013, EUKARYOT CELL, V12, P665, DOI 10.1128/EC.00363-12; SIRON R, 1989, MAR ECOL PROG SER, V55, P95, DOI 10.3354/meps055095; Stansell GR, 2012, J APPL PHYCOL, V24, P791, DOI 10.1007/s10811-011-9696-x; Sugimoto K, 2008, BIOCHEM BIOPH RES CO, V369, P660, DOI 10.1016/j.bbrc.2008.02.058; SUKENIK A, 1990, J PHYCOL, V26, P463, DOI 10.1111/j.0022-3646.1990.00463.x; Takagi M, 2006, J BIOSCI BIOENG, V101, P223, DOI 10.1263/jbb.101.223; TORNABENE TG, 1983, ENZYME MICROB TECH, V5, P435, DOI 10.1016/0141-0229(83)90026-1; VOLKMAN JK, 1989, J EXP MAR BIOL ECOL, V128, P219, DOI 10.1016/0022-0981(89)90029-4; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Williams PJL, 2010, ENERG ENVIRON SCI, V3, P554, DOI 10.1039/b924978h; Yu ET, 2009, J APPL PHYCOL, V21, P669, DOI 10.1007/s10811-008-9400-y; Zendejas FJ, 2012, BIOTECHNOL BIOENG, V109, P1146, DOI 10.1002/bit.24395	48	95	98	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e103389	10.1371/journal.pone.0103389	http://dx.doi.org/10.1371/journal.pone.0103389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171084	Green Published, gold			2022-12-25	WOS:000341127500011
J	Rocha, RJM; Silva, AMB; Fernandes, MHV; Cruz, ICS; Rosa, R; Calado, R				Rocha, Rui J. M.; Silva, Ana M. B.; Vaz Fernandes, M. Helena; Cruz, Igor C. S.; Rosa, Rui; Calado, Ricardo			Contrasting Light Spectra Constrain the Macro and Microstructures of Scleractinian Corals	PLOS ONE			English	Article							MORPHOLOGICAL PLASTICITY; PHENOTYPIC PLASTICITY; MONTASTRAEA-ANNULARIS; GALAXEA-FASCICULARIS; REEF CORALS; GROWTH; PORITES; ENVIRONMENT; BIOMINERALIZATION; SIDERASTREA	The morphological plasticity of scleractinian corals can be influenced by numerous factors in their natural environment. However, it is difficult to identify in situ the relative influence of a single biotic or abiotic factor, due to potential interactions between them. Light is considered as a major factor affecting coral skeleton morphology, due to their symbiotic relation with photosynthetic zooxanthellae. Nonetheless, most studies addressing the importance of light on coral morphological plasticity have focused on photosynthetically active radiation (PAR) intensity, with the effect of light spectra remaining largely unknown. The present study evaluated how different light spectra affect the skeleton macro- and microstructures in two coral species (Acropora formosa sensu Veron (2000) and Stylophora pistillata) maintained under controlled laboratory conditions. We tested the effect of three light treatments with the same PAR but with a distinct spectral emission: 1) T5 fluorescent lamps with blue emission; 2) Light Emitting Diodes (LED) with predominantly blue emission; and 3) Light Emitting Plasma (LEP) with full spectra emission. To exclude potential bias generated by genetic variability, the experiment was performed with clonal fragments for both species. After 6 months of experiment, it was possible to detect in coral fragments of both species exposed to different light spectra significant differences in morphometry (e.g., distance among corallites, corallite diameter, and theca thickness), as well as in the organization of their skeleton microstructure. The variability found in the skeleton macro- and microstructures of clonal organisms points to the potential pitfalls associated with the exclusive use of morphometry on coral taxonomy. Moreover, the identification of a single factor influencing the morphology of coral skeletons is relevant for coral aquaculture and can allow the optimization of reef restoration efforts.	[Rocha, Rui J. M.; Calado, Ricardo] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Rocha, Rui J. M.; Calado, Ricardo] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Silva, Ana M. B.; Vaz Fernandes, M. Helena] Univ Aveiro, Dept Engn Mat & Ceram, CICECO, P-3800 Aveiro, Portugal; [Cruz, Igor C. S.] Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Lab Ecol Marinha, BR-20550011 Rio De Janeiro, Brazil; [Rosa, Rui] Univ Lisbon, Fac Ciencias, Ctr Oceanog, Lab Maritimo Guia, Cascais, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Universidade do Estado do Rio de Janeiro; Universidade de Lisboa	Rocha, RJM (corresponding author), Univ Aveiro, Dept Biol, Campus Univ Santiago, P-3800 Aveiro, Portugal.	ruimirandarocha@gmail.com	Calado, Ricardo Jorge Guerra/C-7035-2008; Rosa, Rui/A-4580-2009; Cruz, Igor Cristino Silva/O-9525-2014; Cruz, Igor Cristino Silva/H-3292-2019; Rocha, Rui/AAP-9828-2021	Calado, Ricardo Jorge Guerra/0000-0002-1670-9335; Rosa, Rui/0000-0003-2801-5178; Cruz, Igor Cristino Silva/0000-0002-7475-533X; Cruz, Igor Cristino Silva/0000-0002-7475-533X; Rocha, Rui/0000-0002-4385-6074; V Fernandes, Maria Helena/0000-0002-1240-2512	Sustainable Use of Marine Resources-MARES [CENTRO-07-ST24-FEDER-002033]; QREN; Mais Centro e Programa Operacional Regional do Centro, Portugal; European Union/European Regional Development Fund	Sustainable Use of Marine Resources-MARES; QREN; Mais Centro e Programa Operacional Regional do Centro, Portugal; European Union/European Regional Development Fund(European Commission)	This research was not funded by any agency or project. Only RJMR was supported by a grant financed by project "Sustainable Use of Marine Resources-MARES'' (CENTRO-07-ST24-FEDER-002033), co-funded by QREN, Mais Centro e Programa Operacional Regional do Centro, Portugal and European Union/European Regional Development Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Benzoni F, 2010, ZOOL J LINN SOC-LOND, V160, P421, DOI 10.1111/j.1096-3642.2010.00622.x; Bongiorni L, 2003, MAR POLLUT BULL, V46, P1120, DOI 10.1016/S0025-326X(03)00240-6; Bongiorni L, 2003, MAR ECOL PROG SER, V253, P137, DOI 10.3354/meps253137; Bruckschen B., 2005, BIOEDIZINISCHE TECH, V50, P1609; Bruno JF, 1997, ECOLOGY, V78, P2177, DOI 10.2307/2265954; CHAPPELL J, 1980, NATURE, V286, P249, DOI 10.1038/286249a0; Cohen FPA, 2013, REV FISH SCI, V21, P98, DOI 10.1080/10641262.2012.760522; Crabbe MJC, 2006, COMPUT BIOL CHEM, V30, P155, DOI 10.1016/j.compbiolchem.2005.11.004; Crowell B, 2013, LIGHT MATTER; Cuif Jean-Pierre, 1999, Zoosystema, V21, P137; Cuif JP, 2003, ZOOL SCR, V32, P459, DOI 10.1046/j.1463-6409.2003.00133.x; Menezes NM, 2013, BIOTA NEOTROP, V13, P108, DOI 10.1590/S1676-06032013000100012; Dullo W.-C., 1987, Facies, V16, P11, DOI 10.1007/BF02536746; FOSTER AB, 1980, B MAR SCI, V30, P678; GRAUS RR, 1976, SCIENCE, V193, P895, DOI 10.1126/science.193.4256.895; Kaniewska P, 2011, J PHYCOL, V47, P846, DOI 10.1111/j.1529-8817.2011.01021.x; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Levy O, 2006, J EXP MAR BIOL ECOL, V328, P35, DOI 10.1016/j.jembe.2005.06.018; Levy O, 2003, J EXP BIOL, V206, P4041, DOI 10.1242/jeb.00622; Muko S, 2000, B MAR SCI, V66, P225; Nir O, 2011, CORAL REEFS, V30, P1089, DOI 10.1007/s00338-011-0801-z; Nothdurft LD, 2007, FACIES, V53, P1, DOI 10.1007/s10347-006-0090-0; Osinga R, 2011, MAR BIOTECHNOL, V13, P658, DOI 10.1007/s10126-011-9382-7; Padilla-Gamino JL, 2012, J EXP MAR BIOL ECOL, V434, P71, DOI 10.1016/j.jembe.2012.08.006; POTTS DC, 1976, COELENTERATE ECOLOGY, P79; POTTS DC, 1978, ATOLL RES B, V220, P55; Raymundo LJ, 2001, CORAL REEFS, V20, P263, DOI 10.1007/s003380100170; Riegl B, 1996, MAR ECOL PROG SER, V145, P87, DOI 10.3354/meps145087; Rinkevich B, 2005, ENVIRON SCI TECHNOL, V39, P4333, DOI 10.1021/es0482583; Rocha RJM, 2013, AQUACULTURE, V402, P38, DOI 10.1016/j.aquaculture.2013.03.028; Schmidt-Roach S, 2014, ZOOL J LINN SOC-LOND, V170, P1, DOI 10.1111/zoj12092; Shafir S, 2006, MAR BIOL, V149, P679, DOI 10.1007/s00227-005-0236-6; SORAUF J E, 1972, Palaeontology (Oxford), V15, P88; STAFFORDSMITH MG, 1993, MAR BIOL, V115, P229, DOI 10.1007/BF00346340; Stefani F, 2011, CORAL REEFS, V30, P1033, DOI 10.1007/s00338-011-0797-4; Stobart B, 2000, ZOOL STUD, V39, P179; Stolarski J, 2002, ACTA PALAEONTOL POL, V47, P651; Stolarski J, 2001, J PALEONTOL, V75, P1090, DOI 10.1666/0022-3360(2001)075<1090:TANSOE>2.0.CO;2; Todd PA, 2004, MAR BIOL, V145, P323, DOI 10.1007/s00227-004-1324-8; Todd PA, 2004, MAR ECOL PROG SER, V271, P167, DOI 10.3354/meps271167; Todd PA, 2004, J EXP MAR BIOL ECOL, V299, P97, DOI 10.1016/j.jembe.2003.09.005; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; Veron J, 2013, ZOOLOGICAL J LINNEAN; Veron J.E.N., 2000, CORALS WORLD, V1-3; VERON JEN, 1995, CORALS SPACE TIME BI; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; WEIL E, 1994, B MAR SCI, V55, P151; Wells J. W., 1956, pf328; Wijgerde T, 2012, AQUACULTURE, V344, P188, DOI 10.1016/j.aquaculture.2012.03.025	50	12	12	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105863	10.1371/journal.pone.0105863	http://dx.doi.org/10.1371/journal.pone.0105863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170981	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500075
J	Spearman, DG; Poliacek, I; Rose, MJ; Bolser, DC; Pitts, T				Spearman, Daniel G.; Poliacek, Ivan; Rose, Melanie J.; Bolser, Donald C.; Pitts, Teresa			Variability of the Pharyngeal Phase of Swallow in the Cat	PLOS ONE			English	Article							RHYTHMIC ORAL ACTIVITY; RESPIRATORY NEURONS; PHARYNGOESOPHAGEAL SEGMENT; LARYNGEAL MOTONEURONS; ESOPHAGEAL MOTILITY; ASPIRATION REFLEXES; DE-GLUTITION; IN-VIVO; COUGH; BOLUS	Objective: The pharyngeal phase of swallow has been thought to be a stereotypical motor behavior. Study Design: This is a prospective, preclinical, hypothesis driven, one group by three-task design. Methods: We sought to compare the effects of pharyngeal swabbing, water only, and water plus punctate mechanical stimulation on the spatiotemporal features of the pharyngeal phase of swallow in the cat. Swallow was elicited under these three conditions in six anaesthetized cats. Electromyographic activity was recorded from seven muscles used to evaluate swallow: mylohyoid, geniohyoid, thyrohyoid, thyroarytenoid, thyropharyngeus, cricopharyngeus, and parasternal. Results: Pharyngeal swabbing in comparison to the other stimulus conditions, results in decreases in post-swallow cricopharyngeus activity (upper esophageal sphincter); a significant increase in parasternal (schluckatmung; swallow breath) activity; and increases in thyrohyoid (laryngeal elevator), thyroarytenoid (laryngeal adductor) and parasternal muscles burst duration. Pearson correlations were found of moderate strength between 19% of burst duration comparisons and weak to moderate relationships between 29% of burst amplitude comparisons. However, there were no positive significant relationships between phase durations and electromyogram amplitudes between any of the muscles studied during swallow. Conclusions: The results support the concept that a stereotypical behavior, such as pharyngeal swallowing in animal models, can be modified by sensory feedback from pharyngeal mucosal mechanoreceptors. Furthermore, differences in swallow phase durations and amplitudes provide evidence that separate regulatory mechanisms exist which regulate spatial and temporal aspects of the behavior.	[Spearman, Daniel G.; Poliacek, Ivan; Rose, Melanie J.; Bolser, Donald C.; Pitts, Teresa] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Poliacek, Ivan] Comenius Univ, Jessenius Fac Med, Inst Med Biophys, Martin, Slovakia	State University System of Florida; University of Florida; Comenius University Bratislava	Pitts, T (corresponding author), Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA.	tepitts@ufl.edu	Bolser, Donald/CAI-2644-2022	Rose, Melanie/0000-0003-0021-3498; Pitts, Teresa/0000-0001-9448-2175	National Institutes of Health [HL 89104, HL103415, HL109025, HL107745]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL089104, R01HL109025, K99HL111215, R01HL103415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by National Institutes of Health HL 89104, HL103415, HL109025, and HL107745. There are no other financial disclosures to report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON M, 1957, J CLIN INVEST, V36, P581, DOI 10.1172/JCI103457; Baekey DM, 2001, J PHYSIOL-LONDON, V534, P565, DOI 10.1111/j.1469-7793.2001.t01-1-00565.x; BASMAJIAN JV, 1962, J APPL PHYSIOL, V17, P849, DOI 10.1152/jappl.1962.17.5.849; Beyak MJ, 1997, NEUROGASTROENT MOTIL, V9, P117, DOI 10.1046/j.1365-2982.1997.d01-22.x; Bolser D. C., 2009, V187, P203, DOI 10.1007/978-3-540-79842-2_10; Bolser DC, 1996, PULM PHARMACOL THER, V9, P357, DOI 10.1006/pulp.1996.0047; Bolser DC, 2000, J APPL PHYSIOL, V89, P785, DOI 10.1152/jappl.2000.89.2.785; Bolser DC, 2006, CHEST, V129, p238S, DOI 10.1378/chest.129.1_suppl.238S; Bolser DC, 2008, LUNG, V186, pS74, DOI 10.1007/s00408-007-9033-y; Bolser DC, 2007, CURR OPIN ALLERGY CL, V7, P32, DOI 10.1097/ACI.0b013e3280115145; Bonis JM, 2011, RESP PHYSIOL NEUROBI, V175, P272, DOI 10.1016/j.resp.2010.12.002; Cedborg AIH, 2009, EXP PHYSIOL, V94, P459, DOI 10.1113/expphysiol.2008.045724; CERENKO D, 1989, OTOLARYNG HEAD NECK, V100, P57, DOI 10.1177/019459988910000109; CLARK FJ, 1972, J PHYSIOL-LONDON, V222, P267, DOI 10.1113/jphysiol.1972.sp009797; Davenport PW, 2011, HEAD NECK-J SCI SPEC, V33, pS8, DOI 10.1002/hed.21845; DICK TE, 1993, J PHYSIOL-LONDON, V465, P715, DOI 10.1113/jphysiol.1993.sp019702; Doty R., 1968, HDB PHYSL, V4; DOTY RW, 1956, J NEUROPHYSIOL, V19, P44, DOI 10.1152/jn.1956.19.1.44; DOTY RW, 1956, J NEUROPHYSIOL, V19, P401, DOI 10.1152/jn.1956.19.5.401; Ertekin C, 2000, NEUROGASTROENT MOTIL, V12, P567, DOI 10.1046/j.1365-2982.2000.00232.x; Ertekin C, 2000, BRAIN, V123, P125, DOI 10.1093/brain/123.1.125; ERTEKIN C, 2000, CLIN NEUROPHYSIOL, V53, P148; German RZ, 2009, J NEUROPHYSIOL, V102, P1017, DOI 10.1152/jn.00100.2009; Gestreau C, 1996, EXP BRAIN RES, V108, P247; Gestreau C, 2000, EXP BRAIN RES, V130, P27, DOI 10.1007/s002210050003; Gewolb IH, 2001, DEV MED CHILD NEUROL, V43, P454, DOI 10.1017/S0012162201000834; Hegland KW, 2011, J SPEECH LANG HEAR R, V54, P777, DOI [10.1044/1092-4388(2010/09-0237), 10.1044/1092-4388(2010/09-0237]; HUKUHARA TAKESI, 1956, JAPANESE JOUR PHYSIOL, V6, P162; INGELFINGER FJ, 1958, PHYSIOL REV, V38, P533; Jean A, 2001, PHYSIOL REV, V81, P929, DOI 10.1152/physrev.2001.81.2.929; Kahrilas Peter J., 1993, Dysphagia, V8, P259, DOI 10.1007/BF01354548; Kendall KA, 2002, LARYNGOSCOPE, V112, P547, DOI 10.1097/00005537-200203000-00025; Kendall KA, 2001, ARCH OTOLARYNGOL, V127, P1224, DOI 10.1001/archotol.127.10.1224; Kim YS, 2008, DYSPHAGIA, V23, P274, DOI 10.1007/s00455-007-9135-y; Kitagawa JI, 2002, AM J PHYSIOL-REG I, V282, pR1342, DOI 10.1152/ajpregu.00556.2001; KU DN, 1990, ANN BIOMED ENG, V18, P655, DOI 10.1007/BF02368453; Leow LP, 2007, CHEM SENSES, V32, P119, DOI 10.1093/chemse/bjl037; LOGEMANN JA, 1995, J SPEECH HEAR RES, V38, P556, DOI 10.1044/jshr.3803.556; Martin-Harris B, 2003, J APPL PHYSIOL, V94, P1735, DOI 10.1152/japplphysiol.00806.2002; McConnel F M, 1988, Dysphagia, V2, P187, DOI 10.1007/BF02414425; McConnel F. M. S., 1994, Acta Oto-Rhino-Laryngologica Belgica, V48, P157; MCCONNEL FMS, 1986, HEAD NECK-J SCI SPEC, V9, P3, DOI 10.1002/hed.2890090103; MCCONNEL FMS, 1988, OTOLARYNG CLIN N AM, V21, P625; MCCONNEL FMS, 1988, LARYNGOSCOPE, V98, P71; MCCONNEL FMS, 1994, LARYNGOSCOPE, V104, P571, DOI 10.1002/lary.5541040512; MCCONNEL FMS, 1988, ARCH OTOLARYNGOL, V114, P1413; MCCONNEL FMS, 1992, OTOLARYNG HEAD NECK, V106, P169, DOI 10.1177/019459989210600219; MCCONNEL FMS, 1987, HEAD NECK-J SCI SPEC, V9, P142, DOI 10.1002/hed.2890090303; MCCONNEL FMS, 1988, LARYNGOSCOPE, V98, P705; MCCONNEL FMS, 1988, PLAST RECONSTR SURG, V81, P346, DOI 10.1097/00006534-198803000-00005; MCCONNEL FMS, 1991, LARYNGOSCOPE, V101, P510; MENDELSOHN MS, 1987, LARYNGOSCOPE, V97, P483; Miller AJ, 2002, CRIT REV ORAL BIOL M, V13, P409, DOI 10.1177/154411130201300505; MILLER AJ, 1982, PHYSIOL REV, V62, P129, DOI 10.1152/physrev.1982.62.1.129; Miller F. R., 1916, QUART J EXP PHYSIOL, V9, P147, DOI 10.1113/expphysiol.1915.sp000201; NAIL BS, 1969, J PHYSIOL-LONDON, V204, P91, DOI 10.1113/jphysiol.1969.sp008900; OKU Y, 1994, J PHYSIOL-LONDON, V480, P309, DOI 10.1113/jphysiol.1994.sp020361; OOTANI S, 1995, BRAIN RES BULL, V37, P397, DOI 10.1016/0361-9230(95)00018-6; Paik NJ, 2008, J ELECTROMYOGR KINES, V18, P329, DOI 10.1016/j.jelekin.2006.09.011; Paterson WG, 1999, NEUROGASTROENT MOTIL, V11, P63; Perlman AL, 2000, DYSPHAGIA, V15, P89, DOI 10.1007/s004550010006; Pitts T, 2013, RESP PHYSIOL NEUROBI, V189, P543, DOI 10.1016/j.resp.2013.08.009; Pitts T, 2012, EXP PHYSIOL, V97, P469, DOI 10.1113/expphysiol.2011.063362; Poliacek I, 2003, PHYSIOL RES, V52, P749; Poliacek I, 2009, J PHYSIOL PHARMACOL, V60, P99; Pommerenke WT, 1928, AM J PHYSIOL, V84, P36, DOI 10.1152/ajplegacy.1928.84.1.36; Rademaker AW, 1998, J SPEECH LANG HEAR R, V41, P275, DOI 10.1044/jslhr.4102.275; Richet Charles, 1900, DICT PHYSL; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; Saito Y, 2002, J PHYSIOL-LONDON, V540, P1047, DOI 10.1113/jphysiol.2001.014985; Shannon R, 1996, PULM PHARMACOL THER, V9, P343, DOI 10.1006/pulp.1996.0045; Sherrington C.S., 1915, EXP PHYSIOL, V9, P147, DOI [10.1113/expphysiol.1915.sp000201, DOI 10.1113/EXPPHYSIOL.1915.SP000201]; SHINGAI T, 1976, JPN J PHYSIOL, V26, P455; STOREY AT, 1975, EXP NEUROL, V47, P42, DOI 10.1016/0014-4886(75)90235-6; STOREY AT, 1968, EXP NEUROL, V20, P366, DOI 10.1016/0014-4886(68)90080-0; STOREY AT, 1968, EXP NEUROL, V20, P359, DOI 10.1016/0014-4886(68)90079-4; SUMI T, 1967, JPN J PHYSIOL, V17, P200; Thexton AJ, 2007, J APPL PHYSIOL, V102, P587, DOI 10.1152/japplphysiol.00456.2006; Thexton AJ, 2009, J NEUROPHYSIOL, V101, P1386, DOI 10.1152/jn.90847.2008; Tomori Z, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00467; Troche MS, 2010, NEUROLOGY, V75, P1912, DOI 10.1212/WNL.0b013e3181fef115; Troche MS, 2008, DYSPHAGIA, V23, P26, DOI 10.1007/s00455-007-9090-7; Vantrappen G., 1967, DIGEST DIS SCI, V12, P255; Wang Cheng, 2009, Cough, V5, P12, DOI 10.1186/1745-9974-5-12; Wheeler K, 2008, PHYSL ASPECTS SWALLO; WILSON SL, 1981, J APPL PHYSIOL, V50, P851, DOI 10.1152/jappl.1981.50.4.851	86	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106121	10.1371/journal.pone.0106121	http://dx.doi.org/10.1371/journal.pone.0106121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171095	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500109
J	King, TL; Henderson, AP; Kynard, BE; Kieffer, MC; Peterson, DL; Aunins, AW; Brown, BL				King, Tim L.; Henderson, Anne P.; Kynard, Boyd E.; Kieffer, Micah C.; Peterson, Douglas L.; Aunins, Aaron W.; Brown, Bonnie L.			A Nuclear DNA Perspective on Delineating Evolutionarily Significant Lineages in Polyploids: The Case of the Endangered Shortnose Sturgeon (Acipenser brevirostrum)	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; LIFE-HISTORY; POPULATION-STRUCTURE; MICROSATELLITE LOCI; OXYRINCHUS-DESOTOI; GREEN STURGEON; CONSERVATION; RIVER; BIOGEOGRAPHY; INDIVIDUALS	The shortnose sturgeon, Acipenser brevirostrum, oft considered a phylogenetic relic, is listed as an "endangered species threatened with extinction'' in the US and "Vulnerable'' on the IUCN Red List. Effective conservation of A. brevirostrum depends on understanding its diversity and evolutionary processes, yet challenges associated with the polyploid nature of its nuclear genome have heretofore limited population genetic analysis to maternally inherited haploid characters. We developed a suite of polysomic microsatellite DNA markers and characterized a sample of 561 shortnose sturgeon collected from major extant populations along the North American Atlantic coast. The 181 alleles observed at 11 loci were scored as binary loci and the data were subjected to multivariate ordination, Bayesian clustering, hierarchical partitioning of variance, and among-population distance metric tests. The methods uncovered moderately high levels of gene diversity suggesting population structuring across and within three metapopulations (Northeast, Mid-Atlantic, and Southeast) that encompass seven demographically discrete and evolutionarily distinct lineages. The predicted groups are consistent with previously described behavioral patterns, especially dispersal and migration, supporting the interpretation that A. brevirostrum exhibit adaptive differences based on watershed. Combined with results of prior genetic (mitochondrial DNA) and behavioral studies, the current work suggests that dispersal is an important factor in maintaining genetic diversity in A. brevirostrum and that the basic unit for conservation management is arguably the local population.	[King, Tim L.] US Geol Survey, Leetown Sci Ctr, Aquat Ecol Branch, Kearneysville, WV 25430 USA; [Henderson, Anne P.] USGS, Leetown Sci Ctr, Fish Hlth Branch, Kearneysville, WV USA; [Kynard, Boyd E.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Kieffer, Micah C.] USGS, Leetown Sci Ctr, SO Conte Anadromous Fish Res Lab, Turners Falls, MA USA; [Peterson, Douglas L.] Univ Georgia, Warnell Sch Forest Resources, Athens, GA 30602 USA; [Aunins, Aaron W.] Cherokee Nat Technol Solut, Leetown Sci Ctr, Kearneysville, WV USA; [Brown, Bonnie L.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Massachusetts System; University of Massachusetts Amherst; United States Department of the Interior; United States Geological Survey; University System of Georgia; University of Georgia; Virginia Commonwealth University	King, TL (corresponding author), US Geol Survey, Leetown Sci Ctr, Aquat Ecol Branch, Kearneysville, WV 25430 USA.	tlking@usgs.gov			National Capital Region (NCR) of the U.S. National Park Service (NPS); U.S. Geological Survey's (USGS) Leetown Science Center through the National Resources Preservation Program; Northeast Regional Office, Protected Resources Division, NOAA Fisheries, Department of Commerce	National Capital Region (NCR) of the U.S. National Park Service (NPS); U.S. Geological Survey's (USGS) Leetown Science Center through the National Resources Preservation Program; Northeast Regional Office, Protected Resources Division, NOAA Fisheries, Department of Commerce	The National Capital Region (NCR) of the U.S. National Park Service (NPS), and the U.S. Geological Survey's (USGS) Leetown Science Center provided principal funding for this project through the National Resources Preservation Program. The Northeast Regional Office, Protected Resources Division, NOAA Fisheries, Department of Commerce also provided partial funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000251; Balloux F, 2000, EVOLUTION, V54, P1414, DOI 10.1111/j.0014-3820.2000.tb00573.x; Bemis WE, 1997, ENVIRON BIOL FISH, V48, P25, DOI 10.1023/A:1007370213924; Bemis WE, 1997, ENVIRON BIOL FISH, V48, P167, DOI 10.1023/A:1007312524792; Birstein VJ, 2002, COPEIA, P287, DOI 10.1643/0045-8511(2002)002[0287:MPOANS]2.0.CO;2; Birstein VJ, 1998, MOL PHYLOGENET EVOL, V9, P141, DOI 10.1006/mpev.1997.0443; Birstein VJ, 1997, ENVIRON BIOL FISH, V48, P127, DOI 10.1023/A:1007366100353; BLACKLIDGE KH, 1993, J HERED, V84, P427, DOI 10.1093/oxfordjournals.jhered.a111367; Chakraborty R, 1987, POPULATION GENETICS, P89; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; DADSWELL MJ, 1979, CAN J ZOOL, V57, P2186, DOI 10.1139/z79-287; DINGERKUS G, 1976, SCIENCE, V194, P842, DOI 10.1126/science.982045; Duchesne P, 2002, MOL ECOL NOTES, V2, P380, DOI 10.1046/j.1471-8286.2002.00251.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fernandes SJ, 2008, THESIS U MAINE; Fernandes SJ, 2008, INVESTIGATION DISTRI; Fontana F, 2008, GENOME, V51, P113, DOI [10.1139/G07-112, 10.1139/g07-112]; Furlong RF, 2002, PHILOS T R SOC B, V357, P531, DOI 10.1098/rstb.2001.1035; Gardiner B.G., 1984, P148; Grunwald C, 2002, MOL ECOL, V11, P1885, DOI 10.1046/j.1365-294X.2002.01575.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Henderson AP, 2012, CONSERV GENET RESOUR, V4, P853, DOI 10.1007/s12686-012-9658-x; Hett AK, 2005, GENOME, V48, P181, DOI 10.1139/G04-112; HUFF DR, 1993, THEOR APPL GENET, V86, P927, DOI 10.1007/BF00211043; Israel JA, 2009, CAN J FISH AQUAT SCI, V66, P1491, DOI 10.1139/F09-091; Jaccard P., 1901, B SOC VAUD SCI NAT, V37, P547, DOI DOI 10.5169/SEALS-266450; Kieffer MC, 1996, T AM FISH SOC, V125, P179, DOI 10.1577/1548-8659(1996)125&lt;0179:SOTSSI&gt;2.3.CO;2; Kim DS, 2005, ICHTHYOL RES, V52, P94, DOI 10.1007/s10228-004-0257-z; Koskinen MT, 2002, ECOL LETT, V5, P193, DOI 10.1046/j.1461-0248.2002.00302.x; Kosman E, 2005, MOL ECOL, V14, P415, DOI 10.1111/j.1365-294X.2005.02416.x; Krieger J, 2008, J APPL ICHTHYOL, V24, P36, DOI 10.1111/j.1439-0426.2008.01088.x; Krieger J, 2002, MOL BIOL EVOL, V19, P891, DOI 10.1093/oxfordjournals.molbev.a004146; Kruskal JB, 1978, SAGE U PAPER SERIES, V07-011, DOI DOI 10.4135/9781412985130; Kynard B, 2004, ENVIRON BIOL FISH, V70, P43, DOI 10.1023/B:EBFI.0000022855.96143.95; Kynard B, 2009, J APPL ICHTHYOL, V25, P34, DOI 10.1111/j.1439-0426.2009.01224.x; Kynard B, 1997, ENVIRON BIOL FISH, V48, P319, DOI 10.1023/A:1007372913578; Kynard B, 2005, ENVIRON BIOL FISH, V71, P145; Kynard B, 2010, ENVIRON BIOL FISH, V88, P65, DOI 10.1007/s10641-010-9618-9; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Lanfredi M, 2001, CHROMOSOME RES, V9, P47, DOI 10.1023/A:1026739616749; Lazzari B, 2008, MAR GENOM, V1, P15, DOI 10.1016/j.margen.2008.04.002; Ludwig A, 2006, EUR J WILDLIFE RES, V52, P3, DOI 10.1007/s10344-005-0006-2; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; MANTEL N, 1967, CANCER RES, V27, P209; Nei M, 1987, MOL EVOLUTIONARY GEN; Obbard DJ, 2006, HEREDITY, V97, P296, DOI 10.1038/sj.hdy.6800862; OELLERMANN LK, 1990, J FISH BIOL, V37, P105, DOI 10.1111/j.1095-8649.1990.tb05932.x; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Parker E, 2005, LATITUDINAL DIFFEREN; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Quattro JM, 2002, CONSERV GENET, V3, P155, DOI 10.1023/A:1015275602748; Robles F, 2004, GENE, V338, P133, DOI 10.1016/j.gene.2004.06.001; Rodzen JA, 2002, GENOME, V45, P1064, DOI [10.1139/g02-083, 10.1139/G02-083]; ROHLF FJ, 1993, NTSYS PC NUMERICAL T; RYMAN N, 1995, REV FISH BIOL FISHER, V5, P417, DOI 10.1007/BF01103814; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 1989, MOL CLONING LAB MANU; Savoy TF, 2004, AM FI SOC M, V9, P345; Schultz R.J., 1980, POLYPLOIDY BIOL RELE, P313; Shortnose Sturgeon Status Review Team, 2010, BIOL ASS SHORTN STUR; Smith TIJ, 2002, J APPL ICHTHYOL, V18, P470, DOI 10.1046/j.1439-0426.2002.00412.x; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Waldman JR, 2002, J APPL ICHTHYOL, V18, P509, DOI 10.1046/j.1439-0426.2002.00361.x; Walsh MG, 2001, ESTUARIES, V24, P41, DOI 10.2307/1352811; Welsh AB, 2003, MOL ECOL NOTES, V3, P47, DOI 10.1046/j.1471-8286.2003.00346.x; Welsh SA, 2002, ESTUARIES, V25, P101, DOI 10.1007/BF02696053; Wirgin I, 2005, ESTUARIES, V28, P406, DOI 10.1007/BF02693923; Wirgin II, 1997, ENVIRON BIOL FISH, V48, P385, DOI 10.1023/A:1007306911163; Wirgin I, 2010, CONSERV GENET, V11, P689, DOI 10.1007/s10592-009-9840-1; WRIGHT S., 1969, Evolution and the genetics of populations. Vol. 2. The theory of gene frequencies., V2; Zhang SM, 2000, SCI CHINA SER C, V43, P129, DOI 10.1007/BF02879121; [No title captured]	75	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e102784	10.1371/journal.pone.0102784	http://dx.doi.org/10.1371/journal.pone.0102784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166503	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303700002
J	Agrati, C; Castilletti, C; Cimini, E; Lapa, D; Quartu, S; Caglioti, C; Lanini, S; Cattoli, G; Martini, F; Ippolito, G; Capobianchi, MR				Agrati, Chiara; Castilletti, Concetta; Cimini, Eleonora; Lapa, Daniele; Quartu, Serena; Caglioti, Claudia; Lanini, Simone; Cattoli, Giovanni; Martini, Federico; Ippolito, Giuseppe; Capobianchi, Maria R.			Cellular and Humoral Cross-Immunity against Two H3N2v Influenza Strains in Presumably Unexposed Healthy and HIV-Infected Subjects	PLOS ONE			English	Article							A VIRUS; EMERGING VARIANTS; UNITED-STATES; T-CELLS; PROTECTION; VACCINE; H1N1; IMMUNOGENICITY; TRANSMISSION; MORTALITY	Human cases of infection due to a novel swine-origin variant of influenza A virus subtype H3N2 (H3N2v) have recently been identified in the United States. Pre-existing humoral and cellular immunity has been recognized as one of the key factors in limiting the infection burden of an emerging influenza virus strain, contributing to restrict its circulation and to mitigate clinical presentation. Aim of this study was to assess humoral and cell-mediated cross immune responses to H3N2v in immuno-competent (healthy donors, n = 45) and immuno-compromised hosts (HIV-infected subjects, n = 46) never exposed to H3N2v influenza strain. Humoral response against i) H3N2v (A/H3N2/Ind/08/11), ii) animal vaccine H3N2 strain (A/H3N2/ Min/11/10), and iii) pandemic H1N1 virus (A/H1N1/Cal/07/09) was analysed by hemagglutination inhibition assay; cell-mediated response against the same influenza strains was analysed by ELISpot assay. A large proportion of healthy and HIV subjects displayed cross-reacting humoral and cellular immune responses against two H3N2v strains, suggesting the presence of B-and T-cell clones able to recognize epitopes from emerging viral strains in both groups. Specifically, humoral response was lower in HIV subjects than in HD, and a specific age-related pattern of antibody response against different influenza strains was observed both in HD and in HIV. Cellular immune response was similar between HD and HIV groups and no relationship with age was reported. Finally, no correlation between humoral and cellular immune response was observed. Overall, a high prevalence of HD and HIV patients showing cross reactive immunity against two H3N2v strains was observed, with a slightly lower proportion in HIV persons. Other studies focused on HIV subjects at different stages of diseases are needed in order to define how cross immunity can be affected by advanced immunosuppression.	[Agrati, Chiara; Castilletti, Concetta; Lapa, Daniele; Quartu, Serena; Caglioti, Claudia; Capobianchi, Maria R.] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Virol Lab, Rome, Italy; [Agrati, Chiara; Cimini, Eleonora; Martini, Federico] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Cellular Immunol Lab, Rome, Italy; [Lanini, Simone; Ippolito, Giuseppe] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Dept Epidemiol, Rome, Italy; [Cattoli, Giovanni] Ist Zooprofilatt Sperimentale Venezie, Padua, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; IZS delle Venezie	Capobianchi, MR (corresponding author), IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Virol Lab, Rome, Italy.	maria.capobianchi@inmi.it	Castilletti, Concetta/AAA-8408-2019; Ippolito, Giuseppe/J-7207-2017; Castilletti, Concetta/B-6545-2016; Lanini, Simone/C-7523-2012; Cimini, Eleonora/K-8878-2016; Agrati, Chiara/K-8806-2016	Castilletti, Concetta/0000-0001-9819-236X; Castilletti, Concetta/0000-0001-9819-236X; Lanini, Simone/0000-0002-6743-4001; Cimini, Eleonora/0000-0002-2659-0868; Agrati, Chiara/0000-0002-5252-0927; Ippolito, Giuseppe/0000-0002-1076-2979; Capobianchi, Maria Rosaria/0000-0003-3465-0071	Italian Ministry of Health; European Union [278433-PREDEMICS]; Fondazione Cariplo [2011]	Italian Ministry of Health(Ministry of Health, Italy); European Union(European Commission); Fondazione Cariplo(Fondazione Cariplo)	This study was partly funded by grants from the Italian Ministry of Health (Ricerca Corrente), the European Union's Seventh Framework Programme for research, technological development and demonstration under Grant Agreement no 278433-PREDEMICS, and Fondazione Cariplo (grant 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2012, AIDS RES HUM RETROV, V28, P1606, DOI [10.1089/aid.2011.0371, 10.1089/AID.2011.0371]; Agrati C, 2010, J INFECT DIS, V202, P681, DOI 10.1086/655469; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Branch Alicia, 2012, Morbidity and Mortality Weekly Report, V61, P237; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P561; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V60, P1741; Christensen JP, 2000, J VIROL, V74, P11690, DOI 10.1128/JVI.74.24.11690-11696.2000; Cox CM, 2011, EMERG INFECT DIS, V17, P1143, DOI [10.3201/eid1706.101488, 10.3201/eid/1706.101488]; DiOrio Mary, 2012, Morbidity and Mortality Weekly Report, V61, P764; Epperson Scott, 2012, Morbidity and Mortality Weekly Report, V61, P785; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Forrest BD, 2008, CLIN VACCINE IMMUNOL, V15, P1042, DOI 10.1128/CVI.00397-07; Ganatra Rahul, 2012, Morbidity and Mortality Weekly Report, V61, P414; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; Hillaire MLB, 2013, J GEN VIROL, V94, P583, DOI 10.1099/vir.0.048652-0; Houser KV, 2013, J VIROL, V87, P13480, DOI 10.1128/JVI.02434-13; Houser KV, 2013, J VIROL, V87, P1261, DOI 10.1128/JVI.02625-12; Klein MB, 2007, CLIN INFECT DIS, V45, P234, DOI 10.1086/518986; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Lin JC, 2001, ARCH INTERN MED, V161, P441, DOI 10.1001/archinte.161.3.441; Lindstrom S, 2012, EMERG INFECT DIS, V18, P834, DOI 10.3201/eid1805.111922; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; O'Neill E, 2000, J GEN VIROL, V81, P2689, DOI 10.1099/0022-1317-81-11-2689; Oh DY, 2008, J CLIN MICROBIOL, V46, P2189, DOI 10.1128/JCM.00398-08; Pearce MB, 2012, P NATL ACAD SCI USA, V109, P3944, DOI 10.1073/pnas.1119945109; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Rimmelzwaan GF, 2009, VACCINE, V27, P6363, DOI 10.1016/j.vaccine.2009.01.016; SAFRIN S, 1990, CHEST, V98, P33, DOI 10.1378/chest.98.1.33; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Shu B, 2012, VIROLOGY, V422, P151, DOI 10.1016/j.virol.2011.10.016; Skowronski DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054015; Skowronski DM, 2012, J INFECT DIS, V206, P1852, DOI 10.1093/infdis/jis500; Tebas P, 2010, AIDS, V24, P2187, DOI 10.1097/QAD.0b013e32833c6d5c; Waalen K, 2012, EURO SURVEILL, V17; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000; Webby RJ, 2003, P NATL ACAD SCI USA, V100, P7235, DOI 10.1073/pnas.1232449100; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; WHO Manual on Animal Influenza Diagnosis and Surveillance, 2013, WHOCDSCSRNCS20025REV	40	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105651	10.1371/journal.pone.0105651	http://dx.doi.org/10.1371/journal.pone.0105651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162670	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900041
J	Gao, C; Li, JT; Fang, L; Xu, YY; Zhao, HC				Gao, Chun; Li, Jing-Tao; Fang, Long; Xu, Ying-Ying; Zhao, Hong-Chuan			Drug Allergy and the Risk of Lymph Node Metastasis in Rectal Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; PROGNOSTIC-SIGNIFICANCE; METAANALYSIS; HISTORY; MORTALITY; DISEASES; NUMBER; HEALTH; ASTHMA; ATOPY	Background: Previous epidemiologic studies have reported that a history of allergy is associated with reduced risk of colorectal cancer and other malignancies. However, no information is available for the association between allergy and the risk of lymph node metastasis. Our study was designed to determine this association in rectal cancer. Methods: Patients who were treated at our hospital in the period from January 2003 to June 2011, and with a pathologically hospital discharge diagnosis of rectal adencarcinoma, were included. The clinical, laboratory, and pathologic parameters were analyzed. A multivariate logistic regression model was used to determine the association. Moreover, for type of allergic drug, sub-group analysis was performed. Results: 469 patients were included, including 231 with pathological lymph node metastasis (pLNM) (49.3%) and 238 without pLNM. Univariate analysis showed, compared with patients without pLNM, patients with pLNM had a younger age (60.6 +/- 12.8 yr vs. 63.6 +/- 12.2 yr, P = 0.012), a lower percentage of drug allergy (8.7% vs. 16.0%, P = 0.016), an increased CEA (median/interquartile-range 5.40/2.40-13.95 vs. 3.50/2.08-8.67, P = 0.009), and a lower serum sodium (141 +/- 3.1 mmol/L vs. 142 +/- 2.9 mmol/L, P = 0.028). Multivariate analysis showed that drug allergy was associated with a reduced risk of pLNM (OR = 0.553; 95% CI, 0.308-0.994; P = 0.048). In addition, our results showed that: (1) for tumor classification, patients with drug allergy had a higher percentage of group patients with pT1/pT2; and (2) for type of allergic drug, this inverse association was found for penicillins, not for other allergic drugs. Conclusion: Drug allergy is associated with a reduced risk of pLNM in rectal cancer.	[Gao, Chun; Li, Jing-Tao; Fang, Long; Xu, Ying-Ying; Zhao, Hong-Chuan] Minist Hlth, China Japan Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China	China-Japan Friendship Hospital	Zhao, HC (corresponding author), Minist Hlth, China Japan Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China.	hongchuanzhao@hotmail.com		Gao, Chun/0000-0003-3477-5886	National Specific Research Project for Health and Welfare of China [200902002-1]; Research Fund of Beijing Municipal Science & Technology Commission [Z111107067311021]; Beijing NOVA Programme [Z131107000413067]; Research Fund of China-Japan Friendship Hospital, Ministry of Health [2013-QN-07, 2013-QN-06]	National Specific Research Project for Health and Welfare of China; Research Fund of Beijing Municipal Science & Technology Commission; Beijing NOVA Programme(Beijing Municipal Science & Technology Commission); Research Fund of China-Japan Friendship Hospital, Ministry of Health	Dr. Hong-Chuan Zhao received funds from the National Specific Research Project for Health and Welfare of China (No. 200902002-1) and the Research Fund of Beijing Municipal Science & Technology Commission (No. Z111107067311021); Dr. Chun Gao received funds from the Beijing NOVA Programme (No. Z131107000413067) and the Research Fund of China-Japan Friendship Hospital, Ministry of Health (No. 2013-QN-07); and Dr. Long Fang received the Research Fund of China-Japan Friendship Hospital, Ministry of Health (No. 2013-QN-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg-Beckhoff G, 2009, EUR J EPIDEMIOL, V24, P433, DOI 10.1007/s10654-009-9355-6; Bosetti C, 2004, EUR J CANCER PREV, V13, P173, DOI 10.1097/01.cej.0000130016.85687.cf; Caywood J, 2005, ANN SURG ONCOL, V12, P1061, DOI 10.1245/ASO.2005.02.013; Chang HC, 2012, ANN SURG ONCOL, V19, P2477, DOI 10.1245/s10434-012-2303-9; Chen C, 2011, EUR J NEUROL, V18, P387, DOI 10.1111/j.1468-1331.2010.03187.x; Ding PR, 2011, J GASTROINTEST SURG, V15, P130, DOI 10.1007/s11605-010-1353-1; Dobbins SE, 2011, INT J CANCER, V128, P1736, DOI 10.1002/ijc.25483; Eriksson NE, 2005, J INVEST ALLERG CLIN, V15, P161; Ferro DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020706; Fujita S, 2009, INT J COLORECTAL DIS, V24, P1085, DOI 10.1007/s00384-009-0704-4; Gandini S, 2005, CANCER EPIDEM BIOMAR, V14, P1908, DOI 10.1158/1055-9965.EPI-05-0119; Gergen PJ, 2000, CLIN EXP ALLERGY, V30, P1717, DOI 10.1046/j.1365-2222.2000.00971.x; Jensen-Jarolim E, 2008, ALLERGY, V63, P1255, DOI 10.1111/j.1398-9995.2008.01768.x; KALLEN B, 1993, EUR RESPIR J, V6, P694; Kim JS, 2011, J SURG ONCOL, V104, P486, DOI 10.1002/jso.21966; Kim YW, 2009, ANN SURG, V249, P965, DOI 10.1097/SLA.0b013e3181a6cc25; LAVECCHIA C, 1991, EUR J CANCER, V27, P582, DOI 10.1016/0277-5379(91)90223-Z; Li T, 2013, WORLD J GASTROENTERO, V19, P5615, DOI 10.3748/wjg.v19.i34.5615; Linabery AM, 2010, AM J EPIDEMIOL, V171, P749, DOI 10.1093/aje/kwq004; MCWHORTER WP, 1988, CANCER-AM CANCER SOC, V62, P451, DOI 10.1002/1097-0142(19880715)62:2<451::AID-CNCR2820620234>3.0.CO;2-D; MILLS PK, 1992, AM J EPIDEMIOL, V136, P287, DOI 10.1093/oxfordjournals.aje.a116494; Mirabelli MC, 2009, CANCER EPIDEM BIOMAR, V18, P2650, DOI 10.1158/1055-9965.EPI-09-0446; Negri E, 1999, EUR J CANCER, V35, P1838, DOI 10.1016/S0959-8049(99)00209-9; Peng J, 2013, COLORECTAL DIS, V15, pE13, DOI 10.1111/codi.12055; Pichler WJ, 2010, MED CLIN N AM, V94, P645, DOI 10.1016/j.mcna.2010.04.003; Prizment AE, 2007, CANCER EPIDEM BIOMAR, V16, P2357, DOI 10.1158/1055-9965.EPI-07-0468; Reis-Alves SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081048; Rittmeyer D, 2012, INT ARCH ALLERGY IMM, V159, P216, DOI 10.1159/000338994; Santillan AA, 2003, CANCER CAUSE CONTROL, V14, P327, DOI 10.1023/A:1023982402137; Saraste D, 2013, EUR J CANCER, V49, P1104, DOI 10.1016/j.ejca.2012.10.005; Sherman PW, 2008, Q REV BIOL, V83, P339, DOI 10.1086/592850; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh R, 2004, CANCER-AM CANCER SOC, V100, P1807, DOI 10.1002/cncr.20206; Tepper JE, 2001, J CLIN ONCOL, V19, P157, DOI 10.1200/JCO.2001.19.1.157; Tsai CJ, 2011, CANCER-AM CANCER SOC, V117, P3713, DOI 10.1002/cncr.25973; Turner MC, 2005, AM J EPIDEMIOL, V162, P212, DOI 10.1093/aje/kwi193; Wang H, 2005, ALLERGY, V60, P1098, DOI 10.1111/j.1398-9995.2005.00813.x; Wiemels JL, 2011, INT J CANCER, V129, P1932, DOI 10.1002/ijc.25858; Wu ZY, 2007, WORLD J GASTROENTERO, V13, P6048, DOI 10.3748/wjg.13.6048	39	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106123	10.1371/journal.pone.0106123	http://dx.doi.org/10.1371/journal.pone.0106123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162236	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900091
J	Levy, S; Katusic, SK; Colligan, RC; Weaver, AL; Killian, JM; Voigt, RG; Barbaresi, WJ				Levy, Sharon; Katusic, Slavica K.; Colligan, Robert C.; Weaver, Amy L.; Killian, Jill M.; Voigt, Robert G.; Barbaresi, William J.			Childhood ADHD and Risk for Substance Dependence in Adulthood: A Longitudinal, Population-Based Study	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NEUROPSYCHIATRIC INTERVIEW MINI; DEFICIT HYPERACTIVITY DISORDER; EXECUTIVE FUNCTIONS; MEDICATION TREATMENT; DSM-IV; ADOLESCENTS; ABUSE; HISTORY; INHIBITION	Background: Adolescents with attention-deficit/hyperactivity disorder (ADHD) are known to be at significantly greater risk for the development of substance use disorders (SUD) compared to peers. Impulsivity, which could lead to higher levels of drug use, is a known symptom of ADHD and likely accounts, in part, for this relationship. Other factors, such as a biologically increased susceptibility to substance dependence (addiction), may also play a role. Objective: This report further examines the relationships between childhood ADHD, adolescent-onset SUD, and substance abuse and substance dependence in adulthood. Method: Individuals with childhood ADHD and non-ADHD controls from the same population-based birth cohort were invited to participate in a prospective outcome study. Participants completed a structured neuropsychiatric interview with modules for SUD and a psychosocial questionnaire. Information on adolescent SUD was obtained retrospectively, in a previous study, from medical and school records. Associations were summarized using odds ratios (OR) and 95% CIs estimated from logistic regression models adjusted for age and gender. Results: A total of 232 ADHD cases and 335 non-ADHD controls participated (mean age, 27.0 and 28.6 years, respectively). ADHD cases were more likely than controls to have a SUD diagnosed in adolescence and were more likely to have alcohol (adjusted OR 14.38, 95% CI 1.49-138.88) and drug (adjusted OR 3.48, 95% CI 1.38-8.79) dependence in adulthood. The subgroup of participating ADHD cases who did not have SUD during adolescence were no more likely than controls to develop new onset alcohol dependence as adults, although they were significantly more likely to develop new onset drug dependence. Conclusions: Our study found preliminary evidence that adults with childhood ADHD are more susceptible than peers to developing drug dependence, a disorder associated with neurological changes in the brain. The relationship between ADHD and alcohol dependence appears to be more complex.	[Levy, Sharon; Barbaresi, William J.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Dev Med, Boston, MA USA; [Katusic, Slavica K.; Weaver, Amy L.; Killian, Jill M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Colligan, Robert C.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Voigt, Robert G.] Baylor Coll Med, Dept Pediat, Texas Childrens Hosp, Houston, TX 77030 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Mayo Clinic; Mayo Clinic; Baylor College of Medicine	Katusic, SK (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.	Slavica.Katusic@mayo.edu; William.Barbaresi@childrens.harvard.edu	Voigt, Robert/AAO-6336-2021		Public Health Service research grants [MH076111, HD29745, AG034676]; McNeil Consumer and Specialty Pharmaceuticals; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029745] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER	Public Health Service research grants; McNeil Consumer and Specialty Pharmaceuticals; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by Public Health Service research grants MH076111, HD29745, and AG034676. Pilot work for the prospective portion of the project was funded by an investigator-initiated grant from McNeil Consumer and Specialty Pharmaceuticals. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; Barbaresi WJ, 2006, J DEV BEHAV PEDIATR, V27, P1, DOI 10.1097/00004703-200602000-00001; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Booth JR, 2005, J CHILD PSYCHOL PSYC, V46, P94, DOI 10.1111/j.1469-7610.2004.00337.x; Chen CY, 2009, ADDICT BEHAV, V34, P319, DOI 10.1016/j.addbeh.2008.10.021; Deas D, 2000, ALCOHOL CLIN EXP RES, V24, P232, DOI 10.1111/j.1530-0277.2000.tb04596.x; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Grant BF, 1998, J SUBST ABUSE, V10, P163, DOI 10.1016/S0899-3289(99)80131-X; Grella CE, 2001, J NERV MENT DIS, V189, P384, DOI 10.1097/00005053-200106000-00006; Groenman AP, 2013, ADDICTION, V108, P1503, DOI 10.1111/add.12188; Hingson RW, 2006, ARCH PEDIAT ADOL MED, V160, P739, DOI 10.1001/archpedi.160.7.739; Jasti S, 2008, NURS RES, V57, P118, DOI 10.1097/01.NNR.0000313479.55002.74; Katusic SK, 2005, J CHILD ADOL PSYCHOP, V15, P764, DOI 10.1089/cap.2005.15.764; Lee SS, 2011, CLIN PSYCHOL REV, V31, P328, DOI 10.1016/j.cpr.2011.01.006; Mariani JJ, 2007, AM J ADDICTION, V16, P45, DOI 10.1080/10550490601082783; Mayo-Smith M., 2009, PRINCIPLES ADDICTION, P559; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Molina BSG, 2013, J AM ACAD CHILD PSY, V52, P250, DOI 10.1016/j.jaac.2012.12.014; Molina BSG, 2003, J ABNORM PSYCHOL, V112, P497, DOI 10.1037/0021-843X.112.3.497; Molina BSG, 2001, J LEARN DISABIL-US, V34, P333, DOI 10.1177/002221940103400408; National Institute on Alcohol Abuse and Alcoholism, 2011, NIH PUBLICATION, V11-7805; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nigg JT, 2005, J ABNORM PSYCHOL, V114, P706, DOI 10.1037/0021-843X.114.3.706; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; Rocca WA, 2012, MAYO CLIN PROC, V87, P1202, DOI 10.1016/j.mayocp.2012.08.012; Rubia K, 2005, AM J PSYCHIAT, V162, P1067, DOI 10.1176/appi.ajp.162.6.1067; Schachar R, 2000, J ABNORM CHILD PSYCH, V28, P227, DOI 10.1023/A:1005140103162; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; TAIOLI E, 1991, NEW ENGL J MED, V325, P968; Upadhyaya HP, 2005, J CHILD ADOL PSYCHOP, V15, P799, DOI 10.1089/cap.2005.15.799; Vasic N, 2012, J ATTEN DISORD; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Wilens TE, 1998, AM J ADDICTION, V7, P156; Wilens TE, 2004, J CLIN PSYCHIAT, V65, P38; Wise BK, 2001, J SUBST ABUSE TREAT, V21, P161, DOI 10.1016/S0740-5472(01)00193-3; Yoshimasu K, 2012, J CHILD PSYCHOL PSYC, V53, P1036, DOI 10.1111/j.1469-7610.2012.02567.x	40	44	44	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105640	10.1371/journal.pone.0105640	http://dx.doi.org/10.1371/journal.pone.0105640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8UR	25162629	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900040
J	Ohkawara, H; Ishibashi, T; Sugimoto, K; Ikeda, K; Ogawa, K; Takeishi, Y				Ohkawara, Hiroshi; Ishibashi, Toshiyuki; Sugimoto, Koichi; Ikeda, Kazuhiko; Ogawa, Kazuei; Takeishi, Yasuchika			Membrane Type 1-Matrix Metalloproteinase/Akt Signaling Axis Modulates TNF-alpha-Induced Procoagulant Activity and Apoptosis in Endothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; TISSUE FACTOR; 3-KINASE/AKT PATHWAY; ACTIVATION; EXPRESSION; MT1-MMP; AKT; MICROENVIRONMENT; ATHEROSCLEROSIS; THROMBOMODULIN	Membrane type 1-matrix metalloproteinase (MT1-MMP) functions as a signaling molecule in addition to a proteolytic enzyme. Our hypothesis was that MT1-MMP cooperates with protein kinase B (Akt) in tumor necrosis factor (TNF)-alpha-induced signaling pathways of vascular responses, including tissue factor (TF) procoagulant activity and endothelial apoptosis, in cultured human aortic endothelial cells (ECs). TNF-alpha (10 ng/mL) induced a decrease in Akt phosphorylation within 60 minutes in ECs. A chemical inhibitor of MMP, TIMP-2 and selective small interfering RNA (siRNA)-mediated suppression of MT1-MMP reversed TNF-alpha-triggered transient decrease of Akt phosphorylation within 60 minutes, suggesting that MT1-MMP may be a key regulator of Akt phosphorylation in TNF-alpha-stimulated ECs. In the downstream events, TNF-alpha increased TF antigen and activity, and suppressed the expression of thrombomodulin (TM) antigen. Inhibition of Akt markedly enhanced TNF-alpha-induced expression of TF antigen and activity, and further reduced the expression of TM antigen. Silencing of MT1-MMP by siRNA also reversed the changed expression of TF and TM induced by TNF-alpha. Moreover, TNF-alpha induced apoptosis of ECs through Akt- and forkhead box protein O1 (FoxO1)-dependent signaling pathway and nuclear factor-kB (NF-kB) activation. Knockdown of MT1-MMP by siRNA reversed apoptosis of ECs by inhibiting TNF-alpha-induced Akt-dependent regulation of FoxO1 in TNF-alpha-stimulated ECs. Immunoprecipitation demonstrated that TNF-alpha induced the changes in the associations between the cytoplasmic fraction of MT1-MMP and Akt in ECs. In conclusion, we show new evidence that MT1-MMP/Akt signaling axis is a key modifier for TNF-alpha-induced signaling pathways for modulation of procoagulant activity and apoptosis of ECs.	[Ohkawara, Hiroshi; Sugimoto, Koichi; Ikeda, Kazuhiko; Ogawa, Kazuei; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan; [Ishibashi, Toshiyuki] Ohara Gen Hosp, Med Ctr, Dept Cardiovasc Med, Fukushima, Japan	Fukushima Medical University	Ohkawara, H (corresponding author), Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan.	ohkawara@fmu.ac.jp		Ohkawara, Hiroshi/0000-0002-3129-1977	Fukushima Medical University Research Project; Japan Society for the Promotion of Science [22790718]	Fukushima Medical University Research Project; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Fukushima Medical University Research Project and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (22790718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Lopez-Ramirez MA, 2012, J IMMUNOL, V189, P3130, DOI 10.4049/jimmunol.1103460; Alikhani M, 2005, J BIOL CHEM, V280, P12096, DOI 10.1074/jbc.M412171200; Ando K, 2011, J ATHEROSCLER THROMB, V18, P762, DOI 10.5551/jat.6783; Annabi B, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-8; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Behl Y, 2009, DIABETES, V58, P917, DOI 10.2337/db08-0537; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Esmon CT, 2004, J THROMB HAEMOST, V2, P209, DOI 10.1046/j.1538-7933.2003.00537.x; Grehan JF, 2005, J IMMUNOL, V175, P1903, DOI 10.4049/jimmunol.175.3.1903; Hemmings BA, 1997, SCIENCE, V275, P628, DOI 10.1126/science.275.5300.628; Hoshino D, 2009, J BIOL CHEM, V284, P27315, DOI 10.1074/jbc.M109.041400; Ikeda K, 2011, BLOOD, V117, P5860, DOI 10.1182/blood-2011-02-334425; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jander S, 2001, STROKE, V32, P850, DOI 10.1161/01.STR.32.4.850; Kamioka M, 2011, J CELL PHYSIOL, V226, P1554, DOI 10.1002/jcp.22492; Kandalam V, 2010, CIRC RES, V106, P796, DOI 10.1161/CIRCRESAHA.109.209189; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim CW, 2012, FEBS LETT, V586, P229, DOI 10.1016/j.febslet.2011.12.011; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; Lee YJ, 2009, J NAT MED-TOKYO, V63, P463, DOI 10.1007/s11418-009-0352-6; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Moons AHM, 2002, CARDIOVASC RES, V53, P313, DOI 10.1016/S0008-6363(01)00452-7; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Oussaief L, 2009, J BIOL CHEM, V284, P23912, DOI 10.1074/jbc.M109.036483; Rajavashisth TB, 1999, CIRCULATION, V99, P3103, DOI 10.1161/01.CIR.99.24.3103; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sakamoto T, 2005, ARTERIOSCL THROM VAS, V25, P2005, DOI 10.1161/01.ATV.0000178171.61754.cd; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Schabbauer G, 2004, ARTERIOSCL THROM VAS, V24, P1963, DOI 10.1161/01.ATV.0000143096.15099.ce; Shirvaikar N, 2011, STEM CELLS DEV, V20, P19, DOI 10.1089/scd.2010.0118; Sina A, 2010, J CELL COMMUN SIGNAL, V4, P31, DOI 10.1007/s12079-009-0084-0; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; Sugimoto K, 2009, CARDIOVASC RES, V84, P127, DOI 10.1093/cvr/cvp177; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; Tellier E, 2007, MOL CELL BIOL, V27, P2997, DOI 10.1128/MCB.01485-06; Vagima Y, 2009, J CLIN INVEST, V119, P492, DOI 10.1172/JCI36541; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; Yokoyama K, 2002, CIRCULATION, V105, P962, DOI 10.1161/hc0802.104457; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010	43	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105697	10.1371/journal.pone.0105697	http://dx.doi.org/10.1371/journal.pone.0105697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162582	gold, Green Submitted, Green Published			2022-12-25	WOS:000340880900045
J	Sendek, A; Fuller, HR; Hayre, NR; Singh, RRP; Cox, DL				Sendek, Austin; Fuller, Henry R.; Hayre, N. Robert; Singh, Rajiv R. P.; Cox, Daniel L.			Simulated Cytoskeletal Collapse via Tau Degradation	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AMYLOID-BETA; PROTEIN-TAU; MICROTUBULES; DEGENERATION; PERCOLATION; TUBULIN; SITE	We present a coarse-grained two dimensional mechanical model for the microtubule-tau bundles in neuronal axons in which we remove taus, as can happen in various neurodegenerative conditions such as Alzheimers disease, tauopathies, and chronic traumatic encephalopathy. Our simplified model includes (i) taus modeled as entropic springs between microtubules, (ii) removal of taus from the bundles due to phosphorylation, and (iii) a possible depletion force between microtubules due to these dissociated phosphorylated taus. We equilibrate upon tau removal using steepest descent relaxation. In the absence of the depletion force, the transverse rigidity to radial compression of the bundles falls to zero at about 60% tau occupancy, in agreement with standard percolation theory results. However, with the attractive depletion force, spring removal leads to a first order collapse of the bundles over a wide range of tau occupancies for physiologically realizable conditions. While our simplest calculations assume a constant concentration of microtubule intercalants to mediate the depletion force, including a dependence that is linear in the detached taus yields the same collapse. Applying percolation theory to removal of taus at microtubule tips, which are likely to be the protective sites against dynamic instability, we argue that the microtubule instability can only obtain at low tau occupancy, from 0.06-0.30 depending upon the tau coordination at the microtubule tips. Hence, the collapse we discover is likely to be more robust over a wide range of tau occupancies than the dynamic instability. We suggest in vitro tests of our predicted collapse.	[Sendek, Austin] Stanford Univ, Dept Appl Phys, Palo Alto, CA 94304 USA; [Sendek, Austin; Fuller, Henry R.; Hayre, N. Robert; Singh, Rajiv R. P.; Cox, Daniel L.] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; [Sendek, Austin; Fuller, Henry R.; Hayre, N. Robert; Singh, Rajiv R. P.; Cox, Daniel L.] Univ Calif Davis, Inst Complex Adapt Matter, Davis, CA 95616 USA	Stanford University; University of California System; University of California Davis; University of California System; University of California Davis	Cox, DL (corresponding author), Univ Calif Davis, Dept Phys, Davis, CA 95616 USA.	dlcox@ucdavis.edu	Sendek, Austin/K-3460-2017	Sendek, Austin/0000-0003-3338-1615	United States National Science Foundation [DMR-1207624]; International Institute for Complex Adaptive Matter, United States National Science Foundation [DMR-0844115]; Division Of Materials Research [1207624, 0844115] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); International Institute for Complex Adaptive Matter, United States National Science Foundation; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by United States National Science Foundation Grant DMR-1207624 (A.S., H.F., N.R.H., R.R.P.S., D.L.C). It was also supported by International Institute for Complex Adaptive Matter, United States National Science Foundation Grant DMR-0844115 (computing cluster) (N.R.H, D.L.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Brady ST, 2013, FUNDAMENTAL NEUROSCI, P97; Chau MF, 1998, BIOCHEMISTRY-US, V37, P17692, DOI 10.1021/bi9812118; Chtcheglova LA, 2004, BIOPHYS J, V86, P1177, DOI 10.1016/S0006-3495(04)74192-2; Dietz H, 2006, P NATL ACAD SCI USA, V103, P12724, DOI 10.1073/pnas.0602995103; Fein JA, 2008, AM J PATHOL, V172, P1683, DOI 10.2353/ajpath.2008.070829; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hawkins TL, 2013, BIOPHYS J, V104, P1517, DOI 10.1016/j.bpj.2013.02.026; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Huang J, 2007, AM J NEURORADIOL, V28, P1943, DOI 10.3174/ajnr.A0700; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; King ME, 1999, BIOCHEMISTRY-US, V38, P14851, DOI 10.1021/bi9911839; Lingor P, 2012, CELL TISSUE RES, V349, P289, DOI 10.1007/s00441-012-1362-3; Lulevich V, 2010, P NATL ACAD SCI USA, V107, P13872, DOI 10.1073/pnas.1008341107; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Michaelis Mary L., 2006, Current Alzheimer Research, V3, P215, DOI 10.2174/156720506777632880; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Mylonas E, 2008, BIOCHEMISTRY-US, V47, P10345, DOI 10.1021/bi800900d; Needleman DJ, 2005, BIOPHYS J, V89, P3410, DOI 10.1529/biophysj.104.057679; Phillips R., 2008, PHYS BIOL CELL, P313; Phillips R, 2008, PHYS BIOL CELL, P526; Pontes B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067708; Press W, 2007, NUMERICAL RECIPES; Reifert J, 2011, J BIOL CHEM, V286, P20797, DOI 10.1074/jbc.M111.234674; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Smith JA, 2010, BIOCHEMISTRY-US, V49, P1331, DOI 10.1021/bi901810u; SYKES MF, 1964, J MATH PHYS, V5, P1117, DOI 10.1063/1.1704215; TANG W, 1988, PHYS REV B, V37, P5539, DOI 10.1103/PhysRevB.37.5539; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	33	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e104965	10.1371/journal.pone.0104965	http://dx.doi.org/10.1371/journal.pone.0104965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162587	Green Submitted, Green Published, gold			2022-12-25	WOS:000340880900024
J	Zhou, YH; Rideout, WM; Bressel, A; Yalavarthi, S; Zi, T; Potz, D; Farlow, S; Brodeur, J; Monti, A; Reddipalli, S; Xiao, QR; Bottega, S; Feng, B; Chiu, MI; Bosenberg, M; Heyer, J				Zhou, Yinghui; Rideout, William M., III; Bressel, Angela; Yalavarthi, Sireesha; Zi, Tong; Potz, Darren; Farlow, Samuel; Brodeur, Joelle; Monti, Anthony; Reddipalli, Shailaja; Xiao, Qiurong; Bottega, Steve; Feng, Bin; Chiu, M. Isabel; Bosenberg, Marcus; Heyer, Joerg			Spontaneous Genomic Alterations in a Chimeric Model of Colorectal Cancer Enable Metastasis and Guide Effective Combinatorial Therapy	PLOS ONE			English	Article							COLON-CANCER; PATHWAY ACTIVATION; TUMOR XENOGRAFTS; MOUSE MODELS; C-MET; RECEPTOR; OVEREXPRESSION; GROWTH; ADENOCARCINOMA; PROGRESSION	Colon cancer is the second most common cause of cancer mortality in the Western world with metastasis commonly present at the time of diagnosis. Screening for propagation and metastatic behavior in a novel chimeric-mouse colon cancer model, driven by mutant p53 and beta-Catenin, led to the identification of a unique, invasive adenocarcinoma. Comparison of the genome of this tumor, CB42, with genomes from non-propagating tumors by array CGH and sequencing revealed an amplicon on chromosome five containing CDK6 and CDK14, and a KRAS mutation, respectively. Single agent small molecule inhibition of either CDK6 or MEK, a kinase downstream of KRAS, led to tumor growth inhibition in vivo whereas combination therapy not only led to regression of the subcutaneous tumors, but also near complete inhibition of lung metastasis; thus, genomic analysis of this tumor led to effective, individualized treatment.	[Zhou, Yinghui; Rideout, William M., III; Bressel, Angela; Yalavarthi, Sireesha; Zi, Tong; Potz, Darren; Farlow, Samuel; Brodeur, Joelle; Monti, Anthony; Reddipalli, Shailaja; Xiao, Qiurong; Bottega, Steve; Feng, Bin; Chiu, M. Isabel; Heyer, Joerg] AVEO Pharmaceut Inc, Dept Res, Cambridge, MA 02139 USA; [Bosenberg, Marcus] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA	Yale University	Zhou, YH (corresponding author), AVEO Pharmaceut Inc, Dept Res, Cambridge, MA 02139 USA.	yinghuizhou01@gmail.com			AVEO Pharmaceuticals	AVEO Pharmaceuticals	This work was entirely funded by AVEO Pharmaceuticals. AVEO Pharmaceuticals is/was the employer of all the authors except for Marcus Bosenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Baughn LB, 2006, CANCER RES, V66, P7661, DOI 10.1158/0008-5472.CAN-06-1098; Carethers JM, 2012, J GASTROINTEST SURG, V16, P1648, DOI 10.1007/s11605-012-1942-2; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen QH, 2003, ONCOGENE, V22, P992, DOI 10.1038/sj.onc.1206193; Dangles-Marie V, 2007, CANCER RES, V67, P398, DOI 10.1158/0008-5472.CAN-06-0594; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fry DW, 2004, MOL CANCER THER, V3, P1427; Goldstein NS, 2001, CANCER, V92, P1331, DOI 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M; Goncalves R, J NATL COMPR CANC NE, V11, P182; Goncalves R, 2013, J NATL COMPR CANC NE, V11, P174, DOI 10.6004/jnccn.2013.0025; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Henley S. Jane, 2010, Morbidity and Mortality Weekly Report, V59, P1; Hiscox SE, 1997, CANCER INVEST, V15, P513, DOI 10.3109/07357909709047592; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Johnson DB, 2014, ONCOLOGIST, V19, P616, DOI 10.1634/theoncologist.2014-0011; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Kwong LN, 2012, NAT MED, V18, P1503, DOI 10.1038/nm.2941; Li C, ONCOL LETT, V7, P1673; Lyubynska N, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001069; Meeske C, 2009, AACR M, P4922; Miyagaki H, 2012, BRIT J CANCER, V106, P947, DOI 10.1038/bjc.2012.35; Miyaki M, 1999, CANCER RES, V59, P4506; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Pang EYT, 2007, HEPATOLOGY, V46, P436, DOI 10.1002/hep.21691; Roper J, 2012, TRENDS PHARMACOL SCI, V33, P449, DOI 10.1016/j.tips.2012.05.001; Takeuchi H, 2003, CLIN CANCER RES, V9, P1480; Tanami H, 2005, LAB INVEST, V85, P1118, DOI 10.1038/labinvest.3700312; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Timmermann S, 1997, CELL GROWTH DIFFER, V8, P361; United States Department of Health and Human Services Centers for Disease Control and Prevention and National Cancer Institute, 2013, US CANC STAT 1999 20; Watters JW, 2009, CANCER RES, V69, P8949, DOI 10.1158/0008-5472.CAN-09-1544; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Yang K, 1997, J EXP ZOOL, V277, P245, DOI 10.1002/(SICI)1097-010X(19970215)277:3<245::AID-JEZ5>3.3.CO;2-N; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595	45	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105886	10.1371/journal.pone.0105886	http://dx.doi.org/10.1371/journal.pone.0105886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162504	Green Published, Green Submitted, gold			2022-12-25	WOS:000340880900058
J	Chen, YG; Seybold, SJ				Chen, Yigen; Seybold, Steven J.			Crepuscular Flight Activity of an Invasive Insect Governed by Interacting Abiotic Factors	PLOS ONE			English	Article							WALNUT TWIG BEETLE; BLACKMAN COLEOPTERA-SCOLYTIDAE; MOUNTAIN PINE-BEETLE; PITYOPHTHORUS-JUGLANDIS; DENDROCTONUS-PONDEROSAE; MATING DISRUPTION; IPS-PINI; BEHAVIOR; TEMPERATURE; WIND	Seasonal and diurnal flight patterns of the invasive walnut twig beetle, Pityophthorus juglandis, were assessed between 2011 and 2014 in northern California, USA in the context of the effects of ambient temperature, light intensity, wind speed, and barometric pressure. Pityophthorus juglandis generally initiated flight in late January and continued until late November. This seasonal flight could be divided approximately into three phases (emergence: January-March; primary flight: May-July; and secondary flight: September-October). The seasonal flight response to the male-produced aggregation pheromone was consistently female-biased (mean of 58.9% females). Diurnal flight followed a bimodal pattern with a minor peak in mid-morning and a major peak at dusk (76.4% caught between 1800 and 2200 h). The primarily crepuscular flight activity had a Gaussian relationship with ambient temperature and barometric pressure but a negative exponential relationship with increasing light intensity and wind speed. A model selection procedure indicated that the four abiotic factors collectively and interactively governed P. juglandis diurnal flight. For both sexes, flight peaked under the following second-order interactions among the factors when: 1) temperature between was 25 and 30 degrees C and light intensity was less than 2000 lux; 2) temperature was between 25 and 35 degrees C and barometric pressure was between 752 and 762 mba (and declined otherwise); 3) barometric pressure was between 755 and 761 mba and light intensity was less than 2000 lux (and declined otherwise); and 4) temperature was ca. 30 degrees C and wind speed was ca. 2 km/h. Thus, crepuscular flight activity of this insect can be best explained by the coincidence of moderately high temperature, low light intensity, moderate wind speed, and low to moderate barometric pressure. The new knowledge provides physical and temporal guidelines for the application of semiochemical-based control techniques as part of an IPM program for this invasive pest.	[Chen, Yigen] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Seybold, Steven J.] Chem Ecol Forest Insects, USDA Forest Serv Pacific Southwest Res Stn, Davis, CA USA	University of California System; University of California Davis	Chen, YG (corresponding author), Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.	ygchen2007@gmail.com			USDA Forest Service, Pacific Southwest Research Station; USDA Forest Service, Washington Office Forest Health Protection and USDA APHIS CPHST [10-CA-11272172-055, 10-JV-11272172-092]; USDA FS; USDA APHIS	USDA Forest Service, Pacific Southwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); USDA Forest Service, Washington Office Forest Health Protection and USDA APHIS CPHST; USDA FS; USDA APHIS(United States Department of Agriculture (USDA))	Funding for this work was provided by the USDA Forest Service, Pacific Southwest Research Station, and by grants from the USDA Forest Service, Washington Office Forest Health Protection and USDA APHIS CPHST administered by Mary Louise Flint through cooperative agreements #10-CA-11272172-055 and 10-JV-11272172-092 between the USDA FS PSW Station and the UC-Davis Department of Entomology. The authors are especially grateful to Bruce Moltzan for facilitating the funding from the USDA FS and to David Lance for facilitating the funding from USDA APHIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PA, 1964, NATURE, V201, P20, DOI 10.1038/201020a0; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Aukema BH, 2005, POPUL ECOL, V47, P61, DOI 10.1007/s10144-004-0202-z; Bentz BJ, 2006, CAN J FOREST RES, V36, P351, DOI [10.1139/x05-241, 10.1139/X05-241]; BLACKBURN TM, 1992, OIKOS, V65, P107, DOI 10.2307/3544892; Bonsignore CP, 2007, EUR J ENTOMOL, V104, P425, DOI 10.14411/eje.2007.062; Bright D. E., 2014, Insecta Mundi, P1; Bright Jr DE, 1981, MEMOIRS ENTOMOL SOC, V118; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Byers JA, 2000, ECOL MODEL, V125, P231, DOI 10.1016/S0304-3800(99)00187-8; CARDE RT, 1995, ANNU REV ENTOMOL, V40, P559, DOI 10.1146/annurev.en.40.010195.003015; CASEY TM, 1992, AM ZOOL, V32, P225; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; Charlton RE, 1999, J INSECT BEHAV, V12, P517, DOI 10.1023/A:1020918924471; Chen GF, 2010, PEST MANAG SCI, V66, P213, DOI 10.1002/ps.1867; Daterman GE, 1965, AGR EXPT STATION TEC, V87; Elliott AC, 2011, COMPUT METH PROG BIO, V102, P75, DOI 10.1016/j.cmpb.2010.11.002; FARKAS SR, 1972, SCIENCE, V178, P67, DOI 10.1126/science.178.4056.67; Fettig CJ, 2004, J ENTOMOL SCI, V39, P453, DOI 10.18474/0749-8004-39.3.453; Fournier F, 2005, ENVIRON ENTOMOL, V34, P1534, DOI 10.1603/0046-225X-34.6.1534; Gillette NE, 2006, AGR FOREST ENTOMOL, V8, P243, DOI 10.1111/j.1461-9563.2006.00303.x; HAACK RA, 1985, FLA ENTOMOL, V68, P658, DOI 10.2307/3494870; Joern A, 2012, ECOLOGY, V93, P1002, DOI 10.1890/11-1142.1; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kolarik M, 2011, MYCOLOGIA, V103, P325, DOI 10.3852/10-124; KUWABARA M, 1959, NATURE, V184, P455, DOI 10.1038/184455a0; Marchand D, 2000, J INSECT BEHAV, V13, P187, DOI 10.1023/A:1007732113390; MAY ML, 1995, J EXP BIOL, V198, P2385; MCCAMBRIDGE WF, 1971, ANN ENTOMOL SOC AM, V64, P534, DOI 10.1093/aesa/64.2.534; MENDEL Z, 1991, PHYTOPARASITICA, V19, P23, DOI 10.1007/BF02981008; MEYER HJ, 1973, ANN ENTOMOL SOC AM, V66, P505, DOI 10.1093/aesa/66.3.505; Montecchio L, 2013, PLANT DIS; Newton L, 2009, PATHWAY ASSESSMENT G, V1; REID R. W., 1962, CANADIAN ENTOMOL, V94, P531; Reynolds AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015758; Rousse P, 2009, ENVIRON ENTOMOL, V38, P896, DOI 10.1603/022.038.0344; RUDINSKY J A, 1971, Zeitschrift fuer Angewandte Entomologie, V67, P179; RUDINSKY JA, 1963, CONTRIB BOYCE THOMPS, V22, P23; RUDINSKY JA, 1964, CAN ENTOMOL, V96, P1339, DOI 10.4039/Ent961339-10; Ruiz-Montiel C, 2009, ENVIRON ENTOMOL, V38, P1423, DOI 10.1603/022.038.0510; Ryne C, 2001, J CHEM ECOL, V27, P2109, DOI 10.1023/A:1012251106037; Safranyik L., 2006, The mountain pine beetle: a synthesis of biology, management and impacts on lodgepole pine; Safranyik L, 1978, THEORY PRACTICE MOUN, P77; SALOM SM, 1991, J CHEM ECOL, V17, P647, DOI 10.1007/BF00982133; SAS Institute Inc, 2010, SAS STAT 9 2 US GUID; Schmid JM, 1972, RM211 USDA FOR SERV; SEYBERT JP, 1970, ANN ENTOMOL SOC AM, V63, P947, DOI 10.1093/aesa/63.4.947; Seybold SJ, 2013, U.S Patent Publication, Patent No. [2013/0014428 A1, 20130014428]; Seybold SJ, 2013, DETECTING IDENTIFYIN; Seybold SJ, 2013, NAPR0210 USDA FOR SE; Seybold SJ, 2012, PAN-PAC ENTOMOL, V88, P277, DOI 10.3956/2012-32.1; Seybold SJ, 2012, PAN-PAC ENTOMOL, V88, P231, DOI 10.3956/2012-21.1; SHEPHERD RF, 1966, CAN ENTOMOL, V98, P507, DOI 10.4039/Ent98507-5; Tisserat N., 2011, PLANT HLTH PROGR, V10, P1094, DOI DOI 10.1094/PHP-2011-0630-01-BR; VITE JP, 1964, CONTRIB BOYCE THOMPS, V22, P461; Walton VM, 2006, J ECON ENTOMOL, V99, P1280, DOI 10.1603/0022-0493-99.4.1280; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y; Wood S.L., 2007, BARK AMBROSIA BEETLE; Wood SL, 1992, CATALOG SCOLYTIDAE 2	59	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105945	10.1371/journal.pone.0105945	http://dx.doi.org/10.1371/journal.pone.0105945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157977	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303200080
J	Jia, XW; Jia, Q; Zhang, ZH; Gao, WM; Zhang, XA; Niu, Y; Meng, T; Feng, B; Duan, HW; Ye, M; Dai, YF; Jia, ZW; Zheng, YX				Jia, Xiaowei; Jia, Qiang; Zhang, Zhihu; Gao, Weimin; Zhang, Xianan; Niu, Yong; Meng, Tao; Feng, Bin; Duan, Huawei; Ye, Meng; Dai, Yufei; Jia, Zhongwei; Zheng, Yuxin			Effects of Formaldehyde on Lymphocyte Subsets and Cytokines in the Peripheral Blood of Exposed Workers	PLOS ONE			English	Article							CONTACT-DERMATITIS GROUP; T-CELL CLONE; IN-VITRO; INHALATION EXPOSURE; NASAL-MUCOSA; FORMIC-ACID; NK CELLS; EXPRESSION; IL-4; INTERLEUKIN-10	Formaldehyde (FA) is a well-known irritant, and it is suggested to increase the risk of immune diseases and cancer. The present study aimed to evaluate the distribution of major lymphocyte subsets and cytokine expression profiles in the peripheral blood of FA-exposed workers. A total of 118 FA-exposed workers and 79 controls were enrolled in the study. High performance liquid chromatography, flow cytometry, and cytometric bead array were used to analyze FA in air sample and formic acid in urine, blood lymphocyte subpopulations, and serum cytokines, respectively. The FA-exposed workers were divided into low and high exposure groups according to their exposure levels. The results showed that both the low and high FA-exposed groups had a significant increase of formic acid in urine when compared to the controls. Both the low and high exposure groups had a significant increase in the percentage of B cells (CD19(+)) compared to the control group (p<0.01). A significant increase in the percentage of the natural killer (NK) cells (CD56(+)) was observed in the low exposure group compared to the control (p = 0.013). Moreover, the FA-exposed workers in both exposure groups showed a significant higher level of IL-10 but lower level of IL-8 than the control (p<0.01). Subjects in the high exposure group had a higher level of IL-4 but a lower level of IFN-gamma than the control (p<0.05). Finally, there is a significant correlation between the levels of IL-10, IL-4, and IL-8 and formic acid (p<0.05). The findings from the present study may explain, at least in part, the association between FA exposure and immune diseases and cancer.	[Jia, Xiaowei; Zhang, Xianan; Niu, Yong; Meng, Tao; Duan, Huawei; Ye, Meng; Dai, Yufei; Zheng, Yuxin] Chinese Ctr Dis Control & Prevent, Natl Inst Occupat Hlth & Poison Control, Key Lab Chem Safety & Hlth, Beijing, Peoples R China; [Jia, Qiang; Zhang, Zhihu; Feng, Bin] Shandong Acad Occupat Hlth & Occupat Med, Jinan, Shandong, Peoples R China; [Gao, Weimin] Texas Tech Univ, Inst Environm & Human Hlth, Dept Environm Toxicol, Lubbock, TX 79409 USA; [Jia, Zhongwei] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Occupational Health & Poison Control, Chinese Center for Disease Control & Prevention; Shandong First Medical University & Shandong Academy of Medical Sciences; Texas Tech University System; Texas Tech University; Peking University	Zheng, YX (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Occupat Hlth & Poison Control, Key Lab Chem Safety & Hlth, Beijing, Peoples R China.	yxzheng@163bj.com	Duan, Huawei/GQQ-0241-2022		National Natural Science Foundation of China [81102103]; Key Program of Scientific Research of Public Welfare Project of the Ministry of Health of China [200902006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Scientific Research of Public Welfare Project of the Ministry of Health of China	This work was supported by grants of National Natural Science Foundation of China (81102103) (XJ), a Key Program of Scientific Research of Public Welfare Project of the Ministry of Health of China (No. 200902006) (YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agner T, 1999, Am J Contact Dermat, V10, P12; Arrandale VH, 2012, AM J IND MED, V55, P353, DOI 10.1002/ajim.22015; Aydin S, 2013, ARCH TOXICOL, V87, P145, DOI 10.1007/s00204-012-0961-9; Balharry D, 2008, TOXICOLOGY, V244, P66, DOI 10.1016/j.tox.2007.11.001; BARDANA EJ, 1991, ANN ALLERGY, V66, P441; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; Chung F, 2001, MEDIAT INFLAMM, V10, P51, DOI 10.1080/09629350120054518; CRONIN E, 1991, CONTACT DERMATITIS, V25, P276, DOI 10.1111/j.1600-0536.1991.tb01874.x; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; De Jong WH, 2009, TOXICOLOGY, V261, P103, DOI 10.1016/j.tox.2009.04.057; Deo SS, 2010, LUNG INDIA, V27, P66, DOI 10.4103/0970-2113.63609; GOTTSCHLING LM, 1984, AM IND HYG ASSOC J, V45, P19, DOI 10.1080/15298668491399299; Haczku A, 2006, J IMMUNOL, V176, P3557, DOI 10.4049/jimmunol.176.6.3557; Handzel Z T, 2000, Rev Environ Health, V15, P325; HODGKIN PD, 1988, J IMMUNOL, V141, P151; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Hosgood HD, 2013, AM J IND MED, V56, P252, DOI 10.1002/ajim.22088; International Agency for Research on Cancer , 2006, FORM 2 BUT 1 TERT BU; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Kastner PE, 2011, TOXICOL LETT, V200, P109, DOI 10.1016/j.toxlet.2010.11.003; KAWAKAMI K, 1995, MICROBIOL IMMUNOL, V39, P135, DOI 10.1111/j.1348-0421.1995.tb02180.x; Kim EM, 2013, TOXICOL LETT, V223, P154, DOI 10.1016/j.toxlet.2013.09.008; Li Q, 2013, ENVIRON TOXICOL PHAR, V36, P948, DOI 10.1016/j.etap.2013.08.005; MADISON RE, 1991, ENVIRON HEALTH PERSP, V94, P219, DOI 10.2307/3431314; Malaviya Anand M, 2006, J Assoc Physicians India, V54 Suppl, P15; MALEFYT RD, 1991, J EXP MED, V174, P915; Maouad M, 1999, J AM ACAD DERMATOL, V41, P573, DOI 10.1016/S0190-9622(99)70299-9; Marks JG, 1998, J AM ACAD DERMATOL, V38, P911, DOI 10.1016/S0190-9622(98)70587-0; Minang JT, 2006, CLIN EXP IMMUNOL, V143, P494, DOI 10.1111/j.1365-2249.2006.03018.x; MISRA N, 1995, IMMUNOLOGY, V86, P97; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Ohtsuka R, 2003, EXP TOXICOL PATHOL, V54, P287, DOI 10.1078/0940-2993-00266; Rager JE, 2011, ENVIRON HEALTH PERSP, V119, P494, DOI 10.1289/ehp.1002614; STANDIFORD TJ, 1990, J IMMUNOL, V145, P1435; Sun J, 2007, J IMMUNOL, V178, P1635, DOI 10.4049/jimmunol.178.3.1635; Tarkowski M, 2008, INT J OCCUP MED ENV, V21, P253, DOI 10.2478/v10001-008-0031-y; Taub DD, 1996, J CLIN INVEST, V97, P1931, DOI 10.1172/JCI118625; THRASHER JD, 1990, ARCH ENVIRON HEALTH, V45, P217, DOI 10.1080/00039896.1990.9940805; Tournoy KG, 2000, CLIN EXP ALLERGY, V30, P775; TRIEBIG G, 1980, CLIN CHIM ACTA, V108, P355, DOI 10.1016/0009-8981(80)90341-1; Wang F, 2012, J TOXICOL SCI, V37, P739, DOI 10.2131/jts.37.739; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062827; Xiang JW, 1996, J WENZHOU MED COLL, V26, P47; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Ye XL, 2005, MUTAT RES-GEN TOX EN, V588, P22, DOI 10.1016/j.mrgentox.2005.08.005; Ying CJ, 1999, BIOMED ENVIRON SCI, V12, P88; Yue W, 2004, CHIN J PUBLIC HLTH, V20, P904	53	32	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104069	10.1371/journal.pone.0104069	http://dx.doi.org/10.1371/journal.pone.0104069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157974	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303200008
J	Miranda, JA; Stanley, P; Gore, K; Turner, J; Dias, R; Rees, H				Miranda, Jason A.; Stanley, Phil; Gore, Katrina; Turner, Jamie; Dias, Rebecca; Rees, Huw			A Preclinical Physiological Assay to Test Modulation of Knee Joint Pain in the Spinal Cord: Effects of Oxycodone and Naproxen	PLOS ONE			English	Article							IODOACETATE-INDUCED OSTEOARTHRITIS; PRIMARY AFFERENT NEURONS; CANCER PAIN; RAT MODELS; MORPHINE; RESPONSES; EFFICACY; PHARMACOKINETICS; PHARMACODYNAMICS; NOCICEPTORS	Sensory processing in the spinal cord during disease states can reveal mechanisms for novel treatments, yet very little is known about pain processing at this level in the most commonly used animal models of articular pain. Here we report a test of the prediction that two clinically effective compounds, naproxen (an NSAID) and oxycodone (an opiate), are efficacious in reducing the response of spinal dorsal horn neurons to noxious knee joint rotation in the monosodium iodoacetate (MIA) sensitized rat. The overall objective for these experiments was to develop a high quality in vivo electrophysiology assay to confidently test novel compounds for efficacy against pain. Given the recent calls for improved preclinical experimental quality we also developed and implemented an Assay Capability Tool to determine the quality of our assay and ensure the quality of our results. Spinal dorsal horn neurons receiving input from the hind limb knee joint were recorded in anesthetized rats 14 days after they were sensitized with 1 mg of MIA. Intravenous administered oxycodone and naproxen were each tested separately for their effects on phasic, tonic, ongoing and afterdischarge action potential counts in response to innocuous and noxious knee joint rotation. Oxycodone reduced tonic spike counts more than the other measures, doing so by up to 85%. Tonic counts were therefore designated the primary endpoint when testing naproxen which reduced counts by up to 81%. Both reductions occurred at doses consistent with clinically effective doses for osteoarthritis. These results demonstrate that clinically effective doses of standard treatments for osteoarthritis reduce pain processing measured at the level of the spinal cord for two different mechanisms. The Assay Capability Tool helped to guide experimental design leading to a high quality and robust preclinical assay to use in discovering novel treatments for pain.	[Miranda, Jason A.; Turner, Jamie; Dias, Rebecca; Rees, Huw] Pfizer, Neusentis Res Unit, Cambridge, England; [Stanley, Phil; Gore, Katrina] Pfizer, Clin Res, Res Stat, Cambridge, England	Pfizer; Pfizer	Miranda, JA (corresponding author), Pfizer, Neusentis Res Unit, Cambridge, England.	jason.miranda2@pfizer.com	Miranda, Jason/B-8043-2009	Miranda, Jason/0000-0002-1459-2022	Pfizer LTD	Pfizer LTD(Pfizer)	All work was funded by Pfizer LTD. Pfizer LTD. provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2013, NATURE, V496, P398, DOI 10.1038/496398a; Bove SE, 2003, OSTEOARTHR CARTILAGE, V11, P821, DOI 10.1016/S1063-4584(03)00163-8; BROGDEN RN, 1979, DRUGS, V18, P241, DOI 10.2165/00003495-197918040-00001; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Chu KL, 2011, BRAIN RES, V1369, P158, DOI 10.1016/j.brainres.2010.10.101; COGGESHALL RE, 1983, BRAIN RES, V272, P185, DOI 10.1016/0006-8993(83)90379-7; Combe R, 2004, NEUROSCI LETT, V370, P236, DOI 10.1016/j.neulet.2004.08.023; Currie GL, 2013, PAIN, V154, P917, DOI 10.1016/j.pain.2013.02.033; Davies NM, 1997, CLIN PHARMACOKINET, V32, P268, DOI 10.2165/00003088-199732040-00002; Ferland CE, 2011, PHARMACOL BIOCHEM BE, V97, P603, DOI 10.1016/j.pbb.2010.11.003; Ferland CE, 2011, NEUROPEPTIDES, V45, P423, DOI 10.1016/j.npep.2011.07.007; GLARE PA, 1993, J CLIN ONCOL, V11, P973, DOI 10.1200/JCO.1993.11.5.973; Gregory MH, 2012, ARTHRITIS, DOI 10.1155/2012/764621; Grubb BD, 1996, NEUROSCIENCE, V74, P1077, DOI 10.1016/S0306-4522(96)00272-2; Guingamp C, 1997, ARTHRITIS RHEUM, V40, P1670, DOI 10.1002/art.1780400917; HANESCH U, 1991, NEUROSCIENCE, V45, P185, DOI 10.1016/0306-4522(91)90114-4; Harvey VL, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-18; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Im HJ, 2010, ARTHRITIS RHEUM-US, V62, P2995, DOI 10.1002/art.27608; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Patino-Camacho SI, 2013, DRUG DEVELOP RES, V74, P31, DOI 10.1002/ddr.21053; JURNA I, 1988, PAIN, V35, P349, DOI 10.1016/0304-3959(88)90144-3; Just S, 2000, J NEUROSCI METH, V103, P157, DOI 10.1016/S0165-0270(00)00310-1; KALSO E, 1990, PHARMACOL TOXICOL, V67, P322, DOI 10.1111/j.1600-0773.1990.tb00838.x; KAYSER V, 1981, BRAIN RES, V226, P344, DOI 10.1016/0006-8993(81)91110-0; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim JH, 2011, J NEUROPHYSIOL, V105, P2043, DOI 10.1152/jn.00852.2010; Lalovic B, 2006, CLIN PHARMACOL THER, V79, P461, DOI 10.1016/j.clpt.2006.01.009; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lee Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-39; Li J, 1999, PAIN, V79, P75, DOI 10.1016/S0304-3959(98)00154-7; Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20; Malfait AM, 2013, OSTEOARTHR CARTILAGE, V21, P1316, DOI 10.1016/j.joca.2013.06.003; McDougall JJ, 2004, AM J PHYSIOL-REG I, V286, pR634, DOI 10.1152/ajpregu.00464.2003; Meert TF, 2005, PHARMACOL BIOCHEM BE, V80, P309, DOI 10.1016/j.pbb.2004.12.002; Michaelis M, 1996, CLIN EXP PHARMACOL P, V23, P99, DOI 10.1111/j.1440-1681.1996.tb02579.x; Miller TR, 2013, EUR J PAIN, V17, P692, DOI 10.1002/j.1532-2149.2012.00232.x; Moonesinghe R, 2007, PLOS MED, V4, P218, DOI 10.1371/journal.pmed.0040028; Nagase H, 2012, J PHARMACOL TOX MET, V65, P29, DOI 10.1016/j.vascn.2011.10.002; Nielsen CK, 2007, PAIN, V132, P289, DOI 10.1016/j.pain.2007.03.022; OBRIEN C, 1989, NEUROSCIENCE, V32, P493, DOI 10.1016/0306-4522(89)90096-1; Orita S, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-134; Peers IS, 2014, NAT REV DRUG DISCOV, V13, DOI 10.1038/nrd4090-c1; POYHIA R, 1992, PHARMACOL TOXICOL, V70, P125; Prochazkova M, 2009, PHYSIOL RES, V58, P419, DOI 10.33549/physiolres.931439; Rahman W, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-45; Rashid MH, 2013, EUR J PAIN, V17, P210, DOI 10.1002/j.1532-2149.2012.00176.x; Richter F, 2012, ARTHRITIS RHEUM-US, V64, P4125, DOI 10.1002/art.37695; Sagar DR, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-88; Salo PT, 1997, J ANAT, V190, P515, DOI 10.1046/j.1469-7580.1997.19040515.x; SATTERWHITE JH, 1995, EXP GERONTOL, V30, P505, DOI 10.1016/0531-5565(95)00012-6; Schiff M, 2004, J RHEUMATOL, V31, P1373; Schuelert N, 2008, ARTHRITIS RHEUM, V58, P145, DOI 10.1002/art.23156; Schuelert N, 2011, PAIN, V152, P975, DOI 10.1016/j.pain.2010.11.025; Schuelert N, 2009, NEUROSCI LETT, V465, P184, DOI 10.1016/j.neulet.2009.08.063; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Senn S, 2006, STAT MED, V25, P4334, DOI 10.1002/sim.2682; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Smith ESJ, 2009, J COMP PHYSIOL A, V195, P1089, DOI 10.1007/s00359-009-0482-z; Staahl C, 2006, PAIN, V123, P28, DOI 10.1016/j.pain.2006.02.006; Thakur M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033730; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Vesterinen HV, 2011, J CEREBR BLOOD F MET, V31, P1064, DOI 10.1038/jcbfm.2010.217; Vickers A J, 2001, BMC Med Res Methodol, V1, P6, DOI 10.1186/1471-2288-1-6; WALTERS ET, 1996, NEUROBIOLOGY NOCICEP, P92; Zhang RX, 2013, OSTEOARTHR CARTILAGE, V21, P1308, DOI 10.1016/j.joca.2013.06.013	69	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e106108	10.1371/journal.pone.0106108	http://dx.doi.org/10.1371/journal.pone.0106108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157947	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303200089
J	Pham, TD				Pham, Tuan D.			Spatial Uncertainty Modeling of Fuzzy Information in Images for Pattern Classification	PLOS ONE			English	Article							INDICATOR KRIGING APPROACH; PROBABILITY-MEASURES; C-MEANS; RECOGNITION; TEXTURE; ENTROPY; SPACE	The modeling of the spatial distribution of image properties is important for many pattern recognition problems in science and engineering. Mathematical methods are needed to quantify the variability of this spatial distribution based on which a decision of classification can be made in an optimal sense. However, image properties are often subject to uncertainty due to both incomplete and imprecise information. This paper presents an integrated approach for estimating the spatial uncertainty of vagueness in images using the theory of geostatistics and the calculus of probability measures of fuzzy events. Such a model for the quantification of spatial uncertainty is utilized as a new image feature extraction method, based on which classifiers can be trained to perform the task of pattern recognition. Applications of the proposed algorithm to the classification of various types of image data suggest the usefulness of the proposed uncertainty modeling technique for texture feature extraction.	Univ Aizu, Ctr Adv Informat Sci & Technol, Aizu Res Cluster Med Engn & Informat, Aizu Wakamatsu, Fukushima, Japan	University of Aizu	Pham, TD (corresponding author), Univ Aizu, Ctr Adv Informat Sci & Technol, Aizu Res Cluster Med Engn & Informat, Aizu Wakamatsu, Fukushima, Japan.	tdpham@u-aizu.ac.jp			University of Aizu Special Grant; CRF Grant	University of Aizu Special Grant; CRF Grant	This work was funded by the FY2013 President of The University of Aizu Special Grant and FY2014 CRF Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asyali MH, 2005, BIOINFORMATICS, V21, P644, DOI 10.1093/bioinformatics/bti036; Bezdek J.C., 1992, FUZZY MODELS PATTERN; Bezdek JC, 1981, PATTERN RECOGNITION, DOI 10.1007/978-1-4757-0450-1; BHANDARI D, 1992, PATTERN RECOGN LETT, V13, P857, DOI 10.1016/0167-8655(92)90085-E; Caers J, 2011, MODELING UNCERTAINTY IN THE EARTH SCIENCES, P1, DOI 10.1002/9781119995920; Castanon CAB, 2007, PATTERN RECOGN, V40, P1899, DOI 10.1016/j.patcog.2006.12.006; Castellano G, 2004, CLIN RADIOL, V59, P1061, DOI 10.1016/j.crad.2004.07.008; Cheng HD, 1998, PATTERN RECOGN, V31, P857, DOI 10.1016/S0031-3203(97)00113-1; Chi Z., 1996, FUZZY ALGORITHMS APP; Chiang JL, 2014, IEEE T GEOSCI REMOTE, V52, P4046, DOI 10.1109/TGRS.2013.2279118; Chica-Olmo M, 2000, COMPUT GEOSCI, V26, P373, DOI 10.1016/S0098-3004(99)00118-1; Chiles J.-P., 2012, GEOSTATISTICS MODELI; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Cressie N, 2011, STAT SPATIO TEMPORAL; Davis J.C., 2002, STAT DATA ANAL GEOLO; DELUCA A, 1972, INFORM CONTROL, V20, P301, DOI 10.1016/S0019-9958(72)90199-4; Deutsch C.V., 2002, GEOSTATISTICAL RESER; Duda R.O., 2006, PATTERN CLASSIFICATI; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Gonzalez-Rufino E, 2013, PATTERN RECOGN, V46, P2391, DOI 10.1016/j.patcog.2013.02.009; Hoshino D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002479; Howson AG, 1976, HDB TERMS USED ALGEB; Iannaccone P.M., 1996, FRACTAL GEOMETRY BIO, V1; Isaaks E.H., 1989, APPL GEOSTATISTICS; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Leuangthong O., 2008, SOLVED PROBLEMS GEOS; Liu J, 2012, PATTERN RECOGN, V45, P1759, DOI 10.1016/j.patcog.2011.11.001; Nguyen-Thanh N, 2013, PROCEEDINGS OF THE 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY (CIBCB), P218, DOI 10.1109/CIBCB.2013.6595412; Nixon M., 2008, FEATURE EXTRACTION I; Nixon M., 2012, FEATURE EXTRACTION I; Oh W, 1999, IEEE T PATTERN ANAL, V21, P590, DOI 10.1109/34.777370; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Petrou M., 2003, IMAGE PROCESSING FUN; Pham T.D., 2003, P SPIE C APPL ART NE, V5015, P12; Pham TD, 2004, BIOINFORMATICS, V20, P2189, DOI 10.1093/bioinformatics/bth213; Pham TD, 2003, P SOC PHOTO-OPT INS, V5010, P20, DOI 10.1117/12.472840; Pham TD, 2003, PATTERN RECOGN, V36, P3023, DOI 10.1016/S0031-3203(03)00125-0; Pham TD, 2001, IEEE IMAGE PROC, P722, DOI 10.1109/ICIP.2001.959147; Pham TD, 2001, 10TH IEEE INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS, VOLS 1-3, P69, DOI 10.1109/FUZZ.2001.1007249; Pham TD, 2000, INT J PATTERN RECOGN, V14, P1025, DOI 10.1142/S0218001400000659; Pham TD, 2014, INFORM SCIENCES, V270, P134, DOI 10.1016/j.ins.2014.02.102; Pham TD, 2014, PROC SPIE, V9069, DOI 10.1117/12.2050102; Pham TD, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-62; Pham TD, 2014, COMPUT METH PROG BIO, V113, P153, DOI 10.1016/j.cmpb.2013.09.019; Pham TD, 2011, IEEE T INF TECHNOL B, V15, P242, DOI 10.1109/TITB.2010.2081996; Plissiti ME, 2011, PATTERN RECOGN LETT, V32, P838, DOI 10.1016/j.patrec.2011.01.008; Sanchez-Brea LM, 2006, IEEE T IMAGE PROCESS, V15, P3131, DOI 10.1109/TIP.2006.877505; Singpurwalla ND, 2004, J AM STAT ASSOC, V99, P867, DOI 10.1198/016214504000001196; Szczepaniak P. S., 2000, FUZZY SYSTEMS MED; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Uchida S, 2013, DEV GROWTH DIFFER, V55, P523, DOI 10.1111/dgd.12054; VanderMeer F, 1996, INT J REMOTE SENS, V17, P1233, DOI 10.1080/01431169608949079; Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094211; ZADEH LA, 1968, J MATH ANAL APPL, V23, P421, DOI 10.1016/0022-247X(68)90078-4; Zhang BL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-128	55	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105075	10.1371/journal.pone.0105075	http://dx.doi.org/10.1371/journal.pone.0105075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157744	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303200023
J	Rosario, CO; Kazazian, K; Zih, FSW; Brashavitskaya, O; Haffani, Y; Xu, RSZ; George, A; Dennis, JW; Swallow, CJ				Rosario, C. O.; Kazazian, K.; Zih, F. S. W.; Brashavitskaya, O.; Haffani, Y.; Xu, R. S. Z.; George, A.; Dennis, J. W.; Swallow, C. J.			A novel role for Plk4 in regulating cell spreading and motility	ONCOGENE			English	Article							POLO-LIKE KINASE; CENTRIOLE DUPLICATION; CENTROSOME DUPLICATION; CYTOKINESIS; EXPRESSION; PROTEIN; REVEALS; FAILURE; CANCER; SAK	Polo family kinase 4 (Plk4) is required for mitotic progression, and is haploinsufficient for tumor suppression and timely hepatocyte polarization in regenerating liver. At the same time, recent evidence suggests that Plk4 expression may have a role in clinical cancer progression, although the mechanisms are not clear. Here we identify a gene expression pattern predictive of reduced motility in Plk4(+/-) murine embryonic fibroblasts (MEFs) and validate this prediction with functional assays of cell spreading, migration and invasion. Increased Plk4 expression enhances cell spreading in Plk4(+/-) MEFs and migration in human embryonic kidney 293T cells, and increases invasion by DLD-1 colon cancer cells. Plk4 depletion impairs invasion of wild-type MEFs and suppresses invasion by MDA-MB231 breast cancer cells. Cytoskeletal reorganization and development of polarity are impaired in Plk4-deficient cells that have been stimulated to migrate. Endogenous Plk4 phosphorylated at the autophosphorylation site S305 localizes to the protrusions of motile cells, coincident with the RhoA GEF Ect2, GTP-bound RhoA and the RhoA effector mDia. Taken together, our findings reveal an unexpected activity of Plk4 that promotes cell migration and may underlie an association between increased Plk4 expression, cancer progression and death from metastasis in solid tumor patients.	[Rosario, C. O.; Kazazian, K.; Zih, F. S. W.; Brashavitskaya, O.; Haffani, Y.; Xu, R. S. Z.; George, A.; Dennis, J. W.; Swallow, C. J.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Rosario, C. O.; Brashavitskaya, O.; Dennis, J. W.; Swallow, C. J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Kazazian, K.; Zih, F. S. W.; Swallow, C. J.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Kazazian, K.; Zih, F. S. W.; Xu, R. S. Z.; Swallow, C. J.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Dennis, J. W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Swallow, CJ (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	cswallow@mtsinai.on.ca	Dennis, James/E-7268-2013	Haffani, Yosr Z./0000-0003-2956-3651	CIHR; NCIC; Syd Cooper Program for the Prevention of Cancer Progression	CIHR(Canadian Institutes of Health Research (CIHR)); NCIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Syd Cooper Program for the Prevention of Cancer Progression	This work was supported by grants from CIHR (CJS) and NCIC (JWD), and from the Syd Cooper Program for the Prevention of Cancer Progression (CJS). We acknowledge Karina Pacholczyk, Peter E Wu and Kevin Yau for technical assistance, Judy Pawling for manuscript review, and Jayne Danska and Laurence Pelletier for helpful discussions.	Agarwal R, 2009, CLIN CANCER RES, V15, P3654, DOI 10.1158/1078-0432.CCR-08-3293; Bahtz R, 2012, J CELL SCI, V125, P486, DOI 10.1242/jcs.093930; Basu R, 2007, CURR OPIN CELL BIOL, V19, P88, DOI 10.1016/j.ceb.2006.12.012; Brownlee CW, 2011, J CELL BIOL, V195, P231, DOI 10.1083/jcb.201107086; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Coelho PA, 2013, DEV CELL, V27, P586, DOI 10.1016/j.devcel.2013.09.029; Cunha-Ferreira I, 2013, CURR BIOL, V23, P2245, DOI 10.1016/j.cub.2013.09.037; Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Finetti P, 2008, CANCER RES, V68, P767, DOI 10.1158/0008-5472.CAN-07-5516; Fischer M, 2014, NUCLEIC ACIDS RES, V42, P163, DOI 10.1093/nar/gkt849; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Holland AJ, 2012, GENE DEV, V26, P2684, DOI 10.1101/gad.207027.112; Holland AJ, 2012, MOL BIOL CELL, V23, P1838, DOI 10.1091/mbc.E11-12-1043; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Hudson JW, 2001, CURR BIOL, V11, P441, DOI 10.1016/S0960-9822(01)00117-8; Johnson EF, 2007, BIOCHEMISTRY-US, V46, P9551, DOI 10.1021/bi7008745; Klebba JE, 2013, CURR BIOL, V23, P2255, DOI 10.1016/j.cub.2013.09.019; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Korzeniewski N, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-61; Laufer R, 2013, J MED CHEM, V56, P6069, DOI 10.1021/jm400380m; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Leung GC, 2007, FEBS LETT, V581, P77, DOI 10.1016/j.febslet.2006.11.080; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macmillan JC, 2001, ANN SURG ONCOL, V8, P729, DOI 10.1245/aso.2001.8.9.729; Martindill DMJ, 2007, NAT CELL BIOL, V9, P1131, DOI 10.1038/ncb1633; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moss DK, 2007, J CELL SCI, V120, P3064, DOI 10.1242/jcs.010322; Nakamura T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2752; Nguyen TN, 2000, EXP CELL RES, V258, P171, DOI 10.1006/excr.2000.4929; Ohn T, 2010, WIRES RNA, V1, P486, DOI 10.1002/wrna.23; Park AYJ, 2009, J BIOL CHEM, V284, P9418, DOI 10.1074/jbc.M809040200; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Puklowski A, 2011, NAT CELL BIOL, V13, P1004, DOI 10.1038/ncb2282; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; Rosario CO, 2010, P NATL ACAD SCI USA, V107, P6888, DOI 10.1073/pnas.0910941107; Rosario CO, 2010, EFFECTS POLO LIKE KI; Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505; Slevin LK, 2012, STRUCTURE, V20, P1905, DOI 10.1016/j.str.2012.08.025; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; Swallow CJ, 2005, ONCOGENE, V24, P306, DOI 10.1038/sj.onc.1208275	51	36	37	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	26					3441	3451		10.1038/onc.2014.275	http://dx.doi.org/10.1038/onc.2014.275			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CL3SU	25174401				2022-12-25	WOS:000356871700009
J	Jove, M; Naudi, A; Portero-Otin, M; Cabre, R; Rovira-Llopis, S; Banuls, C; Rocha, M; Hernandez-Mijares, A; Victor, VM; Pamplona, R				Jove, Mariona; Naudi, Alba; Portero-Otin, Manuel; Cabre, Rosanna; Rovira-Llopis, Susana; Banuls, Celia; Rocha, Milagros; Hernandez-Mijares, Antonio; Victor, Victor M.; Pamplona, Reinald			Plasma lipidomics discloses metabolic syndrome with a specific HDL phenotype	FASEB JOURNAL			English	Article						lipid peroxidation; lipids species; lipoprotein metabolism; mass spectrometry; peroxidizability index	CARDIOVASCULAR-DISEASE; CHOLESTEROL ABSORPTION; SCIENTIFIC STATEMENT; MASS-SPECTROMETRY; BLOOD-PLASMA; LONGEVITY; MEMBRANE; REVEALS; PROFILE; RISK	Lipidomics reveals a remarkable diversity of lipids in human plasma. In this study, we have performed an in-depth lipidomic analysis of human plasma from healthy individuals and subjects with metabolic syndrome (MetS) in order to determine the lipidomic profile that allows prognosis of a pathological subpopulation with altered high-density lipoprotein (HDL) metabolism. The MetS population was categorized as having pathological or nonpathological HDL. Anthropometric parameters, cardiovascular risk markers, and lipoprotein subclasses of HDL and low-density lipoproteins were also evaluated. Lipidomic analysis revealed 357 differential molecules that were clustered (k means) in the two groups. The molecules identified in the whole lipidome showed that MetS subjects presented lower levels of glycerolipids and higher levels of glycerophospholipids with respect to control subjects. In contrast, when only statistically differential lipids were taken into account, differences were found between the two groups in almost cases. Furthermore, levels of saturated fatty acids were higher in patients with pathological HDL levels than in controls, whereas levels of unsaturated fatty acids were lower. These results highlight the potential of lipidomics as a clinical tool for risk assessment and monitoring of disease.	[Jove, Mariona; Naudi, Alba; Portero-Otin, Manuel; Cabre, Rosanna; Pamplona, Reinald] Univ Lleida, Biomed Res Inst Lleida, Dept Expt Med, Lleida, Spain; [Rovira-Llopis, Susana; Banuls, Celia; Rocha, Milagros; Hernandez-Mijares, Antonio; Victor, Victor M.] Fdn Promot Healthcare & Biomed Res Valencian Comm, Serv Endocrinol, Valencia, Spain; [Rovira-Llopis, Susana; Banuls, Celia; Rocha, Milagros; Hernandez-Mijares, Antonio; Victor, Victor M.] Univ Valencia INCLIVA, Hosp Clin, Fdn Invest, Valencia, Spain; [Hernandez-Mijares, Antonio] Univ Valencia, Dept Med, Valencia, Spain; [Victor, Victor M.] Univ Valencia, Dept Physiol, Valencia, Spain	Universitat de Lleida; University of Valencia; University of Valencia	Victor, VM (corresponding author), Univ Valencia, Hosp Univ Doctor Peset, FISABIO, Avda Gaspar Aguilar 90, Valencia 46017, Spain.	victor.victor@uv.es; reinald.pamplona@mex.udl.cat	victor, victor/Q-4843-2019; Rocha, Milagros/ABE-4931-2020; Pamplona, Reinald/A-7359-2010; BaÃuls, Celia/H-7359-2017; Naudí, Alba/B-5594-2009; Mijares, Antonio Hernandez/D-3411-2011; VICTOR, VICTOR M/I-3270-2015; Portero-Otin, Manuel/B-7122-2009; Jové, Mariona/M-9104-2016; Rocha, Milagros/I-4987-2015; Cerviño, Alejandro/L-5853-2014; Rovira-Llopis, Susana/AAX-8666-2021; Hernandez Mijares, Antonio/D-3411-2011	Rocha, Milagros/0000-0003-2923-6546; Pamplona, Reinald/0000-0003-4337-6107; BaÃuls, Celia/0000-0001-8077-7642; Naudí, Alba/0000-0003-0699-1004; Mijares, Antonio Hernandez/0000-0003-2197-0607; Portero-Otin, Manuel/0000-0002-1823-0299; Jové, Mariona/0000-0001-5577-6162; Rocha, Milagros/0000-0003-2923-6546; Cerviño, Alejandro/0000-0001-8014-3279; Rovira-Llopis, Susana/0000-0002-8476-5128; Hernandez Mijares, Antonio/0000-0003-4099-1905; VICTOR, VICTOR/0000-0002-3027-3945	Fund for Health Research (FIS); European Regional Development Fund of the European Union (FEDER); Spanish Ministry of Health [PI11-01532]; Spanish Ministry of Science and Innovation [BFU2009-11879/BFI]; Spanish Ministry of Economy and Competitiveness [PI13/00584]; Generalitat of Catalonia [2014SGR]; Generalitat of Catalonia Predoctoral Fellowship; Ministry of Health of the Valencian Regional Government [CES10/030]; Carlos III Health Institute [CP10/0360, FI11/00637]; CIBERehd [CB06/04/0071]; PROMETEO [2010/060, PI12/01984, PI13/0073, PI13/1025]	Fund for Health Research (FIS); European Regional Development Fund of the European Union (FEDER); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat of Catalonia; Generalitat of Catalonia Predoctoral Fellowship; Ministry of Health of the Valencian Regional Government; Carlos III Health Institute(Instituto de Salud Carlos III); CIBERehd; PROMETEO	The authors acknowledge funding from the Fund for Health Research (FIS) and cofunding from the European Regional Development Fund of the European Union (FEDER), CIBERehd CB06/04/0071, PROMETEO 2010/060, PI12/01984, PI13/0073, and PI13/1025 (A.H.M, M.R., and V.M.V, respectively); from the Spanish Ministry of Health (PI11-01532, M.P.O.); the Spanish Ministry of Science and Innovation (BFU2009-11879/BFI); the Spanish Ministry of Economy and Competitiveness (PI13/00584); and the Generalitat of Catalonia (2014SGR). R.P.R.C. was funded by a Generalitat of Catalonia Predoctoral Fellowship. V.M.V. and M.R. are recipients of contracts from the Ministry of Health of the Valencian Regional Government and Carlos III Health Institute (CES10/030 and CP10/0360, respectively). S.R. is the recipient of a predoctoral fellowship from Carlos III Health Institute (FI11/00637). V.M.V. and R.P. designed the experiments; M.J., M.R., V.M.V., A.H.M., and R.P. analyzed the data; M.J., A.N., M.P.O., R.C., C.B., and S.R-L. performed the experiments; R.P. supervised the design and data interpretation; M.J., V.M.V., and R.P. wrote the manuscript, R.P. edited the manuscript. All authors discussed the results and commented on the manuscript. The authors declare no conflicts of interest.	Agency for Toxic Substances and Disease Registry, 1997, TOX PROF CHLOR; Ascaso J, 2007, AM J CARDIOVASC DRUG, V7, P39, DOI 10.2165/00129784-200707010-00004; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boullart ACI, 2012, BBA-MOL CELL BIOL L, V1821, P867, DOI 10.1016/j.bbalip.2011.10.002; Caprari P, 1999, EXP GERONTOL, V34, P47, DOI 10.1016/S0531-5565(98)00055-2; Caro P, 2009, REJUV RES, V12, P421, DOI 10.1089/rej.2009.0902; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Gonzalez-Covarrubias V, 2013, BIOGERONTOLOGY, V14, P663, DOI 10.1007/s10522-013-9450-7; Gonzalez-Covarrubias V, 2013, AGING CELL, V12, P426, DOI 10.1111/acel.12064; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gylling H, 2007, TRANSL RES, V149, P310, DOI 10.1016/j.trsl.2006.11.012; Han XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021643; Heijmans BT, 2006, PLOS MED, V3, P2317, DOI 10.1371/journal.pmed.0030495; Hernandez-Mijares A, 2011, CLIN NUTR, V30, P604, DOI 10.1016/j.clnu.2011.03.005; Hoefner DM, 2001, CLIN CHEM, V47, P266; Jove M, 2014, FASEB J, V28, P1071, DOI 10.1096/fj.13-234419; Jove M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03346; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Kulkarni H, 2013, HYPERTENSION, V62, P621, DOI 10.1161/HYPERTENSIONAHA.113.01396; Laaksonen R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000097; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Montoliu I, 2014, AGING-US, V6, P9, DOI 10.18632/aging.100630; Naudi A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00372; Nelson J, 2006, AM J EPIDEMIOL, V163, P903, DOI 10.1093/aje/kwj140; Ng TW, 2012, CLIN LIPIDOL, V7, P641, DOI 10.2217/CLP.12.75; Osborn MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072737; Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x; Pamplona R, 2008, BBA-BIOENERGETICS, V1777, P1249, DOI 10.1016/j.bbabio.2008.07.003; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Puca AA, 2008, REJUV RES, V11, P63, DOI 10.1089/rej.2007.0566; Quehenberger O, 2011, NEW ENGL J MED, V365, P1812, DOI 10.1056/NEJMra1104901; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Sandra K, 2010, J CHROMATOGR A, V1217, P4087, DOI 10.1016/j.chroma.2010.02.039; Simonen P, 2000, AM J CLIN NUTR, V72, P82; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Sysi-Aho M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002257; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Yang J, 2004, J CHROMATOGR B, V813, P53, DOI 10.1016/j.jchromb.2004.09.023; Yeboah J, 2010, ARTERIOSCL THROM VAS, V30, P628, DOI 10.1161/ATVBAHA.109.199281; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	45	36	38	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5163	5171		10.1096/fj.14-253187	http://dx.doi.org/10.1096/fj.14-253187			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25169057				2022-12-25	WOS:000345894500012
J	Andersson, S				Andersson, Stefan			Indirect Genetic Effects from Competition in the Clonal Herb Sedum album (Crassulaceae)	PLOS ONE			English	Article							ECOLOGICAL INTERACTIONS; MULTILEVEL SELECTION; ARABIDOPSIS-THALIANA; HERITABLE VARIATION; TRIFOLIUM-REPENS; PLANT MIXTURES; GROWTH; POPULATIONS; INHERITANCE; EVOLUTION	Recent years have seen increasing interest in indirect genetic effects, i.e. influences on the phenotype that depend on the genotype of other conspecific individuals; however, the empirical evidence for such effects is still limited, especially in wild plant species. The present study of the clonal herb Sedum album assessed direct and indirect genetic effects on performance-related traits in a 4-year experiment with clonally replicated genotypes, grown in pairs and differing in anthocyanin pigmentation to allow separation of individuals during data collection. In agreement with the existence of indirect genetic effects, the experimentally-paired plants not only expressed their own genotype but were also affected by the genotype of their pair mate. The effect of neighbour genotype explained up to one-fourth of the variation in performance and most likely resulted from competition, imposed by the close physical contact between paired individuals and the limiting conditions used in the garden environment. Indirect genetic effects from competition have the potential to enhance the efficacy of group-level selection relative to individual selection, given the nutrient-poor and spatially-confined substrate available to plants of S. album in the natural habitat.	Lund Univ, Dept Biol, Lund, Sweden	Lund University	Andersson, S (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	stefan.andersson@biol.lu.se	Andersson, Stefan/E-1349-2016	Andersson, Stefan/0000-0003-3828-5016	University of Lund, Sweden	University of Lund, Sweden	Financial support was provided by University of Lund, Sweden. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSSEN LW, 1985, J ECOL, V73, P605, DOI 10.2307/2260497; Agrawal AF, 2001, AM NAT, V158, P308, DOI 10.1086/321324; Bengtsson Karin, 1988, ACTA PHYTOGEOGR SUEC, P21; Bergsma R, 2008, GENETICS, V178, P1559, DOI 10.1534/genetics.107.084236; Bijma P, 2007, GENETICS, V175, P277, DOI 10.1534/genetics.106.062711; Bijma P, 2007, GENETICS, V175, P289, DOI 10.1534/genetics.106.062729; Bijma P, 2011, GENETICS, V189, P1347, DOI 10.1534/genetics.111.130617; Bijma P, 2010, GENETICS, V186, P1013, DOI 10.1534/genetics.110.120493; Brotherstone S, 2011, SILVAE GENET, V60, P149, DOI 10.1515/sg-2011-0020; Cappa EP, 2008, SILVAE GENET, V57, P45, DOI 10.1515/sg-2008-0008; Costa e Silva J, 2013, NEW PHYTOL, V197, P631; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Falconer D. S, 1996, INTRO QUANTITATIVE G; Frank SA, 2007, CURR BIOL, V17, pR648, DOI 10.1016/j.cub.2007.06.005; GRIFFING B, 1967, AUST J BIOL SCI, V20, P127, DOI 10.1071/BI9670127; GRIFFING B, 1989, GENETICS, V122, P943; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; KELLEY SE, 1987, EVOLUTION, V41, P92, DOI 10.1111/j.1558-5646.1987.tb05773.x; KIRKPATRICK M, 1989, EVOLUTION, V43, P485, DOI 10.1111/j.1558-5646.1989.tb04247.x; LOVETTDOUST L, 1982, NEW SCI, V95, P81; Lynch M., 1998, GENETICS ANAL QUANTI; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Muir WM, 2005, GENETICS, V170, P1247, DOI 10.1534/genetics.104.035956; Muir WM, 1996, POULTRY SCI, V75, P447, DOI 10.3382/ps.0750447; Mutic JJ, 2007, MOL ECOL, V16, P2371, DOI 10.1111/j.1365-294X.2007.03259.x; RUZZANTE DE, 1991, EVOLUTION, V45, P1936, DOI 10.1111/j.1558-5646.1991.tb02698.x; SAKAI KI, 1955, COLD SPRING HARB SYM, V20, P137, DOI 10.1101/SQB.1955.020.01.015; SAYED OH, 1994, BIOL PLANTARUM, V36, P383, DOI 10.1007/BF02920936; SOLANGAARACHCHI SM, 1989, OECOLOGIA, V78, P208, DOI 10.1007/BF00377157; Turkington R, 1996, EUPHYTICA, V92, P105, DOI 10.1007/BF00022835; Tutin TG, 1993, FLORA EUROPAEA, V1; Wilson AJ, 2011, J EVOLUTION BIOL, V24, P772, DOI 10.1111/j.1420-9101.2010.02212.x; Wolf JB, 2011, PHILOS T R SOC B, V366, P1358, DOI 10.1098/rstb.2010.0239; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0	34	4	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106104	10.1371/journal.pone.0106104	http://dx.doi.org/10.1371/journal.pone.0106104			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170872	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500104
J	Long, DM; Blake, MR; Dutta, S; Holbrook, SD; Kotwica-Rolinska, J; Kretzschmar, D; Giebultowicz, JM				Long, Dani M.; Blake, Matthew R.; Dutta, Sudeshna; Holbrook, Scott D.; Kotwica-Rolinska, Joanna; Kretzschmar, Doris; Giebultowicz, Jadwiga M.			Relationships between the Circadian System and Alzheimer's Disease-Like Symptoms in Drosophila	PLOS ONE			English	Article							A-BETA; CLOCK; NEURODEGENERATION; RHYTHMS; MODEL; AGGREGATION; PATHOLOGIES; HOMEOSTASIS; DISTURBANCE; HEALTHSPAN	Circadian clocks coordinate physiological, neurological, and behavioral functions into circa 24 hour rhythms, and the molecular mechanisms underlying circadian clock oscillations are conserved from Drosophila to humans. Clock oscillations and clock-controlled rhythms are known to dampen during aging; additionally, genetic or environmental clock disruption leads to accelerated aging and increased susceptibility to age-related pathologies. Neurodegenerative diseases, such as Alzheimer's disease ( AD), are associated with a decay of circadian rhythms, but it is not clear whether circadian disruption accelerates neuronal and motor decline associated with these diseases. To address this question, we utilized transgenic Drosophila expressing various Amyloid-beta (A beta) peptides, which are prone to form aggregates characteristic of AD pathology in humans. We compared development of AD-like symptoms in adult flies expressing A beta peptides in the wild type background and in flies with clocks disrupted via a null mutation in the clock gene period (per(01)). No significant differences were observed in longevity, climbing ability and brain neurodegeneration levels between control and clock-deficient flies, suggesting that loss of clock function does not exacerbate pathogenicity caused by human-derived A beta peptides in flies. However, AD-like pathologies affected the circadian system in aging flies. We report that rest/activity rhythms were impaired in an age-dependent manner. Flies expressing the highly pathogenic arctic A beta peptide showed a dramatic degradation of these rhythms in tune with their reduced longevity and impaired climbing ability. At the same time, the central pacemaker remained intact in these flies providing evidence that expression of A beta peptides causes rhythm degradation downstream from the central clock mechanism.	[Long, Dani M.; Blake, Matthew R.; Kotwica-Rolinska, Joanna; Giebultowicz, Jadwiga M.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Dutta, Sudeshna; Holbrook, Scott D.; Kretzschmar, Doris] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA	Oregon State University; Oregon Health & Science University	Giebultowicz, JM (corresponding author), Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA.	giebultj@science.oregonstate.edu	Kotwica-Rolinska, Joanna/AAC-2866-2021; Kotwica-Rolinska, Joanna/K-2941-2014	Kotwica-Rolinska, Joanna/0000-0001-5984-4126; Kotwica-Rolinska, Joanna/0000-0001-5984-4126; Long, Dani/0000-0002-8066-3300; kretzschmar, doris/0000-0002-0519-2377	National Institute of Aging of the National Institutes of Health [R01 AG045830]; Oregon Institute of Occupational Health Sciences; NATIONAL INSTITUTE ON AGING [R21AG055943, R01AG045830] Funding Source: NIH RePORTER	National Institute of Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Oregon Institute of Occupational Health Sciences; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National Institute of Aging of the National Institutes of Health under award number R01 AG045830 to JMG and by a pilot project grant from the Oregon Institute of Occupational Health Sciences to DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cermakian N, 2011, J BIOL RHYTHM, V26, P160, DOI 10.1177/0748730410395732; Chen KF, 2014, DIS MODEL MECH, V7, P445, DOI 10.1242/dmm.014134; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; da Cruz AB, 2005, MOL BIOL CELL, V16, P2433, DOI 10.1091/mbc.E04-11-1004; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Hardin PE, 2013, CURR OPIN NEUROBIOL, V23, P724, DOI 10.1016/j.conb.2013.02.018; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harper DG, 2004, NEUROBIOL AGING, V25, P771, DOI 10.1016/j.neurobiolaging.2003.04.009; Harper DG, 2005, AM J GERIAT PSYCHIAT, V13, P359, DOI 10.1176/appi.ajgp.13.5.359; Helfrich-Forster C, 2007, COLD SPRING HARB SYM, V72, P517, DOI 10.1101/sqb.2007.72.063; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kerr F, 2011, NEUROBIOL AGING, V32, P1977, DOI 10.1016/j.neurobiolaging.2009.10.015; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Krishnan N, 2012, NEUROBIOL DIS, V45, P1129, DOI 10.1016/j.nbd.2011.12.034; Krishnan N, 2009, AGING-US, V1, P937, DOI 10.18632/aging.100103; Luo WY, 2012, AGING CELL, V11, P428, DOI 10.1111/j.1474-9726.2012.00800.x; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Rakshit K, 2013, AGING CELL, V12, P752, DOI 10.1111/acel.12100; Rogers I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040569; Roh JH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004291; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Speretta E, 2012, J BIOL CHEM, V287, P20748, DOI 10.1074/jbc.M112.350124; Sterniczuk R, 2010, BRAIN RES, V1348, P139, DOI 10.1016/j.brainres.2010.05.013; Tranah GJ, 2011, ANN NEUROL, V70, P722, DOI 10.1002/ana.22468; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; Wu YH, 2007, SLEEP MED, V8, P623, DOI 10.1016/j.sleep.2006.11.010	32	28	28	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106068	10.1371/journal.pone.0106068	http://dx.doi.org/10.1371/journal.pone.0106068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171136	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500097
J	Matsushita, N; Kashihara, T; Shimojo, H; Suzuki, S; Nakada, T; Takeishi, Y; Mende, U; Taira, E; Yamada, M; Sanbe, A; Hirose, M				Matsushita, Naoko; Kashihara, Toshihide; Shimojo, Hisashi; Suzuki, Satoshi; Nakada, Tsutomu; Takeishi, Yasuchika; Mende, Ulrike; Taira, Eiichi; Yamada, Mitsuhiko; Sanbe, Atsushi; Hirose, Masamichi			Cardiac Overexpression of Constitutively Active Galpha q Causes Angiotensin II Type1 Receptor Activation, Leading to Progressive Heart Failure and Ventricular Arrhythmias in Transgenic Mice	PLOS ONE			English	Article							PRESSURE-OVERLOAD; HYPERTROPHY; EXPRESSION; DYSFUNCTION	Background: Transgenic mice with transient cardiac expression of constitutively active Galpha q (G alpha(q)-TG) exhibt progressive heart failure and ventricular arrhythmias after the initiating stimulus of transfected constitutively active G alpha(q) becomes undetectable. However, the mechanisms are still unknown. We examined the effects of chronic administration of olmesartan on heart failure and ventricular arrhythmia in G alpha(q)-TG mice. Methodology/Principal Findings: Olmesartan (1 mg/kg/day) or vehicle was chronically administered to G alpha(q)-TG from 6 to 32 weeks of age, and all experiments were performed in mice at the age of 32 weeks. Chronic olmesartan administration prevented the severe reduction of left ventricular fractional shortening, and inhibited ventricular interstitial fibrosis and ventricular myocyte hypertrophy in G alpha(q)-TG. Electrocardiogram demonstrated that premature ventricular contraction (PVC) was frequently (more than 20 beats/min) observed in 9 of 10 vehicle-treated G alpha(q)-TG but in none of 10 olmesartan-treated G alpha(q)-TG. The collected QT interval and monophasic action potential duration in the left ventricle were significantly shorter in olmesartan-treated G alpha(q)-TG than in vehicle-treated G alpha(q)-TG. CTGF, collagen type 1, ANP, BNP, and beta-MHC gene expression was increased and olmesartan significantly decreased the expression of these genes in G alpha(q)-TG mouse ventricles. The expression of canonical transient receptor potential (TRPC) 3 and 6 channel and angiotensin converting enzyme (ACE) proteins but not angiotensin II type 1 (AT(1)) receptor was increased in G alpha(q)-TG ventricles compared with NTG mouse ventricles. Olmesartan significantly decreased TRPC6 and tended to decrease ACE expressions in G alpha(q)-TG. Moreover, it increased AT(1) receptor in G alpha(q)-TG. Conclusions/Significance: These findings suggest that angiotensin II type 1 receptor activation plays an important role in the development of heart failure and ventricular arrhythmia in G alpha(q)-TG mouse model of heart failure.	[Matsushita, Naoko; Hirose, Masamichi] Iwate Med Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Shiwa, Iwate, Japan; [Matsushita, Naoko; Taira, Eiichi] Iwate Med Univ, Sch Med, Dept Pharmacol, Shiwa, Iwate, Japan; [Kashihara, Toshihide; Nakada, Tsutomu; Yamada, Mitsuhiko] Shinshu Univ, Sch Med, Dept Mol Pharmacol, Matsumoto, Nagano 390, Japan; [Shimojo, Hisashi] Shinshu Univ, Sch Med, Dept Pathol, Matsumoto, Nagano 390, Japan; [Suzuki, Satoshi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan; [Mende, Ulrike] Brown Univ, Rhode Isl Hosp, Cardiovasc Res Ctr, Div Cardiol, Providence, RI 02903 USA; [Mende, Ulrike] Brown Univ, Alpert Med Sch, Providence, RI USA; [Sanbe, Atsushi] Iwate Med Univ, Sch Pharmaceut Sci, Dept Pharmacotherapeut, Shiwa, Iwate, Japan	Iwate Medical University; Iwate Medical University; Shinshu University; Shinshu University; Fukushima Medical University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Iwate Medical University	Hirose, M (corresponding author), Iwate Med Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Shiwa, Iwate, Japan.	mhirose@iwate-med.ac.jp	yamada, Mitsuhiko/V-1269-2019	yamada, Mitsuhiko/0000-0002-7515-3824; Kashihara, Toshihide/0000-0001-8787-5376	Ministry of Education, Culture, Sports, Science and Technology, Japan [21590276]; KEIRYOKAI research foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114784] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26860145] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KEIRYOKAI research foundation(Keiryokai Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 21590276) (M.H.) and the grant from KEIRYOKAI research foundation (M.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Domenighetti AA, 2007, J MOL CELL CARDIOL, V42, P63, DOI 10.1016/j.yjmcc.2006.09.019; Farmer J A, 2001, Curr Atheroscler Rep, V3, P117, DOI 10.1007/s11883-001-0047-2; Fukui S, 2009, HYPERTENS RES, V32, P472, DOI 10.1038/hr.2009.43; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Harada K, 1998, CIRCULATION, V97, P1952, DOI 10.1161/01.CIR.97.19.1952; Hirose M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052667; Hirose M, 2011, CIRC J, V75, P2333, DOI 10.1253/circj.CJ-10-1213; Hirose M, 2009, HEART RHYTHM, V6, P78, DOI 10.1016/j.hrthm.2008.10.018; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Izumiya Y, 2003, CIRC RES, V93, P874, DOI 10.1161/01.RES.0000100665.67510.F5; Kamiyoshi Y, 2005, J MOL CELL CARDIOL, V39, P467, DOI 10.1016/j.yjmcc.2005.04.004; Lin L, 2014, J CARDIOVASC PHARM; Mazzolai L, 1998, HYPERTENSION, V31, P1324, DOI 10.1161/01.HYP.31.6.1324; Mende U, 1999, CIRC RES, V85, P1085; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; Niizeki T, 2008, AM J PHYSIOL-HEART C, V295, pH245, DOI 10.1152/ajpheart.00066.2008; Niizeki T, 2008, CIRC J, V72, P309, DOI 10.1253/circj.72.309; Nishio M, 2007, J HYPERTENS, V25, P455, DOI 10.1097/HJH.0b013e328010d635; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Qin YJ, 2009, HYPERTENS RES, V32, P875, DOI 10.1038/hr.2009.117; Sanbe A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018922; Sanbe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005351; Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190; Sun Y, 1994, J Card Fail, V1, P81, DOI 10.1016/1071-9164(94)90011-6; Takeishi Y, 1999, CIRC RES, V85, P264, DOI 10.1161/01.RES.85.3.264; Wang XH, 2013, EUR REV MED PHARMACO, V17, P2619; Yasuno S, 2013, BRIT J PHARMACOL, V170, P1384, DOI 10.1111/bph.12328; Yoshida K, 2004, CARDIOVASC DRUG REV, V22, P285; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	30	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106354	10.1371/journal.pone.0106354	http://dx.doi.org/10.1371/journal.pone.0106354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171374	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500155
J	Ramasamy, R; Jude, PJ; Veluppillai, T; Eswaramohan, T; Surendran, SN				Ramasamy, Ranjan; Jude, Pavilupillai J.; Veluppillai, Thabothiny; Eswaramohan, Thampoe; Surendran, Sinnathamby N.			Biological Differences between Brackish and Fresh Water-Derived Aedes aegypti from Two Locations in the Jaffna Peninsula of Sri Lanka and the Implications for Arboviral Disease Transmission	PLOS ONE			English	Article							MOSQUITO VECTORS; ALBOPICTUS; SALINITY; DISPERSAL; DIPTERA; IMPACT; LARVAE	The mainly fresh water arboviral vector Aedes aegypti L. (Diptera: Culicidae) can also undergo pre-imaginal development in brackish water of up to 15 ppt (parts per thousand) salt in coastal areas. We investigated differences in salinity tolerance, egg laying preference, egg hatching and larval development times and resistance to common insecticides in Ae. aegypti collected from brackish and fresh water habitats in Jaffna, Sri Lanka. Brackish water-derived Ae. aegypti were more tolerant of salinity than fresh water-derived Ae. aegypti and this difference was only partly reduced after their transfer to fresh water for up to five generations. Brackish water-derived Ae. aegypti did not significantly discriminate between 10 ppt salt brackish water and fresh water for oviposition, while fresh water-derived Ae. aegypti preferred fresh water. The hatching of eggs from both brackish and fresh water-derived Ae. aegypti was less efficient and the time taken for larvae to develop into pupae was prolonged in 10 ppt salt brackish water. Ae. aegypti isolated from coastal brackish water were less resistant to the organophosphate insecticide malathion than inland fresh water Ae. aegypti. Brackish and fresh water-derived Ae. aegypti however were able to mate and produce viable offspring in the laboratory. The results suggest that development in brackish water is characterised by pertinent biological changes, and that there is restricted genetic exchange between coastal brackish and inland fresh water Ae. aegypti isolates from sites 5 km apart. The findings highlight the need for monitoring Ae. aegypti developing in coastal brackish waters and extending vector control measures to their habitats.	[Ramasamy, Ranjan; Jude, Pavilupillai J.; Veluppillai, Thabothiny; Eswaramohan, Thampoe; Surendran, Sinnathamby N.] Univ Jaffna, Fac Sci, Dept Zool, Jaffna, Sri Lanka	University Jaffna	Ramasamy, R (corresponding author), Univ Jaffna, Fac Sci, Dept Zool, Jaffna, Sri Lanka.	ranjanramasamy@yahoo.co.uk; noble@jfn.ac.lk	Surendran, Sinnathamby/ABG-8282-2020; Ramasamy, Ranjan/AAF-3921-2020	Surendran, Sinnathamby/0000-0002-7861-2037; Ramasamy, Ranjan/0000-0003-0246-7053				[Anonymous], GLOBAL ENV CHANGES S; Barraud PJ, 1934, FAUNA BRIT INDIA INC, P28; BRADLEY TJ, 1987, ANNU REV ENTOMOL, V32, P439, DOI 10.1146/annurev.en.32.010187.002255; Clark TM, 2004, J EXP BIOL, V207, P2289, DOI 10.1242/jeb.01018; Coluzzi M., 1969, Parassitologia, V11, P177; Delatte H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002111; EDWARDS HA, 1982, J EXP BIOL, V101, P153; Endersby NM, 2011, J MED ENTOMOL, V48, P999, DOI 10.1603/ME10264; GARRETT MA, 1987, J EXP BIOL, V129, P231; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Herrera F, 2006, MEM I OSWALDO CRUZ, V101, P625, DOI 10.1590/S0074-02762006000600008; Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005; Idris FH, 2013, J VECTOR ECOL, V38, P197, DOI 10.1111/j.1948-7134.2013.12029.x; Jude PJ, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-269; Ministry of Healthcare and Nutrition of Sri Lanka, 2013, MONTHL DISTR SUSP DE; Ramasamy R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00198; Ramasamy R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001369; Ramasamy R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-18; Smith KE, 2008, J EXP BIOL, V211, P3067, DOI 10.1242/jeb.019299; Surendran S. N., 2007, Tropical Medicine and Health, V35, P249, DOI 10.2149/tmh.35.249; Surendran SN, 2012, J VECTOR ECOL, V37, P471, DOI 10.1111/j.1948-7134.2012.00254.x; Surendran SN, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-34; Van Schie C, 2009, SALINITY TOLERANCE A; WALLIS RC, 1954, AM J HYG, V60, P135, DOI 10.1093/oxfordjournals.aje.a119710; Walter Reed Biosystematics Unit, 2013, KEYS MED IMP MOSQ SP; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Wheeler MW, 2006, ENVIRON TOXICOL CHEM, V25, P1441, DOI 10.1897/05-320R.1; White BJ, 2013, J EXP BIOL, V216, P3433, DOI 10.1242/jeb.087189; WHO, 2009, WHO TECH REP SER, V958, P1; Yee DA, 2014, MED VET ENTOMOL, V28, P60, DOI 10.1111/mve.12007	30	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e104977	10.1371/journal.pone.0104977	http://dx.doi.org/10.1371/journal.pone.0104977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170879	Green Submitted, Green Published, gold			2022-12-25	WOS:000341127500028
J	Szedlak, A; Paternostro, G; Piermarocchi, C				Szedlak, Anthony; Paternostro, Giovanni; Piermarocchi, Carlo			Control of Asymmetric Hopfield Networks and Application to Cancer Attractors	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; FOLLICULAR LYMPHOMA; REGULATORY NETWORK; CELL; EXPRESSION; SYSTEMS; TARGET; ALGORITHMS; REPRESSION; MUTATIONS	The asymmetric Hopfield model is used to simulate signaling dynamics in gene regulatory networks. The model allows for a direct mapping of a gene expression pattern into attractor states. We analyze different control strategies aimed at disrupting attractor patterns using selective local fields representing therapeutic interventions. The control strategies are based on the identification of signaling bottlenecks, which are single nodes or strongly connected clusters of nodes that have a large impact on the signaling. We provide a theorem with bounds on the minimum number of nodes that guarantee control of bottlenecks consisting of strongly connected components. The control strategies are applied to the identification of sets of proteins that, when inhibited, selectively disrupt the signaling of cancer cells while preserving the signaling of normal cells. We use an experimentally validated non-specific and an algorithmically-assembled specific B cell gene regulatory network reconstructed from gene expression data to model cancer signaling in lung and B cells, respectively. Among the potential targets identified here are TP53, FOXM1, BCL6 and SRC. This model could help in the rational design of novel robust therapeutic interventions based on our increasing knowledge of complex gene signaling networks.	[Szedlak, Anthony; Piermarocchi, Carlo] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [Paternostro, Giovanni] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Paternostro, Giovanni; Piermarocchi, Carlo] Salgomed Inc, Del Mar, CA USA	Michigan State University; Sanford Burnham Prebys Medical Discovery Institute	Szedlak, A (corresponding author), Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA.	szedlak1@msu.edu	Piermarocchi, Carlo/AAH-2162-2019	Piermarocchi, Carlo/0000-0003-2762-8562	Congressionally Directed Medical Research Program (DOD) Lung Cancer Research [W81XWH-12-1-0233]; NIH/NCI [1R41CA174059-01]; Salgomed Inc.; NATIONAL CANCER INSTITUTE [R41CA174059] Funding Source: NIH RePORTER	Congressionally Directed Medical Research Program (DOD) Lung Cancer Research; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Salgomed Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge support from the Congressionally Directed Medical Research Program (DOD, http://cdmrp.army.mil) Lung Cancer Research (W81XWH-12-1-0233) and NIH/NCI (Grant 1R41CA174059-01). Salgomed Inc., provided support in the form of salaries for authors G.P. and C.P., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agoston V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051909; Akasaka T, 2003, BLOOD, V102, P1443, DOI 10.1182/blood-2002-08-2482; Akutsu T, 2007, J THEOR BIOL, V244, P670, DOI 10.1016/j.jtbi.2006.09.023; Aldana M, 2003, PERSPECTIVES AND PROBLEMS IN NONLINEAR SCIENCE, P23; Amari S, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022814; AMIT DJ, 1985, PHYS REV A, V32, P1007, DOI 10.1103/PhysRevA.32.1007; Anafi RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014413; Ao P, 2008, MED HYPOTHESES, V70, P678, DOI 10.1016/j.mehy.2007.03.043; Bai X, 2008, J CANCER RES CLIN, V134, P83, DOI 10.1007/s00432-007-0252-7; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Bengoechea-Alonso MT, 2010, ONCOGENE, V29, P5322, DOI 10.1038/onc.2010.278; Bhardwaj N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000755; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Calzolari D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000547; Choudhary A, 2006, BIOINFORMATICS, V22, P226, DOI 10.1093/bioinformatics/bti765; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Cornelius S, 2013, NATURE COMMUN, V4, P1; Creixell P, 2012, NAT BIOTECHNOL, V30, P842, DOI 10.1038/nbt.2345; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; De Falco G, 2007, BLOOD, V110, P1301, DOI 10.1182/blood-2006-12-064865; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; DERRIDA B, 1987, EUROPHYS LETT, V4, P167, DOI 10.1209/0295-5075/4/2/007; Diaz-Alderete A, 2008, LEUKEMIA LYMPHOMA, V49, P95, DOI 10.1080/10428190701742472; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fabris S, 2013, AM J HEMATOL, V88, P24, DOI 10.1002/ajh.23340; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Feala JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029374; Feala JD, 2010, WIRES SYST BIOL MED, V2, P181, DOI 10.1002/wsbm.51; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Glud SZ, 2005, BLOOD, V106, P3546, DOI 10.1182/blood-2005-02-0493; Hamid R, 2009, MOL ONCOL, V3, P451, DOI 10.1016/j.molonc.2009.07.004; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hartemink AJ, 2005, NAT BIOTECHNOL, V23, P554, DOI 10.1038/nbt0505-554; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2009, SEMIN CELL DEV BIOL, V20, P869, DOI 10.1016/j.semcdb.2009.07.003; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Krotov D, 2014, P NATL ACAD SCI; KURTEN KE, 1988, PHYS LETT A, V129, P157, DOI 10.1016/0375-9601(88)90135-1; KURTEN KE, 1988, J PHYS A-MATH GEN, V21, pL615, DOI 10.1088/0305-4470/21/11/009; Lang AH, 2012, ARXIV12113133V3; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Liborio TN, 2013, OR SURG OR MED OR PA, V116, P614, DOI 10.1016/j.oooo.2013.07.014; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02459570; Mo ML, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-29; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Muggerud AA, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-26; Munoz J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.84; Muzikar KA, 2009, P NATL ACAD SCI USA, V106, P16598, DOI 10.1073/pnas.0909192106; Piccaluga PP, 2011, BLOOD, V117, P3596, DOI 10.1182/blood-2010-08-301556; Plummer Michael D., 1986, MATCHING THEORY; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rohlf T, 2009, UNDERST COMPLEX SYST, P73, DOI 10.1007/978-3-642-01284-6_5; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rothschild SI, 2010, CLIN LUNG CANCER, V11, P238, DOI 10.3816/CLC.2010.n.030; Sartor MA, 2010, BIOINFORMATICS, V26, P456, DOI 10.1093/bioinformatics/btp683; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sontag E.D., 1998, MATH CONTROL THEORY; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001538; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Tompkins VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076889; Valdez BC, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2013.69; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczynski J, 2014, ONCOGENE, V33, P1027, DOI 10.1038/onc.2013.28; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Winter JN, 2006, BLOOD, V107, P4207, DOI 10.1182/blood-2005-10-4222; Yang CY, 2008, BIOINFORMATICS, V24, pI14, DOI 10.1093/bioinformatics/btn297; Zhang YL, 2013, J STEROID BIOCHEM, V138, P17, DOI 10.1016/j.jsbmb.2013.02.010	73	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105842	10.1371/journal.pone.0105842	http://dx.doi.org/10.1371/journal.pone.0105842			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170874	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500071
J	Chan, SSC; Cheung, YTD; Leung, DYP; Mak, YW; Leung, GM; Lam, TH				Chan, Sophia Siu Chee; Cheung, Yee Tak Derek; Leung, Doris Yin Ping; Mak, Yim Wah; Leung, Gabriel M.; Lam, Tai Hing			Secondhand Smoke Exposure and Maternal Action to Protect Children from Secondhand Smoke: Pre- and Post-Smokefree Legislation in Hong Kong	PLOS ONE			English	Article							CROSS-SECTIONAL SURVEY; PASSIVE SMOKING; CHILDHOOD ASTHMA; TOBACCO CONTROL; 2ND-HAND SMOKE; SCOTLAND; IMPLEMENTATION; COUNTRIES; ENGLAND; HEALTH	Background: Smokefree legislation may protect children from secondhand smoke (SHS) in the home from smoking parent(s). We examined the effect of the 2007 smokefree legislation on children's exposure to SHS in the home and maternal action to protect children from SHS exposure in Hong Kong. Methods: Families with a smoking father and a non-smoking mother were recruited from public clinics before (2005-2006, n = 333) and after the legislation (2007-2008, n = 742) which led to a major extension of smokefree places in Hong Kong. Main outcomes included children's SHS exposure in the home, nicotine level in mothers' and children's hair and home environment, mothers' action to protect children from SHS, and their support to the fathers to quit. Results: Fewer mothers post-legislation reported children's SHS exposure in the home (87.2% versus 29.3%, p<0.01), which was consistent with their hair nicotine levels (0.36ng/mg versus 0.04ng/mg, p<0.01). More mothers post-legislation in the last month took their children away from cigarette smoke (6.3% versus 92.2%; p<0.01) and advised fathers to quit over 3 times (8.3% versus 33.8%; p<0.01). No significant change was found in the content of smoking cessation advice and the proportion of mothers who took specific action to support the fathers to quit. Conclusions: SHS exposure in the home decreased and maternal action to protect children from SHS increased after the 2007 smokefree legislation. Maternal support to fathers to quit showed moderate improvement. Cessation services for smokers and specific interventions for smoking families should be expanded together with smokefree legislation.	[Chan, Sophia Siu Chee] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Cheung, Yee Tak Derek; Leung, Gabriel M.; Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Leung, Doris Yin Ping] Chinese Univ Hong Kong, Nethersole Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Lam, Tai Hing] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Hong Kong Polytechnic University	Cheung, YTD (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	derekcheung@hku.hk	Cheung, Derek/O-3682-2018; Leung, Doris Yin-ping/K-4878-2014; Leung, Doris Y.P./T-6985-2019; Lam, Tai Hing/C-4317-2009	Cheung, Derek/0000-0002-5850-5349; Leung, Doris Yin-ping/0000-0003-0138-8839; Leung, Doris Y.P./0000-0003-0138-8839; Leung, Gabriel/0000-0002-2503-6283; Lam, Tai Hing/0000-0002-2033-9971; Mak, Yim Wah/0000-0001-7330-7001	Food and Health Bureau, Hong Kong SAR Government [SHS-T02]	Food and Health Bureau, Hong Kong SAR Government	The funding source for this study was the Food and Health Bureau, Hong Kong SAR Government (Ref: SHS-T02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adda J, 2006, 2191 IZA; Adda J, 2010, AM ECON J-APPL ECON, V2, P1, DOI 10.1257/app.2.1.1; Akhtar PC, 2007, BMJ-BRIT MED J, V335, P545, DOI 10.1136/bmj.39311.550197.AE; Akhtar PC, 2010, J EPIDEMIOL COMMUN H, V64, P341, DOI 10.1136/jech.2008.084178; Bajoga U, 2011, ADDICTION, V106, P1346, DOI 10.1111/j.1360-0443.2011.03446.x; Becquemin MH, 2010, TOB CONTROL, V19, P347, DOI 10.1136/tc.2009.034694; Census and Statistics Department, 2013, 53 CENS STAT DEP HON; Chan SCS, 2011, HONG KONG MED J, V17, pS38; Chan SSC, 2008, AM J HEALTH PROMOT, V23, P31, DOI 10.4278/ajhp.07043040; Chan SSC, 2009, NICOTINE TOB RES, V11, P356, DOI 10.1093/ntr/ntp025; Cheraghi M, 2009, EUR J PEDIATR, V168, P897, DOI 10.1007/s00431-009-0967-3; Dove MS, 2010, PEDIATRICS, V126, P80, DOI 10.1542/peds.2009-3462; Finance committee and Legialstive Council of the Hong Kong Special Administrative Region, 2007, SECR FOOD HLTH REPL, V16; Fowkes FJI, 2008, ADDICTION, V103, P1888, DOI 10.1111/j.1360-0443.2008.02350.x; Gorini G, 2007, PREV MED, V45, P123, DOI 10.1016/j.ypmed.2007.06.019; Hackshaw L, 2010, TOB CONTROL, V19, P160, DOI 10.1136/tc.2009.032656; Haw SJ, 2007, BRIT MED J, V335, P549, DOI 10.1136/bmj.39315.670208.47; Hawkins SS, 2011, TOB CONTROL, V20, P112, DOI 10.1136/tc.2010.037028; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Ho SY, 2010, TOB CONTROL, V19, P129, DOI 10.1136/tc.2009.032003; Holliday JC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-430; Hong Kong Council on Smoking and Health, 2007, HONG KONG COUNC SMOK; Hong Kong Council on Smoking and Health, 2006, HONG KONG COUNC SMOK; Jarvis MJ, 2012, TOB CONTROL, V21, P18, DOI 10.1136/tc.2010.041608; Koplan JP, 2010, LANCET, V375, P1330, DOI 10.1016/S0140-6736(10)60398-4; Legislative Council of the Hong Kong Special Administrative Region, 2014, LACQ18 MAT CHILD HLT; Leung DY, 2010, CIRCULATION, V122, pE274; Leung GM, 2004, ARCH PEDIAT ADOL MED, V158, P687, DOI 10.1001/archpedi.158.7.687; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; Mackay DF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026188; Mao A, 2012, HLTH ED RES; Matt GE, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.037382; McGhee SM, 2005, BMJ-BRIT MED J, V330, P287, DOI 10.1136/bmj.38342.706748.47; Millett C, 2013, PEDIATRICS, V131, pE495, DOI 10.1542/peds.2012-2592; Mons U, 2012, TOBACCO CONTROL; Mons U, 2013, TOB CONTROL, V22, DOI 10.1136/tobaccocontrol-2011-050131; Moore GF, 2012, J PUBLIC HLTH; Nagelhout GE, 2012, EUR J PUBLIC HEALTH, V22, P4, DOI 10.1093/eurpub/ckr203; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Phillips R, 2007, BRIT MED J, V335, P553, DOI 10.1136/bmj.39301.497593.55; Prochaska JO., 1994, TRANSTHEORETICAL APP; Sleiman M, 2010, P NATL ACAD SCI USA, V107, P6576, DOI 10.1073/pnas.0912820107; Strachan DP, 1997, THORAX, V52, P905, DOI 10.1136/thx.52.10.905; Tobacco Control Office Department of Health, 2011, TCO 10 ANN BOOKL; United Nations, 2009, MILLL DEV GOALS REP; Wipfli H, 2008, AM J PUBLIC HEALTH, V98, P672, DOI 10.2105/AJPH.2007.126631	46	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105781	10.1371/journal.pone.0105781	http://dx.doi.org/10.1371/journal.pone.0105781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JP	25166507	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303700043
J	Li, D; Ji, L; Liu, LB; Liu, YZ; Hou, HF; Yu, KK; Sun, Q; Zhao, ZT				Li, Dong; Ji, Long; Liu, Lianbo; Liu, Yizhi; Hou, Haifeng; Yu, Kunkun; Sun, Qiang; Zhao, Zhongtang			Characterization of Circulating MicroRNA Expression in Patients with a Ventricular Septal Defect	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; GATA; GENES; ROLES	Objectives: Ventricular septal defect (VSD), one of the most common types of congenital heart disease (CHD), results from a combination of environmental and genetic factors. Recent studies demonstrated that microRNAs (miRNAs) are involved in development of CHD. This study was to characterize the expression of miRNAs that might be involved in the development or reflect the consequences of VSD. Methods: MiRNA microarray analysis and reverse transcription-polymerase chain reaction (RT-PCR) were employed to determine the miRNA expression profile from 3 patients with VSD and 3 VSD-free controls. 3 target gene databases were employed to predict the target genes of differentially expressed miRNAs. miRNAs that were generally consensus across the three databases were selected and then independently validated using real time PCR in plasma samples from 20 VSD patients and 15 VSD-free controls. Target genes of validated 8 miRNAs were predicted using bioinformatic methods. Results: 36 differentially expressed miRNAs were found in the patients with VSD and the VSD-free controls. Compared with VSD-free controls, expression of 15 miRNAs were up-regulated and 21 miRNAs were downregulated in the VSD group. 15 miRNAs were selected based on database analysis results and expression levels of 8 miRNAs were validated. The results of the real time PCR were consistent with those of the microarray analysis. Gene ontology analysis indicated that the top target genes were mainly related to cardiac right ventricle morphogenesis. NOTCH1, HAND1, ZFPM2, and GATA3 were predicted as targets of hsa-let-7e-5p, hsa-miR-222-3p and hsa-miR-433. Conclusion: We report for the first time the circulating miRNA profile for patients with VSD and showed that 7 miRNAs were downregulated and 1 upregulated when matched to VSD-free controls. Analysis revealed target genes involved in cardiac development were probably regulated by these miRNAs.	[Li, Dong; Zhao, Zhongtang] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan, Shandong, Peoples R China; [Li, Dong; Ji, Long; Liu, Yizhi; Hou, Haifeng; Yu, Kunkun; Sun, Qiang] Taishan Med Univ, Sch Publ Hlth, Tai An, Shandong, Peoples R China; [Liu, Lianbo] Taian Childrens Hosp, Tai An, Shandong, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Zhao, ZT (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan, Shandong, Peoples R China.	ztzhao@sdu.edu.cn		Hou, Haifeng/0000-0002-1131-1619	Natural Science Foundation of Shandong [ZR2011HM018]	Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province)	This work was supported by Natural Science Foundation of Shandong (NO: ZR2011HM018). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias Lopez I, 2008, An Pediatr (Barc), V69, P23; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; Cheng Z, 2012, CLIN CHIM ACTA, V413, P675, DOI 10.1016/j.cca.2011.10.014; Christianson A., 2006, GLOBAL REPORT BIRTH; Espinoza-Lewis RA, 2012, CURR TOP DEV BIOL, V100, P279, DOI 10.1016/B978-0-12-387786-4.00009-9; Gao Y, 2008, CHINESE J EVIDENCE B, V3, P213; Gruber PJ, 2005, CLIN PERINATOL, V32, P845, DOI 10.1016/j.clp.2005.09.003; Huang ZP, 2011, METHODS MOL BIOL, V709, P197, DOI 10.1007/978-1-61737-982-6_12; Huang ZP, 2010, ARTERIOSCL THROM VAS, V30, P2575, DOI 10.1161/ATVBAHA.110.213306; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kratsios P, 2010, CIRC RES, V106, P559, DOI 10.1161/CIRCRESAHA.109.203034; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; LC Jin, 2012, THESIS HEBEI MED U; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li FQ, 2013, MED RECAPITULATE, V19, P43; Li J, 2013, INT J CARDIOL, V168, P1441, DOI 10.1016/j.ijcard.2012.12.048; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Miller SA, 2009, IMMUNOLOGY, V126, P306, DOI 10.1111/j.1365-2567.2008.03040.x; Ministry of Health of the People's Republic of China, 2011, MAT CHILD HLTH MON A, V3, P4; Nigam V, 2010, J HEART VALVE DIS, V19, P459; Penny DJ, 2011, LANCET, V377, P1103, DOI 10.1016/S0140-6736(10)61339-6; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Vincentz JW, 2011, BIRTH DEFECTS RES A, V91, P485, DOI 10.1002/bdra.20796; Wessels MW, 2010, CLIN GENET, V78, P103, DOI 10.1111/j.1399-0004.2010.01435.x; Xing HJ, 2013, EUR REV MED PHARMACO, V17, P2114; Xu J, 2009, HUM MUTAT, V30, P1231, DOI 10.1002/humu.21044; [余章斌 YU Zhangbin], 2011, [实用儿科临床杂志, Journal of Applied Clinical Pediatrics], V26, P1425; Yu ZB, 2011, MED HYPOTHESES, V76, P424, DOI 10.1016/j.mehy.2010.11.010; [余章斌 YU Zhangbin], 2010, [医学分子生物学杂志, Journal of Medical Molecular Biology], V7, P66; Zhang H., 2011, J BEIJING UNION UNIV, V2, P11; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhou B, 2009, J CLIN INVEST, V119, P1462, DOI 10.1172/JCI38723; Zhou H, 2010, J MOL MED, V88, P709, DOI 10.1007/s00109-010-0617-2	41	39	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106318	10.1371/journal.pone.0106318	http://dx.doi.org/10.1371/journal.pone.0106318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165856	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303700087
J	Senyonjo, L; Lindfield, R; Mahmoud, A; Kimani, K; Sanda, S; Schmidt, E				Senyonjo, Laura; Lindfield, Robert; Mahmoud, Abdulraheem; Kimani, Kahaki; Sanda, Safiya; Schmidt, Elena			Ocular Morbidity and Health Seeking Behaviour in Kwara State, Nigeria: Implications for Delivery of Eye Care Services	PLOS ONE			English	Article							IMPACT; PREVALENCE; BLINDNESS	Background: There is currently limited information as to which conditions are most prevalent in communities in developing countries. This makes effective planning of eye services difficult. Methods: 3,899 eligible individuals were recruited and examined in a cross-sectional survey in Asa Local Government Area, Nigeria. Those who self-reported an ocular morbidity were also asked about their health-seeking behaviour. Health records of local facilities were reviewed to collect information on those presenting with ocular morbidities. Results: 25.2% (95% CI: 22.0-28.6) had an ocular morbidity in at least one eye. Leading causes were presbyopia and conditions affecting the lens and conjunctiva. The odds of having an ocular morbidity increased with age and lower educational attainment. 10.1% (7.7-13.0) self-reported ocular morbidity; 48.6% (40.4-56.8) of them reported seeking treatment. At the facility level, 344 patients presented with an ocular morbidity over one month, the most common conditions were red (26.3%) or itchy (20.8%) eyes. Conclusion: Ocular morbidities, including many non vision impairing conditions, were prevalent with a quarter of the population affected. The delivery of eye care services needs to be tailored in order to address this need and ensure delivery in a cost-effective and sustainable manner.	[Senyonjo, Laura; Schmidt, Elena] Sightsavers, Haywards Heath, W Sussex, England; [Lindfield, Robert] London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1, England; [Mahmoud, Abdulraheem] Univ Ilorin Teaching Hosp, Dept Ophthalmol, Ilorin, Kwara State, Nigeria; [Kimani, Kahaki] Univ Nairobi, Dept Ophthalmol, Nairobi, Kenya; [Sanda, Safiya] Sightsavers Nigeria, Kaduna, Nigeria	University of London; London School of Hygiene & Tropical Medicine; University of Ilorin; University of Nairobi	Senyonjo, L (corresponding author), Sightsavers, Haywards Heath, W Sussex, England.	lsenyonjo@sightsavers.org	kimani, kahaki/AAC-9898-2020		Sightsavers	Sightsavers	This study was funded by Sightsavers. Sightsavers is an international charity that works with partners in developing countries to eliminate avoidable blindness (www.sightsavers.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriamanjato HH, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-S1-S3; Bronsard A, 2008, OPHTHAL EPIDEMIOL, V15, P383, DOI 10.1080/09286580802488624; Byamukama E, 2010, INT HEALTH, V2, P247, DOI 10.1016/j.inhe.2010.07.008; Courtright P, 2010, ANN TROP MED PARASIT, V104, P361, DOI 10.1179/136485910X12743554760225; Dandona Rakhi, 2001, Indian Journal of Ophthalmology, V49, P215; du Toit R, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-102; Foster A, 2005, EYE, V19, P1133, DOI 10.1038/sj.eye.6701973; Gilbert CE, 2010, OPHTHAL EPIDEMIOL, V17, P269, DOI 10.3109/09286586.2010.508349; Hussain A, 2004, OPHTHAL EPIDEMIOL, V11, P413, DOI 10.1080/09286580490888799; Karimurio J, 2008, E AFRICAN J OPHTHALM, V14, P41; Kimani K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070009; Lewallen S, 2001, BRIT J OPHTHALMOL, V85, P897, DOI 10.1136/bjo.85.8.897; Melese M, 2004, TROP MED INT HEALTH, V9, P426, DOI 10.1111/j.1365-3156.2004.01205.x; Murthy Gvs, 2009, Community Eye Health, V22, P10; Naidoo K, 2007, CLIN EXP OPTOM, V90, P415, DOI 10.1111/j.1444-0938.2007.00197.x; National Population Commission, 2006, PROV RES MAIN FIND 2; Okwen M, 2014, PUBLIC HEALTH, V128, P96, DOI 10.1016/j.puhe.2013.10.007; Omolase C O, 2008, Afr J Med Med Sci, V37, P255; Pitt AD, 2004, OPHTHAL EPIDEMIOL, V11, P17, DOI 10.1076/opep.11.1.17.26437; Tong L, 2010, EYE, V24, P1486, DOI 10.1038/eye.2010.67	20	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e104128	10.1371/journal.pone.0104128	http://dx.doi.org/10.1371/journal.pone.0104128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165984	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000341303700008
J	Wang, Y; Gong, XQ; Wang, SM; Chen, LX; Sun, L				Wang, Yu; Gong, Xueqin; Wang, Shumei; Chen, Lixue; Sun, Li			Separation of Native Allophycocyanin and R-Phycocyanin from Marine Red Macroalga Polysiphonia urceolata by the Polyacrylamide Gel Electrophoresis Performed in Novel Buffer Systems	PLOS ONE			English	Article							B-PHYCOERYTHRIN; PORPHYRIDIUM-CRUENTUM; PURIFICATION; PHYCOBILIPROTEINS; PHYCOBILISOME; COMPLEXES; PIGMENTS	Three buffer systems of Imidazole-Acetic acid, HEPES-Imidazole/Bis-tris and Bis-tris-HEPES-MES were designed based on the principle of discontinuous polyacrylamide gel electrophoresis (PAGE) for the native PAGE which could be performed in pH 7.0 and 6.5 in order to analyze and prepare the minor components of allophycocyanin (AP) and R-phycocyanin (R-PC) from marine red macroalga Polysiphonia urceolata. These AP and R-PC phycobiliproteins are easily denatured in alkaline environments. The obtained results demonstrated that the PAGE modes performed in the buffer systems of HEPES-Imidazole/Bis-tris and Bis-tris-HEPES-MES gave the satisfactory resolution and separation of AP and R-PC proteins. The absorption and fluorescence spectra of the AP and R-PC proteins which were prepared by the established PAGE modes proved that they maintained natural spectroscopic characteristics. The established PAGE modes may also provide useful references and selections for some other proteins that are sensitive to alkaline environments or are not effectively separated by the classical PAGE modes performed normally in alkaline buffer systems.	[Wang, Yu; Chen, Lixue; Sun, Li] Yantai Univ, Coll Life Sci, Yantai, Shandong, Peoples R China; [Wang, Shumei] Yantai Univ, Coll Photoelect Informat Sci & Technol, Yantai, Peoples R China	Yantai University; Yantai University	Sun, L (corresponding author), Yantai Univ, Coll Life Sci, Yantai, Shandong, Peoples R China.	sunlwang@public.ytptt.sd.cn	gong, xue/GYQ-8649-2022					Andrews AT, 1981, THEORY TECHNIQUE BIO; Benedetti S, 2006, J CHROMATOGR B, V833, P12, DOI 10.1016/j.jchromb.2005.10.010; Bermejo R, 2003, J CHROMATOGR B, V790, P317, DOI 10.1016/S1570-0232(03)00168-5; Bermejo R, 2001, J CHROMATOGR A, V917, P135, DOI 10.1016/S0021-9673(01)00692-6; Camara-Artigas A, 2012, FEBS J, V279, P3680, DOI 10.1111/j.1742-4658.2012.08730.x; Colyer C, 2005, ANAL BIOANAL CHEM, V382, P559, DOI 10.1007/s00216-004-3020-4; Eriksen NT, 2008, APPL MICROBIOL BIOT, V80, P1, DOI 10.1007/s00253-008-1542-y; Galland-Irmouli AV, 2000, J CHROMATOGR B, V739, P117, DOI 10.1016/S0378-4347(99)00433-8; GLAZER AN, 1994, J APPL PHYCOL, V6, P105, DOI 10.1007/BF02186064; Guo X, 2005, EXPT TECHNOLOGY PROT; Holmes KL, 2001, METHOD CELL BIOL, V63, P185; Liu LN, 2005, J BIOTECHNOL, V116, P91, DOI 10.1016/j.jbiotec.2004.09.017; Liu LN, 2009, BBA-BIOENERGETICS, V1787, P939, DOI 10.1016/j.bbabio.2009.02.018; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Munier M, 2014, FOOD CHEM, V150, P400, DOI 10.1016/j.foodchem.2013.10.113; Niu JF, 2006, PROTEIN EXPRES PURIF, V49, P23, DOI 10.1016/j.pep.2006.02.001; Qu Y, 2013, J YANTAI U, V26, P106; Ranjitha K, 2005, J SCI IND RES INDIA, V64, P372; REUTER W, 1993, J PHOTOCH PHOTOBIO B, V18, P51, DOI 10.1016/1011-1344(93)80040-G; Rossano R, 2003, J BIOTECHNOL, V101, P289, DOI 10.1016/S0168-1656(03)00002-6; Rowan K.S., 1989, PHOTOSYNTHETIC PIGME; Schluchter W.M., 2002, HEME CHLOROPHYLL BIL, P311, DOI DOI 10.1385/1-59259-243-0:311; Seelert H, 2008, ELECTROPHORESIS, V29, P2617, DOI 10.1002/elps.200800061; Sekar S, 2008, J APPL PHYCOL, V20, P113, DOI 10.1007/s10811-007-9188-1; Su HN, 2010, PHOTOSYNTH RES, V106, P73, DOI 10.1007/s11120-010-9560-x; Sun L, 2004, J PHOTOCH PHOTOBIO B, V76, P1, DOI 10.1016/j.jphotobiol.2004.07.003; Sun L, 2003, J PHOTOCH PHOTOBIO B, V72, P45, DOI 10.1016/j.jphotobiol.2003.07.006; Sun L, 2003, IEEE J SEL TOP QUANT, V9, P177, DOI 10.1109/JSTQE.2003.812499; Sun L, 2011, J PHYCOL, V47, P1304, DOI 10.1111/j.1529-8817.2011.01067.x; Sun L, 2009, BACTERIOL RES DEV, P105; Sun L, 2009, PROTEIN EXPRES PURIF, V64, P146, DOI 10.1016/j.pep.2008.09.013; Wang L, 2010, J YANTAI U, V23, P283; Wang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087833; Westermeier R, 2005, ELECTROPHORESIS IN PRACTICE: A GUIDE TO METHODS AND APPLICATIONS OF DNA AND PROTEIN SEPARATIONS, P1	34	6	6	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106369	10.1371/journal.pone.0106369	http://dx.doi.org/10.1371/journal.pone.0106369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166028	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303700089
J	Liang, TM; Yu, JF; Liu, C; Guo, L				Liang, Tingming; Yu, JiaFeng; Liu, Chang; Guo, Li			An Exploration of Evolution, Maturation, Expression and Function Relationships in Mir-23 similar to 27 similar to 24 Cluster	PLOS ONE			English	Article							MICRORNA EXPRESSION; RNA; BIOGENESIS; REVEALS; ADENYLATION; REPERTOIRE; COMPLEXITY; EVENTS	The study aims to explore the potential relationships of evolution, maturation, expression and function between homologous/clustered miRNAs. mir-23 similar to 27 similar to 24 gene cluster, including the two gene clusters (mir-23a and mir-23b) and the three miRNA gene families (mir-23, mir-27 and mir-24), was typically selected as an example. These related miRNAs show similar evolutionary patterns and various expression patterns. Most of them show consistent isomiR expression pattern, and the "switching" phenomenon can be found between different abundant isomiR species. These findings suggest that these sequence or location related miRNAs show the similar miRNA processing and maturation processes, and the robust selection of the most dominant isomiR exists in specific tissues. Functional analysis show that these miRNAs show similar distributions of enriched gene categories, suggesting the close functional prelateships via direct or indirect coordinate regulation in biological processes. The study reveals the close evolutionary, expression and functional relationships between related homologous/clustered miRNAs, which will further enrich miRNA studies and understand direct or indirect interactions between miRNAs.	[Liang, Tingming; Liu, Chang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Yu, JiaFeng] Dezhou Univ, Inst Biophys, Shandong Prov Key Lab Funct Macromol Biophys, Dezhou, Shandong, Peoples R China; [Guo, Li] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Dezhou University; Nanjing Medical University	Guo, L (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	lguo@njmu.edu.cn	Liang, Tingming/ACL-6141-2022		National Basic Research Program of China (973 Program) [2012CB947600, 2013CB911600]; National Natural Science Foundation of China [31171137, 31271261, 61301251]; Program for New Century Excellent Talents in University by the Chinese Ministry of Education [NCET-11-0990]; Program for the Top Young Talents by the Organization Department of the CPC Central Committee; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); China Postdoctoral Science Foundation [2012M521100]; National Natural Science Foundation of Jiangsu [BK20130885]; Natural Science Foundation of the Jiangsu Higher Education Institutions [12KJB360001, 13KJB330003]; Jiangsu Planned Projects for Postdoctoral Research Funds [1201022B]; Shandong Provincial Key Laboratory of Functional Macromolecular Biophysics; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University by the Chinese Ministry of Education; Program for the Top Young Talents by the Organization Department of the CPC Central Committee; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of Jiangsu; Natural Science Foundation of the Jiangsu Higher Education Institutions; Jiangsu Planned Projects for Postdoctoral Research Funds; Shandong Provincial Key Laboratory of Functional Macromolecular Biophysics; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Basic Research Program of China (973 Program) (2012CB947600, 2013CB911600), the National Natural Science Foundation of China (31171137, 31271261, 61301251), the Program for New Century Excellent Talents in University by the Chinese Ministry of Education (NCET-11-0990), the Program for the Top Young Talents by the Organization Department of the CPC Central Committee, the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University), the China Postdoctoral Science Foundation funded project (No. 2012M521100), the National Natural Science Foundation of Jiangsu (No. BK20130885), the Natural Science Foundation of the Jiangsu Higher Education Institutions (No. 12KJB360001, 13KJB330003), the Jiangsu Planned Projects for Postdoctoral Research Funds (No. 1201022B), Shandong Provincial Key Laboratory of Functional Macromolecular Biophysics, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Chen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.92; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Guo L, 2013, MICRORNA NONCODING R, P127; Guo L, 2014, GENE, V544, P1, DOI 10.1016/j.gene.2014.04.039; Guo L, 2012, MOL BIOL REP, V39, P6699, DOI 10.1007/s11033-012-1493-3; Guo L, 2012, MOL BIOL REP, V39, P2031, DOI 10.1007/s11033-011-0950-8; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Guo L, 2010, COMPUT BIOL CHEM, V34, P165, DOI 10.1016/j.compbiolchem.2010.06.001; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Guo L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007944; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jin LJ, 2013, CANCER RES, V73, P2884, DOI 10.1158/0008-5472.CAN-12-2162; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Li XN, 2013, J BIOL CHEM, V288, P18121, DOI 10.1074/jbc.M113.478560; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin ST, 2013, P NATL ACAD SCI USA, V110, P17468, DOI 10.1073/pnas.1317182110; Lu SF, 2009, NUCLEIC ACIDS RES, V37, P1878, DOI 10.1093/nar/gkp031; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Reid JG, 2008, GENOME RES, V18, P1571, DOI 10.1101/gr.078246.108; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Sun T, 2012, PROSTATE, V72, P1093, DOI 10.1002/pros.22456; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Viswanathan SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006143; Wang F, 2014, NUCLEIC ACIDS RES, V42, P442, DOI 10.1093/nar/gkt848; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Zhang Q, 2014, VIROLOGY, V450, P182, DOI 10.1016/j.virol.2013.12.020; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	51	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e106223	10.1371/journal.pone.0106223	http://dx.doi.org/10.1371/journal.pone.0106223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157521	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303200092
J	Tokuda, S; Higashi, T; Furuse, M				Tokuda, Shinsaku; Higashi, Tomohito; Furuse, Mikio			ZO-1 Knockout by TALEN-Mediated Gene Targeting in MDCK Cells: Involvement of ZO-1 in the Regulation of Cytoskeleton and Cell Shape	PLOS ONE			English	Article							ZONULA OCCLUDENS-1 AND-2; TIGHT JUNCTION STRANDS; BELT-LIKE ADHERENS; EPITHELIAL-CELLS; BARRIER FUNCTION; ACTIN CYTOSKELETON; PROTEIN; EXPRESSION; OCCLUDIN; CLAUDINS	ZO-1, ZO-2 and ZO-3 are tight junction-associated scaffold proteins that bind to transmembrane proteins of tight junctions and the underlying cytoskeleton. ZO-1 is involved in the regulation of cytoskeletal organization, but its detailed molecular mechanism is less well understood. Gene knockout is an ideal method to investigate the functions of proteins that might have redundant functions such as ZO proteins, when compared with methods such as RNA interference-mediated suppression of gene expression. In this study we applied transcription activator-like effector nucleases (TALENs), a recently developed genome editing method for gene knockout, and established ZO-1 knockout clones in Madin-Darby canine kidney (MDCK) cells. ZO-1 knockout induced striking changes in myosin organization at cell-cell contacts and disrupted the localization of tight junction proteins; these findings were previously unseen in studies of ZO-1 knockdown by RNA interference. Rescue experiments revealed that trace ZO-1 expression reversed these changes while excessive ZO-1 expression induced an intensive zigzag shape of cell-cell junctions. These results suggest a role for ZO-1 in the regulation of cytoskeleton and shape of cell-cell junctions in MDCK cells and indicate the advantage of knockout analysis in cultured cells.	[Tokuda, Shinsaku; Higashi, Tomohito; Furuse, Mikio] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Cell Biol, Kobe, Hyogo 657, Japan; [Furuse, Mikio] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 444, Japan	Kobe University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Furuse, M (corresponding author), Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Cell Biol, Kobe, Hyogo 657, Japan.	furuse@nips.ac.jp	Higashi, Tomohito/AHE-7942-2022	Furuse, Mikio/0000-0003-2847-8156; Higashi, Tomohito/0000-0001-5616-1477	Japan Society for the Promotion of Science [LS084, 26291043]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The Funding Program for Next Generation World Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science: LS084 (M. F.). Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science: 26291043 (M. F.) The Global COE Program "Global Center for Education and Research in Integrative Membrane Biology'' from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (S. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aijaz S, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-49; [Anonymous], [No title captured]; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Grau J, 2013, BIOINFORMATICS, V29, P2931, DOI 10.1093/bioinformatics/btt501; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Higashi T, 2013, J CELL SCI, V126, P966, DOI 10.1242/jcs.116442; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Hou JH, 2006, J BIOL CHEM, V281, P36117, DOI 10.1074/jbc.M608853200; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; ITOH M, 1991, J CELL BIOL, V115, P1449, DOI 10.1083/jcb.115.5.1449; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Nakajima H, 2010, J CELL SCI, V123, P555, DOI 10.1242/jcs.057752; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Saitou M, 1997, EUR J CELL BIOL, V73, P222; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Tsukita S, 2009, ANN NY ACAD SCI, V1165, P44, DOI 10.1111/j.1749-6632.2009.04056.x; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320	41	46	47	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104994	10.1371/journal.pone.0104994	http://dx.doi.org/10.1371/journal.pone.0104994			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157572	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303200021
J	Wan, QQ; Xu, WX; Yan, JL; Yokota, H; Na, S				Wan, Qiaoqiao; Xu, Wenxiao; Yan, Jing-Long; Yokota, Hiroki; Na, Sungsoo			Distinctive Subcellular Inhibition of Cytokine-Induced Src by Salubrinal and Fluid Flow	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SIGNAL-TRANSDUCTION; SHEAR-STRESS; PLASMA-MEMBRANE; LIVING CELLS; EXPRESSION; ACTIVATION; CARTILAGE; KINASE; CHONDROCYTES	A non-receptor protein kinase Src plays a crucial role in fundamental cell functions such as proliferation, migration, and differentiation. While inhibition of Src is reported to contribute to chondrocyte homeostasis, its regulation at a subcellular level by chemical inhibitors and mechanical stimulation has not been fully understood. In response to inflammatory cytokines and stress to the endoplasmic reticulum (ER) that increase proteolytic activities in chondrocytes, we addressed two questions: Do cytokines such as interleukin 1 beta (IL1 beta) and tumor necrosis factor alpha (TNF alpha) induce location-dependent Src activation? Can cytokine-induced Src activation be suppressed by chemically alleviating ER stress or by applying fluid flow? Using live cell imaging with two Src biosensors (i.e., cytosolic, and plasma membrane-bound biosensors) for a fluorescence resonance energy transfer (FRET) technique, we determined cytosolic Src activity as well as membrane-bound Src activity in C28/I2 human chondrocytes. In response to TNF alpha and IL1 beta, both cytosolic and plasma membrane-bound Src proteins were activated, but activation in the cytosol occurred earlier than that in the plasma membrane. Treatment with salubrinal or guanabenz, two chemical agents that attenuate ER stress, significantly decreased cytokine-induced Src activities in the cytosol, but not in the plasma membrane. In contrast, fluid flow reduced Src activities in the plasma membrane, but not in the cytosol. Collectively, the results demonstrate that Src activity is differentially regulated by salubrinal/guanabenz and fluid flow in the cytosol and plasma membrane.	[Wan, Qiaoqiao; Yokota, Hiroki; Na, Sungsoo] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Xu, Wenxiao; Yan, Jing-Long] Harbin Med Univ, Clin Hosp 2, Dept Orthoped, Harbin, Peoples R China; [Yokota, Hiroki] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Harbin Medical University; Indiana University System; Indiana University Bloomington	Na, S (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	sungna@iupui.edu	Wan, Qiaoqiao/N-6562-2017		IUPUI Biomechanics and Biomaterials Research Center; 100 Voices of Hope; NIH [AR065149, AR52144]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052144, R03AR065149] Funding Source: NIH RePORTER	IUPUI Biomechanics and Biomaterials Research Center; 100 Voices of Hope; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported in part by grants from the IUPUI Biomechanics and Biomaterials Research Center (SN), 100 Voices of Hope (HY), and NIH AR065149 (SN) and AR52144 (HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Bursell L, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2308; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Carames B, 2008, OSTEOARTHR CARTILAGE, V16, P715, DOI 10.1016/j.joca.2007.10.006; Cawston TE, 2006, BEST PRACT RES CL RH, V20, P983, DOI 10.1016/j.berh.2006.06.007; Chai DH, 2010, OSTEOARTHR CARTILAGE, V18, P249, DOI 10.1016/j.joca.2009.09.002; Chowdhury TT, 2006, BIOMECH MODEL MECHAN, V5, P192, DOI 10.1007/s10237-006-0032-3; DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359; FARAHAT MN, 1993, ANN RHEUM DIS, V52, P870, DOI 10.1136/ard.52.12.870; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Fincham VJ, 1996, J CELL BIOL, V135, P1551, DOI 10.1083/jcb.135.6.1551; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; GOLDRING MB, 1988, J CLIN INVEST, V82, P2026, DOI 10.1172/JCI113823; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; Hamamura K, 2013, OSTEOARTHR CARTILAGE, V21, P764, DOI 10.1016/j.joca.2013.02.657; Hamamura K, 2009, ARCH ORAL BIOL, V54, P279, DOI 10.1016/j.archoralbio.2008.11.003; Karginov AV, 2014, NAT CHEM BIOL, V10, P286, DOI [10.1038/NCHEMBIO.1477, 10.1038/nchembio.1477]; Lee IT, 2010, J CELL PHYSIOL, V224, P454, DOI 10.1002/jcp.22142; Loeser RF, 2002, BIORHEOLOGY, V39, P119; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P660, DOI 10.1016/j.joca.2006.01.005; Lu SY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000127; Madhavan S, 2006, OSTEOARTHR CARTILAGE, V14, P1023, DOI 10.1016/j.joca.2006.03.016; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Melchiorri C, 1998, ARTHRITIS RHEUM-US, V41, P2165, DOI 10.1002/1529-0131(199812)41:12<2165::AID-ART11>3.3.CO;2-F; Millward-Sadler SJ, 2004, ANN BIOMED ENG, V32, P435, DOI 10.1023/B:ABME.0000017538.72511.48; Moos V, 1999, J RHEUMATOL, V26, P870; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; NAWROTH PP, 1986, J EXP MED, V163, P1363, DOI 10.1084/jem.163.6.1363; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Pala D, 2008, J BIOL CHEM, V283, P9239, DOI 10.1074/jbc.M705175200; PASQUALE EB, 1986, P NATL ACAD SCI USA, V83, P5507, DOI 10.1073/pnas.83.15.5507; Poh YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007886; SAKLATVALA J, 1986, NATURE, V322, P547, DOI 10.1038/322547a0; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; SCHLAEPFER DD, 1994, NATURE, V372, P786; SEFTON BM, 1981, CELL, V24, P165, DOI 10.1016/0092-8674(81)90512-2; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Smith MD, 1997, J RHEUMATOL, V24, P365; Smith RL, 1995, J ORTHOPAED RES, V13, P824, DOI 10.1002/jor.1100130604; Smith RL, 2004, CLIN ORTHOP RELAT R, pS89, DOI 10.1097/01.blo.0000143938.30681.9d; Sun HB, 2010, ANN NY ACAD SCI, V1211, P37, DOI 10.1111/j.1749-6632.2010.05808.x; Swaminathan R, 1996, BIOPHYS J, V71, P1140, DOI 10.1016/S0006-3495(96)79316-5; Tetlow LC, 2001, ARTHRITIS RHEUM-US, V44, P585, DOI 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C; Torzilli PA, 2011, CARTILAGE, V2, P364, DOI 10.1177/1947603511407484; Torzilli PA, 2010, OSTEOARTHR CARTILAGE, V18, P97, DOI 10.1016/j.joca.2009.07.012; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Wan QQ, 2013, CELL BIOL INT, V37, P568, DOI 10.1002/cbin.10072; Wan QQ, 2013, BIOCHEM BIOPH RES CO, V433, P502, DOI 10.1016/j.bbrc.2013.03.020; Wang P, 2013, FASEB J, V27, P4664, DOI 10.1096/fj.13-234542; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; WEERNINK PAO, 1995, J BIOL CHEM, V270, P2264, DOI 10.1074/jbc.270.5.2264; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yokota H, 2003, J BIOL CHEM, V278, P47275, DOI 10.1074/jbc.M304652200; Yokota Hiroki, 2011, Curr Osteoporos Rep, V9, P237, DOI 10.1007/s11914-011-0067-y	55	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105699	10.1371/journal.pone.0105699	http://dx.doi.org/10.1371/journal.pone.0105699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157407	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303200046
J	Yu, TF; Maestre-Reyna, M; Ko, CY; Ko, TP; Sun, YJ; Lin, TY; Shaw, JF; Wang, AHJ				Yu, Tsung-Fu; Maestre-Reyna, Manuel; Ko, Chia-Yun; Ko, Tzu-Ping; Sun, Yuh-Ju; Lin, Tsai-Yun; Shaw, Jei-Fu; Wang, Andrew H. -J.			Structural Insights of the ssDNA Binding Site in the Multifunctional Endonuclease AtBFN2 from Arabidopsis thaliana	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; PENICILLIUM-CITRINUM; NUCLEASE P1; CRYSTAL-STRUCTURES; BACILLUS-CEREUS; PHOSPHOLIPASE-C; RESOLUTION; MECHANISM; DNA; CRYSTALLOGRAPHY	The multi S1/P1 nuclease AtBFN2 (EC 3.1.30.1) encoded by the Arabidopsis thaliana At1g68290 gene is a glycoprotein that digests RNA, ssDNA, and dsDNA. AtBFN2 depends on three zinc ions for cleaving DNA and RNA at 3'-OH to yield 5'-nucleotides. In addition, AtBFN2's enzymatic activity is strongly glycan dependent. Plant Zn2+-dependent endonucleases present a unique fold, and belong to the Phospholipase C (PLC)/P1 nuclease superfamily. In this work, we present the first complete, ligand-free, AtBFN2 crystal structure, along with sulfate, phosphate and ssDNA co-crystal structures. With these, we were able to provide better insight into the glycan structure and possible enzymatic mechanism. In comparison with other nucleases, the AtBFN2/ligand-free and AtBFN2/PO4 models suggest a similar, previously proposed, catalytic mechanism. Our data also confirm that the phosphate and vanadate can inhibit the enzyme activity by occupying the active site. More importantly, the AtBFN2/A(5)T structure reveals a novel and conserved secondary binding site, which seems to be important for plant Zn2+-dependent endonucleases. Based on these findings, we propose a rational ssDNA binding model, in which the ssDNA wraps itself around the protein and the attached surface glycan, in turn, reinforces the binding complex.	[Yu, Tsung-Fu; Sun, Yuh-Ju; Lin, Tsai-Yun; Wang, Andrew H. -J.] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Yu, Tsung-Fu; Maestre-Reyna, Manuel; Ko, Tzu-Ping; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Ko, Chia-Yun; Shaw, Jei-Fu; Wang, Andrew H. -J.] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Ko, Chia-Yun] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Shaw, Jei-Fu] I Shou Univ, Dept Biol Sci & Technol, Kaohsiung, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; I Shou University	Wang, AHJ (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.	shawjf@isu.edu.tw; ahjwang@gate.sinica.edu.tw	Ko, Chia-Yun/J-9314-2013		Academia Sinica; Ministry of Science and Technology [NSC-101-2313-B-214-002-MY3, NSC-1033113-P-008-001, NSC-101-2319-B-001-003]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by Academia Sinica, and Ministry of Science and Technology grants: NSC-101-2313-B-214-002-MY3 (to J.- F. Shaw), (NSC-1033113-P-008-001, and NSC-101-2319-B-001-003 (to A. H.- J. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAKRE SE, 1982, BIOCHEM J, V203, P799, DOI 10.1042/bj2030799; Aoyagi S, 1998, FEBS LETT, V429, P134, DOI 10.1016/S0014-5793(98)00563-8; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chou TL, 2013, BIOCATAL AGRIC BIOTE, V2, P191, DOI 10.1016/j.bcab.2013.03.006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farage-Barhom S, 2008, J EXP BOT, V59, P3247, DOI 10.1093/jxb/ern176; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FUJIMOTO M, 1974, AGR BIOL CHEM TOKYO, V38, P785, DOI 10.1080/00021369.1974.10861231; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; HOUGH E, 1989, NATURE, V338, P357, DOI 10.1038/338357a0; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Ito J, 2002, PLANT CELL, V14, P3201, DOI 10.1105/tpc.006411; Ko CY, 2012, J AGR FOOD CHEM, V60, P5169, DOI 10.1021/jf300945c; Koval' T, 2013, ACTA CRYSTALLOGR D, V69, P213, DOI 10.1107/S0907444912043697; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; MAEKAWA K, 1991, EUR J BIOCHEM, V200, P651, DOI 10.1111/j.1432-1033.1991.tb16228.x; McCabe PF, 2000, PLANT MOL BIOL, V44, P359, DOI 10.1023/A:1026500810877; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; OLESON AE, 1980, ARCH BIOCHEM BIOPHYS, V204, P361, DOI 10.1016/0003-9861(80)90044-2; Oron A, 2003, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0804S02; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Amador MA, 2000, PLANT PHYSIOL, V122, P169, DOI 10.1104/pp.122.1.169; Podzimek T, 2011, PLANT SCI, V180, P343, DOI 10.1016/j.plantsci.2010.10.006; Romier C, 1998, PROTEINS, V32, P414, DOI 10.1002/(SICI)1097-0134(19980901)32:4<414::AID-PROT2>3.3.CO;2-5; Sugiyama M, 2000, PLANT MOL BIOL, V44, P387, DOI 10.1023/A:1026504911786; Till BJ, 2004, NUCLEIC ACIDS RES, V32, P2632, DOI 10.1093/nar/gkh599; Vogt V M, 1980, Methods Enzymol, V65, P248; VOLBEDA A, 1991, EMBO J, V10, P1607, DOI 10.1002/j.1460-2075.1991.tb07683.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang B, 2000, BIOCHEMISTRY-US, V39, P3533, DOI 10.1021/bi992376z; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181	34	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105821	10.1371/journal.pone.0105821	http://dx.doi.org/10.1371/journal.pone.0105821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157844	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200069
J	Zhang, L; Nemzow, L; Chen, H; Hu, JJ; Gong, F				Zhang, Ling; Nemzow, Leah; Chen, Hua; Hu, Jennifer J.; Gong, Feng			Whole Genome Expression Profiling Shows that BRG1 Transcriptionally Regulates UV Inducible Genes and Other Novel Targets in Human Cells	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; MAJOR VAULT PROTEIN; DNA-DAMAGE; SWI/SNF COMPLEX; FUNCTIONAL INTERACTIONS; RETINOBLASTOMA PROTEIN; NEGATIVE REGULATION; SIGNALING PATHWAYS; DOWN-REGULATION; P53 EXPRESSION	UV irradiation is known to cause cyclobutane pyrimidine dimers (CPDs) and pyrimidine (6-4) pyrimidone photoproducts (6-4PPs), and plays a large role in the development of cancer. Tumor suppression, through DNA repair and proper cell cycle regulation, is an integral factor in maintaining healthy cells and preventing development of cancer. Transcriptional regulation of the genes involved in the various tumor suppression pathways is essential for them to be expressed when needed and to function properly. BRG1, an ATPase catalytic subunit of the SWI/SNF chromatin remodeling complex, has been identified as a tumor suppressor protein, as it has been shown to play a role in Nucleotide Excision Repair (NER) of CPDs, suppress apoptosis, and restore checkpoint deficiency, in response to UV exposure. Although BRG1 has been shown to regulate transcription of some genes that are instrumental in proper DNA damage repair and cell cycle maintenance in response to UV, its role in transcriptional regulation of the whole genome in response to UV has not yet been elucidated. With whole genome expression profiling in SW13 cells, we show that upon UV induction, BRG1 regulates transcriptional expression of many genes involved in cell stress response. Additionally, our results also highlight BRG1's general role as a master regulator of the genome, as it transcriptionally regulates approximately 4.8% of the human genome, including expression of genes involved in many pathways. RT-PCR and ChIP were used to validate our genome expression analysis. Importantly, our study identifies several novel transcriptional targets of BRG1, such as ATF3. Thus, BRG1 has a larger impact on human genome expression than previously thought, and our studies will provide inroads for future analysis of BRG1's role in gene regulation.	[Zhang, Ling; Nemzow, Leah; Chen, Hua; Hu, Jennifer J.; Gong, Feng] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33132 USA	University of Miami	Gong, F (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33132 USA.	fgong@med.miami.edu			National Institutes of Health [R01ES017784]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a National Institutes of Health grant R01ES017784 to FG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2003, DNA REPAIR, V2, P947, DOI 10.1016/S1568-7864(03)00087-9; Amundson SA, 2008, CANCER RES, V68, P415, DOI 10.1158/0008-5472.CAN-07-2120; An HJ, 2009, CELL BIOCHEM FUNCT, V27, P289, DOI 10.1002/cbf.1571; Banine F, 2005, CANCER RES, V65, P3542, DOI 10.1158/0008-5472.CAN-04-3554; Bennett G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3084; Brazda V, 2012, BIOCHEM BIOPH RES CO, V422, P716, DOI 10.1016/j.bbrc.2012.05.065; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2008, ONCOGENE, V27, P460, DOI 10.1038/sj.onc.1210664; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Cho SJ, 2013, P NATL ACAD SCI USA, V110, P9362, DOI 10.1073/pnas.1221242110; De Giovanni C, 1998, BRIT J CANCER, V78, P1541, DOI 10.1038/bjc.1998.721; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Eichhorn T, 2013, CANCER GENOM PROTEOM, V10, P35; Endo Y, 1996, GENOMICS, V38, P92, DOI 10.1006/geno.1996.0598; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Gali-Muhtasib H, 2008, CANCER RES, V68, P5609, DOI 10.1158/0008-5472.CAN-08-0884; Gong F, 2008, CELL CYCLE, V7, P1067, DOI 10.4161/cc.7.8.5647; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; Hai T, 1999, GENE EXPRESSION, V7, P321; Hamard PJ, 2013, GENE DEV, V27, P1868, DOI 10.1101/gad.224386.113; Han HJ, 1998, HUM MOL GENET, V7, P1039, DOI 10.1093/hmg/7.6.1039; Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Harmes DC, 2003, ONCOGENE, V22, P7607, DOI 10.1038/sj.onc.1207129; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hsu CC, 2012, J BIOL CHEM, V287, P22533, DOI 10.1074/jbc.M111.335331; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Ikeda R, 2014, ONCOL REP, V31, P197, DOI 10.3892/or.2013.2818; Insinga A, 2014, BLOOD CELL MOL DIS, V52, P147, DOI 10.1016/j.bcmd.2013.12.005; Javaid S, 2013, CELL REP, V5, P1679, DOI 10.1016/j.celrep.2013.11.034; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Keenen B, 2009, ONCOGENE; Koch-Paiz CA, 2004, MUTAT RES-FUND MOL M, V549, P65, DOI 10.1016/j.mrfmmm.2004.01.010; Kothandapani A, 2012, EXP CELL RES, V318, P1973, DOI 10.1016/j.yexcr.2012.06.011; Kurki S, 2003, J CELL SCI, V116, P3917, DOI 10.1242/jcs.00714; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; LudesMeyers JH, 1996, MOL CELL BIOL, V16, P6009; Mahmoudi T, 2009, EMBO J, V28, P3329, DOI 10.1038/emboj.2009.285; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; McKinney K, 2002, MOL CELL BIOL, V22, P6797, DOI 10.1128/MCB.22.19.6797-6808.2002; Medina PP, 2005, HUM MOL GENET, V14, P973, DOI 10.1093/hmg/ddi091; Mikryukov A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043330; Mukhopadhyay T, 1996, ANTICANCER RES, V16, P105; Oh J, 2008, J BIOL CHEM, V283, P11924, DOI 10.1074/jbc.M705401200; Okamura S, 1999, ONCOL RES, V11, P281; Palomera-Sanchez Z, 2011, DNA REPAIR, V10, P119, DOI 10.1016/j.dnarep.2010.10.010; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Park JH, 2009, DNA REPAIR, V8, P29, DOI 10.1016/j.dnarep.2008.08.011; Passer BJ, 2003, P NATL ACAD SCI USA, V100, P2284, DOI 10.1073/pnas.0530298100; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reisman DN, 2002, ONCOGENE, V21, P1196, DOI 10.1038/sj.onc.1205188; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Salvador JM, 2013, ADV EXP MED BIOL, V793, P1, DOI 10.1007/978-1-4614-8289-5_1; Sancar A, 2004, ADV PROTEIN CHEM, V69, P43; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; SHIN TH, 1995, MOL CELL BIOL, V15, P4694; Shou J, 2002, ONCOGENE, V21, P878, DOI 10.1038/sj.onc.1205138; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Song SJ, 2014, MOL CANCER RES, V12, P560, DOI 10.1158/1541-7786.MCR-13-0427; Strobeck MW, 2002, J BIOL CHEM, V277, P4782, DOI 10.1074/jbc.M109532200; Strobeck MW, 2001, J BIOL CHEM, V276, P9273, DOI 10.1074/jbc.M009747200; Strober BE, 1996, MOL CELL BIOL, V16, P1576; Taketani K, 2012, ONCOGENE, V31, P2210, DOI 10.1038/onc.2011.397; Tolstorukov MY, 2013, P NATL ACAD SCI USA, V110, P10165, DOI 10.1073/pnas.1302209110; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; Turchi L, 2008, CELL DEATH DIFFER, V15, P1472, DOI 10.1038/cdd.2008.74; Ueda K, 2003, ONCOGENE, V22, P5586, DOI 10.1038/sj.onc.1206845; von Figura G, 2014, NAT CELL BIOL, V16, P255, DOI 10.1038/ncb2916; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wong AKC, 2000, CANCER RES, V60, P6171; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Xu Y, 2007, J BIOL CHEM, V282, P37429, DOI 10.1074/jbc.M706039200; Xu YZ, 2011, J BIOL CHEM, V286, P12839, DOI 10.1074/jbc.M110.185637; Yan CH, 2006, CELL CYCLE, V5, P926, DOI 10.4161/cc.5.9.2714; Yin X, 2003, J CELL PHYSIOL, V196, P474, DOI 10.1002/jcp.10329; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102; Zhang L, 2009, CELL CYCLE, V8, P3953, DOI 10.4161/cc.8.23.10115; Zhao Q, 2009, J BIOL CHEM, V284, P30424, DOI 10.1074/jbc.M109.044982	89	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105764	10.1371/journal.pone.0105764	http://dx.doi.org/10.1371/journal.pone.0105764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157878	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200061
J	Noronha-Matos, JB; Coimbra, J; Sa-e-Sousa, A; Rocha, R; Marinhas, J; Freitas, R; Guerra-Gomes, S; Ferreirinha, F; Costa, MA; Correia-de-Sa, P				Noronha-Matos, Jose Bernardo; Coimbra, Joao; Sa-e-Sousa, Ana; Rocha, Rui; Marinhas, Jose; Freitas, Rolando; Guerra-Gomes, Sonia; Ferreirinha, Fatima; Costa, Maria Adelina; Correia-de-Sa, Paulo			P2X7-induced zeiosis promotes osteogenic differentiation and mineralization of postmenopausal bone marrow-derived mesenchymal stem cells	FASEB JOURNAL			English	Article						membrane blebbing; osteogenesis; P2 purinoceptors; Rho-kinase; bone-nodule formation	DEPENDENT PROTEIN-KINASE; P2X(7) RECEPTOR; ATP RELEASE; RHO-KINASE; EXTRACELLULAR NUCLEOTIDES; HUMAN OSTEOBLASTS; MEDIATED ACTIVATION; P2X7 RECEPTORS; POLYMORPHISMS; EXPRESSION	Polymorphisms of the P2X7 receptor have been associated with increased risk of fractures in postmenopausal women. Although both osteoblasts and osteoclasts express P2X7 receptors, their function in osteogenesis remains controversial. Here, we investigated the role of the P2X7 receptor on osteogenic differentiation and mineralization of bone marrow mesenchymal stem cell (BMSC) cultures from post-menopausal women (age 71 +/- 3 yr, n = 18). We focused on the mechanisms related to intracellular [Ca2+](i) oscillations and plasma membrane-dynamics. ATP, and the P2X7 agonist BzATP (100 mu M), increased [Ca2+](i) in parallel to the formation of membrane pores permeable to TO-PRO-3 dye uptake. ATP and BzATP elicited reversible membrane blebs (zeiosis) in 38 +/- 1 and 70 +/- 1% of the cells, respectively. P2X7-induced zeiosis was Ca2+ independent, but involved phospholipase C, protein kinase C, and Rho-kinase activation. BzATP (100 mu M) progressively increased the expression of Runx-2 and Osterix transcription factors by 452 and 226% (at d 21), respectively, alkaline phosphatase activity by 88% (at d 28), and mineralization by 329% (at d 43) of BMSC cultures in a Rho-kinase-dependent manner. In summary, reversible plasma membrane zeiosis involving cytoskeleton rearrangements due to activation of the P2X7-Rho-kinase axis promotes osteogenic differentiation and mineralization of BMSCs, thus providing new therapeutic targets for postmenopausal bone loss.	[Noronha-Matos, Jose Bernardo; Coimbra, Joao; Sa-e-Sousa, Ana; Guerra-Gomes, Sonia; Ferreirinha, Fatima; Costa, Maria Adelina; Correia-de-Sa, Paulo] ICBAS UP, Lab Farmacol & Neurobiol, P-4050313 Oporto, Portugal; [Costa, Maria Adelina] ICBAS UP, Dept Quim, UMIB, P-4050313 Oporto, Portugal; [Noronha-Matos, Jose Bernardo; Coimbra, Joao; Sa-e-Sousa, Ana; Guerra-Gomes, Sonia; Ferreirinha, Fatima; Costa, Maria Adelina; Correia-de-Sa, Paulo] ICBAS UP, Ctr Drug Discovery & Innovat Med, P-4050313 Oporto, Portugal; [Rocha, Rui; Marinhas, Jose; Freitas, Rolando] Ctr Hosp Vila Nova Gaia Espinho, Serv Ortoped & Traumatol, Vila Nova De Gaia, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Correia-de-Sa, P (corresponding author), ICBAS UP, Lab Farmacol & Neurobiol UMIB, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.	farmacol@icbas.up.pt	Sa-Sousa, Ana/J-1941-2014; Correia-De-Sá, P./F-1079-2015; Coimbra, João/L-5495-2014; Correia-de-Sá, Paulo/AAG-5901-2019; Noronha-Matos, José Bernardo AG/K-7686-2014; Ferreirinha, Fatima/K-8752-2014	Sa-Sousa, Ana/0000-0002-9429-6863; Correia-De-Sá, P./0000-0002-6114-9189; Coimbra, João/0000-0001-9138-7498; Correia-de-Sá, Paulo/0000-0002-6114-9189; Noronha-Matos, José Bernardo AG/0000-0001-6397-2104; Ferreirinha, Fatima/0000-0002-0527-1323; Costa, Maria Adelina Coelho/0000-0001-7664-2075; Guerra-Gomes, Sonia/0000-0002-6717-8941	Fundacao para a Ciencia e a Tecnologia [FCT; Fonds Europeen de Developpement Regional (FEDER)] [PTDC/SAU-OSM/73576/2006, REEQ/1168/SAU/2005, REEQ/1264/SAU/2005, PEst-OE/SAU/UI0215/2011, PEst-OE/SAU/UI0215/2014]; University of Porto/Caixa Geral de Depositos (Investigacao Cientifica na Pre-Graduacao); FCT [SRFH/BD/68584/2010]	Fundacao para a Ciencia e a Tecnologia [FCT; Fonds Europeen de Developpement Regional (FEDER)]; University of Porto/Caixa Geral de Depositos (Investigacao Cientifica na Pre-Graduacao); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research was partially supported by Fundacao para a Ciencia e a Tecnologia [FCT; Fonds Europeen de Developpement Regional (FEDER) funding; PTDC/SAU-OSM/73576/2006, REEQ/1168/SAU/2005, REEQ/1264/SAU/2005, PEst-OE/SAU/UI0215/2011, and PEst-OE/SAU/UI0215/2014] and by University of Porto/Caixa Geral de Depositos (Investigacao Cientifica na Pre-Graduacao) projects. J.B.N.-M. is the recipient of a Ph.D. scholarship from FCT (SRFH/BD/68584/2010). The authors thank Sara Gomes (graduate student) and Elsa Meireles (M.Sc. student) for their collaboration in some experiments. The authors also thank Mrs. Helena Costa e Silva and Belmira Silva for their technical assistance.	Costa MA, 2011, J CELL PHYSIOL, V226, P1353, DOI 10.1002/jcp.22458; Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Alloisio S, 2010, J NEUROCHEM, V113, P796, DOI 10.1111/j.1471-4159.2010.06649.x; Alvarenga EC, 2010, BONE, V46, P355, DOI 10.1016/j.bone.2009.09.017; Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Biswas P, 2009, J BONE MINER RES, V24, P1450, DOI [10.1359/jbmr.090306, 10.1359/JBMR.090306]; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Bobis S, 2006, FOLIA HISTOCHEM CYTO, V44, P215; Bowler WB, 1999, J BIOL CHEM, V274, P14315, DOI 10.1074/jbc.274.20.14315; Buckley KA, 2001, J BIOL CHEM, V276, P9565, DOI 10.1074/jbc.M005672200; Burnstock G, 2013, PURINERG SIGNAL, V9, P541, DOI 10.1007/s11302-013-9381-4; Carrasquero LMG, 2009, J NEUROCHEM, V110, P879, DOI 10.1111/j.1471-4159.2009.06179.x; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Ciciarello M, 2013, STEM CELLS DEV, V22, P1097, DOI 10.1089/scd.2012.0432; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Faria RX, 2010, N-S ARCH PHARMACOL, V382, P73, DOI 10.1007/s00210-010-0523-8; Gartland A, 2001, J BONE MINER RES, V16, P846, DOI 10.1359/jbmr.2001.16.5.846; Hayton MJ, 2005, ULTRASOUND MED BIOL, V31, P1131, DOI 10.1016/j.ultrasmedbio.2005.04.017; Henriksen Z, 2006, CELL CALCIUM, V39, P435, DOI 10.1016/j.ceca.2006.01.012; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Husted LB, 2013, OSTEOPOROSIS INT, V24, P949, DOI 10.1007/s00198-012-2035-5; Jorgensen NR, 2012, EUR J HUM GENET, V20, P675, DOI 10.1038/ejhg.2011.253; Jorgensen NR, 2002, J BIOL CHEM, V277, P7574, DOI 10.1074/jbc.M104608200; Kandabashi T, 2003, ARTERIOSCL THROM VAS, V23, P2209, DOI 10.1161/01.ATV.0000104010.87348.26; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Korcok J, 2004, J BONE MINER RES, V19, P642, DOI 10.1359/JBMR.040108; Leverrier Y, 2001, NAT CELL BIOL, V3, pE91, DOI 10.1038/35070151; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; Maier R, 1997, BIOCHEM BIOPH RES CO, V237, P297, DOI 10.1006/bbrc.1997.7135; Avalos AM, 2009, J CELL SCI, V122, P3462, DOI 10.1242/jcs.034827; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miyazaki T, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.385369; Morelli A, 2003, MOL BIOL CELL, V14, P2655, DOI 10.1091/mbc.02-04-0061; Nakamura E, 2000, AM J PHYSIOL-CELL PH, V279, pC510, DOI 10.1152/ajpcell.2000.279.2.C510; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; NICOTERA P, 1986, FEBS LETT, V209, P139, DOI 10.1016/0014-5793(86)81099-7; Noronha-Matos JB, 2012, J CELL PHYSIOL, V227, P2694, DOI 10.1002/jcp.23014; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ohlendorff SD, 2007, PHARMACOGENET GENOM, V17, P555, DOI 10.1097/FPC.0b013e3280951625; Orriss IR, 2006, BONE, V39, P300, DOI 10.1016/j.bone.2006.02.063; Orriss IR, 2012, BONE, V51, P389, DOI 10.1016/j.bone.2012.06.013; Orriss IR, 2009, J CELL PHYSIOL, V220, P155, DOI 10.1002/jcp.21745; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Panupinthu N, 2007, J BIOL CHEM, V282, P3403, DOI 10.1074/jbc.M605620200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Radeff JM, 2004, J BONE MINER RES, V19, P1882, DOI 10.1359/JBMR.040806; Roger S, 2010, J BIOL CHEM, V285, P17514, DOI 10.1074/jbc.M109.053082; Romanello M, 2001, BIOCHEM BIOPH RES CO, V289, P1275, DOI 10.1006/bbrc.2001.6124; Romanello M, 2006, BONE, V39, P739, DOI 10.1016/j.bone.2006.03.011; Rumney RMH, 2012, J BIOMECH, V45, P549, DOI 10.1016/j.jbiomech.2011.11.036; Sasaki Y, 2002, PHARMACOL THERAPEUT, V93, P225, DOI 10.1016/S0163-7258(02)00191-2; Soulet C, 2005, J THROMB HAEMOST, V3, P2296, DOI 10.1111/j.1538-7836.2005.01588.x; Sovenyhazy KM, 2003, NUCLEIC ACIDS RES, V31, P2561, DOI 10.1093/nar/gkg363; Sun DH, 2013, STEM CELLS, V31, P1170, DOI 10.1002/stem.1356; Tamura M, 2005, BBA-PROTEINS PROTEOM, V1754, P245, DOI 10.1016/j.bbapap.2005.06.015; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728; Wesselius A, 2011, FRONT BIOSCI-LANDMRK, V16, P2572, DOI 10.2741/3873; Xu BY, 2011, CONNECT TISSUE RES, V52, P373, DOI 10.3109/03008207.2010.541961; ZHENG LM, 1991, J CELL BIOL, V112, P279, DOI 10.1083/jcb.112.2.279	65	35	36	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5208	5222		10.1096/fj.14-257923	http://dx.doi.org/10.1096/fj.14-257923			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25169056				2022-12-25	WOS:000345894500016
J	Tarry-Adkins, JL; Fernandez-Twinn, DS; Chen, JH; Hargreaves, IP; Martin-Gronert, MS; McConnell, JM; Ozanne, SE				Tarry-Adkins, Jane L.; Fernandez-Twinn, Denise S.; Chen, Jian-Hua; Hargreaves, Iain P.; Martin-Gronert, Malgorzata S.; McConnell, Josie M.; Ozanne, Susan E.			Nutritional programming of coenzyme Q: potential for prevention and intervention?	FASEB JOURNAL			English	Article						telomeres; cardiovascular disease; aging; vascular disease	POSTNATAL-GROWTH LEADS; CATCH-UP GROWTH; OXIDATIVE STRESS; LIFE-SPAN; TELOMERE LENGTH; DNA-DAMAGE; CARDIOVASCULAR-DISEASE; SAFETY ASSESSMENT; DEFENSE CAPACITY; HEART-FAILURE	Low birth weight and rapid postnatal growth increases risk of cardiovascular-disease (CVD); however, underlying mechanisms are poorly understood. Previously, we demonstrated that rats exposed to a low-protein diet in utero that underwent postnatal catch-up growth (recuperated) have a programmed deficit in cardiac coenzyme Q (CoQ) that was associated with accelerated cardiac aging. It is unknown whether this deficit occurs in all tissues, including those that are clinically accessible. We investigated whether aortic and white blood cell (WBC) CoQ is programmed by suboptimal early nutrition and whether postweaning dietary supplementation with CoQ could prevent programmed accelerated aging. Recuperated male rats had reduced aortic CoQ [22 d (35 +/- 8.4%; P<0.05); 12 m (53 +/- 8.8%; P<0.05)], accelerated aortic telomere shortening (P<0.01), increased DNA damage (79 +/- 13% increase in nei-endonucleaseVIII-like-1), increased oxidative stress (458 +/- 67% increase in NAPDH-oxidase-4; P<0.001), and decreased mitochondrial complex II-III activity (P<0.05). Postweaning dietary supplementation with CoQ prevented these detrimental programming effects. Recuperated WBCs also had reduced CoQ (74 +/- 5.8%; P<0.05). Notably, WBC CoQ levels correlated with aortic telomere-length (P<0.0001) suggesting its potential as a diagnostic marker of vascular aging. We conclude that early intervention with CoQ in at-risk individuals may be a cost-effective and safe way of reducing the global burden of CVDs.	[Tarry-Adkins, Jane L.; Fernandez-Twinn, Denise S.; Chen, Jian-Hua; Martin-Gronert, Malgorzata S.; McConnell, Josie M.; Ozanne, Susan E.] Univ Cambridge, Inst Metab Sci, Metab Res Labs, Cambridge, England; [Hargreaves, Iain P.] UCL, Natl Hosp, Neurometabol Unit, London, England	University of Cambridge; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Tarry-Adkins, JL (corresponding author), Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Treatment Ctr,Addenbrookes Hosp, Level 4,Box 289,Hills Rd, Cambridge CB2 0QQ, England.	janeadkins@googlemail.com	Fernandez-Twinn, Denise/B-3881-2011; Hargreaves, Iain/AAJ-6757-2020	Fernandez-Twinn, Denise/0000-0003-2610-277X; Tarry-Adkins, Jane/0000-0001-9569-6132; Ozanne, Susan/0000-0001-8753-5144	British Heart Foundation [PG/09/037/27387, FS/09/029/27902]; Medical Research Council [MC_UU_12012/4]; UK Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme at University College London Hospital (University College London); Medical Research Council [G0600717B, MC_UU_12012/5, G0600717, MC_UU_12012/5/B] Funding Source: researchfish; MRC [MC_UU_12012/4, G0600717, MC_UU_12012/5] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme at University College London Hospital (University College London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the British Heart Foundation (PG/09/037/27387, FS/09/029/27902) and Medical Research Council (MC_UU_12012/4). S.E.O. is a British Heart Foundation Senior Fellow and a member of the Medical Research Council Metabolic Diseases Unit. I.P.H. is supported by the UK Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme at University College London Hospital (University College London).	Asimakis GK, 2002, CIRCULATION, V105, P981, DOI 10.1161/hc0802.104502; Aviv H, 2001, ATHEROSCLEROSIS, V159, P281, DOI 10.1016/S0021-9150(01)00506-8; BARKER DJP, 1989, LANCET, V2, P577; Bello RI, 2005, EXP GERONTOL, V40, P694, DOI 10.1016/j.exger.2005.07.003; Chen ZY, 1998, J MOL CELL CARDIOL, V30, P2281, DOI 10.1006/jmcc.1998.0789; Corstius HB, 2005, PEDIATR RES, V57, P796, DOI 10.1203/01.PDR.0000157726.65492.CD; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Fotino AD, 2013, AM J CLIN NUTR, V97, P268, DOI 10.3945/ajcn.112.040741; Hales CN, 1996, BIOCHEM SOC T, V24, P341, DOI 10.1042/bst0240341; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Hidaka T, 2008, BIOFACTORS, V32, P199, DOI 10.1002/biof.5520320124; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Ikematsu H, 2006, REGUL TOXICOL PHARM, V44, P212, DOI 10.1016/j.yrtph.2005.12.002; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; Lim KJ, 2006, PEDIATR RES, V60, P83, DOI 10.1203/01.pdr.0000220361.08181.c3; Lonnrot K, 1998, BIOCHEM MOL BIOL INT, V44, P727; Minamino T, 2008, FRONT BIOSCI-LANDMRK, V13, P2971, DOI 10.2741/2902; Molyneux SL, 2009, NEW ZEAL MED J, V122, P74; Nobili Valerio, 2008, Pediatr Endocrinol Rev, V6, P241; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Okuda K, 2000, ATHEROSCLEROSIS, V152, P391, DOI 10.1016/S0021-9150(99)00482-7; Parsons JL, 2013, DNA REPAIR, V12, P326, DOI 10.1016/j.dnarep.2013.02.001; Quiles JL, 2004, EXP GERONTOL, V39, P189, DOI 10.1016/j.exger.2003.10.002; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005; Sander S, 2006, J CARD FAIL, V12, P464, DOI 10.1016/j.cardfail.2006.03.007; Santos-Gonzalez M, 2007, EXP GERONTOL, V42, P798, DOI 10.1016/j.exger.2007.04.013; Saretzki G, 2003, AGING CELL, V2, P141, DOI 10.1046/j.1474-9728.2003.00040.x; Shelley P, 2007, MECH AGEING DEV, V128, P681, DOI 10.1016/j.mad.2007.10.002; Sindhu RK, 2005, LIFE SCI, V76, P945, DOI 10.1016/j.lfs.2004.10.014; Skilton MR, 2006, CLIN SCI, V111, P281, DOI 10.1042/CS20060036; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Tarry-Adkins JL, 2008, FASEB J, V22, P2037, DOI 10.1096/fj.07-099523; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; Tarry-Adkins JL, 2014, P NUTR SOC, V73, P289, DOI 10.1017/S002966511300387X; Tarry-Adkins JL, 2013, MOL METAB, V2, P480, DOI 10.1016/j.molmet.2013.09.004; Tarry-Adkins JL, 2013, FASEB J, V27, P379, DOI 10.1096/fj.12-218685; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182; WHO, 2011, GLOB STAT REP NONC D	43	11	11	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5398	5405		10.1096/fj.14-259473	http://dx.doi.org/10.1096/fj.14-259473			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25172893	Green Published, hybrid			2022-12-25	WOS:000345894500032
J	Chu, BCH; Otten, R; Krewulak, KD; Mulder, FAA; Vogel, HJ				Chu, Byron C. H.; Otten, Renee; Krewulak, Karla D.; Mulder, Frans A. A.; Vogel, Hans J.			The Solution Structure, Binding Properties, and Dynamics of the Bacterial Siderophore-binding Protein FepB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-RESONANCE EXPERIMENTS; ESCHERICHIA-COLI; CROSS-SATURATION; MULTIDIMENSIONAL NMR; FERRIC ENTEROBACTIN; NUCLEOTIDE-SEQUENCE; BETA-CYCLODEXTRIN; TRANSPORT PROTEIN; DIPOLAR COUPLINGS; CRYSTAL-STRUCTURE	The periplasmic binding protein (PBP) FepB plays a key role in transporting the catecholate siderophore ferric enterobactin from the outer to the inner membrane in Gram-negative bacteria. The solution structures of the 34-kDa apo- and holo-FepB from Escherichia coli, solved by NMR, represent the first solution structures determined for the type III class of PBPs. Unlike type I and II PBPs, which undergo large "Venus flytrap" conformational changes upon ligand binding, both forms of FepB maintain similar overall folds; however, binding of the ligand is accompanied by significant loop movements. Reverse methyl cross-saturation experiments corroborated chemical shift perturbation results and uniquely defined the binding pocket for gallium enterobactin (GaEnt). NMR relaxation experiments indicated that a flexible loop (residues 225-250) adopted a more rigid and extended conformation upon ligand binding, which positioned residues for optimal interactions with the ligand and the cytoplasmic membrane ABC transporter (FepCD), respectively. In conclusion, this work highlights the pivotal role that structural dynamics plays in ligand binding and transporter interactions in type III PBPs.	[Chu, Byron C. H.; Krewulak, Karla D.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada; [Otten, Renee; Mulder, Frans A. A.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Mulder, Frans A. A.] Univ Aarhus, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark; [Mulder, Frans A. A.] Univ Aarhus, Dept Chem, DK-8000 Aarhus C, Denmark	University of Calgary; University of Groningen; Aarhus University; Aarhus University	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Biochem Res Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca	Mulder, Frans AA/C-7158-2017	Mulder, Frans AA/0000-0001-9427-8406; Otten, Renee/0000-0001-7342-6131; Krewulak, Karla/0000-0003-0300-4122	Canadian Institutes of Health Research; Alberta Innovates Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions	This work was supported by an operating grant from the Canadian Institutes of Health Research (Novel Alternatives to Antibiotics program).; Recipient of a Scientist Award from Alberta Innovates Health Solutions.	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, J AM CHEM SOC, V128, P8920, DOI 10.1021/ja062046j; Andre I, 2002, ANAL BIOCHEM, V305, P195, DOI 10.1006/abio.2002.5661; Annamalai R, 2004, J BACTERIOL, V186, P3578, DOI 10.1128/JB.186.11.3578-3589.2004; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Bermejo GA, 2010, BIOCHEMISTRY-US, V49, P1893, DOI 10.1021/bi902045p; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Chou JJ, 2000, J BIOMOL NMR, V18, P217, DOI 10.1023/A:1026563923774; Chu BC, 2010, BIOMETALS, V23, P601, DOI 10.1007/s10534-010-9361-x; Chu BCH, 2013, J BIOL CHEM, V288, P31409, DOI 10.1074/jbc.M113.490441; Chu BCH, 2011, BIOL CHEM, V392, P39, DOI 10.1515/BC.2011.012; Coudevylle N, 2010, J BIOL CHEM, V285, P41646, DOI 10.1074/jbc.M110.123331; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Eletsky A, 2001, J BIOMOL NMR, V20, P177, DOI 10.1023/A:1011265430149; ELKINS MF, 1989, J BACTERIOL, V171, P5443, DOI 10.1128/jb.171.10.5443-5451.1989; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Felder CB, 1999, AAPS PHARMSCI, V1; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; Gardner KH, 1997, J AM CHEM SOC, V119, P7599, DOI 10.1021/ja9706514; Gardner KH, 1997, BIOCHEMISTRY-US, V36, P1389, DOI 10.1021/bi9624806; GEEN H, 1991, J MAGN RESON, V93, P93, DOI 10.1016/0022-2364(91)90034-Q; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P2648, DOI 10.1021/bi9726584; Gifford JL, 2011, J BIOMOL NMR, V50, P71, DOI 10.1007/s10858-011-9495-3; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Grigg JC, 2010, J BIOL CHEM, V285, P34579, DOI 10.1074/jbc.M110.172924; Grigg JC, 2010, J BIOL CHEM, V285, P11162, DOI 10.1074/jbc.M109.097865; GRZESIEK S, 1993, J AM CHEM SOC, V115, P4369, DOI 10.1021/ja00063a068; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Ho WW, 2007, J BIOL CHEM, V282, P35796, DOI 10.1074/jbc.M706761200; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang H, 2012, J AM CHEM SOC, V134, P3864, DOI 10.1021/ja2111306; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Hwang PM, 2001, J BIOMOL NMR, V20, P83, DOI 10.1023/A:1011226512421; Kandt C, 2006, BIOCHEMISTRY-US, V45, P13284, DOI 10.1021/bi061280j; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Kneller, 2003, SPARKY 3; Krewulak K. D., 2009, HDB METALLOPROTEINS; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Krewulak KD, 2005, BIOMETALS, V18, P375, DOI 10.1007/s10534-005-3712-z; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Li N, 2012, J BIOL CHEM, V287, P8912, DOI 10.1074/jbc.M111.316034; LIU J, 1989, J BACTERIOL, V171, P791, DOI 10.1128/jb.171.2.791-798.1989; Liu M, 2008, BIOPHYS CHEM, V138, P42, DOI 10.1016/j.bpc.2008.09.001; LLINAS M, 1973, BIOCHEMISTRY-US, V12, P3836, DOI 10.1021/bi00744a007; LOOMIS LD, 1991, INORG CHEM, V30, P906, DOI 10.1021/ic00005a008; MAO B, 1982, J BIOL CHEM, V257, P1131; Mattle D, 2010, J MOL BIOL, V404, P220, DOI 10.1016/j.jmb.2010.09.005; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Muller A, 2006, ANGEW CHEM INT EDIT, V45, P5132, DOI 10.1002/anie.200601198; Orekhov VY, 2003, J BIOMOL NMR, V27, P165, DOI 10.1023/A:1024944720653; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Otten R, 2010, J AM CHEM SOC, V132, P2952, DOI 10.1021/ja907706a; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Peacock RS, 2006, BIOMETALS, V19, P127, DOI 10.1007/s10534-005-5420-0; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Peuckert F, 2009, ANGEW CHEM INT EDIT, V48, P7924, DOI 10.1002/anie.200902495; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; ROHRBACH MR, 1995, J BACTERIOL, V177, P7186, DOI 10.1128/jb.177.24.7186-7193.1995; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHARFF AJ, 1993, BIOCHEMISTRY-US, V32, P10553, DOI 10.1021/bi00091a004; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shimada I, 2009, PROG NUCL MAG RES SP, V54, P123, DOI 10.1016/j.pnmrs.2008.07.001; Skrynnikov NR, 2000, J MOL BIOL, V295, P1265, DOI 10.1006/jmbi.1999.3430; Sobolev V, 2005, NUCLEIC ACIDS RES, V33, pW39, DOI 10.1093/nar/gki398; Sprencel C, 2000, J BACTERIOL, V182, P5359, DOI 10.1128/JB.182.19.5359-5364.2000; Stockner T, 2005, BIOPHYS J, V89, P3362, DOI 10.1529/biophysj.105.069443; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; Takahashi H, 2006, J BIOMOL NMR, V34, P167, DOI 10.1007/s10858-006-0008-8; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Tamiola K, 2012, BIOCHEM SOC T, V40, P1014, DOI 10.1042/BST20120171; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732; TOLMAN JR, 1995, P NATL ACAD SCI USA, V92, P9279, DOI 10.1073/pnas.92.20.9279; Trakhanov S, 2005, BIOCHEMISTRY-US, V44, P6597, DOI 10.1021/bi047302o; Tugarinov V, 2005, P NATL ACAD SCI USA, V102, P622, DOI 10.1073/pnas.0407792102; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Usher KC, 2001, P NATL ACAD SCI USA, V98, P10676, DOI 10.1073/pnas.181353398; Venters RA, 1996, J MOL BIOL, V264, P1101, DOI 10.1006/jmbi.1996.0699; Watts RE, 2012, INFECT IMMUN, V80, P333, DOI 10.1128/IAI.05594-11; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zawadzka AM, 2009, P NATL ACAD SCI USA, V106, P21854, DOI 10.1073/pnas.0904793106; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022; Zhu G, 1999, J BIOMOL NMR, V13, P77, DOI 10.1023/A:1008398227519	93	27	28	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29219	29234		10.1074/jbc.M114.564021	http://dx.doi.org/10.1074/jbc.M114.564021			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25173704	Green Published, hybrid			2022-12-25	WOS:000344141000037
J	Lawrence, SA; Titus, SA; Ferguson, J; Heineman, AL; Taylor, SM; Moran, RG				Lawrence, Scott A.; Titus, Steven A.; Ferguson, Jennifer; Heineman, Amy L.; Taylor, Shirley M.; Moran, Richard G.			Mammalian Mitochondrial and Cytosolic Folylpolyglutamate Synthetase Maintain the Subcellular Compartmentalization of Folates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMATE SYNTHETASE; ONE-CARBON METABOLISM; CHINESE-HAMSTER CELLS; SACCHAROMYCES-CEREVISIAE; LEUKEMIA-CELL; CANCER-CELLS; METHOTREXATE; GLYCINE; TRANSPORT; SERINE	Folylpoly-gamma-glutamate synthetase (FPGS) catalyze the addition of multiple glutamates to tetrahydrofolate derivatives. Two mRNAs for the fpgs gene direct isoforms of FPGS to the cytosol and to mitochondria in mouse and human tissues. We sought to clarify the functions of these two compartmentalized isoforms. Stable cell lines were created that express cDNAs for the mitochondrial and cytosolic isoforms of human FPGS under control of a doxycycline-inducible promoter in the AUXB1 cell line. AUXB1 are devoid of endogenous FPGS activity due to a premature translational stop at codon 432 in the fpgs gene. Loss of folates was not measurable from these doxycycline-induced cells or from parental CHO cells over the course of three CHO cell generations. Likewise, there was no detectable transfer of folate polyglutamates either from the cytosol to mitochondria, or from mitochondria to the cytosol. The cell line expressing cytosolic FPGS required exogenous glycine but not thymidine or purine, whereas cells expressing the mitochondrial isoform required exogenous thymidine and purine but not glycine for optimal growth and survival. We concluded that mitochondrial FPGS is required because folate polyglutamates are not substrates for transport across the mitochondrial membrane in either direction and that polyglutamation not only traps folates in the cytosol, but also in the mitochondrial matrix.	[Lawrence, Scott A.; Moran, Richard G.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [Taylor, Shirley M.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Titus, Steven A.; Ferguson, Jennifer; Heineman, Amy L.; Taylor, Shirley M.; Moran, Richard G.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Moran, RG (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, 401 Coll St, Richmond, VA 23298 USA.	rmoran@vcu.edu			National Institutes of Health-NCI Cancer Center Grant [P30 CA016059]; NATIONAL CANCER INSTITUTE [R01CA039687, P30CA016059] Funding Source: NIH RePORTER	National Institutes of Health-NCI Cancer Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Professor Andrew Bognar for critical review of this manuscript. We also thank Dr. Kellie Archer for assistance with statistical analysis supported by the VCU Massey Cancer Center Biostatistics Shared Resource with funding from National Institutes of Health-NCI Cancer Center Grant P30 CA016059.	Ahmed AU, 2009, INT REV CEL MOL BIO, V273, P49, DOI 10.1016/S1937-6448(08)01802-9; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BARLOWE C K, 1988, Biofactors, V1, P171; Blakley R. L., 1969, THE BIOCHEMISTRY OF; Chen ZS, 2003, CANCER RES, V63, P4048; CHU EHY, 1972, P NATL ACAD SCI USA, V69, P3459, DOI 10.1073/pnas.69.11.3459; Dotzlaf J, 2007, HYBRIDOMA, V26, P155, DOI 10.1089/hyb.2007.004; Drake JC, 1996, BIOCHEM PHARMACOL, V51, P1349, DOI 10.1016/0006-2952(96)00057-3; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; FREEMANTLE SJ, 1995, J BIOL CHEM, V270, P9579, DOI 10.1074/jbc.270.16.9579; FRY DW, 1982, J BIOL CHEM, V257, P1890; GOLDMAN ID, 1968, J BIOL CHEM, V243, P5007; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Kastanos EK, 1997, BIOCHEMISTRY-US, V36, P14956, DOI 10.1021/bi971610n; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Lamers Y, 2009, J NUTR, V139, P666, DOI 10.3945/jn.108.103580; Lawrence SA, 2011, J BIOL CHEM, V286, P31480, DOI 10.1074/jbc.M111.272187; Li Y, 2000, J BACTERIOL, V182, P2886, DOI 10.1128/JB.182.10.2886-2892.2000; LIN BF, 1993, J BIOL CHEM, V268, P21674; LIN BF, 1994, J BIOL CHEM, V269, P9705; LOWE KE, 1993, J BIOL CHEM, V268, P21665; MCBURNEY MW, 1974, CELL, V2, P173, DOI 10.1016/0092-8674(74)90091-9; MCCLOSKEY DE, 1991, J BIOL CHEM, V266, P6181; Moran DM, 2014, MOL CANCER THER, V13, P1611, DOI 10.1158/1535-7163.MCT-13-0649; Perchiniak E, 2007, BIOCHEMISTRY-US, V46, P1557, DOI 10.1021/bi062191+; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Qi H, 1999, ADV ENZYME REGUL, V39, P263, DOI 10.1016/S0065-2571(98)00023-5; RATANASTHIEN K, 1974, J CLIN PATHOL, V27, P875, DOI 10.1136/jcp.27.11.875; Sanghani SP, 1999, J BIOL CHEM, V274, P27018, DOI 10.1074/jbc.274.38.27018; SHANE B, 1989, VITAM HORM, V45, P263; SIROTNAK FM, 1978, BIOCHEM PHARMACOL, V27, P1821, DOI 10.1016/0006-2952(78)90025-4; Sun XL, 1998, P NATL ACAD SCI USA, V95, P6647, DOI 10.1073/pnas.95.12.6647; Sun XL, 2001, J MOL BIOL, V310, P1067, DOI 10.1006/jmbi.2001.4815; TAYLOR RT, 1982, ARCH BIOCHEM BIOPHYS, V217, P609, DOI 10.1016/0003-9861(82)90543-4; Tedeschi PM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.393; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Titus SA, 2000, J BIOL CHEM, V275, P36811, DOI 10.1074/jbc.M005163200; Visentin M, 2014, ANNU REV PHYSIOL, V76, P251, DOI 10.1146/annurev-physiol-020911-153251; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhao RB, 2000, J BIOL CHEM, V275, P26599, DOI 10.1074/jbc.M002580200; Zhao RB, 2011, ANNU REV NUTR, V31, P177, DOI 10.1146/annurev-nutr-072610-145133	41	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29386	29396		10.1074/jbc.M114.593244	http://dx.doi.org/10.1074/jbc.M114.593244			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25164808	Green Published, hybrid			2022-12-25	WOS:000344141000050
J	Scholl, ZN; Yang, WT; Marszalek, PE				Scholl, Zackary N.; Yang, Weitao; Marszalek, Piotr E.			Chaperones Rescue Luciferase Folding by Separating Its Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANICAL UNFOLDING PATHWAYS; SUBSTRATE-BINDING PROPERTIES; PHOTINUS-PYRALIS LUCIFERASE; ATOMIC-FORCE MICROSCOPY; STRUCTURE-BASED MODELS; FIREFLY LUCIFERASE; STRUCTURAL BASIS; PROTEIN-STRUCTURE; SWISS-MODEL; LANDSCAPE	Over the last 50 years, significant progress has been made toward understanding how small single-domain proteins fold. However, very little is known about folding mechanisms of medium and large multidomain proteins that predominate the proteomes of all forms of life. Large proteins frequently fold cotranslationally and/or require chaperones. Firefly (Photinus pyralis) luciferase (Luciferase, 550 residues) has been a model of a cotranslationally folding protein whose extremely slow refolding (approximately days) is catalyzed by chaperones. However, the mechanism by which Luciferase misfolds and how chaperones assist Luciferase refolding remains unknown. Here we combine single-molecule force spectroscopy (atomic force microscopy (AFM)/single-molecule force spectroscopy) with steered molecular dynamic computer simulations to unravel the mechanism of chaperone-assisted Luciferase refolding. Our AFM and steered molecular dynamic results show that partially unfolded Luciferase, with the N-terminal domain remaining folded, can refold robustly without chaperones. Complete unfolding causes Luciferase to get trapped in very stable non-native configurations involving interactions between N- and C-terminal residues. However, chaperones allow the completely unfolded Luciferase to refold quickly in AFM experiments, strongly suggesting that chaperones are able to sequester non-natively contacting residues. More generally, we suggest that many chaperones, rather than actively promoting the folding, mimic the ribosomal exit tunnel and physically separate protein domains, allowing them to fold in a cotranslational-like sequential process.	[Scholl, Zackary N.; Yang, Weitao] Duke Univ, Ctr Biol Inspired Mat & Mat Syst, Program Computat Biol & Bioinformat, Durham, NC 27705 USA; [Yang, Weitao] Duke Univ, Ctr Biol Inspired Mat & Mat Syst, Dept Chem, Durham, NC 27705 USA; [Marszalek, Piotr E.] Duke Univ, Dept Mech Engn & Mat Sci, Ctr Biol Inspired Mat & Mat Syst, Durham, NC 27705 USA	Duke University; Duke University; Duke University	Marszalek, PE (corresponding author), Duke Univ, Dept Mech Engn & Mat Sci, Ctr Biol Inspired Mat & Mat Syst, Durham, NC 27705 USA.	pemar@duke.edu	Yang, Weitao/C-1109-2008	Yang, Weitao/0000-0001-5576-2828	National Science Foundation [1106401]; NSF [MCB-1052208]; Kimberly-Clark Corporation	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Kimberly-Clark Corporation	This work was supported by National Science Foundation Graduate Research Fellowship Program Grant 1106401 (to Z. N. S.) and by NSF Grant MCB-1052208 (to P. E. M. and W. Y.).; Supported by the Kimberly-Clark Corporation. To whom correspondence should be addressed: Dept. of Mechanical Engineering and Materials Science, Center for Biologically Inspired Materials and Material Systems, Duke University, Durham, NC 27705. Tel.: 919-660-5381; E-mail: pemar@duke.edu.	Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592; Bertz M, 2008, J MOL BIOL, V378, P447, DOI 10.1016/j.jmb.2008.02.025; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Chang KH, 1997, BIOCHEMISTRY-US, V36, P15650, DOI 10.1021/bi971262p; Clark PL, 2004, TRENDS BIOCHEM SCI, V29, P527, DOI 10.1016/j.tibs.2004.08.008; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Clementi C, 2008, CURR OPIN STRUC BIOL, V18, P10, DOI 10.1016/j.sbi.2007.10.005; DELUCA M, 1974, BIOCHEMISTRY-US, V13, P921, DOI 10.1021/bi00702a015; DENBURG JL, 1969, ARCH BIOCHEM BIOPHYS, V134, P381, DOI 10.1016/0003-9861(69)90297-5; Dietz H, 2006, P NATL ACAD SCI USA, V103, P1244, DOI 10.1073/pnas.0509217103; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Eaton WA, 2000, ANNU REV BIOPH BIOM, V29, P327, DOI 10.1146/annurev.biophys.29.1.327; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; FERSHT A, 1999, STRUCTURE MECH PROTE, P1; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Herbst R, 1998, BIOCHEMISTRY-US, V37, P6586, DOI 10.1021/bi972928i; Herbst R, 1997, J BIOL CHEM, V272, P7099, DOI 10.1074/jbc.272.11.7099; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim M, 2010, BIOPHYS J, V98, P3086, DOI 10.1016/j.bpj.2010.02.054; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kleinkauf H, 1996, EUR J BIOCHEM, V236, P335, DOI 10.1111/j.1432-1033.1996.00335.x; Lammert H, 2009, PROTEINS, V77, P881, DOI 10.1002/prot.22511; LEE RT, 1970, ARCH BIOCHEM BIOPHYS, V141, P38, DOI 10.1016/0003-9861(70)90103-7; Lee W, 2010, J BIOL CHEM, V285, P38167, DOI 10.1074/jbc.M110.179697; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; Peng Q, 2008, P NATL ACAD SCI USA, V105, P1885, DOI 10.1073/pnas.0706775105; Pirchi M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1504; Porter LL, 2012, P NATL ACAD SCI USA, V109, P9420, DOI 10.1073/pnas.1202604109; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Sapra KT, 2009, ANGEW CHEM INT EDIT, V48, P8306, DOI 10.1002/anie.200904361; Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160; SCHUMACHER RJ, 1994, J BIOL CHEM, V269, P9493; Shank EA, 2010, NATURE, V465, P637, DOI 10.1038/nature09021; Stigler J, 2011, SCIENCE, V334, P512, DOI 10.1126/science.1207598; Svetlov MS, 2006, PROTEIN SCI, V15, P242, DOI 10.1110/ps.051752506; Wang WQ, 2001, BIOCHEM BIOPH RES CO, V282, P28, DOI 10.1006/bbrc.2001.4539; Wolynes PG, 2005, Q REV BIOPHYS, V38, P405, DOI 10.1017/S0033583505004075; Zheng WJ, 2006, P NATL ACAD SCI USA, V103, P7664, DOI 10.1073/pnas.0510426103; Zheng WJ, 2003, P NATL ACAD SCI USA, V100, P13253, DOI 10.1073/pnas.2235686100; Zhou HX, 2001, BIOCHEMISTRY-US, V40, P11289, DOI 10.1021/bi0155504	50	22	22	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28607	28618		10.1074/jbc.M114.582049	http://dx.doi.org/10.1074/jbc.M114.582049			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25160632	hybrid, Green Published			2022-12-25	WOS:000343765400049
J	Hengl, T; de Jesus, JM; MacMillan, RA; Batjes, NH; Heuvelink, GBM; Ribeiro, E; Samuel-Rosa, A; Kempen, B; Leenaars, JGB; Walsh, MG; Gonzalez, MR				Hengl, Tomislav; de Jesus, Jorge Mendes; MacMillan, Robert A.; Batjes, Niels H.; Heuvelink, Gerard B. M.; Ribeiro, Eloi; Samuel-Rosa, Alessandro; Kempen, Bas; Leenaars, Johan G. B.; Walsh, Markus G.; Gonzalez, Maria Ruiperez			SoilGrids1km-Global Soil Information Based on Automated Mapping	PLOS ONE			English	Article							ORGANIC-CARBON; CLIMATE; INTERPOLATION; MODELS; MAPS	Background: Soils are widely recognized as a non-renewable natural resource and as biophysical carbon sinks. As such, there is a growing requirement for global soil information. Although several global soil information systems already exist, these tend to suffer from inconsistencies and limited spatial detail. Methodology/Principal Findings: We present SoilGrids1km - a global 3D soil information system at 1 km resolution containing spatial predictions for a selection of soil properties (at six standard depths): soil organic carbon (g kg-1), soil pH, sand, silt and clay fractions (%), bulk density (kg m-3), cation-exchange capacity (cmol+/kg), coarse fragments (%), soil organic carbon stock (t ha-1), depth to bedrock (cm), World Reference Base soil groups, and USDA Soil Taxonomy suborders. Our predictions are based on global spatial prediction models which we fitted, per soil variable, using a compilation of major international soil profile databases (ca. 110,000 soil profiles), and a selection of ca. 75 global environmental covariates representing soil forming factors. Results of regression modeling indicate that the most useful covariates for modeling soils at the global scale are climatic and biomass indices (based on MODIS images), lithology, and taxonomic mapping units derived from conventional soil survey (Harmonized World Soil Database). Prediction accuracies assessed using 5-fold cross-validation were between 23-51%. Conclusions/Significance: SoilGrids1km provide an initial set of examples of soil spatial data for input into global models at a resolution and consistency not previously available. Some of the main limitations of the current version of SoilGrids1km are: (1) weak relationships between soil properties/classes and explanatory variables due to scale mismatches, (2) difficulty to obtain covariates that capture soil forming factors, (3) low sampling density and spatial clustering of soil profile locations. However, as the SoilGrids system is highly automated and flexible, increasingly accurate predictions can be generated as new input data become available.	[Hengl, Tomislav; de Jesus, Jorge Mendes; Batjes, Niels H.; Heuvelink, Gerard B. M.; Ribeiro, Eloi; Kempen, Bas; Leenaars, Johan G. B.; Gonzalez, Maria Ruiperez] ISRIC World Soil Informat, Wageningen, Netherlands; [MacMillan, Robert A.] LandMapper Environm Solut Inc, Edmonton, AB, Canada; [Heuvelink, Gerard B. M.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Samuel-Rosa, Alessandro] Univ Fed Rural Rio de Janeiro, Rio De Janeiro, Brazil; [Walsh, Markus G.] Columbia Univ, Earth Inst, New York, NY USA; [Walsh, Markus G.] Selian Agr Res Inst, Arusha, Tanzania	Wageningen University & Research; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Columbia University	Hengl, T (corresponding author), ISRIC World Soil Informat, Wageningen, Netherlands.	tom.hengl@wur.nl	Heuvelink, Gerard/AAD-5916-2022; Samuel-Rosa, Alessandro/E-8396-2012; Hengl, Tomislav/AAE-9320-2019; Batjes, Niels H./F-7195-2010	Heuvelink, Gerard/0000-0003-0959-9358; Samuel-Rosa, Alessandro/0000-0003-0877-1320; Hengl, Tomislav/0000-0002-9921-5129; Kempen, Bas/0000-0002-2841-0058; Leenaars, Johan G.B./0000-0003-1091-7114; Mendes de Jesus, Jorge Samuel/0000-0001-9890-067X; Batjes, Niels H./0000-0003-2367-3067; Ribeiro, Eloi/0000-0002-2324-3000	Dutch government; Africa Soil Information Service (AfSIS) - Bill and Melinda Gates foundation; Alliance for a Green Revolution in Africa (AGRA)	Dutch government; Africa Soil Information Service (AfSIS) - Bill and Melinda Gates foundation; Alliance for a Green Revolution in Africa (AGRA)	ISRIC is a non-profit organization primarily funded by the Dutch government. The authors are especially thankful for support from the Africa Soil Information Service (AfSIS) project, funded by the Bill and Melinda Gates foundation and the Alliance for a Green Revolution in Africa (AGRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal DK, 2002, ENVIRON ECOL STAT, V9, P341, DOI 10.1023/A:1020910605990; Antonic O, 2003, ECOL MODEL, V170, P363, DOI 10.1016/S0304-3800(03)00239-4; Arrouays D, 2014, ADV AGRON, V125, P93, DOI 10.1016/B978-0-12-800137-0.00003-0; Batjes N., 2012, ISRIC WISE DERIVED S; Batjes NH, 2009, SOIL USE MANAGE, V25, P124, DOI 10.1111/j.1475-2743.2009.00202.x; Bivand R.S., 2013, APPL SPATIAL DATA AN, V2nd, DOI 10.1007/978-1-4614-7618-4; Bouma J, 1998, GEODERMA, V86, P43, DOI 10.1016/S0016-7061(98)00034-2; Brus DJ, 2011, EUR J SOIL SCI, V62, P394, DOI 10.1111/j.1365-2389.2011.01364.x; Carroll ML, 2009, INT J DIGIT EARTH, V2, P291, DOI 10.1080/17538940902951401; Cooper M, 2005, SOIL SCI SOC AM J, V69, P649, DOI 10.2136/sssaj2004.0140; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Fritz S, 2012, ENVIRON MODELL SOFTW, V31, P110, DOI 10.1016/j.envsoft.2011.11.015; Gonzalez JH, 2010, IEEE T GEOSCI REMOTE, V48, P716, DOI 10.1109/TGRS.2009.2034980; Goovaerts P, 2001, GEODERMA, V103, P3, DOI 10.1016/S0016-7061(01)00067-2; Grunwald S, 2011, SOIL SCI SOC AM J, V75, P1201, DOI 10.2136/sssaj2011.0025; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Hartemink AE, 2013, GEODERMA, V207, P256, DOI 10.1016/j.geoderma.2013.05.003; Hartmann J, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004370; Hastie T.J., 2017, STAT MODELS S, P249, DOI DOI 10.1201/9780203738535; Hengl T, 2013, INT J APPL EARTH OBS, V22, P127, DOI 10.1016/j.jag.2012.02.005; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; Heuvelink G.B., 1998, ERROR PROPAGATION EN; Heuvelink GBM, 2001, GEODERMA, V100, P269, DOI 10.1016/S0016-7061(01)00025-8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hollis JM, 2006, EUR22127EN; Hugelius G, 2014, BIOGEOSCIENCES DISCU, V11, P4771, DOI [10.5194/bgd-11-4771-2014, DOI 10.5194/BGD-11-4771-2014]; IUSS Working Group WRB, 2006, WORLD REFERENCE BASE, V103; Jenny H., 1994, FACTORS SOIL FORMATI; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kilibarda M, 2014, J GEOPHYS RES-ATMOS, V119, P2294, DOI 10.1002/2013JD020803; Knaus J, 2009, R J, V1, P54; Kutner M., 2005, APPL LINEAR STAT MOD; Leenaars J.G.B, 2012, AFRICA SOIL PROFILES; MacDonald K.B., 1992, CANSIS NSDB GEN DESC; McBratney A.B., 2011, HDB SOIL SCI, P1; Minasny B, 2010, PROGR SOIL SCI, V2, P429, DOI 10.1007/978-90-481-8863-5_34; Minasny B, 2014, PROGR SOIL SCI, P45, DOI 10.1007/978-3-319-04084-4_5; Mokma D.L., 1982, ISM MONOGRAPH; Montanarella L., 2013, JRC TECHNICAL REPORT; Montanarella L, 2012, CURR OPIN ENV SUST, V4, P559, DOI 10.1016/j.cosust.2012.06.007; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; ODEH IOA, 1995, GEODERMA, V67, P215, DOI 10.1016/0016-7061(95)00007-B; Omuto C., 2012, STATE ART REPORT GLO; Pebesma E, 2011, COMPUT GEOSCI-UK, V37, P343, DOI 10.1016/j.cageo.2010.03.019; R Development Core Team, 2009, R FDN STAT COMP; Rossel RAV, 2014, GLOBAL CHANGE BIOL, V20, P2953, DOI 10.1111/gcb.12569; Ruesch A., 2008, NEW IPCC TIER 1 GLOB; Sanchez PA, 2009, SCIENCE, V325, P680, DOI 10.1126/science.1175084; Scharlemann JPW, 2014, CARBON MANAG, V5, P81, DOI 10.4155/CMT.13.77; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Shangguan W, 2013, J ADV MODEL EARTH SY, V5, P212, DOI 10.1002/jame.20026; Shore J, 2007, ART AGILE DEV THEORY; Stolbovoi V, 2002, CD ROM LAND RESOURCE; Todd-Brown KEO, 2013, BIOGEOSCIENCES, V10, P1717, DOI 10.5194/bg-10-1717-2013; US Department of Agriculture, 2010, KEYS SOIL TAX; Van Engelen V, 2012, 201204 ISRIC WORLD S; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Verburg PH, 2011, GLOBAL CHANGE BIOL, V17, P974, DOI 10.1111/j.1365-2486.2010.02307.x	59	649	665	11	174	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105992	10.1371/journal.pone.0105992	http://dx.doi.org/10.1371/journal.pone.0105992			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171179	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500088
J	Mavrodiev, EV; Martinez-Azorin, M; Dranishnikov, P; Crespo, MB				Mavrodiev, Evgeny V.; Martinez-Azorin, Mario; Dranishnikov, Peter; Crespo, Manuel B.			At Least 23 Genera Instead of One: The Case of Iris L. s.l. (Iridaceae)	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENETICS; DNA; GENUS; CLASSIFICATION; SYSTEMATICS; EVOLUTION; VERSION; INDEPENDENCE	Background: Iris L. s.l. is one of the most diverse and well-known genera in the Asparagales, with approximately 250-300 circumscribed species and significant economic impact. The taxonomy of the genus has suffered dramatic changes in the last century, particularly in the last decades after the application of molecular techniques. As a result several contrasting systematic arrangements are currently available to taxonomists. Many genera that were split from Iris s.str. in the past, on the basis of morphology (e.g., Hermodactylus, Iridodictyum, Juno, Pardanthopsis, and Xiphion, among others), are now a priori re-included in a very widely circumscribed Iris s.l. (incl. Belamcanda). This resulted in a more heterogeneous genus that is more difficult to define on morphological grounds. Testing congruence between taxonomic treatments and the results of recent molecular studies of Iris has never been performed, mostly due to the lack of proper taxonomic context. Results: We generated several conventional phylogenies for Iris & outgroups using extensive sampling of taxa (187) and characters (10 plastid loci). We demonstrate that the natural history of Iris, written either as conventional molecular phylogenies or, if viewing in the context of the comparative approach, as a nested most parsimonious hierarchy of patterns, appear to be fully congruent with the narrow taxonomical treatment of the genus, restricted to the rhizomatous "bearded" taxa. The resulting topologies place Belamcanda, Pardanthopsis, and Gattenhofia as sisters to Iris s.str. and genus Siphonostylis as sister to Iris s.l. Conclusion: The present study clearly justifies the splitting of Iris s.l. into at least 23 genera, 18 of which have already been accepted in the past by numerous authorities. These genera are characterized by unique combinations of partly overlapping morphological characters and biogeography. Moreover, nearly the same entities, which we here recognize at a generic rank, were for centuries frequently referred to by horticulturists as "working-name" groups.	[Mavrodiev, Evgeny V.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Martinez-Azorin, Mario] Karl Franzens Univ Graz, Inst Plant Sci, Graz, Austria; [Dranishnikov, Peter] Buchholz High Sch, Gainesville, FL USA; [Martinez-Azorin, Mario; Crespo, Manuel B.] Univ Alicante, CIBIO Inst Biodivers, E-03080 Alicante, Spain	State University System of Florida; University of Florida; University of Graz; Universitat d'Alacant	Mavrodiev, EV (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	evgeny@ufl.edu	Martínez-Azorín, Mario/L-4722-2014; Crespo, Manuel B./O-1266-2013	Martínez-Azorín, Mario/0000-0002-2605-9575; Crespo, Manuel B./0000-0002-3294-5637				Adanson M., 1763, FAMILLES DES PLANTES; Anderson E., 1949, INTROGRESSIVE HYBRID; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; ANTONOV AS, 1988, PLANT SYST EVOL, V161, P155, DOI 10.1007/BF00937296; Arnold ML, 2012, HEREDITY, V108, P159, DOI 10.1038/hdy.2011.65; Bansal MS, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-18; Bauhin J, 1651, HIST PLANTARUM UNIVE, DOI [10.5962/bhl.title.146639, DOI 10.5962/BHL.TITLE.146639]; Bruni I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043256; Crespo MB, 2012, TAXON, V61, P684, DOI 10.1002/tax.613022; Crespo MB, 2011, FLORA MONTIBERICA, V49, P60; Crespo Villalba M. B, 2012, FLORA MONTIBERICA, V53, P49; Davies TJ, 2004, P ROY SOC B-BIOL SCI, V271, P2195, DOI 10.1098/rspb.2004.2849; de Vere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037945; DEQUEIROZ K, 1990, CLADISTICS, V6, P61, DOI 10.1111/j.1096-0031.1990.tb00525.x; Dodoens R, 1583, STIRPIUM HIST PEMPTE; Fourreau M.J., 1869, ANN SOC LINNEENNE LY, V17, P89; Fuentes-Bazan S, 2012, WILLDENOWIA, V42, P5, DOI 10.3372/wi42.42101; Givnish TJ, 2010, ANN MO BOT GARD, V97, P584, DOI 10.3417/2010023; Givnish TJ, 2005, P ROY SOC B-BIOL SCI, V272, P1481, DOI 10.1098/rspb.2005.3067; GOLDBLATT P, 1981, ANN MO BOT GARD, V68, P132, DOI 10.2307/2398817; Goldblatt P, 2002, MOL PHYLOGENET EVOL, V25, P341, DOI 10.1016/S1055-7903(02)00235-X; Goldblatt P, 2008, SYST BOT, V33, P495, DOI 10.1600/036364408785679806; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grace OM, 2013, PHYTOTAXA, V76, P7, DOI 10.11646/phytotaxa.76.1.2; Graham SW, 2002, MOL BIOL EVOL, V19, P1769, DOI 10.1093/oxfordjournals.molbev.a003999; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo JY, 2013, SYST BOT, V38, P987, DOI 10.1600/036364413X674724; Hall T., 2001, ANN BOT, V1, P105; Heenan PB, 2013, PHYTOTAXA, V146, P1; Ikinci N, 2011, BOT J LINN SOC, V167, P281, DOI 10.1111/j.1095-8339.2011.01176.x; Ikonnikov S. S, 1972, NOVOSTI SISTEMATIKI, V9, P300; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kitching IJ, 1998, SYSTEMATICS ASS PUBL; LENZ L W, 1972, Aliso, V7, P405; LENZ L W, 1972, Aliso, V7, P401; LENZ LW, 1972, AM HORTIC, V51, P22; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Linnaeus C., 1753, SPECIES PLANTARUM, V2; Maddison WP, 2011, VERSION; Makarevitch I, 2003, INT J PLANT SCI, V164, P229, DOI 10.1086/346160; Mansion G, 2004, TAXON, V53, P719, DOI 10.2307/4135447; Rodriguez JM, 2013, NORD J BOT, V31, P90, DOI 10.1111/j.1756-1051.2012.01582.x; Martinez-Azorin M, 2011, ANN BOT-LONDON, V107, P1, DOI 10.1093/aob/mcq207; Mathew B., 1989, IRIS; Mavrodiev E. V., 2010, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V115, P72; Mavrodiev E. V., 2001, Botanicheskii Zhurnal (St. Petersburg), V86, P120; Mavrodiev E. V., 2002, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V107, P77; Mavrodiev EV, 2003, BOT ZH, V88, P50; Mavrodiev EV, 2010, PROBLEMS BOT S SIBER, V9; Mavrodiev EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048813; Medikus F. C., 1790, HIST COMMENTATIONES, V6, P414; Miller P, 1754, GARDENERS DICT, V4; Miller P, 1768, GARDENERS DICT; MISHLER BD, 1994, AM J PHYS ANTHROPOL, V94, P143, DOI 10.1002/ajpa.1330940111; Murdock AG, 2008, AM J BOT, V95, P626, DOI 10.3732/ajb.2007308; NELSON G, 1991, CLADISTICS, V7, P351, DOI 10.1111/j.1096-0031.1991.tb00044.x; NEVSKII S. A., 1937, Trudy bot. Inst. Akad. Nauk SSSR, P199; Parlatore F, 1860, FLORA ITALIANA; Rambaut A, 2008, SE AL V 2 OA11 MOL E; Rambaut A, 2012, FIGTREE V 1 4 MOL EV; Ranwez V, 2010, BIOINFORMATICS, V26, pi115, DOI 10.1093/bioinformatics/btq196; Reichenbach H. G. L., 1841, DTSCH BOT; Rodioneko G. I., 1999, Botanicheskii Zhurnal (St. Petersburg), V84, P103; Rodionenko G. I., 2006, Botanicheskii Zhurnal (St. Petersburg), V91, P1707; Rodionenko G. I, 2006, Botanicheskii Zhurnal (St. Petersburg), V91, P1895; Rodionenko G. I., 2007, Botanicheskii Zhurnal (St. Petersburg), V92, P547; Rodionenko G. I., 1994, Botanicheskii Zhurnal (St. Petersburg), V79, P100; Rodionenko G. I., 2008, Botanicheskii Zhurnal (St. Petersburg), V93, P321; Rodionenko G. I., 2005, Botanicheskii Zhurnal (St. Petersburg), V90, P55; Rodionenko G. I., 2004, Botanicheskii Zhurnal (St. Petersburg), V89, P1359; Rodionenko G. I., 1987, GENUS IRIS L QUESTIO; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCHULZE W., 1965, OESTERR BOT Z, V112, P331, DOI 10.1007/BF01372955; SCHULZE W, 1969, OSTERR BOT Z, V117, P327, DOI 10.1007/BF01377791; Schulze W., 1964, GRANA, V5, P40; Schulze W., 1971, FEDDES REPERT, V81, P519, DOI DOI 10.1002/FEDR.19710810803; SGBIS, 1997, GUIDE SPECIES IRIS E; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; SHNEER V S, 1990, Botanicheskii Zhurnal (St. Petersburg), V75, P804; SHNEER VS, 1975, DOKL AKAD NAUK SSSR+, V222, P247; Shneyer V. S., 1999, Botanicheskii Zhurnal (St. Petersburg), V84, P37; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tournefort J. Pitton de, 1719, I REI HERBARIAE, V3; Trattinnick L., 1817, AUSWAHL VORZUGLICH S; Williams D. M., 2000, HOMOLOGY SYSTEMATICS, P183; Williams DM, 2004, J BIOGEOGR, V31, P685, DOI 10.1111/j.1365-2699.2004.01063.x; WILLIAMS DM, 2008, FDN SYSTEMATICS BIOG; Wilson CA, 2004, MOL PHYLOGENET EVOL, V33, P402, DOI 10.1016/j.ympev.2004.06.013; Wilson CA, 2011, TAXON, V60, P27, DOI 10.1002/tax.601004; Wilson CA, 2009, SYST BOT, V34, P277, DOI 10.1600/036364409788606316	93	40	47	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106459	10.1371/journal.pone.0106459	http://dx.doi.org/10.1371/journal.pone.0106459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170935	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500161
J	Mondal, D; Dougherty, E; Mukhopadhyay, A; Carbo, A; Yao, G; Xing, JH				Mondal, Debasish; Dougherty, Edward; Mukhopadhyay, Abhishek; Carbo, Adria; Yao, Guang; Xing, Jianhua			Systematic Reverse Engineering of Network Topologies: A Case Study of Resettable Bistable Cellular Responses	PLOS ONE			English	Article							MOTIFS; DYNAMICS	A focused theme in systems biology is to uncover design principles of biological networks, that is, how specific network structures yield specific systems properties. For this purpose, we have previously developed a reverse engineering procedure to identify network topologies with high likelihood in generating desired systems properties. Our method searches the continuous parameter space of an assembly of network topologies, without enumerating individual network topologies separately as traditionally done in other reverse engineering procedures. Here we tested this CPSS (continuous parameter space search) method on a previously studied problem: the resettable bistability of an Rb-E2F gene network in regulating the quiescence-to-proliferation transition of mammalian cells. From a simplified Rb-E2F gene network, we identified network topologies responsible for generating resettable bistability. The CPSS-identified topologies are consistent with those reported in the previous study based on individual topology search (ITS), demonstrating the effectiveness of the CPSS approach. Since the CPSS and ITS searches are based on different mathematical formulations and different algorithms, the consistency of the results also helps cross-validate both approaches. A unique advantage of the CPSS approach lies in its applicability to biological networks with large numbers of nodes. To aid the application of the CPSS approach to the study of other biological systems, we have developed a computer package that is available in Information S1.	[Mondal, Debasish; Xing, Jianhua] Virginia Polytech Inst & State Univ, Dept Biol Sci, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Dougherty, Edward; Carbo, Adria] Virginia Polytech Inst & State Univ, Dept Genet Bioinformat & Computat Biol, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Mukhopadhyay, Abhishek; Xing, Jianhua] Virginia Polytech Inst & State Univ, Dept Phys, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Mukhopadhyay, Abhishek] Virginia Polytech Inst & State Univ, Dept Comp Sci, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Carbo, Adria] Virginia Polytech Inst & State Univ, Nutr Immunol & Mol Med Lab, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Carbo, Adria] Virginia Polytech Inst & State Univ, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Yao, Guang] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Xing, Jianhua] Beijing Computat Sci Res Ctr, Beijing, Peoples R China	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Arizona; Chinese Academy of Engineering Physics; Beijing Computational Science Research Center (CSRC)	Yao, G (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	guangyao@arizona.edu; jxing@vt.edu	Xing, Jianhua/A-8101-2012	Xing, Jianhua/0000-0002-3700-8765; , Guang/0000-0003-0167-777X	National Science Foundation [DMS-0969417]; National Institutes of Health [5R01AT004308, HHSN272201000056]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004308] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [0969417] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work has been supported by National Science Foundation Grants DMS-0969417 (to JX). AC acknowledges the National Institutes of Health for the partial financial support from grants 5R01AT004308 and HHSN272201000056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, INTRO SYSTEMS BIOL D; Fu Y, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S3-S6; Fu Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002526; Hong T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002122; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Kaufman L., 2009, FINDING GROUPS DATA; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; MacQueen J, 1967, SOME METHODS CLASSIF, P14; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Perkins TJ, 2006, PLOS COMPUT BIOL, V2, P417, DOI 10.1371/journal.pcbi.0020051; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schmitt LM, 2001, THEOR COMPUT SCI, V259, P1, DOI 10.1016/S0304-3975(00)00406-0; Schmitt LM, 1998, THEOR COMPUT SCI, V200, P101, DOI 10.1016/S0304-3975(98)00004-8; Shah NA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002085; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Smith PJ, 1997, IEEE J SEL AREA COMM, V15, P597, DOI 10.1109/49.585771; SPATH H, 1985, CLUSTER DISSECTION A; Suli E., 2003, INTRO NUMERICAL ANAL; Tian XJ, 2013, BIOPHYS J, V105, P1079, DOI 10.1016/j.bpj.2013.07.011; Tian XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011926; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Tyson JJ, 2011, NAT REV CANCER, V11, P523, DOI 10.1038/nrc3081; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Vohradsky J, 2001, FASEB J, V15, P846, DOI 10.1096/fj.00-0361com; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wang P, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0068; Weaver D C, 1999, Pac Symp Biocomput, P112; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Wong JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002491; Wong JV, 2011, MOL CELL, V41, P275, DOI 10.1016/j.molcel.2011.01.014; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yao G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.19	36	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105833	10.1371/journal.pone.0105833	http://dx.doi.org/10.1371/journal.pone.0105833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170839	Green Published, gold			2022-12-25	WOS:000341127500070
J	Nishihara, M; Inui, K; Morita, T; Kodaira, M; Mochizuki, H; Otsuru, N; Motomura, E; Ushida, T; Kakigi, R				Nishihara, Makoto; Inui, Koji; Morita, Tomoyo; Kodaira, Minori; Mochizuki, Hideki; Otsuru, Naofumi; Motomura, Eishi; Ushida, Takahiro; Kakigi, Ryusuke			Echoic Memory: Investigation of Its Temporal Resolution by Auditory Offset Cortical Responses	PLOS ONE			English	Article							MISMATCH NEGATIVITY; CORTEX; HUMANS; REPRESENTATION; ADAPTATION; COMPLEX; SERIAL	Previous studies showed that the amplitude and latency of the auditory offset cortical response depended on the history of the sound, which implicated the involvement of echoic memory in shaping a response. When a brief sound was repeated, the latency of the offset response depended precisely on the frequency of the repeat, indicating that the brain recognized the timing of the offset by using information on the repeat frequency stored in memory. In the present study, we investigated the temporal resolution of sensory storage by measuring auditory offset responses with magnetoencephalography (MEG). The offset of a train of clicks for 1 s elicited a clear magnetic response at approximately 60 ms (Off-P50m). The latency of Off-P50m depended on the inter-stimulus interval (ISI) of the click train, which was the longest at 40 ms (25 Hz) and became shorter with shorter ISIs (2.5 similar to 20 ms). The correlation coefficient r(2) for the peak latency and ISI was as high as 0.99, which suggested that sensory storage for the stimulation frequency accurately determined the Off-P50m latency. Statistical analysis revealed that the latency of all pairs, except for that between 200 and 400 Hz, was significantly different, indicating the very high temporal resolution of sensory storage at approximately 5 ms.	[Nishihara, Makoto; Inui, Koji; Morita, Tomoyo; Kodaira, Minori; Mochizuki, Hideki; Otsuru, Naofumi; Kakigi, Ryusuke] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan; [Nishihara, Makoto; Ushida, Takahiro] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi 48011, Japan; [Motomura, Eishi] Mie Univ, Grad Sch Med, Dept Psychiat, Div Neurosci, Tsu, Mie 514, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Aichi Medical University; Mie University	Nishihara, M (corresponding author), Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan.	ck410621@gmail.com						Althen H, 2013, EUR J NEUROSCI, V38, P3448, DOI 10.1111/ejn.12346; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Atkinson R. C., 1968, PSYCHOL LEARN MOTIVA, V2, P89, DOI 10.1016/S0079-7421(08)60422-3; COWAN N, 1984, PSYCHOL BULL, V96, P341, DOI 10.1037/0033-2909.96.2.341; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; HASHIMOTO I, 1981, BRAIN, V104, P841, DOI 10.1093/brain/104.4.841; Inui K, 2004, CEREB CORTEX, V14, P851, DOI 10.1093/cercor/bhh043; Inui K, 2006, CEREB CORTEX, V16, P18, DOI 10.1093/cercor/bhi080; Inui K, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-588; Inui K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-135; Inui K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-80; Leung S, 2013, CLIN NEUROPHYSIOL, V124, P2397, DOI 10.1016/j.clinph.2013.06.001; LU ZL, 1992, SCIENCE, V258, P1668, DOI 10.1126/science.1455246; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; Nakagawa K, 2014, NEUROIMAGE, V86, P131, DOI 10.1016/j.neuroimage.2013.07.082; Nishihara M, 2011, NEUROSCI RES, V71, P145, DOI 10.1016/j.neures.2011.07.004; Nourski KV, 2013, J NEUROPHYSIOL, V109, P1283, DOI 10.1152/jn.00718.2012; Nourski KV, 2011, REV NEUROSCIENCE, V22, P187, DOI 10.1515/RNS.2011.016; Otsuru N, 2011, NEUROSCIENCE, V182, P115, DOI 10.1016/j.neuroscience.2011.03.019; Pratt H, 2007, CLIN NEUROPHYSIOL, V118, P1078, DOI 10.1016/j.clinph.2007.01.005; Qin L, 2007, J NEUROPHYSIOL, V97, P3421, DOI 10.1152/jn.00184.2007; Schroger E, 2007, J PSYCHOPHYSIOL, V21, P138, DOI 10.1027/0269-8803.21.34.138; Sussman ES, 2013, BRAIN TOPOGR, V10; Tanaka E, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-116; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Urakawa T, 2010, NEUROIMAGE, V52, P302, DOI 10.1016/j.neuroimage.2010.03.071; Winkler I, 2005, EXP PSYCHOL, V52, P3, DOI 10.1027/1618-3169.52.1.3; Yamashiro K, 2011, PSYCHOPHYSIOLOGY, V48, P23, DOI 10.1111/j.1469-8986.2010.01038.x; Yamashiro K, 2009, EUR J NEUROSCI, V30, P125, DOI 10.1111/j.1460-9568.2009.06790.x; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373	32	17	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106553	10.1371/journal.pone.0106553	http://dx.doi.org/10.1371/journal.pone.0106553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170608	Green Submitted, gold, Green Published			2022-12-25	WOS:000341127500167
J	Seneviratne, CJ; Leung, KCF; Wong, CH; Lee, SF; Li, X; Leung, PC; Lau, CBS; Wat, E; Jin, LJ				Seneviratne, Chaminda Jayampath; Leung, Ken Cham-Fai; Wong, Chi-Hin; Lee, Siu-Fung; Li, Xuan; Leung, Ping Chung; Lau, Clara Bik San; Wat, Elaine; Jin, Lijian			Nanoparticle-Encapsulated Chlorhexidine against Oral Bacterial Biofilms	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; PORPHYROMONAS-GINGIVALIS; RESISTANCE; EFFICACY; FLUORIDE; DISEASE; MUTANS	Background: Chlorhexidine (CHX) is a widely used antimicrobial agent in dentistry. Herein, we report the synthesis of a novel mesoporous silica nanoparticle-encapsulated pure CHX (Nano-CHX), and its mechanical profile and antimicrobial properties against oral biofilms. Methodology/Principal Findings: The release of CHX from the Nano-CHX was characterized by UV/visible absorption spectroscopy. The antimicrobial properties of Nano-CHX were evaluated in both planktonic and biofilm modes of representative oral pathogenic bacteria. The Nano-CHX demonstrated potent antibacterial effects on planktonic bacteria and mono-species biofilms at the concentrations of 50-200 mu g/mL against Streptococcus mutans, Streptococcus sobrinus, Fusobacterium nucleatum, Aggregatibacter actinomycetemcomitans and Enterococccus faecalis. Moreover, Nano-CHX effectively suppressed multi-species biofilms such as S. mutans, F. nucleatum, A. actinomycetemcomitans and Porphyromonas gingivalis up to 72 h. Conclusions/Significance: This pioneering study demonstrates the potent antibacterial effects of the Nano-CHX on oral biofilms, and it may be developed as a novel and promising anti-biofilm agent for clinical use.	[Seneviratne, Chaminda Jayampath; Li, Xuan; Jin, Lijian] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Seneviratne, Chaminda Jayampath] Natl Univ Singapore, Fac Dent, Singapore 117548, Singapore; [Leung, Ken Cham-Fai; Wong, Chi-Hin] Hong Kong Baptist Univ, Inst Creat, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Leung, Ken Cham-Fai; Wong, Chi-Hin] Hong Kong Baptist Univ, Partner State Key Lab Environm & Biol Anal, Hong Kong, Hong Kong, Peoples R China; [Lee, Siu-Fung] Chinese Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Leung, Ping Chung; Lau, Clara Bik San; Wat, Elaine] Chinese Univ Hong Kong, Inst Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Leung, Ping Chung; Lau, Clara Bik San; Wat, Elaine] Chinese Univ Hong Kong, Partner State Key Lab Phytochem & Plant Resources, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; National University of Singapore; Hong Kong Baptist University; Hong Kong Baptist University; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Jin, LJ (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	ljjin@hku.hk	Lau, Clara Bik-San/AAF-3989-2020; Wong, Kristy/C-8748-2015; Li, Xuan/Y-5295-2019; Leung, Ken Cham-Fai/B-1764-2009	Lau, Clara Bik-San/0000-0002-7409-1270; Li, Xuan/0000-0003-3785-5507; Leung, Ken Cham-Fai/0000-0002-0349-0418; /0000-0003-0816-538X	Hong Kong Research Grants Council [HKU767512M, 768713M]; Modern Dental Laboratory/HKU Endowment Fund	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Modern Dental Laboratory/HKU Endowment Fund	This study has been supported by the General Research Fund (GRF) from the Hong Kong Research Grants Council (HKU767512M and 768713M) and the Modern Dental Laboratory/HKU Endowment Fund to LJJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour Michele E, 2013, Int J Nanomedicine, V8, P3507, DOI 10.2147/IJN.S50140; Cheng L, 2012, DENT MATER, V28, P573, DOI 10.1016/j.dental.2012.01.006; Chu CH, 2012, INT J PAEDIATR DENT, V22, P2, DOI 10.1111/j.1365-263X.2011.01149.x; Cousido MC, 2010, CLIN ORAL INVEST, V14, P397, DOI 10.1007/s00784-009-0320-2; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Darveau RP, 2012, J DENT RES, V91, P816, DOI 10.1177/0022034512453589; Garcia-Caballero L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083522; Goutham Bala Subramanya, 2013, J Int Oral Health, V5, P56; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hench LL, 1999, CERAMIC T, V101; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Lee SF, 2013, ACS APPL MATER INTER, V5, P1566, DOI 10.1021/am4004705; Li L, 2008, J MATER CHEM, V18, P4079, DOI 10.1039/b806090h; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; Milstone AM, 2008, CLIN INFECT DIS, V46, P274, DOI 10.1086/524736; Nguyen TD, 2007, J AM CHEM SOC, V129, P626, DOI 10.1021/ja065485r; Papas AS, 2012, J DENT RES, V91, P150, DOI 10.1177/0022034511424154; SANDHAM HJ, 1992, J DENT RES, V71, P32, DOI 10.1177/00220345920710010501; Seneviratne CJ, 2013, ARCH ORAL BIOL, V58, P1327, DOI 10.1016/j.archoralbio.2013.06.017; Seneviratne CJ, 2012, PROTEOMICS, V12, P651, DOI 10.1002/pmic.201100356; Seneviratne CJ, 2011, CHIN J DENT RES, V14, P87; Shen Y, 2011, J ENDODONT, V37, P657, DOI 10.1016/j.joen.2011.02.007; Sreenivasan P, 2002, J CLIN PERIODONTOL, V29, P965, DOI 10.1034/j.1600-051X.2002.291101.x; Tomas I, 2013, J PERIODONTOL, V84, P1662, DOI 10.1902/jop.2013.120475; Varoni E, 2012, Minerva Stomatol, V61, P399; Wang DW, 2013, J MATER CHEM B, V1, P2934, DOI 10.1039/c3tb20090f; Wang HH, 2009, CHEM-EUR J, V15, P12417, DOI 10.1002/chem.200901548; Wang YXJ, 2011, MATERIALS, V4, P703, DOI 10.3390/ma4040703; Wilson M, 1996, J MED MICROBIOL, V44, P79, DOI 10.1099/00222615-44-2-79; Xuan SH, 2012, ACS APPL MATER INTER, V4, P2033, DOI 10.1021/am300008x; Xuan SH, 2011, CHEM COMMUN, V47, P2514, DOI 10.1039/c0cc05390b; Yamaguchi M, 2013, EUR J ORAL SCI, V121, P162, DOI 10.1111/eos.12050; Zhu XM, 2012, INT J NANOMED, V7, P953, DOI 10.2147/IJN.S28316	33	47	50	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e103234	10.1371/journal.pone.0103234	http://dx.doi.org/10.1371/journal.pone.0103234			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170958	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500010
J	Wang, SM; Lai, MN; Wei, A; Chen, YY; Pu, YS; Chen, PC; Wang, JD				Wang, Shuo-Meng; Lai, Ming-Nan; Wei, Alan; Chen, Ya-Yin; Pu, Yeong-Shiau; Chen, Pau-Chung; Wang, Jung-Der			Increased Risk of Urinary Tract Cancer in ESRD Patients Associated with Usage of Chinese Herbal Products Suspected of Containing Aristolochic Acid	PLOS ONE			English	Article							TRANSITIONAL-CELL-CARCINOMA; DISEASE ENDEMIC AREA; BLADDER-CANCER; UROTHELIAL CARCINOMA; MALIGNANT NEOPLASMS; DIALYSIS PATIENTS; TAIWAN; NEPHROPATHY; ANALGESICS; RESIDENTS	Introduction: Both end-stage renal disease (ESRD) and urothelial cancer (UC) are associated with the consumption of Chinese herbal products containing aristolochic acid (AA) by the general population. The objective of this study was to determine the risk of UC associated with AA-related Chinese herbal products among ESRD patients. Methods: We conducted a cohort study using the National Health Insurance reimbursement database to enroll all ESRD patients in Taiwan from 1998-2002. Cox regression models were constructed and hazard ratios and confidence intervals were estimated after controlling for potential confounders, including age, sex, residence in region with endemic black foot disease, urinary tract infection, and use of non-steroidal anti-inflammatory drugs and acetaminophen. Results: A total of 38,995 ESRD patients were included in the final analysis, and 320 patients developed UC after ESRD. Having been prescribed Mu Tong that was adulterated with Guan Mu Tong (Aristolochia manshuriensis) before 2004, or an estimated consumption of more than 1-100 mg of aristolochic acid, were both associated with an increased risk of UC in the multivariable analyses. Analgesic consumption of more than 150 pills was also associated with an increased risk of UC, although there was little correlation between the two risk factors. Conclusion: Consumption of aristolochic acid-related Chinese herbal products was associated with an increased risk of developing UC in ESRD patients. Regular follow-up screening for UC in ESRD patients who have consumed Chinese herbal products is thus necessary.	[Wang, Shuo-Meng; Chen, Ya-Yin; Pu, Yeong-Shiau] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Lai, Ming-Nan; Chen, Ya-Yin] Feng Chia Univ, Dept Stat, Taichung 40724, Taiwan; [Wei, Alan] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA; [Wang, Shuo-Meng; Chen, Pau-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan	National Taiwan University; National Taiwan University Hospital; Feng Chia University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Taiwan University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Wang, JD (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan.	jdwang121@gmail.com	Chen, Pau-Chung/H-5686-2011	Chen, Pau-Chung/0000-0002-6242-5974; WANG, SHUO-MENG/0000-0003-2090-1757; PU, YEONG-SHIAU/0000-0002-2859-3966	National Health Research Institutes of Taiwan [EO-100-EO-PP04]; Headquarters of University Advancement at the National Cheng Kung University	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Headquarters of University Advancement at the National Cheng Kung University	This study was supported by the National Health Research Institutes of Taiwan (intramural project EO-100-EO-PP04), and a grant from the Headquarters of University Advancement at the National Cheng Kung University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach H, 1997, PLANTA MED, V63, P579, DOI 10.1055/s-2006-957777; [Anonymous], 2008, CANC INCIDENCE RATE; [Anonymous], 2009, TAIWANYEARBOOK; Arlt VM, 2002, MUTAGENESIS, V17, P265, DOI 10.1093/mutage/17.4.265; Centers for Disease Control and Prevention, 2009, INT CLASS DIS; Chang CH, 2007, CANCER-AM CANCER SOC, V109, P1487, DOI 10.1002/cncr.22557; CHEN CJ, 1985, CANCER RES, V45, P5895; CHEN KS, 1995, AM J KIDNEY DIS, V25, P694, DOI 10.1016/0272-6386(95)90544-8; CHIANG HS, 1993, BRIT J UROL, V71, P274, DOI 10.1111/j.1464-410X.1993.tb15942.x; Chiou HY, 2001, AM J EPIDEMIOL, V153, P411, DOI 10.1093/aje/153.5.411; Chuang CH, 2002, ACTA NEPHROLOGICA, V16, P19; Chuang MS, 2002, ANN REPT NLFD TAIWAN, V20, P104; Committee Chinese Medicine and Pharmacy DOH-T, 2002, UN FORM; Cosyns JP, 2003, DRUG SAFETY, V26, P33, DOI 10.2165/00002018-200326010-00004; Cosyns JP, 1999, AM J KIDNEY DIS, V33, P1011, DOI 10.1016/S0272-6386(99)70136-8; DENG JS, 2002, THESIS CHINA MED U T, P75; Gago-Dominguez M, 1999, BRIT J CANCER, V81, P542, DOI 10.1038/sj.bjc.6690728; GONWA TA, 1980, ANN INTERN MED, V93, P249, DOI 10.7326/0003-4819-93-2-249; Groah SL, 2002, ARCH PHYS MED REHAB, V83, P346, DOI 10.1053/apmr.2002.29653; Hsieh SC, 2008, PHARMACOEPIDEM DR S, V17, P609, DOI 10.1002/pds.1611; Hsu YH, 2003, ANN REPT NLFD TAIWAN, V21, P153; Hsu YH, 1997, ANN REPT NLFD TAIWAN, V15, P136; Jiang X, 2009, BRIT J CANCER, V100, P834, DOI 10.1038/sj.bjc.6604889; Johansson SL, 1997, SEMIN SURG ONCOL, V13, P291; Jong TT, 2003, J PHARMACEUT BIOMED, V33, P831, DOI 10.1016/S0731-7085(03)00310-8; KJELLSTRAND CM, 1979, NEPHRON, V23, P159, DOI 10.1159/000181627; Kliem V, 1996, TRANSPLANT INT, V9, P231, DOI 10.1111/j.1432-2277.1996.tb00885.x; Lai MN, 2010, JNCI-J NATL CANCER I, V102, P179, DOI 10.1093/jnci/djp467; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; MATAS AJ, 1975, LANCET, V1, P883; NHRI-Taiwan, 2003, NAT HLTH RES DAT; Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301; Ou JH, 2000, EUR UROL, V37, P90, DOI 10.1159/000020106; PERNEGER TV, 1994, NEW ENGL J MED, V331, P1675, DOI 10.1056/NEJM199412223312502; PORT FK, 1989, AM J KIDNEY DIS, V14, P119, DOI 10.1016/S0272-6386(89)80187-8; Swindle P, 1998, BRIT J UROL, V81, P229; TaiwanCancerRegistry, 2009, CANC INC RAT TAIW 19; Tung C, 1999, CHIN MED COLL J, P35; VANHAELEN M, 1994, LANCET, V343, P174, DOI 10.1016/S0140-6736(94)90964-4; Vanherweghem JL, 1998, J ALTERN COMPLEM MED, V4, P9, DOI 10.1089/acm.1998.4.1-9; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Wiessler M., 1994, V125, P165	43	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105218	10.1371/journal.pone.0105218	http://dx.doi.org/10.1371/journal.pone.0105218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170766	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500036
J	Wang, WY; Wen, QY; Xu, LN; Xie, GY; Li, J; Luo, JD; Chu, SZ; Shi, L; Huang, DH; Li, JH; Fan, SQ				Wang, Weiyuan; Wen, Qiuyuan; Xu, Lina; Xie, Guiyuan; Li, Jiao; Luo, Jiadi; Chu, Shuzhou; Shi, Lei; Huang, Donghai; Li, Jinghe; Fan, Songqing			Activation of Akt/mTOR Pathway Is Associated with Poor Prognosis of Nasopharyngeal Carcinoma	PLOS ONE			English	Article							MTOR SIGNALING PATHWAY; PI3K/AKT/MTOR PATHWAY; BREAST-CANCER; AKT; TRANSLATION; HALLMARK; SURVIVAL; KINASE; GENES	Nasopharyngeal carcinoma (NPC) is a malignant tumor of the head and neck region, which frequently occurs in Southeast Asia, especially in the south of China. It is known that the mammalian target of rapamycin (mTOR) pathway plays a central role in regulating cellular functions, including proliferation, growth, survival, mobility, and angiogenesis. Aberrant expression of the mTOR signaling pathway molecules has been found in many types of cancer. However, whether the alterations of p-Akt, p-p70S6K and p-4EBP1 protein expression are associated with clinicopathological features and prognostic implications in NPC have not been reported. The purposes of the present study are to investigate the association between the expression of p-Akt, p-p70S6K and p-4EBP1 proteins and clinicopathological features in NPC by immunohistochemistry. The results showed that the positive percentage of p-Akt, p-p70S6K and p-4EBP1 proteins expression in NPC (47.2%, 73.0% and 61.7%, respectively) was significantly higher than that in the non-cancerous nasopharyngeal control tissue (33.3%, 59.1% and 47.0%, respectively). There was a significantly higher positive expression of p-Akt in undifferentiated non-keratinizing nasopharyngeal carcinoma than that in differentiated non-keratinizing nasopharyngeal carcinoma (P = 0.014). Additionally, positive expression of p-p70S6K and p-4EBP1 proteins, and positive expression of either of p-Akt, p-p70S6K and p-4EBP1 were significantly correlated inversely with overall survival rates of NPC patients (P = 0.023, P = 0.033, P = 0.008, respectively). Spearman's rank correlation test showed that expression of p-Akt in NPC was significantly associated with expression of p-p70S6K (r = 0.263, P < 0.001) and p-4EBP1(r = 0.284, P < 0.001). Also there was an obviously positive association between expression of p-p70S6K and p-4EBP1 proteins in NPC (r = 0.286, P < 0.001). Multivariate Cox regression analysis further identified positive expression of p-4EBP1 and p-p70S6K proteins were the independent poor prognostic factors for NPC (P = 0.043, P = 0.027, respectively). Taken together, high expression of p-p70S6K and p-4EBP1 proteins may act as valuable independent biomarkers to predict a poor prognosis of NPC.	[Wang, Weiyuan; Wen, Qiuyuan; Xu, Lina; Li, Jiao; Luo, Jiadi; Chu, Shuzhou; Shi, Lei; Fan, Songqing] Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China; [Xie, Guiyuan] Cent S Univ, Xiangya Hosp 2, Dept Oncol, Changsha, Hunan, Peoples R China; [Huang, Donghai] Cent S Univ, Xiangya Hosp, Dept Otorhinolaryngol, Changsha, Hunan, Peoples R China; [Li, Jinghe] Cent S Univ, Basic Med Coll, Dept Pathol, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Fan, SQ (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China.	lijinghe0718@126.com; fansongqing2003@hotmail.com	xu, li/GNH-3667-2022		national natural sciences foundations of China [81071820, 81201523, 81272566, 81372906]	national natural sciences foundations of China(National Natural Science Foundation of China (NSFC))	The work was supported by grants from the national natural sciences foundations of China (NO: 81071820, 81201523, 81272566 and 81372906) (http://isisn.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Adamo B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3071; Bensouda Y, 2011, EUR ANN OTORHINOLARY, V128, P79, DOI 10.1016/j.anorl.2010.10.003; Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; Castellvi J, 2006, CANCER-AM CANCER SOC, V107, P1801, DOI 10.1002/cncr.22195; Chen J, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-30; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Goberdhan DCI, 2009, BIOCHEM SOC T, V37, P213, DOI 10.1042/BST0370213; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Hu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072104; Johnson SM, 2010, J AM COLL SURGEONS, V210, P767, DOI 10.1016/j.jamcollsurg.2009.12.008; Li H, 2009, RADIAT ONCOL, V4, P1; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Morishita N, 2012, PEDIATR BLOOD CANCER, V59, P83, DOI 10.1002/pbc.24034; Pelloski CE, 2006, CLIN CANCER RES, V12, P3935, DOI 10.1158/1078-0432.CCR-05-2202; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Restuccia DF, 2010, DIS MODEL MECH, V3, P705, DOI 10.1242/dmm.004671; Riemenschneider MJ, 2006, CANCER RES, V66, P5618, DOI 10.1158/0008-5472.CAN-06-0364; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Suarez C, 2010, EUR ARCH OTO-RHINO-L, V267, P1811, DOI 10.1007/s00405-010-1385-x; Topisirovic I, 2004, CANCER RES, V64, P8639, DOI 10.1158/0008-5472.CAN-04-2677; Wiedmann MW, 2005, CURR CANCER DRUG TAR, V5, P171, DOI 10.2174/1568009053765771; Woo HG, 2009, CANCER RES, V69, P4059, DOI 10.1158/0008-5472.CAN-09-0164; Xiao L, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-152; Xu ZZ, 2013, ANN HEMATOL, V92, P1351, DOI 10.1007/s00277-013-1770-9; Yoshizawa A, 2010, CLIN CANCER RES, V16, P240, DOI 10.1158/1078-0432.CCR-09-0986	30	49	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106098	10.1371/journal.pone.0106098	http://dx.doi.org/10.1371/journal.pone.0106098			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165983	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303700072
J	Jacobs, RH; Jenkins, LM; Gabriel, LB; Barba, A; Ryan, KA; Weisenbach, SL; Verges, A; Baker, AM; Peters, AT; Crane, NA; Gotlib, IH; Zubieta, JK; Phan, KL; Langenecker, SA; Welsh, RC				Jacobs, Rachel H.; Jenkins, Lisanne M.; Gabriel, Laura B.; Barba, Alyssa; Ryan, Kelly A.; Weisenbach, Sara L.; Verges, Alvaro; Baker, Amanda M.; Peters, Amy T.; Crane, Natania A.; Gotlib, Ian H.; Zubieta, Jon-Kar; Phan, K. Luan; Langenecker, Scott A.; Welsh, Robert C.			Increased Coupling of Intrinsic Networks in Remitted Depressed Youth Predicts Rumination and Cognitive Control	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; STATE FUNCTIONAL CONNECTIVITY; SCALE BRAIN NETWORKS; CLINICAL-APPLICATIONS; SUBGENUAL CINGULATE; INHIBITORY CONTROL; DISORDER; THERAPY; CORTEX; ACTIVATION	Objective: Functional connectivity MRI (fcMRI) studies of individuals currently diagnosed with major depressive disorder (MDD) document hyperconnectivities within the default mode network (DMN) and between the DMN and salience networks (SN) with regions of the cognitive control network (CCN). Studies of individuals in the remitted state are needed to address whether effects derive from trait, and not state or chronic burden features of MDD. Method: fcMRI data from two 3.0 Tesla GE scanners were collected from 30 unmedicated (47% medication naive) youth (aged 18-23, modal depressive episodes = 1, mean age of onset = 16.2, SD = 2.6) with remitted MDD (rMDD; modal years well = 4) and compared with data from 23 healthy controls (HCs) using four bilateral seeds in the DMN and SN (posterior cingulate cortex (PCC), subgenual anterior cingulate (sgACC), and amygdala), followed by voxel-based comparisons of the whole brain. Results: Compared to HCs, rMDD youth exhibited hyperconnectivities from both PCC and sgACC seeds with lateral, parietal, and frontal regions of the CCN, extending to the dorsal medial wall. A factor analysis reduced extracted data and a PCC factor was inversely correlated with rumination among rMDD youth. Two factors from the sgACC hyperconnectivity clusters were related to performance in cognitive control on a Go/NoGo task, one positively and one inversely. Conclusions: Findings document hyperconnectivities of the DMN and SN with the CCN (BA 8/10), which were related to rumination and sustained attention. Given these cognitive markers are known predictors of response and relapse, hyperconnectivities may increase relapse risk or represent compensatory mechanisms.	[Jacobs, Rachel H.; Jenkins, Lisanne M.; Gabriel, Laura B.; Barba, Alyssa; Weisenbach, Sara L.; Verges, Alvaro; Peters, Amy T.; Crane, Natania A.; Phan, K. Luan; Langenecker, Scott A.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Ryan, Kelly A.; Weisenbach, Sara L.; Baker, Amanda M.; Zubieta, Jon-Kar; Langenecker, Scott A.; Welsh, Robert C.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Weisenbach, Sara L.] Jesse Brown VA Med Ctr, Res & Dev Program, Chicago, IL USA; [Weisenbach, Sara L.] VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Gotlib, Ian H.; Welsh, Robert C.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Zubieta, Jon-Kar; Langenecker, Scott A.] Mol & Behav Neurosci Inst, Dept Radiol, Ann Arbor, MI USA; [Phan, K. Luan] Univ Illinois, Dept Psychol, Chicago, IL 60612 USA; [Phan, K. Luan] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Phan, K. Luan] Jesse Brown VA Med Ctr, Mental Hlth Serv Line, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Stanford University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Langenecker, SA (corresponding author), Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA.	slangenecker@psych.uic.edu	Crane, Natania/ABN-2192-2022; Weisenbach, Sara/AAY-6680-2020; Vergés, Alvaro/G-6540-2015; Weisenbach, Sara L/M-2384-2016; Peters, Amy/AAH-5732-2019; Zubieta, Jon-Kar/AAB-5565-2022; Jenkins, Lisanne M/S-2898-2018; Langenecker, Scott/F-3548-2012	Crane, Natania/0000-0003-0487-1404; Vergés, Alvaro/0000-0002-5138-1312; Weisenbach, Sara L/0000-0002-5330-4038; Jenkins, Lisanne M/0000-0002-1241-1662; Langenecker, Scott/0000-0002-7932-5494	NIH [MH 091811]; NCATS [UL1TR000050]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091811] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by NIH MH 091811 and NCATS UL1TR000050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos GS, 2012, J AFFECT DISORDERS, V139, P56, DOI 10.1016/j.jad.2011.12.002; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Berman M.G., 2010, SOC COGN AFFECT NEUR; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bluhm RL, 2011, HUM BRAIN MAPP, V32, P1029, DOI 10.1002/hbm.21090; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Briceno EM, 2013, PSYCHOL MED, V43, P1433, DOI 10.1017/S0033291712002176; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Castellanos FX, 2013, NEUROIMAGE, V80, P527, DOI 10.1016/j.neuroimage.2013.04.083; Connolly CG, 2013, BIOL PSYCHIAT, V74, P898, DOI 10.1016/j.biopsych.2013.05.036; Cooney RE, 2010, COGN AFFECT BEHAV NE, V10, P470, DOI 10.3758/CABN.10.4.470; De Raedt R, 2010, COGN AFFECT BEHAV NE, V10, P50, DOI 10.3758/CABN.10.1.50; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Gaffrey MS, 2012, J CHILD PSYCHOL PSYC, V53, P964, DOI 10.1111/j.1469-7610.2012.02552.x; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Hamilton JP, 2011, BIOL PSYCHIAT, V70, P327, DOI 10.1016/j.biopsych.2011.02.003; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Jo HJ, 2013, J APPL MATH, DOI 10.1155/2013/935154; Keedwell P, 2009, J PSYCHOPHARMACOL, V23, P775, DOI 10.1177/0269881108093589; Keller MB, 2003, JAMA-J AM MED ASSOC, V289, P3152, DOI 10.1001/jama.289.23.3152; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Konarski JZ, 2009, J PSYCHIATR NEUROSCI, V34, P175; Langenecker SA, 2007, J CLIN EXP NEUROPSYC, V29, P842, DOI 10.1080/13803390601147611; Langenecker SA, 2007, BIOL PSYCHIAT, V62, P1272, DOI 10.1016/j.biopsych.2007.02.019; Lynch CJ, 2013, BIOL PSYCHIAT, V74, P212, DOI 10.1016/j.biopsych.2012.12.013; Marchetti I, 2012, NEUROPSYCHOL REV, V22, P229, DOI 10.1007/s11065-012-9199-9; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; McCabe C, 2011, NEUROIMAGE, V57, P1317, DOI 10.1016/j.neuroimage.2011.05.051; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; NOLENHOEKSEMA S, 1991, J PERS SOC PSYCHOL, V61, P115, DOI 10.1037/0022-3514.61.1.115; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Pannekoek JN, 2013, J AFFECT DISORDERS, V145, P29, DOI 10.1016/j.jad.2012.07.006; Pizzagalli DA, 2011, NEUROPSYCHOPHARMACOL, V36, P183, DOI 10.1038/npp.2010.166; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Riso LP, 2003, J CLIN PSYCHOL, V59, P817, DOI 10.1002/jclp.10175; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Siegle GJ, 2006, AM J PSYCHIAT, V163, P735, DOI 10.1176/appi.ajp.163.4.735; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; Votruba KL, 2013, J CLIN EXP NEUROPSYC, V35, P132, DOI 10.1080/13803395.2012.758239; Wang Z, 2012, BEHAV BRAIN RES, V230, P325, DOI 10.1016/j.bbr.2012.02.011; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Yuan YG, 2008, J AFFECT DISORDERS, V111, P145, DOI 10.1016/j.jad.2008.02.016; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	54	73	73	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e104366	10.1371/journal.pone.0104366	http://dx.doi.org/10.1371/journal.pone.0104366			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8UR	25162661	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900012
J	Williams, VL; Cunningham, AB; Kemp, AC; Bruyns, RK				Williams, Vivienne L.; Cunningham, Anthony B.; Kemp, Alan C.; Bruyns, Robin K.			Risks to Birds Traded for African Traditional Medicine: A Quantitative Assessment	PLOS ONE			English	Article							MACKINDERS EAGLE-OWLS; COLLOCALIA-FUCIPHAGA; WILD ANIMALS; CONSERVATION; FARMLANDS; ECOLOGY	Few regional or continent-wide assessments of bird use for traditional medicine have been attempted anywhere in the world. Africa has the highest known diversity of bird species used for this purpose. This study assesses the vulnerability of 354 bird species used for traditional medicine in 25 African countries, from 205 genera, 70 families, and 25 orders. The orders most represented were Passeriformes (107 species), Falconiformes (45 species), and Coraciiformes (24 species), and the families Accipitridae (37 species), Ardeidae (15 species), and Bucerotidae (12 species). The Barn owl (Tyto alba) was the most widely sold species (seven countries). The similarity of avifaunal orders traded is high (analogous to "morphospecies'', and using Sorensen's index), which suggests opportunities for a common understanding of cultural factors driving demand. The highest similarity was between bird orders sold in markets of Benin vs. Burkina Faso (90%), but even bird orders sold in two geographically separated countries (Benin vs. South Africa and Nigeria vs. South Africa) were 87% and 81% similar, respectively. Rabinowitz's "7 forms of rarity'' model, used to group species according to commonness or rarity, indicated that 24% of traded bird species are very common, locally abundant in several habitats, and occur over a large geographical area, but 10% are rare, occur in low numbers in specific habitats, and over a small geographical area. The order with the highest proportion of rare species was the Musophagiformes. An analysis of species mass (as a proxy for size) indicated that large and/or conspicuous species tend to be targeted by harvesters for the traditional medicine trade. Furthermore, based on cluster analyses for species groups of similar risk, vultures, hornbills, and other large avifauna, such as bustards, are most threatened by selective harvesting and should be prioritised for conservation action.	[Williams, Vivienne L.; Bruyns, Robin K.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, ZA-2050 Johannesburg, South Africa; [Cunningham, Anthony B.] Univ Stellenbosch, Sch Publ Leadership, ZA-7600 Stellenbosch, South Africa; [Kemp, Alan C.] Ditsong Museum Nat Hist, Pretoria, South Africa	University of Witwatersrand; Stellenbosch University	Williams, VL (corresponding author), Univ Witwatersrand, Sch Anim Plant & Environm Sci, ZA-2050 Johannesburg, South Africa.	vivwill@netdial.co.za	Williams, Vivienne Linda/M-1453-2019	Williams, Vivienne Linda/0000-0003-0698-6512	University of the Witwatersrand SPARC Prestigious Fellowship; URC Postdoctoral Fellowship; National Research Foundation	University of the Witwatersrand SPARC Prestigious Fellowship; URC Postdoctoral Fellowship; National Research Foundation	VLW was funded by the University of the Witwatersrand SPARC Prestigious and URC Postdoctoral Fellowships. RKB acknowledges funding from the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEOLA MO, 1992, ENVIRON CONSERV, V19, P125, DOI 10.1017/S0376892900030605; Adjakpa J.B., 2002, MALIMBUS, V24, P1; Alves RRN, 2007, BIOSCIENCE, V57, P949, DOI 10.1641/B571107; [Anonymous], [No title captured]; [Anonymous], 2011, STANDARD; ANYINAM C, 1995, SOC SCI MED, V40, P321, DOI 10.1016/0277-9536(94)E0098-D; Barnes K.N, 2000, ESKOM RED DATA BOOK; Baskind R, 2005, EPILEPSIA, V46, P1121, DOI 10.1111/j.1528-1167.2005.03505.x; Beninguisse Gervais, 2004, Afr J Reprod Health, V8, P152, DOI 10.2307/3583401; Betlu ALS, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-56; BirdLife International, 2012, BARN OWL; BirdLife International, 2008, PART BIRDLIFE STAT W; BirdLife International, 2013, STAT AFR BIRDS OUTL; BirdLife International, 2014, TAX; BirdLife International, 2014, COUNTR PROF; Bruyns R.K., 2013, ANIMALS TRADITIONAL, P475; Buckley AD, 1985, YORUBA MED; Butchart SHM, 2008, BIRD CONSERV INT, V18, pS245, DOI 10.1017/S095927090800035X; Chakravorty J, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-13; Chittenden H, 2007, ROBERTS BIRD GUIDE; Cocker Mark, 2001, Bulletin of the African Bird Club, V8, P30; Cocker Mark, 2000, Bulletin of the African Bird Club, V7, P60; Colwell R. K., 2006, ESTIMATES VERSION 8; Costa-Neto EM, 2005, AN ACAD BRAS CIENC, V77, P33, DOI 10.1590/S0001-37652005000100004; Costa-Neto EM, 1999, J ETHNOPHARMACOL, V65, P225, DOI 10.1016/S0378-8741(98)00158-5; CRUMP CM, 2003, HAWKERS HLTH INVESTI; Cunningham AB, 1990, VULTURE NEWS, V24, P3; Cunningham AB, 2001, APPL ETHNOBOTANY PEO; Cunningham AB, 1991, USE ANIMAL PAR UNPUB; DEKOCK AC, 1985, OSTRICH, V56, P278; Del Hoyo J, 2014, HBW BIRDLIF IN PRESS; Derwent Sue, 1997, Africa Birds & Birding, V2, P22; Ding CG, 1996, RISK ANAL, V16, P411, DOI 10.1111/j.1539-6924.1996.tb01475.x; Downs C, 2014, OSTRICH, V85, DOI 10.2989/00306525.2014.912452; El-Kamali HH, 2000, J ETHNOPHARMACOL, V72, P279, DOI 10.1016/S0378-8741(00)00209-9; ETKIN NL, 1982, SOC SCI MED, V16, P1559, DOI 10.1016/0277-9536(82)90167-8; France H, 1905, J ROYAL AFRICAN SOC, V5, P38; Garbutt HW, 1909, J R ANTHROPOL INST G, V39, P530, DOI 10.2307/2843218; GIVEN DR, 1993, BIOL CONSERV, V64, P57, DOI 10.1016/0006-3207(93)90383-C; Graham-Rowe D, 2011, NATURE, V480, pS101, DOI 10.1038/480S101a; Haileselasie T.H., 2012, CURR RES J BIOL SCI, V4, P563, DOI 10.5897/ijbc11.274; HALL AV, 1993, S AFR J BOT, V59, P581, DOI 10.1016/S0254-6299(16)30674-3; Herholdt JJ, 2006, OSTRICH, V77, P127, DOI 10.2989/00306520609485523; Hobbs JJ, 2004, BIODIVERS CONSERV, V13, P2209, DOI 10.1023/B:BIOC.0000047905.79709.7f; Hoft M, 1999, 6 UNESCO; Hollis C, 1901, J ROY AFR SOC, V1, P98; Ichikawa Mitsuo, 1998, African Study Monographs Supplementary Issue, V25, P105; Jaroli DP, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-6; Julliard R, 2004, GLOBAL CHANGE BIOL, V10, P148, DOI 10.1111/j.1365-2486.2003.00723.x; Kemp A, 2000, EMU, V100, P355, DOI 10.1071/MU0003S; Kizungu B, 1998, AFRICAN STUDY MONOGR, V19, P102; Lacaille J, 1951, OUTSPAN, V9, P81; Lacaille J, 1951, OUTSPAN, V9, P47; Lev E, 2003, J ETHNOPHARMACOL, V85, P107, DOI 10.1016/S0378-8741(02)00377-X; LOEB EM, 1956, J AM FOLKLORE, V69, P147, DOI 10.2307/537275; Macdonald IAW, 1985, AFRICAN WILDLIFE, V38, P4; Machado N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072283; Mahawar MM, 2008, J ETHNOBIOL ETHNOMED, V4, DOI 10.1186/1746-4269-4-17; Mander M, 2007, SURVEY TRADE V UNPUB; Marcot Bruce G., 2007, Tyto, V11, P5; Bezerra DMM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-3; Marshall NT, 1998, SEARCHING CURE CONSE; MARTIN TE, 1992, ECOLOGY, V73, P579, DOI 10.2307/1940764; Mishra N, 2013, AFRICAN J PHARM PHAR, V5, P6, DOI [10.5897/AJPP09.241, DOI 10.5897/AJPP09.241]; Myers OB, 1999, HUM ECOL RISK ASSESS, V5, P559, DOI 10.1080/10807039991289536; Ngwenya MP, 2001, NA12404 EZ KZN; Nikolaus Gerhard, 2001, Malimbus, V23, P45; Alves RRN, 2010, HUM ECOL, V38, P691, DOI 10.1007/s10745-010-9352-0; Ntiamoa-Baidu Y., 1987, Unasylva, V39, P27; Ogada DL, 2012, J RAPTOR RES, V46, P327, DOI 10.3356/JRR-11-90.1; Ogada DL, 2010, J RAPTOR RES, V44, P129, DOI 10.3356/JRR-09-49.1; Ogada DL, 2008, ENVIRON CONSERV, V35, P252, DOI 10.1017/S0376892908005006; Ogada DL, 2007, THESIS RHODES U GRAH; Otieno PO, 2010, B ENVIRON CONTAM TOX, V84, P536, DOI 10.1007/s00128-010-9956-5; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rabinowitz D., 1986, CONSERVATION BIOL SC, P182; Rabinowitz D., 1981, 7 FORMS RARITY BIOLO; Ramos MC, 2001, ATMOS RES, V57, P123, DOI 10.1016/S0169-8095(01)00065-5; Saengkrajang W, 2013, J FOOD COMPOS ANAL, V31, P41, DOI 10.1016/j.jfca.2013.05.001; Sankaran R, 2001, BIOL CONSERV, V97, P283, DOI 10.1016/S0006-3207(00)00124-5; Serge BK, 2010, 12 ISE REC DEV; Serle W, 1979, OISEAUX OUEST AFRICA; Simelane TS, 1998, S AFR J WILDL RES, V28, P121; Simeonov V, 2003, CLEAN TECHNOL ENVIR, V5, P190, DOI [10.1007/s10098-003-0201-3, DOI 10.1007/S10098-003-0201-3]; Sinclair I, 2010, CHAMBERLAINS BIRDS A; Sodeinde O.A., 1999, Traffic Bulletin, V18, P35; Soewu DA, 2008, AFR J AGRIC RES, V3, P421; Taylor M.E., 1992, Nigerian Field, V57, P119; Tobias JA, 2010, IBIS, V152, P724, DOI 10.1111/j.1474-919X.2010.01051.x; Vickery JA, 2014, IBIS, V156, P1, DOI 10.1111/ibi.12118; WHITE RM, 2004, INDIGENOUS FORESTS W, P474; Whiting MJ, 2011, J ZOOL, V284, P84, DOI 10.1111/j.1469-7998.2010.00784.x; Williams V.L., 2013, ANIMALS TRADITIONAL, P383; WILLIAMS VL, 2007, THESIS U WITWATERSRA; Wilson G, 2013, IBIS, V155, P476, DOI 10.1111/ibi.12042; Yu JP, 2000, J BIOGEOGR, V27, P131, DOI 10.1046/j.1365-2699.2000.00366.x; Zhao ZZ, 2004, ILLUSTRATED CHINESE	98	31	31	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105397	10.1371/journal.pone.0105397	http://dx.doi.org/10.1371/journal.pone.0105397			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162700	Green Published, gold			2022-12-25	WOS:000340880900034
J	Tang, W; Strachan, RT; Lefkowitz, RJ; Rockman, HA				Tang, Wei; Strachan, Ryan T.; Lefkowitz, Robert J.; Rockman, Howard A.			Allosteric Modulation of beta-Arrestin-biased Angiotensin II Type 1 Receptor Signaling by Membrane Stretch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; TERNARY COMPLEX MODEL; 7-TRANSMEMBRANE RECEPTORS; MECHANICAL-STRESS; ADRENERGIC-RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; CONFORMATIONAL-CHANGES; CARDIAC-HYPERTROPHY; CRYSTAL-STRUCTURE; SHEAR-STRESS	It has recently been appreciated that the angiotensin II type 1 receptor (AT1R), a prototypic member of the G protein-coupled receptor superfamily, also functions as a mechanosensor. Specifically, mechanical stretch activates the AT1R to promote downstream signaling mediated exclusively by the multifunctional scaffold protein, beta-arrestin, in a manner consistent with previously identified beta-arrestin-biased ligands. However, the ligand-independent mechanism by which mechanical stretch promotes beta-arrestin-biased signaling remains unknown. Implicit in the concept of biased agonism (i.e. the ability of an agonist to activate a subset of receptor-mediated signaling pathways) is the notion that distinct active conformations of the receptor mediate differential activation of signaling pathways. Here we determined whether mechanical stretch stabilizes distinct beta-arrestin-activating conformations of the AT1R by using beta-arrestin2-biased agonists as conformational probes in pharmacological and biophysical assays. When tested at cells expressing the AT1R fused to beta-arrestin (AT1R-beta-arrestin2), we found that osmotic stretch increased the binding affinity and potency of the beta-arrestin-biased agonist TRV120023, with no effect on the balanced agonist AngII. In addition, the effect of osmotic stretch on ERK activation was markedly augmented in cells expressing the AT1R-beta-arrestin2 fusion compared with the wild type AT1R and completely blocked in cells expressing the AT1R-G(q) fusion. Biophysical experiments with an intramolecular BRET beta-arrestin2 biosensor revealed that osmotic stretch and TRV120023 activate AT1Rs to stabilize beta-arrestin2 active conformations that differ from those stabilized by the AT1R activated by angiotensin II. Together, these data support a novel ligand-independent mechanism whereby mechanical stretch allosterically stabilizes specific beta-arrestin-biased active conformations of the AT1R and has important implications for understanding pathophysiological AT1R signaling.	[Tang, Wei; Strachan, Ryan T.; Lefkowitz, Robert J.; Rockman, Howard A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Rockman, Howard A.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Rockman, Howard A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Strachan, Ryan T.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Rockman, HA (corresponding author), Duke Univ, DUMC 3104,Rm 226 CARL Bldg, Durham, NC 27710 USA.	h.rockman@duke.edu	Lefkowitz, Robert/AAW-2649-2021		National Institutes of Health [HL56687, HL75443, HL16037, HL70631, T32 HL007101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075443, R01HL070631, R01HL016037, R37HL016037, T32HL007101, R01HL056687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL56687 and HL75443 (to H. A. R.), HL16037 and HL70631 (to R. J. L.), and T32 HL007101 to (W. T.).	Barauna VG, 2013, BIOCHEM BIOPH RES CO, V434, P647, DOI 10.1016/j.bbrc.2013.04.005; Barnett-Norris J, 2005, LIFE SCI, V77, P1625, DOI 10.1016/j.lfs.2005.05.040; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Charest PG, 2005, EMBO REP, V6, P334, DOI 10.1038/sj.embor.7400373; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; Daniels D, 2005, ENDOCRINOLOGY, V146, P5552, DOI 10.1210/en.2005-0774; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Fork C, 2011, BIOCHEM J, V436, P305, DOI 10.1042/BJ20101904; GERWINS P, 1990, MOL PHARMACOL, V38, P660; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Johnson AK, 1996, CLIN EXP PHARMACOL P, V23, P183, DOI 10.1111/j.1440-1681.1996.tb02594.x; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Schnitzler MMY, 2011, CURR OPIN PHARMACOL, V11, P112, DOI 10.1016/j.coph.2010.11.003; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7; Nilius B, 2012, TRENDS NEUROSCI, V35, P477, DOI 10.1016/j.tins.2012.04.002; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Onaran HO, 2012, NAT CHEM BIOL, V8, P674, DOI 10.1038/nchembio.1024; Osol G, 2002, AM J PHYSIOL-HEART C, V283, pH2260, DOI 10.1152/ajpheart.00634.2002; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rakesh K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000769; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Sanni SJ, 2010, BRIT J PHARMACOL, V161, P150, DOI 10.1111/j.1476-5381.2010.00875.x; Schleifenbaum J, 2014, CIRC RES, V115, P263, DOI 10.1161/CIRCRESAHA.115.302882; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; Seifert R, 1999, TRENDS PHARMACOL SCI, V20, P383, DOI 10.1016/S0165-6147(99)01368-1; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Storch U, 2012, AM J PHYSIOL-HEART C, V302, pH1241, DOI 10.1152/ajpheart.00818.2011; Strachan RT, 2014, J BIOL CHEM, V289, P14211, DOI 10.1074/jbc.M114.548131; Swaminath G, 2003, J BIOL CHEM, V278, P352, DOI 10.1074/jbc.M206424200; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Yasuda N, 2008, EMBO REP, V9, P179, DOI 10.1038/sj.embor.7401157; Zablocki D, 2013, CIRC RES, V113, P1192, DOI 10.1161/CIRCRESAHA.113.302501; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	54	39	40	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28271	28283		10.1074/jbc.M114.585067	http://dx.doi.org/10.1074/jbc.M114.585067			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25170081	hybrid, Green Published			2022-12-25	WOS:000343765400023
J	Gedye, CA; Hussain, A; Paterson, J; Smrke, A; Saini, H; Sirskyj, D; Pereira, K; Lobo, N; Stewart, J; Go, C; Ho, J; Medrano, M; Hyatt, E; Yuan, J; Lauriault, S; Kondratyev, M; van den Beucken, T; Jewett, M; Dirks, P; Guidos, CJ; Danska, J; Wang, J; Wouters, B; Neel, B; Rottapel, R; Ailles, LE				Gedye, Craig A.; Hussain, Ali; Paterson, Joshua; Smrke, Alannah; Saini, Harleen; Sirskyj, Danylo; Pereira, Keira; Lobo, Nazleen; Stewart, Jocelyn; Go, Christopher; Ho, Jenny; Medrano, Mauricio; Hyatt, Elzbieta; Yuan, Julie; Lauriault, Stevan; Kondratyev, Maria; van den Beucken, Twan; Jewett, Michael; Dirks, Peter; Guidos, Cynthia J.; Danska, Jayne; Wang, Jean; Wouters, Bradly; Neel, Benjamin; Rottapel, Robert; Ailles, Laurie E.			Cell Surface Profiling Using High-Throughput Flow Cytometry: A Platform for Biomarker Discovery and Analysis of Cellular Heterogeneity	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; MESENCHYMAL STEM-CELLS; OVARIAN-CARCINOMA; MASS CYTOMETRY; EXPRESSION; MUTATIONS; PROTEINS; MARKER; SERVE; TP53	Cell surface proteins have a wide range of biological functions, and are often used as lineage-specific markers. Antibodies that recognize cell surface antigens are widely used as research tools, diagnostic markers, and even therapeutic agents. The ability to obtain broad cell surface protein profiles would thus be of great value in a wide range of fields. There are however currently few available methods for high-throughput analysis of large numbers of cell surface proteins. We describe here a high-throughput flow cytometry (HT-FC) platform for rapid analysis of 363 cell surface antigens. Here we demonstrate that HT-FC provides reproducible results, and use the platform to identify cell surface antigens that are influenced by common cell preparation methods. We show that multiple populations within complex samples such as primary tumors can be simultaneously analyzed by co-staining of cells with lineage-specific antibodies, allowing unprecedented depth of analysis of heterogeneous cell populations. Furthermore, standard informatics methods can be used to visualize, cluster and downsample HT-FC data to reveal novel signatures and biomarkers. We show that the cell surface profile provides sufficient molecular information to classify samples from different cancers and tissue types into biologically relevant clusters using unsupervised hierarchical clustering. Finally, we describe the identification of a candidate lineage marker and its subsequent validation. In summary, HT-FC combines the advantages of a high-throughput screen with a detection method that is sensitive, quantitative, highly reproducible, and allows in-depth analysis of heterogeneous samples. The use of commercially available antibodies means that high quality reagents are immediately available for follow-up studies. HT-FC has a wide range of applications, including biomarker discovery, molecular classification of cancers, or identification of novel lineage specific or stem cell markers.	[Gedye, Craig A.; Paterson, Joshua; Smrke, Alannah; Saini, Harleen; Sirskyj, Danylo; Go, Christopher; Ho, Jenny; Kondratyev, Maria; van den Beucken, Twan; Jewett, Michael; Wang, Jean; Wouters, Bradly; Neel, Benjamin; Rottapel, Robert; Ailles, Laurie E.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Hussain, Ali; Pereira, Keira; Lobo, Nazleen; Stewart, Jocelyn; Medrano, Mauricio; Wouters, Bradly; Neel, Benjamin; Ailles, Laurie E.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Hyatt, Elzbieta; Yuan, Julie; Lauriault, Stevan; Dirks, Peter; Guidos, Cynthia J.; Danska, Jayne] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ailles, LE (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.	lailles@uhnresearch.ca	; Wouters, Bradly/T-1525-2017	Lobo, Nazleen/0000-0003-2696-3676; Gedye, Craig/0000-0002-1629-4352; Wang, Jean/0000-0001-7543-3917; Rottapel, Robert/0000-0002-6024-5558; van den Beucken, Twan/0000-0002-2233-7558; Wouters, Bradly/0000-0002-8187-592X	Ontario Institute for Cancer Research; Canadian Institute for Health Research/Kidney Cancer Canada Fellowship; Royal Australasian College of Physicians CSL Fellowship; National Health and Medical Research Council Overseas Postdoctoral Fellowship; Ontario Ministry of Health and Long Term Care	Ontario Institute for Cancer Research; Canadian Institute for Health Research/Kidney Cancer Canada Fellowship; Royal Australasian College of Physicians CSL Fellowship; National Health and Medical Research Council Overseas Postdoctoral Fellowship; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	Funding for this work was provided to LEA by the Ontario Institute for Cancer Research (http://oicr.on.ca/). CAG was supported by a Canadian Institute for Health Research/Kidney Cancer Canada Fellowship, and has been supported by a Royal Australasian College of Physicians CSL Fellowship and a National Health and Medical Research Council Overseas Postdoctoral Fellowship. This research was funded in part by the Ontario Ministry of Health and Long Term Care. The views expressed do not necessarily reflect those of the OMOHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Basten Sander G, 2013, Cilia, V2, P2, DOI 10.1186/2046-2530-2-2; Bayer-Garner IB, 2001, MODERN PATHOL, V14, P1052, DOI 10.1038/modpathol.3880435; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; da Cunha JPC, 2009, P NATL ACAD SCI USA, V106, P16752, DOI 10.1073/pnas.0907939106; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Gedye Craig, 2013, Methods Mol Biol, V946, P181, DOI 10.1007/978-1-62703-128-8_12; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Goodpaster T, 2008, J HISTOCHEM CYTOCHEM, V56, P347, DOI 10.1369/jhc.7A7287.2007; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Kim Y, 2011, METHODS MOL BIOL, V748, P227, DOI 10.1007/978-1-61779-139-0_16; Krutzik Peter O, 2011, Curr Protoc Cytom, VChapter 6, DOI 10.1002/0471142956.cy0631s55; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Nery AA, 2013, CYTOM PART A, V83A, P48, DOI 10.1002/cyto.a.22205; Ornatsky O, 2010, J IMMUNOL METHODS, V361, P1, DOI 10.1016/j.jim.2010.07.002; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Sewell WA, 2011, PATHOLOGY, V43, P580, DOI 10.1097/PAT.0b013e32834a69ae; Stewart JM, 2011, P NATL ACAD SCI USA, V108, P6468, DOI 10.1073/pnas.1005529108; Streitz M, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-17; True LD, 2010, MODERN PATHOL, V23, P1346, DOI 10.1038/modpathol.2010.122; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Virgo PF, 2012, ANN CLIN BIOCHEM, V49, P17, DOI 10.1258/acb.2011.011128; Warner JK, 2005, LEUKEMIA, V19, P1794, DOI 10.1038/sj.leu.2403917; WIJDENES J, 1997, LEUCOCYTE TYPING, P149; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Wu CC, 2003, NAT BIOTECHNOL, V21, P532, DOI 10.1038/nbt819; Yemelyanova A, 2011, MODERN PATHOL, V24, P1248, DOI 10.1038/modpathol.2011.85; Zhao HJ, 2009, PROSTATE, V69, P991, DOI 10.1002/pros.20946	35	50	50	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105602	10.1371/journal.pone.0105602	http://dx.doi.org/10.1371/journal.pone.0105602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170899	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500061
J	Haymond, A; Johny, C; Dowdy, T; Schweibenz, B; Villarroel, K; Young, R; Mantooth, CJ; Patel, T; Bases, J; Jose, GS; Jackson, ER; Dowd, CS; Couch, RD				Haymond, Amanda; Johny, Chinchu; Dowdy, Tyrone; Schweibenz, Brandon; Villarroel, Karen; Young, Richard; Mantooth, Clark J.; Patel, Trishal; Bases, Jessica; Jose, Geraldine San; Jackson, Emily R.; Dowd, Cynthia S.; Couch, Robin D.			Kinetic Characterization and Allosteric Inhibition of the Yersinia pestis 1-Deoxy-D-Xylulose 5-Phosphate Reductoisomerase (MEP Synthase)	PLOS ONE			English	Article							2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE PATHWAY; TRANSPOSON MUTANT LIBRARY; NON-MEVALONATE PATHWAY; MYCOBACTERIUM-TUBERCULOSIS; ISOPRENOID BIOSYNTHESIS; NONMEVALONATE PATHWAY; ESCHERICHIA-COLI; 4-(CYTIDINE 5'-DIPHOSPHO)-2-C-METHYL-D-ERYTHRITOL; FOSMIDOMYCIN RESISTANCE; DXP SYNTHASE	The methylerythritol phosphate (MEP) pathway found in many bacteria governs the synthesis of isoprenoids, which are crucial lipid precursors for vital cell components such as ubiquinone. Because mammals synthesize isoprenoids via an alternate pathway, the bacterial MEP pathway is an attractive target for novel antibiotic development, necessitated by emerging antibiotic resistance as well as biodefense concerns. The first committed step in the MEP pathway is the reduction and isomerization of 1-deoxy-D-xylulose-5-phosphate (DXP) to methylerythritol phosphate (MEP), catalyzed by MEP synthase. To facilitate drug development, we cloned, expressed, purified, and characterized MEP synthase from Yersinia pestis. Enzyme assays indicate apparent kinetic constants of K-M(DXP) = 252 mu M and K-M(NADPH) = 13 mu M, IC50 values for fosmidomycin and FR900098 of 710 nM and 231 nM respectively, and K-i values for fosmidomycin and FR900098 of 251 nM and 101 nM respectively. To ascertain if the Y. pestis MEP synthase was amenable to a high-throughput screening campaign, the Z-factor was determined (0.9) then the purified enzyme was screened against a pilot scale library containing rationally designed fosmidomycin analogs and natural product extracts. Several hit molecules were obtained, most notably a natural product allosteric affector of MEP synthase and a rationally designed bisubstrate derivative of FR900098 (able to associate with both the NADPH and DXP binding sites in MEP synthase). It is particularly noteworthy that allosteric regulation of MEP synthase has not been described previously. Thus, our discovery implicates an alternative site (and new chemical space) for rational drug development.	[Haymond, Amanda; Johny, Chinchu; Dowdy, Tyrone; Schweibenz, Brandon; Villarroel, Karen; Young, Richard; Mantooth, Clark J.; Patel, Trishal; Bases, Jessica; Couch, Robin D.] George Mason Univ, Dept Chem & Biochem, Manassas, VA 20110 USA; [Jose, Geraldine San; Jackson, Emily R.; Dowd, Cynthia S.] George Washington Univ, Dept Chem, Washington, DC 20052 USA	George Mason University; George Washington University	Couch, RD (corresponding author), George Mason Univ, Dept Chem & Biochem, Manassas, VA 20110 USA.	rcouch@gmu.edu		Haymond Still, Amanda/0000-0002-9553-275X; Schweibenz, Brandon/0000-0003-1532-4502	George Mason University's Department of Chemistry and Biochemistry; U.S. Army Medical Research and Materiel Command [W23RYX1291N601]	George Mason University's Department of Chemistry and Biochemistry; U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This study was supported by George Mason University's Department of Chemistry and Biochemistry and the U.S. Army Medical Research and Materiel Command W23RYX1291N601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P, 2002, P NATL ACAD SCI USA, V99, P12108, DOI 10.1073/pnas.182412599; AGRANOFF BW, 1959, J AM CHEM SOC, V81, P1254, DOI 10.1021/ja01514a059; ALBERTS AW, 1988, AM J CARDIOL, V62, pJ10, DOI 10.1016/0002-9149(88)90002-1; Altincicek B, 2000, FEMS MICROBIOL LETT, V190, P329, DOI 10.1111/j.1574-6968.2000.tb09307.x; Altincicek B, 2002, FEBS LETT, V532, P437, DOI 10.1016/S0014-5793(02)03726-2; Altincicek B, 2001, FEBS LETT, V499, P37, DOI 10.1016/S0014-5793(01)02516-9; Altincicek B, 2001, J BACTERIOL, V183, P2411, DOI 10.1128/JB.183.8.2411-2416.2001; AMDUR BH, 1957, J AM CHEM SOC, V79, P2646, DOI 10.1021/ja01567a077; Andaloussi M, 2011, J MED CHEM, V54, P4964, DOI 10.1021/jm2000085; Arigoni D, 1997, P NATL ACAD SCI USA, V94, P10600, DOI 10.1073/pnas.94.20.10600; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bjorkelid C, 2012, ACTA CRYSTALLOGR D, V68, P134, DOI 10.1107/S0907444911052231; BLOCH K, 1959, J BIOL CHEM, V234, P2595; Brown AC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-78; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Campos N, 2001, FEBS LETT, V488, P170, DOI 10.1016/S0014-5793(00)02420-0; Carretero-Paulet L, 2006, PLANT MOL BIOL, V62, P683, DOI 10.1007/s11103-006-9051-9; Cunningham FX, 2000, J BACTERIOL, V182, P5841, DOI 10.1128/JB.182.20.5841-5848.2000; DHEPAGANON S, 1994, BIOCHEMISTRY-US, V33, P13355, DOI 10.1021/bi00249a023; Dhiman RK, 2005, J BACTERIOL, V187, P8395, DOI 10.1128/JB.187.24.8395-8402.2005; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Grawert T, 2011, CELL MOL LIFE SCI, V68, P3797, DOI 10.1007/s00018-011-0753-z; Haemers T, 2006, BIOORG MED CHEM LETT, V16, P1888, DOI 10.1016/j.bmcl.2005.12.082; Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134; Hecht S, 2001, P NATL ACAD SCI USA, V98, P14837, DOI 10.1073/pnas.201399298; Henriksson LM, 2007, J BIOL CHEM, V282, P19905, DOI 10.1074/jbc.M701935200; Herz S, 2000, P NATL ACAD SCI USA, V97, P2486, DOI 10.1073/pnas.040554697; Hill RE, 1996, J BIOL CHEM, V271, P30426, DOI 10.1074/jbc.271.48.30426; HILL RE, 1989, J AM CHEM SOC, V111, P1916, DOI 10.1021/ja00187a076; Humnabadkar V, 2011, J BIOMOL SCREEN, V16, P303, DOI 10.1177/1087057110394845; Jackson ER, 2012, CURR TOP MED CHEM, V12, P706; Janthawornpong K, 2013, J AM CHEM SOC, V135, P1816, DOI 10.1021/ja309557s; Jawaid S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008288; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Jose GS, 2013, MEDCHEMCOMM, V4, P1099, DOI 10.1039/c3md00085k; JP M, 1983, MECH ACTION BETAOXOA; JULLIARD JH, 1991, P NATL ACAD SCI USA, V88, P2042, DOI 10.1073/pnas.88.6.2042; JULLIARD JH, 1992, CR ACAD SCI III-VIE, V314, P285; Kollas AK, 2002, FEBS LETT, V532, P432, DOI 10.1016/S0014-5793(02)03725-0; Koppisch AT, 2002, BIOCHEMISTRY-US, V41, P236, DOI 10.1021/bi0118207; Kunfermann A, 2014, ANGEW CHEM INT EDIT, V53, P2235, DOI 10.1002/anie.201309557; Kuzuyama T, 2000, J BIOL CHEM, V275, P19928, DOI 10.1074/jbc.M001820200; Kuzuyama T, 2000, TETRAHEDRON LETT, V41, P2925, DOI 10.1016/S0040-4039(00)00295-1; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P7913, DOI 10.1016/S0040-4039(98)01755-9; Kuzuyama T, 2000, TETRAHEDRON LETT, V41, P703, DOI 10.1016/S0040-4039(99)02143-7; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; Luttgen H, 2000, P NATL ACAD SCI USA, V97, P1062, DOI 10.1073/pnas.97.3.1062; Mac Sweeney A, 2005, J MOL BIOL, V345, P115, DOI 10.1016/j.jmb.2004.10.030; Matsue Y, 2010, J ANTIBIOT, V63, P583, DOI 10.1038/ja.2010.100; McAteer S, 2001, J BACTERIOL, V183, P7403, DOI 10.1128/JB.183.24.7403-7407.2001; McKenney ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038167; MIZIORKO HM, 1977, J BIOL CHEM, V252, P1414; MOORE RN, 1985, J AM CHEM SOC, V107, P3694, DOI 10.1021/ja00298a046; Nakagawa K, 2013, BIOSCI BIOTECH BIOCH, V77, P1449, DOI 10.1271/bbb.130094; OKUHARA M, 1980, J ANTIBIOT, V33, P13, DOI 10.7164/antibiotics.33.13; Putra SR, 1998, TETRAHEDRON LETT, V39, P23, DOI 10.1016/S0040-4039(97)10458-0; Ramsden NL, 2009, J MED CHEM, V52, P2531, DOI 10.1021/jm801475n; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; Ray A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-224; Rohdich F, 2005, BIOCHEM SOC T, V33, P785, DOI 10.1042/BST0330785; Rohdich F, 2003, P NATL ACAD SCI USA, V100, P1586, DOI 10.1073/pnas.0337742100; Rohdich F, 2002, P NATL ACAD SCI USA, V99, P1158, DOI 10.1073/pnas.032658999; Rohdich F, 1999, P NATL ACAD SCI USA, V96, P11758, DOI 10.1073/pnas.96.21.11758; Rohmer M, 2008, LIPIDS, V43, P1095, DOI 10.1007/s11745-008-3261-7; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sakamoto Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2030, DOI 10.1271/bbb.67.2030; Singh N, 2007, CURR PHARM DESIGN, V13, P1161, DOI 10.2174/138161207780618939; Smith JM, 2014, J ANTIBIOT, V67, P77, DOI 10.1038/ja.2013.105; Span I, 2014, J AM CHEM SOC, V136, P7926, DOI 10.1021/ja501127j; Takahashi S, 1998, P NATL ACAD SCI USA, V95, P9879, DOI 10.1073/pnas.95.17.9879; Tang M, 2011, BIOORGAN MED CHEM, V19, P5886, DOI 10.1016/j.bmc.2011.08.012; Tidten-Luksch N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035792; Uh E, 2011, BIOORG MED CHEM LETT, V21, P6973, DOI 10.1016/j.bmcl.2011.09.123; Umeda T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00009; Walker JR, 2005, J ORG CHEM, V70, P9955, DOI 10.1021/jo0516786; Wang WX, 2014, ANGEW CHEM INT EDIT, V53, P4294, DOI 10.1002/anie.201306712; Witschel MC, 2011, ANGEW CHEM INT EDIT, V50, P7931, DOI 10.1002/anie.201102281; Woo YH, 2006, BIOORGAN MED CHEM, V14, P2375, DOI 10.1016/j.bmc.2005.11.012; Yajima S, 2007, ACTA CRYSTALLOGR F, V63, P466, DOI 10.1107/S1744309107024475; Yin XH, 2003, BBA-PROTEINS PROTEOM, V1652, P75, DOI 10.1016/j.bbapap.2003.08.005; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Z, 2013, BIOORG MED CHEM LETT, V23, P6860, DOI 10.1016/j.bmcl.2013.09.101	84	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106243	10.1371/journal.pone.0106243	http://dx.doi.org/10.1371/journal.pone.0106243			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171339	Green Submitted, Green Published, gold			2022-12-25	WOS:000341127500133
J	Nankova, BB; Agarwal, R; MacFabe, DF; La Gamma, EF				Nankova, Bistra B.; Agarwal, Raj; MacFabe, Derrick F.; La Gamma, Edmund F.			Enteric Bacterial Metabolites Propionic and Butyric Acid Modulate Gene Expression, Including CREB-Dependent Catecholaminergic Neurotransmission, in PC12 Cells - Possible Relevance to Autism Spectrum Disorders	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; HISTONE DEACETYLASE INHIBITORS; GLUTATHIONE REDOX IMBALANCE; TYROSINE-HYDROXYLASE; VALPROIC ACID; RODENT MODEL; GUT MICROBIOTA; ANIMAL-MODELS; PHYSIOLOGICAL ABNORMALITIES; PRENATAL EXPOSURE	Alterations in gut microbiome composition have an emerging role in health and disease including brain function and behavior. Short chain fatty acids (SCFA) like propionic (PPA), and butyric acid (BA), which are present in diet and are fermentation products of many gastrointestinal bacteria, are showing increasing importance in host health, but also may be environmental contributors in neurodevelopmental disorders including autism spectrum disorders (ASD). Further to this we have shown SCFA administration to rodents over a variety of routes (intracerebroventricular, subcutaneous, intraperitoneal) or developmental time periods can elicit behavioral, electrophysiological, neuropathological and biochemical effects consistent with findings in ASD patients. SCFA are capable of altering host gene expression, partly due to their histone deacetylase inhibitor activity. We have previously shown BA can regulate tyrosine hydroxylase (TH) mRNA levels in a PC12 cell model. Since monoamine concentration is known to be elevated in the brain and blood of ASD patients and in many ASD animal models, we hypothesized that SCFA may directly influence brain monoaminergic pathways. When PC12 cells were transiently transfected with plasmids having a luciferase reporter gene under the control of the TH promoter, PPA was found to induce reporter gene activity over a wide concentration range. CREB transcription factor(s) was necessary for the transcriptional activation of TH gene by PPA. At lower concentrations PPA also caused accumulation of TH mRNA and protein, indicative of increased cell capacity to produce catecholamines. PPA and BA induced broad alterations in gene expression including neurotransmitter systems, neuronal cell adhesion molecules, inflammation, oxidative stress, lipid metabolism and mitochondrial function, all of which have been implicated in ASD. In conclusion, our data are consistent with a molecular mechanism through which gut related environmental signals such as increased levels of SCFA's can epigenetically modulate cell function further supporting their role as environmental contributors to ASD.	[Nankova, Bistra B.; Agarwal, Raj; La Gamma, Edmund F.] Maria Fareri Childrens Hosp, Dept Pediat, New York Med Coll, Valhalla, NY 10595 USA; [MacFabe, Derrick F.] Univ Western Ontario, Kilee Patchell Evans Autism Res Grp, Dept Psychol Neurosci, London, ON, Canada; [MacFabe, Derrick F.] Univ Western Ontario, Dept Psychiat, Div Dev Disabil, London, ON N6A 3K7, Canada	New York Medical College; Western University (University of Western Ontario); Western University (University of Western Ontario)	Nankova, BB (corresponding author), Maria Fareri Childrens Hosp, Dept Pediat, New York Med Coll, Valhalla, NY 10595 USA.	bistra_nankova@nymc.edu	Nankova, Bistra/AEV-0617-2022	LaGamma, Edmund/0000-0001-9720-1949; Nankova, Bistra/0000-0002-3997-4369	Children's Research Foundation; Children's and Women's Physicians of Westchester (CWPW); GoodLife's Children's Foundation; Autism Research Institute	Children's Research Foundation; Children's and Women's Physicians of Westchester (CWPW); GoodLife's Children's Foundation; Autism Research Institute	Children's Research Foundation and Children's and Women's Physicians of Westchester (CWPW) to BN and ELG; GoodLife's Children's Foundation and Autism Research Institute to DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22; Al-Ghamdi M, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-34; Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007; Amminger GP, 2007, BIOL PSYCHIAT, V61, P551, DOI 10.1016/j.biopsych.2006.05.007; Aneja A, 2008, INT REV PSYCHIATR, V20, P165, DOI 10.1080/09540260801889062; Aranyi T, 2007, BIOCHEM BIOPH RES CO, V359, P15, DOI 10.1016/j.bbrc.2007.05.025; Bell JG, 2000, PROSTAG LEUKOTR ESS, V63, P21, DOI 10.1054/plef.2000.0186; Bell JG, 2004, PROSTAG LEUKOTR ESS, V71, P201, DOI 10.1016/j.plefa.2004.03.008; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bergersen L, 2002, NEUROCHEM RES, V27, P89, DOI 10.1023/A:1014806723147; Boccuto L, 2013, EUR J HUM GENET, V21, P310, DOI 10.1038/ejhg.2012.175; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Brusque AM, 1999, PHARMACOL BIOCHEM BE, V64, P529, DOI 10.1016/S0091-3057(99)00127-6; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Chauhan Abha, 2006, Pathophysiology, V13, P171, DOI 10.1016/j.pathophys.2006.05.007; Chauhan A, 2012, NEUROCHEM RES, V37, P1681, DOI 10.1007/s11064-012-0775-4; Chen JS, 2003, CURR CANCER DRUG TAR, V3, P219, DOI 10.2174/1568009033481994; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Christensen J, 2013, JAMA-J AM MED ASSOC, V309, P1696, DOI 10.1001/jama.2013.2270; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cohen OS, 2013, INT J DEV NEUROSCI, V31, P740, DOI 10.1016/j.ijdevneu.2013.09.002; CONN AR, 1983, AM J PHYSIOL, V245, pE253, DOI 10.1152/ajpendo.1983.245.3.E253; COULTER DL, 1991, J CHILD NEUROL, V6, P7, DOI 10.1177/088307389100600102; Cuche G, 1999, NEUROGASTROENT MOTIL, V11, P219; D'Souza A, 2009, BRAIN RES, V1247, P1, DOI 10.1016/j.brainres.2008.09.088; de Theije CGM, 2014, BRAIN BEHAV IMMUN, V37, P197, DOI 10.1016/j.bbi.2013.12.005; de Theije CGM, 2011, EUR J PHARMACOL, V668, pS70, DOI 10.1016/j.ejphar.2011.07.013; DeCastro M, 2005, MOL BRAIN RES, V142, P28, DOI 10.1016/j.molbrainres.2005.09.002; Devine DP, 2012, METHODS MOL BIOL, V829, P65, DOI 10.1007/978-1-61779-458-2_4; Dichter GS, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-19; Ebert SN, 1997, MOL BRAIN RES, V47, P24, DOI 10.1016/S0169-328X(97)00032-6; Ekins S, 2007, METH MOL B, V356, P319; El-Ansary AK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-74; FADER D, 1990, MOL BRAIN RES, V8, P25, DOI 10.1016/0169-328X(90)90005-X; Fatemi SH, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-6; Feliz Brady, 2003, Arch Pathol Lab Med, V127, pe325; Fenton WA, 2001, METABOLIC MOL BASES; Finegold SM, 2011, ANAEROBE, V17, P367, DOI 10.1016/j.anaerobe.2011.03.007; FOLEY KA, 2014, INT J DEV NEUROSCI; Foley KA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087072, 10.1371/journal.pone.0108413]; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.14; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143; Ganapathy V, 2013, CURR OPIN PHARM; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Griswold AJ, 2012, HUM MOL GENET, V21, P3513, DOI 10.1093/hmg/dds164; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Harrington RA, 2013, AUTISM RES, V6, P149, DOI 10.1002/aur.1288; Heerdt BG, 1998, CANCER RES, V58, P2869; Heerdt BG, 1997, CELL GROWTH DIFFER, V8, P523; HEERDT BG, 1994, CANCER RES, V54, P3288; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Ingram JL, 2000, NEUROTOXICOL TERATOL, V22, P319, DOI 10.1016/S0892-0362(99)00083-5; Inoue D, 2012, FEBS LETT, V586, P1547, DOI 10.1016/j.febslet.2012.04.021; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Jones MB, 2004, AM J MED GENET B, V126B, P58, DOI 10.1002/ajmg.b.20172; Karaki S, 2006, CELL TISSUE RES, V324, P353, DOI 10.1007/s00441-005-0140-x; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kim KC, 2011, TOXICOL LETT, V201, P137, DOI 10.1016/j.toxlet.2010.12.018; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Kolker S, 2013, J INHERIT METAB DIS, V36, P635, DOI 10.1007/s10545-013-9600-8; Kumer SC, 1996, J NEUROCHEM, V67, P443; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; LAKE CR, 1977, ARCH GEN PSYCHIAT, V34, P553; Langley B, 2005, CNS NEUROL DISORD-DR, V4, P41, DOI 10.2174/1568007053005091; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Leckman JF, 2002, BIOL PSYCHIAT, V51, P27, DOI 10.1016/S0006-3223(01)01277-X; Lenartowski R, 2011, INT J DEV NEUROSCI, V29, P873, DOI 10.1016/j.ijdevneu.2011.07.006; Lippiello PM, 2006, MED HYPOTHESES, V66, P985, DOI 10.1016/j.mehy.2005.11.015; Macfabe Derrick, 2013, Glob Adv Health Med, V2, P52, DOI 10.7453/gahmj.2013.089; MacFabe DF, 2007, BEHAV BRAIN RES, V176, P149, DOI 10.1016/j.bbr.2006.07.025; MacFabe Derrick F., 2012, Microbial Ecology in Health and Disease, V23, P19260, DOI 10.3402/mehd.v23i0.19260; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; Mally P, 2004, PEDIATR RES, V55, P847, DOI 10.1203/01.PDR.0000119365.21770.45; Mariadason JM, 2000, CANCER RES, V60, P4561; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Martin-Ruiz CM, 2004, MOL BRAIN RES, V123, P81, DOI 10.1016/j.molbrainres.2004.01.003; McCracken JT, 2002, NEW ENGL J MED, V347, P314, DOI 10.1056/NEJMoa013171; McDougle CJ, 2005, AM J PSYCHIAT, V162, P1142, DOI 10.1176/appi.ajp.162.6.1142; McManus CM, 2002, AM J VET RES, V63, P295, DOI 10.2460/ajvr.2002.63.295; Meguid NA, 2008, CLIN BIOCHEM, V41, P1044, DOI 10.1016/j.clinbiochem.2008.05.013; Mitsui R, 2005, JPN J PHYSIOL, V55, P331, DOI 10.2170/jjphysiol.RP000205; Mitsui R, 2005, NEUROGASTROENT MOTIL, V17, P585, DOI 10.1111/j.1365-2982.2005.00669.x; MORTENSEN FV, 1990, GUT, V31, P1391, DOI 10.1136/gut.31.12.1391; Nakasato A, 2008, BRAIN RES, V1193, P128, DOI 10.1016/j.brainres.2007.11.043; Nankova BB, 2003, PEDIATR RES, V53, P113, DOI 10.1203/01.PDR.0000039764.38034.75; Narita N, 2002, PEDIATR RES, V52, P576, DOI 10.1203/01.PDR.0000028406.01104.76; Nguyen NHT, 2007, J NEUROCHEM, V101, P806, DOI 10.1111/j.1471-4159.2006.04397.x; Niederman R, 1997, CRIT REV ORAL BIOL M, V8, P269, DOI 10.1177/10454411970080030301; Niehus R, 2006, J DEV BEHAV PEDIATR, V27, pS120, DOI 10.1097/00004703-200604002-00010; Nikolsky Y, 2005, DRUG DISCOV TODAY, V10, P653, DOI 10.1016/S1359-6446(05)03420-3; Ossenkopp KP, 2012, BEHAV BRAIN RES, V227, P134, DOI 10.1016/j.bbr.2011.10.045; Parab S, 2007, BRAIN RES, V1132, P42, DOI 10.1016/j.brainres.2006.11.013; Patel P, 2005, DEV BRAIN RES, V160, P53, DOI 10.1016/j.devbrainres.2005.08.005; Pearl PL, 2003, NEUROLOGY, V60, P1413, DOI 10.1212/01.WNL.0000059549.70717.80; Pettenuzzo LF, 2002, PHARMACOL BIOCHEM BE, V73, P623, DOI 10.1016/S0091-3057(02)00856-0; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Richardson AJ, 2004, PROSTAG LEUKOTR ESS, V70, P383, DOI 10.1016/j.plefa.2003.12.020; Robinson PD, 2001, AM J MED GENET, V100, P30, DOI 10.1002/ajmg.1187; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Sabban EL, 1997, SEMIN CELL DEV BIOL, V8, P101, DOI 10.1006/scdb.1996.0129; Sanduja S, 2011, WIRES RNA, V2, P42, DOI 10.1002/wrna.28; Schilderink R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00226; Schulpis KH, 2001, EPILEPSIA, V42, P1359, DOI 10.1046/j.1528-1157.2001.47000.x; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; SHAFER TJ, 1991, NEUROTOXICOLOGY, V12, P473; Shah P, 2006, BRAIN RES, V1107, P13, DOI 10.1016/j.brainres.2006.05.097; Shultz SR, 2009, BEHAV BRAIN RES, V200, P33, DOI 10.1016/j.bbr.2008.12.023; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Stilling RM, 2014, GENES BRAIN BEHAV, V13, P69, DOI 10.1111/gbb.12109; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tamiji J, 2010, NEUROSIGNALS, V18, P98, DOI 10.1159/000323189; Tana C, 2010, NEUROGASTROENT MOTIL, V22, P512, DOI 10.1111/j.1365-2982.2009.01427.x; Thomas RH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-153; Thomas RH, 2010, J NEUROCHEM, V113, P515, DOI 10.1111/j.1471-4159.2010.06614.x; Vancassel S, 2001, PROSTAG LEUKOTR ESS, V65, P1, DOI 10.1054/plef.2001.0281; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Wang L, 2014, BIOMARK MED, V8, P331, DOI 10.2217/bmm.14.12; Wang L, 2012, DIGEST DIS SCI, V57, P2096, DOI 10.1007/s10620-012-2167-7; Wiest MM, 2009, PROSTAG LEUKOTR ESS, V80, P221, DOI 10.1016/j.plefa.2009.01.007; Xu LM, 2012, NUCLEIC ACIDS RES, V40, pD1016, DOI 10.1093/nar/gkr1145; Yorifuji T, 2002, HUM GENET, V111, P161, DOI 10.1007/s00439-002-0761-z; Yrigollen CM, 2008, BIOL PSYCHIAT, V63, P911, DOI 10.1016/j.biopsych.2007.11.015; Zhu Wei-Guo, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P187, DOI 10.2174/1568011033482440; Zia MT, 2004, NEUROREPORT, V15, P1177, DOI 10.1097/00001756-200405190-00019; Zouboulis CC, 2005, EXP DERMATOL, V14, P144, DOI 10.1111/j.0906-6705.2005.0285c.x	134	133	143	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e103740	10.1371/journal.pone.0103740	http://dx.doi.org/10.1371/journal.pone.0103740			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170769	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500014
J	Zhu, ED; Li, N; Li, BS; Li, W; Zhang, WJ; Mao, XH; Guo, G; Zou, QM; Xiao, B				Zhu, En-Dong; Li, Na; Li, Bo-Sheng; Li, Wei; Zhang, Wei-Jun; Mao, Xu-Hu; Guo, Gang; Zou, Quan-Ming; Xiao, Bin			miR-30b, Down-Regulated in Gastric Cancer, Promotes Apoptosis and Suppresses Tumor Growth by Targeting Plasminogen Activator Inhibitor-1	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; CELL-PROLIFERATION; MICRORNAS; EXPRESSION; PATHOGENESIS; PROGRESSION; TRANSITION; MIRNAS; SYSTEM; IMPACT	Background: Gastric cancer is one of the most common malignant diseases worldwide. Emerging evidence has shown that microRNAs (miRNAs) are associated with tumor development and progression. Our previous studies have revealed that H. pylori infection was able to induce the altered expression of miR-30b in gastric epithelial cells. However, little is known about the potential role of miR-30b in gastric cancer. Methods: We analyzed the expression of miR-30b in gastric cancer cell lines and human gastric cancer tissues. We examined the effect of miR-30b mimics on the apoptosis of gastric cancer cells in vitro by flow cytometry (FCM) and caspase-3/7 activity assays. Nude mouse xenograft model was used to determine whether miR-30b is involved in tumorigenesis of gastric cancer. The target of miR-30b was identified by bioinformatics analysis, luciferase assay and Western blot. Finally, we performed the correlation analysis between miR-30b and its target expression in gastric cancer. Results: miR-30b was significantly down-regulated in gastric cancer cells and human gastric cancer tissues. Enforced expression of miR-30b promoted the apoptosis of gastric cancer cells in vitro, and miR-30b could significantly inhibit tumorigenicity of gastric cancer by increasing the apoptosis proportion of cancer cells in vivo. Moreover, plasminogen activator inhibitor-1 (PAI-1) was identified as the potential target of miR-30b, and miR-30b level was inversely correlated with PAI-1 expression in gastric cancer. In addition, silencing of PAI-1 was able to phenocopy the effect of miR-30b overexpression on apoptosis regulation of cancer cells, and overexpression of PAI-1 could suppressed the effect of promoting cell apoptosis by miR-30b, indicating PAI-1 is potentially involved in miR-30b-induced apoptosis on cancer cells. Conclusion: miR-30b may function as a novel tumor suppressor gene in gastric cancer by targeting PAI-1 and regulating the apoptosis of cancer cells. miR-30b could serve as a potential biomarker and therapeutic target against gastric cancer.	[Zhu, En-Dong; Li, Na; Li, Bo-Sheng; Zhang, Wei-Jun; Mao, Xu-Hu; Guo, Gang; Zou, Quan-Ming; Xiao, Bin] Third Mil Med Univ, Coll Pharm, Dept Microbiol & Biochem Pharm, Natl Engn Res Ctr Immunol Prod, Chongqing, Peoples R China; [Zhu, En-Dong] Tianjin Med Univ, Collaborat Innovat Ctr Tianjin Med Epigenet 2011, Key Lab Hormones & Dev, Minist Hlth,Metab Dis Hosp, Tianjin, Peoples R China; [Zhu, En-Dong] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, Peoples R China; [Li, Wei] Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing, Peoples R China	Army Medical University; Tianjin Medical University; Tianjin Medical University; Army Medical University	Zou, QM (corresponding author), Third Mil Med Univ, Coll Pharm, Dept Microbiol & Biochem Pharm, Natl Engn Res Ctr Immunol Prod, Chongqing, Peoples R China.	qmzoutmmu@yeah.net; binxiaotmmu@163.com		Li, Na/0000-0002-6227-8433	National Natural Science Foundation of China [81202310]; Scientific Innovation Research Foundation of Third Military Medical University [2009XQN20]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Innovation Research Foundation of Third Military Medical University	This work was supported by National Natural Science Foundation of China (No. 81202310), Scientific Innovation Research Foundation of Third Military Medical University (No. 2009XQN20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bornschein J, 2009, HELICOBACTER, V14, P41, DOI 10.1111/j.1523-5378.2009.00695.x; Braun J, 2010, ONCOGENE; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Declerck PJ, 2013, SEMIN THROMB HEMOST, V39, P356, DOI 10.1055/s-0033-1334487; Ding YC, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-28; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fang H, 2012, JNCI-J NATL CANCER I, V104, P1470, DOI 10.1093/jnci/djs377; Gao W, 2011, J CANC RES CLIN ONCO; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Huang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037188; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kao CJ, 2013, ONCOGENE; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kwaan HC, 2000, BRIT J CANCER, V82, P1702; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Li N, 2012, FEBS LETT, V586, P722, DOI 10.1016/j.febslet.2012.01.025; Li T, 2013, ONCOGENE; Liu SG, 2013, ONCOL LETT, V5, P1639, DOI 10.3892/ol.2013.1251; Liu Z, 2010, MICROBES INFECT, V12, P854, DOI 10.1016/j.micinf.2010.06.002; Lu Yuan, 2009, PLoS One, V4, pe6159, DOI 10.1371/journal.pone.0006159; NEKARDA H, 1994, CANCER RES, V54, P2900; Pencheva N, 2013, NAT CELL BIOL, V15, P546, DOI 10.1038/ncb2769; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Qiao F, 2014, MOL BIOL REP, P1; Romer MU, 2005, THROMB HAEMOSTASIS, V94, P859, DOI 10.1160/TH05-01-0011; Sakakibara T, 2006, CANCER SCI, V97, P395, DOI 10.1111/j.1349-7006.2006.00185.x; Schmitt M, 1997, THROMB HAEMOSTASIS, V78, P285; Song JH, 2012, GASTROENTEROLOGY, V143, P35, DOI 10.1053/j.gastro.2012.05.003; Tang B, 2012, AUTOPHAGY, V8, P1045, DOI 10.4161/auto.20159; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wszolek MF, 2009, UROLOGIC ONCOLOGY; Xiao B, 2012, ONCOL REP, V27, P559, DOI 10.3892/or.2011.1514; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443; Xu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077024; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Xu Y, 2012, ONCOGENE, V31, P1398, DOI 10.1038/onc.2011.340; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Zabaleta Jovanny, 2012, Frontiers in Genetics, V3, P294, DOI 10.3389/fgene.2012.00294; Zhang JC, 2012, BIOCHEM BIOPH RES CO, V417, P1100, DOI 10.1016/j.bbrc.2011.12.121; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156	49	73	77	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106049	10.1371/journal.pone.0106049	http://dx.doi.org/10.1371/journal.pone.0106049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170877	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500093
J	Choi, IY; Gerlag, DM; Holzinger, D; Roth, J; Tak, PP				Choi, Ivy Y.; Gerlag, Danielle M.; Holzinger, Dirk; Roth, Johannes; Tak, Paul P.			From Synovial Tissue to Peripheral Blood: Myeloid Related Protein 8/14 Is a Sensitive Biomarker for Effective Treatment in Early Drug Development in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							CONTROLLED CLINICAL-TRIAL; DISEASE-ACTIVITY; DOUBLE-BLIND; MACROPHAGES; EXPRESSION; BLOCKADE; RECEPTOR	Objective: The change in number of CD68-positive sublining macrophages in serial synovial biopsies has been successfully used to discriminate on the group level between effective and ineffective treatment during early drug development in rheumatoid arthritis (RA) patients. Measurement of a soluble biomarker would clearly have practical advantages. Therefore, we investigated the sensitivity to change of myeloid related protein (MRP) 8/14 in serum. Methods: 139 RA patients who received known effective biologics (infliximab, adalimumab and rituximab) and 28 RA patients who received placebo/ineffective therapies were included. MRP8/14 levels were analyzed in baseline and follow-up serum samples and the standardized response mean (SRM) was calculated to determine the sensitivity to change of MRP8/14 in comparison to C-reactive protein (CRP) levels and the disease activity score evaluated in 28 joints (DAS28). Results: In patients treated with effective treatment, the SRM for MRP8/14 was moderate (0.56), but in patients treated with placebo/ineffective treatment the SRM was 0.06, suggesting that this biomarker is perhaps not susceptible to placebo effects in proof-of-concept studies of relatively short duration. In contrast, the SRM for DAS28 was high for effective treatment (1.07), but also moderate for ineffective treatment (0.58), representing the placebo effect. The SRM for CRP was low in the effective (0.33) and ineffective (0.23) treatment groups. Conclusion: These data support the notion that quantification of changes in MRP8/14 serum levels could be used to predict potential efficacy of novel antirheumatic drugs in an early stage of drug development. A positive result would support the rationale for larger, conventional clinical trials to determine whether the effects are clinically relevant.	[Choi, Ivy Y.; Gerlag, Danielle M.; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Holzinger, Dirk] Univ Childrens Hosp Muenster, Dept Paediat Rheumatol & Immunol, Munster, Germany; [Holzinger, Dirk; Roth, Johannes] Univ Hosp Muenster, Inst Immunol, Munster, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Munster; University of Munster	Tak, PP (corresponding author), Univ Cambridge, Cambridge, England.	paul-peter.x.tak@gsk.com		Holzinger, Dirk/0000-0002-8062-8820	Center for Translational Molecular Medicine (project TRACER) [04I-202]; Innovative Medicines Initiative project BTCure [115142-1]	Center for Translational Molecular Medicine (project TRACER); Innovative Medicines Initiative project BTCure	This research was supported by the Center for Translational Molecular Medicine (project TRACER, grant 04I-202) and the Innovative Medicines Initiative project BTCure (grant agreement number 115142-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bresnihan B, 2009, J RHEUMATOL, V36, P1800, DOI 10.3899/jrheum.090348; Choi I, 2013, ANN RHEUM DIS; Conaghan PG, 2013, ANN RHEUM DIS, V72, P1287, DOI 10.1136/annrheumdis-2012-201611; Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; Gerlag D, 2005, BEST PRACT RES CL RH, V19, P387, DOI 10.1016/j.berh.2005.01.005; Gerlag DM, 2008, BEST PRACT RES CL RH, V22, P311, DOI 10.1016/j.berh.2008.02.002; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Hess A, 2011, P NATL ACAD SCI USA, V108, P3731, DOI 10.1073/pnas.1011774108; Holzinger D, 2012, ANN RHEUM DIS, V71, P974, DOI 10.1136/annrheumdis-2011-200598; Thurlings RM, 2008, ANN RHEUM DIS, V67, P917, DOI 10.1136/ard.2007.080960; van Kuijk AWR, 2010, ANN RHEUM DIS, V69, P2013, DOI 10.1136/ard.2010.131235; Vergunst CE, 2007, RHEUMATOLOGY, V46, P1773, DOI 10.1093/rheumatology/kem222; Vergunst CE, 2008, ARTHRITIS RHEUM-US, V58, P1931, DOI 10.1002/art.23591; Wijbrandts CA, 2008, ANN RHEUM DIS, V67, P1139, DOI 10.1136/ard.2007.080440; Wijbrandts CA, 2009, ANN RHEUM DIS, V68, P1316, DOI 10.1136/ard.2007.086728; Wijbrandts CA, 2007, ARTHRITIS RHEUM, V56, P3869, DOI 10.1002/art.22964	16	13	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106253	10.1371/journal.pone.0106253	http://dx.doi.org/10.1371/journal.pone.0106253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166859	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303700084
J	de Moura, MB; Uppala, R; Zhang, YX; Van Houten, B; Goetzman, ES				de Moura, Michelle Barbi; Uppala, Radha; Zhang, Yuxun; Van Houten, Bennett; Goetzman, Eric S.			Overexpression of Mitochondrial Sirtuins Alters Glycolysis and Mitochondrial Function in HEK293 Cells	PLOS ONE			English	Article							PROTEIN ACYLATION; METABOLISM; SIRT4; DEACETYLATION; OXIDATION; STRESS; NAD; ACETYLATION; BALANCE; ASSAY	SIRT3, SIRT4, and SIRT5 are mitochondrial deacylases that impact multiple facets of energy metabolism and mitochondrial function. SIRT3 activates several mitochondrial enzymes, SIRT4 represses its targets, and SIRT5 has been shown to both activate and repress mitochondrial enzymes. To gain insight into the relative effects of the mitochondrial sirtuins in governing mitochondrial energy metabolism, SIRT3, SIRT4, and SIRT5 overexpressing HEK293 cells were directly compared. When grown under standard cell culture conditions (25 mM glucose) all three sirtuins induced increases in mitochondrial respiration, glycolysis, and glucose oxidation, but with no change in growth rate or in steady-state ATP concentration. Increased proton leak, as evidenced by oxygen consumption in the presence of oligomycin, appeared to explain much of the increase in basal oxygen utilization. Growth in 5 mM glucose normalized the elevations in basal oxygen consumption, proton leak, and glycolysis in all sirtuin over-expressing cells. While the above effects were common to all three mitochondrial sirtuins, some differences between the SIRT3, SIRT4, and SIRT5 expressing cells were noted. Only SIRT3 overexpression affected fatty acid metabolism, and only SIRT4 overexpression altered superoxide levels and mitochondrial membrane potential. We conclude that all three mitochondrial sirtuins can promote increased mitochondrial respiration and cellular metabolism. SIRT3, SIRT4, and SIRT5 appear to respond to excess glucose by inducing a coordinated increase of glycolysis and respiration, with the excess energy dissipated via proton leak.	[de Moura, Michelle Barbi; Van Houten, Bennett] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [de Moura, Michelle Barbi; Van Houten, Bennett] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Uppala, Radha; Zhang, Yuxun; Goetzman, Eric S.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Pediat,Div Med Genet, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Goetzman, ES (corresponding author), Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Pediat,Div Med Genet, Pittsburgh, PA 15260 USA.	eric.goetzman@chp.edu	Van Houten, Bennett/K-2284-2019		National Institute of Diabetes and Digestive and Kidney Diseases [DK090242]; Pennsylvania Commonwealth Universal Research Enhancement Program (PA CURE); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090242] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Pennsylvania Commonwealth Universal Research Enhancement Program (PA CURE); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding to ESG: National Institute of Diabetes and Digestive and Kidney Diseases (DK090242); www.niddk.nih.gov and BVH: Pennsylvania Commonwealth Universal Research Enhancement Program (PA CURE); http://www.portal.state.pa.us/portal/server.pt/community/health_research_program_cure/14189. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BRAND MD, 1987, BIOL REV, V62, P141, DOI 10.1111/j.1469-185X.1987.tb01265.x; Buler M, 2014, FASEB J; Chen Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.14; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Collins CL, 1998, BIOTECHNIQUES, V24, P803, DOI 10.2144/98245st04; de Moura MB, 2014, METHODS MOL BIOL, V1105, P589, DOI 10.1007/978-1-62703-739-6_40; Devin A, 2007, AM J PHYSIOL-CELL PH, V292, pC52, DOI 10.1152/ajpcell.00208.2006; Dolle C, 2013, FEBS J, V280, P3530, DOI 10.1111/febs.12304; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Du JT, 2009, BIOCHEMISTRY-US, V48, P2878, DOI 10.1021/bi802093g; Green MF, 2013, J GERONTOL A-BIOL, V68, P105, DOI 10.1093/gerona/gls132; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Ho JH, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-76; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/bse0470053, 10.1042/BSE0470053]; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Laurent G, 2013, MOL CELL BIOL, V33, P4552, DOI 10.1128/MCB.00087-13; Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Lin ZF, 2013, BIOCHEM BIOPH RES CO, V441, P191, DOI 10.1016/j.bbrc.2013.10.033; Ho L, 2013, AGING-US, V5, P835, DOI 10.18632/aging.100616; Matsushita N, 2011, GENES CELLS, V16, P190, DOI 10.1111/j.1365-2443.2010.01475.x; Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Qian W, 2012, J CELL SCI, V125, P5745, DOI 10.1242/jcs.109769; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013; Rauh D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3327; Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118; Staples JF, 2009, COMP BIOCHEM PHYS A, V153, P95, DOI 10.1016/j.cbpa.2009.02.010; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Yang YJ, 2010, J CELL BIOCHEM, V111, P1051, DOI 10.1002/jcb.22795; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048	41	41	41	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106028	10.1371/journal.pone.0106028	http://dx.doi.org/10.1371/journal.pone.0106028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165814	Green Published, Green Accepted, gold			2022-12-25	WOS:000341303700062
J	Kim, HT; Kim, KJ				Kim, Hyoung Tae; Kim, Ki-Joong			Chloroplast Genome Differences between Asian and American Equisetum arvense (Equisetaceae) and the Origin of the Hypervariable trnY-trnE Intergenic Spacer	PLOS ONE			English	Article							NORTH-AMERICAN; PLASTID GENOMES; EASTERN ASIA; PHYLOGENETIC-RELATIONSHIPS; FLORISTIC DISJUNCTION; SEQUENCE; EVOLUTION; FERN; REARRANGEMENTS; DISTRIBUTIONS	Comparative analyses of complete chloroplast (cp) DNA sequences within a species may provide clues to understand the population dynamics and colonization histories of plant species. Equisetum arvense (Equisetaceae) is a widely distributed fern species in northeastern Asia, Europe, and North America. The complete cp DNA sequences from Asian and American E. arvense individuals were compared in this study. The Asian E. arvense cp genome was 583 bp shorter than that of the American E. arvense. In total, 159 indels were observed between two individuals, most of which were concentrated on the hypervariable trnY-trnE intergenic spacer (IGS) in the large single-copy (LSC) region of the cp genome. This IGS region held a series of 19 bp repeating units. The numbers of the 19 bp repeat unit were responsible for 78% of the total length difference between the two cp genomes. Furthermore, only other closely related species of Equisetum also show the hypervariable nature of the trnY-trnE IGS. By contrast, only a single indel was observed in the gene coding regions: the ycf1 gene showed 24 bp differences between the two continental individuals due to a single tandem-repeat indel. A total of 165 single-nucleotide polymorphisms (SNPs) were recorded between the two cp genomes. Of these, 52 SNPs (31.5%) were distributed in coding regions, 13 SNPs (7.9%) were in introns, and 100 SNPs (60.6%) were in intergenic spacers (IGS). The overall difference between the Asian and American E. arvense cp genomes was 0.12%. Despite the relatively high genetic diversity between Asian and American E. arvense, the two populations are recognized as a single species based on their high morphological similarity. This indicated that the two regional populations have been in morphological stasis.	[Kim, Hyoung Tae; Kim, Ki-Joong] Korea Univ, Sch Life Sci & Biotechnol, Div Life Sci, Seoul, South Korea	Korea University	Kim, KJ (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Div Life Sci, Seoul, South Korea.	kimkj@korea.ac.kr		HyoungTae, Kim/0000-0002-2482-6064	Korea Research Foundation [KRF-2010-0011796]; KEITI [062-091-078, 416-111-005]; NIBR	Korea Research Foundation(National Research Foundation of Korea); KEITI; NIBR	This research was supported by a research grant (#KRF-2010-0011796) from the Korea Research Foundation and by research grants (#062-091-078, #416-111-005) from KEITI to Ki-Joong Kim. A Ph.D. fellowship to HTK was granted by the graduate student education program from NIBR (2012-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Cantrill DJ, 2005, NEW ZEAL J GEOL GEOP, V48, P537, DOI 10.1080/00288306.2005.9515132; Cosner ME, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-27; Des Marais DL, 2003, INT J PLANT SCI, V164, P737, DOI 10.1086/376817; DiMichele WA, 2005, NONMARINE PERMIAN, V30, P56; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; Gao L, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-64; Gao L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-130; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Grewe F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-8; Hauke R. L., 1963, NOVA HEDWIGIA S, V8, P1, DOI DOI 10.2307/1546980; HAUKE RL, 1978, NOVA HEDWIGIA, V30, P385; HIPKINS VD, 1995, CURR GENET, V27, P572, DOI 10.1007/BF00314450; HOEY MT, 1991, AM J BOT, V78, P938, DOI 10.2307/2445172; Jansen R. K., 2012, GENOMICS CHLOROPLAST, P103, DOI [10.1007/978-94-007-2920-9, DOI 10.1007/978-94-007-2920-9_5]; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Karol KG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-321; KATO M, 1993, J BIOGEOGR, V20, P265, DOI 10.2307/2845634; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelber KP, 1998, REV PALAEOBOT PALYNO, V100, P1, DOI 10.1016/S0034-6667(97)00061-4; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li H. L., 1952, Transactions of the American Philosophical Society, Philadelphia, V42, P371, DOI 10.2307/1005654; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu JM, 2011, AM J BOT, V98, P1680, DOI 10.3732/ajb.1100125; Mariotti R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-211; McQueen DR, 1954, PHILOS T R SOC NZ, V82, P231; Morris GP, 2011, MOL ECOL, V20, P4938, DOI 10.1111/j.1365-294X.2011.05335.x; PALMER JD, 1986, METHOD ENZYMOL, V118, P167; Qiu YL, 1995, AM J BOT, V82, P1582, DOI 10.2307/2446187; Roper JM, 2007, AM FERN J, V97, P95, DOI 10.1640/0002-8444(2007)97[95:TCPGSO]2.0.CO;2; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI [10.1007/s00122-007-0567-4, 10.1007/s00122-007-0595-0]; SCHAFFNER JOHN H., 1930, AMER FERN JOUR, V20, P89, DOI 10.2307/1543867; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; VEIT M, 1990, PHYTOCHEMISTRY, V29, P2555, DOI 10.1016/0031-9422(90)85187-K; Wall WA, 2010, MOL ECOL, V19, P4302, DOI 10.1111/j.1365-294X.2010.04793.x; Wang ZQ, 1996, REV PALAEOBOT PALYNO, V91, P121; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wen J, 2001, INT J PLANT SCI, V162, pS117, DOI 10.1086/322940; Whittall JB, 2010, MOL ECOL, V19, P100, DOI 10.1111/j.1365-294X.2009.04474.x; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Wolf PG, 2011, PLANT MOL BIOL, V76, P251, DOI 10.1007/s11103-010-9706-4; Wolf PG, 2003, DNA RES, V10, P59, DOI 10.1093/dnares/10.2.59; Wolf PG, 2001, J BIOGEOGR, V28, P263, DOI 10.1046/j.1365-2699.2001.00531.x; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xiang QY, 2000, MOL PHYLOGENET EVOL, V15, P462, DOI 10.1006/mpev.2000.0766; Xiang QY, 1998, MOL PHYLOGENET EVOL, V10, P178, DOI 10.1006/mpev.1998.0524; Xu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037128; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Yi DK, 2012, MOL CELLS, V33, P497, DOI 10.1007/s10059-012-2281-6; Young HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023980; Zhang Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zhu QH, 2005, NEW PHYTOL, V167, P249, DOI 10.1111/j.1469-8137.2005.01406.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	62	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e103898	10.1371/journal.pone.0103898	http://dx.doi.org/10.1371/journal.pone.0103898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157804	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303200005
J	Lamb, JJ; Hill, RE; Eaton-Rye, JJ; Hohmann-Marriott, MF				Lamb, Jacob J.; Hill, Ryan E.; Eaton-Rye, Julian J.; Hohmann-Marriott, Martin F.			Functional Role of PilA in Iron Acquisition in the Cyanobacterium Synechocystis sp PCC 6803	PLOS ONE			English	Article							CHLOROPHYLL-PROTEIN COMPLEX; TRANSFORMATION COMPETENCE; ISIAB OPERON; SP PCC-6803; MOTILITY; GENES; PHOTOSYNTHESIS; SIDEROPHORES; ORGANIZATION; TRANSPORT	Cyanobacteria require large quantities of iron to maintain their photosynthetic machinery; however, in most environments iron is present in the form of insoluble iron oxides. Whether cyanobacteria can utilize these sources of iron, and the potential molecular mechanisms involved remains to be defined. There is increasing evidence that pili can facilitate electron donation to extracellular electron acceptors, like iron oxides in non-photosynthetic bacteria. In these organisms, the donation of electrons to iron oxides is thought to be crucial for maintaining respiration in the absence of oxygen. Our study investigates if PilA1 (major pilin protein) may also provide a mechanism to convert insoluble ferric iron into soluble ferrous iron. Growth experiments supported by spectroscopic data of a strain deficient in pilA1 indicate that the presence of the pilA1 gene enhances the ability to grow on iron oxides. These observations suggest a novel function of PilA1 in cyanobacterial iron acquisition.	[Lamb, Jacob J.; Hohmann-Marriott, Martin F.] Norwegian Univ Sci & Technol, PhotoSynLab, Dept Biotechnol, N-7034 Trondheim, Norway; [Hill, Ryan E.; Eaton-Rye, Julian J.] Univ Otago, Dept Biochem, Dunedin, New Zealand	Norwegian University of Science & Technology (NTNU); University of Otago	Hohmann-Marriott, MF (corresponding author), Norwegian Univ Sci & Technol, PhotoSynLab, Dept Biotechnol, N-7034 Trondheim, Norway.	martin.hohmann-marriott@ntnu.no	Lamb, Jacob J./AAQ-4270-2020	Lamb, Jacob J./0000-0002-1019-6655; Eaton-Rye, Julian/0000-0003-4137-8838	New Zealand Foundation for Research and Technology; Norwegian University of Science and Technology, Trondheim, Norway	New Zealand Foundation for Research and Technology(New Zealand Foundation for Research, Science and Technology); Norwegian University of Science and Technology, Trondheim, Norway	This study was supported by a Postdoctoral Fellowship to MHM from the New Zealand Foundation for Research and Technology, succeeded by the Ministry of Business, Innovation and Employment; (http://www.msi.govt.nz/). Additional funding was provided through the PhD position awarded to JL by the Norwegian University of Science and Technology, Trondheim, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Badarau A, 2008, J BIOL CHEM, V283, P12520, DOI 10.1074/jbc.M709907200; Bhaya D, 1999, P NATL ACAD SCI USA, V96, P3188, DOI 10.1073/pnas.96.6.3188; Bhaya D, 2001, P NATL ACAD SCI USA, V98, P7540, DOI 10.1073/pnas.131201098; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; Braun V, 1999, TRENDS BIOCHEM SCI, V24, P104, DOI 10.1016/S0968-0004(99)01359-6; Braun V, 2011, CURR OPIN CHEM BIOL, V15, P328, DOI 10.1016/j.cbpa.2011.01.005; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; Eaton-Rye JJ, 2011, METHOD MOL BIOL, V684, P309; Ehrenreich IM, 2005, APPL ENVIRON MICROB, V71, P7401, DOI 10.1128/AEM.71.11.7401-7413.2005; FALK S, 1995, PHOTOSYNTH RES, V45, P51, DOI 10.1007/BF00032235; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Fussenegger M, 1997, GENE, V192, P125, DOI 10.1016/S0378-1119(97)00038-3; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; GUIKEMA JA, 1983, PLANT PHYSIOL, V73, P250, DOI 10.1104/pp.73.2.250; Hopkinson BM, 2009, BIOMETALS, V22, P659, DOI 10.1007/s10534-009-9235-2; Katoh H, 2001, PLANT CELL PHYSIOL, V42, P823, DOI 10.1093/pcp/pce106; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; Kranzler C, 2011, ENVIRON MICROBIOL, V13, P2990, DOI 10.1111/j.1462-2920.2011.02572.x; Kunert A, 2003, FEMS MICROBIOL LETT, V227, P255, DOI 10.1016/S0378-1097(03)00689-X; Lagarde D, 1999, FEBS LETT, V454, P247, DOI 10.1016/S0014-5793(99)00817-0; Lamb JJ, 2013, CURR MICROBIOL, V67, P123, DOI 10.1007/s00284-013-0340-7; Lamb JJ, 2012, PHOTOSYNTH RES, V114, P59, DOI 10.1007/s11120-012-9777-y; Legewie S, 2008, BIOPHYS J, V95, P3232, DOI 10.1529/biophysj.108.133819; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Maldonado MT, 2006, LIMNOL OCEANOGR, V51, P1729, DOI 10.4319/lo.2006.51.4.1729; MEYER TF, 1984, P NATL ACAD SCI-BIOL, V81, P6110, DOI 10.1073/pnas.81.19.6110; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Morris JN, 2014, NEW ZEAL J BOT, V52, P36, DOI 10.1080/0028825X.2013.846267; Murakami A, 1997, PHOTOSYNTH RES, V53, P141, DOI 10.1023/A:1005818317797; Nakasugi K, 2006, MICROBIOL-SGM, V152, P3623, DOI 10.1099/mic.0.29189-0; ODOM WR, 1993, PLANT MOL BIOL, V23, P1255, DOI 10.1007/BF00042358; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; REVSBECH NP, 1983, LIMNOL OCEANOGR, V28, P1062, DOI 10.4319/lo.1983.28.6.1062; RIETHMAN HC, 1988, BIOCHIM BIOPHYS ACTA, V935, P141, DOI 10.1016/0005-2728(88)90211-3; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sandy M, 2009, CHEM REV, V109, P4580, DOI 10.1021/cr9002787; Singh AK, 2007, PHOTOSYNTH RES, V93, P17, DOI 10.1007/s11120-007-9151-7; Singh AK, 2005, PHOTOSYNTH RES, V84, P65, DOI 10.1007/s11120-004-6429-x; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Vinnemeier J, 1998, FEMS MICROBIOL LETT, V169, P323, DOI 10.1111/j.1574-6968.1998.tb13336.x; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; Yoshihara S, 2001, PLANT CELL PHYSIOL, V42, P63, DOI 10.1093/pcp/pce007	47	23	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105761	10.1371/journal.pone.0105761	http://dx.doi.org/10.1371/journal.pone.0105761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157828	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303200060
J	Welsh, TN; Hirst, JJ; Palliser, H; Zakar, T				Welsh, Toni N.; Hirst, Jonathan J.; Palliser, Hannah; Zakar, Tamas			Progesterone Receptor Expression Declines in the Guinea Pig Uterus during Functional Progesterone Withdrawal and in Response to Prostaglandins	PLOS ONE			English	Article							HUMAN MYOMETRIAL CELLS; HUMAN-PREGNANCY; GENE-EXPRESSION; FETAL MEMBRANES; UTERINE CERVIX; PARTURITION; DECIDUA; ESTRADIOL; MECHANISM; FAILURE	Progesterone withdrawal is essential for parturition, but the mechanism of this pivotal hormonal change is unclear in women and other mammals that give birth without a pre-labor drop in maternal progesterone levels. One possibility suggested by uterine tissue analyses and cell culture models is that progesterone receptor levels change at term decreasing the progesterone responsiveness of the myometrium, which causes progesterone withdrawal at the functional level and results in estrogen dominance enhancing uterine contractility. In this investigation we have explored whether receptor mediated functional progesterone withdrawal occurs during late pregnancy and labor in vivo. We have also determined whether prostaglandins that induce labor cause functional progesterone withdrawal by altering myometrial progesterone receptor expression. Pregnant guinea pigs were used, since this animal loses progesterone responsiveness at term and gives birth in the presence of high maternal progesterone level similarly to primates. We found that progesterone receptor mRNA and protein A and B expression decreased in the guinea pig uterus during the last third of gestation and in labor. Prostaglandin administration reduced while prostaglandin synthesis inhibitor treatment increased progesterone receptor A protein abundance. Estrogen receptor-1 protein levels remained unchanged during late gestation, in labor and after prostaglandin or prostaglandin synthesis inhibitor administration. Steroid receptor levels were higher in the non-pregnant than in the pregnant uterine horns. We conclude that the decreasing expression of both progesterone receptors A and B is a physiological mechanism of functional progesterone withdrawal in the guinea pig during late pregnancy and in labor. Further, prostaglandins administered exogenously or produced endogenously stimulate labor in part by suppressing uterine progesterone receptor A expression, which may cause functional progesterone withdrawal, promote estrogen dominance and foster myometrial contractions.	[Welsh, Toni N.; Zakar, Tamas] John Hunter Hosp, Dept Obstet & Gynaecol, New Lambton Hts, NSW, Australia; [Hirst, Jonathan J.; Palliser, Hannah] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Welsh, Toni N.; Zakar, Tamas] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Welsh, Toni N.; Hirst, Jonathan J.; Palliser, Hannah; Zakar, Tamas] Mothers & Babies Res Ctr, New Lambton Hts, NSW, Australia; [Hirst, Jonathan J.; Palliser, Hannah; Zakar, Tamas] Hunter Med Res Inst, New Lambton Hts, NSW, Australia	John Hunter Hospital; University of Newcastle; University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Zakar, T (corresponding author), John Hunter Hosp, Dept Obstet & Gynaecol, New Lambton Hts, NSW, Australia.	Tamas.Zakar@newcastle.edu.au	Hirst, Jonathan/ABC-3250-2021; Zakar, Tamas/G-7507-2013; HIRST, JONATHAN JAMES/G-7822-2013	Hirst, Jonathan/0000-0002-9362-5303; HIRST, JONATHAN JAMES/0000-0002-9362-5303; Palliser, Hannah/0000-0001-5783-9737; Zakar, Tamas/0000-0002-1690-1159	National Health and Medical Research Council of Australia [569282]; Royal Australian and New Zealand College of Obstetricians and Gynaecologists	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Royal Australian and New Zealand College of Obstetricians and Gynaecologists	This work was supported by the National Health and Medical Research Council of Australia (www.nhmrc.gov.au; Project Grant 569282) and The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (www.ranzcog.rdu.au; Ella Macknight Memorial Fellowship for TW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHALLIS JRG, 1971, J ENDOCRINOL, V51, P333, DOI 10.1677/joe.0.0510333; ELGER W, 1985, ACTA PHYSIOL HUNG, V65, P415; GLASIER MA, 1993, STEROIDS, V58, P478, DOI 10.1016/0039-128X(93)90006-9; Goldman S, 2005, MOL HUM REPROD, V11, P269, DOI 10.1093/molehr/gah161; Haluska GJ, 2002, J SOC GYNECOL INVEST, V9, P125, DOI 10.1016/S1071-5576(02)00144-2; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madsen G, 2004, J CLIN ENDOCR METAB, V89, P1010, DOI 10.1210/jc.2003-031037; Merlino AA, 2007, J CLIN ENDOCR METAB, V92, P1927, DOI 10.1210/jc.2007-0077; Mesiano S, 2002, J CLIN ENDOCR METAB, V87, P2924, DOI 10.1210/jc.87.6.2924; Mesiano S, 2011, REPROD SCI, V18, P6, DOI 10.1177/1933719110382922; Nnamani Mauris C., 2013, Evolution Medicine and Public Health, P273, DOI 10.1093/emph/eot022; Palliser HK, 2010, REPROD SCI, V17, P776, DOI 10.1177/1933719110371517; PORTER DG, 1970, J ENDOCRINOL, V46, P425, DOI 10.1677/joe.0.0460425; Rodriguez HA, 2008, J STEROID BIOCHEM, V111, P247, DOI 10.1016/j.jsbmb.2008.06.012; Rodriguez HA, 2003, MOL HUM REPROD, V9, P807, DOI 10.1093/molehr/gag099; Schellenberg JC, 1997, PROSTAGLANDINS, V54, P625, DOI 10.1016/S0090-6980(97)00129-9; Stjernholm-Vladic Y, 2004, GYNECOL ENDOCRINOL, V18, P41, DOI 10.1080/09513590310001651777; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; Tan HQ, 2012, J CLIN ENDOCR METAB, V97, pE719, DOI 10.1210/jc.2011-3251; Terakawa K, 2002, J SOC GYNECOL INVEST, V9, P68, DOI 10.1016/S1071-5576(01)00157-5; TULCHINSKY D, 1972, AM J OBSTET GYNECOL, V112, P1095, DOI 10.1016/0002-9378(72)90185-8; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244; WALSH SW, 1984, J CLIN ENDOCR METAB, V58, P629, DOI 10.1210/jcem-58-4-629; Welsh T, 2005, J PHYSIOL-LONDON, V569, P903, DOI 10.1113/jphysiol.2005.098129; Zakar T, 2007, AM J OBSTET GYNECOL, V196, P289, DOI 10.1016/j.ajog.2006.09.005	27	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105253	10.1371/journal.pone.0105253	http://dx.doi.org/10.1371/journal.pone.0105253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157946	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303200026
J	Lindskog, C; Fagerberg, L; Hallstrom, B; Edlund, K; Hellwig, B; Rahnenfuhrer, J; Kampf, C; Uhlen, M; Ponten, F; Micke, P				Lindskog, Cecilia; Fagerberg, Linn; Hallstrom, Bjorn; Edlund, Karolina; Hellwig, Birte; Rahnenfuehrer, Joerg; Kampf, Caroline; Uhlen, Mathias; Ponten, Fredrik; Micke, Patrick			The lung-specific proteome defined by integration of transcriptomics and antibody-based profiling	FASEB JOURNAL			English	Article						patients; prognosis; expression analysis; in situ detection	TISSUE-SPECIFIC EXPRESSION; GENE-EXPRESSION; SQUAMOUS-CELL; RNA-SEQ; CANCER; ADENOCARCINOMA; IDENTIFICATION; SIGNATURES; DISCOVERY; TOOL	The combined action of multiple cell types is essential for the physiological function of the lung, and increased awareness of the molecular constituents characterizing each cell type is likely to advance the understanding of lung biology and disease. In the current study, we used genome-wide RNA sequencing of normal lung parenchyma and 26 additional tissue types, combined with antibody-based protein profiling, to localize the expression to specific cell types. Altogether, 221 genes were found to be elevated in the lung compared with their expression in other analyzed tissues. Among the gene products were several well-known markers, but also several proteins previously not described in the context of the lung. To link the lungspecific molecular repertoire to human disease, survival associations of pneumocyte-specific genes were assessed by using transcriptomics data from 7 non-small-cell lung cancer (NSCLC) cohorts. Transcript levels of 10 genes (SFTPB, SFTPC, SFTPD, SLC34A2, LAMP3, CACNA2D2, AGER, EMP2, NKX2-1, and NAPSA) were significantly associated with survival in the adenocarcinoma subgroup, thus qualifying as promising biomarker candidates. In summary, based on an integrated omics approach, we identified genes with elevated expression in lung and localized corresponding protein expression to different cell types. As biomarker candidates, these proteins may represent intriguing starting points for further exploration in health and disease.-Lindskog, C., Fagerberg, L., Hallstrom, B., Edlund, K., Hellwig, B., Rahnenfuhrer, J., Kampf, C., Uhlen, M., Ponten, F., Micke, P. The lung-specific proteome defined by integration of transcriptomics and antibody-based profiling.	[Lindskog, Cecilia; Kampf, Caroline; Ponten, Fredrik; Micke, Patrick] Uppsala Univ, Sci Life Lab, Rudbeck Lab, S-75185 Uppsala, Sweden; [Fagerberg, Linn; Hallstrom, Bjorn; Uhlen, Mathias] KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden; [Edlund, Karolina; Rahnenfuehrer, Joerg] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Hellwig, Birte] Dortmund Tech Univ, Dept Stat, Dortmund, Germany	Uppsala University; Royal Institute of Technology; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Dortmund University of Technology	Ponten, F (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Dag Hammarskjolds Vag 20, S-75185 Uppsala, Sweden.	fredrik.ponten@igp.uu.se	Lindskog, Cecilia/AAE-5462-2019; Uhlen, Mathias/AAV-8746-2021; Lindskog, Cecilia/AAO-2441-2021; Uhlen, Mathias/B-3262-2016	Uhlen, Mathias/0000-0002-4858-8056; Lindskog, Cecilia/0000-0001-5611-1015; Fagerberg, Linn/0000-0003-0198-7137; Rahnenfuhrer, Jorg/0000-0002-8947-440X	Knut and Alice Wallenberg Foundation; PROSPECTS, a 7th Framework grant by the European Directorate [HEALTH-F4-2008-201648/PROSPECTS]; Swedish Cancerfonden; Lions Cancerforskningsfond; Swedish Cancer Society; German Research Foundation (Deutsche Forschungsgemeinschaft) [RA 870/5-1]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); PROSPECTS, a 7th Framework grant by the European Directorate; Swedish Cancerfonden; Lions Cancerforskningsfond; Swedish Cancer Society(Swedish Cancer Society); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The authors thank the entire staff of the Human Protein Atlas program and the Science for Life Laboratory for valuable contributions, and the Department of Pathology at the Uppsala Akademiska Hospital and the Uppsala Biobank for kindly providing the clinical diagnostics and specimens used in this study. Funding was provided by the Knut and Alice Wallenberg Foundation and PROSPECTS, a 7th Framework grant by the European Directorate (grant agreement HEALTH-F4-2008-201648/PROSPECTS), and the Swedish Cancerfonden. Parts of this work were also supported by research grants from the Lions Cancerforskningsfond and the Swedish Cancer Society (both to P.M). The work of B.H. was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, grant RA 870/5-1).	[Anonymous], 2012, PICARD SEQUENCE ALIG; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Botling J, 2013, CLIN CANCER RES, V19, P194, DOI 10.1158/1078-0432.CCR-12-1139; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Campbell JD, 2011, RESPIROLOGY, V16, P407, DOI 10.1111/j.1440-1843.2011.01942.x; Carboni GL, 2003, ONCOGENE, V22, P615, DOI 10.1038/sj.onc.1206134; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Corut A, 2006, AM J HUM GENET, V79, P650, DOI 10.1086/508263; CRAPO JD, 1982, AM REV RESPIR DIS, V126, P332; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; Gong HC, 2001, J MEMBRANE BIOL, V184, P35, DOI 10.1007/s00232-001-0072-7; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Ho CC, 2008, LUNG CANCER, V59, P105, DOI 10.1016/j.lungcan.2007.07.024; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishii T, 2012, COPD, V9, P409, DOI 10.3109/15412555.2012.676110; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Joshi N, 2012, SICKLE WINDOWED ADAP; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Lantuejoul S, 2009, HISTOPATHOLOGY, V54, P43, DOI 10.1111/j.1365-2559.2008.03182.x; Lee JG, 2012, LUNG CANCER, V77, P156, DOI 10.1016/j.lungcan.2012.02.013; Liu Y, 2013, AM J PATHOL, V182, P1519, DOI 10.1016/j.ajpath.2013.01.050; Mulugeta S, 2002, J BIOL CHEM, V277, P22147, DOI 10.1074/jbc.M201812200; Nordgard O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062153; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Rimkunas VM, 2012, CLIN CANCER RES, V18, P4449, DOI 10.1158/1078-0432.CCR-11-3351; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Sin DD, 2013, J CLIN ONCOL, V31, P4536, DOI 10.1200/JCO.2013.50.6105; Solis LM, 2012, CANCER-AM CANCER SOC, V118, P2889, DOI 10.1002/cncr.26584; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sutherland KD, 2010, MOL ONCOL, V4, P397, DOI 10.1016/j.molonc.2010.05.002; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ueno T, 2003, BRIT J CANCER, V88, P1229, DOI 10.1038/sj.bjc.6600879; Wadehra M, 2004, MOL BIOL CELL, V15, P2073, DOI 10.1091/mbc.E03-07-0488; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wistuba II, 1999, ONCOGENE, V18, P643, DOI 10.1038/sj.onc.1202349; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	46	42	44	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5184	5196		10.1096/fj.14-254862	http://dx.doi.org/10.1096/fj.14-254862			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25169055				2022-12-25	WOS:000345894500014
J	Bucker, R; Heroven, AK; Becker, J; Dersch, P; Wittmann, C				Buecker, Rene; Heroven, Ann Kathrin; Becker, Judith; Dersch, Petra; Wittmann, Christoph			The Pyruvate-Tricarboxylic Acid Cycle Node A FOCAL POINT OF VIRULENCE CONTROL IN THE ENTERIC PATHOGEN YERSINIA PSEUDOTUBERCULOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Bacterial Metabolism; Bacterial Pathogenesis; Gene Expression; Pyruvate; Systems Biology; Tricarboxylic Acid Cycle (TCA Cycle) (Krebs Cycle); Metabolic Flux Analysis; Yersinia	ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; METABOLIC-RESPONSES; CHROMOSOMAL GENES; LYSINE PRODUCTION; SECRETION SYSTEM; EXPRESSION; FLUX; CARBON; PROTEIN	Background:Yersinia pseudotuberculosis is a human pathogen and the ancestor of Y. pestis. Results: The pyruvate-tricarboxylic acid cycle node in the carbon core metabolism of Y. pseudotuberculosis is a focal point of its virulence control system. Conclusion: Mutants genetically perturbed at this metabolic control point are less virulent in mouse infection studies. Significance: Learning how pathogenic traits are controlled is crucial for finding novel drug targets against the pathogen. Despite our increasing knowledge of the specific pathogenicity factors in bacteria, the contribution of metabolic processes to virulence is largely unknown. Here, we elucidate a tight connection between pathogenicity and core metabolism in the enteric pathogen Yersinia pseudotuberculosis by integrated transcriptome and [C-13]fluxome analysis of the wild type and virulence-regulator mutants. During aerobic growth on glucose, Y. pseudotuberculosis reveals an unusual flux distribution with a high level of secreted pyruvate. The absence of the transcriptional and post-transcriptional regulators RovA, CsrA, and Crp strongly perturbs the fluxes of carbon core metabolism at the level of pyruvate metabolism and the tricarboxylic acid (TCA) cycle, and these perturbations are accompanied by transcriptional changes in the corresponding enzymes. Knock-outs of regulators of this metabolic branch point and of its central enzyme, pyruvate kinase (pykF), result in mutants with significantly reduced virulence in an oral mouse infection model. In summary, our work identifies the pyruvate-TCA cycle node as a focal point for controlling the host colonization and virulence of Yersinia.	[Buecker, Rene; Becker, Judith; Wittmann, Christoph] Univ Saarland, Inst Syst Biotechnol, D-66123 Saarbrucken, Germany; [Buecker, Rene] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Engn, D-38106 Braunschweig, Germany; [Heroven, Ann Kathrin; Dersch, Petra] Helmholtz Ctr Infect Res, Dept Mol Infect Biol, D-38124 Braunschweig, Germany	Saarland University; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research	Wittmann, C (corresponding author), Univ Saarland, Inst Syst Biotechnol, Campus A1-5, D-66123 Saarbrucken, Germany.	christoph.wittmann@uni-saarland.de		Wittmann, Christoph/0000-0002-7952-985X	Deutsche Forschungsgemeinschaft (Host-Adapted Metabolism of Bacterial Pathogens) [SPP 1316]	Deutsche Forschungsgemeinschaft (Host-Adapted Metabolism of Bacterial Pathogens)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Host-Adapted Metabolism of Bacterial Pathogens) Grant SPP 1316.	Abernathy J, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-5; Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Ansong C, 2013, MOL BIOSYST, V9, P44, DOI 10.1039/c2mb25287b; Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Atkinson S, 2008, MOL MICROBIOL, V69, P137, DOI 10.1111/j.1365-2958.2008.06268.x; Atkinson S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001250; Becker J, 2005, APPL ENVIRON MICROB, V71, P8587, DOI 10.1128/AEM.71.12.8587-8596.2005; Becker J, 2013, BIOTECHNOL BIOENG, V110, P3013, DOI 10.1002/bit.24963; Becker J, 2009, APPL ENVIRON MICROB, V75, P7866, DOI 10.1128/AEM.01942-09; Becker J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-8; BOLIN I, 1982, INFECT IMMUN, V37, P506; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Bowden SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013871; Brown T.A., 2002, GENOMES, V2nd; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chubukov V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.66; Commichau FM, 2006, CURR OPIN MICROBIOL, V9, P167, DOI 10.1016/j.mib.2006.01.001; Dacheux D, 2002, INFECT IMMUN, V70, P3973, DOI 10.1128/IAI.70.7.3973-3977.2002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dauner M, 2001, BIOTECHNOL BIOENG, V76, P132, DOI 10.1002/bit.1153; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Dube P, 2009, CURR TOP MICROBIOL, V337, P61, DOI 10.1007/978-3-642-01846-6_3; Emmerling M, 2002, J BACTERIOL, V184, P152, DOI 10.1128/JB.184.1.152-164.2002; Evans MR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-58; FERRARIS RP, 1990, AM J PHYSIOL, V259, pG822, DOI 10.1152/ajpgi.1990.259.5.G822; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gohler AK, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-197; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; Heroven AK, 2008, MOL MICROBIOL, V68, P1179, DOI 10.1111/j.1365-2958.2008.06218.x; Heroven AK, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00158; Heroven AK, 2012, RNA BIOL, V9, P379, DOI 10.4161/rna.19333; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Hofreuter D, 2008, CELL HOST MICROBE, V4, P425, DOI 10.1016/j.chom.2008.10.002; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Jahn S, 2013, BBA-MOL CELL RES, V1833, P2879, DOI 10.1016/j.bbamcr.2013.07.011; Jalava K, 2006, J INFECT DIS, V194, P1209, DOI 10.1086/508191; Kiefer P, 2004, APPL ENVIRON MICROB, V70, P229, DOI 10.1128/AEM.70.1.229-239.2004; Kohlstedt M, 2010, APPL MICROBIOL BIOT, V88, P1065, DOI 10.1007/s00253-010-2854-2; Kromer JO, 2005, ANAL BIOCHEM, V340, P171, DOI 10.1016/j.ab.2005.01.027; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Link H, 2013, NAT BIOTECHNOL, V31, P357, DOI 10.1038/nbt.2489; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Luttmann D, 2009, MOL MICROBIOL, V72, P978, DOI 10.1111/j.1365-2958.2009.06704.x; Mercado-Lubo R, 2009, INFECT IMMUN, V77, P1397, DOI 10.1128/IAI.01335-08; Meza E, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-127; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Monk IR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-96; Motin VL, 2004, J BACTERIOL, V186, P6298, DOI 10.1128/JB.186.18.6298-6305.2004; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; Neidhardt F. C., 1990, PHYSL BACTERIAL CELL, P133; Pradel E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004029; Quek LE, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-25; Revelles O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066386; Rimhanen-Finne R, 2009, EPIDEMIOL INFECT, V137, P342, DOI 10.1017/S0950268807000155; Sambrook J, 2001, MOL CLONING LAB MANU; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schilling O, 2007, APPL ENVIRON MICROB, V73, P499, DOI 10.1128/AEM.02084-06; Schmid A, 2009, J BIOL CHEM, V284, P12165, DOI 10.1074/jbc.M900773200; Siddiquee KA, 2004, APPL MICROBIOL BIOT, V63, P407, DOI 10.1007/s00253-003-1357-9; Silver JD, 2009, BIOSTATISTICS, V10, P352, DOI 10.1093/biostatistics/kxn042; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; SPIRO S, 1991, TRENDS BIOCHEM SCI, V16, P310, DOI 10.1016/0968-0004(91)90125-F; SUZUKI T, 1969, BIOCHIM BIOPHYS ACTA, V191, P559, DOI 10.1016/0005-2744(69)90349-0; Trotter EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025501; Valgepea K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-166; van Rijsewijk BRBH, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.9; Vanderpool CK, 2007, CURR OPIN MICROBIOL, V10, P146, DOI 10.1016/j.mib.2007.03.011; Vanderpool CK, 2007, J BACTERIOL, V189, P2238, DOI 10.1128/JB.01689-06; Walker J., 2002, PROTEIN PROTOCOLS HD, P3; Wittmann C, 2004, APPL ENVIRON MICROB, V70, P7277, DOI 10.1128/AEM.70.12.7277-7287.2004; Wittmann C, 2003, BIOTECHNOL LETT, V25, P377, DOI 10.1023/A:1022402212537; Wittmann C, 2002, ANAL BIOCHEM, V307, P379, DOI 10.1016/S0003-2697(02)00030-1; Wittmann C, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-6; Yang YH, 2003, INST MATH S, V40, P403; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Young GM, 2000, INFECT IMMUN, V68, P4323, DOI 10.1128/IAI.68.7.4323-4326.2000; Yu J, 2013, INFECT IMMUN, V81, P4053, DOI 10.1128/IAI.00880-13; Zhan LJ, 2008, INFECT IMMUN, V76, P5028, DOI 10.1128/IAI.00370-08	88	45	46	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30114	30132		10.1074/jbc.M114.581348	http://dx.doi.org/10.1074/jbc.M114.581348			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25164818	Green Published, hybrid			2022-12-25	WOS:000344370800051
J	Liu, B; Qian, JM; Wang, QB; Wang, FR; Ma, ZY; Qiao, YL				Liu, Bin; Qian, Jianmin; Wang, Qingbao; Wang, Fangrui; Ma, Zhenyu; Qiao, Yingli			Butyrate Protects Rat Liver against Total Hepatic Ischemia Reperfusion Injury with Bowel Congestion	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; NF-KAPPA-B; ISCHEMIA/REPERFUSION INJURY; PARTIAL-HEPATECTOMY; INTESTINAL BARRIER; CARDIAC DEATH; INHIBITION; CELLS; TRANSPLANTATION; ACTIVATION	Hepatic ischemia/reperfusion (I/R) injury is an unavoidable consequence of major liver surgery, especially in liver transplantation with bowel congestion, during which endotoxemia is often evident. The inflammatory response aggravated by endotoxin after I/R contributes to liver dysfunction and failure. The purpose of the present study was to investigate the protective effect of butyrate, a naturally occurring four-carbon fatty acid in the body and a dietary component of foods such as cheese and butter, on hepatic injury complicated by enterogenous endotoxin, as well as to examine the underlying mechanisms involved. SD rats were subjected to a total hepatic ischemia for 30 min after pretreatment with either vehicle or butyrate, followed by 6 h and 24 h of reperfusion. Butyrate preconditioning markedly improved hepatic function and histology, as indicated by reduced transaminase levels and ameliorated tissue pathological changes. The inflammatory factors levels, macrophages activation, TLR4 expression, and neutrophil infiltration in live were attenuated by butyrate. Butyrate also maintained the intestinal barrier structures, reversed the aberrant expression of ZO-1, and decreased the endotoxin translocation. We conclude that butyrate inhibition of endotoxin translocation, macrophages activation, inflammatory factors production, and neutrophil infiltration is involved in the alleviation of total hepatic I/R liver injury in rats. This suggests that butyrate should potentially be utilized in liver transplantation.	[Liu, Bin; Qian, Jianmin; Wang, Fangrui; Ma, Zhenyu] Fudan Univ, Huashan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China; [Wang, Qingbao; Qiao, Yingli] Taishan Med Coll, Affiliated Hosp, Dept Gen Surg, Tai An, Shandong, Peoples R China; [Qiao, Yingli] Taishan Med Coll, Affiliated Liaocheng Hosp, Liaocheng Peoples Hosp, Dept Gen Surg, Liaocheng, Shandong, Peoples R China	Fudan University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences	Qiao, YL (corresponding author), Taishan Med Coll, Affiliated Liaocheng Hosp, Liaocheng Peoples Hosp, Dept Gen Surg, Liaocheng, Shandong, Peoples R China.	qiao-ying-li@126.com			National Natural Science Foundation of China [NO81270530]; Specialized Research Fund for the Health Care [NO201002004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Health Care	This study was supported by the National Natural Science Foundation of China (NO81270530) and Specialized Research Fund for the Health Care (NO201002004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caraceni P, 2009, GUT, V58, P1135, DOI 10.1136/gut.2007.147652; Ellett JD, 2010, J IMMUNOL, V184, P5849, DOI 10.4049/jimmunol.0902024; Fernandez ED, 2000, J ENDOTOXIN RES, V6, P321, DOI 10.1179/096805100101532216; Foley DP, 2005, ANN SURG, V242, P724, DOI 10.1097/01.sla.0000186178.07110.92; Granger A, 2008, FASEB J, V22, P3549, DOI 10.1096/fj.08-108548; Han XN, 2004, SHOCK, V21, P261, DOI 10.1097/01.shk.0000112346.38599.10; Hinnebusch BF, 2002, J NUTR, V132, P1012, DOI 10.1093/jn/132.5.1012; Kaibori M, 2004, TRANSPL P, V36, P1973, DOI 10.1016/j.transproceed.2004.08.061; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; KORUDA MJ, 1990, AM J CLIN NUTR, V51, P685, DOI 10.1093/ajcn/51.4.685; Liu TF, 2012, INFLAMMATION, V35, P1676, DOI 10.1007/s10753-012-9484-z; Ma ZY, 2010, AM J TRANSPLANT, V10, P784, DOI 10.1111/j.1600-6143.2009.02993.x; Meijer K, 2010, CURR OPIN CLIN NUTR, V13, P715, DOI 10.1097/MCO.0b013e32833eebe5; Park JS, 2007, INT IMMUNOPHARMACOL, V7, P70, DOI 10.1016/j.intimp.2006.08.015; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Qiao YL, 2013, J SURG RES; RABINOWITZ SS, 1991, J EXP MED, V174, P827, DOI 10.1084/jem.174.4.827; Reich DJ, 2010, CURR OPIN ORGAN TRAN, V15, P316, DOI 10.1097/MOT.0b013e32833991e3; Samak G, 2010, AM J PHYSIOL-GASTR L, V299, pG572, DOI 10.1152/ajpgi.00265.2010; Strauman MC, 2010, INFECT IMMUN, V78, P4958, DOI 10.1128/IAI.00580-10; Tsuji K, 2005, J HEPATOL, V42, P94, DOI 10.1016/j.jhep.2004.09.018; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; Watanabe M, 2000, SURGERY, V127, P456, DOI 10.1067/msy.2000.104744; Xing Hui-Chun, 2005, Hepatobiliary Pancreat Dis Int, V4, P274; Zhai Y, 2004, J IMMUNOL, V173, P7115, DOI 10.4049/jimmunol.173.12.7115; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhang F, 2010, AMINO ACIDS, V38, P237, DOI 10.1007/s00726-009-0233-z; Zhang LT, 2007, SHOCK, V27, P672, DOI 10.1097/SHK.0b013e31802e3f4c	29	52	55	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106184	10.1371/journal.pone.0106184	http://dx.doi.org/10.1371/journal.pone.0106184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171217	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500121
J	Strong, JS; Leroux, SJ				Strong, Justin S.; Leroux, Shawn J.			Impact of Non-Native Terrestrial Mammals on the Structure of the Terrestrial Mammal Food Web of Newfoundland, Canada	PLOS ONE			English	Article							PREDATION; INVADERS; INVASION; DIET; COMMUNITIES; SUMMER; PLANT; PREY; ROBUSTNESS; COMPLEXITY	The island of Newfoundland is unique because it has as many non-native terrestrial mammals as native ones. The impacts of non-native species on native flora and fauna can be profound and invasive species have been identified as one of the primary drivers of species extinction. Few studies, however, have investigated the effects of a non-native species assemblage on community and ecosystem properties. We reviewed the literature to build the first terrestrial mammal food web for the island of Newfoundland and then used network analyses to investigate how the timing of introductions and trophic position of non-native species has affected the structure of the terrestrial mammal food web in Newfoundland. The first non-native mammals (house mouse and brown rat) became established in Newfoundland with human settlement in the late 15th and early 16th centuries. Coyotes and southern red-backed voles are the most recent mammals to establish themselves on the island in 1985 and 1998, respectively. The fraction of intermediate species increased with the addition of non-native mammals over time whereas the fraction of basal and top species declined over time. This increase in intermediate species mediated by non-native species arrivals led to an overall increase in the terrestrial mammal food web connectance and generality (i.e. mean number of prey per predator). This diverse prey base and sources of carrion may have facilitated the natural establishment of coyotes on the island. Also, there is some evidence that the introduction of non-native prey species such as the southern red-backed vole has contributed to the recovery of the threatened American marten. Long-term monitoring of the food web is required to understand and predict the impacts of the diverse novel interactions that are developing in the terrestrial mammal food web of Newfoundland.	[Strong, Justin S.; Leroux, Shawn J.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Strong, Justin S.] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada	Memorial University Newfoundland; Concordia University - Canada	Leroux, SJ (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF, Canada.	sleroux@mun.ca	Leroux, Shawn/AAY-9390-2020	Leroux, Shawn/0000-0001-9580-0294	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	JSS was supported by a Undergraduate Summer Research Award from the Natural Sciences and Engineering Research Council of Canada (NSERC) and SJL was supported by a Discovery Grant from NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, COSEWIC ASS UPD STAT; Atkinson IAE, 2001, BIOL CONSERV, V99, P81, DOI 10.1016/S0006-3207(00)00189-0; Baillie J. E., 2004, GLOBAL SPECIES ASSES; Beard KH, 2002, OECOLOGIA, V133, P583, DOI 10.1007/s00442-002-1071-9; Bezemer TM, 2014, ANNU REV ENTOMOL, V59, P119, DOI 10.1146/annurev-ento-011613-162104; Bridger K.E., 2005, THESIS MEMORIAL U NE; Britton JR, 2013, TRENDS ECOL EVOL, V28, P93, DOI 10.1016/j.tree.2012.08.020; Carlsson NOL, 2009, FRONT ECOL ENVIRON, V7, P525, DOI 10.1890/080093; CEBALLOS G, 1995, CONSERV BIOL, V9, P559, DOI 10.1046/j.1523-1739.1995.09030559.x; Chesson P, 2008, NATURE, V456, P235, DOI 10.1038/nature07248; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Dalerum F, 2000, ARCTIC, V53, P1; Day SM, 1997, THESIS ACADIA U WOLF; Department of Conservation and Environment, 2013, INTR LAND MAMM NEWF; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Dodd LE, 2012, J MAMMAL, V93, P1119, DOI 10.1644/11-MAMM-A-218.1; DODDS DONALD G., 1960, JOUR WILDLIFE MANAGEMENT, V24, P52, DOI 10.2307/3797356; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Dunne JA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001579; Ebenhard T, 1998, SWEDISH WILDL RES, V13, P1; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; FERRON J, 1986, CAN J ZOOL, V64, P385, DOI 10.1139/z86-060; Gephi, 2014, OP GRAPH VIZ PLATF; Gosse J, 2011, NAT AREA J, V31, P331, DOI 10.3375/043.031.0403; Gosse JW, 2005, CAN FIELD NAT, V119, P43, DOI 10.22621/cfn.v119i1.79; Gravel D, 2011, ECOL LETT, V14, P1010, DOI 10.1111/j.1461-0248.2011.01667.x; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Hearn BJ, 2006, CAN FIELD NAT, V120, P50, DOI 10.22621/cfn.v120i1.245; Hedges SB, 2012, ZOOTAXA, P1; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Johnson PTJ, 2009, OECOLOGIA, V159, P161, DOI 10.1007/s00442-008-1176-x; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Larter NC, 1999, CAN FIELD NAT, V113, P481; Lever C., 1994, NATURALIZED ANIMALS; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Lockwood JL, 2013, INVASION ECOLOGY; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; Lowe S, 2001, 100 WORLDS WORST INV; Major HL, 2007, J ZOOL, V271, P463, DOI 10.1111/j.1469-7998.2006.00230.x; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McLaren Brian E., 2004, Alces, V40, P45; Milakovic B, 2011, J MAMMAL, V92, P295, DOI 10.1644/10-MAMM-A-038.1; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Nentwig W, 2010, CONSERV BIOL, V24, P302, DOI 10.1111/j.1523-1739.2009.01289.x; NORTHCOTT TH, 1971, OIKOS, V22, P407, DOI 10.2307/3543866; Pascual M, 2006, SFI S SCI C, P3; Pearse IS, 2013, OIKOS, V122, P1554, DOI 10.1111/j.1600-0706.2013.00527.x; Pearse IS, 2013, ECOL LETT, V16, P1088, DOI 10.1111/ele.12143; PEKINS PJ, 1990, CAN J ZOOL, V68, P656, DOI 10.1139/z90-095; Perdomo G, 2012, FOODWEB VISUALISATIO; Pillai P, 2010, THEOR ECOL-NETH, V3, P223, DOI 10.1007/s12080-009-0065-1; PIMLOTT DOUGLAS H., 1959, JOUR WILDLIFE MANAGEMENT, V23, P381, DOI 10.2307/3796486; Pope KL, 2008, BIOL CONSERV, V141, P1321, DOI 10.1016/j.biocon.2008.03.008; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; R Development Core Team, 2011, R V 3 0 2 R LANG ENV; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; Ricciardi A, 2013, ECOL MONOGR, V83, P263, DOI 10.1890/13-0183.1; Riede JO, 2010, ADV ECOL RES, V42, P139, DOI 10.1016/S0065-2504(10)42003-6; Riewe RR, 1971, ECOLOGY MEADOW VOLE; Ripple WJ, 2013, BIOL CONSERV, V160, P70, DOI 10.1016/j.biocon.2012.12.033; Romanuk TN, 2009, PHILOS T R SOC B, V364, P1743, DOI 10.1098/rstb.2008.0286; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Saunders J. K., 1963, Journal of Wildlife Management, V27, P384, DOI 10.2307/3798511; SCHOENER TW, 1989, ECOLOGY, V70, P1559, DOI 10.2307/1938088; Seccombe-Hett P, 2008, OIKOS, V117, P1874, DOI 10.1111/j.1600-0706.2008.16773.x; SEIP DR, 1992, CAN J ZOOL, V70, P1494, DOI 10.1139/z92-206; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Srinivasan UT, 2007, ECOLOGY, V88, P671, DOI 10.1890/06-0971; Staniczenko PPA, 2010, ECOL LETT, V13, P891, DOI 10.1111/j.1461-0248.2010.01485.x; Strong JS, 2013, TERRESTRIAL MAMMAL F; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; Thompson ID, 1995, CAN J ZOOL, V73, P2059, DOI 10.1139/z95-242; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Walsworth TE, 2013, ECOL FRESHW FISH, V22, P439, DOI 10.1111/eff.12038; Ward JM, 2007, DIVERS DISTRIB, V13, P155, DOI 10.1111/j.1472-4642.2007.00336.x; WELLS MC, 1982, J MAMMAL, V63, P118, DOI 10.2307/1380678; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wittmer HU, 2005, OECOLOGIA, V144, P257, DOI 10.1007/s00442-005-0055-y; Woodward G, 2001, J ANIM ECOL, V70, P273, DOI 10.1046/j.1365-2656.2001.00497.x	83	17	17	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106264	10.1371/journal.pone.0106264	http://dx.doi.org/10.1371/journal.pone.0106264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170923	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000341127500137
J	Gan, GM; Lv, HH; Xie, W				Gan, Guangming; Lv, Huihui; Xie, Wei			Morphological Identification and Development of Neurite in Drosophila Ventral Nerve Cord Neuropil	PLOS ONE			English	Article							NEUROMUSCULAR-JUNCTIONS; EMBRYONIC-DEVELOPMENT; GLIAL-CELLS; GROWTH CONE; ORGANIZATION; ULTRASTRUCTURE; BRUCHPILOT; MUTANTS; PROTEIN; BRAIN	In Drosophila, ventral nerve cord (VNC) occupies most of the larval central nervous system (CNS). However, there is little literature elaborating upon the specific types and growth of neurites as defined by their structural appearance in Drosophila larval VNC neuropil. Here we report the ultrastructural development of different types VNC neurites in ten selected time points in embryonic and larval stages utilizing transmission electron microscopy. There are four types of axonal neurites as classified by the type of vesicular content: clear vesicle (CV) neurites have clear vesicles and some T-bar structures; Densecore vesicle (DV) neurites have dense-core vesicles and without T-bar structures; Mixed vesicle (MV) neurites have mixed vesicles and some T-bar structures; Large vesicle (LV) neurites are dominated by large, translucent spherical vesicles but rarely display T-bar structures. We found dramatic remodeling in CV neurites which can be divided into five developmental phases. The neurite is vacuolated in primary (P) phase, they have mitochondria, microtubules or big dark vesicles in the second (S) phase, and they contain immature synaptic features in the third (T) phase. The subsequent bifurcate (B) phase appears to undergo major remodeling with the appearance of the bifurcation or dendritic growth. In the final mature (M) phase, high density of commensurate synaptic vesicles are distributed around T-bar structures. There are four kinds of morphological elaboration of the CVI neurite sub-types. First, new neurite produces at the end of axon. Second, new neurite bubbles along the axon. Third, the preexisting neurite buds and develops into several neurites. The last, the bundled axons form irregularly shape neurites. Most CVI neurites in M phase have about 1.5-3 mu m diameter, they could be suitable to analyze their morphology and subcellular localization of specific proteins by light microscopy, and they could serve as a potential model in CNS in vivo development.	[Gan, Guangming; Lv, Huihui; Xie, Wei] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Gan, Guangming] Southeast Univ, Sch Med, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Gan, GM (corresponding author), Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Minist Educ, Nanjing, Jiangsu, Peoples R China.	ganguangm@seu.edu.cn			National Natural Science Foundation of China [31171041]; Youth Science Foundation of Medical School, Southeast University, China [1124007001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Science Foundation of Medical School, Southeast University, China	This work was supported by the National Natural Science Foundation of China (31171041) and Youth Science Foundation of Medical School, Southeast University, China (1124007001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Beckervordersandforth RM, 2008, MECH DEVELOP, V125, P542, DOI 10.1016/j.mod.2007.12.004; Boerner J, 2010, J COMP NEUROL, V518, P2437, DOI 10.1002/cne.22346; Butcher NJ, 2012, J COMP NEUROL, V520, P2185, DOI 10.1002/cne.23037; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; Chen KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011115; Featherstone DE, 2001, J NEUROSCI, V21, P4215, DOI 10.1523/JNEUROSCI.21-12-04215.2001; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; Granderath S, 1999, CURR OPIN NEUROBIOL, V9, P531, DOI 10.1016/S0959-4388(99)00008-2; Hartenstein V, 1998, J COMP NEUROL, V402, P32; Hartenstein V, 2011, GLIA, V59, P1237, DOI 10.1002/glia.21162; Hodges JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024149; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; JACOBS JR, 1989, J NEUROSCI, V9, P2402; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Koper A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036339; Landgraf M, 2003, DEV BIOL, V260, P207, DOI 10.1016/S0012-1606(03)00215-X; Leiss F, 2009, J COMP NEUROL, V517, P808, DOI 10.1002/cne.22184; Leitinger G, 2012, J COMP NEUROL, V520, P384, DOI 10.1002/cne.22744; Millard SS, 2010, NEURON, V67, P761, DOI 10.1016/j.neuron.2010.08.030; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Prokop A, 2006, SEMIN CELL DEV BIOL, V17, P20, DOI 10.1016/j.semcdb.2005.11.010; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Prokop A, 1999, CELL TISSUE RES, V297, P169, DOI 10.1007/s004410051345; Reist NE, 1998, J NEUROSCI, V18, P7662; Rivlin PK, 2004, J COMP NEUROL, V468, P596, DOI 10.1002/cne.10977; Robert F, 2012, NEUROSCIENCE, V200, P248, DOI 10.1016/j.neuroscience.2011.10.002; ROBERTS A, 1985, J NEUROSCI RES, V13, P23, DOI 10.1002/jnr.490130103; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Suzuki E, 2000, J NEUROBIOL, V42, P448, DOI 10.1002/(SICI)1097-4695(200003)42:4<448::AID-NEU6>3.0.CO;2-H; Sweet Eric S, 2011, Bioarchitecture, V1, P69; Tortosa E, 2011, J BIOL CHEM, V286, P40638, DOI 10.1074/jbc.M111.271320; Vitriol EA, 2012, NEURON, V73, P1068, DOI 10.1016/j.neuron.2012.03.005; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Yoshihara M, 1997, J NEUROSCI, V17, P8408; Younossi-Hartenstein A, 2003, J COMP NEUROL, V455, P435, DOI 10.1002/cne.10483; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	41	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105497	10.1371/journal.pone.0105497	http://dx.doi.org/10.1371/journal.pone.0105497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166897	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303700028
J	Kim, IH; Hevezi, P; Varga, C; Pathak, MM; Hong, L; Ta, D; Tran, CT; Zlotnik, A; Soltesz, I; Tombola, F				Kim, Iris H.; Hevezi, Peter; Varga, Csaba; Pathak, Medha M.; Hong, Liang; Ta, Dennis; Tran, Chau T.; Zlotnik, Albert; Soltesz, Ivan; Tombola, Francesco			Evidence for Functional Diversity between the Voltage-Gated Proton Channel Hv1 and Its Closest Related Protein HVRP1	PLOS ONE			English	Article							K+ CHANNEL; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; SUBUNIT STOICHIOMETRY; STRUCTURE PREDICTION; SELECTIVITY FILTER; GENE-EXPRESSION; SENSING DOMAIN; 2 PORES; SENSOR; PHOSPHATASE	The Hv1 channel and voltage-sensitive phosphatases share with voltage-gated sodium, potassium, and calcium channels the ability to detect changes in membrane potential through voltage-sensing domains (VSDs). However, they lack the pore domain typical of these other channels. Na-V, K-V, and Ca-V proteins can be found in neurons and muscles, where they play important roles in electrical excitability. In contrast, VSD-containing proteins lacking a pore domain are found in non-excitable cells and are not involved in neuronal signaling. Here, we report the identification of HVRP1, a protein related to the Hv1 channel (from which the name Hv1 Related Protein 1 is derived), which we find to be expressed primarily in the central nervous system, and particularly in the cerebellum. Within the cerebellar tissue, HVRP1 is specifically expressed in granule neurons, as determined by in situ hybridization and immunohistochemistry. Analysis of subcellular distribution via electron microscopy and immunogold labeling reveals that the protein localizes on the post-synaptic side of contacts between glutamatergic mossy fibers and the granule cells. We also find that, despite the similarities in amino acid sequence and structural organization between Hv1 and HVRP1, the two proteins have distinct functional properties. The high conservation of HVRP1 in vertebrates and its cellular and subcellular localizations suggest an important function in the nervous system.	[Kim, Iris H.; Hevezi, Peter; Pathak, Medha M.; Hong, Liang; Ta, Dennis; Tran, Chau T.; Zlotnik, Albert; Tombola, Francesco] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Varga, Csaba; Soltesz, Ivan] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Tombola, F (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA.	ftombola@uci.edu	Tran, Chau/GRX-4633-2022; Tombola, Francesco/ABA-6002-2020; Hong, Liang/C-4251-2008; Tombola, Francesco/C-7311-2011	Tombola, Francesco/0000-0002-9315-0352; Hong, Liang/0000-0001-8152-5631; Soltesz, Ivan/0000-0003-1493-3744; Varga, Csaba/0000-0002-9188-1282	National Institute of General Medical Sciences at the National Institute of Health [GM098973]; University of California, Irvine (UCI) through Committee on Research and Graduate Academic Programs; Academic Senate Council on Research, Computing, and Libraries; National Institute of Neurological Disorders and Stroke [NS074432]; National Cancer Institute [P30CA062203]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074432] Funding Source: NIH RePORTER	National Institute of General Medical Sciences at the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of California, Irvine (UCI) through Committee on Research and Graduate Academic Programs(University of California System); Academic Senate Council on Research, Computing, and Libraries; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of General Medical Sciences (http://www.nigms.nih.gov) at the National Institute of Health, grant GM098973, and by the University of California, Irvine (UCI) (http://www.uci.edu) through seed grants from the Committee on Research and Graduate Academic Programs and from the Academic Senate Council on Research, Computing, and Libraries to FT. The authors also acknowledge support from the National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov), grant NS074432 to IS. The Optical Biology Core Facility at UCI was supported by the National Cancer Institute (http://www.cancer.gov) under award P30CA062203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashcroft FM, 2000, ION CHANNELS DIS; Cannon SC, 2006, ANNU REV NEUROSCI, V29, P387, DOI 10.1146/annurev.neuro.29.051605.112815; Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Chamberlin A, 2014, P NATL ACAD SCI USA, V111, pE273, DOI 10.1073/pnas.1318018111; Choe H, 1997, AM J PHYSIOL-RENAL, V273, pF516, DOI 10.1152/ajprenal.1997.273.4.F516; DeCoursey TE, 2013, PHYSIOL REV, V93, P599, DOI 10.1152/physrev.00011.2012; Fujiwara Y, 2012, J PHYSL, V591, P627; Fujiwara Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1823; Gonzalez C, 2010, NAT STRUCT MOL BIOL, V17, P51, DOI 10.1038/nsmb.1739; Hevezi P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006395; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hong L, 2013, NEURON, V77, P274, DOI 10.1016/j.neuron.2012.11.013; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; Kohout SC, 2010, NAT CHEM BIOL, V6, P369, DOI 10.1038/nchembio.349; Kulleperuma K, 2013, J GEN PHYSIOL, V141, P445, DOI 10.1085/jgp.201210856; Lacroix JJ, 2011, P NATL ACAD SCI USA, V108, P6444, DOI 10.1073/pnas.1103397108; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Li QF, 2014, NAT STRUCT MOL BIOL, V21, P244, DOI 10.1038/nsmb.2768; Li SJ, 2010, J BIOL CHEM, V285, P12047, DOI 10.1074/jbc.M109.040360; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Morgan D, 2013, J GEN PHYSIOL, V142, P625, DOI 10.1085/jgp.201311045; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Musset B, 2011, NATURE, V480, P273, DOI 10.1038/nature10557; Musset B, 2010, J PHYSIOL-LONDON, V588, P1435, DOI 10.1113/jphysiol.2010.188318; Neuhaus H, 2009, GENE EXPR PATTERNS, V9, P568, DOI 10.1016/j.gep.2009.09.002; Okamura Y, 2007, PFLUG ARCH EUR J PHY, V454, P361, DOI 10.1007/s00424-007-0222-6; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; Qiu F, 2013, NEURON, V77, P288, DOI 10.1016/j.neuron.2012.12.021; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ratzan WJ, 2011, J CELL PHYSIOL, V226, P2740, DOI 10.1002/jcp.22854; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Smith SME, 2011, P NATL ACAD SCI USA, V108, P18162, DOI 10.1073/pnas.1115405108; Suh BC, 2010, NEURON, V67, P224, DOI 10.1016/j.neuron.2010.07.001; Takeshita K, 2014, NAT STRUCT MOL BIOL, V21, P352, DOI 10.1038/nsmb.2783; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Tapparel C, 2003, GENE, V323, P189, DOI 10.1016/j.gene.2003.09.038; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Tombola F, 2010, NAT STRUCT MOL BIOL, V17, P44, DOI 10.1038/nsmb.1738; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Wu LJ, 2012, NAT NEUROSCI, V15, P565, DOI 10.1038/nn.3059; Wu Y, 2001, J BIOL CHEM, V276, P21745, DOI 10.1074/jbc.M101480200; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Yudin Y, 2011, J PHYSIOL-LONDON, V589, P6007, DOI 10.1113/jphysiol.2011.220228	54	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105926	10.1371/journal.pone.0105926	http://dx.doi.org/10.1371/journal.pone.0105926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165868	Green Published, gold			2022-12-25	WOS:000341303700055
J	Liu, H; Xu, J; Liang, RB; Liu, JH				Liu, Huan; Xu, Jing; Liang, Rubing; Liu, Jianhua			Characterization of the Medium- and Long-Chain n-Alkanes Degrading Pseudomonas aeruginosa Strain SJTD-1 and Its Alkane Hydroxylase Genes	PLOS ONE			English	Article							CRUDE-OIL; GENOME SEQUENCE; DEGRADATION; BACTERIUM; OXIDATION; SYSTEMS; EXPRESSION; PHENOL; GROW; PCR	A gram-negative aliphatic hydrocarbon-degrading bacterium SJTD-1 isolated from oil-contaminated soil was identified as Pseudomonas aeruginosa by comparative analyses of the 16S rRNA sequence, phenotype, and physiological features. SJTD-1 could efficiently mineralize medium-and long-chain n-alkanes (C-12-C-30) as its sole carbon source within seven days, showing the most optimal growth on n-hexadecane, followed by n-octadecane, and n-eicosane. In 36 h, 500 mg/L of tetradecane, hexadecane, and octadecane were transformed completely; and 2 g/L n-hexadecane was degraded to undetectable levels within 72 h. Two putative alkane-degrading genes (gene 3623 and gene 4712) were characterized and our results indicated that their gene products were rate-limiting enzymes involved in the synergetic catabolism of C-12-C-16 alkanes. On the basis of bioinformatics and transcriptional analysis, two P450 monooxygenases, along with a putative AlmA-like oxygenase, were examined. Genetically defective mutants lacking the characteristic alkane hydroxylase failed to degrade n-octadecane, thereby suggesting a different catalytic mechanism for the microbial transformation of alkanes with chain lengths over C-18.	[Liu, Huan; Xu, Jing; Liang, Rubing; Liu, Jianhua] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai, Peoples R China; [Liu, Huan; Xu, Jing; Liang, Rubing; Liu, Jianhua] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liang, RB (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai, Peoples R China.	icelike@sjtu.edu.cn; jianhualiudl@sjtu.edu.cn			National Science Foundation of China [31370152/21135004]; Shanghai Pujiang Program; Chen Xing Grant of Shanghai Jiaotong University	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Chen Xing Grant of Shanghai Jiaotong University	This work was sponsored by the National Science Foundation of China (Grant No. 31370152/21135004), Shanghai Pujiang Program and Chen Xing Grant of Shanghai Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 1999, ENVIRON MICROBIOL, V1, P421, DOI 10.1046/j.1462-2920.1999.00052.x; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Feng L, 2007, P NATL ACAD SCI USA, V104, P5602, DOI 10.1073/pnas.0609650104; Hao RX, 2004, CAN J MICROBIOL, V50, P175, DOI [10.1139/w03-116, 10.1139/W03-116]; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Holt J., 1994, INT EDITION BERGEYS; Joseph S, 2001, MOL CLONING LAB MANU; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Liang RB, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-209; Liu CL, 2011, ENVIRON MICROBIOL, V13, P1168, DOI 10.1111/j.1462-2920.2010.02416.x; Liu H, 2012, J BACTERIOL, V194, P4783, DOI 10.1128/JB.01061-12; Liu YC, 2010, BIORESOURCE TECHNOL, V101, P310, DOI 10.1016/j.biortech.2009.08.028; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeng JH, 1996, J BACTERIOL, V178, P3695, DOI 10.1128/jb.178.13.3695-3700.1996; Marin MM, 2003, J BACTERIOL, V185, P3232, DOI 10.1128/JB.185.10.3232-3237.2003; Mohanty S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/328608; Nie Y, 2011, APPL ENVIRON MICROB, V77, P7279, DOI 10.1128/AEM.00203-11; Prince RC, 2005, PETROLEUM MICROBIOLOGY, P317; REHM HJ, 1981, ADV BIOCHEM ENG, V19, P175, DOI DOI 10.1007/3-540-10464-X_; Rojo F, 2009, ENVIRON MICROBIOL, V11, P2477, DOI 10.1111/j.1462-2920.2009.01948.x; Santos PM, 2004, PROTEOMICS, V4, P2640, DOI 10.1002/pmic.200300793; Smits THM, 2003, ANTON LEEUW INT J G, V84, P193, DOI 10.1023/A:1026000622765; Smits THM, 2002, J BACTERIOL, V184, P1733, DOI 10.1128/JB.184.6.1733-1742.2002; SORKHOH NA, 1993, APPL MICROBIOL BIOT, V39, P123, DOI 10.1007/BF00166860; Spiers AJ, 2000, MICROBIOL-SGM, V146, P2345, DOI 10.1099/00221287-146-10-2345; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sun JQ, 2012, BIORESOURCE TECHNOL, V123, P664, DOI 10.1016/j.biortech.2012.06.072; Throne-Holst M, 2007, APPL ENVIRON MICROB, V73, P3327, DOI 10.1128/AEM.00064-07; Throne-Holst M, 2006, APPL MICROBIOL BIOT, V72, P353, DOI 10.1007/s00253-005-0262-9; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; Van Beilen Jan B., 1994, Biodegradation, V5, P161, DOI 10.1007/BF00696457; van Beilen JB, 2004, ENVIRON MICROBIOL, V6, P264, DOI 10.1111/j.1462-2920.2004.00567.x; van Beilen JB, 2001, MICROBIOL-SGM, V147, P1621, DOI 10.1099/00221287-147-6-1621; van Beilen JB, 1998, STUD ORG CHEM, V53, P211; Van Hamme JD, 2001, APPL ENVIRON MICROB, V67, P4874, DOI 10.1128/AEM.67.10.4874-4879.2001; Wang XB, 2011, BIORESOURCE TECHNOL, V102, P7755, DOI 10.1016/j.biortech.2011.06.009; Whyte LG, 2002, APPL ENVIRON MICROB, V68, P5933, DOI 10.1128/AEM.68.12.5933-5942.2002; Yuste L, 2000, FEMS MICROBIOL ECOL, V32, P69, DOI 10.1111/j.1574-6941.2000.tb00700.x; Zhang ZZ, 2011, BIORESOURCE TECHNOL, V102, P4111, DOI 10.1016/j.biortech.2010.12.064	39	63	65	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105506	10.1371/journal.pone.0105506	http://dx.doi.org/10.1371/journal.pone.0105506			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165808	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303700030
J	Macey, PM; Kumar, R; Ogren, JA; Woo, MA; Harper, RM				Macey, Paul M.; Kumar, Rajesh; Ogren, Jennifer A.; Woo, Mary A.; Harper, Ronald M.			Global Brain Blood-Oxygen Level Responses to Autonomic Challenges in Obstructive Sleep Apnea	PLOS ONE			English	Article							IMPAIRED CEREBRAL AUTOREGULATION; VALSALVA MANEUVER; DIABETES-MELLITUS; HANDGRIP EXERCISE; SEX-DIFFERENCES; SIGNAL CHANGES; HEART-RATE; REM-SLEEP; FLOW; HEMODYNAMICS	Obstructive sleep apnea (OSA) is accompanied by brain injury, perhaps resulting from apnea-related hypoxia or periods of impaired cerebral perfusion. Perfusion changes can be determined indirectly by evaluation of cerebral blood volume and oxygenation alterations, which can be measured rapidly and non-invasively with the global blood oxygen level dependent (BOLD) signal, a magnetic resonance imaging procedure. We assessed acute BOLD responses in OSA subjects to pressor challenges that elicit cerebral blood flow changes, using a two-group comparative design with healthy subjects as a reference. We separately assessed female and male patterns, since OSA characteristics and brain injury differ between sexes. We studied 94 subjects, 37 with newly-diagnosed, untreated OSA (6 female (age mean +/- std: 52.1 +/- 8.1 yrs; apnea/hypopnea index [AHI]: 27.7 +/- 15.6 events/hr and 31 male 54.3 +/- 8.4 yrs; AHI: 37.4 +/- 19.6 events/hr), and 20 female (age 50.5 +/- 8.1 yrs) and 37 male (age 45.6 +/- 9.2 yrs) healthy control subjects. We measured brain BOLD responses every 2 s while subjects underwent cold pressor, hand grip, and Valsalva maneuver challenges. The global BOLD signal rapidly changed after the first 2 s of each challenge, and differed in magnitude between groups to two challenges (cold pressor, hand grip), but not to the Valsalva maneuver (repeated measures ANOVA, p<0.05). OSA females showed greater differences from males in response magnitude and pattern, relative to healthy counterparts. Cold pressor BOLD signal increases (mean 6 adjusted standard error) at the 8 s peak were: OSA 0.14 +/- 0.08% vs. Control 0.31 +/- 0.06%, and hand grip at 6 s were: OSA 0.08 +/- 0.03% vs. Control at 0.30 +/- 0.02%. These findings, indicative of reduced cerebral blood flow changes to autonomic challenges in OSA, complement earlier reports of altered resting blood flow and reduced cerebral artery responsiveness. Females are more affected than males, an outcome which may contribute to the sex-specific brain injury in the syndrome.	[Macey, Paul M.; Ogren, Jennifer A.; Woo, Mary A.] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA; [Macey, Paul M.; Harper, Ronald M.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Kumar, Rajesh] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Kumar, Rajesh] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA; [Harper, Ronald M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Macey, PM (corresponding author), Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA.	pmacey@ucla.edu	Macey, Paul M./B-5037-2008	Macey, Paul M./0000-0003-4093-7458	National Institute of Nursing Research [NR 013693]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013693] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported by NR 013693, National Institute of Nursing Research (https://www.ninr.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Asil T, 2007, CLIN NEUROL NEUROSUR, V109, P1, DOI 10.1016/j.clineuro.2006.03.010; BALFORS EM, 1994, AM J RESP CRIT CARE, V150, P1587, DOI 10.1164/ajrccm.150.6.7952619; Bandettini PA, 1997, NMR BIOMED, V10, P197, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<197::AID-NBM466>3.0.CO;2-S; Bangash MF, 2008, SLEEP, V31, P321, DOI 10.1093/sleep/31.3.321; Binks AP, 2008, J APPL PHYSIOL, V104, P212, DOI 10.1152/japplphysiol.00069.2007; Burgess KR, 2010, CHEST, V137, P707, DOI 10.1378/chest.09-1329; CAJOCHEN C, 1994, PHYSIOL BEHAV, V55, P769, DOI 10.1016/0031-9384(94)90058-2; Cassaglia PA, 2009, J APPL PHYSIOL, V106, P1050, DOI 10.1152/japplphysiol.91349.2008; Chesler M, 2005, GLIA, V50, P398, DOI 10.1002/glia.20141; COOTE JH, 1982, J EXP BIOL, V100, P223; Corfield DR, 2006, ADV EXP MED BIOL, V588, P65; DALY J A, 1990, American Review of Respiratory Disease, V141, pA376; DeVisser A, 2011, NEUROBIOL DIS, V44, P161, DOI 10.1016/j.nbd.2011.06.005; Durgan DJ, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000091; Ficker J H, 1997, Pneumologie, V51, P926; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Fujishima M, 1995, Hypertens Res, V18, P111, DOI 10.1291/hypres.18.111; Furtner M, 2009, SLEEP MED, V10, P875, DOI 10.1016/j.sleep.2008.09.011; GLOBUS MYT, 1991, J NEUROCHEM, V57, P470, DOI 10.1111/j.1471-4159.1991.tb03775.x; GUR RC, 1982, SCIENCE, V217, P659, DOI 10.1126/science.217.4560.657; Harper RM, 2003, J APPL PHYSIOL, V94, P1583, DOI 10.1152/japplphysiol.00881.2002; Hayakawa T, 1996, CHEST, V109, P916, DOI 10.1378/chest.109.4.916; Henderson LA, 2003, J APPL PHYSIOL, V94, P1063, DOI 10.1152/japplphysiol.00702.2002; Horsfield MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062588; Huq R, 2012, DIABETIC MED, V29, P609, DOI 10.1111/j.1464-5491.2011.03497.x; Ikemura T, 2012, EUR J APPL PHYSIOL, V112, P641, DOI 10.1007/s00421-011-2016-y; Joo EY, 2007, SLEEP, V30, P1515, DOI 10.1093/sleep/30.11.1515; Joo EY, 2010, SLEEP, V33, P235, DOI 10.1093/sleep/33.2.235; Kastrup A, 1999, AM J NEURORADIOL, V20, P1233; Katsuta Toshiro, 1997, Fukuoka Acta Medica, V88, P65; KETY SS, 1948, J CLIN INVEST, V27, P493, DOI 10.1172/JCI101996; Kim SG, 1999, MAGN RESON MED, V41, P1152, DOI 10.1002/(SICI)1522-2594(199906)41:6<1152::AID-MRM11>3.0.CO;2-T; Kim YS, 2008, CLIN SCI, V115, P255, DOI 10.1042/CS20070458; Kiratli PO, 2010, HELL J NUCL MED, V13, P138; Koller A, 2012, J VASC RES, V49, P375, DOI 10.1159/000338747; Kumar R, 2008, NEUROSCI LETT, V438, P330, DOI 10.1016/j.neulet.2008.04.071; Kumar R, 2012, J NEUROSCI RES, V90, P2043, DOI 10.1002/jnr.23083; Lee JF, 2014, CLIN AUTON RES, V24, P39, DOI 10.1007/s10286-013-0222-x; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Loos N, 2005, J SLEEP RES, V14, P275, DOI 10.1111/j.1365-2869.2005.00464.x; Macey KE, 2006, RESP PHYSIOL NEUROBI, V151, P44, DOI 10.1016/j.resp.2005.05.024; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076631; Macey PM, 2012, SLEEP, V35, P1603, DOI 10.5665/sleep.2228; Macey PM, 2003, RESP PHYSIOL NEUROBI, V138, P275, DOI 10.1016/j.resp.2003.09.002; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; MATHEW RJ, 1986, BIOL PSYCHIAT, V21, P907, DOI 10.1016/0006-3223(86)90264-7; MCHEDLISHVILI G, 1980, STROKE, V11, P240, DOI 10.1161/01.STR.11.3.240; MEYER JS, 1987, BRAIN COGNITION, V6, P266, DOI 10.1016/0278-2626(87)90127-8; MEYER JS, 1980, ANN NEUROL, V7, P479, DOI 10.1002/ana.410070515; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Munger DM, 1998, EARLY HUM DEV, V52, P27, DOI 10.1016/S0378-3782(98)00002-4; Nasr N, 2009, EUR J NEUROL, V16, P386, DOI 10.1111/j.1468-1331.2008.02505.x; Netzer N, 1998, STROKE, V29, P87, DOI 10.1161/01.STR.29.1.87; Nogueira RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070821; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Ogoh S, 2010, J APPL PHYSIOL, V108, P1701, DOI 10.1152/japplphysiol.01031.2009; Pott F, 2000, J APPL PHYSIOL, V88, P1545, DOI 10.1152/jappl.2000.88.5.1545; Rodrigue KM, 2011, NEUROIMAGE, V54, P750, DOI 10.1016/j.neuroimage.2010.09.068; SACHS C, 1982, SLEEP, V5, P227, DOI 10.1093/sleep/5.3.227; Shaul ME, 2014, J ALZHEIMERS DIS; Silvani A, 2008, CLIN EXP PHARMACOL P, V35, P987, DOI 10.1111/j.1440-1681.2008.04985.x; Sohn YH, 1998, YONSEI MED J, V39, P322, DOI 10.3349/ymj.1998.39.4.322; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Tiecks FP, 1996, STROKE, V27, P1177, DOI 10.1161/01.STR.27.7.1177; Ulatowski JA, 1999, J CEREBR BLOOD F MET, V19, P809, DOI 10.1097/00004647-199907000-00012; Urbano F, 2008, J APPL PHYSIOL, V105, P1852, DOI 10.1152/japplphysiol.90900.2008; Urlesberger B, 2000, NEUROPEDIATRICS, V31, P75; Veale D, 1996, EUR RESPIR J, V9, P2122, DOI 10.1183/09031936.96.09102122; Virtanen J, 2012, SLEEP BREATH, V16, P309, DOI 10.1007/s11325-011-0526-9; Weiss JW, 1996, SLEEP, V19, P388, DOI 10.1093/sleep/19.5.388; Williams B, 2009, J AM COLL CARDIOL, V54, P705, DOI [10.1016/j.jacc.2009.02.088, 10.1016/j.jacc.2009.06.043]; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Winklewski PJ, 2013, BLOOD PRESSURE, V22, P27, DOI 10.3109/08037051.2012.701407; WOODROW KM, 1972, PSYCHOSOM MED, V34, P548, DOI 10.1097/00006842-197211000-00007; Woodson BT, 2004, OTOLARYNG HEAD NECK, V130, P643, DOI 10.1016/S0194-5998(03)01318-4; Xie AL, 2009, J APPL PHYSIOL, V106, P850, DOI 10.1152/japplphysiol.90914.2008; Yadav SK, 2013, NEUROSCI LETT, V555, P159, DOI 10.1016/j.neulet.2013.09.033; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Zhang R, 2004, STROKE, V35, P843, DOI 10.1161/01.STR.0000120309.84666.AE	84	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105261	10.1371/journal.pone.0105261	http://dx.doi.org/10.1371/journal.pone.0105261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166862	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303700020
J	Reinhard, K; Tikidji-Hamburyan, A; Seitter, H; Idrees, S; Mutter, M; Benkner, B; Munch, TA				Reinhard, Katja; Tikidji-Hamburyan, Alexandra; Seitter, Hartwig; Idrees, Saad; Mutter, Marion; Benkner, Boris; Muench, Thomas A.			Step-By-Step Instructions for Retina Recordings with Perforated Multi Electrode Arrays	PLOS ONE			English	Article								Multi-electrode arrays are a state-of-the-art tool in electrophysiology, also in retina research. The output cells of the retina, the retinal ganglion cells, form a monolayer in many species and are well accessible due to their proximity to the inner retinal surface. This structure has allowed the use of multi-electrode arrays for high-throughput, parallel recordings of retinal responses to presented visual stimuli, and has led to significant new insights into retinal organization and function. However, using conventional arrays where electrodes are embedded into a glass or ceramic plate can be associated with three main problems: (1) low signal-to-noise ratio due to poor contact between electrodes and tissue, especially in the case of strongly curved retinas from small animals, e. g. rodents; (2) insufficient oxygen and nutrient supply to cells located on the bottom of the recording chamber; and (3) displacement of the tissue during recordings. Perforated multi-electrode arrays (pMEAs) have been found to alleviate all three issues in brain slice recordings. Over the last years, we have been using such perforated arrays to study light evoked activity in the retinas of various species including mouse, pig, and human. In this article, we provide detailed step-by-step instructions for the use of perforated MEAs to record visual responses from the retina, including spike recordings from retinal ganglion cells and in vitro electroretinograms (ERG). In addition, we provide in-depth technical and methodological troubleshooting information, and show example recordings of good quality as well as examples for the various problems which might be encountered. While our description is based on the specific equipment we use in our own lab, it may also prove useful when establishing retinal MEA recordings with other equipment.	[Reinhard, Katja] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; Univ Tubingen, Bernstein Ctr Computat Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Munch, TA (corresponding author), Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany.	thomas.muench@cin.uni-tuebingen.de	Reinhard, Katja/AAA-9104-2022	Reinhard, Katja/0000-0002-8719-7445; Idrees, Saad/0000-0002-8514-1237; Seitter, Hartwig/0000-0003-2100-4193; Munch, Thomas/0000-0002-8884-6961	Deutsche Forschungsgemeinschaft (DFG) [EXC 307]; German Ministry of Education, Science, Research and Technology (BMBF) [FKZ 01GQ1002]; Pro-Retina Foundation, Germany; Deutsche Forschungsgemeinschaft; Tuebingen University	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Ministry of Education, Science, Research and Technology (BMBF)(Federal Ministry of Education & Research (BMBF)); Pro-Retina Foundation, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	This study was supported by funds from the Deutsche Forschungsgemeinschaft to the Werner Reichardt Centre for Integrative Neuroscience Tubingen (DFG EXC 307), and the German Ministry of Education, Science, Research and Technology to the Bernstein Center for Computational Neuroscience Tubingen (BMBF FKZ 01GQ1002), and a PhD stipend of the Pro-Retina Foundation, Germany, to KR. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLNICK DA, 1979, VISION RES, V19, P1117, DOI 10.1016/0042-6989(79)90006-3; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; Egert U, 2005, MIKR K FREIB; Feitl M, 2006, ADV NETWORK ELECTROP; Frey U, 2009, BIOSENS BIOELECTRON, V24, P2191, DOI 10.1016/j.bios.2008.11.028; Gonzalez-Sulser A, 2012, J NEUROPHYSIOL, V108, P2568, DOI 10.1152/jn.00363.2012; Gonzalez-Sulser A, 2011, NEUROPHARMACOLOGY, V60, P1142, DOI 10.1016/j.neuropharm.2010.10.007; Grosser S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086250; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Motamedi GK, 2012, NEUROTHERAPEUTICS, V9, P199, DOI 10.1007/s13311-011-0078-5; Multi Channel Systems MCS GmbH, 2013, 60PMEA200 30IR TI; Schmidt SL, 2013, NEUROPHARMACOLOGY, V72, P259, DOI 10.1016/j.neuropharm.2013.04.045; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; Zeck GM, 2007, EUR J NEUROSCI, V26, P367, DOI 10.1111/j.1460-9568.2007.05670.x	15	44	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106148	10.1371/journal.pone.0106148	http://dx.doi.org/10.1371/journal.pone.0106148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165854	Green Submitted, gold, Green Published			2022-12-25	WOS:000341303700079
J	Johnson, JI; Kavanaugh, SI; Nguyen, C; Tsai, PS				Johnson, Joshua I.; Kavanaugh, Scott I.; Cindy Nguyen; Tsai, Pei-San			Localization and Functional Characterization of a Novel Adipokinetic Hormone in the Mollusk, Aplysia californica	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; PIGMENT-CONCENTRATING HORMONE; CEREBRAL GANGLION; CORAZONIN; PEPTIDE; ENERGY; INDUCTION; PATTERN; HEPATOPANCREAS; NEUROPEPTIDES	Increasing evidence suggests that gonadotropin-releasing hormone (GnRH), corazonin, adipokinetic hormone (AKH), and red pigment-concentrating hormone all share common ancestry to form a GnRH superfamily. Despite the wide presence of these peptides in protostomes, their biological effects remain poorly characterized in many taxa. This study had three goals. First, we cloned the full-length sequence of a novel AKH, termed Aplysia-AKH, and examined its distribution in an opisthobranch mollusk, Aplysia californica. Second, we investigated in vivo biological effects of Aplysia-AKH. Lastly, we compared the effects of Aplysia-AKH to a related A. californica peptide, Aplysia-GnRH. Results suggest that Aplysia-AKH mRNA and peptide are localized exclusively in central tissues, with abdominal, cerebral, and pleural ganglia being the primary sites of Aplysia-AKH production. However, Aplysia-AKH-positive fibers were found in all central ganglia, suggesting diverse neuromodulatory roles. Injections of A. californica with Aplysia-AKH significantly inhibited feeding, reduced body mass, increased excretion of feces, and reduced gonadal mass and oocyte diameter. The in vivo effects of Aplysia-AKH differed substantially from Aplysia-GnRH. Overall, the distribution and biological effects of Aplysia-AKH suggest it has diverged functionally from Aplysia-GnRH over the course of evolution. Further, that both Aplysia-AKH and Aplysia-GnRH failed to activate reproduction suggest the critical role of GnRH as a reproductive activator may be a phenomenon unique to vertebrates.	[Tsai, Pei-San] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Tsai, PS (corresponding author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA.	pei-san.tsai@colorado.edu	Johnson, Johnson/HDL-9124-2022	Tsai, Pei-San/0000-0002-8650-647X	National Science Foundation [IOS-0743818]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation Grant IOS-0743818 to PST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews E.B., 1988, P381; AUDESIRK TE, 1979, BIOL BULL, V157, P407, DOI 10.2307/1541026; Bayne B.L., 1983, P407; Boerjan B, 2010, GEN COMP ENDOCR, V166, P222, DOI 10.1016/j.ygcen.2009.09.004; Burton RF, 1983, MOLLUSCA 2, V5, P291; CAREW TJ, 1977, J NEUROPHYSIOL, V40, P692, DOI 10.1152/jn.1977.40.3.692; CONNOLLY PB, 1987, BIOL REPROD, V36, P1238, DOI 10.1095/biolreprod36.5.1238; Dickinson PS, 1997, J NEUROPHYSIOL, V77, P599, DOI 10.1152/jn.1997.77.2.599; DICKINSON PS, 1993, J NEUROPHYSIOL, V69, P1475, DOI 10.1152/jn.1993.69.5.1475; DUDEK FE, 1980, CAN J ZOOL, V58, P2220, DOI 10.1139/z80-304; Gabbott P.A., 1983, P165; GADE G, 1990, J INSECT PHYSIOL, V36, P1, DOI 10.1016/0022-1910(90)90145-6; Gade G, 2003, GEN COMP ENDOCR, V132, P10, DOI 10.1016/S0016-6480(03)00159-X; Gade G., 2013, HDB BIOL ACTIVE PEPT, V2nd ed., P185, DOI DOI 10.1016/B978-0-12-385095-9.00028-2; Gade G, 2009, ANN NY ACAD SCI, V1163, P125, DOI 10.1111/j.1749-6632.2008.03625.x; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Horn CC, 1998, BEHAV NEUROSCI, V112, P1258, DOI 10.1037/0735-7044.112.5.1258; JAHANPARWAR B, 1976, COMP BIOCHEM PHYS A, V54, P347, DOI 10.1016/S0300-9629(76)80124-7; JAHANPARWAR B, 1969, AM J PHYSIOL, V216, P1246, DOI 10.1152/ajplegacy.1969.216.5.1246; Johnson Bruce R., 1992, P1; Jung LH, 2014, GEN COMP ENDOCR, V195, P132, DOI 10.1016/j.ygcen.2013.11.007; Kah O, 2007, GEN COMP ENDOCR, V153, P346, DOI 10.1016/j.ygcen.2007.01.030; Kandel E. R., 1979, BEHAV BIOL APLYSIA C; Kauffman AS, 2004, ENDOCRINOLOGY, V145, P686, DOI 10.1210/en.2003-1150; KIRSCHNE.LB, 1967, ANNU REV PHYSIOL, V29, P169, DOI 10.1146/annurev.ph.29.030167.001125; Kodrik D, 2008, PHYSIOL ENTOMOL, V33, P171, DOI 10.1111/j.1365-3032.2008.00625.x; KOESTER J, 1989, J NEUROSCI, V9, P4078; Livingstone D.R., 1983, P177; LIVINGSTONE DR, 1981, COMP BIOCHEM PHYS B, V69, P147, DOI 10.1016/0305-0491(81)90224-8; Lorenz MW, 2009, INTEGR COMP BIOL, V49, P380, DOI 10.1093/icb/icp019; Lorenz MW, 2003, COMP BIOCHEM PHYS B, V136, P197, DOI 10.1016/S1096-4959(03)00227-6; MARTIN AW, 1958, J EXP BIOL, V35, P260; Matsuda K, 2008, HORM BEHAV, V54, P83, DOI 10.1016/j.yhbeh.2008.01.011; MOSHITZKY P, 1990, INSECT BIOCHEM, V20, P319, DOI 10.1016/0020-1790(90)90050-5; Naimo TJ, 1998, J N AM BENTHOL SOC, V17, P121, DOI 10.2307/1468056; Newell R.C., 1980, Advances in Marine Biology, V17, P329, DOI 10.1016/S0065-2881(08)60304-1; NUSBAUM MP, 1988, J EXP BIOL, V135, P165; Poljaroen J, 2011, AQUACULTURE, V321, P121, DOI 10.1016/j.aquaculture.2011.08.022; PORTER DA, 1985, GEN COMP ENDOCR, V59, P308, DOI 10.1016/0016-6480(85)90383-1; Predel R, 2007, PEPTIDES, V28, P3, DOI 10.1016/j.peptides.2006.10.011; RAM JL, 1992, EXPERIENTIA, V48, P14, DOI 10.1007/BF01923596; RAYPORT SG, 1983, J NEUROPHYSIOL, V49, P864, DOI 10.1152/jn.1983.49.4.864; Roch GJ, 2011, GEN COMP ENDOCR, V171, P1, DOI 10.1016/j.ygcen.2010.12.014; Rubakhin SS, 1999, J NEUROPHYSIOL, V81, P1251, DOI 10.1152/jn.1999.81.3.1251; SAROJINI R, 1995, J EXP BIOL, V198, P1253; Scharrer B, 1944, BIOL BULL-US, V87, P242, DOI 10.2307/1537959; Siangcham T, 2013, GEN COMP ENDOCR, V193, P10, DOI 10.1016/j.ygcen.2013.06.028; Simkiss K, 1977, Symposia Zool Soc Lond, VNo. 39, P35; STINNAKRE J, 1969, J EXP BIOL, V51, P347; STRUMWASSER F, 1969, COMP BIOCHEM PHYSIOL, V29, P197, DOI 10.1016/0010-406X(69)91735-6; SWETHA CH, 2011, J MARINE SCI RES D S, V3, DOI DOI 10.4172/2155-9910.S3-001; Temple JL, 2003, ENDOCRINOLOGY, V144, P13, DOI 10.1210/en.2002-220883; THELER JM, 1987, CELL TISSUE RES, V247, P639; Trudeau VL, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-14; Tsai PS, 2010, GEN COMP ENDOCR, V166, P280, DOI 10.1016/j.ygcen.2009.09.009; VANWEEL PB, 1957, Z VERGL PHYSIOL, V39, P492; VEENSTRA JA, 1989, FEBS LETT, V250, P231, DOI 10.1016/0014-5793(89)80727-6; Veenstra JA, 2009, INSECT BIOCHEM MOLEC, V39, P755, DOI 10.1016/j.ibmb.2009.09.008; Wayne NL, 1996, GEN COMP ENDOCR, V102, P351, DOI 10.1006/gcen.1996.0078; Wayne NL, 2001, J BIOL RHYTHM, V16, P391, DOI 10.1177/074873001129002097; WEISS KR, 1989, P NATL ACAD SCI USA, V86, P2913, DOI 10.1073/pnas.86.8.2913; Wirmer A, 2012, ARTHROPOD STRUCT DEV, V41, P409, DOI 10.1016/j.asd.2012.04.003; Xin YP, 2001, J NEUROPHYSIOL, V85, P174, DOI 10.1152/jn.2001.85.1.174; YOUNG ES, 1991, COMP BIOCHEM PHYS A, V100, P607, DOI 10.1016/0300-9629(91)90378-P; Zhang LH, 2008, GEN COMP ENDOCR, V156, P201, DOI 10.1016/j.ygcen.2007.11.015	65	85	85	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106014	10.1371/journal.pone.0106014	http://dx.doi.org/10.1371/journal.pone.0106014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162698	Green Published, Green Submitted, gold			2022-12-25	WOS:000340880900076
J	Dahal, RA; Pramod, AB; Sharma, B; Krout, D; Foster, JD; Cha, JH; Cao, JJ; Newman, AH; Lever, JR; Vaughan, RA; Henry, LK				Dahal, Rejwi Acharya; Pramod, Akula Bala; Sharma, Babita; Krout, Danielle; Foster, James D.; Cha, Joo Hwan; Cao, Jianjing; Newman, Amy Hauck; Lever, John R.; Vaughan, Roxanne A.; Henry, L. Keith			Computational and Biochemical Docking of the Irreversible Cocaine Analog RTI 82 Directly Demonstrates Ligand Positioning in the Dopamine Transporter Central Substrate-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Addiction; Dopamine Transporter; Molecular Docking; Molecular Dynamics; Monoamine Transporter; Photoaffinity Labeling; SCAM; Topane	HUMAN SEROTONIN TRANSPORTERS; TRANSMEMBRANE DOMAIN-I; ACID METHYL-ESTERS; NEUROTRANSMITTER TRANSPORTERS; MONOAMINE TRANSPORTERS; MOLECULAR-DYNAMICS; CONFORMATIONAL-CHANGES; PHOTOAFFINITY LIGANDS; IMPLICATES PROXIMITY; LEUCINE TRANSPORTER	Background: Cocaine interaction with DAT was assessed using the irreversible binding cocaine analog RTI 82. Results: Molecular modeling and peptide mapping identify adduction of RTI 82 to Phe-319 and Phe-320 of rat DAT and human DAT, respectively. Conclusion: Tropane-based pharmacophores bind to DAT in the central substrate site. Significance: Mapping the cocaine-binding site reveals new insights for medication discovery. The dopamine transporter (DAT) functions as a key regulator of dopaminergic neurotransmission via re-uptake of synaptic dopamine (DA). Cocaine binding to DAT blocks this activity and elevates extracellular DA, leading to psychomotor stimulation and addiction, but the mechanisms by which cocaine interacts with DAT and inhibits transport remain incompletely understood. Here, we addressed these questions using computational and biochemical methodologies to localize the binding and adduction sites of the photoactivatable irreversible cocaine analog 3-(p-chlorophenyl)tropane-2-carboxylic acid, 4-azido-3-iodophenylethyl ester ([I-125]RTI 82). Comparative modeling and small molecule docking indicated that the tropane pharmacophore of RTI 82 was positioned in the central DA active site with an orientation that juxtaposed the aryliodoazide group for cross-linking to rat DAT Phe-319. This prediction was verified by focused methionine substitution of residues flanking this site followed by cyanogen bromide mapping of the [I-125]RTI 82-labeled mutants and by the substituted cysteine accessibility method protection analyses. These findings provide positive functional evidence linking tropane pharmacophore interaction with the core substrate-binding site and support a competitive mechanism for transport inhibition. This synergistic application of computational and biochemical methodologies overcomes many uncertainties inherent in other approaches and furnishes a schematic framework for elucidating the ligand-protein interactions of other classes of DA transport inhibitors.	[Dahal, Rejwi Acharya; Pramod, Akula Bala; Sharma, Babita; Krout, Danielle; Foster, James D.; Vaughan, Roxanne A.; Henry, L. Keith] Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58203 USA; [Cha, Joo Hwan; Cao, Jianjing; Newman, Amy Hauck] NIDA, Med Chem Sect, Intramural Res Program, Baltimore, MD 21224 USA; [Lever, John R.] Harry S Truman Mem Vet Hosp, Res Serv, Columbia, MO 65201 USA; [Lever, John R.] Univ Missouri, Dept Radiol, Radiopharmaceut Sci Inst, Columbia, MO 65211 USA; [Lever, John R.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA	University of North Dakota Grand Forks; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Vaughan, RA (corresponding author), 501 N Columbia Rd,Stop 9037, Grand Forks, ND 58202 USA.	roxanne.vaughan@med.und.edu; keith.henry@med.und.edu			National Institutes of Health Grants from the INBRE Program of the NCRR; NIDA-Intramural Research Program; COBRE Program of the NCRR [DA027845, P20 RR017699]; ND EPSCoR IIG [P20 RR016741]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027845, ZIADA000389] Funding Source: NIH RePORTER	National Institutes of Health Grants from the INBRE Program of the NCRR; NIDA-Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); COBRE Program of the NCRR; ND EPSCoR IIG; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants from the INBRE Program of the NCRR and the NIDA-Intramural Research Program (to A. H. N.), Grants DA027845 (to L. K. H. and R. A. V.), P20 RR017699 (to University of North Dakota) from the COBRE Program of the NCRR, and Grant P20 RR016741 from ND EPSCoR IIG (to R. A. V. and J. D. F.).	Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Barker EL, 1999, J NEUROSCI, V19, P4705; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Bisgaard H, 2011, NEUROPHARMACOLOGY, V60, P182, DOI 10.1016/j.neuropharm.2010.08.021; Boja JW, 1998, SYNAPSE, V30, P9, DOI 10.1002/(SICI)1098-2396(199809)30:1<9::AID-SYN2>3.3.CO;2-P; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; CARROLL FI, 1992, J MED CHEM, V35, P1813, DOI 10.1021/jm00088a017; CARROLL FI, 1991, J MED CHEM, V34, P2719, DOI 10.1021/jm00113a008; CARROLL FI, 1994, J MED CHEM, V37, P2865, DOI 10.1021/jm00044a007; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen NH, 2004, J NEUROCHEM, V89, P750, DOI 10.1111/j.1471-4159.2004.02409.x; Chen NH, 2001, J NEUROCHEM, V77, P1116, DOI 10.1046/j.1471-4159.2001.00312.x; Chen R, 2005, J NEUROCHEM, V94, P352, DOI 10.1111/j.1471-4159.2005.03199.x; Combs SA, 2013, NAT PROTOC, V8, P1277, DOI 10.1038/nprot.2013.074; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W. L, 2013, PYMOL MOL GRAPHICS S; Desai RI, 2005, J NEUROSCI, V25, P1889, DOI 10.1523/JNEUROSCI.4778-04.2005; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Felts B, 2014, J BIOL CHEM, V289, P1825, DOI 10.1074/jbc.M113.504654; Ferrer JV, 1998, P NATL ACAD SCI USA, V95, P9238, DOI 10.1073/pnas.95.16.9238; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Gabrielsen M, 2012, J MOL MODEL, V18, P1073, DOI 10.1007/s00894-011-1133-1; Gaffaney JD, 2014, NEUROCHEM INT, V73, P16, DOI 10.1016/j.neuint.2013.11.003; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Geurink PP, 2012, TOP CURR CHEM, V324, P85, DOI 10.1007/128_2011_286; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Hahn MK, 2007, ANNU REV PHARMACOL, V47, P401, DOI 10.1146/annurev.pharmtox.47.120505.105242; Henry LK, 2007, MOL INTERV, V7, P306, DOI 10.1124/mi.7.6.4; Henry LK, 2011, J BIOL CHEM, V286, P30823, DOI 10.1074/jbc.M111.250308; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hill ER, 2011, NEUROPHARMACOLOGY, V61, P112, DOI 10.1016/j.neuropharm.2011.03.014; Huang XQ, 2009, J PHYS CHEM B, V113, P15057, DOI 10.1021/jp900963n; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Indarte M, 2008, PROTEINS, V70, P1033, DOI 10.1002/prot.21598; Itokawa M, 2000, MOL PHARMACOL, V57, P1093; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Koldso H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002246; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kurian MA, 2011, LANCET NEUROL, V10, P54, DOI 10.1016/S1474-4422(10)70269-6; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee SH, 2000, MOL PHARMACOL, V57, P883; LEVER JR, 1993, J LABELLED COMPD RAD, V33, P1131, DOI 10.1002/jlcr.2580331207; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Lin ZC, 2000, MOL PHARMACOL, V58, P1581, DOI 10.1124/mol.58.6.1581; Lin ZC, 1999, MOL PHARMACOL, V56, P434, DOI 10.1124/mol.56.2.434; Lin ZC, 2002, MOL PHARMACOL, V61, P885, DOI 10.1124/mol.61.4.885; Loland CJ, 2008, MOL PHARMACOL, V73, P813, DOI 10.1124/mol.107.039800; Loland CJ, 2012, BIOL PSYCHIAT, V72, P405, DOI 10.1016/j.biopsych.2012.03.022; MADRAS BK, 1989, MOL PHARMACOL, V36, P518; Madras BK, 1996, SYNAPSE, V24, P340; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; MCELVAIN JS, 1992, BIOCHEM PHARMACOL, V43, P2189, DOI 10.1016/0006-2952(92)90178-L; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Meltzer PC, 1997, J MED CHEM, V40, P2661, DOI 10.1021/jm9703045; Merchant BA, 2012, J MOL GRAPH MODEL, V38, P1, DOI 10.1016/j.jmgm.2012.05.007; Mereu M, 2013, PSYCHOPHARMACOLOGY, V229, P415, DOI 10.1007/s00213-013-3232-4; MISSALE C, 1985, J NEUROCHEM, V45, P51, DOI 10.1111/j.1471-4159.1985.tb05473.x; MOE, 2012, MOL OP ENV; Parnas ML, 2008, MOL PHARMACOL, V73, P1141, DOI 10.1124/mol.107.043679; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Piscitelli CL, 2012, EMBO J, V31, P228, DOI 10.1038/emboj.2011.353; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Plenge P, 2007, EUR J PHARMACOL, V567, P1, DOI 10.1016/j.ejphar.2007.03.055; Plenge P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371765; Pramod AB, 2013, MOL ASPECTS MED, V34, P197, DOI 10.1016/j.mam.2012.07.002; QUACPAC, 2011, OPENEYE SCI SOFTW; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Runyon S.P., 2008, DOPAMINE TRANSPORTER, P125; Schmitt KC, 2013, J PHARMACOL EXP THER, V346, P2, DOI 10.1124/jpet.111.191056; Schmitt KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025790; Sen N, 2005, NEUROPHARMACOLOGY, V49, P780, DOI 10.1016/j.neuropharm.2005.08.014; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, CHANNELS, V2, P380, DOI 10.4161/chan.2.5.6904; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Tanda G, 2013, PSYCHOPHARMACOLOGY, V229, P307, DOI 10.1007/s00213-013-3109-6; Tanda G, 2009, ADV PHARMACOL, V57, P253, DOI 10.1016/S1054-3589(08)57007-4; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; Ukairo OT, 2005, J PHARMACOL EXP THER, V314, P575, DOI 10.1124/jpet.105.085829; Vaughan RA, 1996, J BIOL CHEM, V271, P21672, DOI 10.1074/jbc.271.35.21672; Vaughan RA, 1999, J NEUROSCI, V19, P630; Vaughan RA, 2001, MOL PHARMACOL, V59, P1157, DOI 10.1124/mol.59.5.1157; Vaughan RA, 2007, J BIOL CHEM, V282, P8915, DOI 10.1074/jbc.M610633200; Velazquez-Sanchez C, 2010, EUR NEUROPSYCHOPHARM, V20, P501, DOI 10.1016/j.euroneuro.2010.03.005; WALL SC, 1993, MOL PHARMACOL, V43, P264; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wu XH, 2003, MOL PHARMACOL, V63, P653, DOI 10.1124/mol.63.3.653; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zdravkovic I, 2012, BBA-BIOMEMBRANES, V1818, P337, DOI 10.1016/j.bbamem.2011.10.031; Zhan CG, 2005, J COMPUT CHEM, V26, P980, DOI 10.1002/jcc.20241; Zhao CF, 2012, BIOPHYS J, V103, P878, DOI 10.1016/j.bpj.2012.07.044; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	109	20	20	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29712	29727		10.1074/jbc.M114.571521	http://dx.doi.org/10.1074/jbc.M114.571521			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25179220	Green Published, hybrid			2022-12-25	WOS:000344370800020
J	Kacprzyk-Stokowiec, A; Kulma, M; Traczyk, G; Kwiatkowska, K; Sobota, A; Dadlez, M				Kacprzyk-Stokowiec, Aleksandra; Kulma, Magdalena; Traczyk, Gabriela; Kwiatkowska, Katarzyna; Sobota, Andrzej; Dadlez, Michal			Crucial Role of Perfringolysin O D1 Domain in Orchestrating Structural Transitions Leading to Membrane-perforating Pores A HYDROGEN-DEUTERIUM EXCHANGE STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; STAPHYLOCOCCAL ALPHA-HEMOLYSIN; THIOL-ACTIVATED CYTOLYSIN; MASS-SPECTROMETRY; CLOSTRIDIUM-PERFRINGENS; CONFORMATIONAL-CHANGES; STREPTOLYSIN-O; THETA-TOXIN; MECHANISM; PREPORE	Perfringolysin O(PFO) is a toxic protein that binds to cholesterol-containing membranes, oligomerizes, and forms a beta-barrel transmembrane pore, leading to cell lysis. Previous studies have uncovered the sequence of events in this multistage structural transition to a considerable detail, but the underlying molecular mechanisms are not yet fully understood. By measuring hydrogen-deuterium exchange patterns of peptide bond amide protons monitored by mass spectrometry (MS), we have mapped structural changes in PFO and its variant bearing a point mutation during incorporation to the lipid environment. We have defined all regions that undergo structural changes caused by the interaction with the lipid environment both in wild-type PFO, thus providing new experimental constraints for molecular modeling of the pore formation process, and in a point mutant, W165T, for which the pore formation process is known to be inefficient. We have demonstrated that point mutation W165T causes destabilization of protein solution structure, strongest for domain D1, which interrupts the pathway of structural transitions in other domains necessary for proper oligomerization in the membrane. In PFO, the strongest changes accompanying binding to the membrane focus in D1; the C-terminal part of D4; and strands beta 1, beta 4, and beta 5 of D3. These changes were much weaker for PFOl(ipo)(W165T) where substantial stabilization was observed only in D4 domain. In this study, the application of hydrogen-deuterium exchange analysis monitored by MS provided new insight into conformational changes of PFO associated with the membrane binding, oligomerization, and lytic pore formation.	[Kacprzyk-Stokowiec, Aleksandra; Kulma, Magdalena; Dadlez, Michal] Polish Acad Sci, Dept Biophys, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Traczyk, Gabriela; Kwiatkowska, Katarzyna; Sobota, Andrzej] Polish Acad Sci, Nencki Inst Expt Biol, Dept Cell Biol, PL-02093 Warsaw, Poland; [Dadlez, Michal] Warsaw Univ, Inst Genet & Biotechnol, Dept Biol, PL-02185 Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Warsaw	Dadlez, M (corresponding author), Polish Acad Sci, Dept Biophys, Inst Biochem & Biophys, 5A Pawinskiego St, PL-02106 Warsaw, Poland.	michald@ibb.waw.pl	Kwiatkowska, Katarzyna/R-4087-2016; Kwiatkowska, Katarzyna/ABE-9713-2021	Kwiatkowska, Katarzyna/0000-0002-0550-8394; Dadlez, Michal/0000-0001-8811-5176; Traczyk, Gabriela/0000-0003-2065-440X	Foundation for Polish Science TEAM Program [TEAM/2011-7/1]; Centre of Preclinical Research and Technology Grant [POIG.02.02.00- 14-024/08-00]; NanoFun [POIGT.02.02.00-00-025/09-00]	Foundation for Polish Science TEAM Program; Centre of Preclinical Research and Technology Grant; NanoFun	This work was supported by Foundation for Polish Science TEAM Program Grant TEAM/2011-7/1, Centre of Preclinical Research and Technology Grant POIG.02.02.00- 14-024/08-00, and NanoFun Grant POIGT.02.02.00-00-025/09-00.	Bourdeau RW, 2009, J BIOL CHEM, V284, P14645, DOI 10.1074/jbc.M807631200; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Dang TX, 2005, J STRUCT BIOL, V150, P100, DOI 10.1016/j.jsb.2005.02.003; delosToyos JR, 1996, INFECT IMMUN, V64, P480, DOI 10.1128/IAI.64.2.480-484.1996; Dowd KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002787; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Hebling CM, 2010, ANAL CHEM, V82, P5415, DOI 10.1021/ac100962c; Heuck AP, 2007, J BIOL CHEM, V282, P22629, DOI 10.1074/jbc.M703207200; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Hotze EM, 2012, J BIOL CHEM, V287, P24534, DOI 10.1074/jbc.M112.380139; Hotze EM, 2012, BBA-BIOMEMBRANES, V1818, P1028, DOI 10.1016/j.bbamem.2011.07.036; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; IWAMOTO M, 1987, EUR J BIOCHEM, V167, P425, DOI 10.1111/j.1432-1033.1987.tb13355.x; Kaltashov IA, 2013, PROTEIN SCI, V22, P530, DOI 10.1002/pro.2238; Koshy SS, 2013, BIOCHEMISTRY-US, V52, P8833, DOI 10.1021/bi401261b; Kulma M, 2010, BBA-BIOMEMBRANES, V1798, P471, DOI 10.1016/j.bbamem.2009.12.004; Kupniewska-Kozak A, 2010, J MOL BIOL, V403, P52, DOI 10.1016/j.jmb.2010.08.027; Kwiatkowska K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-64; Miles G, 2002, PROTEIN SCI, V11, P1813, DOI 10.1110/ps.0204002; Morgan CR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010876; NAKAMURA M, 1995, BIOCHEMISTRY-US, V34, P6513, DOI 10.1021/bi00019a032; NELSON GJ, 1967, J LIPID RES, V8, P374; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Rossjohn J, 2007, J MOL BIOL, V367, P1227, DOI 10.1016/j.jmb.2007.01.042; SALO P, 1993, INFECT IMMUN, V61, P2822, DOI 10.1128/IAI.61.7.2822-2826.1993; Schuerch DW, 2005, P NATL ACAD SCI USA, V102, P12537, DOI 10.1073/pnas.0500558102; Sellman BR, 1997, MOL MICROBIOL, V23, P551, DOI 10.1046/j.1365-2958.1997.d01-1876.x; Shakor ABA, 2004, J BIOL CHEM, V279, P36778, DOI 10.1074/jbc.M402170200; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; Sitkiewicz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076353; Solovyova AS, 2004, BIOPHYS J, V87, P540, DOI 10.1529/biophysj.104.039974; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; TWETEN RK, 1988, INFECT IMMUN, V56, P3235, DOI 10.1128/IAI.56.12.3235-3240.1988; WALKER B, 1992, J BIOL CHEM, V267, P21782; Walzthoeni T, 2013, CURR OPIN STRUC BIOL, V23, P252, DOI 10.1016/j.sbi.2013.02.008	43	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28738	28752		10.1074/jbc.M114.577981	http://dx.doi.org/10.1074/jbc.M114.577981			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25164812	hybrid, Green Published			2022-12-25	WOS:000343765400061
J	Han, YC; Perner, M				Han, Yuchen; Perner, Mirjam			The Role of Hydrogen for Sulfurimonas denitrificans' Metabolism	PLOS ONE			English	Article							RANGE CLONING VECTOR; SP-NOV.; EMENDED DESCRIPTION; GENUS SULFURIMONAS; CHEMOLITHOAUTOTROPH; MICROORGANISMS; PBBR1MCS; SULFIDE; GROWTH; FIELD	Sulfurimonas denitrificans was originally isolated from coastal marine sediments. It can grow with thiosulfate and nitrate or sulfide and oxygen. Recently sequencing of its genome revealed that it encodes periplasmic and cytoplasmic [NiFe]-hydrogenases but the role of hydrogen for its metabolism has remained unknown. We show the first experimental evidence that S. denitrificans can indeed express a functional hydrogen uptake active hydrogenase and can grow on hydrogen. In fact, under the provided conditions it grew faster and denser on hydrogen than on thiosulfate alone and even grew with hydrogen in the absence of reduced sulfur compounds. In our experiments, at the time points tested, the hydrogen uptake activity appeared to be related to the periplasmic hydrogenase and not to the cytoplasmic hydrogenase. Our data suggest that under the provided conditions S. denitrificans can grow more efficiently with hydrogen than with thiosulfate.	[Han, Yuchen; Perner, Mirjam] Univ Hamburg, Bioctr Klein Flottbek, Hamburg, Germany	University of Hamburg	Perner, M (corresponding author), Univ Hamburg, Bioctr Klein Flottbek, Hamburg, Germany.	mirjam.perner@uni-hamburg.de	Perner, Mirjam/A-8158-2018	Perner, Mirjam/0000-0003-1223-9310; Han, Yuchen/0000-0003-3834-0310	MIN-faculty of the University of Hamburg	MIN-faculty of the University of Hamburg	This work was supported by the equal opportunity funding of the MIN-faculty of the University of Hamburg for Yuchen Han. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Gevertz D, 2000, APPL ENVIRON MICROB, V66, P2491, DOI 10.1128/AEM.66.6.2491-2501.2000; Guiral M, 2005, J BIOL CHEM, V280, P42004, DOI 10.1074/jbc.M508034200; HEIJNEN JJ, 1992, BIOTECHNOL BIOENG, V39, P833, DOI 10.1002/bit.260390806; Inagaki F, 2003, INT J SYST EVOL MICR, V53, P1801, DOI 10.1099/ijs.0.02682-0; Kodama Y, 2003, APPL ENVIRON MICROB, V69, P107, DOI 10.1128/AEM.69.1.107-112.2003; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kuenen JG, 1999, BIOL PROKARYOTES, P234; Labrenz M, 2013, INT J SYST EVOL MICR, V63, P4141, DOI 10.1099/ijs.0.048827-0; LOVLEY DR, 1989, APPL ENVIRON MICROB, V55, P700, DOI 10.1128/AEM.55.3.700-706.1989; Maroti G, 2009, APPL ENVIRON MICROB, V75, P5821, DOI 10.1128/AEM.00580-09; MEINCKE M, 1992, ARCH MICROBIOL, V158, P127, DOI 10.1007/BF00245215; Mukhopadhyay B, 1999, APPL ENVIRON MICROB, V65, P301; Nishihara H, 1997, BIOCHEM BIOPH RES CO, V232, P766, DOI 10.1006/bbrc.1997.6369; Perner M, 2013, ENVIRON MICROBIOL, V15, P1551, DOI 10.1111/1462-2920.12038; Perner M, 2010, FEMS MICROBIOL ECOL, V74, P55, DOI 10.1111/j.1574-6941.2010.00940.x; QUENTIN KE, 1964, FRESEN Z ANAL CHEM, V200, P250, DOI 10.1007/BF00472716; Sievert SM, 2008, APPL ENVIRON MICROB, V74, P1145, DOI 10.1128/AEM.01844-07; Takai K, 2005, APPL ENVIRON MICROB, V71, P7310, DOI 10.1128/AEM.71.11.7310-7320.2005; Takai K, 2006, INT J SYST EVOL MICR, V56, P1725, DOI 10.1099/ijs.0.64255-0; Timmer-Ten Hoor A., 1975, NETH J SEA RES, V9, P344, DOI DOI 10.1016/0077-7579(75)90008-3; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159	26	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106218	10.1371/journal.pone.0106218	http://dx.doi.org/10.1371/journal.pone.0106218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170905	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000341127500126
J	Kapralova, KH; Franzdottir, SR; Jonsson, H; Snorrason, SS; Jonsson, ZO				Kapralova, Kalina H.; Franzdottir, Sigridur Rut; Jonsson, Hakon; Snorrason, Sigurour S.; Jonsson, Zophonias O.			Patterns of MiRNA Expression in Arctic Charr Development	PLOS ONE			English	Article							SALVELINUS-ALPINUS; SKELETAL DEVELOPMENT; SYMPATRIC MORPHS; EMBRYONIC-DEVELOPMENT; MICRORNA EXPRESSION; ADAPTIVE RADIATION; GENE-REGULATION; DIFFERENTIATION; THINGVALLAVATN; EVOLUTION	Micro-RNAs (miRNAs) are now recognized as a major class of developmental regulators. Sequences of many miRNAs are highly conserved, yet they often exhibit temporal and spatial heterogeneity in expression among species and have been proposed as an important reservoir for adaptive evolution and divergence. With this in mind we studied miRNA expression during embryonic development of offspring from two contrasting morphs of the highly polymorphic salmonid Arctic charr (Salvelinus alpinus), a small benthic morph from Lake Thingvallavatn (SB) and an aquaculture stock (AC). These morphs differ extensively in morphology and adult body size. We established offspring groups of the two morphs and sampled at several time points during development. Four time points (3 embryonic and one just before first feeding) were selected for high-throughput small-RNA sequencing. We identified a total of 326 conserved and 427 novel miRNA candidates in Arctic charr, of which 51 conserved and 6 novel miRNA candidates were differentially expressed among developmental stages. Furthermore, 53 known and 19 novel miRNAs showed significantly different levels of expression in the two contrasting morphs. Hierarchical clustering of the 53 conserved miRNAs revealed that the expression differences are confined to the embryonic stages, where miRNAs such as sal-miR-130, 30, 451, 133, 26 and 199a were highly expressed in AC, whereas sal-miR-146, 183, 206 and 196a were highly expressed in SB embryos. The majority of these miRNAs have previously been found to be involved in key developmental processes in other species such as development of brain and sensory epithelia, skeletogenesis and myogenesis. Four of the novel miRNA candidates were only detected in either AC or SB. miRNA candidates identified in this study will be combined with available mRNA expression data to identify potential targets and involvement in developmental regulation.	[Kapralova, Kalina H.; Franzdottir, Sigridur Rut; Jonsson, Hakon; Snorrason, Sigurour S.; Jonsson, Zophonias O.] Univ Iceland, Inst Life & Environm Sci, Reykjavik, Iceland	University of Iceland	Jonsson, ZO (corresponding author), Univ Iceland, Inst Life & Environm Sci, Reykjavik, Iceland.	zjons@hi.is	Jónsson, Zophonías/E-1960-2015; Jónsson, Zophonías Oddur/AAO-1354-2020; Franzdottir, Sigridur/M-2534-2015	Jónsson, Zophonías Oddur/0000-0001-5798-9647; Kapralova, Kalina/0000-0002-5571-0160	Icelandic Centre for Research (RANNIS) [100204011, 110285-0061, 130756-051]; University of Iceland Research Fund	Icelandic Centre for Research (RANNIS); University of Iceland Research Fund	This project was supported by grants from The Icelandic Centre for Research (RANNIS, http://http://www.rannis.is/), grants #100204011, #110285-0061 and #130756-051, and the University of Iceland Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahi EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arif S, 2013, EVOLUTON MIR 92A UND; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bekaert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070136; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brunner PC, 2001, EVOLUTION, V55, P573, DOI 10.1554/0014-3820(2001)055[0573:HPOACS]2.0.CO;2; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Di Genova A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar050; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Eiriksson G. M., 1999, Journal of Fish Biology, V55, P175, DOI 10.1111/j.1095-8649.1999.tb01054.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Filteau M, 2013, MOL BIOL EVOL, V30, P1384, DOI 10.1093/molbev/mst053; FRANDSEN F, 1989, J FISH BIOL, V34, P281, DOI 10.1111/j.1095-8649.1989.tb03309.x; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gislason D, 1999, CAN J FISH AQUAT SCI, V56, P2229, DOI 10.1139/cjfas-56-12-2229; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gorodilov YN, 1996, ENVIRON BIOL FISH, V47, P109, DOI 10.1007/BF00005034; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He XJ, 2011, DEV BIOL, V357, P463, DOI 10.1016/j.ydbio.2011.07.014; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Henning F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-171; Hinits Y, 2011, DEV BIOL, V358, P102, DOI 10.1016/j.ydbio.2011.07.015; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; JONSSON B, 1988, CAN J FISH AQUAT SCI, V45, P1537, DOI 10.1139/f88-182; Kapralova KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069402; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li JJ, 2013, TRENDS GENET, V29, P116, DOI 10.1016/j.tig.2012.10.008; Liu N, 2008, CELL RES, V18, P985, DOI 10.1038/cr.2008.278; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Ma H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039649; Mallarino R, 2012, P NATL ACAD SCI USA, V109, P16222, DOI 10.1073/pnas.1206205109; MALMQUIST HJ, 1992, J ANIM ECOL, V61, P21, DOI 10.2307/5505; Manousaki T, 2013, MOL ECOL, V22, P650, DOI 10.1111/mec.12034; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; McGlinn E, 2009, P NATL ACAD SCI USA, V106, P18610, DOI 10.1073/pnas.0910374106; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mishima Y, 2012, DEV GROWTH DIFFER, V54, P55, DOI 10.1111/j.1440-169X.2011.01306.x; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; Papaioannou G, 2013, P NATL ACAD SCI USA, V110, pE3291, DOI 10.1073/pnas.1302797110; Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Ramachandra RK, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-41; Roberts RB, 2011, P NATL ACAD SCI USA, V108, P13194, DOI 10.1073/pnas.1018456108; Robinson BW, 2000, ADAPTIVE GENETIC VARIATION IN THE WILD, P65; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SANDLUND OT, 1992, OIKOS, V64, P305, DOI 10.2307/3545056; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; SCHLUTER D, 1993, TRENDS ECOL EVOL, V8, P197, DOI 10.1016/0169-5347(93)90098-A; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; SKULASON S, 1993, ANIM BEHAV, V45, P1179, DOI 10.1006/anbe.1993.1140; Skulason S, 1996, CAN J FISH AQUAT SCI, V53, P1807, DOI 10.1139/cjfas-53-8-1807; SKULASON S, 1989, BIOL J LINN SOC, V38, P281, DOI 10.1111/j.1095-8312.1989.tb01579.x; Snorrason S, 1989, PHYSL ECOLOGY JAPAN, V1, P393; Snorrason Signour S., 2004, P210; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Sylvester JB, 2010, P NATL ACAD SCI USA, V107, P9718, DOI 10.1073/pnas.1000395107; Tarver JE, 2013, MOL BIOL EVOL, V30, P2369, DOI 10.1093/molbev/mst133; Watanabe T, 2008, DEV DYNAM, V237, P3738, DOI 10.1002/dvdy.21787; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wilson AJ, 2004, MOL ECOL, V13, P1129, DOI 10.1111/j.1365-294X.2004.02149.x; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Woods PJ, 2012, ICELAND 1 DETECTON U; Yamamoto Y, 2009, DEV BIOL, V330, P200, DOI 10.1016/j.ydbio.2009.03.003; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	80	12	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106084	10.1371/journal.pone.0106084	http://dx.doi.org/10.1371/journal.pone.0106084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170615	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500101
J	Wekesa, E; Coast, E				Wekesa, Eliud; Coast, Ernestina			Fertility Desires among Men and Women Living with HIV/AIDS in Nairobi Slums: A Mixed Methods Study	PLOS ONE			English	Article							HIV-POSITIVE WOMEN; ANTIRETROVIRAL THERAPY; DISCORDANT COUPLES; REPRODUCTIVE INTENTIONS; SOUTH-AFRICA; INFECTION; TRANSMISSION; HEALTH; PREVALENCE; SUPPORT	Objectives: Fertility desires require new understanding in a context of expanding access to antiretroviral therapy for people living with HIV/AIDS in Sub-Saharan Africa. This paper studies the fertility desires and their rationales, of slum-dwelling Kenyan men and women living with HIV/AIDS who know their serostatus, but have different antiretroviral therapy treatment statuses. It addresses two research questions: How do people living with HIV/AIDS consider their future fertility? What factors contribute to an explanation of fertility desires among people living with HIV/AIDS. Methods: A mixed methods study (survey [n = 513] and in-depth interviews [n = 41]) with adults living with HIV/AIDS living in Nairobi slums was conducted in 2010. Regression analyses assess independent relationships between fertility desires and socio-demographic factors. Analyses of in-depth interviews are used to interpret the statistical analyses of fertility desires. Results: Our analyses show that fertility desires are complex and ambivalent, reflecting tensions between familial and societal pressures to have children versus pressures for HIV (re-)infection prevention. More than a third (34%) of men and women living with HIV expressed future fertility desires; however, this is significantly lower than in the general population. Factors independently associated with desiring a child among people living with HIV/AIDS were age, sex, number of surviving children, social support and household wealth of the respondent. Discussion: Increasing access to ART is changing the context of future childbearing for people living with HIV/AIDS. Prevailing values mean that, for many people living with HIV/AIDS, having children is seen as necessary for a "normal'' and healthy adult life. However, the social rewards of childbearing conflict with moral imperatives of HIV prevention, presenting dilemmas about the "proper'' reproductive behaviour of people living with HIV/AIDS. The health policy and service delivery implications of these findings are explored.	[Wekesa, Eliud] Populat Council, Nairobi, Kenya; [Coast, Ernestina] London Sch Econ, London WC2A 2AE, England	University of London; London School Economics & Political Science	Wekesa, E (corresponding author), Populat Council, Nairobi, Kenya.	ewekesa@popcouncil.org		coast, ernestina/0000-0002-8703-307X	Wellcome Trust [078471/Z/05/A]; Fred H. Bixby Fellowship	Wellcome Trust(Wellcome TrustEuropean Commission); Fred H. Bixby Fellowship	The authors are grateful to Wellcome Trust [078471/Z/05/A] for funding the research on which this paper is based. A Fred H. Bixby Fellowship funded EW's time to write this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agadjanian V, 2005, POPUL RES POLICY REV, V24, P617, DOI 10.1007/s11113-005-5096-8; Amuyunzu-Nyamongo M, 2007, AIDS CARE, V19, pS25, DOI 10.1080/09540120601114618; [Anonymous], 2003, SLUMS WORLD FAC URB; APHRC (African Population and Health Research Centre), 2002, POP HLTH DYN NAIR IN; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Beyeza-Kashesya J, 2009, AFR HEALTH SCI, V9, P2; Casterline JB, 2007, DEMOGRAPHY, V44, P729, DOI 10.1353/dem.2007.0043; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; Cooper D, 2009, AIDS BEHAV, V13, pS38, DOI 10.1007/s10461-009-9550-1; Creswell J.W., 2007, DESIGNING CONDUCTING; Creswell JW, 2009, RES DESIGN QUALITATI, DOI DOI 10.1007/S11252-005-3264-6; CRR Fida-Kenya, 2008, RISK RIGHT VIOL HIV; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Gliem J., 2003, MIDWEST RES TO PRACT; Heys J, 2009, AIDS, V23, pS37, DOI 10.1097/01.aids.0000363776.76129.fd; Iliyasu Zubairu, 2009, Afr J Reprod Health, V13, P71; Kaida A, 2011, AM J PUBLIC HEALTH, V101, P350, DOI 10.2105/AJPH.2009.177469; Kakaire O, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-27; Kanniappan S, 2008, AIDS CARE, V20, P625, DOI 10.1080/09540120701660361; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Laher F, 2009, AIDS BEHAV, V13, pS47, DOI 10.1007/s10461-009-9544-z; Lam PK, 2007, AIDS PATIENT CARE ST, V21, P20, DOI 10.1089/apc.2006.005; Madise NJ, 2012, HEALTH PLACE, V18, P1144, DOI 10.1016/j.healthplace.2012.04.003; Magnani R, 1997, SAMPLING GUIDE; Maier M, 2009, AIDS BEHAV, V13, pS28, DOI 10.1007/s10461-008-9371-7; Mastro TD, 2011, AIDS, V25, P2049, DOI 10.1097/QAD.0b013e32834c4c62; Matthews LT, 2009, AIDS BEHAV, V13, pS5, DOI 10.1007/s10461-009-9551-0; Minkoff H, 2003, OBSTET GYNECOL, V101, P797, DOI 10.1016/S0029-7844(03)00051-6; Mujugira A, 2013, JAIDS-J ACQ IMM DEF, V63, pE33, DOI 10.1097/QAI.0b013e318288bb32; Myer L, 2007, AIDS PATIENT CARE ST, V21, P278, DOI 10.1089/apc.2006.0108; Nakayiwa S, 2006, AIDS BEHAV, V10, pS95, DOI 10.1007/s10461-006-9126-2; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Nobrega AA, 2007, AIDS PATIENT CARE ST, V21, P261, DOI 10.1089/apc.2006.0116; Oladapo Olufemi T, 2005, J Natl Med Assoc, V97, P1672; QSR International, 2009, NVIVO8; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Santelli J, 2003, PERSPECT SEX REPRO H, V35, P94, DOI 10.1111/j.1931-2393.2003.tb00111.x; Smith DJ, 2007, AIDS, V21, pS37, DOI 10.1097/01.aids.0000298101.56614.af; StataCorp, 2009, STATA IC 11 1; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Undie CC, 2009, CULT HEALTH SEX, V11, P767, DOI 10.1080/13691050903105031; Vernazza PL, 2011, AIDS, V25, P2005, DOI 10.1097/QAD.0b013e32834a36d0; Wagner G, 2011, MATERN CHILD HLTH J, P1; Wekesa E, 2012, NEW LEASE LIFE SEXUA; WHO, 2013, GLOB UPD HIV TREATM; World Health Organization, 2012, GUID OR PREEXP PROPH; Yeatman SE, 2009, AIDS BEHAV, V13, pS12, DOI 10.1007/s10461-009-9534-1; Zulu EM, 2011, J URBAN HEALTH, V88, P185, DOI 10.1007/s11524-011-9595-0	50	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106292	10.1371/journal.pone.0106292	http://dx.doi.org/10.1371/journal.pone.0106292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171593	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000341127500144
J	Williams, LM; Campbell, FM; Drew, JE; Koch, C; Hoggard, N; Rees, WD; Kamolrat, T; Ngo, HT; Steffensen, IL; Gray, SR; Tups, A				Williams, Lynda M.; Campbell, Fiona M.; Drew, Janice E.; Koch, Christiane; Hoggard, Nigel; Rees, William D.; Kamolrat, Torkamol; Ha Thi Ngo; Steffensen, Inger-Lise; Gray, Stuart R.; Tups, Alexander			The Development of Diet-Induced Obesity and Glucose Intolerance in C57Bl/6 Mice on a High-Fat Diet Consists of Distinct Phases	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; APOLIPOPROTEIN-A-IV; METABOLIC SYNDROME; ADIPOSE-TISSUE; IKK-BETA; INFLAMMATION; SENSITIVITY; HOMEOSTASIS; ACTIVATION; TERM	High-fat (HF) diet-induced obesity and insulin insensitivity are associated with inflammation, particularly in white adipose tissue (WAT). However, insulin insensitivity is apparent within days of HF feeding when gains in adiposity and changes in markers of inflammation are relatively minor. To investigate further the effects of HF diet, C57Bl/6J mice were fed either a low (LF) or HF diet for 3 days to 16 weeks, or fed the HF-diet matched to the caloric intake of the LF diet (PF) for 3 days or 1 week, with the time course of glucose tolerance and inflammatory gene expression measured in liver, muscle and WAT. HF fed mice gained adiposity and liver lipid steadily over 16 weeks, but developed glucose intolerance, assessed by intraperitoneal glucose tolerance tests (IPGTT), in two phases. The first phase, after 3 days, resulted in a 50% increase in area under the curve (AUC) for HF and PF mice, which improved to 30% after 1 week and remained stable until 12 weeks. Between 12 and 16 weeks the difference in AUC increased to 60%, when gene markers of inflammation appeared in WAT and muscle but not in liver. Plasma proteomics were used to reveal an acute phase response at day 3. Data from PF mice reveals that glucose intolerance and the acute phase response are the result of the HF composition of the diet and increased caloric intake respectively. Thus, the initial increase in glucose intolerance due to a HF diet occurs concurrently with an acute phase response but these effects are caused by different properties of the diet. The second increase in glucose intolerance occurs between 12 - 16 weeks of HF diet and is correlated with WAT and muscle inflammation. Between these times glucose tolerance remains stable and markers of inflammation are undetectable.	[Williams, Lynda M.; Campbell, Fiona M.; Drew, Janice E.; Hoggard, Nigel; Rees, William D.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Koch, Christiane; Tups, Alexander] Univ Marburg, Fac Biol, Dept Anim Physiol, Marburg, Germany; [Kamolrat, Torkamol; Gray, Stuart R.] Univ Aberdeen, Inst Med Sci, Musculoskeletal Res Programme, Aberdeen, Scotland; [Ha Thi Ngo; Steffensen, Inger-Lise] Norwegian Inst Publ Hlth, Div Environm Med, Dept Food Water & Cosmet, Oslo, Norway	University of Aberdeen; Philipps University Marburg; University of Aberdeen; Norwegian Institute of Public Health (NIPH)	Williams, LM (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland.	L.Williams@abdn.ac.uk	Gray, Stuart R/L-2489-2017	Gray, Stuart R/0000-0001-8969-9636; Hoggard, Nigel/0000-0002-7403-5375	Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS); German Ministry of Research and Education [0315087]; Research Council of Norway [196112/H10]	Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS); German Ministry of Research and Education(Federal Ministry of Education & Research (BMBF)); Research Council of Norway(Research Council of Norway)	LMW, FMC, JED, CG, GH, ACM, PN, AJF, NH, WDR, SMH were funded by the Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS). AT and KC were funded by the German Ministry of Research and Education (Ref. No: 0315087), HTN and I-LS were funded by The Research Council of Norway (project no. 196112/H10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Atkinson KE, 1989, INTRO NUMERICAL ANAL; Benoit B, 2013, NUTR RES, V33, P952, DOI 10.1016/j.nutres.2013.07.017; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Campbell FM, 2010, ANAL BIOCHEM, V398, P76, DOI 10.1016/j.ab.2009.11.021; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caricilli AM, 2008, J ENDOCRINOL, V199, P399, DOI 10.1677/JOE-08-0354; Chin-Chance C, 2000, J CLIN ENDOCR METAB, V85, P2685, DOI 10.1210/jc.85.8.2685; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GAULDIE J, 1989, ANN NY ACAD SCI, V557, P46; Hoeg LD, 2011, DIABETES, V60, P64, DOI 10.2337/db10-0698; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jahangiri A, 2010, CURR OPIN ENDOCRINOL, V17, P156, DOI 10.1097/MED.0b013e328337278b; Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Lanthier N, 2011, FASEB J, V25, P4301, DOI 10.1096/fj.11-189472; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Mirhashemi F, 2011, EXP CLIN ENDOCR DIAB, V119, P167, DOI 10.1055/s-0030-1263127; Nappo F, 2002, J AM COLL CARDIOL, V39, P1145, DOI 10.1016/S0735-1097(02)01741-2; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Rodriguez MD, 1997, AM J PHYSIOL-REG I, V272, pR1170, DOI 10.1152/ajpregu.1997.272.4.R1170; Stan S, 2003, BBA-MOL CELL BIOL L, V1631, P177, DOI 10.1016/S1388-1981(03)00004-0; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Tso P, 2004, PHYSIOL BEHAV, V83, P631, DOI 10.1016/j.physbeh.2004.07.032; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Wiedemann MSF, 2013, AM J PHYSIOL-ENDOC M, V305, pE388, DOI 10.1152/ajpendo.00179.2013; Wright LE, 2011, DIABETOLOGIA, V54, P1417, DOI 10.1007/s00125-011-2068-x; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	37	98	101	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106159	10.1371/journal.pone.0106159	http://dx.doi.org/10.1371/journal.pone.0106159			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170916	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000341127500118
J	Tuo, WW; Wang, D; Liang, WJ; Huang, YX				Tuo, Wei-Wei; Wang, Di; Liang, Wen-Jing; Huang, Yao-Xiong			How Cell Number and Cellular Properties of Blood-Banked Red Blood Cells of Different Cell Ages Decline during Storage	PLOS ONE			English	Article							TRANSFUSED BLOOD; PROLONGED STORAGE; STORED-BLOOD; MORTALITY; TIME; SEPARATION; MORBIDITY; DURATION; LENGTH; MICROPARTICLES	Aims: Numerous studies have suggested that transfusion of red blood cells (RBCs) stored over a long period of time may induce harmful effects due to storage-induced lesions. However, the underlying mechanisms responsible for this damage have not been identified. Furthermore, it is unclear why and how up to 30% of long-stored RBCs disappear from the circulation within 24 hours after transfusion. The aim of this study was to determine how the cell number of RBCs of different ages changes during storage and how these cells undergo cumulative structural and functional changes with storage time. Methods and Results: We used Percoll centrifugation to fractionate the RBCs in blood bank stored RBC units into different aged sub-populations and then measured the number of intact cells in each sub-population as well the cells' biomechanical and biochemical parameters as functions of the storage period. We found that the RBC units stored for <= 14 days could be separated into four fractions: the top or young cell fraction, two middle fractions, and the lower or old fraction. However, after 14 days of storage, the cell number and cellular properties declined rapidly whereby the units stored for 21 days only exhibited the three lower fractions and not the young fraction. The cell number within a unit stored for 21 days decreased by 23% compared to a fresh unit and the cells that were lost had hemolyzed into harmful membrane fragments, microparticles, and free hemoglobin. All remaining cells exhibited cellular properties similar to those of senescent cells. Conclusion: In RBC units stored for greater than 14 days, there were fewer intact cells with no healthy cells present, as well as harmful membrane fragments, microparticles, and free hemoglobin. Therefore, transfusion of these stored units would not likely help patients and may induce a series of clinical problems.	[Tuo, Wei-Wei; Wang, Di; Liang, Wen-Jing; Huang, Yao-Xiong] Ji Nan Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China	Jinan University	Huang, YX (corresponding author), Ji Nan Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China.	tyxhuang@jnu.edu.cn			Chinese National Natural Science Foundation [30940019, 60377043]; Guang Dong Provincial Science and Technology Foundation	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guang Dong Provincial Science and Technology Foundation	This work was supported partly by the Chinese National Natural Science Foundation (Nos. 30940019 and 60377043) and Guang Dong Provincial Science and Technology Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson JW, 2008, NEW ENGL J MED, V358, P1295, DOI 10.1056/NEJMe0800520; Almizraq R, 2013, TRANSFUSION, V53, P2258, DOI 10.1111/trf.12080; Barshtein G, 2011, TRANSFUS MED REV, V25, P24, DOI 10.1016/j.tmrv.2010.08.004; Basran S, 2006, ANESTH ANALG, V103, P15, DOI 10.1213/01.ane.0000221167.58135.3d; Berezina TL, 2002, J SURG RES, V102, P6, DOI 10.1006/jsre.2001.6306; BEUTLER E, 1969, TRANSFUSION, V9, P109, DOI 10.1111/j.1537-2995.1969.tb05527.x; BOSCH FH, 1992, BLOOD, V79, P254; Card R T, 1988, Transfus Med Rev, V2, P40, DOI 10.1016/S0887-7963(88)70030-9; CARD RT, 1982, TRANSFUSION, V22, P96, DOI 10.1046/j.1537-2995.1982.22282177134.x; CARD RT, 1983, BRIT J HAEMATOL, V53, P237, DOI 10.1111/j.1365-2141.1983.tb02016.x; ChinYee I, 1997, TRANSFUS SCI, V18, P447, DOI 10.1016/S0955-3886(97)00043-X; Christian JA, 1998, BLOOD, V92, P2590, DOI 10.1182/blood.V92.7.2590.2590_2590_2591; Condon MR, 2003, AM J PHYSIOL-HEART C, V284, pH2177, DOI 10.1152/ajpheart.01069.2002; de Watering LV, 2006, TRANSFUSION, V46, P1712, DOI 10.1111/j.1537-2995.00958.x; Donadee C, 2011, CIRCULATION, V124, P465, DOI 10.1161/CIRCULATIONAHA.110.008698; Dumont LJ, 2008, TRANSFUSION, V48, P1053, DOI 10.1111/j.1537-2995.2008.01642.x; Fernandes CJ, 2001, CRIT CARE, V5, P362, DOI 10.1186/cc1070; Frenzel T, 2009, CURR OPIN ANESTHESIO, V22, P275, DOI 10.1097/ACO.0b013e328323f7c4; Glynn SA, 2010, TRANSFUSION, V50, P1164, DOI 10.1111/j.1537-2995.2010.02674.x; Gyorgy B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595; HARADIN AR, 1969, TRANSFUSION, V9, P229; Hargett LA, 2013, PULM CIRC, V3, P329, DOI 10.4103/2045-8932.114760; Hebert PC, 2005, ANESTH ANALG, V100, P1433, DOI 10.1213/01.ANE.0000148690.48803.27; Hess JR, 2006, TRANSFUSION, V46, P50, DOI 10.1111/j.1537-2995.2005.00672.x; Hod EA, 2010, BLOOD, V115, P4284, DOI 10.1182/blood-2009-10-245001; Huang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081708; Huang YX, 2011, J CELL MOL MED, V15, P2634, DOI 10.1111/j.1582-4934.2011.01310.x; Huang YX, 2005, CURR APPL PHYS, V5, P553, DOI 10.1016/j.cap.2005.01.030; Kim-Shapiro DB, 2011, TRANSFUSION, V51, P844, DOI 10.1111/j.1537-2995.2011.03100.x; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Leal-Noval SR, 2003, ANESTHESIOLOGY, V98, P815, DOI 10.1097/00000542-200304000-00005; Li J, 2006, CHINESE SCI BULL, V51, P143, DOI 10.1007/s11434-004-0573-8; Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P70, DOI 10.2450/2008.0038-07; Llohn AH, 2005, TRANSFUS APHER SCI, V33, P113, DOI 10.1016/j.transci.2004.12.002; LUTZ HU, 1992, BIOCHIM BIOPHYS ACTA, V1116, P1, DOI 10.1016/0304-4165(92)90120-J; MARIK PE, 1993, JAMA-J AM MED ASSOC, V269, P3024, DOI 10.1001/jama.269.23.3024; Murrell Z, 2005, AM SURGEON, V71, P781; Mynster T, 2000, SCAND J GASTROENTERO, V35, P212; Mynster T, 2001, DIS COLON RECTUM, V44, P955, DOI 10.1007/BF02235483; Ness PM, 2011, TRANSFUSION, V51, P666, DOI 10.1111/j.1537-2995.2011.03121.x; Oda S, 1973, B YAMAGUCHI MED SCH, V20, P139; PIOMELLI S, 1978, P NATL ACAD SCI USA, V75, P3474, DOI 10.1073/pnas.75.7.3474; PIOMELLI S, 1967, J LAB CLIN MED, V69, P659; Purdy FR, 1997, CAN J ANAESTH, V44, P1256, DOI 10.1007/BF03012772; Queloz PA, 2006, PROTEOMICS, V6, P5605, DOI 10.1002/pmic.200600179; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Romero Pedro J., 2004, Acta Cientifica Venezolana, V55, P83; SALVO G, 1982, CLIN CHIM ACTA, V122, P293, DOI 10.1016/0009-8981(82)90290-X; Solomon SB, 2013, BLOOD, V121, P1663, DOI 10.1182/blood-2012-10-462945; Taylor RW, 2006, CRIT CARE MED, V34, P2302, DOI 10.1097/01.CCM.0000234034.51040.7F; Tscharnuter WW, 2001, APPL OPTICS, V40, P3995, DOI 10.1364/AO.40.003995; Vamvakas EC, 1999, TRANSFUSION, V39, P701, DOI 10.1046/j.1537-2995.1999.39070701.x; Vamvakas EC, 2000, TRANSFUSION, V40, P101, DOI 10.1046/j.1537-2995.2000.40010101.x; Weinberg JA, 2010, J TRAUMA, V69, P1427, DOI 10.1097/TA.0b013e3181fa0019; Whitaker BI, 2011, 2009 NATL BLOOD COLL; Zallen G, 1999, AM J SURG, V178, P570, DOI 10.1016/S0002-9610(99)00239-1; Zimrin AB, 2009, VOX SANG, V96, P93, DOI 10.1111/j.1423-0410.2008.01117.x	57	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105692	10.1371/journal.pone.0105692	http://dx.doi.org/10.1371/journal.pone.0105692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25167052	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303700037
J	Yoshida, T; Iwase, A; Hirasawa, H; Murata, H; Mayama, C; Araie, M; Asaoka, R				Yoshida, Tatsuya; Iwase, Aiko; Hirasawa, Hiroyo; Murata, Hiroshi; Mayama, Chihiro; Araie, Makoto; Asaoka, Ryo			Discriminating between Glaucoma and Normal Eyes Using Optical Coherence Tomography and the 'Random Forests' Classifier	PLOS ONE			English	Article							NERVE-FIBER LAYER; GANGLION-CELL COMPLEX; OPERATING CHARACTERISTIC CURVES; FOURIER-DOMAIN OCT; DIAGNOSTIC-ACCURACY; PARAMETERS; THICKNESS; AREAS; DISK; PERFORMANCE	Purpose: To diagnose glaucoma based on spectral domain optical coherence tomography (SD-OCT) measurements using the 'Random Forests' method. Methods: SD-OCT was conducted in 126 eyes of 126 open angle glaucoma (OAG) patients and 84 eyes of 84 normal subjects. The Random Forests method was then applied to discriminate between glaucoma and normal eyes using 151 OCT parameters including thickness measurements of circumpapillary retinal nerve fiber layer (cpRNFL), the macular RNFL (mRNFL) and the ganglion cell layer-inner plexiform layer combined (GCIPL). The area under the receiver operating characteristic curve (AROC) was calculated using the Random Forests method adopting leave-one-out cross validation. For comparison, AROCs were calculated based on each one of the 151 OCT parameters. Results: The AROC obtained with the Random Forests method was 98.5% [95% Confidence interval (CI): 97.1-99.9%], which was significantly larger than the AROCs derived from any single OCT parameter (maxima were: 92.8 [CI: 89.4-96.2] %, 94.3 [CI: 91.1-97.6] % and 91.8 [CI: 88.2-95.4] % for cpRNFL-, mRNFL- and GCIPL-related parameters, respectively; P < 0.05, DeLong's method with Holm's correction for multiple comparisons). The partial AROC above specificity of 80%, for the Random Forests method was equal to 18.5 [CI: 16.8-19.6] %, which was also significantly larger than the AROCs of any single OCT parameter (P < 0.05, Bootstrap method with Holm's correction for multiple comparisons). Conclusions: The Random Forests method, analyzing multiple SD-OCT parameters concurrently, significantly improves the diagnosis of glaucoma compared with using any single SD-OCT measurement.	[Yoshida, Tatsuya; Hirasawa, Hiroyo; Murata, Hiroshi; Mayama, Chihiro; Asaoka, Ryo] Univ Tokyo, Dept Ophthalmol, Tokyo 113, Japan; [Iwase, Aiko] Tajimi Iwase Eye Clin, Tajimi, Japan; [Araie, Makoto] Kanto Cent Hosp, Mutual Aid Assoc Publ Sch Teachers, Tokyo, Japan	University of Tokyo	Asaoka, R (corresponding author), Univ Tokyo, Dept Ophthalmol, Tokyo 113, Japan.	rasaoka-tky@umin.ac.jp			JST-CREST; Ministry of Education, Culture, Sports, Science and Technology of Japan [26462679]	JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported in part by JST-CREST and 26462679 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Anderson DR., 1999, AUTOMATED STATIC PER; APPLE DJ, 1982, SURV OPHTHALMOL, V27, P3, DOI 10.1016/0039-6257(82)90111-4; Baskaran M, 2012, INVEST OPHTH VIS SCI, V53, P2314, DOI 10.1167/iovs.11-8035; Bengtsson B, 2000, INVEST OPHTH VIS SCI, V41, P2201; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2004, RANDOM FORESTS; Burgansky-Eliash Z, 2005, INVEST OPHTH VIS SCI, V46, P4147, DOI 10.1167/iovs.05-0366; Cho JW, 2010, INVEST OPHTH VIS SCI, V51, P6401, DOI 10.1167/iovs.09-5035; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Demsar J, 2006, J MACH LEARN RES, V7, P1; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dietterich T.G., 2002, HDB BRAIN THEORY NEU; Douglas PK, 2011, NEUROIMAGE, V56, P544, DOI 10.1016/j.neuroimage.2010.11.002; Garas A, 2011, EYE, V25, P57, DOI 10.1038/eye.2010.139; Han J, 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HOLM S, 1979, SCAND J STAT, V6, P65; Kim NR, 2011, BRIT J OPHTHALMOL, V95, P1115, DOI 10.1136/bjo.2010.182493; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Lisboa R, 2013, INVEST OPHTH VIS SCI, V54, P3417, DOI 10.1167/iovs.13-11676; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; LITTMANN H, 1988, KLIN MONATSBL AUGENH, V192, P66, DOI 10.1055/s-2008-1050076; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Maroco Joao, 2011, BMC Res Notes, V4, P299, DOI 10.1186/1756-0500-4-299; Mayama C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086417; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Moreno PAM, 2011, CAN J OPHTHALMOL, V46, P543, DOI 10.1016/j.jcjo.2011.09.006; Mwanza JC, 2013, INVEST OPHTH VIS SCI, V54, P8393, DOI 10.1167/iovs.13-12749; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; PEDERSON JE, 1980, ARCH OPHTHALMOL-CHIC, V98, P490; QUIGLEY HA, 1992, OPHTHALMOLOGY, V99, P19; Rao HL, 2012, EYE, V26, P133, DOI 10.1038/eye.2011.277; Rao HL, 2012, INVEST OPHTH VIS SCI, V53, P1058, DOI 10.1167/iovs.11-8463; Rao HL, 2010, OPHTHALMOLOGY, V117, P1692, DOI 10.1016/j.ophtha.2010.01.031; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schulze A, 2011, GRAEF ARCH CLIN EXP, V249, P1039, DOI 10.1007/s00417-010-1585-5; Segal MR, 2001, BIOMETRICS, V57, P632, DOI 10.1111/j.0006-341X.2001.00632.x; Shah M., 2011, EVALUATING LEARNING, DOI [10.1017/CBO9780511921803, DOI 10.1017/CBO9780511921803]; Shields MB., 1997, TXB GLAUCOMA; Shoji T, 2012, GRAEF ARCH CLIN EXP, V250, P1843, DOI 10.1007/s00417-012-1994-8; Shotton J., 2008, IEEE C COMP VIS PATT, P1, DOI DOI 10.1109/CVPR.2008.4587503; SOMMER A, 1979, ARCH OPHTHALMOL-CHIC, V97, P1444, DOI 10.1001/archopht.1979.01020020106002; SOMMER A, 1977, ARCH OPHTHALMOL-CHIC, V95, P2149; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; SOMMER A, 1984, ARCH OPHTHALMOL-CHIC, V102, P1766; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Sugimoto K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003114; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Wang LA, 2010, IEEE IMAGE PROC, P1457, DOI 10.1109/ICIP.2010.5653902; Yamazaki Y, 1999, JPN J OPHTHALMOL, V43, P392, DOI 10.1016/S0021-5155(99)00096-9; Yang Q, 2010, OPT EXPRESS, V18, P21293, DOI 10.1364/OE.18.021293; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zimmerman TJ, 2001, CLIN PATHWAYS GLAUCO	54	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106117	10.1371/journal.pone.0106117	http://dx.doi.org/10.1371/journal.pone.0106117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25167053	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303700077
J	Fitchett, JR; Head, MG; Cooke, MK; Wurie, FB; Atun, R				Fitchett, Joseph R.; Head, Michael G.; Cooke, Mary K.; Wurie, Fatima B.; Atun, Rifat			Funding Infectious Disease Research: A Systematic Analysis of UK Research Investments by Funders 1997-2010	PLOS ONE			English	Article							HEALTH; BURDEN	Background: Research investments are essential to address the burden of disease, however allocation of limited resources is poorly documented. We systematically reviewed the investments awarded by funding organisations to UK institutions and their global partners for infectious disease research. Methodology/Principal Findings: Public and philanthropic investments for the period 1997 to 2010 were included. We categorised studies by infectious disease, cross-cutting theme, and by research and development value chain, reflecting the type of science. We identified 6165 funded studies, with a total research investment of UK (sic)2.6 billion. Public organisations provided (sic)1.4 billion (54.0%) of investments compared with (sic)1.1 billion (42.4%) by philanthropic organisations. Global health studies represented an investment of (sic)928 million (35.7%). The Wellcome Trust was the leading investor with (sic)688 million (26.5%), closely followed by the UK Medical Research Council (MRC) with (sic)673 million (25.9%). Funding over time was volatile, ranging from similar to(sic)40 million to similar to(sic)160 million per year for philanthropic organisations and similar to(sic)30 million to similar to(sic)230 million for public funders. Conclusions/Significance: Infectious disease research funding requires global coordination and strategic long-term vision. Our analysis demonstrates the diversity and inconsistent patterns in investment, with volatility in annual funding amounts and limited investment for product development and clinical trials.	[Fitchett, Joseph R.] Kings Coll London, Dept Infect Dis, London WC2R 2LS, England; [Head, Michael G.; Cooke, Mary K.; Wurie, Fatima B.] UCL, Dept Infect & Populat Hlth, London, England; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Business Sch, London, England; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Atun, Rifat] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of London; King's College London; University of London; University College London; Imperial College London; Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health	Fitchett, JR (corresponding author), Kings Coll London, Dept Infect Dis, London WC2R 2LS, England.	joseph.fitchett@doctors.org.uk	Head, Michael G/H-6595-2019; Atun, Rifat/AAH-5537-2021	Head, Michael G/0000-0003-1189-0531; Wurie, Fatima/0000-0003-4802-2308; Atun, Rifat/0000-0002-1531-5983	Medical Research Council [MR/K006584/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Atun R, 2012, LANCET, V380, P2044, DOI 10.1016/S0140-6736(12)61460-3; Cobelens F, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001358; Dorsey ER, 2011, J MED LIBR ASSOC, V99, P255, DOI 10.3163/1536-5050.99.3.013; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Head MG, 2013, LANCET INFECT DIS, V13, P653, DOI 10.1016/S1473-3099(13)70169-5; Head MG, 2013, LANCET INFECT DIS, V13, P55, DOI 10.1016/S1473-3099(12)70261-X; Katz I, 2010, INT J TUBERC LUNG D, V14, P1097; Katz I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017166; Kyratsis Y, 2013, LANCET INFECT DIS, V13, P6, DOI 10.1016/S1473-3099(12)70289-X; Lal SS, 2011, TROP MED INT HEALTH, V16, P685, DOI 10.1111/j.1365-3156.2011.02749.x; Mccoy D, 2009, HEALTH POLICY PLANN, V24, P407, DOI 10.1093/heapol/czp026; Moran M, 2012, G FINDER NEGLECTED D; Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6; Rottingen JA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001219; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; Terry RF, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-28; WHO, 2012, WORK PAP GL IN PRESS; WHO, 2012, RES DEV MEET HLTH NE; Wolfson LJ, 2008, B WORLD HEALTH ORGAN, V86, P27, DOI 10.2471/BLT.07.045096; Zachariah R, 2012, LANCET INFECT DIS, V12, P415, DOI 10.1016/S1473-3099(11)70309-7	23	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105722	10.1371/journal.pone.0105722	http://dx.doi.org/10.1371/journal.pone.0105722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162631	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000340880900046
J	Tucker, MA; Rogers, TL				Tucker, Marlee A.; Rogers, Tracey L.			Examining the Prey Mass of Terrestrial and Aquatic Carnivorous Mammals: Minimum, Maximum and Range	PLOS ONE			English	Article							DIETARY NICHE BREADTH; BODY-SIZE; MODEL SELECTION; MULTIMODEL INFERENCE; BEHAVIORAL ECOLOGY; CLIMATE-CHANGE; PREDATOR SIZE; EXTINCTION; PATTERNS; CONSTRAINTS	Predator-prey body mass relationships are a vital part of food webs across ecosystems and provide key information for predicting the susceptibility of carnivore populations to extinction. Despite this, there has been limited research on the minimum and maximum prey size of mammalian carnivores. Without information on large-scale patterns of prey mass, we limit our understanding of predation pressure, trophic cascades and susceptibility of carnivores to decreasing prey populations. The majority of studies that examine predator-prey body mass relationships focus on either a single or a subset of mammalian species, which limits the strength of our models as well as their broader application. We examine the relationship between predator body mass and the minimum, maximum and range of their prey's body mass across 108 mammalian carnivores, from weasels to baleen whales (Carnivora and Cetacea). We test whether mammals show a positive relationship between prey and predator body mass, as in reptiles and birds, as well as examine how environment (aquatic and terrestrial) and phylogenetic relatedness play a role in this relationship. We found that phylogenetic relatedness is a strong driver of predator-prey mass patterns in carnivorous mammals and accounts for a higher proportion of variance compared with the biological drivers of body mass and environment. We show a positive predator-prey body mass pattern for terrestrial mammals as found in reptiles and birds, but no relationship for aquatic mammals. Our results will benefit our understanding of trophic interactions, the susceptibility of carnivores to population declines and the role of carnivores within ecosystems.	[Tucker, Marlee A.; Rogers, Tracey L.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney	Tucker, MA (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	marlee.tucker@unsw.edu.au	Tucker, Marlee/M-9546-2019; Rogers, Tracey L/C-3419-2008	Tucker, Marlee/0000-0001-7535-3431; Rogers, Tracey/0000-0002-7141-4177	Australian Research Council [LP0989933]	Australian Research Council(Australian Research Council)	This work is supported by the Australian Research Council grant # LP0989933 to TLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KH, 2009, P ROY SOC B-BIOL SCI, V276, P109, DOI 10.1098/rspb.2008.0951; Bates D., 2015, LINEAR MIXED EFFECTS, V67, P1, DOI 10.18637/jss.v067.i01; BRANDL R, 1994, OECOLOGIA, V98, P109, DOI 10.1007/BF00326096; Bromham L, 2012, P ROY SOC B-BIOL SCI, V279, P4024, DOI 10.1098/rspb.2012.1437; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Brose U, 2010, FUNCT ECOL, V24, P28, DOI 10.1111/j.1365-2435.2009.01618.x; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.2307/3802723, DOI 10.2307/3802723]; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Caballero S, 2008, MOL PHYLOGENET EVOL, V46, P252, DOI 10.1016/j.ympev.2007.10.015; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Costa GC, 2008, GLOBAL ECOL BIOGEOGR, V17, P670, DOI 10.1111/j.1466-8238.2008.00405.x; Costa GC, 2009, ECOLOGY, V90, P2014, DOI 10.1890/08-1150.1; Creel S, 1997, ANIM BEHAV, V54, P1319, DOI 10.1006/anbe.1997.0481; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Davies TJ, 2007, ECOL LETT, V10, P146, DOI 10.1111/j.1461-0248.2006.01005.x; Dell'Arte GL, 2007, ACTA OECOL, V31, P276, DOI 10.1016/j.actao.2006.12.007; Drummond A.J., 2012, MOL BIOL EVOLUTION; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; HAIRSTON NG, 1993, AM NAT, V142, P379, DOI 10.1086/285546; Hayward MW, 2006, J ZOOL, V270, P606, DOI 10.1111/j.1469-7998.2006.00183.x; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; King RB, 2002, FUNCT ECOL, V16, P766, DOI 10.1046/j.1365-2435.2002.00678.x; Kuhn TS, 2011, METHODS ECOL EVOL, V2, P427, DOI 10.1111/j.2041-210X.2011.00103.x; Luhrs ML, 2013, BEHAV ECOL, V24, P21, DOI 10.1093/beheco/ars150; Maddison WP, 2017, MESQUITE MODULAR SYS; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; McCain CM, 2014, GLOBAL CHANGE BIOL; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Novaro AJ, 2000, BIOL CONSERV, V92, P25, DOI 10.1016/S0006-3207(99)00065-8; Orme D, 2012, CAPER COMP ANAL PHYL; Ottaviani D, 2006, J ZOOL, V269, P317, DOI 10.1111/j.1469-7998.2006.00060.x; Pawar S, 2012, NATURE, V486, P485, DOI 10.1038/nature11131; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Core Team, 2021, R LANG ENV STAT COMP; Rasmussen GSA, 2008, AM NAT, V172, P508, DOI 10.1086/590965; Renaud S, 2005, P ROY SOC B-BIOL SCI, V272, P609, DOI 10.1098/rspb.2004.2992; Riede JO, 2011, ECOL LETT, V14, P169, DOI 10.1111/j.1461-0248.2010.01568.x; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Smith FA, 2011, PHILOS T R SOC B, V366, P2364, DOI 10.1098/rstb.2011.0067; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tucker MA, 2014, GLOBAL ECOL BIOGEOGR, V23, P1105, DOI 10.1111/geb.12194	49	11	11	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106402	10.1371/journal.pone.0106402	http://dx.doi.org/10.1371/journal.pone.0106402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162695	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900104
J	Liang, Z; Liu, LF; Chen, XP; Shi, XM; Guo, HY; Lin, K; Guo, JP; Shan, ZL; Wang, YT				Liang, Zhuo; Liu, Li-feng; Chen, Xin-pei; Shi, Xiang-min; Guo, Hong-yang; Lin, Kun; Guo, Jian-ping; Shan, Zhao-liang; Wang, Yu-tang			Establishment of a Model of Renal Impairment with Mild Renal Insufficiency Associated with Atrial Fibrillation in Canines	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SYMPATHETIC DENERVATION; ENDOTHELIAL DYSFUNCTION; ACTIVATION; MECHANISMS; SYSTEM	Background: Chronic kidney disease and occurrence of atrial fibrillation (AF) are closely related. No studies have examined whether renal impairment (RI) without severe renal dysfunction is associated with the occurrence of AF. Methods: Unilateral RI with mild renal insufficiency was induced in beagles by embolization of small branches of the renal artery in the left kidney for 2 weeks using gelatin sponge granules in the model group (n = 5). The sham group (n = 5) underwent the same procedure, except for embolization. Parameters associated with RI and renal function were tested, cardiac electrophysiological parameters, blood pressure, left ventricular pressure, and AF vulnerability were investigated. The activity of the sympathetic nervous system, renin-angiotensin-aldosterone system, inflammation, and oxidative stress were measured. Histological studies associated with atrial interstitial fibrosis were performed. Results: Embolization of small branches of the renal artery in the left kidney led to ischemic RI with mild renal insufficiency. The following changes occurred after embolization. Heart rate and P wave duration were increased. Blood pressure and left ventricular systolic pressure were elevated. The atrial effective refractory period and antegrade Wenckebach point were shortened. Episodes and duration of AF, as well as atrial and ventricular rate during AF were increased in the model group. Plasma levels of norepinephrine, renin, and aldosterone were increased, angiotensin II and aldosterone levels in atrial tissue were elevated, and atrial interstitial fibrosis was enhanced after 2 weeks of embolization in the model group. Conclusions: We successfully established a model of RI with mild renal insufficiency in a large animal. We found that RI with mild renal insufficiency was associated with AF in this model.	[Liang, Zhuo; Wang, Yu-tang] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China; [Liu, Li-feng; Chen, Xin-pei; Shi, Xiang-min; Guo, Hong-yang; Lin, Kun; Guo, Jian-ping; Shan, Zhao-liang] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Shan, ZL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing, Peoples R China.	shanzl301@sina.com; wyt301@sina.com	Chen, Xinpei/AAO-1879-2021		National Natural Science Foundation of China [30570737, 81270308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30570737; 81270308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Brown SA, 2013, J VET EMERG CRIT CAR, V23, P115, DOI 10.1111/vec.12030; Chan CT, 2008, NEPHROL DIAL TRANSPL, V23, P3061, DOI 10.1093/ndt/gfn280; Chen LY, 2007, HEART RHYTHM, V4, pS1, DOI 10.1016/j.hrthm.2006.12.018; Everett TH, 2007, HEART RHYTHM, V4, pS24, DOI 10.1016/j.hrthm.2006.12.040; Ewen S, 2013, CURR HYPERTENS REP, V15, P370, DOI 10.1007/s11906-013-0365-0; Fukunaga N, 2012, HEART RHYTHM, V9, P2023, DOI 10.1016/j.hrthm.2012.08.019; Grassi G, 2011, HYPERTENSION, V57, P846, DOI 10.1161/HYPERTENSIONAHA.110.164780; Guo YT, 2013, INT J CARDIOL, V168, P1502, DOI 10.1016/j.ijcard.2012.12.099; Hou YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078218; Kestenbaum B, 2007, CLIN J AM SOC NEPHRO, V2, P501, DOI 10.2215/CJN.04231206; Landray MJ, 2004, AM J KIDNEY DIS, V43, P244, DOI 10.1053/j.ajkd.2003.10.037; Linz D, 2013, HYPERTENSION, V62, P767, DOI 10.1161/HYPERTENSIONAHA.113.01728; Linz D, 2013, HYPERTENSION, V61, P225, DOI 10.1161/HYPERTENSIONAHA.111.00182; Linz D, 2012, HEART RHYTHM, V9, P2032, DOI 10.1016/j.hrthm.2012.08.024; Linz D, 2012, HYPERTENSION, V60, P172, DOI 10.1161/HYPERTENSIONAHA.112.191965; Mayyas F, 2013, INT J CARDIOL, V168, P5135, DOI 10.1016/j.ijcard.2013.08.022; Naruse Y, 2011, HEART RHYTHM, V8, P335, DOI 10.1016/j.hrthm.2010.10.047; Park HW, 2012, CURR OPIN CARDIOL, V27, P24, DOI 10.1097/HCO.0b013e32834dc4e8; Redpath CJ, 2006, J MOL CELL CARDIOL, V40, P717, DOI 10.1016/j.yjmcc.2006.01.012; Sapoznikov D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078338; Savelieva I, 2011, EUROPACE, V13, P610, DOI 10.1093/europace/eur023; Schlaich MP, 2009, J AM SOC NEPHROL, V20, P933, DOI 10.1681/ASN.2008040402; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Siragy HM, 2010, AM J NEPHROL, V31, P541, DOI 10.1159/000313363; Soliman EZ, 2010, AM HEART J, V159, P1102, DOI 10.1016/j.ahj.2010.03.027; Wang Y, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-26; Watanabe T, 2007, J VET MED SCI, V69, P1015, DOI 10.1292/jvms.69.1015; Ye SH, 2002, AM J HYPERTENS, V15, P717, DOI 10.1016/S0895-7061(02)02959-X; Zhao QY, 2013, INT J CARDIOL, V168, P1672, DOI 10.1016/j.ijcard.2013.03.091; Zhao QY, 2012, J INTERV CARD ELECTR, V35, P119, DOI 10.1007/s10840-012-9717-y; Zimmerman D, 2012, NEPHROL DIAL TRANSPL, V27, P3816, DOI 10.1093/ndt/gfs416	32	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105974	10.1371/journal.pone.0105974	http://dx.doi.org/10.1371/journal.pone.0105974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157494	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303200083
J	Lopes, MS; Bastiaansen, JWM; Harlizius, B; Knol, EF; Bovenhuis, H				Lopes, Marcos S.; Bastiaansen, John W. M.; Harlizius, Barbara; Knol, Egbert F.; Bovenhuis, Henk			A Genome-Wide Association Study Reveals Dominance Effects on Number of Teats in Pigs	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MILK FATTY-ACIDS; RESOURCE POPULATION; AFFECTING REPRODUCTION; CARCASS COMPOSITION; GENETIC-BASIS; DAIRY-CATTLE; MEAT QUALITY; QTL ANALYSIS; MEISHAN	Dominance has been suggested as one of the genetic mechanisms explaining heterosis. However, using traditional quantitative genetic methods it is difficult to obtain accurate estimates of dominance effects. With the availability of dense SNP (Single Nucleotide Polymorphism) panels, we now have new opportunities for the detection and use of dominance at individual loci. Thus, the aim of this study was to detect additive and dominance effects on number of teats (NT), specifically to investigate the importance of dominance in a Landrace-based population of pigs. In total, 1,550 animals, genotyped for 32,911 SNPs, were used in single SNP analysis. SNPs with a significant genetic effect were tested for their mode of gene action being additive, dominant or a combination. In total, 21 SNPs were associated with NT, located in three regions with additive (SSC6, 7 and 12) and one region with dominant effects (SSC4). Estimates of additive effects ranged from 0.24 to 0.29 teats. The dominance effect of the QTL located on SSC4 was negative (-0.26 teats). The additive variance of the four QTLs together explained 7.37% of the total phenotypic variance. The dominance variance of the four QTLs together explained 1.82% of the total phenotypic variance, which corresponds to one-fourth of the variance explained by additive effects. The results suggest that dominance effects play a relevant role in the genetic architecture of NT. The QTL region on SSC7 contains the most promising candidate gene: VRTN. This gene has been suggested to be related to the number of vertebrae, a trait correlated with NT.	[Lopes, Marcos S.; Harlizius, Barbara; Knol, Egbert F.] TOPIGS Res Ctr IPG BV, Beuningen, Netherlands; [Lopes, Marcos S.; Bastiaansen, John W. M.; Bovenhuis, Henk] Wageningen Univ, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Lopes, MS (corresponding author), TOPIGS Res Ctr IPG BV, Beuningen, Netherlands.	Marcos.Lopes@TOPIGS.com	Bastiaansen, John WM/A-5733-2010; Bovenhuis, Henk/E-4750-2012	Bastiaansen, John WM/0000-0002-6562-176X; Lopes, Marcos Soares/0000-0002-4715-853X	TOPIGS; Breed4Food Consortium; TOPIGS Research Center IPG B.V.	TOPIGS; Breed4Food Consortium; TOPIGS Research Center IPG B.V.	Financial support from TOPIGS and Breed4Food Consortium is gratefully acknowledged. Co-authors MSL, BH and EFK are employed by TOPIGS Research Center B.V. TOPIGS and TOPIGS Research Center IPG B.V. (the daughter company of TOPIGS) provided support in the form of salaries for authors MSL, BH and EFK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Alvarez-Castro JM, GENET RES, V94, P255; Amuzu-Aweh EN, 2013, HEREDITY, V111, P530, DOI 10.1038/hdy.2013.77; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BARBATO GF, 1992, POULTRY SCI, V71, P789, DOI 10.3382/ps.0710789; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beavis William D., 1998, P145; BERESKIN B, 1971, J ANIM SCI, V32, P413; Bidanel JP, 2008, ANIMAL, V2, P813, DOI 10.1017/S1751731108002097; Borchers N, 2004, J ANIM BREED GENET, V121, P392, DOI 10.1111/j.1439-0388.2004.00482.x; Bouwman AC, 2012, BMC GENET, V13, P1, DOI 10.1186/1471-2156-13-93; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Boysen TJ, 2013, GENETICS, V193, P431, DOI 10.1534/genetics.112.144535; Bruce A. B., 1910, Science New York N S, V32, DOI 10.1126/science.32.827.627-a; Campo JL, 2002, POULTRY SCI, V81, P1448, DOI 10.1093/ps/81.10.1448; Cassady JP, 2001, J ANIM SCI, V79, P623; Choi Hyungwon, 2012, Frontiers in Genetics, V2, P105, DOI [10.3389/fgene.2011.00018, 10.3389/fgene.2011.00105]; Coster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031825; Dabney A, 2010, QVALUE Q VALUE ESTIM; Davenport CB, 1908, SCIENCE, V28, P454, DOI 10.1126/science.28.718.454-b; Dekkers JCM, 2011, GENETICS OF THE PIG, 2ND EDITION, P390, DOI 10.1079/9781845937560.0390; Denic S, 2005, MED HYPOTHESES, V64, P1002, DOI 10.1016/j.mehy.2004.10.013; Ding NS, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-6; Edwards DB, 2008, J ANIM SCI, V86, P254, DOI 10.2527/jas.2006-626; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062534; Geldermann H, 2003, J ANIM BREED GENET, V120, P363, DOI 10.1046/j.0931-2668.2003.00408.x; Gilmour AR, 2009, ASREML USER GUIDE RE; Goddard ME, 2012, ANIM PROD SCI, V52, P73, DOI 10.1071/AN11180; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Guo YM, 2008, ANIM GENET, V39, P486, DOI 10.1111/j.1365-2052.2008.01756.x; Hirooka H, 2001, J ANIM SCI, V79, P2320; Holl JW, 2004, J ANIM SCI, V82, P3421; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; KING J. W. B., 1960, Animal Prod., V2, P59; Ma J, 2009, ANIM GENET, V40, P637, DOI 10.1111/j.1365-2052.2009.01892.x; Melchinger AE, 2007, GENETICS, V177, P1827, DOI [10.1534/genetics.107.080564, 10.1534/genetics.107.084871]; Mikawa S, 2005, J ANIM SCI, V83, P2247; Mikawa S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-5; Minozzi G, 2008, LIVEST SCI, V119, P221, DOI 10.1016/j.livsci.2008.04.007; Moyle LC, 2009, GENETICS, V181, P347, DOI 10.1534/genetics.108.095679; Nishio M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085792; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Ren DR, 2012, ANIM GENET, V43, P545, DOI 10.1111/j.1365-2052.2011.02313.x; Rodriguez C, 2005, ANIM GENET, V36, P490, DOI 10.1111/j.1365-2052.2005.01358.x; Sato S, 2006, J ANIM SCI, V84, P2895, DOI 10.2527/jas.2006-176; Sato S, 2003, J ANIM SCI, V81, P2938; SELLIER P, 1976, Livestock Production Science, V3, P203, DOI 10.1016/0301-6226(76)90016-6; Shull, 1914, Z INDUKT ABSTAMMUNGS, V12, P97, DOI DOI 10.1007/BF01837282; Shull GH, 1908, J HERED, P296; Steibel JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016766; STERN C, 1948, GENETICS, V33, P215; Su GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045293; Toro MA, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-33; Tortereau F, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-42; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Visscher P, 2000, LIVEST PROD SCI, V65, P57, DOI 10.1016/S0301-6226(99)00180-3; Vitezica ZG, 2013, GENETICS, V195, P1223, DOI 10.1534/genetics.113.155176; Wada Y, 2000, ANIM GENET, V31, P376, DOI 10.1046/j.1365-2052.2000.00696.x; Wang JK, 2004, CROP SCI, V44, P2006, DOI 10.2135/cropsci2004.2006; Wei WH, 2011, ANIM GENET, V42, P15, DOI 10.1111/j.1365-2052.2010.02082.x; Wellmann R, 2012, GENET RES, V94, P21, DOI 10.1017/S0016672312000018; Wijga S, 2012, J DAIRY SCI, V95, P899, DOI 10.3168/jds.2011-4717; XIAO JH, 1995, GENETICS, V140, P745; Zhang Jinghu, 2007, Journal of Genetics and Genomics, V34, P307, DOI 10.1016/S1673-8527(07)60032-0	65	37	39	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105867	10.1371/journal.pone.0105867	http://dx.doi.org/10.1371/journal.pone.0105867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25158056	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200072
J	Gurbuz, N; Ashour, AA; Alpay, SN; Ozpolat, B				Gurbuz, Nilgun; Ashour, Ahmed A.; Alpay, S. Neslihan; Ozpolat, Bulent			Down-Regulation of 5-HT1B and 5-HT1D Receptors Inhibits Proliferation, Clonogenicity and Invasion of Human Pancreatic Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TISSUE TRANSGLUTAMINASE; KAPPA-B; TYROSINE KINASE; SEROTONIN RECEPTORS; PROSTATE-CANCER; MOUSE MODEL; EXPRESSION; GROWTH; ADHESION	Pancreatic ductal adenocarcinoma is characterized by extensive local tumor invasion, metastasis and early systemic dissemination. The vast majority of pancreatic cancer (PaCa) patients already have metastatic complications at the time of diagnosis, and the death rate of this lethal type of cancer has increased over the past decades. Thus, efforts at identifying novel molecularly targeted therapies are priorities. Recent studies have suggested that serotonin (5-HT) contributes to the tumor growth in a variety of cancers including prostate, colon, bladder and liver cancer. However, there is lack of evidence about the impact of 5-HT receptors on promoting pancreatic cancer. Having considered the role of 5-HT-1 receptors, especially 5-HT1B and 5-HT1D subtypes in different types of malignancies, the aim of this study was to investigate the role of 5-HT1B and 5-HT1D receptors in PaCa growth and progression and analyze their potential as cytotoxic targets. We found that knockdown of 5-HT1B and 5-HT1D receptors expression, using specific small interfering RNA (siRNA), induced significant inhibition of proliferation and clonogenicity of PaCa cells. Also, it significantly suppressed PaCa cells invasion and reduced the activity of uPAR/MMP-2 signaling and Integrin/Src/Fak-mediated signaling, as integral tumor cell pathways associated with invasion, migration, adhesion, and proliferation. Moreover, targeting 5-HT1B and 5-HT1D receptors down-regulates zinc finger ZEB1 and Snail proteins, the hallmarks transcription factors regulating epithelial-mesenchymal transition (EMT), concomitantly with up-regulating of claudin-1 and E-Cadherin. In conclusion, our data suggests that 5-HT1B- and 5-HT1D-mediated signaling play an important role in the regulation of the proliferative and invasive phenotype of PaCa. It also highlights the therapeutic potential of targeting of 5-HT1B/1D receptors in the treatment of PaCa, and opens a new avenue for biomarkers identification, and valuable new therapeutic targets for managing pancreatic cancer.	[Gurbuz, Nilgun; Ashour, Ahmed A.; Alpay, S. Neslihan; Ozpolat, Bulent] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Ashour, Ahmed A.] Al Azhar Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt; [Ozpolat, Bulent] Univ Texas MD Anderson Canc Ctr, Noncoding RNA, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Egyptian Knowledge Bank (EKB); Al Azhar University; University of Texas System; UTMD Anderson Cancer Center	Ozpolat, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	bozpolat@mdanderson.org		Ashour, Ahmed/0000-0003-4422-5802	Texas Center for Cancer Nanomedicine (TCCN); National Cancer Institute's (NCI) Center for Nanotechnology [454CA151668]; siRNA Center project; M.D. Anderson Cancer Center, UT, Houston, Texas, USA; NATIONAL CANCER INSTITUTE [U54CA151668] Funding Source: NIH RePORTER	Texas Center for Cancer Nanomedicine (TCCN); National Cancer Institute's (NCI) Center for Nanotechnology; siRNA Center project; M.D. Anderson Cancer Center, UT, Houston, Texas, USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by The Texas Center for Cancer Nanomedicine (TCCN), a National Cancer Institute's (NCI) Center for Nanotechnology (454CA151668), and by siRNA Center project, M.D. Anderson Cancer Center, UT, Houston, Texas, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KM, 2013, CANCER RES, V73, P3737, DOI 10.1158/0008-5472.CAN-12-3537; Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Akar U, 2008, AUTOPHAGY, V4, P669, DOI 10.4161/auto.6083; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Alpini G, 2008, CANCER RES, V68, P9184, DOI 10.1158/0008-5472.CAN-08-2133; [Anonymous], J HEPATOBILIARY PANC; Ashour AA, 2014, APOPTOSIS, V19, P241, DOI 10.1007/s10495-013-0927-2; Ataee R, 2010, J CANCER RES CLIN, V136, P1461, DOI 10.1007/s00432-010-0801-3; Baramova EN, 1997, FEBS LETT, V405, P157, DOI 10.1016/S0014-5793(97)00175-0; Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Beausejour M, 2012, APOPTOSIS, V17, P566, DOI 10.1007/s10495-012-0713-6; BEHRENDT N, 1990, J BIOL CHEM, V265, P6453; Blasi F, 2010, FEBS LETT, V584, P1923, DOI 10.1016/j.febslet.2009.12.039; Bonkhoff H, 2004, UROLOGE A, V43, P836, DOI 10.1007/s00120-004-0559-9; CATTANEO MG, 1995, EUR J PHARM-MOLEC PH, V291, P209, DOI 10.1016/0014-2999(95)90106-X; Chhabra A, 2009, ANTICANCER RES, V29, P1909; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; Coufal M, 2010, INT J CANCER, V126, P2112, DOI 10.1002/ijc.24909; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dizeyi N, 2004, PROSTATE, V59, P328, DOI 10.1002/pros.10374; El Kamar FG, 2003, ONCOLOGIST, V8, P18, DOI 10.1634/theoncologist.8-1-18; ELLIS V, 1991, J BIOL CHEM, V266, P12752; Filip M, 2009, PHARMACOL REP, V61, P761, DOI 10.1016/S1734-1140(09)70132-X; Furukawa K, 2010, ONCOL REP, V24, P843, DOI 10.3892/or_00000928; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; He Y, 2007, CLIN CANCER RES, V13, P3115, DOI 10.1158/1078-0432.CCR-06-2088; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; ISHIZUKA J, 1992, J CELL PHYSIOL, V150, P1, DOI 10.1002/jcp.1041500102; Ito H, 2003, SURGERY, V134, P221, DOI 10.1067/msy.2003.224; Jallal H, 2007, CANCER RES, V67, P1580, DOI 10.1158/0008-5472.CAN-06-2027; Kojima T, 2008, LIVER INT, V28, P534, DOI 10.1111/j.1478-3231.2007.01631.x; Kojima T, 2011, EXP CELL RES, V317, P2288, DOI 10.1016/j.yexcr.2011.06.020; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Kyuno D, 2013, CARCINOGENESIS, V34, P1232, DOI 10.1093/carcin/bgt057; Launay JM, 1996, J BIOL CHEM, V271, P3141, DOI 10.1074/jbc.271.6.3141; Lin CY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-87; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Ma JM, 2013, JNCI-J NATL CANCER I, V105, P1694, DOI 10.1093/jnci/djt292; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Mao CY, 1998, INT J PANCREATOL, V23, P153, DOI 10.1385/IJGC:23:2:153; Marelli UK, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00222; Martin TA, 2009, BBA-BIOMEMBRANES, V1788, P872, DOI 10.1016/j.bbamem.2008.11.005; Michl P, 2003, CANCER RES, V63, P6265; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Nagaraj NS, 2010, MOL CANCER THER, V9, P2322, DOI 10.1158/1535-7163.MCT-09-1212; NEMECEK GM, 1986, P NATL ACAD SCI USA, V83, P674, DOI 10.1073/pnas.83.3.674; Nocito A, 2008, CANCER RES, V68, P5152, DOI 10.1158/0008-5472.CAN-08-0202; Pai VP, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2448; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; PEROUTKA SJ, 1988, ANNU REV NEUROSCI, V11, P45, DOI 10.1146/annurev.ne.11.030188.000401; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Plumb JA, 1999, METH MOLEC MED, V28, P17, DOI 10.1385/1-59259-687-8:17; Rajeshkumar NV, 2009, CLIN CANCER RES, V15, P4138, DOI 10.1158/1078-0432.CCR-08-3021; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Schuller HM, 2010, FUTURE ONCOL, V6, P221, DOI [10.2217/fon.09.171, 10.2217/FON.09.171]; SEUWEN K, 1990, BIOCHEM PHARMACOL, V39, P985, DOI 10.1016/0006-2952(90)90276-Q; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Sharpe CR, 2002, BRIT J CANCER, V86, P92, DOI 10.1038/sj.bjc.6600013; Shaw Leslie M., 2004, V294, P97; Siddiqui EJ, 2006, BJU INT, V97, P634, DOI 10.1111/j.1464-410X.2006.06056.x; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Slassi Abdelmalik, 2002, Current Topics in Medicinal Chemistry, V2, P559, DOI 10.2174/1568026023393903; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; Soll C, 2012, CLIN CANCER RES, V18, P5902, DOI 10.1158/1078-0432.CCR-11-1813; Soll C, 2010, HEPATOLOGY, V51, P1244, DOI 10.1002/hep.23441; Sonier B, 2006, BIOCHEM BIOPH RES CO, V343, P1053, DOI 10.1016/j.bbrc.2006.03.080; TAKUWA N, 1989, AM J PHYSIOL, V257, pF431, DOI 10.1152/ajprenal.1989.257.3.F431; TUTTON PJM, 1982, BRIT J CANCER, V46, P260, DOI 10.1038/bjc.1982.191; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Verma A, 2008, CLIN CANCER RES, V14, P2476, DOI 10.1158/1078-0432.CCR-07-4529; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Xie XD, 1999, FEBS LETT, V456, P63, DOI 10.1016/S0014-5793(99)00918-7; Yakubov B, 2013, NEOPLASIA, V15, P609, DOI 10.1593/neo.121878; Yezhelyev MV, 2004, CLIN CANCER RES, V10, P8028, DOI 10.1158/1078-0432.CCR-04-0621; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863	88	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105245	10.1371/journal.pone.0105245	http://dx.doi.org/10.1371/journal.pone.0105245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170871	Green Published, gold			2022-12-25	WOS:000341127500038
J	Miao, HY; Sangster, MY; Livingstone, AM; Hilchey, SP; Zhang, L; Topham, DJ; Mosmann, TR; Holden-Wiltse, J; Perelson, AS; Wu, HL; Zand, MS				Miao, Hongyu; Sangster, Mark Y.; Livingstone, Alexandra M.; Hilchey, Shannon P.; Zhang, Le; Topham, David J.; Mosmann, Tim R.; Holden-Wiltse, Jeanne; Perelson, Alan S.; Wu, Hulin; Zand, Martin S.			Modeling the Dynamics and Migratory Pathways of Virus-Specific Antibody-Secreting Cell Populations in Primary Influenza Infection	PLOS ONE			English	Article							ANTIGEN PRESENTATION; LYMPHOID-TISSUE; CUTTING EDGE; T-CELLS; MICE; RESPONSES; MEMORY; LUNG; IDENTIFIABILITY; COMPARTMENTS	The B cell response to influenza infection of the respiratory tract contributes to viral clearance and establishes profound resistance to reinfection by related viruses. Numerous studies have measured virus-specific antibody-secreting cell (ASC) frequencies in different anatomical compartments after influenza infection and provided a general picture of the kinetics of ASC formation and dispersion. However, the dynamics of ASC populations are difficult to determine experimentally and have received little attention. Here, we applied mathematical modeling to investigate the dynamics of ASC growth, death, and migration over the 2-week period following primary influenza infection in mice. Experimental data for model fitting came from high frequency measurements of virus-specific IgM, IgG, and IgA ASCs in the mediastinal lymph node (MLN), spleen, and lung. Model construction was based on a set of assumptions about ASC gain and loss from the sampled sites, and also on the directionality of ASC trafficking pathways. Most notably, modeling results suggest that differences in ASC fate and trafficking patterns reflect the site of formation and the expressed antibody class. Essentially all early IgA ASCs in the MLN migrated to spleen or lung, whereas cell death was likely the major reason for IgM and IgG ASC loss from the MLN. In contrast, the spleen contributed most of the IgM and IgG ASCs that migrated to the lung, but essentially none of the IgA ASCs. This finding points to a critical role for regional lymph nodes such as the MLN in the rapid generation of IgA ASCs that seed the lung. Results for the MLN also suggest that ASC death is a significant early feature of the B cell response. Overall, our analysis is consistent with accepted concepts in many regards, but it also indicates novel features of the B cell response to influenza that warrant further investigation.	[Miao, Hongyu; Zhang, Le; Holden-Wiltse, Jeanne; Wu, Hulin] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Sangster, Mark Y.; Livingstone, Alexandra M.; Topham, David J.; Mosmann, Tim R.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA; [Hilchey, Shannon P.; Zand, Martin S.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Perelson, Alan S.] Los Alamos Natl Lab, Los Alamos, NM USA	University of Rochester; University of Rochester; University of Rochester; United States Department of Energy (DOE); Los Alamos National Laboratory	Zand, MS (corresponding author), Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA.	martin_zand@urmc.rochester.edu	Zhang, Le/AAD-9104-2019; Perelson, Alan S/Z-1959-2019; Zand, Martin/A-8612-2015	Zhang, Le/0000-0002-3708-1727; Perelson, Alan S/0000-0002-2455-0002; Zand, Martin/0000-0002-7095-8682; Sangster, Mark/0000-0002-1599-5894	National Institute of Allergy and Infectious Diseases [HHSN272201000055C, R01 AI069351]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098112, R01AI069351] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institute of Allergy and Infectious Diseases contract HHSN272201000055C and R01 AI069351 (MZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KG, 2012, J IMMUNOL, V189, P2702, DOI 10.4049/jimmunol.1201682; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Boyden AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040733; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chu VT, 2013, IMMUNOL REV, V251, P177, DOI 10.1111/imr.12011; Cyster JG, 2003, IMMUNOL REV, V194, P48, DOI 10.1034/j.1600-065X.2003.00041.x; DAVIES L, 1993, J AM STAT ASSOC, V88, P782, DOI 10.2307/2290763; Efron B., 1993, INTRO BOOSTRAP; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; JONES PD, 1987, CELL IMMUNOL, V109, P53, DOI 10.1016/0008-8749(87)90291-7; JONES PD, 1986, J VIROL, V60, P614, DOI 10.1128/JVI.60.2.614-619.1986; Joo HM, 2008, P NATL ACAD SCI USA, V105, P3485, DOI 10.1073/pnas.0800003105; Kallies A, 2010, EMBO J, V29, P3896, DOI 10.1038/emboj.2010.282; Kim HJ, 2006, PLOS COMPUT BIOL, V2, P1232, DOI 10.1371/journal.pcbi.0020135; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Liang B, 2001, J VIROL, V75, P5416, DOI 10.1128/JVI.75.11.5416-5420.2001; Liang H, 2010, ANN APPL STAT, V4, P460, DOI 10.1214/09-AOAS290; Marshall D, 1999, J IMMUNOL, V163, P4673; MCDERMOTT MR, 1979, J IMMUNOL, V122, P1892; Miao HY, 2012, B MATH BIOL, V74, P300, DOI 10.1007/s11538-011-9668-y; Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009; Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10; Moles CG, 2004, APPL SOFT COMPUT, V5, P35, DOI 10.1016/j.asoc.2004.03.011; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rothaeusler K, 2010, EUR J IMMUNOL, V40, P366, DOI 10.1002/eji.200939798; Saltelli A., 2000, SENSITIVITY ANAL; SANGSTER M, 1995, VIROLOGY, V207, P287, DOI 10.1006/viro.1995.1079; Sangster MY, 2003, J EXP MED, V198, P1011, DOI 10.1084/jem.20021745; Sangster MY, 2000, J IMMUNOL, V164, P1820, DOI 10.4049/jimmunol.164.4.1820; Sealy R, 2003, IMMUNOLOGY, V108, P431, DOI 10.1046/j.1365-2567.2003.01615.x; Smith AM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001081; Smyth GK, 2003, INST MATH S, V40, P115; Stock AT, 2004, J IMMUNOL, V173, P2241, DOI 10.4049/jimmunol.173.4.2241; Tamura S, 1998, J GEN VIROL, V79, P291, DOI 10.1099/0022-1317-79-2-291; Waffarn EE, 2011, J IMMUNOL, V186, P3823, DOI 10.4049/jimmunol.1002090; Wolf AI, 2011, J CLIN INVEST, V121, P3954, DOI 10.1172/JCI57362; Wu HL, 2011, J IMMUNOL, V187, P4474, DOI 10.4049/jimmunol.1101443; Xia X, 2003, IEEE T AUTOMAT CONTR, V48, P330, DOI 10.1109/TAC.2002.808494	45	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e104781	10.1371/journal.pone.0104781	http://dx.doi.org/10.1371/journal.pone.0104781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171166	Green Submitted, gold, Green Published			2022-12-25	WOS:000341127500022
J	Xiao, K; Song, ZH; Jiao, LF; Ke, YL; Hu, CH				Xiao, Kan; Song, Ze-He; Jiao, Le-Fei; Ke, Ya-Lu; Hu, Cai-Hong			Developmental Changes of TGF-beta 1 and Smads Signaling Pathway in Intestinal Adaption of Weaned Pigs	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TIGHT JUNCTION PROTEINS; BARRIER FUNCTION; TGF-BETA; GENE-EXPRESSION; PERMEABILITY; DISRUPTION; PERFORMANCE; MODULATION; CYTOKINES	Weaning stress caused marked changes in intestinal structure and function. Transforming growth factor-beta 1 (TGF-beta 1) and canonical Smads signaling pathway are suspected to play an important regulatory role in post-weaning adaptation of the small intestine. In the present study, the intestinal morphology and permeability, developmental expressions of tight junction proteins and TGF-beta 1 in the intestine of piglets during the 2 weeks after weaning were assessed. The expressions of TGF-beta receptor I/II (T beta RI, T beta RII), smad2/3, smad4 and smad7 were determined to investigate whether canonical smads signaling pathways were involved in early weaning adaption process. The results showed that a shorter villus and deeper crypt were observed on d 3 and d 7 postweaning and intestinal morphology recovered to preweaning values on d 14 postweaning. Early weaning increased (P<0.05) plasma level of diamine oxidase (DAO) and decreased DAO activities (P<0.05) in intestinal mucosa on d 3 and d 7 post-weaning. Compared with the pre-weaning stage (d 0), tight junction proteins level of occludin and claudin-1 were reduced (P<0.05) on d 3, 7 and 14 post-weaning, and ZO-1 protein was reduced (P<0.05) on d 3 and d 7 post-weaning. An increase (P<0.05) of TGF-beta 1 in intestinal mucosa was observed on d 3 and d 7 and then level down on d 14 post-weaning. Although there was an increase (P<0.05) of T beta R II protein expression in the intestinal mucosa on d3 and d 7, no significant increase of mRNA of T beta RI, T beta RII, smad2/3, smad4 and smad7 was observed during postweaning. The results indicated that TGF-beta 1 was associated with the restoration of intestinal morphology and barrier function following weaning stress. The increased intestinal endogenous TGF-beta 1 didn't activate the canonical Smads signaling pathway.	[Xiao, Kan; Song, Ze-He; Jiao, Le-Fei; Ke, Ya-Lu; Hu, Cai-Hong] Zhejiang Univ, Anim Sci Coll, Key Lab Mol Anim Nutr, Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Hu, CH (corresponding author), Zhejiang Univ, Anim Sci Coll, Key Lab Mol Anim Nutr, Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China.	chhu@zju.edu.cn			National Natural Science Foundation of China [31472103, 31072039]; Special Fund for Agroscientific Research in the Public Interest [201403047]; Zhejiang Provincial Qianjiang Talent Project [2013R10036]; Fundamental Research Funds for the Central Universities [2014FZA6020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agroscientific Research in the Public Interest; Zhejiang Provincial Qianjiang Talent Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was jointly supported by National Natural Science Foundation of China (31472103, 31072039), the Special Fund for Agroscientific Research in the Public Interest (201403047), Zhejiang Provincial Qianjiang Talent Project (2013R10036), Fundamental Research Funds for the Central Universities (2014FZA6020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P975, DOI 10.1053/gast.1996.v110.pm8613031; BARNARD JA, 1989, P NATL ACAD SCI USA, V86, P1578, DOI 10.1073/pnas.86.5.1578; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Chen HH, 2013, ARCH MED RES, V44, P93, DOI 10.1016/j.arcmed.2013.01.004; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dignass AU, 2001, INFLAMM BOWEL DIS, V7, P68, DOI 10.1097/00054725-200102000-00014; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Hering NA, 2011, J NUTR, V141, P783, DOI 10.3945/jn.110.137588; Hough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042513; Howe KL, 2005, AM J PATHOL, V167, P1587, DOI 10.1016/S0002-9440(10)61243-6; Hu CH, 2013, ANIM FEED SCI TECH, V181, P65, DOI 10.1016/j.anifeedsci.2013.02.003; Hu CH, 2013, J ANIM SCI, V91, P1094, DOI 10.2527/jas.2012-5796; Hu CH, 2012, ANIM FEED SCI TECH, V177, P108, DOI 10.1016/j.anifeedsci.2012.07.028; Hu CH, 2014, INNATE IMMUN-LONDON, V20, P478, DOI 10.1177/1753425913499947; Hu CH, 2013, BRIT J NUTR, V110, P681, DOI 10.1017/S0007114512005508; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Liu Y, 2008, BRIT J NUTR, V100, P552, DOI 10.1017/S0007114508911612; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin-Martin N, 2011, AM J PHYSIOL-RENAL, V301, pF1281, DOI 10.1152/ajprenal.00188.2010; McLamb BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059838; Mehra A, 2002, BIOCHEM CELL BIOL, V80, P605, DOI 10.1139/O02-161; Mei J, 2005, BRIT J NUTR, V93, P37, DOI 10.1079/BJN20041302; Mei J, 2006, LIVEST SCI, V105, P214, DOI 10.1016/j.livsci.2006.06.017; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V293, pG413, DOI 10.1152/ajpgi.00304.2006; Penttila IA, 1998, PEDIATR RES, V44, P524, DOI 10.1203/00006450-199810000-00010; Ren WK, 2014, J NUTR, V144, P988, DOI 10.3945/jn.114.192120; Ren WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088335; Roche JK, 2000, INFECT IMMUN, V68, P5635, DOI 10.1128/IAI.68.10.5635-5644.2000; Smith F, 2010, AM J PHYSIOL-GASTR L, V298, pG352, DOI 10.1152/ajpgi.00081.2009; Song ZQ, 2014, INTERNATIONAL CONFERENCE ON CONTROL ENGINEERING AND AUTOMATION (ICCEA 2014), P1; Suer S, 2009, CELL TISSUE RES, V336, P213, DOI 10.1007/s00441-009-0776-z; van't Land B, 2002, BRIT J CANCER, V87, P113, DOI 10.1038/sj.bjc.6600342; Wang JJ, 2008, J NUTR, V138, P1025, DOI 10.1093/jn/138.6.1025; Wang ZC, 2014, ASIAN PAC J TROP MED, V7, P321, DOI 10.1016/S1995-7645(14)60048-1; Wei J, 2014, CELL BIOL INT; Wijtten PJA, 2011, BRIT J NUTR, V105, P967, DOI 10.1017/S0007114510005660; WOLVEKAMP MCJ, 1994, DIGEST DIS, V12, P2; Xu RJ, 2000, LIVEST PROD SCI, V66, P95, DOI 10.1016/S0301-6226(00)00217-7; Yin J, 2014, J ANIM SCI, V92, P612, DOI 10.2527/jas.2013-6986	41	27	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e104589	10.1371/journal.pone.0104589	http://dx.doi.org/10.1371/journal.pone.0104589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170924	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500019
J	Ahn, SG; Lee, M; Jeon, TJ; Han, K; Lee, HM; Lee, SA; Ryu, YH; Son, EJ; Jeong, J				Ahn, Sung Gwe; Lee, Minkyung; Jeon, Tae Joo; Han, Kyunghwa; Lee, Hak Min; Lee, Seung Ah; Ryu, Young Hoon; Son, Eun Ju; Jeong, Joon			[18F]-Fluorodeoxyglucose Positron Emission Tomography Can Contribute to Discriminate Patients with Poor Prognosis in Hormone Receptor-Positive Breast Cancer	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; PROGESTERONE-RECEPTOR; PRIMARY THERAPY; F-18-FDG PET; IMMUNOHISTOCHEMISTRY; HIGHLIGHTS; MICROARRAY; KI-67	Background: Patients with hormone receptor-positive breast cancer typically show favorable survival. However, identifying individuals at high risk of recurrence among these patients is a crucial issue. We tested the hypothesis that [F-18]-fluorodeoxyglucose positron emission tomography (FDG-PET) scans can help predict prognosis in patients with hormone receptor-positive breast cancer. Methods: Between April 2004 and December 2008, 305 patients with hormone receptor-positive breast cancer who underwent FGD-PET were enrolled. Patients with luminal B subtype were identified by positivity for human epidermal growth factor receptor-2 (HER2) or high Ki67 (>= 14%) according to criteria recently recommended by the St. Gallen panelists. The cut-off value of SUVmax was defined using the time-dependent receiver operator characteristic curve for recurrence-free survival (RFS). Results: At a median follow up of 6.23 years, continuous SUVmax was a significant prognostic factor with a hazard ratio (HR) of 1.21 (p = 0.021). The cut-off value of SUVmax was defined as 4. Patients with luminal B subtype (n = 82) or high SUVmax (n = 107) showed a reduced RFS (p = 0.031 and 0.002, respectively). In multivariate analysis for RFS, SUVmax carried independent prognostic significance (p = 0.012) whereas classification with immunohistochemical markers did not (p = 0.274). The Harell c-index was 0.729. High SUVmax was significantly associated with larger tumor size, positive nodes, HER2 positivity, high Ki67 (>= 14%), high tumor grade, and luminal B subtype. Conclusions: Among patients with hormone receptor-positive breast cancer, FDG-PET can help discriminate patients at high risk of tumor relapse.	[Ahn, Sung Gwe; Lee, Hak Min; Jeong, Joon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea; [Lee, Minkyung; Jeon, Tae Joo; Ryu, Young Hoon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Nucl Med, Seoul, South Korea; [Han, Kyunghwa] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Gangnam Med Res Ctr,Biostat Collaborat Unit, Seoul, South Korea; [Son, Eun Ju] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea; [Lee, Seung Ah] Eulji Univ, Coll Med, Dept Surg, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Eulji University	Jeong, J (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea.	gsjjoon@yuhs.ac	, 정준/I-2133-2019	, 정준/0000-0003-0397-0005; Ahn, Sung Gwe/0000-0002-8778-9686; Son, Eun Ju/0000-0002-7895-0335; Jeon, Tae Joo/0000-0002-7574-6734; RYU, YOUNG HOON/0000-0002-9000-5563; Han, Kyunghwa/0000-0002-5687-7237	Basic Science Research Program through the National Research Foundation of Korea (NRF) -Ministry of Education, Science and Technology [2013R1A1A2007759]	Basic Science Research Program through the National Research Foundation of Korea (NRF) -Ministry of Education, Science and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology grant 2013R1A1A2007759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Allred DC, 1998, MODERN PATHOL, V11, P155; Basu S, 2008, CANCER-AM CANCER SOC, V112, P995, DOI 10.1002/cncr.23226; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Cerfolio RJ, 2005, J THORAC CARDIOV SUR, V130, P151, DOI 10.1016/j.jtcvs.2004.11.007; Chalkidou A, 2012, EUR J CANCER, V48, P3499, DOI 10.1016/j.ejca.2012.05.001; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Fletcher JW, 2008, J NUCL MED, V49, P480, DOI 10.2967/jnumed.107.047787; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Humbert O, 2012, ANN ONCOL, V23, P2572, DOI 10.1093/annonc/mds071; Millar EKA, 2011, BRIT J CANCER, V105, P272, DOI 10.1038/bjc.2011.228; Moeder CB, 2007, J CLIN ONCOL, V25, P5418, DOI 10.1200/JCO.2007.12.8033; Mohsin SK, 2004, MODERN PATHOL, V17, P1545, DOI 10.1038/modpathol.3800229; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Osborne JR, 2010, J NUCL MED, V51, P543, DOI 10.2967/jnumed.108.060459; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Sanli Y, 2012, ANN NUCL MED, V26, P345, DOI 10.1007/s12149-012-0579-2; Seo S, 2007, CLIN CANCER RES, V13, P427, DOI 10.1158/1078-0432.CCR-06-1357; Shimoda Wataru, 2007, Breast Cancer, V14, P260, DOI 10.2325/jbcs.14.260; Smyczek-Gargya B, 2004, EUR J NUCL MED MOL I, V31, P720, DOI 10.1007/s00259-004-1462-8	24	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105905	10.1371/journal.pone.0105905	http://dx.doi.org/10.1371/journal.pone.0105905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25167062	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303700053
J	Gerry, SP; Ellerby, DJ				Gerry, Shannon P.; Ellerby, David J.			Resolving Shifting Patterns of Muscle Energy Use in Swimming Fish	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; FOWL NUMIDA-MELEAGRIS; COD GADUS-MORHUA; BLOOD-FLOW DISTRIBUTION; SALMO-GAIRDNERI RICHARDSON; RAINBOW-TROUT; CARDIAC-OUTPUT; OXYGEN-TRANSPORT; MECHANICAL POWER; BLUEGILL SUNFISH	Muscle metabolism dominates the energy costs of locomotion. Although in vivo measures of muscle strain, activity and force can indicate mechanical function, similar muscle-level measures of energy use are challenging to obtain. Without this information locomotor systems are essentially a black box in terms of the distribution of metabolic energy. Although in situ measurements of muscle metabolism are not practical in multiple muscles, the rate of blood flow to skeletal muscle tissue can be used as a proxy for aerobic metabolism, allowing the cost of particular muscle functions to be estimated. Axial, undulatory swimming is one of the most common modes of vertebrate locomotion. In fish, segmented myotomal muscles are the primary power source, driving undulations of the body axis that transfer momentum to the water. Multiple fins and the associated fin muscles also contribute to thrust production, and stabilization and control of the swimming trajectory. We have used blood flow tracers in swimming rainbow trout (Oncorhynchus mykiss) to estimate the regional distribution of energy use across the myotomal and fin muscle groups to reveal the functional distribution of metabolic energy use within a swimming animal for the first time. Energy use by the myotomal muscle increased with speed to meet thrust requirements, particularly in posterior myotomes where muscle power outputs are greatest. At low speeds, there was high fin muscle energy use, consistent with active stability control. As speed increased, and fins were adducted, overall fin muscle energy use declined, except in the caudal fin muscles where active fin stiffening is required to maintain power transfer to the wake. The present data were obtained under steady-state conditions which rarely apply in natural, physical environments. This approach also has potential to reveal the mechanical factors that underlie changes in locomotor cost associated with movement through unsteady flow regimes.	[Gerry, Shannon P.] Fairfield Univ, Dept Biol, Fairfield, CT 06430 USA; [Ellerby, David J.] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA	Fairfield University; Wellesley College	Ellerby, DJ (corresponding author), Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA.	dellerby@wellesley.edu	Gerry, Shannon/AAE-9295-2020	Ellerby, David/0000-0003-4045-0201	National Science Foundation [0715937]	National Science Foundation(National Science Foundation (NSF))	The project was supported by National Science Foundation grant 0715937 to DJE (www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AN, 2002, J EXP BIOL, V205, P379; Alexander RM, 2006, PRINCIPLES ANIMAL LO; ALTRINGHAM JD, 1993, J EXP BIOL, V182, P191; Askew GN, 2007, BIOLOGY LETT, V3, P445, DOI 10.1098/rsbl.2007.0182; AXELSSON M, 1991, J EXP BIOL, V158, P181; AXELSSON M, 1993, AM J PHYSIOL, V264, pR963, DOI 10.1152/ajpregu.1993.264.5.R963; Axelsson Michael, 1994, Biochemistry and Molecular Biology of Fishes, V3, P17; BARRON MG, 1987, J FISH BIOL, V31, P735, DOI 10.1111/j.1095-8649.1987.tb05276.x; Behnke BJ, 2003, J PHYSIOL-LONDON, V549, P597, DOI 10.1113/jphysiol.2002.035915; Boddeke R., 1959, Proceedings Nederlandse Akademie van Wetenschappen Amsterdam, V62C, P576; BONE Q, 1978, FISH B-NOAA, V76, P691; Boushel R, 2003, CAN J APPL PHYSIOL, V28, P754, DOI 10.1139/h03-057; Brett J.R., 1979, FISH PHYSIOL, V8, P280; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Burgetz IJ, 1998, J EXP BIOL, V201, P2711; Cameron JN, 1974, COMP BIOCH PHYSL A, V52A, P441; Claireaux G, 2006, J EXP BIOL, V209, P3420, DOI 10.1242/jeb.02346; Coughlin DJ, 2000, J EXP BIOL, V203, P617; Crocker CE, 2000, AM J PHYSIOL-REG I, V279, pR617, DOI 10.1152/ajpregu.2000.279.2.R617; DAVIE PS, 1986, J EXP ZOOL, V237, P159, DOI 10.1002/jez.1402370203; Davies M, 1993, PHYSIOL ZOOL, V68, P673; DAVISON W, 1977, J EXP BIOL, V70, P1; Delp MD, 1998, ACTA PHYSIOL SCAND, V162, P411, DOI 10.1046/j.1365-201X.1998.0324e.x; Dial KP, 1997, NATURE, V390, P67, DOI 10.1038/36330; Drucker EG, 2003, J EXP BIOL, V206, P813, DOI 10.1242/jeb.00139; Drucker EG, 2005, J EXP BIOL, V208, P4479, DOI 10.1242/jeb.01922; Drucker EG, 2001, J EXP BIOL, V204, P2943; DULING BR, 1987, CIRC RES, V60, P1; EGGINTON S, 1988, RESP PHYSIOL, V74, P383, DOI 10.1016/0034-5687(88)90045-X; Ellerby DJ, 2006, J EXP BIOL, V209, P2064, DOI 10.1242/jeb.02227; Ellerby DJ, 2000, J EXP BIOL, V203, P2001; Ellerby DJ, 2005, J PHYSIOL-LONDON, V564, P631, DOI 10.1113/jphysiol.2005.082974; Enders EC, 2003, CAN J FISH AQUAT SCI, V60, P1149, DOI [10.1139/f03-101, 10.1139/F03-101]; Farrell AP, 2007, PHILOS T R SOC B, V362, P2017, DOI 10.1098/rstb.2007.2111; Farrell AP, 1996, J EXP BIOL, V199, P663; FARRELL AP, 1986, CAN J ZOOL, V64, P481, DOI 10.1139/z86-071; Farrell AP, 2003, J EXP BIOL, V206, P487, DOI 10.1242/jeb.00100; FARRELL AP, 1987, FISH PHYSIOL BIOCHEM, V4, P73, DOI 10.1007/BF02044316; Farrell AP, 2001, COMP BIOCHEM PHYS A, V128, P551, DOI 10.1016/S1095-6433(00)00335-4; Flammang BE, 2008, J EXP BIOL, V211, P587, DOI 10.1242/jeb.012096; FURNELL DJ, 1987, CAN J ZOOL, V65, P486, DOI 10.1139/z87-075; Gallaugher PE, 2001, J EXP BIOL, V204, P2861; GAMPERL AK, 1995, AM J PHYSIOL-REG I, V269, pR1258, DOI 10.1152/ajpregu.1995.269.5.R1258; Girgenrath M, 1999, J EXP BIOL, V202, P3225; GREERWALKER M, 1978, J FISH BIOL, V13, P475; Hammond L, 1998, J EXP BIOL, V201, P1659; Hill A. V., 1950, Science Progress London, V38, P209; HOLMGREN S, 1992, J EXP BIOL, V168, P161; HUDSON RCL, 1973, J EXP BIOL, V58, P509; JAYNE BC, 1993, J COMP PHYSIOL A, V173, P495; JOHNSTON IA, 1975, J FISH BIOL, V7, P451, DOI 10.1111/j.1095-8649.1975.tb04620.x; JOHNSTON IA, 1995, J EXP BIOL, V198, P1851; KICENIUK JW, 1977, J EXP BIOL, V69, P247; KOLOK AS, 1993, J EXP BIOL, V183, P301; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Laughlin MH, 2001, MED SCI SPORT EXER, V33, P81; Lurman GJ, 2007, J EXP BIOL, V210, P3749, DOI 10.1242/jeb.008763; Marsh RL, 2006, J EXP BIOL, V209, P2385, DOI 10.1242/jeb.02287; Marsh RL, 2004, SCIENCE, V303, P80, DOI 10.1126/science.1090704; Morris CR, 2010, J EXP BIOL, V213, P2788, DOI 10.1242/jeb.035717; Murrant CL, 2000, ACTA PHYSIOL SCAND, V168, P531, DOI 10.1046/j.1365-201x.2000.00706.x; NASH GB, 1993, J EXP BIOL, V174, P109; NEUMANN P, 1983, J EXP BIOL, V105, P1; NISHIMURA H, 1982, FED PROC, V41, P2355; Randall, 1978, FISH PHYSIOL, P361; RANDALL DJ, 1982, CAN J ZOOL, V60, P1135, DOI 10.1139/z82-158; Roberts TJ, 1997, SCIENCE, V275, P1113, DOI 10.1126/science.275.5303.1113; ROME LC, 1993, SCIENCE, V261, P340, DOI 10.1126/science.8332898; Rubenson J, 2006, J EXP BIOL, V209, P2395, DOI 10.1242/jeb.02310; Rubenson J, 2009, J APPL PHYSIOL, V106, P1618, DOI 10.1152/japplphysiol.91115.2008; Sarelius I, 2010, ACTA PHYSIOL, V199, P349, DOI 10.1111/j.1748-1716.2010.02129.x; SCHMIDTNIELSEN K, 1972, SCIENCE, V177, P222, DOI 10.1126/science.177.4045.222; Schultz IR, 1999, J FISH BIOL, V54, P1275, DOI 10.1111/j.1095-8649.1999.tb02054.x; Segal SS, 2005, MICROCIRCULATION, V12, P33, DOI 10.1080/10739680590895028; Soivio A., 1975, J EXP BIOL, V62, P207; Standen EM, 2007, J EXP BIOL, V210, P325, DOI 10.1242/jeb.02661; Standen EM, 2010, J EXP BIOL, V213, P831, DOI 10.1242/jeb.033084; Steffensen, 1985, J EXP BIOL, V114, P141; STEVENS ED, 1967, J EXP BIOL, V46, P329; Syme DA, 2002, J EXP BIOL, V205, P189; Syme DA, 2008, PHYSIOL BIOCHEM ZOOL, V81, P320, DOI 10.1086/528784; TAYLOR CR, 1980, J EXP BIOL, V86, P9; Taylor SE, 1996, J EXP BIOL, V199, P835; Teulier L, 2013, J EXP BIOL, V216, P4549, DOI 10.1242/jeb.091058; THORARENSEN H, 1993, J EXP BIOL, V179, P115; Tritico HM, 2010, J EXP BIOL, V213, P2284, DOI 10.1242/jeb.041806; TUCKER VA, 1973, J EXP BIOL, V58, P689; Tudorache C, 2011, FISH PHYSIOL BIOCHEM, V37, P307, DOI 10.1007/s10695-011-9498-8; Tytell ED, 2008, J EXP BIOL, V211, P3359, DOI 10.1242/jeb.020917; Tytell ED, 2008, J EXP BIOL, V211, P187, DOI 10.1242/jeb.008128; WARDLE CS, 1995, J EXP BIOL, V198, P1629; Webb PW, 2010, INTEGR COMP BIOL, V50, P1155, DOI 10.1093/icb/icq020; Webb PW, 2011, FISH PHYSIOL BIOCHEM, V37, P297, DOI 10.1007/s10695-011-9497-9; WEBB PW, 1991, CAN J FISH AQUAT SCI, V48, P583, DOI 10.1139/f91-074; Webb PW, 2002, INTEGR COMP BIOL, V42, P94, DOI 10.1093/icb/42.1.94; WEBB PW, 1971, J EXP BIOL, V55, P521; WEBB PW, 2000, P 1 INT S AQ BIOM IN, P21; Webber DM, 1998, J EXP BIOL, V201, P2779; WHITE FC, 1988, EXP BIOL, V47, P161; Wieser W., 1989, ENERGY TRANSFORMATIO, P98; WILLIAMS TL, 1989, J EXP BIOL, V143, P559; WILSON RW, 1994, J EXP BIOL, V192, P299	102	16	16	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106030	10.1371/journal.pone.0106030	http://dx.doi.org/10.1371/journal.pone.0106030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165858	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303700063
J	Kawashima, A; Koide, K; Ventura, W; Hori, K; Takenaka, S; Maruyama, D; Matsuoka, R; Ichizuka, K; Sekizawa, A				Kawashima, Akihiro; Koide, Keiko; Ventura, Walter; Hori, Kyoko; Takenaka, Shin; Maruyama, Daisuke; Matsuoka, Ryu; Ichizuka, Kiyotake; Sekizawa, Akihiko			Effects of Maternal Smoking on the Placental Expression of Genes Related to Angiogenesis and Apoptosis during the First Trimester	PLOS ONE			English	Article							CIGARETTE-SMOKING; UNITED-STATES; COTININE CONCENTRATIONS; PREGNANCY OUTCOMES; TOBACCO-SMOKE; RISK-FACTORS; PREECLAMPSIA; WOMEN; POPULATION; CELLS	Objective: Maternal cigarette smoking is reportedly associated with miscarriage, fetal growth restriction and placental abruption, and is paradoxically associated with a decreased risk of developing preeclampsia. In the present study, we investigated the gene expression levels of villous tissues in early gestation. We compared the expression levels of the genes related to angiogenesis and apoptosis in the villous tissues obtained from smoking and non-smoking pregnant women. Materials and Methods: We collected villous tissue samples from 57 women requesting surgical termination due to non-medical reasons at 6-8 weeks of gestation. The maternal cigarette smoking status was evaluated by the level of serum cotinine and patients were divided into active smokers and non-smokers by the serum cotinine level. The placental levels of VEGFA, PGF, FLT1, HIF1A, TP53, BAX and BCL2 mRNA were quantified by real time PCR. Results: The gene expression level of PGF and HIF1A in the active smoker group was significantly higher than that in the non-smoker group. We did not observe any significant differences in the VEGFA or FLT1 expression between the groups. In active smoker group, the gene expression levels of TP53 and BAX were significantly higher than those in the non-smoker group. The ratio of BAX/BCL2 mRNA in the active smoker group was significantly higher than that in the non-smoker group. Conclusions: Our findings revealed that smoking might affect the placenta during early pregnancy. Maternal cigarette smoking in early pregnancy may be associated with villus hypoxia, which may influence angiogenesis and apoptosis.	[Kawashima, Akihiro; Koide, Keiko; Ventura, Walter; Hori, Kyoko; Takenaka, Shin; Maruyama, Daisuke; Matsuoka, Ryu; Ichizuka, Kiyotake; Sekizawa, Akihiko] Showa Univ, Sch Med, Dept Obstet & Gynecol, Shinagawa Ku, Tokyo 142, Japan	Showa University	Kawashima, A (corresponding author), Showa Univ, Sch Med, Dept Obstet & Gynecol, Shinagawa Ku, Tokyo 142, Japan.	kurobei343@mac.com	Kawashima, Akihiro/HDL-7864-2022	Kawashima, Akihiro/0000-0002-3501-4854; Ventura, Walter/0000-0002-2888-1394; takenaka, shin/0000-0002-4333-6271	Ministry of Education, Science, Sport and Culture of Japan [26462501]; Smoking Research Foundation; JAOG Ogyaa Donation Foundation; Grants-in-Aid for Scientific Research [26462501] Funding Source: KAKEN	Ministry of Education, Science, Sport and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation; JAOG Ogyaa Donation Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sport and Culture of Japan (No. 26462501), Smoking Research Foundation, and JAOG Ogyaa Donation Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASMUSSEN I, 1977, ACTA OBSTET GYN SCAN, V56, P119, DOI 10.3109/00016347709158353; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Burscha W, 2008, TOXICOLOGY, V254, P147, DOI 10.1016/j.tox.2008.07.048; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chelchowska Magdalena, 2013, Przegl Lek, V70, P800; Chen BS, 2010, AM J PHYSIOL-CELL PH, V299, pC968, DOI 10.1152/ajpcell.00154.2010; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; DEMIR R, 1994, PATHOL RES PRACT, V190, P656, DOI 10.1016/S0344-0338(11)80744-2; Dietz PM, 2011, AM J EPIDEMIOL, V173, P355, DOI 10.1093/aje/kwq381; DOMINGUEZROJAS V, 1994, EUR J EPIDEMIOL, V10, P665, DOI 10.1007/BF01719278; Drukteinis JS, 2005, PLACENTA, V26, pS87, DOI 10.1016/j.placenta.2005.01.013; Einarson A, 2009, EUR J CLIN PHARMACOL, V65, P325, DOI 10.1007/s00228-008-0609-0; England LJ, 2007, NICOTINE TOB RES, V9, P1005, DOI 10.1080/14622200701491255; England MC, 2013, AM J PERINAT, V30, P821, DOI 10.1055/s-0032-1333408; Farina A, 2008, PRENATAL DIAG, V28, P956, DOI 10.1002/pd.2109; Genbacev O, 2003, REPROD TOXICOL, V17, P509, DOI 10.1016/S0890-6238(03)00094-7; Goodwin RD, 2007, OBSTET GYNECOL, V109, P875, DOI 10.1097/01.AOG.0000255979.62280.e6; Hu Ya-Yi, 2006, Sichuan Da Xue Xue Bao Yi Xue Ban, V37, P901; Hu YY, 2006, SICHUAN DA XUE XUE B, V37, P942; Humphrey RG, 2008, ENDOCRINOLOGY, V149, P2131, DOI 10.1210/en.2007-1253; Hung TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040957; Jacqz-Aigrain E, 2002, BJOG-INT J OBSTET GY, V109, P909, DOI 10.1016/S1470-0328(02)01322-8; JAUNIAUX E, 1992, OBSTET GYNECOL, V79, P645; Kvalvik LG, 2012, PEDIATR RES, V72, P101, DOI 10.1038/pr.2012.36; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; LIEBERMAN E, 1994, AM J PUBLIC HEALTH, V84, P1127, DOI 10.2105/AJPH.84.7.1127; Llurba E, 2013, HYPERTENS PREGNANCY, V32, P50, DOI 10.3109/10641955.2012.704107; MARCOUX S, 1989, AM J EPIDEMIOL, V130, P950, DOI 10.1093/oxfordjournals.aje.a115427; Matikainen T, 2001, NAT GENET, V28, P355, DOI 10.1038/ng575; Matikainen TM, 2002, ENDOCRINOLOGY, V143, P615, DOI 10.1210/en.143.2.615; Mehendale R, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.025; Menon R, 2011, PLACENTA, V32, P317, DOI 10.1016/j.placenta.2011.01.015; Menon R, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.051; Newman M G, 2001, J Matern Fetal Med, V10, P166, DOI 10.1080/714904321; PEREZSTABLE EJ, 1992, AM REV RESPIR DIS, V145, P53, DOI 10.1164/ajrccm/145.1.53; Perni UC, 2012, AM J HYPERTENS, V25, P372, DOI 10.1038/ajh.2011.225; Plaisier M, 2008, REPROD SCI, V15, P720, DOI 10.1177/1933719108317300; Raisanen S, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-28; Shinjo A, 2014, FETAL DIAGN THER; SIBAI BM, 1995, AM J OBSTET GYNECOL, V172, P642, DOI 10.1016/0002-9378(95)90586-3; Suter M, 2011, EPIGENETICS-US, V6, P1284, DOI 10.4161/epi.6.11.17819; Votavova H, 2011, PLACENTA, V32, P763, DOI 10.1016/j.placenta.2011.06.022; Votavova H, 2012, NICOTINE TOB RES, V14, P1073, DOI 10.1093/ntr/ntr325; Zdravkovic T, 2005, PLACENTA, V26, pS81, DOI 10.1016/j.placenta.2005.02.003; Zhang J, 1999, AM J OBSTET GYNECOL, V181, P1407, DOI 10.1016/S0002-9378(99)70384-4; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	50	33	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106140	10.1371/journal.pone.0106140	http://dx.doi.org/10.1371/journal.pone.0106140			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165809	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303700078
J	Monaco, CJ; Wethey, DS; Helmuth, B				Monaco, Cristian J.; Wethey, David S.; Helmuth, Brian			A Dynamic Energy Budget (DEB) Model for the Keystone Predator Pisaster ochraceus	PLOS ONE			English	Article							SEA STARS; PHOTOPERIODIC REGULATION; PHENOTYPIC PLASTICITY; ENVIRONMENTAL-STRESS; INTERTIDAL MUSSELS; COVARIATION METHOD; WATER TEMPERATURE; CLIMATE-CHANGE; LIFE-HISTORY; GROWTH	We present a Dynamic Energy Budget (DEB) model for the quintessential keystone predator, the rocky-intertidal sea star Pisaster ochraceus. Based on first principles, DEB theory is used to illuminate underlying physiological processes (maintenance, growth, development, and reproduction), thus providing a framework to predict individual-level responses to environmental change. We parameterized the model for P. ochraceus using both data from the literature and experiments conducted specifically for the DEB framework. We devoted special attention to the model's capacity to (1) describe growth trajectories at different life-stages, including pelagic larval and post-metamorphic phases, (2) simulate shrinkage when prey availability is insufficient to meet maintenance requirements, and (3) deal with the combined effects of changing body temperature and food supply. We further validated the model using an independent growth data set. Using standard statistics to compare model outputs with real data (e.g. Mean Absolute Percent Error, MAPE) we demonstrated that the model is capable of tracking P. ochraceus' growth in length at different life-stages (larvae: MAPE = 12.27%; post-metamorphic, MAPE = 9.22%), as well as quantifying reproductive output index. However, the model's skill dropped when trying to predict changes in body mass (MAPE = 24.59%), potentially because of the challenge of precisely anticipating spawning events. Interestingly, the model revealed that P. ochraceus reserves contribute little to total biomass, suggesting that animals draw energy from structure when food is limited. The latter appears to drive indeterminate growth dynamics in P. ochraceus. Individual-based mechanistic models, which can illuminate underlying physiological responses, offer a viable framework for forecasting population dynamics in the keystone predator Pisaster ochraceus. The DEB model herein represents a critical step in that direction, especially in a period of increased anthropogenic pressure on natural systems and an observed recent decline in populations of this keystone species.	[Monaco, Cristian J.; Wethey, David S.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Helmuth, Brian] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Northeastern University	Monaco, CJ (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	cristianmonaco@gmail.com	Helmuth, Brian/AAD-2664-2019; Wethey, David S/K-8063-2014; Monaco, Cristian/B-5927-2015	Helmuth, Brian/0000-0003-0180-3414; Wethey, David S/0000-0002-2549-1606; Monaco, Cristian/0000-0003-4057-5290	National Science Foundation (NSF) [OCE-0926581, OCE-1129401]; National Aeronautics and Space Administration (NASA) [NNX11AP77]; Graduate Assistance in Areas of National Need (GAANN) fellowship [P200A090301]; Directorate For Geosciences [1129401] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); Graduate Assistance in Areas of National Need (GAANN) fellowship(US Department of Education); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this research was provided by the National Science Foundation (NSF, grant no. OCE-0926581) to BH, the National Science Foundation (NSF, grant no. OCE-1129401) to DSW, the National Aeronautics and Space Administration (NASA, grant no. NNX11AP77) to BH and DSW, and the Graduate Assistance in Areas of National Need (GAANN) fellowship (no. P200A090301) to CJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre J, 2010, GLOBAL CHANGE BIOL, V16, P2866, DOI 10.1111/j.1365-2486.2010.02223.x; Angilletta MJ, 2006, J THERM BIOL, V31, P541, DOI 10.1016/j.jtherbio.2006.06.002; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Aquinas Nimitz O P Sister M, 1971, Biol Bull, V140, P461, DOI 10.2307/1540281; Augustine S, 2011, J SEA RES, V66, P411, DOI 10.1016/j.seares.2011.07.006; Bertness ME, 1976, VELIGER, V19; BURROWS MT, 1989, J MOLLUS STUD, V55, P285, DOI 10.1093/mollus/55.2.285; CHEREL Y, 1988, CAN J ZOOL, V66, P159, DOI 10.1139/z88-022; Connell SD, 2011, J EXP MAR BIOL ECOL, V400, P296, DOI 10.1016/j.jembe.2011.02.031; Dell AI, 2014, J ANIM ECOL, V83, P70, DOI 10.1111/1365-2656.12081; Denny M, 2009, INTEGR COMP BIOL, V49, P197, DOI 10.1093/icb/icp070; DUGGINS DO, 1980, ECOLOGY, V61, P447, DOI 10.2307/1937405; Emlet RB, 2006, INTEGR COMP BIOL, V46, P334, DOI 10.1093/icb/icj023; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; FAUTH JE, 1991, ECOLOGY, V72, P827, DOI 10.2307/1940585; Feder H. M., 1956, NATURAL HIST STUDIES; Filgueira R, 2011, J SEA RES, V66, P403, DOI 10.1016/j.seares.2011.04.006; Fly EK, 2012, J EXP MAR BIOL ECOL, V422, P20, DOI 10.1016/j.jembe.2012.04.007; Flye-Sainte-Marie J, 2009, J SEA RES, V62, P114, DOI 10.1016/j.seares.2009.01.007; FRASER A, 1981, CAN J ZOOL, V59, P1700, DOI 10.1139/z81-234; Freitas V, 2007, J THERM BIOL, V32, P328, DOI 10.1016/j.jtherbio.2007.04.004; Gebauer P, 1999, J EXP MAR BIOL ECOL, V238, P271, DOI 10.1016/S0022-0981(98)00219-6; George SB, 1999, J EXP MAR BIOL ECOL, V237, P203, DOI 10.1016/S0022-0981(98)00205-6; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; HARROLD C, 1980, J EXP MAR BIOL ECOL, V48, P169, DOI 10.1016/0022-0981(80)90015-5; HART MW, 1995, AM NAT, V146, P415, DOI 10.1086/285807; Hettinger A, 2013, GLOBAL CHANGE BIOL, V19, P3317, DOI 10.1111/gcb.12307; Himmelman JH, 2008, MAR ECOL PROG SER, V361, P161, DOI 10.3354/meps07415; Howard J, 2013, OCEANOGR MAR BIOL, V51, P71; Hyndman RJ, 2006, INT J FORECASTING, V22, P679, DOI 10.1016/j.ijforecast.2006.03.001; Jusup M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021903; Karasov W. H., 2007, PHYSL ECOLOGY ANIMAL; Kearney M, 2010, PHILOS T R SOC B, V365, P3469, DOI 10.1098/rstb.2010.0034; Kooijman SALM, 2008, BIOL REV, V83, P533, DOI 10.1111/j.1469-185X.2008.00053.x; Kooijman SALM, 2011, J SEA RES, V66, P419, DOI 10.1016/j.seares.2011.04.016; Kooijman S.A.L.M., 2010, DYNAMIC ENERGY BUDGE; KOOIJMAN SALM, 1986, J THEOR BIOL, V121, P269, DOI 10.1016/S0022-5193(86)80107-2; Kordas RL, 2011, J EXP MAR BIOL ECOL, V400, P218, DOI 10.1016/j.jembe.2011.02.029; LEVINTON JS, 1983, BIOL BULL, V165, P686, DOI 10.2307/1541471; Lika K, 2011, J SEA RES, V66, P270, DOI 10.1016/j.seares.2011.07.010; Lika K, 2011, J SEA RES, V66, P278, DOI 10.1016/j.seares.2011.09.004; Linton DL, 2000, J EXP MAR BIOL ECOL, V254, P85, DOI 10.1016/S0022-0981(00)00266-5; Matzelle A, 2014, J SEA RES; MAUZEY KP, 1966, BIOL BULL-US, V131, P127, DOI 10.2307/1539653; MENGE BA, 1975, MAR BIOL, V31, P87, DOI 10.1007/BF00390651; MENGE BA, 1994, ECOL MONOGR, V64, P249, DOI 10.2307/2937163; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; Monaco CJ, 2011, ADV MARINE BIOL; Mumby PJ, 2011, FRONT ECOL ENVIRON, V9, P94, DOI 10.1890/11.WB.002; Newell RC., 1970, BIOL INTERTIDAL ANIM; Nimitz AMS, 1976, BIOL BULL, V151, P357; Nisbet RM, 2000, J ANIM ECOL, V69, P913, DOI 10.1046/j.1365-2656.2000.00448.x; Nisbet RM, 2012, J EXP BIOL, V215, P892, DOI 10.1242/jeb.059675; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; PEARSE JS, 1986, AM ZOOL, V26, P417; PEARSE JS, 1982, MAR BIOL, V67, P121, DOI 10.1007/BF00401277; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Pecquerie L, 2011, J SEA RES, V66, P424, DOI 10.1016/j.seares.2011.07.005; Pecquerie L, 2009, J SEA RES, V62, P93, DOI 10.1016/j.seares.2009.06.002; Peters DPC, 2007, ECOSYSTEMS, V10, P790, DOI 10.1007/s10021-007-9055-6; Petes LE, 2008, ECOL MONOGR, V78, P387, DOI 10.1890/07-0605.1; Petes LE, 2008, OECOLOGIA, V156, P671, DOI 10.1007/s00442-008-1018-x; Petes LE, 2007, J EXP MAR BIOL ECOL, V351, P83, DOI 10.1016/j.jembe.2007.06.025; Pia TS, 2012, J PLANKTON RES, V34, P590, DOI 10.1093/plankt/fbs032; Pincebourde S, 2012, ECOLOGY LETT; Pincebourde S, 2008, LIMNOL OCEANOGR, V53, P1562, DOI 10.4319/lo.2008.53.4.1562; R Core Team, 2021, R LANG ENV STAT COMP; Ren JS, 2008, J EXPT MARINE BIOL E, V361, P28; Richmond CE, 2007, ECOL MODEL, V209, P189, DOI 10.1016/j.ecolmodel.2007.06.023; Rico-Villa B, 2010, AQUACULTURE, V305, P84, DOI 10.1016/j.aquaculture.2010.04.018; Sanford E, 2002, INTEGR COMP BIOL, V42, P881, DOI 10.1093/icb/42.4.881; Sanford E, 2002, J EXP MAR BIOL ECOL, V273, P199, DOI 10.1016/S0022-0981(02)00164-8; Sanford E, 2007, MAR ECOL PROG SER, V349, P1, DOI 10.3354/meps07166; Sara G, 2013, MAR ECOL PROG SER, V480, P99, DOI 10.3354/meps10195; Schulte PM, 2011, INTEGR COMP BIOL, V51, P691, DOI 10.1093/icb/icr097; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.es.18.110187.002103; Shi PJ, 2010, J THERM BIOL, V35, P225, DOI 10.1016/j.jtherbio.2010.05.005; Sokolova IM, 2008, CLIM RES, V37, P181, DOI 10.3354/cr00764; Sokolova IM, 2013, INTEGR COMP BIOL, V53, P597, DOI 10.1093/icb/ict028; Sousa T, 2010, PHILOS T R SOC B, V365, P3413, DOI 10.1098/rstb.2010.0166; STRATHMANN R, 1978, J EXP MAR BIOL ECOL, V34, P23, DOI 10.1016/0022-0981(78)90054-0; STRATHMANN R R, 1971, Journal of Experimental Marine Biology and Ecology, V6, P109, DOI 10.1016/0022-0981(71)90054-2; Tenore KR, 1985, LIMNOLOGY OCEANOGRAP, V30; van der Meer J, 2006, J SEA RES, V56, P85, DOI 10.1016/j.seares.2006.03.001; Vickery MS, 2000, BIOL BULL, V199, P298, DOI 10.2307/1543186; Wethey DS, 2002, INTEGR COMP BIOL, V42, P872, DOI 10.1093/icb/42.4.872; ZWARTS L, 1992, MAR ECOL PROG SER, V83, P113, DOI 10.3354/meps083113	89	31	31	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e104658	10.1371/journal.pone.0104658	http://dx.doi.org/10.1371/journal.pone.0104658			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166351	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303700010
J	Naseer, N; Shapiro, JA; Chander, M				Naseer, Nawar; Shapiro, Joshua A.; Chander, Monica			RNA-Seq Analysis Reveals a Six-Gene SoxR Regulon in Streptomyces coelicolor	PLOS ONE			English	Article							SUPEROXIDE RESPONSE REGULON; ESCHERICHIA-COLI; INDUCIBLE EXPRESSION; GENE-EXPRESSION; STRESS; ACTIVATION; ALIGNMENT; PARADIGM; SEQUENCE; PROTEIN	The redox-regulated transcription factor SoxR is conserved in diverse bacteria, but emerging studies suggest that this protein plays distinct physiological roles in different bacteria. SoxR regulates a global oxidative stress response (involving. 100 genes) against exogenous redox-cycling drugs in Escherichia coli and related enterics. In the antibiotic producers Streptomyces coelicolor and Pseudomonas aeruginosa, however, SoxR regulates a smaller number of genes that encode membrane transporters and proteins with homology to antibiotic-tailoring enzymes. In both S. coelicolor and P. aeruginosa, SoxR-regulated genes are expressed in stationary phase during the production of endogenously-produced redox-active antibiotics. These observations suggest that SoxR evolved to sense endogenous secondary metabolites and activate machinery to process and transport them in antibiotic-producing bacteria. Previous bioinformatics analysis that searched the genome for SoxR-binding sites in putative promoters defined a five-gene SoxR regulon in S. coelicolor including an ABC transporter, two oxidoreductases, a monooxygenase and an epimerase/dehydratase. Since this in silico screen may have missed potential SoxR-targets, we conducted a whole genome transcriptome comparison of wild type S. coelicolor and a soxR-deficient mutant in stationary phase using RNA-Seq. Our analysis revealed a sixth SoxR-regulated gene in S. coelicolor that encodes a putative quinone oxidoreductase. Knowledge of the full complement of genes regulated by SoxR will facilitate studies to elucidate the function of this regulatory molecule in antibiotic producers.	[Naseer, Nawar; Shapiro, Joshua A.; Chander, Monica] Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA	Bryn Mawr College	Chander, M (corresponding author), Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA.	mchander@brynmawr.edu	Shapiro, Joshua/B-5948-2008	Shapiro, Joshua/0000-0002-6224-0347; Naseer, Nawar/0000-0002-0700-7155	AREA grant from the National Institute of General Medical Sciences [R15GM093366]; Bryn Mawr College faculty research award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM093366] Funding Source: NIH RePORTER	AREA grant from the National Institute of General Medical Sciences; Bryn Mawr College faculty research award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an AREA grant from the National Institute of General Medical Sciences (R15GM093366) to MC. Publication expenses were supported by a Bryn Mawr College faculty research award to MC. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMABILECUEVAS CF, 1991, NUCLEIC ACIDS RES, V19, P4479, DOI 10.1093/nar/19.16.4479; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bradley TM, 1997, NUCLEIC ACIDS RES, V25, P1469, DOI 10.1093/nar/25.8.1469; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Dela Cruz R, 2010, J BACTERIOL, V192, P6428, DOI 10.1128/JB.00916-10; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Eiamphungporn W, 2006, J BACTERIOL, V188, P8669, DOI 10.1128/JB.00856-06; Floriano B, 1996, MOL MICROBIOL, V21, P385, DOI 10.1046/j.1365-2958.1996.6491364.x; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; GREENBERG JT, 1990, P NATL ACAD SCI USA, V87, P6181, DOI 10.1073/pnas.87.16.6181; Huang JQ, 2001, GENE DEV, V15, P3183, DOI 10.1101/gad.943401; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kobayashi K, 2004, J BIOCHEM, V136, P607, DOI 10.1093/jb/mvh168; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mahavihakanont A, 2012, J BACTERIOL, V194, P209, DOI 10.1128/JB.05603-11; NUNOSHIBA T, 1992, J BACTERIOL, V174, P6054, DOI 10.1128/JB.174.19.6054-6060.1992; Palma M, 2005, INFECT IMMUN, V73, P2958, DOI 10.1128/IAI.73.5.2958-2966.2005; Park W, 2006, BIOCHEM BIOPH RES CO, V341, P51, DOI 10.1016/j.bbrc.2005.12.142; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rozen S, 2000, Methods Mol Biol, V132, P365; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; Sheplock R, 2013, MOL MICROBIOL, V87, P368, DOI 10.1111/mmi.12101; Shin JH, 2011, J BACTERIOL, V193, P75, DOI 10.1128/JB.00965-10; Singh AK, 2013, MOL MICROBIOL, V90, P983, DOI 10.1111/mmi.12410; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; TSANEVA IR, 1990, J BACTERIOL, V172, P4197, DOI 10.1128/jb.172.8.4197-4205.1990; WU J, 1991, J BACTERIOL, V173, P2864, DOI 10.1128/JB.173.9.2864-2871.1991	35	16	16	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106181	10.1371/journal.pone.0106181	http://dx.doi.org/10.1371/journal.pone.0106181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162599	Green Submitted, Green Published, gold			2022-12-25	WOS:000340880900094
J	Hare, RF; Hueffer, K				Hare, Rebekah F.; Hueffer, Karsten			Francisella novicida Pathogenicity Island Encoded Proteins Were Secreted during Infection of Macrophage-Like Cells	PLOS ONE			English	Article							VI SECRETION; TULARENSIS; VIRULENCE; ESCAPE; IGLC; IDENTIFICATION; REPLICATION; SYSTEM; GENES	Intracellular pathogens and other organisms have evolved mechanisms to exploit host cells for their life cycles. Virulence genes of some intracellular bacteria responsible for these mechanisms are located in pathogenicity islands, such as secretion systems that secrete effector proteins. The Francisella pathogenicity island is required for phagosomal escape, intracellular replication, evasion of host immune responses, virulence, and encodes a type 6 secretion system. We hypothesize that some Francisella novicida pathogenicity island proteins are secreted during infection of host cells. To test this hypothesis, expression plasmids for all Francisella novicida FPI-encoded proteins with C-terminal and N-terminal epitope FLAG tags were developed. These plasmids expressed their respective epitope FLAG-tagged proteins at their predicted molecular weights. J774 murine macrophage-like cells were infected with Francisella novicida containing these plasmids. The FPI proteins expressed from these plasmids successfully restored the intramacrophage growth phenotype in mutants of the respective genes that were deficient for intramacrophage growth. Using these expression plasmids, the localization of the Francisella pathogenicity island proteins were examined via immuno-fluorescence microscopy within infected macrophage-like cells. Several Francisella pathogenicity island encoded proteins (IglABCDEFGHIJ, PdpACE, DotU and VgrG) were detected extracellularly and they were co-localized with the bacteria, while PdpBD and Anmk were not detected and thus remained inside bacteria. Proteins that were co-localized with bacteria had different patterns of localization. The localization of IglC was dependent on the type 6 secretion system. This suggests that some Francisella pathogenicity island proteins were secreted while others remain within the bacterium during infection of host cells as structural components of the secretion system and were necessary for secretion.	[Hare, Rebekah F.] Univ Alaska Fairbanks, Inst Arctic Biol, Dept Biol & Wildlife, Fairbanks, AK USA; [Hueffer, Karsten] Univ Alaska Fairbanks, Dept Vet Med, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Hueffer, K (corresponding author), Univ Alaska Fairbanks, Dept Vet Med, Fairbanks, AK 99775 USA.	khueffer@alaska.edu		Hueffer, Karsten/0000-0001-7154-9066	National Institute of General Medical Sciences of the National Institutes of Health [P20GM103395]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103395] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM103395. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Broms J. E., 2012, PLOS ONE, V7; Broms JE, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00136; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; de Bruin OM, 2011, MICROBIOL-SGM, V157, P3483, DOI 10.1099/mic.0.052308-0; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gray CG, 2002, FEMS MICROBIOL LETT, V215, P53, DOI 10.1016/S0378-1097(02)00911-4; Johnson MB, 2013, JOVE-J VIS EXP, DOI 10.3791/50729; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0; Lindgren M, 2013, INFECT IMMUN, V81, P2076, DOI 10.1128/IAI.00275-13; Lindgren M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-20; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; Mattoo S, 2007, CURR OPIN IMMUNOL, V19, P392, DOI 10.1016/j.coi.2007.06.005; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Nix EB, 2006, INFECT IMMUN, V74, P4809, DOI 10.1128/IAI.00034-06; OWEN CR, 1964, J BACTERIOL, V87, P676, DOI 10.1128/JB.87.3.676-683.1964; Patel JC, 2009, CELL, V137, P283, DOI 10.1016/j.cell.2009.01.056; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Read A, 2008, J MED ENTOMOL, V45, P1108, DOI 10.1603/0022-2585(2008)45[1108:FGRFRI]2.0.CO;2; Robertson GT, 2013, INFECT IMMUN, V81, P4026, DOI 10.1128/IAI.00595-13; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2006, TRENDS MICROBIOL, V14, P37, DOI 10.1016/j.tim.2005.11.008; Santic M, 2007, CELL MICROBIOL, V9, P2391, DOI 10.1111/j.1462-5822.2007.00968.x; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1498, DOI 10.1099/mic.0.025445-0; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; TYERYAR FJ, 1970, J BACTERIOL, V104, P1312, DOI 10.1128/JB.104.3.1312-1317.1970; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	40	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105773	10.1371/journal.pone.0105773	http://dx.doi.org/10.1371/journal.pone.0105773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25158041	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303200063
J	Yuan, ZL; Chen, LQ				Yuan, Zhilin; Chen, Lianqing			The Role of Endophytic Fungal Individuals and Communities in the Decomposition of Pinus massoniana Needle Litter	PLOS ONE			English	Article							LEAF-LITTER; DIVERSITY; FOREST; PLANTATION; LEAVES; CHINA; SOIL; SEQUENCES; ENZYMES; GENES	The role of fungal endophytes (FEs) as "pioneer" decomposers has recently been recognized; however, the extent to which FEs contribute to litter loss is less well understood. The genetic and enzymatic bases of FE-mediated decomposition have also rarely been addressed. The effects of populations and individuals (with an emphasis on two dominant Lophodermium taxa) of FEs on needle-litter decomposition were assessed for Pinus massoniana, a ubiquitous pine in southern China. Data from in vivo (microcosm) experiments indicated that the percentage of litter-mass loss triggered by FEs was linearly correlated with incubation time and approached 60% after seven months. In vitro decomposition tests also confirmed that endophytic Lophodermium isolates caused 14-22% mass loss within two months. Qualitative analysis of exoenzymes (cellulase and laccase, important for lignocellulose degradation) revealed that almost all of the Lophodermium isolates showed moderate or strong positive reactions. Furthermore, partial sequences of beta-glucosidase (glycoside hydrolase family 3, GH3), laccase, and cellobiohydrolase (GH7) genes were amplified from Lophodermium isolates as "functional markers" to evaluate their potential for lignocellulolytic activity. Three different genes were detected, suggesting a flexible and delicate decomposition system rich in FEs. Our work highlights the possibility that the saprophytism and endophytism of FEs may be prerequisites to initiating rapid decomposition and thus may be key in Fes' contribution to litter decomposition, at least in the early stage. Potential indicators of the presence of core fungal decomposers are also briefly discussed.	[Yuan, Zhilin; Chen, Lianqing] Chinese Acad Forestry, Inst Subtrop Forestry, Fuyang, Zhejiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Yuan, ZL (corresponding author), Chinese Acad Forestry, Inst Subtrop Forestry, Fuyang, Zhejiang, Peoples R China.	zlyuanmycology@gmail.com		Yuan, Zhilin/0000-0002-5799-8401	National Natural Science Foundation of China [31100463]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been financially supported by the National Natural Science Foundation of China (No. 31100463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boberg JB, 2011, FUNGAL ECOL, V4, P110, DOI 10.1016/j.funeco.2010.09.002; Cox P, 2001, BIOL FERT SOILS, V33, P246, DOI 10.1007/s003740000315; Edwards IP, 2008, APPL ENVIRON MICROB, V74, P3481, DOI 10.1128/AEM.02893-07; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GRIFFITH GS, 1990, NEW PHYTOL, V116, P407, DOI 10.1111/j.1469-8137.1990.tb00526.x; He XB, 2012, ECOL RES, V27, P273, DOI 10.1007/s11284-011-0898-0; Hirose D, 2013, MYCOLOGIA, V105, P837, DOI 10.3852/12-385; Kellner H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010971; Korkama-Rajala T, 2008, MICROB ECOL, V56, P76, DOI 10.1007/s00248-007-9326-y; Koukol O, 2012, FUNGAL DIVERS, V54, P69, DOI 10.1007/s13225-011-0112-2; Kumaresan V, 2002, FUNGAL DIVERS, V9, P81; Lacap DC, 2003, FUNGAL DIVERS, V12, P53; Luis P, 2004, SOIL BIOL BIOCHEM, V36, P1025, DOI 10.1016/j.soilbio.2004.02.017; Lumyong S, 2002, CAN J MICROBIOL, V48, P1109, DOI 10.1139/W02-112; Lyons JI, 2003, MICROB ECOL, V45, P270, DOI 10.1007/s00248-002-1055-7; Mo JM, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008017; Muller MM, 2001, MOL ECOL, V10, P1801, DOI 10.1046/j.1365-294X.2001.01304.x; Nicholas KB., 1997, GENEDOC TOOL EDITING; Osono T, 2002, MYCOLOGIA, V94, P421, DOI 10.2307/3761776; Osono T, 2006, MYCOLOGIA, V98, P172, DOI 10.3852/mycologia.98.2.172; Osono T, 2009, APPLIED MYCOLOGY, P92, DOI 10.1079/9781845935344.0092; Pointing Stephen B., 1999, Fungal Diversity, V2, P17; Purahong W, 2012, ANN FOREST SCI, V69, P659, DOI 10.1007/s13595-012-0210-7; Robl D, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-94; SIEBERCANAVESI F, 1993, NEW PHYTOL, V125, P149, DOI 10.1111/j.1469-8137.1993.tb03873.x; Snajdr J, 2011, FEMS MICROBIOL ECOL, V75, P291, DOI 10.1111/j.1574-6941.2010.00999.x; Sun X, 2011, FUNGAL DIVERS, V47, P85, DOI 10.1007/s13225-010-0086-5; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Wang CY, 2012, J PLANT ECOL, V5, P279, DOI 10.1093/jpe/rtr013; Weber CF, 2012, APPL ENVIRON MICROB, V78, P3950, DOI 10.1128/AEM.08018-11; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Yuan ZL, 2011, FUNGAL BIOL-UK, V115, P197, DOI 10.1016/j.funbio.2010.11.002; Yuan ZL, 2015, MYCOSCIENCE, V56, P205, DOI 10.1016/j.myc.2014.06.004; Zifcakova L, 2011, FUNGAL ECOL, V4, P427, DOI 10.1016/j.funeco.2011.04.002	34	13	16	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105911	10.1371/journal.pone.0105911	http://dx.doi.org/10.1371/journal.pone.0105911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157631	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303200076
J	Kasinski, AL; Kelnar, K; Stahlhut, C; Orellana, E; Zhao, J; Shimer, E; Dysart, S; Chen, X; Bader, AG; Slack, FJ				Kasinski, A. L.; Kelnar, K.; Stahlhut, C.; Orellana, E.; Zhao, J.; Shimer, E.; Dysart, S.; Chen, X.; Bader, A. G.; Slack, F. J.			A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer	ONCOGENE			English	Article							MOUSE MODELS; MIR-34A; ACTIVATION; EXPRESSION; INITIATION; DELIVERY; TARGET; GROWTH; RAS	Targeted cancer therapies, although often effective, have limited utility owing to preexisting primary or acquired secondary resistance. Consequently, agents are sometimes used in combination to simultaneously affect multiple targets. MicroRNA mimics are excellent therapeutic candidates because of their ability to repress multiple oncogenic pathways at once. Here we treated the aggressive Kras; p53 non-small cell lung cancer mouse model and demonstrated efficacy with a combination of two tumor-suppressive microRNAs (miRNAs). Systemic nanodelivery of miR-34 and let-7 suppressed tumor growth leading to survival advantage. This combinatorial miRNA therapeutic approach engages numerous components of tumor cell-addictive pathways and highlights the ability to deliver multiple miRNAs in a safe and effective manner to target lung tissue.	[Kasinski, A. L.; Stahlhut, C.; Shimer, E.; Chen, X.; Slack, F. J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Kasinski, A. L.; Orellana, E.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Kelnar, K.; Zhao, J.; Dysart, S.; Bader, A. G.] Mirna Therapeut Inc, Austin, TX 78744 USA; [Slack, F. J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Yale University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Harvard University; Harvard Medical School	Slack, FJ (corresponding author), Harvard Univ, Sch Med, Dept Pathol, BIDMC, 3 Blackfan Circle CLS412, Boston, MA 02115 USA.	abader@mirnarx.com; fslack@bidmc.harvard.edu	Kasinski, Andrea/AAF-3864-2021; Orellana, Esteban/N-8004-2019; Orellana, Esteban/I-3653-2014; Kasinski, Andrea L/E-7951-2014	Kasinski, Andrea/0000-0002-9602-7827; Orellana, Esteban/0000-0003-4369-9416; Orellana, Esteban/0000-0003-4369-9416; Slack, Frank/0000-0001-8263-0409; Stahlhut, Carlos/0000-0002-8472-7156	American Cancer Society [PF-11-244-01]; NIH [CA178091, CA131301]; Cancer Prevention Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE [F32CA153885, R00CA178091, R01CA131301, K99CA178091] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	ALK was supported by an American Cancer Society Fellowship (PF-11-244-01) and an NIH Pathway to Independence Award (CA178091). This work was supported by a grant to FJS from the NIH (CA131301) and by a commercialization grant from the Cancer Prevention Research Institute of Texas (CPRIT) to AGB.	Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bouchie A, 2013, NAT BIOTECHNOL, V31, P577, DOI 10.1038/nbt0713-577; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kasinski AL, 2012, CANCER RES, V72, P5576, DOI 10.1158/0008-5472.CAN-12-2001; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lin PY, 2010, BRIT J CANCER, V103, P1144, DOI 10.1038/sj.bjc.6605901; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Trang P, 2011, MOL THER, V19, P1116, DOI 10.1038/mt.2011.48; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Xue W, 2011, CANCER DISCOV, V1, P236, DOI 10.1158/2159-8290.CD-11-0073; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhao J, 2013, MOL THER, V21, P1678, DOI 10.1038/mt.2013.148	34	153	160	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	27					3547	3555		10.1038/onc.2014.282	http://dx.doi.org/10.1038/onc.2014.282			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM1IQ	25174400	Green Accepted			2022-12-25	WOS:000357434900007
J	Bin, BH; Bhin, J; Yang, SH; Choi, DH; Park, K; Shin, DW; Lee, AY; Hwang, D; Cho, EG; Lee, TR				Bin, Bum-Ho; Bhin, Jinhyuk; Yang, Seung Ha; Choi, Dong-Hwa; Park, Kyuhee; Shin, Dong Wook; Lee, Ai-Young; Hwang, Daehee; Cho, Eun-Gyung; Lee, Tae Ryong			Hyperosmotic Stress Reduces Melanin Production by Altering Melanosome Formation	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; RENAL MEDULLARY CELLS; LYSOSOME-RELATED ORGANELLES; ORGANIC OSMOLYTES; HUMAN-SKIN; AUTOPHAGY; PROTEIN; OSMOREGULATION; KERATINOCYTES; MELANOGENESIS	Many tissues of the human body encounter hyperosmotic stress. The effect of extracellular osmotic changes on melanin production has not yet been elucidated. In this study, we determined that hyperosmotic stress induced by organic osmolytes results in reduced melanin production in human melanoma MNT-1 cells. Under hyperosmotic stress, few pigmented mature melanosomes were detected, but there was an increase in swollen vacuoles. These vacuoles were stained with an anti-M6PR antibody that recognizes late endosomal components and with anti-TA99 and anti-HMB45 antibodies, implying that melanosome formation was affected by hyperosmotic stress. Electron microscopic analysis revealed that the M6PR-positive swollen vacuoles were multi-layered and contained melanized granules, and they produced melanin when L-DOPA was applied, indicating that these vacuoles were still capable of producing melanin, but the inner conditions were not compatible with melanin production. The vacuolation phenomenon induced by hyperosmotic conditions disappeared with treatment with the PI3K activator 740 Y-P, indicating that the PI3K pathway is affected by hyperosmotic conditions and is responsible for the proper formation and maturation of melanosomes. The microarray analysis showed alterations of the vesicle organization and transport under hyperosmotic stress. Our findings suggest that melanogenesis could be regulated by physiological conditions, such as osmotic pressure.	[Bin, Bum-Ho; Yang, Seung Ha; Shin, Dong Wook; Cho, Eun-Gyung; Lee, Tae Ryong] Amorepacific Corp, R&D Ctr, Biosci Res Inst, Yongin, South Korea; [Bhin, Jinhyuk; Hwang, Daehee] POSTECH, Dept Chem Engn, Pohang, South Korea; [Choi, Dong-Hwa; Park, Kyuhee] Gyeonggi Inst Sci & Technol Promot, Gyeonggi Bio Ctr, Suwon, South Korea; [Lee, Ai-Young] Dongguk Univ Ilsan Hosp, Dept Dermatol, Goyang, South Korea	Samsung; Pohang University of Science & Technology (POSTECH); Dongguk University	Cho, EG (corresponding author), Amorepacific Corp, R&D Ctr, Biosci Res Inst, Yongin, South Korea.	egcho@amorepacific.com; TRLee@amorepacific.com	Bhin, jinhyuk/ABC-9131-2021					Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Bin BH, 2013, EXP DERMATOL, V22, P541, DOI 10.1111/exd.12195; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bright NA, 1997, J CELL SCI, V110, P2027; Bright NA, 2001, TRAFFIC, V2, P631, DOI 10.1034/j.1600-0854.2001.20906.x; Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; BURG MB, 1994, J EXP ZOOL, V268, P171, DOI 10.1002/jez.1402680216; Dell'Angelica EC, 2000, J BIOL CHEM, V275, P1300, DOI 10.1074/jbc.275.2.1300; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dmitrieva NI, 2005, MUTAT RES-FUND MOL M, V569, P65, DOI 10.1016/j.mrfmmm.2004.06.053; GARCIAPEREZ A, 1990, HYPERTENSION, V16, P595, DOI 10.1161/01.HYP.16.6.595; GARCIAPEREZ A, 1991, PHYSIOL REV, V71, P1081, DOI 10.1152/physrev.1991.71.4.1081; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Hoashi T, 2010, FASEB J, V24, P1616, DOI 10.1096/fj.09-151019; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17302, DOI 10.1073/pnas.0508649102; Kim ES, 2013, FEBS LETT, V587, P3955, DOI 10.1016/j.febslet.2013.10.027; Lee JS, 2010, MOL CELL, V39, P71, DOI 10.1016/j.molcel.2010.06.008; Mavrogonatou E, 2012, J CELL PHYSIOL, V227, P1179, DOI 10.1002/jcp.22840; MORIYAMA T, 1990, AM J PHYSIOL, V259, pF847, DOI 10.1152/ajprenal.1990.259.5.F847; Murase D, 2013, J INVEST DERMATOL, V133, P2416, DOI 10.1038/jid.2013.165; Nguyen T, 2004, J INVEST DERMATOL, V122, P452, DOI 10.1046/j.0022-202X.2004.22117.x; Nunes P, 2013, AUTOPHAGY, V9, P550, DOI 10.4161/auto.23662; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Reaves BJ, 1996, J CELL SCI, V109, P749; Rockel N, 2007, J IMMUNOL, V179, P3604, DOI 10.4049/jimmunol.179.6.3604; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Shotelersuk V, 1998, MOL GENET METAB, V65, P85, DOI 10.1006/mgme.1998.2729; Sitaram A, 2012, PHYSIOLOGY, V27, P85, DOI 10.1152/physiol.00043.2011; Sougrat R, 2002, J INVEST DERMATOL, V118, P678, DOI 10.1046/j.1523-1747.2002.01710.x; Starcevic M, 2002, SEMIN CELL DEV BIOL, V13, P271, DOI 10.1016/S1084952102000563; Truschel ST, 2009, TRAFFIC, V10, P1318, DOI 10.1111/j.1600-0854.2009.00955.x; Urban JPG, 2002, BIOCHEM SOC T, V30, P858, DOI 10.1042/bst0300858; WARNER RR, 1988, J INVEST DERMATOL, V90, P218, DOI 10.1111/1523-1747.ep12462252; Warskulat U, 2004, J INVEST DERMATOL, V123, P516, DOI 10.1111/j.0022-202X.2004.23313.x; Warskulat U, 2008, EXP DERMATOL, V17, P1031, DOI 10.1111/j.1600-0625.2008.00746.x; Wasmeier C, 2008, J CELL SCI, V121, P3995, DOI 10.1242/jcs.040667	39	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105965	10.1371/journal.pone.0105965	http://dx.doi.org/10.1371/journal.pone.0105965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170965	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500086
J	Kubo, T; Kamekura, R; Kumagai, A; Kawata, K; Yamashita, K; Mitsuhashi, Y; Kojima, T; Sugimoto, K; Yoneta, A; Sumikawa, Y; Yamashita, T; Sato, N; Himi, T; Ichimiya, S				Kubo, Terufumi; Kamekura, Ryuta; Kumagai, Ayako; Kawata, Koji; Yamashita, Keiji; Mitsuhashi, Yukari; Kojima, Takashi; Sugimoto, Kotaro; Yoneta, Akihiro; Sumikawa, Yasuyuki; Yamashita, Toshiharu; Sato, Noriyuki; Himi, Tetsuo; Ichimiya, Shingo			Delta Np63 Controls a TLR3-Mediated Mechanism That Abundantly Provides Thymic Stromal Lymphopoietin in Atopic Dermatitis	PLOS ONE			English	Article							HUMAN EPITHELIAL-CELLS; HUMAN KERATINOCYTES; DOWN-REGULATION; P53 HOMOLOG; NULL MICE; FILAGGRIN; P63; SKIN; TLR3; DIFFERENTIATION	In the skin lesions of atopic dermatitis (AD), keratinocytes release large quantities of thymic stromal lymphopoietin (TSLP), causing unfavorable inflammation along with skin damage. Nevertheless, how TSLP influences keratinocytes themselves is still unknown. In this study, we showed that Delta Np63, a p53-homologue, predominantly expressed in keratinocytes regulated the receptor complex of TSLP, which determines susceptibility to self-derived TSLP. Expression of TSLP receptors in skin tissues and keratinocytes was assessed by immunohistochemistry and quantitative RT-PCR, and in vitro studies were also performed to examine the functional relevance of Delta Np63 in the expression of TSLP receptors and the constituting autocrine and/or paracrine pathway of TSLP under the condition of stimuli to innate receptors sensing cell damage. The results showed that normal keratinocytes in the upper epidermis preferentially expressed TSLP receptors and conversely lacked Delta Np63, which has an inhibitory effect on the expression of TSLP receptors. Interestingly, the epidermis of AD lesions was found to abundantly contain keratinocytes with low or undetectable levels of Delta Np63 (Delta Np63(lo/-)). Moreover, in the absence of Delta Np63, keratinocytes readily presented TSLP and other cytokines by stimuli through Toll-like receptor 3 (TLR3). Together with the evidence that extrinsic TSLP itself augments TSLP production by keratinocytes without Delta Np63, the results indicate that Delta Np63(lo/-) keratinocytes generate TSLP through a putative autocrine and/or paracrine pathway upon TLR3 stimulation within AD lesions, since moieties of damaged cells and pathogens stimulate TLR3.	[Kubo, Terufumi; Sugimoto, Kotaro; Sato, Noriyuki] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Kamekura, Ryuta; Yamashita, Keiji; Mitsuhashi, Yukari; Himi, Tetsuo] Sapporo Med Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido, Japan; [Kamekura, Ryuta; Kumagai, Ayako; Kawata, Koji; Yamashita, Keiji; Mitsuhashi, Yukari; Ichimiya, Shingo] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Human Immunol, Sapporo, Hokkaido, Japan; [Kumagai, Ayako; Yoneta, Akihiro; Sumikawa, Yasuyuki; Yamashita, Toshiharu] Sapporo Med Univ, Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan; [Kojima, Takashi] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Cell Sci, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Ichimiya, S (corresponding author), Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Human Immunol, Sapporo, Hokkaido, Japan.	ichimiya@sapmed.ac.jp	Sugimoto, Kotaro/AAE-9873-2020	Sugimoto, Kotaro/0000-0002-5299-7610	Japan Society of Promotion of Science; Grants-in-Aid for Scientific Research [26861398] Funding Source: KAKEN	Japan Society of Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research to S. Ichimiya and Research Fellowships for young scientists to T. Kubo from the Japan Society of Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Bamberger C, 2002, J INVEST DERMATOL, V118, P133, DOI 10.1046/j.0022-202x.2001.01649.x; Barton CE, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.49; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Brauweiler AM, 2013, J ALLERGY CLIN IMMUN, V131, P421, DOI 10.1016/j.jaci.2012.10.030; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; De Laurenzi V, 2000, BIOCHEM BIOPH RES CO, V273, P342, DOI 10.1006/bbrc.2000.2932; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Ichimiya S, 2002, J HISTOCHEM CYTOCHEM, V50, P455, DOI 10.1177/002215540205000402; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; JECKLER J, 1988, BRIT J DERMATOL, V119, P697, DOI 10.1111/j.1365-2133.1988.tb03490.x; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Kinoshita H, 2009, J ALLERGY CLIN IMMUN, V123, P179, DOI 10.1016/j.jaci.2008.10.008; Koshiba S, 2008, J PATHOL, V214, P75, DOI 10.1002/path.2266; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Lee KH, 2011, EXP DERMATOL, V20, P149, DOI 10.1111/j.1600-0625.2010.01203.x; Leong CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866; Liefer KM, 2000, CANCER RES, V60, P4016; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nagashima T, 2011, AM J PATHOL, V178, P222, DOI 10.1016/j.ajpath.2010.11.033; Ozawa M, 1999, J EXP MED, V189, P711, DOI 10.1084/jem.189.4.711; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Romano RA, 2007, J INVEST DERMATOL, V127, P1175, DOI 10.1038/sj.jid.5700652; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Tajima T, 1998, J DERMATOL SCI, V17, P101, DOI 10.1016/S0923-1811(97)00080-7; Watanabe N, 2004, NAT IMMUNOL, V5, P426, DOI 10.1038/ni1048; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Williams HC, 2005, NEW ENGL J MED, V352, P2314, DOI 10.1056/NEJMcp042803; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhang Z, 2009, P NATL ACAD SCI USA, V106, P1536, DOI 10.1073/pnas.0812668106	36	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105498	10.1371/journal.pone.0105498	http://dx.doi.org/10.1371/journal.pone.0105498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171086	Green Submitted, gold, Green Published			2022-12-25	WOS:000341127500052
J	Lai, JG; Tsai, SM; Tu, HC; Chen, WC; Kou, FJ; Lu, JW; Wang, HD; Huang, CL; Yuh, CH				Lai, Ju-Geng; Tsai, Su-Mei; Tu, Hsiao-Chen; Chen, Wen-Chuan; Kou, Fong-Ji; Lu, Jeng-Wei; Wang, Horng-Dar; Huang, Chou-Long; Yuh, Chiou-Hwa			Zebrafish WNK Lysine Deficient Protein Kinase 1 (wnk1) Affects Angiogenesis Associated with VEGF Signaling	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; PROTEIN-KINASE; BLOOD-PRESSURE; HYPERTENSION; SPAK; CELLS; OSR1; COTRANSPORTERS; IDENTIFICATION; ACTIVATION	The WNK1 (WNK lysine deficient protein kinase 1) protein is a serine/threonine protein kinase with emerging roles in cancer. WNK1 causes hypertension and hyperkalemia when overexpressed and cardiovascular defects when ablated in mice. In this study, the role of Wnk1 in angiogenesis was explored using the zebrafish model. There are two zebrafish wnk1 isoforms, wnk1a and wnk1b, and both contain all the functional domains found in the human WNK1 protein. Both isoforms are expressed in the embryo at the initiation of angiogenesis and in the posterior cardinal vein (PCV), similar to fms-related tyrosine kinase 4 (flt4). Using morpholino antisense oligonucleotides against wnk1a and wnk1b, we observed that wnk1 morphants have defects in angiogenesis in the head and trunk, similar to flk1/vegfr2 morphants. Furthermore, both wnk1a and wnk1b mRNA can partially rescue the defects in vascular formation caused by flk1/vegfr2 knockdown. Mutation of the kinase domain or the Akt/PI3K phosphorylation site within wnk1 destroys this rescue capability. The rescue experiments provide evidence that wnk1 is a downstream target for Vegfr2 (vascular endothelial growth factor receptor-2) and Akt/PI3K signaling and thereby affects angiogenesis in zebrafish embryos. Furthermore, we found that knockdown of vascular endothelial growth factor receptor-2 (flk1/vegfr2) or vascular endothelial growth factor receptor-3 (flt4/vegfr3) results in a decrease in wnk1a expression, as assessed by in situ hybridization and q-RT-PCR analysis. Thus, the Vegf/Vegfr signaling pathway controls angiogenesis in zebrafish via Akt kinase-mediated phosphorylation and activation of Wnk1 as well as transcriptional regulation of wnk1 expression.	[Lai, Ju-Geng; Tsai, Su-Mei; Tu, Hsiao-Chen; Chen, Wen-Chuan; Kou, Fong-Ji; Lu, Jeng-Wei; Yuh, Chiou-Hwa] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan Town, Miaoli, Taiwan; [Tu, Hsiao-Chen; Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA; [Yuh, Chiou-Hwa] Natl Tsing Hua Univ, Coll Life Sci, Hsinchu, Taiwan; [Yuh, Chiou-Hwa] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Yuh, Chiou-Hwa] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Yuh, Chiou-Hwa] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Tsing Hua University; National Tsing Hua University; National Yang Ming Chiao Tung University; Kaohsiung Medical University	Huang, CL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA.	Chou-Long.Huang@UTSouthwestern.edu; chyuh@nhri.org.tw	Yuh, Chiou-Hwa/AAL-2938-2020; Yuh, Chiou-Hwa/E-3972-2010; Yuh, Chiou-Hwa/AAL-3531-2020	Lu, Jeng-Wei/0000-0003-2128-2046; Lai, Ju-Geng/0000-0002-2794-8016; Wang, Horng-Dar/0000-0001-9570-3611	NSC grant from Taiwan [99-3112-B-400-010, 101-2321-B-400-017, 102-2321-B-400-016]; NIH grant from USA [RO1DK59530]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059530] Funding Source: NIH RePORTER	NSC grant from Taiwan; NIH grant from USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the NSC grant from Taiwan (99-3112-B-400-010, 101-2321-B-400-017 and 102-2321-B-400-016) to C.H.Y., and the NIH grant from USA (RO1DK59530) to C.L.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Amsterdam A, 2006, TRENDS GENET, V22, P473, DOI 10.1016/j.tig.2006.06.011; Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Avanesov A, 2004, METHODS CELL BIOL, V76, P333; Baldessari D, 2008, PHARMACOL THERAPEUT, V118, P206, DOI 10.1016/j.pharmthera.2008.02.010; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; DRIEVER W, 1994, TRENDS GENET, V10, P152, DOI 10.1016/0168-9525(94)90091-4; Drummond IA, 2000, PEDIATR NEPHROL, V14, P428, DOI 10.1007/s004670050788; El Sheikh Soha Salama, 2003, BMC Clin Pathol, V3, P4, DOI 10.1186/1472-6890-3-4; Flatman PW, 2007, CLIN SCI, V112, P203, DOI 10.1042/CS20060225; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Glickman NS, 2002, SEMIN CELL DEV BIOL, V13, P507, DOI 10.1016/S1084952102001040; Goessling W, 2007, NAT METHODS, V4, P551, DOI 10.1038/NMETH1059; Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8; Hirashima M, 2009, ANAT SCI INT, V84, P95, DOI 10.1007/s12565-009-0026-1; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jakobsson L, 2009, BIOCHEM SOC T, V37, P1233, DOI 10.1042/BST0371233; Jiang ZY, 2005, J BIOL CHEM, V280, P21622, DOI 10.1074/jbc.m414464200; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Lam CS, 2009, DEV DYNAM, V238, P475, DOI 10.1002/dvdy.21853; Langenberg T, 2003, DEV DYNAM, V228, P464, DOI 10.1002/dvdy.10395; Lauter G, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-43; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lele Z, 1996, BIOTECHNOL ADV, V14, P57, DOI 10.1016/0734-9750(96)00004-3; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Malicki J, 2000, TRENDS NEUROSCI, V23, P531, DOI 10.1016/S0166-2236(00)01655-6; Malicki JJ, 2002, VISION RES, V42, P527, DOI 10.1016/S0042-6989(01)00262-0; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Nicoli S, 2009, J CELL MOL MED, V13, P2061, DOI 10.1111/j.1582-4934.2008.00432.x; Orlov SN, 2010, AM J HYPERTENS, V23, P321, DOI 10.1038/ajh.2009.249; Peterson SM, 2009, ZEBRAFISH, V6, P355, DOI 10.1089/zeb.2009.0600; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Sun XT, 2006, J NEUROCHEM, V99, P1114, DOI 10.1111/j.1471-4159.2006.04159.x; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Tao SJ, 2009, DEVELOPMENT, V136, P2757, DOI 10.1242/dev.034959; Tseng WF, 2011, DEV BIOL, V357, P541, DOI 10.1016/j.ydbio.2011.06.040; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Vitari AC, 2004, BIOCHEM J, V378, P257, DOI 10.1042/BJ20031692; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xie J, 2009, AM J PATHOL, V175, P1315, DOI 10.2353/ajpath.2009.090094; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2002, J BIOL CHEM, V277, P48456, DOI 10.1074/jbc.M207917200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zeng XXI, 2009, DEV BIOL, V328, P363, DOI 10.1016/j.ydbio.2009.01.035	56	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106129	10.1371/journal.pone.0106129	http://dx.doi.org/10.1371/journal.pone.0106129			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171174	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500110
J	Stoelting, RE; Measey, GJ; Drewes, RC				Stoelting, Ricka E.; Measey, G. John; Drewes, Robert C.			Population Genetics of the Sao Tome Caecilian (Gymnophiona: Dermophiidae: Schistometopum thomense) Reveals Strong Geographic Structuring	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; HOMOZYGOSITY TEST; SPECIES RICHNESS; ISLAND; PHYLOGEOGRAPHY; MITOCHONDRIAL; DIVERSITY; AMPHIBIA; GUINEA	Islands provide exciting opportunities for exploring ecological and evolutionary mechanisms. The oceanic island of Sao Tome in the Gulf of Guinea exhibits high diversity of fauna including the endemic caecilian amphibian, Schistometopum thomense. Variation in pigmentation, morphology and size of this taxon over its c. 45 km island range is extreme, motivating a number of taxonomic, ecological, and evolutionary hypotheses to explain the observed diversity. We conducted a population genetic study of S. thomense using partial sequences of two mitochondrial DNA genes (ND4 and 16S), together with morphological examination, to address competing hypotheses of taxonomic or clinal variation. Using Bayesian phylogenetic analysis and Spatial Analysis of Molecular Variance, we found evidence of four geographic clades, whose range and approximated age (c. 253 Kya - 27 Kya) are consistent with the spread and age of recent volcanic flows. These clades explained 90% of variation in ND4 (phi(CT) = 0.892), and diverged by 4.3% minimum pairwise distance at the deepest node. Most notably, using Mismatch Distributions and Mantel Tests, we identified a zone of population admixture that dissected the island. In the northern clade, we found evidence of recent population expansion (Fu's F-s = -13.08 and Tajima's D = -1.80) and limited dispersal (Mantel correlation coefficient = 0.36, p = 0.01). Color assignment to clades was not absolute. Paired with multinomial regression of chromatic data, our analyses suggested that the genetic groups and a latitudinal gradient together describe variation in color of S. thomense. We propose that volcanism and limited dispersal ability are the likely proximal causes of the observed genetic structure. This is the first population genetic study of any caecilian and demonstrates that these animals have deep genetic divisions over very small areas in accordance with previous speculations of low dispersal abilities.	[Stoelting, Ricka E.; Drewes, Robert C.] Calif Acad Sci, Dept Herpetol, San Francisco, CA 94118 USA; [Stoelting, Ricka E.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA; [Measey, G. John] Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, ZA-7600 Stellenbosch, South Africa	California Academy of Sciences; University of Wisconsin System; University of Wisconsin Madison; Stellenbosch University	Stoelting, RE (corresponding author), Calif Acad Sci, Dept Herpetol, San Francisco, CA 94118 USA.	stoelting@wisc.edu	Measey, John/F-2028-2010	Measey, John/0000-0001-9939-7615	European Commission Marie Curie Fellowship [HPMF-CT-2001-01407]; G. Lindsay Field Research Fund of the California Academy of Sciences; Hagey Research Investment Fund of the California Academy of Sciences	European Commission Marie Curie Fellowship(European Commission); G. Lindsay Field Research Fund of the California Academy of Sciences; Hagey Research Investment Fund of the California Academy of Sciences	The authors thank the European Commission Marie Curie Fellowship (HPMF-CT-2001-01407, field work support for GJM), the G. Lindsay Field Research Fund of the California Academy of Sciences (field work support for RES and RCD in 2001), and the Hagey Research Investment Fund of the California Academy of Sciences (field work support for RCD in 2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Arntzen JW, 2007, CONTRIB ZOOL, V76, P261, DOI 10.1163/18759866-07604005; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Barboza du Bocage JV, 1873, J SCI MATH PHYS NATU, V4, P209; Barfod DN, 2014, QUAT GEOCHRONOL, V21, P77, DOI 10.1016/j.quageo.2012.11.006; Beebee TJC, 2005, HEREDITY, V95, P423, DOI 10.1038/sj.hdy.6800736; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.2307/3802723, DOI 10.2307/3802723]; Caldeira R, 2002, J AFR EARTH SCI, V34, P231, DOI 10.1016/S0899-5362(02)00022-2; Caldeira R, 2003, CARACTERIZACAO PRINC; Castoe TA, 2003, HERPETOLOGICA, V59, P420, DOI 10.1655/01-105.2; CHAKRABORTY R, 1990, AM J HUM GENET, V47, P87; Dallimer M, 2009, ANIM CONSERV, V12, P209, DOI 10.1111/j.1469-1795.2009.00240.x; Darwin C., 1859, ORIGIN SPECIES MEANS; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; Deletre M, 2004, ETHOL ECOL EVOL, V16, P243; deQueiroz A., 2014, MONKEYS VOYAGE IMPRO; Doan TM, 2003, HERPETOLOGICA, V59, P432, DOI 10.1655/03-09; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Estoup A, 2001, GENETICS, V159, P1671; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fahr Jakob, 1993, Faunistische Abhandlungen (Dresden), V19, P75; Figueiredo E, 2011, BOTHALIA, V41, P41, DOI 10.4102/abc.v41i1.34; Filardi CE, 2005, NATURE, V438, P216, DOI 10.1038/nature04057; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fu YX, 1997, GENETICS, V147, P915; Fuerst GS, 2004, J HERPETOL, V38, P257, DOI 10.1670/190-03A; Goldstien SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016755; Gower DJ, 2007, J ZOOL, V272, P266, DOI 10.1111/j.1469-7998.2006.00266.x; Gower DJ, 2005, CONSERV BIOL, V19, P45, DOI 10.1111/j.1523-1739.2005.00589.x; Haft Jan, 1996, Herpetofauna (Weinstadt), V18, P5; Haft Jan, 1992, Bonner Zoologische Beitraege, V43, P477; Hardy ME, 2002, MOL ECOL, V11, P2393, DOI 10.1046/j.1365-294X.2002.01616.x; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Huson DH, 2011, GENOME BIOL EVOL, V3, P23, DOI 10.1093/gbe/evq077; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Janzen FJ, 2002, MOL ECOL, V11, P1739, DOI 10.1046/j.1365-294X.2002.01571.x; Jehle R, 2005, J EVOLUTION BIOL, V18, P619, DOI 10.1111/j.1420-9101.2004.00864.x; Jesus J, 2005, MOL PHYLOGENET EVOL, V37, P503, DOI 10.1016/j.ympev.2005.04.032; Jesus J, 2005, MOL PHYLOGENET EVOL, V34, P480, DOI 10.1016/j.ympev.2004.11.006; Jesus J, 2009, HERPETOL J, V19, P41; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; LEE DC, 1994, EARTH PLANET SC LETT, V123, P119, DOI 10.1016/0012-821X(94)90262-3; Levy E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046351; Loader SP, 2007, BIOL LETTERS, V3, P505, DOI 10.1098/rsbl.2007.0266; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Loumont Catherine, 1992, Alytes (Paris), V10, P37; MAC ARTHUR ROBERT H., 1967; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; MANTEL N, 1967, CANCER RES, V27, P209; Measey GJ, 2006, EUR J SOIL BIOL, V42, pS103, DOI 10.1016/j.ejsobi.2006.07.034; Measey GJ, 2007, J BIOGEOGR, V34, P7, DOI 10.1111/j.1365-2699.2006.01589.x; Measey GJ, 2006, EVOL ECOL RES, V8, P1049; Measey J, 2004, IUCN RED LIST THREAT; MELO M, 2006, THESIS U EDINBURGH E; Melo M, 2011, MOL ECOL, V20, P4953, DOI 10.1111/j.1365-294X.2011.05099.x; Mendes Luis F., 2012, Boletin de la SEA, P157; Mila B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040541; Miller EC, 2012, AFR J HERPETOL, V61, P40, DOI 10.1080/21564574.2012.666680; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; MORITZ C, 1992, SYST BIOL, V41, P273, DOI 10.2307/2992567; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nei M., 1987, MOL EVOLUTIONARY GEN, P180; Nishikawa K, 2012, MOL PHYLOGENET EVOL, V63, P714, DOI 10.1016/j.ympev.2012.02.017; Nussbaum RA, 1998, MISC PUBL MUS ZOOL U, V187; Nylander J. A. A., 2004, MRMODELTEST V 2 PROG; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; Peters W, 1874, MONATSBERICHT KONIGL, V1874, P616; Peters W.C.H., 1880, MONATSBERICHTE KONIG, V1880, P217; Presswell B, 2002, THESIS U GLASGOW SCO; Ricklefs RE, 1999, J ANIM ECOL, V68, P1142, DOI 10.1046/j.1365-2656.1999.00358.x; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Schatti Beat, 1992, Zoologische Abhandlungen (Dresden), V47, P23; Schneider S, 1999, GENETICS, V152, P1079; Seyahooei Majeed Askari, 2011, BMC Ecology, V11, P4, DOI 10.1186/1472-6785-11-4; Slatkin M, 1996, GENET RES, V68, P259, DOI 10.1017/S0016672300034236; SLATKIN M, 1994, GENET RES, V64, P71, DOI 10.1017/S0016672300032560; Stoelting RE, 2006, THESIS SAN FRANCISCO; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Taylor E. H., 1965, Kansas University Science Bulletin, V46, P253; Taylor E.H., 1968, CAECILIANS WORLD TAX; Townsend TM, 2011, BIOL LETTERS, V7, P225, DOI 10.1098/rsbl.2010.0701; Trewick SA, 2000, J BIOGEOGR, V27, P1189, DOI 10.1046/j.1365-2699.2000.00492.x; Vences M, 2003, P ROY SOC B-BIOL SCI, V270, P2435, DOI 10.1098/rspb.2003.2516; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vences M, 2001, J BIOGEOGR, V28, P1091, DOI 10.1046/j.1365-2699.2001.00624.x; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Vicario S, 2003, MOL PHYLOGENET EVOL, V26, P243, DOI 10.1016/S1055-7903(02)00313-5; WATTERSON GA, 1978, GENETICS, V88, P405; WATTERSON GA, 1986, GENETICS, V112, P899; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x; Wielstra B, 2010, MOL PHYLOGENET EVOL, V56, P888, DOI 10.1016/j.ympev.2010.04.030; Wilkinson M, 2011, ZOOTAXA, P41; Wollenberg KC, 2009, J EVOLUTION BIOL, V22, P1046, DOI 10.1111/j.1420-9101.2009.01717.x; Zhang P, 2009, MOL PHYLOGENET EVOL, V53, P479, DOI 10.1016/j.ympev.2009.06.018	106	11	11	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e104628	10.1371/journal.pone.0104628	http://dx.doi.org/10.1371/journal.pone.0104628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171066	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500021
J	Yuan, XY; Zhang, LG; Ning, N; Wen, YY; Dong, SQ; Yin, MQ; Guo, MJ; Wang, BQ; Feng, L; Guo, PY				Yuan, Xiangyang; Zhang, Liguang; Ning, Na; Wen, Yinyuan; Dong, Shuqi; Yin, Meiqiang; Guo, Meijun; Wang, Binqiang; Feng, Lei; Guo, Pingyi			Photosynthetic Physiological Response of Radix Isatidis (Isatis indigotica Fort.) Seedlings to Nicosulfuron	PLOS ONE			English	Article							PHOTOINHIBITION; FLUORESCENCE; CHLOROPHYLL; ABSORPTION; STRESS; GROWTH	Radix Isatidis (Isatis indigotica Fort.) is one of the most important traditional Chinese medicine plants. However, there is no suitable herbicide used for weed control in Radix Isatidis field during postemergence stage. To explore the safety of sulfonylurea herbicide nicosulfuron on Radix Isatidis (Isatis indigotica Fort.) seedlings and the photosynthetic physiological response of the plant to the herbicide, biological mass, leaf area, photosynthetic pigment content, photosynthetic rate, chlorophyll fluorescence characteristics, and P-700 parameters of Radix Isatidis seedlings were analyzed 10 d after nicosulfuron treatment at 5th leaf stage in this greenhouse research. The results showed that biological mass, total chlorophyll, chlorophyll a, and carotenoids content, photosynthetic rate, stomatal conductance, PS II maximum quantum yield, PS II effective quantum yield, PS II electron transport rate, photochemical quenching, maximal P700 change, photochemical quantum yield of PS I, and PS I electron transport rate decreased with increasing herbicide concentrations, whereas initial fluorescence, quantum yield of non-regulated energy dissipation in PS II and quantum yield of non-photochemical energy dissipation due to acceptor side limitation in PS I increased. It suggests that nicosulfuron >= 1 mg L-1 causes the damage of chloroplast, PS II and PS I structure. Electron transport limitations in PS I receptor side, and blocked dark reaction process may be the main cause of the significantly inhibited growth and decreased photosynthetic rate of Radix Isatidis seedlings.	[Yuan, Xiangyang; Zhang, Liguang; Ning, Na; Wen, Yinyuan; Dong, Shuqi; Yin, Meiqiang; Guo, Meijun; Wang, Binqiang; Feng, Lei; Guo, Pingyi] Shanxi Agr Univ, Agron Coll, Lab Crop Chem Regulat & Chem Weed Control, Taigu, Peoples R China; [Zhang, Liguang] Shanxi Acad Agr Sci, Inst Crop Sci, Taiyuan, Peoples R China	Shanxi Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Shanxi Agricultural University	Guo, PY (corresponding author), Shanxi Agr Univ, Agron Coll, Lab Crop Chem Regulat & Chem Weed Control, Taigu, Peoples R China.	yuanxiangyang200@126.com			Scientific and Technological Project in Shanxi Province, China [20100321103]; Key Research Foundation for Returness in Shanxi Province, China [201004]; Shanxi Agricultural University Technology Innovation Fund [201023]	Scientific and Technological Project in Shanxi Province, China; Key Research Foundation for Returness in Shanxi Province, China; Shanxi Agricultural University Technology Innovation Fund	This paper was supported by "Scientific and Technological Project in Shanxi Province, China'' (20100321103), "Key Research Foundation for Returness in Shanxi Province, China'' (201004), and "Shanxi Agricultural University Technology Innovation Fund'' (201023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DEMMIG B, 1987, PLANT PHYSIOL, V84, P218, DOI 10.1104/pp.84.2.218; Dong XiaoWen, 2007, Acta Phytophylacica Sinica, V34, P182; Erhard P., 2008, PAM APPL NOTES, V1, P21; Frankart C, 2003, ENVIRON EXP BOT, V49, P159, DOI 10.1016/S0098-8472(02)00067-9; Gallaher K, 1999, WEED SCI, V47, P8, DOI 10.1017/S0043174500090585; Hennigh DS, 2010, WEED TECHNOL, V24, P411, DOI 10.1614/WT-D-09-00061.1; Hennigh DS, 2010, WEED SCI, V58, P189, DOI 10.1614/WS-D-09-00042.1; Hjorth M, 2006, PEST MANAG SCI, V62, P515, DOI 10.1002/ps.1194; Klughammer C., 2008, PAM APP NOTES, V1, P11, DOI DOI 10.1007/S00415-017-8571-3; Kocurek V, 2009, CEREAL RES COMMUN, V37, P289; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Li J, 2011, VALUE ENG, V30, P328; Liu Zhi-Hua, 2007, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V33, P165; Lum AF, 2005, CROP PROT, V24, P41, DOI 10.1016/j.cropro.2004.06.006; Moro F. V., 1999, Planta Daninha, V17, P331, DOI 10.1590/S0100-83581999000300001; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Nordby JN, 2008, WEED SCI, V56, P376, DOI 10.1614/WS-07-145.1; O'Sullivan J, 1998, CAN J PLANT SCI, V78, P151, DOI 10.4141/P97-054; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Qian HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019451; Ramanjulu S, 1998, PHOTOSYNTHETICA, V35, P279, DOI 10.1023/A:1006979327921; Scheller HV, 2005, PLANTA, V221, P5, DOI 10.1007/s00425-005-1507-7; Schrader SM, 2004, PLANT CELL ENVIRON, V27, P725, DOI 10.1111/j.1365-3040.2004.01172.x; Tan W, 2012, PESTIC BIOCHEM PHYS, V103, P210, DOI 10.1016/j.pestbp.2012.05.010; Wang Xin, 2012, Journal of Medicinal Plants Research, V6, P1770, DOI 10.5897/JMPR11.1612; Wang ZhengGui, 2011, Journal of Agro-Environment Science, V30, P1037; Wu JY., 2003, CHINESE J PESTIC SCI, P77; [袁世林 Yuan Shilin], 2003, [山西农业科学, Journal of Shanxi Agricultural Sciences], V31, P78; Yuan XY, 2013, PESTIC BIOCHEM PHYS, V106, P45, DOI 10.1016/j.pestbp.2013.04.002; Zhang L, 2012, WEED SCI, V30, P58; Zhao R, 2010, J PLANT DIS PROTECT, V117, P55, DOI 10.1007/BF03356335; Zhou Q, 2007, PESTIC BIOCHEM PHYS, V89, P89, DOI 10.1016/j.pestbp.2007.04.004	32	18	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105310	10.1371/journal.pone.0105310	http://dx.doi.org/10.1371/journal.pone.0105310			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165819	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303700022
J	Zickovich, JM; Meyer, SI; Yagita, H; Obar, JJ				Zickovich, Julianne M.; Meyer, Susan I.; Yagita, Hideo; Obar, Joshua J.			Agonistic Anti-CD40 Enhances the CD8(+) T Cell Response during Vesicular Stomatitis Virus Infection	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; MEMORY CELLS; IN-VIVO; TERMINAL DIFFERENTIATION; ANTIGEN PRESENTATION; BACTERIAL-INFECTION; CD8-T-CELL MEMORY; IMMUNE-RESPONSES; RECALL RESPONSES; CD4-T-CELL HELP	Intracellular pathogens are capable of inducing vigorous CD8(+) T cell responses. However, we do not entirely understand the factors driving the generation of large pools of highly protective memory CD8(+) T cells. Here, we studied the generation of endogenous ovalbumin-specific memory CD8(+) T cells following infection with recombinant vesicular stomatitis virus (VSV) and Listeria monocytogenes (LM). VSV infection resulted in the generation of a large ovalbumin-specific memory CD8(+) T cell population, which provided minimal protective immunity that waned with time. In contrast, the CD8(+) T cell population of LM-ova provided protective immunity and remained stable with time. Agonistic CD40 stimulation during CD8(+) T cell priming in response to VSV infection enabled the resultant memory CD8(+) T cell population to provide strong protective immunity against secondary infection. Enhanced protective immunity by agonistic anti-CD40 was dependent on CD70. Agonistic anti-CD40 not only enhanced the size of the resultant memory CD8(+) T cell population, but enhanced their polyfunctionality and sensitivity to antigen. Our data suggest that immunomodulation of CD40 signaling may be a key adjuvant to enhance CD8(+) T cell response during development of VSV vaccine strategies.	[Zickovich, Julianne M.; Meyer, Susan I.; Obar, Joshua J.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan	Montana State University System; Montana State University Bozeman; Juntendo University	Obar, JJ (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.	joshua.obar@montana.edu		Obar, Joshua/0000-0003-4068-7911	National Institutes of Health [GM103500, GM110732]; MSU Agricultural Experiment Station; M. J. Murdock Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110732, P20GM103500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSU Agricultural Experiment Station; M. J. Murdock Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health- NCRR COBRE Grants GM103500 and GM110732, the MSU Agricultural Experiment Station, and an equipment grant from the M. J. Murdock Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Ahmed M, 2006, J VIROL, V80, P2194, DOI 10.1128/JVI.80.5.2194-2205.2006; Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Bahjat KS, 2006, INFECT IMMUN, V74, P6387, DOI 10.1128/IAI.01088-06; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Cui W, 2009, VACCINE, V27, P2177, DOI 10.1016/j.vaccine.2009.01.088; Derz GI, 2002, J VIROL, V76, P12388; Frank GM, 2010, J IMMUNOL, V184, P277, DOI 10.4049/jimmunol.0902373; Fuse S, 2008, CRIT REV IMMUNOL, V28, P159, DOI 10.1615/CritRevImmunol.v28.i2.40; Fuse S, 2009, J IMMUNOL, V182, P4244, DOI 10.4049/jimmunol.0802041; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; GOBET R, 1988, EXP CELL BIOL, V56, P175; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kedzierska K, 2005, P NATL ACAD SCI USA, V102, P11432, DOI 10.1073/pnas.0504851102; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marzo AL, 2004, J IMMUNOL, V173, P969, DOI 10.4049/jimmunol.173.2.969; Masopust D, 2001, J IMMUNOL, V166, P2348, DOI 10.4049/jimmunol.166.4.2348; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; McWilliams JA, 2010, VACCINE, V28, P1468, DOI 10.1016/j.vaccine.2009.11.071; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Mueller SN, 2010, J IMMUNOL, V185, P2182, DOI 10.4049/jimmunol.1001142; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Obar JJ, 2004, J IMMUNOL, V173, P2705, DOI 10.4049/jimmunol.173.4.2705; Obar JJ, 2006, J VIROL, V80, P8303, DOI 10.1128/JVI.00237-06; Obar JJ, 2011, J IMMUNOL, V187, P4967, DOI 10.4049/jimmunol.1102335; Obar JJ, 2010, INT IMMUNOL, V22, P619, DOI 10.1093/intimm/dxq053; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Oshima H, 1998, INT IMMUNOL, V10, P517, DOI 10.1093/intimm/10.4.517; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Richardson BA, 2005, J VIROL, V79, P669, DOI 10.1128/JVI.79.2.669-676.2005; Robbins SH, 2003, J IMMUNOL, V170, P5876, DOI 10.4049/jimmunol.170.12.5876; Roberts A, 1998, J VIROL, V72, P4704, DOI 10.1128/JVI.72.6.4704-4711.1998; Roberts AD, 2005, J EXP MED, V202, P123, DOI 10.1084/jem.20050137; Rose NF, 2001, CELL, V106, P539, DOI 10.1016/S0092-8674(01)00482-2; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sanchez PJ, 2007, J IMMUNOL, V178, P1564, DOI 10.4049/jimmunol.178.3.1564; Sanchez PJ, 2012, VACCINE, V30, P1154, DOI 10.1016/j.vaccine.2011.12.017; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Simon ID, 2007, J VIROL, V81, P2078, DOI 10.1128/JVI.02525-06; Simon ID, 2010, J VIROL, V84, P3280, DOI 10.1128/JVI.02052-09; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Strandberg TE, 2009, JAMA-J AM MED ASSOC, V301, P380, DOI 10.1001/jama.2009.4; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Turner DL, 2007, J VIROL, V81, P2039, DOI 10.1128/JVI.02167-06; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Yamazaki H, 2005, J IMMUNOL, V175, P1586, DOI 10.4049/jimmunol.175.3.1586; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015	64	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106060	10.1371/journal.pone.0106060	http://dx.doi.org/10.1371/journal.pone.0106060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166494	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303700066
J	Comar, M; Zanotta, N; Bonotti, A; Tognon, M; Negro, C; Cristaudo, A; Bovenzi, M				Comar, Manola; Zanotta, Nunzia; Bonotti, Alessandra; Tognon, Mauro; Negro, Corrado; Cristaudo, Alfonso; Bovenzi, Massimo			Increased Levels of C-C Chemokine RANTES in Asbestos Exposed Workers and in Malignant Mesothelioma Patients from an Hyperendemic Area	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PLEURAL MESOTHELIOMA; SV40; EXPRESSION; CELLS; TRANSFORMATION; INTERLEUKIN-8; INFLAMMASOME; INHIBITION; ACTIVATION	Background: Asbestos-induced mesothelial inflammatory processes are thought to be the basic mechanisms underlying Malignant Mesothelioma (MM) development. Detection of MM often occurs at late stage due to the long and unpredictable latent period and the low incidence in asbestos exposed individuals. The aim of this study was to investigate early immunological biomarkers to characterize the prognostic profile of a possible asbestos-induced disease, in subjects from a MM hyperendemic area. Methods: The Luminex Multiplex Panel Technology was used for the simultaneous measurement of serum levels of a large panel of 47 analytes, including cytokines and growth factors, from workers previously exposed to asbestos (Asb-workers), asbestos-induced MM patients and healthy subjects. In addition, to explore the influence on serum cytokines profile exerted by SV40 infection, a cofactor in MM development, a quantitative real time PCR was performed for sequences detection in the N-terminal and intronic regions of the SV40 Tag gene. Statistical analysis was done by means of the Mann-Whitney test and the Kruskall-Wallis test for variance analysis. Results: A variety of 25 cytokines linked to pulmonary inflammation and tumor development were found significantly associated with Asb-workers and MM patients compared with healthy controls. A specific pattern of cytokines were found highly expressed in Asb-workers: IFN-alpha (p<0.05), EOTAXIN (p<0.01), RANTES (p<0.001), and in MM patients: IL-12(p40), IL-3, IL-1 alpha, MCP-3, beta-NGF, TNF-beta, RANTES (p<0.001). Notably, the chemokine RANTES measured the highest serum level showing an increased gradient of concentration from healthy subjects to Asb-workers and MM patients (p, 0.001), independently of SV40 infection. Conclusion: This study shows that, in subjects from an hyperendemic area for MM, the C-C chemokine RANTES is associated with the exposure to asbestos fibres. If validated in larger samples, this factor could have the potential to be a critical biomarker for MM prognosis as recently reported for breast tumor.	[Comar, Manola; Zanotta, Nunzia] IRCCS Burlo Garofolo Trieste, Inst Maternal & Child Hlth, Trieste, Italy; [Comar, Manola] Univ Trieste, Dept Med Sci, Clin Unit Hyg, Trieste, Italy; [Bonotti, Alessandra; Cristaudo, Alfonso] Univ Hosp Pisa, Div Occupat & Prevent Med, Pisa, Italy; [Tognon, Mauro] Univ Ferrara, Sch Med, Sect Pathol Oncol & Expt Biol, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Negro, Corrado; Bovenzi, Massimo] Univ Trieste, Dept Med Sci, Clin Unit Occupat Med, Trieste, Italy	IRCCS Burlo Garofolo; University of Trieste; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Ferrara; University of Trieste	Comar, M (corresponding author), IRCCS Burlo Garofolo Trieste, Inst Maternal & Child Hlth, Trieste, Italy.	comar@burlo.trieste.it	Zanotta, Nunzia/K-4539-2016; Comar, Manola/K-4613-2016; COMAR, Manola/K-4613-2016	Zanotta, Nunzia/0000-0002-6458-1946; Comar, Manola/0000-0001-6310-3320; BOVENZI, MASSIMO/0000-0002-6001-5218; COMAR, Manola/0000-0002-9487-861X	Friuli Venezia Giulia region, Italy [889/APREV]	Friuli Venezia Giulia region, Italy(Regione Friuli Venezia Giulia)	This study was funded through grant from Friuli Venezia Giulia region (decree 889/APREV, 15-10-2013), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2006, INT J CANCER, V119, P1303, DOI 10.1002/ijc.22006; BielefeldtOhmann H, 1996, J PATHOL, V178, P369, DOI 10.1002/(SICI)1096-9896(199604)178:4<369::AID-PATH460>3.0.CO;2-8; Bocchetta M, 2003, ONCOGENE, V22, P81, DOI 10.1038/sj.onc.1206097; Borczuk AC, 2008, ONCOGENE, V27, P557, DOI 10.1038/sj.onc.1210662; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; Cacciotti P, 2001, P NATL ACAD SCI USA, V98, P12032, DOI 10.1073/pnas.211026798; Carbone M, 1997, NAT MED, V3, P908, DOI 10.1038/nm0897-908; Catalano A, 2002, ONCOGENE, V21, P2896, DOI 10.1038/sj.onc.1205382; Chow MT, 2012, IMMUNOL CELL BIOL, V90, P983, DOI 10.1038/icb.2012.46; CICALA C, 1993, AM J PATHOL, V142, P1524; Comar M, 2007, CANCER RES, V67, P8456, DOI 10.1158/0008-5472.CAN-07-2232; Comar M, 2012, TUMORI J, V98, P210, DOI 10.1700/1088.11931; Cristaudo A, 2005, CANCER RES, V65, P3049, DOI 10.1158/0008-5472.CAN-04-2219; Cutrone R, 2005, CANCER RES, V65, P10273, DOI 10.1158/0008-5472.CAN-05-2028; Davidson B, 2004, LUNG CANCER, V44, P159, DOI 10.1016/j.lungcan.2003.11.014; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2009, EMBO MOL MED, V1, P92, DOI 10.1002/emmm.200900014; Fox SA, 2012, ONCOL REP, V28, P707, DOI 10.3892/or.2012.1809; Galffy G, 1999, CANCER RES, V59, P367; Galffy G, 1999, ONCOL RES, V11, P187; GARLEPP MJ, 1995, EUR RESPIR J, V8, P643; Heintz NH, 2010, AM J RESP CELL MOL, V42, P133, DOI 10.1165/rcmb.2009-0206TR; Hillegass JM, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-39; Hillegass JM, 2010, ANN NY ACAD SCI, V1203, P7, DOI 10.1111/j.1749-6632.2010.05554.x; Lopez-Rios F, 2004, LANCET, V364, P1157, DOI 10.1016/S0140-6736(04)17102-X; Mantovani A, 2004, SEMIN CANCER BIOL, V14, P155, DOI 10.1016/j.semcancer.2003.10.001; Marinaccio A, 2005, INT J CANCER, V115, P142, DOI 10.1002/ijc.20820; Marinaccio A, 2010, 3 ISPESL; Mazzoni E, 2012, P NATL ACAD SCI USA, V109, P18066, DOI 10.1073/pnas.1213238109; Mossman BT, 2013, AM J PATHOL, V182, P1065, DOI 10.1016/j.ajpath.2012.12.028; Mossman BT, 2011, J TOXICOL ENV HEAL B, V14, P76, DOI 10.1080/10937404.2011.556047; Niwa Y, 2001, CLIN CANCER RES, V7, P285; Pass HI, 1996, CANCER RES, V56, P4044; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Price B, 2009, CRIT REV TOXICOL, V39, P576, DOI 10.1080/10408440903044928; Qi F, 2013, AM J PATHOL, V183, P1654, DOI 10.1016/j.ajpath.2013.07.029; Robinson BM, 2012, ANN CARDIOTHORAC SUR, V1, P491, DOI 10.3978/j.issn.2225-319X.2012.11.04; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Wang YH, 2004, INT J ONCOL, V25, P173; WHO (World Health Organization), 2006, ASB HIST; Wojta J, 1999, LAB INVEST, V79, P427; World Health Organization (WHO) International Agency for Research on Cancer (IARC), 2012, IARC MON EV CARC RIS, V100E; Yaal-Hahoshen N, 2006, CLIN CANCER RES, V12, P4474, DOI 10.1158/1078-0432.CCR-06-0074; Zanella CL, 1996, CANCER RES, V56, P5334; Zucali PA, 2006, EUR J CANCER, V42, P2706, DOI 10.1016/j.ejca.2006.07.011	45	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e104848	10.1371/journal.pone.0104848	http://dx.doi.org/10.1371/journal.pone.0104848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162674	gold, Green Submitted, Green Published			2022-12-25	WOS:000340880900020
J	Gupta, A; Gopal, M; Thomas, GV; Manikandan, V; Gajewski, J; Thomas, G; Seshagiri, S; Schuster, SC; Rajesh, P; Gupta, R				Gupta, Alka; Gopal, Murali; Thomas, George V.; Manikandan, Vinu; Gajewski, John; Thomas, George; Seshagiri, Somasekar; Schuster, Stephan C.; Rajesh, Preeti; Gupta, Ravi			Whole Genome Sequencing and Analysis of Plant Growth Promoting Bacteria Isolated from the Rhizosphere of Plantation Crops Coconut, Cocoa and Arecanut	PLOS ONE			English	Article							BETA-KETOADIPATE PATHWAY; PSEUDOMONAS-FLUORESCENS; PHOSPHATE SOLUBILIZATION; BACILLUS-SUBTILIS; III SECRETION; CODON USAGE; GENES; STRAIN; METABOLISM; PROTEIN	Coconut, cocoa and arecanut are commercial plantation crops that play a vital role in the Indian economy while sustaining the livelihood of more than 10 million Indians. According to 2012 Food and Agricultural organization's report, India is the third largest producer of coconut and it dominates the production of arecanut worldwide. In this study, three Plant Growth Promoting Rhizobacteria (PGPR) from coconut (CPCRI-1), cocoa (CPCRI-2) and arecanut (CPCRI-3) characterized for the PGP activities have been sequenced. The draft genome sizes were 4.7 Mb (56% GC), 5.9 Mb (63.6% GC) and 5.1 Mb (54.8% GB) for CPCRI-1, CPCRI-2, CPCRI-3, respectively. These genomes encoded 4056 (CPCRI-1), 4637 (CPCRI-2) and 4286 (CPCRI-3) protein-coding genes. Phylogenetic analysis revealed that both CPCRI-1 and CPCRI-3 belonged to Enterobacteriaceae family, while, CPCRI-2 was a Pseudomonadaceae family member. Functional annotation of the genes predicted that all three bacteria encoded genes needed for mineral phosphate solubilization, siderophores, acetoin, butanediol, 1-aminocyclopropane-1-carboxylate (ACC) deaminase, chitinase, phenazine, 4-hydroxybenzoate, trehalose and quorum sensing molecules supportive of the plant growth promoting traits observed in the course of their isolation and characterization. Additionally, in all the three CPCRI PGPRs, we identified genes involved in synthesis of hydrogen sulfide (H2S), which recently has been proposed to aid plant growth. The PGPRs also carried genes for central carbohydrate metabolism indicating that the bacteria can efficiently utilize the root exudates and other organic materials as energy source. Genes for production of peroxidases, catalases and superoxide dismutases that confer resistance to oxidative stresses in plants were identified. Besides these, genes for heat shock tolerance, cold shock tolerance and glycine-betaine production that enable bacteria to survive abiotic stress were also identified.	[Gupta, Alka; Gopal, Murali; Thomas, George V.] Cent Plantat Crops Res Inst, Kasaragod, Kerala, India; [Manikandan, Vinu; Rajesh, Preeti; Gupta, Ravi] SciGenom Labs Pvt Ltd, Cochin, Kerala, India; [Gajewski, John; Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Thomas, George] SciGenom Res Fdn, Cochin, Kerala, India; [Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Schuster, Stephan C.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore	Indian Council of Agricultural Research (ICAR); ICAR - Central Plantation Crops Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Roche Holding; Genentech; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Gopal, M (corresponding author), Cent Plantat Crops Res Inst, Kasaragod, Kerala, India.	mgcpcri@yahoo.co.in; preeti@scigenom.com; ravig@scigenom.com	Thomas, George/CAG-6062-2022; Gopal, Murali/AAI-7837-2020; Gupta, Alka/F-4598-2016	Gopal, Murali/0000-0002-0826-0013; Seshagiri, Somasekar/0000-0003-4272-6443; Gupta, Alka/0000-0002-7877-4466	SciGenom Labs Pvt Ltd.	SciGenom Labs Pvt Ltd.	The study was internally funded by SciGenom Labs Pvt Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anusree GK, ISOLATION C IN PRESS; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barret M, 2013, ENV MICROBIOL REP, V5, P377, DOI 10.1111/1758-2229.12039; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; BLOMQVIST K, 1993, J BACTERIOL, V175, P1392, DOI 10.1128/JB.175.5.1392-1404.1993; Bopaiah B. M., 1985, Journal of Plantation Crops, V13, P60; BOPAIAH BM, 1991, SOIL BIOL BIOCHEM, V23, P89, DOI 10.1016/0038-0717(91)90167-I; Callahan SM, 2000, J BACTERIOL, V182, P2811, DOI 10.1128/JB.182.10.2811-2822.2000; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cooper RM, 1996, NATURE, V379, P159, DOI 10.1038/379159a0; Couillerot O, 2009, LETT APPL MICROBIOL, V48, P505, DOI 10.1111/j.1472-765X.2009.02566.x; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dooley FD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062048; Duan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058640; Duca D, 2014, ANTON LEEUW INT J G, V106, P85, DOI 10.1007/s10482-013-0095-y; Emile M, 2010, AFR J BIOTECHNOL, V9, P5665; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; George P, 2012, J PLANTATION CROPS, V40, P61; George P, 2013, WORLD J MICROB BIOT, V29, P109, DOI 10.1007/s11274-012-1163-6; GHAI SK, 1989, PLANT SOIL, V114, P235, DOI 10.1007/BF02220803; Gill SS, 2011, PLANT SIGNAL BEHAV, V6, P215, DOI 10.4161/psb.6.2.14880; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Goldstein AH, 1996, INVOLVEMENT QUINOPRO, P197; Gupta A, 2006, 34 C ANN M EUR SOC N; Gupta A, 2013, CONSOLIDATED REPORT; Han JI, 2011, J BACTERIOL, V193, P1183, DOI 10.1128/JB.00925-10; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Humann JL, 2011, STAND GENOMIC SCI, V5, P279, DOI 10.4056/sigs.2174950; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jones P., 2014, BIOINFORMATICS; Kadowaki MAS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-230; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kelley DR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1067; Kertesz MA, 2007, ADV APPL MICROBIOL, V62, P235, DOI 10.1016/S0065-2164(07)62008-5; Kim YS, 2002, J BIOCHEM MOL BIOL, V35, P443; Kloepper JW, 1978, P 4 INT C PLANT PATH, VII, P879; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Koo JH, 1999, EUR J BIOCHEM, V266, P683, DOI 10.1046/j.1432-1327.1999.00924.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li DH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-36; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Ma MC, 2011, J BACTERIOL, V193, P311, DOI 10.1128/JB.01234-10; MacLean AA, 2006, APPL ENVIRON MICROB, V72, P5403, DOI 10.1128/AEM.00580-06; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mathimaran N, 2012, J BACTERIOL, V194, P3272, DOI 10.1128/JB.00349-12; Matilla MA, 2011, J BACTERIOL, V193, P1290, DOI 10.1128/JB.01281-10; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Mehnaz S, 2014, GENOME ANNOUNC, V2; MUTO A, 1987, P NATL ACAD SCI USA, V84, P166, DOI 10.1073/pnas.84.1.166; Nelson L. M., 2004, Crop Management, P1; Nemat MA, 2011, INT J AGRONOMY, V2011; Ochman H, 2006, SCIENCE, V311, P1730, DOI 10.1126/science.1119966; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pereira CS, 2009, J BACTERIOL, V191, P6975, DOI 10.1128/JB.00976-09; Pereira CS, 2008, MOL MICROBIOL, V70, P1223, DOI 10.1111/j.1365-2958.2008.06477.x; Preston GM, 2001, MOL MICROBIOL, V41, P999, DOI 10.1046/j.1365-2958.2001.02560.x; Rameshkumar N, 2010, INT J SYST EVOL MICR, V60, P179, DOI 10.1099/ijs.0.008292-0; Ratcliff WC, 2008, FEMS MICROBIOL ECOL, V65, P391, DOI 10.1111/j.1574-6941.2008.00544.x; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; Ren Y, 2010, J BACTERIOL, V192, P2463, DOI 10.1128/JB.00067-10; RENNA MC, 1993, J BACTERIOL, V175, P3863, DOI 10.1128/JB.175.12.3863-3875.1993; Rodriguez H, 2006, PLANT SOIL, V287, P15, DOI 10.1007/s11104-006-9056-9; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Shah S, 1998, CAN J MICROBIOL, V44, P833, DOI 10.1139/cjm-44-9-833; Shankar M, 2012, J BACTERIOL, V194, P4479, DOI 10.1128/JB.00964-12; Sharma V, 2005, CAN J MICROBIOL, V51, P477, DOI 10.1139/W05-032; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; Shen XM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-271; Snyder EE, 2007, NUCLEIC ACIDS RES, V35, pD401, DOI 10.1093/nar/gkl858; Song JY, 2012, J BACTERIOL, V194, P3760, DOI 10.1128/JB.00676-12; Straub D, 2013, J EXP BOT, V64, P4603, DOI 10.1093/jxb/ert276; Sugawara M, 2010, APPL ENVIRON MICROB, V76, P1071, DOI 10.1128/AEM.02483-09; Taghavi S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000943; Thomas G. V., 1991, Journal of Plantation Crops, V19, P127; Thomas GV, 2014, CONSOLIDATED REPORT; Thomas L, 2013, THESIS MANGALORE U K; Thomas L, 2011, J PLANTATION CROPS, V39, P370; Vicario S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-226; Viollet A, 2011, FEMS MICROBIOL ECOL, V75, P457, DOI 10.1111/j.1574-6941.2010.01021.x; Whistler CA, 1998, J BACTERIOL, V180, P6635, DOI 10.1128/JB.180.24.6635-6641.1998; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Wu M, 2012, BIOINFORMATICS, V28, P1033, DOI 10.1093/bioinformatics/bts079; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Yu H, 2011, J BACTERIOL, V193, P5541, DOI 10.1128/JB.05663-11; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999; Zhu B, 2012, J BACTERIOL, V194, P6963, DOI 10.1128/JB.01933-12	96	65	66	5	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e104259	10.1371/journal.pone.0104259	http://dx.doi.org/10.1371/journal.pone.0104259			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162593	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900010
J	Harpur, BA; Chernyshova, A; Soltani, A; Tsvetkov, N; Mahjoorighasrodashti, M; Xu, ZX; Zayed, A				Harpur, Brock A.; Chernyshova, Anna; Soltani, Arash; Tsvetkov, Nadejda; Mahjoorighasrodashti, Mohammad; Xu, Zhixing; Zayed, Amro			No Genetic Tradeoffs between Hygienic Behaviour and Individual Innate Immunity in the Honey Bee, Apis mellifera	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; VARROA-DESTRUCTOR; BROOD DISEASES; BODY-SIZE; RESISTANCE; WORKER; EXPRESSION; DEFENSE; BUMBLEBEES; DIVERSITY	Many animals have individual and social mechanisms for combating pathogens. Animals may exhibit short-term physiological tradeoffs between social and individual immunity because the latter is often energetically costly. Genetic tradeoffs between these two traits can also occur if mutations that enhance social immunity diminish individual immunity, or vice versa. Physiological tradeoffs between individual and social immunity have been previously documented in insects, but there has been no study of genetic tradeoffs involving these traits. There is strong evidence that some genes influence both innate immunity and behaviour in social insects -a prerequisite for genetic tradeoffs. Quantifying genetic tradeoffs is critical for understanding the evolution of immunity in social insects and for devising effective strategies for breeding disease-resistant pollinator populations. We conducted two experiments to test the hypothesis of a genetic tradeoff between social and individual immunity in the honey bee, Apis mellifera. First, we estimated the relative contribution of genetics to individual variation in innate immunity of honey bee workers, as only heritable traits can experience genetic tradeoffs. Second, we examined if worker bees with hygienic sisters have reduced individual innate immune response. We genotyped several hundred workers from two colonies and found that patriline genotype does not significantly influence the antimicrobial activity of a worker's hemolymph. Further, we did not find a negative correlation between hygienic behaviour and the average antimicrobial activity of a worker's hemolymph across 30 honey bee colonies. Taken together, our work indicates no genetic tradeoffs between hygienic behaviour and innate immunity in honey bees. Our work suggests that using artificial selection to increase hygienic behaviour of honey bee colonies is not expected to concurrently compromise individual innate immunity of worker bees.	[Harpur, Brock A.; Chernyshova, Anna; Soltani, Arash; Tsvetkov, Nadejda; Mahjoorighasrodashti, Mohammad; Xu, Zhixing; Zayed, Amro] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	York University - Canada	Zayed, A (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	zayed@yorku.ca	Tsvetkov, Nadejda/ABC-9029-2020; Zayed, Amro/G-6405-2011; Chernyshova, A. L./C-8608-2012	Zayed, Amro/0000-0003-3233-4585; Chernyshova, A. L./0000-0002-8194-2811; Tsvetkov, Nadejda/0000-0002-4966-9042; Harpur, Brock/0000-0001-8722-272X	Elia Scholarship from York University; Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Ministry of Research and Innovation; Bee Research Fund from Canadian Honey Council	Elia Scholarship from York University; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Bee Research Fund from Canadian Honey Council	BAH was supported by an Elia Scholarship from York University (www.yorku.ca). Experiment 1 was funded by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca) and an Early Researcher Award from the Ontario Ministry of Research and Innovation (http://www.ontario.ca/business-and-economy/funding-academic-research-early-researcher-awards) to AZ. Experiment 2 was funded by a Bee Research Fund from Canadian Honey Council (http://www.honeycouncil.ca/cbrf.php) to AZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghamdi A, 2008, BIOL LETTERS, V4, P479, DOI 10.1098/rsbl.2008.0331; Alghamdi A, 2009, BIOL LETTERS, V5, P55, DOI 10.1098/rsbl.2008.0514; Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Arathi HS, 2000, ETHOLOGY, V106, P365, DOI 10.1046/j.1439-0310.2000.00556.x; Buchler R, 2010, APIDOLOGIE, V41, P393, DOI 10.1051/apido/2010011; Bull JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003083; Chandrasekaran S, 2011, P NATL ACAD SCI USA, V108, P18020, DOI 10.1073/pnas.1114093108; Cotter SC, 2010, BEHAV ECOL, V21, P663, DOI 10.1093/beheco/arq070; Cotter SC, 2013, J ANIM ECOL, V82, P846, DOI 10.1111/1365-2656.12047; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Decanini LI, 2007, J HERED, V98, P195, DOI 10.1093/jhered/esm008; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Fjerdingstad EJ, 2005, MOL ECOL, V14, P3123, DOI 10.1111/j.1365-294X.2005.02648.x; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Harpur BA, 2014, P NATL ACAD SCI USA, V111, P2614, DOI 10.1073/pnas.1315506111; Harpur BA, 2013, MOL ECOL, V22, P3211, DOI 10.1111/mec.12332; Harpur BA, 2013, MOL BIOL EVOL, V30, P1665, DOI 10.1093/molbev/mst061; Harpur BA, 2012, MOL ECOL, V21, P4414, DOI 10.1111/j.1365-294X.2012.05614.x; Ibrahim AG, 2006, APIDOLOGIE, V38, P67, DOI DOI 10.1051/apido:2006065; Invernizzi C, 2009, INSECT SOC, V56, P233, DOI 10.1007/s00040-009-0016-2; Jensen AB, 2009, APIDOLOGIE, V40, P524, DOI 10.1051/apido/2009029; Kent CF, 2011, MOL ECOL, V20, P5226, DOI 10.1111/j.1365-294X.2011.05299.x; Korner P, 2004, J INVERTEBR PATHOL, V87, P59, DOI 10.1016/j.jip.2004.07.004; Kovacs JL, 2010, INSECT SOC, V57, P53, DOI 10.1007/s00040-009-0050-0; Kraus FB, 2011, BEHAV GENET, V41, P323, DOI 10.1007/s10519-010-9382-9; Laloi D, 2010, APIDOLOGIE, V41, P436, DOI 10.1051/apido/2009080; Lapidge KL, 2002, NATURWISSENSCHAFTEN, V89, P565, DOI 10.1007/s00114-002-0371-6; Laughton AM, 2011, J INSECT PHYSIOL, V57, P1023, DOI 10.1016/j.jinsphys.2011.04.020; Laughton AM, 2010, APIDOLOGIE; Lynch M., 1998, GENETICS ANAL QUANTI; Macedo P, 2001, J APICULT RES, V40, P4; Mallon EB, 2003, P ROY SOC B-BIOL SCI, V270, P2471, DOI 10.1098/rspb.2003.2456; Moreno-Garcia M, 2013, B ENTOMOL RES, V103, P127, DOI 10.1017/S000748531200048X; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Otto SP, 2004, P ROY SOC B-BIOL SCI, V271, P705, DOI 10.1098/rspb.2003.2635; Oxley PR, 2010, MOL ECOL, V19, P1452, DOI 10.1111/j.1365-294X.2010.04569.x; PAGE RE, 1980, GENETICS, V96, P263; Palmer KA, 2003, NATURWISSENSCHAFTEN, V90, P265, DOI 10.1007/s00114-003-0418-3; Riddell CE, 2006, BRAIN BEHAV IMMUN, V20, P135, DOI 10.1016/j.bbi.2005.06.008; Rinderer TE, 2010, APIDOLOGIE, V41, P409, DOI 10.1051/apido/2010015; Shaibi T, 2008, MOL ECOL RESOUR, V8, P1034, DOI 10.1111/j.1755-0998.2008.02146.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Spivak M, 1996, APIDOLOGIE, V27, P245, DOI 10.1051/apido:19960407; Spivak M, 1998, APIDOLOGIE, V29, P291, DOI 10.1051/apido:19980308; Spivak M, 1998, BEE WORLD, V79, P124, DOI 10.1080/0005772X.1998.11099394; Spivak M, 1998, BEE WORLD, V79, P169, DOI 10.1080/0005772X.1998.11099408; SPIVAK M, 1993, J APICULT RES, V32, P147, DOI 10.1080/00218839.1993.11101300; Spivak M, 1998, J ECON ENTOMOL, V91, P64, DOI 10.1093/jee/91.1.64; Team RDC, 2019, R LANG ENV STAT COMP; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Viljakainen L, 2009, MOL BIOL EVOL, V26, P1791, DOI 10.1093/molbev/msp086; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wilfert L, 2007, EVOLUTION, V61, P804, DOI 10.1111/j.1558-5646.2007.00079.x; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301; Wilson-Rich N, 2012, J INSECT PHYSIOL, V58, P402, DOI 10.1016/j.jinsphys.2011.12.020; Zayed A, 2012, GENES BRAIN BEHAV, V11, P253, DOI 10.1111/j.1601-183X.2011.00750.x; Zayed A, 2012, ANNU REV GENET, V46, P591, DOI 10.1146/annurev-genet-110711-155517	60	19	19	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e104214	10.1371/journal.pone.0104214	http://dx.doi.org/10.1371/journal.pone.0104214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162411	Green Published, Green Submitted, gold			2022-12-25	WOS:000340880900008
J	Marelli, CA; Simons, ELR				Marelli, Crystal A.; Simons, Erin L. R.			Microstructure and Cross-Sectional Shape of Limb Bones in Great Horned Owls and Red-Tailed Hawks: How Do These Features Relate to Differences in Flight and Hunting Behavior?	PLOS ONE			English	Article							LONG BONES; FUNCTIONAL-MORPHOLOGY; FORELIMB SKELETON; BODY-SIZE; BIRDS; GEOMETRY; LAMINARITY; LOCOMOTION; HINDLIMB; RAPTORS	The Red-tailed Hawk and Great Horned Owl are two species of raptor that are similar in body size, diet, and habitat. Both species use their hindlimbs during hunting, but differ in foot morphology, how they approach and immobilize prey, and the average size of prey captured. They also differ in primary flight style: the Red-tailed Hawk uses static soaring and the Great Horned Owl uses flap-gliding. The objectives of this study were to characterize the microstructure and cross-sectional shape of limb bones of these species and examine the relationship with flight and hunting behaviors. The mid-shaft of six limb bones from six individuals of each species was sampled. The degree of bone laminarity (proportion of circular primary vascular canals) and cross-sectional geometric parameters were calculated. In both species, the humerus and femur exhibited features that suggest high resistance to torsional loading, whereas the tibiotarsus and phalanges had a shape more likely to resist compression and bending in a specific plane. The femur of the Red-tailed Hawk exhibited higher laminarity and larger polar moment of area than that of the Great Horned Owl. The tibiotarsus was more elliptical than that of the Great Horned Owl. The hawk approaches prey from a more horizontal axis, takes prey of greater mass, and is more likely to pursue prey on the ground, which could potentially be causing more torsional loads on the femur and bending loads on the tibiotarsus. In addition, differences in polar moment of area of the phalanges between the species could relate to differences in foot morphology or digit length. The humerus and ulna of the flap-gliding Great Horned Owl are more elliptical than the static soaring Red-tailed Hawk, a shape that may better resist the bending loads associated with a larger amount of flapping.	[Marelli, Crystal A.] Midwestern Univ, Arizona Coll Osteopath Med, Glendale, AZ USA; [Simons, Erin L. R.] Midwestern Univ, Arizona Coll Osteopath Med, Dept Anat, Glendale, AZ 85308 USA	Midwestern University; Midwestern University	Simons, ELR (corresponding author), Midwestern Univ, Arizona Coll Osteopath Med, Dept Anat, Glendale, AZ 85308 USA.	esimon@midwestern.edu			Midwestern University College of Health Sciences Biomedical Sciences	Midwestern University College of Health Sciences Biomedical Sciences	This work was supported by Midwestern University College of Health Sciences Biomedical Sciences graduate student funding to CAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y.H., 2003, HDB HISTOLOGY METHOD; BALLAM JM, 1984, AUK, V101, P519, DOI 10.1093/auk/101.3.519; BIEWENER AA, 1995, J MORPHOL, V225, P61, DOI 10.1002/jmor.1052250106; Carrano MT, 1999, J MORPHOL, V240, P237, DOI 10.1002/(SICI)1097-4687(199906)240:3<237::AID-JMOR3>3.3.CO;2-E; Carter R, 1991, J BIOMECH, V24, P3; Cubo J, 1998, EUR J MORPHOL, V36, P19, DOI 10.1076/ejom.36.1.19.9029; Currey J.D., 2002, BONES STRUCTURE MECH; DACKE CG, 1993, J EXP BIOL, V184, P63; Daegling DJ, 2002, J HUM EVOL, V43, P229, DOI 10.1006/jhev.2002.0574; De Margerie E, 2005, ANAT REC PART A, V282A, P49, DOI 10.1002/ar.a.20141; de Margerie E, 2002, J ANAT, V201, P521, DOI 10.1046/j.1469-7580.2002.00118.x; de Ricqles P, 1991, BONE, V3, P1; del Hoyo J., 1999, HDB BIRDS WORLD; DEMES B, 1993, J HUM EVOL, V25, P57, DOI 10.1006/jhev.1993.1038; DunningJr J. B., 2007, CRC HDB AVIAN BODY M, VSecond; Einoder L, 2006, IBIS, V148, P515, DOI 10.1111/j.1474-919X.2006.00541.x; Einoder LD, 2007, AUK, V124, P773, DOI 10.1642/0004-8038(2007)124[773:AOTHMO]2.0.CO;2; Enlow D. H., 1957, Texas Journal of Science, V9, P186; Fitch Henry S., 1946, CONDOR, V48, P205, DOI 10.2307/1363939; Fowler DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007999; GOSLOW GE, 1971, AUK, V88, P815, DOI 10.2307/4083840; GOSLOW GE, 1972, AUK, V89, P47, DOI 10.2307/4084059; Habib MB, 2008, ZOOL J LINN SOC-LOND, V153, P601, DOI 10.1111/j.1096-3642.2008.00402.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Humphrey J. D., 2004, INTRO BIOMECHANICS S, P271; Klein-Nulend J, 2005, PATHOL BIOL, V53, P576, DOI 10.1016/j.patbio.2004.12.005; Lee AH, 2013, J VERTEBR PALEONTOL, V33, P865, DOI 10.1080/02724634.2013.743898; Lieberman DE, 2004, AM J PHYS ANTHROPOL, V123, P156, DOI 10.1002/ajpa.10316; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Main RP, 2007, J EXP BIOL, V210, P2676, DOI 10.1242/jeb.004580; Marti CD, 1995, WILSON BULL, V107, P615; MARTI CD, 1974, CONDOR, V76, P45, DOI 10.2307/1365983; Mi Y, 2005, BIOMECHANICAL MODEL, V4, P118; Norberg UM, 1984, FLYING GLIDING SOARI, P129; Preston CR, 1993, BIRDS N AM AM ORNITH; Rath NC, 2000, POULTRY SCI, V79, P1024, DOI 10.1093/ps/79.7.1024; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; SELANDER RK, 1966, CONDOR, V68, P113, DOI 10.2307/1365712; Simons ELR, 2012, ANAT REC, V295, P386, DOI 10.1002/ar.22402; Simons ELR, 2011, J MORPHOL, V272, P958, DOI 10.1002/jmor.10963; Skedros JG, 2004, J ANAT, V205, P121, DOI 10.1111/j.0021-8782.2004.00318.x; SPRINGER MA, 1978, OHIO J SCI, V78, P323; Sustaita D, 2008, J MORPHOL, V269, P283, DOI 10.1002/jmor.10577; Sustaita D, 2013, BIOL REV, V88, P380, DOI 10.1111/brv.12010; Wainwright S.A., 1976, MECH DESIGN ORGANISM; Ward AB, 2002, AUK, V119, P1052, DOI 10.1642/0004-8038(2002)119[1052:FMORHI]2.0.CO;2; Young W C, 1989, ROARKS FORMULAS STRE	47	11	11	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106094	10.1371/journal.pone.0106094	http://dx.doi.org/10.1371/journal.pone.0106094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162595	Green Submitted, gold, Green Published			2022-12-25	WOS:000340880900088
J	Wang, PS; Liu, ZC; Liu, XL; Teng, HM; Zhang, CL; Hou, L; Zou, XY				Wang, Peisheng; Liu, Zhichao; Liu, Xianli; Teng, Hongming; Zhang, Cuili; Hou, Lin; Zou, Xiangyang			Anti-Metastasis Effect of Fucoidan from Undaria pinnatifida Sporophylls in Mouse Hepatocarcinoma Hca-F Cells	PLOS ONE			English	Article							SMMC-7721 CELLS; IN-VITRO; EXPRESSION; VEGF; ANGIOGENESIS; ANTITUMOR; METALLOPROTEINASES; LYMPHANGIOGENESIS; ANTICOAGULANT; PROLIFERATION	Metastasis is one of the major causes of cancer-related death. It is a complex biological process involving multiple genes, steps, and phases. It is also closely connected to many biological activities of cancer cells, such as growth, invasion, adhesion, hematogenous metastasis, and lymphatic metastasis. Fucoidan derived from Undaria pinnatifida sporophylls (Ups-fucoidan) is a sulfated polysaccharide with more biological activities than other fucoidans. However, there is no information on the effects of Ups-fucoidan on tumor invasion and metastasis. We used the mouse hepatocarcinoma Hca-F cell line, which has high invasive and lymphatic metastasis potential in vitro and in vivo, to examine the effect of Ups-fucoidan on cancer cell invasion and metastasis. Ups-fucoidan exerted a concentration-and time-dependent inhibitory effect on tumor metastasis in vivo and inhibited Hca-F cell growth, migration, invasion, and adhesion capabilities in vitro. Ups-fucoidan inhibited growth and metastasis by downregulating vascular endothelial growth factor (VEGF) C/VEGF receptor 3, hepatocyte growth factor/c-MET, cyclin D1, cyclin-dependent kinase 4, phosphorylated (p) phosphoinositide 3-kinase, p-Akt, p-extracellular signal regulated kinase (ERK) 1/2, and nuclear transcription factor-kappa B (NF-kappa B), and suppressed adhesion and invasion by downregulating L-Selectin, and upregulating protein levels of tissue inhibitor of metalloproteinases (TIMPs). The results suggest that Ups-fucoidan suppresses Hca-F cell growth, adhesion, invasion, and metastasis capabilities and that these functions are mediated through the mechanism involving inactivation of the NF-kB pathway mediated by PI3K/Akt and ERK signaling pathways.	[Wang, Peisheng; Liu, Zhichao; Liu, Xianli; Teng, Hongming; Zhang, Cuili; Zou, Xiangyang] Dalian Med Univ, Dept Biotechnol, Dalian, Peoples R China; [Hou, Lin] Liaoning Normal Univ, Coll Life Sci, Dalian, Peoples R China	Dalian Medical University; Liaoning Normal University	Zou, XY (corresponding author), Dalian Med Univ, Dept Biotechnol, Dalian, Peoples R China.	houlin01@126.com; zouxiangyang@126.com			Education Department of Liaoning Province of the People's Republic of China [2009A199]; Science and Technology Department Program of Liaoning Province of China [2011225013]	Education Department of Liaoning Province of the People's Republic of China; Science and Technology Department Program of Liaoning Province of China	This research was supported by the Research Fund from the Education Department of Liaoning Province of the People's Republic of China (No. 2009A199), and the Science and Technology Department Program of Liaoning Province of China (2011225013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ale MT, 2011, MAR DRUGS, V9, P2106, DOI 10.3390/md9102106; Baker Stacey J, 2012, Genes Cancer, V3, P658, DOI 10.1177/1947601913478972; Cao ZF, 2013, BBA-REV CANCER, V1836, P273, DOI 10.1016/j.bbcan.2013.08.001; Chen D, 2010, J ETHNOPHARMACOL, V127, P702, DOI 10.1016/j.jep.2009.12.003; Cho ML, 2011, MOLECULES, V16, P291, DOI 10.3390/molecules16010291; Choi JS, 2011, ONCOL RES, V19, P455, DOI 10.3727/096504012X13285365944256; Chung HJ, 2010, PHYTOTHER RES, V24, P1078, DOI 10.1002/ptr.3138; Ciznadija D, 2011, CANCER RES, V71, P6174, DOI 10.1158/0008-5472.CAN-11-1031; Cumashi A, 2007, GLYCOBIOLOGY, V17, P541, DOI 10.1093/glycob/cwm014; Dai L, 2009, CANCER LETT, V283, P159, DOI 10.1016/j.canlet.2009.03.036; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Fournier NM, 2012, NEUROPHARMACOLOGY, V63, P642, DOI 10.1016/j.neuropharm.2012.04.033; Hirano T, 2013, BIOCHEM PHARMACOL, V86, P1419, DOI 10.1016/j.bcp.2013.09.001; Hsu HY, 2013, CARCINOGENESIS, V34, P874, DOI 10.1093/carcin/bgs396; Ikeguchi M, 2011, ONCOL LETT, V2, P319, DOI 10.3892/ol.2011.254; Ivetic A, 2013, INT J BIOCHEM CELL B, V45, P550, DOI 10.1016/j.biocel.2012.12.023; Jia L, 2006, IUBMB LIFE, V58, P209, DOI 10.1080/15216540600719580; Kim HG, 2012, FOOD CHEM, V133, P1521, DOI 10.1016/j.foodchem.2012.02.043; Kim KJ, 2012, NUTR RES, V32, P439, DOI 10.1016/j.nutres.2012.04.003; Kim KJ, 2010, FOOD CHEM TOXICOL, V48, P1101, DOI 10.1016/j.fct.2010.01.032; Kimura Y, 2013, PHYTOMEDICINE, V20, P328, DOI 10.1016/j.phymed.2012.10.016; Koh YW, 2011, J NUTR BIOCHEM, V22, P1074, DOI 10.1016/j.jnutbio.2010.09.005; Koyanagi S, 2003, BIOCHEM PHARMACOL, V65, P173, DOI 10.1016/S0006-2952(02)01478-8; Kwak JY, 2014, MAR DRUGS, V12, P851, DOI 10.3390/md12020851; Lee H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050624; Lee KW, 2013, CARBOHYD POLYM, V94, P850, DOI 10.1016/j.carbpol.2013.02.018; Lekstan A, 2012, J PHYSIOL PHARMACOL, V63, P589; Li Y, 2013, MOL MED REP, V8, P655, DOI 10.3892/mmr.2013.1527; Liu F, 2012, PHYTOMEDICINE, V19, P797, DOI 10.1016/j.phymed.2012.03.015; Liu HD, 2011, MICROVASC RES, V82, P131, DOI 10.1016/j.mvr.2011.04.011; Mak W, 2013, CARBOHYD POLYM, V95, P606, DOI 10.1016/j.carbpol.2013.02.047; Meng F, 2007, AM J PHYSIOL-CELL PH, V293, pC749, DOI 10.1152/ajpcell.00537.2006; Nataraj NB, 2013, CELL SIGNAL, V25, P277, DOI 10.1016/j.cellsig.2012.09.013; Ogunwobi OO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063765; Park HY, 2011, FOOD CHEM TOXICOL, V49, P1745, DOI 10.1016/j.fct.2011.04.020; Ran S, 2010, PATHOPHYSIOLOGY, V17, P229, DOI DOI 10.1016/J.PATH0PHYS.2009.11.003; Resto VA, 2008, J BIOL CHEM, V283, P15816, DOI 10.1074/jbc.M708899200; Scagliotti GV, 2013, CANCER TREAT REV, V39, P793, DOI 10.1016/j.ctrv.2013.02.001; Senthilkumar K, 2013, INT J BIOL MACROMOL, V60, P366, DOI 10.1016/j.ijbiomac.2013.06.030; Stella MC, 1999, INT J BIOCHEM CELL B, V31, P1357, DOI 10.1016/S1357-2725(99)00089-8; Sulminoe A, 2007, LEUKEMIA RES, V31, P1437, DOI 10.1016/j.leukres.2007.01.015; Synytsya A, 2010, CARBOHYD POLYM, V81, P41, DOI 10.1016/j.carbpol.2010.01.052; Tsutsui S, 2010, ONCOL REP, V23, P621, DOI 10.3892/or_00000677; Wang J, 2011, CHIN J OCEANOL LIMN, V29, P679, DOI 10.1007/s00343-011-0181-9; Wang SJ, 2011, IUBMB LIFE, V63, P775, DOI 10.1002/iub.507; Yang LL, 2013, MAR DRUGS, V11, P1961, DOI 10.3390/md11061961; Zhang ZH, 2013, PLOS ONE, V8, pe6528; Zhang ZY, 2013, MAR DRUGS, V11, P81, DOI 10.3390/md11010081; Zhao R, 2010, CANCER LETT, V287, P150, DOI 10.1016/j.canlet.2009.06.006; Zhou HM, 2006, BIOCHEM BIOPH RES CO, V345, P486, DOI 10.1016/j.bbrc.2006.03.246; Zhu L, 2007, BIOMED PHARMACOTHER, V61, P558, DOI 10.1016/j.biopha.2007.08.015	51	27	27	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106071	10.1371/journal.pone.0106071	http://dx.doi.org/10.1371/journal.pone.0106071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162296	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900085
J	Zhao, WJ; Song, Q; Wang, YH; Li, KJ; Mao, L; Hu, X; Lian, HZ; Zheng, WJ; Hua, ZC				Zhao, Wen-jie; Song, Qun; Wang, Yan-hong; Li, Ke-jin; Mao, Li; Hu, Xin; Lian, Hong-zhen; Zheng, Wei-juan; Hua, Zi-chun			Zn-Responsive Proteome Profiling and Time-Dependent Expression of Proteins Regulated by MTF-1 in A549 Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MTF-1; METALLOTHIONEIN-I; GENE-EXPRESSION; ESCHERICHIA-COLI; BINDING PROTEINS; TRANSGENIC MICE; HEAVY-METALS; ZINC-BINDING; DNA-BINDING; IDENTIFICATION	Zinc plays a critical role in many biological processes. However, it is toxic at high concentrations and its homeostasis is strictly regulated by metal-responsive transcription factor 1 (MTF-1) together with many other proteins to protect cells against metal toxicity and oxidative stresses. In this paper, we used high-resolution two-dimensional gel electrophoresis (2DE) to profile global changes of the whole soluble proteome in human lung adenocarcinoma (A549) cells in response to exogenous zinc treatment for 24 h. Eighteen differentially expressed proteins were identified by MALDI TOF/TOF and MASCOT search. In addition, we used Western blotting and RT-PCR to examine the time-dependent changes in expression of proteins regulated by MTF-1 in response to Zn treatment, including the metal binding protein MT-1, the zinc efflux protein ZnT-1, and the zinc influx regulator ZIP-1. The results indicated that variations in their mRNA and protein levels were consistent with their functions in maintaining the homeostasis of zinc. However, the accumulation of ZIP-1 transcripts was down-regulated while the protein level was up-regulated during the same time period. This may be due to the complex regulatory mechanism of ZIP-1, which is involved in multiple signaling pathways. Maximal changes in protein abundance were observed at 10 h following Zn treatment, but only slight changes in protein or mRNA levels were observed at 24 h, which was the time-point frequently used for 2DE analyses. Therefore, further study of the time-dependent Zn-response of A549 cells would help to understand the dynamic nature of the cellular response to Zn stress. Our findings provide the basis for further study into zinc-regulated cellular signaling pathways.	[Zhao, Wen-jie; Song, Qun; Wang, Yan-hong; Hu, Xin; Lian, Hong-zhen] Nanjing Univ, State Key Lab Analyt Chem Life Sci, Sch Chem & Chem Engn, Nanjing 210008, Jiangsu, Peoples R China; [Zhao, Wen-jie; Song, Qun; Wang, Yan-hong; Hu, Xin; Lian, Hong-zhen] Nanjing Univ, Ctr Mat Anal, Nanjing 210008, Jiangsu, Peoples R China; [Li, Ke-jin; Zheng, Wei-juan; Hua, Zi-chun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Mao, Li] Nanjing Med Univ, Sch Publ Hlth, MOE Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing Medical University	Lian, HZ (corresponding author), Nanjing Univ, State Key Lab Analyt Chem Life Sci, Sch Chem & Chem Engn, Nanjing 210008, Jiangsu, Peoples R China.	hzlian@nju.edu.cn; wjzheng@nju.edu.cn	wang, yan/GSE-6489-2022; wang, yi/GVT-8516-2022; Hu, Xin/B-1792-2009; Wang, Yanbo/HFZ-8018-2022	Hu, Xin/0000-0003-3400-554X; 	National Basic Research Program of China (973 program) [2011CB911003]; National Natural Science Foundation of China [90913012, 21275069, 21177061, 21121091]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 program, 2011CB911003) and National Natural Science Foundation of China (90913012, 21275069, 21177061, 21121091) http://www.nsfc.gov.cn/publish/portal0/default.htm; http://www.973.gov.cn/AreaAppl.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews GK, 2001, BIOMETALS, V14, P223, DOI 10.1023/A:1012932712483; Balesaria S, 2010, FEBS LETT, V584, P719, DOI 10.1016/j.febslet.2009.12.023; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Binet MRB, 2003, ANAL BIOCHEM, V318, P30, DOI 10.1016/S0003-2697(03)00190-8; Bittel D, 1998, J BIOL CHEM, V273, P7127, DOI 10.1074/jbc.273.12.7127; BRUGNERA E, 1994, NUCLEIC ACIDS RES, V22, P3167, DOI 10.1093/nar/22.15.3167; Chen DS, 2011, AQUAT TOXICOL, V104, P270, DOI 10.1016/j.aquatox.2011.05.004; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; Conradas KA, 2005, MOL CELL PROTEOMICS, V4, P1284, DOI 10.1074/mcp.M500082-MCP200; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Dalton T, 1996, J NUTR, V126, P825, DOI 10.1093/jn/126.4.825; Dalton TP, 1997, MOL CELL BIOL, V17, P2781, DOI 10.1128/MCB.17.5.2781; Devergnas S, 2004, BIOCHEM PHARMACOL, V68, P99; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Fukao Y, 2009, PLANT CELL PHYSIOL, V50, P2234, DOI 10.1093/pcp/pcp154; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Gumulec J, 2011, CURR MED CHEM, V18, P5041, DOI 10.2174/092986711797636126; Haase H, 2007, MOL MED, V13, P362, DOI 10.2119/2007-00049.Haase; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; Hogstrand C, 2008, BIOCHEM SOC T, V36, P1252, DOI 10.1042/BST0361252; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Jayaraman AK, 2011, J NUTR BIOCHEM, V22, P79, DOI 10.1016/j.jnutbio.2009.12.001; Katayama A, 2002, EUR J BIOCHEM, V269, P2403, DOI 10.1046/j.1432-1033.2002.02900.x; Kuo CC, 2005, PROTEOMICS, V5, P894, DOI 10.1002/pmic.200401144; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; LaRochelle O, 2008, J BIOL CHEM, V283, P8190, DOI 10.1074/jbc.M800640200; LAZO JS, 1995, J BIOL CHEM, V270, P5506, DOI 10.1074/jbc.270.10.5506; Leung KW, 2008, INVEST OPHTH VIS SCI, V49, P1221, DOI 10.1167/iovs.07-0781; Li Y, 2008, MOL CELL BIOL, V28, P4275, DOI 10.1128/MCB.00369-08; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Martin SAM, 2007, PROTEOMICS, V7, P2275, DOI 10.1002/pmic.200700020; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Munday DC, 2010, PROTEOMICS, V10, P4320, DOI 10.1002/pmic.201000228; Palmiter RD, 2004, P NATL ACAD SCI USA, V101, P4918, DOI 10.1073/pnas.0401022101; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Pandey A, 2000, P NATL ACAD SCI USA, V97, P179, DOI 10.1073/pnas.97.1.179; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; ROGERS FB, 1963, B MED LIBR ASSOC, V51, P114; Rogowska-Wrzesinska A, 2013, J PROTEOMICS, V88, P4, DOI 10.1016/j.jprot.2013.01.010; Sauvageau JA, 2013, CELL BIOL TOXICOL, V29, P159, DOI 10.1007/s10565-013-9243-4; Saydam N, 2002, J BIOL CHEM, V277, P20438, DOI 10.1074/jbc.M110631200; Scheurer SB, 2004, PROTEOMICS, V4, P1737, DOI 10.1002/pmic.200300689; Sigdel TK, 2006, BIOMETALS, V19, P461, DOI 10.1007/s10534-005-4962-5; Song Y, 2010, FREE RADICAL BIO MED, V48, P82, DOI 10.1016/j.freeradbiomed.2009.10.030; Tougu V, 2011, METALLOMICS, V3, P250, DOI 10.1039/c0mt00073f; Troadec MB, 2010, BLOOD, V116, P4657, DOI 10.1182/blood-2010-04-278614; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Zeng XW, 2011, CHEMOSPHERE, V82, P321, DOI 10.1016/j.chemosphere.2010.10.030; Zhang B, 2003, MOL CELL BIOL, V23, P8471, DOI 10.1128/MCB.23.23.8471-8485.2003	54	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105797	10.1371/journal.pone.0105797	http://dx.doi.org/10.1371/journal.pone.0105797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162517	Green Submitted, Green Published, gold			2022-12-25	WOS:000340880900051
J	Miyamoto, K; Matsumoto, T; Okada, A; Komiyama, K; Chujo, T; Yoshikawa, H; Nojiri, H; Yamane, H; Okada, K				Miyamoto, Koji; Matsumoto, Takashi; Okada, Atsushi; Komiyama, Kohei; Chujo, Tetsuya; Yoshikawa, Hirofumi; Nojiri, Hideaki; Yamane, Hisakazu; Okada, Kazunori			Identification of Target Genes of the bZIP Transcription Factor OsTGAP1, Whose Overexpression Causes Elicitor-Induced Hyperaccumulation of Diterpenoid Phytoalexins in Rice Cells	PLOS ONE			English	Article							DISEASE-RESISTANCE; BINDING-SITES; BIOSYNTHESIS; CLUSTER; PROTEIN; MOMILACTONES; ISOPRENOIDS; MECHANISMS; EXPRESSION; REPRESSOR	Phytoalexins are specialised antimicrobial metabolites that are produced by plants in response to pathogen attack. Momilactones and phytocassanes are the major diterpenoid phytoalexins in rice and are synthesised from geranylgeranyl diphosphate, which is derived from the methylerythritol phosphate (MEP) pathway. The hyperaccumulation of momilactones and phytocassanes due to the hyperinductive expression of the relevant biosynthetic genes and the MEP pathway gene OsDXS3 in OsTGAP1-overexpressing (OsTGAP1ox) rice cells has previously been shown to be stimulated by the chitin oligosaccharide elicitor. In this study, to clarify the mechanisms of the elicitor-stimulated coordinated hyperinduction of these phytoalexin biosynthetic genes in OsTGAP1ox cells, transcriptome analysis and chromatin immunoprecipitation with next-generation sequencing were performed, resulting in the identification of 122 OsTGAP1 target genes. Transcriptome analysis revealed that nearly all of the momilactone and phytocassane biosynthetic genes, which are clustered on chromosomes 4 and 2, respectively, and the MEP pathway genes were hyperinductively expressed in the elicitor-stimulated OsTGAP1ox cells. Unexpectedly, none of the clustered genes was included among the OsTGAP1 target genes, suggesting that OsTGAP1 did not directly regulate the expression of these biosynthetic genes through binding to each promoter region. Interestingly, however, several OsTGAP1-binding regions were found in the intergenic regions among and near the cluster regions. Concerning the MEP pathway genes, only OsDXS3, which encodes a key enzyme of the MEP pathway, possessed an OsTGAP1-binding region in its upstream region. A subsequent transactivation assay further confirmed the direct regulation of OsDXS3 expression by OsTGAP1, but other MEP pathway genes were not included among the OsTGAP1 target genes. Collectively, these results suggest that OsTGAP1 participates in the enhanced accumulation of diterpenoid phytoalexins, primarily through mechanisms other than the direct transcriptional regulation of the genes involved in the biosynthetic pathway of these phytoalexins.	[Miyamoto, Koji; Yamane, Hisakazu] Teikyo Univ, Dept Biosci, Utsunomiya, Tochigi, Japan; [Miyamoto, Koji; Okada, Atsushi; Komiyama, Kohei; Chujo, Tetsuya; Nojiri, Hideaki; Yamane, Hisakazu; Okada, Kazunori] Univ Tokyo, Bunkyo Ku, Biotechnol Res Ctr, Tokyo 113, Japan; [Matsumoto, Takashi; Yoshikawa, Hirofumi] Tokyo Univ Agr, Setagaya Ku, Nodai Res Inst, Genome Res Ctr, Tokyo 1568502, Japan; [Yoshikawa, Hirofumi] Tokyo Univ Agr, Setagaya Ku, Dept Biosci, Tokyo 1568502, Japan	Teikyo University; University of Tokyo; Tokyo University of Agriculture; Tokyo University of Agriculture	Okada, K (corresponding author), Univ Tokyo, Bunkyo Ku, Biotechnol Res Ctr, Tokyo 113, Japan.	ukokada@mail.ecc.u-tokyo.ac.jp	Miyamoto, Koji/N-1504-2014	Miyamoto, Koji/0000-0002-9862-7412	JSPS [22380066, 09J01084]; Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Education, Culture, Sports, Science and Technology-Supported Program for the Strategic Research Foundation at Private Universities [S131052A01]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Education, Culture, Sports, Science and Technology-Supported Program for the Strategic Research Foundation at Private Universities	This work was supported by a JSPS Grant-in-Aid for Scientific Research to H.Y. (No. 22380066), by a Grant-in-Aid for JSPS Fellows to K.M. (No. 09J01084), and by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) to K.O. This work was funded in part by Ministry of Education, Culture, Sports, Science and Technology- Supported Program for the Strategic Research Foundation at Private Universities [2013-2017] to H.Y. [project number S131052A01]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; CARTWRIGHT DW, 1981, PHYTOCHEMISTRY, V20, P535, DOI 10.1016/S0031-9422(00)84189-8; Chern MS, 2001, PLANT J, V27, P101, DOI 10.1046/j.1365-313x.2001.01070.x; Cho EM, 2004, PLANT J, V37, P1, DOI 10.1046/j.1365-313X.2003.01926.x; Chujo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098737; Delteil A, 2012, MOL PLANT PATHOL, V13, P72, DOI 10.1111/j.1364-3703.2011.00731.x; Fitzgerald HA, 2005, PLANT J, V43, P335, DOI 10.1111/j.1365-313X.2005.02457.x; Ikeda M, 2009, PLANT CELL, V21, P3493, DOI 10.1105/tpc.109.069997; Ito Y, 1997, PLANT J, V12, P347, DOI 10.1046/j.1365-313X.1997.12020347.x; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; KATO T, 1973, TETRAHEDRON LETT, P3861; Kim BR, 2005, BIOTECHNOL LETT, V27, P997, DOI 10.1007/s10529-005-7849-1; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lichtenthaler HK, 1997, FEBS LETT, V400, P271, DOI 10.1016/S0014-5793(96)01404-4; Lois LM, 2000, PLANT J, V22, P503, DOI 10.1046/j.1365-313x.2000.00764.x; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Moore JW, 2011, PLANT CELL, V23, P2809, DOI 10.1105/tpc.111.087346; Morita Y, 2007, PLANT CELL PHYSIOL, V48, P540, DOI 10.1093/pcp/pcm024; Nakagawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P624, DOI 10.1271/bbb.70678; NEUWALD AF, 1995, PROTEIN SCI, V4, P1618, DOI 10.1002/pro.5560040820; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; Oh E, 2009, PLANT CELL, V21, P403, DOI 10.1105/tpc.108.064691; Ohta M, 2000, PLANT J, V22, P29, DOI 10.1046/j.1365-313x.2000.00709.x; Okada A, 2007, PLANT MOL BIOL, V65, P177, DOI 10.1007/s11103-007-9207-2; Okada A, 2009, J BIOL CHEM, V284, P26510, DOI 10.1074/jbc.M109.036871; Okada K, 2011, BIOSCI BIOTECH BIOCH, V75, P1219, DOI 10.1271/bbb.110228; Otomo K, 2004, BIOSCI BIOTECH BIOCH, V68, P2001, DOI 10.1271/bbb.68.2001; Otomo K, 2004, PLANT J, V39, P886, DOI 10.1111/j.1365-313X.2004.02175.x; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Swaminathan S, 2009, PLANT CELL, V21, P3315, DOI 10.1105/tpc.108.063677; Thibaud-Nissen F, 2006, PLANT J, V47, P152, DOI 10.1111/j.1365-313X.2006.02770.x; Tong HN, 2009, PLANT J, V58, P803, DOI 10.1111/j.1365-313X.2009.03825.x; Wang Q, 2012, PLANT PHYSIOL, V158, P1418, DOI 10.1104/pp.111.187518; Wang Q, 2012, J BIOL CHEM, V287, P6159, DOI 10.1074/jbc.M111.305599; Wang QA, 2011, PLANT J, V65, P87, DOI 10.1111/j.1365-313X.2010.04408.x; Wu YS, 2011, FEBS LETT, V585, P3446, DOI 10.1016/j.febslet.2011.09.038; Yamaguchi T, 2009, PLANT PHYSIOL, V150, P308, DOI 10.1104/pp.108.131979; Yamane H, 2013, BIOSCI BIOTECH BIOCH, V77, P1141, DOI 10.1271/bbb.130109; Yokotani N, 2013, J EXP BOT, V64, P5085, DOI 10.1093/jxb/ert298; Yuan YX, 2007, PLANT BIOTECHNOL J, V5, P313, DOI 10.1111/j.1467-7652.2007.00243.x; Zheng YM, 2009, PLANT CELL, V21, P2563, DOI 10.1105/tpc.109.068890	44	26	30	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105823	10.1371/journal.pone.0105823	http://dx.doi.org/10.1371/journal.pone.0105823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157897	Green Submitted, gold, Green Published			2022-12-25	WOS:000341303200070
J	Wu, BJ; Chiu, CC; Chen, CL; Wang, WD; Wang, JH; Wen, ZH; Liu, WT; Chang, HW; Wu, CY				Wu, Bao-Jueng; Chiu, Chien-Chih; Chen, Chun-Lin; Wang, Wen-Der; Wang, Jia-Hong; Wen, Zhi-Hong; Liu, Wangta; Chang, Hsueh-Wei; Wu, Chang-Yi			Nuclear Receptor Subfamily 2 Group F Member 1a (nr2f1a) Is Required for Vascular Development in Zebrafish	PLOS ONE			English	Article							LYMPHATIC ENDOTHELIAL-CELLS; COUP-TFII; VENOUS DIFFERENTIATION; GENE-EXPRESSION; ORPHAN; ANGIOGENESIS; EMBRYOS; PROX1	Genetic regulators and signaling pathways are important for the formation of blood vessels. Transcription factors controlling vein identity, intersegmental vessels (ISV) growth and caudal vein plexus (CVP) formation in zebrafish are little understood as yet. Here, we show the importance of the nuclear receptor subfamily member 1A (nr2f1a) in zebrafish vascular development. Amino acid sequence alignment and phylogenetic analysis of nr2f1a is highly conserved among the vertebrates. Our in situ hybridization results showed nr2f1a mRNA is expressed in the lateral plate mesoderm at 18 somite stage and in vessels at 24-30 hpf, suggesting its roles in vasculization. Consistent with this morpholino-based knockdown of nr2fla impaired ISV growth and failed to develop fenestrated vascular structure in CVP, suggesting that nr2f1a has important roles in controlling ISV and CVP growth. Consequently, nr2f1a morphants showed pericardial edema and circulation defects. We further demonstrated reduced ISV cells and decreased CVP endothelial cells sprouting in nr2f1a morphants, indicating the growth impairment of ISV and CVP is due to a decrease of cell proliferation and migration, but not results from cell death in endothelial cells after morpholino knockdown. To test molecular mechanisms and signals that are associated with nr2f1a, we examined the expression of vascular markers. We found that a loss of nr2f1a results in a decreased expression of vein/ISV specific markers, flt4, mrc1, vascular markers stabilin and ephrinb2. This indicates the regulatory role of nr2f1a in controlling vascular development. We further showed that nr2f1a likely interact with Notch signaling by examining nr2f1a expression in rbpsuh morphants and DAPT-treatment embryos. Together, we show nr2f1a plays a critical role for vascular development in zebrafish.	[Chen, Chun-Lin; Wang, Jia-Hong; Wu, Chang-Yi] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Chen, Chun-Lin; Wen, Zhi-Hong; Wu, Chang-Yi] Natl Sun Yat Sen Univ, Marine Biotechnol Doctoral Program, Kaohsiung 80424, Taiwan; [Wu, Bao-Jueng; Wen, Zhi-Hong] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan; [Wu, Bao-Jueng] Kaohsiung Armed Forces Gen Hosp, Zuoying Branch, Kaohsiung, Taiwan; [Chiu, Chien-Chih; Liu, Wangta] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Wang, Wen-Der] Natl Chiayi Univ, Dept Bioagr Sci, Chiayi, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan	National Sun Yat Sen University; National Sun Yat Sen University; National Sun Yat Sen University; Kaohsiung Medical University; National Chiayi University; Kaohsiung Medical University	Wu, CY (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan.	cywu@mail.nsysu.edu.tw	Chang, Hsueh-Wei/C-9654-2009; Wen, Zhi-Hong/AAG-8034-2019; Chiu, Chien-Chih/AAW-9861-2020; Wang, Wen-Der/AGO-2974-2022	Chang, Hsueh-Wei/0000-0003-0068-2366; Chiu, Chien-Chih/0000-0001-7307-2468; 	National Science Council, Taiwan [NSC101-2311-B-110-002, NSC102-2311-B-110-002]; NSYSU-KMU Joint Research Project [NSYSUKMU102-P028]; Zuoying Branch of Kaohsiung Armed Forces General Hospital, Taiwan [ZAFGH 102-03]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NSYSU-KMU Joint Research Project; Zuoying Branch of Kaohsiung Armed Forces General Hospital, Taiwan	This work was supported by the grants from National Science Council, Taiwan (NSC101-2311-B-110-002, NSC102-2311-B-110-002) and from the NSYSU-KMU Joint Research Project (#NSYSUKMU102-P028) to CYW; the grant from Zuoying Branch of Kaohsiung Armed Forces General Hospital, Taiwan to BJW (ZAFGH 102-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranguren XL, 2011, BIOCHEM BIOPH RES CO, V410, P121, DOI 10.1016/j.bbrc.2011.05.117; Bertrand S, 2007, PLOS GENET, V3, P2085, DOI 10.1371/journal.pgen.0030188; Childs S, 2002, DEVELOPMENT, V129, P973; Choi J, 2007, DEV BIOL, V304, P735, DOI 10.1016/j.ydbio.2007.01.023; Christie TL, 2010, DEV BIOL, V340, P22, DOI 10.1016/j.ydbio.2010.01.011; Hamik A, 2006, ARTERIOSCLER THROMB, V5, P797; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; Kim J, 2012, DEV CELL, V23; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lamont Ryan E, 2006, Sci STKE, V2006, ppe39, DOI 10.1126/stke.3552006pe39; Lamont RE, 2010, MECH DEVELOP, V127, P159, DOI 10.1016/j.mod.2010.02.001; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lin FJ, 2011, ENDOCR REV, V32, P404, DOI 10.1210/er.2010-0021; Love CE, 2012, DEV DYNAM, V241, P1603, DOI 10.1002/dvdy.23838; Montemayor C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008910; Patterson C, 2009, NAT MED, V15, P137, DOI 10.1038/nm0209-137; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Srinivasan RS, 2010, GENE DEV, V24, P696, DOI 10.1101/gad.1859310; Swift MR, 2014, DEV BIOL, V390, P116, DOI 10.1016/j.ydbio.2014.03.018; Tang K, 2010, DEVELOPMENT, V137, P725, DOI 10.1242/dev.040568; Thisse B, 2005, HIGH THROUGHPUT EXPR; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232; Wong KS, 2009, DEV DYNAM, V238, P1836, DOI 10.1002/dvdy.21990; Yamazaki T, 2009, GENES CELLS, V14, P425, DOI 10.1111/j.1365-2443.2008.01279.x; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zhou C, 2001, GENES DEV, V15	31	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105939	10.1371/journal.pone.0105939	http://dx.doi.org/10.1371/journal.pone.0105939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157918	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303200079
J	King, ML; Lindberg, ME; Stodden, GR; Okuda, H; Ebers, SD; Johnson, A; Montag, A; Lengyel, E; MacLean, JA; Hayashi, K				King, M. L.; Lindberg, M. E.; Stodden, G. R.; Okuda, H.; Ebers, S. D.; Johnson, A.; Montag, A.; Lengyel, E.; MacLean, J. A., II; Hayashi, K.			WNT7A/beta-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer	ONCOGENE			English	Article							TUMOR-CELL GROWTH; E-CADHERIN; POTENTIAL REGULATION; ADVANCED-STAGE; WNT PATHWAY; EXPRESSION; INHIBITION; CATENIN; TARGET; GENE	We previously characterized the link between WNT7A and the progression of ovarian cancer. Other groups have identified FGF1 as a relevant risk factor in ovarian cancer. Here, we show a linkage between these two signaling pathways that may be exploited to improve treatment and prognosis of patients with ovarian cancer. High expression of WNT7A and FGF1 are correlated in ovarian carcinomas and poor overall patient survival. A chromatin immunoprecipitation assay demonstrated that WNT7A/beta-catenin signaling directly regulates FGF1 expression via TCF binding elements in the FGF1-1C promoter locus. In vitro gene manipulation studies revealed that FGF1 is sufficient to drive the tumor-promoting effects of WNT7A. In vivo xenograft studies confirmed that the stable overexpression of WNT7A or FGF1 induced a significant increase in tumor incidence, whereas FGF1 knockdown in WNT7A overexpressing cells caused a significant reduction in tumor size. Niclosamide most efficiently abrogated WNT7A/beta-catenin signaling in our model, inhibited beta-catenin transcriptional activity and cell viability, and increased cell death. Furthermore, niclosamide decreased cell migration following an increase in E-cadherin subsequent to decreased levels of SLUG. The effects of niclosamide on cell functions were more potent in WNT7A-overexpressing cells. Oral niclosamide inhibited tumor growth and progression in an intraperitoneal xenograft mouse model representative of human ovarian cancer. Collectively, these results indicate that FGF1 is a direct downstream target of WNT7A/beta-catenin signaling and this pathway has potential as a therapeutic target in ovarian cancer. Moreover, niclosamide is a promising inhibitor of this pathway and may have clinical relevance.	[King, M. L.; Lindberg, M. E.; Stodden, G. R.; Ebers, S. D.; MacLean, J. A., II; Hayashi, K.] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; [Okuda, H.] Kyoto Univ, Grad Sch Med, Lab Malignancy Control Res, Kyoto, Japan; [Johnson, A.; Lengyel, E.] Univ Chicago, Dept Obstet & Gynecol, Med Ctr, Gynecol Oncol Sect, Chicago, IL 60637 USA; [Montag, A.] Univ Chicago, Med Ctr, Dept Pathol, Chicago, IL 60637 USA	Southern Illinois University System; Southern Illinois University; Kyoto University; University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center	Hayashi, K (corresponding author), So Illinois Univ, Sch Med, Dept Physiol, 1135 Lincoln Dr, Carbondale, IL 62901 USA.	khayashi@siumed.edu	Lengyel, Ernst/D-9220-2014	Lengyel, Ernst/0000-0001-8624-1507; Okuda, Hiroshi/0000-0002-5747-8086; Hayashi, Kanako/0000-0002-5028-799X	NIH/NCI [CA179214, ACS-IL 139038]; NIH/NICHD [HD065584]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD065584] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R15CA179214] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Gail Isenberg for editing the manuscript. This work was supported by NIH/NCI CA179214 and ACS-IL 139038 (to KH), and NIH/NICHD HD065584 (to JAM).	Aletti GD, 2007, MAYO CLIN PROC, V82, P751; Arend RC, 2013, GYNECOL ONCOL, V131, P772, DOI 10.1016/j.ygyno.2013.09.034; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Birrer MJ, 2007, J CLIN ONCOL, V25, P2281, DOI 10.1200/JCO.2006.09.0795; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chauhan SC, 2009, CANCER RES, V69, P765, DOI 10.1158/0008-5472.CAN-08-0587; Chen MY, 2009, BIOCHEMISTRY-US, V48, P10267, DOI 10.1021/bi9009677; Chen W, 2010, AM J PHYSIOL-GASTR L, V299, pG293, DOI 10.1152/ajpgi.00005.2010; Chotani MA, 1997, CELL GROWTH DIFFER, V8, P999; Cooke PS, 2013, MOL HUM REPROD, V19, P547, DOI 10.1093/molehr/gat031; Curtin JC, 2010, ONCOTARGET, V1, P563, DOI 10.18632/oncotarget.191; Denkert C, 2009, J PATHOL, V218, P273, DOI 10.1002/path.2547; Dodge ME, 2011, ANNU REV PHARMACOL, V51, P289, DOI 10.1146/annurev-pharmtox-010510-100558; Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638; FRIESEL RE, 1995, FASEB J, V9, P919, DOI 10.1096/fasebj.9.10.7542215; Goff BA, 2004, JAMA-J AM MED ASSOC, V291, P2705, DOI 10.1001/jama.291.22.2705; Hayashi K, 2007, ENDOCRINOLOGY, V148, P3496, DOI 10.1210/en.2007-0283; Hayashi K, 2009, BIOL REPROD, V80, P989, DOI 10.1095/biolreprod.108.075416; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Lau MT, 2011, ONCOGENE, V30, P2753, DOI 10.1038/onc.2011.6; Li R, 2013, MOL CANCER THER, V12, P2200, DOI 10.1158/1535-7163.MCT-13-0095; Lu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029290; MacLean JA, 2013, J BIOL CHEM, V288, P34809, DOI 10.1074/jbc.M113.486340; Madiai F, 1999, J BIOL CHEM, V274, P11937, DOI 10.1074/jbc.274.17.11937; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Meng QH, 2014, CLIN CHEM, V60, P222, DOI 10.1373/clinchem.2013.211490; Mook RA, 2013, BIOORG MED CHEM LETT, V23, P2187, DOI 10.1016/j.bmcl.2013.01.101; Osada T, 2011, CANCER RES, V71, P4172, DOI 10.1158/0008-5472.CAN-10-3978; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Sack U, 2011, JNCI-J NATL CANCER I, V103, P1018, DOI 10.1093/jnci/djr190; Sassoon D, 1999, MOL CELL ENDOCRINOL, V158, P1, DOI 10.1016/S0303-7207(99)00170-7; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Smith GS, 2012, NEUROPSYCHOPHARMACOL, V37, P1, DOI 10.1038/npp.2011.233; Steele IA, 2001, ONCOGENE, V20, P5878, DOI 10.1038/sj.onc.1204755; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Teo R, 2006, DEV BIOL, V289, P91, DOI 10.1016/j.ydbio.2005.10.009; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Wieland A, 2013, CLIN CANCER RES, V19, P4124, DOI 10.1158/1078-0432.CCR-12-2895; Yo YT, 2012, MOL CANCER THER, V11, P1703, DOI 10.1158/1535-7163.MCT-12-0002; Yoshioka S, 2012, MOL CANCER RES, V10, P469, DOI 10.1158/1541-7786.MCR-11-0177; You S, 2014, MOL CANCER THER, V13, P606, DOI 10.1158/1535-7163.MCT-13-0608; Zaid TM, 2013, CLIN CANCER RES, V19, P809, DOI 10.1158/1078-0432.CCR-12-2736	52	63	66	1	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	26					3452	3462		10.1038/onc.2014.277	http://dx.doi.org/10.1038/onc.2014.277			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CL3SU	25174399	Green Accepted, hybrid			2022-12-25	WOS:000356871700010
J	Liu, ZB; Chen, XX; Wang, Y; Peng, HY; Wang, YA; Jing, YL; Zhang, HB				Liu, Zhibo; Chen, Xinxin; Wang, Ying; Peng, Haiyong; Wang, Yanan; Jing, Yanling; Zhang, Hongbing			PDK4 Protein Promotes Tumorigenesis through Activation of cAMP-response Element-binding Protein (CREB)-Ras Homolog Enriched in Brain (RHEB)-mTORC1 Signaling Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cAMP-response Element-binding Protein (CREB); Cellular Regulation; DNA-Protein Interaction; Mechanistic Target of Rapamycin (mTOR); Warburg Effect; Ras Homolog Enriched in Brain; Pyruvate Dehydrogenase Kinase 4; Signaling; Tumorigenesis	PYRUVATE-DEHYDROGENASE COMPLEX; TUBEROUS SCLEROSIS COMPLEX-1; MAMMALIAN TARGET; GROWTH-CONTROL; UP-REGULATION; RAT MODEL; MTOR; PHOSPHORYLATION; RAPAMYCIN; CANCER	Background: mTOR integrates various intracellular and extracellular signals to regulate cell growth, proliferation, and survival. Results: PDK4 promotes tumorigenesis through activation of the CREB-RHEB-mTORC1 signaling cascade. Conclusion: PDK4 is a novel activator of mTOR signaling. Significance: PDK4 activation of mTORC1 may be targeted for the treatment of mTOR-mediated cancer and other diseases. Mechanistic target of rapamycin (mTOR) integrates multiple extracellular and intracellular signals to regulate cell growth and survival. Hyperactivation of mTOR has been observed in various cancers. Regulation of mTOR activity is thus of importance in physiological processes and tumor development. Here, we present pyruvate dehydrogenase kinase 4 (PDK4) as a novel regulator of mTORC1 signaling. mTORC1 activity was augmented with PDK4 overexpression and reduced by PDK4 suppression in various cell lines. Furthermore, PDK4 bound to cAMP-response element-binding protein (CREB) and prevented its degradation. The enhanced CREB consequently transactivated the expression of Ras homolog enriched in brain (RHEB), a direct key activator of mTORC1, independent of AMP-activated protein kinase or tuberous sclerosis complex protein 2. PDK4 potentiated the mTORC1 effectors hypoxia-inducible factor 1 and pyruvate kinase isozymes M2 and promoted aerobic glycolysis (Warburg effect). Knockdown of PDK4 suppressed the tumor development of cancer cells with activated mTORC1. The abundance of PDK4 dictated the responsiveness of cells to the mTOR inhibitor, rapamycin. Combinatory suppression of mTOR and PDK4 exerted synergistic inhibition on cancer cell proliferation. Therefore, PDK4 promotes tumorigenesis through activation of the CREB-RHEB-mTORC1 signaling cascade.	[Liu, Zhibo; Chen, Xinxin; Wang, Ying; Peng, Haiyong; Wang, Yanan; Jing, Yanling; Zhang, Hongbing] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Physiol, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Liu, Zhibo; Chen, Xinxin; Wang, Ying; Peng, Haiyong; Wang, Yanan; Jing, Yanling; Zhang, Hongbing] Peking Union Med Coll, Grad Sch, Sch Basic Med, Beijing 100005, Peoples R China; [Wang, Ying] Dalian Med Univ, Inst Canc Stem Cell, Dalian 116044, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Dalian Medical University	Zhang, HB (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100005, Peoples R China.	hbzhang@ibms.pumc.edu.cn	Peng, Haiyong/S-8045-2016		National Science and Technology Major Project [2013ZX10002008]; National Basic Research Program of China 973 Program [2011CB965002]; National Natural Science Foundation of China [81101516, 81130085]; Ministry of Education of China 211 Project [B08007]	National Science and Technology Major Project; National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China 211 Project	This work was supported by the National Science and Technology Major Project (2013ZX10002008), the National Basic Research Program of China 973 Program Grant (2011CB965002), the National Natural Science Foundation of China (Grants 81101516 and 81130085), and the Ministry of Education of China 211 Project (B08007).	Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; DEANGELO AB, 1991, FUND APPL TOXICOL, V16, P337, DOI 10.1016/0272-0590(91)90118-N; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guo LJ, 2012, INT J MOL SCI, V13, P3563, DOI 10.3390/ijms13033563; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li Y, 2007, J BIOL CHEM, V282, P35803, DOI 10.1074/jbc.M705231200; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma JH, 2011, J GENET GENOMICS, V38, P533, DOI 10.1016/j.jgg.2011.10.002; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Mu J, 2013, NEUROBIOL DIS, V51, P133, DOI 10.1016/j.nbd.2012.11.003; Peng H, 2013, ONCOGENE, V32, P4702, DOI 10.1038/onc.2012.481; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Stacpoole PW, 1998, ENVIRON HEALTH PERSP, V106, P989, DOI 10.1289/ehp.98106s4989; Stapoole PW, 2008, ADV DRUG DELIVER REV, V60, P1478, DOI 10.1016/j.addr.2008.02.014; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zheng M, 2011, NAT CELL BIOL, V13, P263, DOI 10.1038/ncb2168; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	43	56	59	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29739	29749		10.1074/jbc.M114.584821	http://dx.doi.org/10.1074/jbc.M114.584821			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25164809	Green Published, hybrid			2022-12-25	WOS:000344370800022
J	Jennelle, L; Hunegnaw, R; Dubrovsky, L; Pushkarsky, T; Fitzgerald, ML; Sviridov, D; Popratiloff, A; Brichacek, B; Bukrinsky, M				Jennelle, Lucas; Hunegnaw, Ruth; Dubrovsky, Larisa; Pushkarsky, Tatiana; Fitzgerald, Michael L.; Sviridov, Dmitri; Popratiloff, Anastas; Brichacek, Beda; Bukrinsky, Michael			HIV-1 Protein Nef Inhibits Activity of ATP-binding Cassette Transporter A1 by Targeting Endoplasmic Reticulum Chaperone Calnexin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 ENVELOPE GLYCOPROTEIN; CHOLESTEROL EFFLUX; QUALITY-CONTROL; CLASS-I; INTRACELLULAR TRAFFICKING; EXTRACELLULAR DOMAIN; P-GLYCOPROTEIN; ABCA1; CALRETICULIN; LOCALIZATION	HIV-infected patients are at increased risk of developing atherosclerosis, in part due to an altered high density lipoprotein profile exacerbated by down-modulation and impairment of ATP-binding cassette transporter A1 (ABCA1) activity by the HIV-1 protein Nef. However, the mechanisms of this Nef effect remain unknown. Here, we show that Nef interacts with an endoplasmic reticulum chaperone calnexin, which regulates folding and maturation of glycosylated proteins. Nef disrupted interaction between calnexin and ABCA1 but increased affinity and enhanced interaction of calnexin with HIV-1 gp160. The Nef mutant that did not bind to calnexin did not affect the calnexin- ABCA1 interaction. Interaction with calnexin was essential for functionality of ABCA1, as knockdown of calnexin blocked the ABCA1 exit from the endoplasmic reticulum, reduced ABCA1 abundance, and inhibited cholesterol efflux; the same effects were observed after Nef overexpression. However, the effects of calnexin knockdown and Nef on cholesterol efflux were not additive; in fact, the combined effect of these two factors together did not differ significantly from the effect of calnexin knockdown alone. Interestingly, gp160 and ABCA1 interacted with calnexin differently; although gp160 binding to calnexin was dependent on glycosylation, glycosylation was of little importance for the interaction between ABCA1 and calnexin. Thus, Nef regulates the activity of calnexin to stimulate its interaction with gp160 at the expense of ABCA1. This study identifies a mechanism for Nef-dependent inactivation of ABCA1 and dysregulation of cholesterol metabolism.	[Jennelle, Lucas; Hunegnaw, Ruth; Dubrovsky, Larisa; Pushkarsky, Tatiana; Brichacek, Beda; Bukrinsky, Michael] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20037 USA; [Fitzgerald, Michael L.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Sviridov, Dmitri] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Popratiloff, Anastas] George Washington Ctr Microscopy & Image Anal, Off VP Res, Washington, DC 20037 USA	George Washington University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Baker Heart and Diabetes Institute	Bukrinsky, M (corresponding author), George Washington Univ, Dept Microbiol Immunol & Trop Med, Ross Hall Rm 624,2300 Eye St NW, Washington, DC 20037 USA.	mbukrins@gwu.edu	Sviridov, Dmitri/E-7943-2010		National Institutes of Health [HL093818, HL101274, AI108533];  [5P30AI087714]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112661, R01HL093818, R01HL101274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI087714, R21AI108533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL093818, HL101274, and AI108533 and by Program Grant 5P30AI087714 (to District of Columbia Developmental Center for AIDS Research). This work is part of a dissertation to be presented by R. H. to the Institute for Biomedical Sciences, George Washington University, in partial fulfillment of the requirements for the Ph.D. degree.	Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Asztalos BF, 2010, J INFECT DIS, V202, P614, DOI 10.1086/654817; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Cui HL, 2012, J LIPID RES, V53, P696, DOI 10.1194/jlr.M023119; Danilczyk UG, 2001, J BIOL CHEM, V276, P25532, DOI 10.1074/jbc.M100270200; Desvarieux M, 2013, AIDS, V27, P2603, DOI 10.1097/QAD.0b013e3283634819; Dettenhofer M, 2001, J BIOL CHEM, V276, P5985, DOI 10.1074/jbc.M008933200; Dubrovsky L, 2012, BIOCHEM BIOPH RES CO, V419, P95, DOI 10.1016/j.bbrc.2012.01.137; Feng B, 2002, J BIOL CHEM, V277, P43271, DOI 10.1074/jbc.M207532200; Fu Y, 2013, CELL METAB, V18, P225, DOI 10.1016/j.cmet.2013.07.003; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Giannarelli C, 2011, ATHEROSCLEROSIS, V219, P384, DOI 10.1016/j.atherosclerosis.2011.06.003; Hagmann W, 2002, BIOL CHEM, V383, P1001, DOI 10.1515/BC.2002.107; Jacob D, 2014, BIOCHEM BIOPH RES CO, V444, P19, DOI 10.1016/j.bbrc.2013.12.141; Jiang H, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-69; Land A, 2001, BIOCHIMIE, V83, P783, DOI 10.1016/S0300-9084(01)01314-1; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Leonard JA, 2011, J VIROL, V85, P6867, DOI 10.1128/JVI.00229-11; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; LOO TW, 1994, J BIOL CHEM, V269, P28683; Low H, 2012, JOVE-J VIS EXP, DOI 10.3791/3810; MATSUSHITA S, 1988, J VIROL, V62, P2107, DOI 10.1128/JVI.62.6.2107-2114.1988; Morrow MP, 2010, MOL PHARMACOL, V78, P215, DOI 10.1124/mol.110.065029; Mujawar Z, 2006, PLOS BIOL, V4, P1970, DOI 10.1371/journal.pbio.0040365; Mujawar Z, 2010, BIOCHEMISTRY-US, V49, P8338, DOI 10.1021/bi100466q; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Okiyoneda T, 2004, MOL BIOL CELL, V15, P563, DOI 10.1091/mbc.E03-06-0379; Okiyoneda T, 2006, BIOCHEM BIOPH RES CO, V347, P67, DOI 10.1016/j.bbrc.2006.06.032; Otteken A, 1996, J BIOL CHEM, V271, P97, DOI 10.1074/jbc.271.1.97; Papadopoulos M, 2007, J BIOL CHEM, V282, P9401, DOI 10.1074/jbc.M610429200; Papandreou MJ, 2010, J BIOL CHEM, V285, P13788, DOI 10.1074/jbc.M109.066670; PARLATI F, 1995, J BIOL CHEM, V270, P244, DOI 10.1074/jbc.270.1.244; PIND S, 1994, J BIOL CHEM, V269, P12784; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; RUSCHE JR, 1987, P NATL ACAD SCI USA, V84, P6924, DOI 10.1073/pnas.84.19.6924; Schindler M, 2005, J VIROL, V79, P5489, DOI 10.1128/JVI.79.9.5489-5498.2005; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; SIMM M, 1995, J VIROL, V69, P4582, DOI 10.1128/JVI.69.7.4582-4586.1995; Suh WK, 1996, J EXP MED, V184, P337, DOI 10.1084/jem.184.2.337; Tamehiro N, 2008, BIOCHEMISTRY-US, V47, P6138, DOI 10.1021/bi800182t; Tanaka AR, 2001, BIOCHEM BIOPH RES CO, V283, P1019, DOI 10.1006/bbrc.2001.4891; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; Vassilakos A, 1996, EMBO J, V15, P1495, DOI 10.1002/j.1460-2075.1996.tb00493.x	46	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28870	28884		10.1074/jbc.M114.583591	http://dx.doi.org/10.1074/jbc.M114.583591			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25170080	Green Published, hybrid			2022-12-25	WOS:000344141000011
J	Ko, E; Choi, H; Kim, B; Kim, M; Park, KN; Bae, IH; Sung, YK; Lee, TR; Shin, DW; Bae, YS				Ko, Eunbi; Choi, Hyun; Kim, Borim; Kim, Minsun; Park, Kkot-Nara; Bae, Il-Hong; Sung, Young Kwan; Lee, Tae Ryong; Shin, Dong Wook; Bae, Yun Soo			Testosterone Stimulates Duox1 Activity through GPRC6A in Skin Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-GENOMIC ACTIONS; RECEPTOR ACTIVATION; NADPH OXIDASE; CELL-DEATH; APOPTOSIS; TISSUE; CA2+; GENERATION; EXPRESSION; CASPASE-3	Testosterone is an endocrine hormone with functions in reproductive organs, anabolic events, and skin homeostasis. We report here that GPRC6A serves as a sensor and mediator of the rapid action of testosterone in epidermal keratinocytes. The silencing of GPRC6A inhibited testosterone-induced intracellular calcium ([Ca2+](i)) mobilization and H2O2 generation. These results indicated that a testosterone-GPRC6A complex is required for activation of G(q) protein, IP3 generation, and [Ca2+](i) mobilization, leading to Duox1 activation. H2O2 generation by testosterone stimulated the apoptosis of keratinocytes through the activation of caspase-3. The application of testosterone into three-dimensional skin equivalents increased the apoptosis of keratinocytes between the granular and stratified corneum layers. These results support an understanding of the molecular mechanism of testosterone-dependent apoptosis in which testosterone stimulates H2O2 generation through the activation of Duox1.	[Ko, Eunbi; Kim, Borim; Kim, Minsun; Park, Kkot-Nara; Bae, Yun Soo] Ewha Womans Univ, Dept Life Sci, Yongin 446729, Geyonggi Do, South Korea; [Ko, Eunbi; Kim, Borim; Kim, Minsun; Park, Kkot-Nara; Bae, Yun Soo] Ewha Womans Univ, Program GT5, Yongin 446729, Geyonggi Do, South Korea; [Choi, Hyun; Bae, Il-Hong; Lee, Tae Ryong; Shin, Dong Wook] Amorepacific Corp R&D Ctr, Biosci Res Inst, Yongin 446729, Geyonggi Do, South Korea; [Sung, Young Kwan] Kyungpook Natl Univ, Sch Med, Dept Immunol, Taegu 700422, South Korea	Ewha Womans University; Ewha Womans University; Kyungpook National University	Shin, DW (corresponding author), Amorepacific Corp R&D Ctr, 314-1 Bora Dong, Yongin 446729, Geyonggi Do, South Korea.	biopang@amorepacific.com; baeys@ewha.ac.kr		Bae, Il-Hong/0000-0003-0535-8303	National Research Foundation of Korea (NRF) [2012R1A5A1048236]; Bio & Medical Technology Development Program Grant [2012M3A9B4028785]; Redoxomics Grant - Ministry of Science, ICT & Future Planning [2012M3A9C5048708]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Bio & Medical Technology Development Program Grant; Redoxomics Grant - Ministry of Science, ICT & Future Planning	This work was supported by National Research Foundation of Korea (NRF) Grant 2012R1A5A1048236, Bio & Medical Technology Development Program Grant 2012M3A9B4028785, and Redoxomics Grant 2012M3A9C5048708 funded by the Ministry of Science, ICT & Future Planning.	Abdel-Latif AM, 2009, CLIN EXP DERMATOL, V34, P390, DOI 10.1111/j.1365-2230.2008.03029.x; Aguirre J, 2010, FREE RADICAL BIO MED, V49, P1342, DOI 10.1016/j.freeradbiomed.2010.07.027; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Bito T, 2012, J DERMATOL SCI, V68, P3, DOI 10.1016/j.jdermsci.2012.06.006; Blattermann S, 2012, NAT CHEM BIOL, V8, P631, DOI [10.1038/NCHEMBIO.962, 10.1038/nchembio.962]; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Bowles DK, 2007, AM J PHYSIOL-CELL PH, V293, pC805, DOI 10.1152/ajpcell.00127.2007; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chignalia AZ, 2012, HYPERTENSION, V59, P1263, DOI 10.1161/HYPERTENSIONAHA.111.180620; CHOUDHRY R, 1992, J ENDOCRINOL, V133, P467, DOI 10.1677/joe.0.1330467; De Gendt K, 2012, MOL CELL ENDOCRINOL, V352, P13, DOI 10.1016/j.mce.2011.08.008; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; ELIAS PM, 1983, J INVEST DERMATOL, V80, pS44, DOI 10.1038/jid.1983.12; Estrada M, 2006, J BIOL CHEM, V281, P25492, DOI 10.1074/jbc.M603193200; Faure H, 2009, CELL CALCIUM, V46, P323, DOI 10.1016/j.ceca.2009.09.004; Feingold KR, 2012, CLIN DERMATOL, V30, P263, DOI 10.1016/j.clindermatol.2011.08.008; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gul R, 2012, AM J PHYSIOL-HEART C, V302, pH901, DOI 10.1152/ajpheart.00250.2011; HELLMAN L, 1977, J CLIN ENDOCR METAB, V45, P1224, DOI 10.1210/jcem-45-6-1224; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Joo JH, 2012, ANTIOXID REDOX SIGN, V16, P57, DOI 10.1089/ars.2011.3898; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Ling SH, 2002, ENDOCRINOLOGY, V143, P1119, DOI 10.1210/en.143.3.1119; Loss ES, 2011, LIFE SCI, V89, P577, DOI 10.1016/j.lfs.2011.05.017; Miller FJ, 2010, ANTIOXID REDOX SIGN, V12, P583, DOI 10.1089/ars.2009.2857; Naito A, 2008, INT J MOL MED, V22, P725, DOI 10.3892/ijmm_00000078; Papadopoulou N, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-88; Petry A, 2010, ANTIOXID REDOX SIGN, V13, P467, DOI 10.1089/ars.2009.3026; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2012, ENDOCRINOLOGY, V153, P4608, DOI 10.1210/en.2012-1301; Pi M, 2012, ENDOCRINOLOGY, V153, P2062, DOI 10.1210/en.2011-2117; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Rahman F, 2007, TRENDS ENDOCRIN MET, V18, P371, DOI 10.1016/j.tem.2007.09.004; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Simoncini T, 2003, EUR J ENDOCRINOL, V148, P281, DOI 10.1530/eje.0.1480281; Taieb J, 2003, CLIN CHEM, V49, P1381, DOI 10.1373/49.8.1381; Thiboutot D, 1998, DERMATOLOGY, V196, P38, DOI 10.1159/000017863; Trueb Ralph M, 2009, Int J Trichology, V1, P6, DOI 10.4103/0974-7753.51923; TYMIANSKI M, 1994, J CEREBR BLOOD F MET, V14, P911, DOI 10.1038/jcbfm.1994.122; Ulivieri C, 2010, TISSUE CELL, V42, P339, DOI 10.1016/j.tice.2010.10.004; Vaccari JPD, 2012, DERMATOL SURG, V38, P1033, DOI 10.1111/j.1524-4725.2012.02378.x; Verzola D, 2004, KIDNEY INT, V65, P1252, DOI 10.1111/j.1523-1755.2004.00497.x; Winiarska A, 2006, SKIN PHARMACOL PHYS, V19, P311, DOI 10.1159/000095251; Zouboulis CC, 2007, HORM METAB RES, V39, P85, DOI 10.1055/s-2007-961807; Zouboulis CC, 2004, EXP DERMATOL, V13, P5, DOI 10.1111/j.1600-0625.2004.00255.x	54	27	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28835	28845		10.1074/jbc.M114.583450	http://dx.doi.org/10.1074/jbc.M114.583450			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25164816	Green Published, hybrid			2022-12-25	WOS:000344141000008
J	Jin, YZ; McFie, PJ; Banman, SL; Brandt, C; Stone, SJ				Jin, Youzhi; McFie, Pamela J.; Banman, Shanna L.; Brandt, Curtis; Stone, Scot J.			Diacylglycerol Acyltransferase-2 (DGAT2) and Monoacylglycerol Acyltransferase-2 (MGAT2) Interact to Promote Triacylglycerol Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; ACYL-COA; ENDOPLASMIC-RETICULUM; INSULIN-RESISTANCE; MEMBRANE-FRACTION; LIPID DROPLETS; FAT-ABSORPTION; CACO-2 CELLS; RAT-LIVER; LOCALIZATION	Acyl CoA:1,2-diacylglycerol acyltransferase (DGAT)-2 is an integral membrane protein that catalyzes triacylglycerol (TG) synthesis using diacylglycerol and fatty acyl CoA as substrates. DGAT2 resides in the endoplasmic reticulum (ER), but when cells are incubated with fatty acids, DGAT2 interacts with lipid droplets presumably to catalyze localized TG synthesis for lipid droplet expansion. Previous studies have shown that DGAT2 interacts with proteins that synthesize its fatty acyl CoA substrates. In this study, we provide additional evidence that DGAT2 is present in a protein complex. Using a chemical crosslinker, disuccinimidyl suberate (DSS), we demonstrated that DGAT2 formed a dimer and was also part of a protein complex of similar to 650 kDa, both in membranes and on lipid droplets. Using co-immunoprecipitation experiments and an in situ proximity ligation assay, we found that DGAT2 interacted with monoacylglycerol acyltransferase (MGAT)-2, an enzyme that catalyzes the synthesis of diacylglycerol. Deletion mutagenesis showed that the interaction with MGAT2 was dependent on the two transmembrane domains of DGAT2. No significant interaction of DGAT2 with lipin1, another enzyme that synthesizes diacylglycerol, could be detected. When co-expressed in cells, DGAT2 and MGAT2 co-localized in the ER and on lipid droplets. Co-expression also resulted in increased TG storage compared with expression of DGAT2 or MGAT2 alone. Incubating McArdle rat hepatoma RH7777 cells with 2-monoacylglycerol caused DGAT2 to translocate to lipid droplets. This also led to the formation of large cytosolic lipid droplets, characteristic of DGAT2, but not DGAT1, and indicated that DGAT2 can utilize monoacylglycerol-derived diacylglycerol. These findings suggest that the interaction of DGAT2 and MGAT2 serves to channel lipid substrates efficiently for TG biosynthesis.	[Jin, Youzhi; McFie, Pamela J.; Brandt, Curtis; Stone, Scot J.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Banman, Shanna L.] Univ Saskatchewan, Western Coll Vet Med, Saskatoon, SK S7N 5B4, Canada	University of Saskatchewan; University of Saskatchewan	Stone, SJ (corresponding author), Univ Saskatchewan, Dept Biochem, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	scot.stone@usask.ca			Heart and Stroke Foundation of Saskatchewan; CIHR [FRN 123385]; CFI	Heart and Stroke Foundation of Saskatchewan; CIHR(Canadian Institutes of Health Research (CIHR)); CFI(Canada Foundation for Innovation)	This work was supported in part by a Heart and Stroke Foundation of Saskatchewan Grant-in-Aid, CIHR (FRN 123385) and the CFI.	BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Cao JS, 2004, J BIOL CHEM, V279, P18878, DOI 10.1074/jbc.M313272200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Cheng D, 2008, J BIOL CHEM, V283, P29802, DOI 10.1074/jbc.M800494200; Coe NR, 1999, J BIOL CHEM, V274, P36300, DOI 10.1074/jbc.274.51.36300; COLEMAN RA, 1984, J BIOL CHEM, V259, P8934; CUI Z, 1993, J BIOL CHEM, V268, P16655; Gangar A, 2001, J BIOL CHEM, V276, P10290, DOI 10.1074/jbc.M009550200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Ho SY, 2002, J BIOL CHEM, V277, P1816, DOI 10.1074/jbc.M108027200; KENNEDY EP, 1957, ANNU REV BIOCHEM, V26, P119, DOI 10.1146/annurev.bi.26.070157.001003; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; LEHNER R, 1995, J BIOL CHEM, V270, P13630, DOI 10.1074/jbc.270.23.13630; Levin MC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1772, DOI 10.1152/ajpendo.00158.2007; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; Liu Q, 2012, PROG LIPID RES, V51, P350, DOI 10.1016/j.plipres.2012.06.001; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; McFie PJ, 2011, J LIPID RES, V52, P1760, DOI 10.1194/jlr.D016626; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; Miernyk JA, 2008, PLANT J, V53, P597, DOI 10.1111/j.1365-313X.2007.03316.x; Millar JS, 2006, J LIPID RES, V47, P2297, DOI 10.1194/jlr.M600213-JLR200; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Ren L, 2003, J BIOCHEM BIOPH METH, V57, P143, DOI 10.1016/S0165-022X(03)00105-2; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Seyer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058224; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zhang J, 2014, J BIOL CHEM, V289, P10909, DOI 10.1074/jbc.M113.530022	45	45	45	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28237	28248		10.1074/jbc.M114.571190	http://dx.doi.org/10.1074/jbc.M114.571190			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25164810	hybrid, Green Published			2022-12-25	WOS:000343765400020
J	Bauer, CCC; Barrios, FA; Diaz, JL				Bauer, Clemens C. C.; Barrios, Fernando A.; Diaz, Jose-Luis			Subjective Somatosensory Experiences Disclosed by Focused Attention: Cortical-Hippocampal-Insular and Amygdala Contributions	PLOS ONE			English	Article							SUSTAINED ATTENTION; TOP-DOWN; BRAIN; ACTIVATION; CORTEX; MEMORY; FMRI; ATTRIBUTION; INHIBITION; PATTERNS	In order to explore the neurobiological foundations of qualitative subjective experiences, the present study was designed to correlate objective third-person brain fMRI measures with subjective first-person identification and scaling of local, subtle, and specific somatosensory sensations, obtained directly after the imaging procedure. Thus, thirty-four volunteers were instructed to focus and sustain their attention to either provoked or spontaneous sensations of each thumb during the fMRI procedure. By means of a Likert scale applied immediately afterwards, the participants recalled and evaluated the intensity of their attention and identified specific somatosensory sensations (e.g. pulsation, vibration, heat). Using the subject's subjective scores as covariates to model both attention intensity and general somatosensory experiences regressors, the whole-brain random effect analyses revealed activations in the frontopolar prefrontal cortex (BA10), primary somatosensory cortex (BA1), premotor cortex (BA 6), precuneus (BA 7), temporopolar cortex (BA 38), inferior parietal lobe (BA 39), hippocampus, insula and amygdala. Furthermore, BA10 showed differential activity, with ventral BA10 correlating exclusively with attention (r(32) = 0.54, p = 0.0013) and dorsal BA10 correlating exclusively with somatosensory sensation (r(32) = 0.46, p = 0.007). All other reported brain areas showed significant positive correlations solely with subjective somatosensory experiences reports. These results provide evidence that the frontopolar prefrontal cortex has dissociable functions depending on specific cognitive demands; i.e. the dorsal portion of the frontopolar prefrontal cortex in conjunction with primary somatosensory cortex, temporopolar cortex, inferior parietal lobe, hippocampus, insula and amygdala are involved in the processing of spontaneous general subjective somatosensory experiences disclosed by focused and sustained attention.	[Bauer, Clemens C. C.; Barrios, Fernando A.] Univ Nacl Autonoma Mexico, Inst Neurobiol, Lab Neuroimagen Funct, Mexico City 04510, DF, Mexico; [Diaz, Jose-Luis] Univ Nacl Autonoma Mexico, Fac Med, Dept Hist Filosofia Med, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Diaz, JL (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Lab Neuroimagen Funct, Mexico City 04510, DF, Mexico.	barrios@inb.unam.mx; jldiaz43@gmail.com	Barrios, Fernando Alejandro/D-1591-2016; Bauer, Clemens/N-2916-2019	Barrios, Fernando Alejandro/0000-0002-5699-4222; Bauer, Clemens/0000-0002-3481-4438	Consejo Nacional de Ciencia y Tecnologia, Mexico, National Council of Science and Technology (CONACyT) [250718]; CONACyT [CB167271]	Consejo Nacional de Ciencia y Tecnologia, Mexico, National Council of Science and Technology (CONACyT); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	C. C. C. B. is a doctoral student from "Programa de Doctorado en Ciencias Biomedicas'', Universidad Nacional Autonoma de Mexico (UNAM) and received the doctoral scholarship 250718 from The Consejo Nacional de Ciencia y Tecnologia, Mexico, the National Council of Science and Technology (CONACyT). This project was partially funded by CONACyT CB167271. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asari T, 2008, NEUROIMAGE, V41, P145, DOI 10.1016/j.neuroimage.2008.01.059; Bauer CCC, 2014, BRAIN COGNITION, V87, P86, DOI 10.1016/j.bandc.2014.03.009; Behrendt RP, 2013, REV NEUROSCIENCE, V24, P239, DOI 10.1515/revneuro-2012-0088; Brass M, 2005, NEUROPSYCHOLOGIA, V43, P89, DOI 10.1016/j.neuropsychologia.2004.06.018; Brozzoli C, 2012, J NEUROSCI, V32, P14573, DOI 10.1523/JNEUROSCI.2660-12.2012; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Cabanis M, 2013, COGN AFFECT BEHAV NE, V13, P330, DOI 10.3758/s13415-012-0143-5; Cahn BR, 2010, COGN PROCESS, V11, P39, DOI 10.1007/s10339-009-0352-1; Campana F, 2013, NEUROPSYCHOLOGIA, V51, P1050, DOI 10.1016/j.neuropsychologia.2013.02.021; Christoff K, 2004, CORTEX, V40, P623, DOI 10.1016/S0010-9452(08)70158-8; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Damasio A. R., 1999, FEELING WHAT HAPPENS; DIAZ J.L., 2007, CONCIENCIA VIVIENTE; Diaz JL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00739; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Farb NAS, 2013, CEREB CORTEX, V23, P114, DOI 10.1093/cercor/bhr385; Feinstein JS, 2004, CONSCIOUS COGN, V13, P323, DOI 10.1016/j.concog.2003.10.004; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Freton M, 2014, BRAIN STRUCT FUNCT, V219, P959, DOI 10.1007/s00429-013-0546-2; Frewen PA, 2013, SOC COGN AFFECT NEUR, V8, P546, DOI 10.1093/scan/nss032; Garrison KA, 2013, NEUROIMAGE, V81, P110, DOI 10.1016/j.neuroimage.2013.05.030; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gonzalez-Santos L, 2007, SALUD MENT, V30, P31; Guterstam A, 2013, J COGNITIVE NEUROSCI, V25, P1078, DOI 10.1162/jocn_a_00393; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Klingner CM, 2011, BEHAV BRAIN RES, V225, P432, DOI 10.1016/j.bbr.2011.07.053; Lepsien J, 2002, J COGNITIVE NEUROSCI, V14, P127, DOI 10.1162/089892902317236795; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lutz A., 2002, Phenomenology and the Cognitive Sciences, V1, P133, DOI 10.1023/A:1020320221083; Lutz A, 2002, P NATL ACAD SCI USA, V99, P1586, DOI 10.1073/pnas.032658199; Martinelli P, 2013, HUM BRAIN MAPP, V34, P1515, DOI 10.1002/hbm.22008; McCaig RG, 2011, NEUROIMAGE, V55, P1298, DOI 10.1016/j.neuroimage.2010.12.016; MORAN MA, 1987, J COMP NEUROL, V256, P88, DOI 10.1002/cne.902560108; Moulton EA, 2005, J NEUROPHYSIOL, V93, P2183, DOI 10.1152/jn.01025.2004; NAGEL T, 1974, PHILOS REV, V83, P435, DOI 10.2307/2183914; Northoff G, 2003, J CONSCIOUSNESS STUD, V10, P14; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paradiso S, 1999, AM J PSYCHIAT, V156, P1618, DOI 10.1176/ajp.156.10.1618; Pascual B, 2015, CEREB CORTEX, V25, P680, DOI 10.1093/cercor/bht260; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Pollmann S, 2006, VIS COGN, V14, P877, DOI 10.1080/13506280500196142; Prebble SC, 2013, PSYCHOL BULL, V139, P815, DOI 10.1037/a0030146; Ramsoy TZ, 2009, NEUROIMAGE, V47, P1863, DOI 10.1016/j.neuroimage.2009.03.082; Rees G, 2013, ANN NY ACAD SCI, V1296, P4, DOI 10.1111/nyas.12257; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Sadaghiani S, 2013, NEUROIMAGE; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schwarz KA, 2013, SOC COGN AFFECT NEUR, V8, P438, DOI 10.1093/scan/nss013; Seth AK, 2013, TRENDS COGN SCI, V17, P565, DOI 10.1016/j.tics.2013.09.007; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Smith C, 2005, J NEUROSCI, V25, P10138, DOI 10.1523/JNEUROSCI.2731-05.2005; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; THOMPSON Evan, 2004, PHENOMENOL COGN SCI, V3, P381, DOI [10.1023/B:PHEN.0000048936.73339.dd, DOI 10.1023/B:PHEN.0000048936.73339.DD]; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Varela Francisco J., 1996, J CONSCIOUSNESS STUD, V3, P330; Worsley K. J., 2001, FUNCTIONAL MRI INTRO, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]	59	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e104721	10.1371/journal.pone.0104721	http://dx.doi.org/10.1371/journal.pone.0104721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166875	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303700012
J	Jung, HJ; Dong, XS; Park, JI; Thamilarasan, SK; Lee, SS; Kim, YK; Lim, YP; Nou, IS; Hur, YK				Jung, Hee-Jeong; Dong, Xiangshu; Park, Jong-In; Thamilarasan, Senthil Kumar; Lee, Sang Sook; Kim, Yeon-Ki; Lim, Yong-Pyo; Nou, Ill-Sup; Hur, Yoonkang			Genome-Wide Transcriptome Analysis of Two Contrasting Brassica rapa Doubled Haploid Lines under Cold-Stresses Using Br135K Oligomeric Chip	PLOS ONE			English	Article							FREEZING TOLERANCE; ARABIDOPSIS-THALIANA; LOW-TEMPERATURE; DROUGHT TOLERANCE; RESPONSE PATHWAY; GENE-EXPRESSION; CHINESE-CABBAGE; CROP PLANTS; ACCLIMATION; REGULATOR	Genome wide transcription analysis in response to stresses is important to provide a basis of effective engineering strategies to improve stress tolerance in crop plants. We assembled a Brassica rapa oligomeric microarray (Br135K microarray) using sequence information from 41,173 unigenes and analyzed the transcription profiles of two contrasting doubled haploid (DH) lines, Chiifu and Kenshin, under cold-treatments. The two DH lines showed great differences in electrolyte leakage below -4 degrees C, but similar patterns from 4 degrees C to -2 degrees C. Cold-treatments induced 885 and 858 genes in Chiifu and Kenshin, respectively. Overall, 134, and 56 genes showed an intrinsic difference in expression in Chiifu and Kenshin, respectively. Among 5,349 genes that showed no hit found (NHF) in public databases, 61 and 24 were specifically expressed in Chiifu and Kenshin, respectively. Many transcription factor genes (TFs) also showed various characteristics of expression. BrMYB12, BrMYBL2, BrbHLHs, BrbHLH038, a C2H2, a WRKY, BrDREB19 and a integrase-type TF were induced in a Chiifu-specific fashion, while a bHLH (Bra001826/AT3G21330), bHLH, cycling Dof factor and two Dof type TFs were Kenshin specific. Similar to previous studies, a large number of genes were differently induced or regulated among the two genotypes, but many genes, including NHFs, were specifically or intrinsically expressed with genotype specificity. Expression patterns of known-cold responsive genes in plants resulted in discrepancy to membrane leakage in the two DH lines, indicating that timing of gene expression is more important to conferring freezing tolerance rather than expression levels. Otherwise, the tolerance will be related to the levels of transcripts before cold-treatment or regulated by other mechanisms. Overall, these results indicate common signaling pathways and various transcriptional regulatory mechanisms are working together during cold-treatment of B. rapa. Our newly developed Br135K oligomeric microarray will be useful for transcriptome profiling, and will deliver valuable insight into cold stresses in B. rapa.	[Jung, Hee-Jeong; Park, Jong-In; Thamilarasan, Senthil Kumar; Nou, Ill-Sup] Sunchon Natl Univ, Dept Hort, Sunchon, Jeonnam, South Korea; [Dong, Xiangshu; Lee, Sang Sook; Hur, Yoonkang] Chungnam Natl Univ, Coll Biol Sci & Biotechnol, Dept Biol, Taejon, South Korea; [Kim, Yeon-Ki] GreenGene Biotech Inc, Genom & Genet Inst, Yongin, South Korea; [Lim, Yong-Pyo] Chungnam Natl Univ, Dept Hort, Taejon, South Korea	Sunchon National University; Chungnam National University; Chungnam National University	Nou, IS (corresponding author), Sunchon Natl Univ, Dept Hort, Sunchon, Jeonnam, South Korea.	nis@sunchon.ac.kr; ykhur@cnu.ac.kr	Thamilarasan, Senthil Kumar/AAX-5643-2021	Thamilarasan, Senthil Kumar/0000-0003-3691-5838; Dong, Xiangshu/0000-0002-6640-0731; Hur, Yoonkang/0000-0002-2325-2249	Golden Seed Project (Center for Horticultural Seed Development) [213003-04-1-CG100]; Ministry of Agriculture, Food and Rural Affairs (MAFRA); Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea [PJ009085]	Golden Seed Project (Center for Horticultural Seed Development); Ministry of Agriculture, Food and Rural Affairs (MAFRA); Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea	This research was supported by Golden Seed Project (Center for Horticultural Seed Development, No. 213003-04-1-CG100), Ministry of Agriculture, Food and Rural Affairs (MAFRA), and by a Grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center no. PJ009085), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DJ, 2001, TRENDS PLANT SCI, V6, P36, DOI 10.1016/S1360-1385(00)01808-2; Alonso R, 2009, PLANT CELL, V21, P1747, DOI 10.1105/tpc.108.062968; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Catala R, 2011, P NATL ACAD SCI USA, V108, P16475, DOI 10.1073/pnas.1107161108; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Dong CH, 2006, P NATL ACAD SCI USA, V103, P8281, DOI 10.1073/pnas.0602874103; Dong X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072178; Dubos C, 2008, PLANT J, V55, P940, DOI 10.1111/j.1365-313X.2008.03564.x; Duroux M, 2004, PLANT J, V40, P660, DOI 10.1111/j.1365-313X.2004.02242.x; Frank G, 2009, J EXP BOT, V60, P3891, DOI 10.1093/jxb/erp234; Fursova OV, 2009, GENE, V429, P98, DOI 10.1016/j.gene.2008.10.016; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hsieh TH, 2002, PLANT PHYSIOL, V129, P1086, DOI 10.1104/pp.003442; Iwasaki M, 2013, DEVELOPMENT, V140, P1958, DOI 10.1242/dev.085365; Joyce CP, 2008, PLANT PHYSIOL, V146, P1242; Kim KC, 2008, PLANT CELL, V20, P2357, DOI 10.1105/tpc.107.055566; KOSTER KL, 1992, PLANT PHYSIOL, V98, P108, DOI 10.1104/pp.98.1.108; Kumari S, 2009, FUNCT INTEGR GENOMIC, V9, P109, DOI 10.1007/s10142-008-0088-5; Lee CM, 2012, P NATL ACAD SCI USA, V109, P15054, DOI 10.1073/pnas.1211295109; Lee J, 2013, GENES GENOM, V35, P273, DOI 10.1007/s13258-013-0088-2; Lee SC, 2008, MOL CELLS, V26, P595; Li CY, 2002, PHYSIOL PLANTARUM, V116, P478, DOI 10.1034/j.1399-3054.2002.1160406.x; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Luo X, 2013, J EXP BOT, V64, P2155, DOI 10.1093/jxb/ert073; Luo XM, 2010, DEV CELL, V19, P872, DOI 10.1016/j.devcel.2010.10.023; Maibam P, 2013, INT J MOL SCI, V14, P11527, DOI 10.3390/ijms140611527; Martz F, 2006, TREE PHYSIOL, V26, P783, DOI 10.1093/treephys/26.6.783; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Miura K, 2013, INT J MOL SCI, V14, P5312, DOI 10.3390/ijms14035312; Nakamichi N, 2012, P NATL ACAD SCI USA, V109, P17123, DOI 10.1073/pnas.1205156109; Nakamichi N, 2009, PLANT CELL PHYSIOL, V50, P447, DOI 10.1093/pcp/pcp004; Nishizawa-Yokoi A, 2011, PLANT CELL PHYSIOL, V52, P933, DOI 10.1093/pcp/pcr045; Oh E, 2009, PLANT CELL, V21, P403, DOI 10.1105/tpc.108.064691; Rakow G, 2004, BIOTECHNOL AGRIC FOR, V54, P3; Rapacz M, 2002, ANN BOT-LONDON, V89, P543, DOI 10.1093/aob/mcf090; Sanghera GS, 2011, CURR GENOMICS, V12, P30, DOI 10.2174/138920211794520178; Sharma P, 2005, BIOESSAYS, V27, P1048, DOI 10.1002/bies.20307; Song WY, 2011, P NATL ACAD SCI USA, V108, P19808, DOI 10.1073/pnas.1104905108; Song XM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-573; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Takagi T, 2003, PLANT CELL PHYSIOL, V44, P922, DOI 10.1093/pcp/pcg117; Takahashi D, 2013, J PROTEOME RES, V12, P4998, DOI 10.1021/pr400750g; Thamilarasan SK, 2013, INDIAN J EXP BIOL, V51, P522; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Wallis JG, 1997, PLANT MOL BIOL, V35, P323, DOI 10.1023/A:1005886210159; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Welling A, 2008, PLANT PHYSIOL, V147, P1199, DOI 10.1104/pp.108.117812; Yao KN, 2003, PLANT BIOTECHNOL J, V1, P221, DOI 10.1046/j.1467-7652.2003.00021.x; Zbierzak AM, 2013, PLANT J, V75, P539, DOI 10.1111/tpj.12219; Zhang JY, 2007, PLANT MOL BIOL, V64, P265, DOI 10.1007/s11103-007-9150-2; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043274; Zhang X, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r165; Zhang ZW, 2013, PLANT MOL BIOL, V83, P445, DOI 10.1007/s11103-013-0102-8; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8; Zhu JJ, 2013, PLANT PHYSIOL BIOCH, V73, P427, DOI 10.1016/j.plaphy.2013.07.008	58	19	24	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106069	10.1371/journal.pone.0106069	http://dx.doi.org/10.1371/journal.pone.0106069			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25167163	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303700069
J	Morales-Miranda, S; Jacobson, JO; Loya-Montiel, I; Mendizabal-Burastero, R; Galindo-Arandi, C; Flores, C; Chen, SY				Morales-Miranda, Sonia; Jacobson, Jerry O.; Loya-Montiel, Itzel; Mendizabal-Burastero, Ricardo; Galindo-Arandi, Cesar; Flores, Carlos; Chen, Sanny Y.			Scale-Up, Retention and HIV/STI Prevalence Trends among Female Sex Workers Attending VICITS Clinics in Guatemala	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HIV	Background: Since 2007, Guatemala integrated STI clinical service with an HIV prevention model into four existing public health clinics to prevent HIV infection, known as the VICITS strategy. We present the first assessment of VICITS scale-up, retention, HIV and STI prevalence trends, and risk factors associated with HIV infection among Female Sex Workers (FSW) attending VICITS clinics in Guatemala. Methods: Demographic, behavioral and clinical data were collected using a standardized form. Data was analyzed by year and health center. HIV and STI prevalence were estimated from routine visits. Retention was estimated as the percent of new users attending VICITS clinics who returned for at least one follow-up visit to any VICITS clinic within 12 months. Separate multivariate logistic regression models were conducted to investigate factors associated with HIV infection and program retention. Results: During 2007-2011 5,682 FSW visited a VICITS clinic for the first-time. HIV prevalence varied from 0.4% to 5.8%, and chlamydia prevalence from 0% to 14.3%, across sites. Attending the Puerto Barrios clinic, having a current syphilis infection, working primarily on the street, and using the telephone or internet to contact clients were associated with HIV infection. The number of FSW accessing VICITS annually increased from 556 to 2,557 (361%) during the period. In 2011 retention varied across locations from 7.7% to 42.7%. Factors negatively impacting retention included current HIV diagnosis, having practiced sex work in another country, being born in Honduras, and attending Marco Antonio Foundation or Quetzaltenango clinic sites. Systematic time trends did not emerge, however 2008 and 2010 were characterized by reduced retention. Conclusions: Our data show local differences in HIV prevalence and clinic attendance that can be used to prioritize prevention activities targeting FSW in Guatemala. VICITS achieved rapid scale-up; however, a better understanding of the causes of low return rates is urgently needed.	[Morales-Miranda, Sonia; Loya-Montiel, Itzel; Mendizabal-Burastero, Ricardo; Galindo-Arandi, Cesar] Univ Valle Guatemala, Ctr Hlth Studies, Guatemala City, Guatemala; [Flores, Carlos] Minist Publ Hlth, Natl STI HIV AIDS Program, Guatemala City, Guatemala; [Chen, Sanny Y.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Cent Amer Reg Off, Guatemala City, Guatemala	Universidad del Valle de Guatemala	Morales-Miranda, S (corresponding author), Univ Valle Guatemala, Ctr Hlth Studies, Guatemala City, Guatemala.	smorales@ces.uvg.edu.gt			President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention [GH000011]; Del Valle University of Guatemala	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Del Valle University of Guatemala	This project was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention under the terms of the Cooperative Agreement #GH000011 with Del Valle University of Guatemala. DISCLAIMER: The findings and conclusions in this paper are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Use of trade names and commercial sources are for identification purposes only and does not imply endorsement by the Public Health Service or the U. S. Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown, 2021, PEOPLE MANAGEMENT; Campos PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081041; Hernandez B, 2000, PREVALENCIA VIH POBL; Levine WC, 1998, AIDS; Morales-Miranda S, 2013, ENCUESTA VIGILANCIA; MSPAS, 1986, AC GUB 342 86 REGL C; MSPAS/CNE, 2012, EST PROYECC HIV VIH; ONUSIDA/OPS/UNICEF, 2009, RET PLANT EP VIH ER; PINZON Z, 2003, ESTUDIO MULTICENTRIC; PNS, 2008, LIN OR ITS VIH SIDA; Porras C, 2008, CULT HEALTH SEX, V10, P529, DOI 10.1080/13691050701861421; Sabido M, 2009, JAIDS-J ACQ IMM DEF, V51, pS35, DOI 10.1097/QAI.0b013e3181a2656f; Tinajeros F, 2012, INT J STD AIDS, V23, P88, DOI 10.1258/ijsa.2011.011047; Uribe-Salas F, 2003, SEX TRANSM DIS, V30, P266, DOI 10.1097/00007435-200303000-00018; VM, 2010, INF LIN FIN EV PROYE; VM, 2006, EST LIN BAS PROYECT	16	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e103455	10.1371/journal.pone.0103455	http://dx.doi.org/10.1371/journal.pone.0103455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25167141	Green Published, gold			2022-12-25	WOS:000341303700005
J	Zhang, YF; Liu, YY; Ma, QW; Song, YQ; Zhang, Q; Wang, XY; Chen, F				Zhang, Yifei; Liu, Yingyi; Ma, Qingwei; Song, Yeqing; Zhang, Qian; Wang, Xiaoyan; Chen, Feng			Identification of Lactobacillus from the Saliva of Adult Patients with Caries Using Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry	PLOS ONE			English	Article							MALDI-TOF MS; DENTAL-CARIES; RAPID IDENTIFICATION; MUTANS STREPTOCOCCI; ACTIVITY TESTS; CHILDREN; MICROORGANISMS; BACTERIAL; ADOLESCENTS; PREVALENCE	Matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) mass spectrometry (MS) has been presented as a superior method for the detection of microorganisms in body fluid samples (e.g., blood, saliva, pus, etc.) However, the performance of MALDI-TOF MS in routine identification of caries-related Lactobacillus isolates from saliva of adult patients with caries has not been determined. In the present study, we introduced a new MALDI-TOF MS system for identification of lactobacilli. Saliva samples were collected from 120 subjects with caries. Bacteria were isolated and cultured, and each isolate was identified by both 16S rRNA sequencing and MALDI-TOF MS. The identification results obtained by MALDI-TOF MS were concordant at the genus level with those of conventional 16S rRNA-based sequencing for 88.6% of lactobacilli (62/70) and 95.5% of non-lactobacilli (21/22). Up to 96 results could be obtained in parallel on a single MALDI target, suggesting that this is a reliable high-throughput approach for routine identification of lactobacilli. However, additional reference strains are necessary to increase the sensitivity and specificity of species-level identification.	[Zhang, Yifei; Song, Yeqing; Zhang, Qian; Chen, Feng] Peking Univ, Sch & Hosp Stomatol, Cent Lab, Beijing 100871, Peoples R China; [Liu, Yingyi; Wang, Xiaoyan] Peking Univ, Sch & Hosp Stomatol, Dept Cariol & Endodontol, Beijing 100871, Peoples R China; [Ma, Qingwei] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Chen, F (corresponding author), Peking Univ, Sch & Hosp Stomatol, Cent Lab, Beijing 100871, Peoples R China.	moleculecf@gmail.com	LIU, YING/GZL-7252-2022		National Natural Science Foundation of China [81300880, 81200762]; Peking University School of Stomatology [PKUSS20110301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University School of Stomatology	This work was supported by grants 81300880 and 81200762 from National Natural Science Foundation of China, and by funding from Peking University School of Stomatology (PKUSS20110301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALALUUSUA S, 1989, CARIES RES, V23, P49, DOI 10.1159/000261154; Badet C, 2008, Open Microbiol J, V2, P38, DOI 10.2174/1874285800802010038; Callaway A, 2013, CLIN LAB, V59, P1373, DOI 10.7754/Clin.Lab.2013.121225; Carbonnelle E, 2012, J MICROBIOL METH, V89, P133, DOI 10.1016/j.mimet.2012.03.003; Chen WH, 2013, J CHROMATOGR A, V1288, P21, DOI 10.1016/j.chroma.2013.02.030; Chhour KL, 2005, J CLIN MICROBIOL, V43, P843, DOI 10.1128/JCM.43.2.843-849.2005; Colloca ME, 2000, ORAL DIS, V6, P227, DOI 10.1111/j.1601-0825.2000.tb00118.x; CROSSNER CG, 1981, COMMUNITY DENT ORAL, V9, P182, DOI 10.1111/j.1600-0528.1981.tb01052.x; Dupont C, 2010, CLIN MICROBIOL INFEC, V16, P998, DOI 10.1111/j.1469-0691.2009.03036.x; Duskova M, 2012, INT J FOOD MICROBIOL, V159, P107, DOI 10.1016/j.ijfoodmicro.2012.07.029; Gabris K, 1999, CARIES RES, V33, P191, DOI 10.1159/000016516; GRANATH L, 1994, SCAND J DENT RES, V102, P319; Holland RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6; Ilina EN, 2009, J MOL DIAGN, V11, P75, DOI 10.2353/jmoldx.2009.080079; KOHLER B, 1987, COMMUNITY DENT ORAL, V15, P332, DOI 10.1111/j.1600-0528.1987.tb01747.x; Koll-Klais P, 2004, Eur J Paediatr Dent, V5, P107; Leli C, 2013, INT J MED MICROBIOL, V303, P205, DOI 10.1016/j.ijmm.2013.03.002; Malamud D., 1993, SALIVA DIAGNOSTIC FL; Mazengo MC, 1996, COMMUNITY DENT ORAL, V24, P169, DOI 10.1111/j.1600-0528.1996.tb00836.x; Mellmann A, 2008, J CLIN MICROBIOL, V46, P1946, DOI 10.1128/JCM.00157-08; OWEN OW, 1949, AM J ORTHOD DENTOFAC, V35, P672, DOI 10.1016/0002-9416(49)90123-2; Piwat S, 2010, MOL ORAL MICROBIOL, V25, P157, DOI 10.1111/j.2041-1014.2009.00556.x; Richard B, 2001, RES MICROBIOL, V152, P157, DOI 10.1016/S0923-2508(01)01187-1; Roeters J, 1995, J DENT CHILD, V62, P401; RUSSELL JI, 1990, COMMUNITY DENT ORAL, V18, P120, DOI 10.1111/j.1600-0528.1990.tb00035.x; SCHEININ A, 1994, COMMUNITY DENT ORAL, V22, P126, DOI 10.1111/j.1600-0528.1994.tb01587.x; Schmidt F, 2009, PROTEOMICS, V9, P1994, DOI 10.1002/pmic.200701028; Shi S, 1999, Chin J Dent Res, V2, P34; Teanpaisan R, 2006, ORAL MICROBIOL IMMUN, V21, P79, DOI 10.1111/j.1399-302X.2006.00259.x; Veloo ACM, 2011, SYST APPL MICROBIOL, V34, P58, DOI 10.1016/j.syapm.2010.11.005; Wicht MJ, 2004, CARIES RES, V38, P436, DOI 10.1159/000079624; Wieser A, 2012, APPL MICROBIOL BIOT, V93, P965, DOI 10.1007/s00253-011-3783-4; WRIGHT JT, 1992, COMMUNITY DENT ORAL, V20, P138, DOI 10.1111/j.1600-0528.1992.tb01548.x; Yoshizawa JM, 2013, CLIN MICROBIOL REV, V26, P781, DOI 10.1128/CMR.00021-13; ZICKERT I, 1982, COMMUNITY DENT ORAL, V10, P77, DOI 10.1111/j.1600-0528.1982.tb00367.x	35	10	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106185	10.1371/journal.pone.0106185	http://dx.doi.org/10.1371/journal.pone.0106185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166027	Green Published, gold			2022-12-25	WOS:000341303700081
J	Lin, Q; Ye, QH; Zhu, DX; Wei, Y; Ren, L; Ye, LC; Feng, QY; Xu, PP; Zheng, P; Lv, MZ; Fan, J; Xu, JM				Lin, Qi; Ye, Qinghai; Zhu, Dexiang; Wei, Ye; Ren, Li; Ye, Lechi; Feng, Qingyang; Xu, Pingping; Zheng, Peng; Lv, Minzhi; Fan, Jia; Xu, Jianmin			Determinants of Long-Term Outcome in Patients Undergoing Simultaneous Resection of Synchronous Colorectal Liver Metastases	PLOS ONE			English	Article							HEPATIC RESECTION; PROGNOSTIC INDEX; CANCER; CHEMOTHERAPY; SURVIVAL; MANAGEMENT; SURGERY; SCORE; MODEL	Background: It remains unclear which patients can benefit from simultaneous resection of synchronous colorectal liver metastases (SCRLMs). This study aimed to examine the prognostic value of patient-and tumor-related factors in predicting long-term outcomes of patients undergoing simultaneous resection of SCRLMs and to help patients select a suitable therapeutic regimen and proper surveillance. Methods: Clinicopathological and outcome data of 154 consecutive SCRLM patients who underwent simultaneous resection between July 2003 and July 2013 were collected from our prospectively established SCRLM data and analyzed with univariate and multivariate methods, and the prognostic index (PI) was formulated based on the regression coefficients (beta) of the Cox model. The patients were classified into high-and low-risk groups according to the PI value; the cut-off point was the third quartile. Results: The 5-year overall survival rate was 46%, and the 5-year disease-free survival rate was 35%. Five factors were found to be independent predictors of poor overall survival (OS) by multivariate analysis: positive lymph node status, vascular invasion, BRAF mutation, the distribution of bilobar liver metastases (LMs) and non-R0 resection of LMs. Compared to low PI (<= 5.978), high PI (>5.978) was highly predictive of shorter OS. Three factors were found to be independent predictors of poor disease-free survival (DFS) by multivariate analysis: tumor deposits, BRAF mutation and bilobar LM distribution. We also determined the PI for DFS. Compared to low PI (<= 2.945), high PI (>2.945) was highly predictive of shorter DFS. Conclusions: Simultaneous resection of SCRLM may lead to various long-term outcomes. Patients with low PI have longer OS and DFS, while those with high PI have shorter OS and DFS. Thus, patients with high PI may receive more aggressive treatment and intensive surveillance, This model needs further validation.	[Lin, Qi; Zhu, Dexiang; Wei, Ye; Ren, Li; Ye, Lechi; Feng, Qingyang; Xu, Pingping; Zheng, Peng; Xu, Jianmin] Fudan Univ, Dept Gen Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Ye, Qinghai; Fan, Jia] Fudan Univ, Dept Liver Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Lv, Minzhi] Fudan Univ, Sch Publ Hlth, Dept Biostat, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Xu, JM (corresponding author), Fudan Univ, Dept Gen Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China.	xujmin@aliyun.com	Fan, Jia/C-6689-2017		Key Projects of the Clinical Disciplines; Shanghai Science and Technology Committee Talent Program [12XD1401900]; Outstanding Academic Leaders Project of Health System in Shanghai [XBR2011031]	Key Projects of the Clinical Disciplines; Shanghai Science and Technology Committee Talent Program; Outstanding Academic Leaders Project of Health System in Shanghai	This project received financial support from the Key Projects of the Clinical Disciplines, which is administered by the Ministry of Health (Projects from 2010-2012), Shanghai Science and Technology Committee Talent Program (12XD1401900) and Outstanding Academic Leaders Project of Health System in Shanghai (XBR2011031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AM, 2013, ANN SURG ONCOL, V20, P139, DOI 10.1245/s10434-012-2515-z; Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16; Allen PJ, 2003, J GASTROINTEST SURG, V7, P109, DOI 10.1016/S1091-255X(02)00121-X; Araujo R, 2013, ANN SURG ONCOL, V20, P4312, DOI 10.1245/s10434-013-3162-8; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; de Santibanes E, 2010, WORLD J SURG, V34, P2133, DOI 10.1007/s00268-010-0654-6; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Francart J, 2009, EUR J CANCER, V45, P2304, DOI 10.1016/j.ejca.2009.04.028; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; John SKP, 2013, DIGEST SURG, V30, P293, DOI 10.1159/000354310; Kimura F, 1996, BRIT J SURG, V83, P1002, DOI 10.1002/bjs.1800830738; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Malik HZ, 2007, ANN SURG, V246, P806, DOI 10.1097/SLA.0b013e318142d964; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Martin RCG, 2009, J AM COLL SURGEONS, V208, P842, DOI 10.1016/j.jamcollsurg.2009.01.031; Mayo SC, 2013, J AM COLL SURGEONS, V216, P707, DOI 10.1016/j.jamcollsurg.2012.12.029; Nanji S, 2013, ANN SURG ONCOL, V20, P295, DOI 10.1245/s10434-012-2424-1; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Reddy SK, 2009, ANN SURG ONCOL, V16, P1809, DOI 10.1245/s10434-008-0181-y; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; Robertson DJ, 2009, CANCER-AM CANCER SOC, V115, P752, DOI 10.1002/cncr.24081; Sebastian SO, 2000, ARCH SURG-CHICAGO, V135, P272, DOI 10.1001/archsurg.135.3.272; Settmacher U, 2011, INT J COLORECTAL DIS, V26, P967, DOI 10.1007/s00384-011-1195-7; Slesser AAP, 2013, SURG ONCOL, V22, P36, DOI 10.1016/j.suronc.2012.11.002; Sobin LHGM., 2009, TNM CLASSIFICATION M, V7th; Teramukai S, 2007, J CLIN ONCOL, V25, P3302, DOI 10.1200/JCO.2007.11.0114; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Van Cutsem E, 2009, ANN ONCOL, V20, P1842, DOI 10.1093/annonc/mdp233; Xu JM, 2011, J CANCER RES CLIN, V137, P1379, DOI 10.1007/s00432-011-0999-8; Yin Z, 2013, HEPATOLOGY, V57, P2346, DOI 10.1002/hep.26283	30	22	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105747	10.1371/journal.pone.0105747	http://dx.doi.org/10.1371/journal.pone.0105747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162714	Green Submitted, Green Published, gold			2022-12-25	WOS:000340880900048
J	Pance, A; Morrissey-Wettey, FR; Craig, H; Downing, A; Talbot, R; Jackson, AP				Pance, Alena; Morrissey-Wettey, Frank R.; Craig, Helen; Downing, Alison; Talbot, Richard; Jackson, Antony P.			SDF-1 Chemokine Signalling Modulates the Apoptotic Responses to Iron Deprivation of Clathrin-Depleted DT40 Cells	PLOS ONE			English	Article							TRANSENDOTHELIAL MIGRATION; MEDIATED ENDOCYTOSIS; MONOCLONAL-ANTIBODY; CXCR4 EXPRESSION; IN-VITRO; T-CELLS; RECEPTOR; TRANSFERRIN; SURVIVAL; BINDING	We have previously deleted both endogenous copies of the clathrin heavy-chain gene in the chicken pre B-cell-line DT40 and replaced them with clathrin under the control of a tetracycline-regulatable promoter (Tet-Off). The originally derived cell-line DKO-S underwent apoptosis when clathrin expression was repressed. We have also described a cell-line DKO-R derived from DKO-S cells that was less sensitive to clathrin-depletion. Here we show that the restriction of transferrin uptake, resulting in iron deprivation, is responsible for the lethal consequence of clathrin-depletion. We further show that the DKO-R cells have up-regulated an anti-apoptotic survival pathway based on the chemokine SDF-1 and its receptor CXCR4. Our work clarifies several puzzling features of clathrin-depleted DT40 cells and reveals an example of how SDF-1/CXCR4 signalling can abrogate pro-apoptotic pathways and increase cell survival. We propose that the phenomenon described here has implications for the therapeutic approach to a variety of cancers.	[Morrissey-Wettey, Frank R.; Craig, Helen; Jackson, Antony P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Downing, Alison; Talbot, Richard] Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Pance, Alena] Wellcome Trust Sanger Inst, Cambridge, England	University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; Wellcome Trust Sanger Institute	Pance, A (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	apj10@cam.ac.uk; alena.pance@sanger.ac.uk	Pance, Alena/AAH-2878-2021	Pance, Alena/0000-0002-9017-2644; Jackson, Antony Philip/0000-0002-2895-7387	Department of Biochemistry, University of Cambridge, BBSRC; Marie Curie Fellowship (FRMW); BBSRC [BBS/E/D/20310000] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20310000, BB/D001242/1] Funding Source: researchfish	Department of Biochemistry, University of Cambridge, BBSRC; Marie Curie Fellowship (FRMW); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by the following: Department of Biochemistry, University of Cambridge, BBSRC, and Marie Curie Fellowship (FRMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISEN P, 1978, J BIOL CHEM, V253, P1930; AUSUBEL FM, 2002, CURRENT PROTOCOLS MO; BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; BEILBY J, 1992, CLIN CHEM, V38, P2078; BOUILLON R, 1980, J BIOL CHEM, V255, P925; Buchegger F, 1996, EUR J BIOCHEM, V235, P9, DOI 10.1111/j.1432-1033.1996.0009u.x; Buckley SJ, 2004, INT J BIOCHEM CELL B, V36, P1281, DOI 10.1016/j.biocel.2003.02.001; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Burger JA, 2000, BLOOD, V96, P2655; Burger JA, 2002, LEUKEMIA LYMPHOMA, V43, P461, DOI 10.1080/10428190290011921; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Burnside J, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-13; Caldieri G, 2012, EUR J CELL BIOL, V91, P961, DOI 10.1016/j.ejcb.2012.03.005; Dayani PN, 2004, J NEURO-ONCOL, V67, P367, DOI 10.1023/B:NEON.0000024238.21349.37; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; Diaz-Griffero F, 2005, VIROLOGY, V337, P45, DOI 10.1016/j.virol.2005.02.027; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Gazitt Y, 2001, J CELL PHYSIOL, V187, P124, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1061>3.0.CO;2-E; Greene BT, 2002, J BIOL CHEM, V277, P25568, DOI 10.1074/jbc.M110345200; Guinamard R, 1999, J EXP MED, V189, P1461, DOI 10.1084/jem.189.9.1461; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; HANN HWL, 1990, HEPATOLOGY, V11, P566, DOI 10.1002/hep.1840110407; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Heath JL, 2013, NUTRIENTS, V5, P2836, DOI 10.3390/nu5082836; HILETI D, 1995, BRIT J HAEMATOL, V89, P181, DOI 10.1111/j.1365-2141.1995.tb08927.x; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Horuk R, 2001, CYTOKINE GROWTH F R, V12, P313, DOI 10.1016/S1359-6101(01)00014-4; Jackson AP, 2003, J CELL BIOL, V163, P231, DOI 10.1083/jcb.200304079; Kakuta K, 1997, COMP BIOCHEM PHYS A, V118, P165, DOI 10.1016/S0300-9629(96)00403-3; KARIN M, 1981, J BIOL CHEM, V256, P3245; Kovar J, 2001, IN VITRO CELL DEV-AN, V37, P450; Kucia M, 2004, J MOL HISTOL, V35, P233; Kukreja P, 2005, CANCER RES, V65, P9891, DOI 10.1158/0008-5472.CAN-05-1293; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lataillade JJ, 2002, BLOOD, V99, P1117, DOI 10.1182/blood.V99.4.1117; Lataillade JJ, 2004, EUR CYTOKINE NETW, V15, P177; MASON AB, 1987, J BIOL CHEM, V262, P9011; McGinn OJ, 2012, J CELL SCI, V125, P5467, DOI 10.1242/jcs.109488; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Moura IC, 2004, BLOOD, V103, P1838, DOI 10.1182/blood-2003-07-2440; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; NATHKE IS, 1992, CELL, V68, P899, DOI 10.1016/0092-8674(92)90033-9; Neumann-Staubitz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012017; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; SELIGMAN PA, 1992, PATHOBIOLOGY, V60, P19, DOI 10.1159/000163692; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; TROWBRIDGE IS, 1982, P NATL ACAD SCI-BIOL, V79, P1175, DOI 10.1073/pnas.79.4.1175; Vlahakis SR, 2002, J IMMUNOL, V169, P5546, DOI 10.4049/jimmunol.169.10.5546; Wettey FR, 2002, SCIENCE, V297, P1521, DOI 10.1126/science.1074222; Winding P, 2001, J IMMUNOL METHODS, V249, P1, DOI 10.1016/S0022-1759(00)00333-1; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yang YC, 2007, INT J GYNECOL CANCER, V17, P676, DOI 10.1111/j.1525-1438.2007.00841.x; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269	57	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106278	10.1371/journal.pone.0106278	http://dx.doi.org/10.1371/journal.pone.0106278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162584	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900101
J	Djiane, A; Zaessinger, S; Babaoglan, AB; Bray, SJ				Djiane, Alexandre; Zaessinger, Sophie; Babaoglan, A. Burcu; Bray, Sarah J.			Notch Inhibits Yorkie Activity in Drosophila Wing Discs	PLOS ONE			English	Article							HIPPO SIGNALING PATHWAY; SPLIT COMPLEX GENES; ORGAN SIZE CONTROL; CELL-PROLIFERATION; PROMOTES APOPTOSIS; REGULATORY NETWORK; TEAD/TEF FAMILY; VESTIGIAL GENE; TISSUE-GROWTH; SELF-RENEWAL	During development, tissues and organs must coordinate growth and patterning so they reach the right size and shape. During larval stages, a dramatic increase in size and cell number of Drosophila wing imaginal discs is controlled by the action of several signaling pathways. Complex cross-talk between these pathways also pattern these discs to specify different regions with different fates and growth potentials. We show that the Notch signaling pathway is both required and sufficient to inhibit the activity of Yorkie (Yki), the Salvador/Warts/Hippo (SWH) pathway terminal transcription activator, but only in the central regions of the wing disc, where the TEAD factor and Yki partner Scalloped (Sd) is expressed. We show that this cross-talk between the Notch and SWH pathways is mediated, at least in part, by the Notch target and Sd partner Vestigial (Vg). We propose that, by altering the ratios between Yki, Sd and Vg, Notch pathway activation restricts the effects of Yki mediated transcription, therefore contributing to define a zone of low proliferation in the central wing discs.	[Djiane, Alexandre; Babaoglan, A. Burcu; Bray, Sarah J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Djiane, Alexandre; Zaessinger, Sophie] IRCM, Montpellier, France; [Djiane, Alexandre; Zaessinger, Sophie] INSERM, U896, Montpellier, France; [Djiane, Alexandre; Zaessinger, Sophie] Univ Montpellier I, Montpellier, France; [Djiane, Alexandre; Zaessinger, Sophie] Inst Reg Canc Montpellier, Montpellier, France	University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Djiane, A (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	alexandre.djiane@inserm.fr		Bray, Sarah/0000-0002-1642-599X; Djiane, Alexandre/0000-0001-6210-2713	Wellcome Trust [WT083576MA]; ATIP-Avenir grant; MRC programme grant [G0800034]; MRC [G0800034, MR/L007177/1] Funding Source: UKRI; Medical Research Council [G0800034, MR/L007177/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); ATIP-Avenir grant(French National Research Agency (ANR)); MRC programme grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a project grant from the Wellcome Trust to AD and SJB (WT083576MA). AD is supported by an ATIP-Avenir grant. SJB is supported by a MRC programme grant (G0800034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaoglan AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075632; Baena-Lopez LA, 2012, CURR OPIN CELL BIOL, V24, P166, DOI 10.1016/j.ceb.2011.12.010; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Baonza A, 2000, P NATL ACAD SCI USA, V97, P2609, DOI 10.1073/pnas.040576497; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; deCelis JF, 1996, DEVELOPMENT, V122, P2719; deCelis JF, 1996, DEVELOPMENT, V122, P359; Djiane A, 2013, EMBO J, V32, P60, DOI 10.1038/emboj.2012.326; Giraldez AJ, 2003, DEVELOPMENT, V130, P6533, DOI 10.1242/dev.00904; Go MJ, 1998, DEVELOPMENT, V125, P2031; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Graves HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037615; Guo T, 2013, CELL RES, V23, P1201, DOI 10.1038/cr.2013.120; Guss KA, 2001, SCIENCE, V292, P1164, DOI 10.1126/science.1058312; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; Halder G, 2001, DEVELOPMENT, V128, P3295; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Heitzler P, 1996, DEVELOPMENT, V122, P161; Herranz H, 2008, EMBO J, V27, P1633, DOI 10.1038/emboj.2008.84; Housden B, 2012, G3-GENES GENOM GENET, V2, P79, DOI 10.1534/g3.111.001321; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Klein T, 1999, DEVELOPMENT, V126, P913; Koontz LM, 2013, DEV CELL, V25, P388, DOI 10.1016/j.devcel.2013.04.021; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; Meignin C, 2007, CURR BIOL, V17, P1871, DOI 10.1016/j.cub.2007.09.062; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Nagel AC, 2001, MECH DEVELOP, V109, P241, DOI 10.1016/S0925-4773(01)00539-1; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Polesello C, 2007, CURR BIOL, V17, P1864, DOI 10.1016/j.cub.2007.09.049; Rafel N, 2008, DEVELOPMENT, V135, P3995, DOI 10.1242/dev.027789; San Juan BP, 2012, BIOL OPEN, V1, P667, DOI 10.1242/bio.20121172; Simmonds AJ, 1998, GENE DEV, V12, P3815, DOI 10.1101/gad.12.24.3815; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; WILLIAMS JA, 1994, NATURE, V368, P299, DOI 10.1038/368299a0; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zacharioudaki E, 2012, DEVELOPMENT, V139, P1258, DOI 10.1242/dev.071779; Zecca M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000386; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Ziosi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001140	53	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e106211	10.1371/journal.pone.0106211	http://dx.doi.org/10.1371/journal.pone.0106211			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157415	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303200091
J	Radhakrishnan, EK; Bava, SV; Narayanan, SS; Nath, LR; Thulasidasan, AKT; Soniya, EV; Anto, RJ				Radhakrishnan, E. K.; Bava, Smitha V.; Narayanan, Sai Shyam; Nath, Lekshmi R.; Thulasidasan, Arun Kumar T.; Soniya, Eppurathu Vasudevan; Anto, Ruby John			[6]-Gingerol Induces Caspase-Dependent Apoptosis and Prevents PMA-Induced Proliferation in Colon Cancer Cells by Inhibiting MAPK/AP-1 Signaling	PLOS ONE			English	Article							PROTEIN-KINASE-C; FACTOR-KAPPA-B; IN-VITRO; EPITHELIAL-CELLS; CARCINOMA CELLS; PHORBOL ESTER; DOWN-REGULATION; ACTIVATION; EXPRESSION; GINGER	We report mechanism-based evidence for the anticancer and chemopreventive efficacy of [6]-gingerol, the major active principle of the medicinal plant, Ginger (Zingiber officinale), in colon cancer cells. The compound was evaluated in two human colon cancer cell lines for its cytotoxic effect and the most sensitive cell line, SW-480, was selected for the mechanistic evaluation of its anticancer and chemopreventive efficacy. The non-toxic nature of [6]-gingerol was confirmed by viability assays on rapidly dividing normal mouse colon cells. [6]-gingerol inhibited cell proliferation and induced apoptosis as evidenced by externalization of phosphatidyl serine in SW-480, while the normal colon cells were unaffected. Sensitivity to [6]-gingerol in SW-480 cells was associated with activation of caspases 8, 9, 3 & 7 and cleavage of PARP, which attests induction of apoptotic cell death. Mechanistically, [6]-gingerol down-regulated Phorbol Myristate Acetate (PMA) induced phosphorylation of ERK1/2 and JNK MAP kinases and activation of AP-1 transcription factor, but had only little effects on phosphorylation of p38 MAP kinase and activation of NF-kappa B. Additionally, it complemented the inhibitors of either ERK1/ 2 or JNK MAP kinase in bringing down the PMA-induced cell proliferation in SW-480 cells. We report the inhibition of ERK1/2/JNK/AP-1 pathway as a possible mechanism behind the anticancer as well as chemopreventive efficacy of [6]-gingerol against colon cancer.	[Radhakrishnan, E. K.; Soniya, Eppurathu Vasudevan] Rajiv Gandhi Ctr Biotechnol, Div Plant Mol Biol, Thiruvananthapuram, Kerala, India; [Bava, Smitha V.; Narayanan, Sai Shyam; Nath, Lekshmi R.; Thulasidasan, Arun Kumar T.; Anto, Ruby John] Rajiv Gandhi Ctr Biotechnol, Div Canc Res, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Soniya, EV (corresponding author), Rajiv Gandhi Ctr Biotechnol, Div Plant Mol Biol, Thiruvananthapuram, Kerala, India.	evsoniya@rgcb.res.in; rjanto@rgcb.res.in						Anto RJ, 2002, CARCINOGENESIS, V23, P143, DOI 10.1093/carcin/23.1.143; Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511; Ashida Reiko, 2005, Inflammopharmacology, V13, P113, DOI 10.1163/156856005774423935; AZZI A, 1992, EUR J BIOCHEM, V208, P547, DOI 10.1111/j.1432-1033.1992.tb17219.x; Baliga MS, 2011, CRIT REV FOOD SCI, V51, P499, DOI 10.1080/10408391003698669; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bava SV, 2011, INT J BIOCHEM CELL B, V43, P331, DOI 10.1016/j.biocel.2010.09.011; Bava SV, 2005, J BIOL CHEM, V280, P6301, DOI 10.1074/jbc.M410647200; Bode AM, 2001, CANCER RES, V61, P850; Brown AC, 2009, PHYTOTHER RES, V23, P640, DOI 10.1002/ptr.2677; Bubici C, 2006, HISTOL HISTOPATHOL, V21, P69, DOI 10.14670/HH-21.69; Chakraborty D, 2012, EUR J PHARMACOL, V694, P20, DOI 10.1016/j.ejphar.2012.08.001; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Chen F, 2007, CANCER RES, V67, P11093, DOI 10.1158/0008-5472.CAN-07-1576; Cho HJ, 2007, CARCINOGENESIS, V28, P1104, DOI 10.1093/carcin/bgl217; Collett GP, 2004, CARCINOGENESIS, V25, P2183, DOI 10.1093/carcin/bgh233; Cordero-Herrera I, 2013, NUTR CANCER, V65, P718, DOI 10.1080/01635581.2013.795981; Debruyne PR, 2001, MUTAT RES-FUND MOL M, V480, P359, DOI 10.1016/S0027-5107(01)00195-6; Han HH, 2010, MOL CANCER RES, V8, P1477, DOI 10.1158/1541-7786.MCR-10-0114; Heider I, 2004, ONCOL RES, V14, P475, DOI 10.3727/0965040042380496; Jeong CH, 2009, CANCER RES, V69, P5584, DOI 10.1158/0008-5472.CAN-09-0491; Jiang SZ, 2008, BIOPHARM DRUG DISPOS, V29, P529, DOI 10.1002/bdd.638; Ju SA, 2012, INT J CANCER, V130, P2618, DOI 10.1002/ijc.26316; Kim SO, 2005, ONCOGENE, V24, P2558, DOI 10.1038/sj.onc.1208446; Krell J, 2012, LANCET ONCOL, V13, P235, DOI 10.1016/S1470-2045(12)70097-9; Kudinov Y, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-4; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Lee E, 1998, CANCER LETT, V134, P163, DOI 10.1016/S0304-3835(98)00253-5; Lee HS, 2008, J NUTR BIOCHEM, V19, P313, DOI 10.1016/j.jnutbio.2007.05.008; Lee SH, 2008, MOL CARCINOGEN, V47, P197, DOI 10.1002/mc.20374; Lin CB, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/326096; Magalhaes B, 2012, EUR J CANCER PREV, V21, P15, DOI 10.1097/CEJ.0b013e3283472241; Masur K, 2001, MOL BIOL CELL, V12, P1973, DOI 10.1091/mbc.12.7.1973; Mayer RJ, 2009, NEW ENGL J MED, V360, P623, DOI 10.1056/NEJMe0809343; Meyer E, 2005, CANCER RES, V65, P4261, DOI 10.1158/0008-5472.CAN-04-2908; Miao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057226; Mowla S, 2011, BIOCHEM J, V433, P145, DOI 10.1042/BJ20100886; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Park KK, 1998, CANCER LETT, V129, P139, DOI 10.1016/S0304-3835(98)00081-0; Park KA, 2007, CARCINOGENESIS, V28, P71, DOI 10.1093/carcin/bgl094; Park YJ, 2006, YONSEI MED J, V47, P688, DOI 10.3349/ymj.2006.47.5.688; Puliyappadamba VT, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-220; Rhode Jennifer, 2007, BMC Complement Altern Med, V7, P44, DOI 10.1186/1472-6882-7-44; Rickard KL, 1999, CARCINOGENESIS, V20, P977, DOI 10.1093/carcin/20.6.977; Seo EY, 2011, J GINSENG RES, V35, P315, DOI 10.5142/jgr.2011.35.3.315; Shao JY, 2000, J BIOL CHEM, V275, P33951, DOI 10.1074/jbc.M002324200; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shukla Y, 2007, MOL NUTR FOOD RES, V51, P1492, DOI 10.1002/mnfr.200700197; Shukla Y, 2007, FOOD CHEM TOXICOL, V45, P683, DOI 10.1016/j.fct.2006.11.002; Surh YJ, 1998, MUTAT RES-FUND MOL M, V402, P259, DOI 10.1016/S0027-5107(97)00305-9; Vaiopoulos AG, 2010, INT J BIOCHEM CELL B, V42, P1061, DOI 10.1016/j.biocel.2010.03.018; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Weng CJ, 2012, MOL NUTR FOOD RES, V56, P1304, DOI 10.1002/mnfr.201200173; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; Yang G, 2010, CHEM-BIOL INTERACT, V185, P12, DOI 10.1016/j.cbi.2010.02.017; Yu R, 2001, MOL PHARMACOL, V60, P217, DOI 10.1124/mol.60.1.217; Yu YK, 2011, AAPS J, V13, P417, DOI 10.1208/s12248-011-9286-5; Zick SM, 2008, CANCER EPIDEM BIOMAR, V17, P1930, DOI 10.1158/1055-9965.EPI-07-2934	58	76	79	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104401	10.1371/journal.pone.0104401	http://dx.doi.org/10.1371/journal.pone.0104401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157570	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303200012
J	Reitz, T; Rossberg, A; Barkleit, A; Selenska-Pobell, S; Merroun, ML				Reitz, Thomas; Rossberg, Andre; Barkleit, Astrid; Selenska-Pobell, Sonja; Merroun, Mohamed L.			Decrease of U(VI) Immobilization Capability of the Facultative Anaerobic Strain Paenibacillus sp JG-TB8 under Anoxic Conditions Due to Strongly Reduced Phosphatase Activity	PLOS ONE			English	Article							INDUCED FLUORESCENCE SPECTROSCOPY; URANIUM(VI) COMPLEXES; SULFOLOBUS-ACIDOCALDARIUS; BACILLUS-SUBTILIS; RADIOACTIVE-WASTE; ACID-PHOSPHATASE; HEAVY-METALS; SP-NOV; BIOMINERALIZATION; REDUCTION	Interactions of a facultative anaerobic bacterial isolate named Paenibacillus sp. JG-TB8 with U(VI) were studied under oxic and anoxic conditions in order to assess the influence of the oxygen-dependent cell metabolism on microbial uranium mobilization and immobilization. We demonstrated that aerobically and anaerobically grown cells of Paenibacillus sp. JG-TB8 accumulate uranium from aqueous solutions under acidic conditions (pH 2 to 6), under oxic and anoxic conditions. A combination of spectroscopic and microscopic methods revealed that the speciation of U(VI) associated with the cells of the strain depend on the pH as well as on the aeration conditions. At pH 2 and pH 3, uranium was exclusively bound by organic phosphate groups provided by cellular components, independently on the aeration conditions. At higher pH values, a part (pH 4.5) or the total amount (pH 6) of the dissolved uranium was precipitated under oxic conditions in a meta-autunite-like uranyl phosphate mineral phase without supplying an additional organic phosphate substrate. In contrast to that, under anoxic conditions no mineral formation was observed at pH 4.5 and pH 6, which was clearly assigned to decreased orthophosphate release by the cells. This in turn was caused by a suppression of the indigenous phosphatase activity of the strain. The results demonstrate that changes in the metabolism of facultative anaerobic microorganisms caused by the presence or absence of oxygen can decisively influence U(VI) biomineralization.	[Reitz, Thomas; Rossberg, Andre; Barkleit, Astrid; Selenska-Pobell, Sonja] Helmholtz Ctr Dresden Rossendorf, Inst Resource Ecol, Dresden, Germany; [Reitz, Thomas] Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany; [Merroun, Mohamed L.] Univ Granada, Dept Microbiol, Granada, Spain	Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Granada	Reitz, T (corresponding author), Helmholtz Ctr Dresden Rossendorf, Inst Resource Ecol, Dresden, Germany.	thomas.reitz@ufz.de	Barkleit, Astrid/N-3827-2017; ESRF, ROBL: The Rossendorf Beamline at/A-2586-2011; Reitz, Thomas/AFP-6355-2022; Merroun, Mohamed L./L-4514-2014	Barkleit, Astrid/0000-0003-3241-3443; ESRF, ROBL: The Rossendorf Beamline at/0000-0002-6608-5428; Merroun, Mohamed L./0000-0003-4553-5976	Ministerio de Ciencia e Innovacion, Spain [CGL2009-09760, CGL2012-36505]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was partially funded by the grants CGL2009-09760 and CGL2012-36505 (Ministerio de Ciencia e Innovacion, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearne JF, 1997, PHYS TODAY, V50, P24, DOI 10.1063/1.881763; Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; ASH C, 1993, ANTON LEEUW INT J G, V64, P253; Atlas RM., 2004, HDB MICROBIOLOGICAL; Baik MH, 2004, RADIOCHIM ACTA, V92, P663, DOI 10.1524/ract.92.9.663.54980; Barkleit A, 2008, DALTON T, P2879, DOI 10.1039/b715669c; Barkleit A, 2009, DALTON T, P5379, DOI 10.1039/b818702a; Barnett MO, 2000, SOIL SCI SOC AM J, V64, P908, DOI 10.2136/sssaj2000.643908x; Bauerlein E, 2003, ANGEW CHEM INT EDIT, V42, P614, DOI 10.1002/anie.200390176; Beazley MJ, 2007, ENVIRON SCI TECHNOL, V41, P5701, DOI 10.1021/es070567g; Beazley MJ, 2011, GEOCHIM COSMOCHIM AC, V75, P5648, DOI 10.1016/j.gca.2011.07.006; Beazley MJ, 2009, GEOMICROBIOL J, V26, P431, DOI 10.1080/01490450903060780; Boswell CD, 1999, MICROBIOL-UK, V145, P1711, DOI 10.1099/13500872-145-7-1711; Burns PC, 1997, CAN MINERAL, V35, P1551; BUSS JE, 1983, METHOD ENZYMOL, V99, P7; DASSA E, 1982, J BIOL CHEM, V257, P6669; Deuerling E, 1997, MOL MICROBIOL, V23, P921, DOI 10.1046/j.1365-2958.1997.2721636.x; EKMAN P, 1993, ANAL BIOCHEM, V214, P138, DOI 10.1006/abio.1993.1468; Elo S, 2001, INT J SYST EVOL MICR, V51, P535, DOI 10.1099/00207713-51-2-535; Fanghanel T., 2003, UPDATE CHEM THERMODY; Fowle DA, 2000, ENVIRON SCI TECHNOL, V34, P3737, DOI 10.1021/es991356h; Gadd GM, 2009, J CHEM TECHNOL BIOT, V84, P13, DOI 10.1002/jctb.1999; Geipel G, 2000, RADIOCHIM ACTA, V88, P757, DOI 10.1524/ract.2000.88.9-11.757; Geissler A, 2009, GEOBIOLOGY, V7, P282, DOI 10.1111/j.1472-4669.2009.00199.x; Goel R, 1998, WATER RES, V32, P2081, DOI 10.1016/S0043-1354(97)00425-9; Hennig C, 2001, RADIOCHIM ACTA, V89, P625, DOI 10.1524/ract.2001.89.10.625; Hudson EA, 1996, PHYS REV B, V54, P156, DOI 10.1103/PhysRevB.54.156; Jroundi F, 2007, GEOMICROBIOL J, V24, P441, DOI 10.1080/01490450701437651; Koban A, 2007, J INORG BIOCHEM, V101, P750, DOI 10.1016/j.jinorgbio.2007.01.001; Koban A, 2004, RADIOCHIM ACTA, V92, P903, DOI 10.1524/ract.92.12.903.55114; Koban A, 2004, POLYHEDRON, V23, P1793, DOI 10.1016/j.poly.2004.04.022; Kurosawa N, 2000, CURR MICROBIOL, V40, P57, DOI 10.1007/s002849910011; Liu CX, 2002, BIOTECHNOL BIOENG, V80, P637, DOI 10.1002/bit.10430; Lloyd JR, 2002, INTERACTIONS MICROOR; LOVLEY DR, 1991, NATURE, V350, P413, DOI 10.1038/350413a0; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Lucks C, 2012, INORG CHEM, V51, P12288, DOI 10.1021/ic301565p; MACASKIE LE, 1994, FEMS MICROBIOL REV, V14, P351, DOI 10.1016/0168-6445(94)90053-1; MACASKIE LE, 1992, SCIENCE, V257, P782, DOI 10.1126/science.1496397; MACASKIE LE, 1994, FEMS MICROBIOL LETT, V121, P141, DOI 10.1111/j.1574-6968.1994.tb07090.x; Markich Scott J, 2002, ScientificWorldJournal, V2, P707; Matz W, 1999, J SYNCHROTRON RADIAT, V6, P1076, DOI 10.1107/S0909049599010663; Merroun M, 2003, RADIOCHIM ACTA, V91, P583, DOI 10.1524/ract.91.10.583.22477; Merroun ML, 2003, BIOMETALS, V16, P331, DOI 10.1023/A:1020612600726; Merroun ML, 2011, J HAZARD MATER, V197, P1, DOI 10.1016/j.jhazmat.2011.09.049; Merroun ML, 2008, J CONTAM HYDROL, V102, P285, DOI 10.1016/j.jconhyd.2008.09.019; Murphy WM, 1999, REV MINERAL <D>, V38, P221; Nakano MM, 1997, J BACTERIOL, V179, P6749, DOI 10.1128/jb.179.21.6749-6755.1997; Nedelkova M, 2007, FEMS MICROBIOL ECOL, V59, P694, DOI 10.1111/j.1574-6941.2006.00261.x; Pedersen K, 2005, J NUCL RADIOCHEM SCI, V6, P11; PORSCHEN RK, 1974, APPL MICROBIOL, V27, P744, DOI 10.1128/AEM.27.4.744-747.1974; Powers LG, 2002, FEMS MICROBIOL ECOL, V41, P115, DOI 10.1111/j.1574-6941.2002.tb00972.x; Reitz T, 2011, RADIOCHIM ACTA, V99, P543, DOI 10.1524/ract.2011.1848; Reitz T, 2010, RADIOCHIM ACTA, V98, P249, DOI 10.1524/ract.2010.1716; Renninger N, 2004, APPL ENVIRON MICROB, V70, P7404, DOI 10.1128/AEM.70.12.7404-7412.2004; Renshaw JC, 2007, CR CHIM, V10, P1067, DOI 10.1016/j.crci.2007.02.013; Salome KR, 2013, GEOCHIM COSMOCHIM AC, V106, P344, DOI 10.1016/j.gca.2012.12.037; Sar P, 2001, J CHEM TECHNOL BIOT, V76, P1286, DOI 10.1002/jctb.517; SATTA G, 1979, J CLIN PATHOL, V32, P391, DOI 10.1136/jcp.32.4.391; Sivaswamy V, 2011, BIOTECHNOL BIOENG, V108, P264, DOI 10.1002/bit.22956; Suzuki Y, 2004, RADIOCHIM ACTA, V92, P11, DOI 10.1524/ract.92.1.11.25404; Vogel M, 2010, SCI TOTAL ENVIRON, V409, P384, DOI 10.1016/j.scitotenv.2010.10.011; Wall JD, 2006, ANNU REV MICROBIOL, V60, P149, DOI 10.1146/annurev.micro.59.030804.121357; Wolery TJ, 1992, EQ3 6 SOFTWARE PACKA	64	15	16	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e102447	10.1371/journal.pone.0102447	http://dx.doi.org/10.1371/journal.pone.0102447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157416	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200001
J	Yu, QX; Sheng, LL; Yang, M; Zhu, M; Huang, XL; Li, QF				Yu, Qingxiong; Sheng, Lingling; Yang, Mei; Zhu, Ming; Huang, Xiaolu; Li, Qingfeng			Tanshinon IIA Injection Accelerates Tissue Expansion by Reducing the Formation of the Fibrous Capsule	PLOS ONE			English	Article							FOREIGN-BODY RESPONSE; IMPLANTS; REGENERATION	The tissue expansion technique has been applied to obtain new skin tissue to repair large defects in clinical practice. The implantation of tissue expander could initiate a host response to foreign body (FBR), which leads to fibrotic encapsulation around the expander and prolongs the period of tissue expansion. Tanshinon IIA (Tan IIA) has been shown to have anti-inflammation and immunoregulation effect. The rat tissue expansion model was used in this study to observe whether Tan IIA injection systematically could inhibit the FBR to reduce fibrous capsule formation and accelerate the process of tissue expansion. Forty-eight rats were randomly divided into the Tan IIA group and control group with 24 rats in each group. The expansion was conducted twice a week to maintain a capsule pressure of 60 mmHg. The expansion volume and expanded area were measured. The expanded tissue in the two groups was harvested, and histological staining was performed; proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and interleukin-1 beta (IL-1 beta) and transforming growth factor-beta (TGF-beta) were examined. The expansion volume and the expanded area in the Tan IIA group were greater than that of the control group. The thickness of the fibrous capsule in the Tan IIA group was reduced with no influence on the normal skin regeneration. Decreased infiltration of macrophages, lower level of TNF-alpha, IL-6, IL-1 beta and TGF-beta, less proliferating myofibroblasts and enhanced neovascularization were observed in the Tan IIA group. Our findings indicated that the Tan IIA injection reduced the formation of the fibrous capsule and accelerated the process of tissue expansion by inhibiting the FBR.	[Yu, Qingxiong; Sheng, Lingling; Zhu, Ming; Huang, Xiaolu; Li, Qingfeng] Shanghai Jiao Tong Univ, Shanghai Ninth Peoples Hosp, Sch Med, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China; [Yang, Mei] So Illinois Univ, Div Plast Surg, Springfield, IL USA	Shanghai Jiao Tong University; Southern Illinois University System; Southern Illinois University	Li, QF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ninth Peoples Hosp, Sch Med, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China.	dr.liqingfeng@yahoo.com			National Key Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China [2012BAI11B03]; Shanghai Jiaotong University School of Medicine Doctoral Innovation Foundation [BXJ201230]	National Key Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China; Shanghai Jiaotong University School of Medicine Doctoral Innovation Foundation	This study was supported by the National Key Project of Scientific and Technical Supporting Programs funded by the Ministry of Science & Technology of China (no. 2012BAI11B03) and Shanghai Jiaotong University School of Medicine Doctoral Innovation Foundation (BXJ201230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozkurt A, 2008, BURNS, V34, P1113, DOI 10.1016/j.burns.2008.05.008; Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; HEPPLESTON AG, 1967, NATURE, V214, P521, DOI 10.1038/214521a0; Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962; Joseph J, 2010, J MATER SCI-MATER M, V21, P1665, DOI 10.1007/s10856-010-4015-7; LAITUNG JKG, 1987, ANN PLAS SURG, V19, P208, DOI 10.1097/00000637-198709000-00005; LEE P, 1985, PLAST RECONSTR SURG, V76, P604, DOI 10.1097/00006534-198510000-00023; Li AG, 2007, J BIOMED MATER RES A, V82A, P498, DOI 10.1002/jbm.a.31168; Li JH, 2011, RESP PHYSIOL NEUROBI, V176, P39, DOI 10.1016/j.resp.2011.01.005; MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805; Poeppl N, 2007, AESTHET PLAST SURG, V31, P133, DOI 10.1007/s00266-006-0091-y; Prantl L, 2007, PLAST RECONSTR SURG, V120, P275, DOI 10.1097/01.prs.0000264398.85652.9a; Raposio E, 1999, BRIT J PLAST SURG, V52, P194, DOI 10.1054/bjps.1998.3096; Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8; Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027; Ruiz-de-Erenchun R, 2005, PLAST RECONSTR SURG, V116, P1370, DOI 10.1097/01.prs.0000181694.07661.0d; SCHMIDT SC, 1991, PLAST RECONSTR SURG, V87, P10, DOI 10.1097/00006534-199101000-00003; Sheng LL, 2014, MOL MED REP, V9, P872, DOI 10.3892/mmr.2013.1881; Sheng LL, 2013, WOUND REPAIR REGEN, V21, P746, DOI 10.1111/wrr.12080; Sheng LL, 2013, J PLAST RECONSTR AES, V66, P551, DOI 10.1016/j.bjps.2012.11.008; Siggelkow W, 2003, BIOMATERIALS, V24, P1101, DOI 10.1016/S0142-9612(02)00429-5; Tang Y, 2004, PLAST RECONSTR SURG, V114, P1166, DOI 10.1097/01.prs.0000135854.48570.76; Tavazzani F, 2005, J BIOMED MATER RES A, V72A, P161, DOI 10.1002/jbm.a.30181; Wu WY, 2013, BRIT J PHARMACOL, V169, P1058, DOI 10.1111/bph.12185; Xu SW, 2013, EXPERT OPIN THER PAT, V23, P149, DOI 10.1517/13543776.2013.743995; Yang M, 2011, ANN SURG, V253, P202, DOI 10.1097/SLA.0b013e3181f9ba1ah; Yin S, 2010, TISSUE ENG PT A, V16, P1633, DOI 10.1089/ten.TEA.2009.0570; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038381, 10.1371/journal.pone.0051853]	29	5	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105756	10.1371/journal.pone.0105756	http://dx.doi.org/10.1371/journal.pone.0105756			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157742	Green Submitted, gold, Green Published			2022-12-25	WOS:000341303200059
J	Hoppner, A; Widderich, N; Lenders, M; Bremer, E; Smits, SHJ				Hoeppner, Astrid; Widderich, Nils; Lenders, Michael; Bremer, Erhard; Smits, Sander H. J.			Crystal Structure of the Ectoine Hydroxylase, a Snapshot of the Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biosynthesis; Chemical Biology; Crystal Structure; Dioxygenase; Enzyme Structure; Enzymes	COMPATIBLE SOLUTE ECTOINE; HALOMONAS-ELONGATA; ESCHERICHIA-COLI; TETRAHYDROPYRIMIDINE DERIVATIVES; SPHINGOPYXIS-ALASKENSIS; PSEUDOMONAS-PUTIDA; HALOGENASE SYRB2; HEAT STRESSES; IN-VITRO; BIOSYNTHESIS	Background: 5-Hydroxyectoine is a compatible solute synthesized by the ectoine hydroxylase (EctD), a non-heme containing iron(II) and 2-oxoglutarate-dependent dioxygenase. Results: The structure of EctD was solved in different forms. Conclusion: The architecture of the catalytic core of EctD was revealed. Significance: The crystal structure increases our understanding of the structural-functional relationship in an evolutionary conserved group of enzymes. Ectoine and its derivative 5-hydroxyectoine are compatible solutes that are widely synthesized by bacteria to cope physiologically with osmotic stress. They also serve as chemical chaperones and maintain the functionality of macromolecules. 5-Hydroxyectoine is produced from ectoine through a stereo-specific hydroxylation, an enzymatic reaction catalyzed by the ectoine hydroxylase (EctD). The EctD protein is a member of the non-heme-containing iron(II) and 2-oxoglutarate-dependent dioxygenase superfamily and is evolutionarily well conserved. We studied the ectoine hydroxylase from the cold-adapted marine ultra-microbacterium Sphingopyxis alaskensis (Sa) and found that the purified SaEctD protein is a homodimer in solution. We determined the SaEctD crystal structure in its apo-form, complexed with the iron catalyst, and in a form that contained iron, the co-substrate 2-oxoglutarate, and the reaction product of EctD, 5-hydroxyectoine. The iron and 2-oxoglutarate ligands are bound within the EctD active site in a fashion similar to that found in other members of the dioxygenase superfamily. 5-Hydroxyectoine, however, is coordinated by EctD in manner different from that found in high affinity solute receptor proteins operating in conjunction with microbial import systems for ectoines. Our crystallographic analysis provides a detailed view into the active site of the ectoine hydroxylase and exposes an intricate network of interactions between the enzyme and its ligands that collectively ensure the hydroxylation of the ectoine substrate in a position- and stereo-specific manner.	[Hoeppner, Astrid] Univ Dusseldorf, Xray Facil, D-40225 Dusseldorf, Germany; [Hoeppner, Astrid] Univ Dusseldorf, Crystal Farm, D-40225 Dusseldorf, Germany; [Widderich, Nils; Bremer, Erhard] Univ Marburg, Microbiol Lab, Dept Biol, D-35043 Marburg, Germany; [Widderich, Nils] Max Planck Inst Terr Microbiol, Emeritus Grp RK Thauer, D-35043 Marburg, Germany; [Lenders, Michael; Smits, Sander H. J.] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; [Bremer, Erhard] Univ Marburg, LOEWE Ctr Synthet Microbiol, D-35043 Marburg, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Philipps University Marburg; Max Planck Society; Heinrich Heine University Dusseldorf; Philipps University Marburg	Bremer, E (corresponding author), Univ Marburg, Karl von Frisch Str 8, D-35043 Marburg, Germany.	bremer@staff.uni-marburg.de; Sander.Smits@hhu.de		Hoeppner, Astrid/0000-0002-7076-5936	Deutsche Forschungsgemeinschaft [SFB 987]; LOEWE program of the State of Hessen (via the Center for Synthetic Microbiology, Marburg); Max-Planck Institute for Terrestrial Microbiology (Marburg) through the Emeritus Group of R. K. Thauer; Heinrich-Heine-University Dusseldorf and its Institute of Biochemistry; initiative "Fit for Excellence" of the Heinrich-Heine-University; International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology, Marburg, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE program of the State of Hessen (via the Center for Synthetic Microbiology, Marburg); Max-Planck Institute for Terrestrial Microbiology (Marburg) through the Emeritus Group of R. K. Thauer; Heinrich-Heine-University Dusseldorf and its Institute of Biochemistry; initiative "Fit for Excellence" of the Heinrich-Heine-University; International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology, Marburg, Germany	This work was supported in part by Deutsche Forschungsgemeinschaft Grant SFB 987, the LOEWE program of the State of Hessen (via the Center for Synthetic Microbiology, Marburg), the Max-Planck Institute for Terrestrial Microbiology (Marburg) through the Emeritus Group of R. K. Thauer, a contribution by the Fonds der Chemischen Industrie, by the Heinrich-Heine-University Dusseldorf and its Institute of Biochemistry, and by the initiative "Fit for Excellence" of the Heinrich-Heine-University.; Recipient of a Ph.D. fellowship from the International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology, Marburg, Germany.	Abdel-Aziz H, 2013, PHYTOMEDICINE, V20, P585, DOI 10.1016/j.phymed.2013.01.009; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Becker J, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-110; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; Bourot S, 2000, J BIOL CHEM, V275, P1050, DOI 10.1074/jbc.275.2.1050; Bremer E, 2000, BACTERIAL STRESS RESPONSES, P79; Bursy J, 2008, APPL ENVIRON MICROB, V74, P7286, DOI 10.1128/AEM.00768-08; Bursy J, 2007, J BIOL CHEM, V282, P31147, DOI 10.1074/jbc.M704023200; Diamant S, 2001, J BIOL CHEM, V276, P39586, DOI 10.1074/jbc.M103081200; Doan VT, 2013, APPL MICROBIOL BIOT, V97, P6271, DOI 10.1007/s00253-012-4528-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GALINSKI EA, 1985, EUR J BIOCHEM, V149, P135, DOI 10.1111/j.1432-1033.1985.tb08903.x; Garcia-Estepa R, 2006, J BACTERIOL, V188, P3774, DOI 10.1128/JB.00136-06; Graf R, 2008, CLIN DERMATOL, V26, P326, DOI 10.1016/j.clindermatol.2008.01.002; Grzyska PK, 2010, P NATL ACAD SCI USA, V107, P3982, DOI 10.1073/pnas.0911565107; Hanekop N, 2007, J MOL BIOL, V374, P1237, DOI 10.1016/j.jmb.2007.09.071; Hangasky JA, 2013, METALLOMICS, V5, P287, DOI 10.1039/c3mt20153h; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Helmetag V, 2009, FEBS J, V276, P3669, DOI 10.1111/j.1742-4658.2009.07085.x; Hoeppner A., 2013, ADV TOPICS CRYSTAL G, P3; Hoeppner A, 2014, ACTA CRYSTALLOGR F, V70, P493, DOI 10.1107/S2053230X14004798; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; INBAR L, 1988, J BIOL CHEM, V263, P16014; INBAR L, 1993, EUR J BIOCHEM, V214, P897, DOI 10.1111/j.1432-1033.1993.tb17993.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Khare D, 2010, P NATL ACAD SCI USA, V107, P14099, DOI 10.1073/pnas.1006738107; Knapp S, 1999, EXTREMOPHILES, V3, P191, DOI 10.1007/s007920050116; Knauer SH, 2012, FEBS J, V279, P816, DOI 10.1111/j.1742-4658.2012.08473.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhlmann AU, 2008, APPL ENVIRON MICROB, V74, P4560, DOI 10.1128/AEM.00492-08; Kuhlmann AU, 2002, APPL ENVIRON MICROB, V68, P772, DOI 10.1128/AEM.68.2.772-783.2002; Kuhlmann SI, 2008, BIOCHEMISTRY-US, V47, P9475, DOI 10.1021/bi8006719; Kundu Siddhartha, 2012, BMC Res Notes, V5, P410, DOI 10.1186/1756-0500-5-410; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurz Matthias, 2008, Saline Syst, V4, P6, DOI 10.1186/1746-1448-4-6; Lecher J, 2009, J MOL BIOL, V389, P58, DOI 10.1016/j.jmb.2009.03.077; Lentzen G, 2006, APPL MICROBIOL BIOT, V72, P623, DOI 10.1007/s00253-006-0553-9; LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61; Louis P, 1997, MICROBIOL-UK, V143, P1141, DOI 10.1099/00221287-143-4-1141; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; Manzanera M, 2002, APPL ENVIRON MICROB, V68, P4328, DOI 10.1128/AEM.68.9.4328-4333.2002; Marini A, 2014, SKIN PHARMACOL PHYS, V27, P57, DOI 10.1159/000351381; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonough MA, 2005, J BIOL CHEM, V280, P41101, DOI 10.1074/jbc.M507528200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mustakhimov II, 2010, J BACTERIOL, V192, P410, DOI 10.1128/JB.00553-09; Ono H, 1999, J BACTERIOL, V181, P91, DOI 10.1128/JB.181.1.91-99.1999; Pastor JM, 2010, BIOTECHNOL ADV, V28, P782, DOI 10.1016/j.biotechadv.2010.06.005; PETERS P, 1990, FEMS MICROBIOL LETT, V71, P157; Prabhu J, 2004, APPL ENVIRON MICROB, V70, P3130, DOI 10.1128/AEM.70.5.3130-3132.2004; Reuter K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010647; Saum SH, 2008, ENVIRON MICROBIOL, V10, P716, DOI 10.1111/j.1462-2920.2007.01494.x; Schnoor M, 2004, BIOCHEM BIOPH RES CO, V322, P867, DOI 10.1016/j.bbrc.2004.07.200; Schwibbert K, 2011, ENVIRON MICROBIOL, V13, P1973, DOI 10.1111/j.1462-2920.2010.02336.x; Stoveken N, 2011, J BACTERIOL, V193, P4456, DOI 10.1128/JB.00345-11; Straganz GD, 2006, CHEMBIOCHEM, V7, P1536, DOI 10.1002/cbic.200600152; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Strieker M, 2007, ACS CHEM BIOL, V2, P187, DOI 10.1021/cb700012y; Sun H, 2012, CRYOLETTERS, V33, P485; Tanne C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00150; Ting L, 2010, ENVIRON MICROBIOL, V12, P2658, DOI 10.1111/j.1462-2920.2010.02235.x; Widderich N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093809; Widderich N, 2014, J MOL BIOL, V426, P586, DOI 10.1016/j.jmb.2013.10.028; Witt EMHJ, 2011, APPL MICROBIOL BIOT, V91, P113, DOI 10.1007/s00253-011-3211-9; Wong C, 2009, J AM CHEM SOC, V131, P4872, DOI 10.1021/ja8097355; Wong SD, 2013, NATURE, V499, P320, DOI 10.1038/nature12304; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Zhang ZH, 2011, BIOCHEM BIOPH RES CO, V408, P553, DOI 10.1016/j.bbrc.2011.04.059	71	28	30	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29570	29583		10.1074/jbc.M114.576769	http://dx.doi.org/10.1074/jbc.M114.576769			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25172507	hybrid, Green Published			2022-12-25	WOS:000344370800009
J	Ma, TM; Paul, BD; Fu, CL; Hu, SH; Zhu, H; Blackshaw, S; Wolosker, H; Snyder, SH				Ma, Ting Martin; Paul, Bindu D.; Fu, Chenglai; Hu, Shaohui; Zhu, Heng; Blackshaw, Seth; Wolosker, Herman; Snyder, Solomon H.			Serine Racemase Regulated by Binding to Stargazin and PSD-95 POTENTIAL N-METHYL-D-ASPARTATE-alpha-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID (NMDA-AMPA) GLUTAMATE NEUROTRANSMISSION CROSS-TALK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme; Ionotropic Glutamate Receptor; Neuron; Neurotransmitter; Synapse; D-Serine; PSD-95; Stargazin	ENDOPLASMIC-RETICULUM; SILENT SYNAPSES; RECEPTORS; PROTEIN; ACTIVATION; APOPTOSIS; EXPRESSION; SUBUNITS; GLYCINE; CELLS	Background: d-Serine, generated by serine racemase (SR), is an endogenous co-agonist for NMDA receptors. Results: SR binds PSD-95 and stargazin, which inhibits SR enzymatic activity. This complex is disrupted by AMPA receptor activation, activating d-serine synthesis. Conclusion: SR/stargazin/PSD-95 interactions mediate NMDA/AMPA receptor cross-talk. Significance: d-Serine may link AMPA and NMDA neurotransmission. d-Serine, an endogenous co-agonist for the glycine site of the synaptic NMDA glutamate receptor, regulates synaptic plasticity and is implicated in schizophrenia. Serine racemase (SR) is the enzyme that converts l-serine to d-serine. In this study, we demonstrate that SR interacts with the synaptic proteins, postsynaptic density protein 95 (PSD-95) and stargazin, forming a ternary complex. SR binds to the PDZ3 domain of PSD-95 through the PDZ domain ligand at its C terminus. SR also binds to the C terminus of stargazin, which facilitates the cell membrane localization of SR and inhibits its activity. AMPA receptor activation internalizes SR and disrupts its interaction with stargazin, therefore derepressing SR activity, leading to more d-serine production and potentially facilitating NMDA receptor activation. These interactions regulate the enzymatic activity as well as the intracellular localization of SR, potentially coupling the activities of NMDA and AMPA receptors. This shuttling of a neurotransmitter synthesizing enzyme between two receptors appears to be a novel mode of synaptic regulation.	[Ma, Ting Martin; Paul, Bindu D.; Fu, Chenglai; Blackshaw, Seth; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Hu, Shaohui; Zhu, Heng; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Wolosker, Herman] Technion Israel Inst Technol, Dept Biochem, IL-31096 Haifa, Israel	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Technion Israel Institute of Technology	Snyder, SH (corresponding author), Johns Hopkins Univ, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	Fu, Chenglai/H-5330-2018; Hu, Shaohui/AAE-4433-2020	Fu, Chenglai/0000-0003-4300-9948; Wolosker, Herman/0000-0001-5508-9194	National Institutes of Health from USPHS [MH18501]; Technion-Johns Hopkins Collaboration Program; Prince Center for Aging of the Brain; Israel Science Foundation; Legacy Heritage Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018501, R01MH018501] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; Technion-Johns Hopkins Collaboration Program; Prince Center for Aging of the Brain; Israel Science Foundation(Israel Science Foundation); Legacy Heritage Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH18501 from USPHS (to S. H. S.) and grants from Technion-Johns Hopkins Collaboration Program, The Prince Center for Aging of the Brain, the Israel Science Foundation, and the Legacy Heritage Fund (to H. W.).	Akundi RS, 2003, ANN NY ACAD SCI, V1010, P304, DOI 10.1196/annals.1299.053; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Blackburn-Munro G, 2004, NEUROPHARMACOLOGY, V47, P351, DOI 10.1016/j.neuropharm.2004.04.007; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Fujii K, 2006, MOL PSYCHIATR, V11, P150, DOI 10.1038/sj.mp.4001776; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; HASHIMOTO A, 1992, FEBS LETT, V296, P33, DOI 10.1016/0014-5793(92)80397-Y; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; Hikida T, 2008, BIOL PSYCHIAT, V63, P997, DOI 10.1016/j.biopsych.2007.09.025; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Jantas D, 2008, NEUROCHEM INT, V52, P864, DOI 10.1016/j.neuint.2007.10.003; Jeong J. S., 2012, MOL CELL PROTEOMICS, V111; Kang BN, 2010, J NEUROSCI, V30, P93, DOI 10.1523/JNEUROSCI.3974-09.2010; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Koldobskiy MA, 2010, P NATL ACAD SCI USA, V107, P20947, DOI 10.1073/pnas.1015671107; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kulikov AV, 2007, B EXP BIOL MED+, V144, P626, DOI 10.1007/s10517-007-0390-6; Leem JW, 2010, EXP NEUROL, V224, P321, DOI 10.1016/j.expneurol.2010.02.012; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Ma QP, 1998, PAIN, V77, P49, DOI 10.1016/S0304-3959(98)00081-5; Ma TM, 2013, MOL PSYCHIATR, V18, P557, DOI 10.1038/mp.2012.97; Minami T, 2001, BRAIN RES, V895, P178, DOI 10.1016/S0006-8993(01)02069-8; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Mustafa AK, 2007, P NATL ACAD SCI USA, V104, P2950, DOI 10.1073/pnas.0611620104; Mustafaa AK, 2009, P NATL ACAD SCI USA, V106, P2921, DOI 10.1073/pnas.0813105106; NAARALA J, 1993, FEBS LETT, V330, P222, DOI 10.1016/0014-5793(93)80278-3; Nair VD, 1996, J NEUROCHEM, V66, P2390; Nissenbaum J, 2010, GENOME RES, V20, P1180, DOI 10.1101/gr.104976.110; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sun DD, 1998, AM J PHYSIOL-CELL PH, V275, pC772, DOI 10.1152/ajpcell.1998.275.3.C772; Tao F, 2006, J NEUROSCI RES, V84, P867, DOI 10.1002/jnr.20973; Taubert D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000385; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2006, P NATL ACAD SCI USA, V103, P10064, DOI 10.1073/pnas.0603128103; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wu H., 2012, ANALG RESUSC CURR RE, DOI [10.4172/2324-903X.1000101, DOI 10.4172/2324-903X.1000101]; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Yu XM, 1998, NATURE, V396, P469, DOI 10.1038/24877	52	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29631	29641		10.1074/jbc.M114.571604	http://dx.doi.org/10.1074/jbc.M114.571604			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25164819	Green Published, hybrid			2022-12-25	WOS:000344370800013
J	Cunyat, F; Beerens, N; Garcia, E; Clotet, B; Kjems, J; Cabrera, C				Cunyat, Francesc; Beerens, Nancy; Garcia, Elisabet; Clotet, Bonaventura; Kjems, Jorgen; Cabrera, Cecilia			Functional Analyses Reveal Extensive RRE Plasticity in Primary HIV-1 Sequences Selected under Selective Pressure	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RESPONSIVE ELEMENT RNA; SECONDARY STRUCTURE; TARGET SEQUENCE; GENE-EXPRESSION; ANTIRETROVIRAL THERAPY; TRANS-ACTIVATOR; NUCLEAR EXPORT; REX PROTEINS; BINDING	Background: HIV-1 Rev response element (RRE) is a functional region of viral RNA lying immediately downstream to the junction of gp120 and gp41 in the env coding sequence. The RRE is essential for HIV replication and binds with the Rev protein to facilitate the export of viral mRNA from nucleus to cytoplasm. It has been suggested that changes in the predicted secondary structure of primary RRE sequences impact the function of the RREs; however, functional assays have not yet been performed. The aim of this study was to characterize the genetic, structural and functional variation in the RRE primary sequences selected in vivo by Enfuvirtide pressure. Results: Multiple RRE variants were obtained from viruses isolated from patients who failed an Enfuvirtide-containing regimen. Different alterations were observed in the predicted RRE secondary structures, with the abrogation of the primary Rev binding site in one of the variants. In spite of this, most of the RRE variants were able to bind Rev and promote the cytoplasmic export of the viral mRNAs with equivalent efficiency in a cell-based assay. Only RRE45 and RRE40-45 showed an impaired ability to bind Rev in a gel-shift binding assay. Unexpectedly, this impairment was not reflected in functional capacity when RNA export was evaluated using a reporter assay, or during virus replication in lymphoid cells, suggesting that in vivo the RRE would be highly malleable. Conclusions: The Rev-RRE functionality is unaffected in RRE variants selected in patients failing an ENF-containing regimen. Our data show that the current understanding of the Rev-RRE complex structure does not suffice and fails to rationally predict the function of naturally occurring RRE mutants. Therefore, this data should be taken into account in the development of antiviral agents that target the RRE-Rev complex.	[Cunyat, Francesc; Garcia, Elisabet; Clotet, Bonaventura; Cabrera, Cecilia] Univ Autonoma Barcelona, Hosp Germans Trias, IrsiCaixa HIVACAT, Inst Rec Ciencies Salut Germans Trias & Pujol, Barcelona, Catalonia, Spain; [Beerens, Nancy] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Kjems, Jorgen] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Dept Mol Biol & Genet, Aarhus, Denmark	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Aarhus University; Aarhus University	Cabrera, C (corresponding author), Univ Autonoma Barcelona, Hosp Germans Trias, IrsiCaixa HIVACAT, Inst Rec Ciencies Salut Germans Trias & Pujol, Barcelona, Catalonia, Spain.	ccabrera@irsicaixa.es	Kjems, Jorgen/I-3490-2016; Cabrera, Cecilia/S-1113-2019	Kjems, Jorgen/0000-0003-4128-9317; Cabrera, Cecilia/0000-0002-9941-6828; Cunyat, Francesc/0000-0002-1284-6324	Fondo de Investigacion Sanitaria (FIS) [07/0418]; Spanish AIDS network [RD06/0006]; Health Department of the Catalan Government (Generalitat de Catalunya); FIS [07/0418]	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Spanish AIDS network; Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); FIS(Instituto de Salud Carlos III)	This work was supported by the Fondo de Investigacion Sanitaria (FIS) project 07/0418 (to CC) and the Spanish AIDS network, "RIS, Red Tematica Cooperativa de Investigacion en SIDA (RD06/0006).'' C. Cabrera is researcher from Fundacio Institut de Recerca en Ciencies de la Salut Germans Trias i Pujol supported by the Health Department of the Catalan Government (Generalitat de Catalunya). F. Cunyat was supported by the FIS project 07/0418. This work was part of the PhD thesis of F. Cunyat at Universitat Autonoma de Barcelona, Barcelona, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blissenbach M, 2010, J VIROL, V84, P6598, DOI 10.1128/JVI.02264-09; Cabrera C, 2006, AIDS, V20, P2075, DOI 10.1097/QAD.0b013e3280102377; Charpentier B, 1997, J MOL BIOL, V266, P950, DOI 10.1006/jmbi.1996.0858; Daugherty MD, 2008, MOL CELL, V31, P824, DOI 10.1016/j.molcel.2008.07.016; Dayton ET, 1992, J VIROL, V66, P14; Dimonte S, 2012, INTERVIROLOGY, V55, P385, DOI 10.1159/000334696; Fang JH, 2004, VIROLOGY, V330, P471, DOI 10.1016/j.virol.2004.09.039; Fang XY, 2013, CELL, V155, P594, DOI 10.1016/j.cell.2013.10.008; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P343, DOI 10.1089/aid.1994.10.343; Groom HCT, 2009, J GEN VIROL, V90, P1303, DOI 10.1099/vir.0.011460-0; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hamm TE, 1999, J VIROL, V73, P5741, DOI 10.1128/JVI.73.7.5741-5747.1999; HOLLAND SM, 1990, J VIROL, V64, P5966, DOI 10.1128/JVI.64.12.5966-5975.1990; HOPE TJ, 1990, J VIROL, V64, P5360, DOI 10.1128/JVI.64.11.5360-5366.1990; KJEMS J, 1992, EMBO J, V11, P1119, DOI 10.1002/j.1460-2075.1992.tb05152.x; KJEMS J, 1991, P NATL ACAD SCI USA, V88, P683, DOI 10.1073/pnas.88.3.683; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Legiewicz M, 2008, P NATL ACAD SCI USA, V105, P14365, DOI 10.1073/pnas.0804461105; LEWIS N, 1990, J VIROL, V64, P1690, DOI 10.1128/JVI.64.4.1690-1697.1990; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; MCDONALD D, 1992, J VIROL, V66, P7232, DOI 10.1128/JVI.66.12.7232-7238.1992; Nameki D, 2005, J VIROL, V79, P764, DOI 10.1128/JVI.79.2.764-770.2005; OLSEN HS, 1990, SCIENCE, V247, P845, DOI 10.1126/science.2406903; Pallesen J, 2009, FEBS J, V276, P4223, DOI 10.1111/j.1742-4658.2009.07130.x; Pasternak AO, 2012, J INFECT DIS, V206, P1443, DOI 10.1093/infdis/jis502; Peterson RD, 1996, J MOL BIOL, V264, P863, DOI 10.1006/jmbi.1996.0683; Phuphuakrat A, 2005, VIRUS GENES, V30, P23, DOI 10.1007/s11262-004-4578-9; Phuphuakrat A, 2005, J MED VIROL, V75, P367, DOI 10.1002/jmv.20279; Phuphuakrat A, 2003, AIDS RES HUM RETROV, V19, P569, DOI 10.1089/088922203322230932; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Ramakrishnan R, 2007, VIROLOGY, V359, P201, DOI 10.1016/j.virol.2006.09.003; Sharma Y, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-28; Shuck-Lee D, 2011, J VIROL, V85, P3940, DOI 10.1128/JVI.02683-10; Sloan EA, 2013, J VIROL, V87, P11173, DOI 10.1128/JVI.01392-13; Svicher V, 2009, ANTIMICROB AGENTS CH, V53, P2816, DOI 10.1128/AAC.01067-08; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Yedavalli VSRK, 2010, P NATL ACAD SCI USA, V107, P14787, DOI 10.1073/pnas.1009490107; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722; Zhang MJ, 1996, J ACQ IMMUN DEF SYND, V13, P403, DOI 10.1097/00042560-199612150-00001; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106299	10.1371/journal.pone.0106299	http://dx.doi.org/10.1371/journal.pone.0106299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170621	Green Submitted, Green Published, gold			2022-12-25	WOS:000341127500145
J	Fischer, A; Selge, S; van der Wal, R; Larson, BMH				Fischer, Anke; Selge, Sebastian; van der Wal, Rene; Larson, Brendon M. H.			The Public and Professionals Reason Similarly about the Management of Non-Native Invasive Species: A Quantitative Investigation of the Relationship between Beliefs and Attitudes	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; SOCIAL PERCEPTIONS; ALIEN; SCIENCE; BIODIVERSITY; KNOWLEDGE; EUROPE; EXPLORATION; BENEFITS; IMPACTS	Despite continued critique of the idea of clear boundaries between scientific and lay knowledge, the 'deficit-model' of public understanding of ecological issues still seems prevalent in discourses of biodiversity management. Prominent invasion biologists, for example, still argue that citizens need to be educated so that they accept scientists' views on the management of non-native invasive species. We conducted a questionnaire-based survey with members of the public and professionals in invasive species management (n = 732) in Canada and the UK to investigate commonalities and differences in their perceptions of species and, more importantly, how these perceptions were connected to attitudes towards species management. Both native and non-native mammal and tree species were included. Professionals tended to have more extreme views than the public, especially in relation to nativeness and abundance of a species. In both groups, species that were perceived to be more abundant, non-native, unattractive or harmful to nature and the economy were more likely to be regarded as in need of management. While perceptions of species and attitudes towards management thus often differed between public and professionals, these perceptions were linked to attitudes in very similar ways across the two groups. This suggests that ways of reasoning about invasive species employed by professionals and the public might be more compatible with each other than commonly thought. We recommend that managers and local people engage in open discussion about each other's beliefs and attitudes prior to an invasive species control programme. This could ultimately reduce conflict over invasive species control.	[Fischer, Anke; Selge, Sebastian] James Hutton Inst, Social Econ & Geog Sci Grp, Aberdeen, Scotland; [Selge, Sebastian; van der Wal, Rene] Univ Aberdeen, Aberdeen Ctr Environm Sustainabil, Aberdeen, Scotland; [Selge, Sebastian; van der Wal, Rene] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Larson, Brendon M. H.] Univ Waterloo, Dept Environm & Resource Studies, Waterloo, ON N2L 3G1, Canada	James Hutton Institute; University of Aberdeen; University of Aberdeen; University of Waterloo	Fischer, A (corresponding author), James Hutton Inst, Social Econ & Geog Sci Grp, Aberdeen, Scotland.	anke.fischer@hutton.ac.uk		Fischer, Anke/0000-0002-0034-3690	University of Aberdeen, Scotland's RERAD (Rural and Environment Research and Analysis Directorate) Programme 3; Standard Research Grant from the Social Sciences and Humanities Research Council of Canada (SSHRC)	University of Aberdeen, Scotland's RERAD (Rural and Environment Research and Analysis Directorate) Programme 3; Standard Research Grant from the Social Sciences and Humanities Research Council of Canada (SSHRC)	This study was funded by the University of Aberdeen, Scotland's RERAD (Rural and Environment Research and Analysis Directorate) Programme 3 and a Standard Research Grant from the Social Sciences and Humanities Research Council of Canada (SSHRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I., 2005, ATTITUDES PERSONALIT, V2nd ed.; Andreu J, 2009, ENVIRON MANAGE, V43, P1244, DOI 10.1007/s00267-009-9280-1; Bardsley DK, 2007, ENVIRON SCI POLICY, V10, P230, DOI 10.1016/j.envsci.2006.12.002; Bell M, 2005, J HIST GEOGR, V31, P496, DOI 10.1016/j.jhg.2004.09.001; Besley J. C, 2011, PUBLIC UNDERST SCI, P1; Bremner A, 2007, BIOL CONSERV, V139, P306, DOI 10.1016/j.biocon.2007.07.005; Buijs A, 2012, SOC NATUR RESOUR, V25, P1167, DOI 10.1080/08941920.2012.670369; Buijs AE, 2013, BIOL CONSERV, V168, P184, DOI 10.1016/j.biocon.2013.08.020; Buijs AE, 2011, GEOFORUM, V42, P329, DOI 10.1016/j.geoforum.2010.12.008; Colautti RI, 2004, DIVERS DISTRIB, V10, P135, DOI 10.1111/j.1366-9516.2004.00061.x; Dallimer M, 2012, BIOSCIENCE, V62, P47, DOI 10.1525/bio.2012.62.1.9; Dandy N, 2011, LANDSCAPE URBAN PLAN, V102, P43, DOI 10.1016/j.landurbplan.2011.03.008; Davis M. A., 2009, INVASION BIOL; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Department for Environment Food Rural Affairs (Defra), 2008, INV NONN SPEC FRAM S; Fischer A, 2007, BIOL CONSERV, V135, P256, DOI 10.1016/j.biocon.2006.10.026; Fischer A, 2011, J ENVIRON PSYCHOL, V31, P118, DOI 10.1016/j.jenvp.2010.05.005; Fischer A, 2011, BIOL CONSERV, V144, P998, DOI 10.1016/j.biocon.2010.12.004; Fischer A, 2011, ECOL ECON, V70, P1178, DOI 10.1016/j.ecolecon.2011.01.014; Fulton David, 1996, HUM DIMENS WILDL, V1, P24, DOI 10.1080/10871209609359060; Garcia-Llorente M, 2008, BIOL CONSERV, V141, P2969, DOI 10.1016/j.biocon.2008.09.003; Giddens, 1994, REFLEXIVE MODERNIZAT, P56; GIERYN TF, 1983, AM SOCIOL REV, V48, P781, DOI 10.2307/2095325; Gobster PH, 2011, INVASIVE INTRO PLANT; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Humair F., 2014, NeoBiota, P1; Hunziker M, 2008, MT RES DEV, V28, P140, DOI 10.1659/mrd.0952; Jeschke JM, 2005, P NATL ACAD SCI USA, V102, P7198, DOI 10.1073/pnas.0501271102; Jordan RC, 2011, CONSERV BIOL, V25, P1148, DOI 10.1111/j.1523-1739.2011.01745.x; Larson B., 2011, METAPHORS ENV SUSTAI; Larson BMH, 2007, BIOL INVASIONS, V9, P947, DOI 10.1007/s10530-007-9095-z; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Marshall NA, 2011, ENVIRON SCI POLICY, V14, P327, DOI 10.1016/j.envsci.2010.10.005; McDaniels TL, 1997, RISK ANAL, V17, P341, DOI 10.1111/j.1539-6924.1997.tb00872.x; Milfont TL, 2010, J ENVIRON PSYCHOL, V30, P80, DOI 10.1016/j.jenvp.2009.09.001; Montgomery CA, 2002, J ENVIRON MANAGE, V65, P313, DOI 10.1006/jema.2002.0553; Naughton D., 2012, NATURAL HIST CANADIA, DOI 10.3138/9781442669574; OSGOOD CE, 1952, PSYCHOL BULL, V49, P197, DOI 10.1037/h0055737; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Perry D, 2008, CONSERV BIOL, V22, P27, DOI 10.1111/j.1523-1739.2007.00845.x; Rauschmayer F, 2008, ENVIRON PLANN C, V27, P42; Roux DJ, 2006, ECOL SOC, V11; Sadler TD, 2005, SCI EDUC, V89, P71, DOI 10.1002/sce.20023; Schuttler E, 2011, J NAT CONSERV, V19, P175, DOI 10.1016/j.jnc.2010.12.001; Selge S, 2011, BIOL CONSERV, V144, P3089, DOI 10.1016/j.biocon.2011.09.014; Sharp RL, 2011, BIOL CONSERV, V144, P2097, DOI 10.1016/j.biocon.2011.04.032; Simberloff D., 2007, CONSERVATION MAGAZIN, V8, P18; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Skogen K, 2008, SOC NATUR RESOUR, V21, P17, DOI 10.1080/08941920701460408; Somaweera R, 2010, BIOL CONSERV, V143, P1477, DOI 10.1016/j.biocon.2010.03.027; Trumbull DJ, 2000, SCI EDUC, V84, P265, DOI 10.1002/(SICI)1098-237X(200003)84:2<265::AID-SCE7>3.0.CO;2-5; Tveit MS, 2009, J ENVIRON MANAGE, V90, P2882, DOI 10.1016/j.jenvman.2007.12.021; Verbrugge LNH, 2013, ENVIRON MANAGE, V52, P1562, DOI 10.1007/s00267-013-0170-1; Warren CR, 2007, PROG HUM GEOG, V31, P427, DOI 10.1177/0309132507079499; Wynne B., 1996, RISK ENV MODERNITY N, P44, DOI DOI 10.4135/9781446221983.N3; Young AM, 2011, ENVIRON RES, V111, P893, DOI 10.1016/j.envres.2011.06.006	56	48	49	2	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105495	10.1371/journal.pone.0105495	http://dx.doi.org/10.1371/journal.pone.0105495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO2EE	25170957	Green Submitted, Green Published, gold			2022-12-25	WOS:000341127500051
J	Nelder, MP; Russell, C; Lindsay, LR; Dhar, B; Patel, SN; Johnson, S; Moore, S; Kristjanson, E; Li, Y; Ralevski, F				Nelder, Mark P.; Russell, Curtis; Lindsay, L. Robbin; Dhar, Badal; Patel, Samir N.; Johnson, Steven; Moore, Stephen; Kristjanson, Erik; Li, Ye; Ralevski, Filip			Population-Based Passive Tick Surveillance and Detection of Expanding Foci of Blacklegged Ticks Ixodes scapularis and the Lyme Disease Agent Borrelia burgdorferi in Ontario, Canada	PLOS ONE			English	Article							NEW-YORK-STATE; RANGE EXPANSION; ANAPLASMA-PHAGOCYTOPHILUM; GEOGRAPHIC-DISTRIBUTION; AMBLYOMMA-AMERICANUM; POWASSAN VIRUS; CLIMATE-CHANGE; VECTOR; IXODIDAE; ACARI	We identified ticks submitted by the public from 2008 through 2012 in Ontario, Canada, and tested blacklegged ticks Ixodes scapularis for Borrelia burgdorferi and Anaplasma phagocytophilum. Among the 18 species of ticks identified, I. scapularis, Dermacentor variabilis, Ixodes cookei and Amblyomma americanum represented 98.1% of the 14,369 ticks submitted. Rates of blacklegged tick submission per 100,000 population were highest in Ontario's Eastern region; D. variabilis in Central West and Eastern regions; I. cookei in Eastern and South West regions; and A. americanum had a scattered distribution. Rates of blacklegged tick submission per 100,000 population were highest from children (0-9 years old) and older adults (55-74 years old). In two health units in the Eastern region (i.e., Leeds, Grenville & Lanark District and Kingston-Frontenac and Lennox & Addington), the rate of submission for engorged and B. burgdorferi-positive blacklegged ticks was 47 x higher than the rest of Ontario. Rate of spread for blacklegged ticks was relatively faster and across a larger geographic area along the northern shore of Lake Ontario/St. Lawrence River, compared with slower spread from isolated populations along the northern shore of Lake Erie. The infection prevalence of B. burgdorferi in blacklegged ticks increased in Ontario over the study period from 8.4% in 2008 to 19.1% in 2012. The prevalence of B. burgdorferi-positive blacklegged ticks increased yearly during the surveillance period and, while increases were not uniform across all regions, increases were greatest in the Central West region, followed by Eastern and South West regions. The overall infection prevalence of A. phagocytophilum in blacklegged ticks was 0.3%. This study provides essential information on ticks of medical importance in Ontario, and identifies demographic and geographic areas for focused public education on the prevention of tick bites and tick-borne diseases.	[Nelder, Mark P.; Russell, Curtis; Moore, Stephen] Publ Hlth Ontario, Communicable & Infect Dis Prevent & Control, Enter Zoonot & Vector Borne Dis, Toronto, ON, Canada; [Lindsay, L. Robbin] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Dhar, Badal; Moore, Stephen; Li, Ye] Publ Hlth Ontario, Analyt Serv, Knowledge Serv, Toronto, ON, Canada; [Patel, Samir N.; Kristjanson, Erik; Ralevski, Filip] Publ Hlth Ontario, Publ Hlth Ontario Lab Toronto, Toronto, ON, Canada; [Patel, Samir N.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Li, Ye] Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Public Health Agency of Canada; University of Toronto; University of Toronto	Nelder, MP (corresponding author), Publ Hlth Ontario, Communicable & Infect Dis Prevent & Control, Enter Zoonot & Vector Borne Dis, Toronto, ON, Canada.	mark.nelder@oahpp.ca		Lindsay, Robbin/0000-0001-7236-2930				ARTSOB H, 1984, J MED ENTOMOL, V21, P165, DOI 10.1093/jmedent/21.2.165; Artsob H, 1996, GERMS IDEAS, V2, P35; Barker IK, 2000, CAN MED ASSOC J, V162, P1573; BARKER IK, 1988, ONT DIS SURV REP, V9, P151; BEQUAERT J. C., 1945, Entomologica Americana, V25, P73; Birge J, 2012, EMERG INFECT DIS, V18, P1669, DOI 10.3201/eid1810.120621; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Courtney JW, 2004, J CLIN MICROBIOL, V42, P3164, DOI 10.1128/JCM.42.7.3164-3168.2004; Dibernardo A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-183; Ertel SH, 2012, EMERG INFECT DIS, V18, P242, DOI 10.3201/eid1802.101219; Gregson JD, CAN DEP AGR PUBL, V930, P92; Koffi JK, 2012, J MED ENTOMOL, V49, P400, DOI 10.1603/ME11210; Kwiecinski G, 1998, MAMMALIAN SPECIES AC; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Lindsay LR, 1999, J MED ENTOMOL, V36, P243, DOI 10.1093/jmedent/36.3.243; MAGNARELLI LA, 1986, J WILDLIFE DIS, V22, P178, DOI 10.7589/0090-3558-22.2.178; Means RG, 1997, J VECTOR ECOL, V22, P133; Ministry of Health and Long-Term Care, 2011, LETS TARG LYM; Ministry of Health and Long-Term Care, 2009, IN REP PUBL HLTH; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Ogden NH, 2006, J MED ENTOMOL, V43, P600, DOI 10.1603/0022-2585(2006)43[600:ISTCBP]2.0.CO;2; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Ogden NH, 2009, CAN MED ASSOC J, V180, P1221, DOI 10.1503/cmaj.080148; Ogden NH, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-24; Phillips CB, 2001, AM J PREV MED, V20, P219, DOI 10.1016/S0749-3797(00)00315-9; Public Health Ontario, 2013, VECT BORN DIS 2012 S; Rand PW, 2007, J MED ENTOMOL, V44, P1118, DOI 10.1603/0022-2585(2007)44[1118:PSIMAA]2.0.CO;2; SCHOLTEN T, 1977, CAN J PUBLIC HEALTH, V68, P494; Schulze TL, 2003, J MED ENTOMOL, V40, P555, DOI 10.1603/0022-2585-40.4.555; Schwan TG, 2002, EMERG INFECT DIS, V8, P115, DOI 10.3201/eid0802.010198; Scott JD, 2004, J MED ENTOMOL, V41, P226, DOI 10.1603/0022-2585-41.2.226; Sonenshine D.E., 1993, ECOLOGY NIDICOLOUS T, V2; SONENSHINE DE, 1979, RES DIV B, V139; SPIELMAN A, 1994, ANN NY ACAD SCI, V740, P146, DOI 10.1111/j.1749-6632.1994.tb19865.x; Statistics Canada, 2007, 2006 CENS REL TOP; Telford SR, 1997, SCI MED, V4, P24; Vazquez M, 2008, EMERG INFECT DIS, V14, P210, DOI 10.3201/eid1402.070725; Wadkins L., 2011, FOREST RESOURCES ONT; Walker ED, 1998, J MED ENTOMOL, V35, P872, DOI 10.1093/jmedent/35.5.872; Watson T.G., 1976, Journal Wildl Dis, V12, P66; WILKINSON PR, 1967, CAN J ZOOLOG, V45, P517, DOI 10.1139/z67-066; Zar J. H., 1996, BIOSTATISTICAL ANAL; [No title captured]	44	68	68	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105358	10.1371/journal.pone.0105358	http://dx.doi.org/10.1371/journal.pone.0105358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171252	Green Submitted, Green Published, gold			2022-12-25	WOS:000341127500045
J	Que, YX; Su, YC; Guo, JL; Wu, QB; Xu, LP				Que, Youxiong; Su, Yachun; Guo, Jinlong; Wu, Qibin; Xu, Liping			A Global View of Transcriptome Dynamics during Sporisorium scitamineum Challenge in Sugarcane by RNA-seq	PLOS ONE			English	Article							I CHITINASE GENE; DISEASE RESISTANCE; ABSCISIC-ACID; PATHOGEN; EXPRESSION; RICE; IDENTIFICATION; STRESS; GENOME; WHEAT	Sugarcane smut caused by Sporisorium scitamineum is a critical fungal disease in the sugarcane industry. However, molecular mechanistic studies of pathological response of sugarcane to S. scitamineum are scarce and preliminary. Here, transcriptome analysis of sugarcane disease induced by S. scitamineum at 24, 48 and 120 h was conducted, using an S. scitamineum-resistant and -susceptible genotype (Yacheng05-179 and "ROC" 22). The reliability of Illumina data was confirmed by real-time quantitative PCR. In total, transcriptome sequencing of eight samples revealed gene annotations of 65,852 unigenes. Correlation analysis of differentially expressed genes indicated that after S. scitamineum infection, most differentially expressed genes and related metabolic pathways in both sugarcane genotypes were common, covering most biological activities. However, expression of resistance-associated genes in Yacheng05-179 (24-48 h) occurred earlier than those in "ROC" 22 (48-120 h), and more transcript expressions were observed in the former, suggesting resistance specificity and early timing of these genes in non-affinity sugarcane and S. scitamineum interactions. Obtained unigenes were related to cellular components, molecular functions and biological processes. From these data, functional annotations associated with resistance were obtained, including signal transduction mechanisms, energy production and conversion, inorganic ion transport and metabolism, and defense mechanisms. Pathway enrichment analysis revealed that differentially expressed genes are involved in plant hormone signal transduction, flavonoid biosynthesis, plant-pathogen interaction, cell wall fortification pathway and other resistance-associated metabolic pathways. Disease inoculation experiments and the validation of in vitro antibacterial activity of the chitinase gene ScChi show that this sugarcane chitinase gene identified through RNA-Seq analysis is relevant to plant-pathogen interactions. In conclusion, expression data here represent the most comprehensive dataset available for sugarcane smut induced by S. scitamineum and will serve as a resource for finally unraveling the molecular mechanisms of sugarcane responses to S. scitamineum.	[Que, Youxiong; Su, Yachun; Guo, Jinlong; Wu, Qibin; Xu, Liping] Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs	Xu, LP (corresponding author), Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou, Fujian, Peoples R China.	xlpmail@126.com		Su, Yachun/0000-0002-3893-2909	National Natural Science Foundation of China [31101196, 31340060]; earmarked fund for the Modern Agriculture Technology of China [CARS-20]; Program for New Century Excellent Talents in Fujian Province University; Research Funds for Distinguished Young Scientists in Fujian Agriculture and Forestry University [xjq201202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for the Modern Agriculture Technology of China; Program for New Century Excellent Talents in Fujian Province University(Program for New Century Excellent Talents in University (NCET)); Research Funds for Distinguished Young Scientists in Fujian Agriculture and Forestry University	This work was funded by National Natural Science Foundation of China (31101196 and 31340060), the earmarked fund for the Modern Agriculture Technology of China (CARS-20), Program for New Century Excellent Talents in Fujian Province University (2014) and Research Funds for Distinguished Young Scientists in Fujian Agriculture and Forestry University (xjq201202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bolton MD, 2008, MOL PLANT MICROBE IN, V21, P1515, DOI 10.1094/MPMI-21-12-1515; Borras-Hidalgo O, 2005, PLANT PHYSIOL BIOCH, V43, P1115, DOI 10.1016/j.plaphy.2005.07.011; Bozkurt TO, 2010, MOL PLANT PATHOL, V11, P625, DOI [10.1111/J.1364-3703.2010.00633.X, 10.1111/j.1364-3703.2010.00633.x]; Cantu D, 2008, TRENDS PLANT SCI, V13, P610, DOI 10.1016/j.tplants.2008.09.002; CHAO CP, 1990, PHYTOPATHOLOGY, V80, P622, DOI 10.1094/Phyto-80-622; Chen QZ., 2013, THESIS FUJIAN AGR FO; Chen RQ, 2010, MENOPAUSE, V17, P630, DOI 10.1097/gme.0b013e3181ca0adb; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Coram TE, 2008, MOL PLANT PATHOL, V9, P479, DOI [10.1111/j.1364-3703.2008.00476.x, 10.1111/J.1364-3703.2008.00476.X]; Daniel X, 1999, PLANT J, V20, P57, DOI 10.1046/j.1365-313X.1999.00578.x; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Fuchs H, 1996, MOL PLANT MICROBE IN, V9, P91, DOI 10.1094/MPMI-9-0091; [顾丽红 Gu Lihong], 2008, [分子植物育种, Molecular Plant Breeding], V6, P277; Hao LM, 2001, J HEBEI AGR, V5, P73; Heinze B. S., 2001, P S AFR SUG TECHNOL, V75, P88; Hu Shuai, 2012, Yichuan, V34, P560, DOI 10.3724/SP.J.1005.2012.00560; Jia JH, 2000, PROG BIOTECHNOL, V20, P21; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; LI C, 2007, THESIS CHINESE ACAD; Li Xiang-Long, 2012, Yichuan, V34, P102, DOI 10.3724/SP.J.1005.2012.00102; Li XY, 2012, THESIS JILIN AGR U; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo HL, 2011, J TROP ORGANISMS, V2, P83; LUTHEA J. C., 1940, Proceedings of the National Academy of Sciences of India, V12, P118; MAUCH F, 1988, PLANT PHYSIOL, V88, P936, DOI 10.1104/pp.88.3.936; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Maximova SN, 2006, PLANTA, V224, P740, DOI 10.1007/s00425-005-0188-6; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Mittler R, 1999, P NATL ACAD SCI USA, V96, P14165, DOI 10.1073/pnas.96.24.14165; Moosawi-Jorf S. A., 2007, Journal of Applied Sciences, V7, P3768; Neuhaus JM, 1996, PLANT MOL BIOL REP, V14, P102, DOI 10.1007/BF02684897; Padmanaban P., 1988, Indian Phytopathology, V41, P367; Que YX, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/989016; [阙友雄 Que Youxiong], 2009, [热带作物学报, Chinese Journal of Tropical Crops], V30, P274; Que YouXiong, 2009, Acta Agronomica Sinica, V35, P452; Que YX, 2011, BIOMED RES INT; Raboin L.M., 2001, Proc. South Afr. Sugar Technol. Assoc, V75, P94; Rahul PR, 2013, J PLANT BIOCHEM BIOT, P1; Romero GO, 1998, GENE, V223, P311, DOI 10.1016/S0378-1119(98)00368-0; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Shen Qian, 2012, Journal of Shanghai Jiaotong University - Agricultural Science, V30, P51; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Singh A, 2007, PROTEIN EXPRES PURIF, V56, P100, DOI 10.1016/j.pep.2007.06.013; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Strauss T, 2012, P NATL ACAD SCI USA, V109, P19480, DOI 10.1073/pnas.1212415109; Su YC, 2013, PLANT CELL REP, V32, P1503, DOI 10.1007/s00299-013-1463-9; Su YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084426; Thokoane L. N., 2001, Proceedings of the Annual Congress - South African Sugar Technologists' Association, P104; Underwood W, 2008, J EXP BOT, V59, P3501, DOI 10.1093/jxb/ern205; Walia H, 2005, PLANT PHYSIOL, V139, P822, DOI 10.1104/pp.105.065961; Wang B., 2007, SUGAR CROPS CHINA, V3, P48; [王全伟 Wang Quanwei], 2008, [分子植物育种, Molecular Plant Breeding], V6, P53; Ward J, 2011, P 10 INT RUB RIB S, P946; Wu J, 2012, BMC PLANT BIOL, V10, P234; Wu QB, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/298920; Xiao YH, 2007, BIOSCI BIOTECH BIOCH, V71, P1211, DOI 10.1271/bbb.60658; Xu LP, 2005, CHIN J APPL ENV BIOL, V10, P263; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Xu ZS, 2008, BOTANY, V86, P969, DOI 10.1139/B08-041; Ye SJ, 2013, J CENT S FORES U, V38, P50; Zhou JinXin, 2008, Journal of Agricultural Biotechnology, V16, P169	66	41	49	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106476	10.1371/journal.pone.0106476	http://dx.doi.org/10.1371/journal.pone.0106476			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171065	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500163
J	Rahman, MM; Turchini, GM; Gasparini, C; Norambuena, F; Evans, JP				Rahman, Md. Moshiur; Turchini, Giovanni M.; Gasparini, Clelia; Norambuena, Fernando; Evans, Jonathan P.			The Expression of Pre- and Postcopulatory Sexually Selected Traits Reflects Levels of Dietary Stress in Guppies	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; BROILER BREEDER MALES; CONDITION-DEPENDENT EXPRESSION; POECILIA-RETICULATA; SEMEN QUALITY; SPERM COMPETITION; LIPID-COMPOSITION; MATING TACTICS; REPRODUCTIVE-PERFORMANCE; INBREEDING DEPRESSION	Environmental and ecological conditions can shape the evolution of life history traits in many animals. Among such factors, food or nutrition availability can play an important evolutionary role in moderating an animal's life history traits, particularly sexually selected traits. Here, we test whether diet quantity and/or composition in the form of omega-3 long chain polyunsaturated fatty acids (here termed 'n3LC') influence the expression of pre- and postcopulatory traits in the guppy (Poecilia reticulata), a livebearing poeciliid fish. We assigned males haphazardly to one of two experimental diets supplemented with n3LC, and each of these diet treatments was further divided into two diet 'quantity' treatments. Our experimental design therefore explored the main and interacting effects of two factors (n3LC content and diet quantity) on the expression of precopulatory (sexual behaviour and sexual ornamentation, including the size, number and spectral properties of colour spots) and postcopulatory (the velocity, viability, number and length of sperm) sexually selected traits. Our study revealed that diet quantity had significant effects on most of the pre- and postcopulatory traits, while n3LC manipulation had a significant effect on sperm traits and in particular on sperm viability. Our analyses also revealed interacting effects of diet quantity and n3LC levels on courtship displays, and the area of orange and iridescent colour spots in the males' colour patterns. We also confirmed that our dietary manipulations of n3LC resulted in the differential uptake of n3LC in body and testes tissues in the different n3LC groups. This study reveals the effects of diet quantity and n3LC on behavioural, ornamental and ejaculate traits in P. reticulata and underscores the likely role that diet plays in maintaining the high variability in these condition-dependent sexual traits.	[Rahman, Md. Moshiur; Gasparini, Clelia; Evans, Jonathan P.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA, Australia; [Turchini, Giovanni M.; Norambuena, Fernando] Deakin Univ, Fac Sci Engn & Built Environm, Sch Life & Environm Sci, Warrnambool, Vic, Australia	University of Western Australia; Deakin University	Gasparini, C (corresponding author), Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA, Australia.	clelia.gasparini@uwa.edu.au	Gasparini, Clelia/F-2159-2011; Evans, Jonathan/A-1992-2011	Turchini, Giovanni/0000-0003-0694-4283; Rahman, Md Moshiur/0000-0001-8319-395X	School of Animal Biology (University of Western Australia); Marie Curie Outgoing fellowship; Australian Research Council	School of Animal Biology (University of Western Australia); Marie Curie Outgoing fellowship(European Commission); Australian Research Council(Australian Research Council)	This research was funded through a Ph.D. stipend to MMR from the School of Animal Biology (University of Western Australia), Marie Curie Outgoing fellowship to CG, and a research grant from the Australian Research Council to JPE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daraji H.J., 2010, INT J POULT SCI, V9, P656; Anderson JT, 2014, HEREDITY, V112, P4, DOI 10.1038/hdy.2013.33; Archambault JM, 2014, FRESHWATER BIOL, V59, P601, DOI 10.1111/fwb.12290; Azeddine A, 2010, AGR BIOL J N AM, V1, P175; Billard R., 1990, P153; Blay S, 1997, ANIM BEHAV, V54, P59, DOI 10.1006/anbe.1996.0445; Boland MP, 2001, THERIOGENOLOGY, V55, P1323, DOI 10.1016/S0093-691X(01)00485-X; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Bozynski CC, 2003, ANIM BEHAV, V65, P53, DOI 10.1006/anbe.2002.2024; Brooks R, 2001, EVOLUTION, V55, P1002, DOI 10.1554/0014-3820(2001)055[1002:DAISSA]2.0.CO;2; Brown TD, 2010, AQUACULTURE, V300, P148, DOI 10.1016/j.aquaculture.2009.12.020; BUCKNER RE, 1986, POULTRY SCI, V65, P85, DOI 10.3382/ps.0650085; Carlson SE, 1996, AM J CLIN NUTR, V63, P687, DOI 10.1093/ajcn/63.5.687; Castellano CA, 2010, J ANIM SCI, V88, P2346, DOI 10.2527/jas.2009-2779; Castenmiller JJM, 1998, ANNU REV NUTR, V18, P19, DOI 10.1146/annurev.nutr.18.1.19; Cerolini S, 2003, WORLD POULTRY SCI J, V59, P65, DOI 10.1079/WPS20030003; CEROLINI S, 1995, BRIT POULTRY SCI, V36, P677, DOI 10.1080/00071669508417812; Connor WE, 1998, J LIPID RES, V39, P1404; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; Cotton S, 2004, EVOLUTION, V58, P1038, DOI 10.1111/j.0014-3820.2004.tb00437.x; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; de Wilde MC, 2003, BRAIN RES, V988, P9, DOI 10.1016/S0006-8993(03)03320-1; Devigili A, 2013, BEHAV ECOL, V24, P740, DOI 10.1093/beheco/ars204; Dolatpanah MB, 2008, ASIAN AUSTRAL J ANIM, V21, P29, DOI 10.5713/ajas.2008.70035; DUNN TG, 1992, J ANIM SCI, V70, P1580, DOI 10.2527/1992.7051580x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Engqvist L, 2003, ETHOLOGY, V109, P911, DOI 10.1046/j.1439-0310.2003.00937.x; ENSLEN M, 1991, LIPIDS, V26, P203, DOI 10.1007/BF02543972; ERDMAN JW, 1993, ANN NY ACAD SCI, V691, P76, DOI 10.1111/j.1749-6632.1993.tb26159.x; Estienne MJ, 2008, THERIOGENOLOGY, V70, P70, DOI 10.1016/j.theriogenology.2008.02.007; Evans JP, 2009, NATURWISSENSCHAFTEN, V96, P771, DOI 10.1007/s00114-009-0529-6; FOLCH J, 1957, J BIOL CHEM, V226, P497; GAGE MJG, 1994, FUNCT ECOL, V8, P594, DOI 10.2307/2389920; GARDINER DM, 1978, COMP BIOCHEM PHYS A, V59, P165, DOI 10.1016/0300-9629(78)90200-1; Gasparini C, 2013, ECOL EVOL, V3, P4940, DOI 10.1002/ece3.870; Gasparini C, 2009, BIOL LETTERS, V5, P792, DOI 10.1098/rsbl.2009.0413; GILCHRIST BM, 1960, PROC R SOC SER B-BIO, V152, P118, DOI 10.1098/rspb.1960.0028; Grether GF, 2000, EVOLUTION, V54, P1712, DOI 10.1111/j.0014-3820.2000.tb00715.x; Grubert MA, 2004, AQUACULTURE, V242, P297, DOI 10.1016/j.aquaculture.2004.08.033; Gurr M. I., 2002, LIPID BIOCH INTRO; Harlioglu MM, 2013, AQUACULT INT, V21, P273, DOI 10.1007/s10499-012-9549-x; Harpaz S, 2005, AQUAC RES, V36, P996, DOI 10.1111/j.1365-2109.2005.01308.x; Hastings RP, 2013, J APPL ICHTHYOL, V29, P1208, DOI 10.1111/jai.12273; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Head ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015279; Henrotte E, 2010, AQUAC RES, V41, pe31, DOI 10.1111/j.1365-2109.2009.02452.x; Hill GE, 2000, J AVIAN BIOL, V31, P559, DOI 10.1034/j.1600-048X.2000.310415.x; Hooper RE, 1999, PHYSIOL ENTOMOL, V24, P364, DOI 10.1046/j.1365-3032.1999.00152.x; Houde A.E., 1997, SEX COLOR MATE CHOIC; Hylander S, 2014, FUNCT ECOL, V28, P149, DOI 10.1111/1365-2435.12159; Immler S, 2010, EVOLUTION, V64, P1634, DOI 10.1111/j.1558-5646.2009.00924.x; Iwasa Y, 1999, J THEOR BIOL, V200, P97, DOI 10.1006/jtbi.1999.0979; Izquierdo MS, 2001, AQUACULTURE, V197, P25, DOI 10.1016/S0044-8486(01)00581-6; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jennions MD, 1998, BEHAV ECOL, V9, P605, DOI 10.1093/beheco/9.6.605; Karino K, 2004, BEHAVIOUR, V141, P585, DOI 10.1163/1568539041166672; Kemp DJ, 2009, P ROY SOC B-BIOL SCI, V276, P4335, DOI 10.1098/rspb.2009.1226; KISHIMOTO Y, 1969, J NEUROCHEM, V16, P397, DOI 10.1111/j.1471-4159.1969.tb10380.x; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; Kolluru GR, 2009, BEHAV ECOL, V20, P131, DOI 10.1093/beheco/arn124; Kolluru GR, 2005, BEHAV ECOL, V16, P294, DOI 10.1093/beheco/arh161; Kotiaho JS, 2000, BEHAV ECOL SOCIOBIOL, V48, P188, DOI 10.1007/s002650000221; Krause ET, 2014, EVOL ECOL, V28, P263, DOI 10.1007/s10682-013-9674-7; KRINSKY NI, 1965, COMP BIOCHEM PHYSIOL, V16, P181, DOI 10.1016/0010-406X(65)90057-5; Lahnsteiner F, 2010, COMP BIOCHEM PHYS B, V157, P39, DOI 10.1016/j.cbpb.2010.04.016; Lakshminarayana R, 2013, EUR J LIPID SCI TECH, V115, P1085, DOI 10.1002/ejlt.201200254; Langsrud Y, 2003, STAT COMPUT, V13, P163, DOI 10.1023/A:1023260610025; Lenzi A, 1996, HUM REPROD UPDATE, V2, P246, DOI 10.1093/humupd/2.3.246; Lewis Z, 2011, ANIM BEHAV, V81, P579, DOI 10.1016/j.anbehav.2010.12.001; Luszczek-Trojnar E, 2014, ENVIRON SCI POLLUT R, V21, P2465, DOI 10.1007/s11356-013-2184-x; Maldjian A, 2005, THERIOGENOLOGY, V63, P411, DOI 10.1016/j.theriogenology.2004.09.021; MARTIN GB, 1995, J REPROD FERTIL, P437; Matthews IM, 1997, P ROY SOC B-BIOL SCI, V264, P695, DOI 10.1098/rspb.1997.0099; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; NICOLETTO PF, 1993, ANIM BEHAV, V46, P441, DOI 10.1006/anbe.1993.1213; Norambuena F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081705; PARKER GA, 1970, J INSECT PHYSIOL, V16, P1301, DOI 10.1016/0022-1910(70)90131-9; PARKER GV, 1972, AUST J AGR RES, V23, P109, DOI 10.1071/AR9720109; Parker RS, 1996, FASEB J, V10, P542, DOI 10.1096/fasebj.10.5.8621054; Perry JC, 2010, P ROY SOC B-BIOL SCI, V277, P3639, DOI 10.1098/rspb.2010.0810; Pike TW, 2010, BIOL LETTERS, V6, P191, DOI 10.1098/rsbl.2009.0815; Pilastro A, 1999, P ROY SOC B-BIOL SCI, V266, P1887, DOI 10.1098/rspb.1999.0862; Pitcher TE, 2001, CAN J ZOOL, V79, P1891, DOI 10.1139/cjz-79-10-1891; POULOS A, 1986, BIOCHEM J, V240, P891, DOI 10.1042/bj2400891; PRINCE MR, 1993, AM J CLIN NUTR, V57, P175, DOI 10.1093/ajcn/57.2.175; R Development Core Team, 2014, R LANG ENV STAT COMP; Rahman MM, 2013, ECOL EVOL, V3, P2197, DOI 10.1002/ece3.632; Rick IP, 2014, OECOLOGIA, V174, P393, DOI 10.1007/s00442-013-2773-x; Ritschard M, 2012, EVOL ECOL, V26, P801, DOI 10.1007/s10682-011-9541-3; Robbins WA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101634; Rogers-Bennett L, 2010, J SHELLFISH RES, V29, P599, DOI 10.2983/035.029.0308; Rooke JA, 2001, REPRODUCTION, V121, P315, DOI 10.1530/rep.0.1210315; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Samadian F, 2010, ANIMAL, V4, P2017, DOI 10.1017/S1751731110001308; San-Jose LM, 2012, FUNCT ECOL, V26, P646, DOI 10.1111/j.1365-2435.2012.01970.x; Scabini V, 2011, AQUACULT NUTR, V17, P304, DOI 10.1111/j.1365-2095.2010.00766.x; SCHATRAL A, 1993, J INSECT BEHAV, V6, P379, DOI 10.1007/BF01048118; SCHILLO KK, 1992, J ANIM SCI, V70, P1271, DOI 10.2527/1992.7041271x; Selvaraju S, 2012, THERIOGENOLOGY, V78, P646, DOI 10.1016/j.theriogenology.2012.03.010; SEXTON KJ, 1989, POULTRY SCI, V68, P569, DOI 10.3382/ps.0680569; Simmons LW, 2012, BEHAV ECOL, V23, P168, DOI 10.1093/beheco/arr170; Simmons LW, 2002, EVOLUTION, V56, P1622, DOI 10.1111/j.0014-3820.2002.tb01474.x; Skinner AMJ, 2007, BEHAV ECOL, V18, P47, DOI 10.1093/beheco/arl049; STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4; Surai PF, 2000, ASIAN AUSTRAL J ANIM, V13, P1518, DOI 10.5713/ajas.2000.1518; Surai PF, 1998, COMP BIOCHEM PHYS B, V120, P527, DOI 10.1016/S0305-0491(98)10039-1; THORNHILL R, 1983, AM NAT, V122, P765, DOI 10.1086/284170; Tibbetts EA, 2010, AM NAT, V175, P495, DOI 10.1086/651596; van Oosterhout C, 2003, J EVOLUTION BIOL, V16, P273, DOI 10.1046/j.1420-9101.2003.00511.x; Vassallo-Agius R, 2001, FISHERIES SCI, V67, P818, DOI 10.1046/j.1444-2906.2001.00328.x; Wang H, 2014, AQUAC RES, V45, P259, DOI 10.1111/j.1365-2109.2012.03222.x; WARD PI, 1991, BEHAV ECOL SOCIOBIOL, V29, P77, DOI 10.1007/BF00166481; Wathes DC, 2007, BIOL REPROD, V77, P190, DOI 10.1095/biolreprod.107.060558; Watts JL, 2003, GENETICS, V163, P581; Wilson-Leedy JG, 2007, THERIOGENOLOGY, V67, P661, DOI 10.1016/j.theriogenology.2006.10.003; Yan L, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-33; Yasui Y, 1997, AM NAT, V149, P573, DOI 10.1086/286006; Yonekura L, 2007, MOL NUTR FOOD RES, V51, P107, DOI 10.1002/mnfr.200600145; Yue DB, 2010, ANIM REPROD SCI, V118, P217, DOI 10.1016/j.anireprosci.2009.08.004; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	121	21	22	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105856	10.1371/journal.pone.0105856	http://dx.doi.org/10.1371/journal.pone.0105856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170940	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500074
J	Seubwai, W; Wongkham, C; Puapairoj, A; Khuntikeo, N; Pugkhem, A; Hahnvajanawong, C; Chaiyagool, J; Umezawa, K; Okada, S; Wongkham, S				Seubwai, Wunchana; Wongkham, Chaisiri; Puapairoj, Anucha; Khuntikeo, Narong; Pugkhem, Ake; Hahnvajanawong, Chariya; Chaiyagool, Jariya; Umezawa, Kazuo; Okada, Seiji; Wongkham, Sopit			Aberrant Expression of NF-kappa B in Liver Fluke Associated Cholangiocarcinoma: Implications for Targeted Therapy	PLOS ONE			English	Article							CELL-CYCLE ARREST; CANCER-CELLS; IN-VIVO; OPISTHORCHIS-VIVERRINI; NUCLEAR TRANSLOCATION; ADENOCARCINOMA CELLS; ANTITUMOR-ACTIVITY; PANCREATIC-CANCER; RISK-FACTORS; APOPTOSIS	Background: Up-regulation and association of nuclear factor kappa B (NF-kappa B) with carcinogenesis and tumor progression has been reported in several malignancies. In the current study, expression of NF-kappa B in cholangiocarcinoma (CCA) patient tissues and its clinical significance were determined. The possibility of using NF-kappa B as the therapeutic target of CCA was demonstrated. Methodology: Expression of NF-kappa B in CCA patient tissues was determined using immunohistochemistry. Dehydroxymethylepoxyquinomicin (DHMEQ), a specific NF-kappa B inhibitor, was used to inhibit NF-kappa B action. Cell growth was determined using an MTT assay, and cell apoptosis was shown by DNA fragmentation, flow cytometry and immunocytofluorescent staining. Effects of DHMEQ on growth and apoptosis were demonstrated in CCA cell lines and CCA-inoculated mice. DHMEQ-induced apoptosis in patient tissues using a histoculture drug response assay was quantified by TUNEL assay. Principal Findings: Normal bile duct epithelia rarely expressed NF-kappa B (subunits p50, p52 and p65), whereas all CCA patient tissues (n = 48) over-expressed all NF-kB subunits. Inhibiting NF-kappa B action by DHMEQ significantly inhibited growth of human CCA cell lines in a dose-and time-dependent manner. DHMEQ increased cell apoptosis by decreasing the antiapoptotic protein expressions-Bcl-2, XIAP-and activating caspase pathway. DHMEQ effectively reduced tumor size in CCA-inoculated mice and induced cell apoptosis in primary histocultures of CCA patient tissues. Conclusions: NF-kappa B was over-expressed in CCA tissues. Inhibition of NF-kappa B action significantly reduced cell growth and enhanced cell apoptosis. This study highlights NF-kappa B as a molecular target for CCA therapy.	[Seubwai, Wunchana; Wongkham, Chaisiri; Wongkham, Sopit] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand; [Seubwai, Wunchana] Khon Kaen Univ, Fac Med, Dept Forens Med, Khon Kaen, Thailand; [Puapairoj, Anucha] Khon Kaen Univ, Fac Med, Dept Pathol, Khon Kaen, Japan; [Khuntikeo, Narong; Pugkhem, Ake] Khon Kaen Univ, Fac Med, Dept Surg, Khon Kaen, Thailand; [Hahnvajanawong, Chariya; Chaiyagool, Jariya] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Seubwai, Wunchana; Wongkham, Chaisiri; Puapairoj, Anucha; Khuntikeo, Narong; Pugkhem, Ake; Hahnvajanawong, Chariya; Wongkham, Sopit] Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand; [Umezawa, Kazuo] Aichi Med Univ, Dept Mol Target Med Screening, Nagakute, Aichi 48011, Japan; [Okada, Seiji] Kumamoto Univ, Ctr AIDS Res, Div Hematopoiesis, Kumamoto, Japan	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Aichi Medical University; Kumamoto University	Okada, S (corresponding author), Kumamoto Univ, Ctr AIDS Res, Div Hematopoiesis, Kumamoto, Japan.	okadas@kumamoto-u.ac.jp; sopit@kku.ac.th	Wongkham, Sopit/ABB-6966-2021		Khon Kaen University Research grant; Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission through the Health cluster (SHeP-GMS) [H-2553-PD-5]; Ministry of Education, Science, Sport, and Culture (MEXT) of Japan [21107522, 21591209]	Khon Kaen University Research grant; Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission through the Health cluster (SHeP-GMS); Ministry of Education, Science, Sport, and Culture (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Khon Kaen University Research grant and the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, through the Health cluster (SHeP-GMS) to S. Wongkham and for the Postdoctoral fellowship to W. Seubwai (H-2553-PD-5); Grants-in-Aid for Science Research (No. 21107522 and 21591209) from the Ministry of Education, Science, Sport, and Culture (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariga A, 2002, J BIOL CHEM, V277, P24625, DOI 10.1074/jbc.M112063200; Ban JO, 2009, MOL CANCER THER, V8, P1613, DOI 10.1158/1535-7163.MCT-08-0694; Brown M, 2008, EXPERT OPIN THER TAR, V12, P1109, DOI 10.1517/14728222.12.9.1109 ; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Du HP, 2010, ONCOL REP, V23, P709, DOI 10.3892/or_00000688; Fahy BN, 2004, J AM COLL SURGEONS, V198, P591, DOI 10.1016/j.jamcollsurg.2003.12.005; Fujita Y, 2009, ONCOL REP, V21, P499, DOI 10.3892/or_00000250; Fukushima T, 2012, NEURO-ONCOLOGY, V14, P19, DOI 10.1093/neuonc/nor168; Furuta H, 2012, INT J CANCER, V131, pE625, DOI 10.1002/ijc.27435; Godwin P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00120; Hayashi S, 2010, INT J MOL MED, V25, P81, DOI 10.3892/ijmm_00000316; Hussain AR, 2008, MOL CANCER THER, V7, P3318, DOI 10.1158/1535-7163.MCT-08-0541; Kamsa-ard S, 2011, ASIAN PAC J CANCER P, V12, P2209; Kodaira K, 2010, UROLOGY, V75, P805, DOI 10.1016/j.urology.2009.11.048; Kodera Yasuhiro, 2006, Int J Clin Oncol, V11, P449, DOI 10.1007/s10147-006-0618-x; Kozakai N, 2012, BRIT J CANCER, V107, P652, DOI 10.1038/bjc.2012.321; Liu MR, 2009, AM J PATHOL, V174, P1910, DOI 10.2353/ajpath.2009.080706; Madhusoodhanan R, 2009, CANCER BIOL THER, V8, P765, DOI 10.4161/cbt.8.9.8105; Matsumoto G, 2005, CLIN CANCER RES, V11, P1287; Mauro C, 2009, METHODS MOL BIOL, V512, P169, DOI 10.1007/978-1-60327-530-9_10; Meng ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033597; Nishimura D, 2006, INT J ONCOL, V29, P713; Onori P, 2009, INT J CANCER, V125, P565, DOI 10.1002/ijc.24271; Pinlaor S, 2006, INT J CANCER, V119, P1067, DOI 10.1002/ijc.21893; Prakobwong S, 2011, CARCINOGENESIS, V32, P1372, DOI 10.1093/carcin/bgr032; Rahman KMW, 2005, CANCER RES, V65, P364; Seubwai W, 2010, CANCER SCI, V101, P1590, DOI 10.1111/j.1349-7006.2010.01572.x; Shen HM, 2009, APOPTOSIS, V14, P348, DOI 10.1007/s10495-009-0315-0; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; Solomon LA, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-9; Sripa B, 2008, CURR OPIN GASTROEN, V24, P349, DOI 10.1097/MOG.0b013e3282fbf9b3; Sripa B, 2005, WORLD J GASTROENTERO, V11, P3392, DOI 10.3748/wjg.v11.i22.3392; Sripa B, 2012, TRENDS PARASITOL, V28, P395, DOI 10.1016/j.pt.2012.07.006; SRIVATANAKUL P, 1991, INT J CANCER, V48, P821, DOI 10.1002/ijc.2910480606; Starenki DV, 2004, CLIN CANCER RES, V10, P6821, DOI 10.1158/1078-0432.CCR-04-0463; Stein SJ, 2011, ONCOGENE, V30, P4557, DOI 10.1038/onc.2011.156; Suzuki K, 2013, CLIN EXP METASTAS, V30, P381, DOI 10.1007/s10585-012-9544-7; The Bureau of Policy and Strategy MoPh Thailand, 2010, PUBL HLTH STAT 2010; Uen YH, 2007, J CELL BIOCHEM, V101, P1165, DOI 10.1002/jcb.21240; Umezawa K, 2002, MOL CELLS, V14, P163; Umezawa K, 2006, CANCER SCI, V97, P990, DOI 10.1111/j.1349-7006.2006.00285.x; Uthaisar K, 2012, ASIAN PAC J CANCER P, V13, P149, DOI 10.7314/APJCP.2012.13.KKSuppl.149; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Yamamoto M, 2008, J MED CHEM, V51, P5780, DOI 10.1021/jm8006245; Yasuda A, 2011, ORAL ONCOL, V47, P334, DOI 10.1016/j.oraloncology.2011.03.001; Yeh PY, 2003, BIOCHEM PHARMACOL, V66, P25, DOI 10.1016/S0006-2952(03)00250-8; Zhang L, 2012, MOLECULES, V17, P3736, DOI 10.3390/molecules17043736	47	37	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106056	10.1371/journal.pone.0106056	http://dx.doi.org/10.1371/journal.pone.0106056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170898	Green Submitted, gold, Green Published			2022-12-25	WOS:000341127500094
J	Hasegawa, T; Yamaguchi, R; Nagasaki, M; Miyano, S; Imoto, S				Hasegawa, Takanori; Yamaguchi, Rui; Nagasaki, Masao; Miyano, Satoru; Imoto, Seiya			Inference of Gene Regulatory Networks Incorporating Multi-Source Biological Knowledge via a State Space Model with L1 Regularization	PLOS ONE			English	Article							COMBINATORIAL TRANSCRIPTIONAL DYNAMICS; CORTICOSTEROID PHARMACOGENOMICS; DIFFERENTIAL-EQUATIONS; PARAMETER-ESTIMATION; MAXIMUM-LIKELIHOOD; EXPRESSION; SYSTEMS; METHYLPREDNISOLONE; ALGORITHM; RECEPTOR	Comprehensive understanding of gene regulatory networks (GRNs) is a major challenge in the field of systems biology. Currently, there are two main approaches in GRN analysis using time-course observation data, namely an ordinary differential equation (ODE)-based approach and a statistical model-based approach. The ODE-based approach can generate complex dynamics of GRNs according to biologically validated nonlinear models. However, it cannot be applied to ten or more genes to simultaneously estimate system dynamics and regulatory relationships due to the computational difficulties. The statistical model-based approach uses highly abstract models to simply describe biological systems and to infer relationships among several hundreds of genes from the data. However, the high abstraction generates false regulations that are not permitted biologically. Thus, when dealing with several tens of genes of which the relationships are partially known, a method that can infer regulatory relationships based on a model with low abstraction and that can emulate the dynamics of ODE-based models while incorporating prior knowledge is urgently required. To accomplish this, we propose a method for inference of GRNs using a state space representation of a vector auto-regressive (VAR) model with L1 regularization. This method can estimate the dynamic behavior of genes based on linear time-series modeling constructed from an ODE-based model and can infer the regulatory structure among several tens of genes maximizing prediction ability for the observational data. Furthermore, the method is capable of incorporating various types of existing biological knowledge, e. g., drug kinetics and literature-recorded pathways. The effectiveness of the proposed method is shown through a comparison of simulation studies with several previous methods. For an application example, we evaluated mRNA expression profiles over time upon corticosteroid stimulation in rats, thus incorporating corticosteroid kinetics/dynamics, literature-recorded pathways and transcription factor (TF) information.	[Hasegawa, Takanori] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto, Japan; [Yamaguchi, Rui; Miyano, Satoru; Imoto, Seiya] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo, Japan; [Nagasaki, Masao] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi 980, Japan	Kyoto University; University of Tokyo; Tohoku University	Hasegawa, T (corresponding author), Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto, Japan.	hasegw@kuicr.kyoto-u.ac.jp		xing zhi, shi zhi/0000-0003-3289-5681; Miyano, Satoru/0000-0002-1753-6616; Nagasaki, Masao/0000-0002-4292-8785	 [24-9639]; Grants-in-Aid for Scientific Research [12J09639] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for JSPS Fellows (24-9639) received by TH (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almon RR, 2005, J ENDOCRINOL, V184, P219, DOI 10.1677/joe.1.05953; Asif HMS, 2011, BIOINFORMATICS, V27, P1277, DOI 10.1093/bioinformatics/btr113; Bard Y., 1974, NONLINEAR PARAMETER; Barenco M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r25; Beal MJ, 2005, BIOINFORMATICS, V21, P349, DOI 10.1093/bioinformatics/bti014; Chen KC, 2005, BIOINFORMATICS, V21, P2883, DOI 10.1093/bioinformatics/bti415; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; do Rego TG, 2012, BIOINFORMATICS, V28, P2297, DOI 10.1093/bioinformatics/bts362; Dong CY, 2012, BIOINFORMATICS, V28, P2146, DOI 10.1093/bioinformatics/bts354; Eduati F, 2012, BIOINFORMATICS, V28, P2311, DOI 10.1093/bioinformatics/bts363; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Foti D, 2003, MOL CELL BIOL, V23, P2720, DOI 10.1128/MCB.23.8.2720-2732.2003; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Greenfield A, 2013, BIOINFORMATICS, V29, P1060, DOI 10.1093/bioinformatics/btt099; Hasegawa T, 2011, LECT N BIOINFORMAT, V6674, P160, DOI 10.1007/978-3-642-21260-4_18; Hazra A, 2008, GENE REGUL SYST BIO, V2, P1; Henderson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094003; Hirose O, 2008, BIOINFORMATICS, V24, P932, DOI 10.1093/bioinformatics/btm639; Imoto Seiya, 2002, Pac Symp Biocomput, P175; Jin JY, 2003, J PHARMACOL EXP THER, V307, P93, DOI 10.1124/jpet.103.053256; Julier SJ, 2004, P IEEE, V92, P401, DOI 10.1109/JPROC.2003.823141; Julier SJ, 1997, P SOC PHOTO-OPT INS, V3068, P182, DOI 10.1117/12.280797; Kalman R. E, 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kim S, 2004, BIOSYSTEMS, V75, P57, DOI 10.1016/j.biosystems.2004.03.004; Kitagawa G., 1996, J OF COMPUTATIONAL A, V5, P1, DOI DOI 10.2307/1390750; Kojima Kaname, 2010, V22, P56; Lawrence N.D., 2006, ADV NEURAL INFORM PR, P785; Lebre S, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1294; Lillacci G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000696; Liu X, 2012, BIOINFORMATICS, V28, P1501, DOI 10.1093/bioinformatics/bts161; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Maybeck P. S., 1979, STOCHASTIC MODELS ES, V1; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Nagasaki Masao, 2006, Genome Inform, V17, P46; Nakamura K, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P227; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Opper M, 2010, BIOINFORMATICS, V26, P1623, DOI 10.1093/bioinformatics/btq244; Quach M, 2007, BIOINFORMATICS, V23, P3209, DOI 10.1093/bioinformatics/btm510; Ramsay JO, 2007, J ROY STAT SOC B, V69, P741, DOI 10.1111/j.1467-9868.2007.00610.x; Rangel C, 2004, BIOINFORMATICS, V20, P1361, DOI 10.1093/bioinformatics/bth093; Rogers S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S2; Sabatti C, 2006, BIOINFORMATICS, V22, P739, DOI 10.1093/bioinformatics/btk017; SAVAGEAU MA, 1987, MATH BIOSCI, V87, P83, DOI 10.1016/0025-5564(87)90035-6; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P370, DOI 10.1016/S0022-5193(69)80027-5; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shimamura T, 2010, BIOINFORMATICS, V26, P1064, DOI 10.1093/bioinformatics/btq080; Shimamura T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-41; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Shumway R. H., 1982, Journal of Time Series Analysis, V3, P253, DOI 10.1111/j.1467-9892.1982.tb00349.x; Sun XD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003758; Tamada Y, 2011, BIOINFORMATICS, V27, P1172, DOI 10.1093/bioinformatics/btr078; Yamaguchi R, 2006, INT J DATA MIN BIOIN, V1, P77, DOI 10.1504/IJDMB.2006.009922; Yao Z, 2008, MOL PHARMACEUT, V5, P328, DOI 10.1021/mp700094s; Zacher B, 2012, BIOINFORMATICS, V28, P1714, DOI 10.1093/bioinformatics/bts257; Zheng GY, 2008, BIOINFORMATICS, V24, P2416, DOI 10.1093/bioinformatics/btn439; Zou H, 2007, ANN STAT, V35, P2173, DOI 10.1214/009053607000000127	63	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105942	10.1371/journal.pone.0105942	http://dx.doi.org/10.1371/journal.pone.0105942			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162401	Green Submitted, Green Published, gold			2022-12-25	WOS:000340880900064
J	Kaiser, HA; Ben Abdallah, A; Lin, N; Tellor, BR; Helwani, M; Smith, JR; Moon, MR; Avidan, MS				Kaiser, Heiko A.; Ben Abdallah, Arbi; Lin, Nan; Tellor, Bethany R.; Helwani, Mohammad; Smith, Jennifer R.; Moon, Marc R.; Avidan, Michael S.			Contaminated Heparin and Outcomes after Cardiac Surgery: A Retrospective Propensity-Matched Cohort Study	PLOS ONE			English	Article							ANGIOTENSIN; EVENTS	Background: During 2007 and 2008 it is likely that millions of patients in the US received heparin contaminated (CH) with oversulfated chondroitin sulfate, which was associated with anaphylactoid reactions. We tested the hypothesis that CH was associated with serious morbidity, mortality, intensive care unit (ICU) stay and heparin-induced thrombocytopenia following adult cardiac surgery. Methods and Findings: We conducted a single center, retrospective, propensity-matched cohort study during the period of CH and the equivalent time frame in the three preceding or the two following years. Perioperative data were obtained from the institutional record of the Society of Thoracic Surgeons National Database, for which the data collection is prospective, standardized and performed by independent investigators. After matching, logistic regression was performed to evaluate the independent effect of CH on the composite adverse outcome (myocardial infarction, stroke, pneumonia, dialysis, cardiac arrest) and on mortality. Cox regression was used to determine the association between CH and ICU length of stay. The 1: 5 matched groups included 220 patients potentially exposed to CH and 918 controls. There were more adverse outcomes in the exposed cohort (20.9% versus 12.0%; difference = 8.9%; 95% CI 3.6% to 15.1%, P<0.001) with an odds ratio for CH of 2.0 (95% CI, 1.4 to 3.0, P<0.001). In the exposed group there was a non-significant increase in mortality (5.9% versus 3.5%, difference = 2.4%; 95% CI, -0.4 to 3.5%, P = 0.1), the median ICU stay was longer by 14.1 hours (interquartile range -26.6 to 79.8, S = 3299, P = 0.0004) with an estimated hazard ratio for CH of 1.2 (95% CI, 1.0 to 1.4, P = 0.04). There was no difference in nadir platelet counts between cohorts. Conclusions: The results from this single center study suggest the possibility that contaminated heparin might have contributed to serious morbidity following cardiac surgery.	[Kaiser, Heiko A.; Ben Abdallah, Arbi; Helwani, Mohammad; Avidan, Michael S.] Washington Univ, St Louis Sch Med, Dept Anesthesiol, St Louis, MO 63130 USA; [Lin, Nan] Washington Univ, St Louis Sch Med, Dept Math, St Louis, MO USA; [Tellor, Bethany R.; Smith, Jennifer R.] Barnes Jewish Hosp, Dept Pharm, St Louis, MO 63110 USA; [Moon, Marc R.] Washington Univ, St Louis Sch Med, Dept Cardiothorac Surg, St Louis, MO USA	Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL)	Kaiser, HA (corresponding author), Washington Univ, St Louis Sch Med, Dept Anesthesiol, St Louis, MO 63130 USA.	heikokaiser@me.com	Kaiser, Heiko/AAB-1198-2021	Pennington, Bethany/0000-0003-1571-6434; Avidan, Michael/0000-0001-6248-044X; Kaiser, Heiko/0000-0002-6082-9510				Adiguzel C, 2009, CLIN APPL THROMB-HEM, V15, P145, DOI 10.1177/1076029609332802; Arepally GM, 2006, NEW ENGL J MED, V355, P809, DOI 10.1056/NEJMcp052967; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Bas M, 2007, ALLERGY, V62, P842, DOI 10.1111/j.1398-9995.2007.01427.x; Blossom DB, 2008, NEW ENGL J MED, V359, P2674, DOI 10.1056/NEJMoa0806450; Brown NJ, 1998, CIRCULATION, V97, P1411, DOI 10.1161/01.CIR.97.14.1411; DE Ho, 2009, J STAT SOFTWARE; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Haller G, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3974; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Jepsen P, 2004, HEART, V90, P956, DOI 10.1136/hrt.2003.017269; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Nashef SAM, 2012, EUR J CARDIO-THORAC, V41, P734, DOI 10.1093/ejcts/ezs043; Ruiz-Ortega M, 2002, KIDNEY INT, V62, pS12, DOI 10.1046/j.1523-1755.62.s82.4.x; Schwartz LB, 2008, NEW ENGL J MED, V358, P2505, DOI 10.1056/NEJMe0803599; Shahian DM, 2013, HEART, V99, P1494, DOI 10.1136/heartjnl-2012-303456; Shi PC, 2013, J CARDIOTHOR VASC AN, V27, P703, DOI 10.1053/j.jvca.2013.01.012; Spiess Bruce D, 2004, Semin Cardiothorac Vasc Anesth, V8, P267, DOI 10.1177/108925320400800402; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wang X, 2009, SCAND CARDIOVASC J, V43, P72, DOI 10.1080/14017430802180449; Warkentin TE, 2009, EXPERT OPIN DRUG SAF, V8, P129, DOI [10.1517/14740330902778180, 10.1517/14740330902778180 ]	24	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106096	10.1371/journal.pone.0106096	http://dx.doi.org/10.1371/journal.pone.0106096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162640	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900089
J	Kloskowski, T; Jundzill, A; Kowalczyk, T; Nowacki, M; Bodnar, M; Marszalek, A; Pokrywczynska, M; Frontczak-Baniewicz, M; Kowalewski, TA; Chlosta, P; Drewa, T				Kloskowski, Tomasz; Jundzill, Arkadiusz; Kowalczyk, Tomasz; Nowacki, Maciej; Bodnar, Magdalena; Marszalek, Andrzej; Pokrywczynska, Marta; Frontczak-Baniewicz, Malgorzata; Kowalewski, Tomasz A.; Chlosta, Piotr; Drewa, Tomasz			Ureter Regeneration-The Proper Scaffold Has to Be Defined	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; MESENCHYMAL STEM-CELLS; URINARY-DIVERSION; ACELLULAR MATRIX; MECHANICAL-PROPERTIES; IN-VITRO; TISSUE; REPLACEMENT; RECONSTRUCTION; DEGRADATION	The aim of this study was to compare two different acellular scaffolds: natural and synthetic, for urinary conduit construction and ureter segment reconstruction. Acellular aortic arch (AAM) and poly(L-lactide-co-caprolactone) (PLCL) were used in 24 rats for ureter reconstruction in both tested groups. Follow-up period was 4 weeks. Intravenous pyelography, histological and immunohistochemical analysis were performed. All animals survived surgical procedures. Patent uretero-conduit junction was observed only in one case using PLCL. In case of ureter segment reconstruction ureters were patent in one case using AAM and in four cases using PLCL scaffolds. Regeneration of urothelium layer and focal regeneration of smooth muscle layer was observed on both tested scaffolds. Obtained results indicates that synthetic acellular PLCL scaffolds showed better properties for ureter reconstruction than naturally derived acellular aortic arch.	[Kloskowski, Tomasz; Jundzill, Arkadiusz; Nowacki, Maciej; Pokrywczynska, Marta; Drewa, Tomasz] Nicholas Copernicus Univ, Coll Med, Dept Tissue Engn, Chair Regenerat Med, Bydgoszcz, Poland; [Kowalczyk, Tomasz; Kowalewski, Tomasz A.] Polish Acad Sci, Inst Fundamental Technol Res, Warsaw, Poland; [Bodnar, Magdalena; Marszalek, Andrzej] Nicholas Copernicus Univ, Coll Med, Dept Clin Pathomorphol, Bydgoszcz, Poland; [Frontczak-Baniewicz, Malgorzata] Polish Acad Sci, Mossakowski Med Res Ctr, Electron Microscopy Platform, Warsaw, Poland; [Chlosta, Piotr] Jagiellonian Univ, Dept Urol, Krakow, Poland; [Drewa, Tomasz] Nicholas Copernicus Univ, Dept Urol, Torun, Poland	Nicolaus Copernicus University; Ludwik Rydygier Collegium Medicum; Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences; Nicolaus Copernicus University; Ludwik Rydygier Collegium Medicum; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Jagiellonian University; Nicolaus Copernicus University	Kloskowski, T (corresponding author), Nicholas Copernicus Univ, Coll Med, Dept Tissue Engn, Chair Regenerat Med, Bydgoszcz, Poland.	tomaszkloskowski@op.pl	Bodnar, Magdalena/D-6131-2014; Kloskowski, Tomasz/D-4353-2014; Kowalczyk, Tomasz/H-3872-2012; Pokrywczynska, Marta/E-9323-2014; Kowalewski, Tomasz Aleksander/F-2055-2011	Bodnar, Magdalena/0000-0003-3748-1058; Kloskowski, Tomasz/0000-0001-5599-9315; Kowalczyk, Tomasz/0000-0003-2381-4122; Kowalewski, Tomasz Aleksander/0000-0002-3664-9659; Drewa, Tomasz/0000-0002-5529-4320; Pokrywczynska, Marta/0000-0003-3259-087X; Jundzill, Arkadiusz/0000-0002-7743-8540				Adamowicz J, 2012, TRANSPL P, V44, P1439, DOI 10.1016/j.transproceed.2012.01.128; Adamowicz J, 2013, CENT EUR J UROL, V66, P202, DOI 10.5173/ceju.2013.02.art23; Arkill KP, 2010, J ANAT, V216, P547, DOI 10.1111/j.1469-7580.2010.01215.x; Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7; Bajek A, 2012, CENT EUR J UROL, V65, P7, DOI 10.5173/ceju.2012.01.art2; Baltaci S, 1998, UROLOGY, V51, P400, DOI 10.1016/S0090-4295(97)00632-8; Bandyopadhyay B, 2013, BIOTECHNOL PROGR, V29, P197, DOI 10.1002/btpr.1665; BOHNE AW, 1957, J UROLOGY, V77, P725, DOI 10.1016/S0022-5347(17)66624-2; Bolgen N, 2005, J BIOMAT SCI-POLYM E, V16, P1537, DOI 10.1163/156856205774576655; Brandt AS, 2010, UROLOGE, V49, P812, DOI 10.1007/s00120-010-2333-5; Cottam E, 2009, MED ENG PHYS, V31, P221, DOI 10.1016/j.medengphy.2008.07.005; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Dahms SE, 1997, UROLOGY, V50, P818, DOI 10.1016/S0090-4295(97)00391-9; Dong YX, 2009, TISSUE ENG PART B-RE, V15, P333, DOI [10.1089/ten.teb.2008.0619, 10.1089/ten.TEB.2008.0619]; Drewa T, 2007, TRANSPL P, V39, P1647, DOI 10.1016/j.transproceed.2007.02.092; Drewa T, 2010, SURG INNOV, V17, P295, DOI 10.1177/1553350610375092; Duchene DA, 2004, J ENDOUROL, V18, P507, DOI 10.1089/0892779041271472; Eble JA, 2009, CURR PHARM DESIGN, V15, P1385, DOI 10.2174/138161209787846757; El-Assmy A, 2004, J UROLOGY, V171, P1939, DOI 10.1097/01.ju.0000121437.94629.ef; Frontczak-Baniewicz M, 2011, FOLIA NEUROPATHOL, V49, P204; Gajda M, 2006, INT UROL NEPHROL, V38, P215, DOI 10.1007/s11255-006-6677-0; Geutjes P, 2012, J UROLOGY, V188, P653, DOI 10.1016/j.juro.2012.03.119; Hautmann RE, 2007, UROLOGY, V69, P17, DOI 10.1016/j.urology.2006.05.058; Jeong SI, 2004, BIOMATERIALS, V25, P5939, DOI 10.1016/j.biomaterials.2004.01.057; KLIPPEL KF, 1979, INVEST UROL, V16, P447; Kloskowski T, 2013, INT J ARTIF ORGANS, V36, P392, DOI 10.5301/ijao.5000130; Kowalczyk T, 2008, BIOMACROMOLECULES, V9, P2087, DOI 10.1021/bm800421s; Koziak A, 2007, INT J UROL, V14, P607, DOI 10.1111/j.1442-2042.2007.01781.x; Krynauw H, 2011, J BIOMED MATER RES B, V99B, P359, DOI 10.1002/jbm.b.31907; Liao WB, 2013, CHINESE MED J-PEKING, V126, P335, DOI 10.3760/cma.j.issn.0366-6999.20120443; Liao WB, 2013, J SURG RES, V182, P185, DOI 10.1016/j.jss.2012.10.024; Liatsikos EN, 2001, J UROLOGY, V165, P1719, DOI 10.1016/S0022-5347(05)66401-4; Marszalek A, 2011, FOLIA HISTOCHEM CYTO, V49, P357, DOI 10.5603/FHC.2011.0049; MEEZAN E, 1975, LIFE SCI, V17, P1721, DOI 10.1016/0024-3205(75)90119-8; Morita SI, 2002, TISSUE ENGINEERING AND BIODEGRADABLE EQUIVALENTS: SCIENTIFIC AND CLINICAL APPLICATIONS, P111; Osman Y, 2004, J UROLOGY, V172, P1151, DOI 10.1097/01.ju.0000134886.44065.00; Pokrywczynska M, 2013, ARCH IMMUNOL THER EX, V61, P483, DOI 10.1007/s00005-013-0249-7; Reneker DH, 2007, ADV APPL MECH, V41, P43, DOI 10.1016/S0065-2156(07)41002-X; Rokicki G, 2000, POLYM J, V32, P381, DOI 10.1295/polymj.32.381; Rokicki G, 2001, POLIMERY-W, V46, P483, DOI 10.14314/polimery.2001.483; Roupret M, 2013, EUR UROL, V63, P1059, DOI 10.1016/j.eururo.2013.03.032; Sabanegh ES, 1996, UROLOGY, V48, P312, DOI 10.1016/S0090-4295(96)00185-9; Seyednejad H, 2011, MACROMOL BIOSCI, V11, P1684, DOI 10.1002/mabi.201100229; Shen J, 2010, INT J ARTIF ORGANS, V33, P161, DOI 10.1177/039139881003300305; Simaioforidis V, 2013, TISSUE ENG PART B-RE, V19, P413, DOI [10.1089/ten.teb.2012.0737, 10.1089/ten.TEB.2012.0737]; Sofer M, 2002, J ENDOUROL, V16, P27, DOI 10.1089/089277902753483682; Thapsukhon B, 2013, J APPL POLYM SCI, V130, P4357, DOI 10.1002/app.39675; TSULUKIDZE A., 1964, BRIT J UROL, V36, P102, DOI 10.1111/j.1464-410X.1964.tb09488.x; Woods AM, 2004, BIOMATERIALS, V25, P515, DOI 10.1016/S0142-9612(03)00552-0; Zhang F, 2001, J RECONSTR MICROSURG, V17, P179, DOI 10.1055/s-2001-14349; Zhang J, 2012, UROL INT, V88, P60, DOI 10.1159/000335002	51	20	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106023	10.1371/journal.pone.0106023	http://dx.doi.org/10.1371/journal.pone.0106023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162415	Green Published, gold			2022-12-25	WOS:000340880900078
J	Chapman, LAC; Shipley, RJ; Whiteley, JP; Ellis, MJ; Byrne, HM; Waters, SL				Chapman, Lloyd A. C.; Shipley, Rebecca J.; Whiteley, Jonathan P.; Ellis, Marianne J.; Byrne, Helen M.; Waters, Sarah L.			Optimising Cell Aggregate Expansion in a Perfused Hollow Fibre Bioreactor via Mathematical Modelling	PLOS ONE			English	Article							3-DIMENSIONAL BONE TISSUE; SHEAR-STRESS; MICROCHANNEL BIOREACTOR; NUTRIENT TRANSPORT; MASS-TRANSPORT; CULTURE; PROLIFERATION; GROWTH; SCAFFOLD; SIMULATION	The need for efficient and controlled expansion of cell populations is paramount in tissue engineering. Hollow fibre bioreactors (HFBs) have the potential to meet this need, but only with improved understanding of how operating conditions and cell seeding strategy affect cell proliferation in the bioreactor. This study is designed to assess the effects of two key operating parameters (the flow rate of culture medium into the fibre lumen and the fluid pressure imposed at the lumen outlet), together with the cell seeding distribution, on cell population growth in a single-fibre HFB. This is achieved using mathematical modelling and numerical methods to simulate the growth of cell aggregates along the outer surface of the fibre in response to the local oxygen concentration and fluid shear stress. The oxygen delivery to the cell aggregates and the fluid shear stress increase as the flow rate and pressure imposed at the lumen outlet are increased. Although the increased oxygen delivery promotes growth, the higher fluid shear stress can lead to cell death. For a given cell type and initial aggregate distribution, the operating parameters that give the most rapid overall growth can be identified from simulations. For example, when aggregates of rat cardiomyocytes that can tolerate shear stresses of up to 0.05 Pa are evenly distributed along the fibre, the inlet flow rate and outlet pressure that maximise the overall growth rate are predicted to be in the ranges 2.75 x 10(-5)m(2) s(-1) to 3 x 10(-5)m(2) s(-1) (equivalent to 2.07 ml min(-1) to 2.26 ml min(-1)) and 1.077 x 10(5) Pa to 1.083 x 10(5) Pa (or 15.6 psi to 15.7 psi) respectively. The combined effects of the seeding distribution and flow on the growth are also investigated and the optimal conditions for growth found to depend on the shear tolerance and oxygen demands of the cells.	[Chapman, Lloyd A. C.; Byrne, Helen M.; Waters, Sarah L.] Univ Oxford, Math Inst, Oxford, England; [Shipley, Rebecca J.] UCL, Dept Mech Engn, London, England; [Chapman, Lloyd A. C.; Whiteley, Jonathan P.; Byrne, Helen M.] Univ Oxford, Dept Comp Sci, Oxford, England; [Ellis, Marianne J.] Univ Bath, Dept Chem Engn, Bath BA2 7AY, Avon, England	University of Oxford; University of London; University College London; University of Oxford; University of Bath	Waters, SL (corresponding author), Univ Oxford, Math Inst, Oxford, England.	waters@maths.ox.ac.uk		Waters, Sarah/0000-0001-5285-0523; Ellis, Marianne/0000-0003-4155-0853; Chapman, Lloyd/0000-0001-7727-7102; Shipley, Rebecca/0000-0002-2818-6228; Byrne, Helen/0000-0003-1771-5910	EPSRC Life Sciences Interface Doctoral Training Centre from the University of Oxford [EP/F500394/1]; King Abdullah University of Science and Technology, Saudi Arabia [KUK-C1-013-04]; EPSRC through an Advanced Research Fellowship; EPSRC [EP/D070635/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D070635/2] Funding Source: researchfish	EPSRC Life Sciences Interface Doctoral Training Centre from the University of Oxford(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); King Abdullah University of Science and Technology, Saudi Arabia(King Abdullah University of Science & Technology); EPSRC through an Advanced Research Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work is primarily supported by an EPSRC Life Sciences Interface Doctoral Training Centre grant from the University of Oxford (EP/F500394/1). HMB is supported by King Abdullah University of Science and Technology, Saudi Arabia (Award No. KUK-C1-013-04). SLW is funded by the EPSRC through an Advanced Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brayfield CA, 2008, THESIS U PITTSBURGH; Brotherton JD, 1996, BIOTECHNOL PROGR, V12, P575, DOI 10.1021/bp960002g; Elert G, 2011, DENSITY PHYS HYPERTE; Ellis MJ, 2007, BIOTECHNOL BIOENG, V96, P177, DOI 10.1002/bit.21093; Korin N, 2007, LAB CHIP, V7, P611, DOI 10.1039/b702392h; Ladoux B, 2009, NAT PHYS, V5, P377, DOI 10.1038/nphys1281; Landman KA, 2007, B MATH BIOL, V69, P2405, DOI 10.1007/s11538-007-9225-x; Lemon G, 2006, J MATH BIOL, V52, P571, DOI 10.1007/s00285-005-0363-1; Lu HF, 2005, TISSUE ENG, V11, P1667, DOI 10.1089/ten.2005.11.1667; McCoy RJ, 2010, TISSUE ENG PART B-RE, V16, P587, DOI [10.1089/ten.teb.2010.0370, 10.1089/ten.TEB.2010.0370]; MCELWAIN DLS, 1977, MATH BIOSCI, V35, P267, DOI 10.1016/0025-5564(77)90028-1; Meneghello G, 2009, J MEMBRANE SCI, V344, P55, DOI 10.1016/j.memsci.2009.07.034; Mohebbi-Kalhori D, 2012, J ARTIF ORGANS, V15, P250, DOI 10.1007/s10047-012-0649-1; O'Dea RD, 2010, MATH MED BIOL, V27, P95, DOI 10.1093/imammb/dqp003; O'Dea RD, 2013, COMPUTATIONAL MODELI, P229; Pearson NC, 2014, MATH MED BIOL, V31, P393, DOI 10.1093/imammb/dqt015; Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004; Rodrigues CAV, 2011, BIOTECHNOL ADV, V29, P815, DOI 10.1016/j.biotechadv.2011.06.009; Saxby L, 1998, BRIT J OPHTHALMOL, V82, P945, DOI 10.1136/bjo.82.8.945; Shakeel M, 2013, MATH MED BIOL, V30, P21, DOI 10.1093/imammb/dqr022; Shipley RJ, 2010, BIOTECHNOL BIOENG, V107, P382, DOI 10.1002/bit.22815; Shipley RJ, 2012, MATH MED BIOL, V29, P329, DOI 10.1093/imammb/dqr025; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; THARAKAN JP, 1986, BIOTECHNOL BIOENG, V28, P329, DOI 10.1002/bit.260280305; Treloar KK, 2014, J THEOR BIOL, V356, P71, DOI 10.1016/j.jtbi.2014.04.026; Ye H, 2006, J MEMBRANE SCI, V272, P169, DOI 10.1016/j.memsci.2005.07.040; Yeatts AB, 2011, BONE, V48, P171, DOI 10.1016/j.bone.2010.09.138; Zahm JM, 1997, CELL MOTIL CYTOSKEL, V37, P33, DOI 10.1002/(SICI)1097-0169(1997)37:1<33::AID-CM4>3.0.CO;2-I; Zeng Y, 2006, J BIOMECH ENG-T ASME, V128, P185, DOI 10.1115/1.2170118; Zhao F, 2005, BIOTECHNOL PROGR, V21, P1269, DOI 10.1021/bp0500664; Zhao F, 2007, BIOTECHNOL BIOENG, V96, P584, DOI 10.1002/bit.21184	31	17	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105813	10.1371/journal.pone.0105813	http://dx.doi.org/10.1371/journal.pone.0105813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157635	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000341303200067
J	Sousa, JB; Vieira-Rocha, MS; Sa, C; Ferreirinha, F; Correia-de-Sa, P; Fresco, P; Diniz, C				Sousa, Joana Beatriz; Vieira-Rocha, Maria Sofia; Sa, Carlos; Ferreirinha, Fatima; Correia-de-Sa, Paulo; Fresco, Paula; Diniz, Carmen			Lack of Endogenous Adenosine Tonus on Sympathetic Neurotransmission in Spontaneously Hypertensive Rat Mesenteric Artery	PLOS ONE			English	Article							MOTOR-NERVE TERMINALS; PIG VAS-DEFERENS; NORADRENALINE RELEASE; TAIL ARTERY; A(1) RECEPTORS; A(1)-ADENOSINE RECEPTORS; ACETYLCHOLINE-RELEASE; A(2A); FACILITATION; INNERVATION	Background: Increased sympathetic activity has been implicated in hypertension. Adenosine has been shown to play a role in blood flow regulation. In the present study, the endogenous adenosine neuromodulatory role, in mesenteric arteries from normotensive and spontaneously hypertensive rats, was investigated. Methods and Results: The role of endogenous adenosine in sympathetic neurotransmission was studied using electrically-evoked [H-3]-noradrenaline release experiments. Purine content was determined by HPLC with fluorescence detection. Localization of adenosine A(1) or A(2A) receptors in adventitia of mesenteric arteries was investigated by Laser Scanning Confocal Microscopy. Results indicate a higher electrically-evoked noradrenaline release from hypertensive mesenteric arteries. The tonic inhibitory modulation of noradrenaline release is mediated by adenosine A(1) receptors and is lacking in arteries from hypertensive animals, despite their purine levels being higher comparatively to those determined in normotensive ones. Tonic facilitatory adenosine A(2A) receptor-mediated effects were absent in arteries from both strains. Immunohistochemistry revealed an adenosine A(1) receptors redistribution from sympathetic fibers to Schwann cells, in adventitia of hypertensive mesenteric arteries which can explain, at least in part, the absence of effects observed for these receptors. Conclusion: Data highlight the role of purines in hypertension revealing that an increase in sympathetic activity in hypertensive arteries is occurring due to a higher noradrenaline/ATP release from sympathetic nerves and the loss of endogenous adenosine inhibitory tonus. The observed nerve-to-glial redistribution of inhibitory adenosine A1 receptors in hypertensive arteries may explain the latter effect.	[Sousa, Joana Beatriz; Vieira-Rocha, Maria Sofia; Fresco, Paula; Diniz, Carmen] Univ Porto, Fac Farm, REQUIMTE FARMA, Dept Ciencias Med,Lab Farmacol, P-4100 Oporto, Portugal; [Sousa, Joana Beatriz; Vieira-Rocha, Maria Sofia; Ferreirinha, Fatima; Correia-de-Sa, Paulo; Fresco, Paula; Diniz, Carmen] Univ Porto, MedInUP, Ctr Invest Farmacol & Inovacao Med, P-4100 Oporto, Portugal; [Sa, Carlos] Univ Porto, Ctr Mat, P-4100 Oporto, Portugal; [Ferreirinha, Fatima; Correia-de-Sa, Paulo] Univ Porto, UMIB, Inst Ciencias Biomed Abel Salazar, Lab Farmacol & Neurobiol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Diniz, C (corresponding author), Univ Porto, Fac Farm, REQUIMTE FARMA, Dept Ciencias Med,Lab Farmacol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	cdiniz@ff.up.pt	Ferreirinha, Fatima/K-8752-2014; Correia-De-Sá, P./F-1079-2015; , CDiniz/D-6293-2013; Sousa, Joana/N-4763-2019; Fresco, Paula/D-4845-2013; Correia-de-Sá, Paulo/AAG-5901-2019	Ferreirinha, Fatima/0000-0002-0527-1323; Correia-De-Sá, P./0000-0002-6114-9189; , CDiniz/0000-0003-4668-9360; Sousa, Joana/0000-0002-1744-7840; Fresco, Paula/0000-0001-6705-7798; Correia-de-Sá, Paulo/0000-0002-6114-9189; Sa, Carlos/0000-0001-8814-8832	FEDER through the Program of Operational Competitiveness Factors-COMPETE; National Funds; Strategic Projects framework for Scientific Research Units of R&D through FCT - Foundation for Science and Technology [REEQ/1168/SAU/2005, REEQ/1264/SAU/2005, PEst-OE/SAU/UI0215/2011, PEst-OE/SAU/UI0215/2014]; FCT [SFRH/BD//2009]	FEDER through the Program of Operational Competitiveness Factors-COMPETE; National Funds; Strategic Projects framework for Scientific Research Units of R&D through FCT - Foundation for Science and Technology; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by FEDER through the Program of Operational Competitiveness Factors-COMPETE and National Funds and by Strategic Projects framework for Scientific Research Units of R&D (REEQ/1168/SAU/2005, REEQ/1264/SAU/2005, PEst-OE/SAU/UI0215/2011 and PEst-OE/SAU/UI0215/2014) through FCT - Foundation for Science and Technology. JBS thanks FCT for her PhD grant (SFRH/BD//2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN FW, 1981, HYPERTENSION, V3, P119; Barroso A, 2007, BRIT J PHARMACOL, V151, P541, DOI 10.1038/sj.bjp.0707242; Bobalova J, 2002, ANAL BIOCHEM, V305, P269, DOI 10.1006/abio.2002.5667; Bobalova J, 2001, CLIN EXP PHARMACOL P, V28, P397; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Burnstock G, 2009, EXP PHYSIOL, V94, P20, DOI [10.1113/expphysiol.2008.043620, 10.3410/B1-46]; CorreiaDeSa P, 1996, NEUROSCIENCE, V73, P85, DOI 10.1016/0306-4522(96)00028-0; De Fontgalland D, 2008, NEUROGASTROENT MOTIL, V20, P1212, DOI 10.1111/j.1365-2982.2008.01150.x; Diniz C, 2005, CLIN EXP PHARMACOL P, V32, P721, DOI 10.1111/j.1440-1681.2005.04252.x; Diniz C, 2004, EUR J PHARMACOL, V504, P17, DOI 10.1016/j.ejphar.2004.09.048; Donoso MV, 2006, J NEUROCHEM, V96, P1680, DOI 10.1111/j.1471-4159.2006.03671.x; Duarte-Araujo M, 2004, BRIT J PHARMACOL, V141, P925, DOI 10.1038/sj.bjp.0705697; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Fredholm BB, 2011, ADV PHARMACOL, V61, P77, DOI 10.1016/B978-0-12-385526-8.00003-5; Fresco P, 2004, CARDIOVASC RES, V63, P739, DOI 10.1016/j.cardiores.2004.05.015; Fresco P, 2002, BRIT J PHARMACOL, V136, P230, DOI 10.1038/sj.bjp.0704686; Goonetilleke L, 2013, J HYPERTENS, V31, P312, DOI 10.1097/HJH.0b013e32835bd74d; HEAD RJ, 1989, BLOOD VESSELS, V26, P1; ILLES P, 1989, EUR J PHARMACOL, V174, P237, DOI 10.1016/0014-2999(89)90316-6; Kegler K, 2014, J NEURAL TRANSM; KONG JQ, 1991, J PHARMACOL EXP THER, V258, P13; LEVITT B, 1984, ANAL BIOCHEM, V137, P93, DOI 10.1016/0003-2697(84)90352-X; Luff SE, 2005, J VASC RES, V42, P348, DOI 10.1159/000086886; Luo M, 2004, AM J PHYSIOL-HEART C, V286, pH1558, DOI 10.1152/ajpheart.00592.2003; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; Majesky MW, 2011, ARTERIOSCL THROM VAS, V31, P1530, DOI 10.1161/ATVBAHA.110.221549; MANGIARUA EI, 1990, CAN J PHYSIOL PHARM, V68, P492, DOI 10.1139/y90-070; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Ralevic V, 2000, EUR J PHARMACOL, V387, P287, DOI 10.1016/S0014-2999(99)00810-9; Rocha-Pereira C, 2013, NEUROCHEM INT, V62, P399, DOI 10.1016/j.neuint.2013.02.010; Rocha-Pereira C, 2013, J PHARMACOL SCI, V122, P59, DOI 10.1254/jphs.12266FP; SNEDDON P, 1984, EUR J PHARMACOL, V106, P149, DOI 10.1016/0014-2999(84)90688-5; Talaia C, 2006, NEUROCHEM INT, V49, P698, DOI 10.1016/j.neuint.2006.07.002; Todorov LD, 1996, J PHYSIOL-LONDON, V496, P731, DOI 10.1113/jphysiol.1996.sp021723; TRIPPODO NC, 1981, CIRC RES, V48, P309, DOI 10.1161/01.RES.48.3.309	35	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105540	10.1371/journal.pone.0105540	http://dx.doi.org/10.1371/journal.pone.0105540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25158061	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303200036
J	Wu, BH; Cao, YG; Guan, L; Xin, HP; Li, JH; Li, SH				Wu, Ben-Hong; Cao, Yue-Gang; Guan, Le; Xin, Hai-Ping; Li, Ji-Hu; Li, Shao-Hua			Genome-Wide Transcriptional Profiles of the Berry Skin of Two Red Grape Cultivars (Vitis vinifera) in Which Anthocyanin Synthesis Is Sunlight-Dependent or -Independent	PLOS ONE			English	Article							LIGHT SIGNAL-TRANSDUCTION; CABERNET-SAUVIGNON GRAPES; GENE-EXPRESSION; O-METHYLTRANSFERASES; PLANT; BIOSYNTHESIS; ACCUMULATION; FRUIT; PHYTOCHROME; PROTEINS	Global gene expression was analyzed in the berry skin of two red grape cultivars, which can ('Jingyan') or cannot ('Jingxiu') synthesize anthocyanins after sunlight exclusion from fruit set until maturity. Gene transcripts responding to sunlight exclusion in 'Jingyan' were less complex than in 'Jingxiu'; 528 genes were induced and 383 repressed in the former, whereas 2655 genes were induced and 205 suppressed in 'Jingxiu'. They were regulated either in the same or opposing manner in the two cultivars, or in only one cultivar. In addition to VvUFGT and VvMYBA1, some candidate genes (e.g. AOMT, GST, and ANP) were identified which are probably involved in the differential responses of 'Jingxiu' and 'Jingyan' to sunlight exclusion. In addition, 26 MYB, 14 bHLH and 23 WD40 genes responded differently to sunlight exclusion in the two cultivars. Interestingly, all of the 189 genes classified as being relevant to ubiquitin-dependent protein degradation were down-regulated by sunlight exclusion in 'Jingxiu', but the majority (162) remained unchanged in 'Jingyan' berry skin. It would be of interest to determine the precise role of the ubiquitin pathway following sunlight exclusion, particularly the role of COP9 signalosome, cullins, RING-Box 1, and COP1-interacting proteins. Only a few genes in the light signal system were found to be regulated by sunlight exclusion in either or both cultivars. This study provides a valuable overview of the transcriptome changes and gives insight into the genetic background that may be responsible for sunlight-dependent versus independent anthocyanin biosynthesis in berry skin.	[Wu, Ben-Hong; Cao, Yue-Gang; Guan, Le; Li, Ji-Hu; Li, Shao-Hua] Chinese Acad Sci, Inst Bot, Beijing Key Lab Grape Sci & Enol, Beijing, Peoples R China; [Wu, Ben-Hong; Cao, Yue-Gang; Guan, Le; Li, Ji-Hu; Li, Shao-Hua] Chinese Acad Sci, Inst Bot, CAS Key Lab Plant Resources, Beijing, Peoples R China; [Cao, Yue-Gang; Guan, Le] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xin, Hai-Ping; Li, Shao-Hua] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Li, SH (corresponding author), Chinese Acad Sci, Inst Bot, Beijing Key Lab Grape Sci & Enol, Beijing, Peoples R China.	shhli@ibcas.ac.cn	Li, Jihu/ABI-5460-2020; Wu, Benhong/Q-5328-2016		National Natural Science Foundation of China (NSFC) [31372047, 31071757]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (NSFC 31372047, 31071757). BHW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NW, 2009, J EXP BOT, V60, P2191, DOI 10.1093/jxb/erp097; Ali MB, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-7; Arguello-Astorga G, 1998, ANNU REV PLANT PHYS, V49, P525, DOI 10.1146/annurev.arplant.49.1.525; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barnes SA, 1997, TRENDS CELL BIOL, V7, P21, DOI 10.1016/S0962-8924(97)10043-5; BATE NJ, 1994, P NATL ACAD SCI USA, V91, P7608, DOI 10.1073/pnas.91.16.7608; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Boss P.K., 2009, GRAPEVINE MOL PHYSL, P263, DOI DOI 10.1007/978-90-481-2305-6_10; Boss PK, 1996, PLANT PHYSIOL, V111, P1059, DOI 10.1104/pp.111.4.1059; BOWLER C, 1994, CELL, V77, P73, DOI 10.1016/0092-8674(94)90236-4; Broun P, 2005, CURR OPIN PLANT BIOL, V8, P272, DOI 10.1016/j.pbi.2005.03.006; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Chen HD, 2010, PLANT CELL, V22, P108, DOI 10.1105/tpc.109.065490; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Chorti E, 2010, AM J ENOL VITICULT, V61, P23; Christie JM, 1996, PLANT CELL, V8, P1555, DOI 10.1105/tpc.8.9.1555; Conn S, 2008, J EXP BOT, V59, P3621, DOI 10.1093/jxb/ern217; Cortell JM, 2006, J AGR FOOD CHEM, V54, P8510, DOI 10.1021/jf0616560; Costantini E, 2007, PLANT PHYSIOL, V143, P1689, DOI 10.1104/pp.106.095232; Cutanda-Perez MC, 2009, PLANT MOL BIOL, V69, P633, DOI 10.1007/s11103-008-9446-x; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Das PK, 2011, PLANT SIGNAL BEHAV, V6, P23, DOI 10.4161/psb.6.1.14082; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Dokoozlian NK, 1996, J AM SOC HORTIC SCI, V121, P869, DOI 10.21273/JASHS.121.5.869; Fasoli M, 2012, PLANT CELL, V24, P3489, DOI 10.1105/tpc.112.100230; Feldbrugge M, 1997, PLANT J, V11, P1079, DOI 10.1046/j.1365-313X.1997.11051079.x; Gong ZZ, 1999, MOL GEN GENET, V262, P65, DOI 10.1007/PL00008639; Guo J, 2008, AFR J BIOTECHNOL, V7, P4966; Harari-Steinberg O, 2001, PLANT PHYSIOL, V127, P986, DOI 10.1104/pp.010270; Hardtke CS, 2000, PLANT PHYSIOL, V124, P1548, DOI 10.1104/pp.124.4.1548; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; Heddad M, 2006, PLANT PHYSIOL, V142, P75, DOI 10.1104/pp.106.081489; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Hugueney P, 2009, PLANT PHYSIOL, V150, P2057, DOI 10.1104/pp.109.140376; HUNTER JJ, 1991, AM J ENOL VITICULT, V42, P13; Ibrahim RK, 1998, PLANT MOL BIOL, V36, P1, DOI 10.1023/A:1005939803300; Inada S, 2004, PLANT CELL, V16, P887, DOI 10.1105/tpc.019901; Jeong ST, 2004, PLANT SCI, V167, P247, DOI 10.1016/j.plantsci.2004.03.021; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; KLIEWER WM, 1977, AM J ENOL VITICULT, V28, P215; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Kobayashi S, 2001, PLANT SCI, V160, P543, DOI 10.1016/S0168-9452(00)00425-8; Lau OS, 2012, TRENDS PLANT SCI, V17, P584, DOI 10.1016/j.tplants.2012.05.004; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Li JH, 2013, AM J ENOL VITICULT, V64, P349, DOI 10.5344/ajev.2013.12130; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANCINELLI AL, 1991, PLANT PHYSIOL, V96, P1079, DOI 10.1104/pp.96.4.1079; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; MILLAR AJ, 1994, ANNU REV GENET, V28, P325, DOI 10.1146/annurev.ge.28.120194.001545; Mol J, 1996, CRIT REV PLANT SCI, V15, P525, DOI 10.1080/07352689609382369; MORRISON JC, 1990, AM J ENOL VITICULT, V41, P193; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nishimura T, 2008, ACTA HORTIC, P425, DOI 10.17660/ActaHortic.2008.797.61; Niu N, 2013, J PLANT PHYSIOL, V170, P748, DOI 10.1016/j.jplph.2012.12.020; Parvathi K, 2001, PLANT J, V25, P193, DOI 10.1046/j.1365-313x.2001.00956.x; Piazza P, 2002, PLANT PHYSIOL, V128, P1077, DOI 10.1104/pp.010799; ROJASLARA BA, 1989, VITIS, V28, P199; SCHNEIDE.MJ, 1971, PLANT PHYSIOL, V48, P312, DOI 10.1104/pp.48.3.312; Schroder G, 2002, PHYTOCHEMISTRY, V59, P1, DOI 10.1016/S0031-9422(01)00421-6; Spayd SE, 2002, AM J ENOL VITICULT, V53, P171; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Terrier N, 2009, PLANT PHYSIOL, V149, P1028, DOI 10.1104/pp.108.131862; Tilbrook Kimberley, 2013, Arabidopsis Book, V11, pe0164, DOI 10.1199/tab.0164; Van Buskirk EK, 2012, PLANT PHYSIOL, V158, P52, DOI 10.1104/pp.111.186411; VANGYSEL A, 1993, GENE, V136, P79, DOI 10.1016/0378-1119(93)90450-H; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Wang M, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.16; Waters Daniel L. E., 2005, Functional & Integrative Genomics, V5, P40, DOI 10.1007/s10142-004-0124-z; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zheng J, 2010, PLANT MOL BIOL, V72, P407, DOI 10.1007/s11103-009-9579-6; Zheng Y, 2013, AUST J GRAPE WINE R, V19, P238, DOI 10.1111/ajgw.12023; Zhou B, 2007, J EXP BOT, V58, P1771, DOI 10.1093/jxb/erm036	79	24	27	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105959	10.1371/journal.pone.0105959	http://dx.doi.org/10.1371/journal.pone.0105959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25158067	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303200081
J	Zhuang, Q; Di, ZR; Wu, JS				Zhuang, Qian; Di, Zengru; Wu, Jinshan			Stability of Mixed-Strategy-Based Iterative Logit Quantal Response Dynamics in Game Theory	PLOS ONE			English	Article							NASH EQUILIBRIUM; FICTITIOUS PLAY	Using the Logit quantal response form as the response function in each step, the original definition of static quantal response equilibrium (QRE) is extended into an iterative evolution process. QREs remain as the fixed points of the dynamic process. However, depending on whether such fixed points are the long-term solutions of the dynamic process, they can be classified into stable (SQREs) and unstable (USQREs) equilibriums. This extension resembles the extension from static Nash equilibriums (NEs) to evolutionary stable solutions in the framework of evolutionary game theory. The relation between SQREs and other solution concepts of games, including NEs and QREs, is discussed. Using experimental data from other published papers, we perform a preliminary comparison between SQREs, NEs, QREs and the observed behavioral outcomes of those experiments. For certain games, we determine that SQREs have better predictive power than QREs and NEs.	[Zhuang, Qian; Di, Zengru; Wu, Jinshan] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China; [Zhuang, Qian] Nanjing Agr Univ, Coll Informat Sci & Technol, Nanjing, Jiangsu, Peoples R China	Beijing Normal University; Nanjing Agricultural University	Wu, JS (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	jinshanw@bnu.edu.cn	Wu, Jinshan/C-1203-2010	Wu, Jinshan/0000-0001-5014-385X	Fundamental Research Funds for the Central Universities, China	Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This paper was supported by the Fundamental Research Funds for the Central Universities, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alos-Ferrer C, 2010, GAME ECON BEHAV, V68, P413, DOI 10.1016/j.geb.2009.08.004; AUMANN RJ, 1987, ECONOMETRICA, V55, P1, DOI 10.2307/1911154; Baron R, 2002, J EVOL ECON, V12, P563, DOI 10.1007/s00191-002-0135-7; Berger U, 2005, J ECON THEORY, V120, P139, DOI 10.1016/j.jet.2004.02.003; Borgers T, 1997, J ECON THEORY, V77, P1, DOI 10.1006/jeth.1997.2319; Brown G., 1951, ACT ANAL PROD ALLOCA, P374; Chen HC, 1997, GAME ECON BEHAV, V18, P32, DOI 10.1006/game.1997.0514; Dixit A., 2009, GAMES STRATEGY, V3rd; Erev I, 2007, ECON THEOR, V33, P29, DOI 10.1007/s00199-007-0214-y; FUDENBERG D, 1993, GAME ECON BEHAV, V5, P320, DOI 10.1006/game.1993.1021; Fudenberg D., 1998, MIT PRESS SERIES EC; Fudenberg D, 2009, ANNU REV ECON, V1, P385, DOI 10.1146/annurev.economics.050708.142930; Goeree JK, 2004, GAME ECON BEHAV, V46, P365, DOI 10.1016/S0899-8256(03)00145-3; Goeree JK, 2001, AM ECON REV, V91, P1402, DOI 10.1257/aer.91.5.1402; Haile PA, 2008, AM ECON REV, V98, P180, DOI 10.1257/aer.98.1.180; Harsanyi J. C., 1988, GEN THEORY EQUILIBRI; Hofbauer J, 1996, J ECON THEORY, V71, P558, DOI 10.1006/jeth.1996.0133; Holt CA, 2004, P NATL ACAD SCI USA, V101, P3999, DOI 10.1073/pnas.0308738101; Hommes CH, 2012, GAME ECON BEHAV, V74, P434, DOI 10.1016/j.geb.2011.05.014; Hopkins E, 2002, ECONOMETRICA, V70, P2141, DOI 10.1111/j.1468-0262.2002.00436.x; JORDAN JS, 1993, GAME ECON BEHAV, V5, P368, DOI 10.1006/game.1993.1022; Konno T, 2011, EXACT SOLUTION SPATI; Krishna V, 1998, MATH OPER RES, V23, P479, DOI 10.1287/moor.23.2.479; McKelvey R. D., 1998, Experimental Economics, V1, P9, DOI 10.1023/A:1009905800005; Mckelvey R. D., 1996, JAPANESE EC REV, V47, P186; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; Morgan J, 2002, GAME ECON BEHAV, V40, P123, DOI 10.1006/game.2001.0905; Myerson Roger., 1978, INT J GAME THEORY, V7, P73, DOI DOI 10.1007/BF01753236; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; OCHS J, 1995, GAME ECON BEHAV, V10, P202, DOI 10.1006/game.1995.1030; Sabourian H, 2007, FDN FORMAL SCI 5; Samuelson L., 1998, EVOLUTIONARY GAMES E; Strogatz SH., 1994, NONLINEAR DYNAMICS C, V1; Weibull J W, 1997, EVOLUTIONARY GAME TH; Wolpert DH, 2006, UND COM SYS, P262; Wu J, 2004, ARXIVQUANTPH0404159; Xu B, 2012, PHYS LETT A, V376, P1318, DOI 10.1016/j.physleta.2012.02.047	38	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105391	10.1371/journal.pone.0105391	http://dx.doi.org/10.1371/journal.pone.0105391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157502	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303200029
J	Su, R; Lin, HS; Zhang, XH; Yin, XL; Ning, HM; Liu, B; Zhai, PF; Gong, JN; Shen, C; Song, L; Chen, J; Wang, F; Zhao, HL; Ma, YN; Yu, J; Zhang, JW				Su, R.; Lin, H-S; Zhang, X-H; Yin, X-L; Ning, H-M; Liu, B.; Zhai, P-F; Gong, J-N; Shen, C.; Song, L.; Chen, J.; Wang, F.; Zhao, H-L; Ma, Y-N; Yu, J.; Zhang, J-W			MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets	ONCOGENE			English	Article							PROTEIN-KINASE-C; RETINOIC ACID; CELL-DIFFERENTIATION; MICRORNA EXPRESSION; TUMOR-SUPPRESSOR; GENE-EXPRESSION; PKC-DELTA; CARDIAC FIBROBLASTS; DOWN-REGULATION; BREAST-CANCER	MicroRNAs have been shown to play an important role in normal hematopoisis and leukemogenesis. Here, we report function and mechanisms of miR-181 family in myeloid differentiation and acute myeloid leukemia (AML). The aberrant overexpression of all the miR-181 family members (miR-181a/b/c/d) was detected in French-American-British M1, M2 and M3 subtypes of adult AML patients. By conducting gain-and loss-of-function experiments, we demonstrated that miR-181a inhibits granulocytic and macrophage-like differentiation of HL-60 cells and CD34+ hematopoietic stem/progenitor cells (HSPCs) by directly targeting and downregulating the expression of PRKCD (which then affected the PRKCD-P38-C/EBPa pathway), CTDSPL (which then affected the phosphorylation of retinoblastoma protein) and CAMKK1. The three genes were also demonstrated to be the targets of miR-181b, miR-181c and miR-181d, respectively. Significantly decreases in the expression levels of the target proteins were detected in AML patients. Inhibition of the expression of miR-181 family members owing to Lenti-miRZip-181a infection in bone marrow blasts of AML patients increased target protein expression levels and partially reversed myeloid differentiation blockage. In the mice implanted with AML CD34+ HSPCs, expression inhibition of the miR-181 family by Lenti-miRZip-181a injection improved myeloid differentiation, inhibited engraftment and infiltration of the leukemic CD34+ cells into the bone marrow and spleen, and released leukemic symptoms. In conclusion, our findings revealed new mechanism of miR-181 family in normal hematopoiesis and AML development, and suggested that expression inhibition of the miR-181 family could provide a new strategy for AML therapy.	[Su, R.; Lin, H-S; Zhai, P-F; Gong, J-N; Shen, C.; Song, L.; Chen, J.; Wang, F.; Zhao, H-L; Ma, Y-N; Yu, J.; Zhang, J-W] Chinese Acad Med Sci, Key State Lab Med Mol Biol, Dept Biochem & Mol Biol, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Su, R.; Lin, H-S; Zhai, P-F; Gong, J-N; Shen, C.; Song, L.; Chen, J.; Wang, F.; Zhao, H-L; Ma, Y-N; Yu, J.; Zhang, J-W] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, X-H; Yin, X-L] 303 Hosp, Dept Hematol, Nanning, Guangxi, Peoples R China; [Ning, H-M] Acad Mil Med Sci, Inst Mil Hemopoiet Stem Cell, Dept Stem Cell Transplantat Ctr, Hosp, Beijing, Peoples R China; [Ning, H-M] Acad Mil Med Sci, Affiliated Hosp, Lvy Translat Med Ctr 307, Lab Oncol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China	Zhang, JW (corresponding author), Chinese Acad Med Sci, Key State Lab Med Mol Biol, Dept Biochem & Mol Biol, Inst Basic Med Sci, Beijing 100730, Peoples R China.	junwu_zhang@pumc.edu.cn	Su, Rui/Y-8157-2018	Shen, Chao/0000-0002-9406-7075; Su, Rui/0000-0002-4807-6229	National Natural Science Foundation of China [31171311, 30970616, 81070435]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China grants 31171311 and 30970616 (to J-WZ) and 81070435 (to H-MN).	BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Bisso A, 2013, CELL CYCLE, V12, P1679, DOI 10.4161/cc.24757; Careccia S, 2009, ONCOGENE, V28, P4034, DOI 10.1038/onc.2009.255; Charrad RS, 1999, NAT MED, V5, P669, DOI 10.1038/9518; Chen C, 2012, BRIT J PHARMACOL, V166, P676, DOI 10.1111/j.1476-5381.2011.01785.x; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen G, 2010, ONCOL REP, V23, P997, DOI 10.3892/or_00000725; Cuesta R, 2009, MOL CELL BIOL, V29, P2841, DOI 10.1128/MCB.01971-08; Debernardi S, 2007, LEUKEMIA, V21, P912, DOI 10.1038/sj.leu.2404605; Dick FA, 2003, MOL CELL, V12, P639, DOI 10.1016/S1097-2765(03)00344-7; EGELAND T, 1991, BLOOD, V78, P3192; Feng W, 2010, BRIT J PHARMACOL, V159, P1598, DOI 10.1111/j.1476-5381.2009.00558.x; Fragoso R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002855; Gan XQ, 2012, NAT CELL BIOL, V14, P686, DOI 10.1038/ncb2507; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Guest CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001606; Hampson P, 2005, BLOOD, V106, P1362, DOI 10.1182/blood-2004-10-4117; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Kambhampati S, 2003, J BIOL CHEM, V278, P32544, DOI 10.1074/jbc.M301523200; Kashuba VI, 2004, P NATL ACAD SCI USA, V101, P4906, DOI 10.1073/pnas.0401238101; Ke G, 2013, ONCOGENE, V32, P3019, DOI 10.1038/onc.2012.323; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Lawson ND, 1999, EXP HEMATOL, V27, P1682, DOI 10.1016/S0301-472X(99)00108-3; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li ZJ, 2012, BLOOD, V119, P2314, DOI 10.1182/blood-2011-10-386235; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nitti M, 2010, CELL SIGNAL, V22, P828, DOI 10.1016/j.cellsig.2010.01.007; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Pons A, 2009, LEUKEMIA LYMPHOMA, V50, P1854, DOI 10.3109/10428190903147645; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Schwind S, 2010, J CLIN ONCOL, V28, P5257, DOI 10.1200/JCO.2010.29.2953; Senchenko VN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-75; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Studzinski GP, 2005, J STEROID BIOCHEM, V97, P47, DOI 10.1016/j.jsbmb.2005.06.010; Taylor MA, 2013, J CLIN INVEST, V123, P150, DOI 10.1172/JCI64946; Verploegen S, 2005, BLOOD, V106, P1076, DOI 10.1182/blood-2004-09-3755; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang XS, 2012, BLOOD, V119, P4992, DOI 10.1182/blood-2011-10-385716; Wang XN, 2009, CELL CYCLE, V8, P736, DOI 10.4161/cc.8.5.7870; Yendamuri S, 2009, LEUKEMIA, V23, P1257, DOI 10.1038/leu.2008.382; Zhao KW, 2004, BLOOD, V104, P3731, DOI 10.1182/blood-2004-04-1630; Zheng YS, 2012, ONCOGENE, V31, P80, DOI 10.1038/onc.2011.208	50	118	120	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	25					3226	3239		10.1038/onc.2014.274	http://dx.doi.org/10.1038/onc.2014.274			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK9XH	25174404				2022-12-25	WOS:000356592300002
J	Kauffenstein, G; Pelletier, J; Lavoie, EG; Kukulski, F; Martin-Satue, M; Dufresne, SS; Frenette, J; Furstenau, CR; Sereda, MJ; Toutain, B; Henrion, D; Sullivan, R; Vial, C; Sevigny, J				Kauffenstein, Gilles; Pelletier, Julie; Lavoie, Elise G.; Kukulski, Filip; Martin-Satue, Mireia; Dufresne, Sebastien S.; Frenette, Jerome; Fuerstenau, Cristina Ribas; Sereda, Michal J.; Toutain, Bertrand; Henrion, Daniel; Sullivan, Robert; Vial, Catherine; Sevigny, Jean			Nucleoside Triphosphate Diphosphohydrolase-1 Ectonucleotidase Is Required for Normal Vas Deferens Contraction and Male Fertility through Maintaining P2X1 Receptor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE REPRODUCTIVE-TRACT; SMOOTH-MUSCLE; GUINEA-PIG; P2X(1) RECEPTOR; PURINERGIC NEUROTRANSMISSION; ECTO-ATPASE; CELLS; MOUSE; ACTIVATION; EXPRESSION	In this work, we report that Entpd1(-/-) mice, deficient for the ectonucleotidase nucleoside triphosphate diphosphohydrolase-1 (NTPDase1), produce smaller litters (27% reduction) compared with wild-type C57BL6 animals. This deficit is linked to reduced in vivo oocyte fertilization by Entpd1(-/-) males (61 +/- 11% versus 88 +/- 7% for Entpd1(-/-)). Normal epididymal sperm count, spermatozoa morphology, capacitation, and motility and reduced ejaculated sperm number (2.4 +/- 0.5 versus 3.7 +/- 0.4 million for Entpd1(-/-)) pointed to vas deferens dysfunction. NTPDase1 was localized by immunofluorescence in the tunica muscularis of the vas deferens. Its absence resulted in a major ATP hydrolysis deficiency, as observed in situ by histochemistry and in primary smooth muscle cell cultures. In vitro, Entpd1(-/-) vas deferens displayed an exacerbated contraction to ATP, a diminished response to its non-hydrolysable analog alpha beta MeATP, and a reduced contraction to electrical field stimulation, suggesting altered P2X1 receptor function with a propensity to desensitize. This functional alteration was accompanied by a 3-fold decrease in P2X1 protein expression in Entpd1(-/-) vas deferens with no variation in mRNA levels. Accordingly, exogenous nucleotidase activity was required to fully preserve P2X1 receptor activation by ATP in vitro. Our study demonstrates that NTPDase1 is required to maintain normal P2X1 receptor functionality in the vas deferens and that its absence leads to impaired peristalsis, reduced spermatozoa concentration in the semen, and, eventually, reduced fertility. This suggests that alteration of NTPDase1 activity affects ejaculation efficacy and male fertility. This work may contribute to unveil a cause of infertility and open new therapeutic potentials.	[Kauffenstein, Gilles; Lavoie, Elise G.; Kukulski, Filip; Martin-Satue, Mireia; Fuerstenau, Cristina Ribas; Sevigny, Jean] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1V 0A6, Canada; [Kauffenstein, Gilles; Pelletier, Julie; Lavoie, Elise G.; Kukulski, Filip; Martin-Satue, Mireia; Dufresne, Sebastien S.; Frenette, Jerome; Fuerstenau, Cristina Ribas; Sullivan, Robert; Sevigny, Jean] Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ G1V 4G2, Canada; [Kauffenstein, Gilles; Toutain, Bertrand; Henrion, Daniel] Univ Angers, CNRS, Unite Mixte Rech 6214, INSERM,U1083, F-49045 Angers, France; [Martin-Satue, Mireia] Univ Barcelona, Fac Med, Dept Patol & Terapeut Expt, Barcelona 08907, Spain; [Dufresne, Sebastien S.; Frenette, Jerome] Univ Laval, Fac Med, Dept Readaptat, Quebec City, PQ G1V 0A6, Canada; [Sereda, Michal J.; Vial, Catherine] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Sullivan, Robert] Univ Laval, Fac Med, Dept Obstet Gynecol & Reprod, Quebec City, PQ G1V 0A6, Canada	Laval University; Laval University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; University of Barcelona; Laval University; University of Leicester; Laval University	Kauffenstein, G (corresponding author), CNRS, UMR 6214, INSERM 1083, UFR Sci Med, Rue Haute Reculee, F-49045 Angers, France.	gilles.kauffenstein@gmail.com; Jean.Sevigny@crchul.ulaval.ca	Dufresne, Sebastien S./AAL-7005-2021; Henrion, Daniel/AAK-1995-2021; Henrion, Daniel/J-8141-2015; Kauffenstein, Gilles/K-2867-2015; Sévigny, Jean/AGH-9323-2022; Henrion, Daniel/N-7023-2015; Sevigny, Jean/E-8039-2012; Toutain, Bertrand/M-1982-2015	Dufresne, Sebastien S./0000-0001-5924-7962; Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Kauffenstein, Gilles/0000-0003-4994-8305; Sévigny, Jean/0000-0003-2922-1600; Henrion, Daniel/0000-0003-1094-0285; Sevigny, Jean/0000-0003-2922-1600; Toutain, Bertrand/0000-0002-7571-4062; Frenette, Jerome/0000-0002-4308-9418	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada; CIHR; Canadian Stroke Network; Fonds de Recherche en Sante du Quebec (FRSQ); CAPES (Brazilian Ministry of Education); Fonds de Recherche du Quebec-Sante (FRQS)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Stroke Network; Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); CAPES (Brazilian Ministry of Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fonds de Recherche du Quebec-Sante (FRQS)	This work was supported by Canadian Institutes of Health Research (CIHR) grants (to J. S.).; Recipient of a fellowship from the Heart and Stroke Foundation of Canada in partnership with the CIHR and the Canadian Stroke Network. To whom correspondence may be addressed: UMR CNRS 6214 - INSERM 1083, UFR Sciences Medicales, Rue Haute de Reculee, 49045 Angers cedex, France. Tel.: 33-2-41-73-58-77; Fax: 33-2-41-73-58-95; E-mail: gilles.kauffenstein@gmail.com.; Recipient of a scholarship from the Fonds de Recherche en Sante du Quebec (FRSQ).; Supported by the CIHR.; Recipient of a fellowship for visiting scholars at the Universite Laval sponsored by CAPES (Brazilian Ministry of Education). Present address: Instituto de Genetica e Bioquimica, Universidade Federal de Uberlandia, Campus Patos de Minas, Patos de Minas-MG 38700-152, Brazil.; Recipient of a "Chercheur National" award from the Fonds de Recherche du Quebec-Sante (FRQS). To whom correspondence may be addressed: Centre de Recherche du CHU de Quebec, CHUL, 2705 Blvd. Laurier, Office T1-49, Quebec G1V 4G2, Canada. Tel. 418-525-4444, ext. 46319; Fax: 418-654-2765; E-mail: Jean.Sevigny@crchul.ulaval.ca.	Adeoya-Osiguwa SA, 2002, MOL REPROD DEV, V63, P245, DOI 10.1002/mrd.90009; Banks FCL, 2010, FERTIL STERIL, V93, P1415, DOI 10.1016/j.fertnstert.2009.02.061; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BENHAM CD, 1987, NATURE, V328, P275, DOI 10.1038/328275a0; Brain KL, 2002, J PHYSIOL-LONDON, V541, P849, DOI 10.1113/jphysiol.2002.019612; Braun N, 2000, EUR J NEUROSCI, V12, P4357, DOI 10.1046/j.1460-9568.2000.01342.x; Brownhill VR, 1996, N-S ARCH PHARMACOL, V353, P499; Buell G, 1996, BLOOD, V87, P2659, DOI 10.1182/blood.V87.7.2659.bloodjournal8772659; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Burnstock G, 2010, TRENDS PHARMACOL SCI, V31, P131, DOI 10.1016/j.tips.2009.12.002; Dutton JL, 2000, NEUROPHARMACOLOGY, V39, P2054, DOI 10.1016/S0028-3908(00)00058-7; Edwards SE, 2007, REPROD SCI, V14, P655, DOI 10.1177/1933719107306227; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Ennion SJ, 2001, FEBS LETT, V489, P154, DOI 10.1016/S0014-5793(01)02102-0; Erlinge D, 1998, BIOCHEM BIOPH RES CO, V248, P864, DOI 10.1006/bbrc.1998.9083; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; FRENCH AM, 1983, EXPERIENTIA, V39, P264, DOI 10.1007/BF01955295; Green M. C., 1991, HDB GENETICALLY STAN; Hardy TA, 1999, BRIT J PHARMACOL, V126, P1761, DOI 10.1038/sj.bjp.0702514; HARRIS GS, 1972, EUR J PHARMACOL, V19, P137, DOI 10.1016/0014-2999(72)90091-X; Kauffenstein G, 2010, CARDIOVASC RES, V85, P204, DOI 10.1093/cvr/cvp265; Koziak K, 1999, THROMB HAEMOSTASIS, V82, P1538; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; Kukulski F, 2011, ADV PHARMACOL, V61, P263, DOI 10.1016/B978-0-12-385526-8.00009-6; Lavoie EG, 2011, AM J PHYSIOL-GASTR L, V300, pG608, DOI 10.1152/ajpgi.00207.2010; Martin-Satue M, 2009, HISTOCHEM CELL BIOL, V131, P615, DOI 10.1007/s00418-008-0551-3; Martin-Satue M, 2010, HISTOCHEM CELL BIOL, V133, P659, DOI 10.1007/s00418-010-0704-z; Moon SK, 2001, AM J PHYSIOL-HEART C, V280, pH2779, DOI 10.1152/ajpheart.2001.280.6.H2779; Morrier A, 2002, CAN J ANIM SCI, V82, P347, DOI 10.4141/A01-045; Mulryan K, 2000, NATURE, V403, P86, DOI 10.1038/47495; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; OLDSCLARKE P, 1993, DEV BIOL, V155, P14, DOI 10.1006/dbio.1993.1002; Picher M, 1996, BIOCHEM PHARMACOL, V51, P1453, DOI 10.1016/0006-2952(96)00086-X; Queiroz G, 2003, J NEUROCHEM, V85, P740, DOI 10.1046/j.1471-4159.2003.01715.x; Rettinger J, 2004, J BIOL CHEM, V279, P6426, DOI 10.1074/jbc.M306987200; Robaye B, 1997, EUR J PHARMACOL, V329, P231, DOI 10.1016/S0014-2999(97)89184-4; Rolf MG, 2001, THROMB HAEMOSTASIS, V85, P303, DOI 10.1055/s-0037-1615684; SNEDDON P, 1984, J PHYSIOL-LONDON, V347, P561, DOI 10.1113/jphysiol.1984.sp015083; SNEDDON P, 1984, EUR J PHARMACOL, V100, P85, DOI 10.1016/0014-2999(84)90318-2; STJARNE L, 1984, NEUROSCIENCE, V13, P21, DOI 10.1016/0306-4522(84)90256-2; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Westfall TD, 1996, BRIT J PHARMACOL, V117, P867, DOI 10.1111/j.1476-5381.1996.tb15273.x; White CW, 2013, P NATL ACAD SCI USA, V110, P20825, DOI 10.1073/pnas.1318624110; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yu WQ, 2013, FASEB J, V27, P1895, DOI 10.1096/fj.12-219006	47	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28629	28639		10.1074/jbc.M114.604082	http://dx.doi.org/10.1074/jbc.M114.604082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25160621	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000343765400051
J	Bustamante, DM; De Urioste-Stone, SM; Juarez, JG; Pennington, PM				Bustamante, Dulce M.; De Urioste-Stone, Sandra M.; Juarez, Jose G.; Pennington, Pamela M.			Ecological, Social and Biological Risk Factors for Continued Trypanosoma cruzi Transmission by Triatoma dimidiata in Guatemala	PLOS ONE			English	Article							CHAGAS-DISEASE; SAMPLE-SIZE; LOGISTIC-REGRESSION; VECTOR CONTROL; ENDEMIC AREA; MAIN VECTOR; INFESTATION; BLOOD; DOGS; PREVALENCE	Background: Chagas disease transmission by Triatoma dimidiata persists in Guatemala and elsewhere in Central America under undefined ecological, biological and social (eco-bio-social) conditions. Methodology: Eco-bio-social risk factors associated with persistent domiciliary infestation were identified by a cross-sectional survey and qualitative participatory methods. Quantitative and qualitative data were generated regarding Trypanosoma cruzi reservoirs and triatomine hosts. Blood meal analysis and infection of insects, dogs and rodents were determined. Based on these data, multimodel inference was used to identify risk factors for domestic infestation with the greatest relative importance (>0.75). Principal Findings: Blood meal analysis showed that 64% of 36 bugs fed on chickens, 50% on humans, 17% on dogs; 24% of 34 bugs fed on Rattus rattus and 21% on Mus musculus. Seroprevalence among 80 dogs was 37%. Eight (17%) of 46 M. musculus and three (43%) of seven R. rattus from households with infected triatomines were infected with T. cruzi Distinct Typing Unit I. Results from interviews and participatory meetings indicated that vector control personnel and some householders perceived chickens roosting and laying eggs in the house as bug infestation risk factors. House construction practices were seen as a risk factor for bug and rodent infestation, with rodents being perceived as a pest by study participants. Multimodel inference showed that house infestation risk factors of high relative importance are dog density, mouse presence, interior wall plaster condition, dirt floor, tile roofing and coffee tree presence. Conclusions/Significance: Persistent house infestation is closely related to eco-bio-social factors that maintain productive T. dimidiata habitats associated with dogs, chickens and rodents. Triatomine, dog and rodent infections indicate active T. cruzi transmission. Integrated vector control methods should include actions that consider the role of peridomestic animals in transmission and community members level of knowledge, attitudes and practices associated with the disease and transmission process.	[Bustamante, Dulce M.] San Carlos Univ, Dept Biol, Guatemala City, Guatemala; [De Urioste-Stone, Sandra M.] Univ Maine, Sch Forest Resources, Orono, ME USA; [Juarez, Jose G.; Pennington, Pamela M.] Univ Valle Guatemala, Ctr Hlth Studies, Guatemala City, Guatemala	Universidad de San Carlos de Guatemala; University of Maine System; University of Maine Orono; Universidad del Valle de Guatemala	Pennington, PM (corresponding author), Univ Valle Guatemala, Ctr Hlth Studies, Guatemala City, Guatemala.	pamelap@uvg.edu.gt	Valdez, Jose Juarez/AAW-5841-2020	Valdez, Jose Juarez/0000-0002-0583-478X	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) [A90299]; Canada's International Development Research Centre (IDRC)	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR)(World Health Organization); Canada's International Development Research Centre (IDRC)	This investigation received financial support from the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), grant Number A90299 to PMP, in the context of the TDR/IDRC research initiative Towards Improved Chagas and Dengue Disease Control through Innovative Ecosystem Management and Community-Directed Interventions: An Eco-Bio-Social Research Programme on Chagas and Dengue Disease Control in Latin America and the Caribbean'', supported by Canada's International Development Research Centre (IDRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001207; Aiga H., 2012, American Journal of Tropical Medicine and Hygiene, V86, P972, DOI 10.4269/ajtmh.2012.11-0652; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Beteta H, 2006, MAPAS POBREZA GUATEM, P1; Calcagno V, 2013, R PACKAGE VERSION, V1, P7; Calcagno V, 2010, J STAT SOFTW, V34, P1; Cardinal MV, 2007, ACTA TROP, V103, P201, DOI 10.1016/j.actatropica.2007.06.007; Ceballos LA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001365; Cecere MC, 1997, MED VET ENTOMOL, V11, P383, DOI 10.1111/j.1365-2915.1997.tb00426.x; Chevalier J.M., 2013, PARTICIPATORY ACTION, DOI [10.4324/9780203107386, DOI 10.4324/9780203107386]; CLARK DA, 1982, ECOLOGY, V63, P763, DOI 10.2307/1936797; Core Team R, 2013, R LANG ENV STAT COMP; Creswell J., 2007, DESIGNING CONDUCTING, V3rd Edn; Davis S, 2005, VECTOR-BORNE ZOONOT, V5, P305, DOI 10.1089/vbz.2005.5.305; Demidenko E, 2008, STAT MED, V27, P36, DOI 10.1002/sim.2980; Demidenko E, 2007, STAT MED, V26, P3385, DOI 10.1002/sim.2771; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; Dumonteil E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002466; Erlandson DA, 1993, DOING NATURALISTIC I; Gibbs G.R., 2007, ANAL QUALITATIVE DAT; Green L.W., 2005, HLTH PROGRAM PLANNIN, V4th; Grijalva MJ, 2010, MEM I OSWALDO CRUZ, V105, P677, DOI 10.1590/S0074-02762010000500013; Gurevitz JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001349; Gurtler RE, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000447; Hashimoto K, 2006, AM J TROP MED HYG, V75, P226, DOI 10.4269/ajtmh.2006.75.2.0750226; Hashimoto K, 2012, MEM I OSWALDO CRUZ, V107, P877, DOI 10.1590/S0074-02762012000700007; Healey J.F., 2012, STAT TOOL SOCIAL RES, V9; King RJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001035; Levy MZ, 2008, AM J TROP MED HYG, V79, P528; Lucero DE, 2013, AM J TROP MED HYG, V88, P630, DOI 10.4269/ajtmh.12-0448; Malhotra RK, 2010, INDIAN J OPHTHALMOL, V58, P519, DOI 10.4103/0301-4738.71699; Manne J, 2012, AM J TROP MED HYG, V86, P446, DOI 10.4269/ajtmh.2012.11-0052; Bustamante DM, 2009, CAD SAUDE PUBLICA, V25, pS83, DOI 10.1590/S0102-311X2009001300008; Messenger LA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001584; Monteiro FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070974; Montenegro VM, 2002, MEM I OSWALDO CRUZ, V97, P491, DOI 10.1590/S0074-02762002000400006; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Padgett D.K., 2012, QUALITATIVE MIXED ME, DOI DOI 10.4135/; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Pellecer MJ, 2013, AM J TROP MED HYG, V88, P638, DOI 10.4269/ajtmh.12-0458; Pineda V, 2011, VET PARASITOL, V178, P360, DOI 10.1016/j.vetpar.2010.12.043; Pinto J, 2012, REV INST MED TROP SP, V54, P83, DOI 10.1590/S0036-46652012000200005; Reiczigel J, 2010, EPIDEMIOL INFECT, V138, P1674, DOI 10.1017/S0950268810000385; Rocha FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067463; Rosypal AC, 2011, J PARASITOL, V97, P140, DOI 10.1645/GE-2559.1; Scheaffer R. L., 2012, ELEMENTARY SURVEY SA, V7th; Schwarz A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000532; Sommerfeld J, 2012, PATHOG GLOB HEALTH, V106, P428, DOI 10.1179/2047773212Y.0000000055; Stake R.E., 2010, QUALITATIVE RES STUD; Strauss AL, 1998, BASICS QUALITATIVE R, V2nd; Valenca-Barbosa C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002861; Vazquez-Prokopec GM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001788; Weeks ENI, 2013, B ENTOMOL RES, V103, P634, DOI 10.1017/S000748531300014X; WHO, 2007, WHO REP GLOB PARTN M; WHO, 2005, IMM COV CLUST SURV R; World Health Organization, 2008, ADVOCACY COMMUNICATI; ZELEDON R, 1970, J PARASITOL, V56, P102, DOI 10.2307/3277461; ZELEDON R, 1975, AM J TROP MED HYG, V24, P214, DOI 10.4269/ajtmh.1975.24.214; Zeledon R, 2001, MEM I OSWALDO CRUZ, V96, P659, DOI 10.1590/S0074-02762001000500012; Zuur Alain F., 2009, P1	61	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e104599	10.1371/journal.pone.0104599	http://dx.doi.org/10.1371/journal.pone.0104599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170955	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500020
J	Conceicao, KS; Ulrich, W; Diniz, CAR; Rodrigues, FA; de Andrade, MG				Conceicao, Katiane Silva; Ulrich, Werner; Ribeiro Diniz, Carlos Alberto; Rodrigues, Francisco Aparecido; de Andrade, Marinho Gomes			A Generalized Approach to the Modeling of the Species-Area Relationship	PLOS ONE			English	Article							SELF-SIMILARITY; CURVES; DIVERSITY; SHAPES	This paper proposes a statistical generalized species-area model (GSAM) to represent various patterns of species-area relationship (SAR), which is one of the fundamental patterns in ecology. The approach enables the generalization of many preliminary models, as power-curve model, which is commonly used to mathematically describe the SAR. The GSAM is applied to simulated data set of species diversity in areas of different sizes and a real-world data of insects of Hymenoptera order has been modeled. We show that the GSAM enables the identification of the best statistical model and estimates the number of species according to the area.	[Conceicao, Katiane Silva; Rodrigues, Francisco Aparecido; de Andrade, Marinho Gomes] Univ Sao Paulo, Dept Matemat Aplicada & Estat, Inst Ciencias Matemat & Comp, Sao Carlos, SP, Brazil; [Ulrich, Werner] Nicholas Copernicus Univ, Dept Anim Ecol, Torun, Poland; [Ribeiro Diniz, Carlos Alberto] Univ Fed Sao Carlos, Dept Stat, BR-13560 Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Nicolaus Copernicus University; Universidade Federal de Sao Carlos	de Andrade, MG (corresponding author), Univ Sao Paulo, Dept Matemat Aplicada & Estat, Inst Ciencias Matemat & Comp, Sao Carlos, SP, Brazil.	marinho@icmc.usp.br	Andrade, Marinho G./F-2245-2011; Diniz, Carlos Alberto Ribeiro/E-3089-2012; Rodrigues, Francisco A./E-4418-2011	Rodrigues, Francisco A./0000-0002-0145-5571; Ribeiro Diniz, Carlos alberto/0000-0003-3464-1108; Ulrich, Werner/0000-0002-8715-6619	FAPESP [2008/10613-1, 2013/26416-9, 2014/15860-8]; CNPq [305940/2010-4]; NAP eScience - PRP - USP	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NAP eScience - PRP - USP	K. S. Conceicao would like to acknowledge FAPESP (grant # 2008/10613-1). F. A. Rodrigues would like to thank CNPq (grant # 305940/2010-4), Fapesp (grant # 2013/26416-9) and NAP eScience - PRP - USP for financial support. The authors also thank Fapesp (grant # 2014/15860-8) for funding the publication of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Burnham K. P., 1998, MODEL SELECTION INFE; Chiarucci A, 2006, OIKOS, V115, P475, DOI 10.1111/j.2006.0030-1299.15116.x; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Cordeiro GM, 2009, J STAT PLAN INFER, V139, P2970, DOI 10.1016/j.jspi.2009.02.002; Dengler J, 2009, J BIOGEOGR, V36, P728, DOI 10.1111/j.1365-2699.2008.02038.x; Dobson A. J., 2010, INTRO GEN LINEAR MOD, V2nd; GITAY H, 1991, J VEG SCI, V2, P113, DOI 10.2307/3235903; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; Guilhaumon F, 2010, ECOGRAPHY, V33, P420, DOI 10.1111/j.1600-0587.2010.06304.x; Hubbell Stephen P., 2001, V32, pi; Kallimanis AS, 2008, GLOBAL ECOL BIOGEOGR, V17, P532, DOI 10.1111/j.1466-8238.2008.00393.x; LaSalle J., 1991, Redia, V74, P315; MAC ARTHUR ROBERT H., 1967; Mood Alexander McFarlane, 1950, INTRO THEORY STAT, P1; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; Tjorve E, 2003, J BIOGEOGR, V30, P827, DOI 10.1046/j.1365-2699.2003.00877.x; Tjorve E, 2009, J BIOGEOGR, V36, P1435, DOI 10.1111/j.1365-2699.2009.02101.x; Tjorve E, 2008, ECOLOGY, V89, P3528, DOI 10.1890/07-1685.1; Ulrich W, 2004, BASIC APPL ECOL, V5, P231, DOI 10.1016/j.baae.2004.04.002; Ulrich W, 2003, BASIC APPL ECOL, V4, P263, DOI 10.1078/1439-1791-00139; Ulrich W, 2001, SCHRIFTENR FORSCHZ A, V171, p249 S; Wurtz P, 2008, J BIOPHYSICS, V2008; Zillio T, 2007, OIKOS, V116, P931, DOI 10.1111/j.2007.0030-1299.15662.x	27	1	1	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105132	10.1371/journal.pone.0105132	http://dx.doi.org/10.1371/journal.pone.0105132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171161	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500031
J	Gopalakrishnan, RC; Karunakaran, M				Gopalakrishnan, Ravichandran C.; Karunakaran, Manivannan			Dynamic Quality of Service Model for Improving Performance of Multimedia Real-Time Transmission in Industrial Networks	PLOS ONE			English	Article							ETHERNET; COMMUNICATION	Nowadays, quality of service (QoS) is very popular in various research areas like distributed systems, multimedia real-time applications and networking. The requirements of these systems are to satisfy reliability, uptime, security constraints and throughput as well as application specific requirements. The real-time multimedia applications are commonly distributed over the network and meet various time constraints across networks without creating any intervention over control flows. In particular, video compressors make variable bit-rate streams that mismatch the constant-bit-rate channels typically provided by classical real-time protocols, severely reducing the efficiency of network utilization. Thus, it is necessary to enlarge the communication bandwidth to transfer the compressed multimedia streams using Flexible Time Triggered-Enhanced Switched Ethernet (FTT-ESE) protocol. FTT-ESE provides automation to calculate the compression level and change the bandwidth of the stream. This paper focuses on low-latency multimedia transmission over Ethernet with dynamic quality-of-service (QoS) management. This proposed framework deals with a dynamic QoS for multimedia transmission over Ethernet with FTT-ESE protocol. This paper also presents distinct QoS metrics based both on the image quality and network features. Some experiments with recorded and live video streams show the advantages of the proposed framework. To validate the solution we have designed and implemented a simulator based on the Matlab/Simulink, which is a tool to evaluate different network architecture using Simulink blocks.	[Gopalakrishnan, Ravichandran C.] SCAD Inst Technol, Tiruppur, Tamil Nadu, India; [Karunakaran, Manivannan] PSNA Coll Engn & Technol, Dept Comp Sci & Engn, Dindigul, Tamil Nadu, India	PSNA College of Engineering & Technology	Karunakaran, M (corresponding author), PSNA Coll Engn & Technol, Dept Comp Sci & Engn, Dindigul, Tamil Nadu, India.	manivannancse@hotmail.com	K, Manivannan/AAR-5137-2020	K, Manivannan/0000-0002-6080-7581				AlSbou Yazeed A, 2013, INT J QOS ISSUES NET, V1; Bouras C, 2003, INT J COMMUN SYST, V16, P225, DOI 10.1002/dac.585; Cho CS, 2005, IEEE T IND ELECTRON, V52, P1073, DOI 10.1109/TIE.2005.851648; Decotignie JD, 2005, P IEEE, V93, P1102, DOI 10.1109/JPROC.2005.849721; Decotignie JD, 2009, IEEE IND ELECTRON M, V3, P8, DOI 10.1109/MIE.2009.932171; Hwang CL, 2009, IEEE T IND ELECTRON, V56, P846, DOI 10.1109/TIE.2008.2004388; Jasperneite J, 2009, IEEE T IND INFORM, V5, P75, DOI 10.1109/TII.2009.2017259; Kumar A, 2008, IEEE T IND ELECTRON, V55, P348, DOI 10.1109/TIE.1930.896476; Mammeri S, 2012, INT ARAB J INFORM TE, V5; Manivannan K., 2014, INT REV COMPUT SOFTW, V9, P396; Marau R, 2007, IEEE INT C EMERG, P1481; Mittal A, 2012, SIGNAL IMAGE VIDEO P; Molinero FG, 2007, P 19 EUR REAL TIM SY; Pedreiras P., 2003, Proceedings International Parallel and Distributed Processing Symposium, DOI 10.1109/IPDPS.2003.1213243; Pedreiras P, 2005, IEEE T IND INFORM, V1, P162, DOI 10.1109/TII.2005.852068; Silvestre J, 2004, WFCS 2004: IEEE INTERNATIONAL WORKSHOP ON FACTORY COMMUNICATION SYSTEMS, PROCEEDINGS, P343; Skeie T, 2006, IEEE T IND INFORM, V2, P25, DOI 10.1109/TII.2006.869934; Tsai JC, 2005, IEEE T CIRC SYST VID, V15, P133, DOI 10.1109/TCSVT.2004.837015; Vadakkepat P, 2008, IEEE T IND ELECTRON, V55, P1385, DOI 10.1109/TIE.2007.903993; Wang Z, 2004, SIGNAL PROCESS-IMAGE, V19, P121, DOI 10.1016/S0923-5965(03)00076-6; Xie WF, 2009, IEEE T IND ELECTRON, V56, P520, DOI 10.1109/TIE.2008.2003217; Yu T, 2004, CEC 2004: IEEE INTERNATIONAL CONFERENCE ON E-COMMERCE TECHNOLOGY, PROCEEDINGS, P129	22	0	0	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105885	10.1371/journal.pone.0105885	http://dx.doi.org/10.1371/journal.pone.0105885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170768	gold, Green Submitted, Green Published			2022-12-25	WOS:000341127500080
J	Jacob, H; Bruck, C; Plewnia, C; Wildgruber, D				Jacob, Heike; Brueck, Carolin; Plewnia, Christian; Wildgruber, Dirk			Cerebral Processing of Prosodic Emotional Signals: Evaluation of a Network Model Using rTMS	PLOS ONE			English	Article							FUNCTIONAL-ANATOMIC ORGANIZATION; STRUCTURAL CONNECTIONS; VOICE; AREAS; METAANALYSIS; PERCEPTION; LANGUAGE; LESION; CORTEX; FACE	A great number of functional imaging studies contributed to developing a cerebral network model illustrating the processing of prosody in the brain. According to this model, the processing of prosodic emotional signals is divided into three main steps, each related to different brain areas. The present study sought to evaluate parts of the aforementioned model by using low-frequency repetitive transcranial magnetic stimulation (rTMS) over two important brain regions identified by the model: the superior temporal cortex (Experiment 1) and the inferior frontal cortex (Experiment 2). The aim of both experiments was to reduce cortical activity in the respective brain areas and evaluate whether these reductions lead to measurable behavioral effects during prosody processing. However, results obtained in this study revealed no rTMS effects on the acquired behavioral data. Possible explanations for these findings are discussed in the paper.	[Jacob, Heike; Brueck, Carolin; Plewnia, Christian; Wildgruber, Dirk] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Jacob, Heike] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Jacob, H (corresponding author), Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany.	HeikeJacob@gmx.de	Plewnia, Christian/D-1652-2015	Plewnia, Christian/0000-0003-3852-9906	Werner Reichardt Centre for Integrative Neuroscience at the Eberhard Karls University of Tubingen [CIN 2011-17, CIN 2012-04, CIN 2011-11]; Deutsche Forschungsgemeinschaft (DFG) [EXC 307]	Werner Reichardt Centre for Integrative Neuroscience at the Eberhard Karls University of Tubingen; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Werner Reichardt Centre for Integrative Neuroscience (CIN 2011-17, CIN 2012-04, CIN 2011-11) at the Eberhard Karls University of Tubingen. The CIN is an Excellence Cluster funded by the Deutsche Forschungsgemeinschaft (DFG) within the framework of the Excellence Initiative (EXC 307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackenheil M., 1999, MINI MINI INT NEUROP; Alba-Ferrara L, 2012, BRAIN STIMUL, V5, P347, DOI 10.1016/j.brs.2011.06.004; Andoh J, 2008, EUR PSYCHIAT, V23, P281, DOI 10.1016/j.eurpsy.2007.10.012; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Bestelmeyer PEG, 2011, CURR BIOL, V21, pR838, DOI 10.1016/j.cub.2011.08.046; Bolognini N, 2010, J NEUROSCI, V30, P9647, DOI 10.1523/JNEUROSCI.1990-10.2010; Borod Joan C, 2002, Appl Neuropsychol, V9, P23, DOI 10.1207/S15324826AN0901_4; Bruck C, 2011, PHYS LIFE REV, V8, P383, DOI 10.1016/j.plrev.2011.10.002; Ethofer T, 2006, NEUROIMAGE, V30, P580, DOI 10.1016/j.neuroimage.2005.09.059; Ethofer T, 2013, NEUROIMAGE, V76, P45, DOI 10.1016/j.neuroimage.2013.02.064; Ethofer T, 2012, CEREB CORTEX, V22, P191, DOI 10.1093/cercor/bhr113; Ethofer T, 2009, J COGNITIVE NEUROSCI, V21, P1255, DOI 10.1162/jocn.2009.21099; GEISSER S, 1958, ANN MATH STAT, V29, P885, DOI 10.1214/aoms/1177706545; Hartwigsen G, 2013, P NATL ACAD SCI USA, V110, P16402, DOI 10.1073/pnas.1310190110; HEILMAN KM, 1984, NEUROLOGY, V34, P917, DOI 10.1212/WNL.34.7.917; Hoekert M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-93; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Plewnia C, 2003, NEUROREPORT, V14, P609, DOI 10.1097/00001756-200303240-00017; ROSS ED, 1981, ARCH NEUROL-CHICAGO, V38, P561, DOI 10.1001/archneur.1981.00510090055006; Ross ED, 2008, BRAIN LANG, V104, P51, DOI 10.1016/j.bandl.2007.04.007; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; STARKSTEIN SE, 1994, NEUROLOGY, V44, P515, DOI 10.1212/WNL.44.3_Part_1.515; van Rijn S, 2005, EUR J NEUROSCI, V21, P3195, DOI 10.1111/j.1460-9568.2005.04130.x; Varnava A, 2011, J NEUROSCI METH, V201, P327, DOI 10.1016/j.jneumeth.2011.08.016; Wildgruber D, 2006, PROG BRAIN RES, V156, P249, DOI 10.1016/S0079-6123(06)56013-3; Wildgruber D, 2004, CEREB CORTEX, V14, P1384, DOI 10.1093/cercor/bhh099; Wildgruber D., 2009, INT J SPEECH-LANG PA, V11, P277, DOI [10.1080/17549500902943043, DOI 10.1080/17549500902943043]; Witteman J, 2012, NEUROPSYCHOLOGIA, V50, P2752, DOI 10.1016/j.neuropsychologia.2012.07.026; Witteman J, 2011, NEUROPSYCHOLOGIA, V49, P3722, DOI 10.1016/j.neuropsychologia.2011.09.028	32	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105509	10.1371/journal.pone.0105509	http://dx.doi.org/10.1371/journal.pone.0105509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171220	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500054
J	Tan, LK; Ooi, PT; Carniel, E; Thong, KL				Tan, Lai Kuan; Ooi, Peck Toung; Carniel, Elisabeth; Thong, Kwai Lin			Evaluation of a Modified Cefsulodin-Irgasan-Novobiocin Agar for Isolation of Yersinia spp.	PLOS ONE			English	Article							CHROMOGENIC AGAR; ENTEROCOLITICA; PSEUDOTUBERCULOSIS; SURVEILLANCE; PREVALENCE; RECOVERY; STATES; PLATE; PIGS	Y. enterocolitica and Y. pseudotuberculosis are important food borne pathogens. However, the presence of competitive microbiota makes the isolation of Y. enterocolitica and Y. pseudotuberculosis from naturally contaminated foods difficult. We attempted to evaluate the performance of a modified Cefsulodin-Irgasan-Novobiocin (CIN) agar in the differentiation of Y. enterocolitica from non-Yersinia species, particularly the natural intestinal microbiota. The modified CIN enabled the growth of Y. enterocolitica colonies with the same efficiency as CIN and Luria-Bertani agar. The detection limits of the modified CIN for Y. enterocolitica in culture medium (10 cfu/ml) and in artificially contaminated pork (10(4) cfu/ml) were also comparable to those of CIN. However, the modified CIN provided a better discrimination of Yersinia colonies from other bacteria exhibiting Yersinia-like colonies on CIN (H2S-producing Citrobacter freundii, C. braakii, Enterobacter cloacae, Aeromonas hydrophila, Providencia rettgeri, and Morganella morganii). The modified CIN exhibited a higher recovery rate of Y. enterocolitica from artificially prepared bacterial cultures and naturally contaminated samples compared with CIN. Our results thus demonstrated that the use of modified CIN may be a valuable means to increase the recovery rate of food borne Yersinia from natural samples, which are usually contaminated by multiple types of bacteria.	[Tan, Lai Kuan; Thong, Kwai Lin] Univ Malaya, Fac Sci, Inst Biol Sci, Div Microbiol, Kuala Lumpur, Malaysia; [Ooi, Peck Toung] Univ Putra Malaysia, Fac Vet Med, Dept Clin Vet Studies, Serdang 43400, Malaysia; [Carniel, Elisabeth] Inst Pasteur, Natl Reference Lab, Yersinia Res Unit, Paris, France; [Carniel, Elisabeth] Inst Pasteur, WHO Collaborating Ctr Yersinia, Paris, France	Universiti Malaya; Universiti Putra Malaysia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Thong, KL (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Div Microbiol, Kuala Lumpur, Malaysia.	thongkl@um.edu.my	Ooi, Peck Toung/E-7365-2017; Thong, Kwai Lin/B-3946-2009; Thong, Kwai-Lin/Q-2458-2019; Tan, Lai Kuan/C-2630-2012	Ooi, Peck Toung/0000-0002-1174-0288; Thong, Kwai-Lin/0000-0001-8557-5185; Tan, Lai Kuan/0000-0002-9279-4455	University of Malaya High-Impact Research Grant [UM.C/625/1/HIR/MOHE/02]; University of Malaya Postgraduate Research Fund [PS316/2010B]; MOSTI [GA013-2013]; 'Institut de Veille Sanitaire' (InVS) of France; University of Malaya	University of Malaya High-Impact Research Grant; University of Malaya Postgraduate Research Fund(Universiti Malaya); MOSTI(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); 'Institut de Veille Sanitaire' (InVS) of France; University of Malaya(Universiti Malaya)	This work was financially supported by the University of Malaya High-Impact Research Grant (reference UM.C/625/1/HIR/MOHE/02), University of Malaya Postgraduate Research Fund (PS316/2010B), MOSTI (GA013-2013), and partly by the 'Institut de Veille Sanitaire' (InVS) of France. LKT was supported by a fellowship from University of Malaya. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULISIO CCG, 1980, APPL ENVIRON MICROB, V39, P135, DOI 10.1128/AEM.39.1.135-140.1980; Bergey DH, 1948, BERGEYS MANUAL DETER; Blom M, 1999, J CLIN MICROBIOL, V37, P2312, DOI 10.1128/JCM.37.7.2312-2316.1999; CDC, 2014, FOODB DIS ACT SURV N; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V1st, DOI [10.1017/cbo9780511543470, DOI 10.1017/CBO9780511543470]; Denis M, 2011, J PATHOG, V2011, DOI 10.4061/2011/296275; Denys GA, 2013, J CLIN MICROBIOL, V51, P202, DOI 10.1128/JCM.02022-12; EFSA ( European Food Safety Authority), 2007, EFSA J, V595, P130; Fondrevez M, 2010, J MICROBIOL METH, V83, P244, DOI 10.1016/j.mimet.2010.09.012; FUKUSHIMA H, 1985, APPL ENVIRON MICROB, V50, P710, DOI 10.1128/AEM.50.3.710-712.1985; FUKUSHIMA H, 1987, J CLIN MICROBIOL, V25, P1068, DOI 10.1128/JCM.25.6.1068-1073.1987; FUKUSHIMA H, 1986, APPL ENVIRON MICROB, V51, P990, DOI 10.1128/AEM.51.5.990-994.1986; Gould LH, 2013, MMWR SURVEILL SUMM, V62, P1; HEAD CB, 1982, J CLIN MICROBIOL, V16, P615, DOI 10.1128/JCM.16.4.615-621.1982; Health Canada, 2011, COMP AN METH; Hudson JA, 2008, INT J FOOD MICROBIOL, V123, P25, DOI 10.1016/j.ijfoodmicro.2007.11.069; Johnson JA, 1998, J HEALTHC MANAG, V43, P1; Liang JR, 2012, APPL ENVIRON MICROB, V78, P2949, DOI 10.1128/AEM.07893-11; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Renaud N, 2013, J CLIN MICROBIOL, V51, P1184, DOI 10.1128/JCM.02903-12; Savin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041176; SCHIEMANN DA, 1979, CAN J MICROBIOL, V25, P1298, DOI 10.1139/m79-205; SCHIEMANN DA, 1984, APPL ENVIRON MICROB, V48, P539, DOI 10.1128/AEM.48.3.539-544.1984; Stilinovic B, 2009, ACTA BOT CROAT, V68, P57; Tan LK, 2014, FOOD CONTROL, V35, P94, DOI 10.1016/j.foodcont.2013.06.053; Van Damme I, 2013, FOOD MICROBIOL, V36, P170, DOI 10.1016/j.fm.2013.05.007; Vishnubhatla A, 2001, J FOOD PROTECT, V64, P355, DOI 10.4315/0362-028X-64.3.355; Vlachaki E, 2007, NETH J MED, V65, P311; Wang X, 2009, EUR J CLIN MICROBIOL, V28, P1237, DOI 10.1007/s10096-009-0773-x; Wannet WJB, 2001, J CLIN MICROBIOL, V39, P4483, DOI 10.1128/JCM.39.12.4483-4486.2001; Wauters G, 1987, Contrib Microbiol Immunol, V9, P14; WEAGANT SD, 2001, BACTERIOLOGICAL ANAL; Weagant SD, 2008, J MICROBIOL METH, V72, P185, DOI 10.1016/j.mimet.2007.11.019; Zheng XB, 1996, J APPL BACTERIOL, V81, P681	34	12	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106329	10.1371/journal.pone.0106329	http://dx.doi.org/10.1371/journal.pone.0106329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170941	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500150
J	Godreuil, S; Leban, N; Padilla, A; Hamel, R; Luplertlop, N; Chauffour, A; Vittecoq, M; Hoh, F; Thomas, F; Sougakoff, W; Lionne, C; Yssel, H; Misse, D				Godreuil, Sylvain; Leban, Nadia; Padilla, Andre; Hamel, Rodolphe; Luplertlop, Natthanej; Chauffour, Aurelie; Vittecoq, Marion; Hoh, Francois; Thomas, Frederic; Sougakoff, Wladimir; Lionne, Corinne; Yssel, Hans; Misse, Dorothee			Aedesin: Structure and Antimicrobial Activity against Multidrug Resistant Bacterial Strains	PLOS ONE			English	Article							IMMUNE-RESPONSE; PEPTIDES; ANTIBACTERIAL; INFECTIONS; LIPOPHOSPHOGLYCAN; EXPRESSION; DROSOPHILA; MEMBRANE; CECROPIN; NMR	Multidrug resistance, which is acquired by both Gram-positive and Gram-negative bacteria, causes infections that are associated with significant morbidity and mortality in many clinical settings around the world. Because of the rapidly increasing incidence of pathogens that have become resistant to all or nearly all available antibiotics, there is a need for a new generation of antimicrobials with a broad therapeutic range for specific applications against infections. Aedesin is a cecropin-like anti-microbial peptide that was recently isolated from dengue virus-infected salivary glands of the Aedes aegypti mosquito. In the present study, we have refined the analysis of its structural characteristics and have determined its antimicrobial effects against a large panel of multidrug resistant bacterial strains, directly isolated from infected patients. Based the results from nuclear magnetic resonance spectroscopy analysis, Aedesin has a helix-bend-helix structure typical for a member of the family of a-helix anti-microbial peptides. Aedesin efficiently killed Gram-negative bacterial strains that display the most worrisome resistance mechanisms encountered in the clinic, including resistance to carbapenems, aminoglycosides, cephalosporins, 4th generation fluoroquinolones, folate inhibitors and monobactams. In contrast, Gram-positive strains were insensitive to the lytic effects of the peptide. The anti-bacterial activity of Aedesin was found to be salt-resistant, indicating that it is active under physiological conditions encountered in body fluids characterized by ionic salt concentrations. In conclusion, because of its strong lytic activity against multidrug resistant Gram-negative bacterial strains displaying all types of clinically relevant resistance mechanisms known today, Aedesin might be an interesting candidate for the development of alternative treatment for infections caused by these types of bacteria.	[Godreuil, Sylvain] Ctr Hosp Reg Univ Montpellier, Hop Arnaud Villeneuve, Dept Bacteriol Virol, Montpellier, France; [Leban, Nadia; Lionne, Corinne] CNRS UMR 5236 UM1 UM2, Ctr Etud Agents Pathogenes & Biotechnol Sante, Montpellier, France; [Padilla, Andre; Hoh, Francois] CNRS UMR5048, Inserm U1054, Ctr Biochim Struct, Montpellier, France; [Hamel, Rodolphe; Thomas, Frederic; Misse, Dorothee] UMR 224 IRD CNRS UM1, Lab MIVEGEC, Montpellier, France; [Luplertlop, Natthanej] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Chauffour, Aurelie; Sougakoff, Wladimir; Yssel, Hans] Univ Paris 04, Hop La Pitie Salpetriere, AP HP, Ctr Immunol & Malad Infect,Inserm U1135,UPMC, Paris, France; [Vittecoq, Marion] Ctr Rech Tour Valat, Arles, France	Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Mahidol University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Misse, D (corresponding author), UMR 224 IRD CNRS UM1, Lab MIVEGEC, Montpellier, France.	dorothee.misse@ird.fr	Hamel, Rodolphe/AAG-1714-2020; SOUGAKOFF, Wladimir/O-9754-2017; LIONNE, Corinne/AFV-1826-2022; Yssel, Hans/C-6406-2009; CHAUFFOUR, Aurélie/AAI-2326-2021; MISSE, DOROTHEE/A-7590-2012; Yssel, Hans/AFV-2907-2022	Hamel, Rodolphe/0000-0001-8603-7039; SOUGAKOFF, Wladimir/0000-0002-2447-517X; LIONNE, Corinne/0000-0002-6348-5311; Yssel, Hans/0000-0001-7454-1836; CHAUFFOUR, Aurélie/0000-0002-8846-5069; MISSE, DOROTHEE/0000-0002-6485-3841; Yssel, Hans/0000-0001-7454-1836; PADILLA, ANDRE/0000-0001-9702-4612; THOMAS, Frederic/0000-0003-2238-1978; hoh, francois/0000-0002-2905-7081; godreuil, sylvain/0000-0003-3436-0082	French Research Agency Agence Nationale de la Recherche [ANR-12-BSV3-0004-01]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Infectiopole Sud foundation	French Research Agency Agence Nationale de la Recherche(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI); Infectiopole Sud foundation	This work was supported by grants from the French Research Agency Agence Nationale de la Recherche (ANR-12-BSV3-0004-01) and the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01. Nadia Leban was supported by a fellowship of the Infectiopole Sud foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cole AM, 2000, ANTIMICROB AGENTS CH, V44, P2039, DOI 10.1128/AAC.44.8.2039-2045.2000; Cole N, 2010, INVEST OPHTH VIS SCI, V51, P390, DOI 10.1167/iovs.09-4068; Diene SM, 2013, EXPERT REV ANTI-INFE, V11, P277, DOI [10.1586/ERI.13.1, 10.1586/eri.13.1]; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; HULTMARK D, 1980, EUR J BIOCHEM, V106, P7, DOI 10.1111/j.1432-1033.1980.tb05991.x; Kim JK, 2011, J BIOL CHEM, V286, P41296, DOI 10.1074/jbc.M111.269225; Knappe D, 2010, ANTIMICROB AGENTS CH, V54, P4003, DOI 10.1128/AAC.00300-10; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee E, 2013, BMB REP, V46, P282, DOI 10.5483/BMBRep.2013.46.5.252; Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; MCCONVILLE MJ, 1990, MOL BIOCHEM PARASIT, V38, P57, DOI 10.1016/0166-6851(90)90205-Z; Moore AJ, 1996, J ANTIMICROB CHEMOTH, V37, P1077, DOI 10.1093/jac/37.6.1077; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Nigam A, 2014, MICROBIOL RES; ORLANDI PA, 1987, J BIOL CHEM, V262, P10384; Park SC, 2011, INT J MOL SCI, V12, P5971, DOI 10.3390/ijms12095971; PIERS KL, 1994, ANTIMICROB AGENTS CH, V38, P2311, DOI 10.1128/AAC.38.10.2311; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; Silvestro L, 2000, ANTIMICROB AGENTS CH, V44, P602, DOI 10.1128/AAC.44.3.602-607.2000; Toke O, 2005, BIOPOLYMERS, V80, P717, DOI 10.1002/bip.20286; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; YAO H, 1992, BIOPHYS J, V61, P683, DOI 10.1016/S0006-3495(92)81873-8; Zikou S, 2007, J PEPT SCI, V13, P481, DOI 10.1002/psc.876	34	12	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105441	10.1371/journal.pone.0105441	http://dx.doi.org/10.1371/journal.pone.0105441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162372	gold, Green Published, Green Submitted			2022-12-25	WOS:000340880900036
J	Lazarus, ED; McGill, BJ				Lazarus, Eli D.; McGill, Brian J.			Pushing the Pace of Tree Species Migration	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; EASTERN UNITED-STATES; CLIMATE-CHANGE; HABITAT FRAGMENTATION; PLANT MIGRATION; NORTH-AMERICA; RANGE SHIFTS; CONSERVATION; MODEL; RATES	Plants and animals have responded to past climate changes by migrating with habitable environments, sometimes shifting the boundaries of their geographic ranges by tens of kilometers per year or more. Species migrating in response to present climate conditions, however, must contend with landscapes fragmented by anthropogenic disturbance. We consider this problem in the context of wind-dispersed tree species. Mechanisms of long-distance seed dispersal make these species capable of rapid migration rates. Models of species-front migration suggest that even tree species with the capacity for long-distance dispersal will be unable to keep pace with future spatial changes in temperature gradients, exclusive of habitat fragmentation effects. Here we present a numerical model that captures the salient dynamics of migration by long-distance dispersal for a generic tree species. We then use the model to explore the possible effects of assisted colonization within a fragmented landscape under a simulated tree-planting scheme. Our results suggest that an assisted-colonization program could accelerate species-front migration rates enough to match the speed of climate change, but such a program would involve an environmental-sustainability intervention at a massive scale.	[Lazarus, Eli D.] Cardiff Univ, Environm Dynam Lab Earth, Earth Surface Proc Grp, Sch Earth & Ocean Sci, Cardiff CF10 3AX, S Glam, Wales; [McGill, Brian J.] Univ Maine, Sch Biol & Ecol, Orono, ME USA	Cardiff University; University of Maine System; University of Maine Orono	Lazarus, ED (corresponding author), Cardiff Univ, Environm Dynam Lab Earth, Earth Surface Proc Grp, Sch Earth & Ocean Sci, Cardiff CF10 3AX, S Glam, Wales.	LazarusED@cf.ac.uk	McGill, Brian J/A-3476-2008; Lazarus, Eli/J-8221-2013	McGill, Brian J/0000-0002-0850-1913; Lazarus, Eli/0000-0003-2404-9661	U.S. National Science Foundation [EPS-0904155]	U.S. National Science Foundation(National Science Foundation (NSF))	This research was supported by the U.S. National Science Foundation award EPS-0904155. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alston KP, 2006, BIOL CONSERV, V132, P183, DOI 10.1016/j.biocon.2006.03.023; Carey PD, 1996, GLOBAL ECOL BIOGEOGR, V5, P217, DOI 10.2307/2997790; CLARK DA, 1984, AM NAT, V124, P769, DOI 10.1086/284316; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Collingham YC, 2000, ECOL APPL, V10, P131, DOI 10.1890/1051-0761(2000)010[0131:IOHFAP]2.0.CO;2; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Earn DJD, 2000, SCIENCE, V290, P1360, DOI 10.1126/science.290.5495.1360; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hastings HM, 1993, FRACTALS USERS GUIDE; Higgins SI, 2003, J ECOL, V91, P341, DOI 10.1046/j.1365-2745.2003.00781.x; Higgins SI, 1999, AM NAT, V153, P464, DOI 10.1086/303193; Hill MF, 1999, ECOL LETT, V2, P121, DOI 10.1046/j.1461-0248.1999.22061.x; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Huntley B., 1983, An atlas of past and present pollen maps of Europe: 0-13 000 years ago.; IPCC, 2007, CONTRIBUTION WORKING; Iverson LR, 1999, ECOL MODEL, V115, P77, DOI 10.1016/S0304-3800(98)00200-2; Iverson LR, 2004, GLOBAL ECOL BIOGEOGR, V13, P209, DOI 10.1111/j.1466-822X.2004.00093.x; Jackson ST, 1999, P NATL ACAD SCI USA, V96, P13847, DOI 10.1073/pnas.96.24.13847; Johst K, 2002, OIKOS, V98, P263, DOI 10.1034/j.1600-0706.2002.980208.x; Latham R.E., 1993, SPECIES DIVERSITY EC; Lloyd KM, 2000, J VEG SCI, V11, P903, DOI 10.2307/3236560; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lyons SK, 2003, J MAMMAL, V84, P385, DOI 10.1644/1545-1542(2003)084<0385:AQAOTR>2.0.CO;2; McGill BJ, 2005, P NATL ACAD SCI USA, V102, P16701, DOI 10.1073/pnas.0504225102; McInerny G, 2007, ECOL INFORM, V2, P1, DOI 10.1016/j.ecoinf.2006.12.001; Morin X, 2008, J ECOL, V96, P784, DOI 10.1111/j.1365-2745.2008.01369.x; Murray AB, 2007, GEOMORPHOLOGY, V90, P178, DOI 10.1016/j.geomorph.2006.10.020; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; NEILSON RP, 1993, ECOL APPL, V3, P385, DOI 10.2307/1941907; Paola C, 2009, EARTH-SCI REV, V97, P1, DOI 10.1016/j.earscirev.2009.05.003; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PASTOR J, 1988, NATURE, V334, P55, DOI 10.1038/334055a0; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Pearson RG, 2005, BIOL CONSERV, V123, P389, DOI 10.1016/j.biocon.2004.12.006; Popescu SC, 2003, CAN J REMOTE SENS, V29, P564, DOI 10.5589/m03-027; Rayner S, 2010, CLIM POLICY, V10, P615, DOI 10.3763/cpol.2010.0138; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; SCHWARTZ MW, 1993, BIODIVERS CONSERV, V2, P51, DOI 10.1007/BF00055102; SIMBERLOFF D, 1992, CONSERV BIOL, V6, P493, DOI 10.1046/j.1523-1739.1992.06040493.x; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Vitt P, 2010, BIOL CONSERV, V143, P18, DOI 10.1016/j.biocon.2009.08.015; Wilbanks TJ, 1999, CLIMATIC CHANGE, V43, P601, DOI 10.1023/A:1005418924748; Williams JW, 2004, ECOL MONOGR, V74, P309, DOI 10.1890/02-4045; ZIFF RM, 1986, J PHYS A-MATH GEN, V19, pL1169, DOI 10.1088/0305-4470/19/18/010	46	15	15	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105380	10.1371/journal.pone.0105380	http://dx.doi.org/10.1371/journal.pone.0105380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162663	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000340880900033
J	Ning, HX; Lei, HE; Xu, YD; Guan, RL; Venstrom, JM; Lin, GT; Lue, TF; Xin, ZC; Lin, CS				Ning, Hongxiu; Lei, Hong-En; Xu, Yong-De; Guan, Rui-Li; Venstrom, Jeffrey M.; Lin, Guiting; Lue, Tom F.; Xin, Zhongcheng; Lin, Ching-Shwun			Conversion of Adipose-Derived Stem Cells into Natural Killer-Like Cells with Anti-Tumor Activities in Nude Mice	PLOS ONE			English	Article							BLOOD CD34(+) CELLS; HEMATOPOIETIC STEM; STROMAL CELLS; NK CELLS; TISSUE; IDENTIFICATION; IMMUNOTHERAPY; GENERATION; THERAPY; INNATE	Efforts to develop peripheral blood-derived nature killer (NK) cells into therapeutic products have been hampered by these cells' low abundance and histoincompatibility. On the other hand, derivation of NK-like cells from more abundant cell sources such as embryonic stem cells (ESCs) and umbilical cord blood (UCB) requires the selection of rare CD34+ cells. Thus, we sought to convert adipose-derived stem cells (ADSCs), which are abundant and natively CD34+, into NK-like cells. When grown in hematopoietic induction medium, ADSCs formed sphere clusters and expressed hematopoietic markers CD34, CD45, and KDR. Further induction in NK cell-specific medium resulted in a population of cells that expressed NK cell marker CD56, and thus termed ADSC-NK. Alternatively, the hematopoietically induced ADSCs were transduced with NK cell-specific transcription factor E4BP4 prior to induction in NK cell-specific medium. This latter population of cells, termed ADSC-NKE, expressed CD56 and additional NK cell markers such as CD16, CD94, CD158, CD314, FasL, and NKp46. ADSC-NKE was as potent as NK leukemia cell NKL in killing breast cancer cell MCF7 and prostate cancer cells DU145, PC3, LnCap, DuPro, C4-2 and CWR22, but exhibited no killing activity toward normal endothelial and smooth muscle cells. In nude mice test ADSC-NKE was able to significantly delay the progression of tumors formed by MCF7 and PC3. When injected into immunocompetent rats, ADSC-NKE was detectable in bone marrow and spleen for at least 5 weeks. Together, these results suggest that ADSCs can be converted into NK-like cells with anti-tumor activities.	[Ning, Hongxiu; Lin, Guiting; Lue, Tom F.; Lin, Ching-Shwun] Univ Calif San Francisco, Sch Med, Dept Urol, Knuppe Mol Urol Lab, San Francisco, CA 94143 USA; [Lei, Hong-En; Xu, Yong-De; Guan, Rui-Li; Xin, Zhongcheng] Peking Univ, Hosp 1, Androl Ctr, Beijing 100871, Peoples R China; [Venstrom, Jeffrey M.] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; Peking University; University of California System; University of California San Francisco	Xin, ZC (corresponding author), Univ Calif San Francisco, Sch Med, Dept Urol, Knuppe Mol Urol Lab, San Francisco, CA 94143 USA.	xinzc@bjmu.edu.cn; clin@urology.ucsf.edu	Lei, Hongen/C-5684-2008		National Institutes of Health [DK64538, DK045370, DK069655]; National Natural Science Fund of China [81272531]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069655, R37DK045370, P50DK064538, R01DK045370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health (DK64538, DK045370, and DK069655 to TFL). National Natural Science Fund of China (No. 81272531 to ZX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alici E, 2007, EXP HEMATOL, V35, P1839, DOI 10.1016/j.exphem.2007.08.006; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; De Francesco F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006537; Eto H, 2013, STEM CELLS DEV, V22, P985, DOI 10.1089/scd.2012.0442; Fang BJ, 2009, ARCH MED RES, V40, P311, DOI 10.1016/j.arcmed.2009.04.007; Freisinger E, 2010, J CELL PHYSIOL, V225, P888, DOI 10.1002/jcp.22299; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Guimaraes F, 2006, LEUKEMIA, V20, P833, DOI 10.1038/sj.leu.2404147; Han J, 2010, BLOOD, V115, P957, DOI 10.1182/blood-2009-05-219923; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kao IT, 2007, STEM CELLS DEV, V16, P1043, DOI 10.1089/scd.2007.0033; Lanier LL, 2013, NAT REV IMMUNOL, V13, P73, DOI 10.1038/nri3389; Lin CS, 2012, STEM CELLS DEV, V21, P834, DOI 10.1089/scd.2011.0621; Lin CS, 2012, STEM CELLS DEV, V21, P343, DOI 10.1089/scd.2011.0303; Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807; Lin CS, 1999, DNA CELL BIOL, V18, P27, DOI 10.1089/104454999315592; Lin G, 2008, STEM CELLS DEV, V17, P1053, DOI 10.1089/scd.2008.0117; Lin GT, 2012, CYTOTHERAPY, V14, P240, DOI 10.3109/14653249.2011.627918; Lin GT, 2010, PROSTATE, V70, P1066, DOI 10.1002/pros.21140; Lin GT, 2009, CYTOTHERAPY, V11, P864, DOI 10.3109/14653240903180084; Luevano M, 2012, CELL MOL IMMUNOL, V9, P310, DOI 10.1038/cmi.2012.17; Minana MD, 2008, STEM CELLS, V26, P2696, DOI 10.1634/stemcells.2007-0988; Nazari-Shafti TZ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-3; Ning H, 2013, INT J IMPOT RES, V25, P63, DOI 10.1038/ijir.2012.36; Ning HX, 2009, DIFFERENTIATION, V77, P172, DOI 10.1016/j.diff.2008.09.019; Ning HX, 2009, J SEX MED, V6, P967, DOI 10.1111/j.1743-6109.2008.01172.x; Pinho MJ, 2012, J RECEPT SIG TRANSD, V32, P238, DOI 10.3109/10799893.2012.700716; Poglio S, 2012, BLOOD, V120, P4952, DOI 10.1182/blood-2012-01-406959; Spanholtz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009221; Tang Q, 2011, BLOOD, V117, P4052, DOI 10.1182/blood-2010-09-303081; Woll PS, 2009, BLOOD, V113, P6094, DOI 10.1182/blood-2008-06-165225; Woll PS, 2005, J IMMUNOL, V175, P5095, DOI 10.4049/jimmunol.175.8.5095	32	11	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106246	10.1371/journal.pone.0106246	http://dx.doi.org/10.1371/journal.pone.0106246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162225	Green Published, Green Submitted, gold			2022-12-25	WOS:000340880900098
J	Pomeroy, E; Stock, JT; Cole, TJ; O'Callaghan, M; Wells, JCK				Pomeroy, Emma; Stock, Jay T.; Cole, Tim J.; O'Callaghan, Michael; Wells, Jonathan C. K.			Relationships between Neonatal Weight, Limb Lengths, Skinfold Thicknesses, Body Breadths and Circumferences in an Australian Cohort	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LOW-BIRTH-WEIGHT; LEG LENGTH; FETAL-GROWTH; TRUNK LENGTH; INTRAUTERINE GROWTH; INSULIN-RESISTANCE; NHANES-III; IN-UTERO; HEALTH	Background: Low birth weight has been consistently associated with adult chronic disease risk. The thrifty phenotype hypothesis assumes that reduced fetal growth impacts some organs more than others. However, it remains unclear how birth weight relates to different body components, such as circumferences, adiposity, body segment lengths and limb proportions. We hypothesized that these components vary in their relationship to birth weight. Methods: We analysed the relationship between birth weight and detailed anthropometry in 1270 singleton live-born neonates (668 male) from the Mater-University of Queensland Study of Pregnancy (Brisbane, Australia). We tested adjusted anthropometry for correlations with birth weight. We then performed stepwise multiple regression on birth weight of: body lengths, breadths and circumferences; relative limb to neck-rump proportions; or skinfold thicknesses. All analyses were adjusted for sex and gestational age, and used logged data. Results: Circumferences, especially chest, were most strongly related to birth weight, while segment lengths (neck-rump, thigh, upper arm, and especially lower arm and lower leg) were relatively weakly related to birth weight, and limb lengths relative to neck-rump length showed no relationship. Skinfolds accounted for 36% of birth weight variance, but adjusting for size (neck-rump, thigh and upper arm lengths, and head circumference), this decreased to 10%. There was no evidence that heavier babies had proportionally thicker skinfolds. Conclusions: Neonatal body measurements vary in their association with birth weight: head and chest circumferences showed the strongest associations while limb segment lengths did not relate strongly to birth weight. After adjusting for body size, subcutaneous fatness accounted for a smaller proportion of birth weight variance than previously reported. While heavier babies had absolutely thicker skinfolds, this was proportional to their size. Relative limb to trunk length was unrelated to birth weight, suggesting that limb proportions at birth do not index factors relevant to prenatal life.	[Pomeroy, Emma] Univ Cambridge, Newnham Coll, Cambridge, England; [Pomeroy, Emma; Stock, Jay T.; Wells, Jonathan C. K.] Univ Cambridge, Dept Archaeol & Anthropol, Div Biol Anthropol, Cambridge, England; [Cole, Tim J.] UCL Inst Child Hlth, London, England; [O'Callaghan, Michael] Univ Queensland, Sch Med, Mater Clin Sch, Brisbane, Qld, Australia; [Wells, Jonathan C. K.] UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England	University of Cambridge; University of Cambridge; University of London; University College London; University of Queensland; University of London; University College London	Pomeroy, E (corresponding author), Univ Cambridge, Newnham Coll, Cambridge, England.	emma.pomeroy@cantab.net	Wells, Jonathan/A-4604-2009; Cole, Tim J/B-7883-2008; Stock, Jay T/B-6453-2011	Wells, Jonathan/0000-0003-0411-8025; Cole, Tim J/0000-0001-5711-8200; Stock, Jay T/0000-0003-0147-8631; Pomeroy, Emma/0000-0001-6251-2165	National Health and Medical Research Council, Australia; Newnham College, University of Cambridge, UK; Medical Research Council (UK) [MR/J004839/1]; Medical Research Council [MR/J004839/1] Funding Source: researchfish; MRC [MR/J004839/1] Funding Source: UKRI	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Newnham College, University of Cambridge, UK; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The relevant part of the data collection of the Mater-University of Queensland Study of Pregnancy (MUSP) was funded by the National Health and Medical Research Council, Australia (www.nhmrc.gov.au). EP is funded by the Henry Sidgwick Research Fellowship from Newnham College, University of Cambridge, UK (www.newn.cam.ac.uk). TJC is funded by Medical Research Council (UK) grant MR/J004839/1 (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis.	Aboderin I., 2002, LIFE COURSE PERSPECT; Ahlsson F, 2010, ACTA PAEDIATR, V99, P89, DOI 10.1111/j.1651-2227.2009.01532.x; [Anonymous], 2005, PREV CHRON DIS VIT I; Asao K, 2006, DIABETES CARE, V29, P1632, DOI 10.2337/dc05-1997; Azhar BS, 2013, ISRN PUBLIC HLTH, V2013, P8; Bailey SM, 2007, AM J HUM BIOL, V19, P662, DOI 10.1002/ajhb.20667; Barker DJP, 2004, J EPIDEMIOL COMMUN H, V58, P114, DOI 10.1136/jech.58.2.114; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Barker DJP, 1998, MOTHERS BABIES DIS L; BHARGAVA SK, 1985, BMJ-BRIT MED J, V291, P1617, DOI 10.1136/bmj.291.6509.1617; Bogin B, 2002, AM J HUM BIOL, V14, P753, DOI 10.1002/ajhb.10092; Bogin B, 2012, AM J PHYS ANTHROPOL, V148, P487, DOI 10.1002/ajpa.22064; Bogin B, 2010, INT J ENV RES PUB HE, V7, P1047, DOI 10.3390/ijerph7031047; BROOKE OG, 1984, EARLY HUM DEV, V10, P85, DOI 10.1016/0378-3782(84)90114-2; Catalano PM, 2009, AM J CLIN NUTR, V90, P1303, DOI 10.3945/ajcn.2008.27416; Catalano PM, 2003, AM J OBSTET GYNECOL, V189, P1698, DOI 10.1016/S0002-9378(03)00828-7; CATALANO PM, 1992, OBSTET GYNECOL, V79, P46; Crowther NJ, 2012, BEST PRACT RES CL EN, V26, P655, DOI 10.1016/j.beem.2012.03.006; DANGERFIELD PH, 1983, EARLY HUM DEV, V8, P225, DOI 10.1016/0378-3782(83)90005-1; DIAMOND I, 1993, B WORLD HEALTH ORGAN, V71, P157; Elizabeth NL, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-54; Ferrie JE, 2006, INT J EPIDEMIOL, V35, P1532, DOI 10.1093/ije/dyl184; Gigante DP, 2009, EUR J CLIN NUTR, V63, P375, DOI 10.1038/sj.ejcn.1602949; Giussani DA, 2011, P NATL ACAD SCI USA, V108, P2641, DOI 10.1073/pnas.1019726108; Gunnell D, 2003, J EPIDEMIOL COMMUN H, V57, P141, DOI 10.1136/jech.57.2.141; Gunnell D, 1999, LANCET, V354, P1526, DOI 10.1016/S0140-6736(99)02937-2; Gunnell DJ, 1998, PAEDIATR PERINAT EP, V12, P96, DOI 10.1046/j.1365-3016.1998.0120s1096.x; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hindmarsh PC, 2002, PEDIATR RES, V52, DOI 10.1023/01.PDR.0000020600.45753.78; HUNTER C, 1973, J ANAT, V114, P201; Jantz LM, 1999, AM J PHYS ANTHROPOL, V110, P57, DOI 10.1002/(SICI)1096-8644(199909)110:1<57::AID-AJPA5>3.0.CO;2-1; Keeping JD, 1981, DETERMINANTS COMPONE; Kim JM, 2003, J NEUROL NEUROSUR PS, V74, P427, DOI 10.1136/jnnp.74.4.427; Krishnaveni GV, 2005, INDIAN PEDIATR, V42, P527; Lampl M, 2005, AM J HUM BIOL, V17, P66, DOI 10.1002/ajhb.20094; Lampl M, 2004, AM J HUM BIOL, V16, P237, DOI 10.1002/ajhb.20015; Lampl M, 2003, AM J HUM BIOL, V15, P533, DOI 10.1002/ajhb.10140; Larciprete G, 2003, ULTRASOUND OBST GYN, V22, P591, DOI 10.1002/uog.926; Law TL, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.027; Lawlor DA, 2004, HEART, V90, P745, DOI 10.1136/hrt.2003.019950; Lee W, 2009, ULTRASOUND OBST GYN, V33, P441, DOI 10.1002/uog.6317; Lee W, 2012, J MATERN-FETAL NEO M, V25, P1933, DOI 10.3109/14767058.2012.683084; Lindsay CA, 1997, AM J OBSTET GYNECOL, V177, P1124, DOI 10.1016/S0002-9378(97)70027-9; Luque V, 2009, ANN HUM BIOL, V36, P88, DOI 10.1080/03014460802575633; Martín Moreno V., 2003, Nutr. Hosp., V18, P341; McGrath JJ, 2005, EARLY HUM DEV, V81, P609, DOI 10.1016/j.earlhumdev.2005.03.013; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Muthayya S, 2006, PUBLIC HEALTH NUTR, V9, P896, DOI 10.1017/PHN2006943; Naik Dhananjay B., 2003, Indian Journal of Pediatrics, V70, P145, DOI 10.1007/BF02723742; Najman JM, 2005, INT J EPIDEMIOL, V34, P992, DOI 10.1093/ije/dyi119; Pomeroy E, 2013, AM J HUM BIOL, V25, P629, DOI 10.1002/ajhb.22422; Pomeroy E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051795; Prentice AM, 2005, ARCH DIS CHILD, V90, P429, DOI 10.1136/adc.2004.059030; Prentice AM, 2003, BMJ-BRIT MED J, V327, P880, DOI 10.1136/bmj.327.7420.880; Rodriguez G, 2005, ARCH DIS CHILD-FETAL, V90, P273, DOI 10.1136/adc.2004.060723; RUFF CB, 1991, J HUM EVOL, V21, P81, DOI 10.1016/0047-2484(91)90001-C; Rush EC, 2009, BRIT J NUTR, V102, P632, DOI 10.1017/S0007114508207221; Sajjadian N, 2011, HEALTH, V3, P752; Schwartz J, 2003, ULTRASOUND OBST GYN, V22, P329, DOI 10.1002/uog.887; Sewell MF, 2006, AM J OBSTET GYNECOL, V195, P1100, DOI 10.1016/j.ajog.2006.06.014; Smith GD, 2001, J EPIDEMIOL COMMUN H, V55, P867, DOI 10.1136/jech.55.12.867; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Stetzer BP, 2002, J PERINATOL, V22, P397; SUMNERS JE, 1990, J CLIN ULTRASOUND, V18, P9, DOI 10.1002/jcu.1870180104; Tikellis G, 2012, INT J OBESITY, V36, P496, DOI 10.1038/ijo.2011.261; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; Wells JCK, 2006, HORM RES, V66, P58, DOI 10.1159/000096624; Wells JCK, 2012, AM J PHYS ANTHROPOL, V147, P169, DOI 10.1002/ajpa.21591; Whitley E, 2010, J EPIDEMIOL COMMUNIT, V24, P24; Whitley E, 2008, ANN HUM BIOL, V35, P518, DOI 10.1080/03014460802294250; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219; Zambrano E, 2010, J PHYSIOL-LONDON, V588, P1791, DOI 10.1113/jphysiol.2010.190033; Zhang J, 2010, AM J OBSTET GYNECOL, V202, P522, DOI 10.1016/j.ajog.2009.10.889	73	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105108	10.1371/journal.pone.0105108	http://dx.doi.org/10.1371/journal.pone.0105108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162658	gold, Green Submitted, Green Published			2022-12-25	WOS:000340880900026
J	Zhang, CL; Ren, HJ; Liu, MM; Li, XG; Sun, DL; Li, N; Ming, L				Zhang, Chun Li; Ren, Hui Jun; Liu, Meng Meng; Li, Xiao Gai; Sun, De Li; Li, Nan; Ming, Liang			Modulation of Intestinal Epithelial Cell Proliferation, Migration, and Differentiation In Vitro by Astragalus Polysaccharides	PLOS ONE			English	Article							ORNITHINE-DECARBOXYLASE; RESTITUTION; PROTEIN; GROWTH; RATS; POLYAMINES; EXPRESSION; IMMUNITY; MUCOSA; MODEL	Previous studies have shown that Astragalus polysaccharides (APS) can be used to treat general gastrointestinal disturbances including intestinal mucosal injury. However, the mechanism by which APS mediate this effect is unclear. In the present study, the effects of APS on proliferation, migration, and differentiation of intestinal epithelial cells (IEC-6) were assessed using an in vitro wounding model and colorimetric thiazolyl blue (MTT) assays. The effect of APS on IEC-6 cell differentiation was observed using a light microscope and scanning electron microscope, and the expression of differentiation-specific markers of IEC-6 cells, such as cytokeratin 18 (CK18), alkaline phosphatase (ALP), tight junction protein ZO-2, and sucrase-isomaltase (SI), was determined by immunofluorescence assay (IFA) and real-time PCR. In addition, APS-induced signaling pathways in IEC-6 cells were characterized. Our results indicated that APS significantly enhance migration and proliferation of IEC-6 cells in vitro. APS-treated IEC-6 cells have numerous microvilli on their apical surface and also highly express CK18, ALP, ZO-2, and SI. Moreover, APS-treated IEC-6 cells, in which the activity and expression level of ornithine decarboxylase (ODC) were significantly elevated, also exhibited an increase in cellular putrescine, whereas no significant increase in TGF-beta levels was observed. These findings suggest that APS may enhance intestinal epithelial cell proliferation, migration, and differentiation in vitro by stimulating ODC gene expression and activity and putrescine production, independent of TGF-beta. Exogenous administration of APS may provide a new approach for modulating intestinal epithelial wound restitution in vivo.	[Zhang, Chun Li; Sun, De Li] Peoples Hosp Zhengzhou, Dept Gen Surg, Zhengzhou, Peoples R China; [Ren, Hui Jun; Li, Xiao Gai; Li, Nan] Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Lab, Zhengzhou 450052, Peoples R China; [Liu, Meng Meng] Third Peoples Hosp Zhengzhou, Dept Pathol, Zhengzhou, Peoples R China	Zhengzhou University	Ming, L (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Lab, Zhengzhou 450052, Peoples R China.	mingliang@zzu.edu.cn						BJARNASON I, 1995, GASTROENTEROLOGY, V108, P1566, DOI 10.1016/0016-5085(95)90708-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chen AQ, 2009, ANIM REPROD SCI, V115, P39, DOI 10.1016/j.anireprosci.2008.10.022; Cheng YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027437; CIACCI C, 1993, GASTROENTEROLOGY, V105, P93, DOI 10.1016/0016-5085(93)90014-4; Dalloul RA, 2006, POULTRY SCI, V85, P446, DOI 10.1093/ps/85.3.446; Dang SS, 2009, WORLD J GASTROENTERO, V15, P5669, DOI 10.3748/wjg.15.5669; DIGNASS AU, 1994, GASTROENTEROLOGY, V106, P1254, DOI 10.1016/0016-5085(94)90017-5; GORDON JI, 1994, CURR OPIN CELL BIOL, V6, P795, DOI 10.1016/0955-0674(94)90047-7; GROBLEWSKI GE, 1992, AM J PHYSIOL, V263, pG742, DOI 10.1152/ajpgi.1992.263.5.G742; Guo FC, 2004, POULTRY SCI, V83, P175, DOI 10.1093/ps/83.2.175; Hei ZQ, 2005, WORLD J GASTROENTERO, V11, P4986, DOI 10.3748/wjg.v11.i32.4986; Hikita C, 2000, J CELL BIOL, V151, P1235, DOI 10.1083/jcb.151.6.1235; Huang XY, 2008, INT J BIOL MACROMOL, V42, P166, DOI 10.1016/j.ijbiomac.2007.10.019; Hwang S, 2012, J BIOL CHEM, V287, P22227, DOI 10.1074/jbc.M112.367979; JANNE J, 1991, ANN MED, V23, P241, DOI 10.3109/07853899109148056; Lange I, 2014, J MOL BIOL, V426, P332, DOI 10.1016/j.jmb.2013.09.037; Li RJ, 2007, BIOL PHARM BULL, V30, P470, DOI 10.1248/bpb.30.470; Li SG, 2007, INT IMMUNOPHARMACOL, V7, P23, DOI 10.1016/j.intimp.2006.08.016; NUSRAT A, 1992, J CLIN INVEST, V89, P1501, DOI 10.1172/JCI115741; Paclik D, 2008, INFLAMM BOWEL DIS, V14, P1366, DOI 10.1002/ibd.20499; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Rao JN, 2002, AM J PHYSIOL-CELL PH, V282, pC885, DOI 10.1152/ajpcell.00361.2001; Ray RM, 2012, J BIOL CHEM, V287, P3674, DOI 10.1074/jbc.M111.232561; Ren HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027010; Samal K, 2013, INT J CANCER, V133, P1323, DOI 10.1002/ijc.28139; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Song HP, 2014, J ETHNOPHARMACOL, V152, P163, DOI 10.1016/j.jep.2013.12.049; Stettler M, 2001, ANTIMICROB AGENTS CH, V45, P2256, DOI 10.1128/AAC.45.8.2256-2262.2001; Sturm A, 1999, GASTROENTEROLOGY, V117, P368, DOI 10.1053/gast.1999.0029900368; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Tzianabos AO, 2000, CLIN MICROBIOL REV, V13, P523, DOI 10.1128/CMR.13.4.523-533.2000; WANG JY, 1991, GASTROENTEROLOGY, V100, P333, DOI 10.1016/0016-5085(91)90200-5; Wargovich MJ, 2001, J NUTR, V131, p3034S, DOI 10.1093/jn/131.11.3034S; Wu F, 2009, FASEB J, V23, P565, DOI 10.1096/fj.08-115121; Xu DJ, 2008, MOLECULES, V13, P2408, DOI 10.3390/molecules13102408; Yamada Y, 2013, DIGEST DIS SCI, V58, P1207, DOI 10.1007/s10620-012-2515-7; Zhao P, 2008, TOXICOL LETT, V182, P29, DOI 10.1016/j.toxlet.2008.08.002	40	29	36	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e106674	10.1371/journal.pone.0106674	http://dx.doi.org/10.1371/journal.pone.0106674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157577	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200093
J	Ono, K; Fujimoto, E; Fujimoto, N; Akiyama, M; Satoh, T; Maeda, H; Fujii, N; Tajima, S				Ono, Koji; Fujimoto, Eita; Fujimoto, Norihiro; Akiyama, Minoru; Satoh, Takahiro; Maeda, Hiroki; Fujii, Noriko; Tajima, Shingo			In Vitro Amyloidogenic Peptides of Galectin-7 POSSIBLE MECHANISM OF AMYLOIDOGENESIS OF PRIMARY LOCALIZED CUTANEOUS AMYLOIDOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRIL FORMATION; THIOFLAVIN-T; INTRACELLULAR ACIDIFICATION; P COMPONENT; APOPTOSIS; BETA; SKIN; BETA(2)-MICROGLOBULIN; ACTIVATION; KERATIN	Pathogenesis of primary localized cutaneous amyloidosis (PLCA) is unclear, but pathogenic relationship to keratinocyte apoptosis has been implicated. We have previously identified galectin-7, actin, and cytokeratins as the major constituents of PLCA. Determination of the amyloidogenetic potential of these proteins by thioflavin T (ThT) method demonstrated that galectin-7 molecule incubated at pH 2.0 was capable of binding to the dye, but failed to form amyloid fibrils. When a series of galectin-7 fragments containing beta-strand peptides were prepared to compare their amyloidogenesis, Ser(31)-Gln(67) and Arg(120)-Phe(136) were aggregated to form amyloid fibrils at pH 2.0. The rates of aggregation of Ser(31)-Gln(67) and Arg(120)-Phe(136) were dose-dependent with maximal ThT levels after 3 and 48 h, respectively. Their synthetic analogs, Phe(33)-Lys(65) and Leu(121)-Arg(134), which are both putative tryptic peptides, showed comparable amyloidogenesis. The addition of sonicated fibrous form of Ser(31)-Gln(67) or Phe(33)-Lys(65) to monomeric Ser(31)-Gln(67) or Phe(33)-Lys(65) solution, respectively, resulted in an increased rate of aggregation and extension of amyloid fibrils. Amyloidogenic potentials of Ser(31)-Gln(67) and Phe(33)-Lys(65) were inhibited by actin and cytokeratin fragments, whereas those of Arg(120)-Phe(136) and Leu(121)-Arg(134) were enhanced in the presence of Gly(84)-Arg(113), a putative tryptic peptide of galectin-7. Degraded fragments of the galectin-7 molecule produced by limited trypsin digestion, formed amyloid fibrils after incubation at pH 2.0. These results suggest that the tryptic peptides of galectin-7 released at neutral pH, may lead to amyloid fibril formation of PLCA in the intracellular acidified conditions during keratinocyte apoptosis via regulation by the galectin-7 peptide as well as actin and cytokeratins.	[Ono, Koji; Fujimoto, Eita; Fujimoto, Norihiro; Akiyama, Minoru; Satoh, Takahiro; Tajima, Shingo] Natl Def Med Coll, Dept Dermatol, Tokorozawa, Saitama 3598513, Japan; [Maeda, Hiroki; Fujii, Noriko] Kyoto Univ, Inst Res Reactor, Osaka 5900494, Japan	National Defense Medical College - Japan; Kyoto University	Ono, K (corresponding author), Natl Def Med Coll, Dept Dermatol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	drde998@ndmc.ac.jp						Arita K, 2008, AM J HUM GENET, V82, P73, DOI 10.1016/j.ajhg.2007.09.002; Bernerd F, 1999, P NATL ACAD SCI USA, V96, P11329, DOI 10.1073/pnas.96.20.11329; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; BREATHNACH SM, 1981, BRIT J DERMATOL, V105, P115, DOI 10.1111/j.1365-2133.1981.tb01195.x; Chang YT, 1999, BRIT J DERMATOL, V140, P210, DOI 10.1111/j.1365-2133.1999.02651.x; Choi CY, 2000, J ANIM SCI, V78, P2990; Conus S, 2012, J BIOL CHEM, V287, P21142, DOI 10.1074/jbc.M111.306399; Debela M, 2008, BIOL CHEM, V389, P623, DOI 10.1515/BC.2008.075; Esler WP, 1999, METHOD ENZYMOL, V309, P350; ETO H, 1984, AM J PATHOL, V116, P473; Furumoto H, 1998, J INVEST DERMATOL, V111, P417, DOI 10.1046/j.1523-1747.1998.00294.x; Gendronneau G, 2008, MOL BIOL CELL, V19, P5541, DOI 10.1091/mbc.E08-02-0166; GLENNER GG, 1980, NEW ENGL J MED, V302, P1283, DOI 10.1056/NEJM198006053022305; GOTTLIEB RA, 1995, P NATL ACAD SCI USA, V92, P5965, DOI 10.1073/pnas.92.13.5965; Gottlieb RA, 1996, P NATL ACAD SCI USA, V93, P654, DOI 10.1073/pnas.93.2.654; HASHIMOTO K, 1984, J INVEST DERMATOL, V82, P1, DOI 10.1111/1523-1747.ep12258661; Heenan PJ, 2005, LEVERS HISTOPATHOLOG, V9th, P980; HINTNER H, 1988, J INVEST DERMATOL, V91, P22, DOI 10.1111/1523-1747.ep12463283; Hsu DK, 2006, METHOD ENZYMOL, V417, P256, DOI 10.1016/S0076-6879(06)17018-4; Inoue K, 2000, AMYLOID, V7, P259, DOI 10.3109/13506120009146439; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; JONES JCR, 1982, CELL MOTIL CYTOSKEL, V2, P197, DOI 10.1002/cm.970020302; Jones S, 2003, J MOL BIOL, V325, P249, DOI 10.1016/S0022-2836(02)01227-5; Kagedal K, 2001, FASEB J, V15, P1592, DOI 10.1096/fj.00-0708fje; Kalagala Y., 1992, BIOCHEM BIOPH RES CO, V182, P1440; KOBAYASHI H, 1983, J INVEST DERMATOL, V80, P66, DOI 10.1111/1523-1747.ep12531130; Kozhukh GV, 2002, J BIOL CHEM, V277, P1310, DOI 10.1074/jbc.M108753200; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Kuwabara I, 2002, J BIOL CHEM, V277, P3487, DOI 10.1074/jbc.M109360200; Leonidas DD, 1998, BIOCHEMISTRY-US, V37, P13930, DOI 10.1021/bi981056x; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LI JF, 1995, J BIOL CHEM, V270, P3203, DOI 10.1074/jbc.270.7.3203; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; MADSEN P, 1995, J BIOL CHEM, V270, P5823, DOI 10.1074/jbc.270.11.5823; Magnaldo T, 1998, DIFFERENTIATION, V63, P159, DOI 10.1046/j.1432-0436.1998.6330159.x; Meisenholder GW, 1996, J BIOL CHEM, V271, P16260, DOI 10.1074/jbc.271.27.16260; Miura Y, 2013, EXP DERMATOL, V22, P36, DOI 10.1111/exd.12065; Naiki H, 1999, METHOD ENZYMOL, V309, P305; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nakanishi J, 2010, J INVEST DERMATOL, V130, P944, DOI 10.1038/jid.2009.364; NEWTON JA, 1985, BRIT J DERMATOL, V112, P201, DOI 10.1111/j.1365-2133.1985.tb00084.x; Ohhashi Y, 2004, J BIOL CHEM, V279, P10814, DOI 10.1074/jbc.M310334200; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Rodriguez J, 2008, J PROTEOME RES, V7, P300, DOI 10.1021/pr0705035; Sasahara K, 2007, BIOCHEMISTRY-US, V46, P3286, DOI 10.1021/bi602403v; SHIRAHAMA T, 1967, J CELL BIOL, V33, P679, DOI 10.1083/jcb.33.3.679; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Wang HQ, 2003, J BIOL CHEM, V278, P45737, DOI 10.1074/jbc.M300574200; Yamaguchi I, 2001, AMYLOID, V8, P30, DOI 10.3109/13506120108993812; Zhivotovsky B, 1997, BIOCHEM BIOPH RES CO, V230, P481, DOI 10.1006/bbrc.1996.6016	51	7	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29195	29207		10.1074/jbc.M114.592998	http://dx.doi.org/10.1074/jbc.M114.592998			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25172508	hybrid, Green Published			2022-12-25	WOS:000344141000035
J	Torsvik, J; Johansson, BB; Dalva, M; Marie, M; Fjeld, K; Johansson, S; Bjorkoy, G; Saraste, J; Njolstad, PR; Molven, A				Torsvik, Janniche; Johansson, Bente B.; Dalva, Monica; Marie, Michael; Fjeld, Karianne; Johansson, Stefan; Bjorkoy, Geir; Saraste, Jaakko; Njolstad, Pal R.; Molven, Anders			Endocytosis of Secreted Carboxyl Ester Lipase in a Syndrome of Diabetes and Pancreatic Exocrine Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-DEPENDENT LIPASE; STIMULATED LIPASE; HUMAN-MILK; SUBSTRATE-SPECIFICITY; ACTIVATED LIPASE; CEL GENE; PROTEIN; AUTOPHAGY; MUTATIONS; GLYCOSYLATION	Maturity-onset diabetes of the young, type 8 (MODY8) is characterized by a syndrome of autosomal dominantly inherited diabetes and exocrine pancreatic dysfunction. It is caused by deletion mutations in the last exon of the carboxyl ester lipase (CEL) gene, resulting in a CEL protein with increased tendency to aggregate. In this study we investigated the intracellular distribution of the wild type (WT) and mutant (MUT) CEL proteins in cellular models. We found that both CEL-WT and CEL-MUT were secreted via the endoplasmic reticulum and Golgi compartments. However, their subcellular distributions differed, as only CEL-MUT was observed as an aggregate at the cell surface and inside large cytoplasmic vacuoles. Many of the vacuoles were identified as components of the endosomal system, and after its secretion, the mutant CEL protein was re-internalized, transported to the lysosomes, and degraded. Internalization of CEL-MUT also led to reduced viability of pancreatic acinar and beta cells. These findings may have implications for the understanding of how the acinar-specific CEL-MUT protein causes both exocrine and endocrine pancreatic disease.	[Torsvik, Janniche; Johansson, Bente B.; Dalva, Monica; Fjeld, Karianne; Johansson, Stefan; Njolstad, Pal R.; Molven, Anders] Univ Bergen, KG Jebsen Ctr Diabet Res, Dept Clin Sci, N-5021 Bergen, Norway; [Torsvik, Janniche; Johansson, Bente B.; Dalva, Monica; Fjeld, Karianne; Johansson, Stefan] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Dalva, Monica; Molven, Anders] Univ Bergen, Gade Lab Pathol, Dept Clin Med, N-5021 Bergen, Norway; [Marie, Michael; Saraste, Jaakko] Univ Bergen, Dept Biomed, N-5021 Bergen, Norway; [Marie, Michael; Saraste, Jaakko] Univ Bergen, Mol Imaging Ctr, N-5021 Bergen, Norway; [Bjorkoy, Geir] Univ Coll Sor Trondelag, Dept Technol, Trondheim, Norway; [Bjorkoy, Geir] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Ctr Mol Inflammat Res, N-7034 Trondheim, Norway; [Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Molven, A (corresponding author), Univ Bergen, Gade Lab Pathol, Dept Clin Med, N-5021 Bergen, Norway.	anders.molven@gades.uib.no	Johansson, Bente Berg/AAE-7666-2022; Fjeld, Karianne/Q-7122-2018; Johansson, Stefan/C-4394-2011	Fjeld, Karianne/0000-0003-0441-1475; Johansson, Stefan/0000-0002-2298-7008; Bjorkoy, Geir/0000-0003-0031-8361; Johansson, Bente Berg/0000-0001-8893-1915	Translational Fund of the Bergen Medical Research Foundation; KG Jebsen Foundation; University of Bergen; Research Council of Norway; Haukeland University Hospital; Innovest; Western Norway Regional Health Authority	Translational Fund of the Bergen Medical Research Foundation; KG Jebsen Foundation; University of Bergen; Research Council of Norway(Research Council of Norway); Haukeland University Hospital; Innovest; Western Norway Regional Health Authority	This work was supported by grants from the Translational Fund of the Bergen Medical Research Foundation, the KG Jebsen Foundation, the University of Bergen, the Research Council of Norway, Haukeland University Hospital, Innovest, and the Western Norway Regional Health Authority (to A. M. and P. R. N.).	ABOUAKIL N, 1993, J BIOL CHEM, V268, P25755; BERNBACK S, 1990, J CLIN INVEST, V85, P1221, DOI 10.1172/JCI114556; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; BLACKBERG L, 1987, FEBS LETT, V217, P37, DOI 10.1016/0014-5793(87)81237-1; Brown W. J., 1999, CURRENT PROTOCOLS CE; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; BRUNEAU N, 1995, EUR J BIOCHEM, V233, P209, DOI 10.1111/j.1432-1033.1995.209_1.x; Bruneau N, 2000, MICROSC RES TECHNIQ, V49, P329, DOI 10.1002/(SICI)1097-0029(20000515)49:4<329::AID-JEMT2>3.0.CO;2-H; Bruneau N, 2003, MOL BIOL CELL, V14, P2861, DOI 10.1091/mbc.E02-08-0544; Bruneau N, 1997, J BIOL CHEM, V272, P27353, DOI 10.1074/jbc.272.43.27353; Bruneau N, 1998, J CELL SCI, V111, P2665; BRUNEAU N, 1995, J BIOL CHEM, V270, P13524, DOI 10.1074/jbc.270.22.13524; Caillol N, 1997, LIPIDS, V32, P1147, DOI 10.1007/s11745-997-0147-4; Chen N, 2011, J CLIN GASTROENTEROL, V45, P850, DOI 10.1097/MCG.0b013e31822a2ae5; Comte B, 2006, KIDNEY INT, V69, P1048, DOI 10.1038/sj.ki.5000133; DOWNS D, 1994, BIOCHEMISTRY-US, V33, P7979, DOI 10.1021/bi00192a001; FEBBRAIO M, 1990, J BIOL CHEM, V265, P18531; Franceschi C, 2011, J IMMUNOL, V186, P4067, DOI 10.4049/jimmunol.1000408; HANSSON L, 1993, J BIOL CHEM, V268, P26692; Higuchi S, 2002, J HUM GENET, V47, P213, DOI 10.1007/s100380200027; Johansson BB, 2011, J BIOL CHEM, V286, P34593, DOI 10.1074/jbc.M111.222679; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; LOMBARDO D, 1980, BIOCHIM BIOPHYS ACTA, V611, P136, DOI 10.1016/0005-2744(80)90049-2; LOMBARDO D, 1978, BIOCHIM BIOPHYS ACTA, V527, P142, DOI 10.1016/0005-2744(78)90263-2; LOMBARDO D, 1980, BIOCHIM BIOPHYS ACTA, V611, P147, DOI 10.1016/0005-2744(80)90050-9; Loomes KM, 1999, EUR J BIOCHEM, V266, P105, DOI 10.1046/j.1432-1327.1999.00824.x; Loomes KM, 1997, FEBS LETT, V405, P369, DOI 10.1016/S0014-5793(97)00215-9; LOOMES KM, 1995, EUR J BIOCHEM, V230, P607; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pasqualini E, 2000, BIOCHEM J, V345, P121, DOI 10.1042/0264-6021:3450121; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Raeder H, 2007, DIABETES, V56, P444, DOI 10.2337/db06-0859; Raeder H, 2014, DIABETES, V63, P259, DOI 10.2337/db13-1012; Ragvin A, 2013, PANCREATOLOGY, V13, P29, DOI 10.1016/j.pan.2012.12.059; REUE K, 1991, J LIPID RES, V32, P267; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; ROUDANI S, 1995, BBA-GENE STRUCT EXPR, V1264, P141, DOI 10.1016/0167-4781(95)00141-3; Sannerud R, 2006, MOL BIOL CELL, V17, P1514, DOI 10.1091/mbc.E05-08-0792; Sannerud Ragna, 2008, V457, P253, DOI 10.1007/978-1-59745-261-8_19; Sasikala M, 2012, DIGEST DIS SCI, V57, P1764, DOI 10.1007/s10620-012-2086-7; Teo AKK, 2013, J BIOL CHEM, V288, P5353, DOI 10.1074/jbc.C112.428979; Tjora E, 2013, PANCREAS, V42, P1078, DOI 10.1097/MPA.0b013e3182920e9c; Torsvik J, 2010, HUM GENET, V127, P55, DOI 10.1007/s00439-009-0740-8; Vesterhus M, 2010, PANCREATOLOGY, V10, P467, DOI 10.1159/000266284; Watanabe Y, 2011, J CELL SCI, V124, P2692, DOI 10.1242/jcs.081232; Ying M, 2000, J CELL SCI, V113, P3623; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023	53	27	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29097	29111		10.1074/jbc.M114.574244	http://dx.doi.org/10.1074/jbc.M114.574244			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25160620	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000344141000027
J	Yu, H; Hausinger, RP; Tang, HZ; Xu, P				Yu, Hao; Hausinger, Robert P.; Tang, Hong-Zhi; Xu, Ping			Mechanism of the 6-Hydroxy-3-succinoyl-pyridine 3-Monooxygenase Flavoprotein from Pseudomonas putida S16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTAINING MONO-OXYGENASE; NICOTINE DEGRADATION; HALF-REACTION; STRAIN S16; MONOOXYGENASES; PYRIDINE; FLAVOENZYMES; DERIVATIVES; IDENTIFICATION; 1-HYDROXYLASE	6-Hydroxy-3-succinoyl-pyridine (HSP) 3-monooxygenase (HspB), a flavoprotein essential to the pyrrolidine pathway of nicotine degradation, catalyzes pyridine-ring beta-hydroxylation, resulting in carbon-carbon cleavage and production of 2,5-dihydroxypyridine. Here, we generated His(6)-tagged HspB in Escherichia coli, characterized the properties of the recombinant enzyme, and investigated its mechanism of catalysis. In contrast to conclusions reported previously, the second product of the HspB reaction was shown to be succinate, with isotope labeling experiments providing direct evidence that the newly introduced oxygen atom of succinate is derived from H2O. Phylogenetic analysis reveals that HspB is the most closely related to two p-nitrophenol 4-monooxygenases, and the experimental results exhibit that p-nitrophenol is a substrate of HspB. The reduction of HspB (with maxima at 375 and 460 nm, and a shoulder at 485 nm) by NADH was followed by stopped-flow spectroscopy, and the rate constant for reduction was shown to be stimulated by HSP. Reduced HspB reacts with oxygen to form a C-(4a)-(hydro)peroxyflavin intermediate with an absorbance maximum at similar to 400 nm within the first few milliseconds before converting to the oxidized flavoenzyme species. The formed C-(4a)-hydroperoxyflavin intermediate reacts with HSP to form an intermediate that hydrolyzes to the products 2,5-dihydroxypyridine and succinate. The investigation on the catalytic mechanism of a flavoprotein pyridine-ring beta-position hydroxylase provides useful information for the biosynthesis of pyridine derivatives.	[Yu, Hao; Tang, Hong-Zhi; Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Yu, Hao; Tang, Hong-Zhi; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Hausinger, Robert P.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Michigan State University	Xu, P (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China.	pingxu@sjtu.edu.cn		Hausinger, Robert/0000-0002-3643-2054; Xu, Ping/0000-0002-4418-9680	Chinese National Natural Science Foundation [31230002, 31270154, 31121064]; Shanghai Rising-Star Program [13QA1401700]; Shanghai Jiao Tong University	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Shanghai Jiao Tong University	This work was supported in part by grants from the Chinese National Natural Science Foundation Grants 31230002, 31270154, and 31121064, "Shanghai Rising-Star Program" Grant 13QA1401700, and the "Chen Xing" project from Shanghai Jiao Tong University.	BEATY NB, 1981, J BIOL CHEM, V256, P4619; BEATY NB, 1981, J BIOL CHEM, V256, P4611; Brandsch R, 2006, APPL MICROBIOL BIOT, V69, P493, DOI 10.1007/s00253-005-0226-0; Bull JA, 2012, CHEM REV, V112, P2642, DOI 10.1021/cr200251d; Crozier-Reabe K, 2012, INT J MOL SCI, V13, P15601, DOI 10.3390/ijms131215601; Eppink MHM, 1997, J BACTERIOL, V179, P6680, DOI 10.1128/jb.179.21.6680-6687.1997; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Gabriel DW, 2006, MOL PLANT MICROBE IN, V19, P69, DOI 10.1094/MPMI-19-0069; Gadda G., 2012, HDB FLAVOPROTEINS; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; GRETHERBECK S, 1994, MOL MICROBIOL, V13, P929, DOI 10.1111/j.1365-2958.1994.tb00484.x; HARELAND WA, 1975, J BACTERIOL, V121, P272, DOI 10.1128/JB.121.1.272-285.1975; Hill MD, 2010, CHEM-EUR J, V16, P12052, DOI 10.1002/chem.201001100; Hille R, 2005, ARCH BIOCHEM BIOPHYS, V433, P107, DOI 10.1016/j.abb.2004.08.012; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Jimenez JI, 2008, P NATL ACAD SCI USA, V105, P11329, DOI 10.1073/pnas.0802273105; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Kaiser JP, 1996, MICROBIOL REV, V60, P483, DOI 10.1128/MMBR.60.3.483-498.1996; Kamerbeek NM, 2001, EUR J BIOCHEM, V268, P2547, DOI 10.1046/j.1432-1327.2001.02137.x; Leisch H, 2011, CHEM REV, V111, P4165, DOI 10.1021/cr1003437; Liu CL, 2013, ARKIVOC, P154, DOI 10.3998/ark.5550190.0014.105; Nakano H, 1999, EUR J BIOCHEM, V260, P120, DOI 10.1046/j.1432-1327.1999.00124.x; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; Peng Q, 1997, CANCER-AM CANCER SOC, V79, P2282; Petersen M, 1999, GREEN CHEM, V1, P99, DOI 10.1039/a809538h; Romero E, 2012, BBA-PROTEINS PROTEOM, V1824, P850, DOI 10.1016/j.bbapap.2012.03.004; Shen WJ, 2010, BIORESOURCE TECHNOL, V101, P7516, DOI 10.1016/j.biortech.2010.04.052; Sucharitakul J, 2013, J BIOL CHEM, V288, P35210, DOI 10.1074/jbc.M113.515205; Sun JQ, 2014, APPL MICROBIOL BIOT, V98, P455, DOI 10.1007/s00253-013-4818-9; Tang HZ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003923; Tang HZ, 2011, J BIOL CHEM, V286, P39179, DOI 10.1074/jbc.M111.283929; Treiber N, 2008, J MOL BIOL, V379, P94, DOI 10.1016/j.jmb.2008.03.032; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; WAN P, 1988, J AM CHEM SOC, V110, P4336, DOI 10.1021/ja00221a038; Wang SN, 2007, MICROBIOL-SGM, V153, P1556, DOI 10.1099/mic.0.2006/005223-0; Wang SN, 2005, ENVIRON SCI TECHNOL, V39, P6877, DOI 10.1021/es0500759; Wei Q, 2010, BIODEGRADATION, V21, P575, DOI 10.1007/s10532-009-9325-4; Wu XF, 2013, CHEM REV, V113, P1, DOI 10.1021/cr300100s; Yu H, 2011, J BACTERIOL, V193, P5541, DOI 10.1128/JB.05663-11; Zhang JJ, 2009, J BACTERIOL, V191, P2703, DOI 10.1128/JB.01566-08	42	23	26	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29158	29170		10.1074/jbc.M114.558049	http://dx.doi.org/10.1074/jbc.M114.558049			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25172510	Green Published, hybrid			2022-12-25	WOS:000344141000032
J	Desai, M; Buff, AM; Khagayi, S; Byass, P; Amek, N; van Eijk, A; Slutsker, L; Vulule, J; Odhiambo, FO; Phillips-Howard, PA; Lindblade, KA; Laserson, KF; Hamel, MJ				Desai, Meghna; Buff, Ann M.; Khagayi, Sammy; Byass, Peter; Amek, Nyaguara; van Eijk, Annemieke; Slutsker, Laurence; Vulule, John; Odhiambo, Frank O.; Phillips-Howard, Penelope A.; Lindblade, Kimberly A.; Laserson, Kayla F.; Hamel, Mary J.			Age-Specific Malaria Mortality Rates in the KEMRI/CDC Health and Demographic Surveillance System in Western Kenya, 2003-2010	PLOS ONE			English	Article							CHILD-MORTALITY; INTERVA-4; IMPACT	Recent global malaria burden modeling efforts have produced significantly different estimates, particularly in adult malaria mortality. To measure malaria control progress, accurate malaria burden estimates across age groups are necessary. We determined age-specific malaria mortality rates in western Kenya to compare with recent global estimates. We collected data from 148,000 persons in a health and demographic surveillance system from 2003-2010. Standardized verbal autopsies were conducted for all deaths; probable cause of death was assigned using the InterVA-4 model. Annual malaria mortality rates per 1,000 person-years were generated by age group. Trends were analyzed using Poisson regression. From 2003-2010, in children <5 years the malaria mortality rate decreased from 13.2 to 3.7 per 1,000 person-years; the declines were greatest in the first three years of life. In children 5-14 years, the malaria mortality rate remained stable at 0.5 per 1,000 person-years. In persons >= 15 years, the malaria mortality rate decreased from 1.5 to 0.4 per 1,000 person-years. The malaria mortality rates in young children and persons aged >= 15 years decreased dramatically from 2003-2010 in western Kenya, but rates in older children have not declined. Sharp declines in some age groups likely reflect the national scale up of malaria control interventions and rapid expansion of HIV prevention services. These data highlight the importance of agespecific malaria mortality ascertainment and support current strategies to include all age groups in malaria control interventions.	[Desai, Meghna; Phillips-Howard, Penelope A.; Laserson, Kayla F.] Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent, KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya; [Desai, Meghna; Slutsker, Laurence; Lindblade, Kimberly A.; Hamel, Mary J.] CGH, DPDM, Atlanta, GA USA; [Buff, Ann M.] Presidents Malaria Initiat Kenya, CDC, CGH, DPDM, Nairobi, Kenya; [Khagayi, Sammy; Amek, Nyaguara; Odhiambo, Frank O.] KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya; [Khagayi, Sammy; Amek, Nyaguara; Vulule, John; Odhiambo, Frank O.] KEMRI Ctr Global Hlth Res, Kisumu, Kenya; [Byass, Peter] Umea Ctr Global Hlth Res, WHO Collaborating Ctr Verbal Autopsy, Umea, Sweden; [van Eijk, Annemieke] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Phillips-Howard, Penelope A.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Laserson, Kayla F.] CDC, Ctr Global Hlth, Atlanta, GA 30333 USA	Kenya Medical Research Institute; Liverpool School of Tropical Medicine; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool; Centers for Disease Control & Prevention - USA	Desai, M (corresponding author), Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent, KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya.	mdesai@cdc.gov	van Eijk, Anna Maria/AAQ-9894-2021	Lindblade, Kim/0000-0002-5593-0470; Phillips-Howard, Penelope A/0000-0003-1018-116X; Byass, Peter/0000-0001-5474-4361; van Eijk, Anna Maria/0000-0003-1635-1289	President's Emergency Plan for AIDS Relief (PEPFAR); U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Global HIV/AIDS (DGHA) [GH10-1001]; Division of Parasitic Diseases and Malaria (DPDM); HDSS; INDEPTH network	President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Global HIV/AIDS (DGHA); Division of Parasitic Diseases and Malaria (DPDM); HDSS; INDEPTH network	The KEMRI/CDC HDSS receives funding from the President's Emergency Plan for AIDS Relief (PEPFAR) and the President's Malaria Initiative (PMI) through cooperative agreement No. GH10-1001 from the U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Global HIV/AIDS (DGHA) and Division of Parasitic Diseases and Malaria (DPDM). Funding has also been received through the studies nested in the HDSS and the INDEPTH network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; [Anonymous], 2008, WORLD MAL REP 2008; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Byass P, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.22448; Byass P, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19281; Demombynes G, 2012, WHAT HAS DRIVEN DELI; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; DOMC, 2011, KEN MAL IND SURV 201; Feikin DR, 2010, B WORLD HEALTH ORGAN, V88, P601, DOI 10.2471/BLT.09.069732; Gargano JW, 2012, AIDS, V26, P1545, DOI 10.1097/QAD.0b013e328353b7b9; Griffin JT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4136; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hightower A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-183; KEMRI/CDC, 2010, KEMRI CDC HLTH DEM S; Larson E, 2014, INT J STD AIDS, V25, P636, DOI 10.1177/0956462413515639; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; NASCOP, 2013, KEN AIDS IND SURV 20; National AIDS and STI Control Program (NASCOP), 2009, KEN AIDS IND SURV 20; NMCP DOPH MOH, 2015, UPD GUID MAL DIAGN T; Noor AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-369; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Phillips-Howard PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047017; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Wang H, 2014, LANCET; WHO, 2011, WORLD MALARIA REPORT 2011, P1; World Health Organization, 2012, VERB AUT STAND 2012; World Health Organization, 2005, MAL CONTR TOD CURR W; Zurovac D, 2008, TROP MED INT HEALTH, V13, P784, DOI 10.1111/j.1365-3156.2008.02072.x	29	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106197	10.1371/journal.pone.0106197	http://dx.doi.org/10.1371/journal.pone.0106197			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180495	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000341231500058
J	Bermond, G; Cavigliasso, F; Mallez, S; Spencer, J; Guillemaud, T				Bermond, Gerald; Cavigliasso, Fanny; Mallez, Sophie; Spencer, Joseph; Guillemaud, Thomas			No Clear Effect of Admixture between Two European Invading Outbreaks of Diabrotica virgifera virgifera in Natura	PLOS ONE			English	Article							WESTERN CORN-ROOTWORM; MULTIPLE TRANSATLANTIC INTRODUCTIONS; LIFE-HISTORY STRATEGIES; GENETIC-VARIATION; OUTBREEDING DEPRESSION; INBREEDING DEPRESSION; INVASIVE POPULATIONS; INTRASPECIFIC HYBRIDIZATION; BIOLOGICAL INVASIONS; SUCCESS	In this study, we challenged the hypothesis that admixture may have had a positive impact in the context of the European invasion of the western corn rootworm (WCR), Diabrotica virgifera virgifera, LeConte. This beetle was introduced in Europe from the USA several times since the 1980's. The multiple introductions of this major pest of cultivated corn led to the formation of two major outbreaks in North Western (NW) Italy and in Central and South Eastern (CSE) Europe that eventually merged into a secondary contact zone where insects from both outbreaks interbreed. We collected about 600 insects from this contact zone and genotyped them using 13 microsatellite markers. Three types of information were obtained from the collected individuals: (i) their survival under starvation; (ii) their admixed status, determined through a Bayesian method of genetic clustering and (iii) their mating probability, studied via the detection, isolation and genotyping of sperm in female spermathecae. Twenty six % and 12% of the individuals were assigned to the NW Italy or the CSE Europe parental types, respectively, and 23% and 39% to the F1 and backcross hybrid types, respectively. Globally, our results do not reveal any significant impact of the admixed status on the mating probability and on the choice of mating partners. However the admixed status had a sex-and sampling site-dependent effect on survival in adults under starvation. In addition sex had an effect on survival, with mortality hazard about 3 times larger in males than in females. The consequences of these findings for the evolution of the admixture zone of northern Italy are discussed.	[Bermond, Gerald; Cavigliasso, Fanny; Mallez, Sophie; Guillemaud, Thomas] INRA, Inst Sophia Agrobiotech, UMR 1355, Sophia Antipolis, France; [Bermond, Gerald; Cavigliasso, Fanny; Mallez, Sophie; Guillemaud, Thomas] Univ Nice Sophia Antipolis, UMR Inst Sophia Agrobiotech, Sophia Antipolis, France; [Bermond, Gerald; Cavigliasso, Fanny; Mallez, Sophie; Guillemaud, Thomas] CNRS, Inst Sophia Agrobiotech, UMR 7254, Sophia Antipolis, France; [Spencer, Joseph] Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	Bermond, G (corresponding author), INRA, Inst Sophia Agrobiotech, UMR 1355, Sophia Antipolis, France.	geraldbermond@gmail.com	guillemaud, thomas/B-4899-2012; Spencer, Joe/B-6876-2012	guillemaud, thomas/0000-0003-0451-1644; Spencer, Joe/0000-0003-4757-563X; Cavigliasso, Fanny/0000-0002-7764-4934	Agence Nationale de la Recherche [ANR-06-BDIV-008-01, ANR-09-BLAN-0145-01]; Agropolis Foundation (RTRA-Montpellier, BIOFIS) [1001-001]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Agropolis Foundation (RTRA-Montpellier, BIOFIS)	This work was supported by a grant from the Agence Nationale de la Recherche (ANR-06-BDIV-008-01 and ANR-09-BLAN-0145-01) and from the Agropolis Foundation (RTRA-Montpellier, BIOFIS project number 1001-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendroth, 2011, IOWA STATE U PUBLICA; Allee W., 1949, PRINCIPLES ANIMAL EC; Anderson EC, 2002, GENETICS, V160, P1217; Anderson EC, 2003, TECHNICAL REPORT; Arnaud Ludovic, 1999, Biotechnologie Agronomie Societe et Environnement, V3, P86; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P13; Benvenuto C, 2012, EVOL ECOL, V26, P1311, DOI 10.1007/s10682-011-9553-z; Bermond G, 2013, MOL ECOL, V22, P5368, DOI 10.1111/mec.12489; Bermond G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050129; BRANSON TF, 1981, ENVIRON ENTOMOL, V10, P826, DOI 10.1093/ee/10.6.826; Chapple DG, 2013, DIVERS DISTRIB, V19, P134, DOI 10.1111/j.1472-4642.2012.00919.x; CHIANG HC, 1973, ANNU REV ENTOMOL, V18, P47, DOI 10.1146/annurev.en.18.010173.000403; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; COX DR, 1972, J R STAT SOC B, V34, P187; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dobzhansky T., 1952, Heterosis., P218; Drake JM, 2006, BIOL LETTERS, V2, P304, DOI 10.1098/rsbl.2006.0459; Edmands S, 1999, EVOLUTION, V53, P1757, DOI 10.1111/j.1558-5646.1999.tb04560.x; Edmands S, 2002, TRENDS ECOL EVOL, V17, P520, DOI 10.1016/S0169-5347(02)02585-5; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Elton C. S., 1958, ECOLOGY INVASIONS AN; Escobar JS, 2008, GENETICS, V180, P1593, DOI 10.1534/genetics.108.092718; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Facon B, 2005, J EVOLUTION BIOL, V18, P524, DOI 10.1111/j.1420-9101.2005.00887.x; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Falush D, 2003, GENETICS, V164, P1567; Fauvergue X, 2012, EVOL APPL, V5, P424, DOI 10.1111/j.1752-4571.2012.00272.x; Fitzpatrick BM, 2008, AM NAT, V171, P491, DOI 10.1086/528991; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Glemin S, 2011, GENETICS, V187, P217, DOI 10.1534/genetics.110.120808; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Gurevitch J, 2011, ECOL LETT, V14, P407, DOI 10.1111/j.1461-0248.2011.01594.x; HILL RE, 1975, J ECON ENTOMOL, V68, P311, DOI 10.1093/jee/68.3.311; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; Kolbe JJ, 2008, BIOL LETTERS, V4, P434, DOI 10.1098/rsbl.2008.0205; Kolbe JJ, 2007, CONSERV BIOL, V21, P1612, DOI 10.1111/j.1523-1739.2007.00826.x; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Li H, 2010, J APPL ENTOMOL, V134, P449, DOI 10.1111/j.1439-0418.2009.01489.x; LUDWIG KA, 1975, ENVIRON ENTOMOL, V4, P435, DOI 10.1093/ee/4.3.435; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Miller NJ, 2007, J APPL ENTOMOL, V131, P378, DOI 10.1111/j.1439-0418.2007.01190.x; Moeser J, 2005, ENTOMOL EXP APPL, V114, P55, DOI 10.1111/j.0013-8703.2005.00228.x; Moody ML, 2002, P NATL ACAD SCI USA, V99, P14867, DOI 10.1073/pnas.172391499; Moyle PB, 1996, ECOLOGY, V77, P1666, DOI 10.2307/2265770; Murphy AF, 2011, ENVIRON ENTOMOL, V40, P1585, DOI 10.1603/EN11137; Nei M., 1987, MOL EVOLUTIONARY GEN; Orians CM, 2000, AM J BOT, V87, P1749, DOI 10.2307/2656824; Orr HA, 2001, EVOLUTION, V55, P1085; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; QUIRING DT, 1990, J APPL ECOL, V27, P965, DOI 10.2307/2404390; R Development Core Team, 2012, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reif JC, 2003, CROP SCI, V43, P1275, DOI 10.2135/cropsci2003.1275; Rieux A, 2013, ECOL LETT, V16, P721, DOI 10.1111/ele.12090; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schierup MH, 1996, HEREDITY, V77, P461, DOI 10.1038/hdy.1996.172; Shull, 1914, Z INDUKT ABSTAMMUNGS, V12, P97, DOI DOI 10.1007/BF01837282; SMITH RAY F., 1966, BULL ENTOMOL SOC AMER, V12, P108; Spencer JL, 2009, AGR FOREST ENTOMOL, V11, P9, DOI 10.1111/j.1461-9563.2008.00399.x; Tallmon DA, 2004, GENETICS, V167, P977, DOI 10.1534/genetics.103.026146; Taylor DR, 2007, EVOLUTION, V61, P334, DOI 10.1111/j.1558-5646.2007.00037.x; Turelli M, 2000, GENETICS, V154, P1663; Vahed K, 1998, BIOL REV, V73, P43, DOI 10.1017/S0006323197005112; Verhoeven KJF, 2011, P ROY SOC B-BIOL SCI, V278, P2, DOI 10.1098/rspb.2010.1272; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Willi Y, 2005, HEREDITY, V95, P437, DOI 10.1038/sj.hdy.6800732; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769	82	2	3	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106139	10.1371/journal.pone.0106139	http://dx.doi.org/10.1371/journal.pone.0106139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170837	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500114
J	Dahl, KA; Patterson, WF				Dahl, Kristen A.; Patterson, William F., III			Habitat-Specific Density and Diet of Rapidly Expanding Invasive Red Lionfish, Pterois volitans, Populations in the Northern Gulf of Mexico	PLOS ONE			English	Article							INDO-PACIFIC LIONFISH; FLORIDA-KEYS; BIOLOGICAL INVASIONS; ARTIFICIAL REEFS; ATLANTIC; PREDATION; MILES; CONSEQUENCES; RECRUITMENT; CALIFORNIA	Invasive Indo-Pacific red lionfish, Pterois volitans, were first reported in the northern Gulf of Mexico (nGOM) in summer 2010. To examine potential impacts on native reef fish communities, lionfish density and size distributions were estimated from fall 2010 to fall 2013 with a remotely operated vehicle at natural (n = 16) and artificial (n = 22) reef sites. Lionfish (n = 934) also were sampled via spearfishing to examine effects of habitat type, season, and fish size on their diet and trophic ecology. There was an exponential increase in lionfish density at both natural and artificial reefs over the study period. By fall 2013, mean lionfish density at artificial reefs (14.7 fish 100 m(-2)) was two orders of magnitude higher than at natural reefs (0.49 fish 100 m(-2)), and already was among the highest reported in the western Atlantic. Lionfish diet was significantly different among habitats, seasons, and size classes, with smaller (<250 mm total length) fish consuming more benthic invertebrates and the diet of lionfish sampled from artificial reefs being composed predominantly of non-reef associated prey. The ontogenetic shift in lionfish feeding ecology was consistent with delta N-15 values of white muscle tissue that were positively related to total length. Overall, diet results indicate lionfish are generalist mesopredators in the nGOM that become more piscivorous at larger size. However, lionfish diet was much more varied at artificial reef sites where they clearly were foraging on open substrates away from reef structure. These results have important implications for tracking the lionfish invasion in the nGOM, as well as estimating potential direct and indirect impacts on native reef fish communities in this region.	[Dahl, Kristen A.; Patterson, William F., III] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA	University of South Alabama	Dahl, KA (corresponding author), Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA.	kristenadahl@gmail.com		Dahl, Kristen/0000-0003-4939-1084	BP/The Gulf of Mexico Research Initiative; Florida Institute of Oceanography Block Grant; GoMRI Center for the Integrated Modeling and Analysis of the Gulf Ecosystem; Florida Fish and Wildlife Conservation Commission and the Florida Fish and Wildlife Research Institute [FWC-08304]	BP/The Gulf of Mexico Research Initiative; Florida Institute of Oceanography Block Grant; GoMRI Center for the Integrated Modeling and Analysis of the Gulf Ecosystem; Florida Fish and Wildlife Conservation Commission and the Florida Fish and Wildlife Research Institute	This research was made possible in part by a grant from BP/The Gulf of Mexico Research Initiative, Florida Institute of Oceanography Block Grant, and GoMRI Center for the Integrated Modeling and Analysis of the Gulf Ecosystem (http://gulfresearchinitiative.org/). Funding for this study was also received in part from the Florida Fish and Wildlife Conservation Commission and the Florida Fish and Wildlife Research Institute, Grant FWC-08304 (http://myfwc. com/research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrenholz DW, 2010, ENVIRON BIOL FISH, V88, P305, DOI 10.1007/s10641-010-9647-4; Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Albins MA, 2013, BIOL INVASIONS, V15, P29, DOI 10.1007/s10530-012-0266-1; Albins MA, 2013, ENVIRON BIOL FISH, V96, P1151, DOI 10.1007/s10641-011-9795-1; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Aquilar-Perera A, 2010, AQUAT INVASIONS, V5, pS19; Benkwitt CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066995; Bowen Stephen H., 1996, P513; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; CARLTON JT, 1989, CONSERV BIOL, V3, P265, DOI 10.1111/j.1523-1739.1989.tb00086.x; CARR MH, 1995, MAR ECOL PROG SER, V124, P31, DOI 10.3354/meps124031; Carr MH, 1997, FISHERIES, V22, P28, DOI 10.1577/1548-8446(1997)022<0028:ARTIOC>2.0.CO;2; Caut S, 2008, J APPL ECOL, V45, P428, DOI 10.1111/j.1365-2664.2007.01438.x; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cote IM, 2013, BIOL CONSERV, V164, P50, DOI 10.1016/j.biocon.2013.04.014; Cote IM, 2010, MAR ECOL PROG SER, V404, P219, DOI 10.3354/meps08458; Dance MA, 2011, B MAR SCI, V87, P301, DOI 10.5343/bms.2010.1040; Darling ES, 2011, BIOL INVASIONS, V13, P2045, DOI 10.1007/s10530-011-0020-0; Diller JL, 2014, J EXP MAR BIOL ECOL, V455, P45, DOI 10.1016/j.jembe.2014.02.014; Fogg Alexander Q., 2013, Gulf and Caribbean Research, V25, P111; Green SJ, 2009, CORAL REEFS, V28, P107, DOI 10.1007/s00338-008-0446-8; Green SJ, 2011, MAR ECOL PROG SER, V433, P159, DOI 10.3354/meps09208; Green SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032596; Grosholz ED, 2000, ECOLOGY, V81, P1206, DOI 10.2307/177202; Hackerott S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068259; HACUNDA JS, 1981, FISH B-NOAA, V79, P775; Hornstra Heidie M., 2004, Journal of Morphology, V260, P299; JONES GP, 1987, ECOLOGY, V68, P1534, DOI 10.2307/1939237; Jud ZR, 2012, J EXP MAR BIOL ECOL, V414, P69, DOI 10.1016/j.jembe.2012.01.015; Jud ZR, 2011, AQUAT BIOL, V13, P21, DOI 10.3354/ab00351; Kimball ME, 2004, MAR ECOL PROG SER, V283, P269, DOI 10.3354/meps283269; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kulbicki M, 2012, MAR ECOL PROG SER, V446, P189, DOI 10.3354/meps09442; LEE TN, 1992, CONT SHELF RES, V12, P971, DOI 10.1016/0278-4343(92)90055-O; Lee TN, 1999, B MAR SCI, V64, P35; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Lindeman KC, 2000, B MAR SCI, V66, P929; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Maljkovic A, 2008, CORAL REEFS, V27, P501, DOI 10.1007/s00338-008-0372-9; McDonald PS, 2001, J EXP MAR BIOL ECOL, V258, P39, DOI 10.1016/S0022-0981(00)00344-0; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Moncreiff CA, 2001, MAR ECOL PROG SER, V215, P93, DOI 10.3354/meps215093; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Morris, 2009, THESIS N CAROLINA ST; Morris J.A., 2009, NOAA TECH MEMO NOS N, V99, P1; Morris JA, 2011, SCI MAR, V75, P147, DOI 10.3989/scimar.2011.75n1147; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Moyle PB, 2006, BIOSCIENCE, V56, P515, DOI 10.1641/0006-3568(2006)56[515:PISFFI]2.0.CO;2; Mumby PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021510; Munoz RC, 2011, MAR ECOL PROG SER, V432, P181, DOI 10.3354/meps09154; Nuttall MF, 2014, BIOINVASION IN PRESS, V3; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Patterson III WF, 2009, P GULF CARIB FISH I, V61, P263; Patterson W. F. III, 2014, P 66 GULF CAR FISH I, P4; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Ruiz GM, 1997, AM ZOOL, V37, P621; Ruttenberg BI, 2012, B MAR SCI, V88, P1051, DOI 10.5343/bms.2011.1108; Schofield P. J., 2013, PTEROIS VOLITANS MIL; Schofield PJ, 2010, AQUAT INVASIONS, V5, pS117, DOI 10.3391/ai.2010.5.S1.024; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; Smith NS, 2010, P GULF CARIB FISH I, V63, P342; Strelcheck AJ, 2005, B MAR SCI, V77, P425; Tarnecki JH, 2014, P GULF CARI IN PRESS, V67; Turpin RK, 2002, ICES J MAR SCI, V59, pS74, DOI 10.1006/jmsc.2002.1191; Webster MS, 2002, OECOLOGIA, V131, P52, DOI 10.1007/s00442-001-0860-x; Whitfield PE, 2007, BIOL INVASIONS, V9, P53, DOI 10.1007/s10530-006-9005-9	69	84	87	4	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105852	10.1371/journal.pone.0105852	http://dx.doi.org/10.1371/journal.pone.0105852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170922	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500073
J	Hadji, L; Berger, E; Soula, H; Vidal, H; Geloen, A				Hadji, Lilas; Berger, Emmanuelle; Soula, Hedi; Vidal, Hubert; Geloen, Alain			White Adipose Tissue Resilience to Insulin Deprivation and Replacement	PLOS ONE			English	Article							CELL-SIZE; LEPTIN SECRETION; BODY-COMPOSITION; GENE-EXPRESSION; PPAR-GAMMA; ADIPOCYTE; MECHANISMS; OBESITY; INDIVIDUALS; RESISTANT	Introduction: Adipocyte size and body fat distribution are strongly linked to the metabolic complications of obesity. The aim of the present study was to test the plasticity of white adipose tissue in response to insulin deprivation and replacement. We have characterized the changes of adipose cell size repartition and gene expressions in type 1 diabetes Sprague-Dawley rats and type 1 diabetic supplemented with insulin. Methods: Using streptozotocin (STZ)-induced diabetes, we induced rapid changes in rat adipose tissue weights to study the changes in the distribution of adipose cell sizes in retroperitoneal (rWAT), epididymal (eWAT) and subcutaneous adipose tissues (scWAT). Adipose tissue weights of type 1 diabetic rats were then rapidly restored by insulin supplementation. Cell size distributions were analyzed using multisizer IV (Beckman Coulter). Cell size changes were correlated to transcriptional regulation of genes coding for proteins involved in lipid and glucose metabolisms and adipocytokines. Results: The initial body weight of the rats was 46565.2 g. Insulin privation was stopped when rats lost 100 g which induced reductions in fat mass of 68% for rWAT, 42% for eWAT and 59% for scWAT corresponding to decreased mode cell diameters by 31.1%, 20%, 25.3%, respectively. The most affected size distribution by insulin deprivation was observed in rWAT. The bimodal distribution of adipose cell sizes disappeared in response to insulin deprivation in rWAT and scWAT. The most important observation is that cell size distribution returned close to control values in response to insulin treatment. mRNAs coding for adiponectin, leptin and apelin were more stimulated in scWAT compared to other depots in diabetic plus insulin group. Conclusion: Fat depots have specific responses to insulin deprivation and supplementation. The results show that insulin is a major determinant of bimodal cell repartition in adipose tissues.	[Hadji, Lilas; Berger, Emmanuelle; Soula, Hedi; Vidal, Hubert; Geloen, Alain] Univ Lyon, CARMEN INSERM U1060, INSA Lyon, F-69621 Villeurbanne, France; [Soula, Hedi] IXXI Complex Syst Inst, F-69007 Lyon, France; [Soula, Hedi] EPI BEAGLE INRIA, F-69621 Villeurbanne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Geloen, A (corresponding author), Univ Lyon, CARMEN INSERM U1060, INSA Lyon, F-69621 Villeurbanne, France.	alain.geloen@insa-lyon.fr	Carmen, Team1/Y-7382-2019; Vidal, Hubert/M-6674-2017	Carmen, Team1/0000-0003-4234-1746; Vidal, Hubert/0000-0002-9467-0317; GELOEN, Alain/0000-0001-7921-1254; Lab, Carmen/0000-0002-5935-3236	French "Ministere de la Recherche et de la Technologie"	French "Ministere de la Recherche et de la Technologie"	LH was the recipient for a grant from the French "Ministere de la Recherche et de la Technologie". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AT, 2013, EUR J CELL BIOL, V92, P229, DOI 10.1016/j.ejcb.2013.06.001; [Anonymous], 2002, INT J POSTCOLONIAL S, V4, DOI DOI 10.1029/2001WR000759; BAILEY JW, 1993, J NUTR, V123, P52, DOI 10.1093/jn/123.1.52; Cammisotto PG, 2002, AM J PHYSIOL-CELL PH, V283, pC244, DOI 10.1152/ajpcell.00033.2002; Carmean CM, 2014, BBA-MOL BASIS DIS, V1842, P424, DOI 10.1016/j.bbadis.2013.06.004; Czech MP, 2013, DIABETOLOGIA, V56, P949, DOI 10.1007/s00125-013-2869-1; DEMARTINIS FD, 1982, J LIPID RES, V23, P1107; Dulloo AG, 2012, OBES REV, V13, P1, DOI 10.1111/j.1467-789X.2012.01032.x; Farnier C, 2003, INT J OBESITY, V27, P1178, DOI 10.1038/sj.ijo.0802399; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; GELOEN A, 1989, AM J PHYSIOL, V257, pE547, DOI 10.1152/ajpendo.1989.257.4.E547; GELOEN A, 1989, AM J PHYSIOL, V256, pC190, DOI 10.1152/ajpcell.1989.256.1.C190; Hammarstedt A, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-42; Harris RBS, 2014, BBA-MOL BASIS DIS, V1842, P414, DOI 10.1016/j.bbadis.2013.05.009; HIRSCH J, 1968, J LIPID RES, V9, P110; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Leal VD, 2013, CLIN CHIM ACTA, V419, P87, DOI 10.1016/j.cca.2013.02.003; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; McLaughlin T, 2010, DIABETOLOGIA, V53, P369, DOI 10.1007/s00125-009-1496-3; Meyer LK, 2013, ADIPOCYTE, V2, P217, DOI 10.4161/adip.24953; Pasarica M, 2009, J CLIN ENDOCR METAB, V94, P5155, DOI 10.1210/jc.2009-0947; Patel P, 2013, J OBES, V2013, DOI 10.1155/2013/489187; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; RODBELL M, 1964, J BIOL CHEM, V239, P375; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Soula HA, 2013, J THEOR BIOL, V332, P89, DOI 10.1016/j.jtbi.2013.04.025; Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Stephens JM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001436; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Tentolouris N, 2006, ANN NY ACAD SCI, V1083, P129, DOI 10.1196/annals.1367.010; Thompson D, 1999, ARCH INTERN MED, V159, P2177, DOI 10.1001/archinte.159.18.2177; Veilleux A, 2011, DIABETES, V60, P1504, DOI 10.2337/db10-1039; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang Y, 2014, BIOCHEM J, V458, P491, DOI 10.1042/BJ20131176; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Zhang YY, 2014, OBESITY, V22, P691, DOI 10.1002/oby.20528	42	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106214	10.1371/journal.pone.0106214	http://dx.doi.org/10.1371/journal.pone.0106214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170835	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500125
J	Hagihara, GN; Lobato, NS; Filgueira, FP; Akamine, EH; Aragao, DS; Casarini, DE; Carvalho, MHC; Fortes, ZB				Hagihara, Graziela N.; Lobato, Nubia S.; Filgueira, Fernando P.; Akamine, Eliana H.; Aragao, Danielle S.; Casarini, Dulce E.; Carvalho, Maria Helena C.; Fortes, Zuleica B.			Upregulation of ERK1/2-eNOS via AT2 Receptors Decreases the Contractile Response to Angiotensin II in Resistance Mesenteric Arteries from Obese Rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TYPE-2 RECEPTOR; AT(2) RECEPTOR; STIMULATED CONTRACTION; AT(1) RECEPTOR; IN-VIVO; KINASE; SYSTEM; ACTIVATION; MECHANISMS	It has been clearly established that mitogen-activated protein kinases (MAPKS) are important mediators of angiotensin II (Ang II) signaling via AT1 receptors in the vasculature. However, evidence for a role of these kinases in changes of Ang II-induced vasoconstriction in obesity is still lacking. Here we sought to determine whether vascular MAPKs are differentially activated by Ang II in obese animals. The role of AT2 receptors was also evaluated. Male monosodium glutamate-induced obese (obese) and non-obese Wistar rats (control) were used. The circulating concentrations of Ang I and Ang II, determined by HPLC, were increased in obese rats. Ang II-induced isometric contraction was decreased in endothelium-intact resistance mesenteric arteries from obese compared with control rats and exhibited a retarded AT1 receptor antagonist response. Blocking of AT2 receptors and inhibition of either endothelial nitric oxide synthase (eNOS) or extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) restored Ang II-induced contraction in obese rats. Western blot analysis revealed increased protein expression of AT2 receptors in arteries from obese rats. Basal and Ang II-induced ERK1/2 phosphorylation was also increased in obese rats. Blockade of either AT1 or AT2 receptors corrected the increased ERK1/2 phosphorylation in arteries from obese rats to levels observed in control preparations. Phosphorylation of eNOS was increased in obese rats. Incubation with the ERK1/2 inhibitor before Ang II stimulation did not affect eNOS phosphorylation in control rats; however, it corrected the increased phosphorylation of eNOS in obese rats. These results clearly demonstrate that enhanced AT2 receptor and ERK1/2-induced, NO-mediated vasodilation reduces Ang II-induced contraction in an endothelium-dependent manner in obese rats.	[Hagihara, Graziela N.; Akamine, Eliana H.; Carvalho, Maria Helena C.; Fortes, Zuleica B.] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil; [Lobato, Nubia S.; Filgueira, Fernando P.] Univ Fed Goias, Div Cardiovasc Physiol, Dept Biol Sci, Jatai, Brazil; [Aragao, Danielle S.; Casarini, Dulce E.] Univ Fed Sao Paulo, Div Nephrol, Dept Med, Escola Paulista Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Goias; Universidade Federal de Sao Paulo (UNIFESP)	Fortes, ZB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil.	zbfortes@icb.usp.br	Akamine, Eliana Hiromi/C-5231-2012; Hagihara, Graziela/P-6459-2016; Filgueira, Fernando/C-5668-2013; Casarini, Dulce E/D-4091-2012; Carvalho, Maria Helena C/C-8539-2013	Akamine, Eliana Hiromi/0000-0003-2715-7158; Filgueira, Fernando/0000-0001-8910-1796; Casarini, Dulce/0000-0003-1912-4292	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2007/58311-0, 2008/51622-3, 2010/03642-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - INCT Obesity and Diabetes; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - INCT Obesity and Diabetes; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2007/58311-0, 2008/51622-3 and 2010/03642-5], Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - INCT Obesity and Diabetes and individual research grants to MHCC and ZBF -, and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akishita M, 1999, BIOCHEM BIOPH RES CO, V261, P345, DOI 10.1006/bbrc.1999.1027; Akishita M, 2000, PHYSIOL GENOMICS, V2, P13; Barber MN, 1999, HYPERTENSION, V34, P1112, DOI 10.1161/01.HYP.34.5.1112; Barton M, 2000, HYPERTENSION, V35, P329, DOI 10.1161/01.HYP.35.1.329; Batenburg WW, 2004, CIRCULATION, V109, P2296, DOI 10.1161/01.CIR.0000128696.12245.57; Bilman V, 2012, PEPTIDES, V37, P247, DOI 10.1016/j.peptides.2012.08.002; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Carey RM, 2005, HYPERTENSION, V45, P840, DOI 10.1161/01.HYP.0000159192.93968.8f; Carey RM, 2003, ENDOCR REV, V24, P261, DOI 10.1210/er.2003-0001; CHIU AT, 1989, BIOCHEM BIOPH RES CO, V165, P196, DOI 10.1016/0006-291X(89)91054-1; Chung O, 1999, J HUM HYPERTENS, V13, pS11, DOI 10.1038/sj.jhh.1000744; Engeli S, 2001, J MOL MED, V79, P21, DOI 10.1007/s001090000144; Ferreira AJ, 2010, HYPERTENSION, V55, P207, DOI 10.1161/HYPERTENSIONAHA.109.140145; Franco MCP, 2008, CLIN SCI, V114, P375, DOI 10.1042/CS20070284; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Hakam AC, 2005, HYPERTENSION, V45, P270, DOI 10.1161/01.HYP.0000151622.47814.6f; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hiyoshi H, 2005, HYPERTENSION, V45, P967, DOI 10.1161/01.HYP.0000164571.77710.19; Ishida M, 1998, CIRC RES, V82, P7; Ishida T, 1999, J CLIN INVEST, V103, P789, DOI 10.1172/JCI4189; JUUL B, 1987, EUR J PHARMACOL, V135, P61, DOI 10.1016/0014-2999(87)90757-6; LASSEGUE B, 1995, MOL PHARMACOL, V48, P601; Lee JH, 2008, AM J PHYSIOL-REG I, V295, pR144, DOI 10.1152/ajpregu.00191.2008; Lobato NS, 2011, NUTR METAB CARDIOVAS, V21, P808, DOI 10.1016/j.numecd.2010.02.006; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazzacoratti M.G.Naffah, 1992, ARQ BRAS ENDOCRINOL, V36, P119; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Meloche S, 2000, AM J PHYSIOL-HEART C, V279, pH741, DOI 10.1152/ajpheart.2000.279.2.H741; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Rahmouni K, 2004, AM J PHYSIOL-ENDOC M, V286, pE891, DOI 10.1152/ajpendo.00551.2003; SANTOS RAS, 1985, HYPERTENSION, V7, P244, DOI 10.1161/01.HYP.7.2.244; Santos RAS, 2007, CURR OPIN NEPHROL HY, V16, P122, DOI 10.1097/MNH.0b013e328031f362; Santos SHS, 2012, REGUL PEPTIDES, V178, P64, DOI 10.1016/j.regpep.2012.06.009; Siddiqui AH, 2007, AM J PHYSIOL-HEART C, V292, pH1722, DOI 10.1152/ajpheart.00612.2006; Siragy HM, 1997, J CLIN INVEST, V100, P264, DOI 10.1172/JCI119531; Santos SHS, 2014, CURR CLIN PHARMACOL, V9, P2, DOI 10.2174/15748847112079990050; Stepp DW, 2007, AM J PHYSIOL-HEART C, V293, pH2537, DOI 10.1152/ajpheart.01081.2006; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Taniyama Y, 2004, AM J PHYSIOL-CELL PH, V287, P494; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Touyz RM, 1999, J HYPERTENS, V17, P907, DOI 10.1097/00004872-199917070-00006; Touyz RM, 2004, J HYPERTENS, V22, P1141, DOI 10.1097/00004872-200406000-00015; Touyz RM, 1999, HYPERTENSION, V33, P366, DOI 10.1161/01.HYP.33.1.366; Touyz RM, 1999, CIRCULATION, V99, P392, DOI 10.1161/01.CIR.99.3.392; Touyz RM, 2001, HYPERTENSION, V38, P56, DOI 10.1161/01.HYP.38.1.56; TUCK ML, 1981, NEW ENGL J MED, V304, P930, DOI 10.1056/NEJM198104163041602; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Zhao YL, 2005, REGUL PEPTIDES, V128, P43, DOI 10.1016/j.regpep.2004.12.012; Zhou MS, 2010, J CARDIOVASC PHARM T, V15, P78, DOI 10.1177/1074248409354603	49	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106029	10.1371/journal.pone.0106029	http://dx.doi.org/10.1371/journal.pone.0106029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170617	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500090
J	Morshed, KN; Bark, D; Forleo, M; Dasi, LP				Morshed, Khandakar Niaz; Bark, David, Jr.; Forleo, Marcio; Dasi, Lakshmi Prasad			Theory to Predict Shear Stress on Cells in Turbulent Blood Flow	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; ENERGY-DISSIPATION; HEART-VALVES; HEMOLYSIS; VISCOSITY; ACTIVATION; DEPENDENCE; PLATELETS; TRANSPORT; ADHESION	Shear stress on blood cells and platelets transported in a turbulent flow dictates the fate and biological activity of these cells. We present a theoretical link between energy dissipation in turbulent flows to the shear stress that cells experience and show that for the case of physiological turbulent blood flow: (a) the Newtonian assumption is valid, (b) turbulent eddies are universal for the most complex of blood flow problems, and (c) shear stress distribution on turbulent blood flows is possibly universal. Further we resolve a long standing inconsistency in hemolysis between laminar and turbulent flow using the theoretical framework. This work demonstrates that energy dissipation as opposed to bulk shear stress in laminar or turbulent blood flow dictates local mechanical environment of blood cells and platelets universally.	[Morshed, Khandakar Niaz; Bark, David, Jr.; Dasi, Lakshmi Prasad] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA; [Bark, David, Jr.; Forleo, Marcio; Dasi, Lakshmi Prasad] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Dasi, LP (corresponding author), Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.	lakshmi.dasi@colostate.edu			National Institutes of Health (NIH) [R01HL119824]; American Heart Association under award [11SDG5170011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119824] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association under award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding from National Institutes of Health (NIH) under Award Number R01HL119824, and the American Heart Association under award 11SDG5170011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antiga L, 2009, BIORHEOLOGY, V46, P77, DOI 10.3233/BIR-2009-0538; BACHER RP, 1970, J LAB CLIN MED, V76, P485; Bailey SCC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.014502; Bark DL, 2013, BIOPHYS J, V105, P502, DOI 10.1016/j.bpj.2013.05.049; Bark DL, 2010, J BIOMECH, V43, P2970, DOI 10.1016/j.jbiomech.2010.07.011; Bark Jr DL, 2013, SHEAR EFFECTS PLATEL, P1592; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bellofiore A, 2011, ANN BIOMED ENG, V39, P2417, DOI 10.1007/s10439-011-0329-y; Biferale L, 2008, PHYS FLUIDS, V20; BLUESTEI.M, 1969, MED BIOL ENG, V7, P1, DOI 10.1007/BF02474665; Bramwell ST, 1998, NATURE, V396, P552, DOI 10.1038/25083; Brouwers JJH, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2793147; Colace TV, ARTERIOSCLER THROMB, V33, P105; COULTER NA, 1949, AM J PHYSIOL, V159, P401, DOI 10.1152/ajplegacy.1949.159.2.401; Dasi LP, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2743261; Dooley PN, 2009, ANN BIOMED ENG, V37, P2449, DOI 10.1007/s10439-009-9789-8; Fahraeus R, 1931, AM J PHYSIOL, V96, P562, DOI 10.1152/ajplegacy.1931.96.3.562; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; FISCHER TM, 1980, BIOPHYS J, V32, P863, DOI 10.1016/S0006-3495(80)85022-3; Forleo M, 2013, ANN BIOMED ENG, P1, DOI DOI 10.1007/S10439-013-0896-1; Gardiner EE, TRANSFUS MED REV; Gauthier NC, 2012, TRENDS CELL BIOL; Ge L, 2008, ANN BIOMED ENG, V36, P276, DOI 10.1007/s10439-007-9411-x; Geisen U, 2008, EUR J CARDIO-THORAC, V33, P679, DOI 10.1016/j.ejcts.2007.12.047; GERSHFELD NL, 1988, J MEMBRANE BIOL, V101, P67, DOI 10.1007/BF01872821; Ghasemzadeh M, 2013, BLOOD, V121, P4555, DOI 10.1182/blood-2012-09-459636; Grigioni M, 1999, J BIOMECH, V32, P1107, DOI 10.1016/S0021-9290(99)00063-9; HAM TH, 1948, BLOOD, V3, P373, DOI 10.1182/blood.V3.4.373.373; Hamlington PE, 2012, J FLUID MECH, V701, P419, DOI 10.1017/jfm.2012.170; HARRISON P, 1993, BLOOD REV, V7, P52, DOI 10.1016/0268-960X(93)90024-X; HELLUMS JD, 1994, ANN BIOMED ENG, V22, P445, DOI 10.1007/BF02367081; Helms CC, 2013, J THROMB HAEMOST, V11, P2148, DOI 10.1111/jth.12422; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; HUBBELL JA, 1986, BIOPHYS J, V50, P937, DOI 10.1016/S0006-3495(86)83535-4; JONES SA, 1995, ANN BIOMED ENG, V23, P21, DOI 10.1007/BF02368297; Kameneva MV, 2004, ASAIO J, V50, P418, DOI 10.1097/01.MAT.0000136512.36370.B5; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; Meyer AL, 2010, CIRC-HEART FAIL, V3, P675, DOI 10.1161/CIRCHEARTFAILURE.109.877597; Morshed KN, 2013, EXP FLUIDS, V54, DOI 10.1007/s00348-013-1521-7; Morshed KN, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4774039; NELKIN M, 1992, SCIENCE, V255, P566, DOI 10.1126/science.255.5044.566; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Nicklin MJH, 2000, J EXP MED, V191, P303, DOI 10.1084/jem.191.2.303; Nomura S, 2001, ATHEROSCLEROSIS, V158, P277, DOI 10.1016/S0021-9150(01)00433-6; PRIES AR, 1994, CIRC RES, V75, P904, DOI 10.1161/01.RES.75.5.904; Quinlan NJ, 2007, ANN BIOMED ENG, V35, P1347, DOI 10.1007/s10439-007-9308-8; ROONEY JA, 1970, SCIENCE, V169, P869, DOI 10.1126/science.169.3948.869; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Schumacher J, 2007, EPL, V80; Shankaran H, 2003, BLOOD, V101, P2637, DOI 10.1182/blood-2002-05-1550; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Sreenivasan KR, 1997, ANNU REV FLUID MECH, V29, P435, DOI 10.1146/annurev.fluid.29.1.435; SREENIVASAN KR, 1991, ANNU REV FLUID MECH, V23, P539; Tay JH, 2001, APPL MICROBIOL BIOT, V57, P227; TRANSONTAY R, 1984, BIOPHYS J, V46, P65, DOI 10.1016/S0006-3495(84)83999-5; WELLS RE, 1961, SCIENCE, V133, P763, DOI 10.1126/science.133.3455.763; Yakhot V, 2006, PHYSICA D, V215, P166, DOI 10.1016/j.physd.2006.01.012; Yakhot V, 2005, J STAT PHYS, V121, P823, DOI 10.1007/s10955-005-8666-6; Yun BM, 2014, J FLUID MECH, V754, P122, DOI 10.1017/jfm.2014.393; ZYDNEY AL, 1988, PHYSICOCHEM HYDRODYN, V10, P77	60	44	44	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105357	10.1371/journal.pone.0105357	http://dx.doi.org/10.1371/journal.pone.0105357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171175	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500044
J	Zahoor, MA; Xue, GG; Sato, H; Murakami, T; Takeshima, S; Aida, Y				Zahoor, Muhammad Atif; Xue, Guangai; Sato, Hirotaka; Murakami, Tomoyuki; Takeshima, Shin-nosuke; Aida, Yoko			HIV-1 Vpr Induces Interferon-Stimulated Genes in Human Monocyte-Derived Macrophages	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL PROTEIN-R; TERMINALLY TRUNCATED FORM; NUCLEAR IMPORT; T-CELLS; UBIQUITIN LIGASE; APOPTOSIS; REPLICATION; ACTIVATION; INDUCTION	Macrophages act as reservoirs of human immunodeficiency virus type 1 (HIV-1) and play an important role in its transmission to other cells. HIV-1 Vpr is a multi-functional protein involved in HIV-1 replication and pathogenesis; however, its exact role in HIV-1-infected human macrophages remains poorly understood. In this study, we used a microarray approach to explore the effects of HIV-1 Vpr on the transcriptional profile of human monocyte-derived macrophages (MDMs). More than 500 genes, mainly those involved in the innate immune response, the type I interferon pathway, cytokine production, and signal transduction, were differentially regulated (fold change >2.0) after infection with a recombinant adenovirus expressing HIV-1 Vpr protein. The differential expression profiles of select interferon-stimulated genes (ISGs) and genes involved in the innate immune response, including STAT1, IRF7, MX1, MX2, ISG15, ISG20, IFIT1, IFIT2, IFIT3, IFI27, IFI44L, APOBEC3A, DDX58 (RIG-I), TNFSF10 (TRAIL), and RSAD2 (viperin) were confirmed by real-time quantitative PCR and were consistent with the microarray data. In addition, at the post-translational level, HIV-1 Vpr induced the phosphorylation of STAT1 at tyrosine 701 in human MDMs. These results demonstrate that HIV-1 Vpr leads to the induction of ISGs and expand the current understanding of the function of Vpr and its role in HIV-1 immune pathogenesis.	[Zahoor, Muhammad Atif; Xue, Guangai; Sato, Hirotaka; Murakami, Tomoyuki; Takeshima, Shin-nosuke; Aida, Yoko] RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan; [Zahoor, Muhammad Atif; Xue, Guangai] Japanese Fdn AIDS Prevent, Tokyo, Japan	RIKEN	Aida, Y (corresponding author), RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan.	aida@riken.jp	Zahoor, Muhammad/ADH-5812-2022; Takeshima, Shinnosuke/E-1246-2011	Zahoor, Muhammad/0000-0003-2302-3689; Takeshima, Shinnosuke/0000-0001-9648-0480; Sato, Hirotaka/0000-0002-8321-9731	Ministry of Health, Labor and Welfare of Japan; Japan Society for the Promotion of Science (JSPS)	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan, Research on HIV/AIDS: (http://www.jhsf.or.jp/English/index_e.html) and the Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship for Foreign Researchers (http://www. jsps.go.jp/english/e-fellow/postdoctoral. html). The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Aida Y, 2009, CURR HIV RES, V7, P136, DOI 10.2174/157016209787581418; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Ayyavoo V, 1997, J LEUKOCYTE BIOL, V62, P93, DOI 10.1002/jlb.62.1.93; BALOTTA C, 1993, J VIROL, V67, P4409, DOI 10.1128/JVI.67.7.4409-4414.1993; Barrero CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068376; Bovolenta C, 1999, BLOOD, V94, P4202, DOI 10.1182/blood.V94.12.4202.424k22_4202_4209; Carlson KA, 2004, J NEUROIMMUNOL, V147, P35, DOI 10.1016/j.jneuroim.2003.10.039; Chaudhuri A, 2008, BLOOD, V111, P2062, DOI 10.1182/blood-2007-05-091207; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DEDERA D, 1989, J VIROL, V63, P3205, DOI 10.1128/JVI.63.7.3205-3208.1989; Espert L, 2005, J GEN VIROL, V86, P2221, DOI 10.1099/vir.0.81074-0; Felzien LK, 1998, P NATL ACAD SCI USA, V95, P5281, DOI 10.1073/pnas.95.9.5281; Fenard D, 2009, NUCLEIC ACIDS RES, V37, P6008, DOI 10.1093/nar/gkp673; Foley JF, 2005, J IMMUNOL, V174, P4892, DOI 10.4049/jimmunol.174.8.4892; Hashizume C, 2007, MICROBES INFECT, V9, P490, DOI 10.1016/j.micinf.2007.01.013; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Herbeuval JP, 2005, BLOOD, V105, P2458, DOI 10.1182/blood-2004-08-3058; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Huang YL, 2006, J IMMUNOL, V177, P2304, DOI 10.4049/jimmunol.177.4.2304; Huang YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005397; Janket ML, 2004, BIOCHEM BIOPH RES CO, V314, P1126, DOI 10.1016/j.bbrc.2004.01.008; Kamata M, 2005, J VIROL, V79, P3557, DOI 10.1128/JVI.79.6.3557-3564.2005; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Kilareski EM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-118; Kohler JJ, 2003, J LEUKOCYTE BIOL, V73, P407, DOI 10.1189/jlb.0702358; Kuramitsu M, 2005, MICROBES INFECT, V7, P1150, DOI 10.1016/j.micinf.2005.03.022; Laforge M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002087; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Langevin C, 2009, J VIROL, V83, P10256, DOI 10.1128/JVI.02654-08; LAVALLEE C, 1994, J VIROL, V68, P1926; Lum JJ, 2001, J VIROL, V75, P11128, DOI 10.1128/JVI.75.22.11128-11136.2001; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Murakami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086840; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; Nekorchuk MD, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-138; Nishizawa M, 2000, J VIROL, V74, P6058, DOI 10.1128/JVI.74.13.6058-6067.2000; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Nonaka M, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-20; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Pilz A, 2003, EMBO REP, V4, P368, DOI 10.1038/sj.embor.embor802; Pincetic A, 2010, J VIROL, V84, P4725, DOI 10.1128/JVI.02478-09; Planelles V, 2009, CURR TOP MICROBIOL, V339, P177, DOI 10.1007/978-3-642-02175-6_9; Poon B, 1998, SCIENCE, V281, P266, DOI 10.1126/science.281.5374.266; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Sherman MP, 2002, DNA CELL BIOL, V21, P679, DOI 10.1089/104454902760330228; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sirois M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028125; Takeda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027815; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; TRISTEM M, 1992, EMBO J, V11, P3405, DOI 10.1002/j.1460-2075.1992.tb05419.x; Van den Bergh R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-53; Vazquez N, 2005, J VIROL, V79, P4479, DOI 10.1128/JVI.79.7.4479-4491.2005; Wang XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024193; Zhou T, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-93	59	54	55	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106418	10.1371/journal.pone.0106418	http://dx.doi.org/10.1371/journal.pone.0106418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170834	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500158
J	Morimoto, A; Tatsumi, Y; Soyano, F; Miyamatsu, N; Sonoda, N; Godai, K; Ohno, Y; Noda, M; Deura, K				Morimoto, Akiko; Tatsumi, Yukako; Soyano, Fumie; Miyamatsu, Naomi; Sonoda, Nao; Godai, Kayo; Ohno, Yuko; Noda, Mitsuhiko; Deura, Kijyo			Increase in Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) Had a Strong Impact on the Development of Type 2 Diabetes in Japanese Individuals with Impaired Insulin Secretion: The Saku Study	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; FOLLOW-UP; MELLITUS; SENSITIVITY; RISK; PATHOGENESIS; INTOLERANCE; DYSFUNCTION; NIDDM; MEN	Our aim was to assess the impact of increase in homeostasis model assessment of insulin resistance (HOMA-IR) on the development of type 2 diabetes in Japanese individuals with impaired insulin secretion (IIS). This study included 2,209 participants aged 30-69 without diabetes at baseline who underwent comprehensive medical check-ups between April 2006 and March 2007 at Saku Central Hospital. Participants were classified into eight groups according to the combination of baseline IIS status (non-IIS and IIS) and category of HOMA-IR change between the baseline and follow-up examinations (decrease, no change/small increase, moderate increase, and large increase). Type 2 diabetes was determined from fasting and 2 h post-load plasma glucose concentrations at the follow-up examination between April 2009 and March 2011. At baseline, 669 individuals (30.3%) were classified as having IIS. At follow-up, 74 individuals developed type 2 diabetes. After adjusting for confounding factors including baseline HOMA-IR values, the multivariable-adjusted odds ratios (95% confidence intervals) for type 2 diabetes in the non-IIS with a decrease (mean change in HOMA-IR: -0.47), non-IIS with a moderate increase (mean change in HOMA-IR: 0.28), non-IIS with a large increase (mean change in HOMA-IR: 0.83), IIS with a decrease (mean change in HOMA-IR: -0.36), IIS with no change/small increase (mean change in HOMA-IR: 0.08), IIS with a moderate increase (mean change in HOMA-IR: 0.27), and IIS with a large increase (mean change in HOMA-IR: 0.73) groups, relative to the non-IIS with no change/small increase (mean change in HOMA-IR: 0.08) group were 0.23 (0.04, 1.11), 1.22 (0.26, 5.72), 2.01 (0.70, 6.46), 1.37 (0.32, 4.28), 3.60 (0.83, 15.57), 5.24 (1.34, 20.52), and 7.01 (1.75, 24.18), respectively. Moderate and large increases in HOMA-IR had a strong impact on the development of type 2 diabetes among individuals with IIS in this Japanese population.	[Morimoto, Akiko; Tatsumi, Yukako; Miyamatsu, Naomi; Sonoda, Nao; Godai, Kayo] Shiga Univ Med Sci, Dept Clin Nursing, Otsu, Shiga 52021, Japan; [Tatsumi, Yukako; Ohno, Yuko] Osaka Univ, Grad Sch Med, Dept Math Hlth Sci, Suita, Osaka, Japan; [Soyano, Fumie; Deura, Kijyo] Saku Cent Hosp, Nagano, Japan; [Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet Res, Shinjuku Ku, Tokyo, Japan	Shiga University of Medical Science; Osaka University; National Center for Global Health & Medicine - Japan	Morimoto, A (corresponding author), Shiga Univ Med Sci, Dept Clin Nursing, Otsu, Shiga 52021, Japan.	aki62@belle.shiga-med.ac.jp	Noda, Mitsuhiko/W-3905-2019	Noda, Mitsuhiko/0000-0003-0413-4631	JSPS [25882019]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS Grant-in-Aid for Research Activity Start-up (No. 25882019). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063690; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; EFENDIC S, 1984, ENDOCR REV, V5, P395, DOI 10.1210/edrv-5-3-395; Ferrannini E, 1998, ENDOCR REV, V19, P477, DOI 10.1210/edrv.19.4.0336; Fukushima M, 2004, METABOLISM, V53, P831, DOI 10.1016/j.metabol.2004.02.012; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; HAFFNER SM, 1995, DIABETES, V44, P1386, DOI 10.2337/diabetes.44.12.1386; Hu C, 2009, DIABETOLOGIA, V52, P1322, DOI 10.1007/s00125-009-1335-6; Jonsson A, 2009, DIABETES, V58, P2409, DOI 10.2337/db09-0246; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Lee JWR, 2011, DIABETES CARE, V34, P353, DOI 10.2337/dc10-0746; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; LUNDGREN H, 1990, DIABETIC MED, V7, P407, DOI 10.1111/j.1464-5491.1990.tb01415.x; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ministry of Health Labor and Welfare, 2005, NAT HLTH NUTR EX SUR; Morimoto A, 2013, DIABETOLOGIA, V56, P2546, DOI 10.1007/s00125-013-3068-9; Morimoto A, 2013, DIABETOLOGIA, V56, P1671, DOI 10.1007/s00125-013-2932-y; Morimoto A, 2013, J DIABETES INVEST, V4, P274, DOI 10.1111/jdi.12019; Okamoto K, 2012, DIABETES, V61, P1734, DOI 10.2337/db11-1201; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; SELTZER HS, 1967, J CLIN INVEST, V46, P323, DOI 10.1172/JCI105534; SKARFORS ET, 1991, BRIT MED J, V303, P755, DOI 10.1136/bmj.303.6805.755; TANIGUCHI A, 1992, DIABETES, V41, P1540, DOI 10.2337/diabetes.41.12.1540; The Japan Diabetes Society, 2013, EV BAS PRACT GUID TR; Tripathy D, 2000, DIABETES, V49, P975, DOI 10.2337/diabetes.49.6.975; Tripathy D, 2004, DIABETES CARE, V27, P2204, DOI 10.2337/diacare.27.9.2204; van Vliet-Ostaptchouk JV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032148; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; World Health Organization, 1999, REP WHO CONS DEF DIA; Yoshiike N, 2002, ASIA PAC J CLIN NUTR, V11, pS727, DOI 10.1046/j.1440-6047.11.s8.18.x; Yoshiike N, 2002, Obes Rev, V3, P183, DOI 10.1046/j.1467-789X.2002.00070.x	32	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105827	10.1371/journal.pone.0105827	http://dx.doi.org/10.1371/journal.pone.0105827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166121	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303700049
J	Kuwana, Y; Sezutsu, H; Nakajima, K; Tamada, Y; Kojima, K				Kuwana, Yoshihiko; Sezutsu, Hideki; Nakajima, Ken-ichi; Tamada, Yasushi; Kojima, Katsura			High-Toughness Silk Produced by a Transgenic Silkworm Expressing Spider (Araneus ventricosus) Dragline Silk Protein	PLOS ONE			English	Article							BOMBYX-MORI; MECHANICAL-PROPERTIES; ESCHERICHIA-COLI; FIBROIN GENE; FIBERS; PURIFICATION; SOLUBILITY; TOBACCO; SYSTEM; CELLS	Spider dragline silk is a natural fiber that has excellent tensile properties; however, it is difficult to produce artificially as a long, strong fiber. Here, the spider (Araneus ventricosus) dragline protein gene was cloned and a transgenic silkworm was generated, that expressed the fusion protein of the fibroin heavy chain and spider dragline protein in cocoon silk. The spider silk protein content ranged from 0.37 to 0.61% w/w (1.4-2.4 mol%) native silkworm fibroin. Using a good silk-producing strain, C515, as the transgenic silkworm can make the raw silk from its cocoons for the first time. The tensile characteristics (toughness) of the raw silk improved by 53% after the introduction of spider dragline silk protein; the improvement depended on the quantity of the expressed spider dragline protein. To demonstrate the commercial feasibility for machine reeling, weaving, and sewing, we used the transgenic spider silk to weave a vest and scarf; this was the first application of spider silk fibers from transgenic silkworms.	[Kuwana, Yoshihiko; Tamada, Yasushi; Kojima, Katsura] Natl Inst Agrobiol Sci, Silk Mat Res Unit, Tsukuba, Ibaraki, Japan; [Sezutsu, Hideki; Nakajima, Ken-ichi] Natl Inst Agrobiol Sci, Transgen Silkworm Res Unit, Tsukuba, Ibaraki, Japan; [Tamada, Yasushi] Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 386, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan; Shinshu University	Kojima, K (corresponding author), Natl Inst Agrobiol Sci, Silk Mat Res Unit, Tsukuba, Ibaraki, Japan.	kojikei@affrc.go.jp		Sezutsu, Hideki/0000-0001-8886-1611	MAFF Research projects of NIAS; Ministry of Agriculture, Forestry, and Fisheries of Japan	MAFF Research projects of NIAS; Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This Study was supported by MAFF Research projects of NIAS and by Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry, and Fisheries grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan. (http://www.s.affrc.go.jp/docs/research_fund2009.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2003, BIO-MED MATER ENG, V13, P309; Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133; Dochin T, 1972, SANSI KENKYU, P153; Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883; Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q; Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.ibmb.2004.10.002; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; Kachi ND, 2010, BIO-MED MATER ENG, V20, P55, DOI 10.3233/BME-2010-0615; Kambe Y, 2010, BIOMATERIALS, V31, P7503, DOI 10.1016/j.biomaterials.2010.06.045; Karatzas CN, 1999, Patent No. [WO/1999/047661, 1999047661]; Kojima K, 2007, KOBUNSHI RONBUNSHU, V64, P817, DOI 10.1295/koron.64.817; Kojima K, 2007, BIOSCI BIOTECH BIOCH, V71, P2943, DOI 10.1271/bbb.70353; Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780; Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060; Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x; Miao YG, 2006, APPL MICROBIOL BIOT, V71, P192, DOI 10.1007/s00253-005-0127-2; MITA K, 1994, J MOL EVOL, V38, P583; Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335; Shimizu Kazuhiko, 2004, Journal of Sericultural Science of Japan, V73, P15; Shimizu Kazuhiko, 2004, Journal of Sericultural Science of Japan, V73, P23; Swanson BO, 2006, EVOLUTION, V60, P2539; Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Teule F, 2007, J MATER SCI, V42, P8974, DOI 10.1007/s10853-007-1642-6; Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109; Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2; Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Zhang YS, 2008, MOL BIOL REP, V35, P329, DOI 10.1007/s11033-007-9090-6; Zhu ZH, 2010, J BIOMAT SCI-POLYM E, V21, P395, DOI 10.1163/156856209X423126	34	55	63	9	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105325	10.1371/journal.pone.0105325	http://dx.doi.org/10.1371/journal.pone.0105325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162624	Green Submitted, Green Published, gold			2022-12-25	WOS:000340880900032
J	Octeau, JC; Schrader, JM; Masuho, I; Sharma, M; Aiudi, C; Chen, CK; Kovoor, A; Celver, J				Octeau, J. Christopher; Schrader, Joseph M.; Masuho, Ikuo; Sharma, Meenakshi; Aiudi, Christopher; Chen, Ching-Kang; Kovoor, Abraham; Celver, Jeremy			G Protein Beta 5 Is Targeted to D2-Dopamine Receptor-Containing Biochemical Compartments and Blocks Dopamine-Dependent Receptor Internalization	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; MUSCARINIC M3 RECEPTOR; SIGNALING RGS 7; COUPLED RECEPTORS; PLASMA-MEMBRANE; DEP-DOMAIN; SUBUNIT G-BETA-5; BIASED AGONISM; MICE LACKING; REGULATORS	G beta 5 (Gbeta5, G beta 5) is a unique G protein beta subunit that is thought to be expressed as an obligate heterodimer with R7 regulator of G protein signaling (RGS) proteins instead of with G gamma (G gamma) subunits. We found that D2-dopamine receptor (D2R) coexpression enhances the expression of G beta 5, but not that of the G beta 1 (G beta 1) subunit, in HEK293 cells, and that the enhancement of expression occurs through a stabilization of G beta 5 protein. We had previously demonstrated that the vast majority of D2R either expressed endogenously in the brain or exogenously in cell lines segregates into detergent-resistant biochemical fractions. We report that when expressed alone in HEK293 cells, G beta 5 is highly soluble, but is retargeted to the detergent-resistant fraction after D2R coexpression. Furthermore, an in-cell biotin transfer proximity assay indicated that D2R and G beta 5 segregating into the detergent-resistant fraction specifically interacted in intact living cell membranes. Dopamine-induced D2R internalization was blocked by coexpression of G beta 5, but not G beta 1. However, the same G beta 5 coexpression levels had no effect on agonist-induced internalization of the mu opioid receptor (MOR), cell surface D2R levels, dopamine-mediated recruitment of beta-arrestin to D2R, the amplitude of D2R-G protein coupling, or the deactivation kinetics of D2R-activated G protein signals. The latter data suggest that the interactions between D2R and G beta 5 are not mediated by endogenously expressed R7 RGS proteins.	[Octeau, J. Christopher; Schrader, Joseph M.; Sharma, Meenakshi; Aiudi, Christopher; Kovoor, Abraham; Celver, Jeremy] Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA; [Masuho, Ikuo] Scripps Res Inst, Dept Neurosci, Jupiter, FL USA; [Chen, Ching-Kang] Baylor Coll Med, Cullen Eye Inst, Houston, TX 77030 USA	University of Rhode Island; Scripps Research Institute; Baylor College of Medicine	Kovoor, A (corresponding author), Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA.	abekovoor@uri.edu; jeremy.celver@hotmail.com		Octeau, Chris/0000-0001-6462-9439; Aiudi, Christopher/0000-0003-0546-7227	National Institutes of Health, NIMH [R15MH091639]; Rhode Island Institutional Development Award (IDeA) Network of Biomedical Research Excellence (INBRE) Award, National Center for Research Resources (NCRR), National Institutes of Health [P20RR016457-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R15MH091639] Funding Source: NIH RePORTER	National Institutes of Health, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Rhode Island Institutional Development Award (IDeA) Network of Biomedical Research Excellence (INBRE) Award, National Center for Research Resources (NCRR), National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health, NIMH, Grant R15MH091639 (to A.K. and M.S.) and a Rhode Island Institutional Development Award (IDeA) Network of Biomedical Research Excellence (INBRE) Award, P20RR016457-10, from the National Center for Research Resources (NCRR), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Celver J, 2013, J NEUROCHEM, V127, P57, DOI 10.1111/jnc.12359; Celver J, 2012, J NEUROCHEM, V120, P56, DOI 10.1111/j.1471-4159.2011.07559.x; Celver J, 2010, J NEUROCHEM, V114, P739, DOI 10.1111/j.1471-4159.2010.06805.x; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Cho D, 2010, MOL ENDOCRINOL, V24, P574, DOI 10.1210/me.2009-0369; De Vries TJ, 1999, PSYCHOPHARMACOLOGY, V143, P254, DOI 10.1007/s002130050944; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Fernandez-Suarez M, 2008, J AM CHEM SOC, V130, P9251, DOI 10.1021/ja801445p; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Kearn CS, 2005, MOL PHARMACOL, V67, P1697, DOI 10.1124/mol.104.006882; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Keren-Raifman T, 2001, FEBS LETT, V492, P20, DOI 10.1016/S0014-5793(01)02220-7; Kovoor A, 2000, J BIOL CHEM, V275, P3397, DOI 10.1074/jbc.275.5.3397; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Laroche G, 2010, AM J PHYSIOL-CELL PH, V299, pC654, DOI 10.1152/ajpcell.00441.2009; Mancuso JJ, 2010, J NEUROCHEM, V112, P651, DOI 10.1111/j.1471-4159.2009.06488.x; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010902; Masuho I, 2013, J BIOL CHEM, V288, P25129, DOI 10.1074/jbc.M113.462283; Masuho I, 2011, J BIOL CHEM, V286, P21806, DOI 10.1074/jbc.M111.241513; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Park BS, 2013, CURR MED CHEM, V20, P3872; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Periasamy A, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.011001; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Psifogeorgou K, 2007, J NEUROCHEM, V103, P617, DOI 10.1111/j.1471-4159.2007.04812.x; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rehm A, 1997, FEBS LETT, V416, P39, DOI 10.1016/S0014-5793(97)01119-8; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sandiford SL, 2010, BIOCHEMISTRY-US, V49, P4998, DOI 10.1021/bi100080p; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Sethakorn N, 2010, CELL SIGNAL, V22, P1274, DOI 10.1016/j.cellsig.2010.03.016; Sharma M, 2013, J BIOL CHEM, V288, P12554, DOI 10.1074/jbc.M112.443945; Shim H, 2012, J BIOL CHEM, V287, P14873, DOI 10.1074/jbc.M112.345751; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Slepak VZ, 2009, PROG MOL BIOL TRANSL, V86, P157, DOI 10.1016/S1877-1173(09)86006-7; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Wang Q, 2011, FASEB J; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Xie KQ, 2012, PSYCHOPHARMACOLOGY, V219, P823, DOI 10.1007/s00213-011-2409-y; Zhang JH, 2011, J NEUROCHEM, V119, P544, DOI 10.1111/j.1471-4159.2011.07457.x	55	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105791	10.1371/journal.pone.0105791	http://dx.doi.org/10.1371/journal.pone.0105791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162404	Green Published, Green Submitted, gold			2022-12-25	WOS:000340880900050
J	Rasul, E; Salamon, D; Nagy, N; Leveau, B; Banati, F; Szenthe, K; Koroknai, A; Minarovits, J; Klein, G; Klein, E				Rasul, Eahsan; Salamon, Daniel; Nagy, Noemi; Leveau, Benjamin; Banati, Ferenc; Szenthe, Kalman; Koroknai, Anita; Minarovits, Janos; Klein, George; Klein, Eva			The MEC1 and MEC2 Lines Represent Two CLL Subclones in Different Stages of Progression towards Prolymphocytic Leukemia	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; CHRONIC LYMPHOCYTIC-LEUKEMIA; LYMPHOBLASTOID CELL-LINES; B-CELLS; IN-VITRO; NUCLEAR ANTIGEN-2; C PROMOTER; EXPRESSION; TRANSFORMATION; METHYLATION	The EBV carrying lines MEC1 and MEC2 were established earlier from explants of blood derived cells of a chronic lymphocytic leukemia (CLL) patient at different stages of progression to prolymphocytoid transformation (PLL). This pair of lines is unique in several respects. Their common clonal origin was proven by the rearrangement of the immunoglobulin genes. The cells were driven to proliferation in vitro by the same indigenous EBV strain. They are phenotypically different and represent subsequent subclones emerging in the CLL population. Furthermore they reflect the clinical progression of the disease. We emphasize that the support for the expression of the EBV encoded growth program is an important differentiation marker of the CLL cells of origin that was shared by the two subclones. It can be surmised that proliferation of EBV carrying cells in vitro, but not in vivo, reflects the efficient surveillance that functions even in the severe leukemic condition. The MEC1 line arose before the aggressive clinical stage from an EBV carrying cell within the subclone that was in the early prolymphocytic transformation stage while the MEC2 line originated one year later, from the subsequent subclone with overt PLL characteristics. At this time the disease was disseminated and the blood lymphocyte count was considerably elevated. The EBV induced proliferation of the MEC cells belonging to the subclones with markers of PLL agrees with earlier reports in which cells of PLL disease were infected in vitro and immortalized to LCL. They prove also that the expression of EBV encoded set of proteins can be determined at the event of infection. This pair of lines is particularly important as they provide in vitro cells that represent the subclonal evolution of the CLL disease. Furthermore, the phenotype of the MEC1 cells shares several characteristics of ex vivo CLL cells.	[Rasul, Eahsan; Salamon, Daniel; Nagy, Noemi; Leveau, Benjamin; Klein, George; Klein, Eva] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Banati, Ferenc; Szenthe, Kalman] RT Europe Nonprofit Res Ltd, Mosonmagyarovar, Hungary; [Koroknai, Anita; Minarovits, Janos] Natl Ctr Epidemiol, Microbiol Res Grp, Budapest, Hungary; [Minarovits, Janos] Univ Szeged, Fac Dent, Dept Oral Biol & Expt Dent Res, Szeged, Hungary	Karolinska Institutet; Szeged University	Rasul, E (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	eahsan.rasul@ki.se	Rasul, Eahsan/CAF-4837-2022; Salamon, Daniel/AAZ-4807-2021; Nagy, Noemi/J-2936-2012; , A. Rasul/GMW-9774-2022	, A. Rasul/0000-0002-1014-525X; Nagy, Noemi/0000-0002-7800-3493; Szenthe, Kalman/0000-0002-5109-5842	Swedish Cancer Society; Cancer Research Institute (New York, NY)/Concern Foundation (Los Angeles, CA)	Swedish Cancer Society(Swedish Cancer Society); Cancer Research Institute (New York, NY)/Concern Foundation (Los Angeles, CA)	This work was supported by the Swedish Cancer Society and by the Cancer Research Institute (New York, NY)/Concern Foundation (Los Angeles, CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra D, 2014, LEUKEMIA, V28, P98, DOI 10.1038/leu.2013.246; Anastasiadou E, 2009, CANCER LETT, V284, P165, DOI 10.1016/j.canlet.2009.04.025; Ansell SM, 1999, AM J HEMATOL, V60, P99, DOI 10.1002/(SICI)1096-8652(199902)60:2<99::AID-AJH3>3.0.CO;2-T; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Babcock GJ, 2000, IMMUNITY, V13, P497, DOI 10.1016/S1074-7613(00)00049-2; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; BERREBI A, 1990, AM J HEMATOL, V34, P181, DOI 10.1002/ajh.2830340305; Bertilaccio MTS, 2010, BLOOD, V115, P1605, DOI 10.1182/blood-2009-05-223586; BIRD AG, 1981, NATURE, V289, P300, DOI 10.1038/289300a0; Borestrom C, 2012, J GEN VIROL, V93, P1065, DOI 10.1099/vir.0.038752-0; Brink AATP, 1997, J CLIN PATHOL, V50, P911, DOI 10.1136/jcp.50.11.911; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Burger JA, 2012, CURR OPIN ONCOL, V24, P643, DOI 10.1097/CCO.0b013e3283589950; Calissano C, 2011, MOL MED, V17, P1374, DOI 10.2119/molmed.2011.00360; Calissano C, 2009, BLOOD, V114, P4832, DOI 10.1182/blood-2009-05-219634; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Damle RN, 2007, BLOOD, V110, P3352, DOI 10.1182/blood-2007-04-083832; Damle RN, 2010, BEST PRACT RES CL HA, V23, P33, DOI 10.1016/j.beha.2010.02.001; Davids MS, 2012, OPEN J HEMATOL, V3; de Totero D, 2006, BLOOD, V107, P3708, DOI 10.1182/blood-2005-09-3535; Dungarwalla M, 2008, EUR J HAEMATOL, V80, P469, DOI 10.1111/j.1600-0609.2008.01069.x; Elliott J, 2004, J VIROL, V78, P14062, DOI 10.1128/JVI.78.24.14062-14065.2004; ERNBERG I, 1989, J GEN VIROL, V70, P2989, DOI 10.1099/0022-1317-70-11-2989; Ghia P, 2007, LEUKEMIA, V21, P1, DOI 10.1038/sj.leu.2404457; Kelly GL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000341; Kis LL, 2010, P NATL ACAD SCI USA, V107, P872, DOI 10.1073/pnas.0912920107; KLEIN E, 1968, CANCER RES, V28, P1300; Klein E, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23035; KLEIN G, 1974, P NATL ACAD SCI USA, V71, P3283, DOI 10.1073/pnas.71.8.3283; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Kurth J, 2003, P NATL ACAD SCI USA, V100, P4730, DOI 10.1073/pnas.2627966100; Lanemo Myhrinder A, 2013, LEUK LYMPHOMA; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; LEWIN N, 1991, INT J CANCER, V48, P62, DOI 10.1002/ijc.2910480112; LEWIN N, 1988, INT J CANCER, V41, P892, DOI 10.1002/ijc.2910410621; LEWIN N, 1995, INT J CANCER, V61, P159, DOI 10.1002/ijc.2910610203; Loisel S, 2005, LEUKEMIA RES, V29, P1347, DOI 10.1016/j.leukres.2005.04.017; Malavasi F, 2011, BLOOD, V118, P3470, DOI 10.1182/blood-2011-06-275610; Matutes E, 2000, Rev Clin Exp Hematol, V4, P22, DOI 10.1046/j.1468-0734.2000.00002.x; Matutes E, 2010, BEST PRACT RES CL HA, V23, P3, DOI 10.1016/j.beha.2010.01.001; Nagy N, 2012, P NATL ACAD SCI USA, V109, P1512, DOI 10.1073/pnas.1120587109; Nakayama T, 2002, J VIROL, V76, P3072, DOI 10.1128/JVI.76.6.3072-3077.2002; NILSSON K, 1977, INT J CANCER, V19, P337, DOI 10.1002/ijc.2910190309; Pokrovskaja K, 2002, INT J CANCER, V99, P705, DOI 10.1002/ijc.10417; POPE JH, 1968, INT J CANCER, V3, P857, DOI 10.1002/ijc.2910030619; RAABTRAUB N, 1986, CELL, V47, P883, DOI 10.1016/0092-8674(86)90803-2; RANHEIM EA, 1995, BLOOD, V85, P3556, DOI 10.1182/blood.V85.12.3556.bloodjournal85123556; Rasul A, 2012, J IMMUNOL METHODS, V385, P60, DOI 10.1016/j.jim.2012.08.008; Reiniger L, 2006, LEUKEMIA, V20, P1089, DOI 10.1038/sj.leu.2404183; Rosen A, 2012, ONCOIMMUNOLOGY, V1, P18, DOI 10.4161/onci.1.1.18400; Rosen A, 2010, SEMIN CANCER BIOL, V20, P400, DOI 10.1016/j.semcancer.2010.09.004; Salamon D, 2009, J GEN VIROL, V90, P1183, DOI 10.1099/vir.0.007344-0; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; TAKEUCHI H, 1993, LEUKEMIA LYMPHOMA, V10, P209, DOI 10.3109/10428199309145885; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Tsimberidou AM, 2006, CANCER-AM CANCER SOC, V107, P1294, DOI 10.1002/cncr.22121; Tsimberidou AM, 2006, LEUKEMIA LYMPHOMA, V47, P827, DOI 10.1080/10428190500398856; Voltan R, 2011, CLIN CANCER RES, V17, P5649, DOI 10.1158/1078-0432.CCR-11-1064; WALLS EV, 1989, INT J CANCER, V44, P846, DOI 10.1002/ijc.2910440517; WANG F, 1987, P NATL ACAD SCI USA, V84, P3452, DOI 10.1073/pnas.84.10.3452; Zauli G, 2011, CLIN CANCER RES, V17, P762, DOI 10.1158/1078-0432.CCR-10-2572	61	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106008	10.1371/journal.pone.0106008	http://dx.doi.org/10.1371/journal.pone.0106008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162594	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900073
J	Richoz, O; Kling, S; Zandi, S; Hammer, A; Spoerl, E; Hafezi, F				Richoz, Olivier; Kling, Sabine; Zandi, Souska; Hammer, Arthur; Spoerl, Eberhard; Hafezi, Farhad			A Constant-Force Technique to Measure Corneal Biomechanical Changes after Collagen Cross-Linking	PLOS ONE			English	Article							HYPOOSMOLAR RIBOFLAVIN SOLUTION; ULTRAVIOLET-A LIGHT; PORCINE CORNEAS; KERATOCONUS; KERATECTASIA; PREGNANCY; SMOKING; PROTEOGLYCANS; DEGRADATION; IRRADIATION	Purpose: To introduce a constant-force technique for the analysis of corneal biomechanical changes induced after collagen cross-linking (CXL) that is better adapted to the natural loading in the eye than previous methods. Methods: For the biomechanical testing, a total of 50 freshly enucleated eyes were obtained and subdivided in groups of 5 eyes each. A Zwicki-Line Testing Machine was used to analyze the strain of 11 mm long and 5 mm wide porcine corneal strips, with and without CXL. Before material testing, the corneal tissues were pre-stressed with 0.02 N until force stabilization. Standard strip extensiometry was performed as control technique. For the constant-force technique, tissue elongation (Delta strain, %) was analyzed for 180 seconds while different constant forces (0.25 N, 0.5 N, 1 N, 5 N) were applied. Results: Using a constant force of 0.5 N, we observed a significant difference in Dstrain between 0.26 +/- 0.01% in controls and 0.12 +/- 0.03% in the CXL-treated group (p = 0.003) over baseline. Similarly, using a constant force of 1 N, Delta strain was 0.31 +/- 0.03% in controls and 0.19 +/- 0.02% after CXL treatment (p = 0.008). No significant differences were observed between CXL-treated groups and controls with 0.25 N or 5 N constant forces. Standard stress-strain extensiometry failed to show significant differences between CXL-treated groups and controls at all percentages of strains tested. Conclusion: We propose a constant-force technique to measure corneal biomechanics in a more physiologic way. When compared to standard stress-strain extensiometry, the constant-force technique provides less variability and thus reaches significant results with a lower sample number.	[Richoz, Olivier; Kling, Sabine; Zandi, Souska; Hammer, Arthur; Hafezi, Farhad] Univ Hosp Geneva, Dept Ophthalmol, Geneva, Switzerland; [Spoerl, Eberhard] Univ Hosp Dresden, Dept Ophthalmol, Dresden, Germany; [Hafezi, Farhad] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA	University of Geneva; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Southern California	Hafezi, F (corresponding author), Univ Hosp Geneva, Dept Ophthalmol, Geneva, Switzerland.	farhad@hafezi.ch		Zandi, Souska/0000-0001-9351-4278; Kling, Sabine/0000-0001-7202-7200; Hammer, Arthur/0000-0003-3225-5035	Swiss National Fonds; Castier Foundation, Geneva, Switzerland	Swiss National Fonds(Swiss National Science Foundation (SNSF)); Castier Foundation, Geneva, Switzerland	This work was supported in part by a grant of the Swiss National Fonds and the Castier Foundation, Geneva, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almubrad T, 2011, MOL VIS, V17, P2283; Borja D, 2004, CORNEA, V23, P61, DOI 10.1097/00003226-200401000-00010; Brummer G, 2011, INVEST OPHTH VIS SCI, V52, P6363, DOI 10.1167/iovs.11-7585; Chatzis N, 2012, J REFRACT SURG, V28, P753, DOI 10.3928/1081597X-20121011-01; Coskunseven E, 2009, J REFRACT SURG, V25, P371, DOI 10.3928/1081597X-20090401-02; Diakonis VF, 2012, EUR J OPHTHALMOL, V22, pS51, DOI 10.5301/ejo.5000114; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Gatzioufas Z, 2008, J ENDOCRINOL INVEST, V31, P262, DOI 10.1007/BF03345600; Hafezi F, 2008, J CATARACT REFR SURG, V34, P1219, DOI 10.1016/j.jcrs.2008.02.036; Hafezi F, 2007, J CATARACT REFR SURG, V33, P2035, DOI 10.1016/j.jcrs.2007.07.028; Hafezi F, 2012, J REFRACT SURG, V28, P242, DOI 10.3928/1081597X-20120401-07; Hafezi F, 2011, CORNEA, V30, P917, DOI 10.1097/ICO.0b013e31820143d1; Hafezi F, 2010, INVEST OPHTH VIS SCI, V51, P6892, DOI 10.1167/iovs.09-4735; Hafezi F, 2009, OPHTHALMOLOGY, V116, P2259, DOI 10.1016/j.ophtha.2009.07.039; Hafezi F, 2009, J CATARACT REFR SURG, V35, P621, DOI 10.1016/j.jcrs.2008.10.060; Hashemi H, 2013, OPHTHALMOLOGY; Hersh PS, 2011, J CATARACT REFR SURG, V37, P149, DOI 10.1016/j.jcrs.2010.07.030; Hoogewoud F, 2013, J REFRACT SURG, V29, P144, DOI 10.3928/1081597X-20130117-11; KAHAN IL, 1990, EXP EYE RES, V50, P339, DOI 10.1016/0014-4835(90)90134-G; Kamaev P, 2012, INVEST OPHTH VIS SCI, V53, P2360, DOI 10.1167/iovs.11-9385; Kohlhaas M, 2006, J CATARACT REFR SURG, V32, P279, DOI 10.1016/j.jcrs.2005.12.092; Kohlhaas M, 2005, KLIN MONATSBL AUGENH, V222, P430, DOI 10.1055/s-2005-857950; Luce DA, 2005, J CATARACT REFR SURG, V31, P156, DOI 10.1016/j.jcrs.2004.10.044; Noguera GE, 2007, INVEST OPHTH VIS SCI, V48, P1860; Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039; Richoz O, 2013, OPHTHALMOLOGY; Robert L, 2008, BIOGERONTOLOGY, V9, P119, DOI 10.1007/s10522-007-9122-6; Schumacher S, 2011, INVEST OPHTH VIS SCI, V52, P9048, DOI 10.1167/iovs.11-7818; Spoerl E, 1998, EXP EYE RES, V66, P97, DOI 10.1006/exer.1997.0410; Spoerl E, 2004, CURR EYE RES, V29, P35, DOI 10.1080/02713680490513182; Spoerl E, 1999, J REFRACT SURG, V15, P711; Spoerl E, 2008, J REFRACT SURG, V24, pS737, DOI 10.3928/1081597X-20080901-18; Spoerl Eberhard, 1997, Ophthalmologe, V94, P902; Spoerl E, 2011, J REFRACT SURG, V27, P452, DOI 10.3928/1081597X-20110106-01; Vetter JM, 2012, J CATARACT REFR SURG, V38, P525, DOI 10.1016/j.jcrs.2011.09.045; Vinciguerra P, 2010, J REFRACT SURG, P1; Wernli J, 2013, INVEST OPHTH VIS SCI, V54, P1176, DOI 10.1167/iovs.12-11409; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Zhang YT, 2013, INVEST OPHTH VIS SCI, V54, P1014, DOI 10.1167/iovs.12-11277; Zhang YT, 2011, J BIOL CHEM, V286, P13011, DOI 10.1074/jbc.M110.169813	41	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105095	10.1371/journal.pone.0105095	http://dx.doi.org/10.1371/journal.pone.0105095			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162621	gold, Green Published, Green Submitted			2022-12-25	WOS:000340880900025
J	Artegoitia, VM; Middleton, JL; Harte, FM; Campagna, SR; de Veth, MJ				Artegoitia, Virginia M.; Middleton, Jesse L.; Harte, Federico M.; Campagna, Shawn R.; de Veth, Michael J.			Choline and Choline Metabolite Patterns and Associations in Blood and Milk during Lactation in Dairy Cows	PLOS ONE			English	Article							RUMEN-PROTECTED CHOLINE; ESSENTIAL NUTRIENT; PHOSPHATIDYLCHOLINE; BIOSYNTHESIS; PHOSPHOLIPIDS; SECRETION; ESTERS; ACID	Milk and dairy products are an important source of choline, a nutrient essential for human health. Infant formula derived from bovine milk contains a number of metabolic forms of choline, all contribute to the growth and development of the newborn. At present, little is known about the factors that influence the concentrations of choline metabolites in milk. The objectives of this study were to characterize and then evaluate associations for choline and its metabolites in blood and milk through the first 37 weeks of lactation in the dairy cow. Milk and blood samples from twelve Holstein cows were collected in early, mid and late lactation and analyzed for acetylcholine, free choline, betaine, glycerophosphocholine, lysophosphatidylcholine, phosphatidylcholine, phosphocholine and sphingomyelin using hydrophilic interaction liquid chromatography-tandem mass spectrometry, and quantified using stable isotope-labeled internal standards. Total choline concentration in plasma, which was almost entirely phosphatidylcholine, increased 10-times from early to late lactation (1305 to 13,535 mu mol/L). In milk, phosphocholine was the main metabolite in early lactation (492 mu mol/L), which is a similar concentration to that found in human milk, however, phosphocholine concentration decreased exponentially through lactation to 43 mu mol/L in late lactation. In contrast, phosphatidylcholine was the main metabolite in mid and late lactation (188 mu mol/L and 659 mu mol/L, respectively), with the increase through lactation positively correlated with phosphatidylcholine in plasma (R-2 = 0.78). Unlike previously reported with human milk we found no correlation between plasma free choline concentration and milk choline metabolites. The changes in pattern of phosphocholine and phosphatidylcholine in milk through lactation observed in the bovine suggests that it is possible to manufacture infant formula that more closely matches these metabolites profile in human milk.	[Artegoitia, Virginia M.; Harte, Federico M.] Univ Tennessee, Dept Food Sci & Technol, Knoxville, TN 37901 USA; [Middleton, Jesse L.; Campagna, Shawn R.] Univ Tennessee, Dept Chem, Knoxville, TN 37901 USA; [de Veth, Michael J.] Univ Tennessee, Dept Anim Sci, Knoxville, TN 37901 USA; [de Veth, Michael J.] Balchem Corp, New Hampton, NY USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	de Veth, MJ (corresponding author), Univ Tennessee, Dept Anim Sci, Knoxville, TN 37901 USA.	mdeveth@utk.edu	Harte, Federico M/N-4283-2015	Harte, Federico/0000-0001-6822-0083	University of Tennessee Agricultural Experiment Station and Balchem Corporation, New Hampton, NY	University of Tennessee Agricultural Experiment Station and Balchem Corporation, New Hampton, NY	This research was supported by The University of Tennessee Agricultural Experiment Station and Balchem Corporation, New Hampton, NY (http://www.balchem.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi A, 2006, CAN J ANIM SCI, V86, P207, DOI 10.4141/A05-061; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Caudill MA, 2010, J AM DIET ASSOC, V110, P1198, DOI 10.1016/j.jada.2010.05.009; CHAO CK, 1988, BIOCHEM J, V254, P33, DOI 10.1042/bj2540033; Cheng WL, 1996, J NUTR BIOCHEM, V7, P457, DOI 10.1016/0955-2863(96)00079-4; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Committee on the Evaluation of the Addition of Ingredients New to Infant Formula, 2004, INF FORM EV SAF NEW; da Costa KA, 2011, AM J CLIN NUTR, V93, P968, DOI 10.3945/ajcn.110.011064; Davenport C, 2013, HUM HEALT HANDB, P335, DOI 10.3920/978-90-8686-764-6_17; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Deuchler KN, 1998, J DAIRY SCI, V81, P238, DOI 10.3168/jds.S0022-0302(98)75571-7; Donovan SM, 1997, J NUTR BIOCHEM, V8, P603, DOI 10.1016/S0955-2863(97)00115-0; Gallazzini M, 2009, PHYSIOLOGY, V24, P245, DOI 10.1152/physiol.00009.2009; Garrow TA, 2007, HDB VITAMINS, P459; Goselink RMA, 2013, J DAIRY SCI, V96, P1102, DOI 10.3168/jds.2012-5396; Holmes HC, 2000, EUR J PEDIATR, V159, P198, DOI 10.1007/s004310050050; HolmesMcNary MQ, 1996, AM J CLIN NUTR, V64, P572, DOI 10.1093/ajcn/64.4.572; Ilcol YO, 2005, J NUTR BIOCHEM, V16, P489, DOI 10.1016/j.jnutbio.2005.01.011; Klein MS, 2012, J PROTEOME RES, V11, P1373, DOI 10.1021/pr201017n; LEHUEROU I, 1992, DIGEST DIS SCI, V37, P40, DOI 10.1007/BF01308340; LEHUEROULURON I, 1992, J NUTR, V122, P1434, DOI 10.1093/jn/122.7.1434; Lopez C, 2008, J AGR FOOD CHEM, V56, P5226, DOI 10.1021/jf7036104; National Research Council (NRC), 2001, NUTR REQ DAIR CATTL; NEILL AR, 1979, BIOCHEM J, V180, P559, DOI 10.1042/bj1800559; Pinotti L, 2003, J VET MED A, V50, P18, DOI 10.1046/j.1439-0442.2003.00502.x; Pinotti L, 2002, NUTR RES REV, V15, P315, DOI 10.1079/NRR200247; Pitkin RM., 2000, DIETARY REFERENCE IN; Pynn CJ, 2011, J LIPID RES, V52, P399, DOI 10.1194/jlr.d011916; RAPHAEL BC, 1973, J DAIRY SCI, V56, P1025, DOI 10.3168/jds.S0022-0302(73)85300-7; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; ROBINSON BS, 1987, BIOCHEM J, V244, P367, DOI 10.1042/bj2440367; SHARMA BK, 1989, J DAIRY SCI, V72, P2772, DOI 10.3168/jds.S0022-0302(89)79421-2; Xiong YP, 2012, J CHROMATOGR B, V911, P170, DOI 10.1016/j.jchromb.2012.10.038; YAO ZM, 1988, J BIOL CHEM, V263, P2998; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413; Zeisel SH, 2003, J NUTR, V133, P1302; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061; ZEISEL SH, 1990, J NUTR BIOCHEM, V1, P332, DOI 10.1016/0955-2863(90)90001-2; Zeisel SH, 2009, NUTR REV, V67, P615, DOI 10.1111/j.1753-4887.2009.00246.x; Zhao YY, 2011, J CHROMATOGR A, V1218, P5470, DOI 10.1016/j.chroma.2011.06.025; Zom RLG, 2011, J DAIRY SCI, V94, P4016, DOI 10.3168/jds.2011-4233	42	46	48	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e103412	10.1371/journal.pone.0103412	http://dx.doi.org/10.1371/journal.pone.0103412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157578	Green Published, gold			2022-12-25	WOS:000341303200003
J	Wang, YK; Chu, P; Yang, Q; Chang, SX; Chen, JM; Hu, ML; Guan, RZ				Wang, Yankun; Chu, Pu; Yang, Qing; Chang, Shengxin; Chen, Jianmei; Hu, Maolong; Guan, Rongzhan			Complete Mitochondrial Genome of Eruca sativa Mill. (Garden Rocket)	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; CYTOPLASMIC MALE-STERILITY; RAPHANUS-SATIVUS; BRASSICA-NAPUS; GENE; DNA; DIVERGENCE; EVOLUTION; CONTAINS; L.	Eruca sativa (Cruciferae family) is an ancient crop of great economic and agronomic importance. Here, the complete mitochondrial genome of Eruca sativa was sequenced and annotated. The circular molecule is 247 696 bp long, with a G+C content of 45.07%, containing 33 protein-coding genes, three rRNA genes, and 18 tRNA genes. The Eruca sativa mitochondrial genome may be divided into six master circles and four subgenomic molecules via three pairwise large repeats, resulting in a more dynamic structure of the Eruca sativa mtDNA compared with other cruciferous mitotypes. Comparison with the Brassica napus MtDNA revealed that most of the genes with known function are conserved between these two mitotypes except for the ccmFN2 and rrn18 genes, and 27 point mutations were scattered in the 14 protein-coding genes. Evolutionary relationships analysis suggested that Eruca sativa is more closely related to the Brassica species and to Raphanus sativus than to Arabidopsis thaliana.	[Wang, Yankun; Chu, Pu; Yang, Qing; Chang, Shengxin; Chen, Jianmei; Guan, Rongzhan] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Hu, Maolong] Jiangsu Acad Agr Sci, Inst Econ Crop, Nanjing, Jiangsu, Peoples R China; [Guan, Rongzhan] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; Nanjing Agricultural University	Guan, RZ (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	guanrz@njau.edu.cn	Chang, Scott X/G-2029-2011	Guan, Rongzhan/0000-0001-9177-6610	National Natural Science Foundation of China [31270386, 31301352, 31101174]; National Key Technology R & D Program, in China [2010BAD01B02, 2011BAD13B09]; Open Research Fund of State Key Laboratory of State Key Laboratory of Crop Genetics and Germplasm Enhancement [ZW2011006]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Special Fund for Independent innovation of Agricultural Science and Technology in Jiangsu province [CX (11) 1026]; Science and Technology Support Program of Jiangsu Province [BE2012327]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R & D Program, in China(National Key Technology R&D Program); Open Research Fund of State Key Laboratory of State Key Laboratory of Crop Genetics and Germplasm Enhancement; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Special Fund for Independent innovation of Agricultural Science and Technology in Jiangsu province; Science and Technology Support Program of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (No. 31270386, 31301352 and 31101174), the National Key Technology R & D Program (No. 2010BAD01B02 and 2011BAD13B09) in China, the Open Research Fund of State Key Laboratory of State Key Laboratory of Crop Genetics and Germplasm Enhancement(ZW2011006), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Special Fund for Independent innovation of Agricultural Science and Technology in Jiangsu province (Nos. CX (11) 1026), and the Science and Technology Support Program of Jiangsu Province (BE2012327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Anjum NA, 2012, PLANT FAMILY BRASSIC, P1, DOI DOI 10.1007/978-94-007-3913-0_1; Arrieta-Montiel MP, 2011, ADVAN PL BIO, V1, P65; Arrieta-Montiel MP, 2009, GENETICS, V183, P1261, DOI 10.1534/genetics.109.108514; ASHRAF M, 1994, BIOL PLANTARUM, V36, P255, DOI 10.1007/BF02921095; Chang SX, 2013, J GENET GENOMICS, V40, P117, DOI 10.1016/j.jgg.2013.01.003; Chang SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056502; Chang SX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-497; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Chen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017662; Diamond M, 2011, ADVAN PL BIO, V1, P439; Fahleson J, 1997, PLANT SCI, V123, P133, DOI 10.1016/S0168-9452(96)04575-X; Fang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037164; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; Goremykin VV, 2012, PLANT J, V71, P615, DOI 10.1111/j.1365-313X.2012.05014.x; GRABAU EA, 1985, PLANT MOL BIOL, V5, P119, DOI 10.1007/BF00020094; GRAY MW, 1982, CAN J BIOCHEM CELL B, V60, P157, DOI 10.1139/o82-022; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Huang S, 2011, ADVAN PL BIO, V1, P207; Kubo T, 2008, MITOCHONDRION, V8, P5, DOI 10.1016/j.mito.2007.10.006; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LAKSHMIKUMARAN M, 1994, PLANT MOL BIOL, V24, P915, DOI 10.1007/BF00014445; Mower J.P., 2012, PLANT GENOME DIVERSI, P123, DOI DOI 10.1007/978-3-7091-1130-7_9; Ogihara Y, 2005, NUCLEIC ACIDS RES, V33, P6235, DOI 10.1093/nar/gki925; PALMER JD, 1987, CURR GENET, V11, P565, DOI 10.1007/BF00384620; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Park JY, 2013, THEOR APPL GENET, V126, P1763, DOI 10.1007/s00122-013-2090-0; Pellny TK, 2008, PLANT J, V54, P976, DOI 10.1111/j.1365-313X.2008.03472.x; Rayapuram N, 2008, J BIOL CHEM, V283, P25200, DOI 10.1074/jbc.M802621200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandhu APS, 2007, P NATL ACAD SCI USA, V104, P1766, DOI 10.1073/pnas.0609344104; Sastry E. V. D., 2003, Agricultural Reviews, V24, P235; Slater SM, 2013, BIOTECHNOLOGY NEGLEC, P203; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Tanaka Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-352; Tsunoda S., 1980, Brassica crops and wild allies. Biology and breeding., P109; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Wang J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-675; Woloszynska M, 2010, J EXP BOT, V61, P657, DOI 10.1093/jxb/erp361; Yuan ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-597; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	44	5	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105748	10.1371/journal.pone.0105748	http://dx.doi.org/10.1371/journal.pone.0105748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157569	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200057
J	Althoff, K; Beckers, A; Bell, E; Nortmeyer, M; Thor, T; Sprussel, A; Lindner, S; De Preter, K; Florin, A; Heukamp, LC; Klein-Hitpass, L; Astrahantseff, K; Kumps, C; Speleman, F; Eggert, A; Westermann, F; Schramm, A; Schulte, JH				Althoff, K.; Beckers, A.; Bell, E.; Nortmeyer, M.; Thor, T.; Spruessel, A.; Lindner, S.; De Preter, K.; Florin, A.; Heukamp, L. C.; Klein-Hitpass, L.; Astrahantseff, K.; Kumps, C.; Speleman, F.; Eggert, A.; Westermann, F.; Schramm, A.; Schulte, J. H.			A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies	ONCOGENE			English	Article							RISK STRATIFICATION; MIRNA EXPRESSION; GENE-EXPRESSION; P-TEFB; DIFFERENTIATION; PROGRESSION; PHENOTYPE; BIOLOGY; GAINS	Neuroblastoma, a childhood cancer that originates from neural crest-derived cells, is the most common deadly solid tumor of infancy. Amplification of the MYCN oncogene, which occurs in approximately 20-25% of human neuroblastomas, is the most prominent genetic marker of high-stage disease. The availability of valid preclinical in vivo models is a prerequisite to develop novel targeted therapies. We here report on the generation of transgenic mice with Cre-conditional induction of MYCN in dopamine a-hydroxylase-expressing cells, termed LSL-MYCN; Dbh-iCre. These mice develop neuroblastic tumors with an incidence of 475%, regardless of strain background. Molecular profiling of tumors revealed upregulation of the MYCN-dependent miR-17-92 cluster as well as expression of neuroblastoma marker genes, including tyrosine hydroxylase and the neural cell adhesion molecule 1. Gene set enrichment analyses demonstrated significant correlation with MYC-associated expression patterns. Array comparative genome hybridization showed that chromosomal aberrations in LSL-MYCN; Dbh-iCre tumors were syntenic to those observed in human neuroblastomas. Treatment of a cell line established from a tumor derived from a LSL-MYCN; Dbh-iCre mouse with JQ1 or MLN8237 reduced cell viability and demonstrated oncogene addiction to MYCN. Here we report establishment of the first Cre-conditional human MYCN-driven mouse model for neuroblastoma that closely recapitulates the human disease with respect to tumor localization, histology, marker expression and genomic make up. This mouse model is a valuable tool for further functional studies and to assess the effect of targeted therapies.	[Althoff, K.; Thor, T.; Spruessel, A.; Lindner, S.; Schramm, A.; Schulte, J. H.] Univ Childrens Hosp Essen, Dept Pediat Oncol & Haematol, D-45122 Essen, Germany; [Althoff, K.; Thor, T.; Spruessel, A.; Lindner, S.; Schulte, J. H.] German Canc Consortium DKTK, Hufelandstr, Germany; [Beckers, A.; De Preter, K.; Kumps, C.; Speleman, F.; Schulte, J. H.] Ghent Univ Hosp, Ctr Med Genet Ghent, Ghent, Belgium; [Bell, E.; Nortmeyer, M.; Thor, T.; Spruessel, A.; Lindner, S.; Westermann, F.; Schulte, J. H.] German Canc Res Ctr, Heidelberg, Germany; [Thor, T.; Spruessel, A.; Lindner, S.; Schulte, J. H.] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Translat Neurooncol, Essen, Germany; [Florin, A.; Heukamp, L. C.] Univ Hosp Cologne, Inst Pathol, Cologne, Germany; [Heukamp, L. C.] Blackfield AG, New Oncol, Cologne, Germany; [Klein-Hitpass, L.] Univ Duisburg Essen, Fac Med, Inst Cell Biol Canc Res, Essen, Germany; [Astrahantseff, K.; Eggert, A.] Charite, Dept Pediat Oncol Hematol & BMT, D-13353 Berlin, Germany	University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Ghent University; Ghent University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; University of Cologne; University of Duisburg Essen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schulte, JH (corresponding author), Univ Childrens Hosp Essen, Dept Pediat Oncol & Haematol, Hufeland St 55, D-45122 Essen, Germany.	Johannes.schulte@uni-due.de	Schulte, Johannes H./V-2474-2018; speleman, frank/AAR-5184-2020; Westermann, Frank/F-7509-2013; Schramm, Alexander/G-5688-2010; Eggert, Angelika/AAE-6907-2022; De Preter, Katleen/I-7135-2013; Heukamp, Lukas/G-9967-2012	speleman, frank/0000-0002-6628-8559; Schramm, Alexander/0000-0001-7670-7529; Eggert, Angelika/0000-0003-3476-8184; De Preter, Katleen/0000-0002-7726-5096; Heukamp, Lukas/0000-0002-3388-3482; Schulte, Johannes Hubertus/0000-0003-0671-1201	National Genome Research Network of the German Ministry for Education and Research (NGFNplus) [PKN-01GS0894-6]; European Union [259348-2]; German research council [SFB 832]; German Cancer Aid [111301]; Agency for Innovation by Science and Technology (IWT); Fund for Scientific Research Flanders (FWO)	National Genome Research Network of the German Ministry for Education and Research (NGFNplus); European Union(European Commission); German research council(German Research Foundation (DFG)); German Cancer Aid(Deutsche Krebshilfe); Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific Research Flanders (FWO)(FWO)	We thank S Dreesmann, A Odersky, S Schafers and N Solomentsew for excellent technical assistance and A Henssen for helpful discussions. This work was supported by the National Genome Research Network of the German Ministry for Education and Research (NGFNplus grant #PKN-01GS0894-6 to JHS, AE and AS), the 7th framework European Union project, ASSET (contract #259348-2 to AE, FS and JHS), the German research council (SFB 832, A5 and Z1 to LCH), by the German Cancer Aid (Grant No 111301 to JHS), by the Agency for Innovation by Science and Technology (IWT PhD grant to AB and CK) and the Fund for Scientific Research Flanders (FWO post-doc grant to KDP).	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Brockmann M, 2013, CANCER CELL, V24, P75, DOI 10.1016/j.ccr.2013.05.005; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Casola S, 2010, METHODS MOL BIOL, V667, P145, DOI 10.1007/978-1-60761-811-9_10; Cimmino F, 2009, ONCOGENE, V28, P2015, DOI 10.1038/onc.2009.70; De Preter K, 2011, CLIN CANCER RES, V17, P7684, DOI 10.1158/1078-0432.CCR-11-0610; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Gargano B, 2007, CELL CYCLE, V6, P2031, DOI 10.4161/cc.6.16.4554; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hackett CS, 2003, CANCER RES, V63, P5266; Hansford LM, 2004, P NATL ACAD SCI USA, V101, P12664, DOI 10.1073/pnas.0401083101; Heukamp LC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003967; Hong F, 2011, R PACKAGE VERSION; Jiang MR, 2011, CURR TOP DEV BIOL, V94, P77, DOI 10.1016/B978-0-12-380916-2.00004-8; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Menten B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-124; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ora I, 2011, SEMIN CANCER BIOL, V21, P217, DOI 10.1016/j.semcancer.2011.07.002; Park JR, 2010, HEMATOL ONCOL CLIN N, V24, P65, DOI 10.1016/j.hoc.2009.11.011; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Rasmuson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051297; Schleiermacher G, 2010, J CLIN ONCOL, V28, P3122, DOI 10.1200/JCO.2009.26.7955; Schramm A, 2007, CLIN CANCER RES, V13, P1459, DOI 10.1158/1078-0432.CCR-06-2032; Schulte JH, 2013, ONCOGENE, V32, P1059, DOI 10.1038/onc.2012.106; Schulte JH, 2011, CLIN CANCER RES, V17, P5082, DOI 10.1158/1078-0432.CCR-10-2809; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Simon T, 2011, PEDIATR BLOOD CANCER, V56, P578, DOI 10.1002/pbc.22693; Stallings RL, 2003, CANCER GENET CYTOGEN, V140, P133, DOI 10.1016/S0165-4608(02)00681-7; Stanke M, 2006, DEVELOPMENT, V133, P141, DOI 10.1242/dev.02189; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tchorz JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030011; Vandesompele J, 2005, J CLIN ONCOL, V23, P2280, DOI 10.1200/JCO.2005.06.104; Vandesompele J, 2001, MED PEDIATR ONCOL, V36, P5, DOI 10.1002/1096-911X(20010101)36:1<5::AID-MPO1003>3.0.CO;2-E; Weiss WA, 2000, CANCER RES, V60, P2483; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Whiteford CC, 2007, CANCER RES, V67, P32, DOI 10.1158/0008-5472.CAN-06-0610; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07	44	69	69	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	26					3357	3368		10.1038/onc.2014.269	http://dx.doi.org/10.1038/onc.2014.269			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CL3SU	25174395	Green Published, hybrid			2022-12-25	WOS:000356871700002
J	Babbitt, SE; Francisco, BS; Mendez, DL; Lukat-Rodgers, GS; Rodgers, KR; Bretsnyder, EC; Kranz, RG				Babbitt, Shalon E.; Francisco, Brian San; Mendez, Deanna L.; Lukat-Rodgers, Gudrun S.; Rodgers, Kenton R.; Bretsnyder, Eric C.; Kranz, Robert G.			Mechanisms of Mitochondrial Holocytochrome c Synthase and the Key Roles Played by Cysteines and Histidine of the Heme Attachment Site, Cys-XX-Cys-His	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHYRIN FORCE-FIELD; RESONANCE RAMAN-SPECTRA; CYTOCHROME-C; SACCHAROMYCES-CEREVISIAE; NICKEL OCTAETHYLPORPHYRIN; APOCYTOCHROME-C; THIOETHER BOND; ISOTOPE SHIFTS; BIOGENESIS; SYNTHETASE	Mitochondrial cytochrome c assembly requires the covalent attachment of heme by thioether bonds between heme vinyl groups and a conserved CXXCH motif of cytochrome c/c(1). The enzyme holocytochrome c synthase (HCCS) binds heme and apocytochrome c substrate to catalyze this attachment, subsequently releasing holocytochrome c for proper folding to its native structure. We address mechanisms of assembly using a functional Escherichia coli recombinant system expressing human HCCS. Human cytochrome c variants with individual cysteine, histidine, double cysteine, and triple cysteine/histidine substitutions (of CXXCH) were co-purified with HCCS. Single and double mutants form a complex with HCCS but not the triple mutant. Resonance Raman and UV-visible spectroscopy support the proposal that heme puckering induced by both thioether bonds facilitate release of holocytochrome c from the complex. His-19 (of CXXCH) supplies the second axial ligand to heme in the complex, the first axial ligand was previously shown to be from HCCS residue His-154. Substitutions of His-19 in cytochrome c to seven other residues (Gly, Ala, Met, Arg, Lys, Cys, and Tyr) were used with various approaches to establish other roles played by His-19. Three roles for His-19 in HCCS-mediated assembly are suggested: (i) to provide the second axial ligand to the heme iron in preparation for covalent attachment; (ii) to spatially position the two cysteinyl sulfurs adjacent to the two heme vinyl groups for thioether formation; and (iii) to aid in release of the holocytochrome c from the HCCS active site. Only H19M is able to carry out these three roles, albeit at lower efficiencies than the natural His-19.	[Babbitt, Shalon E.; Francisco, Brian San; Mendez, Deanna L.; Bretsnyder, Eric C.; Kranz, Robert G.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Lukat-Rodgers, Gudrun S.; Rodgers, Kenton R.] N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58102 USA	Washington University (WUSTL); North Dakota State University Fargo	Kranz, RG (corresponding author), 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	kranz@biology.wustl.edu		Mendez, Deanna/0000-0002-0481-4816	National Institutes of Health [RO1 GM47909, RO1 AI072719]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI072719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM47909 (to R. G. K.) and RO1 AI072719 (to K. R. R.).	Allen JWA, 2011, FEBS J, V278, P4198, DOI 10.1111/j.1742-4658.2011.08231.x; BARRICK D, 1994, BIOCHEMISTRY-US, V33, P6546, DOI 10.1021/bi00187a023; Bernard DG, 2003, J BIOL CHEM, V278, P49732, DOI 10.1074/jbc.M308881200; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; DICKERSON RE, 1971, J BIOL CHEM, V246, P1511; DUMONT ME, 1987, EMBO J, V6, P235, DOI 10.1002/j.1460-2075.1987.tb04744.x; Feissner R, 2003, ANAL BIOCHEM, V315, P90, DOI 10.1016/S0003-2697(02)00658-9; Feissner RE, 2006, MOL MICROBIOL, V60, P563, DOI 10.1111/j.1365-2958.2006.05132.x; Francisco BS, 2011, BIOCHEMISTRY-US, V50, P10974, DOI 10.1021/bi201508t; Frawley ER, 2009, P NATL ACAD SCI USA, V106, P10201, DOI 10.1073/pnas.0903132106; Hamel P, 2009, BBA-MOL CELL RES, V1793, P125, DOI 10.1016/j.bbamcr.2008.06.017; HU SZ, 1993, J AM CHEM SOC, V115, P12446, DOI 10.1021/ja00079a028; Kiryu-Seo S, 2006, EMBO J, V25, P3411, DOI 10.1038/sj.emboj.7601225; Kleingardner JG, 2011, METALLOMICS, V3, P396, DOI 10.1039/c0mt00086h; Kranz R, 1998, MOL MICROBIOL, V29, P383, DOI 10.1046/j.1365-2958.1998.00869.x; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; Leu BM, 2009, J PHYS CHEM B, V113, P2193, DOI 10.1021/jp806574t; LI XY, 1990, J PHYS CHEM-US, V94, P47, DOI 10.1021/j100364a008; LI XY, 1989, J AM CHEM SOC, V111, P7012, DOI 10.1021/ja00200a018; LI XY, 1990, J PHYS CHEM-US, V94, P31, DOI 10.1021/j100364a007; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MURPHY MEP, 1992, J MOL BIOL, V227, P160, DOI 10.1016/0022-2836(92)90689-H; NICHOLLS DG, 2013, BIOENERGETICS; Rosell FI, 2002, BIOCHEMISTRY-US, V41, P7811, DOI 10.1021/bi016060e; San Francisco B, 2013, P NATL ACAD SCI USA, V110, P3221, DOI 10.1073/pnas.1213897109; Schaefer L, 1996, GENOMICS, V34, P166, DOI 10.1006/geno.1996.0261; SORRELL TN, 1989, J AM CHEM SOC, V111, P766, DOI 10.1021/ja00184a074; SPIRO TG, 1990, COORDIN CHEM REV, V100, P541, DOI 10.1016/0010-8545(90)85019-O; Streit BR, 2010, J AM CHEM SOC, V132, P5711, DOI 10.1021/ja9082182; TANAKA Y, 1990, J BIOCHEM-TOKYO, V108, P7, DOI 10.1093/oxfordjournals.jbchem.a123165; Verissimo AF, 2012, BIOCHEM BIOPH RES CO, V424, P130, DOI 10.1016/j.bbrc.2012.06.088; VISCO C, 1985, J BIOL CHEM, V260, P6133; ZOLLNER A, 1992, EUR J BIOCHEM, V207, P1093, DOI 10.1111/j.1432-1033.1992.tb17146.x	33	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28795	28807		10.1074/jbc.M114.593509	http://dx.doi.org/10.1074/jbc.M114.593509			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25170082	Green Published, hybrid			2022-12-25	WOS:000344141000004
J	Li, LJ; Zhang, LC; Liu, GY; Feng, RN; Jiang, YS; Yang, L; Zhang, SH; Liao, MZ; Hua, JL				Li, Leijie; Zhang, Liangcai; Liu, Guiyou; Feng, Rennan; Jiang, Yongshuai; Yang, Lei; Zhang, Shihua; Liao, Mingzhi; Hua, Jinlian			Synergistic Transcriptional and Post-Transcriptional Regulation of ESC Characteristics by Core Pluripotency Transcription Factors in Protein-Protein Interaction Networks	PLOS ONE			English	Article							STEM-CELLS; SOMATIC-CELLS; SELF-RENEWAL; MOUSE; NANOG; CIRCUITRY; OCT4; FIBROBLASTS; INTEGRATION; LINEAGES	The molecular mechanism that maintains the pluripotency of embryonic stem cells (ESCs) is not well understood but may be reflected in complex biological networks. However, there have been few studies on the effects of transcriptional and post-transcriptional regulation during the development of ESCs from the perspective of computational systems biology. In this study, we analyzed the topological properties of the "core'' pluripotency transcription factors (TFs) OCT4, SOX2 and NANOG in protein-protein interaction networks (PPINs). Further, we identified synergistic interactions between these TFs and microRNAs (miRNAs) in PPINs during ESC development. Results show that there were significant differences in centrality characters between TF-targets and non-TF-targets in PPINs. We also found that there was consistent regulation of multiple "core'' pluripotency TFs. Based on the analysis of shortest path length, we found that the module properties were not only within the targets regulated by common or multiple "core'' pluripotency TFs but also between the groups of targets regulated by different TFs. Finally, we identified synergistic regulation of these TFs and miRNAs. In summary, the synergistic effects of "core'' pluripotency TFs and miRNAs were analyzed using computational methods in both human and mouse PPINs.	[Li, Leijie; Liao, Mingzhi] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Zhang, Liangcai; Liu, Guiyou; Feng, Rennan; Jiang, Yongshuai; Yang, Lei] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Zhang, Liangcai] Rice Univ, Dept Stat, Houston, TX 77251 USA; [Liu, Guiyou] Chinese Acad Sci, Genome Anal Lab, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Feng, Rennan] Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China; [Zhang, Shihua] Anhui Agr Univ, Sch Sci, Dept Biostat, Hefei, Peoples R China; [Hua, Jinlian] Northwest A&F Univ, Shaanxi Ctr Stem Cells Engn & Technol, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Harbin Medical University; Rice University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Harbin Medical University; Anhui Agricultural University; Northwest A&F University - China	Liao, MZ (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	zhangshihua@ahau.edu.cn; liaomingzhi83@163.com; jlhua2003@126.com	Zhang, Liang/GWM-6088-2022; Zhang, Liangcai/AAD-4415-2020	Jiang, Yongshuai/0000-0002-7163-6554; zhang, shihua/0000-0002-3877-9166; Liu, Guiyou/0000-0002-1126-2888	Fund of Northwest AF University [2013XZ-28]; National Natural Science Foundation of China [31301938, 81300945, 31200934, 31301248, 31272518]	Fund of Northwest AF University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fund of Northwest A&F University and innovation experiment program for university students 2013XZ-28 (website: http://www.nwsuaf.edu.cn/); the National Natural Science Foundation of China Grants 31301938, 81300945, 31200934, 31301248, and 31272518 (website: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2014, MOL NUTR FOOD RES, V58, P79, DOI 10.1002/mnfr.201300528; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Archer TC, 2011, DEV BIOL, V350, P429, DOI 10.1016/j.ydbio.2010.12.013; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cassar PA, 2012, J CELL PHYSIOL, V227, P439, DOI 10.1002/jcp.22787; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Fazi F, 2008, CARDIOVASC RES, V79, P553, DOI 10.1093/cvr/cvn151; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2011, GENOME MED, V3, DOI 10.1186/gm291; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu S, 2014, J CELL BIOCH; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Orkin SH, 2005, CELL, V122, P828, DOI 10.1016/j.cell.2005.09.002; Pan LN, 2007, CELL MOL IMMUNOL, V4, P337; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reichmann J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002486; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilson KD, 2010, CIRC-CARDIOVASC GENE, V3, P426, DOI 10.1161/CIRCGENETICS.109.934281; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang P, 2008, PHYSICA A, V387, P6869, DOI 10.1016/j.physa.2008.09.006	52	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105180	10.1371/journal.pone.0105180	http://dx.doi.org/10.1371/journal.pone.0105180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171496	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500034
J	Gehrmann, M; Stangl, S; Foulds, GA; Oellinger, R; Breuninger, S; Rad, R; Pockley, AG; Multhoff, G				Gehrmann, Mathias; Stangl, Stefan; Foulds, Gemma A.; Oellinger, Rupert; Breuninger, Stephanie; Rad, Roland; Pockley, Alan G.; Multhoff, Gabriele			Tumor Imaging and Targeting Potential of an Hsp70-Derived 14-Mer Peptide	PLOS ONE			English	Article							SHOCK-PROTEIN 72; MEMBRANE-BOUND HEAT-SHOCK-PROTEIN-70; ACUTE MYELOID-LEUKEMIA; RECOGNITION STRUCTURE; CANCER-THERAPY; BREAST-CANCER; HSP70; EXPRESSION; CELLS; DELIVERY	Background: We have previously used a unique mouse monoclonal antibody cmHsp70.1 to demonstrate the selective presence of a membrane-bound form of Hsp70 (memHsp70) on a variety of leukemia cells and on single cell suspensions derived from solid tumors of different entities, but not on non-transformed cells or cells from corresponding 'healthy' tissue. This antibody can be used to image tumors in vivo and target them for antibody-dependent cellular cytotoxicity. Tumor-specific expression of memHsp70 therefore has the potential to be exploited for theranostic purposes. Given the advantages of peptides as imaging and targeting agents, this study assessed whether a 14-mer tumor penetrating peptide (TPP; TKDNNLLGRFELSG), the sequence of which is derived from the oligomerization domain of Hsp70 which is expressed on the cell surface of tumor cells, can also be used for targeting membrane Hsp70 positive (memHsp70+) tumor cells, in vitro. Methodology/Principal Findings: The specificity of carboxy-fluorescein (CF-) labeled TPP (TPP) to Hsp70 was proven in an Hsp70 knockout mammary tumor cell system. TPP specifically binds to different memHsp70+ mouse and human tumor cell lines and is rapidly taken up via endosomes. Two to four-fold higher levels of CF-labeled TPP were detected in MCF7 (82% memHsp70+) and MDA-MB-231 (75% memHsp70+) cells compared to T47D cells (29% memHsp70+) that exhibit a lower Hsp70 membrane positivity. After 90 min incubation, TPP co-localized with mitochondrial membranes in memHsp70+ tumors. Although there was no evidence that any given vesicle population was specifically localized, fluorophore-labeled cmHsp70.1 antibody and TPP preferentially accumulated in the proximity of the adherent surface of cultured cells. These findings suggest a potential association between membrane Hsp70 expression and cytoskeletal elements that are involved in adherence, the establishment of intercellular synapses and/or membrane reorganization. Conclusions/Significance: This study demonstrates the specific binding and rapid internalization of TPP by tumor cells with a memHsp70+ phenotype. TPP might therefore have potential for targeting and imaging the large proportion of tumors (similar to 50%) that express memHsp70.	[Gehrmann, Mathias; Stangl, Stefan; Breuninger, Stephanie; Multhoff, Gabriele] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-80290 Munich, Germany; [Foulds, Gemma A.; Pockley, Alan G.] Nottingham Trent Univ, John Van Geest Canc Res Ctr, Nottingham, England; [Oellinger, Rupert; Rad, Roland] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-80290 Munich, Germany; [Multhoff, Gabriele] Deutsch Forschungszentrum Gesundheit & Umwelt, Helmholtz Zentrum Munchen, CCG Innate Immun Tumor Biol, Munich, Germany	Technical University of Munich; Nottingham Trent University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Multhoff, G (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-80290 Munich, Germany.	gabriele.multhoff@lrz.tu-muenchen.de	Multhoff, Gabriele/AAW-9796-2021; Pockley, Alan G/I-4704-2015	Multhoff, Gabriele/0000-0002-2616-3137; Pockley, Alan G/0000-0001-9593-6431; Foulds, Gemma/0000-0002-2053-7580	Deutsche Forschungsgemeinschaft (DFG) [SFB824/B4]; DFG [INST95/980-1 FUGG]; DFG-Cluster of Excellence: Munich Advanced Photonics (MAP); Bundesministerium fur Bildung und Forschung (BMBF) MOBITUM [01EZ0826]; m4 Cluster of Excellence [01EX1021C]; Kompetenzverbund Strahlenforschung [03NUK007E]; John and Lucille van Geest Foundation; Wellcome Trust [084399]; multimmune GmbH	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); DFG-Cluster of Excellence: Munich Advanced Photonics (MAP)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF) MOBITUM(Federal Ministry of Education & Research (BMBF)); m4 Cluster of Excellence; Kompetenzverbund Strahlenforschung; John and Lucille van Geest Foundation; Wellcome Trust(Wellcome Trust); multimmune GmbH	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) SFB824/B4, (DFG) INST95/980-1 FUGG, DFG-Cluster of Excellence: Munich Advanced Photonics (MAP), Bundesministerium fur Bildung und Forschung (BMBF) MOBITUM (01EZ0826), m4 Cluster of Excellence (01EX1021C), and Kompetenzverbund Strahlenforschung (03NUK007E). Additional funding was provided to AGP by the John and Lucille van Geest Foundation and the Wellcome Trust (Grant 084399). This study was partly funded by multimmune GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825; Askoxylakis V, 2006, J NUCL MED, V47, P981; Baeuerle PA, 2012, CURR PHARM BIOTECHNO, V13, P1399; Barbet Jacques, 2012, Methods Mol Biol, V907, P681, DOI 10.1007/978-1-61779-974-7_38; Bidwell GL, 2012, THER DELIV, V3, P609, DOI 10.4155/TDE.12.37; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Botzler C, 1996, CANCER IMMUNOL IMMUN, V43, P226, DOI 10.1007/s002620050326; Botzler C, 1998, INT J CANCER, V77, P942, DOI 10.1002/(SICI)1097-0215(19980911)77:6<942::AID-IJC25>3.0.CO;2-1; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Chen WH, 2013, CHEM COMMUN, V49, P6403, DOI 10.1039/c3cc43283a; Chow JYC, 2013, WORLD J GASTROENTERO, V19, P2731, DOI 10.3748/wjg.v19.i18.2731; Condeelis J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003848; Copeland A, 2012, CURR OPIN ONCOL, V24, P466, DOI 10.1097/CCO.0b013e32835689a3; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; FAGER RS, 1977, J LIPID RES, V18, P704; Fani M, 2012, THERANOSTICS, V2, P481, DOI 10.7150/thno.4024; Farkas B, 2003, MELANOMA RES, V13, P147, DOI 10.1097/00008390-200304000-00006; Fass L, 2008, MOL ONCOL, V2, P115, DOI 10.1016/j.molonc.2008.04.001; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Gehrmann M, 2005, CELL DEATH DIFFER, V12, P38, DOI 10.1038/sj.cdd.4401510; Gehrmann M, 2003, HAEMATOLOGICA, V88, P474; Gehrmann M, 2010, INT J CLIN PHARM TH, V48, P492; Gehrmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001925; Gehrmann M, 2008, CELL STRESS CHAPERON, V13, P1, DOI 10.1007/s12192-007-0006-0; Gehrmann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041341; Gehrmann M, 2011, J IMMUNOL METHODS, V371, P8, DOI 10.1016/j.jim.2011.06.007; Goswami Trishna, 2009, Expert Opin Med Diagn, V3, P523, DOI 10.1517/17530050903032653; Gross C, 2003, J BIOL CHEM, V278, P41173, DOI 10.1074/jbc.M302644200; Gyrd-Hansen M, 2004, CELL CYCLE, V3, P1484, DOI 10.4161/cc.3.12.1287; Han CY, 2014, ARTIF CELL NANOMED B, V42, P161, DOI 10.3109/21691401.2013.801848; Hantschel M, 2000, CELL STRESS CHAPERON, V5, P438, DOI 10.1379/1466-1268(2000)005<0438:HPMEOP>2.0.CO;2; Hilgendorf KI, 2013, GENE DEV, V27, P1003, DOI 10.1101/gad.211326.112; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kaumaya PTP, 2012, FUTURE ONCOL, V8, P961, DOI [10.2217/FON.12.95, 10.2217/fon.12.95]; Kleinjung T, 2003, INT J RADIAT ONCOL, V57, P820, DOI 10.1016/S0360-3016(03)00629-1; Lee SA, 2013, BIOMATERIALS, V34, P7495, DOI 10.1016/j.biomaterials.2013.06.015; Lee SJ, 2001, CELL STRESS CHAPERON, V6, P273, DOI 10.1379/1466-1268(2001)006<0273:ROIHSP>2.0.CO;2; Li S, 2011, AM J PATHOL, V179, P2822, DOI 10.1016/j.ajpath.2011.08.013; Lim KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066084; Lu RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066128; Ma CY, 2013, BIOTECHNOL LETT, V35, P1791, DOI 10.1007/s10529-013-1263-x; Ma XC, 2013, ADV HEALTHC MATER, V2, P1638, DOI 10.1002/adhm.201300037; Malhi SS, 2012, INT J PHARMACEUT, V432, P63, DOI 10.1016/j.ijpharm.2012.04.030; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; McGee SF, 2006, EXPERT OPIN DRUG DIS, V1, P569, DOI 10.1517/174604441.1.6.569; Milanezi Fernanda, 2009, Expert Opin Med Diagn, V3, P607, DOI 10.1517/17530050903222221; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Moktan S, 2012, INT J PEPT RES THER, V18, P227, DOI 10.1007/s10989-012-9295-y; Multhoff G, 1997, INT J HYPERTHER, V13, P39, DOI 10.3109/02656739709056428; Multhoff G, 1997, J IMMUNOL, V158, P4341; MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222; Multhoff G, 2007, METHODS, V43, P229, DOI 10.1016/j.ymeth.2007.06.006; Murphy CG, 2012, ANTI-CANCER DRUG, V23, P765, DOI 10.1097/CAD.0b013e328352d292; Nakatsu Y, 2013, J VIROL, V87, P4683, DOI 10.1128/JVI.02189-12; Okarvi SM, 2008, CANCER TREAT REV, V34, P13, DOI 10.1016/j.ctrv.2007.07.017; Pfister K, 2007, CANCER-AM CANCER SOC, V110, P926, DOI 10.1002/cncr.22864; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rerole AL, 2011, CANCER RES, V71, P484, DOI 10.1158/0008-5472.CAN-10-1443; Rodrigues M, 2013, BBA-GEN SUBJECTS, V1830, P4554, DOI 10.1016/j.bbagen.2013.05.020; Roth A, 2007, MOL CANCER THER, V6, P2737, DOI 10.1158/1535-7163.MCT-07-0140; Schilling D, 2009, FASEB J, V23, P2467, DOI 10.1096/fj.08-125229; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shabaik YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054346; Spang A, 2009, BIOL CHEM, V390, P753, DOI 10.1515/BC.2009.056; Stangl S, 2011, J CELL MOL MED, V15, P874, DOI 10.1111/j.1582-4934.2010.01067.x; Stangl S, 2011, P NATL ACAD SCI USA, V108, P733, DOI 10.1073/pnas.1016065108; Steiner K, 2006, LEUKEMIA, V20, P2076, DOI 10.1038/sj.leu.2404391; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thundimadathil Jyothi, 2012, J Amino Acids, V2012, P967347, DOI 10.1155/2012/967347; Vacchelli E, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22789; Xin L, 2013, FRONT BIOSCI-LANDMRK, V18, P765, DOI 10.2741/4139; Yan X, 2012, THERANOSTICS, V2, P988, DOI 10.7150/thno.4818; Yoon TH, 2002, J CHROMATOGR A, V949, P209, DOI 10.1016/S0021-9673(01)01270-5; Zhang XY, 2013, INT J PHARMACEUT, V453, P498, DOI 10.1016/j.ijpharm.2013.06.038; Zitzmann S, 2007, J NUCL MED, V48, P965, DOI 10.2967/jnumed.106.036699	77	22	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105344	10.1371/journal.pone.0105344	http://dx.doi.org/10.1371/journal.pone.0105344			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165986	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303700024
J	Pilarczyk, M; Mateuszuk, L; Rygula, A; Kepczynski, M; Chlopicki, S; Baranska, M; Kaczor, A				Pilarczyk, Marta; Mateuszuk, Lukasz; Rygula, Anna; Kepczynski, Mariusz; Chlopicki, Stefan; Baranska, Malgorzata; Kaczor, Agnieszka			Endothelium in Spots - High-Content Imaging of Lipid Rafts Clusters in db/db Mice	PLOS ONE			English	Article							RAMAN-SPECTROSCOPY; CELL BIOLOGY; IN-SITU; CANCER; CAVEOLAE; PROTEINS	Lipid rafts (LRs) are dynamic, sterol-and sphingolipid-enriched nanodomains involved in the regulation of cellular functions and signal transduction, that upon stimuli, via (e.g. association of raft proteins and lipids), may cluster into domains of submicron or micron scale. Up to date, however, lipid raft clusters were observed only under artificially promoted conditions and their formation in vivo has not been confirmed. Using non-destructive approach involving Raman and Atomic Force Microscopy imaging we demonstrated the presence of clustered lipid rafts in endothelium of the aorta of the db/db mice that represent a reliable murine model of type 2 diabetes. The raft clusters in the aorta of diabetic mice were shown to occupy a considerably larger (about 10-fold) area of endothelial cells surface as compared to the control. Observation of pathology-promoted LRs confirms that the cellular increase of lipid content results in clustering of LRs. Clustering of LRs leads to the formation of assemblies with diameters up to 3 micrometers and increased lipid character. This massive clustering of lipid rafts in diabetes may trigger a signaling cascade leading to vascular inflammation.	[Pilarczyk, Marta; Kepczynski, Mariusz; Baranska, Malgorzata; Kaczor, Agnieszka] Jagiellonian Univ, Fac Chem, PL-30060 Krakow, Poland; [Pilarczyk, Marta; Mateuszuk, Lukasz; Rygula, Anna; Chlopicki, Stefan; Baranska, Malgorzata; Kaczor, Agnieszka] Jagiellonian Ctr Expt Therapeut, Krakow, Poland; [Chlopicki, Stefan] Jagiellonian Univ, Dept Expt Pharmacol, Krakow, Poland	Jagiellonian University; Jagiellonian University; Jagiellonian University	Kaczor, A (corresponding author), Jagiellonian Univ, Fac Chem, Karasia 3, PL-30060 Krakow, Poland.	kaczor@chemia.uj.edu.pl	Pacia, Marta Zofia/AAG-9558-2019; Rygula, Anna/C-4335-2013	Pacia, Marta Zofia/0000-0002-0391-2502; Chlopicki, Stefan/0000-0002-2878-3858; Kaczor, Agnieszka/0000-0001-8337-8567; Baranska, Malgorzata/0000-0001-8826-3144; Rygula, Anna/0000-0001-6356-1049	European Union [POIG.01.01.02-00069/09]; National Science Centre [DEC-2012/07/N/ST4/00296]; European Regional Development Fund [POIG.02.01.00-12-023/08]	European Union(European Commission); National Science Centre(National Science Centre, Poland); European Regional Development Fund(European Commission)	This work was supported by the European Union under the European Regional Development Fund (grant coordinated by JCET-UJ, POIG.01.01.02-00069/09). MP thanks the National Science Centre (the decision number DEC-2012/07/N/ST4/00296) for financial support. The research was carried out with the equipment purchased thanks to the financial support of the European Regional Development Fund in the framework of the Polish Innovation Economy Operational Program (contract no. POIG.02.01.00-12-023/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brozek-Pluska B, 2012, ANALYST, V137, P3773, DOI 10.1039/c2an16179f; Carver LA, 2003, CANCER RES, V63, P6571; Chakraborty M, 2013, J CLIN INVEST, V123, P1784, DOI 10.1172/JCI60415; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; Goldberg IJ, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0365-1; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Krafft C, 2006, SPECTROSC-INT J, V20, P195, DOI 10.1155/2006/738186; Krafft C, 2005, SPECTROCHIM ACTA A, V61, P1529, DOI 10.1016/j.saa.2004.11.017; Lattermann A, 2013, J BIOPHOTONICS, V6, DOI 10.1002/jbio.201200146; Lemaire-Ewing S, 2012, ATHEROSCLEROSIS, V221, P303, DOI 10.1016/j.atherosclerosis.2011.10.016; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Magonov SN, 1997, SURF SCI, V375, pL385, DOI 10.1016/S0039-6028(96)01591-9; MARTIN Y, 1987, J APPL PHYS, V61, P4723, DOI 10.1063/1.338807; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Patschan S, 2007, DRUG DISC TODAY DIS, V4, P11; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pilarczyk M, 2014, VIBR SPECTR IN PRESS; Pilarczyk M, 2013, J RAMAN SPECTROSC, V44, P1222, DOI 10.1002/jrs.4352; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Raman CV, 1928, NATURE, V121, P501, DOI 10.1038/121501c0; Rehman S, 2007, J RAMAN SPECTROSC, V38, P1345, DOI 10.1002/jrs.1774; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Tollefson M, 2010, BJU INT, V106, P484, DOI 10.1111/j.1464-410X.2010.09185.x; VAN MEER G, 1987, J CELL BIOL, V105, P1623, DOI 10.1083/jcb.105.4.1623; van Zanten TS, 2010, BBA-BIOMEMBRANES, V1798, P777, DOI 10.1016/j.bbamem.2009.09.012; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; ZHONG Q, 1993, SURF SCI, V290, pL688, DOI 10.1016/0039-6028(93)90582-5	43	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106065	10.1371/journal.pone.0106065	http://dx.doi.org/10.1371/journal.pone.0106065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166908	Green Published, gold			2022-12-25	WOS:000341303700068
J	Wu, B; Suo, FM; Lei, WJ; Gu, LF				Wu, Bin; Suo, Fengmei; Lei, Wanjun; Gu, Lianfeng			Comprehensive Analysis of Alternative Splicing in Digitalis purpurea by Strand-Specific RNA-Seq	PLOS ONE			English	Article							GENE; TRANSCRIPTOME; RICE; IDENTIFICATION; ANNOTATION; ALIGNMENT; 5-BETA-REDUCTASE; MICROARRAYS; REGULATORS; EXPRESSION	Digitalis purpurea (D. purpurea) is one of the most important medicinal plants and is well known in the treatment of heart failure because of the cardiac glycosides that are its main active compounds. However, in the absence of strand specific sequencing information, the post-transcriptional mechanism of gene regulation in D. purpurea thus far remains unknown. In this study, a strand-specific RNA-Seq library was constructed and sequenced using Illumina HiSeq platforms to characterize the transcriptome of D. purpurea with a focus on alternative splicing (AS) events and the effect of AS on protein domains. De novo RNA-Seq assembly resulted in 48,475 genes. Based on the assembled transcripts, we reported a list of 3,265 AS genes, including 5,408 AS events in D. purpurea. Interestingly, both glycosyltransferases and monooxygenase, which were involved in the biosynthesis of cardiac glycosides, are regulated by AS. A total of 2,422 AS events occurred in coding regions, and 959 AS events were located in the regions of 882 unique protein domains, which could affect protein function. This D. purpurea transcriptome study substantially increased the expressed sequence resource and presented a better understanding of post-transcriptional regulation to further facilitate the medicinal applications of D. purpurea for human health.	[Wu, Bin; Suo, Fengmei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wu, Bin; Suo, Fengmei] Chinese Acad Med Sci, Ctr Bioinformat, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Lei, Wanjun] Shanxi Agr Univ, Coll Life Sci, Taigu, Peoples R China; [Gu, Lianfeng] Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrat Genome Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Shanxi Agricultural University; University of California System; University of California Riverside	Gu, LF (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrat Genome Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	lianfeng.gu@ucr.edu			Natural Science Foundation of China [81274015]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (No. 81274015) granted to BW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Carvalho RF, 2013, PROTOPLASMA, V250, P639, DOI 10.1007/s00709-012-0448-9; Chen FC, 2007, PLANT PHYSIOL, V143, P1086, DOI 10.1104/pp.106.092460; Chico JM, 2008, CURR OPIN PLANT BIOL, V11, P486, DOI 10.1016/j.pbi.2008.06.003; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; David CJ, 2008, GENE DEV, V22, P279, DOI 10.1101/gad.1643108; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gavidia I, 2007, PHYTOCHEMISTRY, V68, P853, DOI 10.1016/j.phytochem.2006.11.019; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu Lianfeng, 2007, Journal of Genetics and Genomics, V34, P247, DOI 10.1016/S1673-8527(07)60026-5; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Herl V, 2007, PLANTA MED, V73, P704, DOI 10.1055/s-2007-981537; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Juntawong P, 2014, P NATL ACAD SCI USA, V111, pE203, DOI 10.1073/pnas.1317811111; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kitagawa N, 2005, BIOINFORMATICS, V21, P1758, DOI 10.1093/bioinformatics/bti253; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kriventseva EV, 2003, TRENDS GENET, V19, P124, DOI 10.1016/S0168-9525(03)00023-4; Kuate SP, 2008, PHYTOCHEMISTRY, V69, P619, DOI 10.1016/j.phytochem.2007.08.025; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lazar G, 2000, PLANT MOL BIOL, V42, P571, DOI 10.1023/A:1006394207479; Lee C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-231; Levin JZ, 2010, NAT METHODS; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ner-Gaon H, 2007, PLANT PHYSIOL, V144, P1632, DOI 10.1104/pp.107.098640; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Perez-Bermudez P, 2010, NEW PHYTOL, V185, P687, DOI 10.1111/j.1469-8137.2009.03080.x; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Reddy ASN, 2013, PLANT CELL, V25, P3657, DOI 10.1105/tpc.113.117523; Reddy ASN, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00018; Relogio A, 2005, J BIOL CHEM, V280, P4779, DOI 10.1074/jbc.M411976200; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Shen SH, 2010, BIOINFORMATICS, V26, P268, DOI 10.1093/bioinformatics/btp643; Shen YT, 2014, PLANT CELL, V26, P996, DOI 10.1105/tpc.114.122739; Staswick PE, 2008, TRENDS PLANT SCI, V13, P66, DOI 10.1016/j.tplants.2007.11.011; Takeda J, 2006, NUCLEIC ACIDS RES, V34, P3917, DOI 10.1093/nar/gkl507; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Tress ML, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r162; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang BB, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r102; Wang BB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-17; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warren B, 2005, AM J CARDIOL, V95, P544, DOI 10.1016/j.amjcard.2004.09.063; Wray S, 1985, Med Hist Suppl, P132; Wu B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-15; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yuan QP, 2005, PLANT PHYSIOL, V138, P17, DOI 10.1104/pp.104.059063	63	12	12	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106001	10.1371/journal.pone.0106001	http://dx.doi.org/10.1371/journal.pone.0106001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25167195	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303700061
J	Boumis, RJ; Ferry, LA; Pace, CM; Gibb, AC				Boumis, Robert J.; Ferry, Lara A.; Pace, Cinnamon M.; Gibb, Alice C.			Heads or Tails: Do Stranded Fish (Mosquitofish, Gambusia affinis) Know Where They Are on a Slope and How to Return to the Water?	PLOS ONE			English	Article							RESPONSES	Aquatic vertebrates that emerge onto land to spawn, feed, or evade aquatic predators must return to the water to avoid dehydration or asphyxiation. How do such aquatic organisms determine their location on land? Do particular behaviors facilitate a safe return to the aquatic realm? In this study, we asked: will fully-aquatic mosquitofish (Gambusia affinis) stranded on a slope modulate locomotor behavior according to body position to facilitate movement back into the water? To address this question, mosquitofish (n = 53) were placed in four positions relative to an artificial slope (30 degrees inclination) and their responses to stranding were recorded, categorized, and quantified. We found that mosquitofish may remain immobile for up to three minutes after being stranded and then initiate either a "roll'' or a "leap''. During a roll, mass is destabilized to trigger a downslope tumble; during a leap, the fish jumps up, above the substrate. When mosquitofish are oriented with the long axis of the body at 90 degrees to the slope, they almost always (97%) initiate a roll. A roll is an energetically inexpensive way to move back into the water from a cross-slope body orientation because potential energy is converted back into kinetic energy. When placed with their heads toward the apex of the slope, most mosquitofish (>50%) produce a tail-flip jump to leap into ballistic flight. Because a tail-flip generates a caudually-oriented flight trajectory, this locomotor movement will effectively propel a fish downhill when the head is oriented up-slope. However, because the mass of the body is elevated against gravity, leaps require more mechanical work than rolls. We suggest that mosquitofish use the otolith-vestibular system to sense body position and generate a behavior that is "matched'' to their orientation on a slope, thereby increasing the probability of a safe return to the water, relative to the energy expended.	[Boumis, Robert J.; Pace, Cinnamon M.; Gibb, Alice C.] No Arizona Univ, Dept Biol, Flagstaff, AZ 86011 USA; [Ferry, Lara A.] Arizona State Univ, Sch Math & Nat Sci, Glendale, AZ USA	Northern Arizona University; Arizona State University	Gibb, AC (corresponding author), No Arizona Univ, Dept Biol, Flagstaff, AZ 86011 USA.	Alice.Gibb@nau.edu		Boumis, Robert/0000-0002-8545-6706				ANDERSON JH, 1978, EXP BRAIN RES, V32, P491; Ashley-Ross MA, 2013, ZOOL, V117, P7; BAYLIS JR, 1982, COPEIA, P455; Buddelmann B, 1971, J COMP PHYSIOL A, V85A, P283; Gibb AC, 2011, J EXP ZOOL PART A, V315A, P649, DOI 10.1002/jez.711; Graham JB, 1997, AIR BREATHING FISHES, DOI DOI 10.1016/B978-012294860-2/50006-4; Ladich F, 2004, SPR HDB AUD, V22, P95, DOI 10.1007/978-1-4419-8957-4_4; Liem KF., 2001, FUNCTIONAL ANATOMY V; Mast OS, 1915, ANIM BEHAV, V5, P341; PERACHIO AA, 1983, BRAIN RES, V280, P287, DOI 10.1016/0006-8993(83)90058-6; Retzius G., 1881, BIOL UNTERSUCH, V1, P1; Schaeffer PJ, 2013, COMPR PHYSIOL, V3, P289, DOI 10.1002/cphy.c110059; Soares D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061617; STOFFREGEN TA, 1988, PSYCHOL REV, V95, P3, DOI 10.1037/0033-295X.95.1.3	14	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e104569	10.1371/journal.pone.0104569	http://dx.doi.org/10.1371/journal.pone.0104569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162613	gold, Green Published, Green Submitted			2022-12-25	WOS:000340880900018
J	Busch, DS; Maher, M; Thibodeau, P; McElhany, P				Busch, D. Shallin; Maher, Michael; Thibodeau, Patricia; McElhany, Paul			Shell Condition and Survival of Puget Sound Pteropods Are Impaired by Ocean Acidification Conditions	PLOS ONE			English	Article							CORAL ASTRANGIA POCULATA; GLOBAL CLIMATE-CHANGE; SEA-WATER; METABOLIC-RESPONSE; POTENTIAL IMPACTS; LIMACINA-HELICINA; ROSS SEA; CO2; CARBON; SALMON	We tested whether the thecosome pteropod Limacina helicina from Puget Sound, an urbanized estuary in the northwest continental US, experiences shell dissolution and altered mortality rates when exposed to the high CO2, low aragonite saturation state (Omega(a)) conditions that occur in Puget Sound and the northeast Pacific Ocean. Five, week-long experiments were conducted in which we incubated pteropods collected from Puget Sound in four carbon chemistry conditions: current summer surface (similar to 460-500 mu atm CO2, Omega(a)approximate to 1.59), current deep water or surface conditions during upwelling (similar to 760 and,1600-1700 mu atm CO2, Omega(a)approximate to 1.17 and 0.56), and future deep water or surface conditions during upwelling (Omega(a)2800-3400 mu atm CO2, Omega(a)approximate to 0.28). We measured shell condition using a scoring regime of five shell characteristics that capture different aspects of shell dissolution. We characterized carbon chemistry conditions in statistical analyses with Omega(a), and conducted analyses considering Omega(a) both as a continuous dataset and as discrete treatments. Shell dissolution increased linearly as aragonite saturation state decreased. Discrete treatment comparisons indicate that shell dissolution was greater in undersaturated treatments compared to oversaturated treatments. Survival increased linearly with aragonite saturation state, though discrete treatment comparisons indicated that survival was similar in all but the lowest saturation state treatment. These results indicate that, under starvation conditions, pteropod survival may not be greatly affected by current and expected near-future aragonite saturation state in the NE Pacific, but shell dissolution may. Given that subsurface waters in Puget Sound's main basin are undersaturated with respect to aragonite in the winter and can be undersaturated in the summer, the condition and persistence of the species in this estuary warrants further study.	[Busch, D. Shallin; Maher, Michael; Thibodeau, Patricia; McElhany, Paul] NOAA, Conservat Biol Div, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA	Busch, DS (corresponding author), NOAA, Ocean Acidificat Program, Silver Spring, MD 20910 USA.	Shallin.Busch@noaa.gov			NOAA's Ocean Acidification Program, Northwest Fisheries Science Center, and Office of Education	NOAA's Ocean Acidification Program, Northwest Fisheries Science Center, and Office of Education	This project was funded by NOAA's Ocean Acidification Program, Northwest Fisheries Science Center, and Office of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth CH, 2011, ICES J MAR SCI, V68, P1217, DOI 10.1093/icesjms/fsr043; Armstrong JL, 2005, DEEP-SEA RES PT II, V52, P247, DOI 10.1016/j.dsr2.2004.09.019; Aydin KY, 2005, DEEP-SEA RES PT II, V52, P757, DOI 10.1016/j.dsr2.2004.12.017; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; BATHMANN UV, 1991, DEEP-SEA RES, V38, P1341, DOI 10.1016/0198-0149(91)90031-A; Beardall J, 2009, PLANT ECOL DIVERS, V2, P191, DOI 10.1080/17550870903271363; Bednarsek N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0123; Bednarsek N, 2012, NAT GEOSCI, V5, P881, DOI 10.1038/NGEO1635; Bednarsek N., 2012, Global Change Biology, V18, P2378, DOI 10.1111/j.1365-2486.2012.02668.x; Brodeur RD, 1987, NMFS57 NOAA US DEP C; Brodeur RD, 2007, AM FISH S S, V57, P183; Burnham K. P., 1998, MODEL SELECTION INFE; Busch DS, 2013, ICES J MAR SCI, V70, P823, DOI 10.1093/icesjms/fst061; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Cannon CA, 1983, PMEL48 NOAA ERL US D; Collier R, 2000, DEEP-SEA RES PT II, V47, P3491, DOI 10.1016/S0967-0645(00)00076-X; Comeau S, 2012, MAR ECOL PROG SER, V456, P279, DOI 10.3354/meps09696; Comeau S, 2010, MAR BIOL, V157, P2341, DOI 10.1007/s00227-010-1493-6; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; Comeau S, 2012, P ROY SOC B-BIOL SCI, V279, P732, DOI 10.1098/rspb.2011.0910; Comeau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011362; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004157; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Gannefors C, 2005, MAR BIOL, V147, P169, DOI 10.1007/s00227-004-1544-y; Gruber N, 2012, SCIENCE, V337, P220, DOI 10.1126/science.1216773; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hauri C, 2009, OCEANOGRAPHY, V22, P60, DOI 10.5670/oceanog.2009.97; Hettinger A, 2013, BIOGEOSCIENCES, V10, P6629, DOI 10.5194/bg-10-6629-2013; Honisch B, 2012, SCIENCE, V335, P1058, DOI 10.1126/science.1208277; Holcomb M, 2012, BIOGEOSCIENCES, V9, P29, DOI 10.5194/bg-9-29-2012; Holcomb M, 2010, J EXP MAR BIOL ECOL, V386, P27, DOI 10.1016/j.jembe.2010.02.007; Honjo S, 2004, ANTARCT SCI, V16, P501, DOI 10.1017/S0954102004002287; Hunt BPV, 2008, PROG OCEANOGR, V78, P193, DOI 10.1016/j.pocean.2008.06.001; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Le Quere C, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003599; Lewis E, 2012, ORNLCDIAC105 US DEP; Lischka S, 2011, BIOGEOSCIENCES, V8, P919, DOI 10.5194/bg-8-919-2011; Lischka S, 2012, GLOBAL CHANGE BIOL, V18, P3517, DOI 10.1111/gcb.12020; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; Maas AE, 2012, BIOGEOSCIENCES, V9, P747, DOI 10.5194/bg-9-747-2012; Maas AE, 2011, MAR ECOL PROG SER, V441, P129, DOI 10.3354/meps09358; Mackas DL, 2012, ICES J MAR SCI, V69, P448, DOI 10.1093/icesjms/fsr163; Manno C, 2012, ESTUAR COAST SHELF S, V113, P163, DOI 10.1016/j.ecss.2012.07.019; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Ohman MD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039901; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parker Laura M., 2013, Biology - Basel, V2, P651, DOI 10.3390/biology2020651; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Pespeni MH, 2013, P NATL ACAD SCI USA, V110, P6937, DOI 10.1073/pnas.1220673110; R Core Team, 2021, R LANG ENV STAT COMP; Reum JCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089619; Rosenthal JJC, 2009, P NATL ACAD SCI USA, V106, P6192, DOI 10.1073/pnas.0901321106; Rykaczewski RR, 2008, P NATL ACAD SCI USA, V105, P1965, DOI 10.1073/pnas.0711777105; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sato-Okoshi W, 2010, POLAR SCI, V4, P257, DOI 10.1016/j.polar.2010.05.006; Seibel BA, 2003, BIOL BULL-US, V205, P93, DOI 10.2307/1543229; Seibel BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030464; Snover AK., 2005, UNCERTAIN FUTURE CLI; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; UPPSTROM LR, 1974, DEEP-SEA RES, V21, P161, DOI 10.1016/0011-7471(74)90074-6; van Belle G., 2002, STAT RULES THUMB	70	33	34	2	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105884	10.1371/journal.pone.0105884	http://dx.doi.org/10.1371/journal.pone.0105884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162395	Green Published, Green Submitted, gold			2022-12-25	WOS:000340880900057
J	Clifton, MK; Westman, BJ; Thong, SY; O'Connell, MR; Webster, MW; Shepherd, NE; Quinlan, KG; Crossley, M; Blobel, GA; Mackay, JP				Clifton, Molly K.; Westman, Belinda J.; Thong, Sock Yue; O'Connell, Mitchell R.; Webster, Michael W.; Shepherd, Nicholas E.; Quinlan, Kate G.; Crossley, Merlin; Blobel, Gerd A.; Mackay, Joel P.			The Identification and Structure of an N-Terminal PR Domain Show that FOG1 Is a Member of the PRDM Family of Proteins	PLOS ONE			English	Article							HISTONE LYSINE METHYLTRANSFERASES; ZINC-FINGER PROTEIN; SET-DOMAIN; GENE-EXPRESSION; TRANSCRIPTIONAL REPRESSION; GATA-1; DIFFERENTIATION; FRIEND; SPECIFICITY; SEQUENCE	FOG1 is a transcriptional regulator that acts in concert with the hematopoietic master regulator GATA1 to coordinate the differentiation of platelets and erythrocytes. Despite considerable effort, however, the mechanisms through which FOG1 regulates gene expression are only partially understood. Here we report the discovery of a previously unrecognized domain in FOG1: a PR (PRD-BF1 and RIZ) domain that is distantly related in sequence to the SET domains that are found in many histone methyltransferases. We have used NMR spectroscopy to determine the solution structure of this domain, revealing that the domain shares close structural similarity with SET domains. Titration with S-adenosyl-L-homocysteine, the cofactor product synonymous with SET domain methyltransferase activity, indicated that the FOG PR domain is not, however, likely to function as a methyltransferase in the same fashion. We also sought to define the function of this domain using both pulldown experiments and gel shift assays. However, neither pulldowns from mammalian nuclear extracts nor yeast two-hybrid assays reproducibly revealed binding partners, and we were unable to detect nucleic-acid-binding activity in this domain using our high-diversity Pentaprobe oligonucleotides. Overall, our data demonstrate that FOG1 is a member of the PRDM (PR domain containing proteins, with zinc fingers) family of transcriptional regulators. The function of many PR domains, however, remains somewhat enigmatic for the time being.	[Clifton, Molly K.; Westman, Belinda J.; Thong, Sock Yue; O'Connell, Mitchell R.; Webster, Michael W.; Shepherd, Nicholas E.; Quinlan, Kate G.; Crossley, Merlin; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Blobel, Gerd A.] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA	University of Sydney; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Mackay, JP (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	joel.mackay@sydney.edu.au	Mackay, Joel P/D-6834-2011; Shepherd, Nicholas/H-6781-2016; Crossley, Merlin/D-7888-2011	Mackay, Joel P/0000-0001-7508-8033; Shepherd, Nicholas/0000-0001-6234-4456; O'Connell, Mitchell/0000-0002-8642-3973; Crossley, Merlin/0000-0003-2057-3642; Quinlan, Kate/0000-0002-5722-8183	National Health and Medical Research Council [402762]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (www.nhmrc.gov.au, 402762). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Briknarova K, 2008, BIOCHEM BIOPH RES CO, V366, P807, DOI 10.1016/j.bbrc.2007.12.034; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Cantor AB, 2002, MOL CELL BIOL, V22, P4268, DOI 10.1128/MCB.22.12.4268-4279.2002; Ciovacco WA, 2008, GENE, V427, P1, DOI 10.1016/j.gene.2008.09.018; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; Deconinck AE, 2000, DEVELOPMENT, V127, P2031; Derunes C, 2005, BIOCHEM BIOPH RES CO, V333, P925, DOI 10.1016/j.bbrc.2005.05.190; Eom GH, 2009, BIOCHEM BIOPH RES CO, V388, P131, DOI 10.1016/j.bbrc.2009.07.134; Fog CK, 2012, BIOESSAYS, V34, P50, DOI 10.1002/bies.201100107; Fossett N, 2001, P NATL ACAD SCI USA, V98, P7342, DOI 10.1073/pnas.131215798; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Harms MJ, 2014, CELL METAB, V19, P593, DOI 10.1016/j.cmet.2014.03.007; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hohenauer T, 2012, DEVELOPMENT, V139, P2267, DOI 10.1242/dev.070110; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Huang S, 1998, J BIOL CHEM, V273, P15933, DOI 10.1074/jbc.273.26.15933; Jacobs SA, 2002, NAT STRUCT BIOL, V9, P833, DOI 10.1038/nsb861; Johnson LM, 2014, NATURE, V507, P124, DOI 10.1038/nature12931; Kim KC, 2003, CANCER RES, V63, P7619; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Kwan AHY, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng124; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Liew CK, 2005, P NATL ACAD SCI USA, V102, P583, DOI 10.1073/pnas.0407511102; Lin AC, 2004, J BIOL CHEM, V279, P55017, DOI 10.1074/jbc.M411240200; Morishita K, 2007, INT J HEMATOL, V85, P279, DOI 10.1532/IJH97.06174; Muntean AG, 2005, BLOOD, V106, P1223, DOI 10.1182/blood-2005-02-0551; Nakaki F, 2014, TRENDS BIOCH SCI; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simpson RJY, 2004, J BIOL CHEM, V279, P39789, DOI 10.1074/jbc.M404130200; Svensson EC, 2000, J BIOL CHEM, V275, P20762, DOI 10.1074/jbc.M001522200; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Wang X, 2002, EMBO J, V21, P5225, DOI 10.1093/emboj/cdf527; Wu H, 2013, CELL REP, V5, P13, DOI 10.1016/j.celrep.2013.08.035; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Wu YX, 2008, J MOL CELL CARDIOL, V44, P47, DOI 10.1016/j.yjmcc.2007.06.008; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106011	10.1371/journal.pone.0106011	http://dx.doi.org/10.1371/journal.pone.0106011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162672	gold, Green Submitted, Green Published			2022-12-25	WOS:000340880900075
J	Joshi, LT; Mali, BL; Geddes, CD; Baillie, L				Joshi, Lovleen Tina; Mali, Buddha L.; Geddes, Chris D.; Baillie, Les			Extraction and Sensitive Detection of Toxins A and B from the Human Pathogen Clostridium difficile in 40 Seconds Using Microwave-Accelerated Metal-Enhanced Fluorescence	PLOS ONE			English	Article							GLUTAMATE-DEHYDROGENASE; INFECTION; DNA; IDENTIFICATION; IMMUNOASSAY; EPIDEMIC; STRAINS; SPORES; LOCUS	Clostridium difficile is the primary cause of antibiotic associated diarrhea in humans and is a significant cause of morbidity and mortality. Thus the rapid and accurate identification of this pathogen in clinical samples, such as feces, is a key step in reducing the devastating impact of this disease. The bacterium produces two toxins, A and B, which are thought to be responsible for the majority of the pathology associated with the disease, although the relative contribution of each is currently a subject of debate. For this reason we have developed a rapid detection assay based on microwave-accelerated metal-enhanced fluorescence which is capable of detecting the presence of 10 bacteria in unprocessed human feces within 40 seconds. These promising results suggest that this prototype biosensor has the potential to be developed into a rapid, point of care, real time diagnostic assay for C. difficile.	[Joshi, Lovleen Tina; Baillie, Les] Cardiff Univ, Cardiff Sch Pharm & Pharmaceut Sci, Cardiff CF10 3AX, S Glam, Wales; [Mali, Buddha L.; Geddes, Chris D.] Univ Maryland, Inst Fluorescence, Baltimore, MD 21201 USA	Cardiff University; University System of Maryland; University of Maryland Baltimore; University of Maryland Baltimore County	Baillie, L (corresponding author), Cardiff Univ, Cardiff Sch Pharm & Pharmaceut Sci, Cardiff CF10 3AX, S Glam, Wales.	BaillieL@cardiff.ac.uk	JOSHI, lovleen/K-4769-2015; Baillie, Les/AAG-7090-2020; Joshi, Tina Lovleen/I-2943-2019	JOSHI, lovleen/0000-0002-5965-4055; Joshi, Tina Lovleen/0000-0002-5965-4055; Baillie, Les/0000-0002-8186-223X	Cardiff University; Mid-Atlantic Regional Center of Excellence for Biodefence & Emerging Infectious diseases; NIH/NIAll [2 US4AO57168-09]	Cardiff University; Mid-Atlantic Regional Center of Excellence for Biodefence & Emerging Infectious diseases; NIH/NIAll	This work was supported by 1. Cardiff University Travel grant to fund travel and work of Lovleen Tina Joshi at the Institute of Fluorescence, Baltimore, USA; 2. Mid-Atlantic Regional Center of Excellence for Biodefence & Emerging Infectious diseases for funding; and 3. NIH/NIAll for funding: grant 2 US4AO57168-09. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arnold A, 2010, J HOSP INFECT, V76, P18, DOI 10.1016/j.jhin.2010.03.018; Aslan K, 2005, CURR OPIN BIOTECH, V16, P55, DOI 10.1016/j.copbio.2005.01.001; Aslan K, 2005, J FLUORESC, V15, P643, DOI 10.1007/s10895-005-2970-z; Aslan K, 2010, J MED CHEM BIOL RADI, V8, P1; Aslan K, 2008, ANAL CHEM, V80, P4125, DOI 10.1021/ac800519r; Aslan K, 2007, ANALYST, V132, P1130, DOI 10.1039/b707876e; Belanger SD, 2003, J CLIN MICROBIOL, V41, P730, DOI 10.1128/JCM.41.2.730-734.2003; BONGAERTS GPA, 1994, MICROB PATHOGENESIS, V17, P1, DOI 10.1006/mpat.1994.1047; Bowker DW, 2007, PRACTICAL DATA ANAL; Carman RJ, 2012, J CLIN MICROBIOL, V50, P1425, DOI 10.1128/JCM.05600-11; Cohen SH, 2000, J INFECT DIS, V181, P659, DOI 10.1086/315248; Deshpande A, 2011, CLIN INFECT DIS, V53, pE81, DOI 10.1093/cid/cir505; Doing KM, 2010, DIAGN MICR INFEC DIS, V66, P129, DOI 10.1016/j.diagmicrobio.2009.09.001; Drevinek P, 2010, J CLIN MICROBIOL, V48, P34, DOI 10.1128/JCM.01433-09; Eastwood K, 2009, J CLIN MICROBIOL, V47, P3211, DOI 10.1128/JCM.01082-09; Geddes CD, 2002, J FLUORESC, V12, P121, DOI 10.1023/A:1016875709579; Goldenberg SD, 2010, J HOSP INFECT, V74, P48, DOI 10.1016/j.jhin.2009.08.014; Joshi LT, 2012, APPL ENVIRON MICROB, V78, P7671, DOI 10.1128/AEM.01862-12; Knetsch CW, 2011, J CLIN MICROBIOL, V49, P227, DOI 10.1128/JCM.01743-10; Knopp S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000681; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kuntz JL, 2012, EMERG INFECT DIS, V18, P960, DOI 10.3201/eid1806.111528; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P3165, DOI 10.1128/JCM.38.9.3165-3173.2000; Mahenthiralingam E, 1997, J CLIN MICROBIOL, V35, P808, DOI 10.1128/JCM.35.4.808-816.1997; Melendez JH, 2013, J CLIN MICROBIOL, V51, P2913, DOI 10.1128/JCM.00980-13; Michota A, 2001, J RAMAN SPECTROSC, V32, P345, DOI 10.1002/jrs.703; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; MULLIGAN ME, 1979, CURR MICROBIOL, V3, P173, DOI 10.1007/BF02601862; Novak-Weekley SM, 2010, J CLIN MICROBIOL, V48, P889, DOI 10.1128/JCM.01801-09; Planche T, 2008, LANCET INFECT DIS, V8, P777, DOI 10.1016/S1473-3099(08)70233-0; Planche T, 2011, J CLIN PATHOL, V64, P1, DOI 10.1136/jcp.2010.080135; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Rohner F, 2010, J NUTR, V140, P635, DOI 10.3945/jn.109.114256; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Shoemaker NB, 2001, APPL ENVIRON MICROB, V67, P561, DOI 10.1128/AEM.67.2.561-568.2001; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; Tennant SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018700; Tenover FC, 2010, J CLIN MICROBIOL, V48, P3719, DOI 10.1128/JCM.00427-10; Zhang Y, 2011, BOUND VALUE PROBL, P1, DOI 10.1186/1687-2770-2011-29	43	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e104334	10.1371/journal.pone.0104334	http://dx.doi.org/10.1371/journal.pone.0104334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162622	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000340880900011
J	Moore, JM; Oliver, PL; Finelli, MJ; Lee, S; Lickiss, T; Molnar, Z; Davies, KE				Moore, Justin M.; Oliver, Peter L.; Finelli, Mattea J.; Lee, Sheena; Lickiss, Tom; Molnar, Zoltan; Davies, Kay E.			Laf4/Aff3, a Gene Involved in Intellectual Disability, Is Required for Cellular Migration in the Mouse Cerebral Cortex	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; AF4-RELATED GENE; TRANSCRIPTIONAL ELONGATION; ASSOCIATION ANALYSIS; NEURONAL MIGRATION; RADIAL MIGRATION; FMR2; MLL; EXPRESSION; FUSION	Members of the AFF (AF4/FMR2) family of putative transcription factors are involved in infant acute leukaemia and intellectual disability (ID), although very little is known about their transcriptional targets. For example, deletion of human lymphoid nuclear protein related to AF4/AFF member 3 (LAF4/AFF3) is known to cause severe neurodevelopmental defects, and silencing of the gene is also associated with ID at the folate-sensitive fragile site (FSFS) FRA2A; yet the normal function of this gene in the nervous system is unclear. The aim of this study was to further investigate the function of Laf4 in the brain by focusing on its role in the cortex. By manipulating expression levels in organotypic slices, we demonstrate here that Laf4 is required for normal cellular migration in the developing cortex and have subsequently identified Mdga2, an important structural protein in neurodevelopment, as a target of Laf4 transcriptional activity. Furthermore, we show that the migration deficit caused by loss of Laf4 can be partially rescued by Mdga2 over-expression, revealing an important functional relationship between these genes. Our study demonstrates the key transcriptional role of Laf4 during early brain development and reveals a novel function for the gene in the process of cortical cell migration relevant to the haploinsufficiency and silencing observed in human neurodevelopmental disorders.	[Moore, Justin M.; Oliver, Peter L.; Finelli, Mattea J.; Davies, Kay E.] Univ Oxford, MRC, Funct Genom Unit, Oxford, England; [Lee, Sheena; Lickiss, Tom; Molnar, Zoltan] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Oxford; University of Oxford	Davies, KE (corresponding author), Univ Oxford, MRC, Funct Genom Unit, Oxford, England.	kay.davies@dpag.ox.ac.uk	Molnar, Zoltan/J-7281-2012; Oliver, Peter/AAS-4022-2020; Finelli, Mattea/AAD-5783-2022	Molnar, Zoltan/0000-0002-6852-6004; Lickiss, Tom/0000-0002-3423-5030; Oliver, Peter/0000-0003-3347-2461; Finelli, Mattea/0000-0002-0152-3642	UK Medical Research Council; BBSRC [BB/I021833/1] Funding Source: UKRI; MRC [MC_UU_12021/2, G0900901, MC_U137761449] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I021833/1] Funding Source: researchfish; Medical Research Council [MC_U137761449, G0900901, MC_UU_12021/2] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Biswas D, 2011, P NATL ACAD SCI USA, V108, P15751, DOI 10.1073/pnas.1111498108; Bitoun E, 2005, CEREBELLUM, V4, P250, DOI 10.1080/14734220500325897; Bitoun E, 2007, HUM MOL GENET, V16, P92, DOI 10.1093/hmg/ddl444; Bitoun E, 2009, J NEUROSCI, V29, P15366, DOI 10.1523/JNEUROSCI.5188-09.2009; Bjorkblom B, 2012, MOL CELL BIOL, V32, P3513, DOI 10.1128/MCB.00713-12; Britanova O, 2002, GENOMICS, V80, P31, DOI 10.1006/geno.2002.6796; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Cardoso C, 2002, HUM MUTAT, V19, P4, DOI 10.1002/humu.10028; Caspi M, 2000, HUM MOL GENET, V9, P2205, DOI 10.1093/oxfordjournals.hmg.a018911; Chakrabarti L, 1998, HUM MOL GENET, V7, P441, DOI 10.1093/hmg/7.3.441; Chinen Y, 2008, ONCOGENE, V27, P2249, DOI 10.1038/sj.onc.1210857; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; DOMER PH, 1993, P NATL ACAD SCI USA, V90, P7884, DOI 10.1073/pnas.90.16.7884; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fedtsova N, 2008, DEV BIOL, V316, P6, DOI 10.1016/j.ydbio.2007.12.040; Gecz J, 1999, EUR J HUM GENET, V7, P157, DOI 10.1038/sj.ejhg.5200279; Gecz J, 1997, GENOMICS, V44, P201, DOI 10.1006/geno.1997.4867; Gu Y, 2003, CYTOGENET GENOME RES, V100, P129, DOI 10.1159/000072847; Gu YH, 2002, J NEUROSCI, V22, P2753, DOI 10.1523/JNEUROSCI.22-07-02753.2002; Gu YH, 1996, NAT GENET, V13, P109, DOI 10.1038/ng0596-109; Hiwatari M, 2003, ONCOGENE, V22, P2851, DOI 10.1038/sj.onc.1206389; Isaacs AM, 2003, J NEUROSCI, V23, P1631; Ishikawa T, 2011, DEV DYNAM, V240, P96, DOI 10.1002/dvdy.22496; Isnard P, 2000, BLOOD, V96, P705; Joset P, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-22; Kahler AK, 2008, AM J MED GENET B, V147B, P1089, DOI 10.1002/ajmg.b.30726; KNIGHT SJL, 1994, AM J HUM GENET, V55, P81; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Lee K, 2012, P NATL ACAD SCI; Li JY, 2011, SCHIZOPHR RES, V125, P194, DOI 10.1016/j.schres.2010.11.002; Lickiss T, 2012, J ANAT, V220, P201, DOI 10.1111/j.1469-7580.2011.01466.x; Ma C, 1996, BLOOD, V87, P734, DOI 10.1182/blood.V87.2.734.bloodjournal872734; Mazzocco MMM, 1997, AM J MED GENET, V74, P73, DOI 10.1002/(SICI)1096-8628(19970221)74:1<73::AID-AJMG16>3.0.CO;2-O; Melko M, 2013, HUM MOL GENET, V22, P2984, DOI 10.1093/hmg/ddt155; Melko M, 2011, HUM MOL GENET, V20, P1873, DOI 10.1093/hmg/ddr069; Metsu S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004242; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Mueller D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000249; Oliver PL, 2004, P NATL ACAD SCI USA, V101, P14901, DOI 10.1073/pnas.0406196101; Pettem KL, 2013, J CELL BIOL, V200, P321, DOI 10.1083/jcb.201206028; Schulze-Gahmen U, 2013, ELIFE, V2, DOI 10.7554/eLife.00327; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Stancik EK, 2010, J NEUROSCI, V30, P7028, DOI 10.1523/JNEUROSCI.6131-09.2010; Steichen-Gersdorf E, 2008, CLIN GENET, V74, P560, DOI 10.1111/j.1399-0004.2008.01050.x; Takeuchi A, 2006, J NEUROSCI, V26, P4460, DOI 10.1523/JNEUROSCI.4935-05.2006; Taki T, 1999, P NATL ACAD SCI USA, V96, P14535, DOI 10.1073/pnas.96.25.14535; To MD, 2005, INT J CANCER, V115, P568, DOI 10.1002/ijc.20881; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Urano A, 2005, MOL CELL BIOL, V25, P6834, DOI 10.1128/MCB.25.15.6834-6845.2005; van den Oord EJCG, 2008, ARCH GEN PSYCHIAT, V65, P1062, DOI 10.1001/archpsyc.65.9.1062; Vogel T, 2009, GENE EXPR PATTERNS, V9, P83, DOI 10.1016/j.gep.2008.10.004; von Bergh ARM, 2002, GENE CHROMOSOME CANC, V35, P92, DOI 10.1002/gcc.10091	56	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105933	10.1371/journal.pone.0105933	http://dx.doi.org/10.1371/journal.pone.0105933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162227	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900063
J	Cimenser, A; Miller, KD				Cimenser, Aylin; Miller, Kenneth D.			The Effects of Short-Term Synaptic Depression at Thalamocortical Synapses on Orientation Tuning in Cat V1	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; SIMPLE CELLS; RECEPTIVE-FIELD; STRIATE CORTEX; DISCHARGE PATTERNS; THALAMIC INPUT; CONTRAST; SELECTIVITY; INVARIANT; EXCITATION	We examine the effects of short-term synaptic depression on the orientation tuning of the LGN input to simple cells in cat primary visual cortex (V1). The total LGN input has an untuned component as well as a tuned component, both of which grow with stimulus contrast. The untuned component is not visible in the firing rate responses of the simple cells. The suppression of the contribution of the untuned input component to firing rate responses is key to establishing orientation selectivity and its invariance with stimulus contrast. It has been argued that synaptic depression of LGN inputs could contribute to the selective suppression of the untuned component and thus contribute to the tuning observed in simple cells. We examine this using a model fit to the depression observed at thalamocortical synapses in-vivo, and compare this to an earlier model fit based on in-vitro observations. We examine the tuning of both the conductance and the firing rate induced in simple cells by the net LGN input. We find that depression causes minimal suppression of the untuned component. The primary effect of depression is to cause the contrast response curve to saturate at lower contrasts without differentially affecting the tuned vs. untuned components. This effect is slightly weaker for in-vivo vs. in-vitro parameters. Thus, synaptic depression of LGN inputs does not appreciably contribute to the orientation tuning of V1 simple cells.	[Cimenser, Aylin] Harvard Univ, Sch Med, Boston, MA 02138 USA; [Cimenser, Aylin] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Miller, Kenneth D.] Columbia Univ, Coll Physicians & Surg, Ctr Theoret Neurosci, New York, NY USA; [Miller, Kenneth D.] Columbia Univ, Coll Physicians & Surg, Dept Neurosci, New York, NY USA; [Miller, Kenneth D.] Columbia Univ, Coll Physicians & Surg, Swartz Program Theoret Neurosci, New York, NY USA	Harvard University; Harvard Medical School; Boston University; Columbia University; Columbia University; Columbia University	Cimenser, A (corresponding author), Harvard Univ, Sch Med, Boston, MA 02138 USA.	aylin@nmr.mgh.harvard.edu		Cimenser, Aylin/0000-0002-3235-5389	Gatsby Charitable Foundation through the Gatsby Initiative in Brain Circuitry at Columbia University;  [R01-EY11001]; NATIONAL EYE INSTITUTE [R01EY011001] Funding Source: NIH RePORTER	Gatsby Charitable Foundation through the Gatsby Initiative in Brain Circuitry at Columbia University; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by R01-EY11001 (http://report.nih.gov) to KM and by the Gatsby Charitable Foundation through the Gatsby Initiative in Brain Circuitry at Columbia University (http://www.gatsby.org.uk/en/Neuroscience.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Alitto HJ, 2004, J NEUROPHYSIOL, V91, P2797, DOI 10.1152/jn.00943.2003; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Banitt Y, 2007, J NEUROSCI, V27, P10230, DOI 10.1523/JNEUROSCI.1640-07.2007; Berry MJ, 1998, J NEUROSCI, V18, P2200; BI Q, 1989, J ACOUST SOC AM, V85, P2504, DOI 10.1121/1.397745; Boudreau CE, 2005, J NEUROSCI, V25, P7179, DOI 10.1523/JNEUROSCI.1445-05.2005; BULLIER J, 1982, J NEUROPHYSIOL, V47, P417, DOI 10.1152/jn.1982.47.3.417; Carandini M, 2002, J NEUROSCI, V22, P10053; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V541, P319, DOI 10.1113/jphysiol.2002.016857; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Chance FS, 1998, J NEUROSCI, V18, P4785; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Dittman JS, 1998, J NEUROSCI, V18, P6147; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1988, J NEUROSCI, V8, P1172; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; Fuhrmann G, 2004, J PHYSIOL-LONDON, V557, P415, DOI 10.1113/jphysiol.2003.058107; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; Hirsch JA, 2002, J PHYSIOL-LONDON, V540, P335, DOI 10.1113/jphysiol.2001.012777; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JOHNSON DH, 1983, J ACOUST SOC AM, V74, P493, DOI 10.1121/1.389815; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; JONES K, 1985, J ACOUST SOC AM, V78, P90, DOI 10.1121/1.392458; Kara P, 2002, P NATL ACAD SCI USA, V99, P16261, DOI 10.1073/pnas.242625499; Kayser A, 2001, J NEUROPHYSIOL, V85, P2130, DOI 10.1152/jn.2001.85.5.2130; Krukowski AE, 2001, NAT NEUROSCI, V4, P424, DOI 10.1038/86084; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; Lauritzen TZ, 2001, J NEUROPHYSIOL, V86, P1803, DOI 10.1152/jn.2001.86.4.1803; Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; MILLER MI, 1985, J ACOUST SOC AM, V77, P1452, DOI 10.1121/1.392040; Palmer SE, 2007, J NEUROPHYSIOL, V98, P63, DOI 10.1152/jn.00152.2007; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Priebe NJ, 2012, NEURON, V75, P194, DOI 10.1016/j.neuron.2012.06.011; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Rubin DB, 2011, 2011 NEUR M PLAN; Sadagopan S, 2012, NEURON, V74, P911, DOI 10.1016/j.neuron.2012.05.007; SAUL AB, 1992, J NEUROPHYSIOL, V68, P1190, DOI 10.1152/jn.1992.68.4.1190; Scholl B, 2013, J NEUROSCI, V33, P10616, DOI 10.1523/JNEUROSCI.0404-13.2013; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; Troyer TW, 2002, J NEUROPHYSIOL, V87, P2741, DOI 10.1152/jn.2002.87.6.2741; Troyer TW, 1998, J NEUROSCI, V18, P5908; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; WORGOTTER F, 1991, J NEUROSCI, V11, P1959	60	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e106046	10.1371/journal.pone.0106046	http://dx.doi.org/10.1371/journal.pone.0106046			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157879	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303200088
J	Truong, LN; Li, YJ; Sun, E; Ang, K; Hwang, PYH; Wu, XH				Truong, Lan N.; Li, Yongjiang; Sun, Emily; Ang, Katrina; Hwang, Patty Yi-Hwa; Wu, Xiaohua			Homologous Recombination Is a Primary Pathway to Repair DNA Double-Strand Breaks Generated during DNA Rereplication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-ANTIGEN; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; CHROMOSOMAL INSTABILITY; PREVENTS REREPLICATION; DAMAGE RESPONSE; END RESECTION; SV40 ORIGIN; LIGASE-III; IN-VITRO	Re-initiation of DNA replication at origins within a given cell cycle would result in DNA rereplication, which can lead to genome instability and tumorigenesis. DNA rereplication can be induced by loss of licensing control at cellular replication origins, or by viral protein-driven multiple rounds of replication initiation at viral origins. DNA double-strand breaks (DSBs) are generated during rereplication, but the mechanisms of how these DSBs are repaired to maintain genome stability and cell viability are poorly understood in mammalian cells. We generated novel EGFP-based DSB repair substrates, which specifically monitor the repair of rereplication-associated DSBs. We demonstrated that homologous recombination (HR) is an important mechanism to repair rereplication-associated DSBs, and sister chromatids are used as templates for such HR-mediated DSB repair. Micro-homology-mediated non-homologous end joining (MMEJ) can also be used but to a lesser extent compared to HR, whereas Ku-dependent classical non-homologous end joining (C-NHEJ) has a minimal role to repair rereplication-associated DSBs. In addition, loss of HR activity leads to severe cell death when rereplication is induced. Therefore, our studies identify HR, the most conservative repair pathway, as the primary mechanism to repair DSBs upon rereplication.	[Truong, Lan N.; Li, Yongjiang; Sun, Emily; Ang, Katrina; Hwang, Patty Yi-Hwa; Wu, Xiaohua] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Wu, XH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xiaohwu@scripps.edu			National Institutes of Health [CA102361, GM080677, CA140972, CA102361-07S1, CA140972-03S1]; NIH Training Grant [DK007022-30]; NATIONAL CANCER INSTITUTE [R01CA140972, R01CA102361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA102361, GM080677, CA140972, CA102361-07S1, and CA140972-03S1 (to X. W.) and NIH Training Grant DK007022-30 (to L. N. T.).	Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Aladjem MI, 1998, SCIENCE, V281, P1005, DOI 10.1126/science.281.5379.1005; Archambault V, 2005, MOL CELL BIOL, V25, P6707, DOI 10.1128/MCB.25.15.6707-6721.2005; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BOTCHAN M, 1980, CELL, V20, P143, DOI 10.1016/0092-8674(80)90242-1; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; DEB S, 1987, J VIROL, V61, P2143, DOI 10.1128/JVI.61.7.2143-2149.1987; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Diffley JFX, 2001, CURR BIOL, V11, pR367, DOI 10.1016/S0960-9822(01)00196-8; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; Green BM, 2005, MOL BIOL CELL, V16, P421, DOI 10.1091/mbc.e04-09-0833; Hook SS, 2007, CURR OPIN CELL BIOL, V19, P663, DOI 10.1016/j.ceb.2007.10.007; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; MILLER J, 1984, P NATL ACAD SCI-BIOL, V81, P7534, DOI 10.1073/pnas.81.23.7534; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; MYERS RM, 1980, P NATL ACAD SCI-BIOL, V77, P6491, DOI 10.1073/pnas.77.11.6491; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Neelsen KJ, 2013, GENE DEV, V27, P2537, DOI 10.1101/gad.226373.113; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Pinyol M, 2006, INT J CANCER, V119, P2768, DOI 10.1002/ijc.22146; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Seo J, 2005, ONCOGENE, V24, P8176, DOI 10.1038/sj.onc.1208881; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; STARY A, 1992, J GEN VIROL, V73, P1679, DOI 10.1099/0022-1317-73-7-1679; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; Syu LJ, 1997, J MOL BIOL, V271, P76, DOI 10.1006/jmbi.1997.1156; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; TEGTMEYER P, 1972, J VIROL, V10, P591, DOI 10.1128/JVI.10.4.591-598.1972; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wang HL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003277; Wang HL, 2012, J BIOL CHEM, V287, P21471, DOI 10.1074/jbc.M112.355354; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wu XH, 2004, GENE DEV, V18, P1305, DOI 10.1101/gad.1182804; Zhu WG, 2006, MOL CELL BIOL, V26, P4601, DOI 10.1128/MCB.02141-05	61	19	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28910	28923		10.1074/jbc.M114.576488	http://dx.doi.org/10.1074/jbc.M114.576488			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25160628	Green Published, hybrid			2022-12-25	WOS:000344141000014
J	Rotunno, MS; Auclair, JR; Maniatis, S; Shaffer, SA; Agar, J; Bosco, DA				Rotunno, Melissa S.; Auclair, Jared R.; Maniatis, Stephanie; Shaffer, Scott A.; Agar, Jeffrey; Bosco, Daryl A.			Identification of a Misfolded Region in Superoxide Dismutase 1 That Is Exposed in Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE MODIFICATION; MONOCLONAL-ANTIBODY; DISULFIDE BOND; FAMILIAL ALS; MOUSE MODEL; METAL-IONS; SOD1; MUTANT; AGGREGATION; PROTEIN	Mutations and aberrant post-translational modifications within Cu, Zn-superoxide dismutase (SOD1) cause this otherwise protective enzyme to misfold, leading to amyotrophic lateral sclerosis (ALS). The C4F6 antibody selectively binds misfolded SOD1 in spinal cord tissues from postmortem human ALS cases, as well as from an ALS-SOD1 mouse model, suggesting that the C4F6 epitope reports on a pathogenic conformation that is common to misfolded SOD1 variants. To date, the residues and structural elements that comprise this epitope have not been elucidated. Using a chemical cross-linking and mass spectrometry approach, we identified the C4F6 epitope within several ALS-linked SOD1 variants, as well as an oxidized form of WT SOD1, supporting the notion that a similar misfolded conformation is shared among pathological SOD1 proteins. Exposure of the C4F6 epitope was modulated by the SOD1 electrostatic (loop VII) and zinc binding (loop IV) loops and correlated with SOD1-induced toxicity in a primary microglia activation assay. Site-directed mutagenesis revealed Asp(92) and Asp(96) as key residues within the C4F6 epitope required for the SOD1-C4F6 binding interaction. We propose that stabilizing the functional loops within SOD1 and/or obscuring the C4F6 epitope are viable therapeutic strategies for treating SOD1-mediated ALS.	[Rotunno, Melissa S.; Bosco, Daryl A.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Auclair, Jared R.; Agar, Jeffrey] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Maniatis, Stephanie; Shaffer, Scott A.] Univ Massachusetts, Sch Med, Prote & Mass Spectrometry Facil, Shrewsbury, MA 01545 USA; [Shaffer, Scott A.; Bosco, Daryl A.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Northeastern University; University of Massachusetts System; University of Massachusetts System; University of Massachusetts Worcester	Bosco, DA (corresponding author), Albert Sherman Ctr, Dept Neurol, AS6-1057,368 Plantat Dr, Worcester, MA 01605 USA.	Daryl.Bosco@umassmed.edu		Agar, Jeffery/0000-0003-2645-1873	National Institutes of Health [R01NS067206]; ALS Therapy Alliance/CVS Pharmacy; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067206, R01NS065263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Therapy Alliance/CVS Pharmacy; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS067206. This work was also supported by funds from the ALS Therapy Alliance/CVS Pharmacy and the ALS Association (to D. A. B.).	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Auclair JR, 2013, BIOCHEMISTRY-US, V52, P6137, DOI 10.1021/bi4006122; Auclair JR, 2010, P NATL ACAD SCI USA, V107, P21394, DOI 10.1073/pnas.1015463107; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Broering TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061210; Brotherton TE, 2012, P NATL ACAD SCI USA, V109, P5505, DOI 10.1073/pnas.1115009109; Cao XH, 2008, J BIOL CHEM, V283, P16169, DOI 10.1074/jbc.M801522200; Chen XP, 2012, NEUROCHEM RES, V37, P835, DOI 10.1007/s11064-011-0679-8; Coelho T, 2013, J NEUROL, V260, P2802, DOI 10.1007/s00415-013-7051-7; Danielsson J, 2013, P NATL ACAD SCI USA, V110, P3829, DOI 10.1073/pnas.1217306110; Danielsson J, 2011, J BIOL CHEM, V286, P33070, DOI 10.1074/jbc.M111.251223; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Durazo A, 2009, J BIOL CHEM, V284, P34382, DOI 10.1074/jbc.M109.052076; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Fujisawa T, 2012, ANN NEUROL, V72, P739, DOI 10.1002/ana.23668; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gros-Louis F, 2010, J NEUROCHEM, V113, P1188, DOI 10.1111/j.1471-4159.2010.06683.x; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Lemire J, 2008, J APPL TOXICOL, V28, P175, DOI 10.1002/jat.1263; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Lynch SM, 2004, BIOCHEMISTRY-US, V43, P16525, DOI 10.1021/bi048831v; Molnar KS, 2009, J BIOL CHEM, V284, P30965, DOI 10.1074/jbc.M109.023945; Panchaud A, 2010, J PROTEOME RES, V9, P2508, DOI 10.1021/pr9011816; Pickles S, 2013, HUM MOL GENET, V22, P3947, DOI 10.1093/hmg/ddt249; Pokrishevsky E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035050; Prudencio M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-77; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Redler RL, 2014, BIOCHEMISTRY-US, V53, P2423, DOI 10.1021/bi500158w; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rotunno MS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00253; Sasabe J, 2007, EMBO J, V26, P4149, DOI 10.1038/sj.emboj.7601840; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shipp EL, 2003, BIOCHEMISTRY-US, V42, P1890, DOI 10.1021/bi026704y; Sreedharan J, 2013, ANN NEUROL, V74, P309, DOI 10.1002/ana.24012; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; STEINEBACH OM, 1993, TOXICOL APPL PHARM, V118, P245, DOI 10.1006/taap.1993.1030; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; Svensson AKE, 2006, J MOL BIOL, V364, P1084, DOI 10.1016/j.jmb.2006.09.005; Taylor DM, 2007, J BIOL CHEM, V282, P16329, DOI 10.1074/jbc.M610119200; Tiwari A, 2009, J BIOL CHEM, V284, P27746, DOI 10.1074/jbc.M109.043729; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919	53	20	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28527	28538		10.1074/jbc.M114.581801	http://dx.doi.org/10.1074/jbc.M114.581801			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25164820	Green Published, hybrid			2022-12-25	WOS:000343765400043
J	Fu, HQ; Yang, T; Xiao, W; Fan, L; Wu, Y; Terrando, N; Wang, TL				Fu, Hui Qun; Yang, Ting; Xiao, Wei; Fan, Long; Wu, Yan; Terrando, Niccolo; Wang, Tian Long			Prolonged Neuroinflammation after Lipopolysaccharide Exposure in Aged Rats	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; INNATE IMMUNE-SYSTEM; MOBILITY GROUP BOX-1; NF-KAPPA-B; COGNITIVE DECLINE; SICKNESS BEHAVIOR; INFLAMMATION; DYSFUNCTION; ASTROCYTES; MICROGLIA	Inflammation is a hallmark of several disease states ranging from neurodegeneration to sepsis but is also implicated in physiological processes like ageing. Non-resolving inflammation and prolonged neuroinflammation are unclear processes implicated in several conditions, including ageing. In this study we studied the long-term effects of endotoxemia, as systemic lipopolysaccharide (LPS) injection, focusing on the role of astrocyte activation and cytokine release in the brain of aged rats. A single dose of LPS (2 mg/kg) or 0.9% saline was injected intraperitoneally in aged rats. Levels of pro-inflammatory cytokines (TNF alpha and IL-1 beta) and NF-kappa B p65 activation were measured systemically and in hippocampal tissue. Astrocytes and cytokines release in the CNS were detected via double immunofluorescence staining at different time-points up to day 30. Serum levels of TNF alpha and IL-1 beta were significantly increased acutely after 30 minutes (p<0.001) and up to 6 hours (p<0.001) following LPS-injection. Centrally, LPS-treated rats showed up-regulated mRNA expression and protein levels of pro-inflammatory cytokines in the hippocampus. These changes associated with astrogliosis in the hippocampus dentate gyrus (DG), IL-1 beta immunoreactivity and elevated NF-kappa B p65 expression up to day 30 post LPS exposure. Overall, these data demonstrate that LPS induces prolonged neuroinflammation and astrocyte activation in the hippocampus of aged rats. Hippocampal NF-kappa B p65 and excessive astrocytes-derived IL-1 beta release may play a pivotal role in regulating long-lasting neuroinflammation.	[Fu, Hui Qun; Xiao, Wei; Fan, Long; Wang, Tian Long] Capital Med Univ, Xuanwu Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Yang, Ting; Terrando, Niccolo] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Wu, Yan] Capital Med Univ, Dept Anat, Beijing, Peoples R China	Capital Medical University; Karolinska Institutet; Capital Medical University	Wang, TL (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Anesthesiol, Beijing, Peoples R China.	w_tl5595@hotmail.com	wu, Yan/W-3577-2019; Terrando, Niccolo/Y-4349-2019; Figueiredo, Claudia P/F-8424-2012	Terrando, Niccolo/0000-0003-1803-5853; WU, Yan/0000-0002-7032-8875	National Natural Science Foundation of China [81241096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81241096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Barrientos RM, 2006, NEUROBIOL AGING, V27, P723, DOI 10.1016/j.neurobiolaging.2005.03.010; Bossu P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-101; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; Chen J, 2008, BRAIN BEHAV IMMUN, V22, P301, DOI 10.1016/j.bbi.2007.08.014; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Cunningham C, 2013, GLIA, V61, P71, DOI 10.1002/glia.22350; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; David JP, 1997, NEUROSCI LETT, V235, P53, DOI 10.1016/S0304-3940(97)00708-8; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Eckenhoff RG, 2013, PROG NEURO-PSYCHOPH, V47, P162, DOI 10.1016/j.pnpbp.2012.06.011; Esiri MM, 2007, J PATHOL, V211, P181, DOI 10.1002/path.2089; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; He HJ, 2012, CNS NEUROSCI THER, V18, P994, DOI 10.1111/cns.12018; Inouye SK, 2013, LANCET; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lee SJ, 1998, J NEUROIMMUNOL, V92, P196, DOI 10.1016/S0165-5728(98)00209-4; Luo XG, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-12; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Pradillo JM, 2012, J CEREBR BLOOD F MET, V32, P1810, DOI 10.1038/jcbfm.2012.101; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Ramirez SH, 2012, J NEUROSCI, V32, P4004, DOI 10.1523/JNEUROSCI.4628-11.2012; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Sayed BA, 2010, J IMMUNOL, V184, P6891, DOI 10.4049/jimmunol.1000126; Simone MJ, 2011, CNS NEUROSCI THER, V17, P506, DOI 10.1111/j.1755-5949.2010.00173.x; Terrando N, 2013, FASEB J, V27, P3564, DOI 10.1096/fj.13-230276; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2011, MAYO CLIN PROC, V86, P885, DOI 10.4065/mcp.2011.0332; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; Treutiger CJ, 2003, J INTERN MED, V254, P375, DOI 10.1046/j.1365-2796.2003.01204.x; Vilcek J, 2004, TRENDS PHARMACOL SCI, V25, P201, DOI 10.1016/j.tips.2004.02.011; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Xie Z, 2003, EXP NEUROL, V182, P135, DOI 10.1016/S0014-4886(03)00057-8; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334	42	76	79	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106331	10.1371/journal.pone.0106331	http://dx.doi.org/10.1371/journal.pone.0106331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170959	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500151
J	Gu, XF; Fu, MY; Ding, YQ; Ni, HH; Zhang, W; Zhu, YF; Tang, XJ; Xiong, L; Li, J; Qiu, L; Xu, JR; Zhu, J				Gu, Xuefeng; Fu, Maoying; Ding, Yuqin; Ni, Huihui; Zhang, Wei; Zhu, Yanfang; Tang, Xiaojun; Xiong, Lin; Li, Jiang; Qiu, Liang; Xu, Jiaren; Zhu, Jin			TIMP-3 Expression Associates with Malignant Behaviors and Predicts Favorable Survival in HCC	PLOS ONE			English	Article							TISSUE INHIBITOR; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC-SIGNIFICANCE; PROMOTER METHYLATION; METALLOPROTEINASE 3; TUMOR-GROWTH; CANCER; INVASION; RECEPTOR; GENE	The tissue inhibitors of metalloproteinases (TIMPs) are proteins that specifically inhibit the proteolytic activity of the matrix metalloproteinases (MMPs). TIMP-3, the only member of the TIMPs that can tightly bind to the extracellular matrix, has been identified as a unique tumor suppressor that demonstrates the ability to inhibit tumor angiogenesis, invasion, and metastasis. This study aimed to detect the expression of TIMP-3 in hepatocellular carcinoma (HCC) and investigate the association between TIMP-3 expression and its clinicopathological significance in HCC patients. In the current study, reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting of HCC cell lines and one-step quantitative reverse transcription PCR (qPCR) and immunohistochemistry (IHC) analyses in HCC tissues were performed, to characterize the TIMP-3 expression. Kaplan-Meier survival and Cox regression analyses were utilized to evaluate the prognosis of 101 HCC patients. The results showed that the expression of TIMP-3 in HCC was significantly decreased relative to that of non-cancerous cells and tissues. Furthermore, the TIMP-3 expression was statistically associated with malignant behaviors of HCC, including portal vein invasion (p = 0.036) and lymph node metastasis (p = 0.030). Cox regression analysis revealed that TIMP-3 expression was an independent prognostic factor for disease-free survival (p = 0.039) and overall survival (p = 0.049). These data indicate that TIMP-3 expression is a valuable prognostic biomarker for HCC and that TIMP-3 expression suggests a favorable prognosis for HCC patients.	[Gu, Xuefeng; Fu, Maoying; Ding, Yuqin; Ni, Huihui; Zhang, Wei; Zhu, Yanfang] Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Infect Dis, Suzhou, Peoples R China; [Tang, Xiaojun; Zhu, Jin] Nanjing Med Univ, Key Lab Canc Biomarkers, Prevent & Treatment Canc Ctr, Nanjing, Jiangsu, Peoples R China; [Tang, Xiaojun; Zhu, Jin] Nanjing Med Univ, Key Lab Antibody Tech, Minist Hlth, Nanjing, Jiangsu, Peoples R China; [Xiong, Lin] Nanjing Med Univ, Affiliated Hosp 2, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Li, Jiang; Qiu, Liang] Jiangsu Prov Geriatr Inst, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Xu, Jiaren] Jiangsu Prov Hosp, Dept Hematol & Oncol, Nanjing, Jiangsu, Peoples R China; [Zhu, Jin] Huadong Med Inst Biotech, Nanjing, Jiangsu, Peoples R China	Jiangsu University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Xu, JR (corresponding author), Jiangsu Prov Hosp, Dept Hematol & Oncol, Nanjing, Jiangsu, Peoples R China.	xujiaren@tom.com; zhujin1968@njmu.edu.cn		Gu, Xuefeng/0000-0002-6198-2568				Bashash M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059157; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chen YY, 2014, ANGIOGENESIS, V17, P207, DOI 10.1007/s10456-013-9389-y; Chetty C, 2008, CANCER RES, V68, P4736, DOI 10.1158/0008-5472.CAN-07-6612; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cruz-Munoz W, 2006, ONCOGENE, V25, P6489, DOI 10.1038/sj.onc.1209663; De Schutter H, 2009, ONCOL REP, V21, P507, DOI 10.3892/or_00000251; Destouches D, 2012, J BIOL CHEM, V287, P43685, DOI 10.1074/jbc.M112.380402; Ding J, 2014, CANCER LETT, V346, P17, DOI 10.1016/j.canlet.2013.12.024; Fong ZV, 2014, CANCER; Fu MY, 2013, INT J CLIN EXP PATHO, V6, P2515; Fu MY, 2013, INT J CLIN EXP PATHO, V6, P2185; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gu J, 2006, CLIN CANCER RES, V12, P7329, DOI 10.1158/1078-0432.CCR-06-0894; Guan ZY, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-110; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kallio JP, 2011, INT J CANCER, V128, P991, DOI 10.1002/ijc.25404; Kang KH, 2008, CARDIOVASC RES, V79, P150, DOI 10.1093/cvr/cvn072; Kornfeld JW, 2011, BRIT J CANCER, V104, P138, DOI 10.1038/sj.bjc.6606017; Li WH, 2013, INT J CLIN EXP PATHO, V6, P1076; Lin H, 2012, CANCER GENE THER, V19, P845, DOI 10.1038/cgt.2012.70; Liu HQ, 2011, ONCOL LETT, V2, P1319, DOI 10.3892/ol.2011.399; Mahller YY, 2008, CANCER RES, V68, P1170, DOI 10.1158/0008-5472.CAN-07-2734; Mao Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-101; Mino N, 2007, J SURG ONCOL, V95, P250, DOI 10.1002/jso.20663; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Ninomiya I, 2008, ONCOL REP, V20, P1489, DOI 10.3892/or_00000170; Qu LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098257; Rohrs S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-86; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-29; Tan LZ, 2013, AM J PATHOL, V183, P831, DOI 10.1016/j.ajpath.2013.05.010; Turner SL, 2012, INT J ONCOL, V41, P1043, DOI 10.3892/ijo.2012.1525; Varotti G, 2005, EJSO-EUR J SURG ONC, V31, P760, DOI 10.1016/j.ejso.2005.04.008; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wong RJ, 2014, LIVER TRANSPLANT, V20, P528, DOI 10.1002/lt.23820; Wu DW, 2012, AM J PATHOL, V181, P1796, DOI 10.1016/j.ajpath.2012.07.032; Wu ZS, 2008, INT J CANCER, V122, P2050, DOI 10.1002/ijc.23337; Xu CH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0713-6; Zhang H, 2007, HEPATOB PANCREAT DIS, V6, P487; Zhang L, 2010, CANCER GENE THER, V17, P171, DOI 10.1038/cgt.2009.59; Zhang Y, 2008, GYNECOL ONCOL, V108, P234, DOI 10.1016/j.ygyno.2007.09.033	43	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106161	10.1371/journal.pone.0106161	http://dx.doi.org/10.1371/journal.pone.0106161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171061	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500119
J	He, MC; Wang, J; Wu, J; Gong, FY; Hong, C; Xia, Y; Zhang, LJ; Bao, WR; Gao, XM				He, Mi-chun; Wang, Jun; Wu, Jian; Gong, Fang-yuan; Hong, Chao; Xia, Yun; Zhang, Li-juan; Bao, Wan-rong; Gao, Xiao-ming			Immunological Activity Difference between Native Calreticulin Monomers and Oligomers	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATION; ONCHOCERCA-VOLVULUS; LIVING CELLS; PROTEIN; DISEASE; VISUALIZATION; PURIFICATION; DIMERIZATION; ANTIBODIES; ANTIGEN	We have recently demonstrated that the greatly increased immunological activities of recombinant murine calreticulin (rCRT) are largely attributed to its self-oligomerization. Although native CRT (nCRT) can also oligomerize under stress conditions in vitro, whether this phenomenon could occur inside cells and the immunological activity difference between nCRT monomers and oligomers remained unclear. In this study, we illustrated the formation of CRT oligomers in tranfectant cells under "heat & low pH" (42 degrees C/pH 6.5) condition. The mixture of nCRT oligomers and monomers (OnCRT) was obtained after 3 hr treatment of murine monomeric nCRT (MnCRT) under similar condition (42 degrees C/pH 5.0) in vitro. The OnCRT thus obtained was better recognized by 2 monoclonal Abs from mice that had been immunized with oligomeric rCRT. Unlike MnCRT, OnCRT was able to elicit CRT-specific IgG production in mice. OnCRT also stimulated bone-marrow derived dendritic cells (BMDCs) to secrete significantly higher levels of TNF-alpha, IL-6 and IL-12p40 than did MnCRT in vitro. We postulate that oligomerization of soluble CRT may occur under certain pathophysiological conditions (e.g. ultrahyperpyrexia) and the resultant oligomers may exhibit exaggerated immunostimulating activities, thereby affiliating the inflammatory responses in vivo.	[He, Mi-chun; Wang, Jun; Gong, Fang-yuan; Hong, Chao; Xia, Yun; Zhang, Li-juan; Bao, Wan-rong; Gao, Xiao-ming] Soochow Univ, Inst Biol & Med Sci, Suzhou, Jiangsu, Peoples R China; [Wu, Jian] Soochow Univ, Hosp 1, Internal Med Ctr Rheumatoid Dis, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	He, MC (corresponding author), Soochow Univ, Inst Biol & Med Sci, Suzhou, Jiangsu, Peoples R China.	hmc210@163.com; xmgao@suda.edu.cn	Zhang, Li/GWM-7501-2022; Wang, Jun/B-2414-2009; Wang, Jun/AGJ-1311-2022	Wang, Jun/0000-0002-4458-3741; Wang, Jun/0000-0002-4458-3741	Program for Cheung Kong Scholars and Innovative Research Team PCSIRT [IRT1075]; National Foundation of Nature Science of China [30890142/31070781/31200649]; Postgraduate Education Innovation Program of Jiangsu Province [CXZZ12-0827]; Priority Academic Program Development of Jiangsu Province Higher Education Institutions, National Key Basic Research Programs [2010CB529102]	Program for Cheung Kong Scholars and Innovative Research Team PCSIRT; National Foundation of Nature Science of China(National Natural Science Foundation of China (NSFC)); Postgraduate Education Innovation Program of Jiangsu Province; Priority Academic Program Development of Jiangsu Province Higher Education Institutions, National Key Basic Research Programs	This study was supported by grants from the Program for Cheung Kong Scholars and Innovative Research Team PCSIRT (IRT1075), National Foundation of Nature Science of China (30890142/31070781/31200649), Postgraduate Education Innovation Program of Jiangsu Province (CXZZ12-0827), and Priority Academic Program Development of Jiangsu Province Higher Education Institutions, National Key Basic Research Programs (2010CB529102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera R, 2011, CLIN CANCER RES, V17, P2474, DOI 10.1158/1078-0432.CCR-10-2384; Carpio MA, 2013, INT J BIOCHEM CELL B, V45, P1223, DOI 10.1016/j.biocel.2013.03.017; Corthay A, 2001, ANN MED, V33, P456, DOI 10.3109/07853890109002094; Eggleton P, 1999, SCAND J IMMUNOL, V49, P466; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Hong C, 2010, J IMMUNOL, V185, P4561, DOI 10.4049/jimmunol.1000536; HOUEN G, 1994, ACTA CHEM SCAND, V48, P905, DOI 10.3891/acta.chem.scand.48-0905; Huang SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064951; Jeffery E, 2011, J BIOL CHEM, V286, P2402, DOI 10.1074/jbc.M110.180877; Jorgensen CS, 2005, PROTEIN PEPTIDE LETT, V12, P687, DOI 10.2174/0929866054696082; Jorgensen CS, 2003, EUR J BIOCHEM, V270, P4140, DOI 10.1046/j.1432-1033.2003.03808.x; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lee D, 2007, J MOL BIOL, V372, P331, DOI 10.1016/j.jmb.2007.06.071; LUX FA, 1992, J CLIN INVEST, V89, P1945, DOI 10.1172/JCI115801; Mamula MJ, 1999, J BIOL CHEM, V274, P22321, DOI 10.1074/jbc.274.32.22321; MICHALAK M, 1991, EXP CELL RES, V197, P91, DOI 10.1016/0014-4827(91)90484-C; MILNER RE, 1991, J BIOL CHEM, V266, P7155; Nanney LB, 2008, AM J PATHOL, V173, P610, DOI 10.2353/ajpath.2008.071027; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; Qiao SW, 2011, J IMMUNOL, V187, P3064, DOI 10.4049/jimmunol.1101526; Qiu X, 2012, EUR J IMMUNOL, V42, P2419, DOI 10.1002/eji.201142320; ROKEACH LA, 1994, INFECT IMMUN, V62, P3696, DOI 10.1128/IAI.62.9.3696-3704.1994; ROUTSIAS JG, 1993, CLIN EXP IMMUNOL, V91, P437; ROWLING PJE, 1994, PROTEIN EXPRES PURIF, V5, P331, DOI 10.1006/prep.1994.1049; Shyu YJ, 2008, P NATL ACAD SCI USA, V105, P151, DOI 10.1073/pnas.0705181105; SMITH MJ, 1989, EMBO J, V8, P3581, DOI 10.1002/j.1460-2075.1989.tb08530.x; Tarr JM, 2010, ARTHRITIS RHEUM-US, V62, P2919, DOI 10.1002/art.27602; Tesniere A, 2008, CURR OPIN IMMUNOL, V20, P504, DOI 10.1016/j.coi.2008.05.007; Toft KN, 2008, BBA-PROTEINS PROTEOM, V1784, P1265, DOI 10.1016/j.bbapap.2008.05.005; van den Berg RH, 1998, CLIN EXP IMMUNOL, V111, P359; van Lummel M, 2013, CURR OPIN ENDOCRINOL, V20, P299, DOI 10.1097/MED.0b013e3283631417; Wijeyesakere SJ, 2011, J BIOL CHEM, V286, P8771, DOI 10.1074/jbc.M110.169193	36	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105502	10.1371/journal.pone.0105502	http://dx.doi.org/10.1371/journal.pone.0105502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171171	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500053
J	Lewis, ND; Muthukumarana, A; Fogal, SE; Corradini, L; Stefanopoulos, DE; Adusumalli, P; Pelletier, J; Panzenbeck, M; Berg, K; Canfield, M; Cook, BN; Razavi, H; Kuzmich, D; Anderson, S; Allard, D; Harrison, P; Grimaldi, C; Souza, D; Harcken, C; Fryer, RM; Modis, LK; Brown, ML				Lewis, Nuruddeen D.; Muthukumarana, Akalushi; Fogal, Steven E.; Corradini, Laura; Stefanopoulos, Dimitria E.; Adusumalli, Prathima; Pelletier, Josephine; Panzenbeck, Mark; Berg, Karen; Canfield, Melissa; Cook, Brian N.; Razavi, Hossein; Kuzmich, Daniel; Anderson, Shawn; Allard, Devan; Harrison, Paul; Grimaldi, Christine; Souza, Donald; Harcken, Christian; Fryer, Ryan M.; Modis, Louise K.; Brown, Maryanne L.			CCR1 Plays a Critical Role in Modulating Pain through Hematopoietic and Non-Hematopoietic Cells	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; CHEMOKINE RECEPTORS; OPIOID RECEPTORS; NEUROPATHIC PAIN; MICE; RECRUITMENT; NEUTROPHILS; BLOCKADE; INFILTRATION; PATHOGENESIS	Inflammation is associated with immune cells infiltrating into the inflammatory site and pain. CC chemokine receptor 1 (CCR1) mediates trafficking of leukocytes to sites of inflammation. However, the contribution of CCR1 to pain is incompletely understood. Here we report an unexpected discovery that CCR1-mediated trafficking of neutrophils and CCR1 activity on non-hematopoietic cells both modulate pain. Using a genetic approach (CCR1(-/-) animals) and pharmacological inhibition of CCR1 with selective inhibitors, we show significant reductions in pain responses using the acetic acid-induced writhing and complete Freund's adjuvant-induced mechanical hyperalgesia models. Reductions in writhing correlated with reduced trafficking of myeloid cells into the peritoneal cavity. We show that CCR1 is highly expressed on circulating neutrophils and their depletion decreases acetic acid-induced writhing. However, administration of neutrophils into the peritoneal cavity did not enhance acetic acid-induced writhing in wild-type (WT) or CCR1(-/-) mice. Additionally, selective knockout of CCR1 in either the hematopoietic or non-hematopoietic compartments also reduced writhing. Together these data suggest that CCR1 functions to significantly modulate pain by controlling neutrophil trafficking to the inflammatory site and having an unexpected role on non-hematopoietic cells. As inflammatory diseases are often accompanied with infiltrating immune cells at the inflammatory site and pain, CCR1 antagonism may provide a dual benefit by restricting leukocyte trafficking and reducing pain.	[Lewis, Nuruddeen D.; Fogal, Steven E.; Stefanopoulos, Dimitria E.; Adusumalli, Prathima; Pelletier, Josephine; Panzenbeck, Mark; Berg, Karen; Canfield, Melissa; Anderson, Shawn; Allard, Devan; Souza, Donald; Harcken, Christian; Modis, Louise K.; Brown, Maryanne L.] Boehringer Ingelheim Pharmaceut Inc, Dept Immunol & Inflammat, Ridgefield, CT 06877 USA; [Muthukumarana, Akalushi; Grimaldi, Christine; Fryer, Ryan M.] Boehringer Ingelheim Pharmaceut Inc, Dept Cardiometab Dis Res, Ridgefield, CT 06877 USA; [Cook, Brian N.; Razavi, Hossein; Kuzmich, Daniel] Boehringer Ingelheim Pharmaceut Inc, Dept Med Chem, Ridgefield, CT 06877 USA; [Harrison, Paul] Boehringer Ingelheim Pharmaceut Inc, Dept Integrat Toxicol, Ridgefield, CT 06877 USA; [Corradini, Laura] Boehringer Ingelheim Pharma GmbH & Co KG, Dept CNS Dis Res, Biberach, Germany	Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim	Modis, LK (corresponding author), Boehringer Ingelheim Pharmaceut Inc, Dept Immunol & Inflammat, 90 E Ridge POB 368, Ridgefield, CT 06877 USA.	ymodis@gmail.com		Lewis, Nuruddeen/0000-0002-1233-6607; Panzenbeck, Mark/0000-0003-1618-5399	Boehringer Ingelheim Pharmaceuticals	Boehringer Ingelheim Pharmaceuticals(Boehringer Ingelheim)	Boehringer Ingelheim Pharmaceuticals funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2005, TRENDS IMMUNOL, V26, P529, DOI 10.1016/j.it.2005.08.001; Amat M, 2006, BRIT J PHARMACOL, V149, P666, DOI 10.1038/sj.bjp.0706912; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Cook BN, 2011, AZAINDAZOLE COMPOUND; Cunha TM, 2006, J LEUKOCYTE BIOL, V80, P727, DOI 10.1189/jlb.0406244; da Rocha FAC, 2004, EUR J PHARMACOL, V497, P81, DOI 10.1016/j.ejphar.2004.06.025; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Furuichi K, 2008, J IMMUNOL, V181, P8670, DOI 10.4049/jimmunol.181.12.8670; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Gladue RP, 2006, J IMMUNOL, V176, P3141, DOI 10.4049/jimmunol.176.5.3141; Haringman JJ, 2003, ANN RHEUM DIS, V62, P715, DOI 10.1136/ard.62.8.715; Heiberg T, 2002, ARTHRIT RHEUM-ARTHR, V47, P391, DOI 10.1002/art.10515; Jacobs JP, 2010, ARTHRITIS RHEUM-US, V62, P1921, DOI 10.1002/art.27470; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Lee YC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3353; LEVINE JD, 1984, SCIENCE, V225, P743, DOI 10.1126/science.6087456; Liou JT, 2012, PAIN, V153, P1283, DOI 10.1016/j.pain.2012.03.008; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Ness TL, 2004, J IMMUNOL, V173, P6938, DOI 10.4049/jimmunol.173.11.6938; Quick ML, 2012, AM J PHYSIOL-REG I, V303, pR580, DOI 10.1152/ajpregu.00240.2012; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Rittner HL, 2006, J LEUKOCYTE BIOL, V79, P1022, DOI 10.1189/jlb.0805452; Rittner HL, 2005, J LEUKOCYTE BIOL, V78, P1215, DOI 10.1189/jlb.0405223; Rottman JB, 2000, EUR J IMMUNOL, V30, P2372, DOI 10.1002/1521-4141(2000)30:8<2372::AID-IMMU2372>3.0.CO;2-D; Szabo I, 2002, P NATL ACAD SCI USA, V99, P10276, DOI 10.1073/pnas.102327699; Tak PP, 2013, ANN RHEUM DIS, V72, P337, DOI 10.1136/annrheumdis-2011-201605; Taylor P, 2010, J INT MED RES, V38, P1213, DOI 10.1177/147323001003800402; Verri WA, 2007, BRAIN BEHAV IMMUN, V21, P535, DOI 10.1016/j.bbi.2006.11.005; Weber C, 2001, BLOOD, V97, P1144, DOI 10.1182/blood.V97.4.1144; White FA, 2007, P NATL ACAD SCI USA, V104, P20151, DOI 10.1073/pnas.0709250104; White FA, 2008, CURR OPIN ANESTHESIO, V21, P580, DOI 10.1097/ACO.0b013e32830eb69d; Zhang N, 2004, J IMMUNOL, V173, P594, DOI 10.4049/jimmunol.173.1.594; Zhang N, 2005, P NATL ACAD SCI USA, V102, P4536, DOI 10.1073/pnas.0406030102	36	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105883	10.1371/journal.pone.0105883	http://dx.doi.org/10.1371/journal.pone.0105883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170619	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500079
J	Melia, MM; Earle, JP; Abdullah, H; Reaney, K; Tangy, F; Cosby, SL				Melia, Mary M.; Earle, John Philip; Abdullah, Haniah; Reaney, Katherine; Tangy, Frederic; Cosby, Sara Louise			Use of SLAM and PVRL4 and Identification of Pro-HB-EGF as Cell Entry Receptors for Wild Type Phocine Distemper Virus	PLOS ONE			English	Article							MEASLES-VIRUS; CANINE-DISTEMPER; DOWN-REGULATION; GROWTH-FACTOR; NATURAL INFECTION; RHESUS-MONKEYS; CD46; MOLECULE; MORBILLIVIRUSES; HEMAGGLUTININ	Signalling lymphocyte activation molecule (SLAM) has been identified as an immune cell receptor for the morbilliviruses, measles (MV), canine distemper (CDV), rinderpest and peste des petits ruminants (PPRV) viruses, while CD46 is a receptor for vaccine strains of MV. More recently poliovirus like receptor 4 (PVRL4), also known as nectin 4, has been identified as a receptor for MV, CDV and PPRV on the basolateral surface of polarised epithelial cells. PVRL4 is also up-regulated by MV in human brain endothelial cells. Utilisation of PVRL4 as a receptor by phocine distemper virus (PDV) remains to be demonstrated as well as confirmation of use of SLAM. We have observed that unlike wild type (wt) MV or wtCDV, wtPDV strains replicate in African green monkey kidney Vero cells without prior adaptation, suggesting the use of a further receptor. We therefore examined candidate molecules, glycosaminoglycans (GAG) and the tetraspan proteins, integrin beta and the membrane bound form of heparin binding epithelial growth factor (proHB-EGF), for receptor usage by wtPDV in Vero cells. We show that wtPDV replicates in Chinese hamster ovary (CHO) cells expressing SLAM and PVRL4. Similar wtPDV titres are produced in Vero and VeroSLAM cells but more limited fusion occurs in the latter. Infection of Vero cells was not inhibited by anti-CD46 antibody. Removal/disruption of GAG decreased fusion but not the titre of virus. Treatment with anti-integrin beta antibody increased rather than decreased infection of Vero cells by wtPDV. However, infection was inhibited by antibody to HB-EGF and the virus replicated in CHO-proHB-EGF cells, indicating use of this molecule as a receptor. Common use of SLAM and PVRL4 by morbilliviruses increases the possibility of cross-species infection. Lack of a requirement for wtPDV adaptation to Vero cells raises the possibility of usage of proHB-EGF as a receptor in vivo but requires further investigation.	[Melia, Mary M.; Earle, John Philip; Abdullah, Haniah; Reaney, Katherine; Cosby, Sara Louise] Queens Univ Belfast, Ctr Infect & Immun, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Tangy, Frederic] CNRS, URA3015, Inst Pasteur, Viral Genom & Vaccinat Lab, Paris, France	Queens University Belfast; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cosby, SL (corresponding author), Abott Ireland Diagnost Div, Sligo, Co Sligo, Ireland.	l.cosby@qub.ac.uk	Cosby, Louise/W-9239-2019	Cosby, Louise/0000-0002-2617-8603	Department of Education and Learning (DEL), Northern Ireland; Health and Social Care Research and Development Office Northern Ireland [9.1]	Department of Education and Learning (DEL), Northern Ireland; Health and Social Care Research and Development Office Northern Ireland	Mary Melia was supported by a studentship from the Department of Education and Learning (DEL), Northern Ireland. This work was also funded by grant 9.1 from the Health and Social Care Research and Development Office Northern Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah H, 2009, NEUROPATH APPL NEURO, V35, P473, DOI 10.1111/j.1365-2990.2009.01023.x; Abdullah H, 2013, J NEUROPATH EXP NEUR, V72, P681, DOI 10.1097/NEN.0b013e31829a26b6; ABRAHAM JA, 1993, BIOCHEM BIOPH RES CO, V190, P125, DOI 10.1006/bbrc.1993.1020; Baron MD, 2005, J GEN VIROL, V86, P1753, DOI 10.1099/vir.0.80836-0; Barrett T, 1999, ADV VIRUS RES, V53, P89, DOI 10.1016/S0065-3527(08)60344-9; Bieringer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057488; Birch J, 2013, J VIROL, V87, P4756, DOI 10.1128/JVI.02792-12; BLIXENKRONEMOLLER M, 1992, ARCH VIROL, V123, P279, DOI 10.1007/BF01317264; Cha JH, 1999, BIOCHEM BIOPH RES CO, V254, P325, DOI 10.1006/bbrc.1998.9899; CHALMERS WSK, 1994, VET REC, V135, P349, DOI 10.1136/vr.135.15.349; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Combredet C, 2003, J VIROL, V77, P11546, DOI 10.1128/JVI.77.21.11546-11554.2003; Cosby SL, 2012, FUTURE VIROL, V7, P1103, DOI 10.2217/FVL.12.103; Coughlan S, 2002, CLIN INFECT DIS, V35, P84, DOI 10.1086/340708; De Vos J, 2001, BLOOD, V98, P771, DOI 10.1182/blood.V98.3.771; de Vries RD, 2014, J VIROL, V88, P4423, DOI 10.1128/JVI.03676-13; de Witte L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000049; Delpeut S, 2014, VIROLOGY, V454, P109, DOI 10.1016/j.virol.2014.02.014; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Earle JAP, 2011, EMERG INFECT DIS, V17, P215, DOI 10.3201/eid1702.100190; Fujita K, 2007, VIROLOGY, V359, P324, DOI 10.1016/j.virol.2006.09.018; Galbraith SE, 1998, J VIROL, V72, P10292, DOI 10.1128/JVI.72.12.10292-10297.1998; IWATSUKI K, 1995, J COMP PATHOL, V113, P185, DOI 10.1016/S0021-9975(05)80033-7; KOBUNE F, 1990, J VIROL, V64, P700, DOI 10.1128/JVI.64.2.700-705.1990; Kurita-Taniguchi M, 2002, MOL IMMUNOL, V38, P689, DOI 10.1016/S0161-5890(01)00100-6; Lozahic S, 2000, EUR J IMMUNOL, V30, P900, DOI 10.1002/1521-4141(200003)30:3<900::AID-IMMU900>3.0.CO;2-X; McQuaid S, 2002, LAB INVEST, V82, P403, DOI 10.1038/labinvest.3780434; Mesman AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049573; Minagawa H, 2001, J GEN VIROL, V82, P2913, DOI 10.1099/0022-1317-82-12-2913; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; NAKAMURA K, 1995, J CELL BIOL, V129, P1691, DOI 10.1083/jcb.129.6.1691; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; NANICHE D, 1993, J GEN VIROL, V74, P1073, DOI 10.1099/0022-1317-74-6-1073; Nielsen O, 2008, J WILDLIFE DIS, V44, P600, DOI 10.7589/0090-3558-44.3.600; Nores JER, 1996, J VIROL, V70, P4419, DOI 10.1128/JVI.70.7.4419-4426.1996; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Ohishi K, 2010, COMP IMMUNOL MICROB, V33, P227, DOI 10.1016/j.cimid.2008.10.003; POHLMEYER G, 1993, J COMP PATHOL, V109, P57, DOI 10.1016/S0021-9975(08)80240-X; Pratakpiriya W, 2012, J VIROL, V86, P10207, DOI 10.1128/JVI.00824-12; Qiu W, 2011, EMERG INFECT DIS, V17, P1541, DOI 10.3201/eid1708.101153; Sakuma T, 1997, J BIOCHEM-TOKYO, V122, P474; SCHNEIDERSCHAULIES J, 1995, P NATL ACAD SCI USA, V92, P3943, DOI 10.1073/pnas.92.9.3943; Singethan K, 2006, J GEN VIROL, V87, P1635, DOI 10.1099/vir.0.81629-0; Singethan Katrin, 2008, Commun Integr Biol, V1, P11; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; Sun ZZ, 2010, VET MICROBIOL, V141, P374, DOI 10.1016/j.vetmic.2009.09.024; SVANSSON V, 1993, ARCH VIROL, V131, P349, DOI 10.1007/BF01378637; Tanaka K, 1998, ARCH VIROL, V143, P213, DOI 10.1007/s007050050281; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; Terao-Muto Y, 2008, ANTIVIR RES, V80, P370, DOI 10.1016/j.antiviral.2008.08.006; van der Vlist M, 2011, EUR J IMMUNOL, V41, P2619, DOI 10.1002/eji.201041305; WILD TF, 1991, J GEN VIROL, V72, P439, DOI 10.1099/0022-1317-72-2-439; Xu Q, 2006, J BIOCHEM MOL BIOL, V39, P406; YOSHIKAWA Y, 1989, VET MICROBIOL, V20, P193, DOI 10.1016/0378-1135(89)90043-6	55	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106281	10.1371/journal.pone.0106281	http://dx.doi.org/10.1371/journal.pone.0106281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171206	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500141
J	Rakshit, H; Rathi, N; Roy, D				Rakshit, Hindol; Rathi, Nitin; Roy, Debjani			Construction and Analysis of the Protein-Protein Interaction Networks Based on Gene Expression Profiles of Parkinson's Disease	PLOS ONE			English	Article							GENOMIC DATA; ANNOTATION; RESOURCE; TOOL; PHOSPHORYLATION; REPRESENTATION; COMPLEXES; SUBSTRATE; DATABASE; PLATFORM	Background: Parkinson's Disease (PD) is one of the most prevailing neurodegenerative diseases. Improving diagnoses and treatments of this disease is essential, as currently there exists no cure for this disease. Microarray and proteomics data have revealed abnormal expression of several genes and proteins responsible for PD. Nevertheless, few studies have been reported involving PD-specific protein-protein interactions. Results: Microarray based gene expression data and protein-protein interaction (PPI) databases were combined to construct the PPI networks of differentially expressed (DE) genes in post mortem brain tissue samples of patients with Parkinson's disease. Samples were collected from the substantia nigra and the frontal cerebral cortex. From the microarray data, two sets of DE genes were selected by 2-tailed t-tests and Significance Analysis of Microarrays (SAM), run separately to construct two Query-Query PPI (QQPPI) networks. Several topological properties of these networks were studied. Nodes with High Connectivity (hubs) and High Betweenness Low Connectivity (bottlenecks) were identified to be the most significant nodes of the networks. Three and four-cliques were identified in the QQPPI networks. These cliques contain most of the topologically significant nodes of the networks which form core functional modules consisting of tightly knitted sub-networks. Hitherto unreported 37 PD disease markers were identified based on their topological significance in the networks. Of these 37 markers, eight were significantly involved in the core functional modules and showed significant change in co-expression levels. Four (ARRB2, STX1A, TFRC and MARCKS) out of the 37 markers were found to be associated with several neurotransmitters including dopamine. Conclusion: This study represents a novel investigation of the PPI networks for PD, a complex disease. 37 proteins identified in our study can be considered as PD network biomarkers. These network biomarkers may provide as potential therapeutic targets for PD applications development.	[Rakshit, Hindol] Visva Bharati Univ, Integrated Sci Educ & Res Ctr, Birbhum, W Bengal, India; [Rathi, Nitin] Cognizant Technol Solut India Pvt Ltd, MIDC, Pune, Maharashtra, India; [Roy, Debjani] Bose Inst, Dept Biophys, Kolkata, India	Visva Bharati University; Department of Science & Technology (India); Bose Institute	Roy, D (corresponding author), Bose Inst, Dept Biophys, Acharya JC Bose Centenary Bldg, Kolkata, India.	drdebjani@yahoo.com						Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barone P, 2010, EUR J NEUROL, V17, P364, DOI 10.1111/j.1468-1331.2009.02900.x; Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Becker MY, 2001, BIOINFORMATICS, V17, P461, DOI 10.1093/bioinformatics/17.5.461; Bjork K, 2013, PSYCHOPHARMACOLOGY, V230, P439, DOI 10.1007/s00213-013-3166-x; Bragina L, 2010, NEUROSCIENCE, V165, P934, DOI 10.1016/j.neuroscience.2009.11.009; Cervinski MA, 2010, NEUROSCIENCE, V170, P408, DOI 10.1016/j.neuroscience.2010.07.025; Chatterjee P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093751; Chen TC, 2009, PROTEOMICS, V9, P4048, DOI 10.1002/pmic.200900231; Chu G., SAM SIGNIFICANCE ANA; Coulomb S, 2005, P ROY SOC B-BIOL SCI, V272, P1721, DOI 10.1098/rspb.2005.3128; Dannenfelser R, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-156; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; Dumitriu A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002794; Ferrer I, 2011, J NEURAL TRANSM, V118, P821, DOI 10.1007/s00702-010-0482-8; Fitzgerald PJ, 2010, NEUROBIOL DIS, V40, P608, DOI 10.1016/j.nbd.2010.08.005; Friedel CC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-297; Gao LB, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-181; Gomez A, 2010, ACTA NEUROPATHOL, V120, P155, DOI 10.1007/s00401-010-0669-y; Goni J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-52; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Guldener U, 2005, NUCLEIC ACIDS RES, V33, pD364, DOI 10.1093/nar/gki053; Gursoy A, 2008, BIOCHEM SOC T, V36, P1398, DOI 10.1042/BST0361398; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Hermjakob H, 2004, NAT BIOTECHNOL, V22, P177, DOI 10.1038/nbt926; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Jellen LC, 2013, NEUROSCIENCE, V252, P13, DOI 10.1016/j.neuroscience.2013.07.058; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kim SJ, 2003, J BIOL CHEM, V278, P41890, DOI 10.1074/jbc.M306017200; Lee SA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S20; Lee SA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-114; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Lu D, 1998, J CELL BIOL, V142, P217, DOI 10.1083/jcb.142.1.217; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Mishima T, 2012, J NEUROSCI, V32, P381, DOI 10.1523/JNEUROSCI.2911-11.2012; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Nakamura K, 2008, INT J NEUROPSYCHOPH, V11, P1073, DOI 10.1017/S1461145708009036; Nakamura K, 2011, PROG NEURO-PSYCHOPH, V35, P454, DOI 10.1016/j.pnpbp.2010.11.033; OUIMET CC, 1990, J NEUROSCI, V10, P1683; Pankratz ND, 2004, PARKINSON DIS OVERVI; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ran JH, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-32; Ray M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r148; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Satoh K, 2009, AM J PHYSIOL-GASTR L, V296, pG1382, DOI 10.1152/ajpgi.90536.2008; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wall DP, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-50; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yip KY, 2006, BIOINFORMATICS, V22, P2968, DOI 10.1093/bioinformatics/btl488; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	69	47	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e103047	10.1371/journal.pone.0103047	http://dx.doi.org/10.1371/journal.pone.0103047			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170921	Green Submitted, gold, Green Published			2022-12-25	WOS:000341127500008
J	Swale, A; Miyajima, F; Roberts, P; Hall, A; Little, M; Beadsworth, MBJ; Beeching, NJ; Kolamunnage-Dona, R; Parry, CM; Pirmohamed, M				Swale, Andrew; Miyajima, Fabio; Roberts, Paul; Hall, Amanda; Little, Margaret; Beadsworth, Mike B. J.; Beeching, Nick J.; Kolamunnage-Dona, Ruwanthi; Parry, Chris M.; Pirmohamed, Munir			Calprotectin and Lactoferrin Faecal Levels in Patients with Clostridium difficile Infection (CDI): A Prospective Cohort Study	PLOS ONE			English	Article							INTESTINAL INFLAMMATION; CROHNS-DISEASE; TOXIN-B; BLOOD LEUKOCYTES; PSEUDOMEMBRANOUS COLITIS; PROSPECTIVE MULTICENTER; ULCERATIVE-COLITIS; ENDOSCOPIC SCORE; ACTIVITY INDEX; DIARRHEA	Measurement of both calprotectin and lactoferrin in faeces has successfully been used to discriminate between functional and inflammatory bowel conditions, but evidence is limited for Clostridium difficile infection (CDI). We prospectively recruited a cohort of 164 CDI cases and 52 controls with antibiotic-associated diarrhoea (AAD). Information on disease severity, duration of symptoms, 30-day mortality and 90-day recurrence as markers of complicated CDI were recorded. Specimens were subject to microbiological culture and PCR-ribotyping. Levels of faecal calprotectin (FC) and lactoferrin (FL) were measured by ELISA. Statistical analysis was conducted using percentile categorisation. ROC curve analysis was employed to determine optimal cut-off values. Both markers were highly correlated with each other (r(2) = 0.74) and elevated in cases compared to controls (p < 0.0001; ROC > 0.85), although we observed a large amount of variability across both groups. The optimal case-control cut-off point was 148 mg/kg for FC and 8.1 ng/mu l for FL. Median values for FL in CDI cases were significantly greater in patients suffering from severe disease compared to non-severe disease (104.6 vs. 40.1 ng/mu l, p = 0.02), but were not significant for FC (969.3 vs. 512.7 mg/kg, p = 0.09). Neither marker was associated with 90-day recurrence, prolonged CDI symptoms, positive culture results and colonisation by ribotype 027. Both FC and FL distinguished between CDI cases and AAD controls. Although FL was associated with disease severity in CDI patients, this showed high inter-individual variability and was an isolated finding. Thus, FC and FL are unlikely to be useful as biomarkers of complicated CDI disease.	[Swale, Andrew; Miyajima, Fabio; Little, Margaret; Pirmohamed, Munir] Univ Liverpool, Wolfson Ctr Personalised Med, Liverpool L69 3BX, Merseyside, England; [Swale, Andrew; Miyajima, Fabio; Roberts, Paul; Little, Margaret; Beadsworth, Mike B. J.; Beeching, Nick J.; Pirmohamed, Munir] Royal Liverpool & Broadgreen Univ Hosp Trust, Liverpool, Merseyside, England; [Hall, Amanda; Parry, Chris M.] Univ Liverpool, Inst Infect & Global Heath, Liverpool L69 3BX, Merseyside, England; [Beeching, Nick J.] NIHR Hlth Protect Unit Gastrointestinal Infect, Liverpool, Merseyside, England; [Beadsworth, Mike B. J.; Beeching, Nick J.; Parry, Chris M.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Kolamunnage-Dona, Ruwanthi] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; University of Liverpool; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool	Pirmohamed, M (corresponding author), Univ Liverpool, Wolfson Ctr Personalised Med, Liverpool L69 3BX, Merseyside, England.	munirp@liv.ac.uk	Kolamunnage-Dona, Ruwanthi/W-7979-2019; Pirmohamed, Munir/H-6004-2011; Miyajima, Fabio/K-6587-2012; Beeching, Nicholas J/L-5363-2017	Kolamunnage-Dona, Ruwanthi/0000-0003-3886-6208; Pirmohamed, Munir/0000-0002-7534-7266; Miyajima, Fabio/0000-0002-1347-4825; Beeching, Nicholas/0000-0002-7019-8791	National Institute for Health Research (NIHR) Biomedical Research Centre in microbial diseases in Liverpool; Medical Research Council [MR/K000551/1]; NIHR [BRF-2011-028]; Medical Research Council [MR/L006758/1] Funding Source: researchfish; National Institute for Health Research [BRF-2011-028, NF-SI-0512-10064] Funding Source: researchfish; MRC [MR/K000551/1, MR/L006758/1] Funding Source: UKRI	National Institute for Health Research (NIHR) Biomedical Research Centre in microbial diseases in Liverpool(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the National Institute for Health Research (NIHR) Biomedical Research Centre in microbial diseases in Liverpool, and by the Medical Research Council [MR/K000551/1]. The authors would also like to thank the NIHR for PhD student funding for Andrew Swale [BRF-2011-028]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archbald-Pannone L, 2010, J AM MED DIR ASSOC, V11, P263, DOI 10.1016/j.jamda.2009.09.006; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Boone JH, 2013, EUR J CLIN MICROBIOL, V32, P1517, DOI 10.1007/s10096-013-1905-x; Boone JH, 2012, US: Techlab, Inc. Patent, Patent No. [US20120276060 A1, 20120276060]; Caplin B, 2011, NEPHROL DIAL TRANSPL, V26, P2656, DOI 10.1093/ndt/gfq763; Costa F, 2003, DIGEST LIVER DIS, V35, P642, DOI 10.1016/S1590-8658(03)00381-5; D'Inca R, 2007, INT J COLORECTAL DIS, V22, P429, DOI 10.1007/s00384-006-0159-9; Daskivich TJ, 2011, CANCER-AM CANCER SOC, V117, P4642, DOI 10.1002/cncr.26104; Daskivich TJ, 2014, EUR UROL; El Feghaly RE, 2013, CLIN INFECT DIS, V56, P1713, DOI 10.1093/cid/cit147; Garcia-Sanchez V, 2010, J CROHNS COLITIS, V4, P144, DOI 10.1016/j.crohns.2009.09.008; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Health Protection Agency, CLOSTR DIFF RIB NETW; Hippenstiel S, 2000, BLOOD, V95, P3044; Hurley BW, 2002, ARCH INTERN MED, V162, P2177, DOI 10.1001/archinte.162.19.2177; Ishida Y, 2004, J IMMUNOL, V172, P3018, DOI 10.4049/jimmunol.172.5.3018; JONES JR, 2008, CONSUM REP, V73, P6; Kelly CP, 2011, J MED MICROBIOL, V60, P1070, DOI 10.1099/jmm.0.030015-0; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kopylov U, 2014, INFLAMM BOWEL DIS; Langhorst J, 2005, INFLAMM BOWEL DIS, V11, P1085, DOI 10.1097/01.MIB.0000187980.08686.18; Langhorst J, 2008, AM J GASTROENTEROL, V103, P162, DOI 10.1111/j.1572-0241.2007.01556.x; LaSala PR, 2013, J CLIN MICROBIOL, V51, P311, DOI 10.1128/JCM.02735-12; Lemee L, 2004, J CLIN MICROBIOL, V42, P5710, DOI 10.1128/JCM.42.12.5710-5714.2004; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; National Institute for Health and Care Excellence, 2013, FAEC CALPR DIAGN TES; Pawlowski SW, 2009, J HOSP INFECT, V73, P185, DOI 10.1016/j.jhin.2009.05.013; Planche TD, 2013, LANCET INFECT DIS, V13, P936, DOI 10.1016/S1473-3099(13)70200-7; PRICE AB, 1977, J CLIN PATHOL, V30, P1, DOI 10.1136/jcp.30.1.1; Public Health England, 2013, UPD GUID MAN TREATM; Savidge TC, 2003, GASTROENTEROLOGY, V125, P413, DOI 10.1016/S0016-5085(03)00902-8; Schoepfer AM, 2008, INFLAMM BOWEL DIS, V14, P32, DOI 10.1002/ibd.20275; Schoepfer AM, 2010, AM J GASTROENTEROL, V105, P162, DOI 10.1038/ajg.2009.545; Schoepfer AM, 2009, INFLAMM BOWEL DIS, V15, P1851, DOI 10.1002/ibd.20986; Shastri YM, 2008, AM J MED, V121, P1099, DOI 10.1016/j.amjmed.2008.06.034; Sipponen T, 2008, ALIMENT PHARM THER, V28, P1221, DOI 10.1111/j.1365-2036.2008.03835.x; Sipponen T, 2008, INFLAMM BOWEL DIS, V14, P1392, DOI 10.1002/ibd.20490; Sipponen T, 2008, INFLAMM BOWEL DIS, V14, P40, DOI 10.1002/ibd.20312; Steiner TS, 1997, CLIN DIAGN LAB IMMUN, V4, P719, DOI 10.1128/CDLI.4.6.719-722.1997; Summerton CB, 2002, EUR J GASTROEN HEPAT, V14, P841, DOI 10.1097/00042737-200208000-00005; Tibble J, 2000, GUT, V47, P506, DOI 10.1136/gut.47.4.506; Vaishnavi C, 2000, MICROBES INFECT, V2, P1827, DOI 10.1016/S1286-4579(00)01343-5; van Langenberg DR, 2010, INTERN MED J, V40, P819, DOI 10.1111/j.1445-5994.2009.02102.x; Whitehead SJ, 2014, J MED MICROBIOL	46	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106118	10.1371/journal.pone.0106118	http://dx.doi.org/10.1371/journal.pone.0106118			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170963	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000341127500108
J	Cannon, G; Callahan, MA; Gronemus, JQ; Lowy, RJ				Cannon, Georgetta; Callahan, Michelle A.; Gronemus, Jenny Q.; Lowy, R. Joel			Early Activation of MAP Kinases by Influenza A Virus X-31 in Murine Macrophage Cell Lines	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; ALVEOLAR MACROPHAGES; CYTOKINE PRODUCTION; NITRIC-OXIDE; IN-VITRO; INFECTION	Early molecular responses to Influenza A (FLUA) virus strain A/X-31 H3N2 in macrophages were explored using J774. A1 and RAW 264.7 murine cell lines. NF-kappa B (NF kappa B) was reported to be central to FLUA host-response in other cell types. Our data showed that FLUA activation of the classical NF kappa B dependent pathway in these macrophages was minimal. Regulator proteins, IkappaB-alpha and -beta (I kappa B alpha, I kappa B beta), showed limited degradation peaking at 2 h post FLUA exposure and p65 was not observed to translocate from the cytoplasm to the nucleus. Additionally, the non-canonical NF kappa B pathway was not activated in response to FLUA. The cells did display early increases in TNF alpha and other inflammatory cytokine and chemokine production. Mitogen activated phosphokinase (MAPK) signaling pathways are also reported to control production of inflammatory cytokines in response to FLUA. The activation of the MAPKs, cJun kinases 1 and 2 (JNK 1/2), extracellular regulated kinases 1 and 2 (ERK 1/2), and p38 were investigated in both cell lines between 0.25 and 3 h post-infection. Each of these kinases showed increased phosphorylation post FLUA exposure. JNK phosphorylation occurred early while p38 phosphorylation appeared later. Phosphorylation of ERK 1/2 occurred earlier in J774. A1 cells compared to RAW 264.7 cells. Inhibition of MAPK activation resulted in decreased production of most FLUA responsive cytokines and chemokines in these cells. The results suggest that in these monocytic cells the MAPK pathways are important in the early response to FLUA.	[Cannon, Georgetta; Callahan, Michelle A.; Lowy, R. Joel] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Sci Res Dept, Bethesda, MD 20814 USA; [Gronemus, Jenny Q.] Amer Type Culture Collect, Cent Accessing Unit, Manassas, VA USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Lowy, RJ (corresponding author), Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Sci Res Dept, Bethesda, MD 20814 USA.	robert.lowy@usuhs.edu			Armed Forces Radiobiology Research Institute [RAB3AM]	Armed Forces Radiobiology Research Institute	Research was supported by the Armed Forces Radiobiology Research Institute under project RAB3AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Federal Agencies reserve the right to review research publications and grant approval for release to the public domain. This approval has been received. The opinions expressed in this manuscript are those of the authors only and do not necessarily reflect those of AFRRI, the Uniformed Services University of the Health Sciences or the Department of Defense.	American Lung Association Research and Program Services EaSU, 2010, TRENDS PNEUM INFL MO; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bernasconi D, 2005, J BIOL CHEM, V280, P24127, DOI 10.1074/jbc.M413726200; Blazejewska P, 2011, VIROLOGY, V412, P36, DOI 10.1016/j.virol.2010.12.047; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chen WH, 2012, IMMUNOL LETT, V141, P227, DOI 10.1016/j.imlet.2011.10.009; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Cline TD, 2013, J VIROL, V87, P1411, DOI 10.1128/JVI.02682-12; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Droebner K, 2011, ANTIVIR RES, V92, P195, DOI 10.1016/j.antiviral.2011.08.002; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Flory E, 2000, J BIOL CHEM, V275, P8307, DOI 10.1074/jbc.275.12.8307; Gao SJ, 2012, CELL MICROBIOL, V14, P1849, DOI 10.1111/cmi.12005; Gao W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030328; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gaur P, 2011, MED SCI MONITOR, V17, pRA148, DOI 10.12659/MSM.881801; Geiler J, 2011, MED MICROBIOL IMMUN, V200, P53, DOI 10.1007/s00430-010-0173-y; Geiler J, 2010, BIOCHEM PHARMACOL, V79, P413, DOI 10.1016/j.bcp.2009.08.025; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hamadmad SN, 2008, J PHARMACOL EXP THER, V324, P1227, DOI 10.1124/jpet.107.129643; Hang DTT, 2011, MOL IMMUNOL, V48, P1253, DOI 10.1016/j.molimm.2011.03.010; Hayden FG, 2011, J INFECT DIS, V203, P6, DOI 10.1093/infdis/jiq012; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Himes SR, 2006, J IMMUNOL, V176, P2219, DOI 10.4049/jimmunol.176.4.2219; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Julkunen I, 2001, CYTOKINE GROWTH F R, V12, P171, DOI 10.1016/S1359-6101(00)00026-5; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; KELLY KA, 1994, INFECT IMMUN, V62, P3122, DOI 10.1128/IAI.62.8.3122-3128.1994; Kim DS, 2003, MOL IMMUNOL, V40, P633, DOI 10.1016/j.molimm.2003.07.001; Kujime K, 2000, J IMMUNOL, V164, P3222, DOI 10.4049/jimmunol.164.6.3222; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lee DCW, 2005, J VIROL, V79, P10147, DOI 10.1128/JVI.79.16.10147-10154.2005; Lee SMY, 2012, J LEUKOCYTE BIOL, V92, P1, DOI 10.1189/jlb.0312130; LEENEN PJM, 1986, DIFFERENTIATION, V32, P157, DOI 10.1111/j.1432-0436.1986.tb00568.x; Lowy RJ, 2003, INT REV IMMUNOL, V22, P425, DOI 10.1080/08830180305216; Lowy RJ, 1997, EXP CELL RES, V234, P249, DOI 10.1006/excr.1997.3602; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Ludwig S, 2001, J BIOL CHEM, V276, P10990, DOI 10.1074/jbc.M009902200; Ludwig S, 2008, BIOL CHEM, V389, P1307, DOI 10.1515/BC.2008.148; Ludwig S, 2011, BIOL CHEM, V392, P837, DOI 10.1515/BC.2011.121; Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161; Marchant D, 2010, J VIROL, V84, P11359, DOI 10.1128/JVI.00804-10; Matikainen S, 2000, VIROLOGY, V276, P138, DOI 10.1006/viro.2000.0542; Mazur I, 2007, CELL MICROBIOL, V9, P1683, DOI 10.1111/j.1462-5822.2007.00902.x; McKinney LC, 2003, VIRUS RES, V97, P117, DOI 10.1016/j.virusres.2003.08.007; Minino Arialdi M, 2010, Natl Vital Stat Rep, V59, P1; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murphy EA, 2011, J INTERF CYTOK RES, V31, P501, DOI 10.1089/jir.2010.0143; Nieminen R, 2006, INT IMMUNOPHARMACOL, V6, P987, DOI 10.1016/j.intimp.2006.01.009; Nimmerjahn F, 2004, J GEN VIROL, V85, P2347, DOI 10.1099/vir.0.79958-0; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; PAHL HL, 1995, J VIROL, V69, P1480, DOI 10.1128/JVI.69.3.1480-1484.1995; Park HH, 2013, INT IMMUNOPHARMACOL, V15, P296, DOI 10.1016/j.intimp.2012.12.005; Park JS, 2007, INT IMMUNOPHARMACOL, V7, P70, DOI 10.1016/j.intimp.2006.08.015; Pinto R, 2011, ANTIVIR RES, V92, P45, DOI 10.1016/j.antiviral.2011.05.009; Pizzorno A, 2011, J INFECT DIS, V203, P25, DOI 10.1093/infdis/jiq010; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Pleschka S, 2008, BIOL CHEM, V389, P1273, DOI 10.1515/BC.2008.145; Pribul PK, 2008, J VIROL, V82, P4441, DOI 10.1128/JVI.02541-07; RALPH P, 1977, J IMMUNOL, V119, P950; RALPH P, 1977, CANCER RES, V37, P546; Rao KMK, 2001, J LEUKOCYTE BIOL, V69, P3; Reading PC, 2000, J VIROL, V74, P5190, DOI 10.1128/JVI.74.11.5190-5197.2000; Schmolke M, 2009, J IMMUNOL, V183, P5180, DOI 10.4049/jimmunol.0804198; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; Sheu TG, 2011, J INFECT DIS, V203, P13, DOI 10.1093/infdis/jiq005; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sutejo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033732; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Riel D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002099; Viemann D, 2011, J IMMUNOL, V186, P164, DOI 10.4049/jimmunol.0904170; Wang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029879; Wang XY, 2007, J IMMUNOL, V178, P6770, DOI 10.4049/jimmunol.178.11.6770; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Xing Z, 2010, J GEN VIROL, V91, P343, DOI 10.1099/vir.0.015578-0; Xu Jiaquan, 2010, Natl Vital Stat Rep, V58, P1; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yi AK, 2001, INT IMMUNOL, V13, P1391, DOI 10.1093/intimm/13.11.1391; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798	91	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105385	10.1371/journal.pone.0105385	http://dx.doi.org/10.1371/journal.pone.0105385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166426	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303700026
J	De Guio, F; Reyes, S; Vignaud, A; Duering, M; Ropele, S; Duchesnay, E; Chabriat, H; Jouvent, E				De Guio, Francois; Reyes, Sonia; Vignaud, Alexandre; Duering, Marco; Ropele, Stefan; Duchesnay, Edouard; Chabriat, Hugues; Jouvent, Eric			In Vivo High-Resolution 7 Tesla MRI Shows Early and Diffuse Cortical Alterations in CADASIL	PLOS ONE			English	Article							APPEARING WHITE-MATTER; SMALL VESSEL DISEASE; SUBCORTICAL INFARCTS; CEREBRAL-CORTEX; BRAIN VOLUME; DEPRESSION; THICKNESS	Background and Purpose: Recent data suggest that early symptoms may be related to cortex alterations in CADASIL (Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy), a monogenic model of cerebral small vessel disease (SVD). The aim of this study was to investigate cortical alterations using both high-resolution T2* acquisitions obtained with 7 Tesla MRI and structural T1 images with 3 Tesla MRI in CADASIL patients with no or only mild symptomatology (modified Rankin's scale <= 1 and Mini Mental State Examination (MMSE) >= 24). Methods: Complete reconstructions of the cortex using 7 Tesla T2* acquisitions with 0.7 mm isotropic resolution were obtained in 11 patients (52.1 +/- 13.2 years, 36% male) and 24 controls (54.8 +/- 11.0 years, 42% male). Seven Tesla T2* within the cortex and cortical thickness and morphology obtained from 3 Tesla images were compared between CADASIL and control subjects using general linear models. Results: MMSE, brain volume, cortical thickness and global sulcal morphology did not differ between groups. By contrast, T2* measured by 7 Tesla MRI was significantly increased in frontal, parietal, occipital and cingulate cortices in patients after correction for multiple testing. These changes were not related to white matter lesions, lacunes or microhemorrhages in patients having no brain atrophy compared to controls. Conclusions: Seven Tesla MRI, by contrast to state of the art post-processing of 3 Tesla acquisitions, shows diffuse T2* alterations within the cortical mantle in CADASIL whose origin remains to be determined.	[De Guio, Francois; Chabriat, Hugues; Jouvent, Eric] Univ Paris Diderot, INSERM, Sorbonne Paris Cite, UMR S 1161, Paris, France; [De Guio, Francois; Chabriat, Hugues; Jouvent, Eric] DHU NeuroVasc Sorbonne Paris Cite, Paris, France; [Reyes, Sonia; Chabriat, Hugues; Jouvent, Eric] Lariboisiere Hosp, AP HP, Dept Neurol, Paris, France; [Vignaud, Alexandre; Duchesnay, Edouard] UNIRS, CEA, Neurospin, Gif Sur Yvette, France; [Duering, Marco] Univ Munich, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Ropele, Stefan] Med Univ Graz, Dept Neurol, Graz, Austria	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; CEA; University of Munich; Medical University of Graz	Jouvent, E (corresponding author), Univ Paris Diderot, INSERM, Sorbonne Paris Cite, UMR S 1161, Paris, France.	eric.jouvent@lrb.aphp.fr	Duering, Marco/AAE-6949-2021; DUCHESNAY, EDOUARD/AAS-4046-2020; Jouvent, Eric/B-4320-2014; Chabriat, Hugues/G-5699-2010	Duering, Marco/0000-0003-2302-3136; DUCHESNAY, EDOUARD/0000-0002-4073-3490; Jouvent, Eric/0000-0001-7797-2236; REYES, Sonia/0000-0002-2907-7867; Vignaud, Alexandre/0000-0001-9203-0247; Chabriat, Hugues/0000-0001-8436-6074; De Guio, Francois/0000-0003-1809-4175	FP6 European Research Area Net (ERA-NET) NEURON grant [01 EW1207]; French CADASIL association; PLAGNIOL foundation; NRJ foundation; Austrian Science Fund (FWF) [I 904] Funding Source: researchfish	FP6 European Research Area Net (ERA-NET) NEURON grant; French CADASIL association; PLAGNIOL foundation; NRJ foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was founded by a FP6 European Research Area Net (ERA-NET) NEURON grant (01 EW1207), with the support of the French CADASIL association, the PLAGNIOL foundation and the NRJ foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP, 1994, DIAGN STAT MAN MENT, V4th; Brown WR, 2007, J NEUROL SCI, V257, P62, DOI 10.1016/j.jns.2007.01.015; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Cognat E, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-49; Cohen-Adad J, 2011, NEUROIMAGE, V57, P55, DOI 10.1016/j.neuroimage.2011.04.009; Cohen-Adad J, 2013, NEUROIMAGE; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; De Guio F, 2014, AM J NEURORADIOL, V35, P72, DOI 10.3174/ajnr.A3639; De Guio F, 2014, STROKE; de Laat KF, 2012, NEUROIMAGE, V59, P1478, DOI 10.1016/j.neuroimage.2011.08.005; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Duering M, 2012, NEUROLOGY, V79, P2025, DOI 10.1212/WNL.0b013e3182749f39; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fukunaga M, 2010, P NATL ACAD SCI USA, V107, P3834, DOI 10.1073/pnas.0911177107; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Joutel A, 2010, J CLIN INVEST, V120, P433, DOI 10.1172/JCI39733; Jouvent E, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.013; Jouvent E, 2011, STROKE, V42, pE27, DOI 10.1161/STROKEAHA.110.594218; Jouvent E, 2008, BRAIN, V131, P2201, DOI 10.1093/brain/awn129; Lassmann H, 2008, NEUROIMAG CLIN N AM, V18, pix; Lassmann H, 2008, NEUROIMAG CLIN N AM, V18, P563, DOI 10.1016/j.nic.2008.06.005; Liem MK, 2012, J NEUROL NEUROSUR PS, V83, P1180, DOI 10.1136/jnnp-2012-302545; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Peters N, 2006, NEUROLOGY, V66, P1517, DOI 10.1212/01.wnl.0000216271.96364.50; Roman GC, 2002, LANCET NEUROL, V1, P426, DOI 10.1016/S1474-4422(02)00190-4; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith EE, 2012, LANCET NEUROL, V11, P272, DOI 10.1016/S1474-4422(11)70307-6; Starkstein SE, 2005, J NEUROL NEUROSUR PS, V76, P1070, DOI 10.1136/jnnp.2004.052795; Stuber C, 2014, NEUROIMAGE, V93, P95, DOI 10.1016/j.neuroimage.2014.02.026; Viswanathan A, 2006, STROKE, V37, P2690, DOI 10.1161/01.STR.0000245091.28429.6a; Viswanathan A, 2010, NEUROBIOL AGING, V31, P1629, DOI 10.1016/j.neurobiolaging.2008.09.001; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Wechsler D., 2001, MEM 3 MANUEL ECHELLE; Westover MB, 2013, NEUROLOGY, V80, P1365, DOI 10.1212/WNL.0b013e31828c2f52; Yao M, 2012, STROKE, V43, P3252, DOI 10.1161/STROKEAHA.112.664854	42	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106311	10.1371/journal.pone.0106311	http://dx.doi.org/10.1371/journal.pone.0106311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165824	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303700086
J	Baskin, R; Park, SO; Keseru, GM; Bisht, KS; Wamsley, HL; Sayeski, PP				Baskin, Rebekah; Park, Sung O.; Keseru, Gyoergy M.; Bisht, Kirpal S.; Wamsley, Heather L.; Sayeski, Peter P.			The Jak2 Small Molecule Inhibitor, G6, Reduces the Tumorigenic Potential of T98G Glioblastoma Cells In Vitro and In Vivo	PLOS ONE			English	Article							SIGNALING PATHWAYS; EXPRESSION; GLIOMA; PROLIFERATION; TEMOZOLOMIDE; PROGRESSION; XENOGRAFTS; INDUCTION; VIMENTIN; FIBROSIS	Glioblastoma multiforme (GBM) is the most common and the most aggressive form of primary brain tumor. Jak2 is a nonreceptor tyrosine kinase that is involved in proliferative signaling through its association with various cell surface receptors. Hyperactive Jak2 signaling has been implicated in numerous hematological disorders as well as in various solid tumors including GBM. Our lab has developed a Jak2 small molecule inhibitor known as G6. It exhibits potent efficacy in vitro and in several in vivo models of Jak2-mediated hematological disease. Here, we hypothesized that G6 would inhibit the pathogenic growth of GBM cells expressing hyperactive Jak2. To test this, we screened several GBM cell lines and found that T98G cells express readily detectable levels of active Jak2. We found that G6 treatment of these cells reduced the phosphorylation of Jak2 and STAT3, in a dose-dependent manner. In addition, G6 treatment reduced the migratory potential, invasive potential, clonogenic growth potential, and overall viability of these cells. The effect of G6 was due to its direct suppression of Jak2 function and not via off-target kinases, as these effects were recapitulated in T98G cells that received Jak2 specific shRNA. G6 also significantly increased the levels of caspase-dependent apoptosis in T98G cells, when compared to cells that were treated with vehicle control. Lastly, when T98G cells were injected into nude mice, G6 treatment significantly reduced tumor volume and this was concomitant with significantly decreased levels of phospho-Jak2 and phospho-STAT3 within the tumors themselves. Furthermore, tumors harvested from mice that received G6 had significantly less vimentin protein levels when compared to tumors from mice that received vehicle control solution. Overall, these combined in vitro and in vivo results indicate that G6 may be a viable therapeutic option against GBM exhibiting hyperactivation of Jak2.	[Baskin, Rebekah; Park, Sung O.; Sayeski, Peter P.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA; [Keseru, Gyoergy M.] Hungarian Acad Sci, Res Ctr Nat Sci, Budapest, Hungary; [Bisht, Kirpal S.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA; [Wamsley, Heather L.] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; State University System of Florida; University of South Florida; State University System of Florida; University of Florida	Sayeski, PP (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA.	psayeski@ufl.edu		Keseru, Gyorgy M/0000-0003-1039-7809	National Institutes of Health [R01-HL67277]; University of Florida; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida(University of Florida); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Award R01-HL67277 (PPS) and a University of Florida Graduate Alumni Fellowship award (RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001888; Baskin R, 2012, CELL SIGNAL, V24, P435, DOI 10.1016/j.cellsig.2011.09.016; COSGROVE M, 1989, AM J SURG PATHOL, V13, P141, DOI 10.1097/00000478-198902000-00007; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Godeny MD, 2007, ANTI-CANCER AGENT ME, V7, P643, DOI 10.2174/187152007782330105; He KY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003900; Heimberger AB, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-38; Karmakar Surajit, 2010, J Cancer Sci Ther, V2, P107; Kayaselcuk F, 2002, J NEURO-ONCOL, V57, P115, DOI 10.1023/A:1015739130208; Kirabo A, 2012, AM J PATHOL, V181, P858, DOI 10.1016/j.ajpath.2012.05.033; Kirabo A, 2011, NEOPLASIA, V13, P1058, DOI 10.1593/neo.111112; Kirabo A, 2011, J BIOL CHEM, V286, P4280, DOI 10.1074/jbc.M110.200774; Kozin SV, 2007, CANCER RES, V67, P5076, DOI 10.1158/0008-5472.CAN-06-3664; Liu T, 2013, J SURG ONCOL, V107, P188, DOI 10.1002/jso.23240; Majumder A, 2011, BIOCHEMISTRY-US, V50, P7774, DOI 10.1021/bi200847n; Majumder A, 2010, J BIOL CHEM, V285, P31399, DOI 10.1074/jbc.M110.168211; Mao H, 2012, CANCER INVEST, V30, P48, DOI 10.3109/07357907.2011.630050; McFarland BC, 2011, MOL CANCER THER, V10, P2384, DOI 10.1158/1535-7163.MCT-11-0480; Ohka F, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/878425; Ono Y, 1996, J NEUROPATH EXP NEUR, V55, P1026, DOI 10.1097/00005072-199655100-00002; Osawa T, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.5; Plimack ER, 2013, ONCOLOGIST, V18, P819, DOI 10.1634/theoncologist.2013-0198; Robert K, 2009, BIOORG MED CHEM LETT, V19, P3598, DOI 10.1016/j.bmcl.2009.04.138; Sai K, 2012, J NEURO-ONCOL, V107, P487, DOI 10.1007/s11060-011-0786-z; Sciaccaluga M, 2007, ONCOL REP, V17, P17; Senft C, 2011, J NEURO-ONCOL, V101, P393, DOI 10.1007/s11060-010-0273-y; Singh S, 2003, CANCER RES, V63, P2306; Skalli O, 2013, HUM PATHOL, V44, P2081, DOI 10.1016/j.humpath.2013.03.013; Stechishin OD, 2013, NEURO-ONCOLOGY, V15, P198, DOI 10.1093/neuonc/nos302; Sun S, 2012, J NEURO-ONCOL, V107, P89, DOI 10.1007/s11060-011-0729-8; Swiatek-Machado K, 2012, CANCER BIOL THER, V13, P657, DOI 10.4161/cbt.20083; Tsukada T, 2012, INT J ONCOL, V41, P476, DOI 10.3892/ijo.2012.1490; Weller M, 2014, INT J CANCER, V134, P2437, DOI 10.1002/ijc.28576; Zheng Q, 2014, NEUROONCOL	34	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105568	10.1371/journal.pone.0105568	http://dx.doi.org/10.1371/journal.pone.0105568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162558	Green Published, Green Submitted, gold			2022-12-25	WOS:000340880900038
J	Frezzotti, P; Giorgio, A; Motolese, I; De Leucio, A; Iester, M; Motolese, E; Federico, A; De Stefano, N				Frezzotti, Paolo; Giorgio, Antonio; Motolese, Ilaria; De Leucio, Alessandro; Iester, Michele; Motolese, Eduardo; Federico, Antonio; De Stefano, Nicola			Structural and Functional Brain Changes beyond Visual System in Patients with Advanced Glaucoma	PLOS ONE			English	Article							WHITE-MATTER ABNORMALITIES; VOXEL-BASED MORPHOMETRY; RESTING-STATE NETWORKS; OPEN-ANGLE GLAUCOMA; NERVE-FIBER LAYER; OPTIC-NERVE; SPATIAL STATISTICS; DIFFUSION; PATHWAY; REGISTRATION	In order to test the hypothesis that in primary open angle glaucoma (POAG), an important cause of irreversible blindness, a spreading of neurodegeneration occurs through the brain, we performed multimodal MRI and subsequent whole-brain explorative voxelwise analyses in 13 advanced POAG patients and 12 age-matched normal controls (NC). Altered integrity (decreased fractional anisotropy or increased diffusivities) of white matter (WM) tracts was found not only along the visual pathway of POAG but also in nonvisual WM tracts (superior longitudinal fascicle, anterior thalamic radiation, corticospinal tract, middle cerebellar peduncle). POAG patients also showed brain atrophy in both visual cortex and other distant grey matter (GM) regions (frontoparietal cortex, hippocampi and cerebellar cortex), decreased functional connectivity (FC) in visual, working memory and dorsal attention networks and increased FC in visual and executive networks. In POAG, abnormalities in structure and FC within and outside visual system correlated with visual field parameters in the poorer performing eyes, thus emphasizing their clinical relevance. Altogether, this represents evidence that a vision disorder such as POAG can be considered a widespread neurodegenerative condition.	[Frezzotti, Paolo; Giorgio, Antonio; De Leucio, Alessandro; Motolese, Eduardo; Federico, Antonio; De Stefano, Nicola] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy; [Motolese, Ilaria; Iester, Michele] Univ Genoa, Dept Ophthalmol, Genoa, Italy	University of Siena; University of Genoa	De Stefano, N (corresponding author), Univ Siena, Dept Med Surg & Neurosci, Via Laterina 8, I-53100 Siena, Italy.	destefano@unisi.it	De Stefano, Nicola/AHE-3052-2022; De Leucio, Alessandro/N-1397-2019	De Stefano, Nicola/0000-0003-4930-7639; De Leucio, Alessandro/0000-0001-6180-1483; Iester, Michele/0000-0002-0524-2637	BioMS Medical; Biogen Idec; Bayer Schering Pharma; Merck Serono; NeuroRx Research; Novartis; Teva Pharmaceutical Industries Ltd; Italian Multiple Sclerosis Society	BioMS Medical; Biogen Idec(Biogen); Bayer Schering Pharma(Bayer AG); Merck Serono(Merck & Company); NeuroRx Research; Novartis(Novartis); Teva Pharmaceutical Industries Ltd(Teva Pharmaceutical Industries); Italian Multiple Sclerosis Society(Fondazione Italiana Sclerosi Multipla (FISM))	Paolo Frezzotti, Antonio Giorgio, Ilaria Motolese, Alessandro De Leucio, Michele Iester, Eduardo Motolese, Antonio Federico declare no competing financial interests. Nicola De Stefano has served on scientific advisory boards, received speaker honoraria, served as a consultant or received research support from BioMS Medical, Biogen Idec, Bayer Schering Pharma, Merck Serono, NeuroRx Research, Novartis, Teva Pharmaceutical Industries Ltd and the Italian Multiple Sclerosis Society. This does not alter adherence to PLOS ONE policies on sharing data and materials.	Adams RB, 2012, SOC COGN AFFECT NEUR, V7, P568, DOI 10.1093/scan/nsr038; Andersson J.L.R., 2007, TR07JA1 FMRIB; Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; Bayer AU, 2002, EUR NEUROL, V47, P165, DOI 10.1159/000047976; Beckmann C., 2009, NEUROIMAGE, V47; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Cesareo M, 2011, ASSESSMENT OPTIC NER; Chen ZQ, 2013, CLIN EXP OPHTHALMOL, V41, P43, DOI 10.1111/j.1442-9071.2012.02832.x; Connally EL, 2013, BRAIN LANG; Dai H, 2013, HUM BRAIN MAPP, V34, P2455, DOI 10.1002/hbm.22079; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; El-Rafei A, 2011, MAGN RESON IMAGING, V29, P1076, DOI 10.1016/j.mri.2011.02.034; Engelhorn T, 2012, SCI WORLD J, P1, DOI 10.1100/2012/849632; Engelhorn T, 2011, ACAD RADIOL, V18, P764, DOI 10.1016/j.acra.2011.01.014; European Glaucoma Society, 2020, TERM GUID GLAUC; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Garaci FG, 2009, RADIOLOGY, V252, P496, DOI 10.1148/radiol.2522081240; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Hardy J, 2012, NEW ENGL J MED, V366, P2126, DOI 10.1056/NEJMcibr1202401; Hernowo AT, 2011, INVEST OPHTH VIS SCI, V52, P2758, DOI 10.1167/iovs.10-5682; Hodapp E, 1993, CLIN DECISION GLAUCO; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Joshi AA, 2010, ANATOMICAL STRUCTURA; Lam DY, 2003, INVEST OPHTH VIS SCI, V44, P2573, DOI 10.1167/iovs.02-0779; Le PV, 2013, INVEST OPHTH VIS SCI, V54, P4287, DOI 10.1167/iovs.12-11388; Li CY, 2012, CURR EYE RES, V37, P794, DOI 10.3109/02713683.2012.683506; Lindner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085014; Loitfelder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042862; Martinez K, 2013, HUM BRAIN MAPP, V34, P3143, DOI 10.1002/hbm.22129; Medeiros FA, 2013, OPHTHALMOLOGY, V120, P736, DOI 10.1016/j.ophtha.2012.09.039; Murai H, 2013, JPN J OPHTHALMOL, V57, P257, DOI 10.1007/s10384-013-0233-0; Nucci C, 2013, CURR OPIN PHARMACOL, V13, P128, DOI 10.1016/j.coph.2012.08.004; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tamura H, 2006, J NEUROL SCI, V246, P79, DOI 10.1016/j.jns.2006.02.009; Wang K, 2008, CEREB CORTEX, V18, P697, DOI 10.1093/cercor/bhm105; Wang MY, 2013, NEURORADIOLOGY, V55, P493, DOI 10.1007/s00234-013-1133-1; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Xu JQ, 2008, NMR BIOMED, V21, P928, DOI 10.1002/nbm.1307; Yu LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073208; Yucel YH, 2008, CAN J OPHTHALMOL, V43, P342, DOI 10.3129/i08-059; Zhang YQ, 2012, ACTA OPHTHALMOL, V90, pE295, DOI 10.1111/j.1755-3768.2011.02346.x; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zikou AK, 2012, AM J NEURORADIOL, V33, P128, DOI 10.3174/ajnr.A2714	52	74	79	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105931	10.1371/journal.pone.0105931	http://dx.doi.org/10.1371/journal.pone.0105931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162716	Green Published, Green Submitted, gold			2022-12-25	WOS:000340880900062
J	Gong, CSA; Lin, SP; Mandell, MS; Tsou, MY; Chang, Y; Ting, CK				Gong, Cihun-Siyong Alex; Lin, Shih-Pin; Mandell, M. Susan; Tsou, Mei-Yung; Chang, Yin; Ting, Chien-Kun			Portable Optical Epidural Needle-A CMOS-Based System Solution and Its Circuit Design	PLOS ONE			English	Article							SPACE; IDENTIFICATION; ANALGESIA	Epidural anesthesia is a common anesthesia method yet up to 10% of procedures fail to provide adequate analgesia. This is usually due to misinterpreting the tactile information derived from the advancing needle through the complex tissue planes. Incorrect placement also can cause dural puncture and neural injury. We developed an optic system capable of reliably identifying tissue planes surrounding the epidural space. However the new technology was too large and cumbersome for practical clinical use. We present a miniaturized version of our optic system using chip technology (first generation CMOS-based system) for logic functions. The new system was connected to an alarm that was triggered once the optic properties of the epidural were identified. The aims of this study were to test our miniaturized system in a porcine model and describe the technology to build this new clinical tool. Our system was tested in a porcine model and identified the epidural space in the lumbar, low and high thoracic regions of the spine. The new technology identified the epidural space in all but 1 of 46 attempts. Experimental results from our fabricated integrated circuit and animal study show the new tool has future clinical potential.	[Lin, Shih-Pin; Tsou, Mei-Yung; Ting, Chien-Kun] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Lin, Shih-Pin; Tsou, Mei-Yung; Ting, Chien-Kun] Natl Yang Ming Univ, Taipei 112, Taiwan; [Gong, Cihun-Siyong Alex] Chang Gung Univ, Coll Engn, Sch Elect & Comp Engn, Dept Elect Engn, Taoyuan, Taiwan; [Gong, Cihun-Siyong Alex] Chang Gung Univ, Coll Engn, Green Technol Res Ctr, Portable Energy Syst Grp, Taoyuan, Taiwan; [Mandell, M. Susan] Univ Colorado, Hlth Sci Ctr, Dept Anesthesiol, Aurora, CO USA; [Chang, Yin] Natl Yang Ming Univ, Inst Biomed Engn, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung University; Chang Gung University; University of Colorado System; University of Colorado Anschutz Medical Campus; National Yang Ming Chiao Tung University	Ting, CK (corresponding author), Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan.	ckting@vghtpe.gov.tw	Ting, Chien-Kun/C-1389-2012	Ting, Chien-Kun/0000-0002-3156-8139	National Science Council (NSC), Taiwan [NSC 102-2218-E-182-003-, 100-2221-E-075-003-MY3]; Chang Gung University [UERPD2D0051, UERPD2D0011]; Ministry of Science and Technology, Taiwan [MOST 103-2221-E-182-070]; Taipei Veterans General Hospital [103DHA0100493]	National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung University; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by the following: 1. National Science Council (NSC), Taiwan, grant numbers NSC 102-2218-E-182-003- and 100-2221-E-075-003-MY3. This funder supported the study design. 2. Chang Gung University, grant numbers UERPD2D0051 and UERPD2D0011. This funder supported the data collection, analysis, and preparation of the manuscript. 3. Ministry of Science and Technology, Taiwan, grant number MOST 103-2221-E-182-070. This funder played a role in supporting the study implementation. 4. Taipei Veterans General Hospital (supporting animal studies), grant number 103DHA0100493.	Al-Sarawi SF, 2002, ELECTRON LETT, V38, P1009, DOI 10.1049/el:20020687; CURATOLO M, 1995, BRIT J ANAESTH, V75, P274, DOI 10.1093/bja/75.3.274; Desjardins AE, 2011, BIOMED OPT EXPRESS, V2, P1452, DOI 10.1364/BOE.2.001452; HOOD DD, 1993, ANESTHESIOLOGY, V79, P1210, DOI 10.1097/00000542-199312000-00011; Karmakar MK, 2009, BRIT J ANAESTH, V102, P845, DOI 10.1093/bja/aep079; Khan TH, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0057-6; Konrad C, 1998, ANESTH ANALG, V86, P635; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Lin SP, 2012, BRIT J ANAESTH, V108, P302, DOI 10.1093/bja/aer369; McLeod A, 2005, CAN J ANAESTH, V52, P717, DOI 10.1007/BF03016559; Pepe M. S., 2003, STAT EVALUATION MED; Rathmell JP, 2010, ANESTHESIOLOGY, V113, P1406, DOI 10.1097/ALN.0b013e3181fcee47; Rigg JRA, 2002, LANCET, V359, P1276, DOI 10.1016/S0140-6736(02)08266-1; Scott DB, 1997, REGION ANESTH, V22, P1, DOI 10.1016/S1098-7339(06)80049-0; Ting CK, 2010, OPT EXPRESS, V18, P11138, DOI 10.1364/OE.18.011138; Ting CK, 2010, ANESTHESIOLOGY, V112, P1128, DOI 10.1097/ALN.0b013e3181d3d958; Weste N., 2010, CMOS VLSI DESIGN CIR; Zivojinovic P, 2004, IEEE T INSTRUM MEAS, V53, P102, DOI 10.1109/TIM.2003.821487	18	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106055	10.1371/journal.pone.0106055	http://dx.doi.org/10.1371/journal.pone.0106055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162150	gold, Green Published, Green Submitted			2022-12-25	WOS:000340880900084
J	Ostertag, R; Inman-Narahari, F; Cordell, S; Giardina, CP; Sack, L				Ostertag, Rebecca; Inman-Narahari, Faith; Cordell, Susan; Giardina, Christian P.; Sack, Lawren			Forest Structure in Low-Diversity Tropical Forests: A Study of Hawaiian Wet and Dry Forests	PLOS ONE			English	Article							ABOVEGROUND LIVE BIOMASS; TREE SPECIES RICHNESS; BASAL AREA; FERAL PIGS; DYNAMICS; GROWTH; SOIL; GRADIENT; ECOLOGY; TEMPERATE	The potential influence of diversity on ecosystem structure and function remains a topic of significant debate, especially for tropical forests where diversity can range widely. We used Center for Tropical Forest Science (CTFS) methodology to establish forest dynamics plots in montane wet forest and lowland dry forest on Hawai'i Island. We compared the species diversity, tree density, basal area, biomass, and size class distributions between the two forest types. We then examined these variables across tropical forests within the CTFS network. Consistent with other island forests, the Hawai'i forests were characterized by low species richness and very high relative dominance. The two Hawai'i forests were floristically distinct, yet similar in species richness (15 vs. 21 species) and stem density (3078 vs. 3486/ha). While these forests were selected for their low invasive species cover relative to surrounding forests, both forests averaged 5->50% invasive species cover; ongoing removal will be necessary to reduce or prevent competitive impacts, especially from woody species. The montane wet forest had much larger trees, resulting in eightfold higher basal area and above-ground biomass. Across the CTFS network, the Hawaiian montane wet forest was similar to other tropical forests with respect to diameter distributions, density, and aboveground biomass, while the Hawai` i lowland dry forest was similar in density to tropical forests with much higher diversity. These findings suggest that forest structural variables can be similar across tropical forests independently of species richness. The inclusion of low-diversity Pacific Island forests in the CTFS network provides an similar to 80-fold range in species richness (15-1182 species), six-fold variation in mean annual rainfall (835-5272 mm yr(-1)) and 1.8-fold variation in mean annual temperature (16.0-28.4 degrees C). Thus, the Hawaiian forest plots expand the global forest plot network to enable testing of ecological theory for links among species diversity, environmental variation and ecosystem function.	[Ostertag, Rebecca] Univ Hawaii, Dept Biol, Hilo, HI 96720 USA; [Inman-Narahari, Faith] Univ Hawaii Manoa, Dept Nat Resources & Environm Management, Honolulu, HI 96822 USA; [Cordell, Susan; Giardina, Christian P.] US Forest Serv, Inst Pacific Isl Forestry, Pacific Southwest Res Stn, USDA, Hilo, HI USA; [Sack, Lawren] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	University of Hawaii System; University Hawaii Hilo; University of Hawaii System; University of Hawaii Manoa; United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Los Angeles	Ostertag, R (corresponding author), Univ Hawaii, Dept Biol, Hilo, HI 96720 USA.	ostertag@hawaii.edu	Sack, Lawren/A-5492-2008; Giardina, Christian P/C-3120-2011; Ostertag, Rebecca/B-1756-2013	Sack, Lawren/0000-0002-7009-7202; Giardina, Christian P/0000-0002-3431-5073; Ostertag, Rebecca/0000-0002-5747-3285	National Science Foundation's EPSCoR [0554657, 0903833]; Smithsonian Tropical Research Institute Center for Tropical Forest Science; University of California, Los Angeles	National Science Foundation's EPSCoR; Smithsonian Tropical Research Institute Center for Tropical Forest Science; University of California, Los Angeles(University of California System)	The major funding for this research came from National Science Foundation's EPSCoR Grants No. 0554657 and No. 0903833 to the University of Hawai 'i. Major in-kind support was provided by the Pacific Southwest Research Station of the United States Forest Service. Logistical or financial support that was supplemental was provided for by the Smithsonian Tropical Research Institute Center for Tropical Forest Science, and the University of California, Los Angeles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatangelo KL, 2009, BIOTROPICA, V41, P154, DOI 10.1111/j.1744-7429.2008.00470.x; [Anonymous], 2004, TROPICAL FOREST DIVE; [Anonymous], RAINFALL ATLAS HAWAI; Arens NC, 2001, AM J BOT, V88, P545, DOI 10.2307/2657118; Ashton PS, 2004, TROPICAL FOREST DIVE; Asner GP, 2011, FRONT ECOL ENVIRON, V9, P434, DOI 10.1890/100179; Asner GP, 2009, ECOSYSTEMS, V12, P261, DOI 10.1007/s10021-008-9221-5; Bellingham PJ, 2006, CAN J FOREST RES, V36, P910, DOI 10.1139/X05-308; Bellingham PJ, 2009, J ECOL, V97, P472, DOI 10.1111/j.1365-2745.2009.01479.x; Bellingham PJ, 1999, J VEG SCI, V10, P825, DOI 10.2307/3237307; Bernabe N, 1999, BIOTROPICA, V31, P83, DOI 10.2307/2663961; Brenes-Arguedas T, 2010, OECOLOGIA, P1; Busby PE, 2010, BIOTROPICA, V42, P80, DOI 10.1111/j.1744-7429.2009.00540.x; Chave J, 2006, NATURE, V441, pE1, DOI 10.1038/nature04826; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chiarucci A, 2003, DIVERS DISTRIB, V9, P283, DOI 10.1046/j.1472-4642.2003.00027.x; Chisholm RA, 2013, J ECOL, V101, DOI 10.1111/1365-2745.12132; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Clark DB, 2010, GLOBAL CHANGE BIOL, V16, P747, DOI 10.1111/j.1365-2486.2009.02004.x; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; CLINEBELL RR, 1995, BIODIVERS CONSERV, V4, P56, DOI 10.1007/BF00115314; Cole RJ, 2012, BIOTROPICA, V44, P463, DOI 10.1111/j.1744-7429.2011.00841.x; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; CONDIT R, 1995, TRENDS ECOL EVOL, V10, P18, DOI 10.1016/S0169-5347(00)88955-7; CONDIT R, 1998, TROPICAL FOREST DENS; Condit R, 1998, TROPICAL FOREST CENS; Connell JH, 2000, ECOLOGY, V81, P568, DOI 10.1890/0012-9658(2000)081[0568:SDOTTY]2.0.CO;2; Coomes DA, 2005, J ECOL, V93, P918, DOI 10.1111/j.1365-2745.2005.01012.x; CREWS TE, 1995, ECOLOGY, V76, P1407, DOI 10.2307/1938144; Nogueira SSD, 2007, APPL ANIM BEHAV SCI, V108, P1, DOI 10.1016/j.applanim.2007.03.011; Davidar P, 2005, J BIOGEOGR, V32, P493, DOI 10.1111/j.1365-2699.2005.01165.x; Durand LZ, 2001, AM FERN J, V91, P25, DOI 10.1640/0002-8444(2001)091[0025:GLCASP]2.0.CO;2; Feeley KJ, 2007, ECOL LETT, V10, P461, DOI 10.1111/j.1461-0248.2007.01033.x; Freifelder RR, 1998, BIOTROPICA, V30, P286, DOI 10.1111/j.1744-7429.1998.tb00062.x; Friday JB, 2008, APPL VEG SCI, V11, P471, DOI 10.3170/2008-7-18538; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Ghazoul J., 2010, TROPICAL RAIN FOREST; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Givnish TJ, 1999, J ECOL, V87, P193, DOI 10.1046/j.1365-2745.1999.00333.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Harrison RD, 2011, BIOSCIENCE, V61, P919, DOI 10.1525/bio.2011.61.11.11; Hawkins BA, 2011, J BIOGEOGR, V38, P1253, DOI 10.1111/j.1365-2699.2011.02490.x; Hobbie JE, 2003, BIOSCIENCE, V53, P21, DOI 10.1641/0006-3568(2003)053[0021:TULTER]2.0.CO;2; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hubbell SP, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P8; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hubbell SP, 1986, CONSERVATION BIOL SC, P205; Hubbell Stephen P., 2001, V32, pi; HUENNEKE LF, 1990, BIOL CONSERV, V53, P199, DOI 10.1016/0006-3207(90)90086-5; Hughes RF, 2005, ECOL APPL, V15, P1615, DOI 10.1890/04-0874; Inman-Narahari F, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00164.1; Jones MM, 2007, J VEG SCI, V18, P13, DOI 10.1111/j.1654-1103.2007.tb02511.x; JUVIK SP, 1998, ATLAS HAWAII; Kammesheidt L, 1999, J TROP ECOL, V15, P143, DOI 10.1017/S0266467499000723; Kellner J. R., 2009, ECOL LETT, V12, P1; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Lach L, 2003, ANN MO BOT GARD, V90, P91, DOI 10.2307/3298529; Lehmann A, 2002, BIODIVERS CONSERV, V11, P2217, DOI 10.1023/A:1021398729516; Litton CM, 2006, FOREST ECOL MANAG, V231, P105, DOI 10.1016/j.foreco.2006.05.008; Lugo AE, 2002, SCOPE SER, V60, P195; Mack MC, 2001, ECOL APPL, V11, P1323, DOI 10.1890/1051-0761(2001)011[1323:AOENDB]2.0.CO;2; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Martinez-Yrizar Angelina, 1995, P326, DOI 10.1017/CBO9780511753398.013; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Moles AT, 2011, FUNCT ECOL, V25, P380, DOI 10.1111/j.1365-2435.2010.01814.x; Moore R. B., 1987, US GEOL SURV PROF PA, V1350, P571; Mueller-Dombois D, 2000, LANDSCAPE URBAN PLAN, V51, P147, DOI 10.1016/S0169-2046(00)00105-5; Murphy MJ, 2014, BIOL INVASIONS, V16, P63, DOI 10.1007/s10530-013-0503-2; Nogueira SLG, 2009, BIODIVERS CONSERV, V18, P3677, DOI 10.1007/s10531-009-9680-9; PHILLIPS OL, 1994, P NATL ACAD SCI USA, V91, P2805, DOI 10.1073/pnas.91.7.2805; Price JP, 2004, EVOLUTION, V58, P2185; Price JP, 2002, P ROY SOC B-BIOL SCI, V269, P2429, DOI 10.1098/rspb.2002.2175; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Sagar R, 2006, ENVIRON CONSERV, V33, P256, DOI 10.1017/S0376892906003237; *SAS I, 2005, JMP INTR GUID REL 6; Shiels A, 2010, BIOL INVASIONS, P1; Shiels AB, 2011, BIOL INVASIONS, V13, P781, DOI 10.1007/s10530-010-9868-7; Slik JWF, 2006, J TROP ECOL, V22, P481, DOI 10.1017/S0266467406003324; Slik JWF, 2010, GLOBAL ECOL BIOGEOGR, V19, P50, DOI 10.1111/j.1466-8238.2009.00489.x; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Spies TA, 1998, NORTHWEST SCI, V72, P34; Stegen JC, 2011, GLOBAL ECOL BIOGEOGR, V20, P744, DOI 10.1111/j.1466-8238.2010.00645.x; TANNER EVJ, 1983, BOT J LINN SOC, V87, P213, DOI 10.1111/j.1095-8339.1983.tb00991.x; TERBORGH J, 1985, AM NAT, V126, P760, DOI 10.1086/284452; Thaxton JM, 2010, PAC SCI, V64, P533, DOI 10.2984/64.4.533; Toledo M, 2011, J TROP ECOL, V27, P333, DOI 10.1017/S0266467411000034; Torti SD, 2001, AM NAT, V157, P141, DOI 10.1086/318629; Tosi J, 2002, LIFE ZONE MAPS HAWAI; Vitousek P, 2009, ECOLOGY, V90, P3074, DOI 10.1890/08-0813.1; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475; Wagner WL, 1999, MANUAL FLOWERING PLA, V1; WHITMORE TC, 1998, INTRO TROPICAL RAIN; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x; Williams-Linera G, 2005, BIODIVERS CONSERV, V14, P119, DOI 10.1007/s10531-005-4053-5; Zanne A.E, 2009, DRYAD DATA REPOSITOR, DOI [10.5061/dryad.5234, DOI 10.5061/DRYAD.5234]; Ziegler AC, 2002, HAWAIIAN NATURAL HIS; Zimmerman JK, 2008, LARGE TROPICAL FORES	102	47	47	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e103268	10.1371/journal.pone.0103268	http://dx.doi.org/10.1371/journal.pone.0103268			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162731	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900006
J	Stratton, MS; Staros, M; Budefeld, T; Searcy, BT; Nash, C; Eitel, C; Carbone, D; Handa, RJ; Majdic, G; Tobet, SA				Stratton, Matthew S.; Staros, Michelle; Budefeld, Tomaz; Searcy, Brian T.; Nash, Connor; Eitel, Chad; Carbone, David; Handa, Robert J.; Majdic, Gregor; Tobet, Stuart A.			Embryonic GABA(B) Receptor Blockade Alters Cell Migration, Adult Hypothalamic Structure, and Anxiety-and Depression-Like Behaviors Sex Specifically in Mice	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; GAMMA-AMINOBUTYRIC-ACID; PARAVENTRICULAR NUCLEUS; EXPRESSING NEURONS; CARDIOVASCULAR-DISEASE; POSTNATAL-DEVELOPMENT; LATERAL HYPOTHALAMUS; RAT-BRAIN; STRESS; RESPONSES	Neurons of the paraventricular nucleus of the hypothalamus (PVN) regulate the hypothalamic-pituitary-adrenal (HPA) axis and the autonomic nervous system. Females lacking functional GABA(B) receptors because of a genetic disruption of the R1 subunit have altered cellular characteristics in and around the PVN at birth. The genetic disruption precluded appropriate assessments of physiology or behavior in adulthood. The current study was conducted to test the long term impact of a temporally restricting pharmacological blockade of the GABA(B) receptor to a 7-day critical period (E11-E17) during embryonic development. Experiments tested the role of GABA(B) receptor signaling in fetal development of the PVN and later adult capacities for adult stress related behaviors and physiology. In organotypic slices containing fetal PVN, there was a female specific, 52% increase in cell movement speeds with GABA(B) receptor antagonist treatment that was consistent with a sex-dependent lateral displacement of cells in vivo following 7 days of fetal exposure to GABA(B) receptor antagonist. Anxiety-like and depression-like behaviors, open-field activity, and HPA mediated responses to restraint stress were measured in adult offspring of mothers treated with GABA(B) receptor antagonist. Embryonic exposure to GABA(B) receptor antagonist resulted in reduced HPA axis activation following restraint stress and reduced depression-like behaviors. There was also increased anxiety-like behavior selectively in females and hyperactivity in males. A sex dependent response to disruptions of GABA(B) receptor signaling was identified for PVN formation and key aspects of physiology and behavior. These changes correspond to sex specific prevalence in similar human disorders, namely anxiety disorders and hyperactivity.	[Stratton, Matthew S.; Staros, Michelle; Searcy, Brian T.; Nash, Connor; Eitel, Chad; Tobet, Stuart A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Budefeld, Tomaz; Majdic, Gregor] Univ Ljubljana, Fac Vet, Ctr Anim Genom, Ljubljana, Slovenia; [Carbone, David; Handa, Robert J.] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ USA; [Tobet, Stuart A.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA	Colorado State University; University of Ljubljana; University of Arizona; Colorado State University	Tobet, SA (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	stuart.tobet@colostate.edu		Stratton, Matthew/0000-0002-0963-6422; Nash, Connor/0000-0002-3949-0110	ORWH-NIMH [P50 MH082679]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH082679] Funding Source: NIH RePORTER	ORWH-NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)NIH Office of Research on Women's Health (ORWH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by ORWH-NIMH P50 MH082679. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao AM, 2008, BRAIN RES REV, V57, P531, DOI 10.1016/j.brainresrev.2007.04.005; Bao AM, 2007, NEUROENDOCRINOLOGY, V85, P27, DOI 10.1159/000099832; Behar TN, 2001, CEREB CORTEX, V11, P744, DOI 10.1093/cercor/11.8.744; Carbone DL, 2012, BRAIN RES, V1477, P19, DOI 10.1016/j.brainres.2012.08.020; Crandall JE, 2007, J NEUROSCI, V27, P3813, DOI 10.1523/JNEUROSCI.5124-06.2007; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Cryan JF, 2010, ADV PHARMACOL, V58, P427, DOI 10.1016/S1054-3589(10)58016-5; Dodd J, 2005, CURR OPIN NEUROBIOL, V15, P1, DOI 10.1016/j.conb.2005.01.019; Epperson CN, 2006, PSYCHOPHARMACOLOGY, V186, P425, DOI 10.1007/s00213-006-0313-7; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ferguson AV, 2008, EXPERT OPIN THER TAR, V12, P717, DOI 10.1517/14728222.12.6.717 ; FLUGGE G, 1986, INT J DEV NEUROSCI, V4, P319, DOI 10.1016/0736-5748(86)90049-3; FRANKFURT M, 1984, NEUROSCI LETT, V50, P245, DOI 10.1016/0304-3940(84)90493-2; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Ghose S, 2011, BRIT J PHARMACOL, V162, P1, DOI 10.1111/j.1476-5381.2010.01004.x; Goldstein JM, 2014, FRONT NEUROENDOCRIN, V35, P140, DOI 10.1016/j.yfrne.2013.12.001; Hahn JD, 2010, BRAIN RES REV, V64, P14, DOI 10.1016/j.brainresrev.2010.02.002; Heldt SA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.101; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Holsen LM, 2011, J AFFECT DISORDERS, V131, P379, DOI 10.1016/j.jad.2010.11.024; Inada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027048; Kalueff AV, 2007, DEPRESS ANXIETY, V24, P495, DOI 10.1002/da.20262; Kasckow JW, 2001, PEPTIDES, V22, P845, DOI 10.1016/S0196-9781(01)00399-0; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; KERR DIB, 1988, NEUROSCI LETT, V92, P92, DOI 10.1016/0304-3940(88)90748-3; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Kugaya A, 2003, BIOL PSYCHIAT, V54, P792, DOI 10.1016/S0006-3223(02)01788-2; Lasarge CL, 2009, NEUROSCIENCE, V164, P941, DOI 10.1016/j.neuroscience.2009.08.055; Lund TD, 2006, J NEUROSCI, V26, P1448, DOI 10.1523/JNEUROSCI.3777-05.2006; Luscher B, 2011, MOL PSYCHIATR, V16, P383, DOI 10.1038/mp.2010.120; Mann EO, 2009, J NEUROSCI, V29, P7513, DOI 10.1523/JNEUROSCI.6162-08.2009; Mcclellan KM, 2008, NEUROSCIENCE, V151, P1119, DOI 10.1016/j.neuroscience.2007.11.048; McClellan KM, 2010, J COMP NEUROL, V518, P2710, DOI 10.1002/cne.22360; Mombereau C, 2005, NEUROREPORT, V16, P307, DOI 10.1097/00001756-200502280-00021; Mombereau C, 2004, NEUROPSYCHOPHARMACOL, V29, P1050, DOI 10.1038/sj.npp.1300413; Peyron C, 1998, J NEUROSCI, V18, P9996; Prosser J, 1997, J CHILD ADOL PSYCHOP, V7, P181, DOI 10.1089/cap.1997.7.181; Pyner S, 2009, J CHEM NEUROANAT, V38, P197, DOI 10.1016/j.jchemneu.2009.03.005; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; RISOLD PY, 1994, J COMP NEUROL, V348, P1, DOI 10.1002/cne.903480102; SMITH OA, 1990, AM J PHYSIOL, V259, pR943, DOI 10.1152/ajpregu.1990.259.5.R943; Smoller JW, 2001, AM J MED GENET, V105, P226, DOI 10.1002/ajmg.1328; Steininger TL, 2004, J CHEM NEUROANAT, V27, P165, DOI 10.1016/j.jchemneu.2004.02.007; Stevens HE, 2013, PSYCHONEUROENDOCRINO, V38, P509, DOI 10.1016/j.psyneuen.2012.07.011; Stork O, 2000, BRAIN RES, V865, P45, DOI 10.1016/S0006-8993(00)02206-X; Stratton MS, 2011, PHYSIOL BEHAV, V104, P327, DOI 10.1016/j.physbeh.2011.01.003; Sundman-Eriksson I, 2002, J AFFECT DISORDERS, V71, P29, DOI 10.1016/S0165-0327(01)00349-4; Thompson M, 2009, J PSYCHIATR RES, V43, P970, DOI 10.1016/j.jpsychires.2009.02.005; Tobet SA, 2013, PFLUG ARCH EUR J PHY, V465, P585, DOI 10.1007/s00424-013-1248-6; Tobet SA, 2003, INTEGR COMP BIOL, V43, P794, DOI 10.1093/icb/43.6.794; Utge S, 2010, AM J MED GENET B, V153B, P468, DOI 10.1002/ajmg.b.31002; Viveros MP, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00084; Wang SS, 2008, MOL PSYCHIATR, V13, P786, DOI 10.1038/mp.2008.38; Weiser MJ, 2009, NEUROSCIENCE, V159, P883, DOI 10.1016/j.neuroscience.2008.12.058	55	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106015	10.1371/journal.pone.0106015	http://dx.doi.org/10.1371/journal.pone.0106015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162235	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900077
J	Wickham, S; Taylor, P; Shevlin, M; Bentall, RP				Wickham, Sophie; Taylor, Peter; Shevlin, Mark; Bentall, Richard P.			The Impact of Social Deprivation on Paranoia, Hallucinations, Mania and Depression: The Role of Discrimination Social Support, Stress and Trust	PLOS ONE			English	Article							INCOME INEQUALITY; MENTAL-HEALTH; PSYCHOLOGICAL-RESEARCH; PERSECUTORY DELUSIONS; SCHIZOPHRENIA; PSYCHOSIS; RISK; ASSOCIATIONS; NEIGHBORHOOD; POPULATION	The negative implications of living in a socially unequal society are now well documented. However, there is poor understanding of the pathways from specific environmental risk to symptoms. Here we examine the associations between social deprivation, depression, and psychotic symptoms using the 2007 Adult Psychiatric Morbidity Survey, a cross-sectional dataset including 7,353 individuals. In addition we looked at the mediating role of stress, discrimination, trust and lack of social support. We found that the participants' neighbourhood index of multiple deprivation (IMD) significantly predicted psychosis and depression. On inspection of specific psychotic symptoms, IMD predicted paranoia, but not hallucinations or hypomania. Stress and trust partially mediated the relationship between IMD and paranoid ideation. Stress, trust and a lack of social support fully mediated the relationship between IMD and depression. Future research should focus on the role deprivation and social inequalities plays in specific manifestations of psychopathology and investigate mechanisms to explain those associations that occur. Targeting the mediating mechanisms through appropriate psychological intervention may go some way to dampen the negative consequences of living in an unjust society; ameliorating economic injustice may improve population mental health.	[Wickham, Sophie; Taylor, Peter; Bentall, Richard P.] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Shevlin, Mark] Univ Ulster, Sch Psychol, Coleraine BT52 1SA, Londonderry, North Ireland	University of Liverpool; Ulster University	Wickham, S (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England.	slw@liverpool.ac.uk	Shevlin, Mark/I-3242-2017	Shevlin, Mark/0000-0001-6262-5223; /0000-0002-7515-2979; Taylor, Peter/0000-0003-1407-0985	University of Liverpool	University of Liverpool	The first author has carried out this work with funding received from the University of Liverpool to carry out her PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Andersen I, 2009, J EPIDEMIOL COMMUN H, V63, P575, DOI 10.1136/jech.2008.082719; Aylaz R, 2012, ARCH GERONTOL GERIAT, V55, P548, DOI 10.1016/j.archger.2012.03.006; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barry Brian., 2002, UNDERSTANDING SOCIAL, P13; BEBBINGTON P, 1995, INT J METHOD PSYCH, V5, P11; Belle D, 2003, PSYCHOL WOMEN QUART, V27, P101, DOI 10.1111/1471-6402.00090; Bentall R.P., 2003, MADNESS EXPLAINED PS; Bentall RP, 2012, SCHIZOPHRENIA BULL, V38, P734, DOI 10.1093/schbul/sbs049; Bentall RP, 2001, CLIN PSYCHOL REV, V21, P1143, DOI 10.1016/S0272-7358(01)00106-4; BENTALL RP, 1990, PSYCHOL BULL, V107, P82, DOI 10.1037/0033-2909.107.1.82; Brookwell ML, 2013, PSYCHOL MED, V43, P2465, DOI 10.1017/S0033291712002760; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Brugha T, 2009, ADULT PSYCHIAT MORBI; Bullock JG, 2010, J PERS SOC PSYCHOL, V98, P550, DOI 10.1037/a0018933; Burns JK, 2008, SOC PSYCH PSYCH EPID, V43, P331, DOI 10.1007/s00127-008-0308-2; Burns JK, 2014, INT J SOC PSYCHIATR, V60, P185, DOI 10.1177/0020764013481426; Combs DR, 2006, J BLACK PSYCHOL, V32, P87, DOI 10.1177/0095798405283175; Cooper C, 2008, BRIT J PSYCHIAT, V192, P185, DOI 10.1192/bjp.bp.107.042291; Croudace TJ, 2000, PSYCHOL MED, V30, P177, DOI 10.1017/S0033291799001464; Crump C, 2011, ANN EPIDEMIOL, V21, P231, DOI 10.1016/j.annepidem.2011.01.005; Cuijpers P, 2008, J CONSULT CLIN PSYCH, V76, P909, DOI 10.1037/a0013075; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Dorling D., 2011, SO YOU THINK YOU KNO; Dorling D., 2010, INJUSTICE WHY SOCIAL; Ellett L, 2008, SCHIZOPHR RES, V99, P77, DOI 10.1016/j.schres.2007.10.027; Fone DL, 2006, HEALTH PLACE, V12, P332, DOI 10.1016/j.healthplace.2005.02.002; Freeman D, 2011, PSYCHOL MED, V41, P923, DOI 10.1017/S0033291710001546; Freeman D, 2002, BRIT J CLIN PSYCHOL, V41, P331, DOI 10.1348/014466502760387461; Fryers Tom, 2005, Clin Pract Epidemiol Ment Health, V1, P14; Galea S, 2007, ANN EPIDEMIOL, V17, P171, DOI 10.1016/j.annepidem.2006.07.008; Gayer-Anderson C, 2013, EPIDEMIOL PSYCH SCI, V22, P131, DOI 10.1017/S2045796012000406; Gilman SE, 2013, SOC PSYCH PSYCH EPID, V48, P59, DOI 10.1007/s00127-012-0575-9; GOLDBERG EM, 1963, BRIT J PSYCHIAT, V109, P785, DOI 10.1192/bjp.109.463.785; Grav S, 2012, J CLIN NURS, V21, P111, DOI 10.1111/j.1365-2702.2011.03868.x; Harper DJ, 2011, HEALTH SOCIOL REV, V20, P423, DOI 10.5172/hesr.2011.20.4.423; Harrison G, 2003, PSYCHOL MED, V33, P723, DOI 10.1017/S0033291703007591; Harrison G, 2001, BRIT J PSYCHIAT, V179, P346, DOI 10.1192/bjp.179.4.346; Heinz A, 2013, WORLD PSYCHIATRY, V12, P187, DOI 10.1002/wps.20056; Johnson SL, 2000, J ABNORM PSYCHOL, V109, P721, DOI 10.1037/0021-843X.109.4.721; Kay AC, 2009, J PERS SOC PSYCHOL, V97, P421, DOI 10.1037/a0015997; Kaymaz N, 2007, J AFFECT DISORDERS, V98, P55, DOI 10.1016/j.jad.2006.06.028; Kim D, 2008, SOC SCI MED, V66, P1719, DOI 10.1016/j.socscimed.2007.12.030; Kirkbride James B, 2014, Schizophr Bull, V40, P169, DOI 10.1093/schbul/sbs151; Kirkbride JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031660; Kirkbride JB, 2011, SCHIZOPHRENIA BULL, V37, P262, DOI 10.1093/schbul/sbq120; Kirkbride JB, 2010, ADVANCES IN SCHIZOPHRENIA RESEARCH 2009, P67, DOI 10.1007/978-1-4419-0913-8_4; Lee H, 2011, SOCIOL COMPASS, V5, P215, DOI 10.1111/j.1751-9020.2010.00355.x; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lorant V, 2007, BRIT J PSYCHIAT, V190, P293, DOI 10.1192/bjp.bp.105.020040; Marmot MG, 2006, JAMA-J AM MED ASSOC, V295, P1304, DOI 10.1001/jama.295.11.1304; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Marmot MG, 2010, STRATEG REV HEAL INE; Marwaha S, 2014, SCHIZOPHRENIA BULL, V40, P269, DOI 10.1093/schbul/sbt149; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013; MIROWSKY J, 1983, AM SOCIOL REV, V48, P228, DOI 10.2307/2095107; Muthen L.K., MPLUS USERS GUIDE, V8th; Nettle D, 2014, PEERJ, V2, DOI 10.7717/peerj.236; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Oher FJ, 2014, PSYCHOL MED, V44, P2419, DOI 10.1017/S0033291713003188; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Rippy AE, 2006, J MUSLIM MENT HEALTH, V1, P5, DOI 10.1080/15564900600654351; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SCLOVE SL, 1987, PSYCHOMETRIKA, V52, P333, DOI 10.1007/BF02294360; Selten JP, 2013, SCHIZOPHRENIA BULL, V39, P1180, DOI 10.1093/schbul/sbt134; Selten JP, 2005, BRIT J PSYCHIAT, V187, P101, DOI 10.1192/bjp.187.2.101; Sherazi R, 2006, HARVARD REV PSYCHIAT, V14, P273, DOI 10.1080/10673220601070047; Singh-Manoux A, 2005, PSYCHOSOM MED, V67, P855, DOI 10.1097/01.psy.0000188434.52941.a0; Sitko K, 2014, PSYCHIAT RES, V217, P202, DOI 10.1016/j.psychres.2014.03.019; Toynbee P, 2008, UNJUST REWARDS ENDIN; Tsai KY, 2014, SOC PSYCH PSYCH EPID, V49, P89, DOI 10.1007/s00127-013-0716-9; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Varma VK, 1997, ACTA PSYCHIAT SCAND, V96, P431, DOI 10.1111/j.1600-0447.1997.tb09944.x; Veling W, 2013, CURR OPIN PSYCHIATR, V26, P166, DOI 10.1097/YCO.0b013e32835d9e43; Walker EF, 1997, PSYCHOL REV, V104, P667, DOI 10.1037/0033-295X.104.4.667; Walker E, 2008, ANNU REV CLIN PSYCHO, V4, P189, DOI 10.1146/annurev.clinpsy.4.022007.141248; Wickham S, 2014, J PUBLIC MENT HEALTH, V13, P114, DOI 10.1108/JPMH-06-2013-0049; Wicks S, 2005, AM J PSYCHIAT, V162, P1652, DOI 10.1176/appi.ajp.162.9.1652; Wicks S, 2010, AM J PSYCHIAT, V167, P1240, DOI 10.1176/appi.ajp.2010.09010114; Wilkinson R., 2009, SPIRIT LEVEL; Wilkinson RG, 2009, ANNU REV SOCIOL, V35, P493, DOI 10.1146/annurev-soc-070308-115926; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Wykes T, 2008, SCHIZOPHRENIA BULL, V34, P523, DOI 10.1093/schbul/sbm114; Yolken RH, 2008, MOL PSYCHIATR, V13, P470, DOI 10.1038/mp.2008.5; Zimmerman FJ, 2006, J EPIDEMIOL COMMUN H, V60, P513, DOI 10.1136/jech.2005.040154	86	81	82	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105140	10.1371/journal.pone.0105140	http://dx.doi.org/10.1371/journal.pone.0105140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8UR	25162703	gold, Green Submitted, Green Published			2022-12-25	WOS:000340880900027
J	Chen, MF; Li, Y; Liu, H; Fu, X; Yu, YX; Yu, GQ; Wang, C; Bao, FF; Liany, H; Wang, ZZ; Shi, ZX; Zhang, DZ; Zhou, GZ; Liu, JJ; Zhang, FR				Chen, Mingfei; Li, Yi; Liu, Hong; Fu, Xi'an; Yu, Yiongxiang; Yu, Gongqi; Wang, Chuan; Bao, Fangfang; Liany, Herty; Wang, Zhenzhen; Shi, Zhongxiang; Zhang, Dizhan; Zhou, Guizhi; Liu, Jianjun; Zhang, Furen			Analysis of POFUT1 Gene Mutation in a Chinese Family with Dowling-Degos Disease	PLOS ONE			English	Article								Dowling-Degos disease (DDD) is an autosomal dominant genodermatosis characterized by reticular pigmented anomaly mainly affecting flexures. Though KRT5 has been identified to be the causal gene of DDD, the heterogeneity of this disease was displayed: for example, POFUT1 and POGLUT1 were recently identified and confirmed to be additional pathogenic genes of DDD. To identify other DDD causative genes, we performed genome-wide linkage and exome sequencing analyses in a multiplex Chinese DDD family, in which the KRT5 mutation was absent. Only a novel 1-bp deletion (c.246+5delG) in POFUT1 was found. No other novel mutation or this deletion was detected in POFUT1 in a second DDD family and a sporadic DDD case by Sanger Sequencing. The result shows the genetic-heterogeneity and complexity of DDD and will contribute to the further understanding of DDD genotype/phenotype correlations and to the pathogenesis of this disease.	[Chen, Mingfei] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Chen, Mingfei] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Chen, Mingfei; Liu, Hong; Fu, Xi'an; Yu, Yiongxiang; Yu, Gongqi; Wang, Chuan; Bao, Fangfang; Wang, Zhenzhen; Zhou, Guizhi; Zhang, Furen] Shandong Prov Inst Dermatol & Venereol, Jinan, Shandong, Peoples R China; [Li, Yi; Liany, Herty; Liu, Jianjun] Genome Inst Singapore, Dept Human Genet, Singapore, Singapore; [Shi, Zhongxiang; Zhang, Dizhan; Zhang, Furen] Shandong Prov Hosp Skin Dis, Jinan, Shandong, Peoples R China; [Chen, Mingfei; Liu, Hong; Fu, Xi'an; Yu, Yiongxiang; Yu, Gongqi; Wang, Chuan; Bao, Fangfang; Wang, Zhenzhen; Zhang, Furen] Shandong Prov Key Lab Dermatovenereol, Jinan, Shandong, Peoples R China; [Shi, Zhongxiang; Zhang, Dizhan; Zhou, Guizhi; Zhang, Furen] Shandong Prov Med Ctr Dermatovenereol, Jinan, Shandong, Peoples R China	Anhui Medical University; Anhui Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences	Zhang, FR (corresponding author), Shandong Prov Inst Dermatol & Venereol, Jinan, Shandong, Peoples R China.	zhangfuren@hotmail.com	Liu, Jianjun/AAK-4989-2020	Liu, Jianjun/0000-0002-3255-3019	Natural Science Foundation of Shandong Province [ZR2011HQ003, ZR2011HQ037]; Project of Taishan scholar; Project of clinical center for Dermatology and Venereology of Shandong Province; Project of Research Foundation of Shandong Provincial Institute of Dermatology and Venereology [2008-7]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Project of Taishan scholar; Project of clinical center for Dermatology and Venereology of Shandong Province; Project of Research Foundation of Shandong Provincial Institute of Dermatology and Venereology	This work was supported by Natural Science Foundation of Shandong Province (ZR2011HQ003, ZR2011HQ037), to FZ; Project of Taishan scholar (2008-), to FZ; Project of clinical center for Dermatology and Venereology of Shandong Province (2010-), to FZ; and Project of Research Foundation of Shandong Provincial Institute of Dermatology and Venereology (2008-7), to FZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Asahina A, 2007, ACTA DERM-VENEREOL, V87, P556, DOI 10.2340/00015555-0313; Basmanav FB, 2014, AM J HUM GENET, V94, P135, DOI 10.1016/j.ajhg.2013.12.003; Betz RC, 2006, AM J HUM GENET, V78, P510, DOI 10.1086/500850; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Chen WJ, 2011, NAT GENET, V43, P1252, DOI 10.1038/ng.1008; DEGOS R, 1954, Ann Dermatol Syphiligr (Paris), V81, P147; Dowling G B, 1938, Proc R Soc Med, V31, P1147; Eng L, 2004, HUM MUTAT, V23, P67, DOI 10.1002/humu.10295; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2013, AM J HUM GENET, V92, P1014, DOI 10.1016/j.ajhg.2013.05.016; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087250; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; REBORA A, 1984, BRIT J DERMATOL, V110, P627; Schouwey K, 2007, DEV DYNAM, V236, P282, DOI 10.1002/dvdy.21000; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Yang J, 2013, MOL NEUROBIOL, V47, P957, DOI 10.1007/s12035-012-8392-4; Yao D, 2011, BLOOD, V117, P5652, DOI 10.1182/blood-2010-12-326074	18	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104496	10.1371/journal.pone.0104496	http://dx.doi.org/10.1371/journal.pone.0104496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157627	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200013
J	Lambert, JE; Fellner, V; McKenney, E; Hartstone-Rose, A				Lambert, Joanna E.; Fellner, Vivek; McKenney, Erin; Hartstone-Rose, Adam			Binturong (Arctictis binturong) and Kinkajou (Potos flavus) Digestive Strategy: Implications for Interpreting Frugivory in Carnivora and Primates	PLOS ONE			English	Article							IN-VITRO FERMENTATION; DIETARY FIBER; GASTROINTESTINAL-TRACT; SEED DISPERSAL; SPIDER MONKEYS; FECAL INOCULUM; GUT PASSAGE; TRADE-OFFS; FOOD; ENERGY	Exclusive frugivory is rare. As a food resource, fruit is temporally and spatially patchy, low in protein, and variable in terms of energy yield from different carbohydrate types. Here, we evaluate the digestive physiology of two frugivorous Carnivora species (Potos flavus, Arctictis binturong) that converge with primates in a diversity of ecological and anatomical traits related to fruit consumption. We conducted feeding trials to determine mean digestive retention times (MRT) on captive animals at the Carnivore Preservation Trust (now Carolina Tiger Rescue), Pittsboro, NC. Fecal samples were collected on study subjects for in vitro analysis to determine methane, pH, and short chain fatty acid profiles; fiber was assayed using standard neutral detergent (NDF) and acid detergent (ADF) fiber methods. Results indicate that both carnivoran species have rapid digestive passage for mammals that consume a predominantly plant-based diet: A. binturong MRT = 6.5 hrs (0.3); P. flavus MRT = 2.5 hrs (1.6). In vitro experiments revealed no fermentation of structural polysaccharides - methane levels did not shift from 0 h to either 24 or 48 hours and no short chain fatty acids were detected. In both species, however, pH declined from one incubation period to another suggesting acidification and bacterial activity of microbes using soluble carbohydrates. A comparison with primates indicates that the study species are most similar in digestive retention times to Ateles - the most frugivorous anthropoid primate taxon.	[Lambert, Joanna E.] Univ Texas San Antonio, Dept Anthropol, San Antonio, TX 78249 USA; N Carolina State Univ, Dept Anim Sci, Raleigh, NC 27695 USA; [McKenney, Erin] Duke Univ, Dept Biol, Durham, NC USA; [Hartstone-Rose, Adam] Univ S Carolina, Dept Cell Biol & Anat, Columbia, SC 29208 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of North Carolina; North Carolina State University; Duke University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Lambert, JE (corresponding author), Univ Texas San Antonio, Dept Anthropol, San Antonio, TX 78249 USA.	joanna.lambert@utsa.edu	Hartstone-Rose, Adam/AAU-3332-2020; Hartstone-Rose, Adam/I-3503-2016	Hartstone-Rose, Adam/0000-0001-5307-5573; Fellner, Vivek/0000-0001-6498-7666; McKenney, Erin/0000-0001-9874-1146	University of Texas at San Antonio	University of Texas at San Antonio	The University of Texas at San Antonio provided financial support for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFIK D, 1995, ECOLOGY, V76, P2247, DOI 10.2307/1941699; [Anonymous], 1999, WALKERS MAMMALS WORL; AOAC, 1995, OFF METH AN AOAC INT; Bjornhag G, 1989, Acta Vet Scand Suppl, V86, P204; Blaine KP, 2012, INTEGR ZOOL, V7, P183, DOI 10.1111/j.1749-4877.2012.00282.x; Brockman DK, 2005, CAM S BIO EVOL ANTHR, V44, P1, DOI 10.1017/CBO9780511542343; BRYANT MP, 1953, J DAIRY SCI, V36, P205, DOI 10.3168/jds.S0022-0302(53)91482-9; Campbell JL, 2002, J NUTR, V132, P3073, DOI 10.1093/jn/131.10.3073; CHAPMAN C, 1987, FOLIA PRIMATOL, V49, P90, DOI 10.1159/000156311; CHIVERS DJ, 1980, J MORPHOL, V166, P337, DOI 10.1002/jmor.1051660306; CLEMENS E, 1980, COMP BIOCHEM PHYS A, V66, P529, DOI 10.1016/0300-9629(80)90204-2; Colon CP, 2013, RAFFLES B ZOOL, V61, P417; Delorme M, 1999, J COMP PHYSIOL B, V169, P123, DOI 10.1007/s003600050202; Depauw S, 2013, J ANIM PHYSIOL AN N, V97, P146, DOI 10.1111/j.1439-0396.2011.01252.x; Di Fiore A, 2010, PRIMATES PERSPECTIVE, P155; DIERENFELD ES, 1982, J NUTR, V112, P636, DOI 10.1093/jn/112.4.636; Djossa Bruno A., 2008, Ecotropica (Bonn), V14, P37; Doran D, 1997, INT J PRIMATOL, V18, P183, DOI 10.1023/A:1026368518431; Edwards MS, 1999, ZOO BIOL, V18, P537, DOI 10.1002/(SICI)1098-2361(1999)18:6&lt;537::AID-ZOO8&gt;3.0.CO;2-F; Felton AM, 2009, BEHAV ECOL, V20, P685, DOI 10.1093/beheco/arp021; Felton AM, 2009, FUNCT ECOL, V23, P70, DOI 10.1111/j.1365-2435.2008.01526.x; Foley WJ, 2000, J COMP PHYSIOL B, V170, P345, DOI 10.1007/s003600000109; FORD L S, 1988, Mammalian Species, P1, DOI 10.2307/3504086; Ganzhorn JU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008253; Graae BJ, 2003, ARCT ANTARCT ALP RES, V36, P468; Hanya G, 2006, PRIMATES, V47, P275, DOI 10.1007/s10329-005-0176-2; IZHAKI I, 1989, OIKOS, V54, P23, DOI 10.2307/3565893; Janson C. H., 1999, PRIMATE COMMUNITIES; Julien-Laferriere D, 1999, J ZOOL, V247, P71, DOI 10.1111/j.1469-7998.1999.tb00194.x; JULIENLAFERRIERE D, 1993, J TROP ECOL, V9, P19, DOI 10.1017/S0266467400006908; Karasov W. H., 2007, PHYSL ECOLOGY ANIMAL; KARASOV WH, 1992, AM J PHYSIOL, V263, pR496, DOI 10.1152/ajpregu.1992.263.3.R496; KARASOV WH, 1990, PHYSIOL ZOOL, V63, P1248, DOI 10.1086/physzool.63.6.30152643; Karasov WH, 2013, COMPR PHYSIOL, V3, P741, DOI 10.1002/cphy.c110054; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; Kay Robin N. B., 1994, P229; Kays RW, 1995, BIOTROPICA, V27, P530, DOI 10.2307/2388969; Kays RW, 1999, J MAMMAL, V80, P589, DOI 10.2307/1383303; Kleiman DV, 1997, WILD MAMMALS CAPTIVI; Koenig A, 1998, BEHAV ECOL SOCIOBIOL, V42, P225, DOI 10.1007/s002650050434; Kortlucke S. M., 1973, OCCASIONAL PAPERS MU, V17, P1; Lambert F, 1990, PRIMATES, V17, P1; Lambert JE, 1998, EVOL ANTHROPOL, V7, P8, DOI 10.1002/(SICI)1520-6505(1998)7:1<8::AID-EVAN3>3.3.CO;2-J; Lambert JE, 1999, AM J PHYS ANTHROPOL, V109, P365, DOI 10.1002/(SICI)1096-8644(199907)109:3&lt;365::AID-AJPA6&gt;3.0.CO;2-Q; Lambert JE, 2002, INT J PRIMATOL, V23, P1169, DOI 10.1023/A:1021166502098; Lambert JE, 2001, PRIMATES PERSPECTIVE, P512; Lambert JE, 2002, GUENONS DIVERSITY AD, P303; Lambert JE, 2012, INT J PRIMATOL, V33, P263, DOI 10.1007/s10764-011-9559-y; Link A, 2006, J TROP ECOL, V22, P235, DOI 10.1017/S0266467405003081; MAISELS F, 1993, FOLIA PRIMATOL, V61, P35, DOI 10.1159/000156725; Martin R.D., 1985, P61; MASON VC, 1969, J AGR SCI, V73, P99, DOI 10.1017/S0021859600024175; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; MCNAB BK, 1995, J MAMMAL, V76, P206, DOI 10.2307/1382329; MILTON K, 1988, J NUTR, V118, P1082, DOI 10.1093/jn/118.9.1082; MILTON K, 1983, COMP BIOCHEM PHYS A, V74, P29, DOI 10.1016/0300-9629(83)90706-5; MILTON K, 1981, AM NAT, V117, P496, DOI 10.1086/283730; Milton K, 1984, ADAPTATIONS FORAGING; MULLER E, 1978, ARCH INT PHYSIOL BIO, V86, P153, DOI 10.3109/13813457809069892; MULLER EF, 1983, Z SAUGETIERKD, V48, P217; Overdorff DJ, 1995, CREATURES OF THE DARK, P61; Pocock RI, 1921, P ZOOL SOC LOND, V1921, P389; Remis MJ, 2004, INT J PRIMATOL, V25, P825, DOI 10.1023/B:IJOP.0000029124.04610.c7; Rothman JM, 2012, INT J PRIMATOL, V33, P542, DOI 10.1007/s10764-011-9568-x; Rothman JM, 2011, BIOL LETTERS, V7, P847, DOI 10.1098/rsbl.2011.0321; Russo SE, 2004, ECOL LETT, V7, P1058, DOI 10.1111/j.1461-0248.2004.00668.x; Schwab C, 2011, CANADIAN J MICROBIOL, V57; Sela DA, 2010, BIFIDOBACTERIA: GENOMICS AND MOLECULAR ASPECTS, P45; Stephens CE, 1995, COMP PHYSL VETEBRATE; Sunvold GD, 1995, J ANIM SCI, V73, P3639; VanSoest PJ, 1996, ZOO BIOL, V15, P455, DOI 10.1002/(SICI)1098-2361(1996)15:5<455::AID-ZOO3>3.0.CO;2-A; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Warner A. C. I., 1981, Nutrition Abstracts and Reviews, B, V51, P789; Watts DP, 2012, AM J PRIMATOL, V74, P114, DOI 10.1002/ajp.21016; WRANGHAM RW, 1991, PHILOS T ROY SOC B, V334, P171, DOI 10.1098/rstb.1991.0106	76	18	18	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105415	10.1371/journal.pone.0105415	http://dx.doi.org/10.1371/journal.pone.0105415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157614	Green Submitted, gold, Green Published			2022-12-25	WOS:000341303200031
J	Huyghe, D; Nakamura, Y; Terunuma, M; Faideau, M; Haydon, P; Pangalos, MN; Moss, SJ				Huyghe, Deborah; Nakamura, Yasuko; Terunuma, Miho; Faideau, Mathilde; Haydon, Philip; Pangalos, Menelas N.; Moss, Stephen J.			Glutamine Synthetase Stability and Subcellular Distribution in Astrocytes Are Regulated by gamma-Aminobutyric Type B Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATIVE GABA(B) RECEPTORS; TEMPORAL-LOBE EPILEPSY; EXPRESSION; PROTEIN; TRAFFICKING; DEFICIENCY; SUBUNITS; CORTEX; BRAIN; REDISTRIBUTION	Emerging evidence suggests that functional gamma-aminobutyric acid B receptors (GABA(B)Rs) are expressed by astrocytes within the mammalian brain. GABA(B)Rs are heterodimeric G-protein-coupled receptors that are composed of R1/R2 subunits. To date, they have been characterized in neurons as the principal mediators of sustained inhibitory signaling; however their roles in astrocytic physiology have been ill defined. Here we reveal that the cytoplasmic tail of the GABA(B)R2 subunit binds directly to the astrocytic protein glutamine synthetase (GS) and that this interaction determines the subcellular localization of GS. We further demonstrate that the binding of GS to GABA(B)R2 increases the steady state expression levels of GS in heterologous cells and in mouse primary astrocyte culture. Mechanistically this increased stability of GS in the presence of GABA(B)R2 occurs via reduced proteasomal degradation. Collectively, our results suggest a novel role for GABA(B)Rs as regulators of GS stability. Given the critical role that GS plays in the glutamineglutamate cycle, astrocytic GABA(B)Rs may play a critical role in supporting both inhibitory and excitatory neurotransmission.	[Huyghe, Deborah; Nakamura, Yasuko; Haydon, Philip; Moss, Stephen J.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Terunuma, Miho] Univ Leicester, Dept Cell Physiol & Pharmacol, Coll Med Biol Sci & Psychol, Leicester LE1 9HN, Leics, England; [Faideau, Mathilde] Lund Univ, Dept Expt Dementia Res, SE-22100 Lund, Sweden; [Pangalos, Menelas N.] AstraZeneca, Innovat Med, Alderley Pk SK10 4TF, Cheshire, England; [Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6B, England	Tufts University; University of Leicester; Lund University; AstraZeneca; University of London; University College London	Moss, SJ (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.	Stephen.Moss@Tufts.edu	Nakamura, Yasuko/O-5551-2016	Nakamura, Yasuko/0000-0002-0660-4126; Terunuma, Miho/0000-0003-1876-9726	National Institutes of Health-NINDS Grants [NS051195, NS056359, NS081735]; NIH-NIMH Grant [MH097446]; Simons Foundation [206026]; American Heart Association [09SDG2260557]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051195, R01NS081986, R01NS056359] Funding Source: NIH RePORTER	National Institutes of Health-NINDS Grants; NIH-NIMH Grant; Simons Foundation; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health-NINDS Grants NS051195, NS056359, NS081735 (to S. J. M.), NIH-NIMH Grant MH097446, (to P. D. and S. J. M.), and a grant from the Simons Foundation (No. 206026 to S. J. M.).; Recipient of a National Scientist Development Grant (09SDG2260557) from the American Heart Association.	Anlauf Enrico, 2013, Front Endocrinol (Lausanne), V4, P144, DOI 10.3389/fendo.2013.00144; Bettler B, 2006, PHARMACOL THERAPEUT, V110, P533, DOI 10.1016/j.pharmthera.2006.03.006; Burbaeva GS, 2005, NEUROCHEM RES, V30, P1443, DOI 10.1007/s11064-005-8654-x; Calver AR, 2001, J NEUROSCI, V21, P1203; Chalifoux JR, 2011, CURR OPIN NEUROBIOL, V21, P339, DOI 10.1016/j.conb.2011.02.004; Charles KJ, 2003, MOL CELL NEUROSCI, V24, P214, DOI 10.1016/S1044-7431(03)00162-3; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; DEROUICHE A, 1991, BRAIN RES, V552, P346, DOI 10.1016/0006-8993(91)90103-3; Eid T, 2012, NEUROCHEM RES, V37, P2339, DOI 10.1007/s11064-012-0766-5; Filippov AK, 2000, J NEUROSCI, V20, P2867; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Haberle J, 2005, NEW ENGL J MED, V353, P1926, DOI 10.1056/NEJMoa050456; Haberle J, 2006, J INHERIT METAB DIS, V29, P352, DOI 10.1007/s10545-006-0256-5; Haberle J, 2011, MOL GENET METAB, V103, P89, DOI 10.1016/j.ymgme.2011.02.001; Hammer J, 2008, GLIA, V56, P856, DOI 10.1002/glia.20659; He YJ, 2010, GLIA, V58, P741, DOI 10.1002/glia.20960; HOSLI E, 1990, EXP BRAIN RES, V80, P621; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Liang SL, 2006, J NEUROSCI, V26, P8537, DOI 10.1523/JNEUROSCI.0329-06.2006; Lunn ML, 2007, NAT NEUROSCI, V10, P1249, DOI 10.1038/nn1953; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; NORENBERG MD, 1979, J HISTOCHEM CYTOCHEM, V27, P756, DOI 10.1177/27.3.39099; Oka M, 2006, BIOCHEM BIOPH RES CO, V341, P874, DOI 10.1016/j.bbrc.2006.01.039; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Papageorgiou IE, 2011, GLIA, V59, P1706, DOI 10.1002/glia.21217; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Saitoh F, 2010, J NEUROSCI, V30, P1204, DOI 10.1523/JNEUROSCI.3591-09.2010; Schousboe Arne, 2013, Front Endocrinol (Lausanne), V4, P102, DOI 10.3389/fendo.2013.00102; SCHWARTZ JP, 1992, GLIA, V5, P75, DOI 10.1002/glia.440050111; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Steffek AE, 2008, SCHIZOPHR RES, V103, P71, DOI 10.1016/j.schres.2008.04.032; Suarez I, 2002, NEUROCHEM INT, V41, P123, DOI 10.1016/S0197-0186(02)00033-5; Taylor PM, 1999, J NEUROSCI, V19, P6360; Thuault SJ, 2004, BIOCHEM PHARMACOL, V68, P1655, DOI 10.1016/j.bcp.2004.07.032; van der Hel WS, 2005, NEUROLOGY, V64, P326, DOI 10.1212/01.WNL.0000149636.44660.99; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x	39	10	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28808	28815		10.1074/jbc.M114.583534	http://dx.doi.org/10.1074/jbc.M114.583534			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25172509	Green Published, hybrid			2022-12-25	WOS:000344141000005
J	Wang, LJ; Huang, HY; Huang, MP; Liou, W; Chang, YT; Wu, CC; Ojcius, DM; Chang, YS				Wang, Li-Jie; Huang, Hsin-Yi; Huang, Meng-Pin; Liou, Willisa; Chang, Ya-Ting; Wu, Chih-Ching; Ojcius, David M.; Chang, Yu-Sun			The Microtubule-associated Protein EB1 Links AIM2 Inflammasomes with Autophagy-dependent Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END-BINDING PROTEIN-1; NLRP3 INFLAMMASOME; CELL-DEATH; ACTIVATION; PHOSPHORYLATION; INTERLEUKIN-1-BETA; IL-1-BETA; RECEPTOR; PROGRAM; PATHWAY	Inflammasomes are multi-protein complexes that regulate chronic inflammation-associated diseases by inducing interleukin-1 beta (IL-1 beta) secretion. Numerous components involved in inflammasome activation have been identified, but the mechanisms of inflammasome-mediated IL-1 beta secretion have not yet been fully explored. Here, we demonstrate that end-binding protein 1 (EB1), which is required for activation of AIM2 inflammasome complex, links the AIM2 inflammasome to autophagy-dependent secretion. Imaging studies revealed that AIM2 inflammasomes colocalize with microtubule organizing centers and autophagosomes. Biochemical analyses showed that poly(dA-dT)-activated AIM2 inflammasomes induce autophagy and IL-1 beta secretion in an LC3-dependent fashion. Furthermore, depletion of EB1 decreases autophagic shedding and intracellular trafficking. Finally, we found that the 5'-AMP activated protein kinase may regulate this EB1-mediated autophagy-based inflammasome-induced secretion of IL-1 beta. These findings reveal a novel EB1-mediated pathway for the secretion of IL-1 beta.	[Wang, Li-Jie; Huang, Meng-Pin; Chang, Ya-Ting; Wu, Chih-Ching; Chang, Yu-Sun] Chang Gung Univ, Mol Med Res Ctr, Coll Med, Taoyuan 333, Taiwan; [Huang, Hsin-Yi; Chang, Yu-Sun] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan 333, Taiwan; [Liou, Willisa] Chang Gung Univ, Dept Anat, Coll Med, Taoyuan 333, Taiwan; [Wu, Chih-Ching] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan 333, Taiwan; [Ojcius, David M.] Univ Calif, Hlth Sci Res Inst, Merced, CA 95343 USA; [Ojcius, David M.] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; University of California System; University of California Merced; University of California System; University of California Merced	Chang, YS (corresponding author), Chang Gung Univ, Mol Med Res Ctr, 259 Wen Hwa 1st Rd, Taoyuan 333, Taiwan.	ysc@mail.cgu.edu.tw	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495; Liou, Willisa/0000-0002-3280-9635; Wu, Chih-Ching/0000-0002-7264-9672; Chang, Yu-Sun/0000-0002-6457-3890	National Science Council of Taiwan [NSC101-2320-B-182-010-MY3, MOST 103-2325-B-182-006]; Ministry of Education of Taiwan [EMRPD1D0031, 1D0631]; Chang Gung Memorial Hospital (Tao-Yuan, Taiwan) [CMRPD1D0101]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education of Taiwan(Ministry of Education, Taiwan); Chang Gung Memorial Hospital (Tao-Yuan, Taiwan)(Chang Gung Memorial Hospital)	This work was supported by Grants NSC101-2320-B-182-010-MY3 and MOST 103-2325-B-182-006 (to Y.-S. C.) from the National Science Council of Taiwan; Grants EMRPD1D0031 and 1D0631 (to Y.-S. C.) from the Ministry of Education of Taiwan; and Grant CMRPD1D0101 (to Y.-S. C.) from the Chang Gung Memorial Hospital (Tao-Yuan, Taiwan).	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; Chen LC, 2012, EMBO MOL MED, V4, P1276, DOI 10.1002/emmm.201201569; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Ferreira JG, 2013, J CELL BIOL, V201, P709, DOI 10.1083/jcb.201301131; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Jiang K, 2011, CURR OPIN CELL BIOL, V23, P94, DOI 10.1016/j.ceb.2010.08.008; Jiang S, 2013, J INNATE IMMUN, V5, P471, DOI 10.1159/000346707; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Korolchuk VI, 2011, AUTOPHAGY, V7, P927, DOI 10.4161/auto.7.8.15862; Lesniewska K, 2014, MOL BIOL CELL, V25, P1025, DOI 10.1091/mbc.E13-08-0504; Liao KC, 2013, INFECT IMMUN, V81, P570, DOI 10.1128/IAI.01003-12; Mackeh R, 2013, J CELL SCI, V126, P1071, DOI 10.1242/jcs.115626; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Martin-Cofreces NB, 2012, EMBO J, V31, P4140, DOI 10.1038/emboj.2012.242; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Messaed C, 2011, J BIOL CHEM, V286, P43313, DOI 10.1074/jbc.M111.306191; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Ponomareva L, 2013, MOL CANCER RES, V11, P1193, DOI 10.1158/1541-7786.MCR-13-0145; Reinholz M, 2013, ARCH DERMATOL RES, V305, P723, DOI 10.1007/s00403-013-1375-0; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Sirois I, 2012, AUTOPHAGY, V8, P927, DOI 10.4161/auto.19768; Stow JL, 2013, NAT REV IMMUNOL, V13, P830, DOI 10.1038/nri3564; Wang LJ, 2012, MOL CELL PROTEOMICS, V11, P1230, DOI 10.1074/mcp.M112.020594; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	39	40	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29322	29333		10.1074/jbc.M114.559153	http://dx.doi.org/10.1074/jbc.M114.559153			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25164813	Green Published, hybrid			2022-12-25	WOS:000344141000045
J	Henning, C; Liehr, K; Girndt, M; Ulrich, C; Glomb, MA				Henning, Christian; Liehr, Kristin; Girndt, Matthias; Ulrich, Christof; Glomb, Marcus A.			Extending the Spectrum of alpha-Dicarbonyl Compounds in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERITONEAL-DIALYSIS FLUIDS; GLYCATION END-PRODUCTS; GLUCOSE DEGRADATION-PRODUCTS; HUMAN SERUM-ALBUMIN; MAILLARD REACTION; DEHYDROASCORBIC ACID; OXIDATIVE STRESS; ASCORBIC-ACID; 1,2-DICARBONYL COMPOUNDS; EXTRACELLULAR-MATRIX	Maillard alpha-dicarbonyl compounds are known as central intermediates in advanced glycation end product (AGE) formation. Glucose is the primary source of energy for the human body, whereas L-threo-ascorbic acid (vitamin C) is an essential nutrient, involved in a variety of enzymatic reactions. Thus, the Maillard degradation of glucose and ascorbic acid is of major importance in vivo. To understand the complex mechanistic pathways of AGE formation, it is crucial to extend the knowledge on plasma concentrations of reactive key alpha-dicarbonyl compounds (e. g. 1-deoxyglucosone). With the present work, we introduce a highly sensitive LC-MS/MS multimethod for human blood plasma based on derivatization with o-phenylenediamine under acidic conditions. The impact of workup and reaction conditions, particularly of pH, was thoroughly evaluated. A comprehensive validation provided the limit of detection, limit of quantitation, coefficients of variation, and recovery rates. The method includes the alpha-dicarbonyls 1-deoxyglucosone, 3-deoxyglucosone, glucosone, Lederer's glucosone, dehydroascorbic acid, 2,3-diketogulonic acid, 1-deoxypentosone, 3-deoxypentosone, 3,4-dideoxypentosone, pentosone, 1-deoxythreosone, 3-deoxythreosone, threosone, methylglyoxal, glyoxal; the alpha-keto-carboxylic acids pyruvic acid and glyoxylic acid; and the dicarboxylic acid oxalic acid. The method was then applied to the analyses of 15 healthy subjects and 24 uremic patients undergoing hemodialysis. The comparison of the results revealed a clear shift in the product spectrum. Inmost cases, the plasma levels of target analytes were significantly higher. Thus, this is the first time that a complete spectrum of alpha-dicarbonyl compounds relevant in vivo has been established. The results provide further insights into the chemistry of AGE formation and will be helpful to find specific markers to differentiate between the various precursors of glycation.	[Henning, Christian; Liehr, Kristin; Glomb, Marcus A.] Univ Halle Wittenberg, Inst Chem Food Chem, D-06120 Halle, Germany; [Girndt, Matthias; Ulrich, Christof] Univ Halle Wittenberg, Dept Internal Med 2, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Glomb, MA (corresponding author), Univ Halle Wittenberg, Inst Chem Food Chem, Kurt Mothes Str 2, D-06120 Halle, Germany.	marcus.glomb@chemie.uni-halle.de	Girndt, Matthias/M-1436-2019	Girndt, Matthias/0000-0003-2823-0847	German Federal Ministry of Education and Research (BMBF) [13N11798]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by German Federal Ministry of Education and Research (BMBF) Project 13N11798.	Ahmed N, 2002, BIOCHEM J, V364, P15, DOI 10.1042/bj3640015; Ankrah NA, 1999, TOXICOL LETT, V109, P61, DOI 10.1016/S0378-4274(99)00114-9; Arribas-Lorenzo G, 2010, J AGR FOOD CHEM, V58, P2966, DOI 10.1021/jf902815p; Arun V, 2009, DYES PIGMENTS, V82, P268, DOI 10.1016/j.dyepig.2009.01.010; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Baynes JW, 2001, EXP GERONTOL, V36, P1527, DOI 10.1016/S0531-5565(01)00138-3; Biemel KM, 2002, J BIOL CHEM, V277, P24907, DOI 10.1074/jbc.M202681200; Chaplen FWR, 1996, ANAL BIOCHEM, V236, P262, DOI 10.1006/abio.1996.0165; Chaplen FWR, 1998, P NATL ACAD SCI USA, V95, P5533, DOI 10.1073/pnas.95.10.5533; Chaplen FWR, 1996, ANAL BIOCHEM, V238, P171, DOI 10.1006/abio.1996.0271; Degen J, 2012, J AGR FOOD CHEM, V60, P7071, DOI 10.1021/jf301306g; Degenhardt T. P., 1998, MAILLARD REACTION FO, P3; Dhar A, 2009, J CHROMATOGR B, V877, P1093, DOI 10.1016/j.jchromb.2009.02.055; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982; Gensberger S, 2012, ANAL BIOANAL CHEM, V403, P2923, DOI 10.1007/s00216-012-5817-x; Glomb MA, 2010, ACS SYM SER, V1042, P35; Glomb MA, 2001, J AGR FOOD CHEM, V49, P5543, DOI 10.1021/jf010148h; Glomb MA, 2001, J AGR FOOD CHEM, V49, P1493, DOI 10.1021/jf001082d; Glomb MA, 2000, CARBOHYD RES, V329, P515, DOI 10.1016/S0008-6215(00)00219-6; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; Glomb MA, 2001, J BIOL CHEM, V276, P41638, DOI 10.1074/jbc.M103557200; Gobert J, 2009, J AGR FOOD CHEM, V57, P8591, DOI 10.1021/jf9019085; Hamada Y, 1996, BIOCHEM BIOPH RES CO, V228, P539, DOI 10.1006/bbrc.1996.1695; Hellwig M, 2010, J AGR FOOD CHEM, V58, P10752, DOI 10.1021/jf102388v; Henning C, 2011, J BIOL CHEM, V286, P44350, DOI 10.1074/jbc.M111.282442; HENSEKE G, 1959, CHEM BER-RECL, V92, P501, DOI 10.1002/cber.19590920236; Karmali A, 2011, APPL BIOCHEM BIOTECH, V163, P906, DOI 10.1007/s12010-010-9094-x; KNECHT KJ, 1992, ARCH BIOCHEM BIOPHYS, V294, P130, DOI 10.1016/0003-9861(92)90146-N; Lapolla A, 2005, ANN NY ACAD SCI, V1043, P217, DOI 10.1196/annals.1333.027; Lapolla A, 2005, MOL NUTR FOOD RES, V49, P685, DOI 10.1002/mnfr.200400093; Linden T, 2001, PERITON DIALYSIS INT, V21, P607; LO TWC, 1994, J BIOL CHEM, V269, P32299; LOPEZANAYA A, 1987, CLIN CHEM, V33, P1874; Lykkesfeldt J, 1997, AM J CLIN NUTR, V65, P959, DOI 10.1093/ajcn/65.4.959; MARGOLIS SA, 1991, AM J CLIN NUTR, V54, pS1315, DOI 10.1093/ajcn/54.6.1315s; Materials Testing Standards Committee NA 062 of the Deutsches Institut fuer Normung (German Institute for Standardization), 1994, 32645 DIN MAT TEST S; MCCANCE DR, 1993, J CLIN INVEST, V91, P2470, DOI 10.1172/JCI116482; MCLELLAN AC, 1992, ANAL BIOCHEM, V206, P17, DOI 10.1016/S0003-2697(05)80005-3; Mirza MA, 2007, ELECTROPHORESIS, V28, P3940, DOI 10.1002/elps.200700129; Mittelmaier S, 2011, ANAL BIOANAL CHEM, V401, P1183, DOI 10.1007/s00216-011-5195-9; Mittelmaier S, 2011, ANAL BIOANAL CHEM, V399, P1689, DOI 10.1007/s00216-010-4456-3; Mittelmaier S, 2010, J CHROMATOGR B, V878, P877, DOI 10.1016/j.jchromb.2010.02.004; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P533, DOI 10.1196/annals.1333.061; Nakayama K, 2008, AM J NEPHROL, V28, P871, DOI 10.1159/000139653; Nemet I, 2011, J BIOL CHEM, V286, P37128, DOI 10.1074/jbc.M111.245100; Niwa T, 1999, J CHROMATOGR B, V731, P23, DOI 10.1016/S0378-4347(99)00113-9; Odani H, 1999, BIOCHEM BIOPH RES CO, V256, P89, DOI 10.1006/bbrc.1999.0221; OTSUKA M, 1986, AGR BIOL CHEM TOKYO, V50, P531, DOI 10.1080/00021369.1986.10867421; Rabbani N, 2012, AMINO ACIDS, V42, P1133, DOI 10.1007/s00726-010-0783-0; Reihl O, 2004, CARBOHYD RES, V339, P483, DOI 10.1016/j.carres.2003.12.004; Rossner J., 2001, Czech Journal of Food Science, V19, P41; Schalkwijk CG, 1999, PERITON DIALYSIS INT, V19, P325; Sell DR, 2005, J BIOL CHEM, V280, P12310, DOI 10.1074/jbc.M500733200; SELL DR, 1992, DIABETES, V41, P1286, DOI 10.2337/diabetes.41.10.1286; SHIN DB, 1990, J CARBOHYD CHEM, V9, P461, DOI 10.1080/07328309008543846; Smuda M, 2013, J AGR FOOD CHEM, V61, P10198, DOI 10.1021/jf305117s; Smuda M, 2013, ANGEW CHEM INT EDIT, V52, P4887, DOI 10.1002/anie.201300399; Smuda M, 2011, J AGR FOOD CHEM, V59, P13254, DOI 10.1021/jf203346b; Smuda M, 2010, J AGR FOOD CHEM, V58, P6458, DOI 10.1021/jf100334r; Sugiyama S, 1998, J AM SOC NEPHROL, V9, P1681; TAKAGI M, 1987, BIOELECTROCH BIOENER, V18, P171, DOI 10.1016/0302-4598(87)85019-5; Tauer A, 2005, MOL NUTR FOOD RES, V49, P710, DOI 10.1002/mnfr.200400111; Tessier FJ, 2012, AMINO ACIDS, V42, P1119, DOI 10.1007/s00726-010-0776-z; Thornalley PJ, 1998, CHEM-BIOL INTERACT, V112, P137, DOI 10.1016/S0009-2797(97)00157-9; Tsukushi S, 1999, KIDNEY INT, V55, P1970, DOI 10.1046/j.1523-1755.1999.00418.x; Vistoli G, 2013, FREE RADICAL RES, V47, P3, DOI 10.3109/10715762.2013.815348; Voigt M, 2009, J AGR FOOD CHEM, V57, P4765, DOI 10.1021/jf900459x; WELLSKNECHT KJ, 1995, BIOCHEMISTRY-US, V34, P3702, DOI 10.1021/bi00011a027	69	71	71	5	82	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28676	28688		10.1074/jbc.M114.563593	http://dx.doi.org/10.1074/jbc.M114.563593			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25164824	Green Published, hybrid			2022-12-25	WOS:000343765400055
J	Westfall, CS; Xu, A; Jez, JM				Westfall, Corey S.; Xu, Ang; Jez, Joseph M.			Structural Evolution of Differential Amino Acid Effector Regulation in Plant Chorismate Mutases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENYLALANINE BIOSYNTHESIS; ALLOSTERIC REGULATION; CRYSTAL-STRUCTURE; YEAST; STATE; MECHANISMS; SEPARATION; ISOENZYMES; SHIKIMATE; ISOZYMES	Chorismate mutase converts chorismate into prephenate for aromatic amino acid biosynthesis. To understand the molecular basis of allosteric regulation in the plant chorismate mutases, we analyzed the three Arabidopsis thaliana chorismate mutase isoforms (AtCM1-3) and determined the x-ray crystal structures of AtCM1 in complex with phenylalanine and tyrosine. Functional analyses show a wider range of effector control in the Arabidopsis chorismate mutases than previously reported. AtCM1 is activated by tryptophan with phenylalanine and tyrosine acting as negative effectors; however, tryptophan, cysteine, and histidine activate AtCM3. AtCM2 is a nonallosteric form. The crystal structure of AtCM1 in complex with tyrosine and phenylalanine identifies differences in the effector sites of the allosterically regulated yeast enzyme and the other two Arabidopsis isoforms. Site-directed mutagenesis of residues in the effector site reveals key features leading to differential effector regulation in these enzymes. In AtCM1, mutations of Gly-213 abolish allosteric regulation, as observed in AtCM2. A second effector site position, Gly-149 in AtCM1 and Asp-132 in AtCM3, controls amino acid effector specificity in AtCM1 and AtCM3. Comparisons of chorismate mutases from multiple plants suggest that subtle differences in the effector site are conserved in different lineages and may lead to specialized regulation of this branch point enzyme.	[Westfall, Corey S.; Xu, Ang; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Jez, JM (corresponding author), Washington Univ, Dept Biol, One Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu			United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	Portions of this research were carried out at the Argonne National Laboratory, Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the United States Department of Energy, Office of Biological and Environmental Research (supported by Grant DE-AC02-06CH11357).	Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; BENESOVA M, 1992, PHYTOCHEMISTRY, V31, P2983, DOI 10.1016/0031-9422(92)83431-W; BORNEMANN S, 1995, J BIOL CHEM, V270, P22811, DOI 10.1074/jbc.270.39.22811; CHOOK YM, 1993, P NATL ACAD SCI USA, V90, P8600, DOI 10.1073/pnas.90.18.8600; Colquhoun TA, 2010, PLANT J, V61, P145, DOI 10.1111/j.1365-313X.2009.04042.x; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DAMATO TA, 1984, PLANTA, V162, P104, DOI 10.1007/BF00410205; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Eberhard J, 1996, PLANT J, V10, P815, DOI 10.1046/j.1365-313X.1996.10050815.x; EBERHARD J, 1993, FEBS LETT, V334, P233, DOI 10.1016/0014-5793(93)81718-F; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GILCHRIST DG, 1972, PLANT PHYSIOL, V49, P52, DOI 10.1104/pp.49.1.52; GOERS SK, 1984, PLANTA, V162, P109, DOI 10.1007/BF00410206; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gosset G, 2009, CURR OPIN BIOTECH, V20, P651, DOI 10.1016/j.copbio.2009.09.012; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Helmstaedt K, 2002, P NATL ACAD SCI USA, V99, P6631, DOI 10.1073/pnas.092130899; Kong YF, 2006, J MOL BIOL, V356, P237, DOI 10.1016/j.jmb.2005.10.064; KUROKI GW, 1988, ARCH BIOCHEM BIOPHYS, V260, P616, DOI 10.1016/0003-9861(88)90489-4; KUROKI GW, 1989, PLANT PHYSIOL, V89, P472, DOI 10.1104/pp.89.2.472; LEE AY, 1995, J AM CHEM SOC, V117, P3627, DOI 10.1021/ja00117a038; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mobley EM, 1999, GENE, V240, P115, DOI 10.1016/S0378-1119(99)00423-0; Rippert P, 2009, PLANT PHYSIOL, V149, P1251, DOI 10.1104/pp.108.130070; SCHMIDHEINI T, 1990, BIOCHEMISTRY-US, V29, P3660, DOI 10.1021/bi00467a011; Schnappauf G, 1998, P NATL ACAD SCI USA, V95, P2868, DOI 10.1073/pnas.95.6.2868; Schnappauf G, 1998, J BIOL CHEM, V273, P17012, DOI 10.1074/jbc.273.27.17012; Stepansky A, 2006, AMINO ACIDS, V30, P121, DOI 10.1007/s00726-005-0246-1; Strater N, 1997, STRUCTURE, V5, P1437, DOI 10.1016/S0969-2126(97)00294-3; Strater N, 1996, P NATL ACAD SCI USA, V93, P3330, DOI 10.1073/pnas.93.8.3330; Tohge T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00062; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; XUE YF, 1994, P NATL ACAD SCI USA, V91, P10814, DOI 10.1073/pnas.91.23.10814; Yi H, 2010, MOL PLANT, V3, P269, DOI 10.1093/mp/ssp112; Yoo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3833; Yu O, 2008, PLANT J, V54, P750, DOI 10.1111/j.1365-313X.2008.03436.x	38	29	29	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28619	28628		10.1074/jbc.M114.591123	http://dx.doi.org/10.1074/jbc.M114.591123			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25160622	Green Published, hybrid			2022-12-25	WOS:000343765400050
J	Alban, SM; de Moura, JF; Thomaz-Soccol, V; Sekula, SB; Alvarenga, LM; Mira, MT; Olortegui, CC; Minozzo, JC				Alban, Silvana Maria; de Moura, Juliana Ferreira; Thomaz-Soccol, Vanete; Sekula, Samira Buehrer; Alvarenga, Larissa Magalhaes; Mira, Marcelo Tavora; Olortegui, Carlos Chavez; Minozzo, Joao Carlos			Phage Display and Synthetic Peptides as Promising Biotechnological Tools for the Serological Diagnosis of Leprosy	PLOS ONE			English	Article							MYCOBACTERIUM-LEPRAE; IDENTIFICATION; ANTIGENS; POINT; TESTS	Background: The diagnosis of leprosy is primarily based on clinical manifestations, and there is no widely available laboratory test for the early detection of this disease, which is caused by Mycobacterium leprae. In fact, early detection and treatment are the key elements to the successful control of leprosy. Methodology/Principal Findings: Peptide ligands for antibodies from leprosy patients were selected from phage-displayed peptide libraries. Three peptide sequences expressed by reactive phage clones were chemically synthesized. Serological assays that used synthetic peptides were evaluated using serum samples from leprosy patients, household contacts (HC) of leprosy patients, tuberculosis patients and endemic controls (EC). A pool of three peptides identified 73.9% (17/23) of multibacillary (MB) leprosy patients using an enzyme-linked immunosorbent assay (ELISA). These peptides also showed some seroreactivities to the HC and EC individuals. The peptides were not reactive to rabbit polyclonal antisera against the different environmental mycobacteria. The same peptides that were conjugated to the carrier protein bovine serum albumin (BSA) induced the production of antibodies in the mice. The anti-peptide antibodies that were used in the Western blotting analysis of M. leprae crude extracts revealed a single band of approximately 30 kDa in one-dimensional electrophoresis and four 30 kDa isoforms in the two-dimensional gel. The Western blotting data indicated that the three peptides are derived from the same bacterial protein. Conclusions/Significance: These new antigens may be useful in the diagnosis of MB leprosy patients. Their potentials as diagnostic reagents must be more extensively evaluated in future studies using a large panel of positive and negative sera. Furthermore, other test approaches using peptides should be assessed to increase their sensitivity and specificity in detecting leprosy patients. We have revealed evidence in support of phage-displayed peptides as promising biotechnological tools for the design of leprosy diagnostic serological assays.	[Alban, Silvana Maria; Thomaz-Soccol, Vanete] Univ Fed Parana, Dept Biotechnol & Bioproc Engn, BR-80060000 Curitiba, Parana, Brazil; [de Moura, Juliana Ferreira] Univ Fed Parana, Basic Pathol Dept, BR-80060000 Curitiba, Parana, Brazil; [Sekula, Samira Buehrer; Alvarenga, Larissa Magalhaes] Univ Fed Goias, Trop Pathol & Publ Hlth Inst, Dept Immunol, Goiania, Go, Brazil; [Mira, Marcelo Tavora] Pontificia Univ Catolica Parana, Sch Med, Hlth Sci Postgrad Program, Curitiba, Parana, Brazil; [Olortegui, Carlos Chavez] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Minozzo, Joao Carlos] Parana State Dept Hlth, Ctr Prod & Res Immunobiol Prod, Piraquara, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana; Universidade Federal de Goias; Pontificia Universidade Catolica do Parana; Universidade Federal de Minas Gerais	Thomaz-Soccol, V (corresponding author), Univ Fed Parana, Dept Biotechnol & Bioproc Engn, BR-80060000 Curitiba, Parana, Brazil.	vanetesoccol@gmail.com	de Moura, Juliana/C-8143-2013; Soccol, Vanete Thomaz/N-9887-2019; Alvarenga, L M/J-2628-2015; Soccol, Vanete Thomaz/F-2392-2015; Mira, Marcelo T/B-5046-2010; Buhrer-Sekula, Samira/H-5115-2012; Chavez Olortegui, Carlos Delfin/F-9227-2019	de Moura, Juliana/0000-0003-1532-2304; Soccol, Vanete Thomaz/0000-0001-9301-541X; Soccol, Vanete Thomaz/0000-0001-9301-541X; Mira, Marcelo T/0000-0002-8087-9400; Alvarenga, Larissa/0000-0002-1756-8183; Buhrer-Sekula, Samira/0000-0002-5984-7770; Chavez Olortegui, Carlos Delfin/0000-0001-9390-7207	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Ministerio da Ciencia, Tecnologia e Inovacao (MCTI) [473061/2007-4]; Fundacao Araucaria, Secretaria de Estado da Ciencia, Tecnologia e Ensino Superior (SETI); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); Fundacao Araucaria, Secretaria de Estado da Ciencia, Tecnologia e Ensino Superior (SETI)(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was financially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br), Ministerio da Ciencia, Tecnologia e Inovacao (MCTI) under grant number 473061/2007-4, grants from the Fundacao Araucaria (www.fundacaoaraucaria.org.br), Secretaria de Estado da Ciencia, Tecnologia e Ensino Superior (SETI) and grant from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) to S.M.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban SM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-42; Alban SM, 2009, LEPROSY REV, V80, P129; Araoz R, 2006, MICROBES INFECT, V8, P2270, DOI 10.1016/j.micinf.2006.04.002; Aseffa A, 2005, LEPROSY REV, V76, P147; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Buhrer-Sekula S, 2007, LEPROSY REV, V78, P70; Stefani MMD, 2008, REV SOC BRAS MED TRO, V41, P89, DOI 10.1590/S0037-86822008000700018; Duthie MS, 2008, CLIN VACCINE IMMUNOL, V15, P1590, DOI 10.1128/CVI.00168-08; Duthie MS, 2007, CLIN VACCINE IMMUNOL, V14, P1400, DOI 10.1128/CVI.00299-07; FILLEY E, 1994, J INFECT DIS, V169, P162, DOI 10.1093/infdis/169.1.162; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Geluk A, 2008, CLIN VACCINE IMMUNOL, V15, P522, DOI 10.1128/CVI.00432-07; Geluk A, 2009, CLIN VACCINE IMMUNOL, V16, P352, DOI 10.1128/CVI.00414-08; Harlow E., 1988, ANTIBODIES LAB MANUA; Lockwood DNJ, 2005, MEDICINE, V33, P26, DOI DOI 10.1383/MEDC.2005.33.7.26; Lyashchenko K, 1998, INFECT IMMUN, V66, P3936, DOI 10.1128/IAI.66.8.3936-3940.1998; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Meyer CG, 1998, TRENDS MICROBIOL, V6, P148, DOI 10.1016/S0966-842X(98)01240-2; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; SOCCOL VT, 2011, Patent No. 015110000997; THOLE JER, 1992, MOL MICROBIOL, V6, P153, DOI 10.1111/j.1365-2958.1992.tb01996.x; Van Regenmortel MHV, 2001, BIOLOGICALS, V29, P209, DOI 10.1006/biol.2001.0308; VONPESSOLANI MC, 1992, INFECT IMMUN, V60, P4452, DOI 10.1128/IAI.60.11.4452-4459.1992; *WHO, 2012, GLOB LEPR SIT 2012; *WHO, 1997, 7 WHO; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; ZWEIG MH, 1993, CLIN CHEM, V39, P561	27	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106222	10.1371/journal.pone.0106222	http://dx.doi.org/10.1371/journal.pone.0106222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170947	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500129
J	Bobulescu, IA; Lotan, Y; Zhang, JN; Rosenthal, TR; Rogers, JT; Adams-Huet, B; Sakhaee, K; Moe, OW				Bobulescu, Ion Alexandru; Lotan, Yair; Zhang, Jianning; Rosenthal, Tara R.; Rogers, John T.; Adams-Huet, Beverley; Sakhaee, Khashayar; Moe, Orson W.			Triglycerides in the Human Kidney Cortex: Relationship with Body Size	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; TUBULE NA+/H+ EXCHANGE; STAGE RENAL-DISEASE; INSULIN-RESISTANCE; MASS INDEX; LIPID-ACCUMULATION; METABOLIC SYNDROME; LIPOTOXICITY; RISK; OBESITY	Obesity is associated with increased risk for kidney disease and uric acid nephrolithiasis, but the pathophysiological mechanisms underpinning these associations are incompletely understood. Animal experiments have suggested that renal lipid accumulation and lipotoxicity may play a role, but whether lipid accumulation occurs in humans with increasing body mass index (BMI) is unknown. The association between obesity and abnormal triglyceride accumulation in non-adipose tissues (steatosis) has been described in the liver, heart, skeletal muscle and pancreas, but not in the human kidney. We used a quantitative biochemical assay to quantify triglyceride in normal kidney cortex samples from 54 patients undergoing nephrectomy for localized renal cell carcinoma. In subsets of the study population we evaluated the localization of lipid droplets by Oil Red O staining and measured 16 common ceramide species by mass spectrometry. There was a positive correlation between kidney cortex trigyceride content and BMI (Spearman R = 0.27, P = 0.04). Lipid droplets detectable by optical microscopy had a sporadic distribution but were generally more prevalent in individuals with higher BMI, with predominant localization in proximal tubule cells and to a lesser extent in glomeruli. Total ceramide content was inversely correlated with triglycerides. We postulate that obesity is associated with abnormal triglyceride accumulation (steatosis) in the human kidney. In turn, steatosis and lipotoxicity may contribute to the pathogenesis of obesity-associated kidney disease and nephrolithiasis.	[Bobulescu, Ion Alexandru; Sakhaee, Khashayar] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Bobulescu, Ion Alexandru; Adams-Huet, Beverley; Sakhaee, Khashayar; Moe, Orson W.] Univ Texas SW Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA; [Lotan, Yair] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Zhang, Jianning; Rosenthal, Tara R.; Rogers, John T.; Moe, Orson W.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Adams-Huet, Beverley] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Moe, Orson W.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bobulescu, IA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	Alexandru.Bobulescu@UTSouthwestern.edu		Bobulescu, Ion Alexandru/0000-0002-3994-1567	United States National Institutes of Health (NIH) [K01-DK090282, R01-DK081423]; NIH [R01-DK041612, R01-DK091392, P30DK-07938]; Simmons Family Foundation; Charles and Jane Pak Foundation; UT Southwestern O'Brien Kidney Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091392, R01DK081423, R01DK041612, K01DK090282, F32DK007938] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simmons Family Foundation; Charles and Jane Pak Foundation; UT Southwestern O'Brien Kidney Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the United States National Institutes of Health (NIH) grants K01-DK090282 (to IAB) and R01-DK081423 (to KS). OWM was supported by NIH grants R01-DK041612 and R01-DK091392, the Simmons Family Foundation, and the Charles and Jane Pak Foundation. The authors also acknowledge support from the research cores of the UT Southwestern O'Brien Kidney Research Center, supported by NIH grant P30DK-07938. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balson KR, 1996, J INTERN MED, V240, P157, DOI 10.1046/j.1365-2796.1996.501855000.x; Bobulescu IA, 2008, AM J PHYSIOL-RENAL, V294, pF1315, DOI 10.1152/ajprenal.00550.2007; Bobulescu IA, 2009, AM J PHYSIOL-RENAL, V297, pF1419, DOI 10.1152/ajprenal.00177.2009; Bobulescu IA, 2007, AM J PHYSL REN UNPUB; Bobulescu IA, 2010, CURR OPIN NEPHROL HY, V19, P393, DOI 10.1097/MNH.0b013e32833aa4ac; DANNO H, 1992, J NUTR SCI VITAMINOL, V38, P517, DOI 10.3177/jnsv.38.517; Daudon M, 2006, UROL RES, V34, P193, DOI 10.1007/s00240-006-0042-8; DRUILHET RE, 1978, INT J BIOCHEM, V9, P729, DOI 10.1016/0020-711X(78)90040-X; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gjone E, 1981, Adv Nephrol Necker Hosp, V10, P167; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Graner M, 2013, J CLIN ENDOCR METAB, V98, P1189, DOI 10.1210/jc.2012-3190; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; GUBLER MC, 1978, KIDNEY INT, V13, P223, DOI 10.1038/ki.1978.32; Hammer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062209; HOVIG T, 1978, LAB INVEST, V38, P540; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Janssen I, 2004, AM J CLIN NUTR, V79, P379; JENNETTE JC, 1990, AM J KIDNEY DIS, V16, P432, DOI 10.1016/S0272-6386(12)80055-2; Kumar V, 2012, ROBBINS BASIC PATHOL; Lingvay I, 2009, J CLIN ENDOCR METAB, V94, P4070, DOI 10.1210/jc.2009-0584; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Maalouf NM, 2004, KIDNEY INT, V65, P1422, DOI 10.1111/j.1523-1755.2004.00522.x; MAGIL AB, 1989, LAB INVEST, V61, P404; Muoio DM, 2010, BBA-MOL CELL BIOL L, V1801, P281, DOI 10.1016/j.bbalip.2009.11.007; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; Rasband W.S., 1997, IMAGE J; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sakhoee K, 2008, SEMIN NEPHROL, V28, P174, DOI 10.1016/j.semnephrol.2008.01.010; Sam R, 2006, AM J KIDNEY DIS, V47, P539, DOI 10.1053/j.ajkd.2005.12.031; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Suganami T, 2012, ENDOCR J, V59, P849, DOI 10.1507/endocrj.EJ12-0271; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Thomas EL, 2013, PROG NUCL MAG RES SP, V73, P56, DOI 10.1016/j.pnmrs.2013.04.001; Thomas EL, 2005, GUT, V54, P122, DOI 10.1136/gut.2003.036566; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Vivante A, 2012, ARCH INTERN MED, V172, P1644, DOI 10.1001/2013.jamainternmed.85; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023; Wickman C, 2013, SEMIN NEPHROL, V33, P14, DOI 10.1016/j.semnephrol.2012.12.006; Zoccali C, 2011, J RENAL NUTR, V21, P87, DOI 10.1053/j.jrn.2010.10.014	48	49	49	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e101285	10.1371/journal.pone.0101285	http://dx.doi.org/10.1371/journal.pone.0101285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170827	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500004
J	Butters, TD; Castro, SJ; Lowe, T; Zhang, YM; Lei, M; Withers, PJ; Zhang, HG				Butters, Timothy D.; Castro, Simon J.; Lowe, Tristan; Zhang, Yanmin; Lei, Ming; Withers, Philip J.; Zhang, Henggui			Optimal Iodine Staining of Cardiac Tissue for X-Ray Computed Tomography	PLOS ONE			English	Article							IMAGE-BASED MODEL; ELECTRICAL ACTIVATION; MYOCARDIAL DENSITY; MICROCT; DISEASE	X-ray computed tomography (XCT) has been shown to be an effective imaging technique for a variety of materials. Due to the relatively low differential attenuation of X-rays in biological tissue, a high density contrast agent is often required to obtain optimal contrast. The contrast agent, iodine potassium iodide (I2KI), has been used in several biological studies to augment the use of XCT scanning. Recently I2KI was used in XCT scans of animal hearts to study cardiac structure and to generate 3D anatomical computer models. However, to date there has been no thorough study into the optimal use of I2KI as a contrast agent in cardiac muscle with respect to the staining times required, which has been shown to impact significantly upon the quality of results. In this study we address this issue by systematically scanning samples at various stages of the staining process. To achieve this, mouse hearts were stained for up to 58 hours and scanned at regular intervals of 6-7 hours throughout this process. Optimal staining was found to depend upon the thickness of the tissue; a simple empirical exponential relationship was derived to allow calculation of the required staining time for cardiac samples of an arbitrary size.	[Butters, Timothy D.; Castro, Simon J.; Zhang, Henggui] Univ Manchester, Sch Phys & Astron, Manchester, Greater Manches, England; [Lowe, Tristan; Withers, Philip J.] Univ Manchester, Sch Mat Sci, Manchester, Greater Manches, England; [Zhang, Yanmin; Lei, Ming] Univ Manchester, Fac Med & Human Sci, Inst Cardiovasc Sci, Manchester, Greater Manches, England; [Zhang, Yanmin; Lei, Ming] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, Oxon, England	University of Manchester; University of Manchester; University of Manchester; University of Oxford	Zhang, HG (corresponding author), Univ Manchester, Sch Phys & Astron, Manchester, Greater Manches, England.	henggui.zhang@manchester.ac.uk	Withers, Phil/A-6760-2009; Zhang, Henggui/AAM-1043-2020; Zhang, Henggui/D-6712-2011; Lei, Ming/S-7209-2016	Withers, Phil/0000-0002-1946-5647; Lei, Ming/0000-0002-0928-341X	EPSRC [EP/J00958X/1, EP/F007906/1, EP/F001452/1, EP/I02249X/1]; MRC [G1002647] Funding Source: UKRI; British Heart Foundation [PG/11/59/29006] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I02249X/1, EP/F007906/1, EP/J00958X/1, EP/F001452/1] Funding Source: researchfish; Medical Research Council [G1002647] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an EPSRC project grant (EP/J00958X/1) and The Manchester Henry Moseley X-ray Imaging Facility was funded in part by the EPSRC (grants EP/F007906/1, EP/F001452/1, and EP/I02249X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslanidi OV, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0069; Aslanidi OV, 2013, IEEE T MED IMAGING, V32, P8, DOI 10.1109/TMI.2012.2209183; Ayache N, 2009, LECT NOTES COMPUTER, V5528, DOI [10.1007/978-3-642-01932-6, DOI 10.1007/978-3-642-01932-6]; Benson AP, 2011, INTERFACE FOCUS, V1, P101, DOI 10.1098/rsfs.2010.0005; Butters TD, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0067; Colman MA, 2013, J PHYSIOL-LONDON, V591, P4249, DOI 10.1113/jphysiol.2013.254987; Dewulf W, SENSE NONSENSE BEAM; Ford WR, 1997, CAN J PHYSIOL PHARM, V75, P1075, DOI 10.1139/cjpp-75-9-1075; GERDES AM, 1995, J MOL CELL CARDIOL, V27, P849, DOI 10.1016/0022-2828(95)90000-4; Guterl KA, 2007, AM J PHYSIOL-HEART C, V293, pH3707, DOI 10.1152/ajpheart.00296.2007; Haibo Ni, 2013, EXTRACTING MYOFIBRE; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Jelicks LA, 2011, ADV PARASIT, V75, P193, DOI 10.1016/B978-0-12-385863-4.00009-5; KAJSTURA J, 1995, CIRCULATION, V92, P2306, DOI 10.1161/01.CIR.92.8.2306; LASCHI R, 1986, SCAN ELECTRON MICROS, V1986, P193; Masugata H, 1999, ULTRASOUND MED BIOL, V25, P1459, DOI 10.1016/S0301-5629(99)00091-5; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Modesti PA, 2004, HYPERTENSION, V43, P101, DOI 10.1161/01.HYP.0000104720.76179.18; Schuster A, 2012, INTERV MED APPL SCI, V4, P186, DOI 10.1556/IMAS.4.2012.4.3; Stephenson RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035299; Sun YL, 2013, 7 INT C ADV COMP ENG; Trinh L, 2013, CHEM ENG SCI, V101, P470, DOI 10.1016/j.ces.2013.06.053; Vickerton P, 2013, J ANAT, V223, P185, DOI 10.1111/joa.12068; Vinnakota KC, 2004, AM J PHYSIOL-HEART C, V286, pH1742, DOI 10.1152/ajpheart.00478.2003; Zhao JC, 2012, IEEE ENG MED BIO, P6365, DOI 10.1109/EMBC.2012.6347450; Zhao JC, 2013, IEEE T MED IMAGING, V32, P18, DOI 10.1109/TMI.2012.2227776; Zhao JC, 2012, CIRC-ARRHYTHMIA ELEC, V5, P361, DOI 10.1161/CIRCEP.111.967950	27	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105552	10.1371/journal.pone.0105552	http://dx.doi.org/10.1371/journal.pone.0105552			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170844	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500059
J	Chen, QW; Cheng, CS; Chen, H; Ning, ZY; Tang, SF; Zhang, X; Zhu, XY; Vargulick, S; Shen, YH; Hua, YQ; Xie, J; Shi, WD; Gao, HF; Xu, LT; Feng, LY; Lin, JH; Chen, Z; Liu, LM; Ping, B; Meng, ZQ				Chen, Qi-wen; Cheng, Chien-shan; Chen, Hao; Ning, Zhou-yu; Tang, Shi-feng; Zhang, Xun; Zhu, Xiao-yan; Vargulick, Sonya; Shen, Ye-hua; Hua, Yong-qiang; Xie, Jing; Shi, Wei-dong; Gao, Hui-feng; Xu, Li-tao; Feng, Lan-yun; Lin, Jun-hua; Chen, Zhen; Liu, Lu-ming; Ping, Bo; Meng, Zhi-qiang			Effectiveness and Complications of Ultrasound Guided Fine Needle Aspiration for Primary Liver Cancer in a Chinese Population with Serum alpha-Fetoprotein Levels <= 200 ng/ml - A Study Based on 4,312 Patients	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; BIOPSY; METASTASIS; DIAGNOSIS; LESIONS	Background: Hepatocellular carcinoma (HCC) can be diagnosed by noninvasive approaches with serum a-fetoprotein (AFP) levels >200 ng/ml and/or a radiological imaging study of tumor mass >2 cm in patients with chronic liver disease. Percutaneous fine needle aspiration (FNA) under ultrasound (US) guidance has a diagnostic specificity of 95% and is superior to radiological imaging studies. Aim: The aim of this study is to elucidate the effectiveness and complications of fine needle aspiration in a Chinese population with primary liver cancer and AFP levels <= 200 ng/ml. Materials and Methods: A retrospective study was conducted over a period of 28 years. This selection period included patients with a suspected diagnosis of primary liver cancer whose AFP levels were <= 200 ng/ml and who underwent US-FNA. This data was then analyzed with cytomorphological features correlating with medical history, radiological imaging, AFP, and follow-up information. Results: Of the 1,929 cases with AFP <= 200 mg/ml, 1,756 underwent FNA. Of these, 1,590 cases were determined malignant and the remaining 166 were determined benign. Further, 1,478 malignant cases were diagnosed by FNA alone, and of these, 1,138 were diagnosed as PLC. The sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy of the diagnoses were 92.96%, 100%, 100%, 59.71%, and 93.62% respectively. There was no significant difference in the sensitivity, specificity, PPV and NPV between the subgroups with tumor size <2 cm and >= 2 cm. Major complications included implantation metastasis and hemorrhage. Conclusion: Patients with PLC, especially those who present with an AFP <= 200 ng/ml, should undergo FNA. If negative results are obtained by FNA, it still could be HCC and repeated FNA procedure may be needed if highly suspicious of HCC on imaging study. The superiority of FNA in overall accuracy may outweigh its potential complications, such like hemorrhage and implantation metastasis.	[Chen, Qi-wen; Chen, Hao; Ning, Zhou-yu; Zhu, Xiao-yan; Shen, Ye-hua; Hua, Yong-qiang; Xie, Jing; Shi, Wei-dong; Gao, Hui-feng; Xu, Li-tao; Feng, Lan-yun; Lin, Jun-hua; Chen, Zhen; Liu, Lu-ming; Meng, Zhi-qiang] Fudan Univ, Shanghai Canc Ctr, Dept Integrat Oncol, Shanghai 200433, Peoples R China; [Chen, Qi-wen; Chen, Hao; Ning, Zhou-yu; Zhang, Xun; Zhu, Xiao-yan; Shen, Ye-hua; Hua, Yong-qiang; Xie, Jing; Shi, Wei-dong; Gao, Hui-feng; Xu, Li-tao; Feng, Lan-yun; Lin, Jun-hua; Chen, Zhen; Liu, Lu-ming; Ping, Bo; Meng, Zhi-qiang] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Cheng, Chien-shan] Univ Hong Kong, Sch Chinese Med, Pokfulam, Hong Kong, Peoples R China; [Tang, Shi-feng] Weifang Hosp Tradit Chinese Med, Canc Treatment Ctr, Dept 1, Weifang, Shandong, Peoples R China; [Zhang, Xun] Fudan Univ, Shanghai Canc Ctr, Dept Ultrasound, Shanghai 200433, Peoples R China; [Vargulick, Sonya] Albany Coll Pharm & Hlth Sci, Albany, NY USA; [Ping, Bo] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; University of Hong Kong; Fudan University; Albany College of Pharmacy & Health Sciences; Fudan University	Ping, B (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China.	bping2007@163.com; mengzhq@gmail.com		Chen, Zhen/0000-0002-4502-0801				Ahn Dong-Won, 2011, Korean J Hepatol, V17, P106, DOI 10.3350/kjhep.2011.17.2.106; Bhatia Kunwar S S, 2013, Cancer Imaging, V13, P260, DOI 10.1102/1470-7330.2013.0027; Bialecki Eldad S, 2005, HPB (Oxford), V7, P26, DOI 10.1080/13651820410024049; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Colli A, 2006, AM J GASTROENTEROL, V101, P1939; FORNARI F, 1989, SCAND J GASTROENTERO, V24, P949, DOI 10.3109/00365528909089239; FROEHLICH F, 1993, DIGEST DIS SCI, V38, P1480, DOI 10.1007/BF01308607; ISHIGURO T, 1985, CANCER, V55, P156, DOI 10.1002/1097-0142(19850101)55:1<156::AID-CNCR2820550124>3.0.CO;2-E; Parajuli S, 2011, J PATHOLOGY NEPAL, V1, P17; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; RYD W, 1983, ACTA PATH MICRO IM A, V91, P17; Shimizu A, 2003, RADIOLOGY, V226, P550, DOI 10.1148/radiol.2262011967; Silva MA, 2008, GUT, V57, P1592, DOI 10.1136/gut.2008.149062; Sparchez Zeno, 2005, Rom J Gastroenterol, V14, P379; Trevisani F, 2001, J HEPATOL, V34, P570, DOI 10.1016/S0168-8278(00)00053-2; Tung WC, 2007, LIVER INT, V27, P192, DOI 10.1111/j.1478-3231.2006.01399.x	17	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e101536	10.1371/journal.pone.0101536	http://dx.doi.org/10.1371/journal.pone.0101536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170868	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500005
J	Higa, LM; Curi, BM; Aguiar, RS; Cardoso, CC; De Lorenzi, AG; Sena, SLF; Zingali, RB; Da Poian, AT				Higa, Luiza M.; Curi, Bruno M.; Aguiar, Renato S.; Cardoso, Cynthia C.; De Lorenzi, Andre G.; Sena, Silvia L. F.; Zingali, Russolina B.; Da Poian, Andrea T.			Modulation of alpha-Enolase Post-Translational Modifications by Dengue Virus: Increased Secretion of the Basic Isoforms in Infected Hepatic Cells	PLOS ONE			English	Article							ALZHEIMERS-DISEASE BRAIN; PLASMINOGEN-BINDING; PROTEOMIC ANALYSIS; GLYCOLYTIC ENZYME; IDENTIFICATION; FIBRINOLYSIS; COAGULATION; PROTEINS; PATHOGENESIS; ACTIVATION	Hepatic cells are major sites of dengue virus (DENV) replication and liver injury constitutes a characteristic of severe forms of dengue. The role of hepatic cells in dengue pathogenesis is not well established, but since hepatocytes are the major source of plasma proteins, changes in protein secretion by these cells during infection might contribute to disease progression. Previously, we showed that DENV infection alters the secretion pattern of hepatic HepG2 cells, with alpha-enolase appearing as one of the major proteins secreted in higher levels by infected cells. ELISA analysis demonstrated that DENV infection modulates alpha-enolase secretion in HepG2 cells in a dose-dependent manner, but has no effect on its gene expression and on the intracellular content of the protein as assessed by PCR and western blot analyses, respectively. Two-dimensional western blots showed that both intracellular and secreted forms of alpha-enolase appear as five spots, revealing alpha-enolase isoforms with similar molecular weights but distinct isoeletric points. Remarkably, quantification of each spot content revealed that DENV infection shifts the isoform distribution pattern of secreted alpha-enolase towards the basic isoforms, whereas the intracellular protein remains unaltered, suggesting that post-translational modifications might be involved in alpha-enolase secretion by infected cells. These findings provide new insights into the mechanisms underlying alpha-enolase secretion by hepatic cells and its relationship with the role of liver in dengue pathogenesis. In addition, preliminary results obtained with plasma samples from DENV-infected patients suggest an association between plasma levels of alpha-enolase and disease severity. Since alpha-enolase binds plasminogen and modulates its activation, it is plausible to speculate the association of the increase in alpha-enolase secretion by infected hepatic cells with the haemostatic dysfunction observed in dengue patients including the promotion of fibrinolysis and vascular permeability alterations.	[Higa, Luiza M.; Curi, Bruno M.; Zingali, Russolina B.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, Brazil; [Aguiar, Renato S.; Cardoso, Cynthia C.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil; [De Lorenzi, Andre G.; Sena, Silvia L. F.] Hosp Naval Marcilio Dias, Clin Doencas Infecciosas & Parasitarias, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, Brazil.	dapoian@bioqmed.ufrj.br	Higa, Luiza/W-2698-2019; Aguiar, Renato S/G-3542-2015; Da Poian, Andrea T./V-1699-2019; Cardoso, Cynthia/K-5824-2012	Aguiar, Renato S/0000-0001-5180-3717; Cardoso, Cynthia/0000-0003-0565-7047; Da Poian, Andrea/0000-0002-3969-704X; Zingali, Russolina/0000-0003-3156-6923	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [550114/2010-6, 550137/2010-6]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/102.919/2011, E-26/110.636/2012]; National Institute of Science and Technology in Dengue (INCT-Dengue); International Research Staff Exchange Scheme (FP7-PEOPLE IRSES); project MEMPEPACROSS [FP7-HEALTH-F3-2008-223414]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Institute of Science and Technology in Dengue (INCT-Dengue); International Research Staff Exchange Scheme (FP7-PEOPLE IRSES); project MEMPEPACROSS	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br/, grant numbers 550114/2010-6 and 550137/2010-6); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, http://www.faperj.br/, grant numbers E-26/102.919/2011 and E-26/110.636/2012); National Institute of Science and Technology in Dengue (INCT-Dengue, http://www.icb.ufmg.br/inctemdengue/); and International Research Staff Exchange Scheme (FP7-PEOPLE IRSES), project MEMPEPACROSS (grant number FP7-HEALTH-F3-2008-223414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON RM, 1995, J BIOL CHEM, V270, P27752, DOI 10.1074/jbc.270.46.27752; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469; Bae S, 2012, J IMMUNOL, V189, P365, DOI 10.4049/jimmunol.1102073; Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Butterfield DA, 2009, J NEUROCHEM, V111, P915, DOI 10.1111/j.1471-4159.2009.06397.x; Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x; Cappello P, 2009, INT J CANCER, V125, P639, DOI 10.1002/ijc.24355; Carlos CC, 2005, AM J TROP MED HYG, V73, P435, DOI 10.4269/ajtmh.2005.73.435; Castegna A, 2003, J NEUROCHEM, V85, P1394, DOI 10.1046/j.1471-4159.2003.01786.x; Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x; Ciborowski P, 2007, VIROLOGY, V363, P198, DOI 10.1016/j.virol.2007.01.013; Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189; Conceicao TM, 2010, J INFECTION, V60, P65, DOI 10.1016/j.jinf.2009.10.003; Diaz-Ramos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050477; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0; FUNAHARA Y, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P346; Giovanni P, 2007, BBA-MOL CELL RES, V1773, P1774, DOI 10.1016/j.bbamcr.2007.09.002; Gitlits VM, 2001, J INVEST MED, V49, P138, DOI 10.2310/6650.2001.34040; Guabiraba R, 2013, EUR J IMMUNOL, V43, P1529, DOI 10.1002/eji.201243229; Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018; Higa LM, 2008, BBA-PROTEINS PROTEOM, V1784, P1607, DOI 10.1016/j.bbapap.2008.06.015; Hsiao KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069354; Huang YH, 2001, J MED VIROL, V63, P247, DOI 10.1002/1096-9071(200103)63:3&lt;247::AID-JMV1008&gt;3.0.CO;2-F; IIDA H, 1985, NATURE, V315, P688, DOI 10.1038/315688a0; ISARANGKURA P B, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P331; Jang B, 2012, BIOCHEM J, V445, P183, DOI 10.1042/BJ20120025; Jin X, 2008, BIOCHEM BIOPH RES CO, V371, P804, DOI 10.1016/j.bbrc.2008.04.166; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Krishnamurti C, 2001, AM J TROP MED HYG, V65, P840, DOI 10.4269/ajtmh.2001.65.840; Kumar Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001887; Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234; Lin YL, 2000, J MED VIROL, V60, P425, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;425::AID-JMV10&gt;3.0.CO;2-A; Lopez-Alemany R, 2003, THROMB HAEMOSTASIS, V90, P724, DOI 10.1160/TH03-04-0291; Luplerdlop N, 2006, EMBO REP, V7, P1176, DOI 10.1038/sj.embor.7400814; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Miura N, 2012, EUKARYOT CELL, V11, P1075, DOI 10.1128/EC.00075-12; Moscato S, 2000, EUR J IMMUNOL, V30, P3575, DOI 10.1002/1521-4141(200012)30:12<3575::AID-IMMU3575>3.0.CO;2-#; Newman SF, 2007, J NEUROSCI RES, V85, P1506, DOI 10.1002/jnr.21275; Olver Christine, 2007, V43, P99, DOI 10.1007/978-1-4020-5943-8_7; Onlamoon N, 2010, BLOOD, V115, P1823, DOI 10.1182/blood-2009-09-242990; Orsi FA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-350; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Patramool S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-138; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Perluigi M, 2005, MOL CELL PROTEOMICS, V4, P1849, DOI 10.1074/mcp.M500090-MCP200; Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919; Pontillo A, 2011, INT J RHEUMATOL, V2011, DOI DOI 10.1155/2011/870214; REDLITZ A, 1995, EUR J BIOCHEM, V227, P407, DOI 10.1111/j.1432-1033.1995.tb20403.x; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rosen L, 1999, AM J TROP MED HYG, V61, P720, DOI 10.4269/ajtmh.1999.61.720; Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007; Sha J, 2009, J BACTERIOL, V191, P3095, DOI 10.1128/JB.00005-09; Sosothikul D, 2007, THROMB HAEMOSTASIS, V97, P627, DOI 10.1160/TH06-02-0094; SRICHAIKUL T, 1977, AM J TROP MED HYG, V26, P525, DOI 10.4269/ajtmh.1977.26.525; Takashima M, 2005, PROTEOMICS, V5, P1686, DOI 10.1002/pmic.200401022; Tchankouo-Nguetcheu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013149; Terrier B, 2007, AUTOIMMUN REV, V6, P176, DOI 10.1016/j.autrev.2006.10.004; Thepparit C, 2004, INTERVIROLOGY, V47, P78, DOI 10.1159/000077830; Tomaino B, 2011, J PROTEOME RES, V10, P105, DOI 10.1021/pr100213b; Tsai ST, 2010, EUR J CANCER, V46, P1712, DOI 10.1016/j.ejca.2010.03.018; van Gorp ECM, 2002, J MED VIROL, V67, P549, DOI 10.1002/jmv.10137; van Gorp ECM, 2001, BRIT J HAEMATOL, V113, P94, DOI 10.1046/j.1365-2141.2001.02710.x; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization ROfS-EA, 2011, COMPR GUID PREV CONT; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837; Yang Hong-bo, 2011, Chinese Medical Sciences Journal, V26, P152; Yu LR, 2007, J PROTEOME RES, V6, P4150, DOI 10.1021/pr070152u; Zhou WD, 2010, J PROTEOME RES, V9, P2929, DOI 10.1021/pr901109w	73	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e88314	10.1371/journal.pone.0088314	http://dx.doi.org/10.1371/journal.pone.0088314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171719	Green Submitted, gold, Green Published			2022-12-25	WOS:000341127500001
J	Kacerovsky, M; Musilova, I; Andrys, C; Drahosova, M; Hornychova, H; Rezac, A; Kostal, M; Jacobsson, B				Kacerovsky, Marian; Musilova, Ivana; Andrys, Ctirad; Drahosova, Marcela; Hornychova, Helena; Rezac, Adam; Kostal, Milan; Jacobsson, Bo			Oligohydramnios in Women with Preterm Prelabor Rupture of Membranes and Adverse Pregnancy and Neonatal Outcomes	PLOS ONE			English	Article							AMNIOTIC-FLUID VOLUME; FETAL INFLAMMATORY RESPONSE; PREMATURE RUPTURE; HISTOLOGICAL CHORIOAMNIONITIS; MICROBIAL INVASION; MULTIPLE PROTEINS; RACIAL DISPARITY; GESTATIONAL-AGE; INTERLEUKIN-6; FUNISITIS	Objective: To determine the association between the presence of oligohydramnios, determined as an amniotic fluid index <= 5 cm and the intra-amniotic inflammatory response, fetal inflammatory response and neonatal outcomes in actively managed preterm prelabor rupture of membranes (PPROM). Methods: Women with singleton pregnancies complicated by PPROM at a gestational age of between 24+0 and 36+6 weeks were included in the study. Ultrasound assessments of the amniotic fluid index and evaluation of the amniotic fluid interleukin (IL)-6 levels were performed at admission. The umbilical cord blood IL-6 levels were evaluated after delivery. Results: In total, 74 women were included. The women with oligohydramnios did not have different amniotic fluid IL-6 levels [with oligohydramnios: median 342 pg/mL, interquartile range (IQR) 110-1809 vs. without oligohydramnios: median 256 pg/mL, IQR 122-748; p = 0.71] or umbilical cord blood IL-6 levels (with oligohydramnios: median 8.2 pg/mL, IQR 3.8-146.9 vs. without oligohydramnios: median 5.9 pg/mL, IQR 2.1-27.9; p = 0.14) than those without oligohydramnios. No association between oligohydramnios and neonatal morbidity was found. A correlation between the amniotic fluid index and the interval from rupture of membranes to amniocentesis was observed (rho = -0.34; p = 0.003). Conclusion: The presence of oligohydramnios is not associated with an adverse outcome in actively managed PPROM in singleton pregnancies in the absence of other complications.	[Kacerovsky, Marian; Musilova, Ivana; Rezac, Adam] Charles Univ Prague, Fac Med Hradec Kralove, Univ Hosp Hradec Kralove, Dept Obstet & Gynecol, Hradec Kralove, Czech Republic; [Kacerovsky, Marian] Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic; [Andrys, Ctirad; Drahosova, Marcela] Charles Univ Prague, Fac Med Hradec Kralove, Univ Hosp Hradec Kralove, Dept Clin Immunol & Allergy, Hradec Kralove, Czech Republic; [Hornychova, Helena] Charles Univ Prague, Fac Med Hradec Kralove, Univ Hosp Hradec Kralove, Fingerlands Dept Pathol, Hradec Kralove, Czech Republic; [Kostal, Milan] Univ Hosp Pardubice, Dept Obstet & Gynecol, Pardubice, Czech Republic; [Jacobsson, Bo] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden; [Jacobsson, Bo] Univ Oslo, Dept Publ Hlth, Oslo, Norway	Charles University Prague; University Hospital Hradec Kralove; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; Sahlgrenska University Hospital; University of Oslo	Kacerovsky, M (corresponding author), Charles Univ Prague, Fac Med Hradec Kralove, Univ Hosp Hradec Kralove, Dept Obstet & Gynecol, Hradec Kralove, Czech Republic.	marian.kacerovsky@gmail.com	Jacobsson, Bo/O-8007-2014; Hornychová, Helena/M-9470-2017; Musilová, Ivana Kacerovská/I-6204-2017; Kacerovsky, Marian/ABE-3437-2020; Kacerovsky, Marian/A-7586-2011	Jacobsson, Bo/0000-0001-5079-2374; Hornychová, Helena/0000-0002-2487-1754; Musilová, Ivana Kacerovská/0000-0002-6960-8319; Andrys, Ctirad/0000-0001-6489-8786; Kacerovsky, Marian/0000-0001-9858-7900	Ministry of Health of the Czech Republic [NT14104-5/2013]; Charles University in Prague; Faculty of Medicine in Hradec Kralove, Czech Republic [P37/10]; Faculty Hospital in Hradec Kralove	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Charles University in Prague; Faculty of Medicine in Hradec Kralove, Czech Republic; Faculty Hospital in Hradec Kralove	This work was supported by a grant from the Ministry of Health of the Czech Republic (NT14104-5/2013), Charles University in Prague, the Faculty of Medicine in Hradec Kralove, Czech Republic, project "PRVOUK'' P37/10, and the Faculty Hospital in Hradec Kralove (a long-term organization development plan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beall MH, 2007, PLACENTA, V28, P816, DOI 10.1016/j.placenta.2006.11.009; Cobo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069341; Cobo T, 2013, ACTA OBSTET GYN SCAN, V92, P61, DOI 10.1111/aogs.12028; Cobo T, 2012, J MATERN-FETAL NEO M, V25, P1995, DOI 10.3109/14767058.2012.666592; Cobo T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043677; El-Haieg DO, 2008, BJOG-INT J OBSTET GY, V115, P836, DOI 10.1111/j.1471-0528.2008.01715.x; Espinoza J, 2013, J MATERN-FETAL NEO M, V13, P2; Fortunato SJ, 2004, AM J OBSTET GYNECOL, V190, P1557, DOI 10.1016/j.ajog.2004.03.053; GAUTHIER DW, 1992, OBSTET GYNECOL, V80, P102; HALLAK M, 1993, J REPROD MED, V38, P853; Holst RM, 2007, J MATERN-FETAL NEO M, V20, P885, DOI 10.1080/14767050701752601; Jacobsson B, 2005, BJOG-INT J OBSTET GY, V112, P719, DOI 10.1111/j.1471-0528.2005.00536.x; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P423, DOI 10.1034/j.1600-0412.2003.00157.x; Kacerovsky M, 2013, J MATERN-FETAL NEO M, V26, P795, DOI 10.3109/14767058.2013.765404; Kacerovsky M, 2012, J MATERN-FETAL NEO M, V25, P2014, DOI 10.3109/14767058.2012.671873; Kurdoglu M, 2010, ARCH GYNECOL OBSTET, V281, P601, DOI 10.1007/s00404-009-1147-4; Lee SE, 2010, J PERINAT MED, V38, P39, DOI [10.1515/JPM.2009.123, 10.1515/jpm.2009.123]; Martinez de Tejada B, 2010, BJOG, V113, P1069; Matoba N, 2009, PEDIATRICS, V123, P1320, DOI 10.1542/peds.2008-1222; Menon R, 2008, AM J OBSTET GYNECOL, V198; Menon R, 2008, AM J OBSTET GYNECOL, V533, pe1; Menon R, 2007, REPROD SCI, V14, P253, DOI 10.1177/1933719107301336; Mercer BM, 2006, AM J OBSTET GYNECOL, V194, P438, DOI 10.1016/j.ajog.2005.07.097; Mercer BM, 2005, OBSTET GYN CLIN N AM, V32, P411, DOI 10.1016/j.ogc.2005.03.003; Mercer BM, 2003, OBSTET GYNECOL, V101, P178, DOI 10.1016/S0029-7844(02)02366-9; MOBERG LJ, 1984, OBSTET GYNECOL, V64, P60; Musilova I, 2012, ACTA OBSTET GYN SCAN, V91, P1119, DOI 10.1111/j.1600-0412.2012.01450.x; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Park JS, 2001, AM J OBSTET GYNECOL, V184, P459, DOI 10.1067/mob.2001.109398; PHELAN JP, 1987, J REPROD MED, V32, P540; Piazze J, 2007, J PERINAT MED, V35, P394, DOI 10.1515/JPM.2007.077; ROMERO R, 1993, AM J OBSTET GYNECOL, V169, P839, DOI 10.1016/0002-9378(93)90014-A; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; Tsiartas P, 2013, J MATERN-FETAL NEO M, V26, P1332, DOI 10.3109/14767058.2013.784741; Vermillion ST, 2000, AM J OBSTET GYNECOL, V183, P271, DOI 10.1067/mob.2000.107653; VINTZILEOS AM, 1985, OBSTET GYNECOL, V66, P162; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4; Yoon BH, 1999, AM J OBSTET GYNECOL, V181, P784, DOI 10.1016/S0002-9378(99)70301-7	38	12	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105882	10.1371/journal.pone.0105882	http://dx.doi.org/10.1371/journal.pone.0105882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171293	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500078
J	Kim, H; Kim, JR; Kang, H; Choi, J; Yang, H; Lee, P; Kim, J; Lee, KW				Kim, Heejung; Kim, Jong Rhan; Kang, Heerim; Choi, Jinhwan; Yang, Hee; Lee, Pomjoo; Kim, Jiyoung; Lee, Ki Won			7,8,4 '-Trihydroxyisoflavone Attenuates DNCB-Induced Atopic Dermatitis-Like Symptoms in NC/Nga Mice	PLOS ONE			English	Article							IMMUNE DYSREGULATION; INHIBITS DEVELOPMENT; BARRIER DYSFUNCTION; SKIN BARRIER; MODEL; MECHANISMS; INFLAMMATION; GENISTEIN; SEVERITY; EXTRACT	Atopic dermatitis (AD) is characterized by chronic highly pruritic and relapsing inflammatory skin lesions. Despite its growing prevalence, therapeutic treatments remain limited. Natural immune modulators from herbal extracts or derivatives may be useful for treating AD symptoms. This study examined the effect of 7,8,4'-trihydroxyisoflavone (7,8,4'-THIF), a metabolite of soy isoflavone daidzin, on AD-like symptoms. Repeated epicutaneous application of 2,4-dinitrochlorobenzene (DNCB) was performed on the ear and dorsal skin of NC/Nga mice to induce AD-like symptoms and skin lesions, and 7,8,4'-THIF (200 and 400 nmol) or tacrolimus (100 mu g) was applied topically for 3 weeks to assess their anti-pruritic effects. We found that 7,8,4'-THIF alleviated DNCB-induced AD-like symptoms as quantified by skin lesion, dermatitis score, ear thickness, and scratching behavior. Histopathological analysis demonstrated that 7,8,4'-THIF decreased DNCB-induced eosinophil and mast cell infiltration into skin lesions. We also found that 7,8,4'-THIF significantly alleviated DNCB-induced loss of water through the epidermal layer. In addition to reducing the DNCB-induced increase in serum IgE ,7,8,4'-THIF also lowered skin lesion levels of the chemokine thymus and activation regulated chemokine; Th2 cytokines interleukin (IL)-4, IL-5, and IL-13; and Th1 cytokines IL-12 and interferon-gamma. These results suggest that 7,8,4'-THIF might be a potential therapeutic candidate for the treatment of atopic dermatitis.	[Kim, Heejung; Kim, Jong Rhan; Kang, Heerim; Choi, Jinhwan; Yang, Hee; Lee, Ki Won] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Jong Rhan; Lee, Pomjoo; Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon, South Korea; [Kim, Jiyoung; Lee, Ki Won] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea; [Kim, Jiyoung] Seoul Natl Univ, Coll Vet Med, Res Inst Vet Sci, Toxicol Lab, Seoul, South Korea; [Lee, Ki Won] Seoul Natl Univ, Inst Green Bio Sci & Technol, Res Inst Bio Food Ind, Pyeongchang, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, J (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	jiyoungkim1107@snu.ac.k; kiwon@snu.ac.kr	Lee, Ki Won/M-4114-2018; Kim, Jiyoung/A-9934-2014	Kim, Jiyoung/0000-0002-2999-3320	Next-Generation BioGreen 21 Program [PJ009542]; Rural Development Administration, Republic of Korea; National Leap Research Program [2010-0029233]; National Research Foundation, Ministry of Education, Science and Technology, Republic of Korea; R&D program-Establishment of Infra Structure for Anti-aging Industry Support [N0000697]; Ministry of Trade, Industry and Energy/Korea Institute for the Advancement of Technology, Republic of Korea	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); National Leap Research Program; National Research Foundation, Ministry of Education, Science and Technology, Republic of Korea; R&D program-Establishment of Infra Structure for Anti-aging Industry Support; Ministry of Trade, Industry and Energy/Korea Institute for the Advancement of Technology, Republic of Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ009542), Rural Development Administration, Republic of Korea. This work was supported by the National Leap Research Program (2010-0029233), National Research Foundation, Ministry of Education, Science and Technology, Republic of Korea. This work was also supported by the R&D program-Establishment of Infra Structure for Anti-aging Industry Support (N0000697), Ministry of Trade, Industry and Energy/Korea Institute for the Advancement of Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelova-Fischer I, 2005, BRIT J DERMATOL, V153, P767, DOI 10.1111/j.1365-2133.2005.06697.x; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Blume-Peytavi U, 2011, J EUR ACAD DERMATOL, V25, P508, DOI 10.1111/j.1468-3083.2010.03942.x; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Chen L, 2004, CLIN EXP IMMUNOL, V138, P375, DOI 10.1111/j.1365-2249.2004.02649.x; Chun J, 2007, J FOOD SCI, V72, pM39, DOI 10.1111/j.1750-3841.2007.00276.x; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Duan W, 2003, AM J RESP CRIT CARE, V167, P185, DOI 10.1164/rccm.200205-420OC; ELDRIDGE AC, 1983, J AGR FOOD CHEM, V31, P394, DOI 10.1021/jf00116a052; Elias PM, 2008, J ALLERGY CLIN IMMUN, V121, P1337, DOI 10.1016/j.jaci.2008.01.022; Fujii Y, 2009, SKIN PHARMACOL PHYS, V22, P240, DOI 10.1159/000235551; Grewe M, 1998, IMMUNOL TODAY, V19, P359, DOI 10.1016/S0167-5699(98)01285-7; Hattori K, 2010, J IMMUNOL, V184, P2729, DOI 10.4049/jimmunol.0900215; Hengge UR, 2006, J AM ACAD DERMATOL, V54, P1, DOI 10.1016/j.jaad.2005.01.010; Ikoma A, 2009, J PHARMACOL SCI, V110, P265, DOI 10.1254/jphs.09R05FM; Jin HL, 2009, J INVEST DERMATOL, V129, P31, DOI 10.1038/jid.2008.106; Jung BG, 2010, VET DERMATOL, V21, P184, DOI 10.1111/j.1365-3164.2009.00796.x; Kotani M, 2000, J ALLERGY CLIN IMMUN, V106, P159, DOI 10.1067/mai.2000.107194; Lee CH, 2011, CURR PROBL DERMATOL, V41, P136, DOI 10.1159/000323307; Lee DE, 2011, J BIOL CHEM, V286, P14246, DOI 10.1074/jbc.M110.147348; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Leung DYM, 1997, CLIN EXP IMMUNOL, V107, P25; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Leung DYM, 2001, J AM ACAD DERMATOL, V44, pS1, DOI 10.1067/mjd.2001.109815; LEUNG DYM, 1990, J ALLERGY CLIN IMMUN, V85, P927, DOI 10.1016/0091-6749(90)90079-J; Lo YL, 2012, TOXICOLOGY, V302, P221, DOI 10.1016/j.tox.2012.08.003; Mahn K, 2005, FASEB J, V19, P1755, DOI 10.1096/fj.05-4008fje; Marsella R, 2011, VET DERMATOL, V22, P239, DOI 10.1111/j.1365-3164.2011.00967.x; Oku H, 2001, PHYTOTHER RES, V15, P506, DOI 10.1002/ptr.964; Ong PY, 2006, CURR ALLERGY ASTHM R, V6, P384, DOI 10.1007/s11882-996-0008-5; Pokharel YR, 2008, EVID-BASED COMPL ALT, V5, P173, DOI 10.1093/ecam/nem015; Sakai T, 2006, J NUTR SCI VITAMINOL, V52, P293, DOI 10.3177/jnsv.52.293; Sakai T, 2008, J MED INVESTIG, V55, P167, DOI 10.2152/jmi.55.167; Sandoval-Lopez G, 2001, CLIN EXP ALLERGY, V31, P1809, DOI 10.1046/j.1365-2222.2001.01268.x; Seo MH, 2013, BIOSCI BIOTECH BIOCH, V77, P1245, DOI 10.1271/bbb.120899; SOTER NA, 1989, ALLERGY, V44, P16, DOI 10.1111/j.1398-9995.1989.tb02449.x; Spergel JM, 1999, J CLIN INVEST, V103, P1103, DOI 10.1172/JCI5669; Takano N, 2003, EUR J PHARMACOL, V471, P223, DOI 10.1016/S0014-2999(03)01828-4; Takeda K, 2009, CURR OPIN IMMUNOL, V21, P660, DOI 10.1016/j.coi.2009.09.005; Trautmann A, 2000, J CLIN INVEST, V106, P25, DOI 10.1172/JCI9199; Verdrengh M, 2003, INFLAMM RES, V52, P341, DOI 10.1007/s00011-003-1182-8; Vestergaard C, 1999, J CLIN INVEST, V104, P1097, DOI 10.1172/JCI7613; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; Yamamoto S, 2003, J NATL CANCER I, V95, P906, DOI 10.1093/jnci/95.12.906; Zhang EY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007703; Ziment I, 2000, J ALLERGY CLIN IMMUN, V106, P603, DOI 10.1067/mai.2000.109432	46	33	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e104938	10.1371/journal.pone.0104938	http://dx.doi.org/10.1371/journal.pone.0104938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170825	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500026
J	Kwon, S; Agollah, GD; Wu, G; Sevick-Muraca, EM				Kwon, Sunkuk; Agollah, Germaine D.; Wu, Grace; Sevick-Muraca, Eva M.			Spatio-Temporal Changes of Lymphatic Contractility and Drainage Patterns following Lymphadenectomy in Mice	PLOS ONE			English	Article							NEAR-INFRARED FLUORESCENCE; CANCER-RELATED LYMPHEDEMA; VEGF-C; BREAST-CANCER; SECONDARY LYMPHEDEMA; EXPERIMENTAL-MODEL; NODE DISSECTION; LYMPHANGIOGENESIS; INSUFFICIENCY; IMPACT	Objective: To investigate the redirection of lymphatic drainage post-lymphadenectomy using non-invasive near-infrared fluorescence (NIRF) imaging, and to subsequently assess impact on metastasis. Background: Cancer-acquired lymphedema arises from dysfunctional fluid transport after lymphadenectomy performed for staging and to disrupt drainage pathways for regional control of disease. However, little is known about the normal regenerative processes of the lymphatics in response to lymphadenectomy and how these responses can be accelerated, delayed, or can impact metastasis. Methods: Changes in lymphatic "pumping'' function and drainage patterns were non-invasively and longitudinally imaged using NIRF lymphatic imaging after popliteal lymphadenectomy in mice. In a cohort of mice, B16F10 melanoma was inoculated on the dorsal aspect of the paw 27 days after lymphadenectomy to assess how drainage patterns affect metastasis. Results: NIRF imaging demonstrates that, although lymphatic function and drainage patterns change significantly in early response to popliteal lymph node (PLN) removal in mice, these changes are transient and regress dramatically due to a high regenerative capacity of the lymphatics and co-opting of collateral lymphatic pathways around the site of obstruction. Metastases followed the pattern of collateral pathways and could be detected proximal to the site of lymphadenectomy. Conclusions: Both lymphatic vessel regeneration and co-opting of contralateral vessels occur following lymphadenectomy, with contractile function restored within 13 days, providing a basis for preclinical and clinical investigations to hasten lymphatic repair and restore contractile lymphatic function after surgery to prevent cancer-acquired lymphedema. Patterns of cancer metastasis after lymphadenectomy were altered, consistent with patterns of re-directed lymphatic drainage.	[Kwon, Sunkuk; Agollah, Germaine D.; Wu, Grace; Sevick-Muraca, Eva M.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Ctr Mol Imaging, Houston, TX 77030 USA; [Agollah, Germaine D.] Univ Texas MD Anderson Canc Ctr, Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Kwon, S (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Ctr Mol Imaging, Houston, TX 77030 USA.	sunkuk.kwon@uth.tmc.edu	Sevick-Muraca, Eva M/A-4152-2017	Sevick-Muraca, Eva M/0000-0002-8152-4847	Schissler Foundation Fellowship;  [R21 CA159293];  [R01 CA128919]; NATIONAL CANCER INSTITUTE [R21CA159293, R01CA128919] Funding Source: NIH RePORTER	Schissler Foundation Fellowship; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by R21 CA159293 (S.K.), R01 CA128919 (E.M.S.), and The Schissler Foundation Fellowship (G.D.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich MB, 2012, BIOMED OPT EXPRESS, V3, P1256, DOI 10.1364/BOE.3.001256; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Armer JM, 2005, CANCER INVEST, V23, P76, DOI 10.1081/CNV-200048707; Blum KS, 2013, BREAST CANCER RES TR, V139, P81, DOI 10.1007/s10549-013-2537-7; Bruna J, 2000, EUR J PLAST SURG, V23, P321, DOI 10.1007/s002380000161; Cormier JN, 2010, CANCER-AM CANCER SOC, V116, P5138, DOI 10.1002/cncr.25458; ESCOBARPRIETO A, 1971, AMER J ROENTGENOL RA, V113, P366, DOI 10.2214/ajr.113.2.366; Goldman J, 2005, CIRC RES, V96, P1193, DOI 10.1161/01.RES.0000168918.27576.78; HAN LY, 1985, ANN PLAS SURG, V15, P303, DOI 10.1097/00000637-198510000-00006; HUANG G-K, 1983, Microsurgery, V4, P236; Ikomi F, 2006, MICROCIRCULATION, V13, P365, DOI 10.1080/10739680600745810; Ikomi F, 2008, MICROCIRCULATION, V15, P591, DOI 10.1080/10739680701815538; KANTER MA, 1990, PLAST RECONSTR SURG, V85, P573, DOI 10.1097/00006534-199004000-00012; Kim C, 2003, LYMPHOLOGY, V36, P111; Kwon Sunkuk, 2007, Lymphatic Research and Biology, V5, P219, DOI 10.1089/lrb.2007.1013; Kwon S, 2011, BIOMED OPT EXPRESS, V2, P1403, DOI 10.1364/BOE.2.001403; Lahteenvuo M, 2011, CIRCULATION, V123, P613, DOI 10.1161/CIRCULATIONAHA.110.965384; Lawenda BD, 2009, CA-CANCER J CLIN, V59, P8, DOI 10.3322/caac.20001; Liu YL, 2008, VASC PHARMACOL, V49, P44, DOI 10.1016/j.vph.2008.05.003; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; McLaughlin SA, 2008, J CLIN ONCOL, V26, P5213, DOI 10.1200/JCO.2008.16.3725; Mendez U, 2012, AM J PHYSIOL-HEART C, V303, pH1107, DOI 10.1152/ajpheart.00522.2012; Mendez U, 2012, AM J PHYSIOL-HEART C, V302, pH2250, DOI 10.1152/ajpheart.01159.2011; Mihara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038182; Nakamura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008380; OLSZEWSKI W, 1973, LYMPHOLOGY, V6, P35; Paskett ED, 2012, J CLIN ONCOL, V30, P3726, DOI 10.1200/JCO.2012.41.8574; Rasmussen JC, 2010, TRANSL ONCOL, V3, P362, DOI 10.1593/tlo.10190; Slavin SA, 1999, ANN SURG, V229, P421, DOI 10.1097/00000658-199903000-00017; Szuba A, 2002, FASEB J, V16, P1985, DOI 10.1096/fj.02-0401fje; Szuba A, 1998, Vasc Med, V3, P145, DOI 10.1177/1358836X9800300209; Tabibiazar R, 2006, PLOS MED, V3, P1114, DOI 10.1371/journal.pmed.0030254; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Unno N, 2007, J VASC SURG, V45, P1016, DOI 10.1016/j.jvs.2007.01.023; WANG G-Y, 1985, Microsurgery, V6, P204, DOI 10.1002/micr.1920060404; Yoon Y, 2003, J CLIN INVEST, V111, P717, DOI 10.1172/JCI200315830; Zampell JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049940; Zampell JC, 2011, AM J PHYSIOL-CELL PH, V300, pC1107, DOI 10.1152/ajpcell.00378.2010	39	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106034	10.1371/journal.pone.0106034	http://dx.doi.org/10.1371/journal.pone.0106034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170770	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500091
J	Malki, N; Koupil, I; Eloranta, S; Weibull, CE; Tiikkaja, S; Ingelsson, E; Sparen, P				Malki, Ninoa; Koupil, Ilona; Eloranta, Sandra; Weibull, Caroline E.; Tiikkaja, Sanna; Ingelsson, Erik; Sparen, Par			Temporal Trends in Incidence of Myocardial Infarction and Ischemic Stroke by Socioeconomic Position in Sweden 1987-2010	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; EDUCATIONAL INEQUALITIES; CASE-FATALITY; DISEASE RISK; MORTALITY; TIME; REGISTER; COHORT; WOMEN; MEN	Background: We analyzed temporal trends in the incidence of myocardial infarction and ischemic stroke in Sweden by socioeconomic position and investigated whether social inequalities in incidence of these diseases changed over time. Materials and Methods: We studied a cohort of almost three million Swedish residents born between 1932 and 1960 followed from 1987 until 2010. Incident cases of myocardial infarction and ischemic stroke were identified in the Swedish National Inpatient Register and Cause of Death Register. Socioeconomic position was retrieved from the Population and Housing Censuses. Incidence rates of myocardial infarction and ischemic stroke and incidence rate ratios comparing levels of socioeconomic position were estimated using flexible parametric survival models adjusted for calendar year, attained age, sex, and birth country. Results: The overall incidences of myocardial infarction and ischemic stroke decreased over time among men, but were stable over time among women. With regard to ischemic stroke incidence, socioeconomic inequality increased over time in the age group 55 to 59: the incidence rate ratios for low manual compared to high non-manual increased from 1.3 (95% CI: 1.2-1.4) in 1997 to 1.5 (1.4-1.7) in 2010 among men, and from 1.4 (1.3-1.6) in 1997 to 2.1 (1.8-2.5) in 2010 among women. The socioeconomic inequality in incidence of myocardial infarction was stable over time for both men and women. Conclusion: There was a decrease in myocardial infarction and ischemic stroke incidence over time among men but no significant change for women. Our study highlights existing, and in some cases increasing, social inequalities in the incidence of cardiovascular diseases.	[Malki, Ninoa; Eloranta, Sandra; Weibull, Caroline E.; Tiikkaja, Sanna; Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Koupil, Ilona] Stockholm Univ, Karolinska Inst, Ctr Hlth Equity Studies CHESS, S-10691 Stockholm, Sweden; [Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Stockholm University; Uppsala University	Malki, N (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	Ninoa.Malki@ki.se	Eloranta, Sandra/X-6661-2018; Koupil, Ilona/AAC-9067-2020; Weibull, Caroline/AAJ-5755-2020	Koupil, Ilona/0000-0002-7034-1922; Tiikkaja, Sanna/0000-0002-5879-6588; Sparen, Par/0000-0002-5184-8971	Health Care Sciences postgraduate School at Karolinska Institutet [2007/10-530]; Swedish Council for Working Life and Social Research [2006-1518]	Health Care Sciences postgraduate School at Karolinska Institutet; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This work was supported by Health Care Sciences postgraduate School at Karolinska Institutet to N.M. (grant number 2007/10-530). I.K. is funded by the Swedish Council for Working Life and Social Research (grant number 2006-1518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelros P, 2011, ACTA NEUROL SCAND, V123, P289, DOI 10.1111/j.1600-0404.2010.01402.x; Bigert C, 2012, SCANDINAVIAN J WORK; Breen R, 2007, AM J SOCIOL, V112, P1775, DOI 10.1086/508790; Cox AM, 2006, LANCET NEUROL, V5, P181, DOI 10.1016/S1474-4422(06)70351-9; ERIKSON R, 1992, CONSTANT FLUX STUDY, P1; Ernstsen L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-266; Evans A, 2001, INT J EPIDEMIOL, V30, pS35, DOI 10.1093/ije/30.suppl_1.S35; Hedlund E, 2007, EUR J EPIDEMIOL, V22, P493, DOI 10.1007/s10654-007-9147-9; Johansson S, 2010, J INTERN MED, V268, P594, DOI 10.1111/j.1365-2796.2010.02278.x; Koster M, 2013, NEUROEPIDEMIOLOGY, V40, P240, DOI 10.1159/000345953; Kunst A.E., 2004, DEMOGR RES S, V2, P229, DOI [10.4054/demres.2004.s2.9, 10.4054/DemRes.2004.S2.9]; Lammintausta A, 2012, ANN EPIDEMIOL, V22, P87, DOI 10.1016/j.annepidem.2011.10.012; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Manrique-Garcia E, 2011, J EPIDEMIOL COMMUN H, V65, P301, DOI 10.1136/jech.2009.104075; McFadden E, 2008, EUR J EPIDEMIOL, V23, P449, DOI 10.1007/s10654-008-9262-2; Medin J, 2004, STROKE, V35, P1047, DOI 10.1161/01.STR.0000125866.78674.96; Modig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064928; Nichols M., 2012, EUROPEAN CARDIOVASCU; Pampel FC, 2005, SOC SCI RES, V34, P117, DOI 10.1016/j.ssresearch.2003.12.003; Peltonen M, 2000, AM J EPIDEMIOL, V151, P283, DOI 10.1093/oxfordjournals.aje.a010204; Pessah-Rasmussen H, 2003, STROKE, V34, P913, DOI 10.1161/01.STR.0000063365.10841.43; Rosengren A, 2013, STROKE, V44, P2388, DOI 10.1161/STROKEAHA.113.001170; Rostila M, 2012, ORATTVISA HALSAN SOC; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Schmidt M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e356; Scholes S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-129; Statistics Sweden, 1983, SOC IND SEI SWED SOC; Statistics Sweden, 2005, MORT CAUS DEATH S AF, P1; Statistics Sweden, 1985, POP HOUS CENS 1980; STEGMAYR B, 1992, NEUROEPIDEMIOLOGY, V11, P204, DOI 10.1159/000110933; Steptoe A, 2002, EUR HEART J, V23, P13, DOI 10.1053/euhj.2001.2611; Strand BH, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c654; Swedish National Board of Health and Welfare, CAUS DEATH REG; The National Board of Health and Welfare, 2012, MYOC INF SWED 1987 2; Tiikkaja S, 2012, SOC SCI MED, V75, P1883, DOI 10.1016/j.socscimed.2012.06.031; Tuchsen F, 1999, INT J EPIDEMIOL, V28, P640, DOI 10.1093/ije/28.4.640; Yang D, 2012, EUR J PREV CARDIOL, V19, P1304, DOI 10.1177/1741826711425340	38	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105279	10.1371/journal.pone.0105279	http://dx.doi.org/10.1371/journal.pone.0105279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO2EE	25170919	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500040
J	Manis, E; Royer, TV; Johnson, LT; Leff, LG				Manis, Erin; Royer, Todd V.; Johnson, Laura T.; Leff, Laura G.			Denitrification in Agriculturally Impacted Streams: Seasonal Changes in Structure and Function of the Bacterial Community	PLOS ONE			English	Article							DENITRIFYING BACTERIA; HEADWATER STREAMS; NITRATE REMOVAL; HOT MOMENTS; LAND-USE; SOIL; SEDIMENTS; NITRIFICATION; DYNAMICS; PATTERNS	Denitrifiers remove fixed nitrogen from aquatic environments and hydrologic conditions are one potential driver of denitrification rate and denitrifier community composition. In this study, two agriculturally impacted streams in the Sugar Creek watershed in Indiana, USA with different hydrologic regimes were examined; one stream is seasonally ephemeral because of its source (tile drainage), whereas the other stream has permanent flow. Additionally, a simulated flooding experiment was performed on the riparian benches of the ephemeral stream during a dry period. Denitrification activity was assayed using the chloramphenicol amended acetylene block method and bacterial communities were examined based on quantitative PCR and terminal restriction length polymorphisms of the nitrous oxide reductase (nosZ) and 16S rRNA genes. In the stream channel, hydrology had a substantial impact on denitrification rates, likely by significantly lowering water potential in sediments. Clear patterns in denitrification rates were observed among pre-drying, dry, and post-drying dates; however, a less clear scenario was apparent when analyzing bacterial community structure suggesting that denitrifier community structure and denitrification rate were not strongly coupled. This implies that the nature of the response to short-term hydrologic changes was physiological rather than increases in abundance of denitrifiers or changes in composition of the denitrifier community. Flooding of riparian bench soils had a short-term, transient effect on denitrification rate. Our results imply that brief flooding of riparian zones is unlikely to contribute substantially to removal of nitrate (NO3-) and that seasonal drying of stream channels has a negative impact on NO3- removal, particularly because of the time lag required for denitrification to rebound. This time lag is presumably attributable to the time required for the denitrifiers to respond physiologically rather than a change in abundance or community composition.	[Manis, Erin; Leff, Laura G.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Royer, Todd V.; Johnson, Laura T.] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Indiana University System; Indiana University Bloomington	Leff, LG (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.	lleff@kent.edu			NSF [DEB 0743396]	NSF(National Science Foundation (NSF))	This research was supported by NSF grant DEB 0743396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 2009, BIOGEOCHEMISTRY, V93, P91, DOI 10.1007/s10533-008-9274-8; Arango CP, 2008, J N AM BENTHOL SOC, V27, P90, DOI 10.1899/07-024.1; Arango CP, 2007, FRESHWATER BIOL, V52, P1210, DOI 10.1111/j.1365-2427.2007.01758.x; Avrahami S, 2002, APPL ENVIRON MICROB, V68, P5685, DOI 10.1128/AEM.68.11.5685-5692.2002; Baker ME, 2001, J AM WATER RESOUR AS, V37, P1615, DOI 10.1111/j.1752-1688.2001.tb03664.x; Baker NT, 2006, OCCURRENCE TRANSPORT; Baldwin DS, 2000, REGUL RIVER, V16, P457, DOI 10.1002/1099-1646(200009/10)16:5&lt;457::AID-RRR597&gt;3.0.CO;2-B; Baxter AM, 2013, AQUAT SCI, V75, P275, DOI 10.1007/s00027-012-0272-5; Baxter AM, 2012, FRESHW SCI, V31, P304, DOI 10.1899/11-066.1; Beaulieu JJ, 2009, J ENVIRON QUAL, V38, P637, DOI 10.2134/jeq2008.0003; Blackwood CB, 2003, APPL ENVIRON MICROB, V69, P926, DOI 10.1128/AEM.69.2.926-932.2003; Blackwood CB, 2005, APPL ENVIRON MICROB, V71, P6193, DOI 10.1128/AEM.71.10.6193-6198.2005; Burgin AJ, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001799; Burt TP, 1999, HYDROL PROCESS, V13, P1451, DOI 10.1002/(SICI)1099-1085(199907)13:10&lt;1451::AID-HYP822&gt;3.0.CO;2-W; Dandie CE, 2008, APPL ENVIRON MICROB, V74, P5997, DOI 10.1128/AEM.00441-08; Erisman JW, 2008, NAT GEOSCI, V1, P636, DOI 10.1038/ngeo325; Feinstein LM, 2009, APPL ENVIRON MICROB, V75, P5428, DOI 10.1128/AEM.00120-09; Fellows CS, 2011, SOIL BIOL BIOCHEM, V43, P324, DOI 10.1016/j.soilbio.2010.10.019; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Findlay SEG, 2011, BIOGEOCHEMISTRY, V104, P381, DOI 10.1007/s10533-010-9512-8; Forshay KJ, 2005, BIOGEOCHEMISTRY, V75, P43, DOI 10.1007/s10533-004-6016-4; GROFFMAN PM, 1993, ECOLOGY, V74, P855, DOI 10.2307/1940811; GROFFMAN PM, 1991, J ENVIRON QUAL, V20, P671, DOI 10.2134/jeq1991.00472425002000030027x; Hefting M, 2004, BIOGEOCHEMISTRY, V67, P113, DOI 10.1023/B:BIOG.0000015320.69868.33; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Herrman KS, 2008, HYDROBIOLOGIA, V598, P305, DOI 10.1007/s10750-007-9164-4; Hill AR, 1996, J ENVIRON QUAL, V25, P743, DOI 10.2134/jeq1996.00472425002500040014x; Holmes RM, 1996, BIOGEOCHEMISTRY, V33, P125, DOI 10.1007/BF02181035; Inwood SE, 2005, J N AM BENTHOL SOC, V24, P227, DOI 10.1899/04-032.1; Jacinthe PA, 2012, J ENVIRON QUAL, V41, P95, DOI 10.2134/jeq2011.0308; Johnson LT, 2012, ECOSYSTEMS, V15, P1027, DOI 10.1007/s10021-012-9563-x; Kemp MJ, 2002, ECOL APPL, V12, P998, DOI 10.1890/1051-0761(2002)012[0998:CONADI]2.0.CO;2; KEPNER RL, 1994, MICROBIOL REV, V58, P603, DOI 10.1128/MMBR.58.4.603-615.1994; Knapp CW, 2009, ENVIRON SCI TECHNOL, V43, P4273, DOI 10.1021/es9001407; KNOWLES R, 1982, MICROBIOL REV, V46, P43, DOI 10.1128/MMBR.46.1.43-70.1982; Lathrop T.R., 2006, ENV SETTING SUGAR CR; Leopold L.B., 1992, FLUVIAL PROCESSES GE; Ma WK, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00110; Martin LA, 2001, J N AM BENTHOL SOC, V20, P505, DOI 10.2307/1468084; Martin TL, 1999, WATER AIR SOIL POLL, V111, P171, DOI 10.1023/A:1005015400607; Marxsen J, 2010, FEMS MICROBIOL ECOL, V71, P374, DOI 10.1111/j.1574-6941.2009.00819.x; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Mulholland PJ, 2009, LIMNOL OCEANOGR, V54, P666, DOI 10.4319/lo.2009.54.3.0666; Pattinson SN, 1998, SCI TOTAL ENVIRON, V210, P289, DOI 10.1016/S0048-9697(98)00019-9; Pina-Ochoa E, 2006, BIOGEOCHEMISTRY, V81, P111, DOI 10.1007/s10533-006-9033-7; Pinay G, 2007, FRESHWATER BIOL, V52, P252, DOI 10.1111/j.1365-2427.2006.01680.x; POFF NL, 1989, CAN J FISH AQUAT SCI, V46, P1805, DOI 10.1139/f89-228; R Core Team, 2012, R LANG ENV STAT COMP; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rich JJ, 2004, SOIL BIOL BIOCHEM, V36, P1431, DOI 10.1016/j.soilbio.2004.03.008; Rich JJ, 2003, APPL ENVIRON MICROB, V69, P5974, DOI 10.1128/AEM.69.10.5974-5982.2003; Roley SS, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001950; Roley SS, 2012, ECOL APPL, V22, P281, DOI 10.1890/11-0381.1; Royer TV, 2004, J ENVIRON QUAL, V33, P1296, DOI 10.2134/jeq2004.1296; SAHRAWAT KL, 1980, PLANT SOIL, V55, P225, DOI 10.1007/BF02181802; Schaller JL, 2004, J N AM BENTHOL SOC, V23, P667, DOI 10.1899/0887-3593(2004)023<0667:DAWPAS>2.0.CO;2; Song K, 2011, EUR J SOIL BIOL, V47, P24, DOI 10.1016/j.ejsobi.2010.10.003; Thompson SP, 2000, J ENVIRON QUAL, V29, P1914, DOI 10.2134/jeq2000.00472425002900060026x; Vidon P, 2011, AGR WATER MANAGE, V98, P532, DOI 10.1016/j.agwat.2010.09.010; Vidon PGF, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002473; Vidon P, 2010, J AM WATER RESOUR AS, V46, P278, DOI 10.1111/j.1752-1688.2010.00420.x; Welti N, 2012, RIV SYST, V20, P1; Wilson JS, 2011, RIVER RES APPL, V27, DOI 10.1002/rra.1352; Zumft WG, 1997, PROKARYOTES EVOLVING	65	13	13	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105149	10.1371/journal.pone.0105149	http://dx.doi.org/10.1371/journal.pone.0105149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171209	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500032
J	Mazumdar, S; Mazumdar, PG; Kanjilal, B; Singh, PK				Mazumdar, Sumit; Mazumdar, Papiya Guha; Kanjilal, Barun; Singh, Prashant Kumar			Multiple Shocks, Coping and Welfare Consequences: Natural Disasters and Health Shocks in the Indian Sundarbans	PLOS ONE			English	Article							CONSUMPTION; RISK; INSURANCE; STRATEGIES; POOR	Background: Based on a household survey in Indian Sundarbans hit by tropical cyclone Aila in May 2009, this study tests for evidence and argues that health and climatic shocks are essentially linked forming a continuum and with exposure to a marginal one, coping mechanisms and welfare outcomes triggered in the response is significantly affected. Data & Methods: The data for this study is based on a cross-sectional household survey carried out during June 2010. The survey was aimed to assess the impact of cyclone Aila on households and consequent coping mechanisms in three of the worst-affected blocks (a sub-district administrative unit), viz. Hingalganj, Gosaba and Patharpratima. The survey covered 809 individuals from 179 households, cross cutting age and gender. A separate module on health-seeking behaviour serves as the information source of health shocks defined as illness episodes (ambulatory or hospitalized) experienced by household members. Key findings: Finding reveals that over half of the households (54%) consider that Aila has dealt a high, damaging impact on their household assets. Result further shows deterioration of health status in the period following the incidence of Aila. Finding suggests having suffered multiple shocks increases the number of adverse welfare outcomes by 55%. Whereas, suffering either from the climatic shock (33%) or the health shock (25%) alone increases such risks by a much lesser extent. The multiple-shock households face a significantly higher degree of difficulty to finance expenses arising out of health shocks, as opposed to their counterparts facing only the health shock. Further, these households are more likely to finance the expenses through informal loans and credit from acquaintances or moneylenders. Conclusion: This paper presented empirical evidence on how natural and health shocks mutually reinforce their resultant impact, making coping increasingly difficult and present significant risks of welfare loss, having short as well as long-run development manifestations.	[Mazumdar, Sumit; Singh, Prashant Kumar] Inst Human Dev, Populat Hlth & Nutr Res Program PHN RP, New Delhi, India; [Mazumdar, Papiya Guha] TERI Univ, Dept Policy Studies, New Delhi, India; [Kanjilal, Barun] Future Hlth Syst RPC India, Jaipur, Rajasthan, India; [Kanjilal, Barun] Indian Inst Hlth Management Res, Jaipur, Rajasthan, India	TERI University	Singh, PK (corresponding author), Inst Human Dev, Populat Hlth & Nutr Res Program PHN RP, New Delhi, India.	prashant_iips@yahoo.co.in		Singh, Prashant Kumar/0000-0003-1742-5534; Mazumdar, Papiya/0000-0002-3197-4698; Mazumdar, Sumit/0000-0002-9278-4396	UK Department for International Development (DFID) under the Future Health Systems research programme consortium [H050474]; Department for International Development (DFID) [201888] Funding Source: researchfish	UK Department for International Development (DFID) under the Future Health Systems research programme consortium; Department for International Development (DFID)	This document is an output from a project funded by the UK Department for International Development (DFID) for the benefit of developing countries (Grant # H050474) under the Future Health Systems research programme consortium. The views expressed are not necessarily those of DFID or other institutions the authors represent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman H., 1992, 164 WORLD BANK; Alderman H, 2006, OXFORD ECON PAP, V58, P450, DOI 10.1093/oep/gpl008; Baez JE., 2007, CHILDRENS VULNERABIL; BINSWANGER HP, 1986, J DEV STUD, V22, P503, DOI 10.1080/00220388608421994; Carter MR, 2007, WORLD DEV, V35, P835, DOI 10.1016/j.worlddev.2006.09.010; Chattopadhyay SS, 2011, FRONTLINE, V26; Danda AA, 2011, INDIAN SUNDARBANS DE; Danda AA., 2010, SUNDARBANS FUTURE IM; de la Fuente A, 2009, RISK, SHOCKS, AND HUMAN DEVELOPMENT: ON THE BRINK, P103; del Nino C, 2001, 122 INT FOOD POL RES; Dercon S, 2005, J AFR ECON, V14, P559, DOI 10.1093/jae/eji022; Dercon S, 2002, WORLD BANK RES OBSER, V17, P141, DOI 10.1093/wbro/17.2.141; Dercon S., 2004, INSURANCE POVERTY, P9; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Fuentes-Nieva R., 2010, RISK SHOCKS HUMAN DE, P144; Gertler P, 2002, AM ECON REV, V92, P51, DOI 10.1257/000282802760015603; Gertler P, 2006, CESIFO ECON STUD, V52, P455, DOI 10.1093/cesifo/ifl012; Government of West Bengal, 2009, W BENG STAT ACT PLAN; Hazra S., 2002, SCI CULT-INDIA, V68, P309; Hazra S, 2003, PERSPECTIVE CLIMATE, P66; Heltberg R, 2009, J DEV STUD, V45, P889, DOI 10.1080/00220380902802214; Kanjilal B, 2010, HLTH CARE SUNDARBANS; Kazianga H, 2006, J DEV ECON, V79, P413, DOI 10.1016/j.jdeveco.2006.01.011; Long J.S., 2006, REGRESSION MODELS CA; Mitra A, 2009, CURR SCI INDIA, V97, P1445; MORDUCH J, 1995, J ECON PERSPECT, V9, P103, DOI 10.1257/jep.9.3.103; Pradhan M, 2000, REV ECON STAT, V82, P462, DOI 10.1162/003465300558821; ROSENZWEIG MR, 1989, J POLIT ECON, V97, P905, DOI 10.1086/261633; Rutstein OS, 2004, DHS COMP REPORTS, V6; SAARC Disaster Management Centre, 2009, S AS DIS REP 2009, P113; Santos IV, 2009, RISK, SHOCKS, AND HUMAN DEVELOPMENT: ON THE BRINK, P128; Sapir D. G., 1986, Health Policy and Planning, V1, P118, DOI 10.1093/heapol/1.2.118; Sawada Y, 2008, J MONEY CREDIT BANK, V40, P463, DOI 10.1111/j.1538-4616.2008.00122.x; Shultz JM, 2005, EPIDEMIOL REV, V27, P21, DOI 10.1093/epirev/mxi011; Spiegel Paul B, 2007, Confl Health, V1, P2, DOI 10.1186/1752-1505-1-2; StataCorp L, 2007, STAT DAT AN STAT SOF; Takasaki Y, 2004, ENVIRON DEV ECON, V9, P203, DOI 10.1017/S1355770X03001232; TOWNSEND RM, 1995, J ECON PERSPECT, V9, P83, DOI 10.1257/jep.9.3.83; TOWNSEND RM, 1994, ECONOMETRICA, V62, P539, DOI 10.2307/2951659; United nations Development Programme (UNDP), 2007, NAT HUM DEV REP RUSS; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wagstaff A., 2010, POLICY RES WORKING P; Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779	43	21	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105427	10.1371/journal.pone.0105427	http://dx.doi.org/10.1371/journal.pone.0105427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO2EE	25170846	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500048
J	Tsai, HL; Deng, WP; Lai, WFT; Chiu, WT; Yang, CB; Tsai, YH; Hwang, SM; Renshaw, PF				Tsai, Hung-Li; Deng, Wing-Ping; Lai, Wen-Fu Thomas; Chiu, Wen-Ta; Yang, Charn-Bing; Tsai, Yu-Hui; Hwang, Shiaw-Min; Renshaw, Perry F.			Wnts Enhance Neurotrophin-Induced Neuronal Differentiation in Adult Bone-Marrow-Derived Mesenchymal Stem Cells via Canonical and Noncanonical Signaling Pathways	PLOS ONE			English	Article							STROMAL CELLS; HUMAN FIBROBLASTS; BETA-CATENIN; FUNCTIONAL-NEURONS; SYNAPTIC-TRANSMISSION; TRANSCRIPTION FACTORS; DOPAMINERGIC-NEURONS; DIRECT CONVERSION; GENE-EXPRESSION; CANCER-CELLS	Wnts were previously shown to regulate the neurogenesis of neural stem or progenitor cells. Here, we explored the underlying molecular mechanisms through which Wnt signaling regulates neurotrophins (NTs) in the NT-induced neuronal differentiation of human mesenchymal stem cells (hMSCs). NTs can increase the expression of Wnt1 and Wnt7a in hMSCs. However, only Wnt7a enables the expression of synapsin-1, a synaptic marker in mature neurons, to be induced and triggers the formation of cholinergic and dopaminergic neurons. Human recombinant (hr) Wnt7a and general neuron makers were positively correlated in a dose- and time-dependent manner. In addition, the expression of synaptic markers and neurites was induced by Wnt7a and lithium, a glycogen synthase kinase-3 beta inhibitor, in the NT-induced hMSCs via the canonical/beta-catenin pathway, but was inhibited by Wnt inhibitors and frizzled-5 (Frz5) blocking antibodies. In addition, hrWnt7a triggered the formation of cholinergic and dopaminergic neurons via the non-canonical/c-jun N-terminal kinase (JNK) pathway, and the formation of these neurons was inhibited by a JNK inhibitor and Frz9 blocking antibodies. In conclusion, hrWnt7a enhances the synthesis of synapse and facilitates neuronal differentiation in hMSCS through various Frz receptors. These mechanisms may be employed widely in the transdifferentiation of other adult stem cells.	[Tsai, Hung-Li; Lai, Wen-Fu Thomas; Tsai, Yu-Hui] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Deng, Wing-Ping] Taipei Med Univ, Grad Inst Biomed Mat & Engn, Taipei, Taiwan; [Lai, Wen-Fu Thomas] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Lai, Wen-Fu Thomas] Harvard Univ, McLean Hosp, Sch Med, McLean Imaging Ctr, Belmont, MA USA; [Lai, Wen-Fu Thomas; Chiu, Wen-Ta] Taipei Med Univ Hosp, Ctr Nanotissue Engn & Image Res, Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Shuan Ho Hosp, Dept Neurosurg, Taipei, Taiwan; [Yang, Charn-Bing] Taipei Cty Hosp, Dept Orthoped, Taipei, Taiwan; [Hwang, Shiaw-Min] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, Hsinchu, Taiwan; [Renshaw, Perry F.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Renshaw, Perry F.] Univ Utah, Inst Brain, Salt Lake City, UT USA	Taipei Medical University; Taipei Medical University; Taipei Medical University; Harvard University; McLean Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Shuang Ho Hospital; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Lai, WFT (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan.	laitw@tmu.edu.tw	Renshaw, Perry/O-1384-2018		National Science Council in Taiwan [NSC-94-2320-B-038-013, NSC-99-2120-M-038-001, NSC-100-2120-M-038-001]; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA031247] Funding Source: NIH RePORTER	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Science Council in Taiwan with Grants NSC-94-2320-B-038-013, NSC-99-2120-M-038-001, and NSC-100-2120-M-038-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080; Barnabe GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005222; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Carmon KS, 2008, MOL CANCER RES, V6, P1017, DOI 10.1158/1541-7786.MCR-08-0039; Carvalho MM, 2011, CURR STEM CELL RES T, V6, P221; Castelo-Branco G, 2004, J CELL SCI, V117, P5731, DOI 10.1242/jcs.01505; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen Chun-Wei David, 2006, Current Alzheimer Research, V3, P63, DOI 10.2174/156720506775697205; Chen Y, 2006, CELL MOL LIFE SCI, V63, P1649, DOI 10.1007/s00018-006-6019-5; Cho KJ, 2005, STEM CELLS, V23, P383, DOI 10.1634/stemcells.2004-0251; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Croft AP, 2006, STEM CELLS, V24, P1841, DOI 10.1634/stemcells.2005-0609; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Guo W, 2008, J BIOL CHEM, V283, P9136, DOI 10.1074/jbc.M708968200; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Jorl FP, 2005, CELL DEATH DIFFER, V12, P65, DOI 10.1038/sj.cdd.4401499; Kondo T, 2011, STEM CELLS, V29, P836, DOI 10.1002/stem.624; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; Munoz-Elias G, 2004, J NEUROSCI, V24, P4585, DOI 10.1523/JNEUROSCI.5060-03.2004; Nagahata T, 2003, CANCER SCI, V94, P515, DOI 10.1111/j.1349-7006.2003.tb01475.x; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park JS, 2012, BIOMATERIALS, V33, P7300, DOI 10.1016/j.biomaterials.2012.06.069; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ribeiro CA, 2011, J TISSUE ENG REGEN M, V5, P668, DOI 10.1002/term.365; Rivera FT, 2006, STEM CELLS, V24, P2209, DOI 10.1634/stemcells.2005-0614; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sanchez-Ramos JR, 2002, J NEUROSCI RES, V69, P880, DOI 10.1002/jnr.10337; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Schapira AHV, 2004, JAMA-J AM MED ASSOC, V291, P358, DOI 10.1001/jama.291.3.358; Shang YC, 2007, CYTOTHERAPY, V9, P667, DOI 10.1080/14653240701508437; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Trzaska KA, 2007, STEM CELLS, V25, P2797, DOI 10.1634/stemcells.2007-0212; Trzaska KA, 2009, J NEUROCHEM, V110, P1058, DOI 10.1111/j.1471-4159.2009.06201.x; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; WHITEHOUSE PJ, 1983, PSYCHOPHARMACOL BULL, V19, P437; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Winn RA, 2006, J BIOL CHEM, V281, P26943, DOI 10.1074/jbc.M604145200; Wislet-Gendebien S, 2005, STEM CELLS, V23, P392, DOI 10.1634/stemcells.2004-0149; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; Yang N, 2011, CELL STEM CELL, V9, P517, DOI 10.1016/j.stem.2011.11.015; Yang YX, 2008, EXP CELL RES, V314, P2257, DOI 10.1016/j.yexcr.2008.04.008; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zaghetto AA, 2007, J NEUROSCI, V27, P9757, DOI 10.1523/JNEUROSCI.0763-07.2007; Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239	64	26	26	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e104937	10.1371/journal.pone.0104937	http://dx.doi.org/10.1371/journal.pone.0104937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170755	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500025
J	Zhang, HL; Li, ZJ; Lai, SJ; Clements, ACA; Wang, LP; Yin, WW; Zhou, H; Yu, HJ; Hu, WB; Yang, WZ				Zhang, Honglong; Li, Zhongjie; Lai, Shengjie; Clements, Archie C. A.; Wang, Liping; Yin, Wenwu; Zhou, Hang; Yu, Hongjie; Hu, Wenbiao; Yang, Weizhong			Evaluation of the Performance of a Dengue Outbreak Detection Tool for China	PLOS ONE			English	Article							ELECTRONIC SURVEILLANCE SYSTEM; DISEASE; EPIDEMICS; VIRUS; FEVER	An outbreak detection and response system, using time series moving percentile method based on historical data, in China has been used for identifying dengue fever outbreaks since 2008. For dengue fever outbreaks reported from 2009 to 2012, this system achieved a sensitivity of 100%, a specificity of 99.8% and a median time to detection of 3 days, which indicated that the system was a useful decision tool for dengue fever control and risk-management programs in China.	[Zhang, Honglong; Li, Zhongjie; Lai, Shengjie; Wang, Liping; Yin, Wenwu; Zhou, Hang; Yu, Hongjie; Yang, Weizhong] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Clements, Archie C. A.] Australian Natl Univ, Coll Med Biol & Environm, Res Sch Populat Hlth, Canberra, ACT, Australia; [Hu, Wenbiao] Univ Queensland, Sch Populat Hlth, Infect Dis Epidemiol Unit, Brisbane, Qld, Australia	Chinese Center for Disease Control & Prevention; Australian National University; University of Queensland	Hu, WB (corresponding author), Univ Queensland, Sch Populat Hlth, Infect Dis Epidemiol Unit, Brisbane, Qld, Australia.	w.hu@sph.uq.edu.au; yangwz@chinacdc.cn	Clements, Archie/ABD-1615-2020; Yang, Wei/HIA-0360-2022; Yu, Hongjie/GZK-5351-2022	Hu, Wenbiao/0000-0001-6422-9240; Lai, Shengjie/0000-0001-9781-8148	Research and Promotion of Key Technology on Health Emergency Preparation and Dispositions [201202006]; National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China [2012ZX10004-201]; Development of Early Warning Systems for Dengue Fever Based on Socio-ecological Factors [NHMRC APP1002608]	Research and Promotion of Key Technology on Health Emergency Preparation and Dispositions; National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China; Development of Early Warning Systems for Dengue Fever Based on Socio-ecological Factors	This work was supported by the grants from Research and Promotion of Key Technology on Health Emergency Preparation and Dispositions (201202006), the National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China (2012ZX10004-201) and Development of Early Warning Systems for Dengue Fever Based on Socio-ecological Factors (NHMRC APP1002608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P1076; Depradine CA, 2004, INT J ENVIRON HEAL R, V14, P429, DOI 10.1080/09603120400012868; Hutwagner L, 2003, J URBAN HEALTH, V80, pI89; Krause G, 2007, EMERG INFECT DIS, V13, P1548, DOI 10.3201/eid1310.070253; Li ZJ, 2012, J AM MED INFORM ASSN, V19, pE51, DOI 10.1136/amiajnl-2011-000126; Lombardo J, 2003, J URBAN HEALTH, V80, pI32; Lowe R, 2013, STAT MED, V32, P864, DOI 10.1002/sim.5549; Ministry of Health of the People's Republic of China, NAT DENG FEV SURV PR; Mohammad J, 2009, BERKALA ILMUKEDOKTER, V41, P134; Sithiprasasna Ratana, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P918; Tsui FC, 2003, J AM MED INFORM ASSN, V10, P399, DOI 10.1197/jamia.M1345; Wang XL, 2010, J BIOMED INFORM, V43, P97, DOI 10.1016/j.jbi.2009.08.003; Wang Y, 2013, NEW ENGL J MED, V368, P2348, DOI 10.1056/NEJMp1305311; Watkins RE, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-37; World Health Organization Special Programme for Research and Training in Tropical Diseases, 2009, DENG GUID DIAGN TREA; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755; Yang W, 2011, DIR DEV, P1; Zhang HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071803; Zhao HL, 1981, CHIN MED J, V61, P466	19	16	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106144	10.1371/journal.pone.0106144	http://dx.doi.org/10.1371/journal.pone.0106144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170873	Green Accepted, Green Published, gold			2022-12-25	WOS:000341127500115
J	Andrae, J; Gouveia, L; He, LQ; Betsholtz, C				Andrae, Johanna; Gouveia, Leonor; He, Liqun; Betsholtz, Christer			Characterization of Platelet-Derived Growth Factor-A Expression in Mouse Tissues Using a lacZ Knock-In Approach	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; PDGF-A; FACTOR RECEPTOR; B-CHAIN; SIGNALING PATHWAYS; GENE-EXPRESSION; DEFICIENT MICE; ALPHA; DIFFERENTIATION; GASTRULATION	Expression of the platelet-derived growth factor A-chain gene (Pdgfa) occurs widely in the developing mouse, where it is mainly localized to various epithelial and neuronal structures. Until now, in situ mRNA hybridization (ISH) has been the only reliable method to identify Pdgfa expression in tissue sections or whole mount preparations. Validated protocols for in situ detection of PDGF-A protein by immunohistochemistry is lacking. In particular, this has hampered understanding of Pdgfa expression pattern in adult tissues, where ISH is technically challenging. Here, we report a gene targeted mouse Pdgfa allele, Pdgfa(ex4COIN), which is a combined conditional knockout and reporter allele. Cre-mediated inversion of the COIN cassette inactivates Pdgfa coding while simultaneously activating a beta-galactosidase (lacZ) reporter under endogenous Pdgfa transcription control. The generated Pdgfa(ex4COIN-INV-lacZ) allele can next be used to identify cells carrying a Pdgfa null allele, as well as to map endogenous Pdgfa expression. We evaluated the Pdgfa(ex4COIN-INV-lacZ) allele as a reporter for endogenous Pdgfa expression patterns in mouse embryos and adults. We conclude that the expression pattern of Pdgfa(ex4COIN-INV-lacZ) recapitulates known expression patterns of Pdgfa. We also report on novel embryonic and adult Pdgfa expression patterns in the mouse and discuss their implications for Pdgfa physiology.	[Andrae, Johanna; Gouveia, Leonor; He, Liqun; Betsholtz, Christer] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Uppsala, Sweden; [Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden	Uppsala University; Karolinska Institutet	Andrae, J (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Uppsala, Sweden.	Johanna.Andrae@igp.uu.se	Gouveia, Leonor/P-4285-2018; Andrae, Johanna/L-3875-2014	Gouveia, Leonor/0000-0002-3825-8571; He, Liqun/0000-0003-2127-7597	Swedish Cancer Society [CAN 2012/433]; European Research Council [294556]; Karolinska Institutet; Uppsala University; Knut and Alice Wallenberg; IngaBritt and Arne Lundberg; Ake Wiberg Foundations [362565719]; Torsten and Ragnar Soderberg	Swedish Cancer Society(Swedish Cancer Society); European Research Council(European Research Council (ERC)European Commission); Karolinska Institutet(Karolinska Institutet); Uppsala University; Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); IngaBritt and Arne Lundberg; Ake Wiberg Foundations; Torsten and Ragnar Soderberg	Funding provided by Swedish Cancer Society (CB - CAN 2012/433), http://www.cancerfonden.se, European Research Council (CB - 294556), http://erc.europa.eu, Karolinska Institutet (CB), http://ki.se/start, Uppsala University (CB), http://www.uu.se, Knut and Alice Wallenberg (CB), https://www.wallenberg.com/kaw/Torsten and Ragnar Soderberg (CB), http://www.torstensoderbergsstiftelse.se/stiftelsen/index1,2.htm, IngaBritt and Arne Lundberg (CB), http://www. lundbergsstiftelsen.se and Ake Wiberg Foundations (JA -362565719), http://ake-wiberg.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita S, 1997, J CLIN INVEST, V99, P2462, DOI 10.1172/JCI119430; ALITALO R, 1987, EMBO J, V6, P1213, DOI 10.1002/j.1460-2075.1987.tb02356.x; ALPERS CE, 1995, KIDNEY INT, V48, P146, DOI 10.1038/ki.1995.278; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Andrae J, 2013, MOL CELL BIOL, V33, P4030, DOI 10.1128/MCB.00749-13; Bax NAM, 2009, DEV DYNAM, V238, P2658, DOI 10.1002/dvdy.22073; Bleyl SB, 2010, HUM MOL GENET, V19, P1286, DOI 10.1093/hmg/ddq005; Bostrom H, 2002, DEV DYNAM, V223, P155, DOI 10.1002/dvdy.1225.abs; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Carvalho I, 2005, BREAST CANCER RES, V7, pR788, DOI 10.1186/bcr1304; Damm EW, 2011, DEVELOPMENT, V138, P565, DOI 10.1242/dev.056903; Ding H, 2004, NAT GENET, V36, P1111, DOI 10.1038/ng1415; Dingemann J, 2010, J PEDIATR SURG, V45, P1989, DOI 10.1016/j.jpedsurg.2010.06.014; Economides AN, 2013, P NATL ACAD SCI USA, V110, pE3179, DOI 10.1073/pnas.1217812110; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Gnessi L, 2000, J CELL BIOL, V149, P1019, DOI 10.1083/jcb.149.5.1019; Heldin C. H., 2013, CELL COMMUNICATION S, P11; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; HUTCHINS JB, 1992, DEV BRAIN RES, V67, P121, DOI 10.1016/0165-3806(92)90213-G; Iwayama T, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0304-0; Kaetzel DM, 2003, CYTOKINE GROWTH F R, V14, P427, DOI 10.1016/S1359-6101(03)00051-0; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Karlsson L, 1999, DEVELOPMENT, V126, P2611; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Lindahl P, 1997, DEVELOPMENT, V124, P3943; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandalos N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045768; Martinho O, 2009, BRIT J CANCER, V101, P973, DOI 10.1038/sj.bjc.6605225; MATOSKOVA B, 1989, MOL CELL BIOL, V9, P3148, DOI 10.1128/MCB.9.7.3148; Montero JA, 2004, TRENDS CELL BIOL, V14, P620, DOI 10.1016/j.tcb.2004.09.008; Nagel M, 2004, DEVELOPMENT, V131, P2727, DOI 10.1242/dev.01141; ORRURTREGER A, 1992, DEVELOPMENT, V115, P1045; OSTMAN A, 1991, CELL REGUL, V2, P503, DOI 10.1091/mbc.2.7.503; Pinzani M, 1996, AM J PATHOL, V148, P785; RAMACHANDRAN RK, 1995, DEV DYNAM, V204, P77, DOI 10.1002/aja.1002040110; Ramachandran RK, 1997, DEVELOPMENT, V124, P2355; Reneker LW, 1996, DEV BIOL, V180, P554, DOI 10.1006/dbio.1996.0328; Rolny C, 2006, BLOOD, V108, P1877, DOI 10.1182/blood-2006-04-014894; RORSMAN F, 1988, MOL CELL BIOL, V8, P571, DOI 10.1128/MCB.8.2.571; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SEJERSEN T, 1986, P NATL ACAD SCI USA, V83, P6844, DOI 10.1073/pnas.83.18.6844; Simon MP, 1997, NAT GENET, V15, P95, DOI 10.1038/ng0197-95; Smith EM, 2009, P NATL ACAD SCI USA, V106, P21683, DOI 10.1073/pnas.0902510106; Soriano P, 1997, DEVELOPMENT, V124, P2691; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Van den Arker NMS, 2005, DEV DYNAM, V233, P1579, DOI 10.1002/dvdy.20476; VOELKER JL, 1991, J NEUROSURG, V74, P535, DOI 10.3171/jns.1991.74.4.0535; Xu X, 2005, DEV DYNAM, V232, P75, DOI 10.1002/dvdy.20197; YEH HJ, 1991, CELL, V64, P209, DOI 10.1016/0092-8674(91)90222-K; Zhao WY, 2011, J MOL CELL CARDIOL, V51, P830, DOI 10.1016/j.yjmcc.2011.06.023; Zhao YJ, 1999, TOHOKU J EXP MED, V189, P239, DOI 10.1620/tjem.189.239	60	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105477	10.1371/journal.pone.0105477	http://dx.doi.org/10.1371/journal.pone.0105477			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166724	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303700027
J	Fan, FH; Cui, BW; Zhang, T; Qiao, G; Ding, GJ; Wen, XP				Fan, Fuhua; Cui, Bowen; Zhang, Ting; Qiao, Guang; Ding, Guijie; Wen, Xiaopeng			The Temporal Transcriptomic Response of Pinus massoniana Seedlings to Phosphorus Deficiency	PLOS ONE			English	Article							PHOSPHATE STARVATION RESPONSES; MADS-BOX GENE; PLASMA-MEMBRANE; RNA-SEQ; EXPRESSION PROFILE; TRANSPORTER GENE; MULTIPLE LEVELS; FAMILY REVEALS; KEY ROLE; ARABIDOPSIS	Background: Phosphorus (P) is an essential macronutrient for plant growth and development. Several genes involved in phosphorus deficiency stress have been identified in various plant species. However, a whole genome understanding of the molecular mechanisms involved in plant adaptations to low P remains elusive, and there is particularly little information on the genetic basis of these acclimations in coniferous trees. Masson pine (Pinus massoniana) is grown mainly in the tropical and subtropical regions in China, many of which are severely lacking in inorganic phosphate (Pi). In previous work, we described an elite P. massoniana genotype demonstrating a high tolerance to Pi-deficiency. Methodology/Principal Findings: To further investigate the mechanism of tolerance to low P, RNA-seq was performed to give an idea of extent of expression from the two mixed libraries, and microarray whose probes were designed based on the unigenes obtained from RNA-seq was used to elucidate the global gene expression profiles for the long-term phosphorus starvation. A total of 70,896 unigenes with lengths ranging from 201 to 20,490 bp were assembled from 112,108,862 high quality reads derived from RNA-Seq libraries. We identified 1,396 and 943 transcripts that were differentially regulated (P<0.05) under P1 (0.01 mM P) and P2 (0.06 mM P) Pi-deficiency conditions, respectively. Numerous transcripts were consistently differentially regulated under Pi deficiency stress, many of which were also up-or down-regulated in other species under the corresponding conditions, and are therefore ideal candidates for monitoring the P status of plants. The results also demonstrated the impact of different Pi starvation levels on global gene expression in Masson pine. Conclusions/Significance: To our knowledge, this work provides the first insight into the molecular mechanisms involved in acclimation to long-term Pi starvation and different Pi availability levels in coniferous trees.	[Fan, Fuhua; Cui, Bowen; Zhang, Ting; Qiao, Guang; Wen, Xiaopeng] Guizhou Univ, Inst Agro Bioengn, Lab Plant Resources Conservat & Germplasm Innovat, Minist Educ, Guiyang 550003, Guizhou, Peoples R China; [Fan, Fuhua; Ding, Guijie] Guizhou Univ, Sch Forestry Sci, Guiyang 550003, Guizhou, Peoples R China; [Fan, Fuhua] Hubei Univ Sci & Technol, Sch Nucl Technol & Chem & Biol, Xianning, Hunan, Peoples R China	Guizhou University; Guizhou University; Hubei University of Science & Technology	Wen, XP (corresponding author), Guizhou Univ, Inst Agro Bioengn, Lab Plant Resources Conservat & Germplasm Innovat, Minist Educ, Guiyang 550003, Guizhou, Peoples R China.	xpwensc@hotmail.com			Special Core Program of Guizhou Province, P.R. China [20126011-1]; 863 Program of China [2011AA10020301]; Natural Science Foundation of Hubei Province P.R. China [2013CFC012]; National Natural Science Foundation of China [31260183]	Special Core Program of Guizhou Province, P.R. China; 863 Program of China(National High Technology Research and Development Program of China); Natural Science Foundation of Hubei Province P.R. China(Natural Science Foundation of Hubei Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project is supported by grants from Special Core Program of Guizhou Province, P.R. China (20126011-1), the 863 Program of China (2011AA10020301), the Natural Science Foundation of Hubei Province P.R. China (2013CFC012) and the National Natural Science Foundation of China (31260183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MX, 2005, J BIOL CHEM, V280, P27578, DOI 10.1074/jbc.M503273200; Andersson MX, 2003, FEBS LETT, V537, P128, DOI 10.1016/S0014-5793(03)00109-1; Awual MR, 2011, J HAZARD MATER, V188, P164, DOI 10.1016/j.jhazmat.2011.01.092; Baek D, 2013, PLANT PHYSIOL, V161, P362, DOI 10.1104/pp.112.205922; Baldwin JC, 2008, PLANTA, V228, P273, DOI 10.1007/s00425-008-0736-y; Bayle V, 2011, PLANT CELL, V23, P1523, DOI 10.1105/tpc.110.081067; Bhabak KP, 2010, ACCOUNTS CHEM RES, V43, P1408, DOI 10.1021/ar100059g; Calderon-Vazquez C, 2008, J EXP BOT, V59, P2479, DOI 10.1093/jxb/ern115; Carvalhais LC, 2011, J PLANT NUTR SOIL SC, V174, P3, DOI 10.1002/jpln.201000085; Chen YF, 2009, PLANT CELL, V21, P3554, DOI 10.1105/tpc.108.064980; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; Cohen O, 2012, J EXP BOT, V63, P4947, DOI 10.1093/jxb/ers172; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Desnos T, 2008, CURR OPIN PLANT BIOL, V11, P82, DOI 10.1016/j.pbi.2007.10.003; Devaiah BN, 2007, PLANT PHYSIOL, V143, P1789, DOI 10.1104/pp.106.093971; Duan K, 2008, PLANT J, V54, P965, DOI 10.1111/j.1365-313X.2008.03460.x; DUFF SMG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI 10.1111/j.1399-3054.1994.tb02539.x; Fang ZY, 2009, PLANT SCI, V176, P170, DOI 10.1016/j.plantsci.2008.09.007; Fita A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035387; Fotopoulos V, 2006, J EXP BOT, V57, P3933, DOI 10.1093/jxb/erl147; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Gaxiola RA, 2011, CHEMOSPHERE, V84, P840, DOI 10.1016/j.chemosphere.2011.01.062; Hackenberg M, 2013, DNA RES, V20, P109, DOI 10.1093/dnares/dss037; Hamburger D, 2002, PLANT CELL, V14, P889, DOI 10.1105/tpc.000745; Hammond JP, 2011, PLANT PHYSIOL, V156, P1230, DOI 10.1104/pp.111.175612; Hammond JP, 2003, PLANT PHYSIOL, V132, P578, DOI 10.1104/pp.103.020941; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hernandez G, 2007, PLANT PHYSIOL, V144, P752, DOI 10.1104/pp.107.096958; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; Huang CF, 2010, PLANT PHYSIOL, V153, P1669, DOI 10.1104/pp.110.155028; Jain A, 2012, CELL MOL LIFE SCI, V69, P3207, DOI 10.1007/s00018-012-1090-6; Kogenaru S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-629; Krouk G, 2011, TRENDS PLANT SCI, V16, P178, DOI 10.1016/j.tplants.2011.02.004; Lan P, 2012, MOL CELL PROTEOMICS, V11, P1156, DOI 10.1074/mcp.M112.020461; Lin WY, 2009, J EXP BOT, V60, P1427, DOI 10.1093/jxb/ern303; Liu TY, 2012, PLANT CELL, V24, P2168, DOI 10.1105/tpc.112.096636; Loth-Pereda V, 2011, PLANT PHYSIOL, V156, P2141, DOI 10.1104/pp.111.180646; Lynch JP, 2011, PLANT PHYSIOL, V156, P1041, DOI 10.1104/pp.111.175414; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Muchhal US, 1996, P NATL ACAD SCI USA, V93, P10519, DOI 10.1073/pnas.93.19.10519; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Nilsson L, 2007, PLANT CELL ENVIRON, V30, P1499, DOI 10.1111/j.1365-3040.2007.01734.x; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; Oono Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-77; Plaxton WC, 2011, PLANT PHYSIOL, V156, P1006, DOI 10.1104/pp.111.175281; Raghothama KG, 2005, PLANT SOIL, V274, P37, DOI 10.1007/s11104-004-2005-6; Raghothama KG, 2000, CURR OPIN PLANT BIOL, V3, P182, DOI 10.1016/S1369-5266(00)00062-5; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Russo MA, 2007, PHYTOCHEMISTRY, V68, P1564, DOI 10.1016/j.phytochem.2007.03.017; Secco D, 2012, NEW PHYTOL, V193, P842, DOI 10.1111/j.1469-8137.2011.04002.x; Secco D, 2010, PLANT PHYSIOL, V152, P1693, DOI 10.1104/pp.109.149872; Shen JB, 2011, PLANT PHYSIOL, V156, P997, DOI 10.1104/pp.111.175232; Shin R, 2005, PLANT CELL PHYSIOL, V46, P1350, DOI 10.1093/pcp/pci145; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thibaud MC, 2010, PLANT J, V64, P775, DOI 10.1111/j.1365-313X.2010.04375.x; Ticconi CA, 2004, TRENDS PLANT SCI, V9, P548, DOI 10.1016/j.tplants.2004.09.003; Torabi S, 2009, PROTEOMICS, V9, P159, DOI 10.1002/pmic.200800350; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Wang C, 2012, NEW PHYTOL, V196, P139, DOI 10.1111/j.1469-8137.2012.04227.x; Wang YH, 2002, PLANT PHYSIOL, V130, P1361, DOI 10.1104/pp.008854; Wasaki J, 2003, PLANT SOIL, V248, P129, DOI 10.1023/A:1022332320384; Wasaki J, 2006, J EXP BOT, V57, P2049, DOI 10.1093/jxb/erj158; Woo J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-62; Xi J, 2012, PLANT J, V69, P782, DOI 10.1111/j.1365-313X.2011.04830.x; Xie YR, 2004, FOREST RES, V17, P278; Xie YuRong, 2005, Scientia Silvae Sinicae, V41, P58; Xu X, 2010, BIORESOURCE TECHNOL, V101, P8558, DOI 10.1016/j.biortech.2010.06.060; Yamamoto A, 2005, J EXP BOT, V56, P1785, DOI 10.1093/jxb/eri167; Yang GZ, 2012, PLANT SOIL, V350, P339, DOI 10.1007/s11104-011-0913-9; Yang XJ, 2010, ANN BOT-LONDON, V105, P513, DOI 10.1093/aob/mcq015; Yao YA, 2011, PLANTA, V233, P523, DOI 10.1007/s00425-010-1311-x; Yazaki K, 2006, FEBS LETT, V580, P1183, DOI 10.1016/j.febslet.2005.12.009; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zhang Y, 2013, PLANT SOIL, V364, P93, DOI 10.1007/s11104-012-1352-y; Zhang Y, 2010, J FOREST RES-JPN, V15, P91, DOI 10.1007/s10310-009-0153-5; Zhou ZhiChun, 2005, Scientia Silvae Sinicae, V41, P25	84	27	34	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105068	10.1371/journal.pone.0105068	http://dx.doi.org/10.1371/journal.pone.0105068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165828	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303700015
J	Fournier, JC; Chase, HW; Almeida, J; Phillips, ML				Fournier, Jay C.; Chase, Henry W.; Almeida, Jorge; Phillips, Mary L.			Model Specification and the Reliability of fMRI Results: Implications for Longitudinal Neuroimaging Studies in Psychiatry	PLOS ONE			English	Article							CINGULATE ACTIVATION; VISUAL ACTIVATION; AMYGDALA ACTIVITY; SINGLE-SUBJECT; FUNCTIONAL MRI; REPRODUCIBILITY; EMOTION; BOLD; PERFORMANCE; DEPRESSION	Functional Magnetic Resonance Imagine (fMRI) is an important assessment tool in longitudinal studies of mental illness and its treatment. Understanding the psychometric properties of fMRI-based metrics, and the factors that influence them, will be critical for properly interpreting the results of these efforts. The current study examined whether the choice among alternative model specifications affects estimates of test-retest reliability in key emotion processing regions across a 6-month interval. Subjects (N = 46) performed an emotional-faces paradigm during fMRI in which neutral faces dynamically morphed into one of four emotional faces. Median voxelwise intraclass correlation coefficients (mvICCs) were calculated to examine stability over time in regions showing task-related activity as well as in bilateral amygdala. Four modeling choices were evaluated: a default model that used the canonical hemodynamic response function (HRF), a flexible HRF model that included additional basis functions, a modified CompCor (mCompCor) model that added corrections for physiological noise in the global signal, and a final model that combined the flexible HRF and mCompCor models. Model residuals were examined to determine the degree to which each pipeline met modeling assumptions. Results indicated that the choice of modeling approaches impacts both the degree to which model assumptions are met and estimates of test-retest reliability. ICC estimates in the visual cortex increased from poor (mvICC = 0.31) in the default pipeline to fair (mvICC = 0.45) in the full alternative pipeline - an increase of 45%. In nearly all tests, the models with the fewest assumption violations generated the highest ICC estimates. Implications for longitudinal treatment studies that utilize fMRI are discussed.	[Fournier, Jay C.; Chase, Henry W.; Phillips, Mary L.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA; [Almeida, Jorge] Brown Univ, Warren Alpert Med Sch, Dept Psychiat & Human Behav, Providence, RI 02912 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University	Fournier, JC (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA.	fournierjc@upmc.edu	Fournier, Jay/AAG-8452-2019; Almeida, Jorge/O-5185-2014	Fournier, Jay/0000-0001-8967-1668; Almeida, Jorge/0000-0002-1213-1986	National Institute of Mental Health, Bethesda, MD [MH076971, K23MH097889]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH097889, R01MH076971] Funding Source: NIH RePORTER	National Institute of Mental Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grants MH076971 (PI: MLP) and K23MH097889 (PI: JCF) from the National Institute of Mental Health, Bethesda, MD (http://www.nimh.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida Jorge Renner Cardoso de, 2011, Front Psychiatry, V2, P69, DOI 10.3389/fpsyt.2011.00069; [Anonymous], 1963, DISTRIBUTION FREE MU; [Anonymous], 2011, ECONOMETRIC ANAL; Ashby F., 2011, STAT ANAL FMRI DATA; Barch DM, 2011, BIOL PSYCHIAT, V70, P13, DOI 10.1016/j.biopsych.2011.01.004; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Blair J. R., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI DOI 10.1080/13854048908403285; Caceres A, 2009, NEUROIMAGE, V45, P758, DOI 10.1016/j.neuroimage.2008.12.035; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Churchill NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031147; Churchill NW, 2012, HUM BRAIN MAPP, V33, P609, DOI 10.1002/hbm.21238; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Cohen J., 2003, APPL MULTIPLE REGRES; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Dunlop BW, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-106; First M. B., 2002, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fournier JC, 2013, PSYCHOL MED, V43, P293, DOI 10.1017/S0033291712000918; Fournier JC, 2013, BIPOLAR DISORD, V15, P741, DOI 10.1111/bdi.12106; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gavrilescu M, 2002, NEUROIMAGE, V17, P532, DOI 10.1006/nimg.2002.1226; Hahn B, 2007, CEREB CORTEX, V17, P1664, DOI 10.1093/cercor/bhl075; Herringa RJ, 2013, PSYCHOL MED, V43, P1533, DOI 10.1017/S0033291712002310; Junghofer M, 2005, NEUROIMAGE, V25, P520, DOI 10.1016/j.neuroimage.2004.12.011; Keener MT, 2012, PSYCHOL MED, V42, P1913, DOI 10.1017/S0033291711002935; Kiebel S, 2007, STAT PARAMETRIC MAPP, P178; Kleinbaum DG, 1998, APPL REGRESSION ANAL; Lenoski B, 2008, IEEE J-STSP, V2, P828, DOI 10.1109/JSTSP.2008.2007819; Liu YW, 2012, J HUAZHONG U SCI-MED, V32, P130, DOI 10.1007/s11596-012-0023-9; Loh JM, 2008, STAT SINICA, V18, P1421; Lund TE, 2005, NEUROIMAGE, V26, P960, DOI 10.1016/j.neuroimage.2005.02.021; Luo WL, 2003, NEUROIMAGE, V19, P1014, DOI 10.1016/S1053-8119(03)00149-6; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McGrath CL, 2013, JAMA PSYCHIAT, V70, P821, DOI 10.1001/jamapsychiatry.2013.143; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Miki A, 2000, AM J NEURORADIOL, V21, P910; Monti MM, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00028; Neter J., 1974, J R STAT SOC C-APPL; Perlman SB, 2012, BIPOLAR DISORD, V14, P162, DOI 10.1111/j.1399-5618.2012.00999.x; Poline JB, 2012, NEUROIMAGE, V62, P871, DOI 10.1016/j.neuroimage.2012.01.133; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; ROGOSA D, 1980, PSYCHOL BULL, V88, P245, DOI 10.1037/0033-2909.88.2.245; Rombouts SARB, 1998, MAGN RESON IMAGING, V16, P105, DOI 10.1016/S0730-725X(97)00253-1; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Skudlarski P, 1999, NEUROIMAGE, V9, P311, DOI 10.1006/nimg.1999.0402; Smith SM, 2005, HUM BRAIN MAPP, V24, P248, DOI 10.1002/hbm.20080; Stokes M.E., 2012, CATEGORICAL DATA ANA; Strother S, 2004, NEUROIMAGE, V23, pS196, DOI 10.1016/j.neuroimage.2004.07.022; Strother SC, 2006, IEEE ENG MED BIOL, V25, P27, DOI 10.1109/MEMB.2006.1607667; Tegeler C, 1999, HUM BRAIN MAPP, V7, P267, DOI 10.1002/(SICI)1097-0193(1999)7:4<267::AID-HBM5>3.0.CO;2-3; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Williams LM, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-4; Zhang H, 2006, HUM BRAIN MAPP, V27, P442, DOI 10.1002/hbm.20253; Zhang J, 2009, MAGN RESON IMAGING, V27, P264, DOI 10.1016/j.mri.2008.05.021	56	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105169	10.1371/journal.pone.0105169	http://dx.doi.org/10.1371/journal.pone.0105169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166022	Green Accepted, gold, Green Published			2022-12-25	WOS:000341303700017
J	Min, CK; Kwon, YJ; Ha, NY; Cho, BA; Kim, JM; Kwon, EK; Kim, YS; Choi, MS; Kim, IS; Cho, NH				Min, Chan-Ki; Kwon, Ye-Jin; Ha, Na-Young; Cho, Bon-A; Kim, Jo-Min; Kwon, Eun-Kyung; Kim, Yeon-Sook; Choi, Myung-Sik; Kim, Ik-Sang; Cho, Nam-Hyuk			Multiple Orientia tsutsugamushi Ankyrin Repeat Proteins Interact with SCF1 Ubiquitin Ligase Complex and Eukaryotic Elongation Factor 1 alpha	PLOS ONE			English	Article							IV SECRETION SYSTEM; HOST-RANGE PROTEIN; SCRUB TYPHUS; LEGIONELLA-PNEUMOPHILA; GENE-EXPRESSION; ACTIN CYTOSKELETON; GENOME EVOLUTION; CHEMOKINE GENES; CELLS; TRANSLATION	Background: Orientia tsutsugamushi, the causative agent of scrub typhus, is an obligate intracellular bacterium. Previously, a large number of genes that encode proteins containing eukaryotic protein-protein interaction motifs such as ankyrin-repeat (Ank) domains were identified in the O. tsutsugamushi genome. However, little is known about the Ank protein function in O. tsutsugamushi. Methodology/Principal Findings: To characterize the function of Ank proteins, we investigated a group of Ank proteins containing an F-box-like domain in the C-terminus in addition to the Ank domains. All nine selected ank genes were expressed at the transcriptional level in host cells infected with O. tsutsugamushi, and specific antibody responses against three Ank proteins were detected in the serum from human patients, indicating an active expression of the bacterial Ank proteins post infection. When ectopically expressed in HeLa cells, the Ank proteins of O. tsutsugamushi were consistently found in the nucleus and/or cytoplasm. In GST pull-down assays, multiple Ank proteins specifically interacted with Cullin1 and Skp1, core components of the SCF1 ubiquitin ligase complex, as well as the eukaryotic elongation factor 1 alpha (EF1 alpha). Moreover, one Ank protein co-localized with the identified host targets and induced downregulation of EF1 alpha potentially via enhanced ubiquitination. The downregulation of EF1 alpha was observed consistently in diverse host cell types infected with O. tsutsugamushi. Conclusion/Significance: These results suggest that conserved targeting and subsequent degradation of EF1 alpha by multiple O. tsutsugamushi Ank proteins could be a novel bacterial strategy for replication and/or pathogenesis during mammalian host infection.	[Min, Chan-Ki; Kwon, Ye-Jin; Ha, Na-Young; Cho, Bon-A; Kim, Jo-Min; Kwon, Eun-Kyung; Choi, Myung-Sik; Kim, Ik-Sang; Cho, Nam-Hyuk] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea; [Min, Chan-Ki; Ha, Na-Young; Kwon, Eun-Kyung; Cho, Nam-Hyuk] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kim, Yeon-Sook] Chungnam Natl Univ Hosp, Div Infect Dis, Taejon, South Korea; [Cho, Nam-Hyuk] Seoul Natl Univ, Med Res Ctr, Inst Endem Dis, Seoul, South Korea; [Cho, Nam-Hyuk] Bundang Hosp, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Chungnam National University; Chungnam National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Cho, NH (corresponding author), Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea.	chonh@snu.ac.kr		Kim, Yeon-Sook/0000-0003-1142-5488	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A084695, A111503]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A084695, A111503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodor S, 2008, MOL MICROBIOL, V70, P908, DOI 10.1111/j.1365-2958.2008.06453.x; Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Beare PA, 2008, CLIN VACCINE IMMUNOL, V15, P1771, DOI 10.1128/CVI.00300-08; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Caturegli P, 2000, INFECT IMMUN, V68, P5277, DOI 10.1128/IAI.68.9.5277-5283.2000; Chang RY, 2007, J CELL BIOCHEM, V100, P267, DOI 10.1002/jcb.20969; Cho BA, 2010, PROTEOMICS, V10, P1699, DOI 10.1002/pmic.200900633; Cho BA, 2010, INFECT IMMUN, V78, P1915, DOI 10.1128/IAI.01316-09; Cho NH, 2007, P NATL ACAD SCI USA, V104, P7981, DOI 10.1073/pnas.0611553104; Cho NH, 2004, MICROBIOL IMMUNOL, V48, P297, DOI 10.1111/j.1348-0421.2004.tb03510.x; Cho NH, 2002, INFECT IMMUN, V70, P4841, DOI 10.1128/IAI.70.9.4841-4850.2002; Cho NH, 2001, INFECT IMMUN, V69, P1265, DOI 10.1128/IAI.69.3.1265-1272.2001; Cho NH, 2000, INFECT IMMUN, V68, P594, DOI 10.1128/IAI.68.2.594-602.2000; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Darby AC, 2007, TRENDS GENET, V23, P511, DOI 10.1016/j.tig.2007.08.002; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Fuxelius HH, 2007, RES MICROBIOL, V158, P745, DOI 10.1016/j.resmic.2007.09.008; Garcia-Garcia JC, 2009, INFECT IMMUN, V77, P2385, DOI 10.1128/IAI.00023-09; Gillespie JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004833; Gillespie JJ, 2010, INFECT IMMUN, V78, P1809, DOI 10.1128/IAI.01384-09; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Ha NY, 2011, INFECT IMMUN, V79, P1718, DOI 10.1128/IAI.01239-10; Habyarimana F, 2008, ENVIRON MICROBIOL, V10, P1460, DOI 10.1111/j.1462-2920.2007.01560.x; Iturbe-Ormaetxe I, 2005, J BACTERIOL, V187, P5136, DOI 10.1128/JB.187.15.5136-5145.2005; Johnston JB, 2005, J VIROL, V79, P10750, DOI 10.1128/JVI.79.16.10750-10763.2005; Kaur SJ, 2012, J BACTERIOL, V194, P4920, DOI 10.1128/JB.00793-12; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; Kim DM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-108; Kim HR, 2004, MICROB PATHOGENESIS, V36, P219, DOI 10.1016/j.micpath.2003.12.005; Kim MK, 2002, INFECT IMMUN, V70, P4692, DOI 10.1128/IAI.70.8.4692-4696.2002; Kim SW, 2001, INFECT IMMUN, V69, P494, DOI 10.1128/IAI.69.1.494-500.2001; Kweon SS, 2009, EMERG INFECT DIS, V15, P1127, DOI 10.3201/eid1507.080399; Lee JH, 2008, J INFECT DIS, V198, P250, DOI 10.1086/589284; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo T, 2012, INFECT IMMUN, V80, P2297, DOI 10.1128/IAI.00154-12; Luo T, 2010, CLIN VACCINE IMMUNOL, V17, P87, DOI 10.1128/CVI.00331-09; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Mathai E, 2003, ANN NY ACAD SCI, V990, P359, DOI 10.1111/j.1749-6632.2003.tb07391.x; Mercer AA, 2005, VIRUS GENES, V31, P127, DOI 10.1007/s11262-005-1784-z; Min CK, 2008, COMP FUNCT GENOM, DOI 10.1155/2008/623145; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Nakayama K, 2008, DNA RES, V15, P185, DOI 10.1093/dnares/dsn011; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Park J, 2004, CELL MICROBIOL, V6, P743, DOI 10.1111/j.1462-5822.2004.00400.x; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rikihisa Y, 2010, CURR OPIN MICROBIOL, V13, P59, DOI 10.1016/j.mib.2009.12.008; Seong SY, 2001, MICROBES INFECT, V3, P11, DOI 10.1016/S1286-4579(00)01352-6; Shen XH, 2009, CELL MICROBIOL, V11, P911, DOI 10.1111/j.1462-5822.2009.01301.x; Siozios S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055390; Sonnberg S, 2008, P NATL ACAD SCI USA, V105, P10955, DOI 10.1073/pnas.0802042105; Sonthayanon P, 2009, J CLIN MICROBIOL, V47, P430, DOI 10.1128/JCM.01927-08; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Suda K, 2001, IN VITRO CELL DEV-AN, V37, P505; Suputtamongkol Y, 2009, ANN NY ACAD SCI, V1166, P172, DOI 10.1111/j.1749-6632.2009.04514.x; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Voth DE, 2009, J BACTERIOL, V191, P4232, DOI 10.1128/JB.01656-08; Wakeel A, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00022; Watt G, 2003, CURR OPIN INFECT DIS, V16, P429, DOI 10.1097/00001432-200310000-00009; Werden SJ, 2008, BBA-PROTEINS PROTEOM, V1784, P228, DOI 10.1016/j.bbapap.2007.08.001; Werden SJ, 2009, J VIROL, V83, P12068, DOI 10.1128/JVI.00963-09; Wernegreen JJ, 2002, NAT REV GENET, V3, P850, DOI 10.1038/nrg931; Zhang LL, 2009, FEBS LETT, V583, P607, DOI 10.1016/j.febslet.2009.01.023; Zhang SY, 2010, J CLIN MICROBIOL, V48, P1241, DOI 10.1128/JCM.01784-09; Zhu B, 2009, INFECT IMMUN, V77, P4243, DOI 10.1128/IAI.00376-09; 김세윤, 2012, Journal of Bacteriology and Virology, V42, P276, DOI 10.4167/jbv.2012.42.4.276	73	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105652	10.1371/journal.pone.0105652	http://dx.doi.org/10.1371/journal.pone.0105652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166298	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303700034
J	Rinz, CJ; Levine, J; Minor, KM; Humphries, HD; Lara, R; Starr-Moss, AN; Guo, LT; Williams, DC; Shelton, GD; Clark, LA				Rinz, Caitlin J.; Levine, Jonathan; Minor, Katie M.; Humphries, Hammon D.; Lara, Renee; Starr-Moss, Alison N.; Guo, Ling T.; Williams, D. Colette; Shelton, G. Diane; Clark, Leigh Anne			A COLQ Missense Mutation in Labrador Retrievers Having Congenital Myasthenic Syndrome	PLOS ONE			English	Article							PLATE ACETYLCHOLINESTERASE DEFICIENCY; NERVE-CONDUCTION-VELOCITY; TAIL SUBUNIT; GRAVIS; GENE; MYOPATHY; BINDING; LINKAGE; DOGS	Congenital myasthenic syndromes (CMSs) are heterogeneous neuromuscular disorders characterized by skeletal muscle weakness caused by disruption of signal transmission across the neuromuscular junction (NMJ). CMSs are rarely encountered in veterinary medicine, and causative mutations have only been identified in Old Danish Pointing Dogs and Brahman cattle to date. Herein, we characterize a novel CMS in 2 Labrador Retriever littermates with an early onset of marked generalized muscle weakness. Because the sire and dam share 2 recent common ancestors, CMS is likely the result of recessive alleles inherited identical by descent (IBD). Genome-wide SNP profiles generated from the Illumina HD array for 9 nuclear family members were used to determine genomic inheritance patterns in chromosomal regions encompassing 18 functional candidate genes. SNP haplotypes spanning 3 genes were consistent with autosomal recessive transmission, and microsatellite data showed that only the segment encompassing COLQ was inherited IBD. COLQ encodes the collagenous tail of acetylcholinesterase, the enzyme responsible for termination of signal transduction in the NMJ. Sequences from COLQ revealed a variant in exon 14 (c.1010T>C) that results in the substitution of a conserved amino acid (I337T) within the C-terminal domain. Both affected puppies were homozygous for this variant, and 16 relatives were heterozygous, while 288 unrelated Labrador Retrievers and 112 dogs of other breeds were wild-type. A recent study in which 2 human CMS patients were found to be homozygous for an identical COLQ mutation (c.1010T>C; I337T) provides further evidence that this mutation is pathogenic. This report describes the first COLQ mutation in canine CMS and demonstrates the utility of SNP profiles from nuclear family members for the identification of private mutations.	[Rinz, Caitlin J.; Starr-Moss, Alison N.; Clark, Leigh Anne] Clemson Univ, Coll Agr Forestry & Life Sci, Dept Biochem & Genet, Clemson, SC USA; [Levine, Jonathan] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX USA; [Minor, Katie M.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Humphries, Hammon D.; Guo, Ling T.; Shelton, G. Diane] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Lara, Renee] Kingdom Anim Hosp, Bryan, TX USA; [Williams, D. Colette] Univ Calif Davis, R Prichard Vet Med Teaching Hosp, Davis, CA 95616 USA	Clemson University; Texas A&M University System; Texas A&M University College Station; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego; University of California System; University of California Davis	Shelton, GD (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA.	gshelton@ucsd.edu; lclark4@clemson.edu	Fiumefreddo, Andrea/T-2977-2019		National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R15AR062868]; Canine Health Foundation [01311]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R15AR062868] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Canine Health Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number R15AR062868 (LAC) and the Canine Health Foundation under Award Number 01311 (ANSM). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or Canine Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abicht A., 2012, CONGENITAL MYASTHENI; Arredondo J, 2014, HUM GENET, V133, P599, DOI 10.1007/s00439-013-1391-3; Beggs AH, 2010, P NATL ACAD SCI USA, V107, P14697, DOI 10.1073/pnas.1003677107; Cargill EJ, 2002, GENOMICS, V80, P250, DOI 10.1006/geno.2002.6827; Clark LA, 2004, GENOMICS, V84, P550, DOI 10.1016/j.ygeno.2004.06.006; Dickinson PJ, 2005, J VET INTERN MED, V19, P920, DOI 10.1892/0891-6640(2005)19[920:CMGISM]2.0.CO;2; Dubowitz V, 2007, HISTOLOGICAL HISTOCH, P21; ENGEL AG, 1977, ANN NEUROL, V1, P315, DOI 10.1002/ana.410010403; FLAGSTAD A, 1989, ACTA VET SCAND, V30, P89; Gill JL, 2012, NEUROBIOL DIS, V45, P130, DOI 10.1016/j.nbd.2011.07.014; Hantai D, 2013, CURR OPIN NEUROL, V26, P561, DOI 10.1097/WCO.0b013e328364dc0f; Ishigaki K, 2003, NEUROMUSCULAR DISORD, V13, P236, DOI 10.1016/S0960-8966(02)00243-2; JOHNSON RP, 1975, J SMALL ANIM PRACT, V16, P641, DOI 10.1111/j.1748-5827.1975.tb05790.x; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; Kimbell LM, 2004, J BIOL CHEM, V279, P10997, DOI 10.1074/jbc.M305462200; Kraner S, 2002, NEUROGENETICS, V4, P87, DOI 10.1007/s10048-002-0134-8; LINDSTROM J, 1988, ADV IMMUNOL, V42, P233, DOI 10.1016/S0065-2776(08)60847-0; LINDSTROM JM, 1978, NEUROLOGY, V28, P130, DOI 10.1212/WNL.28.2.130; Matlik HN, 2014, PEDIATR NEUROL, V51, P165, DOI 10.1016/j.pediatrneurol.2014.03.012; Mihaylova V, 2008, BRAIN, V131, P747, DOI 10.1093/brain/awm325; MILLER LM, 1983, J AM VET MED ASSOC, V182, P694; Nakayama Tsunetomo, 2013, Hana Abu, V36, P1; ODA K, 1984, MUSCLE NERVE, V7, P705, DOI 10.1002/mus.880070904; Ohno K, 2000, ANN NEUROL, V47, P162, DOI 10.1002/1531-8249(200002)47:2<162::AID-ANA5>3.0.CO;2-Q; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; PALMER AC, 1974, VET REC, V95, P452, DOI 10.1136/vr.95.20.452; Patterson EE, 2008, NAT GENET, V40, P1235, DOI 10.1038/ng.224; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Proschowsky HF, 2007, J HERED, V98, P539, DOI 10.1093/jhered/esm026; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Safra N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003646; Seppala EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056825; SIMS MH, 1980, AM J VET RES, V41, P1247; SWALLOW JS, 1977, RES VET SCI, V23, P29, DOI 10.1016/S0034-5288(18)33218-1; Vernau KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057195; Wargon I, 2012, NEUROMUSCULAR DISORD, V22, P318, DOI 10.1016/j.nmd.2011.09.002; Zangerl B, 2006, GENOMICS, V88, P551, DOI 10.1016/j.ygeno.2006.07.007	37	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106425	10.1371/journal.pone.0106425	http://dx.doi.org/10.1371/journal.pone.0106425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166616	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303700091
J	Wani, S; Yuda, M; Fujiwara, Y; Yamamoto, M; Harada, F; Ohkuma, Y; Hirose, Y				Wani, Shotaro; Yuda, Masamichi; Fujiwara, Yosuke; Yamamoto, Masaya; Harada, Fumio; Ohkuma, Yoshiaki; Hirose, Yutaka			Vertebrate Ssu72 Regulates and Coordinates 3 '-End Formation of RNAs Transcribed by RNA Polymerase II	PLOS ONE			English	Article							C-TERMINAL DOMAIN; MESSENGER-RNA; GENE-EXPRESSION; POLYADENYLATION FACTOR; CTD CYCLE; PHOSPHATASE; YEAST; COMPLEX; PROTEIN; KINASE	In eukaryotes, the carboxy-terminal domain (CTD) of the largest subunit of RNA polymerase II (Pol II) is composed of tandem repeats of the heptapeptide YSPTSPS, which is subjected to reversible phosphorylation at Ser2, Ser5, and Ser7 during the transcription cycle. Dynamic changes in CTD phosphorylation patterns, established by the activities of multiple kinases and phosphatases, are responsible for stage-specific recruitment of various factors involved in RNA processing, histone modification, and transcription elongation/termination. Yeast Ssu72, a CTD phosphatase specific for Ser5 and Ser7, functions in 3'-end processing of pre-mRNAs and in transcription termination of small non-coding RNAs such as snoRNAs and snRNAs. Vertebrate Ssu72 exhibits Ser5- and Ser7-specific CTD phosphatase activity in vitro, but its roles in gene expression and CTD dephosphorylation in vivo remain to be elucidated. To investigate the functions of vertebrate Ssu72 in gene expression, we established chicken DT40 B-cell lines in which Ssu72 expression was conditionally inactivated. Ssu72 depletion in DT40 cells caused defects in 3'-end formation of U2 and U4 snRNAs and GAPDH mRNA. Surprisingly, however, Ssu72 inactivation increased the efficiency of 3'-end formation of non-polyadenylated replication-dependent histone mRNA. Chromatin immunoprecipitation analyses revealed that Ssu72 depletion caused a significant increase in both Ser5 and Ser7 phosphorylation of the Pol II CTD on all genes in which 3'-end formation was affected. These results suggest that vertebrate Ssu72 plays positive roles in 3'-end formation of snRNAs and polyadenylated mRNAs, but negative roles in 3'-end formation of histone mRNAs, through dephosphorylation of both Ser5 and Ser7 of the CTD.	[Wani, Shotaro; Fujiwara, Yosuke; Yamamoto, Masaya; Ohkuma, Yoshiaki; Hirose, Yutaka] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Lab Gene Regulat, Sugitani, Toyama, Japan; [Yuda, Masamichi; Harada, Fumio] Kanagawa Univ, Inst Canc Res, Dept Mol & Cellular Biol, Kanazawa, Ishikawa, Japan	University of Toyama; Kanagawa University	Hirose, Y (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Lab Gene Regulat, Sugitani, Toyama, Japan.	yh620@pha.u-toyama.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan; Japan Science and Technology Agency	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports, and Culture of Japan and a Grant-in-Aid for Solution-Oriented Research for Science and Technology from the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Anamika K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038769; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Caldwell Randolph B., 2007, V408, P193, DOI 10.1007/978-1-59745-547-3_11; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Egloff S, 2012, MOL CELL, V45, P111, DOI 10.1016/j.molcel.2011.11.006; Egloff S, 2010, J BIOL CHEM, V285, P20564, DOI 10.1074/jbc.M110.132530; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; Ghazy MA, 2009, MOL CELL BIOL, V29, P2296, DOI 10.1128/MCB.01514-08; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Hausmann S, 2002, J BIOL CHEM, V277, P21213, DOI 10.1074/jbc.M202056200; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; Hintermair C, 2012, EMBO J, V31, P2784, DOI 10.1038/emboj.2012.123; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Hirose Y, 2008, BIOCHEM BIOPH RES CO, V369, P449, DOI 10.1016/j.bbrc.2008.02.042; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Hsin JP, 2011, SCIENCE, V334, P683, DOI 10.1126/science.1206034; Jeronimo C, 2013, CHEM REV, V113, P8491, DOI 10.1021/cr4001397; Kim HS, 2010, EMBO J, V29, P3544, DOI 10.1038/emboj.2010.217; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Lin PS, 2002, J BIOL CHEM, V277, P45949, DOI 10.1074/jbc.M208588200; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Luo YH, 2013, ACS CHEM BIOL, V8, P2042, DOI 10.1021/cb400229c; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; O'Reilly D, 2007, GENOMICS, V90, P407, DOI 10.1016/j.ygeno.2007.04.010; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Perkins KJ, 2008, MOL CELL, V29, P56, DOI 10.1016/j.molcel.2007.11.030; Pirngruber J, 2009, EMBO REP, V10, P894, DOI 10.1038/embor.2009.108; St-Pierre B, 2005, NUCLEIC ACIDS RES, V33, P464, DOI 10.1093/nar/gki171; Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Takao N, 1999, ONCOGENE, V18, P7002, DOI 10.1038/sj.onc.1203172; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Werner-Allen JW, 2011, J BIOL CHEM, V286, P5717, DOI 10.1074/jbc.M110.197129; Xiang KH, 2012, GENE DEV, V26, P2265, DOI 10.1101/gad.198853.112; Xiang KH, 2010, NATURE, V467, P729, DOI 10.1038/nature09391; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Yunokuchi I, 2009, GENES CELLS, V14, P1105, DOI 10.1111/j.1365-2443.2009.01339.x; Zhang DW, 2012, J BIOL CHEM, V287, P8541, DOI 10.1074/jbc.M111.335687; Zhang Y, 2006, MOL CELL, V24, P759, DOI 10.1016/j.molcel.2006.10.027; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	56	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106040	10.1371/journal.pone.0106040	http://dx.doi.org/10.1371/journal.pone.0106040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166011	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303700064
J	Shi, B; Ding, JX; Liu, Y; Zhuang, XM; Zhuang, XL; Chen, XS; Fu, CF				Shi, Bo; Ding, Jianxun; Liu, Yi; Zhuang, Xinming; Zhuang, Xiuli; Chen, Xuesi; Fu, Changfeng			ERK1/2 Pathway-Mediated Differentiation of IGF-1-Transfected Spinal Cord-Derived Neural Stem Cells into Oligodendrocytes	PLOS ONE			English	Article							GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; SIGNALING PATHWAYS; DENDRITIC GROWTH; INJURY; NEURONS; REGENERATION; ACTIVATION; APOPTOSIS; SEVERITY	Spinal cord injury (SCI) is a devastating event that causes substantial morbidity and mortality, for which no fully restorative treatments are available. Stem cells transplantation offers some promise in the restoration of neurological function but with limitations. Insulin-like growth factor 1 (IGF-1) is a well-appreciated neuroprotective factor that is involved with various aspects of neural cells. Herein, the IGF-1 gene was introduced into spinal cord-derived neural stem cells (NSCs) and expressed steadily. The IGF-1-transfected NSCs exhibited higher viability and were promoted to differentiate into oligodendrocytes. Moreover, the most possible underlying mechanism, through which IGF-1 exerted its neuroprotective effects, was investigated. The result revealed that the differentiation was mediated by the IGF-1 activated extracellular signal-regulated kinases 1 and 2 (ERK1/2) and its downstream pathway. These findings provide the evidence for revealing the therapeutic merits of IGF-1-modified NSCs for SCI.	[Shi, Bo; Liu, Yi; Zhuang, Xinming; Fu, Changfeng] Jilin Univ, Hosp 1, Dept Spine Surg, Changchun 130023, Peoples R China; [Ding, Jianxun; Zhuang, Xiuli; Chen, Xuesi] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Polymer Ecomat, Changchun 130022, Peoples R China	Jilin University; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS	Ding, JX (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Polymer Ecomat, Changchun 130022, Peoples R China.	jxding@ciac.ac.cn; 13804312088@163.com	Ding, Jianxun/A-6155-2013; Chen, Xuesi/ABB-5039-2020	Ding, Jianxun/0000-0002-5232-8863; shi, bo/0000-0002-5806-1784				Abematsu M, 2014, NEUROPROTECTION REGE, P247; Almad A, 2011, NEUROTHERAPEUTICS, V8, P262, DOI 10.1007/s13311-011-0033-5; Azari MF, 2010, CURR NEUROPHARMACOL, V8, P316, DOI 10.2174/157015910793358204; Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Cheng CM, 2003, J NEUROSCI RES, V73, P1, DOI 10.1002/jnr.10634; DErcole AJ, 1996, MOL NEUROBIOL, V13, P227, DOI 10.1007/BF02740625; Finnerup NB, 2004, EUR J NEUROL, V11, P73, DOI 10.1046/j.1351-5101.2003.00725.x; Furlan JC, 2011, J NEUROTRAUM, V28, P1371, DOI 10.1089/neu.2009.1147; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; Grossman RG, 2012, J NEUROSURG-SPINE, V17, P119, DOI 10.3171/2012.5.AOSPINE12127; Hung KS, 2007, J NEUROSURG-SPINE, V6, P35, DOI 10.3171/spi.2007.6.1.35; Ishii A, 2013, J NEUROSCI, V33, P175, DOI 10.1523/JNEUROSCI.4403-12.2013; Kooijman R, 2006, CYTOKINE GROWTH F R, V17, P305, DOI 10.1016/j.cytogfr.2006.02.002; La Spada A, 2010, HUM MOL GENET, V19, pR1, DOI 10.1093/hmg/ddq193; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Mason JL, 2000, J NEUROSCI, V20, P5703, DOI 10.1523/JNEUROSCI.20-15-05703.2000; Niblock MM, 2000, J NEUROSCI, V20, P4165; Oh MJ, 2009, J NEUROTRAUM, V26, P2071, DOI [10.1089/neu.2008.0800, 10.1089/neu.2008-0800]; Park SY, 2011, ADV MATER, V23, pH263, DOI 10.1002/adma.201101503; Pernet V, 2005, J NEUROCHEM, V93, P72, DOI 10.1111/j.1471-4159.2005.03002.x; Rubinfeld Hadara, 2004, Methods Mol Biol, V250, P1; Sabelstrom H, 2013, EXP NEUROL; SANDOCK DS, 1995, PARAPLEGIA, V33, P156, DOI 10.1038/sc.1995.34; Sasaki T, 2002, NEUROSURGERY, V51, P1477, DOI 10.1097/00006123-200212000-00019; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Tzeng SF, 2002, J BIOMED SCI, V9, P10, DOI 10.1159/000048194; Varma AK, 2013, NEUROCHEM RES, V38, P895, DOI 10.1007/s11064-013-0991-6; Xiao JH, 2012, J NEUROCHEM, V122, P1167, DOI 10.1111/j.1471-4159.2012.07871.x; Yanagiuchi A, 2009, BJU INT, V103, P1569, DOI 10.1111/j.1464-410X.2008.08318.x; YAO DL, 1995, J NEUROSCI RES, V40, P647, DOI 10.1002/jnr.490400510; Yao DL, 1996, LIFE SCI, V58, P1301, DOI 10.1016/0024-3205(96)00095-1; Ye P, 1999, ENDOCRINOLOGY, V140, P3063, DOI 10.1210/en.140.7.3063; Younes-Rapozo V, 2009, INT J DEV NEUROSCI, V27, P757, DOI 10.1016/j.ijdevneu.2009.08.014	38	16	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106038	10.1371/journal.pone.0106038	http://dx.doi.org/10.1371/journal.pone.0106038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162639	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900081
J	Chen, ZX; Li, C; Xu, YN; Li, YJ; Yang, H; Rao, L				Chen, Zhongxiu; Li, Chen; Xu, Yuanning; Li, Yajiao; Yang, Hao; Rao, Li			Circulating Level of miR-378 Predicts Left Ventricular Hypertrophy in Patients with Aortic Stenosis	PLOS ONE			English	Article							VALVULAR HEART-DISEASE; CARDIAC-HYPERTROPHY; VALVE STENOSIS; POTENTIAL BIOMARKERS; GENE-EXPRESSION; MICRORNAS; REPRESSION; RECOMMENDATIONS; PROLIFERATION; MASS	Aims: Excessively high left ventricle mass is an independent predictor of adverse prognosis. MicroRNAs (miRs) play crucial roles in the regulation of left ventricle hypertrophy (LVH). However, few circulating miRs have been established as predictors of LVH in aortic stenosis (AS) patients. In this study, we aimed to investigate whether circulating levels of miR-1, miR-133, and miR-378 predict LVH in patients with AS. Methods and Results: One-hundred twelve patients with moderate to severe AS and 40 healthy controls were included in the study. Levels of miR-1, miR-133, and miR-378 in the plasma were measured by qPCR. Compared with healthy controls, AS patients had significantly lower circulating levels of miR-1, miR-133, and miR-378. AS patients with LVH had significantly lower miR-378 but not miR-1 and miR-133 compared with those without LVH. Linear regression analysis showed circulating miR-378 had strong correlation with left ventricular mass index (r = 0.283, p = 0.002) and logistic regression showed that lower miR-378 was an independent predictor for LVH in patients with AS (p = 0.037, OR 4.110, 95% CI 1.086 to 15.558). Conclusion: Circulating levels of miR-1, miR-133 and miR-378 were decreased in AS patients, and miR-378 predicts LVH independent of the pressure gradient. Further prospective investigations are needed to elucidate whether these circulating miRs affect clinical outcome.	[Chen, Zhongxiu; Li, Chen; Xu, Yuanning; Li, Yajiao; Yang, Hao; Rao, Li] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610064, Peoples R China	Sichuan University	Rao, L (corresponding author), Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610064, Peoples R China.	lrlz1989@163.com			Natural Science Foundation of China [81300169, 81270289]; Science & Technology Pillar Program of Sichuan Province [2013SZ0082]; Doctoral Fund of Ministry of Education of China [20110181110011]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Pillar Program of Sichuan Province; Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This study was funded by the grant from Natural Science Foundation of China (grant number: 81300169, 81270289), Science & Technology Pillar Program of Sichuan Province (grant number: 2013SZ0082), and Doctoral Fund of Ministry of Education of China (grant number: 20110181110011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Baggish AL, 2014, J APPL PHYSIOL, V116, P522, DOI 10.1152/japplphysiol.01141.2013; Bagnall RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044744; Baumgartner H, 2009, EUR J ECHOCARDIOGR, V10, P1, DOI 10.1093/ejechocard/jen303; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JH, 2012, J MOL CELL CARDIOL, V52, P949, DOI 10.1016/j.yjmcc.2012.01.012; Cioffi G, 2011, HEART, V97, P301, DOI 10.1136/hrt.2010.192997; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cramariuc D, 2010, HEART, V96, P106, DOI 10.1136/hrt.2009.172569; Dong DL, 2010, HYPERTENSION, V55, P946, DOI 10.1161/HYPERTENSIONAHA.109.139519; Dweck MR, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-50; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ganesan J, 2013, CIRCULATION, V127, P2097, DOI 10.1161/CIRCULATIONAHA.112.000882; Garcia R, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000211; HE L, 2004, NAT REV GENET, V5, P522; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Iung B, 2011, NAT REV CARDIOL, V8, P162, DOI 10.1038/nrcardio.2010.202; Karakikes I, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000078; Kumarswamy R, 2013, CIRC RES, V113, P676, DOI 10.1161/CIRCRESAHA.113.300226; Kupari M, 2005, EUR HEART J, V26, P1790, DOI 10.1093/eurheartj/ehi290; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mooren FC, 2014, AM J PHYSIOL-HEART C, V306, pH557, DOI 10.1152/ajpheart.00711.2013; Mureddu GF, 2009, J HYPERTENS, V27, P642, DOI 10.1097/HJH.0b013e32831cec98; Nagalingam RS, 2013, J BIOL CHEM, V288, P11216, DOI 10.1074/jbc.M112.442384; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Owens DS, 2010, AM J CARDIOL, V105, P701, DOI 10.1016/j.amjcard.2009.10.071; Redova M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-55; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Villar AV, 2011, HEART, V97, P1132, DOI 10.1136/hrt.2010.220418; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Zanutto S, 2014, BRIT J CANCER, V110, P1001, DOI 10.1038/bjc.2013.819	39	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105702	10.1371/journal.pone.0105702	http://dx.doi.org/10.1371/journal.pone.0105702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157568	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303200048
J	Chaturvedi, R; de Sablet, T; Asim, M; Piazuelo, MB; Barry, DP; Verriere, TG; Sierra, JC; Hardbower, DM; Delgado, AG; Schneider, BG; Israel, DA; Romero-Gallo, J; Nagy, TA; Morgan, DR; Murray-Stewart, T; Bravo, LE; Peek, RM; Fox, JG; Woster, PM; Caser, RA; Correa, P; Wilson, KT				Chaturvedi, R.; de Sablet, T.; Asim, M.; Piazuelo, M. B.; Barry, D. P.; Verriere, T. G.; Sierra, J. C.; Hardbower, D. M.; Delgado, A. G.; Schneider, B. G.; Israel, D. A.; Romero-Gallo, J.; Nagy, T. A.; Morgan, D. R.; Murray-Stewart, T.; Bravo, L. E.; Peek, R. M., Jr.; Fox, J. G.; Woster, P. M.; Caser, R. A.; Correa, P., Jr.; Wilson, K. T.			Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase	ONCOGENE			English	Article							NECROSIS-FACTOR-ALPHA; EPITHELIAL-CELLS; BIOLOGICAL-ACTIVITY; GENE POLYMORPHISMS; CAGA; INFECTION; CARCINOGENESIS; INDUCTION; APOPTOSIS; LESIONS	Helicobacter pylori infection causes gastric cancer, the third leading cause of cancer death worldwide. More than half of the world's population is infected, making universal eradication impractical. Clinical trials suggest that antibiotic treatment only reduces gastric cancer risk in patients with non-atrophic gastritis (NAG), and is ineffective once preneoplastic lesions of multifocal atrophic gastritis (MAG) and intestinal metaplasia (IM) have occurred. Therefore, additional strategies for risk stratification and chemoprevention of gastric cancer are needed. We have implicated polyamines, generated by the rate-limiting enzyme ornithine decarboxylase (ODC), in gastric carcinogenesis. During H. pylori infection, the enzyme spermine oxidase (SMOX) is induced, which generates hydrogen peroxide from the catabolism of the polyamine spermine. Herein, we assessed the role of SMOX in the increased gastric cancer risk in Colombia associated with the Andean mountain region when compared with the low-risk region on the Pacific coast. When cocultured with gastric epithelial cells, clinical strains of H. pylori from the high-risk region induced more SMOX expression and oxidative DNA damage, and less apoptosis than low-risk strains. These findings were not attributable to differences in the cytotoxin-associated gene A oncoprotein. Gastric tissues from subjects from the high-risk region exhibited greater levels of SMOX and oxidative DNA damage by immunohistochemistry and flow cytometry, and this occurred in NAG, MAG and IM. In Mongolian gerbils, a prototype colonizing strain from the high-risk region induced more SMOX, DNA damage, dysplasia and adenocarcinoma than a colonizing strain from the low-risk region. Treatment of gerbils with either alpha-difluoromethylornithine, an inhibitor of ODC, or MDL 72527 (N-1, N-4-Di(buta-2,3-dien-1-yl) butane-1,4-diamine dihydrochloride), an inhibitor of SMOX, reduced gastric dysplasia and carcinoma, as well as apoptosis-resistant cells with DNA damage. These data indicate that aberrant activation of polyamine-driven oxidative stress is a marker of gastric cancer risk and a target for chemoprevention.	[Chaturvedi, R.; de Sablet, T.; Asim, M.; Piazuelo, M. B.; Barry, D. P.; Verriere, T. G.; Sierra, J. C.; Hardbower, D. M.; Delgado, A. G.; Schneider, B. G.; Israel, D. A.; Romero-Gallo, J.; Nagy, T. A.; Morgan, D. R.; Peek, R. M., Jr.; Correa, P., Jr.; Wilson, K. T.] Vanderbilt Univ, Div Gastroenterol Hepatol & Nutr, Dept Med, Med Ctr, Nashville, TN 37232 USA; [Hardbower, D. M.; Peek, R. M., Jr.; Wilson, K. T.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Med Ctr, Nashville, TN 37232 USA; [Murray-Stewart, T.; Correa, P., Jr.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Bravo, L. E.] Univ Valle, Sch Med, Dept Pathol, Cali, Colombia; [Fox, J. G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Woster, P. M.] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Wilson, K. T.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA; [Wilson, K. T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Johns Hopkins University; Johns Hopkins Medicine; Universidad del Valle; Massachusetts Institute of Technology (MIT); Medical University of South Carolina; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Wilson, KT (corresponding author), Vanderbilt Univ, Div Gastroenterol Hepatol & Nutr, Dept Med, Sch Med, 1030C MRB 4,2215B Garland Ave, Nashville, TN 37232 USA.	keith.wilson@vanderbilt.edu	Barry, Daniel P/B-5647-2008; Bravo, Luis Eduardo/G-9671-2013; Woster, Patrick M/A-5604-2010; Stewart, Tracy Murray/B-6137-2017; de Sablet, Thibaut/AAI-4513-2020; Bravo, Luis Eduardo/AAB-7209-2019; Bravo, Luis/K-9882-2014	Barry, Daniel P/0000-0002-3972-3914; Woster, Patrick M/0000-0002-9471-1916; Stewart, Tracy Murray/0000-0001-8679-6414; Bravo, Luis Eduardo/0000-0002-9708-0312; Bravo, Luis/0000-0002-9708-0312; Wilson, Keith/0000-0003-4421-1830; Casero, Robert/0000-0001-5653-3306; Schneider, Barbara/0000-0003-4421-1355	National Institutes of Health [R01DK053620, R01AT004821, P01CA028842, P01CA116087, R01CA077955, R01DK058587, R01CA051085, R01CA098454, K01AT007324]; Flow Cytometry Core of the Vanderbilt Digestive Disease Research Center [P30DK058404]; Flow Cytometry Core of the Vanderbilt Ingram Cancer Center [P30CA68485]; Office of Medical Research, Department of Veterans Affairs [1I01BX001453]; Philippe Foundation;  [UL1RR024975];  [T32GM008554]; NATIONAL CANCER INSTITUTE [R01CA077955, R01CA051085, P01CA116087, P01CA028842, R01CA190612, P30CA068485, R01CA098454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [K01AT007324] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058587, R01DK053620, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flow Cytometry Core of the Vanderbilt Digestive Disease Research Center; Flow Cytometry Core of the Vanderbilt Ingram Cancer Center; Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); Philippe Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by National Institutes of Health Grants R01DK053620 and R01AT004821 (to KTW), P01CA028842 (to KTW, JGF and PC), P01CA116087 (to RMP and KTW), R01CA077955 and R01DK058587 (to RMP), R01CA051085 and R01CA098454 (to RAC), K01AT007324 (to RC), the Flow Cytometry Core of the Vanderbilt Digestive Disease Research Center grant (P30DK058404), the Flow Cytometry Core of the Vanderbilt Ingram Cancer Center (P30CA68485), UL1RR024975 (Vanderbilt CTSA, Pilot Project to KTW) and Merit Review Grant 1I01BX001453 from the Office of Medical Research, Department of Veterans Affairs (to KTW). DMH was supported by T32GM008554. TDS was supported in part by the Philippe Foundation.	Babbar N, 2006, CANCER RES, V66, P11125, DOI 10.1158/0008-5472.CAN-06-3174; Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Basu HS, 2009, CANCER RES, V69, P7689, DOI 10.1158/0008-5472.CAN-08-2472; BLASER MJ, 1995, CANCER RES, V55, P2111; Bravo LE, 2002, AM J GASTROENTEROL, V97, P2839, DOI 10.1111/j.1572-0241.2002.07031.x; CASERO RA, 1989, CANCER RES, V49, P3829; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; Chaturvedi R, 2014, GASTROENTEROLOGY, V146, P1739, DOI 10.1053/j.gastro.2014.02.005; Chaturvedi R, 2011, GASTROENTEROLOGY, V141, P1696, DOI 10.1053/j.gastro.2011.07.045; Chaturvedi R, 2010, GASTROENTEROLOGY, V139, P1686, DOI 10.1053/j.gastro.2010.06.060; Chen Y, 2008, J INFECT DIS, V198, P553, DOI 10.1086/590158; CORREA P, 1976, JNCI-J NATL CANCER I, V57, P1027, DOI 10.1093/jnci/57.5.1027; CORREA P, 1988, CANCER RES, V48, P3554; CORREA P, 1990, CANCER RES, V50, P4731; Correa P, 2010, AM J GASTROENTEROL, V105, P493, DOI 10.1038/ajg.2009.728; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; CUELLO C, 1976, JNCI-J NATL CANCER I, V57, P1015, DOI 10.1093/jnci/57.5.1015; de Sablet T, 2011, GUT, V60, P1189, DOI 10.1136/gut.2010.234468; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dominguez RL, 2013, CANCER CAUSE CONTROL, V24, P233, DOI 10.1007/s10552-012-0109-5; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Figueiredo C, 2002, J NATL CANCER I, V94, P1680, DOI 10.1093/jnci/94.22.1680; Franco AT, 2008, CANCER RES, V68, P379, DOI 10.1158/0008-5472.CAN-07-0824; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108; Hardbower DM, 2013, GUT MICROBES, V4, P475, DOI 10.4161/gmic.25583; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Kodaman N, 2014, P NATL ACAD SCI USA, V111, P1455, DOI 10.1073/pnas.1318093111; Koike T, 1999, AM J GASTROENTEROL, V94, P3468, DOI 10.1111/j.1572-0241.1999.01593.x; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; Mera R, 2005, GUT, V54, P1536, DOI 10.1136/gut.2005.072009; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Morgan DR, 2013, JAMA-J AM MED ASSOC, V309, P578, DOI 10.1001/jama.2013.311; Moss SF, 1996, GUT, V38, P498, DOI 10.1136/gut.38.4.498; Nagy TA, 2009, J INFECT DIS, V199, P641, DOI 10.1086/596660; Naito M, 2006, GASTROENTEROLOGY, V130, P1181, DOI 10.1053/j.gastro.2005.12.038; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peek RM, 2010, PHYSIOL REV, V90, P831, DOI 10.1152/physrev.00039.2009; Sheh A, 2013, INFECT IMMUN, V81, P2468, DOI 10.1128/IAI.01182-12; Sicinschi LA, 2010, CLIN MICROBIOL INFEC, V16, P369, DOI 10.1111/j.1469-0691.2009.02811.x; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; Torres J, 2013, CANCER CAUSE CONTROL, V24, P249, DOI 10.1007/s10552-012-0114-8; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; TUMMURU MKR, 1994, INFECT IMMUN, V62, P2609, DOI 10.1128/IAI.62.6.2609-2613.1994; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Valentin-Vega YA, 2008, CELL DEATH DIFFER, V15, P1772, DOI 10.1038/cdd.2008.109; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Xu HX, 2004, CANCER RES, V64, P8521, DOI 10.1158/0008-5472.CAN-04-3511; You WC, 2006, JNCI-J NATL CANCER I, V98, P974, DOI 10.1093/jnci/djj264; Zabaleta J, 2006, AM J GASTROENTEROL, V101, P163, DOI 10.1111/j.1572-0241.2006.00387.x; Zell JA, 2010, J NATL CANCER I, V102, P1513, DOI 10.1093/jnci/djq325	55	66	69	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	26					3429	3440		10.1038/onc.2014.273	http://dx.doi.org/10.1038/onc.2014.273			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CL3SU	25174398	Green Submitted, Green Accepted			2022-12-25	WOS:000356871700008
J	Khan, WA; Khan, M; Malik, R				Khan, Waqar Azeem; Khan, Masood; Malik, Rabia			Three-Dimensional Flow of an Oldroyd-B Nanofluid towards Stretching Surface with Heat Generation/Absorption	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; FREE-CONVECTION; VISCOUS-FLOW; SHEET; ONSET	This article addresses the steady three-dimensional flow of an Oldroyd-B nanofluid over a bidirectional stretching surface with heat generation/absorption effects. Suitable similarity transformations are employed to reduce the governing partial differential equations into coupled nonlinear ordinary differential equations. These nonlinear ordinary differential equations are then solved analytically by using the homotpy analysis method (HAM). Graphically results are presented and discussed for various parameters, namely, Deborah numbers beta(1) and beta(2), heat generation/absorption parameter lambda, Prandtl parameter Pr, Brownian motion parameters N-b, thermophoresis parameter N-t and Lewis number Le. We have seen that the increasing values of the Brownian motion parameter N-t and thermophoresis parameter N-t leads to an increase in the temperature field and thermal boundary layer thickness while the opposite behavior is observed for concentration field and concentration boundary layer thickness. To see the validity of the present work, the numerical results are compared with the analytical solutions obtained by Homotopy analysis method and noted an excellent agreement for the limiting cases.	[Khan, Waqar Azeem; Khan, Masood; Malik, Rabia] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan	Quaid I Azam University	Khan, WA (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	Waqar_qau85@yahoo.com	KHAN, Masood/AAA-7384-2020; Khan, Dr. Waqar Azeem/AAZ-9625-2021; khan, Masood/F-7143-2015	KHAN, Masood/0000-0003-4404-1456; 	Higher Education Commission (HEC) of Pakistan	Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan)	This work has the financial support of the Higher Education Commission (HEC) of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaedi A, 2012, COMMUN NONLINEAR SCI, V17, P4210, DOI 10.1016/j.cnsns.2012.03.008; Ariel PD, 2007, COMPUT MATH APPL, V54, P920, DOI 10.1016/j.camwa.2006.12.066; Aziz A, 2012, INT J THERM SCI, V52, P83, DOI 10.1016/j.ijthermalsci.2011.10.001; Bachok N, 2012, INT J HEAT MASS TRAN, V55, P2102, DOI 10.1016/j.ijheatmasstransfer.2011.12.013; Chamkha AJ, 2011, CHEM ENG COMMUN, V198, P425, DOI 10.1080/00986445.2010.520232; Chand R, 2012, J FLUID ENG-T ASME, V134, DOI 10.1115/1.4007901; Chand R, 2012, TRANSPORT POROUS MED, V95, P269, DOI 10.1007/s11242-012-0042-9; Chand R, 2012, INT J HEAT MASS TRAN, V55, P5417, DOI 10.1016/j.ijheatmasstransfer.2012.04.043; Cheng CY, 2012, INT COMMUN HEAT MASS, V39, P931, DOI 10.1016/j.icheatmasstransfer.2012.05.014; Choi S. U., 1995, DEV APPL NONNEWTONIA, V231, P99; Choi SUS, 2001, APPL PHYS LETT, V79, P2252, DOI 10.1063/1.1408272; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Elbashbeshy E. M. A., 2001, Archives of Mechanics, V53, P643; Hady FM, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-229; Hamad MAA, 2012, APPL MATH MECH-ENGL, V33, P923, DOI 10.1007/s10483-012-1595-7; Hamad MAA, 2011, NONLINEAR ANAL-REAL, V12, P1338, DOI 10.1016/j.nonrwa.2010.09.014; Ishak A, 2008, PHYS LETT A, V372, P559, DOI 10.1016/j.physleta.2007.08.003; Kameswaran PK, 2012, INT J HEAT MASS TRAN, V55, P7587, DOI 10.1016/j.ijheatmasstransfer.2012.07.065; Khan WA, 2011, J HEAT TRANS-T ASME, V133, DOI 10.1115/1.4003834; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Matin MH, 2012, J THERM SCI TECH-JPN, V7, P104, DOI 10.1299/jtst.7.104; Nadeem S, 2014, APPL NANOSCI, V4, P1005, DOI 10.1007/s13204-013-0282-1; Nadeem S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069811; Nandy SK, 2013, INT J HEAT MASS TRAN, V64, P1091, DOI 10.1016/j.ijheatmasstransfer.2013.05.040; Narayana M, 2012, INT J HEAT MASS TRAN, V55, P7552, DOI 10.1016/j.ijheatmasstransfer.2012.07.054; Rana GC, 2014, FME TRANS, V42, P1, DOI 10.5937/fmet1401001R; Rana GC, 2013, J APPL FLUID MECH, V6, P87; Rana GC, 2011, JARAM, V3, P44; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; Shehzad SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078240; WANG CY, 1989, Z ANGEW MATH MECH, V69, P418, DOI 10.1002/zamm.19890691115	33	88	89	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105107	10.1371/journal.pone.0105107	http://dx.doi.org/10.1371/journal.pone.0105107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170945	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500029
J	Norris, D; Fortin, MJ; Magnusson, WE				Norris, Darren; Fortin, Marie-Josee; Magnusson, William E.			Towards Monitoring Biodiversity in Amazonian Forests: How Regular Samples Capture Meso-Scale Altitudinal Variation in 25 km(2) Plots	PLOS ONE			English	Article							ECOLOGY; OPTIMIZATION; CONSERVATION; GRADIENTS; EVOLUTION; RICHNESS; MULTIPLE; PATTERNS; SERVICES; DESIGN	Background: Ecological monitoring and sampling optima are context and location specific. Novel applications (e.g. biodiversity monitoring for environmental service payments) call for renewed efforts to establish reliable and robust monitoring in biodiversity rich areas. As there is little information on the distribution of biodiversity across the Amazon basin, we used altitude as a proxy for biological variables to test whether meso-scale variation can be adequately represented by different sample sizes in a standardized, regular-coverage sampling arrangement. Methodology/Principal Findings: We used Shuttle-Radar-Topography-Mission digital elevation values to evaluate if the regular sampling arrangement in standard RAPELD (rapid assessments ("RAP'') over the long-term (LTER ["PELD'' in Portuguese])) grids captured patters in meso-scale spatial variation. The adequacy of different sample sizes (n = 4 to 120) were examined within 32,325 km(2)/3,232,500 ha (1293x25 km(2) sample areas) distributed across the legal Brazilian Amazon. Kolmogorov-Smirnov-tests, correlation and root-mean-square-error were used to measure sample representativeness, similarity and accuracy respectively. Trends and thresholds of these responses in relation to sample size and standard-deviation were modeled using Generalized-Additive-Models and conditional-inference-trees respectively. We found that a regular arrangement of 30 samples captured the distribution of altitude values within these areas. Sample size was more important than sample standard deviation for representativeness and similarity. In contrast, accuracy was more strongly influenced by sample standard deviation. Additionally, analysis of spatially interpolated data showed that spatial patterns in altitude were also recovered within areas using a regular arrangement of 30 samples. Conclusions/Significance: Our findings show that the logistically feasible sample used in the RAPELD system successfully recovers meso-scale altitudinal patterns. This suggests that the sample size and regular arrangement may also be generally appropriate for quantifying spatial patterns in biodiversity at similar scales across at least 90% (approximate to 5 million km(2)) of the Brazilian Amazon.	[Norris, Darren] Univ Fed Amapa, Programa Posgrad Biodiversidade Trop, Macapa, Amapa, Brazil; [Fortin, Marie-Josee] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 1A1, Canada; [Norris, Darren; Magnusson, William E.] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil	Fundacao Universidade Federal do Amapa; University of Toronto; Institute Nacional de Pesquisas da Amazonia	Norris, D (corresponding author), Univ Fed Amapa, Programa Posgrad Biodiversidade Trop, Macapa, Amapa, Brazil.	dnorris75@gmail.com	Norris, Darren/J-5182-2012	Norris, Darren/0000-0003-0015-8214	Brazilian National Counsel of Technological and Scientific Development ("Conselho Nacional de Desenvolvimento Cientifico e Tecnologico'' -CNPq) [401370/2012-7]; CNPq [159806/2012-7, 164999/2013-2]; CAPES [PNPD20130074]	Brazilian National Counsel of Technological and Scientific Development ("Conselho Nacional de Desenvolvimento Cientifico e Tecnologico'' -CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank the Brazilian National Counsel of Technological and Scientific Development ("Conselho Nacional de Desenvolvimento Cientifico e Tecnologico'' -CNPq) for the financial support provided through the Science Without Borders Program ("Ciencia sem Fronteiras'' - process 401370/2012-7). WM held a Bolsa de Produtividade scholarship from CNPq. DN thanks CNPq (process 159806/2012-7 & 164999/2013-2) and CAPES (PNPD20130074) for the scholarships granted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonar Scott A., 2011, P11; Costa FRC, 2010, NAT CONSERVACAO, V8, P3, DOI 10.4322/natcon.00801001; Certain G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018930; Cintra R, 2011, INT J ECOLOGY; Costa FRC, 2009, J VEG SCI, V20, P69, DOI 10.1111/j.1654-1103.2009.05314.x; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; DePatta VP, 1998, ABSTR BOT, V22, P37, DOI 10.2307/43518936; Dickson B, 2012, CURR OPIN ENV SUST, V4, P717, DOI 10.1016/j.cosust.2012.09.017; Druce DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003979; Drucker DP, 2008, J TROP ECOL, V24, P65, DOI 10.1017/S0266467407004701; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Freitas RD, 2014, MYCORRHIZA, V24, P21, DOI 10.1007/s00572-013-0507-x; Gardner T., 2010, MONITORING FOREST BI; Gardner TA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0166; Gitzen R.A., 2012, DESIGN ANAL LONG TER; Greve MH, 2012, ECOL INDIC, V18, P1, DOI 10.1016/j.ecolind.2011.10.006; Groves R.M., 2004, SURVEY ERRORS SURVEY; Gutschick VP, 2003, NEW PHYTOL, V160, P21, DOI 10.1046/j.1469-8137.2003.00866.x; Haining R, 1990, SPATIAL DATA ANAL SO; Hance J, 2014, HAPPY AMAZON 215 MIL; Hengl T., 2011, PRACTICAL GUIDE GEOS; Hijmans RJ, 2013, R PACKAGE VERSION; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Hothorn T., 2013, PARTYKIT TOOLKIT REC; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hothorn T, 2011, ECOL MONOGR, V81, P329, DOI 10.1890/10-0602.1; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Johnson D. H., 2012, DESIGN ANAL LONG TER, P54, DOI [10. 1017/CBO9781139022422, DOI 10.1017/CBO9781139022422.006]; Jones J.P., 2013, KEY TOPICS CONSERVAT, V2, P327, DOI [10.1002/9781118520178.ch18, DOI 10.1002/9781118520178.CH18]; Katz RW, 2005, ECOLOGY, V86, P1124, DOI 10.1890/04-0606; Kinupp VF, 2005, J TROP ECOL, V21, P363, DOI 10.1017/S0266467405002440; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Landeiro VL, 2012, ECOL INDIC, V23, P366, DOI 10.1016/j.ecolind.2012.04.023; Laurance SGW, 2010, J VEG SCI, V21, P96, DOI 10.1111/j.1654-1103.2009.01122.x; Legendre P, 2002, ECOGRAPHY, V25, P601, DOI 10.1034/j.1600-0587.2002.250508.x; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Magnusson W, 2014, NATURE CONS IN PRESS; Magnusson WE, 2013, BIODIVERSITY INTEGRA; Magnusson William E., 2005, Biota Neotrop., V5, P19, DOI 10.1590/S1676-06032005000300002; Malhi Y, 2010, GLOBAL CHANGE BIOL, V16, P3171, DOI 10.1111/j.1365-2486.2010.02323.x; McDonald T., 2012, DESIGN ANAL LONG TER, P101, DOI [10.1017/CBO9781139022422, DOI 10.1017/CBO9781139022422]; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; OLEA RA, 1984, J INT ASS MATH GEOL, V16, P369, DOI 10.1007/BF01029887; Pebesma E, 2005, R NEWS, V5, P9, DOI DOI 10.1007/978-1-4614-7618-4_2; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; R Core Team, 2021, R LANG ENV STAT COMP; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Renschler CS, 2005, J SOIL WATER CONSERV, V60, P446; Sabo JL, 2005, ECOLOGY, V86, P56, DOI 10.1890/04-0668; Skidmore AK, 2011, INT J GEOGR INF SCI, V25, P337, DOI 10.1080/13658816.2011.554296; Sommerville MM, 2011, BIOL CONSERV, V144, P2832, DOI 10.1016/j.biocon.2011.07.036; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Svenning JC, 1999, J ECOL, V87, P55, DOI 10.1046/j.1365-2745.1999.00329.x; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; van Groenigen JW, 1998, J ENVIRON QUAL, V27, P1078, DOI 10.2134/jeq1998.00472425002700050013x; Vanwalleghem T, 2009, ECOSYSTEMS, V12, P1158, DOI 10.1007/s10021-009-9281-1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yao XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056537, 10.1371/journal.pone.0054660]	63	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106150	10.1371/journal.pone.0106150	http://dx.doi.org/10.1371/journal.pone.0106150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170894	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500116
J	Tojo, M; Nagamatsu, M; Hayakawa, K; Mezaki, K; Kirikae, T; Ohmagari, N				Tojo, Masayoshi; Nagamatsu, Maki; Hayakawa, Kayoko; Mezaki, Kazuhisa; Kirikae, Teruo; Ohmagari, Norio			Evaluation of an Automated Rapid Diagnostic Test for Detection of Clostridium difficile	PLOS ONE			English	Article							CLINICAL-SAMPLES; TOXIN; INFECTIONS; CULTURE; ASSAY; PCR	The Verigene Clostridium difficile Nucleic Acid Test (Verigene CDF Test) (Nanosphere, Northbrook, IL, USA) is a new multiplex qualitative polymerase chain reaction (PCR) test used to detect C. difficile toxin genes in fecal specimens. To evaluate the performance of the new method, we tested 69 fecal samples from patients with suspected C. difficile infection using the Verigene CDF test, an enzyme immunoassay (EIA) and PCR following anaerobic fecal culture. The sensitivity, specificity, and accuracy of the Verigene CDF test were 96.7% (29/30), 97.4% (38/39), and 97.1% (67/69) respectively, using PCR following fecal culture as a reference method. We also analyzed the potential clinical impact of the Verigene CDF test using chart reviews of the 69 patients with suspected C. difficile infection and found that 11 of the 69 patients were incorrectly diagnosed, and the Verigene CDF test would have led to them receiving more appropriate management including practice of treatment and contact precaution, although, of the 69 patients, there are two whose samples were incorrectly identified with the Verigene CDF test. The Verigene CDF test will have a positive impact on patient care.	[Tojo, Masayoshi] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Ibaraki, Japan; [Tojo, Masayoshi; Nagamatsu, Maki; Hayakawa, Kayoko; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan; [Tojo, Masayoshi; Nagamatsu, Maki; Kirikae, Teruo] Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Tokyo, Japan; [Mezaki, Kazuhisa] Natl Ctr Global Hlth & Med, Dept Clin Lab, Tokyo, Japan	University of Tsukuba; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Tojo, M (corresponding author), Univ Tsukuba, Fac Med, Dept Anat & Embryol, Ibaraki, Japan.	czh13571@md.tsukuba.ac.jp	Hayakawa, Kayoko/GNW-2394-2022; Ohmagari, Norio/GLN-5290-2022	Ohmagari, Norio/0000-0002-4622-8970	National Center for Global Health and Medicine [24-207]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This work was supported by the grant of National Center for Global Health and Medicine (24-207). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT JG, 1984, REV INFECT DIS, V6, pS235; Bouza E, 2012, CLIN MICROBIOL INFEC, V18, P5, DOI 10.1111/1469-0691.12064; Carroll KC, 2013, J CLIN MICROBIOL, V51, P4120, DOI 10.1128/JCM.01690-13; Carroll KC, 2011, ANNU REV MICROBIOL, V65, P501, DOI 10.1146/annurev-micro-090110-102824; Curry SR, 2013, CLIN INFECT DIS, V57, P1094, DOI 10.1093/cid/cit475; Gould CV, 2013, CLIN INFECT DIS, V57, P1304, DOI 10.1093/cid/cit492; Hicke B, 2012, J CLIN MICROBIOL, V50, P2681, DOI 10.1128/JCM.00621-12; Hink T, 2013, ANAEROBE, V19, P39, DOI 10.1016/j.anaerobe.2012.12.001; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kato H, 1998, J CLIN MICROBIOL, V36, P2178, DOI 10.1128/JCM.36.8.2178-2182.1998; McDonald L. Clifford, 2012, Morbidity and Mortality Weekly Report, V61, P157; Noren T, 2011, J CLIN MICROBIOL, V49, P710, DOI 10.1128/JCM.01824-10; Novak-Weekley SM, 2010, J CLIN MICROBIOL, V48, P889, DOI 10.1128/JCM.01801-09; Stamper PD, 2009, J CLIN MICROBIOL, V47, P3846, DOI 10.1128/JCM.01490-09; Stamper PD, 2009, J CLIN MICROBIOL, V47, P373, DOI 10.1128/JCM.01613-08; Stubbs S, 2000, FEMS MICROBIOL LETT, V186, P307, DOI 10.1016/S0378-1097(00)00162-2; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Viala C, 2012, J MICROBIOL METH, V90, P83, DOI 10.1016/j.mimet.2012.04.017; Viera AJ, 2005, FAM MED, V37, P360	19	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106102	10.1371/journal.pone.0106102	http://dx.doi.org/10.1371/journal.pone.0106102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170836	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500103
J	Hojland, DH; Jensen, KMV; Kristensen, M				Hojland, Dorte H.; Jensen, Karl-Martin Vagn; Kristensen, Michael			Expression of Xenobiotic Metabolizing Cytochrome P450 Genes in a Spinosad-Resistant Musca domestica L. Strain	PLOS ONE			English	Article							HOUSE-FLY; INSECTICIDE RESISTANCE; PYRETHROID-RESISTANT; CROSS-RESISTANCE; P450; FLIES; POPULATIONS; DROSOPHILA; CYP6A1; OVEREXPRESSION	Background: Spinosad is important in pest management strategies of multiple insect pests. However, spinosad resistance is emerging in various pest species. Resistance has in some species been associated with alterations of the target-site receptor, but in others P450s seems to be involved. We test the possible importance of nine cytochrome P450 genes in the spinosad-resistant housefly strain 791spin and investigate the influence of spinosad on P450 expression in four other housefly strains. Results: Significant differences in P450 expression of the nine P450 genes in the four strains after spinosad treatment were identified in 40% of cases, most of these as induction. The highly expressed CYP4G2 was induced 6.6-fold in the insecticide susceptible WHO-SRS females, but decreased 2-fold in resistant 791spin males. CYP6G4 was constitutively higher expressed in the resistant strain compared to the susceptible strain. Furthermore, CYP6G4 gene expression was increased in susceptible WHO-SRS flies by spinosad while the expression level did not alter significantly in resistant fly strains. Expression of CYP6A1 and male CYP6D3 was constitutively higher in the resistant strain compared to the susceptible. However, in both cases male expression was higher than female expression. Conclusion: CYP4G2, CYP6A1, CYP6D3 and CYP6G4 have expressions patterns approaching the expectations of a hypothesized sex specific spinosad resistance gene. CYP4G2 fit requirements of a spinosad resistance gene best, making it the most likely candidate. The overall high expression level of CYP4G2 throughout the strains also indicates importance of this gene. However, the data on 791spin are not conclusive concerning spinosad resistance and small contributions from multiple P450s with different enzymatic capabilities could be speculated to do the job in 791spin. Differential expression of P450s between sexes is more a rule than an exception. Noteworthy differences between spinosad influenced expression of P450 genes between a field population and established laboratory strains were shown.	[Hojland, Dorte H.; Jensen, Karl-Martin Vagn; Kristensen, Michael] Aarhus Univ, Dept Agroecol, Slagelse, Denmark	Aarhus University	Kristensen, M (corresponding author), Aarhus Univ, Dept Agroecol, Slagelse, Denmark.	michael.kristensen@agrsci.dk	Jensen, Karl-Martin Vagn/E-9756-2016; Kristensen, Michael/F-5536-2016	Kristensen, Michael/0000-0001-7332-3490; Hojland, Dorte H./0000-0002-9758-5783	Danish Agency for Science Technology and Innovation	Danish Agency for Science Technology and Innovation	This work was funded by a mobility stipend to Dorte H. Hojland from the Danish Agency for Science Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN JF, 1994, BIOCHEMISTRY-US, V33, P2171, DOI 10.1021/bi00174a025; CARINO FA, 1994, INSECT BIOCHEM MOLEC, V24, P411, DOI 10.1016/0965-1748(94)90034-5; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; FEYEREISEN R, 1995, PESTIC SCI, V43, P233, DOI 10.1002/ps.2780430309; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; Ffrench-Constant RH, 2013, GENETICS, V194, P807, DOI 10.1534/genetics.112.141895; Gao Q, 2012, PESTIC BIOCHEM PHYS, V104, P252, DOI 10.1016/j.pestbp.2012.09.006; Guzov VM, 1998, ARCH BIOCHEM BIOPHYS, V359, P231, DOI 10.1006/abbi.1998.0901; Hojland DH, 2013, PEST MANAG SCI; Hojland DH, 2014, PLOS ONE; Kasai S, 2001, INSECT BIOCHEM MOLEC, V32, P1, DOI 10.1016/S0965-1748(01)00073-X; Kasai S, 2000, PESTIC BIOCHEM PHYS, V68, P34, DOI 10.1006/pest.2000.2492; Kristensen M, 2004, PEST MANAG SCI, V60, P894, DOI 10.1002/ps.883; Kristensen M, 2004, J ECON ENTOMOL, V97, P1042, DOI 10.1603/0022-0493(2004)097[1042:SOSIMD]2.0.CO;2; Kristensen M, 2003, J ECON ENTOMOL, V96, P1300, DOI 10.1603/0022-0493-96.4.1300; Kristensen M, 2001, PEST MANAG SCI, V57, P82, DOI 10.1002/1526-4998(200101)57:1<82::AID-PS251>3.0.CO;2-8; Kristensen M, 2008, PEST MANAG SCI, V64, P126, DOI 10.1002/ps.1481; Kristensen M, 2006, PEST MANAG SCI, V62, P738, DOI 10.1002/ps.1231; Liu N, 1998, INSECT BIOCHEM MOLEC, V28, P531, DOI 10.1016/S0965-1748(98)00039-3; Markussen MDK, 2012, PEST MANAG SCI, V68, P75, DOI 10.1002/ps.2223; Markussen MDK, 2010, PEST MANAG SCI, V66, P1257, DOI 10.1002/ps.2007; Markussen MDK, 2010, PESTIC BIOCHEM PHYS, V98, P50, DOI 10.1016/j.pestbp.2010.04.012; Misra JR, 2013, INSECT BIOCHEM MOLEC, V43, P1116, DOI 10.1016/j.ibmb.2013.09.005; Nauen R, 2003, PESTIC BIOCHEM PHYS, V76, P55, DOI 10.1016/S0048-3575(03)00065-8; Qiu Y, 2012, P NATL ACAD SCI USA, V109, P14858, DOI 10.1073/pnas.1208650109; R Development Core Team, 2012, R LANG ENV STAT COMP; Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x; Sabourault C, 2001, INSECT MOL BIOL, V10, P609, DOI 10.1046/j.0962-1075.2001.00303.x; Scott JG, 2008, J PESTIC SCI, V33, P221, DOI 10.1584/jpestics.R08-04; Scott JG, 2001, PEST MANAG SCI, V57, P958, DOI 10.1002/ps.354; Shi J, 2011, PEST MANAG SCI, V67, P335, DOI 10.1002/ps.2073; Shono T, 2003, PESTIC BIOCHEM PHYS, V75, P1, DOI 10.1016/S0048-3575(03)00011-7; Sparks TC, 2001, PEST MANAG SCI, V57, P896, DOI 10.1002/ps.358; Sparks TC, 2012, PESTIC BIOCHEM PHYS, V102, P1, DOI 10.1016/j.pestbp.2011.11.004; Watson GB, 2001, PESTIC BIOCHEM PHYS, V71, P20, DOI 10.1006/pest.2001.2559; WHEELOCK GD, 1992, J EXP ZOOL, V264, P153, DOI 10.1002/jez.1402640206; WHEELOCK GD, 1992, PESTIC BIOCHEM PHYS, V43, P67, DOI 10.1016/0048-3575(92)90020-Z; Zhang ML, 1996, PESTIC BIOCHEM PHYS, V55, P150, DOI 10.1006/pest.1996.0044; Zhu F, 2008, INSECT MOL BIOL, V17, P27, DOI 10.1111/j.1365-2583.2008.00777.x; Zhu Fang, 2008, BMC Physiology, V8, P18, DOI 10.1186/1472-6793-8-18	41	21	23	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e103689	10.1371/journal.pone.0103689	http://dx.doi.org/10.1371/journal.pone.0103689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165825	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303700006
J	Binh, CTT; Tong, TZ; Gaillard, JF; Gray, KA; Kelly, JJ				Chu Thi Thanh Binh; Tong, Tiezheng; Gaillard, Jean-Francois; Gray, Kimberly A.; Kelly, John J.			Acute Effects of TiO2 Nanomaterials on the Viability and Taxonomic Composition of Aquatic Bacterial Communities Assessed via High-Throughput Screening and Next Generation Sequencing	PLOS ONE			English	Article							FRESH-WATER BACTERIA; TITANIUM-DIOXIDE; NANOPARTICLES; LAKES; IDENTIFICATION; NANO-TIO2; EXPOSURE; RISKS	The nanotechnology industry is growing rapidly, leading to concerns about the potential ecological consequences of the release of engineered nanomaterials (ENMs) to the environment. One challenge of assessing the ecological risks of ENMs is the incredible diversity of ENMs currently available and the rapid pace at which new ENMs are being developed. High-throughput screening (HTS) is a popular approach to assessing ENM cytotoxicity that offers the opportunity to rapidly test in parallel a wide range of ENMs at multiple concentrations. However, current HTS approaches generally test one cell type at a time, which limits their ability to predict responses of complex microbial communities. In this study toxicity screening via a HTS platform was used in combination with next generation sequencing (NGS) to assess responses of bacterial communities from two aquatic habitats, Lake Michigan (LM) and the Chicago River (CR), to short-term exposure in their native waters to several commercial TiO2 nanomaterials under simulated solar irradiation. Results demonstrate that bacterial communities from LM and CR differed in their sensitivity to nano-TiO2, with the community from CR being more resistant. NGS analysis revealed that the composition of the bacterial communities from LM and CR were significantly altered by exposure to nano-TiO2, including decreases in overall bacterial diversity, decreases in the relative abundance of Actinomycetales, Sphingobacteriales, Limnohabitans, and Flavobacterium, and a significant increase in Limnobacter. These results suggest that the release of nano-TiO2 to the environment has the potential to alter the composition of aquatic bacterial communities, which could have implications for the stability and function of aquatic ecosystems. The novel combination of HTS and NGS described in this study represents a major advance over current methods for assessing ENM ecotoxicity because the relative toxicities of multiple ENMs to thousands of naturally occurring bacterial species can be assessed simultaneously under environmentally relevant conditions.	[Chu Thi Thanh Binh; Kelly, John J.] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Tong, Tiezheng; Gaillard, Jean-Francois; Gray, Kimberly A.] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL USA	Loyola University Chicago; Northwestern University	Kelly, JJ (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	jkelly7@luc.edu	Gaillard, Jean-Francois/B-6981-2009; Gaillard, Jean-Francois JF/E-9445-2013; Gray, Kimberly A/B-6989-2009	Gaillard, Jean-Francois JF/0000-0002-8276-6418; Tong, Tiezheng/0000-0002-9289-3330	National Science Foundation [CBET-1067439, CBET-1067751]	National Science Foundation(National Science Foundation (NSF))	The work described in this study was performed with support from the National Science Foundation (Grant No. CBET-1067439 to JK and Grant No. CBET-1067751 to KG and J-FG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardet J.-F., 2006, PROKARYOTES, P481, DOI [10.1007/0-387-30747-8_17, DOI 10.1007/0-387-30747-8_17]; Blake DM, 1999, SEPAR PURIF METHOD, V28, P1, DOI 10.1080/03602549909351643; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Binh CTT, 2014, ENVIRON TOXICOL CHEM, V33, P317, DOI 10.1002/etc.2442; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; Damoiseaux R, 2011, NANOSCALE, V3, P1345, DOI 10.1039/c0nr00618a; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FERNANDEZALVAREZ RM, 1991, J APPL BACTERIOL, V70, P437, DOI 10.1111/j.1365-2672.1991.tb02961.x; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Future Markets I, 2011, WORLD MARKET NANOPAR; George S, 2011, ACS NANO, V5, P1805, DOI 10.1021/nn102734s; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; Hoefel D, 2003, J MICROBIOL METH, V55, P585, DOI 10.1016/S0167-7012(03)00201-X; Holden PA, 2013, ACCOUNTS CHEM RES, V46, P813, DOI 10.1021/ar300069t; Horst AM, 2013, SMALL, V9, P1753, DOI 10.1002/smll.201201455; Illinois EPA, 2004, IEPABOW04006; Jiang CL, 1996, APPL ENVIRON MICROB, V62, P249, DOI 10.1128/AEM.62.1.249-253.1996; Jin X, 2010, ENVIRON SCI TECHNOL, V44, P7321, DOI 10.1021/es100854g; Kampfer PT, 2010, BERGEYS MANUAL SYSTE, V4, P330; KANE MD, 1993, APPL ENVIRON MICROB, V59, P682, DOI 10.1128/AEM.59.3.682-686.1993; Kang JH, 2002, CHEMOSPHERE, V49, P493, DOI 10.1016/S0045-6535(02)00315-6; Kasalicky V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058209; Kiser MA, 2009, ENVIRON SCI TECHNOL, V43, P6757, DOI 10.1021/es901102n; Lednicka D, 2000, SYST APPL MICROBIOL, V23, P292, DOI 10.1016/S0723-2020(00)80017-X; Li MH, 2011, ENVIRON SCI TECHNOL, V45, P8989, DOI 10.1021/es201675m; Li MH, 2011, ENVIRON SCI TECHNOL, V45, P755, DOI 10.1021/es102266g; Li Y, 2012, ACS NANO, V6, P5164, DOI 10.1021/nn300934k; Lubick N, 2008, ENVIRON SCI TECHNOL, V42, P1821, DOI 10.1021/es087058e; Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094; Miller RJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030321, 10.1371/journal.pone.0033885]; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Nel A, 2013, ACCOUNTS CHEM RES, V46, P607, DOI 10.1021/ar300022h; Ottofuelling S, 2011, ENVIRON SCI TECHNOL, V45, P10045, DOI 10.1021/es2023225; Petkovic J, 2011, NANOTOXICOLOGY, V5, P341, DOI 10.3109/17435390.2010.507316; Project on Emerging Nanotechnologies, CONS PROD INV; Robichaud CO, 2009, ENVIRON SCI TECHNOL, V43, P4227, DOI 10.1021/es8032549; Rodgers M, 2003, WORLD J MICROB BIOT, V19, P703, DOI 10.1023/A:1025151902422; Rogers EJ, 2008, TOXICOL IN VITRO, V22, P1639, DOI 10.1016/j.tiv.2008.06.001; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Simek K, 2011, APPL ENVIRON MICROB, V77, P7307, DOI 10.1128/AEM.05107-11; Spring S, 2001, INT J SYST EVOL MICR, V51, P1463, DOI 10.1099/00207713-51-4-1463; Thomas CR, 2011, ACS NANO, V5, P13, DOI 10.1021/nn1034857; Tong TZ, 2013, ENVIRON SCI TECHNOL, V47, P12486, DOI 10.1021/es403079h; Tong TZ, 2013, WATER RES, V47, P2352, DOI 10.1016/j.watres.2013.02.008; United States Environmental Protection Agency Office of Water, 2002, CLEAN WAT DRINK WAT; USEPA, 2007, EPA833R07007, P1; Vedler E, 2013, SYST APPL MICROBIOL, V36, P525, DOI 10.1016/j.syapm.2013.07.004; Westerhoff P, 2011, J ENVIRON MONITOR, V13, P1195, DOI 10.1039/c1em10017c; Wiesner MR, 2006, ENVIRON SCI TECHNOL, V40, P4336, DOI 10.1021/es062726m; Wiesner Mark R., 2007, ENV NANOTECHNOLOGY A; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	56	30	31	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106280	10.1371/journal.pone.0106280	http://dx.doi.org/10.1371/journal.pone.0106280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162615	Green Submitted, Green Published, gold			2022-12-25	WOS:000340880900102
J	Lambert, C; Mannocci, L; Lehodey, P; Ridoux, V				Lambert, Charlotte; Mannocci, Laura; Lehodey, Patrick; Ridoux, Vincent			Predicting Cetacean Habitats from Their Energetic Needs and the Distribution of Their Prey in Two Contrasted Tropical Regions	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; CUVIERS ZIPHIUS-CAVIROSTRIS; SPERM-WHALE; DIVING BEHAVIOR; STENELLA-LONGIROSTRIS; INCIDENTALLY CAUGHT; DISTRIBUTION MODELS; TURSIOPS-TRUNCATUS; STOMACH CONTENTS; FEEDING ECOLOGY	To date, most habitat models of cetaceans have relied on static and oceanographic covariates, and very few have related cetaceans directly to the distribution of their prey, as a result of the limited availability of prey data. By simulating the distribution of six functional micronekton groups between the surface and similar or equal to 1,000 m deep, the SEAPODYM model provides valuable insights into prey distributions. We used SEAPODYM outputs to investigate the habitat of three cetacean guilds with increasing energy requirements: sperm and beaked whales, Globicephalinae and Delphininae. We expected High Energy Requirements cetaceans to preferentially forage in habitats of high prey biomass and/or production, where they might easily meet their high energetic needs, and Low Energy Requirements cetaceans to forage in habitats of either high or low prey biomass and/or production. Cetacean sightings were collected from dedicated aerial surveys in the South West Indian Ocean (SWIO) and French Polynesia (FP). We examined cetacean densities in relation to simulated distributions of their potential prey using Generalised Additive Models and predicted their habitats in both regions. Results supported their known diving abilities, with Delphininae mostly related to prey present in the upper layers of the water column, and Globicephalinae and sperm and beaked whales also related to prey present in deeper layers. Explained deviances ranged from 9% for sperm and beaked whales in the SWIO to 47% for Globicephalinae in FP. Delphininae and Globicephalinae appeared to select areas where high prey biomass and/or production were available at shallow depths. In contrast, sperm and beaked whales showed less clear habitat selection. Using simulated prey distributions as predictors in cetacean habitat models is crucial to understand their strategies of habitat selection in the three dimensions of the ocean.	[Lambert, Charlotte; Ridoux, Vincent] Univ La Rochelle, Inst Littoral & Environm, CNRS, Ctr Etudes Biol Chize La Rochelle,UMR 7372, La Rochelle, France; [Mannocci, Laura] Duke Univ, Marine Geospatial Ecol Lab, Durham, NC USA; [Lehodey, Patrick] Space Oceanog Div, CLS, Marine Ecosyst Modeling & Monitoring Satellites, Ramonville St Agne, France; [Ridoux, Vincent] Univ La Rochelle, CNRS, Observ PELAGIS, UMS 3462, La Rochelle, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Duke University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite	Lambert, C (corresponding author), Univ La Rochelle, Inst Littoral & Environm, CNRS, Ctr Etudes Biol Chize La Rochelle,UMR 7372, La Rochelle, France.	charlotte.lambert@univ-lr.fr	Lambert, Charlotte/GLQ-7201-2022	Lambert, Charlotte/0000-0002-1128-5262; Lehodey, Patrick/0000-0002-2753-4796; Ridoux, Vincent/0000-0002-9779-9319	French Agency for Marine Protected Areas; Ministry in charge of the environment; MEMMS (Marine Ecosystems Modeling and Monitoring by satellites) - CLS ARGOS	French Agency for Marine Protected Areas; Ministry in charge of the environment; MEMMS (Marine Ecosystems Modeling and Monitoring by satellites) - CLS ARGOS	The French Agency for Marine Protected Areas and the Ministry in charge of the environment funded this study. MEMMS (Marine Ecosystems Modeling and Monitoring by satellites) - CLS ARGOS, provided support in the form of a salary for author PL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abecassis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073274; Amano M, 2003, MAR ECOL PROG SER, V258, P291, DOI 10.3354/meps258291; Amir OA, 2005, ESTUAR COAST SHELF S, V63, P429, DOI 10.1016/j.ecss.2004.12.006; Baird RW, 2006, CAN J ZOOL, V84, P1120, DOI 10.1139/Z06-095; Baird RW, 2011, MAR MAMMAL SCI, V27, pE332, DOI 10.1111/j.1748-7692.2010.00458.x; Barnier B, 2006, OCEAN DYNAM, V56, P543, DOI 10.1007/s10236-006-0082-1; Baumgartner MF, 2005, CAN J FISH AQUAT SCI, V62, P527, DOI 10.1139/F04-238; Baumgartner MF, 1997, MAR MAMMAL SCI, V13, P614, DOI 10.1111/j.1748-7692.1997.tb00087.x; Bearzi M, 2005, MAR BIOL RES, V1, P165, DOI 10.1080/17451000510019132; Becker EA, 2010, MAR ECOL PROG SER, V413, P163, DOI 10.3354/meps08696; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Benoit-Bird KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053348; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Blackburn M, 1972, DISTRIBUTION FORAGE; Briand K, 2011, FISH OCEANOGR, V20, P517, DOI 10.1111/j.1365-2419.2011.00599.x; Brodeur R.D., 2005, PICES PRESS, V13, P7; Buckland S.T., 2001, pi; Canadas A, 2005, AQUAT CONSERV, V15, P495, DOI 10.1002/aqc.689; Chambers JM., 1992, STAT MODELS S; de Ruijter WPM, 2004, DEEP-SEA RES PT I, V51, P383, DOI 10.1016/j.dsr.2003.10.011; Di Beneditto APM, 2007, J MAR BIOL ASSOC UK, V87, P253, DOI 10.1017/S0025315407053647; Di Beneditto APM, 2001, ATLANTIC, V2, P2; Dolar MLL, 2003, MAR MAMMAL SCI, V19, P1, DOI 10.1111/j.1748-7692.2003.tb01089.x; dos Santos RA, 2001, FISH RES, V52, P99; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ESRI, 2011, ARCGIS DESKT REL 10; Evans K, 2004, ICES J MAR SCI, V61, P1313, DOI 10.1016/j.icesjms.2004.07.026; Ferguson Megan C., 2005, Journal of Cetacean Research and Management, V7, P287; Forney Karin A., 2012, Endangered Species Research, V16, P113, DOI 10.3354/esr00393; Gannon DP, 2004, MAR MAMMAL SCI, V20, P527, DOI 10.1111/j.1748-7692.2004.tb01177.x; Gannon DP, 1997, OCEANOGR LIT REV, V44; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harrell Jr F, 2013, HMISC HARRELL MISCEL; Hastie T., 1999, GEN ADDITIVE MODELS; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Hazen EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019269; Hazen EL, 2010, FISH OCEANOGR, V19, P427, DOI 10.1111/j.1365-2419.2010.00561.x; Hedley Sharon L., 1999, Journal of Cetacean Research and Management, V1, P255; Hidaka K, 2003, FISH OCEANOGR, V12, P112, DOI 10.1046/j.1365-2419.2003.00230.x; Jaquet N, 1996, MAR ECOL PROG SER, V145, P1, DOI 10.3354/meps145001; Jefferson Thomas A., 1997, Mammalian Species, V553, P1; Kaschner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044075; Klatsky LJ, 2007, J MAMMAL, V88, P59, DOI 10.1644/05-MAMM-A-365R1.1; Lehodey P, 2008, PROG OCEANOGR, V78, P304, DOI 10.1016/j.pocean.2008.06.004; Lehodey P, 2010, PROG OCEANOGR, V84, P69, DOI 10.1016/j.pocean.2009.09.008; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Mannocci L, 2014, ECOGRAPHY, V37, P261, DOI 10.1111/j.1600-0587.2013.00317.x; Mannocci L, 2014, PROG OCEANOGR, V120, P383, DOI 10.1016/j.pocean.2013.11.005; Marques FFC, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P31; Martinez E, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004824; McCullagh P., 1989, GEN LINEAR MODELS; Mulet S, 2012, DEEP-SEA RES PT II, V77-80, P70, DOI 10.1016/j.dsr2.2012.04.012; New AL, 2005, PHILOS T ROY SOC A, V363, P151, DOI 10.1098/rsta.2004.1484; Osterblom H, 2008, OIKOS, V117, P967, DOI 10.1111/j.2008.0030-1299.16501.x; R Core Team, 2012, R LANG ENV STAT COMP; Redfern JV, 2006, TECHNIQUES CETACEAN; ROUGERIE F, 1994, MAR POLLUT BULL, V29, P14, DOI 10.1016/0025-326X(94)90421-9; Saba VS, 2011, BIOGEOSCIENCES, V8, P489, DOI 10.5194/bg-8-489-2011; Santos MB, 2006, MAR MAMMAL SCI, V22, P600, DOI 10.1111/j.1748-7692.2006.00038.x; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schouten MW, 2003, DEEP-SEA RES PT II, V50, P1987, DOI 10.1016/S0967-0645(03)00042-0; Scott MD, 2009, MAR MAMMAL SCI, V25, P137, DOI 10.1111/j.1748-7692.2008.00241.x; Senina I, 2008, PROG OCEANOGR, V78, P319, DOI 10.1016/j.pocean.2008.06.003; Sibert J, 2012, P NATL ACAD SCI USA, V109, P18221, DOI 10.1073/pnas.1209468109; Signorini SR, 1999, GEOPHYS RES LETT, V26, P3121, DOI 10.1029/1999GL010470; Soto NA, 2008, J ANIM ECOL, V77, P936, DOI 10.1111/j.1365-2656.2008.01393.x; Spitz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050096; Spitz J, 2011, DEEP-SEA RES PT I, V58, P273, DOI 10.1016/j.dsr.2010.12.009; Torres LG, 2008, ECOL APPL, V18, P1702, DOI 10.1890/07-1455.1; Torres LG, 2009, MAR MAMMAL SCI, V25, P797, DOI 10.1111/j.1748-7692.2009.00297.x; Tranchant B, 2008, REMOTE SENS ENVIRON, V112, P1476, DOI 10.1016/j.rse.2007.06.023; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Watkins WA, 2002, MAR MAMMAL SCI, V18, P55, DOI 10.1111/j.1748-7692.2002.tb01018.x; West Kristi L., 2011, Mammalian Species, P177, DOI 10.1644/886.1; Willis PM, 1998, CAN FIELD NAT, V112, P114; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood S. N., 2016, MGCV MIXED GAM COMPU	78	37	37	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105958	10.1371/journal.pone.0105958	http://dx.doi.org/10.1371/journal.pone.0105958			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162643	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900067
J	Pokrywczynska, M; Jundzill, A; Adamowicz, J; Kowalczyk, T; Warda, K; Rasmus, M; Buchholz, L; Krzyzanowska, S; Nakielski, P; Chmielewski, T; Bodnar, M; Marszalek, A; Debski, R; Frontczak-Baniewicz, M; Mikulowski, G; Nowacki, M; Kowalewski, TA; Drewa, T				Pokrywczynska, Marta; Jundzill, Arkadiusz; Adamowicz, Jan; Kowalczyk, Tomasz; Warda, Karolina; Rasmus, Marta; Buchholz, Lukasz; Krzyzanowska, Sandra; Nakielski, Pawel; Chmielewski, Tomasz; Bodnar, Magdalena; Marszalek, Andrzej; Debski, Robert; Frontczak-Baniewicz, Malgorzata; Mikulowski, Grzegorz; Nowacki, Maciej; Kowalewski, Tomasz A.; Drewa, Tomasz			Is the Poly (L- Lactide- Co- Caprolactone) Nanofibrous Membrane Suitable for Urinary Bladder Regeneration?	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; TISSUE ENGINEERING APPLICATIONS; MESENCHYMAL STEM-CELLS; POLY(EPSILON-CAPROLACTONE) MEMBRANE; EPSILON-CAPROLACTONE; SURFACE MODIFICATION; IN-VITRO; SCAFFOLDS; PROLIFERATION; FABRICATION	The purpose of this study was to compare: a new five-layered poly (L-lactide-co-caprolactone) (PLC) membrane and small intestinal submucosa (SIS) as a control in rat urinary bladder wall regeneration. The five-layered poly (L-lactide-co-caprolactone) membrane was prepared by an electrospinning process. Adipose tissue was harvested from five 8-week old male Wistar rats. Adipose derived stem cells (ADSCs) were seeded in a density of 3x10(6) cells/cm(2) onto PLC membrane and SIS scaffolds, and cultured for 5-7 days in the stem cell culture medium. Twenty male Wistar rats were randomly divided into five equal groups. Augmentation cystoplasty was performed in a previously created dome defect. Groups: (I) PLC+ 3x10(6) ADSCs; (II) SIS+ 3x10(6) ADSCs; (III) PLC; (IV) SIS; (V) control. Cystography was performed after three months. The reconstructed urinary bladders were evaluated in H&E and Masson's trichrome staining. Regeneration of all components of the normal urinary bladder wall was observed in bladders augmented with cell-seeded SIS matrices. The urinary bladders augmented with SIS matrices without cells showed fibrosis and graft contraction. Bladder augmentation with the PLC membrane led to numerous undesirable events including: bladder wall perforation, fistula or diverticula formation, and incorporation of the reconstructed wall into the bladder lumen. The new five-layered poly (L-lactide-co-caprolactone) membrane possesses poorer potential for regenerating the urinary bladder wall compared with SIS scaffold.	[Pokrywczynska, Marta; Jundzill, Arkadiusz; Adamowicz, Jan; Warda, Karolina; Rasmus, Marta; Buchholz, Lukasz; Krzyzanowska, Sandra; Nowacki, Maciej; Drewa, Tomasz] Nicolaus Copernicus Univ Torun, Dept Tissue Engn, Chair Regenerat Med, Ludwik Rydygier Med Coll Bydgoszcz, Bydgoszcz, Poland; [Kowalczyk, Tomasz] Polish Acad Sci, Inst Fundamental Technol Res, Dept Theory Continuous Media, Warsaw, Poland; [Nakielski, Pawel; Chmielewski, Tomasz; Kowalewski, Tomasz A.] Polish Acad Sci, Inst Fundamental Technol Res, Dept Mech & Phys Fluids, Warsaw, Poland; [Bodnar, Magdalena; Marszalek, Andrzej] Nicolaus Copernicus Univ Torun, Dept Clin Pathomorphol, Ludwik Rydygier Med Coll Bydgoszcz, Bydgoszcz, Poland; [Marszalek, Andrzej] Poznan Univ Med Sci, Ctr Oncol, Dept Tumor Pathol, Poznan, Poland; [Debski, Robert] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Med Coll Bydgoszcz, Dept Pediat Hematol & Oncol, Bydgoszcz, Poland; [Frontczak-Baniewicz, Malgorzata] Polish Acad Sci, Mossakowski Med Res Ctr, Electron Microscopy Platform, Warsaw, Poland; [Mikulowski, Grzegorz] Polish Acad Sci, Inst Fundamental Technol Res, Dept Intelligent Technol, Warsaw, Poland; [Drewa, Tomasz] Nicolaus Copernicus Hosp, Dept Urol, Torun, Poland	Nicolaus Copernicus University; Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences; Nicolaus Copernicus University; Poznan University of Medical Sciences; Wielkopolskie Centrum Onkologii; Nicolaus Copernicus University; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences	Pokrywczynska, M (corresponding author), Nicolaus Copernicus Univ Torun, Dept Tissue Engn, Chair Regenerat Med, Ludwik Rydygier Med Coll Bydgoszcz, Bydgoszcz, Poland.	marta.pokrywczynska@interia.pl	Kowalczyk, Tomasz/H-3872-2012; Pokrywczynska, Marta/E-9323-2014; Rasmus, Marta/D-9461-2019; Bodnar, Magdalena/D-6131-2014; Kowalewski, Tomasz Aleksander/F-2055-2011; Mikułowski, Grzegorz/S-9305-2017; Nakielski, Pawel/A-2077-2013	Kowalczyk, Tomasz/0000-0003-2381-4122; Rasmus, Marta/0000-0003-3671-1501; Bodnar, Magdalena/0000-0003-3748-1058; Kowalewski, Tomasz Aleksander/0000-0002-3664-9659; Mikułowski, Grzegorz/0000-0003-4215-8650; Nakielski, Pawel/0000-0001-6194-701X; adamowicz, jan/0000-0003-2479-7133; Jundzill, Arkadiusz/0000-0002-7743-8540; Drewa, Tomasz/0000-0002-5529-4320; Pokrywczynska, Marta/0000-0003-3259-087X				Adamowicz J, 2012, TRANSPL P, V44, P1439, DOI 10.1016/j.transproceed.2012.01.128; Adamowicz J, 2013, CENT EUR J UROL, V66, P202, DOI 10.5173/ceju.2013.02.art23; Andrychowski J, 2013, FOLIA NEUROPATHOL, V51, P147, DOI 10.5114/fn.2013.35958; Ang LPK, 2006, INVEST OPHTH VIS SCI, V47, P105, DOI 10.1167/iovs.05-0512; Baka-Ostrowska M, 2011, CENT EUR J UROL, V64, P237, DOI 10.5173/ceju.2011.04.art11; Bretcanu O, 2009, MATER CHEM PHYS, V118, P420, DOI 10.1016/j.matchemphys.2009.08.011; Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3; Chen F, 2007, MAT SCI ENG C-BIO S, V27, P325, DOI 10.1016/j.msec.2006.05.004; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071265; Dahms SE, 1998, BRIT J UROL, V82, P411; Davis NF, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.11.036; Feil G, 2006, EUR UROL, V50, P1330, DOI 10.1016/j.eururo.2006.05.041; Fernandez J, 2012, J MECH BEHAV BIOMED, V9, P100, DOI 10.1016/j.jmbbm.2012.01.003; Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002; Horst M, 2014, J BIOMED MATER RES A, V102, P2116, DOI 10.1002/jbm.a.34889; Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269; Jeong SI, 2004, BIOMACROMOLECULES, V5, P1303, DOI 10.1021/bm049921i; Knight Toyin A, 2013, Methods Mol Biol, V1001, P179, DOI 10.1007/978-1-62703-363-3_15; Kropp BP, 2004, J UROLOGY, V172, P1710, DOI 10.1097/01.ju.0000139952.64753.27; Landman J, 2004, J UROLOGY, V171, P2450, DOI 10.1097/01.ju.0000127756.64619.27; Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005; National Research Council, 2011, GUIDE CARE USE LAB A; Park JS, 2007, MACROMOL RES, V15, P424, DOI 10.1007/BF03218809; Paterson RF, 2002, J UROLOGY, V168, P2253, DOI 10.1016/S0022-5347(05)64366-2; Pokrywczynska M, 2014, EXP BIOL MED, V239, P264, DOI 10.1177/1535370213517615; Pokrywczynska M, 2013, ARCH IMMUNOL THER EX, V61, P483, DOI 10.1007/s00005-013-0249-7; Pokrywczynska M, 2013, POSTEP HIG MED DOSW, V67, P790; Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2; Sartoneva R, 2012, J R SOC INTERFACE, V9, P3444, DOI 10.1098/rsif.2012.0458; Sartoneva R, 2011, J R SOC INTERFACE, V8, P671, DOI 10.1098/rsif.2010.0520; Shakhssalim N, 2013, INT J ARTIF ORGANS, V36, P113, DOI 10.5301/ijao.5000175; Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568; Tomadakis MM, 2003, J CHEM PHYS, V119, P1741, DOI 10.1063/1.1582431; Yamaguchi Manae, 2004, J Artif Organs, V7, P187; Yoon JJ, 2004, BIOMATERIALS, V25, P5613, DOI 10.1016/j.biomaterials.2004.01.014; Yu HS, 2009, J BIOMED MATER RES A, V88A, P747, DOI 10.1002/jbm.a.31709; Zhu YB, 2007, BIOMATERIALS, V28, P861, DOI 10.1016/j.biomaterials.2006.09.051	37	36	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105295	10.1371/journal.pone.0105295	http://dx.doi.org/10.1371/journal.pone.0105295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162451	Green Published, gold			2022-12-25	WOS:000340880900030
J	Stabentheiner, A; Kovac, H				Stabentheiner, Anton; Kovac, Helmut			Energetic Optimisation of Foraging Honeybees: Flexible Change of Strategies in Response to Environmental Challenges	PLOS ONE			English	Article							APIS-MELLIFERA; METABOLIC-RATE; THORACIC TEMPERATURE; OXYGEN-CONSUMPTION; THERMAL-STABILITY; BODY-TEMPERATURE; THERMOREGULATION; BEES; NECTAR; FLIGHT	Heterothermic insects like honeybees, foraging in a variable environment, face the challenge of keeping their body temperature high to enable immediate flight and to promote fast exploitation of resources. Because of their small size they have to cope with an enormous heat loss and, therefore, high costs of thermoregulation. This calls for energetic optimisation which may be achieved by different strategies. An 'economizing' strategy would be to reduce energetic investment whenever possible, for example by using external heat from the sun for thermoregulation. An 'investment-guided' strategy, by contrast, would be to invest additional heat production or external heat gain to optimize physiological parameters like body temperature which promise increased energetic returns. Here we show how honeybees balance these strategies in response to changes of their local microclimate. In a novel approach of simultaneous measurement of respiration and body temperature foragers displayed a flexible strategy of thermoregulatory and energetic management. While foraging in shade on an artificial flower they did not save energy with increasing ambient temperature as expected but acted according to an 'investment-guided' strategy, keeping the energy turnover at a high level (similar to 56-69 mW). This increased thorax temperature and speeded up foraging as ambient temperature increased. Solar heat was invested to increase thorax temperature at low ambient temperature ('investment-guided' strategy) but to save energy at high temperature ('economizing' strategy), leading to energy savings per stay of similar to 18-76% in sunshine. This flexible economic strategy minimized costs of foraging, and optimized energetic efficiency in response to broad variation of environmental conditions.	[Stabentheiner, Anton; Kovac, Helmut] Graz Univ, Inst Zool, A-8010 Graz, Austria	University of Graz	Stabentheiner, A (corresponding author), Graz Univ, Inst Zool, A-8010 Graz, Austria.	anton.stabentheiner@uni-graz.at; helmut.kovac@uni-graz.at			Austrian Science Fund (FWF) [P16584-1306, P20802-816, P25042-816]; Austrian Science Fund (FWF) [P 25042] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The research was funded by the Austrian Science Fund (FWF) (http://www.fwf.ac.at/): P16584-1306 to AST and HK, P20802-816 to HK and AST, and P25042-816 to HK and AST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afik O, 2007, ENTOMOL GEN, V29, P135; BALDERRAMA NM, 1992, J COMP PHYSIOL B, V162, P440, DOI 10.1007/BF00258967; Bishop JA, 1999, FUNCT ECOL, V13, P711, DOI 10.1046/j.1365-2435.1999.00351.x; Blatt J, 2001, J EXP BIOL, V204, P2709; CASEY TM, 1981, PHYSIOL ZOOL, V54, P362, DOI 10.1086/physzool.54.3.30159950; COELHO JR, 1991, PHYSIOL ZOOL, V64, P823, DOI 10.1086/physzool.64.3.30158209; COOPER PD, 1985, J EXP BIOL, V114, P1; Dyer AG, 2006, NATURE, V442, P525, DOI 10.1038/442525a; DYER FC, 1987, J EXP BIOL, V127, P1; ESCH H, 1994, J COMP PHYSIOL B, V163, P621, DOI 10.1007/BF00369511; Feuerbacher E, 2003, J EXP BIOL, V206, P1855, DOI 10.1242/jeb.00347; Germ M, 1997, APIDOLOGIE, V28, P385, DOI 10.1051/apido:19970606; GOLLER F, 1991, J COMP PHYSIOL B, V161, P61, DOI 10.1007/BF00258747; Harrison JF, 1996, SCIENCE, V274, P88, DOI 10.1126/science.274.5284.88; HARRISON JF, 1993, NATURE, V363, P258, DOI 10.1038/363258a0; Hartfelder K, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.06; HEINRICH B, 1980, J EXP BIOL, V85, P73; HEINRICH B, 1979, J EXP BIOL, V80, P217; HEINRICH B, 1979, SCIENCE, V205, P1269, DOI 10.1126/science.205.4412.1269; Heinrich B., 1993, HOT BLOODED INSECTS; Kafer H, 2012, J INSECT PHYSIOL, V58, P679, DOI 10.1016/j.jinsphys.2012.01.015; Kovac H, 1996, J INSECT PHYSIOL, V42, P1071, DOI 10.1016/S0022-1910(96)00061-3; Kovac H, 2014, APIDOLOGIE, V45, P664, DOI 10.1007/s13592-014-0284-3; Kovac H, 2011, ECOL ENTOMOL, V36, P686, DOI 10.1111/j.1365-2311.2011.01313.x; Kovac H, 2010, J INSECT PHYSIOL, V56, P1834, DOI 10.1016/j.jinsphys.2010.08.002; Moffatt L, 1997, J COMP PHYSIOL B, V167, P36, DOI 10.1007/s003600050045; Moffatt L, 2000, J COMP PHYSIOL A, V186, P299, DOI 10.1007/s003590050430; Moffatt L, 2001, J EXP BIOL, V204, P759; Nicolson SW, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1597; NICOLSON SW, 1982, J EXP ZOOL, V222, P287, DOI 10.1002/jez.1402220311; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Roberts SP, 1999, J EXP BIOL, V202, P1523; Sadler N, 2011, J EXP BIOL, V214, P469, DOI 10.1242/jeb.049445; SCHMARANZER S, 1988, J COMP PHYSIOL B, V158, P135, DOI 10.1007/BF01075826; Schmaranzer S, 2000, J INSECT PHYSIOL, V46, P1187, DOI 10.1016/S0022-1910(00)00039-1; Schmickl T, 2004, ADAPT BEHAV, V12, P263, DOI 10.1177/105971230401200311; SCHMIDHEMPEL P, 1987, J ANIM ECOL, V56, P219, DOI 10.2307/4811; SCHMIDHEMPEL P, 1985, BEHAV ECOL SOCIOBIOL, V17, P61, DOI 10.1007/BF00299430; SEELEY TD, 1994, ANIM BEHAV, V47, P311, DOI 10.1006/anbe.1994.1044; SEELEY TD, 1986, BEHAV ECOL SOCIOBIOL, V19, P343, DOI 10.1007/BF00295707; SEELEY TD, 1994, BEHAV ECOL SOCIOBIOL, V34, P51, DOI 10.1007/BF00175458; Stabentheiner A., 1987, Thermology, V2, P563; STABENTHEINER A, 1991, NATURWISSENSCHAFTEN, V78, P471, DOI 10.1007/BF01134389; Stabentheiner A, 2003, J INSECT PHYSIOL, V49, P881, DOI 10.1016/S0022-1910(03)00148-3; Stabentheiner A, 2001, J INSECT PHYSIOL, V47, P385, DOI 10.1016/S0022-1910(00)00132-3; Stabentheiner A, 2012, THERMOCHIM ACTA, V534, P77, DOI 10.1016/j.tca.2012.02.006; Tan K, 2014, BEHAV ECOL SOCIOBIOL, V68, P13, DOI 10.1007/s00265-013-1617-3; WADDINGTON KD, 1979, AM NAT, V114, P179, DOI 10.1086/283467; WADDINGTON KD, 1990, J COMP PHYSIOL B, V160, P325, DOI 10.1007/BF00302599; Woods WA, 2005, J EXP BIOL, V208, P1161, DOI 10.1242/jeb.01510	50	24	24	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105432	10.1371/journal.pone.0105432	http://dx.doi.org/10.1371/journal.pone.0105432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162211	Green Published, Green Submitted, gold			2022-12-25	WOS:000340880900035
J	Thoemmes, MS; Fergus, DJ; Urban, J; Trautwein, M; Dunn, RR				Thoemmes, Megan S.; Fergus, Daniel J.; Urban, Julie; Trautwein, Michelle; Dunn, Robert R.			Ubiquity and Diversity of Human-Associated Demodex Mites	PLOS ONE			English	Article							HAIR FOLLICLE MITES; PHYLOGENETIC-RELATIONSHIPS; FOLLICULORUM; DEMODICIDAE; BIOLOGY; BREVIS; ACARI; DNA; POPULATION; MICROBIOTA	Demodex mites are a group of hair follicle and sebaceous gland-dwelling species. The species of these mites found on humans are arguably the animals with which we have the most intimate interactions. Yet, their prevalence and diversity have been poorly explored. Here we use a new molecular method to assess the occurrence of Demodex mites on humans. In addition, we use the 18S rRNA gene (18S rDNA) to assess the genetic diversity and evolutionary history of Demodex lineages. Within our samples, 100% of people over 18 years of age appear to host at least one Demodex species, suggesting that Demodex mites may be universal associates of adult humans. A phylogenetic analysis of 18S rDNA reveals intraspecific structure within one of the two named human-associated Demodex species, D. brevis. The D. brevis clade is geographically structured, suggesting that new lineages are likely to be discovered as humans from additional geographic regions are sampled.	[Thoemmes, Megan S.; Fergus, Daniel J.; Dunn, Robert R.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Thoemmes, Megan S.; Fergus, Daniel J.; Dunn, Robert R.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Fergus, Daniel J.; Urban, Julie] North Carolina Museum Nat Sci, Raleigh, NC USA; [Trautwein, Michelle] Calif Acad Sci, San Francisco, CA 94118 USA; [Trautwein, Michelle] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; California Academy of Sciences; University of North Carolina; North Carolina State University	Thoemmes, MS (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	msthoemm@ncsu.edu		Trautwein, Michelle/0000-0003-4469-5839; Dunn, Robert/0000-0002-6030-4837; Thoemmes, Megan/0000-0001-6732-477X	NASA [ROSES NNX09AK22G]; NSF [0953390]; Direct For Biological Sciences [1257960] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	DJF, RRD, and MST were supported on a NASA Biodiversity grant (ROSES NNX09AK22G), www.nasa.gov/, and NSF Career grant (0953390), www.nsf.gov/, during this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akbulatova L, 1963, VESTN DERMATOL VENER, V38, P34; Andrews J. R. H., 1989, Progress in acarology. Volume 1., P97; Araujo A, 2000, PARASITOL TODAY, V16, P269, DOI 10.1016/S0169-4758(00)01694-X; Arici MK, 2005, OPHTHAL EPIDEMIOL, V12, P287, DOI 10.1080/09286580591005705; BONNAR E, 1993, J AM ACAD DERMATOL, V28, P443, DOI 10.1016/0190-9622(93)70065-2; Boratynski Z, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-355; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Rojas M, 2012, PARASITOL RES, V111, P2165, DOI 10.1007/s00436-012-3067-7; de Rojas M, 2012, PARASITOL RES, V110, P227, DOI 10.1007/s00436-011-2476-3; DESCH C, 1972, J PARASITOL, V58, P169, DOI 10.2307/3278267; Desch CE, 2009, EXP APPL ACAROL, V49, P143, DOI 10.1007/s10493-009-9272-0; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Fuss F., 1933, Annales de Dermatologie et de Syphiligraphie Paris (ser 7) T, V4, P1053; GARVEN HSD, 1946, LANCET, V251, P44; GREVE JH, 1966, J AM VET MED ASSOC, V148, P1043; Hoberg EP, 2002, MICROBES INFECT, V4, P859, DOI 10.1016/S1286-4579(02)01606-4; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Huurre A, 2008, NEONATOLOGY, V93, P236, DOI 10.1159/000111102; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Light JE, 2008, J PARASITOL, V94, P1275, DOI 10.1645/GE-1618.1; Mangold AJ, 1998, PARASITOL RES, V84, P478, DOI 10.1007/s004360050433; Melo-Ferreira J., 2011, SYST BIOL, V61, P367; NORN MS, 1982, ACTA OPHTHALMOL, V60, P575, DOI 10.1111/j.1755-3768.1982.tb00603.x; NUTTING WB, 1976, CORNELL VET, V66, P214; Ozdemir MH, 2003, FORENSIC SCI INT, V135, P226, DOI 10.1016/S0379-0738(03)00216-0; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ravera I, 2013, VET DERMATOL, V24, P168, DOI 10.1111/j.1365-3164.2012.01099.x; Reed DL, 2004, PLOS BIOL, V2, P1972, DOI 10.1371/journal.pbio.0020340; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RUFLI T, 1981, DERMATOLOGICA, V162, P1, DOI 10.1159/000250228; SENGBUSCH HG, 1986, J MED ENTOMOL, V23, P384, DOI 10.1093/jmedent/23.4.384; Simon G, 1842, ARCH ANAT PHYSL WISS, V11, P218; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Wilson E, 1843, PHILOS T R SOC LOND, V2, P305; Yazar Sueleyman, 2008, Turkiye Parazitoloji Dergisi, V32, P238; Yong Z, 2003, CR BIOL, V326, P565, DOI 10.1016/S1631-0691(03)00153-7; Zhao Y-E, 2013, PARASITOL RES, V76, P1; Zhao YE, 2012, PARASITOL RES, V111, P1113, DOI 10.1007/s00436-012-2941-7; Zwickl D., 2006, GARLI GENETIC ALGORI	45	38	41	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e106265	10.1371/journal.pone.0106265	http://dx.doi.org/10.1371/journal.pone.0106265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162399	gold, Green Published, Green Submitted			2022-12-25	WOS:000340880900099
J	Ma, YJ; Liu, JJ; Hou, J; Dong, YK; Lu, Y; Jin, L; Cao, R; Li, TM; Wu, J				Ma, Yanjun; Liu, Jingjing; Hou, Jing; Dong, Yuankai; Lu, Yong; Jin, Liang; Cao, Rongyue; Li, Taiming; Wu, Jie			Oral Administration of Recombinant Lactococcus lactis Expressing HSP65 and Tandemly Repeated P277 Reduces the Incidence of Type I Diabetes in Non-Obese Diabetic Mice	PLOS ONE			English	Article							SUBSP LACTIS; VACCINES; DELIVERY; PROTEIN; INTERLEUKIN-10; THERAPY	Diabetes mellitus type 1 (DM1) is an autoimmune disease that gradually destroys insulin-producing beta-cells. We have previously reported that mucosal administration of fusion protein of HSP65 with tandem repeats of P277 (HSP65-6P277) can reduce the onset of DM1 in non-obese diabetic (NOD) mice. To deliver large amounts of the fusion protein and to enhance long-term immune tolerance effects, in the present study, we investigated the efficacy of using orally administrated L. lactis expressing HSP65-6P277 to reduce the incidence of DM1 in NOD mice. L. lactis strain NZ9000 was engineered to express HSP65-6P277 either constitutively or by nisin induction. After immunization via gavage with the recombinant L. lactis strains to groups of 4-week old female NOD mice for 36 weeks, we observed that oral administration of recombinant L. Lactis resulted in the prevention of hyperglycemia, improved glucose tolerance and reduced insulitis. Immunologic analysis showed that treatment with recombinant L. lactis induced HSP65- and P277- specific T cell immuno-tolerance, as well as antigen-specific proliferation of splenocytes. The results revealed that the DM1-preventing function was in part caused by a reduction in the pro-inflammatory cytokine IFN-gamma and an increase in the anti-inflammatory cytokine IL-10. Orally administered recombinant L. lactis delivering HSP65-6P277 may be an effective therapeutic approach in preventing DM1.	[Ma, Yanjun] Nanjing Forest Police Coll, Forens Ctr, Nanjing, Jiangsu, Peoples R China; [Ma, Yanjun; Liu, Jingjing; Hou, Jing; Dong, Yuankai; Lu, Yong; Jin, Liang; Cao, Rongyue; Li, Taiming; Wu, Jie] China Pharmaceut Univ, Sch Life Sci & Technol, Minigene Pharm Lab, Nanjing, Jiangsu, Peoples R China	Nanjing Forest Police College; China Pharmaceutical University	Wu, J (corresponding author), Nanjing Forest Police Coll, Forens Ctr, Nanjing, Jiangsu, Peoples R China.	wujie@cpu.edu.cn			National Natural Science Foundation of China [81172973, 31270985, 30872393]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos. 81172973, 31270985, and 30872393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel-Patient K, 2005, CLIN EXP ALLERGY, V35, P539, DOI 10.1111/j.1365-2222.2005.02225.x; Bahey-El-Din M, 2011, HUM VACCINES, V7, P106, DOI 10.4161/hv.7.1.13631; Dieye Y, 2001, J BACTERIOL, V183, P4157, DOI 10.1128/JB.183.14.4157-4166.2001; ELIAS D, 1994, LANCET, V343, P704, DOI 10.1016/S0140-6736(94)91582-2; Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001; Hou J, 2011, VACCINE, V29, P4102, DOI 10.1016/j.vaccine.2011.03.105; Jin L, 2008, J IMMUNOL, V180, P58, DOI 10.4049/jimmunol.180.1.58; Jin L, 2007, VACCINE, V25, P2043, DOI 10.1016/j.vaccine.2006.11.052; Jin L, 2010, VACCINE, V28, P3312, DOI 10.1016/j.vaccine.2010.02.100; Lei H, 2010, VIROLOGY, V407, P319, DOI 10.1016/j.virol.2010.08.007; Lu Y, 2009, VACCINE, V27, P5411, DOI 10.1016/j.vaccine.2009.06.089; Luo XR, 2010, IMMUNITY, V32, P488, DOI 10.1016/j.immuni.2010.04.002; Martin S, 1996, J AUTOIMMUN, V9, P637, DOI 10.1006/jaut.1996.0083; MCINTYRE DA, 1989, APPL ENVIRON MICROB, V55, P604, DOI 10.1128/AEM.55.3.604-610.1989; Miettinen M, 1996, INFECT IMMUN, V64, P5403, DOI 10.1128/IAI.64.12.5403-5405.1996; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Neirynck Sabine, 2006, Biotechnol Genet Eng Rev, V22, P253; Nitta Y, 1998, HUM GENE THER, V9, P1701, DOI 10.1089/hum.1998.9.12-1701; Nouaille Sebastien, 2003, Genet Mol Res, V2, P102; Petrovsky N, 2010, NAT REV ENDOCRINOL, V6, P131, DOI 10.1038/nrendo.2009.273; Portaro FCV, 2002, BIOCHEMISTRY-US, V41, P7400, DOI 10.1021/bi011999l; Prud'homme GJ, 1999, GENE THER, V6, P771, DOI 10.1038/sj.gt.3300879; Raz I, 2014, DIABETES CARE, V37, P1392, DOI 10.2337/dc13-1391; Robert S, 2014, DIABETES; Steidler L, 2003, NAT BIOTECHNOL, V21, P785, DOI 10.1038/nbt840; Steidler L, 2006, ANN NY ACAD SCI, V1072, P176, DOI 10.1196/annals.1326.031; Steidler Lothar, 2003, Discov Med, V3, P49; Takiishi T, 2012, J CLIN INVEST, V122, P1717, DOI 10.1172/JCI60530; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; VANASSELDONK M, 1990, GENE, V95, P155, DOI 10.1016/0378-1119(90)90428-T; Vandenbroucke K, 2010, MUCOSAL IMMUNOL, V3, P49, DOI 10.1038/mi.2009.116; VANDERVOSSEN JMBM, 1987, APPL ENVIRON MICROB, V53, P2452, DOI 10.1128/AEM.53.10.2452-2457.1987; Xiong QY, 2009, AUTOIMMUNITY, V42, P475, DOI 10.1080/08916930902887086; Yam KK, 2011, J MED MICROBIOL, V60, P1248, DOI 10.1099/jmm.0.029959-0; Zoka A, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/254874	35	42	51	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105701	10.1371/journal.pone.0105701	http://dx.doi.org/10.1371/journal.pone.0105701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157497	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303200047
J	Wakasugi, M; Sasaki, T; Matsumoto, M; Nagaoka, M; Inoue, K; Inobe, M; Horibata, K; Tanaka, K; Matsunaga, T				Wakasugi, Mitsuo; Sasaki, Takuma; Matsumoto, Megumi; Nagaoka, Miyuki; Inoue, Keiko; Inobe, Manabu; Horibata, Katsuyoshi; Tanaka, Kiyoji; Matsunaga, Tsukasa			Nucleotide Excision Repair-dependent DNA Double-strand Break Formation and ATM Signaling Activation in Mammalian Quiescent Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H2AX PHOSPHORYLATION; RAD3-RELATED PROTEIN ATR; ATAXIA-TELANGIECTASIA; DAMAGE RESPONSE; UV-IRRADIATION; CHECKPOINT ACTIVATION; IONIZING-RADIATION; S-PHASE; NUCLEASE; ESTABLISHMENT	Histone H2A variant H2AX is phosphorylated at Ser(139) in response to DNA double-strand break (DSB) and single-stranded DNA (ssDNA) formation. UV light dominantly induces pyrimidine photodimers, which are removed from the mammalian genome by nucleotide excision repair (NER). We previously reported that in quiescent G(0) phase cells, UV induces ATR-mediated H2AX phosphorylation plausibly caused by persistent ssDNA gap intermediates during NER. In this study, we have found that DSB is also generated following UV irradiation in an NER-dependent manner and contributes to an earlier fraction of UV-induced H2AX phosphorylation. The NER-dependent DSB formation activates ATM kinase and triggers the accumulation of its downstream factors, MRE11, NBS1, and MDC1, at UV-damaged sites. Importantly, ATM-deficient cells exhibited enhanced UV sensitivity under quiescent conditions compared with asynchronously growing conditions. Finally, we show that the NER-dependent H2AX phosphorylation is also observed in murine peripheral T lymphocytes, typical nonproliferating quiescent cells in vivo. These results suggest that in vivo quiescent cells may suffer from NER-mediated secondary DNA damage including ssDNA and DSB.	[Wakasugi, Mitsuo; Sasaki, Takuma; Matsumoto, Megumi; Nagaoka, Miyuki; Inoue, Keiko; Inobe, Manabu; Matsunaga, Tsukasa] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Kanazawa, Ishikawa 9201192, Japan; [Horibata, Katsuyoshi; Tanaka, Kiyoji] Osaka Univ, Grad Sch Frontier Biosci, Human Cell Biol Grp, Suita, Osaka 5650871, Japan	Kanazawa University; Osaka University	Matsunaga, T (corresponding author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	matsukas@p.kanazawa-u.ac.jp	Wakasugi, Mitsuo/D-8417-2015; INOBE, Manabu/D-8393-2015	Wakasugi, Mitsuo/0000-0001-9593-0566; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [21510055, 24510068]; Hokkoku Cancer Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [26870867, 22131009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hokkoku Cancer Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants 21510055 and 24510068 from the Ministry of Education, Culture, Sports, Science and Technology of Japan and also grants from Hokkoku Cancer Foundation (to T. M.) and Takeda Science Foundation (to M. W.).	Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bootsma D., 1998, GENETIC BASIS HUMAN, P245; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Giannattasio M, 2010, MOL CELL, V40, P50, DOI 10.1016/j.molcel.2010.09.004; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Lindsey-Boltz LA, 2014, J BIOL CHEM, V289, P5074, DOI 10.1074/jbc.M113.542787; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; MATSUNAGA T, 1995, J BIOL CHEM, V270, P20862, DOI 10.1074/jbc.270.35.20862; MORI T, 1991, PHOTOCHEM PHOTOBIOL, V54, P225, DOI 10.1111/j.1751-1097.1991.tb02010.x; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; Nakamura H, 2002, J RADIAT RES, V43, P167, DOI 10.1269/jrr.43.167; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Oh KS, 2011, DNA REPAIR, V10, P5, DOI 10.1016/j.dnarep.2010.09.004; Olson E, 2007, J BIOL CHEM, V282, P22939, DOI 10.1074/jbc.M702162200; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Reardon JT, 1997, NUCLEIC ACIDS RES, V25, P1015, DOI 10.1093/nar/25.5.1015; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sertic S, 2011, P NATL ACAD SCI USA, V108, P13647, DOI 10.1073/pnas.1108547108; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Stiff T, 2008, HUM MOL GENET, V17, P3247, DOI 10.1093/hmg/ddn220; Suzuki K, 1999, J BIOL CHEM, V274, P25571, DOI 10.1074/jbc.274.36.25571; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vrouwe MG, 2011, J CELL SCI, V124, P435, DOI 10.1242/jcs.075325; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031; Yajima H, 2009, J MOL BIOL, V385, P800, DOI 10.1016/j.jmb.2008.11.036	39	33	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28730	28737		10.1074/jbc.M114.589747	http://dx.doi.org/10.1074/jbc.M114.589747			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25164823	Green Published, hybrid			2022-12-25	WOS:000343765400060
J	Bonanno, G; Puy, G; Wiaux, Y; van Heeswijk, RB; Piccini, D; Stuber, M				Bonanno, Gabriele; Puy, Gilles; Wiaux, Yves; van Heeswijk, Ruud B.; Piccini, Davide; Stuber, Matthias			Self-Navigation with Compressed Sensing for 2D Translational Motion Correction in Free-Breathing Coronary MRI: A Feasibility Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; CARDIAC CINE MRI; K-T FOCUSS; RESPIRATORY MOTION; IMAGE-RECONSTRUCTION; SPATIAL-RESOLUTION; HEART; HOLD; TRAJECTORIES; ALGORITHMS	Purpose: Respiratory motion correction remains a challenge in coronary magnetic resonance imaging (MRI) and current techniques, such as navigator gating, suffer from sub-optimal scan efficiency and ease-of-use. To overcome these limitations, an image-based self-navigation technique is proposed that uses "sub-images" and compressed sensing (CS) to obtain translational motion correction in 2D. The method was preliminarily implemented as a 2D technique and tested for feasibility for targeted coronary imaging. Methods: During a 2D segmented radial k-space data acquisition, heavily undersampled sub-images were reconstructed from the readouts collected during each cardiac cycle. These sub-images may then be used for respiratory self-navigation. Alternatively, a CS reconstruction may be used to create these sub-images, so as to partially compensate for the heavy undersampling. Both approaches were quantitatively assessed using simulations and in vivo studies, and the resulting self-navigation strategies were then compared to conventional navigator gating. Results: Sub-images reconstructed using CS showed a lower artifact level than sub-images reconstructed without CS. As a result, the final image quality was significantly better when using CS-assisted self-navigation as opposed to the non-CS approach. Moreover, while both self-navigation techniques led to a 69% scan time reduction (as compared to navigator gating), there was no significant difference in image quality between the CS-assisted self-navigation technique and conventional navigator gating, despite the significant decrease in scan time. Conclusions: CS-assisted self-navigation using 2D translational motion correction demonstrated feasibility of producing coronary MRA data with image quality comparable to that obtained with conventional navigator gating, and does so without the use of additional acquisitions or motion modeling, while still allowing for 100% scan efficiency and an improved ease-of-use. In conclusion, compressed sensing may become a critical adjunct for 2D translational motion correction in free-breathing cardiac imaging with high spatial resolution. An expansion to modern 3D approaches is now warranted.	[Bonanno, Gabriele; Wiaux, Yves; van Heeswijk, Ruud B.; Piccini, Davide; Stuber, Matthias] Univ Hosp CHUV, Dept Radiol, Lausanne, VD, Switzerland; [Bonanno, Gabriele; Wiaux, Yves; van Heeswijk, Ruud B.; Piccini, Davide; Stuber, Matthias] Univ Lausanne UNIL, Lausanne, VD, Switzerland; [Bonanno, Gabriele; Wiaux, Yves; van Heeswijk, Ruud B.; Piccini, Davide; Stuber, Matthias] Ctr Biomed Imaging CIBM, Lausanne, VD, Switzerland; [Puy, Gilles; Wiaux, Yves] Ecole Polytech Fed Lausanne, Inst Elect Engn, Lausanne, VD, Switzerland; [Wiaux, Yves] Univ Geneva UniGE, Dept Radiol & Med Informat, Geneva, GE, Switzerland; [Wiaux, Yves] Heriot Watt Univ, Inst Sensors Signals & Syst, Edinburgh, Midlothian, Scotland; [Piccini, Davide] Siemens Healthcare IM BM PI, Adv Clin Imaging Technol, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; Heriot Watt University; Siemens AG	Stuber, M (corresponding author), Univ Hosp CHUV, Dept Radiol, Lausanne, VD, Switzerland.	matthias.stuber@chuv.ch	Piccini, Davide/B-2052-2012; van Heeswijk, Ruud B/F-9711-2010; Stuber, Matthias/B-2949-2010	Piccini, Davide/0000-0003-4663-3244; van Heeswijk, Ruud B/0000-0001-5028-4521; Wiaux, Yves/0000-0002-1658-0121; Stuber, Matthias/0000-0001-9843-2028	Swiss National Science Foundation [320030_143923]; Centre d'Imagerie BioMedicale (CIBM) of the UNIL; UNIGE; HUG; CHUV; EPFL; Leenaards Foundation; Jeantet Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Centre d'Imagerie BioMedicale (CIBM) of the UNIL; UNIGE; HUG; CHUV; EPFL; Leenaards Foundation; Jeantet Foundation	This work is supported by the grant #320030_143923 of the Swiss National Science Foundation (www.snf.ch) and by the Centre d'Imagerie BioMedicale (CIBM) of the UNIL, UNIGE, HUG, CHUV, EPFL and the Leenaards and Jeantet Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elmoniem KZ, 2012, MAGN RESON MED, V68, P822, DOI 10.1002/mrm.23305; Adluru G, 2011, J MAGN RESON IMAGING, V34, P1465, DOI 10.1002/jmri.22808; Akcakaya M, 2011, IEEE T MED IMAGING, V30, P1090, DOI 10.1109/TMI.2010.2089519; Beck A, 2009, IEEE T IMAGE PROCESS, V18, P2419, DOI 10.1109/TIP.2009.2028250; Bhat H, 2011, MAGN RESON MED, V65, P1269, DOI 10.1002/mrm.22717; Botnar RM, 1999, CIRCULATION, V99, P3139, DOI 10.1161/01.CIR.99.24.3139; Buerger C, 2011, MED IMAGE ANAL, V15, P551, DOI 10.1016/j.media.2011.02.009; Carrillo RE, 2013, IEEE SIGNAL PROC LET, V20, P591, DOI 10.1109/LSP.2013.2259813; Chefd'hotel C, 2002, 2002 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING, PROCEEDINGS, P753; Doneva M, 2011, P INT SOC MAG RESON, V19; EHMAN RL, 1989, RADIOLOGY, V173, P255, DOI 10.1148/radiology.173.1.2781017; Etienne A, 2002, MAGNET RESON MED, V48, P658, DOI 10.1002/mrm.10253; Fischer RW, 2006, MAGN RESON MED, V55, P612, DOI 10.1002/mrm.20809; Forman C, 2014, MAGMA; Hansen MS, 2012, MAGN RESON MED, V68, P741, DOI 10.1002/mrm.23284; Hardy CJ, 2003, J MAGN RESON IMAGING, V17, P170, DOI 10.1002/jmri.10250; Henningsson M, 2012, MAGN RESON MED; Henningsson M, 2012, MAGN RESON MED, V67, P437, DOI 10.1002/mrm.23027; Jung H, 2010, MAGN RESON MED, V63, P68, DOI 10.1002/mrm.22172; Jung H, 2009, MAGN RESON MED, V61, P103, DOI 10.1002/mrm.21757; Kawaji K, 2014, MAGN RESON MED, V71, P599, DOI 10.1002/mrm.24698; Lai P, 2008, MAGN RESON MED, V59, P1378, DOI 10.1002/mrm.21617; Larson AC, 2004, MAGN RESON MED, V51, P93, DOI 10.1002/mrm.10664; Li DB, 1996, RADIOLOGY, V201, P857, DOI 10.1148/radiology.201.3.8939242; Liu QH, 1998, IEEE MICROW GUIDED W, V8, P18, DOI 10.1109/75.650975; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; McConnell MV, 1997, MAGN RESON MED, V37, P148, DOI 10.1002/mrm.1910370121; McLeish K, 2004, MAGN RESON MED, V52, P1127, DOI 10.1002/mrm.20252; Moghari MH, 2011, MAGN RESON MED, V66, P1674, DOI 10.1002/mrm.22950; Nagel E, 1999, MAGN RESON MED, V42, P408, DOI 10.1002/(SICI)1522-2594(199908)42:2<408::AID-MRM24>3.0.CO;2-U; Oshinski JN, 1996, RADIOLOGY, V201, P737, DOI 10.1148/radiology.201.3.8939224; Otazo R, 2011, J CARDIOVASCULAR MAG, V13, pO98, DOI DOI 10.1186/1532-429X-13-S1-O98; Otazo R, 2010, MAGN RESON MED, V64, P767, DOI 10.1002/mrm.22463; Pang J, 2013, MAGN RESON MED; Perraudin N., 2014, ARXIV14020779; Piccini D, 2014, P INT SOC MAGN RESON, V23, P2503; Piccini D, 2012, MAGN RESON MED, V68, P571, DOI 10.1002/mrm.23247; Piccini D, 2011, MAGN RESON MED, V66, P1049, DOI 10.1002/mrm.22898; Prieto C, 2014, J MAGN RESON IMAGING; Pruessmann KP, 2001, MAGNET RESON MED, V46, P638, DOI 10.1002/mrm.1241; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Santos JM, 2006, MAGN RESON MED, V55, P371, DOI 10.1002/mrm.20765; Spuentrup E, 2001, J MAGN RESON IMAGING, V14, P311, DOI 10.1002/jmri.1188; Stehning C, 2005, MAGN RESON MED, V54, P476, DOI 10.1002/mrm.20557; Stuber M, 1999, J AM COLL CARDIOL, V34, P524, DOI 10.1016/S0735-1097(99)00223-5; Tsai CM, 2000, MAGNET RESON MED, V43, P452, DOI 10.1002/(SICI)1522-2594(200003)43:3<452::AID-MRM18>3.0.CO;2-B; Usman M, 2013, MAGN RESON MED, V70, P504, DOI 10.1002/mrm.24463; WANG Y, 1995, MAGNET RESON MED, V33, P713, DOI 10.1002/mrm.1910330517	51	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105523	10.1371/journal.pone.0105523	http://dx.doi.org/10.1371/journal.pone.0105523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171369	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500055
J	Catalani, C; Green, E; Owiti, P; Keny, A; Diero, L; Yeung, A; Israelski, D; Biondich, P				Catalani, Caricia; Green, Eric; Owiti, Philip; Keny, Aggrey; Diero, Lameck; Yeung, Ada; Israelski, Dennis; Biondich, Paul			A Clinical Decision Support System for Integrating Tuberculosis and HIV Care in Kenya: A Human-Centered Design Approach	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; ELECTRONIC HEALTH RECORDS; IMPLEMENTATION; BARRIERS; TB; MANAGEMENT; KNOWLEDGE; OPPORTUNITIES; USABILITY; INFECTION	With the aim of integrating HIV and tuberculosis care in rural Kenya, a team of researchers, clinicians, and technologists used the human-centered design approach to facilitate design, development, and deployment processes of new patient-specific TB clinical decision support system for medical providers. In Kenya, approximately 1.6 million people are living with HIV and have a 20-times higher risk of dying of tuberculosis. Although tuberculosis prevention and treatment medication is widely available, proven to save lives, and prioritized by the World Health Organization, ensuring that it reaches the most vulnerable communities remains challenging. Human-centered design, used in the fields of industrial design and information technology for decades, is an approach to improving the effectiveness and impact of innovations that has been scarcely used in the health field. Using this approach, our team followed a 3-step process, involving mixed methods assessment to (1) understand the situation through the collection and analysis of site observation sessions and key informant interviews; (2) develop a new clinical decision support system through iterative prototyping, end-user engagement, and usability testing; and, (3) implement and evaluate the system across 24 clinics in rural West Kenya. Through the application of this approach, we found that human-centered design facilitated the process of digital innovation in a complex and resource-constrained context.	[Catalani, Caricia; Israelski, Dennis] Innovat Support Emergency Dis & Disaster InSTEDD, Sunnyvale, CA 94085 USA; [Catalani, Caricia] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Green, Eric] Kijani Consulting, Chapel Hill, NC USA; [Green, Eric; Keny, Aggrey] Duke Univ, Chapel Hill, NC USA; [Owiti, Philip; Diero, Lameck; Biondich, Paul] Acad Model Prevent & Treatment HIV AMPATH, Eldoret, Kenya; [Yeung, Ada; Biondich, Paul] Indiana Univ, Regenstrief Inst, Indianapolis, IN 46204 USA; [Israelski, Dennis] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA	University of California System; University of California Berkeley; Duke University; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Stanford University	Catalani, C (corresponding author), Innovat Support Emergency Dis & Disaster InSTEDD, Sunnyvale, CA 94085 USA.	catalani@berkeley.edu		Keny, Aggrey/0000-0002-6485-0229	USAID under the Project SEARCH [AID-OAA-TO-11-00060]	USAID under the Project SEARCH(United States Agency for International Development (USAID))	This study was made possible through support provided by the President's Emergency Plan for AIDS Relief and the U.S. Agency for International Development (USAID) via HIVCore, a Task Order funded by USAID under the Project SEARCH indefinite quantity contract (Contract No. AID-OAA-TO-11-00060). The funders had no role in study design, data collection, analysis, or preparation of the manuscript. The authors' views expressed in this report do not necessarily reflect the views of USAID or the United States Government.	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Amirfar S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-753; [Anonymous], 1998, BUSINESS WEEK; [Anonymous], 2011, GUID INT TUB CAS FIN; Auld SC, 2013, INT J TUBERC LUNG D, V17, P186, DOI 10.5588/ijtld.12.0530; Ayaya S O, 2003, East Afr Med J, V80, P83; Bell CA, 2011, INT J TUBERC LUNG D, V15, P1005, DOI 10.5588/ijtld.10.0294; Bevan N, 2009, J USABILITY STUD, V4, P106; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Blank A, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-44; Braitstein P, 2009, JAIDS-J ACQ IMM DEF, V52, pS54, DOI 10.1097/QAI.0b013e3181bbcb67; Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065772; Carter E, 2012, USE ISONIAZID PREVEN; Castillo RS, 2013, CIN-COMPUT INFORM NU, V31, P319, DOI 10.1097/NXN.0b013e3182997a9c; Corbin J., 2015, BASICS QUALITATIVE R; DeRiemer K, 1999, PREV MED, V28, P437, DOI 10.1006/pmed.1998.0452; Fraser Hamish Sf, 2010, AMIA Annu Symp Proc, V2010, P232; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Getahun H, 2010, AIDS, V24, pS57, DOI 10.1097/01.aids.0000391023.03037.1f; Green EP, TRIALS IN PRESS; Grone O, 2001, Int J Integr Care, V1, pe21; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Hemens BJ, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-89; IDEO, 2011, HUM CTR DES TOOLK; International Organization for Standardization, 2010, 92412102010 ISO; Kanjee Z, 2011, J HOSP INFECT, V79, P333, DOI 10.1016/j.jhin.2011.06.017; Kerschberger B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046988; Legido-Quigley H, 2012, TROP MED INT HEALTH, P1; Lester R, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000391021.18284.12; Mamlin Burke W, 2005, AMIA Annu Symp Proc, P490; Moolphate Saiyud, 2013, Glob J Health Sci, V5, P60, DOI 10.5539/gjhs.v5n4p60; Muller Michael J., 2002, HUM FAC ER, P1051; Nansera D, 2010, AFR HEALTH SCI, V10, P312; Nieuwlaat R, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-90; Nijland N., 2011, GROUNDING EHEALTH HO; Norman D, 1986, USER CTR SYSTEM DESI; Norman D. A., 2005, Interactions, V12, P14, DOI 10.1145/1070960.1070976; Oni T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052489; Roshanov PS, 2011, IMPLEMENT SCI, V6, DOI [10.1186/1748-5908-6-92, 10.1186/1748-5908-6-88]; Sahota N, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-91; Skoll, 2013, DO WE CUR MHEALTH PI; Smordal O, 2004, ST HEAL T, V107, P1443; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Souza NM, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-87; TCTA, 2006, INT STAND TUB CAR; Tierney WM, 2007, STUD HEALTH TECHNOL, V129, P372; UNAIDS, 2012, KEN HIV AIDS EST; Uwimana J, 2012, TROP MED INT HEALTH, V17, P658, DOI 10.1111/j.1365-3156.2012.02956.x; Uyei J, 2012, HLTH POLICY PLAN, V131; Were MC, 2013, PEDIATRICS, V131, pE789, DOI 10.1542/peds.2012-2072; Were MC, 2011, J AM MED INFORM ASSN, V18, P150, DOI 10.1136/jamia.2010.005520; Were MC, 2010, J AM MED INFORM ASSN, V17, P237, DOI 10.1136/jamia.2009.002303; World Health Organization, 2019, 10 HLTH ISS WHO WILL, DOI DOI 10.1016/S2213-2600(19)30418-7; World Health Organization, 2011, MHEALTH NEW HORIZONS; Yen PY, 2012, J AM MED INFORM ASSN, V19, P413, DOI 10.1136/amiajnl-2010-000020	55	36	36	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e103205	10.1371/journal.pone.0103205	http://dx.doi.org/10.1371/journal.pone.0103205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170939	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500009
J	Hong, J; Zhang, H; Kuo, DS; Wang, HZ; Huo, YJ; Yang, DY; Wang, NL				Hong, Jie; Zhang, Hui; Kuo, Debbie S.; Wang, Huaizhou; Huo, Yanjiao; Yang, Diya; Wang, Ningli			The Short-Term Effects of Exercise on Intraocular Pressure, Choroidal Thickness and Axial Length	PLOS ONE			English	Article							DYNAMIC EXERCISE; BLOOD-FLOW; EYE LENGTH; INNERVATION; TRABECULECTOMY; BIOMETRY; MODERATE	Purpose: To explore ocular changes in healthy people after exercise. Methods: Twenty five volunteers underwent exercise for 15 minutes on a treadmill. Measurements of choroidal thickness, intraocular pressure (IOP), ocular biometry, and blood pressure were taken before and after exercise. Enhanced Depth Imaging optical coherence tomography (EDI-OCT) was used to measure choroidal thickness at the fovea. Intraocular pressure (IOP) was measured by Goldmann applanation tonometry. Ocular biometric measures were collected using A scan ultrasound. Blood pressure was measured concurrently with the acquisition of the scans. Results: Twenty five volunteers (25 eyes) with a mean age of 25.44 +/- 3.25 years were measured. There was a significant increase in systolic and diastolic pressure after exercise (P<0.05). The IOP showed a significant decrease after exercise (P<0.05). However there was no significant difference in the mean choroidal thickness, ocular axial length, anterior chamber depth, lens thickness, or vitreous length before and after exercise measurements (P>0.05). Conclusion: There was a significant decrease in IOP from exercise without a change in choroidal thickness and ocular biometric measures. IOP and choroidal thickness were not correlated, suggesting that the IOP decrease from exercise is not due to changes in choridal thickness.	[Hong, Jie; Zhang, Hui; Wang, Huaizhou; Huo, Yanjiao; Yang, Diya; Wang, Ningli] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci, Beijing, Peoples R China; [Kuo, Debbie S.] Univ Calif San Francisco, Sch Med, Dept Ophthalmol, San Francisco, CA USA	Capital Medical University; University of California System; University of California San Francisco	Wang, NL (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci, Beijing, Peoples R China.	wningli@vip.163.com		wang, huaizhou/0000-0002-4126-100X	priming scientific research foundation for the junior research in Beijing Tongren Hospital, Capital Medical University	priming scientific research foundation for the junior research in Beijing Tongren Hospital, Capital Medical University	This project was also supported by the priming scientific research foundation for the junior research in Beijing Tongren Hospital, Capital Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwassia AA, 2013, RETINA-J RET VIT DIS, V33, P160, DOI 10.1097/IAE.0b013e3182618c22; Arranz-Marquez E, 2004, BRIT J OPHTHALMOL, V88, P635, DOI 10.1136/bjo.2002.010827; Avunduk AM, 1999, OPHTHALMOLOGICA, V213, P290, DOI 10.1159/000027441; Cashwell LF, 1999, OPHTHALMOLOGY, V106, P2307, DOI 10.1016/S0161-6420(99)90531-6; Drexler W, 1998, AM J OPHTHALMOL, V126, P524, DOI 10.1016/S0002-9394(98)00113-5; Francis BA, 2005, BRIT J OPHTHALMOL, V89, P17, DOI 10.1136/bjo.2004.043950; Gungor K, 2002, J INT MED RES, V30, P26; Haargaard B, 2001, ACTA OPHTHALMOL SCAN, V79, P277, DOI 10.1034/j.1600-0420.2001.790313.x; Hamilton-Maxwell KE, 2012, J GLAUCOMA, V21, P421, DOI 10.1097/IJG.0b013e31821826d0; HARRIS A, 1994, INVEST OPHTH VIS SCI, V35, P3852; Hayashi N, 2010, J PHYSIOL ANTHROPOL, V29, P119, DOI 10.2114/jpa2.29.119; Karabatakis VE, 2004, EUR J OPHTHALMOL, V14, P117, DOI 10.1177/112067210401400206; Kergoat H, 1996, DOC OPHTHALMOL, V92, P145, DOI 10.1007/BF02583286; Kook MS, 2001, J CATARACT REFR SURG, V27, P518, DOI 10.1016/S0886-3350(00)00646-5; LEIGHTON DA, 1970, BRIT J OPHTHALMOL, V54, P599, DOI 10.1136/bjo.54.9.599; Leydolt C, 2008, EYE, V22, P657, DOI 10.1038/sj.eye.6702709; Lutjen-Drecoll E, 2006, EXP EYE RES, V82, P357, DOI 10.1016/j.exer.2005.09.015; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Martin B, 1999, INVEST OPHTH VIS SCI, V40, P1011; MYERS KJ, 1974, INVEST OPHTH VISUAL, V13, P74; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Okuno T, 2006, EYE, V20, P796, DOI 10.1038/sj.eye.6702004; Polska E, 2007, INVEST OPHTH VIS SCI, V48, P3768, DOI 10.1167/iovs.07-0307; Qureshi IA, 1995, ANN HUM BIOL, V22, P545, DOI 10.1080/03014469500004202; Read SA, 2011, EYE, V25, P767, DOI 10.1038/eye.2011.54; Read SA, 2010, EXP EYE RES, V91, P180, DOI 10.1016/j.exer.2010.04.015; Rose LT, 2003, CLIN EXP OPHTHALMOL, V31, P121, DOI 10.1046/j.1442-9071.2003.00617.x; RUSKELL GL, 1971, EXP EYE RES, V12, P166, DOI 10.1016/0014-4835(71)90085-6; Shao L, 2013, INVEST OPHTH VIS SCI, V54, P230, DOI 10.1167/iovs.12-10351; SHAPIRO A, 1978, BRIT J OPHTHALMOL, V62, P679, DOI 10.1136/bjo.62.10.679; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; STONE RA, 1986, EXP EYE RES, V42, P349, DOI 10.1016/0014-4835(86)90028-X; Vasconcelos De Moraes C, 2009, GRAEF ARCH CLIN EXP, V247, P385, DOI 10.1007/s00417-008-0969-2; Wimpissinger B, 2003, INVEST OPHTH VIS SCI, V44, P4859, DOI 10.1167/iovs.03-0391	34	19	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e104294	10.1371/journal.pone.0104294	http://dx.doi.org/10.1371/journal.pone.0104294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170876	gold, Green Submitted, Green Published			2022-12-25	WOS:000341127500016
J	Pizarro, S; Garcia-Lucio, J; Peinado, VI; Tura-Ceide, O; Diez, M; Blanco, I; Sitges, M; Petriz, J; Torralba, Y; Marin, P; Roca, J; Barbera, JA				Pizarro, Sandra; Garcia-Lucio, Jessica; Peinado, Victor I.; Tura-Ceide, Olga; Diez, Marta; Blanco, Isabel; Sitges, Marta; Petriz, Jordi; Torralba, Yolanda; Marin, Pedro; Roca, Josep; Albert Barbera, Joan			Circulating Progenitor Cells and Vascular Dysfunction in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BONE-MARROW; CARDIOVASCULAR RISK; ARTERIAL STIFFNESS; TNF-ALPHA; COPD; SMOKERS; HYPERTENSION; MOBILIZATION; EXPRESSION	Background: In chronic obstructive pulmonary disease (COPD), decreased progenitor cells and impairment of systemic vascular function have been suggested to confer higher cardiovascular risk. The origin of these changes and their relationship with alterations in the pulmonary circulation are unknown. Objectives: To investigate whether changes in the number of circulating hematopoietic progenitor cells are associated with pulmonary hypertension or changes in endothelial function. Methods: 62 COPD patients and 35 controls (18 non-smokers and 17 smokers) without cardiovascular risk factors other than cigarette smoking were studied. The number of circulating progenitors was measured as CD45(+)CD34(+)CD133(+) labeled cells by flow cytometry. Endothelial function was assessed by flow-mediated dilation. Markers of inflammation and angiogenesis were also measured in all subjects. Results: Compared with controls, the number of circulating progenitor cells was reduced in COPD patients. Progenitor cells did not differ between control smokers and non-smokers. COPD patients with pulmonary hypertension showed greater number of progenitor cells than those without pulmonary hypertension. Systemic endothelial function was worse in both control smokers and COPD patients. Interleukin-6, fibrinogen, high sensitivity C-reactive protein, vascular endothelial growth factor and tumor necrosis factor were increased in COPD. In COPD patients, the number of circulating progenitor cells was inversely related to the flow-mediated dilation of systemic arteries. Conclusions: Pulmonary and systemic vascular impairment in COPD is associated with cigarette smoking but not with the reduced number of circulating hematopoietic progenitors. The latter appears to be a consequence of the disease itself not related to smoking habit.	[Pizarro, Sandra; Garcia-Lucio, Jessica; Peinado, Victor I.; Tura-Ceide, Olga; Diez, Marta; Blanco, Isabel; Torralba, Yolanda; Roca, Josep; Albert Barbera, Joan] Univ Barcelona, Dept Pulm Med, Hosp Clin, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain; [Sitges, Marta] Univ Barcelona, Dept Cardiol, Hosp Clin, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain; [Marin, Pedro] Univ Barcelona, Dept Cryopreservervat, Hosp Clin, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain; [Peinado, Victor I.; Tura-Ceide, Olga; Blanco, Isabel; Torralba, Yolanda; Roca, Josep; Albert Barbera, Joan] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Petriz, Jordi] Hosp Univ Vall dHebron, Inst Recerca, Dept Cytometry, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Barbera, JA (corresponding author), Univ Barcelona, Dept Pulm Med, Hosp Clin, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain.	jbarbera@clinic.ub.es	Petriz, Jordi/AAB-7293-2019; Tura-Ceide, Olga/D-6120-2014; Roca, Josep/J-2583-2015; Petriz, Jordi/AAS-4943-2020	Tura-Ceide, Olga/0000-0003-4334-9790; Roca, Josep/0000-0003-4768-8722; Petriz, Jordi/0000-0003-1085-0511; Peinado, Victor Ivo/0000-0001-9793-9433	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III [PI05/0244, PI10/02175]; Fundacio la Marato de TV3 [04310]; SEPAR; European Union [2005-018725/Pulmotension]; Hospital Clinic; IDIBAPS-Biotrack postdoctoral fellowship; Instituto de Salud Carlos III	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fundacio la Marato de TV3; SEPAR; European Union(European Commission); Hospital Clinic; IDIBAPS-Biotrack postdoctoral fellowship; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by grants from the "Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III" PI05/0244 and PI10/02175; "Fundacio la Marato de TV3" (04310); SEPAR 2005; and the European Union (2005-018725/Pulmotension). S. Pizarro was the recipient of a predoctoral research fellowship from Hospital Clinic. O. Tura-Ceide was the recipient of IDIBAPS-Biotrack postdoctoral fellowship and J. Garcia-Lucio was the recipient of a predoctoral research fellowship (PFIS) from the "Instituto de Salud Carlos III." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablin JN, 2006, LIFE SCI, V79, P2364, DOI 10.1016/j.lfs.2006.07.035; Barr RG, 2007, AM J RESP CRIT CARE, V176, P1200, DOI 10.1164/rccm.200707-980OC; Brittan M, 2013, AM J PHYSL LUNG CELL; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Curkendall SM, 2006, EUR J EPIDEMIOL, V21, P803, DOI 10.1007/s10654-006-9066-1; Diez M, 2007, CARDIOVASC RES, V76, P517, DOI 10.1016/j.cardiores.2007.08.007; Diller GP, 2008, CIRCULATION, V117, P3020, DOI 10.1161/CIRCULATIONAHA.108.769646; Dufour C, 2003, BLOOD, V102, P2053, DOI 10.1182/blood-2003-01-0114; Eickhoff P, 2008, AM J RESP CRIT CARE, V178, P1211, DOI 10.1164/rccm.200709-1412OC; Fadini GP, 2006, STEM CELLS, V24, P1806, DOI 10.1634/stemcells.2005-0440; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Gill M, 2001, CIRC RES, V88, P167; Hayashida K, 2005, CHEST, V127, P1793, DOI 10.1378/chest.127.5.1793; Heiss C, 2008, J AM COLL CARDIOL, V51, P1760, DOI 10.1016/j.jacc.2008.01.040; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Huertas A, 2010, RESP PHYSIOL NEUROBI, V170, P23, DOI 10.1016/j.resp.2009.10.003; Huiart L, 2005, CHEST, V128, P2640, DOI 10.1378/chest.128.4.2640; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kondo T, 2004, ARTERIOSCL THROM VAS, V24, P1442, DOI 10.1161/01.ATV.0000135655.52088.c5; Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904; Liu XR, 2012, MOL CELL BIOCHEM, V363, P53, DOI 10.1007/s11010-011-1157-y; Maclay JD, 2009, AM J RESP CRIT CARE, V180, P513, DOI 10.1164/rccm.200903-0414OC; McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC; Mills NL, 2008, THORAX, V63, P306, DOI 10.1136/thx.2007.083493; Moro L, 2008, ANGIOLOGY, V59, P357, DOI 10.1177/0003319707306141; Palange P, 2006, EUR RESPIR J, V27, P529, DOI 10.1183/09031936.06.00120604; Peinado VI, 2006, AM J RESP CELL MOL, V34, P257, DOI 10.1165/rcmb.2005-0255OC; Peinado VI, 2008, CHEST, V134, P808, DOI 10.1378/chest.08-0820; Pennathur Subramaniam, 2007, Curr Diab Rep, V7, P257, DOI 10.1007/s11892-007-0041-3; Perticone F, 2001, CIRCULATION, V104, P191, DOI 10.1161/01.CIR.104.2.191; Sala E, 2010, LUNG, V188, P331, DOI 10.1007/s00408-009-9225-8; Santos S, 2003, AM J RESP CRIT CARE, V167, P1250, DOI 10.1164/rccm.200210-1233OC; Santos S, 2002, EUR RESPIR J, V19, P632, DOI 10.1183/09031936.02.00245902; Sata M, 2003, TRENDS CARDIOVAS MED, V13, P249, DOI 10.1016/S1050-1738(03)00106-3; Takahashi T, 2011, RESPIROLOGY, V16, P680, DOI 10.1111/j.1440-1843.2011.01959.x; Tung YC, 2004, SENSOR ACTUAT B-CHEM, V98, P356, DOI 10.1016/j.snb.2003.10.010; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Wang XX, 2004, J CLIN PHARMACOL, V44, P881, DOI 10.1177/0091270004267593; WEITZENBLUM E, 1981, THORAX, V36, P752, DOI 10.1136/thx.36.10.752; Zhang YM, 2009, FASEB J, V23, P1358, DOI 10.1096/fj.08-110296	45	36	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106163	10.1371/journal.pone.0106163	http://dx.doi.org/10.1371/journal.pone.0106163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25171153	Green Published, Green Submitted, gold			2022-12-25	WOS:000341127500120
J	Beumer, W; Welzen-Coppens, JMC; van Helden-Meeuwsen, CG; Gibney, SM; Drexhage, HA; Versnel, MA				Beumer, Wouter; Welzen-Coppens, Jojanneke M. C.; van Helden-Meeuwsen, Cornelia G.; Gibney, Sinead M.; Drexhage, Hemmo A.; Versnel, Marjan A.			The Gene Expression Profile of CD11c(+)CD8 alpha(-) Dendritic Cells in the Pre-Diabetic Pancreas of the NOD Mouse	PLOS ONE			English	Article							NONOBESE DIABETIC MOUSE; POSTNATAL PANCREAS; APC FUNCTION; IN-VITRO; MICE; TYPE-1; MACROPHAGES; ABNORMALITIES; MATURATION; IMMUNOTHERAPY	Two major dendritic cell (DC) subsets have been described in the pancreas of mice: The CD11c(+)CD8 alpha(-) DCs (strong CD4+ T cell proliferation inducers) and the CD8 alpha(+)CD103(+) DCs (T cell apoptosis inducers). Here we analyzed the larger subset of CD11c(+)CD8 alpha(-) DCs isolated from the pancreas of pre-diabetic NOD mice for genome-wide gene expression (validated by Q-PCR) to elucidate abnormalities in underlying gene expression networks. CD11c(+)CD8 alpha(-) DCs were isolated from 5 week old NOD and control C57BL/6 pancreas. The steady state pancreatic NOD CD11c(+)CD8 alpha(-) DCs showed a reduced expression of several gene networks important for the prime functions of these cells, i.e. for cell renewal, immune tolerance induction, migration and for the provision of growth factors including those for beta cell regeneration. A functional in vivo BrdU incorporation test showed the reduced proliferation of steady state pancreatic DC. The reduced expression of tolerance induction genes (CD200R, CCR5 and CD24) was supported on the protein level by flow cytometry. Also previously published functional tests on maturation, immune stimulation and migration confirm the molecular deficits of NOD steady state DC. Despite these deficiencies NOD pancreas CD11c(+)CD8 alpha(-) DCs showed a hyperreactivity to LPS, which resulted in an enhanced pro-inflammatory state characterized by a gene profile of an enhanced expression of a number of classical inflammatory cytokines. The enhanced up-regulation of inflammatory genes was supported by the in vitro cytokine production profile of the DCs. In conclusion, our data show that NOD pancreatic CD11c(+)CD8 alpha(-) DCs show various deficiencies in steady state, while hyperreactive when encountering a danger signal such as LPS.	[Beumer, Wouter; Welzen-Coppens, Jojanneke M. C.; van Helden-Meeuwsen, Cornelia G.; Gibney, Sinead M.; Drexhage, Hemmo A.; Versnel, Marjan A.] Univ Med Ctr, Erasmus MC, Dept Immunol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Drexhage, HA (corresponding author), Univ Med Ctr, Erasmus MC, Dept Immunol, Rotterdam, Netherlands.	h.drexhage@erasmusmc.nl			Moodinflame [222963]; Juvenile Diabetes Research Foundation (JDRF);  [KP7-HEALTH-2007-B]	Moodinflame; Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); 	This study was funded by KP7-HEALTH-2007-B. Acronym: Moodinflame - Grant Agreement no. 222963 and the Juvenile Diabetes Research Foundation (JDRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Charre S, 2002, HISTOL HISTOPATHOL, V17, P393, DOI 10.14670/HH-17.393; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Durant S, 2003, LAB INVEST, V83, P227, DOI 10.1097/01.LAB.0000053914.93282.A5; FAUSTMAN D, 1991, SCIENCE, V254, P1756, DOI 10.1126/science.1763324; Feili-Hariri M, 2002, EUR J IMMUNOL, V32, P2021, DOI 10.1002/1521-4141(200207)32:7<2021::AID-IMMU2021>3.0.CO;2-J; Feili-Hariri M, 1999, DIABETES, V48, P2300, DOI 10.2337/diabetes.48.12.2300; Geutskens SB, 2004, CELL TISSUE RES, V318, P579, DOI 10.1007/s00441-004-0989-0; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Gurr W, 2002, DIABETES, V51, P339, DOI 10.2337/diabetes.51.2.339; Homo-Delarche F, 2004, TRENDS IMMUNOL, V25, P222, DOI 10.1016/j.it.2004.02.012; Huszarik K, 2010, J IMMUNOL, V185, P5120, DOI 10.4049/jimmunol.1001596; JANSEN A, 1995, LANCET, V345, P491, DOI 10.1016/S0140-6736(95)90586-3; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; KIKUTANI H, 1992, ADV IMMUNOL, V51, P285, DOI 10.1016/S0065-2776(08)60490-3; Kodama K, 2008, CLIN IMMUNOL, V129, P195, DOI 10.1016/j.clim.2008.07.028; Korn EL, 2004, J STAT PLAN INFER, V124, P379, DOI 10.1016/S0378-3758(03)00211-8; LEITER EH, 1987, AM J PATHOL, V128, P380; Marleau AM, 2002, J AUTOIMMUN, V19, P23, DOI 10.1006/jaut.2002.0597; Melli K, 2009, J IMMUNOL, V182, P2590, DOI 10.4049/jimmunol.0803543; Nikolic T, 2005, LAB INVEST, V85, P487, DOI 10.1038/labinvest.3700238; Nikolic T, 2004, J IMMUNOL, V173, P4342, DOI 10.4049/jimmunol.173.7.4342; Parikh Abhirath, 2012, Biomol Concepts, V3, P57; Peng RH, 2003, ANN NY ACAD SCI, V1005, P222, DOI 10.1196/annals.1288.031; Poligone B, 2002, J IMMUNOL, V168, P188, DOI 10.4049/jimmunol.168.1.188; Rosmalen JGM, 2000, LAB INVEST, V80, P769, DOI 10.1038/labinvest.3780080; Saravia F, 2003, TRENDS IMMUNOL, V24, P574, DOI 10.1016/j.it.2003.09.010; Saxena V, 2007, J IMMUNOL, V179, P5041, DOI 10.4049/jimmunol.179.8.5041; Sen P, 2003, J IMMUNOL, V170, P1770, DOI 10.4049/jimmunol.170.4.1770; SIMON R, 2003, DESIGN ANAL DNA MICR; Skarsvik S, 2004, SCAND J IMMUNOL, V60, P647, DOI 10.1111/j.0300-9475.2004.01521.x; Stoffels K, 2004, J AUTOIMMUN, V23, P9, DOI 10.1016/j.jaut.2004.03.012; Strid J, 2001, CLIN EXP IMMUNOL, V123, P375, DOI 10.1046/j.1365-2249.2001.01473.x; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Takahashi K, 1998, J IMMUNOL, V161, P2629; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Tsui H, 2008, ANN NY ACAD SCI, V1150, P32, DOI 10.1196/annals.1447.033; Vasquez AC, 2004, CLIN EXP IMMUNOL, V135, P209, DOI 10.1111/j.1365-2249.2003.02359.x; Vuckovic S, 2007, CLIN IMMUNOL, V123, P281, DOI 10.1016/j.clim.2007.03.002; WATANABE T, 1994, P NATL ACAD SCI USA, V91, P3589, DOI 10.1073/pnas.91.9.3589; Welzen-Coppens JM, 2012, J LEUKOC BIOL; Welzen-Coppens JMC, 2012, EUR J IMMUNOL, V42, P186, DOI 10.1002/eji.201141770; Wu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046941; Yin N, 2012, J IMMUNOL, V188, P4921, DOI 10.4049/jimmunol.1103725; Zacher T, 2002, CLIN IMMUNOL, V105, P17, DOI 10.1006/clim.2002.5265	47	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e103404	10.1371/journal.pone.0103404	http://dx.doi.org/10.1371/journal.pone.0103404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166904	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303700004
J	Lee, BH; Chan, JT; Hazarika, O; Vutskits, L; Sall, JW				Lee, Bradley H.; Chan, John Thomas; Hazarika, Obhi; Vutskits, Laszlo; Sall, Jeffrey W.			Early Exposure to Volatile Anesthetics Impairs Long-Term Associative Learning and Recognition Memory	PLOS ONE			English	Article							EPISODIC-LIKE MEMORY; MEDIAL PREFRONTAL CORTEX; TEMPORAL-LOBE; CELL-DEATH; RECOLLECTION; ISOFLURANE; BRAIN; SEVOFLURANE; RATS; OBJECT	Background: Anesthetic exposure early in life affects neural development and long-term cognitive function, but our understanding of the types of memory that are altered is incomplete. Specific cognitive tests in rodents that isolate different memory processes provide a useful approach for gaining insight into this issue. Methods: Postnatal day 7 (P7) rats were exposed to either desflurane or isoflurane at 1 Minimum Alveolar Concentration for 4 h. Acute neuronal death was assessed 12 h later in the thalamus, CA1-3 regions of hippocampus, and dentate gyrus. In separate behavioral experiments, beginning at P48, subjects were evaluated in a series of object recognition tests relying on associative learning, as well as social recognition. Results: Exposure to either anesthetic led to a significant increase in neuroapoptosis in each brain region. The extent of neuronal death did not differ between groups. Subjects were unaffected in simple tasks of novel object and object-location recognition. However, anesthetized animals from both groups were impaired in allocentric object-location memory and a more complex task requiring subjects to associate an object with its location and contextual setting. Isoflurane exposure led to additional impairment in object-context association and social memory. Conclusion: Isoflurane and desflurane exposure during development result in deficits in tasks relying on associative learning and recognition memory. Isoflurane may potentially cause worse impairment than desflurane.	[Lee, Bradley H.; Chan, John Thomas; Hazarika, Obhi; Sall, Jeffrey W.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Vutskits, Laszlo] Univ Hosp Geneva, Dept Anesthesiol Pharmacol & Intens Care, Geneva, Switzerland	University of California System; University of California San Francisco; University of Geneva	Sall, JW (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.	sallj@anesthesia.ucsf.edu			National Institutes of Health [GM086511]; University of California San Francisco Department of Anesthesia and Perioperative Care Hamilton Award; Swiss National Science Foundation [31003A_130625]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM086511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco Department of Anesthesia and Perioperative Care Hamilton Award; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for the study was provided through National Institutes of Health Grant GM086511 to JWS, the University of California San Francisco Department of Anesthesia and Perioperative Care Hamilton Award to JWS, and by Swiss National Science Foundation Grant 31003A_130625 to LV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2007, HIPPOCAMPUS, V17, P723, DOI 10.1002/hipo.20323; Aggleton JP, 2011, LEARN MEMORY, V18, P384, DOI 10.1101/lm.1884611; Aggleton JP, 1996, BEHAV BRAIN RES, V81, P189, DOI 10.1016/S0166-4328(96)89080-2; Boscolo A, 2013, BR J ANAESTH; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Briner A, 2010, ANESTHESIOLOGY, V112, P546, DOI 10.1097/ALN.0b013e3181cd7942; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Cross L, 2013, LEARN MEMORY, V20, P41, DOI 10.1101/lm.028266.112; Dere E, 2005, BRAIN RES PROTOC, V16, P10, DOI 10.1016/j.brainresprot.2005.08.001; DiMaggio C, 2011, ANESTH ANALG, V113, P1143, DOI 10.1213/ANE.0b013e3182147f42; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; Eacott MJ, 2005, LEARN MEMORY, V12, P221, DOI 10.1101/lm.92505; Eacott MJ, 2004, J NEUROSCI, V24, P1948, DOI 10.1523/JNEUROSCI.2975-03.2004; Easton A, 2010, BEHAV BRAIN RES, V215, P310, DOI 10.1016/j.bbr.2009.10.019; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H, 2010, NEUROPSYCHOLOGIA, V48, P2281, DOI 10.1016/j.neuropsychologia.2009.09.015; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Gentry KR, 2013, ANESTH ANALG, V116, P185, DOI 10.1213/ANE.0b013e31826d37c5; Istaphanous GK, 2011, ANESTHESIOLOGY, V114, P578, DOI 10.1097/ALN.0b013e3182084a70; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kart-Teke E, 2006, NEUROBIOL LEARN MEM, V85, P173, DOI 10.1016/j.nlm.2005.10.002; Kodama M, 2011, ANESTHESIOLOGY, V115, P979, DOI 10.1097/ALN.0b013e318234228b; Koenig JI, 2005, BEHAV BRAIN RES, V156, P251, DOI 10.1016/j.bbr.2004.05.030; Langston RF, 2010, HIPPOCAMPUS, V20, P1139, DOI 10.1002/hipo.20714; Liang G, 2010, ANESTHESIOLOGY, V112, P1325, DOI 10.1097/ALN.0b013e3181d94da5; Lin N, 2013, J NEUROSURG ANESTH, V25, P306, DOI 10.1097/ANA.0b013e318283c3c7; Macbeth AH, 2009, NAT PROTOC, V4, P1574, DOI 10.1038/nprot.2009.141; Masaki E, 2004, ANESTH ANALG, V98, P647, DOI 10.1213/01.ANE.0000103259.72635.72; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Ramage T.M., 2013, BR J ANAESTH; Sall JW, 2009, ANESTHESIOLOGY, V110, P826, DOI 10.1097/ALN.0b013e31819b62e2; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Sauvage MM, 2010, CONSCIOUS COGN, V19, P816, DOI 10.1016/j.concog.2010.06.023; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Shen X, 2013, ANESTHESIOLOGY, V118, P502, DOI 10.1097/ALN.0b013e3182834d77; Shih J, 2012, ANESTHESIOLOGY, V116, P586, DOI 10.1097/ALN.0b013e318247564d; Stratmann G, 2014, NEUROPSYCHOPHARMACOL, V39, P2275, DOI 10.1038/npp.2014.134; Stratmann G, 2009, ANESTH ANALG, V109, P801, DOI 10.1213/ane.0b013e3181aff364; Stratmann G, 2009, ANESTHESIOLOGY, V110, P849, DOI 10.1097/ALN.0b013e31819c7140; Tang AC, 2003, J NEUROSCI, V23, P8254; Wang L, 2008, BRAIN RES, V1241, P157, DOI 10.1016/j.brainres.2008.07.097; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Yonelinas AP, 2001, PHILOS T R SOC B, V356, P1363, DOI 10.1098/rstb.2001.0939	49	32	34	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105340	10.1371/journal.pone.0105340	http://dx.doi.org/10.1371/journal.pone.0105340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JP	25165850	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303700023
J	Tsai, YH; Lee, MH; Weng, HH; Chang, SW; Yang, JT; Huang, YC				Tsai, Yuan-Hsiung; Lee, Ming-Hsueh; Weng, Hsu-Huei; Chang, Sheng-Wei; Yang, Jen-Tsung; Huang, Yen-Chu			Fate of Diffusion Restricted Lesions in Acute Intracerebral Hemorrhage	PLOS ONE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; SMALL VESSEL DISEASE; ISCHEMIC LESIONS; BLOOD-PRESSURE; ACUTE STROKE; BRAIN; MR; SILENT	Background: Diffusion-restricted lesions on diffusion-weighted imaging (DWI) are detected in patients with intracerebral hemorrhage (ICH). In this study, we aimed to determine the fate of DWI lesions in ICH patients and whether the presence of DWI lesions is associated with functional outcome in patients with ICH. Methods: This prospective study enrolled 153 patients with acute ICH. Baseline MRI scans were performed within 2 weeks after ICH to detect DWI lesions and imaging markers for small vessel disease (SVD). Follow-up MRI scans were performed at 3 months after ICH to assess the fate of the DWI lesions. We analyzed the associations between the characteristics of DWI lesions with clinical features and functional outcome. Results: Seventeen of the 153 patients (11.1%) had a total of 25 DWI lesions. Factors associated with DWI lesions were high initial systolic and mean arterial blood pressure (MAP) at the emergency room, additional lowering of MAP within 24 hours, and the presence of white matter hyperintensity and cerebral microbleeds. Thirteen of the 25 DWI lesions (52%) were not visible on follow-up T2-weighted or fluid-attenuated inversion recovery images and were associated with high apparent diffusion coefficient value and a sharper decease in MAP. The regression of DWI lesions was associated with good functional outcome. Conclusions: More than half of the DWI lesions in the ICH patients did not transition to visible, long-term infarction. Only if the DWI lesion finally transitioned to final infarction was a poor functional outcome predicted. A DWI lesion may be regarded as an ischemic change of SVD and does not always indicate certain cerebral infarction or permanent tissue injury.	[Tsai, Yuan-Hsiung; Weng, Hsu-Huei; Chang, Sheng-Wei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Diagnost Radiol, Taoyuan, Taiwan; [Lee, Ming-Hsueh; Yang, Jen-Tsung] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Neurosurg, Taoyuan, Taiwan; [Huang, Yen-Chu] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Neurol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Huang, YC (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Neurol, Taoyuan, Taiwan.	yenchu.huang@msa.hinet.net	Huang, Yenchu/AAO-1140-2020; Weng, Hsu-Huei/N-8329-2014	Weng, Hsu-Huei/0000-0002-2020-8912	Chang Gung Medical Research Fund, Chang Gung Memorial Hospital, Chiayi, Taiwan [CMRPG690472, CMRPG690462]	Chang Gung Medical Research Fund, Chang Gung Memorial Hospital, Chiayi, Taiwan	This research was supported by the Chang Gung Medical Research Fund, Chang Gung Memorial Hospital, Chiayi, Taiwan (CMRPG690472 and CMRPG690462). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albach FN, 2013, STROKE, V44, P1043, DOI 10.1161/STROKEAHA.111.676346; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Arsava EM, 2013, J STROKE CEREBROVASC, V22, P250, DOI 10.1016/j.jstrokecerebrovasdis.2011.08.006; Attems J, 2011, NEUROPATH APPL NEURO, V37, P75, DOI 10.1111/j.1365-2990.2010.01137.x; Garg RK, 2012, STROKE, V43, P67, DOI 10.1161/STROKEAHA.111.629493; Gregoire SM, 2011, BRAIN, V134, P2376, DOI 10.1093/brain/awr172; Guadagno JV, 2006, NEUROLOGY, V67, P824, DOI 10.1212/01.wnl.0000233984.66907.db; Guadagno JV, 2005, CEREBROVASC DIS, V19, P239, DOI 10.1159/000084087; Kang DW, 2012, NEUROLOGY, V79, P848, DOI 10.1212/WNL.0b013e3182648a79; Kimberly WT, 2009, NEUROLOGY, V72, P1230, DOI 10.1212/01.wnl.0000345666.83318.03; Kranz PG, 2009, AM J NEURORADIOL, V30, P1206, DOI 10.3174/ajnr.A1547; Le Bihan D, 2013, RADIOLOGY, V268, P318, DOI 10.1148/radiol.13130420; Li FH, 2000, STROKE, V31, P946, DOI 10.1161/01.STR.31.4.946; Menon RS, 2012, ANN NEUROL, V71, P199, DOI 10.1002/ana.22668; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Orakcioglu B, 2008, NEUROCRIT CARE, V8, P448, DOI 10.1007/s12028-007-9047-6; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Prabhakaran S, 2012, NEUROLOGY, V79, P838, DOI 10.1212/WNL.0b013e3182648a8c; Prabhakaran S, 2010, STROKE, V41, P89, DOI 10.1161/STROKEAHA.109.566257; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Smith EE, 2006, ARCH NEUROL-CHICAGO, V63, P148, DOI 10.1001/archneur.63.1.148; Smith EE, 2012, LANCET NEUROL, V11, P272, DOI 10.1016/S1474-4422(11)70307-6; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7	27	29	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105970	10.1371/journal.pone.0105970	http://dx.doi.org/10.1371/journal.pone.0105970			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166754	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303700059
J	Silva-Baila, MG; Bailao, EFLC; Lechner, BE; Gauthier, GM; Lindner, H; Bailao, AM; Haas, H; Soares, CMD				Silva-Baila, Mirelle Garcia; Luiz Cardoso Bailao, Elisa Flavia; Lechner, Beatrix Elisabeth; Gauthier, Gregory M.; Lindner, Herbert; Bailao, Alexandre Melo; Haas, Hubertus; de Almeida Soares, Celia Maria			Hydroxamate Production as a High Affinity Iron Acquisition Mechanism in Paracoccidioides Spp.	PLOS ONE			English	Article							ASPERGILLUS-FUMIGATUS; SIDEROPHORE BIOSYNTHESIS; HISTOPLASMA-CAPSULATUM; EXTRACELLULAR SIDEROPHORES; PHYLOGENETIC ANALYSIS; MAGNAPORTHE-GRISEA; NEUROSPORA-CRASSA; OXIDATIVE-STRESS; CULTURE-MEDIUM; HUMAN PLASMA	Iron is a micronutrient required by almost all living organisms, including fungi. Although this metal is abundant, its bioavailability is low either in aerobic environments or within mammalian hosts. As a consequence, pathogenic microorganisms evolved high affinity iron acquisition mechanisms which include the production and uptake of siderophores. Here we investigated the utilization of these molecules by species of the Paracoccidioides genus, the causative agents of a systemic mycosis. It was demonstrated that iron starvation induces the expression of Paracoccidioides ortholog genes for siderophore biosynthesis and transport. Reversed-phase HPLC analysis revealed that the fungus produces and secretes coprogen B, which generates dimerumic acid as a breakdown product. Ferricrocin and ferrichrome C were detected in Paracoccidioides as the intracellular produced siderophores. Moreover, the fungus is also able to grow in presence of siderophores as the only iron sources, demonstrating that beyond producing, Paracoccidioides is also able to utilize siderophores for growth, including the xenosiderophore ferrioxamine. Exposure to exogenous ferrioxamine and dimerumic acid increased fungus survival during co-cultivation with macrophages indicating that these molecules play a role during host-pathogen interaction. Furthermore, cross-feeding experiments revealed that Paracoccidioides siderophores promotes growth of Aspergillus nidulans strain unable to produce these iron chelators. Together, these data denote that synthesis and utilization of siderophores is a mechanism used by Paracoccidioides to surpass iron limitation. As iron paucity is found within the host, siderophore production may be related to fungus pathogenicity.	[Silva-Baila, Mirelle Garcia; Luiz Cardoso Bailao, Elisa Flavia; Bailao, Alexandre Melo; de Almeida Soares, Celia Maria] Univ Fed Goias, Inst Ciencias Biol, Mol Biol Lab, Goiania, Go, Brazil; [Silva-Baila, Mirelle Garcia] Univ Brasilia, Programa Posgrad Patol Mol, Brasilia, DF, Brazil; [Luiz Cardoso Bailao, Elisa Flavia] Univ Estadual Goias, Unidade Univ Ipora, Ipora, Go, Brazil; [Lechner, Beatrix Elisabeth; Haas, Hubertus] Med Univ Innsbruck, Bioctr, Div Mol Biol, A-6020 Innsbruck, Austria; [Lindner, Herbert] Med Univ Innsbruck, Bioctr, Div Clin Biochem, A-6020 Innsbruck, Austria; [Gauthier, Gregory M.] Univ Wisconsin, Dept Med, Infect Dis Sect, Madison, WI USA	Universidade Federal de Goias; Universidade de Brasilia; Universidade Estadual de Goias; Medical University of Innsbruck; Medical University of Innsbruck; University of Wisconsin System; University of Wisconsin Madison	Soares, CMD (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Mol Biol Lab, Goiania, Go, Brazil.	cmasoares@gmail.com	Soares, Celia/N-6395-2014; Bailao, Alexandre Melo/H-1272-2013; Bailão, Elisa Flávia Luiz Cardoso/M-6409-2015	Bailao, Alexandre Melo/0000-0001-7754-4047; Luiz Cardoso Bailao, Elisa Flavia/0000-0001-6737-7548; Lechner, Beatrix/0000-0002-4683-4997; Silva-Bailao, Mirelle/0000-0003-2053-204X	Financiadora de Estudos e Projetos (FINEP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG); Coordenacao de Pessoal do Ensino Superior (CAPES); Pronex; Austrian Science Foundation (FWF) [P21643-B11]; CAPES	Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG)(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); Coordenacao de Pessoal do Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pronex; Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Work at Universidade Federal de Goias was supported by grants from Financiadora de Estudos e Projetos (FINEP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG), Coordenacao de Pessoal do Ensino Superior (CAPES) and Pronex. Work at Innsbruck Medical University was supported by the Austrian Science Foundation (FWF P21643-B11 to HH). MGSB was supported by a fellowship from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelo L, 2006, Z NATURFORSCH C, V61, P461; ARANGO R, 1988, J MED VET MYCOL, V26, P113; ATKIN CL, 1970, J BACTERIOL, V103, P722, DOI 10.1128/JB.103.3.722-733.1970; Bailao AM, 2007, FEMS IMMUNOL MED MIC, V51, P43, DOI 10.1111/j.1574-695X.2007.00277.x; Bailao AM, 2006, MICROBES INFECT, V8, P2686, DOI 10.1016/j.micinf.2006.07.019; Blatzer M, 2011, APPL ENVIRON MICROB, V77, P4959, DOI 10.1128/AEM.00182-11; Bocca AL, 2013, FUTURE MICROBIOL, V8, P1177, DOI 10.2217/fmb.13.68; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; BRUMMER E, 1989, INFECT IMMUN, V57, P2289, DOI 10.1128/IAI.57.8.2289-2294.1989; BURT WR, 1982, INFECT IMMUN, V35, P990, DOI 10.1128/IAI.35.3.990-996.1982; Cairo G, 2006, GENES NUTR, V1, P25, DOI 10.1007/BF02829934; CANO LE, 1994, INFECT IMMUN, V62, P1494, DOI 10.1128/IAI.62.4.1494-1496.1994; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; CASTANEDA E, 1988, J MED VET MYCOL, V26, P351; Chao LY, 2008, BIOCHEMISTRY-US, V47, P7274, DOI 10.1021/bi800066s; CHARLANG G, 1981, MOL CELL BIOL, V1, P94, DOI 10.1128/MCB.1.2.94; COX CD, 1994, METHOD ENZYMOL, V235, P315; Dias-Melicio Luciane Alarcão, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P263, DOI 10.1590/S0036-46652005000500005; Eisendle M, 2003, MOL MICROBIOL, V49, P359, DOI 10.1046/j.1365-2958.2003.03586.x; Eisendle M, 2006, EUKARYOT CELL, V5, P1596, DOI 10.1128/EC.00057-06; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Gauthier GM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000846; Greenshields DL, 2007, MOL PLANT PATHOL, V8, P411, DOI [10.1111/j.1364-3703.2007.00401.x, 10.1111/J.1364-3703.2007.00401.X]; Grossklaus DD, 2013, MICROBES INFECT, V15, P347, DOI 10.1016/j.micinf.2012.12.002; Grundlinger M, 2013, MOL MICROBIOL, V88, P862, DOI 10.1111/mmi.12225; Haas H, 1999, J BIOL CHEM, V274, P4613, DOI 10.1074/jbc.274.8.4613; Haas H, 2003, BIOCHEM J, V371, P505, DOI 10.1042/BJ20021685; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Haber F., 1934, P R SOC LOND A, V147, P332, DOI [10.1098/rspa.1934.0221, DOI 10.1098/RSPA.1934.0221, DOI 10.1098/rspa.1934.0221]; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Harrison KA, 2002, BIOCHEMISTRY-US, V41, P15288, DOI 10.1021/bi0204995; Hilty J, 2011, MED MYCOL, V49, P633, DOI 10.3109/13693786.2011.558930; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hissen AHT, 2004, INFECT IMMUN, V72, P1402, DOI 10.1128/IAI.72.3.1402-1408.2004; Hof C, 2007, MOL PLANT PATHOL, V8, P163, DOI 10.1111/j.1364-3703.2007.00380.x; Howard DH, 2000, INFECT IMMUN, V68, P2338, DOI 10.1128/IAI.68.4.2338-2343.2000; Hwang LH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000044; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Longo LVG, 2013, FEMS MICROBIOL LETT, V341, P87, DOI 10.1111/1574-6968.12097; Machuca A, 2003, LETT APPL MICROBIOL, V36, P177, DOI 10.1046/j.1472-765X.2003.01290.x; Martinez R, 1978, Rev Inst Med Trop Sao Paulo, V20, P190; Martinez R, 1978, Rev Inst Med Trop Sao Paulo, V20, P195; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; MATZANKE BF, 1987, J BACTERIOL, V169, P5873, DOI 10.1128/jb.169.12.5873-5876.1987; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; MOR H, 1992, BIOMETALS, V5, P213, DOI 10.1007/BF01061220; NEILANDS JB, 1993, ARCH BIOCHEM BIOPHYS, V302, P1, DOI 10.1006/abbi.1993.1172; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Nevitt T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001322; Oberegger H, 2001, MOL MICROBIOL, V41, P1077, DOI 10.1046/j.1365-2958.2001.02586.x; Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633; PANDEY A, 1994, APPL MICROBIOL BIOT, V40, P735, DOI [10.1007/BF00173337, 10.1007/s002530050058]; Parente AFA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022810; Perez-Miranda S, 2007, J MICROBIOL METH, V70, P127, DOI 10.1016/j.mimet.2007.03.023; Plattner Hans Juergen, 1994, V11, P99; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Recalcati S, 2012, SEMIN IMMUNOL, V24, P393, DOI 10.1016/j.smim.2013.01.001; Renshaw JC, 2002, MYCOL RES, V106, P1123, DOI 10.1017/S0953756202006548; RESTREPO A, 1980, J CLIN MICROBIOL, V12, P279, DOI 10.1128/JCM.12.2.279-281.1980; Salgado-Salazar C, 2010, CLADISTICS, V26, P613, DOI 10.1111/j.1096-0031.2010.00307.x; Scazzocchio C, 2000, CURR OPIN MICROBIOL, V3, P126, DOI 10.1016/S1369-5274(00)00063-1; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Schrettl M, 2008, MOL MICROBIOL, V70, P27, DOI 10.1111/j.1365-2958.2008.06376.x; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Schrettl M, 2010, MICROBES INFECT, V12, P1035, DOI 10.1016/j.micinf.2010.07.005; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Silva MG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00049; Teixeira MD, 2014, MED MYCOL, V52, P19, DOI 10.3109/13693786.2013.794311; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Theodoro RC, 2008, FUNGAL GENET BIOL, V45, P1284, DOI 10.1016/j.fgb.2008.07.003; Van Der Helm Dick, 1994, V11, P39; Wallner A, 2009, APPL ENVIRON MICROB, V75, P4194, DOI 10.1128/AEM.00479-09; Weiss G, 2005, BEST PRACT RES CL HA, V18, P183, DOI 10.1016/j.beha.2004.09.001; Winterberg B, 2010, MOL MICROBIOL, V75, P1260, DOI 10.1111/j.1365-2958.2010.07048.x; Yasmin S, 2012, P NATL ACAD SCI USA, V109, pE497, DOI 10.1073/pnas.1106399108; Youseff BH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002713	79	34	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105805	10.1371/journal.pone.0105805	http://dx.doi.org/10.1371/journal.pone.0105805			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157575	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303200066
J	Slotved, HC; Dalby, T; Hoffmann, S				Slotved, Hans-Christian; Dalby, Tine; Hoffmann, Steen			Invasive Pneumococcal Isolates from Danish Infants (0-90 Days) during the Years 1943 to 2013	PLOS ONE			English	Article							CHILDHOOD IMMUNIZATION PROGRAM; DISEASE; VACCINATION; DENMARK; IMPACT; SEROTYPES; CARRIAGE; CHILDREN; YOUNGER	Background: The seven-valent pneumococcal conjugate vaccine (PCV-7) was introduced in the Danish childhood immunization program (at 3, 5 and 12 months of age) in 2007 and was replaced with PCV-13 in 2010 without changes to the schedule. After the introduction of these vaccines the incidence of invasive pneumococcal disease (IPD) due to vaccine types (VTs) declined markedly in children aged 0-2 years; however, cases among infants too young to be protected by vaccination have not been studied in detail. We present data on IPD in infants less than 90 days from 1943 until 2013. Study design: The study included all infants younger than 90 days born from 1943 through 2013, who had not been PCV vaccinated and from whom a pneumococcus isolate from blood or cerebrospinal fluid had been submitted to the Danish national reference laboratory. All isolates were serotyped using Pneumotest Latex and Quellung reaction. Results: A total of 216 IPD cases were identified. The age group specific incidence (total number of IPD cases per 100,000 live births) varied from 0 to 16 in the period 1943 to 2007 and from 1.7 to 9.2 in the period 2008 to 2013. IPD cases due to PCV-7 serotypes were not observed later than 2009. Conclusion: In Danish infants younger than 90 days, IPD due to PCV-7 serotypes has decreased and has not been observed since 2009, but the total incidence of IPD has not changed.	[Slotved, Hans-Christian; Dalby, Tine; Hoffmann, Steen] Statens Serum Inst, Dept Microbiol & Infect Control, Neisseria & Streptococcus Reference Lab NSRlab, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Slotved, HC (corresponding author), Statens Serum Inst, Dept Microbiol & Infect Control, Neisseria & Streptococcus Reference Lab NSRlab, DK-2300 Copenhagen, Denmark.	hcs@ssi.dk	Slotved, Hans-Christian/H-7476-2019; Dalby, Tine/H-4560-2019	Slotved, Hans-Christian/0000-0002-7294-4911; Dalby, Tine/0000-0003-4774-7091	Pfizer	Pfizer(Pfizer)	Hans-Christian Slotved is participating in a project supported by Pfizer. All three authors are employed at Statens Serum Institut, who produces antisera for typing of pneumococci. This does not alter their adherence to PLOS ONE policies on sharing data and materials.	Borrow R, 2012, CURR OPIN INFECT DIS, V25, P292, DOI 10.1097/QCO.0b013e3283531b0f; Feldman C, 2014, J INFECTION, V69, P309, DOI 10.1016/j.jinf.2014.06.006; Harboe ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051460; Harboe ZB, 2010, VACCINE, V28, P2642, DOI 10.1016/j.vaccine.2010.01.017; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Howitz M, 2008, SCAND J INFECT DIS, V40, P881, DOI 10.1080/00365540802325914; Ingels H, 2012, VACCINE, V30, P3944, DOI 10.1016/j.vaccine.2012.03.060; Kaltoft MS, 2008, J MICROBIOL METH, V75, P540, DOI 10.1016/j.mimet.2008.08.010; Ladhani SN, 2013, CLIN INFECT DIS, V56, P633, DOI 10.1093/cid/cis934; Lambertsen L, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-282; O'Brien KL, 2013, PEDIATR INFECT DIS J, V32, P264, DOI 10.1097/INF.0b013e3182787f89; Olarte L, 2013, PEDIATRICS, V132, pE17, DOI 10.1542/peds.2012-3900; Rashid H, 2012, CURR OPIN INFECT DIS, V25, P243, DOI 10.1097/QCO.0b013e328352f727; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]	14	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e106180	10.1371/journal.pone.0106180	http://dx.doi.org/10.1371/journal.pone.0106180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157997	Green Published, gold			2022-12-25	WOS:000341303200090
J	Vajn, K; Suler, D; Plunkett, JA; Oudega, M				Vajn, Katarina; Suler, Denis; Plunkett, Jeffery A.; Oudega, Martin			Temporal Profile of Endogenous Anatomical Repair and Functional Recovery following Spinal Cord Injury in Adult Zebrafish	PLOS ONE			English	Article							TRANSECTION; REGENERATION; NEURONS	Regenerated cerebrospinal axons are considered to be involved in the spontaneous recovery of swimming ability following a spinal cord injury in adult zebrafish. We employed behavioral analysis, neuronal tracing, and immunocytochemistry to determine the exact temporal relationship between swimming ability and regenerated cerebrospinal axon number in adult zebrafish with a complete spinal cord transection. Between two and eight weeks post-lesion, swimming gradually improved to 44% of sham-injured zebrafish. Neurons within the reticular formation, magnocellular octaval nucleus, and nucleus of the medial longitudinal fascicle grew their axon across and at least four millimeters beyond the lesion. The largest increases in swimming ability and number of regenerated cerebrospinal axons were observed between two and four weeks post-lesion. Regression analyses revealed a significant correlation between swimming ability and the number of regenerated axons. Our results indicate the involvement of cerebrospinal axons in swimming recovery after spinal cord injury in adult zebrafish.	[Vajn, Katarina; Suler, Denis; Oudega, Martin] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Plunkett, Jeffery A.] St Thomas Univ, Sch Sci Technol & Engn Management, Miami, FL USA; [Oudega, Martin] Univ Pittsburgh, Sch Med, Dept Bioengn, Pittsburgh, PA USA; [Oudega, Martin] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vajn, K (corresponding author), Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA.	moudega@pitt.edu			United States Department of Defense Grant [W81XWH-11-0645]; U.S. Army Medical Research and Materiel Command/Telemedicine and Advanced Technology Research Center	United States Department of Defense Grant(United States Department of Defense); U.S. Army Medical Research and Materiel Command/Telemedicine and Advanced Technology Research Center(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	Funding was provided by United States Department of Defense Grant W81XWH-11-0645 to JAP, U.S. Army Medical Research and Materiel Command/Telemedicine and Advanced Technology Research Center (www.tatrc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker CG, 2004, J NEUROSCI, V24, P7837, DOI 10.1523/JNEUROSCI.2420-04.2004; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Becker T, 2001, J COMP NEUROL, V433, P131, DOI 10.1002/cne.1131; Fang P, 2012, J GENET GENOMICS, V39, P481, DOI 10.1016/j.jgg.2012.07.010; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; Hui SP, 2010, DEV DYNAM, V239, P2962, DOI 10.1002/dvdy.22438; Kimura Y, 2013, CURR BIOL, V23, P843, DOI 10.1016/j.cub.2013.03.066; Kuscha V, 2012, J COMP NEUROL, V520, P933, DOI 10.1002/cne.22739; Kyriakatos A, 2011, J NEUROSCI, V31, P8422, DOI 10.1523/JNEUROSCI.1012-11.2011; Ogai K, 2012, NEUROCHEM INT, V61, P1202, DOI 10.1016/j.neuint.2012.08.015; van Raamsdonk W, 1998, ACTA HISTOCHEM, V100, P117, DOI 10.1016/S0065-1281(98)80021-4	11	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105857	10.1371/journal.pone.0105857	http://dx.doi.org/10.1371/journal.pone.0105857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157957	gold, Green Published, Green Accepted			2022-12-25	WOS:000341303200071
J	Vercoulen, Y; Enders, FB; Meerding, J; Plantinga, M; Elst, EF; Varsani, H; van Schieveen, C; Bakker, MH; Klein, M; Scholman, RC; Spliet, W; Ricotti, V; Koenen, HJPM; de Weger, RA; Wedderburn, LR; van Royen-Kerkhof, A; Prakken, BJ				Vercoulen, Yvonne; Enders, Felicitas Bellutti; Meerding, Jenny; Plantinga, Maud; Elst, Elisabeth F.; Varsani, Hemlata; van Schieveen, Christa; Bakker, Mette H.; Klein, Mark; Scholman, Rianne C.; Spliet, Wim; Ricotti, Valeria; Koenen, Hans J. P. M.; de Weger, Roel A.; Wedderburn, Lucy R.; van Royen-Kerkhof, Annet; Prakken, Berent J.			Increased Presence of FOXP3(+) Regulatory T Cells in Inflamed Muscle of Patients with Active Juvenile Dermatomyositis Compared to Peripheral Blood	PLOS ONE			English	Article							INFLAMMATORY MYOPATHIES; IDIOPATHIC ARTHRITIS; DISEASE-ACTIVITY; SKIN; DIFFERENTIATE; SCLEROSIS; CYTOKINES; DAMAGE; VIVO	Juvenile dermatomyositis (JDM) is an immune-mediated inflammatory disease affecting the microvasculature of skin and muscle. CD4(+)CD25(+)FOXP3(+) regulatory T cells (Tregs) are key regulators of immune homeostasis. A role for Tregs in JDM pathogenesis has not yet been established. Here, we explored Treg presence and function in peripheral blood and muscle of JDM patients. We analyzed number, phenotype and function of Tregs in blood from JDM patients by flow cytometry and in vitro suppression assays, in comparison to healthy controls and disease controls (Duchenne's Muscular Dystrophy). Presence of Tregs in muscle was analyzed by immunohistochemistry. Overall, Treg percentages in peripheral blood of JDM patients were similar compared to both control groups. Muscle biopsies of new onset JDM patients showed increased infiltration of numbers of T cells compared to Duchenne's muscular dystrophy. Both in JDM and Duchenne's muscular dystrophy the proportion of FOXP3(+) T cells in muscles were increased compared to JDM peripheral blood. Interestingly, JDM is not a self-remitting disease, suggesting that the high proportion of Tregs in inflamed muscle do not suppress inflammation. In line with this, peripheral blood Tregs of active JDM patients were less capable of suppressing effector T cell activation in vitro, compared to Tregs of JDM in clinical remission. These data show a functional impairment of Tregs in a proportion of patients with active disease, and suggest a regulatory role for Tregs in JDM inflammation.	[Vercoulen, Yvonne; Enders, Felicitas Bellutti; Meerding, Jenny; Plantinga, Maud; Elst, Elisabeth F.; van Schieveen, Christa; Bakker, Mette H.; Klein, Mark; Scholman, Rianne C.; Prakken, Berent J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Lab Translat Immunol Pediat Immunol, Utrecht, Netherlands; [Enders, Felicitas Bellutti] Univ Hosp, Dept Pediat, Div Allergol Immunol & Rheumatol, Lausanne, Switzerland; [Varsani, Hemlata; Wedderburn, Lucy R.] UCL, Inst Child Hlth, Juvenile Dermatomyositis Res Grp, Rheumatol Unit, London, England; [Spliet, Wim; de Weger, Roel A.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Ricotti, Valeria] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Koenen, Hans J. P. M.] Radboud Univ Nijmegen Med Ctr, Dept Lab Med, Sect Med Immunol, Nijmegen, Netherlands; [van Royen-Kerkhof, Annet] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol & Rheumatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of London; University College London; Utrecht University; Utrecht University Medical Center; University of London; University College London; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Vercoulen, Y (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	y.vercoulen@umcutrecht.nl; A.vanRoyen@umcutrecht.nl	Enders, Felicitas Bellutti/AAB-8916-2020; Koenen, Hans J.P.M./A-2852-2014	Vercoulen, Yvonne/0000-0002-5060-2603; Wedderburn, Lucy/0000-0002-7495-1429	Dutch League against Rheumatism; Dutch Organization for Scientific Research; Cathal Hayes Research Trust; Wellcome Trust UK [085860]; Action Medical Research UK [SP4252]; Henry Smith Charity; Arthritis Research UK [14518, 18796]; Raynaud's and Scleroderma Association; UK Myositis Support Group; Swiss Grants: Foundation of Ettore e Valeria Bossi, Switzerland; Great Ormond Street Hospital Childrens Charity [V1286] Funding Source: researchfish	Dutch League against Rheumatism; Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Cathal Hayes Research Trust; Wellcome Trust UK(Wellcome Trust); Action Medical Research UK; Henry Smith Charity; Arthritis Research UK(Versus Arthritis); Raynaud's and Scleroderma Association; UK Myositis Support Group; Swiss Grants: Foundation of Ettore e Valeria Bossi, Switzerland; Great Ormond Street Hospital Childrens Charity	Y.V. is supported by Dutch League against Rheumatism, B.P. by Dutch Organization for Scientific Research, JDM Cohort Study is supported by Cathal Hayes Research Trust, Wellcome Trust UK (085860), Action Medical Research UK (SP4252), The Henry Smith Charity, Arthritis Research UK (14518, 18796), Raynaud's and Scleroderma Association, UK Myositis Support Group. FBE was supported by Swiss Grants: Foundation of Ettore e Valeria Bossi, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antiga E, 2010, BRIT J DERMATOL, V162, P1056, DOI 10.1111/j.1365-2133.2010.09633.x; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Banica L, 2009, AUTOIMMUNITY, V42, P41, DOI 10.1080/08916930802282651; Bellutti Enders F, 2014, CXCL10 TNFR2 GALECTI; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Bovenschen HJ, 2011, J INVEST DERMATOL, V131, P1853, DOI 10.1038/jid.2011.139; Braitch M, 2009, ACTA NEUROL SCAND, V119, P239, DOI 10.1111/j.1600-0404.2008.01090.x; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Chen X, 2006, EUR J IMMUNOL, V36, P2139, DOI 10.1002/eji.200635873; de Kleer IM, 2004, J IMMUNOL, V172, P6435, DOI 10.4049/jimmunol.172.10.6435; De Paepe B, 2009, CURR OPIN RHEUMATOL, V21, P610, DOI 10.1097/BOR.0b013e3283317b31; Deknuydt F, 2009, CLIN IMMUNOL, V131, P298, DOI 10.1016/j.clim.2008.12.008; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Haufe S, 2011, ARTHRITIS RHEUM-US, V63, P3153, DOI 10.1002/art.30503; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; MCDOUALL RM, 1990, J NEUROL SCI, V99, P199, DOI 10.1016/0022-510X(90)90156-H; Mendez EP, 2003, ARTHRIT RHEUM-ARTHR, V49, P300, DOI 10.1002/art.11122; Nistala K, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4311; Nocentini G, 2005, EUR J IMMUNOL, V35, P1016, DOI 10.1002/eji.200425818; Pesenacker AM, 2013, BLOOD, V121, P2647, DOI 10.1182/blood-2012-08-443473; Reed AM, 2012, ARTHRITIS RHEUM-US, V64, P4078, DOI 10.1002/art.34659; Ruperto N, 2003, RHEUMATOLOGY, V42, P1452, DOI 10.1093/rheumatology/keg403; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; Shen H, 2011, SCAND J RHEUMATOL, V40, P217, DOI 10.3109/03009742.2010.517215; SPENCER CH, 1984, J PEDIATR-US, V105, P399, DOI 10.1016/S0022-3476(84)80012-8; Tournadre A, 2012, CURR RHEUMATOL REP, V14, P252, DOI 10.1007/s11926-012-0242-x; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Walker LSK, 2013, J AUTOIMMUN, V45, P49, DOI 10.1016/j.jaut.2013.06.006; Waschbisch A, 2010, J NEUROIMMUNOL, V225, P137, DOI 10.1016/j.jneuroim.2010.03.013; Wehrens EJ, 2013, NAT REV RHEUMATOL, V9, P34, DOI 10.1038/nrrheum.2012.149; Wehrens EJ, 2011, BLOOD, V118, P3538, DOI 10.1182/blood-2010-12-328187	31	26	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105353	10.1371/journal.pone.0105353	http://dx.doi.org/10.1371/journal.pone.0105353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157414	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303200028
J	Zhang, S; Jiao, TW; Chen, YS; Gao, N; Zhang, LL; Jiang, M				Zhang, Shuang; Jiao, Taiwei; Chen, Yushuai; Gao, Nan; Zhang, Lili; Jiang, Min			Methylglyoxal Induces Systemic Symptoms of Irritable Bowel Syndrome	PLOS ONE			English	Article							VISCERAL HYPERSENSITIVITY; INTESTINAL MICROBIOTA; INTRACELLULAR CALCIUM; CARBONYL STRESS; RECEPTOR; BEHAVIOR; METABOLISM; ACTIVATION; DEPRESSION; CONTRIBUTE	Patients with irritable bowel syndrome (IBS) show a wide range of symptoms including diarrhea, abdominal pain, changes in bowel habits, nausea, vomiting, headache, anxiety, depression and cognitive impairment. Methylglyoxal has been proved to be a potential toxic metabolite produced by intestinal bacteria. The present study was aimed at investigating the correlation between methylglyoxal and irritable bowel syndrome. Rats were treated with an enema infusion of methylglyoxal. Fecal water content, visceral sensitivity, behavioral tests and serum 5-hydroxytryptamine (5-HT) were assessed after methylglyoxal exposure. Our data showed that fecal water content was significantly higher than controls after methylglyoxal exposure except that of 30 mM group. Threshold volumes on balloon distension decreased in the treatment groups. All exposed rats showed obvious head scratching and grooming behavior and a decrease in sucrose preference. The serum 5-HT values were increased in 30, 60, 90 mM groups and decreased in 150 mM group. Our findings suggested that methylglyoxal could induce diarrhea, visceral hypersensitivity, headache as well as depression-like behaviors in rats, and might be the key role in triggering systemic symptoms of IBS.	[Zhang, Shuang; Jiao, Taiwei; Jiang, Min] China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Peoples R China; [Chen, Yushuai; Gao, Nan; Zhang, Lili] China Med Univ, Affiliated Hosp 1, Dept Cadre Ward 2, Shenyang, Peoples R China	China Medical University; China Medical University	Jiang, M (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Peoples R China.	minjiangcmu@gmail.com			Innovation Project of Shenyang Bureau of Science and Technology [F13-316-1-12]	Innovation Project of Shenyang Bureau of Science and Technology	This work was supported by the Innovation Project of Shenyang Bureau of Science and Technology (F13-316-1-12) (http://www.systplan.gov.cn/Plan/planindex.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Belgnaoui A, 2012, PSYCHONEUROENDOCRINO, V37, P1885, DOI 10.1016/j.psyneuen.2012.03.024; Al-Chaer ED, 2000, GASTROENTEROLOGY, V119, P1276, DOI 10.1053/gast.2000.19576; Antognelli C, 2013, INT J BIOCHEM CELL B, V45, P836, DOI 10.1016/j.biocel.2013.01.003; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Campbell AK, 2010, TOXICOLOGY, V278, P268, DOI 10.1016/j.tox.2010.09.001; Campbell AK, 2005, POSTGRAD MED J, V81, P248, DOI 10.1136/pgmj.2004.025569; Campbell AK, 2007, ARCH BIOCHEM BIOPHYS, V468, P107, DOI 10.1016/j.abb.2007.09.006; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Cook LJ, 1998, BIOCHEM PHARMACOL, V55, P1361, DOI 10.1016/S0006-2952(97)00619-9; DAQUILA PS, 1994, PHYSIOL BEHAV, V56, P861, DOI 10.1016/0031-9384(94)90316-6; de Arriba SG, 2006, FREE RADICAL BIO MED, V40, P779, DOI 10.1016/j.freeradbiomed.2005.09.038; Degen J, 2013, J AGR FOOD CHEM; Desbonnet L, 2008, J PSYCHIATR RES, V43, P164, DOI 10.1016/j.jpsychires.2008.03.009; Eadala P, 2011, ALIMENT PHARM THER, V34, P735, DOI 10.1111/j.1365-2036.2011.04799.x; EGYUD LG, 1966, P NATL ACAD SCI USA, V55, P388, DOI 10.1073/pnas.55.2.388; Eutamene H, 2007, J NUTR, V137, P1901, DOI 10.1093/jn/137.8.1901; Gallai V, 2003, CEPHALALGIA, V23, P166, DOI 10.1046/j.1468-2982.2003.00552.x; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Gueniche A, 2006, EUR J DERMATOL, V16, P511, DOI 10.1684/ejd.2006.0023; Jan CR, 2005, CELL SIGNAL, V17, P847, DOI 10.1016/j.cellsig.2004.11.007; Kabra N, 2013, INDIAN J PSYCHIAT, V55, P77, DOI 10.4103/0019-5545.105520; Kemper RHA, 1997, NEUROREPORT, V8, P1123, DOI 10.1097/00001756-199703240-00012; Kemper RHA, 1998, PAIN, V78, P181, DOI 10.1016/S0304-3959(98)00125-0; Ledochowski M, 2000, SCAND J GASTROENTERO, V35, P1048, DOI 10.1080/003655200451162; Ledochowski M, 2000, DIGEST DIS SCI, V45, P1255, DOI 10.1023/A:1005527230346; Lee BH, 2013, FREE RADICAL BIO MED, V60, P7, DOI 10.1016/j.freeradbiomed.2013.01.030; Lee DK, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-21; Li W, 2013, FREE RADICAL BIO MED, V54, P51, DOI 10.1016/j.freeradbiomed.2012.10.552; Lomax RB, 1999, GASTROENTEROLOGY, V117, P1363, DOI 10.1016/S0016-5085(99)70286-6; Malinen E, 2010, WORLD J GASTROENTERO, V16, P4532, DOI 10.3748/wjg.v16.i36.4532; Matafome P, 2012, ENDOCRINE; Matthews SB, 2000, LANCET, V355, P1330, DOI 10.1016/S0140-6736(00)02116-4; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; Metchnikoff E, 1908, PROLONGATION LIFE OP, pv; Mukohda M, 2009, J PHARMACOL SCI, V109, P305, DOI 10.1254/jphs.08300FP; NAARALA J, 1993, FEBS LETT, V330, P222, DOI 10.1016/0014-5793(93)80278-3; Naseem R, 2009, J MOL BIOL, V391, P42, DOI 10.1016/j.jmb.2009.05.064; Peregrin AT, 1997, ACTA PHYSIOL SCAND, V160, P379, DOI 10.1046/j.1365-201X.1997.00173.x; Ping FF, 2012, NEUROSCI LETT, V514, P173, DOI 10.1016/j.neulet.2012.02.087; SIMON GL, 1984, GASTROENTEROLOGY, V86, P174; Simren M, 2001, DIGESTION, V63, P108, DOI 10.1159/000051878; SZENTGYO.A, 1967, SCIENCE, V155, P539, DOI 10.1126/science.155.3762.539; Talukdar D, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1059, DOI 10.1134/S0006297909100010; Trist D G, 2000, Pharm Acta Helv, V74, P221, DOI 10.1016/S0031-6865(99)00053-9; Urban MO, 1999, MED CLIN N AM, V83, P585, DOI 10.1016/S0025-7125(05)70125-5; Verdu EF, 2006, GUT, V55, P182, DOI 10.1136/gut.2005.066100	47	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105307	10.1371/journal.pone.0105307	http://dx.doi.org/10.1371/journal.pone.0105307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157984	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303200027
J	De Simone, V; Franze, E; Ronchetti, G; Colantoni, A; Fantini, MC; Di Fusco, D; Sica, GS; Sileri, P; MacDonald, TT; Pallone, F; Monteleone, G; Stolfi, C				De Simone, V.; Franze, E.; Ronchetti, G.; Colantoni, A.; Fantini, M. C.; Di Fusco, D.; Sica, G. S.; Sileri, P.; MacDonald, T. T.; Pallone, F.; Monteleone, G.; Stolfi, C.			Th17-type cytokines, IL-6 and TNF-alpha synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth	ONCOGENE			English	Article							COLITIS-ASSOCIATED CANCER; INTESTINAL EPITHELIAL-CELLS; COLON-CANCER; TRANSCRIPTION FACTOR; MOUSE MODEL; T-CELLS; IMMUNE CELLS; HELPER-CELLS; TUMOR-GROWTH; KAPPA-B	Colorectal cancers (CRCs) often show a dense infiltrate of cytokine-producing immune/inflammatory cells. The exact contribution of each immune cell subset and cytokine in the activation of the intracellular pathways sustaining CRC cell growth is not understood. Herein, we isolate tumor-infiltrating leukocytes (TILs) and lamina propria mononuclear cells (LPMCs) from the tumor area and the macroscopically unaffected, adjacent, colonic mucosa of patients who underwent resection for sporadic CRC and show that the culture supernatants of TILs, but not of LPMCs, potently enhance the growth of human CRC cell lines through the activation of the oncogenic transcription factors signal transducer and activator of transcription 3 (STAT3) and nuclear factor-kappa B (NF-kB). Characterization of immune cell complexity of TILs and LPMCs reveals no differences in the percentages of T cells, natural killer T cells, natural killer (NK) cells, macrophages and B cells. However, T cells from TILs show a functional switch compared with those from LPMCs to produce large amounts of T helper type 17 (Th17)-related cytokines (that is, interleukin-17A (IL-17A), IL-17F, IL-21 and IL-22), tumor necrosis factor-alpha (TNF-alpha) and IL-6. Individual neutralization of IL-17A, IL-17F, IL-21, IL-22, TNF-alpha or IL-6 does not change TIL-derived supernatant-driven STAT3 and NF-kB activation, as well as their proproliferative effect in CRC cells. In contrast, simultaneous neutralization of both IL-17A and TNF-alpha, which abrogates NF-kB signaling, and IL-22 and IL-6, which abrogates STAT3 signaling, reduces the mitogenic effect of supernatants in CRC cells. IL-17A, IL-21, IL-22, TNF-alpha and IL-6 are also produced in excess in the early colonic lesions in a mouse model of sporadic CRC, associated with enhanced STAT3/NF-kB activation. Mice therapeutically given BP-1-102, an orally bioavailable compound targeting STAT3/NF-kB activation and cross-talk, exhibit reduced colon tumorigenesis and diminished expression of STAT3/NF-kB-activating cytokines in the neoplastic areas. These data suggest that strategies aimed at the cotargeting of STAT3/NF-kB activation and interaction between them might represent an attractive and novel approach to combat CRC.	[De Simone, V.; Franze, E.; Ronchetti, G.; Colantoni, A.; Fantini, M. C.; Di Fusco, D.; Pallone, F.; Monteleone, G.; Stolfi, C.] Univ Roma Tor Vergata, Dept Syst Med, I-00133 Rome, Italy; [Sica, G. S.; Sileri, P.] Univ Roma Tor Vergata, Dept Surg, I-00133 Rome, Italy; [MacDonald, T. T.] Barts & London Queen Marys Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Immunol & Infect Dis, London, England	University of Rome Tor Vergata; University of Rome Tor Vergata; University of London; Queen Mary University London	Stolfi, C (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Via Montpellier 1, I-00133 Rome, Italy.	carmine.stolfi@uniroma2.it	Stolfi, Carmine/J-4524-2019; Monteleone, Giovanni/AAE-1418-2021; Sileri, Pierpaolo/W-9593-2019	Sileri, Pierpaolo/0000-0002-1104-6237; Di Fusco, Davide/0000-0002-8908-9237; Stolfi, Carmine/0000-0002-6354-2443; Franze, Eleonora/0000-0003-4343-221X	'Fondazione Umberto di Mario ONLUS', Rome; AIRC [MFAG-12108, IG-13049]	'Fondazione Umberto di Mario ONLUS', Rome; AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the 'Fondazione Umberto di Mario ONLUS', Rome, and AIRC (MFAG-12108 to CS and IG-13049 to GM).	Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Caprioli F, 2008, J IMMUNOL, V180, P1800, DOI 10.4049/jimmunol.180.3.1800; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Fridman WH, 2011, CANCER RES, V71, P5601, DOI 10.1158/0008-5472.CAN-11-1316; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Hyun YS, 2012, CARCINOGENESIS, V33, P931, DOI 10.1093/carcin/bgs106; Issa AY, 2007, CARCINOGENESIS, V28, P1978, DOI 10.1093/carcin/bgm161; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jauch D, 2011, GUT, V60, P1678, DOI 10.1136/gutjnl-2011-300612; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kryczek I, 2014, IMMUNITY, V40, P772, DOI 10.1016/j.immuni.2014.03.010; Lanca T, 2012, ONCOIMMUNOLOGY, V1, P717, DOI 10.4161/onci.20068; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Monteleone G, 1997, GASTROENTEROLOGY, V112, P1169, DOI 10.1016/S0016-5085(97)70128-8; Monteleone G, 2012, INT J MOL SCI, V13, P11071, DOI 10.3390/ijms130911071; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; SENIK A, 1980, ANN INST PASTEUR IMM, VC131, P349; Song XY, 2014, IMMUNITY, V40, P140, DOI 10.1016/j.immuni.2013.11.018; Stolfi C, 2008, BIOCHEM PHARMACOL, V75, P668, DOI 10.1016/j.bcp.2007.09.020; Stolfi C, 2011, J EXP MED, V208, P2279, DOI 10.1084/jem.20111106; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tannenbaum CS, 2000, SEMIN CANCER BIOL, V10, P113, DOI 10.1006/scbi.2000.0314; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Wang KP, 2013, ANN RHEUM DIS, V72, P100, DOI 10.1136/annrheumdis-2012-202201; Wu P, 2014, IMMUNITY, V40, P785, DOI 10.1016/j.immuni.2014.03.013; Xu XL, 1998, CANCER RES, V58, P2832; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Yen HR, 2009, J IMMUNOL, V183, P7161, DOI 10.4049/jimmunol.0900368; Yeste A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4753; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109	46	331	335	4	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	27					3493	3503		10.1038/onc.2014.286	http://dx.doi.org/10.1038/onc.2014.286			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM1IQ	25174402	Green Published, hybrid			2022-12-25	WOS:000357434900002
J	Tripsianes, K; Friberg, A; Barrandon, C; Brooks, M; van Tilbeurgh, H; Seraphin, B; Sattler, M				Tripsianes, Konstantinos; Friberg, Anders; Barrandon, Charlotte; Brooks, Mark; van Tilbeurgh, Herman; Seraphin, Bertrand; Sattler, Michael			A Novel Protein-Protein Interaction in the RES (REtention and Splicing) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA RETENTION; RECOGNITION MOTIF; NMR; YEAST; CRYSTALLOGRAPHY; SPLICEOSOME; SYSTEM; DOMAIN; CORE	The retention and splicing (RES) complex is a conserved spliceosome-associated module that was shown to enhance splicing of a subset of transcripts and promote the nuclear retention of unspliced pre-mRNAs in yeast. The heterotrimeric RES complex is organized around the Snu17p protein that binds to both the Bud13p and Pml1p subunits. Snu17p exhibits an RRM domain that resembles a U2AF homology motif (UHM) and Bud13p harbors a Trp residue reminiscent of an UHM-ligand motif (ULM). It has therefore been proposed that the interaction between Snu17p and Bud13p resembles canonical UHM-ULM complexes. Here, we have used biochemical and NMR structural analysis to characterize the structure of the yeast Snu17p-Bud13p complex. Unlike known UHMs that sequester the Trp residue of the ULM ligand in a hydrophobic pocket, Snu17p and Bud13p utilize a large interaction surface formed around the two helices of the Snu17p domain. In total 18 residues of the Bud13p ligand wrap around the Snu17p helical surface in an U-turn-like arrangement. The invariant Trp232 in Bud13p is located in the center of the turn, and contacts surface residues of Snu17p. The structural data are supported by mutational analysis and indicate that Snu17p provides an extended binding surface with Bud13p that is notably distinct from canonical UHM-ULM interactions. Our data highlight structural diversity in RRM-protein interactions, analogous to the one seen for nucleic acid interactions.	[Tripsianes, Konstantinos] Masaryk Univ, Cent European Inst Technol CEITEC, Brno 62500, Czech Republic; [Friberg, Anders; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Friberg, Anders; Sattler, Michael] Tech Univ Munich, Ctr Integrated Prot Sci Munich, D-85747 Garching, Germany; [Friberg, Anders; Sattler, Michael] Tech Univ Munich, Chair Biomol NMR, D-85747 Garching, Germany; [Barrandon, Charlotte; Seraphin, Bertrand] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; [Brooks, Mark; van Tilbeurgh, Herman] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, UMR8619, F-91405 Orsay, France; [Seraphin, Bertrand] Univ Strasbourg, CNRS, UMR 7104, Equipe Labellisee La Ligue,IGBMC,INSERM,U964, F-67404 Illkirch Graffenstaden, France	Masaryk University Brno; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Tripsianes, K (corresponding author), Masaryk Univ, Cent European Inst Technol, Kamenice 5, Brno 62500, Czech Republic.	kostas.tripsianes@ceitec.muni.cz; sattler@helmholtz-muenchen.de	Tripsianes, Konstantinos/I-8382-2014; Sattler, Michael/A-2407-2012	Tripsianes, Konstantinos/0000-0003-0948-813X; Sattler, Michael/0000-0002-1594-0527; Seraphin, Bertrand/0000-0002-5168-1921; Brooks, Mark/0000-0003-2614-6115; Friberg, Anders/0000-0002-3912-8162	European Social Fund; state budget of the Czech Republic [CZ.1.07/2.3.00/20.0042]; Centre National pour la Recherche Scientifique; European Union [LSHG-CT-2005-512028, LSHG-CT-2005-518238]; Ligue Contre le Cancer (Equipe Labellisee); CERBM-IGBMC; Deutsche Forschungsgemeinschaft [SFB1035]; Elitenetzwerk Bayern;  [ANR-10-LABX-0030-INRT];  [ANR-10-IDEX-0002-02]	European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; Centre National pour la Recherche Scientifique; European Union(European Commission); Ligue Contre le Cancer (Equipe Labellisee); CERBM-IGBMC; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elitenetzwerk Bayern; ; 	This work was supported, in whole or in part, by the European Social Fund and state budget of the Czech Republic Grant CZ.1.07/2.3.00/20.0042 (to K. T.), the Centre National pour la Recherche Scientifique (to B. S.), Grant ANR-10-LABX-0030-INRT managed under the program Investissements d'Avenir ANR-10-IDEX-0002-02 (to B. S.), the European Union Sixth Framework program "3D-Repertoire" Grant LSHG-CT-2005-512028 (to B. S. and M. S.) and EURASNET Grant LSHG-CT-2005-518238 (to B. S.), Ligue Contre le Cancer (Equipe Labellisee 2014) (to B. S.), the CERBM-IGBMC (to B. S.), and Deutsche Forschungsgemeinschaft Grant SFB1035 (to M. S.).; Supported by Elitenetzwerk Bayern. Present address: Bayer HealthCare Pharmaceuticals, Lead Discovery, Mullerstr. 178, 13353 Berlin, Germany.	Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Brooks MA, 2009, NUCLEIC ACIDS RES, V37, P129, DOI 10.1093/nar/gkn894; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collinet B, 2011, J STRUCT BIOL, V175, P147, DOI 10.1016/j.jsb.2011.03.018; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; Corsini L, 2009, J BIOL CHEM, V284, P630, DOI 10.1074/jbc.M805395200; Daubner GM, 2013, CURR OPIN STRUC BIOL, V23, P100, DOI 10.1016/j.sbi.2012.11.006; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dreumont N, 2013, FEBS J, V280, P2712, DOI 10.1111/febs.12277; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; ElAntak L, 2010, J MOL BIOL, V396, P1097, DOI 10.1016/j.jmb.2009.12.047; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Hausmann S, 2008, J BIOL CHEM, V283, P31706, DOI 10.1074/jbc.M806127200; Joshi A, 2011, STRUCTURE, V19, P1816, DOI 10.1016/j.str.2011.09.020; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Loerch S, 2014, J BIOL CHEM, V289, P17325, DOI 10.1074/jbc.M114.558825; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Rideau AP, 2006, NAT STRUCT MOL BIOL, V13, P839, DOI 10.1038/nsmb1137; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scherrer FW, 2006, RNA, V12, P1361, DOI 10.1261/rna.2276806; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Trowitzsch S, 2008, J BIOL CHEM, V283, P32317, DOI 10.1074/jbc.M804977200; Trowitzsch S, 2009, J MOL BIOL, V385, P531, DOI 10.1016/j.jmb.2008.10.087; Tunnicliffe RB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003907; Tunnicliffe RB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001244; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2	35	16	16	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28640	28650		10.1074/jbc.M114.592311	http://dx.doi.org/10.1074/jbc.M114.592311			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25160624	Green Published, hybrid			2022-12-25	WOS:000343765400052
J	Sironi, M; Biasin, M; Gnudi, F; Cagliani, R; Saulle, I; Forni, D; Rainone, V; Trabattoni, D; Garziano, M; Mazzotta, F; Real, LM; Rivero-Juarez, A; Caruz, A; Lo Caputo, S; Clerici, M				Sironi, Manuela; Biasin, Mara; Gnudi, Federica; Cagliani, Rachele; Saulle, Irma; Forni, Diego; Rainone, Veronica; Trabattoni, Daria; Garziano, Micaela; Mazzotta, Francesco; Real, Luis Miguel; Rivero-Juarez, Antonio; Caruz, Antonio; Lo Caputo, Sergio; Clerici, Mario			A Regulatory Polymorphism in HAVCR2 Modulates Susceptibility to HIV-1 Infection	PLOS ONE			English	Article							CD8(+) T-CELLS; TIM-3 EXPRESSION; DISEASE; GENOME; POPULATION; RESISTANCE; NAIROBI; HUMANS	The HAVCR2 gene encodes TIM-3, an immunoglobulin superfamily member expressed by exhausted CD8+ T cells during chronic viral infection. We investigated whether genetic variation at HAVCR2 modulates the susceptibility to HIV-1 acquisition; specifically we focused on a 3' UTR variant (rs4704846, A/G) that represents a natural selection target. We genotyped rs4704846 in three independent cohorts of HIV-1 exposed seronegative (HESN) individuals with different geographic origin (Italy and Spain) and distinct route of exposure to HIV-1 (sexual and injection drug use). Matched HIV-1 positive subjects and healthy controls were also analyzed. In all case-control cohorts the minor G allele at rs4704846 was more common in HIV-1 infected individuals than in HESN, with healthy controls showing intermediate frequency. Results from the three association analyses were combined through a random effect meta-analysis, which revealed no heterogeneity among samples (Cochrane's Q, p value = 0.89, I-2 = 0) and yielded a p value of 6.8 x 10(-4). The minor G allele at rs4704846 was found to increase HAVCR2 expression after in vitro HIV-1 infection. Thus, a positively selected polymorphism in the 3' UTR, which modulates HAVCR2 expression, is associated with the susceptibility to HIV-1 infection. These data warrant further investigation into the role of TIM-3 in the prevention and treatment of HIV-1/AIDS.	[Sironi, Manuela; Cagliani, Rachele; Forni, Diego] Sci Inst IRCCS E MEDEA, Bosisio Parini, Italy; [Biasin, Mara; Gnudi, Federica; Saulle, Irma; Rainone, Veronica; Trabattoni, Daria; Garziano, Micaela] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy; [Mazzotta, Francesco; Lo Caputo, Sergio] S Maria Annunziata Hosp Florence, Infect Dis Unit, Florence, Italy; [Real, Luis Miguel] Valme Hosp, Infect Dis & Microbiol Clin Unit, Seville, Spain; [Rivero-Juarez, Antonio] Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Inst Biomed Res IMIBIC, Cordoba, Spain; [Caruz, Antonio] Univ Jaen, Dept Expt Biol, Immunogenet Unit, Jaen, Spain; [Clerici, Mario] Univ Milan, Dept Physiopathol & Transplantat, Chair Immunol, Milan, Italy; [Clerici, Mario] Don C Gnocchi Fdn ONLUS, IRCCS, Milan, Italy	IRCCS Eugenio Medea; University of Milan; Hospital Valme; Universidad de Cordoba; Universidad de Jaen; University of Milan; IRCCS Fondazione Don Carlo Gnocchi Onlus	Sironi, M (corresponding author), Sci Inst IRCCS E MEDEA, Bosisio Parini, Italy.	manuela.sironi@bp.lnf.it	Sironi, manuela/K-5633-2016; Trabattoni, Daria/G-7424-2012; Real, Luis M/K-9646-2014; Gnudi, Federica/Y-3811-2019; Forni, Diego/K-5643-2016; Caruz, Antonio/N-5557-2014; Cagliani, Rachele/K-4545-2016; Rivero, Antonio/ABE-5294-2020; biasin, mara/G-7426-2012; Rivero-Juarez, Antonio/E-4528-2019	Sironi, manuela/0000-0002-2267-5266; Trabattoni, Daria/0000-0001-9535-3359; Real, Luis M/0000-0003-4932-7429; Gnudi, Federica/0000-0002-4591-5699; Forni, Diego/0000-0001-9291-5352; Caruz, Antonio/0000-0002-5788-7840; Cagliani, Rachele/0000-0003-2670-3532; biasin, mara/0000-0003-3671-4235; Saulle, Irma/0000-0002-8600-2503; Rivero-Juarez, Antonio/0000-0002-5813-6889; Lo Caputo, Sergio/0000-0002-4729-7548; Clerici, Mario/0000-0001-5920-6191	Doctorate School of Molecular Medicine, University of Milan	Doctorate School of Molecular Medicine, University of Milan	D.F. is supported by a fellowship of the Doctorate School of Molecular Medicine, University of Milan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Forni D, 2013, IMMUNITY, V38, P1129, DOI 10.1016/j.immuni.2013.04.008; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Guo LY, 2014, NUCLEIC ACIDS RES, V42, pD1033, DOI 10.1093/nar/gkt1167; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Miyazawa M, 2009, AIDS, V23, P161, DOI 10.1097/QAD.0b013e3283196a80; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Ploquin MJY, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-37; Plummer FA, 1999, IMMUNOL LETT, V66, P27, DOI 10.1016/S0165-2478(98)00182-5; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reddy PBJ, 2011, J IMMUNOL, V187, P5745, DOI 10.4049/jimmunol.1102105; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Wu W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-113	24	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106442	10.1371/journal.pone.0106442	http://dx.doi.org/10.1371/journal.pone.0106442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180498	Green Published, gold, Green Submitted			2022-12-25	WOS:000341231500098
J	Hoentsch, M; Bussiahn, R; Rebl, H; Bergemann, C; Eggert, M; Frank, M; von Woedtke, T; Nebe, B				Hoentsch, Maxi; Bussiahn, Rene; Rebl, Henrike; Bergemann, Claudia; Eggert, Martin; Frank, Marcus; von Woedtke, Thomas; Nebe, Barbara			Persistent Effectivity of Gas Plasma-Treated, Long Time-Stored Liquid on Epithelial Cell Adhesion Capacity and Membrane Morphology	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE PLASMA; TISSUE-TOLERABLE PLASMA; HACAT KERATINOCYTES; ESCHERICHIA-COLI; IN-VITRO; JET; INACTIVATION; EXPRESSION; BARRIER; MOLECULES	Research in plasma medicine includes a major interest in understanding gas plasma-cell interactions. The immediate application of gas plasma in vitro inhibits cell attachment, vitality and cell-cell contacts via the liquid. Interestingly, in our novel experiments described here we found that the liquid-mediated plasma effect is long-lasting after storage up to seven days; i. e. the liquid preserves the characteristics once induced by the argon plasma. Therefore, the complete Dulbecco's Modified Eagle cell culture medium was argon plasma-treated (atmospheric pressure, kINPen09) for 60 s, stored for several days (1, 4 and 7 d) at 37 degrees C and added to a confluent mouse hepatocyte epithelial cell (mHepR1) monolayer. Impaired tight junction architecture as well as shortened microvilli on the cell membrane could be observed, which was accompanied by the loss of cell adhesion capacity. Online-monitoring of vital cells revealed a reduced cell respiration. Our first time-dependent analysis of plasma-treated medium revealed that temperature, hydrogen peroxide production, pH and oxygen content can be excluded as initiators of cell physiological and morphological changes. The here observed persisting biological effects in plasma-treated liquids could open new medical applications in dentistry and orthopaedics.	[Hoentsch, Maxi; Rebl, Henrike; Bergemann, Claudia; Nebe, Barbara] Univ Med Ctr Rostock, Dept Cell Biol, Rostock, Germany; [Bussiahn, Rene; von Woedtke, Thomas] Leibniz Inst Plasma Sci & Technol eV, Greifswald, Germany; [Eggert, Martin] Univ Med Ctr Rostock, Ctr Extracorporeal Organ Support, Dept Internal Med, Rostock, Germany; [Frank, Marcus] Univ Med Ctr Rostock, Med Biol & Electron Microscop Ctr, Rostock, Germany	University of Rostock; Leibniz Institut fur Plasmaforschung und Technologie; University of Rostock; University of Rostock	Nebe, B (corresponding author), Univ Med Ctr Rostock, Dept Cell Biol, Rostock, Germany.	barbara.nebe@med.uni-rostock.de	Rebl, Henrike/ABB-5332-2020; Nebe, Barbara -/C-3577-2015; von Woedtke, Thomas/U-3604-2018	Rebl, Henrike/0000-0001-6000-1724; Nebe, Barbara -/0000-0003-2662-0905; von Woedtke, Thomas/0000-0002-1097-4832	BMBF Germany Pilot Program Campus PlasmaMed [13N11183]; doctoral stipendium of the state Mecklenburg-Vorpommern (Germany); University of Rostock, Interdisciplinary Faculty, Dept. Life, Light and Matter; University Medical Center Rostock, FORUN, project PlasmaBiomedicine	BMBF Germany Pilot Program Campus PlasmaMed(Federal Ministry of Education & Research (BMBF)); doctoral stipendium of the state Mecklenburg-Vorpommern (Germany); University of Rostock, Interdisciplinary Faculty, Dept. Life, Light and Matter; University Medical Center Rostock, FORUN, project PlasmaBiomedicine	HR received financial support from BMBF Germany Pilot Program Campus PlasmaMed (13N11183). MH received support from doctoral stipendium of the state Mecklenburg-Vorpommern (Germany) and of the University of Rostock, Interdisciplinary Faculty, Dept. Life, Light and Matter. CB recevied support from University Medical Center Rostock, FORUN, project PlasmaBiomedicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barekzi N, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/42/422002; BATTINO R, 1966, CHEM REV, V66, P395, DOI 10.1021/cr60242a003; Bojarski C, 2004, J CELL SCI, V117, P2097, DOI 10.1242/jcs.01071; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandenburg R, 2009, IEEE T PLASMA SCI, V37, P877, DOI 10.1109/TPS.2009.2019657; Bundscherer L, 2013, IMMUNOBIOLOGY, V218, P1248, DOI 10.1016/j.imbio.2013.04.015; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Daeschlein G, 2012, J HOSP INFECT, V81, P177, DOI 10.1016/j.jhin.2012.02.012; Daeschlein G, 2012, J DTSCH DERMATOL GES, V10, P509, DOI 10.1111/j.1610-0387.2012.07857.x; Daeschlein G, 2010, PLASMA PROCESS POLYM, V7, P224, DOI 10.1002/ppap.200900059; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Ehret R, 1997, BIOSENS BIOELECTRON, V12, P29, DOI 10.1016/0956-5663(96)89087-7; Ekblom P, 1996, CURR OPIN CELL BIOL, V8, P599, DOI 10.1016/S0955-0674(96)80099-8; Emmert S, 2013, CLIN PLASMA MED, V1, P24, DOI 10.1016/j.cpme.2012.11.002; Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0; Fluhr JW, 2012, EXP DERMATOL, V21, P130, DOI 10.1111/j.1600-0625.2011.01411.x; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Frohling A, 2012, INNOV FOOD SCI EMERG, V13, P142, DOI 10.1016/j.ifset.2011.11.002; GEBICKI S, 1993, BIOCHEM J, V289, P743, DOI 10.1042/bj2890743; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Haertel B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/761451; Haertel B, 2012, CELL BIOL INT, V36, P1217, DOI 10.1042/CBI20120139; Heinlin J, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2010.03702.x; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Hoene A, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035009; Hoentsch M, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/2/025206; Ishaq M, 2014, INT J CANCER, V134, P1517, DOI 10.1002/ijc.28323; Julak J, 2012, PHYS MEDICA, V28, P230, DOI 10.1016/j.ejmp.2011.08.001; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kim SJ, 2009, IEEE T PLASMA SCI, V94; Kimura K, 2010, EXP EYE RES, V90, P337, DOI 10.1016/j.exer.2009.11.012; Knittel T, 1999, AM J PATHOL, V154, P153, DOI 10.1016/S0002-9440(10)65262-5; Lademann O, 2011, SKIN PHARMACOL PHYS, V24, P284, DOI 10.1159/000329913; Lange K, 2002, AM J PHYSIOL-CELL PH, V282, pC1, DOI 10.1152/ajpcell.2002.282.1.C1; Lloyd G, 2010, PLASMA PROCESS POLYM, V7, P194, DOI 10.1002/ppap.200900097; Lukes P., 2012, PLASMA CHEM CATALYSI, V1, P243, DOI DOI 10.1002/9783527649525.CH7; Machala Z, 2013, PLASMA PROCESS POLYM, V10, P649, DOI 10.1002/ppap.201200113; Moreau M, 2008, BIOTECHNOL ADV, V26, P610, DOI 10.1016/j.biotechadv.2008.08.001; Naitali M, 2010, APPL ENVIRON MICROB, V76, P7662, DOI 10.1128/AEM.01615-10; Nastuta AV, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/10/105204; NEBE B, 1995, EXP CELL RES, V218, P479, DOI 10.1006/excr.1995.1181; Nizet V, 1996, INFECT IMMUN, V64, P3818, DOI 10.1128/IAI.64.9.3818-3826.1996; Nosenko T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115013; Oehmigen K, 2010, PLASMA PROCESS POLYM, V7, P250, DOI 10.1002/ppap.200900077; Oehmigen K, 2011, PLASMA PROCESS POLYM, V8, P904, DOI 10.1002/ppap.201000099; Orban E, 2008, PATHOL ONCOL RES, V14, P299, DOI 10.1007/s12253-008-9031-2; PFISTER RR, 1976, INVEST OPHTH VISUAL, V15, P246; Pipa AV, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/8/085201; Plewa JM, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/4/043027; Rebl H, 2010, INT J ARTIF ORGANS, V33, P738; Reuter S, 2012, IEEE T PLASMA SCI, V40, P2986, DOI 10.1109/TPS.2012.2207130; Riedel E, 1999, ALLGEMEINE ANORGANIS; Schmidt A, 2013, FREE RADICAL RES, V47, P577, DOI 10.3109/10715762.2013.804623; Shainsky N, 2011, NONEQUILIBRIUM PLASM; SILICIANO JD, 1988, J CELL BIOL, V107, P2389, DOI 10.1083/jcb.107.6.2389; Stoffels E, 2008, LOW TEMPERATURE PLAS, V2, P1; Stoffels E, 2008, IEEE T PLASMA SCI, V36, P1441, DOI 10.1109/TPS.2008.2001084; Stranak V, 2011, MAT SCI ENG C-MATER, V31, P1512, DOI 10.1016/j.msec.2011.06.009; Traylor MJ, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/47/472001; van Gils CAJ, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/17/175203; Vasilets VN, 2009, HIGH ENERG CHEM, V43, P3; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; von Woedtke Thomas, 2012, NATO Advanced Research Workshop on Plasma for Bio-Decontamination, Medicine and Food Security. Proceedings, P67, DOI 10.1007/978-94-007-2852-3_6; von Woedtke T, 2013, PHYS REP, V530, P291, DOI 10.1016/j.physrep.2013.05.005; Weidmann A, 2008, EUR J CELL BIOL, V87, P75; Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067; Wende K, 2014, CELL BIOL INT, V38, P412, DOI 10.1002/cbin.10200; Wenner J, 2006, THESIS JOHANN WOLFGA; Winter J, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/29/295401; You K, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-36; Zhang X, 2008, APPL PHYS LETT, V93	72	37	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e104559	10.1371/journal.pone.0104559	http://dx.doi.org/10.1371/journal.pone.0104559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170906	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500018
J	Leung, EY; Kim, JE; Askarian-Amiri, M; Rewcastle, GW; Finlay, GJ; Baguley, BC				Leung, Euphemia Y.; Kim, Ji Eun; Askarian-Amiri, Marjan; Rewcastle, Gordon W.; Finlay, Graeme J.; Baguley, Bruce C.			Relationships between Signaling Pathway Usage and Sensitivity to a Pathway Inhibitor: Examination of Trametinib Responses in Cultured Breast Cancer Lines	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ENDOCRINE RESISTANCE; MEK INHIBITORS; PHASE-II; PI3K; EXPRESSION; CELLS; BRAF; NVP-BEZ235; PHOSPHORYLATION	Cellular signaling pathways involving mTOR, PI3K and ERK have dominated recent studies of breast cancer biology, and inhibitors of these pathways have formed a focus of numerous clinical trials. We have chosen trametinib, a drug targeting MEK in the ERK pathway, to address two questions. Firstly, does inhibition of a signaling pathway, as measured by protein phosphorylation, predict the antiproliferative activity of trametinib? Secondly, do inhibitors of the mTOR and PI3K pathways synergize with trametinib in their effects on cell proliferation? A panel of 30 human breast cancer cell lines was chosen to include lines that could be classified according to whether they were ER and PR positive, HER2 over-expressing, and "triple negative''. Everolimus (targeting mTOR), NVP-BEZ235 and GSK2126458 (both targeting PI3K/mTOR) were chosen for combination experiments. Inhibition of cell proliferation was measured by IC50 values and pathway utilization was measured by phosphorylation of signaling kinases. Overall, no correlation was found between trametinib IC50 values and inhibition of ERK signaling. Inhibition of ERK phosphorylation was observed at trametinib concentrations not affecting proliferation, and sensitivity of cell proliferation to trametinib was found in cell lines with low ERK phosphorylation. Evidence was found for synergy between trametinib and either everolimus, NVP-BEZ235 or GSK2126458, but this was cell line specific. The results have implications for the clinical application of PI3K/mTOR and MEK inhibitors.	[Leung, Euphemia Y.; Kim, Ji Eun; Askarian-Amiri, Marjan; Rewcastle, Gordon W.; Finlay, Graeme J.; Baguley, Bruce C.] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand	University of Auckland	Leung, EY (corresponding author), Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand.	e.leung@auckland.ac.nz; b.baguley@auckland.ac.nz	Askarian-Amiri, Marjan E./F-7910-2010	Askarian-Amiri, Marjan E./0000-0003-3524-9626	New Zealand Breast Cancer Foundation; Maurice and Phyllis Paykel trust; Auckland Medical Research Foundation; Robert McClelland Trust; Auckland Cancer Society Research Centre	New Zealand Breast Cancer Foundation; Maurice and Phyllis Paykel trust; Auckland Medical Research Foundation; Robert McClelland Trust; Auckland Cancer Society Research Centre	Funding for this work was obtained from the New Zealand Breast Cancer Foundation, the Maurice and Phyllis Paykel trust, Auckland Medical Research Foundation, and the Robert McClelland Trust. This work is also supported by Auckland Cancer Society Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyinka A, 2002, CLIN CANCER RES, V8, P1747; Aksamitiene E, 2010, CELL SIGNAL, V22, P1369, DOI 10.1016/j.cellsig.2010.05.006; Barlund M, 2000, CANCER RES, V60, P5340; Bartholomeusz C, 2012, ONCOLOGIST, V17, P766, DOI 10.1634/theoncologist.2011-0377; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Baselga J, 2011, ONCOLOGIST, V16, P12, DOI 10.1634/theoncologist.2011-S1-12; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Corcoran RB, 2011, ONCOTARGET, V2, P336; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Garcia-Echeverria C., 2006, PCT International Application, Patent No. [WO 2006122806 A2, 2006122806]; Gee JMW, 2001, INT J CANCER, V95, P247, DOI 10.1002/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S; Ghayad SE, 2010, INT J CANCER, V126, P545, DOI 10.1002/ijc.24750; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Haagensen EJ, 2012, BRIT J CANCER, V106, P1386, DOI 10.1038/bjc.2012.70; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Jing JP, 2012, MOL CANCER THER, V11, P720, DOI 10.1158/1535-7163.MCT-11-0505; Kim JE, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-141; Kim KB, 2013, J CLIN ONCOL, V31, P482, DOI 10.1200/JCO.2012.43.5966; Knight SD, 2010, ACS MED CHEM LETT, V1, P39, DOI 10.1021/ml900028r; Kuntzer J, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-43; Larsen KB, 2010, AUTOPHAGY, V6, P784, DOI 10.4161/auto.6.6.12510; Leung E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/836769; Leung E, 2012, INVEST NEW DRUG, V30, P2103, DOI 10.1007/s10637-011-9768-4; Leung E, 2011, CANCER BIOL THER, V11, P938, DOI 10.4161/cbt.11.11.15527; Leung E, 2010, CANCER BIOL THER, V9, P717, DOI 10.4161/cbt.9.9.11432; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Menzies AM, 2014, CLIN CANCER RES, V20, P2035, DOI 10.1158/1078-0432.CCR-13-2054; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Nazarian RM, 2010, J CUTAN PATHOL, V37, P41, DOI 10.1111/j.1600-0560.2010.01505.x; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Radhakrishnan P, 2013, CANCER RES, V73, P1118, DOI 10.1158/0008-5472.CAN-12-2545; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Saini KS, 2013, CANCER TREAT REV, V39, P935, DOI 10.1016/j.ctrv.2013.03.009; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Stones Clare J., 2013, Frontiers in Genetics, V4, P66, DOI 10.3389/fgene.2013.00066; Stowasser F., 2008, PCT Int. Appl., Patent No. [WO 2008064093 A2 20080529, 2008064093]; Thomas RS, 2008, J MOL ENDOCRINOL, V40, P173, DOI 10.1677/JME-07-0165; Valentino JD, 2014, CLIN CANCER RES, V20, P1212, DOI 10.1158/1078-0432.CCR-13-1897; WHITEHEAD RH, 1983, J NATL CANCER I, V71, P1193; Yip-Schneider MT, 2009, J PHARMACOL EXP THER, V329, P1063, DOI 10.1124/jpet.108.147306; Yu K, 2008, CANCER BIOL THER, V7, P307	42	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105792	10.1371/journal.pone.0105792	http://dx.doi.org/10.1371/journal.pone.0105792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2EE	25170609	gold, Green Published, Green Submitted			2022-12-25	WOS:000341127500068
J	Martin, F; Russell, S; Seeley, J				Martin, Faith; Russell, Steve; Seeley, Janet			Higher Quality of Life and Lower Depression for People on ART in Uganda as Compared to a Community Control Group	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HOPKINS SYMPTOM CHECKLIST-25; POSTTRAUMATIC GROWTH; DEVELOPING-COUNTRIES; TREATMENT PROGRAMS; MENTAL-HEALTH; OLDER-PEOPLE; HIV; ADHERENCE; HIV/AIDS	Provision of antiretroviral treatment (ART) to people living with HIV (PLWH) has increased globally. Research measuring whether ART restores subjective well-being to "normal'' levels is lacking, particularly in resource limited settings. The study objectives are to compare quality of life and depression symptoms for PLWH on ART to a general community population and to explore factors to explain these differences, including socio-economic status and the impact of urban or rural residence. PLWH on ART (n = 263) were recruited from ART delivery sites and participants not on ART (n = 160) were recruited from communities in Wakiso District, Uganda. Participants were interviewed using the translated World Health Organisation Quality of Life brief measure, the Hopkins Symptom Checklist depression section, and questions about socioeconomic status, residence as urban or rural and, for PLWH on ART, self-reported adherence and use of HIV counselling. Compared to the community sample and controlling for location of residence, PLWH on ART had significantly higher quality of life (QOL) for physical, psychological and environment domains, but not the social domain. These differences were not due to socio-economic status alone. Depression scores were significantly lower for PLWH on ART. Both comparisons controlled for the effect of location of residence. People on ART self-reported high adherence and the majority had used HIV counselling services. Our findings show better QOL amongst PLWH on ART compared to a general community sample, which cannot be explained solely by differences in socio-economic status nor location of residence. The general community sample results point towards the challenges of life in this setting. Access to health services may underpin this difference and further research should explore this finding, in addition to identification of psychological mechanisms that relate to better QOL. ART provision infrastructure has clear benefits. Further work should consider sustainability and replication for other health conditions.	[Martin, Faith; Russell, Steve] Univ E Anglia, Sch Int Dev DEV, Norwich NR4 7TJ, Norfolk, England; [Seeley, Janet] London Sch Hyg & Trop Med, London WC1, England; [Seeley, Janet] MRC, Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda	University of East Anglia; University of London; London School of Hygiene & Tropical Medicine; Uganda Virus Research Institute	Martin, F (corresponding author), Univ E Anglia, Sch Int Dev DEV, Norwich NR4 7TJ, Norfolk, England.	psmfm@bath.ac.uk		Seeley, Janet/0000-0002-0583-5272; Martin, Faith/0000-0002-0141-1210	UK Government Economic and Social Research Council (ESRC) [RES-063-23-2663]; Medical Research Council; Department for International Development; Economic and Social Research Council [ES/H043551/1] Funding Source: researchfish; ESRC [ES/H043551/1] Funding Source: UKRI	UK Government Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The research was funded by the UK Government Economic and Social Research Council (ESRC) (project number: RES-063-23-2663), Medical Research Council and Department for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, HIV AIDS SOC STAT; Tran BX, 2011, AIDS CARE, V23, P1236, DOI 10.1080/09540121.2011.555749; Beard J, 2009, AIDS CARE, V21, P1343, DOI 10.1080/09540120902889926; Bekele T, 2013, AIDS CARE, V25, P337, DOI 10.1080/09540121.2012.701716; Blalock AC, 2002, PSYCHOSOMATICS, V43, P400, DOI 10.1176/appi.psy.43.5.400; Bolton P, 2004, SOC PSYCH PSYCH EPID, V39, P442, DOI 10.1007/s00127-004-0763-3; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Bucciardini R, 2000, AIDS, V14, P2567, DOI 10.1097/00002030-200011100-00020; Byakika-Tusiime J, 2009, AIDS BEHAV, V13, pS82, DOI 10.1007/s10461-009-9546-x; Camfield L, 2008, J HEALTH PSYCHOL, V13, P764, DOI 10.1177/1359105308093860; Cepeda-Benito A, 2000, Cultur Divers Ethnic Minor Psychol, V6, P297, DOI 10.1037/1099-9809.6.3.297; Collins PY, 2006, AIDS, V20, P1571, DOI 10.1097/01.aids.0000238402.70379.d4; Cummins RA, 1996, SOC INDIC RES, V38, P303, DOI 10.1007/BF00292050; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; DIENER E, 1993, SOC INDIC RES, V28, P195, DOI 10.1007/BF01079018; Fan APC, 2011, AIDS CARE, V23, P287, DOI 10.1080/09540121.2010.507742; Fawzi MCS, 1997, J TRAUMA STRESS, V10, P101, DOI 10.1002/jts.2490100109; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Gibbie T, 2007, SEX HEALTH, V4, P227, DOI 10.1071/SH06062; Hayes AF, 2011, COMMUN SER, P434; Hefferon K, 2009, BRIT J HEALTH PSYCH, V14, P343, DOI 10.1348/135910708X332936; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Jelsma J, 2005, AIDS CARE, V17, P579, DOI 10.1080/09540120412331319714; Kaaya SF, 2002, ACTA PSYCHIAT SCAND, V106, P9, DOI 10.1034/j.1600-0447.2002.01205.x; Kinyanda E, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-205; Kinyanda E, 2011, SOC PSYCH PSYCH EPID, V46, P35, DOI 10.1007/s00127-009-0164-8; Kunihira NR, 2010, AFR HEALTH SCI, V10, P120; Lee B, 2008, INT J SOC PSYCHIATR, V54, P7, DOI 10.1177/0020764006074995; Lipsey M., 2001, APPL SOCIAL RES METH; Liu CL, 2006, QUAL LIFE RES, V15, P941, DOI 10.1007/s11136-005-5913-x; MacKinnon DP, 2008, INTRO STAT MED ANAL; Mannheimer SB, 2005, AIDS CARE, V17, P10, DOI 10.1080/09540120412331305098; Martin F, 2013, DEV REPORTS POLICY P; Mbonye M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078243; McGrath JW, 2014, MED ANTHR; Men C, 2012, HLTH CULTURE SOC, V2; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Ministry of Finance, 2010, UG NAT REP; Ministry of Health, 2011, UG AIDS IND SURV; Monforte AD, 1998, AIDS, V12, P1631, DOI 10.1097/00002030-199813000-00010; Mutabazi-Mwesigire D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-343; Negin J, 2013, J CROSS-CULT GERONTO, V28, P491, DOI 10.1007/s10823-013-9215-4; Nyirenda M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-259; Ooms G, 2008, GLOBAL HLTH, V4; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Peltzer K, 2008, AJAR-AFR J AIDS RES, V7, P209, DOI 10.2989/AJAR.2008.7.2.6.523; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Preau M, 2004, AIDS CARE, V16, P649, DOI 10.1080/09540120410001716441; Remien RH, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000298104.02356.b3; Rucker DD, 2011, SOC PERSONAL PSYCHOL, V5, P359, DOI 10.1111/j.1751-9004.2011.00355.x; Russell S, 2007, HLTH POLICY PLANNING, P1; Russell S, 2010, SOC SCI MED, V70, P375, DOI 10.1016/j.socscimed.2009.10.039; Scholten F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-886; Schwartz CE, 2009, J CLIN EPIDEMIOL, V62, P1118, DOI 10.1016/j.jclinepi.2009.02.008; Schwartz CE, 2000, ADAPTATION CHANGING; Seeley J., 2014, HIV E AFRICA 30 YEAR; Shi LZ, 2010, HEALTH QUAL LIFE OUT, V8, P12, DOI 10.1186/1477-7525-8-99; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Starace F, 2006, HEALTH PSYCHOL, V25, P153, DOI 10.1037/0278-6133.25.2.153; Teodorescu DS, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-84; Ubel PA, 2003, QUAL LIFE RES, V12, P599, DOI 10.1023/A:1025119931010; Wagner GJ, 2012, PSYCHOSOM MED, V74, P883, DOI 10.1097/PSY.0b013e31826629db; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011	64	13	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e105154	10.1371/journal.pone.0105154	http://dx.doi.org/10.1371/journal.pone.0105154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO2EE	25171340	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000341127500033
J	Kim, C; Jang, MU; Oh, MS; Park, JH; Jung, S; Lee, JH; Yu, KH; Han, MK; Kim, BJ; Park, TH; Park, SS; Lee, KB; Cha, JK; Kim, DH; Lee, J; Kim, SH; Lee, SJ; Ko, Y; Park, JM; Kang, K; Cho, YJ; Hong, KS; Cho, KH; Kim, JT; Kim, DE; Choi, JC; Jang, MS; Bae, HJ; Lee, BC				Kim, Chulho; Jang, Min Uk; Oh, Mi Sun; Park, Jong-Ho; Jung, San; Lee, Ju-Hun; Yu, Kyung-Ho; Han, Moon-Ku; Kim, Beom Joon; Park, Tai Hwan; Park, Sang-Soon; Lee, Kyung Bok; Cha, Jae Kwan; Kim, Dae-Hyun; Lee, Jun; Kim, Sung-Hun; Lee, Soo Joo; Ko, Youngchai; Park, Jong-Moo; Kang, Kyusik; Cho, Young-Jin; Hong, Keun-Sik; Cho, Ki-Hyun; Kim, Joon-Tae; Kim, Dong-Eog; Choi, Jay Chol; Jang, Myung Suk; Bae, Hee-Joon; Lee, Byung-Chul		CRCS-5 Investigators	Off-Hour Effect on 3-Month Functional Outcome after Acute Ischemic Stroke: A Prospective Multicenter Registry	PLOS ONE			English	Article							KOREAN STROKE; CASE-FATALITY; SCALE SCORE; WEEKEND; MORTALITY; ADMISSION; CARE; CENTERS; IMPACT; UNITS	Background and Purpose: The time of hospital arrival may have an effect on prognosis of various vascular diseases. We examined whether off-hour admission would affect the 3-month functional outcome in acute ischemic stroke patients admitted to tertiary hospitals. Methods: We analyzed the 'off-hour effect' in consecutive patients with acute ischemic stroke using multi-center prospective stroke registry. Work-hour admission was defined as when the patient arrived at the emergency department between 8 AM and 6 PM from Monday to Friday and between 8 AM and 1 PM on Saturday. Off-hour admission was defined as the rest of the work-hours and statutory holidays. Multivariable logistic regression was used to analyze the association between off-hour admission and 3-month unfavorable functional outcome defined as modified Rankin Scale (mRS) 3-6. Multivariable model included age, sex, risk factors, prehospital delay time, intravenous thrombolysis, stroke subtypes and severity as covariates. Results: A total of 7075 patients with acute ischemic stroke were included in this analysis: mean age, 67.5 (+/- 13.0) years; male, 58.6%. In multivariable analysis, off-hour admission was not associated with unfavorable functional outcome (OR, 0.89; 95% CI, 0.72-1.09) and mortality (OR, 1.09; 95% CI, 0.77-1.54) at 3 months. Moreover, off-hour admission did not affect a statistically significant shift of 3-month mRS distributions (OR, 0.90; 95% CI, 0.78-1.05). Conclusions: 'Off-hour' admission is not associated with an unfavorable 3-month functional outcome in acute ischemic stroke patients admitted to tertiary hospitals in Korea. This finding indicates that the off-hour effects could be overcome with well-organized stroke management strategies.	[Kim, Chulho; Jang, Min Uk] Hallym Univ, Sacred Heart Hosp, Dept Neurol, Chuncheon Si, South Korea; [Oh, Mi Sun; Yu, Kyung-Ho; Lee, Byung-Chul] Hallym Univ, Sacred Heart Hosp, Dept Neurol, Anyang Si, South Korea; [Park, Jong-Ho] Myongji Hosp, Dept Neurol, Goyang Si, South Korea; [Jung, San] Kangnam Sacred Heart Hosp, Dept Neurol, Seoul, South Korea; [Lee, Ju-Hun] Kangdong Sacred Heart Hosp, Dept Neurol, Seoul, South Korea; [Han, Moon-Ku; Kim, Beom Joon; Jang, Myung Suk; Bae, Hee-Joon] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Songnam, Gyeonggi Do, South Korea; [Han, Moon-Ku; Kim, Beom Joon; Jang, Myung Suk; Bae, Hee-Joon] Seoul Natl Univ, Bundang Hosp, Cerebrovasc Ctr, Songnam, Gyeonggi Do, South Korea; [Park, Tai Hwan; Park, Sang-Soon] Seoul Med Ctr, Dept Neurol, Seoul, South Korea; [Lee, Kyung Bok] Soonchunhyang Univ Hosp, Dept Neurol, Seoul, South Korea; [Cha, Jae Kwan; Kim, Dae-Hyun] Dong A Univ, Dept Neurol, Seoul, South Korea; [Lee, Jun] Yeungnam Univ, Med Ctr, Dept Neurol, Taegu, South Korea; [Kim, Sung-Hun] Kangwon Natl Univ, Coll Med, Dept Neurol, Chuncheon Si, South Korea; [Lee, Soo Joo; Ko, Youngchai] Eulji Univ Hosp, Dept Neurol, Taejon, South Korea; [Park, Jong-Moo; Kang, Kyusik] Eulji Gen Hosp, Dept Neurol, Seoul, South Korea; [Cho, Young-Jin; Hong, Keun-Sik] Inje Univ, Ilsan Paik Hosp, Dept Neurol, Goyang Si, Gyeonggi Do, South Korea; [Cho, Ki-Hyun; Kim, Joon-Tae] Chonnam Natl Univ Hosp, Dept Neurol, Kwangju, South Korea; [Kim, Dong-Eog] Dongguk Univ, Ilsan Hosp, Dept Neurol, Goyang Si, Gyeonggi Do, South Korea; [Choi, Jay Chol] Jeju Natl Univ Hosp, Dept Neurol, Cheju, Jeju Do, South Korea	Hallym University; Hallym University; Myongji Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul Medical Center; Soonchunhyang University; Soonchunhyang University Hospital; Dong A University; Yeungnam University; Kangwon National University; Eulji University; Eulji University; Inje University; Chonnam National University; Chonnam National University Hospital; Dongguk University; NHIS Ilsan Hospital; Jeju National University	Lee, BC (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Neurol, Anyang Si, South Korea.	ssbrain@hallym.ac.kr	Kim, Beom Joon/C-2904-2011; Kim, Chulho/AAC-8708-2022	Kim, Beom Joon/0000-0002-2719-3012; Kim, Chulho/0000-0001-8762-8340; Hong, Keun-Sik/0000-0002-4684-6111; Kim, Beom Joon/0000-0003-2320-7621; HAN, MOON-KU/0000-0003-0166-387X	Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]; Hallym University Specialization Fund [HRF-S-51]	Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Hallym University Specialization Fund	This study was supported by a grant from the Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020), and by Hallym University Specialization Fund (HRF-S-51). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; Albright KC, 2012, CEREBROVASC DIS, V34, P424, DOI 10.1159/000345077; Bejot Y, 2013, EUR J NEUROL, V20, P1177, DOI 10.1111/ene.12154; Bell CM, 2004, AM J MED, V117, P175, DOI 10.1016/j.amjmed.2004.02.047; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Choi HY, 2012, INT J STROKE, V7, P336, DOI 10.1111/j.1747-4949.2012.00788.x; Fang JM, 2010, NEUROLOGY, V75, P1589, DOI 10.1212/WNL.0b013e3181fb84bc; Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870; Haeusler KG, 2011, STROKE, V42, P2521, DOI 10.1161/STROKEAHA.110.612697; Harraf F, 2002, BMJ-BRIT MED J, V325, P17, DOI 10.1136/bmj.325.7354.17; Hasegawa Y, 2005, CEREBROVASC DIS, V20, P325, DOI 10.1159/000087932; 유경호, 2006, [Journal of the Korean Neurological Association, 대한신경과학회지], V24, P535; Hoh BL, 2010, STROKE, V41, P2323, DOI 10.1161/STROKEAHA.110.591081; Hong KS, 2013, J STROKE, V15, P2, DOI 10.5853/jos.2013.15.1.2; Jauss M, 2009, EUR J NEUROL, V16, P1165, DOI 10.1111/j.1468-1331.2009.02656.x; Jung KH, 2012, CIRC-CARDIOVASC QUAL, V5, P327, DOI 10.1161/CIRCOUTCOMES.111.963736; Kazley AS, 2010, ARCH NEUROL-CHICAGO, V67, P39, DOI 10.1001/archneurol.2009.286; Kim BJ, 2014, INT J STROKE, V9, P514, DOI 10.1111/ijs.12199; Kim YS, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-2; Kimberly WT, 2013, NEUROLOGY, V80, P719, DOI 10.1212/WNL.0b013e31828250ff; Kwan J, 2004, AGE AGEING, V33, P116, DOI 10.1093/ageing/afh064; Lee BC, 2006, AM J PREV MED, V31, pS243, DOI 10.1016/j.amepre.2006.08.019; Martinez-Martinez MM, 2012, EUR J NEUROL, V19, P1140, DOI 10.1111/j.1468-1331.2012.03692.x; McKinney JS, 2011, STROKE, V42, P2403, DOI 10.1161/STROKEAHA.110.612317; Nedeltchev K, 2005, J NEUROL NEUROSUR PS, V76, P191, DOI 10.1136/jnnp.2004.040543; O'Rourke K, 2010, EUR J NEUROL, V17, P247, DOI 10.1111/j.1468-1331.2009.02782.x; Ogbu UC, 2011, J NEUROL NEUROSUR PS, V82, P8, DOI 10.1136/jnnp.2009.202176; Palmer WL, 2012, ARCH NEUROL-CHICAGO, V69, P1296, DOI 10.1001/archneurol.2012.1030; Reeves MJ, 2009, STROKE, V40, P569, DOI 10.1161/STROKEAHA.108.519355; Saposnik G, 2007, STROKE, V38, P1211, DOI 10.1161/01.STR.0000259622.78616.ea; Saposnik G, 2009, STROKE, V40, P3321, DOI 10.1161/STROKEAHA.109.554907; Streifler JY, 2012, EUR J NEUROL, V19, P643, DOI 10.1111/j.1468-1331.2011.03603.x; Stroke Unit Trialists' Collaboration, 2000, COCHRANE DB SYST REV, V2; Tung YC, 2009, MED CARE, V47, P1018, DOI 10.1097/MLR.0b013e3181a81144; Weimar C, 2004, STROKE, V35, P158, DOI 10.1161/01.STR.0000106761.94985.8B; Yahalom G, 2009, STROKE, V40, P1296, DOI 10.1161/STROKEAHA.108.520882	36	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105799	10.1371/journal.pone.0105799	http://dx.doi.org/10.1371/journal.pone.0105799			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25165816	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303700046
J	Lin, WC; Chou, KH; Chen, CL; Chen, HL; Lu, CH; Li, SH; Huang, CC; Lin, CP; Cheng, YF				Lin, Wei-Che; Chou, Kun-Hsien; Chen, Chao-Long; Chen, Hsiu-Ling; Lu, Cheng-Hsien; Li, Shau-Hsuan; Huang, Chu-Chung; Lin, Ching-Po; Cheng, Yu-Fan			Longitudinal Brain White Matter Alterations in Minimal Hepatic Encephalopathy before and after Liver Transplantation	PLOS ONE			English	Article							SPATIAL STATISTICS; COGNITIVE FUNCTION; CEREBRAL EDEMA; CIRRHOSIS; VOLUME; NEUROTOXICITY; ABNORMALITIES; SPECTROSCOPY; IMPAIRMENT; FEATURES	Cerebral edema is the common pathogenic mechanism for cognitive impairment in minimal hepatic encephalopathy. Whether complete reversibility of brain edema, cognitive deficits, and their associated imaging can be achieved after liver transplantation remains an open question. To characterize white matter integrity before and after liver transplantation in patients with minimal hepatic encephalopathy, multiple diffusivity indices acquired via diffusion tensor imaging was applied. Twenty-eight patients and thirty age-and sex-matched healthy volunteers were included. Multiple diffusivity indices were obtained from diffusion tensor images, including mean diffusivity, fractional anisotropy, axial diffusivity and radial diffusivity. The assessment was repeated 6-12 month after transplantation. Differences in white matter integrity between groups, as well as longitudinal changes, were evaluated using tract-based spatial statistical analysis. Correlation analyses were performed to identify first scan before transplantation and interval changes among the neuropsychiatric tests, clinical laboratory tests, and diffusion tensor imaging indices. After transplantation, decreased water diffusivity without fractional anisotropy change indicating reversible cerebral edema was found in the left anterior cingulate, claustrum, postcentral gyrus, and right corpus callosum. However, a progressive decrease in fractional anisotropy and an increase in radial diffusivity suggesting demyelination were noted in temporal lobe. Improved pre-transplantation albumin levels and interval changes were associated with better recoveries of diffusion tensor imaging indices. Improvements in interval diffusion tensor imaging indices in the right postcentral gyrus were correlated with visuospatial function score correction. In conclusion, longitudinal voxel-wise analysis of multiple diffusion tensor imaging indices demonstrated different white matter changes in minimal hepatic encephalopathy patients. Transplantation improved extracellular cerebral edema and the results of associated cognition tests. However, white matter demyelination may advance in temporal lobe.	[Lin, Wei-Che; Chen, Hsiu-Ling; Cheng, Yu-Fan] Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung, Taiwan; [Lin, Wei-Che; Chen, Chao-Long; Chen, Hsiu-Ling; Lu, Cheng-Hsien; Li, Shau-Hsuan; Cheng, Yu-Fan] Chang Gung Univ Coll Med, Kaohsiung, Taiwan; [Chou, Kun-Hsien; Lin, Ching-Po] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Chen, Hsiu-Ling; Huang, Chu-Chung; Lin, Ching-Po] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Lu, Cheng-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Li, Shau-Hsuan] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Cheng, YF (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung, Taiwan.	cheng.yufan@msa.hinet.net		Huang, Chu-Chung/0000-0002-9096-9610	Chang Gang Memorial Hospital (Chang Gang Medical Research Project) [CMRPG870482]; National Science Council [NSC 97-2314-B-182A-104-MY3]	Chang Gang Memorial Hospital (Chang Gang Medical Research Project); National Science Council(Ministry of Science and Technology, Taiwan)	Chang Gang Memorial Hospital (Chang Gang Medical Research Project CMRPG870482 to W.-C. Lin) and from the National Science Council (NSC 97-2314-B-182A-104-MY3 to W.-C. Lin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bajaj JS, 2009, HEPATOLOGY, V50, P2014, DOI 10.1002/hep.23216; Barrick TR, 2010, NEUROIMAGE, V51, P565, DOI 10.1016/j.neuroimage.2010.02.033; Bartynski WS, 1997, J COMPUT ASSIST TOMO, V21, P872, DOI 10.1097/00004728-199711000-00005; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Chavarria L, 2011, AM J NEURORADIOL, V32, P1510, DOI 10.3174/ajnr.A2533; Das A, 2001, J GASTROEN HEPATOL, V16, P531, DOI 10.1046/j.1440-1746.2001.02487.x; Donovan JP, 1998, LANCET, V351, P719, DOI 10.1016/S0140-6736(97)07373-X; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Gale SD, 2004, J INT NEUROPSYCH SOC, V10, P60; Garcia-Martinez R, 2011, LIVER TRANSPLANT, V17, P38, DOI 10.1002/lt.22197; Guevara M, 2011, J HEPATOL, V55, P564, DOI 10.1016/j.jhep.2010.12.008; Gupta RK, 2012, CLIN NUTR, V31, P422, DOI 10.1016/j.clnu.2011.11.018; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kale RA, 2006, HEPATOLOGY, V43, P698, DOI 10.1002/hep.21114; Kumar R, 2008, J MAGN RESON IMAGING, V27, P1061, DOI 10.1002/jmri.21342; Lawrence AD, 2000, BRAIN, V123, P1349, DOI 10.1093/brain/123.7.1349; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lin WC, 2012, AM J NEURORADIOL, V33, P239, DOI 10.3174/ajnr.A2769; Lin WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036986; MARLIN AE, 1976, NEUROLOGY, V26, P1159, DOI 10.1212/WNL.26.12.1159; Matsusue E, 2005, AM J NEURORADIOL, V26, P347; Mattarozzi K, 2004, ARCH NEUROL-CHICAGO, V61, P242, DOI 10.1001/archneur.61.2.242; Mattarozzi K, 2012, TRANSPLANTATION, V93, P639, DOI 10.1097/TP.0b013e318244f734; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rovira A, 2001, AM J NEURORADIOL, V22, P1137; Rovira A, 2007, HEPATOLOGY, V46, P1485, DOI 10.1002/hep.21911; Saksena S, 2008, J GASTROEN HEPATOL, V23, pE111, DOI 10.1111/j.1440-1746.2007.05158.x; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; TRUWIT CL, 1991, AM J NEURORADIOL, V12, P651; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; Yang FC, 2014, J NEUROL NEUROSURG P	39	21	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105887	10.1371/journal.pone.0105887	http://dx.doi.org/10.1371/journal.pone.0105887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166619	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303700051
J	Malone, DFG; Falconer, K; Weiland, O; Sandberg, JK				Malone, David F. G.; Falconer, Karolin; Weiland, Ola; Sandberg, Johan K.			The Dynamic Relationship between Innate Immune Biomarkers and Interferon-Based Treatment Effects and Outcome in Hepatitis C Virus Infection Is Altered by Telaprevir	PLOS ONE			English	Article							SOLUBLE CD14; GENE-EXPRESSION; INTERLEUKIN-18; PEGINTERFERON/RIBAVIRIN; HEPATOCYTES; ASSOCIATION; BOCEPREVIR; ACTIVATION; RIBAVIRIN; THERAPY	Soluble CD14 (sCD14) and IL-18 are markers and mediators of the innate immune response, and their plasma levels candidate biomarkers of HCV treatment effects and outcome. Here, we retrospectively studied sCD14 and IL-18 over the course of interferon-based treatment of HCV genotype 1 infection, with the aim to investigate the impact of direct-acting antivirals (DAAs) on the dynamics and relationships between these biomarkers and treatment effects and outcome. Two cohorts were followed longitudinally; one treated with standard dual therapy of pegylated IFN alpha and ribavirin, and one cohort receiving triple therapy including Telaprevir. sCD14 and IL-18 were measured before and during treatment and analyzed in relation to treatment effects. The initial analysis confirmed two patterns previously observed in patients with HCV/HIV-1 co-infection: Baseline levels of sCD14 were significantly lower in patients that went on to clear HCV infection in response to IFN alpha and ribavirin, and sCD14 levels were strongly induced during the course of this treatment. Interestingly, baseline levels of sCD14 and IL-18 in combination predicted treatment outcome in dual therapy better than either marker alone. Notably, these associations were weaker with the addition of Telaprevir to the treatment regimen, suggesting that the relationships between innate immune activation and outcome were altered and diminished by inclusion of a DAA in the treatment. In triple therapy, the dynamic increase of sCD14 in response to treatment was higher in patients clearing the virus, suggesting that the innate response to interferon is still significantly associated with outcome in patients treated with DAA-containing regimens. These results support the notion that levels of innate immune activation before and during treatment are associated with interferon-based treatment outcome. Furthermore, the addition of Telaprevir significantly alters the dynamics and relationships between innate immune biomarkers and treatment effects and outcome.	[Malone, David F. G.; Sandberg, Johan K.] Karolinska Inst, Ctr Infect Med, Dept Med Huddinge, Stockholm, Sweden; [Falconer, Karolin; Weiland, Ola] Karolinska Univ Hosp Huddinge, Infect Dis Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Sandberg, JK (corresponding author), Karolinska Inst, Ctr Infect Med, Dept Med Huddinge, Stockholm, Sweden.	johan.sandberg@ki.se		Sandberg, Johan/0000-0002-6275-0750; Malone, David/0000-0001-9144-1941; Weiland, Ola/0000-0002-6934-9724	Swedish Research Council; Swedish Cancer Foundation; Stockholm County Council; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	The study was supported by the Swedish Research Council (JKS), the Swedish Cancer Foundation (JKS), Stockholm County Council (JKS, OW), and Karolinska Institutet (JKS, OW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony DD, 2012, J INFECT DIS, V206, P969, DOI 10.1093/infdis/jis434; Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; Bouzgarrou N, 2008, J MED VIROL, V80, P607, DOI 10.1002/jmv.21079; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Degasperi E, 2013, EXPERT REV ANTI-INFE, V11, P459, DOI [10.1586/ERI.13.37, 10.1586/eri.13.37]; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Falasca K, 2006, ANN CLIN LAB SCI, V36, P144; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Finotto S, 2004, GUT, V53, P392, DOI 10.1136/gut.2003.018572; Gonzalez VD, 2010, CLIN IMMUNOL, V135, P12, DOI 10.1016/j.clim.2009.12.005; Heim MH, 2013, NAT REV IMMUNOL, V13, P535, DOI 10.1038/nri3463; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Landmann R, 1996, INFECT IMMUN, V64, P1762, DOI 10.1128/IAI.64.5.1762-1769.1996; Lecarpentier E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081160; Leeansyah E, 2013, CURR OPIN HIV AIDS, V8, P117, DOI 10.1097/COH.0b013e32835c7134; Litzman J, 2012, CLIN EXP IMMUNOL, V170, P321, DOI 10.1111/j.1365-2249.2012.04655.x; Marchetti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032028; Meuleman P, 2006, CLIN CHIM ACTA, V366, P156, DOI 10.1016/j.cca.2005.09.022; Ogawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065211; Pan Z, 2000, J BIOL CHEM, V275, P36430, DOI 10.1074/jbc.M003192200; Parekh PJ, 2014, EXPERT REV GASTROENT, V8, P649, DOI 10.1586/17474124.2014.910453; Pearlman BL, 2014, HEPATOLOGY, V59, P71, DOI 10.1002/hep.26624; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Sharma A, 2009, IMMUNOLOGY, V128, pe514, DOI 10.1111/j.1365-2567.2008.03021.x; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Trembling PM, 2013, NAT REV GASTRO HEPAT, V10, P713, DOI 10.1038/nrgastro.2013.163; van de Veerdonk FL, 2012, J INFECT DIS, V206, P197, DOI 10.1093/infdis/jis335; Vecchiet J, 2005, ANN CLIN LAB SCI, V35, P415; Vierling JM, 2014, J HEPATOL, V60, P748, DOI 10.1016/j.jhep.2013.12.013	33	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e105665	10.1371/journal.pone.0105665	http://dx.doi.org/10.1371/journal.pone.0105665			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166593	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303700035
J	Svensson, SL; Pryjma, M; Gaynor, EC				Svensson, Sarah L.; Pryjma, Mark; Gaynor, Erin C.			Flagella-Mediated Adhesion and Extracellular DNA Release Contribute to Biofilm Formation and Stress Tolerance of Campylobacter jejuni	PLOS ONE			English	Article							HELICOBACTER-PYLORI BIOFILMS; HUMAN GASTRIC-MUCOSA; TRANSPOSON MUTAGENESIS; ESCHERICHIA-COLI; SURVIVAL; MOTILITY; COLONIZATION; SYSTEM; IDENTIFICATION; AUTOLYSIS	Campylobacter jejuni is a leading cause of foodbourne gastroenteritis, despite fragile behaviour under standard laboratory conditions. In the environment, C. jejuni may survive within biofilms, which can impart resident bacteria with enhanced stress tolerance compared to their planktonic counterparts. While C. jejuni forms biofilms in vitro and in the wild, it had not been confirmed that this lifestyle confers stress tolerance. Moreover, little is understood about molecular mechanisms of biofilm formation in this pathogen. We previously found that a Delta cprS mutant, which carries a deletion in the sensor kinase of the Delta cprS two-component system, forms enhanced biofilms. Biofilms were also enhanced by the bile salt deoxycholate and contained extracellular DNA. Through more in-depth analysis of Delta cprS and WT under conditions that promote or inhibit biofilms, we sought to further define this lifestyle for C. jejuni. Epistasis experiments with Delta cprS and flagellar mutations (Delta flhA, Delta pflA) suggested that initiation is mediated by flagellum-mediated adherence, a process which was kinetically enhanced by motility. Lysis was also observed, especially under biofilm-enhancing conditions. Microscopy suggested adherence was followed by release of eDNA, which was required for biofilm maturation. Importantly, inhibiting biofilm formation by removal of eDNA with DNase decreased stress tolerance. This work suggests the biofilm lifestyle provides C. jejuni with resilience that has not been apparent from observation of planktonic bacteria during routine laboratory culture, and provides a framework for subsequent molecular studies of C. jejuni biofilms.	[Svensson, Sarah L.; Pryjma, Mark; Gaynor, Erin C.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Gaynor, EC (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	egaynor@mail.ubc.ca		Svensson, Sarah/0000-0002-3183-6084	Michael Smith Foundation for Health Research; Canada Research Chair Award; Burroughs Wellcome Fund Career Development Award; Canadian Institutes of Health Research [MOP-68981]; Natural Sciences and Engineering Research Council of Canada [F11-05378]	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Research Chair Award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Burroughs Wellcome Fund Career Development Award(Burroughs Wellcome Fund); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	S. L. S. is supported by a Senior Graduate Traineeship from the Michael Smith Foundation for Health Research. E. C. G. is supported by a Canada Research Chair Award. This work was funded by a Burroughs Wellcome Fund Career Development Award, Canadian Institutes of Health Research MOP-68981, and Natural Sciences and Engineering Research Council of Canada grant F11-05378 to E. C. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KJ, 2001, FEMS MICROBIOL LETT, V205, P43, DOI 10.1016/S0378-1097(01)00444-X; Apel D, 2012, J BACTERIOL; Barrero-Tobon AM, 2012, MOL MICROBIOL; Barrero-Tobon AM, 2012, MOL MICROBIOL, V84, P352, DOI 10.1111/j.1365-2958.2012.08027.x; Bayliss CD, 2012, NUCL ACIDS RES; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Buswell CM, 1998, APPL ENVIRON MICROB, V64, P733; Candon HL, 2007, J BACTERIOL, V189, P8099, DOI 10.1128/JB.01037-07; Carron MA, 2006, J GASTROINTEST SURG, V10, P712, DOI 10.1016/j.gassur.2005.10.019; Coticchia JM, 2006, J GASTROINTEST SURG, V10, P883, DOI 10.1016/j.gassur.2005.12.009; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; de Boer P, 2002, MOL MICROBIOL, V44, P351, DOI 10.1046/j.1365-2958.2002.02930.x; Dorel C, 2006, RES MICROBIOL, V157, P306, DOI 10.1016/j.resmic.2005.12.003; Ferenci T, 2007, ANN NY ACAD SCI, V1113, P105, DOI 10.1196/annals.1391.003; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fournier B, 2000, J BACTERIOL, V182, P3955, DOI 10.1128/JB.182.14.3955-3964.2000; Frirdich E, 2014, J BIOL CHEM; Frirdich E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002602; Fujita Y, 2005, HELICOBACTER, V10, P567, DOI 10.1111/j.1523-5378.2005.00364.x; Gangaiah D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012142; Gaynor EC, 2005, MOL MICROBIOL, V56, P8, DOI 10.1111/j.1365-2958.2005.04525.x; Gilbreath JJ, 2011, MICROBIOL MOL BIOL R, V75, P84, DOI 10.1128/MMBR.00035-10; Golden NJ, 2002, INFECT IMMUN, V70, P1761, DOI 10.1128/IAI.70.4.1761-1771.2002; Grande R, 2011, J APPL MICROBIOL, V110, P490, DOI 10.1111/j.1365-2672.2010.04911.x; Grant AJ, 2006, FEMS MICROBIOL LETT, V263, P240, DOI 10.1111/j.1574-6968.2006.00449.x; Guerry P, 2007, TRENDS MICROBIOL, V15, P456, DOI 10.1016/j.tim.2007.09.006; Haddock G, 2010, MICROBIOL-SGM, V156, P3079, DOI 10.1099/mic.0.039867-0; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hendrixson DR, 2003, MOL MICROBIOL, V50, P687, DOI 10.1046/j.1365-2958.2003.03731.x; Hendrixson DR, 2001, MOL MICROBIOL, V40, P214, DOI 10.1046/j.1365-2958.2001.02376.x; Howard SL, 2009, INFECT IMMUN, V77, P2544, DOI 10.1128/IAI.01425-08; Hung DT, 2006, MOL MICROBIOL, V59, P193, DOI 10.1111/j.1365-2958.2005.04846.x; Hwang S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-207; Joshua GWP, 2006, MICROBIOL-SGM, V152, P387, DOI 10.1099/mic.0.28358-0; Kalmokoff M, 2006, J BACTERIOL, V188, P4312, DOI 10.1128/JB.01975-05; KARPEL RL, 1981, BIOPHYS CHEM, V13, P151, DOI 10.1016/0301-4622(81)80014-2; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Macfarlane S, 2007, CLIN INFECT DIS, V45, P29, DOI 10.1086/518578; Mahdavi J, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130202; McLennan MK, 2008, J BACTERIOL, V190, P1097, DOI 10.1128/JB.00516-07; Moe KK, 2010, J VET MED SCI, V72, P411, DOI 10.1292/jvms.09-0339; Montanaro L, 2011, INT J ARTIF ORGANS, V34, P824, DOI 10.5301/ijao.5000051; Monteiro C, 2011, J BACTERIOL, V193, P6443, DOI 10.1128/JB.00425-11; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Naito M, 2010, J BACTERIOL, V192, P2182, DOI 10.1128/JB.01222-09; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Oh E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087312; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Rathbun KM, 2009, FEMS MICROBIOL LETT, V300, P188, DOI 10.1111/j.1574-6968.2009.01795.x; Reeser RJ, 2007, APPL ENVIRON MICROB, V73, P1908, DOI 10.1128/AEM.00740-06; Reuter M, 2010, APPL ENVIRON MICROB, V76, P2122, DOI 10.1128/AEM.01878-09; Rivera-Amill V, 2001, J INFECT DIS, V183, P1607, DOI 10.1086/320704; ROLLINS DM, 1986, APPL ENVIRON MICROB, V52, P531, DOI 10.1128/AEM.52.3.531-538.1986; Sanders SQ, 2007, J FOOD PROTECT, V70, P1379, DOI 10.4315/0362-028X-70.6.1379; Svensson SL, 2009, MOL MICROBIOL, V71, P253, DOI 10.1111/j.1365-2958.2008.06534.x; Szymanski C. M., 2012, GUT MICROBES; Theoret JR, 2012, CLIN VACCINE IMMUNOL; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Trachoo N, 2002, J FOOD PROTECT, V65, P1110, DOI 10.4315/0362-028X-65.7.1110; Trachoo N, 2002, J FOOD PROTECT, V65, P1117, DOI 10.4315/0362-028X-65.7.1117; Wright JA, 2009, MICROBIOL-SGM, V155, P80, DOI 10.1099/mic.0.021790-0; YAO RJ, 1994, MOL MICROBIOL, V14, P883, DOI 10.1111/j.1365-2958.1994.tb01324.x; Zimmer M, 2003, AVIAN DIS, V47, P101, DOI 10.1637/0005-2086(2003)047[0101:DOCJSI]2.0.CO;2	67	66	67	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2014	9	8							e106063	10.1371/journal.pone.0106063	http://dx.doi.org/10.1371/journal.pone.0106063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JP	25166748	Green Published, Green Submitted, gold			2022-12-25	WOS:000341303700067
J	Ohkubo, H; Ito, Y; Minamino, T; Eshima, K; Kojo, K; Okizaki, S; Hirata, M; Shibuya, M; Watanabe, M; Majima, M				Ohkubo, Hirotoki; Ito, Yoshiya; Minamino, Tsutomu; Eshima, Koji; Kojo, Ken; Okizaki, Shin-ichiro; Hirata, Mitsuhiro; Shibuya, Masabumi; Watanabe, Masahiko; Majima, Masataka			VEGFR1-Positive Macrophages Facilitate Liver Repair and Sinusoidal Reconstruction after Hepatic Ischemia/Reperfusion Injury	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; ISCHEMIA-REPERFUSION INJURY; ANGIOCRINE SIGNALS; ANGIOGENESIS; CELL; ANGIOPOIETIN-2; VEGF; REGENERATION; CONTRIBUTES; ENHANCEMENT	Liver repair after acute liver injury is characterized by hepatocyte proliferation, removal of necrotic tissue, and restoration of hepatocellular and hepatic microvascular architecture. Macrophage recruitment is essential for liver tissue repair and recovery from injury; however, the underlying mechanisms are unclear. Signaling through vascular endothelial growth factor receptor 1 (VEGFR1) is suggested to play a role in macrophage migration and angiogenesis. The aim of the present study was to examine the role of VEGFR1 in liver repair and sinusoidal reconstruction after hepatic ischemia/reperfusion (I/R). VEGFR1 tyrosine kinase knockout mice (VEGFR1 TK-/- mice) and wild-type (WT) mice were subjected to hepatic warm I/R, and the processes of liver repair and sinusoidal reconstruction were examined. Compared with WT mice, VEGFR1 TK-/- mice exhibited delayed liver repair after hepatic I/R. VEGFR1-expressing macrophages recruited to the injured liver showed reduced expression of epidermal growth factor (EGF). VEGFR1 TK-/- mice also showed evidence of sustained sinusoidal functional and structural damage, and reduced expression of pro-angiogenic factors. Treatment of VEGFR1 TK-/- mice with EGF attenuated hepatoceullar and sinusoidal injury during hepatic I/R. VEGFR1 TK-/- bone marrow (BM) chimeric mice showed impaired liver repair and sinusoidal reconstruction, and reduced recruitment of VEGFR1-expressing macrophages to the injured liver. VEGFR1-macrophages recruited to the liver during hepatic I/R contribute to liver repair and sinusoidal reconstruction. VEGFR1 activation is a potential therapeutic strategy for promoting liver repair and sinusoidal restoration after acute liver injury.	[Ohkubo, Hirotoki; Kojo, Ken; Okizaki, Shin-ichiro; Majima, Masataka] Kitasato Univ, Sch Med, Dept Pharmacol, Sagamihara, Kanagawa 228, Japan; [Ito, Yoshiya; Hirata, Mitsuhiro; Watanabe, Masahiko] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 228, Japan; [Minamino, Tsutomu] Kitasato Univ, Sch Med, Dept Gastroenterol, Sagamihara, Kanagawa 228, Japan; [Eshima, Koji] Kitasato Univ, Sch Med, Dept Immunol, Sagamihara, Kanagawa 228, Japan; [Shibuya, Masabumi] Jobu Univ, Gakubunkan Inst Physiol & Med, Takasaki, Gunma, Japan	Kitasato University; Kitasato University; Kitasato University; Kitasato University	Majima, M (corresponding author), Kitasato Univ, Sch Med, Dept Pharmacol, Sagamihara, Kanagawa 228, Japan.	mmajima@med.kitasato-u.ac.jp	Majima, Masataka/ABH-3063-2021					Amano H, 2013, AM J PATHOL, V182, P553, DOI 10.1016/j.ajpath.2012.10.026; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; Clavien PA, 2008, SWISS MED WKLY, V138, P361, DOI 2008/25/smw-12231; Coulon S, 2013, HEPATOLOGY, V57, P1793, DOI 10.1002/hep.26219; Dambach DM, 2002, HEPATOLOGY, V35, P1093, DOI 10.1053/jhep.2002.33162; Devey L, 2009, MOL THER, V17, P65, DOI 10.1038/mt.2008.237; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Ehling J, 2014, GUT IN PRESS; Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007; Eshima K, 2006, J IMMUNOL, V176, P1628, DOI 10.4049/jimmunol.176.3.1628; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Hadem J, 2012, CRIT CARE MED, V40, P1499, DOI 10.1097/CCM.0b013e318241e34e; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Ho VC, 2012, CIRCULATION, V126, P741, DOI 10.1161/CIRCULATIONAHA.112.091603; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Hosono K, 2011, ARTERIOSCL THROM VAS, V31, P1049, DOI 10.1161/ATVBAHA.110.222356; Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Katagiri H, 2004, HEPATOLOGY, V39, P139, DOI 10.1002/hep.20000; Kato T, 2011, TOXICOL SCI, V120, P218, DOI 10.1093/toxsci/kfq366; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Kimura H, 2004, HEPATOL RES, V29, P51, DOI 10.1016/j.hepres.2004.02.004; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Koga J, 2009, ARTERIOSCL THROM VAS, V29, P458, DOI 10.1161/ATVBAHA.109.183772; Kuboki S, 2008, HEPATOLOGY, V48, P1213, DOI 10.1002/hep.22471; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; McCuskey RS, 1986, PHYS TECH, P247; Mehta VB, 2007, GROWTH FACTORS, V25, P253, DOI 10.1080/08977190701773070; Minamino T, 2012, TOXICOL APPL PHARM, V259, P104, DOI 10.1016/j.taap.2011.12.013; Murakami M, 2008, ARTERIOSCL THROM VAS, V28, P658, DOI 10.1161/ATVBAHA.107.150433; Murakami M, 2006, BLOOD, V108, P1849, DOI 10.1182/blood-2006-04-016030; Oh H, 1999, J BIOL CHEM, V274, P15732, DOI 10.1074/jbc.274.22.15732; Ohkubo H, 2013, FASEB J, V27, P3132, DOI 10.1096/fj.13-227421; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092515; Sato T, 2014, J GASTROENTEROL, V49, P455, DOI 10.1007/s00535-013-0869-z; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Stolz DB, 2007, HEPATOLOGY, V46, P1464, DOI 10.1002/hep.21887; Teoh NC, 2007, GASTROENTEROLOGY, V133, P632, DOI 10.1053/j.gastro.2007.05.027; Tsurui Y, 2005, TRANSPLANTATION, V79, P1110, DOI 10.1097/01.TP.0000161627.84481.5E; Van Sweringen HL, 2011, HEPATOLOGY, V54, P1445, DOI 10.1002/hep.24457; Williams CD, 2010, LIVER INT, V30, P1280, DOI 10.1111/j.1478-3231.2010.02284.x	50	26	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105533	10.1371/journal.pone.0105533	http://dx.doi.org/10.1371/journal.pone.0105533			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162491	Green Published, Green Submitted, gold			2022-12-25	WOS:000340880900037
J	Sirotin, N; Hoover, DR; Shi, QH; Anastos, K; Weiser, SD				Sirotin, Nicole; Hoover, Donald R.; Shi, Qiuhu; Anastos, Kathryn; Weiser, Sheri D.			Food Insecurity with Hunger Is Associated with Obesity among HIV-Infected and at Risk Women in Bronx, NY	PLOS ONE			English	Article							STAMP PROGRAM PARTICIPATION; OF-THE-LITERATURE; INSULIN-RESISTANCE; INTERAGENCY HIV; ENERGY DENSITY; UNITED-STATES; HOUSEHOLD; INDIVIDUALS; WEIGHT; HEALTH	Background: Food insecurity, insufficient quality and quantity of nutritionally adequate food, affects millions of people in the United States (US) yearly, with over 18 million Americans reporting hunger. Food insecurity is associated with obesity in the general population. Due to the increasing prevalence of obesity and risk factors for cardiovascular disease among HIV-infected women, we sought to determine the relationship between food insecurity and obesity in this cohort of urban, HIV-infected and -uninfected but at risk women. Methods: Using a cross-sectional design, we collected data on food insecurity, body mass index and demographic and clinical data from 231 HIV-infected and 119 HIV-negative women enrolled in Bronx site of the Women's Interagency HIV Study (WIHS). We used multivariate logistic regression to identify factors associated with obesity. Results: Food insecurity was highly prevalent, with almost one third of women (110/350, 31%) reporting food insecurity over the previous six months and over 13% of women reported food insecurity with hunger. Over half the women were obese with a Body Mass Index (BMI) of >= 30. In multivariate analyses, women who were food insecure with hunger had higher odds of obesity (Adjusted odds ratio [aOR] = 2.56, 95% Confidence Interval [CI] = 1.27, 5.20) after adjusting for HIV status, age, race, household status, income, drug and alcohol use. Conclusion: Food insecurity with hunger was associated with obesity in this population of HIV-infected and -uninfected, urban women. Both food insecurity and obesity are independent markers for increased mortality; further research is needed to understand this relationship and their role in adverse health outcomes.	[Sirotin, Nicole] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Hoover, Donald R.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, Dept Stat & Biostat, New Brunswick, NJ 08903 USA; [Shi, Qiuhu] New York Med Coll, Dept Epidemiol & Community Hlth, Valhalla, NY 10595 USA; [Anastos, Kathryn] Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA; [Anastos, Kathryn] Montefiore Med Ctr, Dept Epidemiol, Bronx, NY 10467 USA; [Anastos, Kathryn] Montefiore Med Ctr, Dept Populat Hlth, Bronx, NY 10467 USA; [Anastos, Kathryn] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Weiser, Sheri D.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA	Cornell University; Rutgers State University New Brunswick; New York Medical College; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Sirotin, N (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	nicolesirotinmd@gmail.com			National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institute on Drug Abuse [UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI042590, U01AI034989, K22AI134993, U01AI035004, U01AI034994, U01AI031834, U01AI034993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The WIHS is funded by the National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov) with supplemental funding from the National Cancer Institute (www.cancer.gov), and the National Institute on Drug Abuse (www.drugabuse.gov) (UO1-AI-35004, UO1-AI-31834, UO1-A1-34994, UO1-A1-34989, UO1-AI-34993, and UO1-AI-42590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2003, J NUTR, V133, P1070, DOI 10.1093/jn/133.4.1070; Amorosa V, 2005, JAIDS-J ACQ IMM DEF, V39, P557; Anema Aranka, 2009, Curr HIV/AIDS Rep, V6, P224, DOI 10.1007/s11904-009-0030-z; [Anonymous], 2012, FOOD SEC FUT; ATKINSON RL, 1994, JAMA-J AM MED ASSOC, V272, P1196, DOI 10.1001/jama.272.15.1196; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Bickel G., 2000, J COOK GUIDE MEASURI; Carenzi L, 2012, J INT AIDS SOC S4, V15, P18272; Centers for Disease Control and Prevention, 2012, HIV SURVEILLANCE S, V17; Coates J, 2006, J NUTR, V136, P1438, DOI 10.1093/jn/136.5.1438S; Coleman-Jensen A, 2013, HOUSEHOLD FOOD SECUR; Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4; Dinour LM, 2007, J AM DIET ASSOC, V107, P1952, DOI 10.1016/j.jada.2007.08.006; Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Duska F, 2005, CLIN NUTR, V24, P1056, DOI 10.1016/j.clnu.2005.08.008; Franklin B, 2012, J COMMUN HEALTH, V37, P253, DOI 10.1007/s10900-011-9420-4; French AL, 2009, JAIDS-J ACQ IMM DEF, V51, P399, DOI 10.1097/QAI.0b013e3181acb4e5; Garcia J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-215; Gibson D, 2003, J NUTR, V133, P2225, DOI 10.1093/jn/133.7.2225; Gowda C, 2012, AM J PUBLIC HEALTH, V102, P1579, DOI 10.2105/AJPH.2011.300551; Hamelin AM, 1999, J NUTR, V129, p525S, DOI 10.1093/jn/129.2.525S; Hanson KL, 2007, J NUTR, V137, P1460, DOI 10.1093/jn/137.6.1460; IOM (Institute of Medicine), 2011, HUNG OB UND FOOD INS; Ivers LC, 2011, AM J CLIN NUTR, V94, p1740S, DOI 10.3945/ajcn.111.012617; Kalichman S, 2010, J URBAN HLTH B NEW Y; Karnik A, 2011, MED CARE, V49, P658, DOI 10.1097/MLR.0b013e31820fb967; Krishnan S, 2012, JAIDS-J ACQ IMM DEF, V61, P381, DOI 10.1097/QAI.0b013e3182690e3c; Laraia BA, 2009, J AM DIET ASSOC, V109, P1042, DOI 10.1016/j.jada.2009.03.005; Larson NI, 2011, AM J PREV MED, V40, P166, DOI 10.1016/j.amepre.2010.10.028; Lee TK, 2014, FASEB J, V28, P35, DOI 10.1096/fj.13-238345; Leung CW, 2012, AM J CLIN NUTR, V95, P17, DOI 10.3945/ajcn.111.012294; Lopresti AL, 2013, PROG NEURO-PSYCHOPH, V45, P92, DOI 10.1016/j.pnpbp.2013.05.005; Martinez E, 2009, CURR OPIN INFECT DIS, V22, P28, DOI 10.1097/QCO.0b013e328320a849; National Center for Health Statistics, 2013, HLTH US 2012 SPEC FE; Nguyen T, 2012, CAN J CARDIOL, V28, P326, DOI 10.1016/j.cjca.2012.01.001; Normen L, 2005, J NUTR, V135, P820, DOI 10.1093/jn/135.4.820; Patterson RE, 2004, AM J PREV MED, V27, P385, DOI 10.1016/j.amepre.2004.08.001; Piaseu Noppawan, 2004, Health Care Women Int, V25, P604, DOI 10.1080/07399330490458141; Roberts S, 2011, NY TIMES; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Tarasuk VS, 2001, J NUTR, V131, P2670, DOI 10.1093/jn/131.10.2670; Tayie FA, 2009, PREV MED, V48, P480, DOI 10.1016/j.ypmed.2009.03.003; Urbszat D, 2002, J ABNORM PSYCHOL, V111, P396, DOI 10.1037//0021-843X.111.2.396; USDA, 2011, CHAR SNAP HOUS NEWYO, V16; Valcour V, 2012, AIDS RES HUM RETROV, V28, P447, DOI [10.1089/aid.2011.0159, 10.1089/AID.2011.0159]; Vozoris NT, 2003, J NUTR, V133, P120, DOI 10.1093/jn/133.1.120; Webb AL, 2008, PUBLIC HEALTH NUTR, V11, P1248, DOI 10.1017/S1368980008002309; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; Weiser SD, 2009, JAIDS-J ACQ IMM DEF, V52, P342, DOI 10.1097/QAI.0b013e3181b627c2; Weiser SD, 2009, J GEN INTERN MED, V24, P14, DOI 10.1007/s11606-008-0824-5	52	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105957	10.1371/journal.pone.0105957	http://dx.doi.org/10.1371/journal.pone.0105957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25162598	Green Published, gold, Green Submitted			2022-12-25	WOS:000340880900066
J	Sanders, NG; Sullivan, DJ; Mlambo, G; Dimopoulos, G; Tripathi, AK				Sanders, Natalie G.; Sullivan, David J.; Mlambo, Godfree; Dimopoulos, George; Tripathi, Abhai K.			Gametocytocidal Screen Identifies Novel Chemical Classes with Plasmodium falciparum Transmission Blocking Activity	PLOS ONE			English	Article							QUATERNARY AMMONIUM-COMPOUNDS; HIGH-THROUGHPUT ASSAY; METHYLENE-BLUE; ANTIMALARIAL ACTIVITY; COMBINATION THERAPY; PYRVINIUM PAMOATE; CEREBRAL MALARIA; INHIBITORS; EFFICACY; DRUGS	Discovery of transmission blocking compounds is an important intervention strategy necessary to eliminate and eradicate malaria. To date only a small number of drugs that inhibit gametocyte development and thereby transmission from the mosquito to the human host exist. This limitation is largely due to a lack of screening assays easily adaptable to high throughput because of multiple incubation steps or the requirement for high gametocytemia. Here we report the discovery of new compounds with gametocytocidal activity using a simple and robust SYBR Green I-based DNA assay. Our assay utilizes the exflagellation step in male gametocytes and a background suppressor, which masks the staining of dead cells to achieve healthy signal to noise ratio by increasing signal of viable parasites and subtracting signal from dead parasites. By determining the contribution of exflagellation to fluorescent signal and using appropriate cutoff values, we were able to screen for gametocytocidal compounds. After assay validation and optimization, we screened an FDA approved drug library of approximately 1500 compounds, as well as the 400 compound MMV malaria box and identified 44 gametocytocidal compounds with sub to low micromolar IC(50)s. Major classes of compounds with gametocytocidal activity included quaternary ammonium compounds with structural similarity to choline, acridine-like compounds similar to quinacrine and pyronaridine, as well as antidepressant, antineoplastic, and anthelminthic compounds. Top drug candidates showed near complete transmission blocking in membrane feeding assays. This assay is simple, reproducible and demonstrated robust Z-factor values at low gametocytemia levels, making it amenable to HTS for identification of novel and potent gametocytocidal compounds.	[Sanders, Natalie G.; Sullivan, David J.; Mlambo, Godfree; Dimopoulos, George; Tripathi, Abhai K.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Tripathi, AK (corresponding author), Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	atripat2@jhu.edu		Tripathi, Abhai/0000-0001-9848-0142	national Institutes of Health [R01AI061576]; Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; Johns Hopkins University Libraries; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061576] Funding Source: NIH RePORTER	national Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; Johns Hopkins University Libraries(Johns Hopkins University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the national Institutes of Health R01AI061576, the Johns Hopkins Malaria Research Institute and The Bloomberg Family Foundation. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Auparakkitanon S, 2000, BIOCHEM BIOPH RES CO, V269, P406, DOI 10.1006/bbrc.2000.2305; Baker DA, 2010, MOL BIOCHEM PARASIT, V172, P57, DOI 10.1016/j.molbiopara.2010.03.019; Barton V, 2010, CURR OPIN CHEM BIOL, V14, P440, DOI 10.1016/j.cbpa.2010.05.005; BHATTACHARYA BK, 1965, BRIT J PHARM CHEMOTH, V24, P240, DOI 10.1111/j.1476-5381.1965.tb02099.x; Biagini GA, 2008, MOL PHARMACOL, V73, P1347, DOI 10.1124/mol.108.045120; Birkholtz LM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-431; Bobenchik AM, 2013, P NATL ACAD SCI USA, V110, P18262, DOI 10.1073/pnas.1313965110; Bowman JD, 2014, ANTIMICROB AGENTS CH, V58, P811, DOI 10.1128/AAC.01500-13; Calas M, 1997, J MED CHEM, V40, P3557, DOI 10.1021/jm9701886; Chavalitshewinkoon-Petmitr Porntip, 2000, Parasitology International, V48, P275, DOI 10.1016/S1383-5769(99)00028-8; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; Coulibaly B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005318; D'Alessandro S, 2013, J ANTIMICROB CHEMOTH, V68, P2048, DOI 10.1093/jac/dkt165; DARCY PF, 1962, J PHARM PHARMACOL, V14, P129, DOI 10.1111/j.2042-7158.1962.tb11069.x; DARCY PF, 1962, J PHARM PHARMACOL, V14, P193, DOI 10.1111/j.2042-7158.1962.tb11081.x; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; Dormoi J, 2013, ANTIMICROB AGENTS CH, V57, P3412, DOI 10.1128/AAC.02381-12; Dormoi J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-127; Downey AS, 2008, ANTIMICROB AGENTS CH, V52, P3106, DOI 10.1128/AAC.00207-08; Duffy S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-408; Eastman RT, 2013, ANTIMICROB AGENTS CH, V57, P425, DOI 10.1128/AAC.00920-12; Fernandez-Calienes A, 2011, BIOMED PHARMACOTHER, V65, P210, DOI 10.1016/j.biopha.2011.04.001; Guetzoyan L, 2009, BIOORGAN MED CHEM, V17, P8032, DOI 10.1016/j.bmc.2009.10.005; Krawczyk J, 2013, EXPERT OPIN INV DRUG, V22, P1315, DOI 10.1517/13543784.2013.826648; Lelievre J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035019; License A, 2011, PLOS MED, V8; Lucantoni L, 2013, ANTIMICROB AGENTS CH, V57, P6050, DOI 10.1128/AAC.00870-13; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Pascual A, 2011, ANTIMICROB AGENTS CH, V55, P2472, DOI 10.1128/AAC.01466-10; Peatey CL, 2011, MOL BIOCHEM PARASIT, V180, P127, DOI 10.1016/j.molbiopara.2011.09.002; Peyrottes S, 2012, CURR PHARM DESIGN, V18, P3454; Pybus BS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-212; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Sun W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03743; Tanaka TQ, 2013, MOL BIOCHEM PARASIT, V188, P20, DOI 10.1016/j.molbiopara.2013.02.005; Tanaka TQ, 2011, MOL BIOCHEM PARASIT, V177, P160, DOI 10.1016/j.molbiopara.2011.02.005; Teguh SC, 2013, J MED CHEM, V56, P6200, DOI 10.1021/jm400656s; Tischer M, 2012, CHEMMEDCHEM, V7, P22, DOI 10.1002/cmdc.201100404; Tomitsuka E, 2012, J BIOCHEM, V152, P171, DOI 10.1093/jb/mvs041; Valdes Ayme Fernandez-Calienes, 2011, Open Med Chem J, V5, P11, DOI 10.2174/1874104501105010011; Wein S, 2012, BRIT J PHARMACOL, V166, P2263, DOI 10.1111/j.1476-5381.2012.01966.x; Yu XM, 2012, CHEMMEDCHEM, V7, P587, DOI 10.1002/cmdc.201100554; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	45	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105817	10.1371/journal.pone.0105817	http://dx.doi.org/10.1371/journal.pone.0105817			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157792	gold, Green Submitted, Green Published			2022-12-25	WOS:000341303200068
J	Yang, MJ; Zeng, C; Guo, S; Pan, J; Han, YC; Li, ZQ; Li, LJ; Tan, J				Yang, Mingjie; Zeng, Cheng; Guo, Song; Pan, Jie; Han, Yingchao; Li, Zeqing; Li, Lijun; Tan, Jun			Digitalized Design of Extraforaminal Lumbar Interbody Fusion: A Computer-Based Simulation and Cadaveric Study	PLOS ONE			English	Article							COMPLICATIONS; OUTCOMES	Purpose: This study aims to investigate the feasibility of a novel lumbar approach named extraforaminal lumbar interbody fusion (ELIF), a newly emerging minimally invasive technique for treating degenerative lumbar disorders, using a digitalized simulation and a cadaveric study. Methods: The ELIF surgical procedure was simulated using the Mimics surgical simulator and included dissection of the superior articular process, dilation of the vertebral foramen, and placement of pedicle screws and a cage. ELIF anatomical measures were documented using a digitalized technique and subsequently validated on fresh cadavers. Results: The use of the Mimics allowed for the vivid simulation of ELIF surgical procedures, while the cadaveric study proved the feasibility of this novel approach. ELIF had a relatively lateral access approach that was located 8-9 cm lateral to the median line with an access depth of approximately 9 cm through the intermuscular space. Dissection of the superior articular processes could fully expose the target intervertebral discs and facilitate a more inclined placement of the pedicle screws and cage with robust enhancement. Conclusions: According to the computer-based simulation and cadaveric study, it is feasible to perform ELIF. Further research including biomechanical study is needed to prove ELIF has a superior ability to preserve the posterior tension bands of the spinal column, with similar effects on spinal decompression, fixation, and fusion, and if it can enhance post-fusion spinal stability and expedites postoperative recovery.	[Yang, Mingjie; Zeng, Cheng; Guo, Song; Pan, Jie; Han, Yingchao; Li, Zeqing; Li, Lijun; Tan, Jun] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Spine Surg, Shanghai 200092, Peoples R China	Tongji University	Li, LJ (corresponding author), Tongji Univ, Shanghai East Hosp, Sch Med, Dept Spine Surg, Shanghai 200092, Peoples R China.	jesoy@126.com; dr.tan@139.com			Discipline leader plan of the health ministry of pudong area, Shanghai, China	Discipline leader plan of the health ministry of pudong area, Shanghai, China	This study was supported by grants from Discipline leader plan of the health ministry of pudong area, Shanghai, China. Program number PWRD 2011-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cahill KS, 2012, J NEUROSURG-SPINE, V17, P227, DOI 10.3171/2012.5.SPINE1288; DiPaola CP, 2008, J AM ACAD ORTHOP SUR, V16, P130, DOI 10.5435/00124635-200803000-00004; Feng Zhen-Zhou, 2011, Orthopedics, V34, P364, DOI 10.3928/01477447-20110317-05; Hey HWD, 2010, INDIAN J ORTHOP, V44, P159, DOI 10.4103/0019-5413.62066; Holly Langston T, 2006, Neurosurg Focus, V20, pE6; Hong JY, 2011, SPINE, V36, pE1259, DOI 10.1097/BRS.0b013e318205e413; Hsieh PC, 2007, J NEUROSURG-SPINE, V7, P379, DOI 10.3171/SPI-07/10/379; Kadoury S, 2012, EUR SPINE J, V21, P40, DOI 10.1007/s00586-011-2004-2; Lau D, 2011, J CLIN NEUROSCI, V18, P624, DOI 10.1016/j.jocn.2010.09.004; Lee DH, 2011, J BONE JOINT SURG BR, V93B, P1395, DOI 10.1302/0301-620X.93B10.26833; Lee KH, 2012, EUR SPINE J, V21, P2265, DOI 10.1007/s00586-012-2281-4; Lindley EM, 2011, J NEUROSURG-SPINE, V15, P273, DOI 10.3171/2011.3.SPINE10373; Mura PP, 2011, EUR SPINE J, V20, P57, DOI 10.1007/s00586-011-1761-2; Rodgers WB, 2011, SPINE, V36, P26, DOI 10.1097/BRS.0b013e3181e1040a; Rosenberg WS, 2001, NEUROSURGERY, V48, P569, DOI 10.1097/00006123-200103000-00022; Tobler WD, 2011, J BONE JOINT SURG BR, V93B, P955, DOI 10.1302/0301-620X.93B7.25188; Xiao YX, 2009, J INT MED RES, V37, P908, DOI 10.1177/147323000903700337	17	1	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105646	10.1371/journal.pone.0105646	http://dx.doi.org/10.1371/journal.pone.0105646			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157907	gold, Green Published, Green Submitted			2022-12-25	WOS:000341303200043
J	Zhang, M; Hou, M; Ge, LH; Miao, CC; Zhang, JF; Jing, XY; Shi, N; Chen, T; Tang, XF				Zhang, Min; Hou, Min; Ge, Lihua; Miao, Congcong; Zhang, Jianfei; Jing, Xinying; Shi, Ni; Chen, Tong; Tang, Xiaofei			Induction of Peroxiredoxin 1 by Hypoxia Regulates Heme Oxygenase-1 via NF-kappa B in Oral Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; I EXPRESSION; NUCLEAR; ACTIVATION; ASTROCYTES; GENE; HYPOXIA/REOXYGENATION; KERATINOCYTES; EPIDEMIOLOGY; MICROGLIA	Overexpression of peroxiredoxin 1 (Prx1) has been observed in numerous cancers including oral squamous cell carcinoma (OSCC). The precise molecular mechanism of up-regulation of Prx1 in carcinogenesis, however, is still poorly understood. The objective of this study is to investigate the relationship between Prx1 and hypoxia, and potential mechanism(s) of Prx1 in OSCC cell line SCC15 and xenograft model. We treated wild-type and Prx1 knockdown SCC15 cells with transient hypoxia followed by reoxygenation. We detected the condition of hypoxia, production of reactive oxygen species (ROS), and expression and/or activity of Prx1, heme oxygenase 1 (HO-1) and nuclear factor-kappa B (NF-kappa B). We found that hypoxia induces ROS accumulation, up-regulates Prx1, increases NF-kappa B translocation and DNA binding activity, and down-regulates HO-1 in vitro. In Prx1 knockdown cells, the expression level of HO-1 was increased, while NF kappa B translocation and DNA binding activity were decreased after hypoxia or hypoxia/reoxygenation treatment. Moreover, we mimicked the dynamic oxygenation tumor microenvironment in xenograft model and assessed the above indices in tumors with the maximal diameter of 2 mm, 5 mm, 10 mm or 15 mm, respectively. Our data showed that tumor hypoxic condition and expression of Prx1 are significantly associated with tumor growth. The expression of HO-1 and NF-kappa B, and NF-kappa B DNA binding activity were significantly elevated in 15 mm tumors, and the level of 8-hydroxydeoxyguanosine was increased in 10 mm and 15 mm tumors, compared to those in size of 2 mm. The results from this study provide experimental evidence that overexpression of Prx1 is associated with hypoxia, and Prx1/NF-kappa B/HO-1 signaling pathway may be involved in oral carcinogenesis.	[Zhang, Min; Hou, Min; Ge, Lihua; Miao, Congcong; Zhang, Jianfei; Jing, Xinying; Tang, Xiaofei] Capital Med Univ, Beijing Stomatol Hosp, Inst Dent Res, Beijing, Peoples R China; [Zhang, Min; Hou, Min; Ge, Lihua; Miao, Congcong; Zhang, Jianfei; Jing, Xinying; Tang, Xiaofei] Capital Med Univ, Sch Stomatol, Beijing, Peoples R China; [Shi, Ni; Chen, Tong] Ohio State Univ, Arthur G James Canc Hosp, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA; [Shi, Ni; Chen, Tong] Ohio State Univ, Richard J Solove Res Inst, Columbus, OH 43210 USA	Capital Medical University; Capital Medical University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Chen, T (corresponding author), Ohio State Univ, Arthur G James Canc Hosp, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA.	tong.chen@osumc.edu; xftang10@yahoo.com	Chen, Tong/E-2879-2011; zhang, min/GQR-1387-2022		National Natural Science Foundation [81070836]; Beijing Natural Science Foundation [7102065]; Beijing Municipal Administration of Hospital Key Medical Development Project [ZYLX201407]; NATIONAL CANCER INSTITUTE [R01CA131073] Funding Source: NIH RePORTER	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Municipal Administration of Hospital Key Medical Development Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation (81070836), the Beijing Natural Science Foundation (7102065) and ZYLX201407, Beijing Municipal Administration of Hospital Key Medical Development Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan ME, 2012, CELL BIOCHEM FUNCT, V30, P166, DOI 10.1002/cbf.1832; Bach FH, 2005, FASEB J, V19, P1216, DOI 10.1096/fj.04-3485cmt; Bagan JV, 2008, ORAL ONCOL, V44, P103, DOI 10.1016/j.oraloncology.2008.01.008; Bussink J, 2003, RADIOTHER ONCOL, V67, P3, DOI 10.1016/S0167-8140(03)00011-2; dos Santos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045228; Gandini NA, 2012, EXP MOL PATHOL, V93, P237, DOI 10.1016/j.yexmp.2012.05.001; Guo GW, 2006, ANTIOXID REDOX SIGN, V8, P911, DOI 10.1089/ars.2006.8.911; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hansen JM, 2007, FREE RADICAL BIO MED, V43, P282, DOI 10.1016/j.freeradbiomed.2007.04.029; Jeong SI, 2010, ARCH PHARM RES, V33, P1867, DOI 10.1007/s12272-010-1120-6; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kim YJ, 2006, CANCER RES, V66, P7136, DOI 10.1158/0008-5472.CAN-05-4446; Lavrovsky Y, 2000, MECH AGEING DEV, V114, P49, DOI 10.1016/S0047-6374(00)00087-7; Lee HJ, 2008, J ORAL PATHOL MED, V37, P278, DOI 10.1111/j.1600-0714.2007.00616.x; Liu PL, 2010, MOL NUTR FOOD RES, V54, pS196, DOI 10.1002/mnfr.200900550; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Mazza E, 2001, J APPL PHYSIOL, V91, P379, DOI 10.1152/jappl.2001.91.1.379; Miyazaki Y, 2008, INT J ONCOL, V32, P145; Miyoshi A, 2006, INT J ONCOL, V29, P1533; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Nakaso K, 2000, NEUROSCI LETT, V293, P49, DOI 10.1016/S0304-3940(00)01491-9; Nakayama H, 2001, CANCER, V92, P3037, DOI 10.1002/1097-0142(20011215)92:12<3037::AID-CNCR10171>3.0.CO;2-#; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Neumann CA, 2007, CURR OPIN PHARMACOL, V7, P375, DOI 10.1016/j.coph.2007.04.007; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Riddell JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050394; Riddell JR, 2011, CANCER RES, V71, P1637, DOI 10.1158/0008-5472.CAN-10-3674; Ruiz-Ramos R, 2009, MUTAT RES-GEN TOX EN, V674, P109, DOI 10.1016/j.mrgentox.2008.09.021; Rushworth SA, 2010, CANCER RES, V70, P2973, DOI 10.1158/0008-5472.CAN-09-3407; Stanimirovic D, 2001, J NEUROIMMUNOL, V119, P365, DOI 10.1016/S0165-5728(01)00402-7; Wang XM, 2010, MOL BIOL CELL, V21, P2987, DOI 10.1091/mbc.E10-02-0160; Warnakulasuriya S, 2009, BRIT DENT J, V207, P471, DOI 10.1038/sj.bdj.2009.1009; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Yanagawa T, 2005, INT J ORAL MAX SURG, V34, P915, DOI 10.1016/j.ijom.2005.04.015; Yanagawa T, 2000, CANCER LETT, V156, P27, DOI 10.1016/S0304-3835(00)00434-1	36	91	94	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105994	10.1371/journal.pone.0105994	http://dx.doi.org/10.1371/journal.pone.0105994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25295523	gold, Green Published, Green Submitted			2022-12-25	WOS:000340880900070
J	Li, JF; Luo, C; Peng, YH; Xie, QK; Gong, JN; Dong, L; Lai, YX; Li, H; Yao, DZ				Li, Jianfu; Luo, Cheng; Peng, Yueheng; Xie, Qiankun; Gong, Jinnan; Dong, Li; Lai, Yongxiu; Li, Hong; Yao, Dezhong			Probabilistic Diffusion Tractography Reveals Improvement of Structural Network in Musicians	PLOS ONE			English	Article							AUDITORY-EVOKED POTENTIALS; SUPPLEMENTARY MOTOR AREA; WHITE-MATTER PLASTICITY; SMALL-WORLD; GRAY-MATTER; HUMAN BRAIN; CORTICAL REPRESENTATION; PREMOTOR CORTEX; ABSOLUTE PITCH; PIANO PLAYERS	Purpose: Musicians experience a large amount of information transfer and integration of complex sensory, motor, and auditory processes when training and playing musical instruments. Therefore, musicians are a useful model in which to investigate neural adaptations in the brain. Methods: Here, based on diffusion-weighted imaging, probabilistic tractography was used to determine the architecture of white matter anatomical networks in musicians and non-musicians. Furthermore, the features of the white matter networks were analyzed using graph theory. Results: Small-world properties of the white matter network were observed in both groups. Compared with non-musicians, the musicians exhibited significantly increased connectivity strength in the left and right supplementary motor areas, the left calcarine fissure and surrounding cortex and the right caudate nucleus, as well as a significantly larger weighted clustering coefficient in the right olfactory cortex, the left medial superior frontal gyrus, the right gyrus rectus, the left lingual gyrus, the left supramarginal gyrus, and the right pallidum. Furthermore, there were differences in the node betweenness centrality in several regions. However, no significant differences in topological properties were observed at a global level. Conclusions: We illustrated preliminary findings to extend the network level understanding of white matter plasticity in musicians who have had long-term musical training. These structural, network-based findings may indicate that musicians have enhanced information transmission efficiencies in local white matter networks that are related to musical training.	[Li, Jianfu; Luo, Cheng; Peng, Yueheng; Xie, Qiankun; Gong, Jinnan; Dong, Li; Lai, Yongxiu; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China; [Li, Hong] Southwest Univ, Key Lab Cognit & Personal, Minist Educ, Chongqing, Peoples R China	University of Electronic Science & Technology of China; Southwest University - China	Luo, C (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China.	chengluo@uestc.edu.cn; dyao@uestc.edu.cn	zhang, ke/AAH-8217-2019; Luo, Cheng/A-4647-2015	Luo, Cheng/0000-0003-0524-5886; Gong, Jinnan/0000-0002-9908-3517; Yao, Dezhong/0000-0002-8042-879X	973 project [2011CB707803]; National Nature Science Foundation of China [81271547, 81201159, 91232725]; Chinese Fundamental Research Funding for Central Universities [ZYGX 2011J097, ZYGX2012J110]	973 project(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Fundamental Research Funding for Central Universities	This work was supported by grants from the 973 project 2011CB707803, the National Nature Science Foundation of China (grant number: 81271547, 81201159, and 91232725) and the Chinese Fundamental Research Funding for Central Universities (grant number: ZYGX 2011J097, ZYGX2012J110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Kareem IA, 2011, CEREBELLUM, V10, P611, DOI 10.1007/s12311-011-0274-1; Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3<206::AID-HBM5>3.0.CO;2-7; Amunts K, 2000, NEUROPSYCHOLOGIA, V38, P304, DOI 10.1016/S0028-3932(99)00075-5; [Anonymous], [No title captured]; Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; Barrett KE, 2012, GANONGS REV MED PHYS, P239; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Baumann S, 2008, J COGNITIVE NEUROSCI, V20, P2238, DOI 10.1162/jocn.2008.20157; Baumann S, 2007, BRAIN RES, V1161, P65, DOI 10.1016/j.brainres.2007.05.045; Bengtsson SL, 2006, NEUROIMAGE, V30, P272, DOI 10.1016/j.neuroimage.2005.09.019; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bermudez P, 2005, ANN NY ACAD SCI, V1060, P395, DOI 10.1196/annals.1360.057; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carretie L, 2009, NEUROSCIENCE, V164, P1615, DOI 10.1016/j.neuroscience.2009.09.031; Chen JL, 2012, NEUROIMAGE, V59, P1200, DOI 10.1016/j.neuroimage.2011.08.012; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Foundas AL, 1999, NEUROPSY NEUROPSY BE, V12, P1; Gaser C, 2003, ANN NY ACAD SCI, V999, P514, DOI 10.1196/annals.1284.062; Gaser C, 2003, J NEUROSCI, V23, P9240; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Groussard M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013225; Habermeyer B, 2009, HUM BRAIN MAPP, V30, P3736, DOI 10.1002/hbm.20802; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hirata Y, 1999, NEUROREPORT, V10, P999, DOI 10.1097/00001756-199904060-00019; Hoenig K, 2011, NEUROIMAGE, V56, P1714, DOI 10.1016/j.neuroimage.2011.02.065; Huang Z, 2010, NEUROSCIENCE, V168, P179, DOI 10.1016/j.neuroscience.2010.03.027; Hund-Georgiadis M, 1999, EXP BRAIN RES, V125, P417, DOI 10.1007/s002210050698; Hutchinson S, 2003, CEREB CORTEX, V13, P943, DOI 10.1093/cercor/13.9.943; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Imfeld A, 2009, NEUROIMAGE, V46, P600, DOI 10.1016/j.neuroimage.2009.02.025; Ishizu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021852; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Iturria-Medina Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019071; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P177, DOI 10.1016/S0926-6410(00)00028-8; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Kansaku K, 2000, CEREB CORTEX, V10, P866, DOI 10.1093/cercor/10.9.866; Keenan JP, 2001, NEUROIMAGE, V14, P1402, DOI 10.1006/nimg.2001.0925; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Li SY, 2010, CEREB CORTEX, V20, P25, DOI 10.1093/cercor/bhp074; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Luo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036568; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Meister I, 2005, HUM BRAIN MAPP, V25, P345, DOI 10.1002/hbm.20112; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nachev P, 2007, NEUROIMAGE, V36, pT155, DOI 10.1016/j.neuroimage.2007.03.034; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nopoulos P, 2000, PSYCHIAT RES-NEUROIM, V98, P1, DOI 10.1016/S0925-4927(99)00044-X; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Penhune VB, 2011, CORTEX, V47, P1126, DOI 10.1016/j.cortex.2011.05.010; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Russeler J, 2001, NEUROSCI LETT, V308, P33, DOI 10.1016/S0304-3940(01)01977-2; Salimpoor VN, 2013, PSYCHOL AESTHET CREA, V7, P62, DOI 10.1037/a0031819; Schlaug G, 2005, ANN NY ACAD SCI, V1060, P219, DOI 10.1196/annals.1360.015; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Schmithorst VJ, 2002, NEUROSCI LETT, V321, P57, DOI 10.1016/S0304-3940(02)00054-X; Schneider P, 2005, ANN NY ACAD SCI, V1060, P387, DOI 10.1196/annals.1360.033; Schulze K, 2011, HUM BRAIN MAPP, V32, P771, DOI 10.1002/hbm.21060; Shahin A, 2003, J NEUROSCI, V23, P5545; Sloboda JohnA., 1991, PSYCHOL MUSIC, V19, P110, DOI [10.1177/0305735691192002, DOI 10.1177/0305735691192002]; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Steele CJ, 2013, J NEUROSCI, V33, P1282, DOI 10.1523/JNEUROSCI.3578-12.2013; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; THALER D, 1995, EXP BRAIN RES, V102, P445; Toga AW, 2006, NAT REV NEUROSCI, V7, P952, DOI 10.1038/nrn2012; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xue KQ, 2014, EPILEPSY RES, V108, P125, DOI 10.1016/j.eplepsyres.2013.10.002	84	416	423	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105508	10.1371/journal.pone.0105508	http://dx.doi.org/10.1371/journal.pone.0105508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	24587291	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303200034
J	Mao, M; Varadarajan, S; Fukai, T; Bakhshi, FR; Chernaya, O; Dudley, SC; Minshall, RD; Bonini, MG				Mao, Mao; Varadarajan, Sudhahar; Fukai, Tohru; Bakhshi, Farnaz R.; Chernaya, Olga; Dudley, Samuel C., Jr.; Minshall, Richard D.; Bonini, Marcelo G.			Nitroglycerin Tolerance in Caveolin-1 Deficient Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; MICROVASCULAR PERMEABILITY; ENOS ACTIVATION; IN-VIVO; SUPEROXIDE; PEROXYNITRITE; TETRAHYDROBIOPTERIN; PROTEIN; HYPERPERMEABILITY	Nitrate tolerance developed after persistent nitroglycerin (GTN) exposure limits its clinical utility. Previously, we have shown that the vasodilatory action of GTN is dependent on endothelial nitric oxide synthase (eNOS/NOS3) activity. Caveolin-1 (Cav-1) is known to interact with NOS3 on the cytoplasmic side of cholesterol-enriched plasma membrane microdomains (caveolae) and to inhibit NOS3 activity. Loss of Cav-1 expression results in NOS3 hyperactivation and uncoupling, converting NOS3 into a source of superoxide radicals, peroxynitrite, and oxidative stress. Therefore, we hypothesized that nitrate tolerance induced by persistent GTN treatment results from NOS3 dysfunction and vascular toxicity. Exposure to GTN for 48-72 h resulted in nitrosation and depletion (>50%) of Cav-1, NOS3 uncoupling as measured by an increase in peroxynitrite production (>100%), and endothelial toxicity in cultured cells. In the Cav-1 deficient mice, NOS3 dysfunction was accompanied by GTN tolerance (>50% dilation inhibition at low GTN concentrations). In conclusion, GTN tolerance results from Cav-1 modification and depletion by GTN that causes persistent NOS3 activation and uncoupling, preventing it from participating in GTN-medicated vasodilation.	[Mao, Mao; Varadarajan, Sudhahar; Fukai, Tohru; Dudley, Samuel C., Jr.; Bonini, Marcelo G.] Univ Illinois, Dept Med, Cardiol Sect, Chicago, IL 60607 USA; [Mao, Mao; Varadarajan, Sudhahar; Fukai, Tohru; Bakhshi, Farnaz R.; Chernaya, Olga; Minshall, Richard D.; Bonini, Marcelo G.] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Minshall, Richard D.] Univ Illinois, Dept Anesthesiol, Chicago, IL USA; [Mao, Mao] Univ Illinois, Dept Pathol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bonini, MG (corresponding author), Univ Illinois, Dept Med, Cardiol Sect, Chicago, IL 60607 USA.	mbonini@uic.edu	Mao, Mao/E-3783-2013; Dudley, Samuel C/A-7085-2009; Dudley, Samuel/AAR-7950-2021; Varadarajan, Sudhahar/AAJ-6910-2021	Mao, Mao/0000-0003-1524-8853; Dudley, Samuel/0000-0001-5843-5961; Varadarajan, Sudhahar/0000-0002-9675-0097	American Heart Association [09SDG2250933, 13GRNT16400010]; National Institutes of Health NHLBI [PO1-HL060678]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070187, P01HL060678] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association, grants 09SDG2250933 and 13GRNT16400010 (to M.G.B.) and National Institutes of Health NHLBI grant PO1-HL060678 (to R.D.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablikim M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.172002; Bakhshi FR, 2013, PULM CIRC, V3, P816, DOI 10.1086/674753; Bauersachs J, 2005, CARDIOVASC RES, V65, P768, DOI 10.1016/j.cardiores.2004.12.011; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bendall JK, 2005, CIRC RES, V97, P864, DOI 10.1161/01.RES.0000187447.03525.72; Boden WE, 2012, CLIN CARDIOL, V35, P263, DOI 10.1002/clc.21993; Bonini MG, 2008, P NATL ACAD SCI USA, V105, P8569, DOI 10.1073/pnas.0708615105; Bonini MG, 2002, CHEM RES TOXICOL, V15, P506, DOI 10.1021/tx015571z; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Chen ZQ, 2005, P NATL ACAD SCI USA, V102, P12159, DOI 10.1073/pnas.0503723102; Crabtree MJ, 2013, J BIOL CHEM, V288, P561, DOI 10.1074/jbc.M112.415992; Daiber A, 2004, MOL PHARMACOL, V66, P1372, DOI 10.1124/mol.104.002600; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; Karuppiah K, 2011, AM J PHYSIOL-HEART C, V301, pH903, DOI 10.1152/ajpheart.00936.2010; Kollau A, 2005, BIOCHEM J, V385, P769, DOI 10.1042/BJ20041354; KRISHNA MC, 1992, P NATL ACAD SCI USA, V89, P5537, DOI 10.1073/pnas.89.12.5537; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Lin MI, 2007, CANCER RES, V67, P2849, DOI 10.1158/0008-5472.CAN-06-4082; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Mao M, 2012, FREE RADICAL BIO MED, V52, P427, DOI 10.1016/j.freeradbiomed.2011.09.020; Mirza MK, 2010, AM J PATHOL, V176, P2344, DOI 10.2353/ajpath.2010.091088; Morais C, 2012, AM J PATHOL, V180, P1702, DOI 10.1016/j.ajpath.2011.12.018; Munzel T, 1996, Am J Cardiol, V77, p24C, DOI 10.1016/S0002-9149(96)00185-3; Place AT, 2011, MOL PHARMACOL, V80, P665, DOI 10.1124/mol.111.073957; Sanchez FA, 2009, P NATL ACAD SCI USA, V106, P6849, DOI 10.1073/pnas.0812694106; Sato M, 2012, J BIOL CHEM, V287, P20674, DOI 10.1074/jbc.M111.280651; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; Schnorbus B, 2010, CLIN RES CARDIOL, V99, P115, DOI 10.1007/s00392-009-0096-z; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Schuhmacher S, 2011, DIABETES, V60, P2608, DOI 10.2337/db10-1395; Scotland RS, 2005, CIRCULATION, V111, P796, DOI 10.1161/01.CIR.0000155238.70797.4E; Siddiqui MR, 2011, J CELL BIOL, V193, P841, DOI 10.1083/jcb.201012129; Sikora A, 2011, CHEM RES TOXICOL, V24, P687, DOI 10.1021/tx100439a; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Sydow K, 2004, J CLIN INVEST, V113, P482, DOI 10.1172/JCI200419267; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vasquez-Vivar J, 2002, BIOCHEM J, V362, P733, DOI 10.1042/0264-6021:3620733; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080	41	25	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104101	10.1371/journal.pone.0104101	http://dx.doi.org/10.1371/journal.pone.0104101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25329888	Green Published, gold, Green Submitted			2022-12-25	WOS:000341303200009
J	Li, J; Zhang, KQ				Li, Juan; Zhang, Ke-Qin			Independent Expansion of Zincin Metalloproteinases in Onygenales Fungi May Be Associated with Their Pathogenicity	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; AMINO-ACID SITES; GENE FAMILY; PHYLOGENETIC ANALYSIS; LIKELIHOOD METHOD; SEQUENCE; MODEL; DISEASE; RATIO; COCCIDIOIDOMYCOSIS	To get a comprehensive view of fungal M35 family (deuterolysin) and M36 family (fungalysin) genes, we conducted genome-wide investigations and phylogenetic analyses of genes in these two families from 50 sequenced Ascomycota fungi with different life styles. Large variations in the number of M35 family and M36 family genes were found among different fungal genomes, indicating that these two gene families have been highly dynamic through fungal evolution. Moreover, we found obvious expansions of Meps in two families of Onygenales: Onygenaceae and Arthodermataceae, whereas species in family Ajellomycetace did not show expansion of these genes. The strikingly different gene duplication and loss patterns in Onygenales may be associated with the different pathogenicity of these species. Interestingly, likelihood ratio tests (LRT) of both M35 family and M36 family genes suggested that several branches leading to the duplicated genes in dermatophytic and Coccidioides fungi had signatures of positive selection, indicating that the duplicated Mep genes have likely diverged functionally to play important roles during the evolution of pathogenicity of dermatophytic and Coccidioides fungi. The potentially positively selected residues discovered by our analysis may have contributed to the development of new physiological functions of the duplicated Mep genes in dermatophytic fungi and Coccidioides species. Our study adds to the current knowledge of the evolution of Meps in fungi and also establishes a theoretical foundation for future experimental investigations.	[Zhang, Ke-Qin] Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming, Peoples R China	Yunnan University; Yunnan University	Zhang, KQ (corresponding author), Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China.	kqzhang1@ynu.edu.cn	zhang, ke/AAH-8217-2019; Luo, Cheng/A-4647-2015	Luo, Cheng/0000-0003-0524-5886; Gong, Jinnan/0000-0002-9908-3517; Yao, Dezhong/0000-0002-8042-879X	National Basic Research Program of China [2013CB127500]; National Natural Science Foundation of China [31100894]; 1/4 CE Youth Foundation of the Applied Basic Research Programs of Yunnan Province [2012FD006]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 1/4 CE Youth Foundation of the Applied Basic Research Programs of Yunnan Province	This work is jointly funded by National Basic Research Program of China (approved no. 2013CB127500), the National Natural Science Foundation of China (approved nos. 31100894) 1/4 CE Youth Foundation of the Applied Basic Research Programs of Yunnan Province (approved nos. 2012FD006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Bonferroni C. E., 1936, TEORIA STAT CLASSI C; Bonferroni CE, 1935, STUDI ONORE PROFESSO, P13; Brouta F, 2002, INFECT IMMUN, V70, P5676, DOI 10.1128/IAI.70.10.5676-5683.2002; Burmester A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r7; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Desjardins CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002345; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Durkin M, 2001, J INFECT DIS, V183, P1822, DOI 10.1086/320720; Ebersberger I, 2012, MOL BIOL EVOL, V29, P1319, DOI 10.1093/molbev/msr285; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galgiani JN, 1999, ANN INTERN MED, V130, P293, DOI 10.7326/0003-4819-130-4-199902160-00015; Gillespie J. H., 1991, CAUSES MOL EVOLUTION; Gillespie JP, 2000, ARCH INSECT BIOCHEM, V44, P49, DOI 10.1002/1520-6327(200006)44:2&lt;49::AID-ARCH1&gt;3.0.CO;2-F; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haydon DT, 2001, GENETICS, V157, P7; Hector RF, 2005, PLOS MED, V2, P15, DOI 10.1371/journal.pmed.0020002; Hori T, 2001, ACTA CRYSTALLOGR D, V57, P361, DOI 10.1107/S0907444900019740; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031536; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Marcet-Houben M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004357; MARKARYAN A, 1994, INFECT IMMUN, V62, P2149, DOI 10.1128/IAI.62.6.2149-2157.1994; Mathy A, 2010, VET MICROBIOL, V146, P179, DOI 10.1016/j.vetmic.2010.04.019; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Nielsen R, 1998, GENETICS, V148, P929; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sainudiin R, 2005, J MOL EVOL, V60, P315, DOI 10.1007/s00239-004-0153-1; Segurado M, 1999, INFECT IMMUN, V67, P2377, DOI 10.1128/IAI.67.5.2377-2382.1999; Sentandreu M, 1998, J BACTERIOL, V180, P282, DOI 10.1128/JB.180.2.282-289.1998; Sharpton TJ, 2009, GENOME RES, V19, P1722, DOI 10.1101/gr.087551.108; Soanes DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002300; Staib P, 2010, MICROBIOL-SGM, V156, P884, DOI 10.1099/mic.0.033464-0; STLEGER RJ, 1994, ARCH BIOCHEM BIOPHYS, V313, P1, DOI 10.1006/abbi.1994.1350; Suzuki Y, 2001, MOL BIOL EVOL, V18, P2179, DOI 10.1093/oxfordjournals.molbev.a003764; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Untereiner WA, 2004, MYCOLOGIA, V96, P812, DOI 10.2307/3762114; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044	55	416	423	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90225	10.1371/journal.pone.0090225	http://dx.doi.org/10.1371/journal.pone.0090225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24587291	gold, Green Published, Green Submitted			2022-12-25	WOS:000332396200149
J	Hermann, P; Romero, C; Schmidt, C; Reis, C; Zerr, I				Hermann, Peter; Romero, Carlos; Schmidt, Christian; Reis, Clemens; Zerr, Inga			CSF Biomarkers and Neuropsychological Profiles in Patients with Cerebral Small-Vessel Disease	PLOS ONE			English	Article							WHITE-MATTER CHANGES; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; NINDS-AIREN; DIAGNOSIS; CRITERIA; PROTEIN; TAU; MRI	Despite existing criteria, differential diagnosis of Vascular Dementia (VD) and Alzheimer's disease (AD) remains difficult. The aim of this study is to figure out cognitive and biomarker profiles that may help to distinguish between VD, AD and AD + Cerebral Small Vessel Disease (CSVD). We examined a cohort of patients with CSVD (n = 92). After stratification of cognitive impaired patients (n = 59) using the standard CSF beta-amyloid 42/40 ratio cut-off point of 0.975, we obtained two groups which differed with respect to several features: 32 patients with normal beta-amyloid 42/40 ratio (>0.975) showed markedly impaired blood-brain-barrier function as indicated by an elevated albumin ratio (median 8.35). They also differed in cognitive profiles when compared to 27 patients with AD typical beta-amyloid ratio and normal albumin ratio. We also enrolled an additional group of patients with AD (no significant CSVD on MRI, n = 27) which showed no impairment of the blood-brain-barrier. We showed a negative correlation between the albumin ratio and executive cognitive function (p = 0.016) and a negative correlation between memory function and typical AD markers like Tau (p = 0.004) and p181-Tau (p = 0.023) in our cohort. We suppose that the group of patients with normal beta-amyloid ratio represents VD while patients in the other groups represent AD+CSVD and pure AD. Our results support the idea that a dysfunction of the blood-brain-barrier might be contributing factor in the development of cognitive decline in CSVD as it seems to be of more importance than the severity of white matter lesions.	[Hermann, Peter; Schmidt, Christian; Reis, Clemens; Zerr, Inga] Univ Gottingen, Dementia Res Grp, Dept Neurol, D-37073 Gottingen, Germany; [Zerr, Inga] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Romero, Carlos] FLENI, Dept Neuroradiol, Buenos Aires, DF, Argentina; [Romero, Carlos] FLENI, Dept Neuropathol, Buenos Aires, DF, Argentina	University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Zerr, I (corresponding author), Univ Gottingen, Dementia Res Grp, Dept Neurol, D-37073 Gottingen, Germany.	ingazerr@med.uni-goettingen.de		Romero, Teresa/0000-0002-1245-9906	mobility exchange program BMBF [ARG 07/008]	mobility exchange program BMBF(Federal Ministry of Education & Research (BMBF))	Part of the study was supported by the mobility exchange program BMBF ARG 07/008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibl M, 2008, DEMENT GERIATR COGN, V25, P256, DOI 10.1159/000115975; Broderick DF, 2009, NEUROLOGY, V73, P1934, DOI 10.1212/WNL.0b013e3181bd6a46; Bronge L, 2003, PSYCHIAT RES-NEUROIM, V122, P199, DOI 10.1016/S0925-4927(03)00005-2; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Cavalieri M, 2010, NEURODEGENER DIS, V7, P122, DOI 10.1159/000285521; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; HACHINSKI VC, 1987, ARCH NEUROL-CHICAGO, V44, P21, DOI 10.1001/archneur.1987.00520130013009; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hu YY, 2002, AM J PATHOL, V160, P1269, DOI 10.1016/S0002-9440(10)62554-0; Jellinger KA, 2008, J ALZHEIMERS DIS, V14, P107; Jonsson M, 2010, EUR J NEUROL, V17, P377, DOI 10.1111/j.1468-1331.2009.02808.x; Lewczuk P, 2004, NEUROBIOL AGING, V25, P273, DOI 10.1016/S0197-4580(03)00086-1; Ma KC, 1997, CEREBROVASC DIS, V7, P324, DOI 10.1159/000108216; Nitkunan A, 2008, STROKE, V39, P1999, DOI 10.1161/STROKEAHA.107.507475; Pohjasvaara T, 2000, STROKE, V31, P2952, DOI 10.1161/01.STR.31.12.2952; Roman GC, 2002, LANCET NEUROL, V1, P426, DOI 10.1016/S1474-4422(02)00190-4; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Schmidtke K, 2002, J NEUROL SCI, V203, P17, DOI 10.1016/S0022-510X(02)00254-X; Silbert LC, 2009, NEUROLOGY, V73, P120, DOI 10.1212/WNL.0b013e3181ad53fd; Sjogren M, 2001, J NEUROSCI RES, V66, P510, DOI 10.1002/jnr.1242; Verdelho A, 2010, NEUROLOGY, V75, P160, DOI 10.1212/WNL.0b013e3181e7ca05; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318	23	39	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105000	10.1371/journal.pone.0105000	http://dx.doi.org/10.1371/journal.pone.0105000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147945	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600030
J	Zhang, YG; Qiu, L; Li, SJ; Xiang, YC; Chen, JY; Ren, YG				Zhang, Yiguo; Qiu, Lu; Li, Shaojun; Xiang, Yuancai; Chen, Jiayu; Ren, Yonggang			The C-Terminal Domain of Nrf1 Negatively Regulates the Full-Length CNC-bZIP Factor and Its Shorter Isoform LCR-F1/Nrf1 beta; Both Are Also Inhibited by the Small Dominant-Negative Nrf1 gamma/delta Isoforms that Down-Regulate ARE-Battery Gene Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF1; TNF-ALPHA PROMOTER; OXIDATIVE STRESS; PROTEASOMAL DEGRADATION; ENDOPLASMIC-RETICULUM; TARGETED DISRUPTION; EMBRYONIC LETHALITY; BINDING DOMAIN; BETA-TRCP; KEAP1	The C-terminal domain (CTD, aa 686-741) of nuclear factor-erythroid 2 p45-related factor 1 (Nrf1) shares 53% amino acid sequence identity with the equivalent Neh3 domain of Nrf2, a homologous transcription factor. The Neh3 positively regulates Nrf2, but whether the Neh3-like (Neh3L) CTD of Nrf1 has a similar role in regulating Nrf1-target gene expression is unknown. Herein, we report that CTD negatively regulates the full-length Nrf1 (i.e. 120-kDa glycoprotein and 95-kDa deglycoprotein) and its shorter isoform LCR-F1/Nrf1 beta (55-kDa). Attachment of its CTD-adjoining 112-aa to the C-terminus of Nrf2 yields the chimaeric Nrf2-C112(Nrf1) factor with a markedly decreased activity. Live-cell imaging of GFP-CTD reveals that the extra-nuclear portion of the fusion protein is allowed to associate with the endoplasmic reticulum (ER) membrane through the amphipathic Neh3L region of Nrf1 and its basic c-tail. Thus removal of either the entire CTD or the essential Neh3L portion within CTD from Nrf1, LCR-F1/Nrf1 beta and Nrf2-C112(Nrf1), results in an increase in their transcriptional ability to regulate antioxidant response element (ARE)-driven reporter genes. Further examinations unravel that two smaller isoforms, 36-kDa Nrf1 gamma and 25-kDa Nrf1 delta, act as dominant-negative inhibitors to compete against Nrf1, LCR-F1/Nrf1 beta and Nrf2. Relative to Nrf1, LCR-F1/Nrf1 beta is a weak activator, that is positively regulated by its Asn/Ser/Thr-rich (NST) domain and acidic domain 2 (AD2). Like AD1 of Nrf1, both AD2 and NST domain of LCR-F1/Nrf1 beta fused within two different chimaeric contexts to yield Gal4D:Nrf1 beta(607) and Nrf1 beta:C270(Nrf2), positively regulate their transactivation activity of cognate Gal4- and Nrf2-target reporter genes. More importantly, differential expression of endogenous ARE-battery genes is attributable to up-regulation by Nrf1 and LCR-F1/Nrf1 beta and down-regulation by Nrf1 gamma and Nrf1 delta.	[Zhang, Yiguo] Chongqing Univ, Coll Med Bioengn, Lab Cell Biochem & Gene Regulat, Chongqing 630044, Peoples R China; Chongqing Univ, Fac Life Sci, Chongqing 630044, Peoples R China	Chongqing University; Chongqing University	Zhang, YG (corresponding author), Chongqing Univ, Coll Med Bioengn, Lab Cell Biochem & Gene Regulat, Chongqing 630044, Peoples R China.	yiguozhang@cqu.edu.cn		Jia, Jianping/0000-0003-4624-0336; Zhang, Yujuan/0000-0002-3243-1644; Zhang, Yiguo/0000-0003-3910-2779; Hayes, John/0000-0002-2927-5548	National Natural Science Foundation of China [91129703, 31270879]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (key program 91129703 and project 31270879) awarded to Prof. Yiguo Zhang (University of Chongqing, China). The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Bean TL, 1997, NUCLEIC ACIDS RES, V25, P2509, DOI 10.1093/nar/25.12.2509; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen LY, 2003, MOL CELL BIOL, V23, P4673, DOI 10.1128/MCB.23.13.4673-4686.2003; Chepelev NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029167; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Farmer SC, 1997, GENE DEV, V11, P786, DOI 10.1101/gad.11.6.786; Grimberg KB, 2011, MOL CELL BIOL, V31, P897, DOI 10.1128/MCB.00799-10; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Hirotsu Y, 2012, MOL CELL BIOL, V32, P2760, DOI 10.1128/MCB.06706-11; Huang CF, 2000, J BIOL CHEM, V275, P12313, DOI 10.1074/jbc.275.16.12313; Husberg C, 2001, J BIOL CHEM, V276, P17641, DOI 10.1074/jbc.M007951200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Johnsen O, 1996, NUCLEIC ACIDS RES, V24, P4289, DOI 10.1093/nar/24.21.4289; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kim J, 2010, PHYSIOL GENOMICS, V40, P100, DOI 10.1152/physiolgenomics.00105.2009; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2011, GENES CELLS, V16, P692, DOI 10.1111/j.1365-2443.2011.01522.x; Koch A, 2011, CELL CYCLE, V10, P1200, DOI 10.4161/cc.10.8.15327; Kusunoki H, 2002, NAT STRUCT BIOL, V9, P252, DOI 10.1038/nsb771; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Kwong EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048404; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Li X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002119; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; LUNA L, 1994, GENOMICS, V22, P553, DOI 10.1006/geno.1994.1428; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Nioi P, 2005, MOL CELL BIOL, V25, P10895, DOI 10.1128/MCB.25.24.10895-10906.2005; Novotny V, 1998, NUCLEIC ACIDS RES, V26, P5480, DOI 10.1093/nar/26.23.5480; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Prieschl EE, 1998, NUCLEIC ACIDS RES, V26, P2291, DOI 10.1093/nar/26.10.2291; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Rupert PB, 1998, NAT STRUCT BIOL, V5, P484, DOI 10.1038/nsb0698-484; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; SAKURAI A, 1990, MOL ENDOCRINOL, V4, P1988, DOI 10.1210/mend-4-12-1988; Schultz MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087204; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Tsuchiya Y, 2013, MOL CELL BIOL, V33, P3461, DOI 10.1128/MCB.01271-12; Tsuchiya Y, 2011, MOL CELL BIOL, V31, P4500, DOI 10.1128/MCB.05663-11; Wang HY, 2013, CANCER RES, V73, P3097, DOI 10.1158/0008-5472.CAN-12-3386; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Wu JL, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-9; Xiao H, 2013, CURR CHEM BIOL, V7, P151, DOI [DOI 10.2174/2212796811307020008, 10.2174/2212796811307020008]; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Zhang J, 2007, BIOCHEM J, V404, P459, DOI 10.1042/BJ20061611; Zhang Y, 2014, MS1305858; Zhang YG, 2001, J BIOL CHEM, V276, P11775, DOI 10.1074/jbc.M006000200; Zhang Y, 2007, BIOCHEM J, V408, P161, DOI 10.1042/BJ20070761; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhang YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093458; Zhang YG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02006; Zhang YG, 2009, BIOCHEM J, V418, P293, DOI 10.1042/BJ20081575; Zhang Y, 2009, J BIOL CHEM, V284, P3195, DOI 10.1074/jbc.M805337200; [张玉台 Zhang Yutai], 2009, [管理世界, Management World], P1; Zhong YW, 2012, J BIOL CHEM, V287, P28057, DOI 10.1074/jbc.M112.381798	71	446	470	16	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109159	10.1371/journal.pone.0109159	http://dx.doi.org/10.1371/journal.pone.0109159			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290918	Green Published, gold, Green Submitted			2022-12-25	WOS:000342798000041
J	Zhang, YJ; Wang, DM; Yang, LN; Zhou, D; Zhang, JF				Zhang, Yujuan; Wang, Dongmei; Yang, Lina; Zhou, Dan; Zhang, Jingfang			Purification and Characterization of Flavonoids from the Leaves of Zanthoxylum bungeanum and Correlation between Their Structure and Antioxidant Activity	PLOS ONE			English	Article							ALDOSE REDUCTASE; DNA-DAMAGE; EXTRACTS; ALKYLAMIDES; PROTECTION; PERICARPS; QUERCETIN; CHROMATOGRAPHY; CONSTITUENTS; INHIBITION	Nine flavonoids were isolated and characterized from the leaves of Zanthoxylum bungeanum. Their structures were elucidated by spectroscopic techniques as quercetin (1), afzelin (2), quercitrin (3), trifolin (4), quercetin-3-O-beta-D-glucoside (5), isorhamnetin 3-O-alpha-L-rhamnoside (6), hyperoside (7), vitexin (8) and rutin (9). All compounds were isolated from the leaves of Z. bungeanum for the first time. Five compounds (2, 4, 5, 6 and 8) were found for the first time in the genus Zanthoxylum. To learn the mechanisms underlying its health benefits, in vitro (DPPH, ABTS, FRAP and lipid peroxidation inhibition assays) and in vivo (protective effect on Escherichia coli under peroxide stress) antioxidant activities of the nine flavonoids were measured. Quercetin and quercetin glycosides (compounds 1, 3, 5, 7, 9) showed the highest antioxidant activity. Structure-activity relationships indicated that the -OH in 49 position on the B ring and the -OH in 7 position on the A ring possessed high antioxidant activity; B ring and/or A ring with adjacent -OH groups could greatly increase their antioxidant ability. Also, due to the different structures of various flavonoids, they will certainly exhibit different antioxidant capacity when the reactions occur in solution or in oil-in-water emulsion. These findings suggest that Z. bungeanum leaves may have health benefits when consumed. It could become a useful supplement for pharmaceutical products and functional food ingredients in both nutraceutical and food industries as a potential source of natural antioxidants.	[Zhang, Yujuan; Wang, Dongmei; Yang, Lina; Zhou, Dan; Zhang, Jingfang] Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China	Northwest A&F University - China	Wang, DM (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China.	dmwli@163.com		Jia, Jianping/0000-0003-4624-0336; Zhang, Yujuan/0000-0002-3243-1644; Zhang, Yiguo/0000-0003-3910-2779; Hayes, John/0000-0002-2927-5548	Special Fund for Forestry Scientific Research in the Public Interest of China [201304811]; Fundamental Research Funds for the Central Universities [ZD2013010]	Special Fund for Forestry Scientific Research in the Public Interest of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors are grateful to the research fund from the Special Fund for Forestry Scientific Research in the Public Interest of China (201304811) and the Fundamental Research Funds for the Central Universities (ZD2013010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne SA, 2000, FREE RADICAL BIO MED, V29, P507, DOI 10.1016/S0891-5849(00)00360-9; Azimova SS, 2013, PHYSICOCHEMCIAL PHAR; Bauer R, 2011, CURR CLIN UROL, P191, DOI 10.1007/978-1-60327-420-3_10; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bourassa P, 2013, J PHOTOCH PHOTOBIO B, V128, P43, DOI 10.1016/j.jphotobiol.2013.07.021; Chang ZQ, 1981, ACTA PHARM SINICA, V16, P394; Costantino L, 1997, EXPERT OPIN THER PAT, V7, P843, DOI 10.1517/13543776.7.8.843; de Freitas V, 2001, J AGR FOOD CHEM, V49, P940, DOI 10.1021/jf000981z; Decker EA, 2005, J AGR FOOD CHEM, V53, P4303, DOI 10.1021/jf058012x; [邓振义 Deng Zhenyi], 2005, [西北林学院学报, Journal of Northwest Forestry College], V20, P179; Dhar P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-259; Dorman H. J. D., 1995, Journal of Essential Oil Research, V7, P645; Dubeau S, 2010, FOOD CHEM, V122, P539, DOI 10.1016/j.foodchem.2010.03.005; Duke J. A., 1985, MED PLANTS CHINA, P705; Ferrali M, 1997, FEBS LETT, V416, P123, DOI 10.1016/S0014-5793(97)01182-4; GALVEZ J, 1993, J PHARM PHARMACOL, V45, P157, DOI 10.1111/j.2042-7158.1993.tb03706.x; Gouveia S, 2012, PHYTOCHEM ANALYSIS, V23, P72, DOI 10.1002/pca.1326; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; HUANG XL, 1993, PHYTOTHER RES, V7, P41, DOI 10.1002/ptr.2650070111; Ibrahim LF, 2002, MOLECULES, V7, P245; Jung HA, 2011, FOOD CHEM TOXICOL, V49, P376, DOI 10.1016/j.fct.2010.11.012; KIMUYA Y, 1981, CHEM PHARM BULL, V29, P2610; Lee KW, 2003, J AGR FOOD CHEM, V51, P6516, DOI 10.1021/jf034475w; Li H, 2012, FOOD CHEM, V135, P2942, DOI 10.1016/j.foodchem.2012.07.048; Li Y, 2001, Zhong Yao Cai, V24, P572; Ma XF, 2005, J CHROMATOGR A, V1070, P211, DOI 10.1016/j.chroma.2005.02.052; Matsuda H, 2002, CHEM PHARM BULL, V50, P788, DOI 10.1248/cpb.50.788; Melidou M, 2005, FREE RADICAL BIO MED, V39, P1591, DOI 10.1016/j.freeradbiomed.2005.08.009; Miguel G, 2004, FOOD CHEM, V86, P183, DOI 10.1016/j.foodchem.2003.08.031; MIZUTANI K, 1988, CHEM PHARM BULL, V36, P2362, DOI 10.1248/cpb.36.2362; Nassar M. I., 2010, Revista Latinoamericana de Quimica, V38, P103; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; OSHIMA R, 1982, CARBOHYD RES, V107, P169, DOI 10.1016/S0008-6215(00)80536-4; Rastelli G, 2000, BIOORGAN MED CHEM, V8, P1151, DOI 10.1016/S0968-0896(00)00052-3; Ren L, 1981, XAOXUE XUEBAO, V16, P672; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rodriguez P, 2010, FITOTERAPIA, V81, P1220, DOI 10.1016/j.fitote.2010.08.007; Smirnova GV, 2010, WORLD J MICROB BIOT, V26, P2269, DOI 10.1007/s11274-010-0417-4; Smirnova GV, 2009, FREE RADICAL BIO MED, V46, P759, DOI 10.1016/j.freeradbiomed.2008.11.017; Tachakittirungrod S, 2007, FOOD CHEM, V103, P381, DOI 10.1016/j.foodchem.2006.07.034; Tirillini B., 1994, Journal of Essential Oil Research, V6, P249; TK Lim, 2012, ZANTHOXYLUM SIMULANS, P904; Urzhumtsev A, 1997, STRUCTURE, V5, P601, DOI 10.1016/S0969-2126(97)00216-5; Wang DM, 2013, ALLELOPATHY J, V32, P67; Wang S, 2011, J LIQ CHROMATOGR R T, V34, P2640, DOI 10.1080/10826076.2011.593219; Watjen W, 2005, J NUTR, V135, P525, DOI 10.1093/jn/135.3.525; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; XIONG QB, 1995, PHYTOCHEMISTRY, V39, P723, DOI 10.1016/0031-9422(94)00965-V; Xiong QB, 1997, PHYTOCHEMISTRY, V46, P1123, DOI 10.1016/S0031-9422(97)84398-1; Xu HR, 2010, TEXTBOOK OF PERINATAL EPIDEMIOLOGY, P111; Yang LC, 2013, J AGR FOOD CHEM, V61, P1772, DOI 10.1021/jf3042825; Yang XG, 2008, J AGR FOOD CHEM, V56, P1689, DOI 10.1021/jf0728101; YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007; Yeung H., 1985, HDB CHINESE HERBS FO, VVolume 1; Zhou X, 2005, J CHROMATOGR A, V1092, P216, DOI 10.1016/j.chroma.2005.07.064	56	446	470	16	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105725	10.1371/journal.pone.0105725	http://dx.doi.org/10.1371/journal.pone.0105725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25290918	Green Submitted, Green Published, gold			2022-12-25	WOS:000341303200055
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24941042	gold, Green Published, Green Submitted			2022-12-25	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon R. T., 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/NCLIMATE1958, 10.1038/nclimate1958]; R Core Team, 2021, R LANG ENV STAT COMP; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24941042	Green Published, gold, Green Accepted			2022-12-25	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000343943100017
